Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000451.3(SHOX):c.544+1G>A	SHOX		Short stature, idiopathic, X-linked	Pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	VCV000374328	X	601614	X	640879	374328	361265	rs1057518701	NC_000024.10:640878:G:A
NM_000451.3(SHOX):c.-646_-645insTGT	SHOX		Short stature, idiopathic, X-linked	Pathogenic	no assertion criteria provided	VCV000191363	X	585123 - 585124	X	624388 - 624389	191363	189166	rs1556450972	NC_000024.10:624388:TT:TTGTT
NM_006883.2(SHOX):c.633+3382_633+3384delinsAG	SHOX		not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000448378	X	605204 - 605206	X	644469 - 644471	448378	442468	rs1556468777	NC_000024.10:644468:TAC:AG
NM_000451.3(SHOX):c.528G>C (p.Glu176Asp)	SHOX	E176D	Short stature, idiopathic, X-linked	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	VCV000265858	X	601597	X	640862	265858	260558	rs778921118	NC_000024.10:640861:G:C
NM_000451.3(SHOX):c.728dup (p.Pro244fs)	SHOX		Langer mesomelic dysplasia syndrome	Pathogenic(Last reviewed: Jun 15, 2002)	no assertion criteria provided	VCV000009880	X	605214 - 605215	X	644479 - 644480	9880	24919		NC_000024.10:644479:CCCCCC:CCCCCCC
NM_000451.3(SHOX):c.509C>A (p.Ala170Asp)	SHOX	A170D		Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029995	X	601578	X	640843	29995	38950	rs397514462	NC_000024.10:640842:C:A
NM_000451.3(SHOX):c.877T>C (p.Ter293Arg)	SHOX	*293R		Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000009883	X	605369	X	644634	9883	24922	rs137852559	NC_000024.10:644633:T:C
SHOX, 1-BP DEL, 1272G	SHOX			Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000009877					9877	24916		
NM_000451.3(SHOX):c.597C>G (p.Tyr199Ter)	SHOX	Y199*		Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000009873	X	601786	X	641051	9873	24912	rs137852553	NC_000024.10:641050:C:G
NM_000451.3(SHOX):c.728del (p.Pro243fs)	SHOX	P243fs	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000805452	X	605215	X	644480	805452	793898		NC_000024.10:644479:CCCCCC:CCCCC
SHOX, 47.5-KB DEL, DOWNSTREAM ENHANCER	SHOX		Short stature, idiopathic, X-linked|	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000066087					66087	76989		
NM_000451.3(SHOX):c.508G>C (p.Ala170Pro)	SHOX	A170P	Langer mesomelic dysplasia syndrome|	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029994	X	601577	X	640842	29994	38949	rs397514461	NC_000024.10:640841:G:C
SHOX, 1.1-MB DEL	SHOX		|Langer mesomelic dysplasia syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000009884					9884	24923		
NM_000451.3(SHOX):c.502C>T (p.Arg168Trp)	SHOX	R168W	Langer mesomelic dysplasia syndrome|	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000009879	X	601571	X	640836	9879	24918	rs137852557	NC_000024.10:640835:C:T
NM_000451.3(SHOX):c.517C>T (p.Arg173Cys)	SHOX	R173C	|not provided	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000009878	X	601586	X	640851	9878	24917	rs137852556	NC_000024.10:640850:C:T
SHOX, DEL	SHOX		Langer mesomelic dysplasia syndrome|	Pathogenic(Last reviewed: Jun 15, 2002)	no assertion criteria provided	VCV000009874					9874	24913		
NM_000451.3(SHOX):c.583C>T (p.Arg195Ter)	SHOX	R195*	Short stature, idiopathic, X-linked|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000009872	X	601772	X	641037	9872	24911	rs137852552	NC_000024.10:641036:C:T
NM_001031.5(RPS28):c.1A>G (p.Met1Val)	RPS28	M1V	Diamond-Blackfan anemia 15 with mandibulofacial dysostosis	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000187848	19	8386415	19	8321531	187848	185739	rs786203997	NC_000019.10:8321530:A:G
NM_001080472.4(FITM2):c.694G>A (p.Gly232Arg)	FITM2	G232R	SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692232	20	42935360	20	44306720	692232	680036		NC_000020.11:44306719:C:T
NM_001080472.4(FITM2):c.652C>T (p.Gln218Ter)	FITM2	Q218*	SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692231	20	42935402	20	44306762	692231	680035		NC_000020.11:44306761:G:A
NM_001080472.4(FITM2):c.39dup (p.Thr14fs)	FITM2		SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692230	20	42939750	20	44311109 - 44311110	692230	680034		NC_000020.11:44311109:CCCCC:CCCCCC
NM_001080472.4(FITM2):c.4G>T (p.Glu2Ter)	FITM2	E2*	SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692229	20	42939785	20	44311145	692229	680033		NC_000020.11:44311144:C:A
NM_001252.5(CD70):c.552_554CTT[1] (p.Phe186del)	CD70	F186del	Severe combined immunodeficiency due to CD70 deficiency	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599339	19	6586056 - 6586058	19	6586045 - 6586047	599339	590636	rs1568431102	NC_000019.10:6586044:AAGAAG:AAG
NM_001252.5(CD70):c.250del (p.Ser84fs)	CD70	S84fs	Severe combined immunodeficiency due to CD70 deficiency	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599338	19	6586363	19	6586352	599338	590635	rs1568431262	NC_000019.10:6586351:A:
NM_001252.5(CD70):c.535C>T (p.Arg179Ter)	CD70	R179*	Severe combined immunodeficiency due to CD70 deficiency	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599337	19	6586078	19	6586067	599337	590634	rs368303189	NC_000019.10:6586066:G:A
NM_178526.5(SLC25A42):c.380+2T>A	SLC25A42		METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627557	19	19216538	19	19105729	627557	615912	rs1247424432	NC_000019.10:19105728:T:A
NM_006179.4(NTF4):c.617G>A (p.Arg206Gln)	NTF4	R206Q	Glaucoma 1, open angle, O	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000014019	19	49564638	19	49061381	14019	29058	rs121918428	NC_000019.10:49061380:C:T
NM_004218.4(RAB11B):c.202G>A (p.Ala68Thr)	RAB11B	A68T	NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000453255	19	8464908	19	8400024	453255	446837	rs1555690804	NC_000019.10:8400023:G:A
NM_022829.6(SLC13A3):c.1016+3A>G	SLC13A3		LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625426	20	45217796	20	46589157	625426	613740	rs199961976	NC_000020.11:46589156:T:C
NM_022829.6(SLC13A3):c.1642G>A (p.Gly548Ser)	SLC13A3	G548S, G501S, G498S, G466S, G450S	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625425	20	45188828	20	46560189	625425	613739	rs1568904872	NC_000020.11:46560188:C:T
NM_022829.6(SLC13A3):c.761C>A (p.Ala254Asp)	SLC13A3	A254D, A207D, A156D, P232T	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625424	20	45224829	20	46596190	625424	613738	rs1568927501	NC_000020.11:46596189:G:T
NM_001001563.5(TIMM50):c.715C>T (p.Arg239Trp)	TIMM50	R342W, R239W, R126W		Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000488623	19	39978719	19	39488079	488623	481491	rs1449758112	NC_000019.10:39488078:C:T
NM_001001563.5(TIMM50):c.664G>A (p.Ala222Thr)	TIMM50	A325T, A222T, A109T		Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000488622	19	39977103	19	39486463	488622	481490	rs1305711807	NC_000019.10:39486462:G:A
NM_001915.4(CYB561):c.131G>A (p.Trp44Ter)	CYB561	W44*, W51*	ORTHOSTATIC HYPOTENSION 2	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590764	17	61514778	17	63437417	590764	581701	rs1437737028	NC_000017.11:63437416:C:T
NM_001915.4(CYB561):c.262G>A (p.Gly88Arg)	CYB561	G88R, G95R	ORTHOSTATIC HYPOTENSION 2	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590763	17	61513454	17	63436093	590763	581700	rs772361572	NC_000017.11:63436092:C:T
NM_001001563.5(TIMM50):c.340C>T (p.Arg114Trp)	TIMM50	R217W, R114W		Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000440793	19	39976210	19	39485570	440793	434422	rs1300848445	NC_000019.10:39485569:C:T
NM_001001563.5(TIMM50):c.446C>T (p.Thr149Met)	TIMM50	T252M, T149M, T36M		Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000440792	19	39976401	19	39485761	440792	434421	rs1244226820	NC_000019.10:39485760:C:T
NM_005543.4(INSL3):c.217C>T (p.Arg73Ter)	INSL3	R49*, R73*	Cryptorchidism	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000037092	19	17927842	19	17817033	37092	45767	rs398122886	NC_000019.10:17817032:G:A
NM_005543.4(INSL3):c.305G>A (p.Arg102His)	INSL3	R102H, A134T	Cryptorchidism	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014832	19	17927754	19	17816945	14832	29871	rs121912556	NC_000019.10:17816944:C:T
NM_005543.4(INSL3):c.330C>G (p.Asn110Lys)	INSL3	N86K, N110K, T142S	Cryptorchidism	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000014829	19	17927729	19	17816920	14829	29868	rs121912555	NC_000019.10:17816919:G:C
NM_001001563.5(TIMM50):c.26C>A (p.Ser9Ter)	TIMM50	S112*, S9*	Mitochondrial encephalopathy	Pathogenic	criteria provided, single submitter	VCV000559480	19	39971519	19	39480879	559480	550204	rs35135520	NC_000019.10:39480878:C:A
NM_001001563.5(TIMM50):c.260G>C (p.Gly87Ala)	TIMM50	G190A, G87A	Mitochondrial encephalopathy	Pathogenic	criteria provided, single submitter	VCV000559479	19	39973525	19	39482885	559479	550203	rs776019250	NC_000019.10:39482884:G:C
NM_005543.4(INSL3):c.304C>T (p.Arg102Cys)	INSL3	R102C	Cryptorchidism	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014831	19	17927755	19	17816946	14831	29870	rs104894698	NC_000019.10:17816945:G:A
NM_005543.4(INSL3):c.278C>T (p.Pro93Leu)	INSL3	P93L, P125S	Cryptorchidism	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014830	19	17927781	19	17816972	14830	29869	rs104894697	NC_000019.10:17816971:G:A
NM_006003.3(UQCRFS1):c.41T>A (p.Val14Asp)	UQCRFS1	V14D	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10|Propionicacidemia|Lactic acidosis|Cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000619501	19	29703985	19	29213078	619501	610898	rs1568346416	NC_000019.10:29213077:A:T
NM_006003.3(UQCRFS1):c.610C>T (p.Arg204Ter)	UQCRFS1	R204*	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10|Propionicacidemia|Lactic acidosis|Cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000619499	19	29698670	19	29207763	619499	610896	rs1242465339	NC_000019.10:29207762:G:A
NM_006003.3(UQCRFS1):c.215-1G>C	UQCRFS1		MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10|Propionicacidemia|Lactic acidosis|Cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000619297	19	29699066	19	29208159	619297	610695	rs1568344751	NC_000019.10:29208158:C:G
NM_205767.2(MICOS13):c.30-1G>A	MICOS13		Combined oxidative phosphorylation deficiency 37	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000619099	19	5679775	19	5679764	619099	610497	rs1568293849	NC_000019.10:5679763:C:T
NM_138761.4(BAX):c.115_121del (p.Gly39fs)	BAX	G2fs, G39fs	T-cell acute lymphoblastic leukemia	Pathogenic(Last reviewed: Apr 15, 1998)	no assertion criteria provided	VCV000009514	19	49458971 - 49458977	19	48955714 - 48955720	9514	24553	rs398122840	NC_000019.10:48955713:GGGGGGGG:G
NM_138761.4(BAX):c.199G>A (p.Gly67Arg)	BAX	G67R, G30R	T-cell acute lymphoblastic leukemia	Pathogenic(Last reviewed: Apr 15, 1998)	no assertion criteria provided	VCV000009513	19	49459056	19	48955799	9513	24552	rs398122513	NC_000019.10:48955798:G:A
NM_002250.3(KCNN4):c.845T>A (p.Val282Glu)	KCNN4	V282E	Dehydrated hereditary stomatocytosis 2	Pathogenic(Last reviewed: Dec 11, 2015)	no assertion criteria provided	VCV000372186	19	44273956	19	43769804	372186	359091	rs1057519077	NC_000019.10:43769803:A:T
NM_002250.3(KCNN4):c.1055G>A (p.Arg352His)	KCNN4	R352H	not provided|Dehydrated hereditary stomatocytosis 2	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000252601	19	44273179	19	43769027	252601	247170	rs774455945	NC_000019.10:43769026:C:T
NM_002250.3(KCNN4):c.844G>A (p.Val282Met)	KCNN4	V282M	Dehydrated hereditary stomatocytosis 2	Pathogenic(Last reviewed: Dec 11, 2015)	no assertion criteria provided	VCV000372185	19	44273957	19	43769805	372185	359090	rs1057519076	NC_000019.10:43769804:C:T
NM_024656.4(COLGALT1):c.1129G>C (p.Gly377Arg)	COLGALT1	G377R	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000623641	19	17688272	19	17577463	623641	612466	rs1568481244	NC_000019.10:17577462:G:C
NM_024656.4(COLGALT1):c.460G>C (p.Ala154Pro)	COLGALT1	A154P	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000623640	19	17671245	19	17560436	623640	612465	rs181844791	NC_000019.10:17560435:G:C
NM_024656.4(COLGALT1):c.1096del (p.Glu366fs)	COLGALT1	E366fs	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Mar 21, 2019)	no assertion criteria provided	VCV000623639	19	17688238	19	17577429	623639	612464	rs1568481204	NC_000019.10:17577428:GG:G
NM_024656.4(COLGALT1):c.452T>G (p.Leu151Arg)	COLGALT1	L151R	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Mar 21, 2019)	no assertion criteria provided	VCV000623638	19	17671237	19	17560428	623638	612463	rs1478523191	NC_000019.10:17560427:T:G
NM_001282933.2(ZNF341):c.1083del (p.Lys362fs)	ZNF341	K272fs, K355fs, K362fs	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000599412	20	32349722	20	33761916	599412	590749	rs1568945329	NC_000020.11:33761915:G:
NM_001282933.2(ZNF341):c.583C>T (p.Gln195Ter)	ZNF341	Q195*, Q105*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599414	20	32341071	20	33753265	599414	590751	rs1568940507	NC_000020.11:33753264:C:T
NM_001282933.2(ZNF341):c.1647C>G (p.Tyr549Ter)	ZNF341	Y542*, Y549*, Y459*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599413	20	32369121	20	33781315	599413	590750	rs376598954	NC_000020.11:33781314:C:G
NM_001282933.2(ZNF341):c.1156C>T (p.Arg386Ter)	ZNF341	R386*, R379*, R296*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599411	20	32349795	20	33761989	599411	590748	rs982121798	NC_000020.11:33761988:C:T
NM_001282933.2(ZNF341):c.904C>T (p.Arg302Ter)	ZNF341	R302*, R212*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599410	20	32345116	20	33757310	599410	590747	rs746141726	NC_000020.11:33757309:C:T
NM_178526.5(SLC25A42):c.871A>G (p.Asn291Asp)	SLC25A42	N291D	Mitochondrial myopathy|SLC25A42-related mitochondrial disorder|METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219191	19	19221599	19	19110790	219191	217217	rs864321624	NC_000019.10:19110789:A:G
NM_021102.4(SPINT2):c.447G>A (p.Trp149Ter)	SPINT2	W149*, W92*	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Jun 27, 2019)	no assertion criteria provided	VCV000635284	19	38780814	19	38290174	635284	623118		NC_000019.10:38290173:G:A
NM_080675.4(SUN5):c.851C>G (p.Ser284Ter)	SUN5	S284*	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268052	20	31573588	20	32985782	268052	263462	rs886041025	NC_000020.11:32985781:G:C
NM_080675.4(SUN5):c.781G>A (p.Val261Met)	SUN5	V261M	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268051	20	31573658	20	32985852	268051	263461	rs886041024	NC_000020.11:32985851:C:T
NM_080675.4(SUN5):c.381del (p.Val128fs)	SUN5	V128fs	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268050	20	31585453	20	32997647	268050	263460	rs781693813	NC_000020.11:32997646:TTT:TT
NM_080675.4(SUN5):c.485T>A (p.Met162Lys)	SUN5	M162K	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268049	20	31583474	20	32995668	268049	263459	rs886041023	NC_000020.11:32995667:A:T
NM_080675.4(SUN5):c.1066C>T (p.Arg356Cys)	SUN5	R356C	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268048	20	31571674	20	32983868	268048	263458	rs754130052	NC_000020.11:32983867:G:A
NM_080675.4(SUN5):c.824C>T (p.Thr275Met)	SUN5	T275M	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268047	20	31573615	20	32985809	268047	263457	rs756459525	NC_000020.11:32985808:G:A
NM_133171.5(ELMO2):c.2080del (p.Leu694fs)	ELMO2	L606fs, L694fs	Vascular malformation, primary intraosseous	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254193	20	44996082	20	46367443	254193	248708	rs886037919	NC_000020.11:46367442:GG:G
NM_133171.5(ELMO2):c.1802-1G>C	ELMO2		Vascular malformation, primary intraosseous	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254192	20	44999165	20	46370526	254192	248707	rs886037918	NC_000020.11:46370525:C:G
NM_021102.4(SPINT2):c.502G>A (p.Gly168Ser)	SPINT2	G168S, G111S	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000157607	19	38780869	19	38290229	157607	167467	rs606231284	NC_000019.10:38290228:G:A
NM_021102.4(SPINT2):c.1A>T (p.Met1Leu)	SPINT2	M1L	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005208	19	38755533	19	38264893	5208	20247	rs121908404	NC_000019.10:38264892:A:T
NM_021102.4(SPINT2):c.553+2T>A	SPINT2		Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005207	19	38780922	19	38290282	5207	20246	rs112576957	NC_000019.10:38290281:T:A
NM_021102.4(SPINT2):c.337+2T>C	SPINT2		Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005206	19	38778577	19	38287937	5206	20245	rs606231155	NC_000019.10:38287936:T:C
NM_133171.5(ELMO2):c.1065+1G>A	ELMO2		Vascular malformation, primary intraosseous	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254191	20	45003874	20	46375235	254191	248706	rs768410753	NC_000020.11:46375234:C:T
NM_021102.4(SPINT2):c.593-1G>A	SPINT2		Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005204	19	38782479	19	38291839	5204	20243	rs606231154	NC_000019.10:38291838:G:A
NM_021102.4(SPINT2):c.488A>G (p.Tyr163Cys)	SPINT2	Y163C, Y106C	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000005205	19	38780855	19	38290215	5205	20244	rs121908403	NC_000019.10:38290214:A:G
NM_080476.4(PIGU):c.1149C>A (p.Asn383Lys)	PIGU	N383K	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 21	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000689724	20	33162953	20	34575149	689724	677402		NC_000020.11:34575148:G:T
NM_080476.4(PIGU):c.209T>A (p.Ile70Lys)	PIGU	I70K	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 21	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000689723	20	33233125	20	34645321	689723	677401		NC_000020.11:34645320:A:T
NM_176812.5(CHMP4B):c.386A>T (p.Asp129Val)	CHMP4B	D129V		Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001085	20	32438775	20	33850969	1085	16124	rs118203965	NC_000020.11:33850968:A:T
NM_176812.5(CHMP4B):c.481G>A (p.Glu161Lys)	CHMP4B	E161K		Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001086	20	32438870	20	33851064	1086	16125	rs118203966	NC_000020.11:33851063:G:A
NM_001454.4(FOXJ1):c.967del (p.Glu323fs)	FOXJ1	E323fs	CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800281	17	74133733	17	76137652	800281	788387		NC_000017.11:76137651:CCCC:CCC
NM_001454.4(FOXJ1):c.826C>T (p.Gln276Ter)	FOXJ1	Q276*	CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800280	17	74133874	17	76137793	800280	788386		NC_000017.11:76137792:G:A
NM_001454.4(FOXJ1):c.868_871dup (p.Thr291fs)	FOXJ1		CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800279	17	74133828 - 74133829	17	76137747 - 76137748	800279	788385		NC_000017.11:76137747:TGCT:TGCTTGCT
NM_001454.4(FOXJ1):c.901G>T (p.Glu301Ter)	FOXJ1	E301*	CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800278	17	74133799	17	76137718	800278	788384		NC_000017.11:76137717:C:A
NM_032134.2(QRICH2):c.3037C>T (p.Arg1013Ter)	QRICH2	R1013*	SPERMATOGENIC FAILURE 35	Pathogenic(Last reviewed: Oct 7, 2019)	no assertion criteria provided	VCV000619118	17	74287273	17	76291192	619118	610513	rs777214459	NC_000017.11:76291191:G:A
NM_032134.2(QRICH2):c.192G>A (p.Trp64Ter)	QRICH2	L64*, W64*	SPERMATOGENIC FAILURE 35	Pathogenic(Last reviewed: Oct 7, 2019)	no assertion criteria provided	VCV000619117	17	74300511	17	76304430	619117	610512	rs1567790522	NC_000017.11:76304429:C:T
NM_172341.4(PSENEN):c.62-1G>C	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446486	19	36237319	19	35746418	446486	440001	rs1555738836	NC_000019.10:35746417:G:C
NM_172341.4(PSENEN):c.167-2A>G	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446485	19	36237607	19	35746706	446485	440000	rs1555738903	NC_000019.10:35746705:A:G
NM_172341.4(PSENEN):c.35T>A (p.Leu12Ter)	PSENEN	L12*	Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446483	19	36236866	19	35745965	446483	439998	rs1555738763	NC_000019.10:35745964:T:A
NM_172341.3(PSENEN):c.66dup (p.Phe23Valfs)	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446482	19	36237318 - 36237319	19	35746417 - 35746418	446482	439997	rs1555738837	NC_000019.10:35746417:GGGGGG:GGGGGGG
NM_172341.4(PSENEN):c.279del (p.Phe94fs)	PSENEN	F94fs	Acne inversa, familial, 2	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000030682	19	36237720	19	35746819	30682	39639	rs1555738943	NC_000019.10:35746818:CC:C
NM_000961.4(PTGIS):c.1358+2T>C	PTGIS		Essential hypertension	Pathogenic(Last reviewed: Oct 11, 2002)	no assertion criteria provided	VCV000007864	20	48127563	20	49511026	7864	22903	rs13306026	NC_000020.11:49511025:A:G
NM_172341.4(PSENEN):c.194T>G (p.Leu65Arg)	PSENEN	L65R	Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446484	19	36237636	19	35746735	446484	439999	rs1555738906	NC_000019.10:35746734:T:G
NM_172341.3(PSENEN):c.66del (p.Phe23Leufs)	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000030681	19	36237319	19	35746418	30681	39638	rs1555738837	NC_000019.10:35746417:GGGGGG:GGGGG
NM_031310.3(PLVAP):c.101T>C (p.Leu34Pro)	PLVAP	L34P	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590328	19	17487997	19	17377188	590328	581267	rs1568378665	NC_000019.10:17377187:A:G
NM_031310.3(PLVAP):c.988C>T (p.Gln330Ter)	PLVAP	Q330*	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000590327	19	17476286	19	17365477	590327	581266	rs199712527	NC_000019.10:17365476:G:A
NM_031310.3(PLVAP):c.1072C>T (p.Arg358Ter)	PLVAP	R358*	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000590326	19	17476202	19	17365393	590326	581265	rs761158492	NC_000019.10:17365392:G:A
NM_024844.5(NUP85):c.405+1G>A	NUP85		NEPHROTIC SYNDROME, TYPE 17	Pathogenic(Last reviewed: Nov 12, 2018)	no assertion criteria provided	VCV000590317	17	73209215	17	75213120	590317	581256	rs1568070817	NC_000017.11:75213119:G:A
NM_012478.4(WBP2):c.487A>C (p.Met163Leu)	WBP2	M163L	DEAFNESS, AUTOSOMAL RECESSIVE 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437833	17	73843922	17	75847841	437833	431408	rs1555604710	NC_000017.11:75847840:T:G
NM_012478.4(WBP2):c.671C>T (p.Ala224Val)	WBP2	A224V, A179V	DEAFNESS, AUTOSOMAL RECESSIVE 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437832	17	73843050	17	75846969	437832	431407	rs1555604549	NC_000017.11:75846968:G:A
NM_012478.4(WBP2):c.478G>A (p.Ala160Thr)	WBP2	A160T	DEAFNESS, AUTOSOMAL RECESSIVE 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437831	17	73843931	17	75847850	437831	431406	rs202022024	NC_000017.11:75847849:C:T
NM_004917.4(KLK4):c.245del (p.Gly82fs)	KLK4	G82fs	Amelogenesis imperfecta, hypomaturation type, IIA1	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000189294	19	51412065	19	50908809	189294	187180	rs786204825	NC_000019.10:50908808:CCC:CC
NM_004069.5(AP2S1):c.44G>T (p.Arg15Leu)	AP2S1	R15L, R31L, R17L	Hypocalciuric hypercalcemia, familial, type III	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039425	19	47349359	19	46846102	39425	48024	rs397514499	NC_000019.10:46846101:C:A
NM_004917.4(KLK4):c.458G>A (p.Trp153Ter)	KLK4	W153*, W58*	Amelogenesis imperfecta, hypomaturation type, IIA1	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000006079	19	51411852	19	50908596	6079	21118	rs104894704	NC_000019.10:50908595:C:T
NM_001098426.2(SMARCD2):c.401+2T>C	SMARCD2		Specific granule deficiency 2|Specific granule deficiency 1|Autosomal recessive severe congenital neutropenia	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000369731	17	61914799	17	63837439	369731	353957	rs1057518733	NC_000017.11:63837438:A:G
NM_001098426.2(SMARCD2):c.414_438dup (p.Gln147delinsGluAspGlyArgTer)	SMARCD2		Specific granule deficiency 2|Specific granule deficiency 1|Autosomal recessive severe congenital neutropenia	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000369730	17	61914560 - 61914561	17	63837200 - 63837201	369730	353956	rs1555580263	NC_000017.11:63837200:AGGTAGAACCTTATCTGCCATCTTC:AGGTAGAACCTTATCTGCCATCTTCAGGTAGAACCTTATCTGCCATCTTC
NM_001098426.2(SMARCD2):c.1181+1G>A	SMARCD2		Specific granule deficiency 2|Specific granule deficiency 1|Autosomal recessive severe congenital neutropenia	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000369729	17	61911268	17	63833908	369729	353955	rs1057518731	NC_000017.11:63833907:C:T
NM_004069.5(AP2S1):c.44G>A (p.Arg15His)	AP2S1	R15H, R31H, R17H	Hypocalciuric hypercalcemia, familial, type III|not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000039426	19	47349359	19	46846102	39426	48025	rs397514499	NC_000019.10:46846101:C:T
NM_004917.4(KLK4):c.632del (p.Leu211fs)	KLK4	L116fs, L211fs	not provided|Amelogenesis imperfecta, hypomaturation type, IIA1	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000288110	19	51410323	19	50907067	288110	272347	rs556734208	NC_000019.10:50907066:A:
NM_004069.5(AP2S1):c.43C>T (p.Arg15Cys)	AP2S1	R15C, R17C, R31C	Hypocalciuric hypercalcemia, familial, type III	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039424	19	47349360	19	46846103	39424	48023	rs397514498	NC_000019.10:46846102:G:A
NM_022482.5(GZF1):c.1054dup (p.Thr352fs)	GZF1		JOINT LAXITY, SHORT STATURE, AND MYOPIA	Pathogenic(Last reviewed: Sep 11, 2017)	no assertion criteria provided	VCV000438349	20	23346073 - 23346074	20	23365436 - 23365437	438349	431980	rs1555786729	NC_000020.11:23365436:A:AA
NM_022482.5(GZF1):c.865G>T (p.Glu289Ter)	GZF1	E289*	JOINT LAXITY, SHORT STATURE, AND MYOPIA	Pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000438348	20	23345885	20	23365248	438348	431979	rs1555786618	NC_000020.11:23365247:G:T
NM_138761.4(BAX):c.121del (p.Glu41fs)	BAX	E4fs, E41fs	Carcinoma of colon	Pathogenic(Last reviewed: Feb 14, 1997)	no assertion criteria provided	VCV000009512	19	49458971	19	48955714	9512	24551	rs398122840	NC_000019.10:48955713:GGGGGGGG:GGGGGGG
NM_138761.4(BAX):c.121dup (p.Glu41fs)	BAX		Carcinoma of colon	Pathogenic(Last reviewed: Feb 14, 1997)	no assertion criteria provided	VCV000009511	19	49458970 - 49458971	19	48955713 - 48955714	9511	24550	rs398122840	NC_000019.10:48955713:GGGGGGGG:GGGGGGGGG
NM_033550.4(TP53RK):c.728G>T (p.Arg243Leu)	TP53RK	R243L	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444883	20	45315426	20	46686787	444883	438525	rs776588426	NC_000020.11:46686786:C:A
NM_033550.4(TP53RK):c.125G>A (p.Gly42Asp)	TP53RK	G42D	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444882	20	45317929	20	46689290	444882	438524	rs773814837	NC_000020.11:46689289:C:T
NM_033550.4(TP53RK):c.242C>G (p.Thr81Arg)	TP53RK	T81R	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444881	20	45317812	20	46689173	444881	438523	rs1432218739	NC_000020.11:46689172:G:C
NM_033550.4(TP53RK):c.179del (p.Lys60fs)	TP53RK	K60fs	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444880	20	45317875	20	46689236	444880	438522	rs1431526147	NC_000020.11:46689235:TT:T
NM_033068.3(ACP4):c.428C>T (p.Thr143Met)	ACP4	T143M	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Oct 28, 2016)	no assertion criteria provided	VCV000375700	19	51295037	19	50791780	375700	362590	rs546603773	NC_000019.10:50791779:C:T
NM_033068.3(ACP4):c.746C>T (p.Pro249Leu)	ACP4	P249L	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Oct 28, 2016)	no assertion criteria provided	VCV000375694	19	51297041	19	50793784	375694	362584	rs1085307111	NC_000019.10:50793783:C:T
NM_033068.3(ACP4):c.397G>A (p.Glu133Lys)	ACP4	E133K	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374866	19	51295006	19	50791749	374866	361771	rs779823931	NC_000019.10:50791748:G:A
NM_033068.3(ACP4):c.382G>C (p.Ala128Pro)	ACP4	A128P	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374865	19	51294991	19	50791734	374865	361770	rs767907487	NC_000019.10:50791733:G:C
NM_033068.3(ACP4):c.226C>T (p.Arg76Cys)	ACP4	R76C	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374864	19	51294040	19	50790783	374864	361769	rs1057519277	NC_000019.10:50790782:C:T
NM_033068.3(ACP4):c.331C>T (p.Arg111Cys)	ACP4	R111C	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374863	19	51294940	19	50791683	374863	361768	rs202073531	NC_000019.10:50791682:C:T
NM_033068.3(ACP4):c.713C>T (p.Ser238Leu)	ACP4	S238L	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374862	19	51297008	19	50793751	374862	361767	rs763573828	NC_000019.10:50793750:C:T
NM_001086521.2(NDUFAF8):c.45_52dup (p.Phe18fs)	NDUFAF8		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000691644	17	79213202 - 79213203	17	81239402 - 81239403	691644	679357		NC_000017.11:81239402:CGCCTCCGCGCCT:CGCCTCCGCGCCTCCGCGCCT
NM_001086521.2(NDUFAF8):c.1A>G (p.Met1Val)	NDUFAF8	M1V	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000691643	17	79213164	17	81239364	691643	679356		NC_000017.11:81239363:A:G
NM_001086521.2(NDUFAF8):c.195+271C>T	NDUFAF8		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000691642	17	79213749	17	81239949	691642	679359		NC_000017.11:81239948:C:T
NM_014738.6(TMEM94):c.495_496dup (p.His166fs)	TMEM94		not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000817873	17	73484097 - 73484098	17	75488016 - 75488017	817873	805997		NC_000017.11:75488016:GC:GCGC
NM_014738.6(TMEM94):c.3998+5G>A	TMEM94		Intellectual developmental disorder with cardiac defects and dysmorphic facies	Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617671	17	73495168	17	75499087	617671	609074	rs1567985127	NC_000017.11:75499086:G:A
NM_014738.6(TMEM94):c.810del (p.Asp270fs)	TMEM94	D270fs, D280fs	Intellectual developmental disorder with cardiac defects and dysmorphic facies	Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617668	17	73485392	17	75489311	617668	609071	rs1567950778	NC_000017.11:75489310:C:
NM_014738.6(TMEM94):c.2734C>T (p.Arg912Ter)	TMEM94	R922*, R912*, R921*, R896*, R916*	Intellectual developmental disorder with cardiac defects and dysmorphic facies	Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617667	17	73491370	17	75495289	617667	609070	rs557746506	NC_000017.11:75495288:C:T
NM_014975.3(MAST1):c.1549G>A (p.Gly517Ser)	MAST1	G517S	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599361	19	12975903	19	12865089	599361	590669	rs1568413207	NC_000019.10:12865088:G:A
NM_014975.3(MAST1):c.832_834del (p.Leu279del)	MAST1	L279del	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599360	19	12962804 - 12962806	19	12851990 - 12851992	599360	590668	rs1568409502	NC_000019.10:12851989:GTTG:G
NM_014975.3(MAST1):c.826_828AAG[1] (p.Lys277del)	MAST1	K277del	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599359	19	12962798 - 12962800	19	12851984 - 12851986	599359	590667	rs1568409494	NC_000019.10:12851983:GAAGAAG:GAAG
NM_014975.3(MAST1):c.580_582GAG[1] (p.Glu195del)	MAST1	E195del	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599358	19	12958676 - 12958678	19	12847862 - 12847864	599358	590666	rs1568408280	NC_000019.10:12847861:GGAGGAG:GGAG
NM_002144.4(HOXB1):c.66C>G (p.Tyr22Ter)	HOXB1	Y22*	Hereditary congenital facial paresis 3	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000495206	17	46608201	17	48530839	495206	486705	rs1247386618	NC_000017.11:48530838:G:C
NM_002144.4(HOXB1):c.620G>A (p.Arg207His)	HOXB1	R207H	Hereditary congenital facial paresis 3	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000495205	17	46607195	17	48529833	495205	486704	rs1555632121	NC_000017.11:48529832:C:T
NM_021220.4(OVOL2):c.-274T>G	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 30, 2016)	no assertion criteria provided	VCV000224840	20	18038552	20	18057908	224840	226680	rs869320630	NC_000020.11:18057907:A:C
NM_001303461.1(OVOL2):c.-297+949T>C	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 30, 2016)	no assertion criteria provided	VCV000224839	20	18038585	20	18057941	224839	226679	rs869320629	NC_000020.11:18057940:A:G
NM_004714.3(DYRK1B):c.269A>C (p.His90Pro)	DYRK1B	H90P	Abdominal obesity-metabolic syndrome 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000132793	19	40321118	19	39830478	132793	136542	rs587777380	NC_000019.10:39830477:T:G
NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys)	DYRK1B	R102C	Abdominal obesity-metabolic syndrome 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000132792	19	40321083	19	39830443	132792	136541	rs367643250	NC_000019.10:39830442:G:A
NM_002144.4(HOXB1):c.619C>T (p.Arg207Cys)	HOXB1	R207C	Hereditary congenital facial paresis 3	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035567	17	46607196	17	48529834	35567	44236	rs387907239	NC_000017.11:48529833:G:A
NM_001303461.1(OVOL2):c.-297+895_-297+916dup	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000224837	20	18038617 - 18038618	20	18057973 - 18057974	224837	226677	rs869320627	NC_000020.11:18057973:CCGGTTCCGGCGGCCGGGGCTGCC:CCGGTTCCGGCGGCCGGGGCTGCCGGTTCCGGCGGCCGGGGCTGCC
NM_001303461.1(OVOL2):c.-297+886T>C	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 30, 2016)	no assertion criteria provided	VCV000224838	20	18038648	20	18058004	224838	226678	rs869320628	NC_000020.11:18058003:A:G
NM_014738.6(TMEM94):c.765-1G>C	TMEM94		Intellectual developmental disorder with cardiac defects and dysmorphic facies|TMEM94-related condition	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000598744	17	73485346	17	75489265	598744	589808	rs1352010373	NC_000017.11:75489264:G:C
NM_014738.6(TMEM94):c.2605dup (p.Met869fs)	TMEM94		Intellectual developmental disorder with cardiac defects and dysmorphic facies|TMEM94-related condition	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000598743	17	73490986 - 73490987	17	75494905 - 75494906	598743	589809	rs1163944538	NC_000017.11:75494905:AAAAAA:AAAAAAA
GNASAS, 4.7-KB DEL	GNAS-AS1		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001212					1212	16251		
NM_001171155.2(PET100):c.142C>T (p.Gln48Ter)	PET100	Q48*	Congenital lactic acidosis|Mitochondrial complex IV deficiency|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Sep 12, 2016)	no assertion criteria provided	VCV000128250	19	7696362	19	7631476	128250	133699	rs587779779	NC_000019.10:7631475:C:T
NM_001171155.2(PET100):c.3G>C (p.Met1Ile)	PET100	M1I	Mitochondrial complex IV deficiency|not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000125441	19	7694722	19	7629836	125441	130979	rs587777839	NC_000019.10:7629835:G:C
NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs)	CALR	L367fs	Myelofibrosis|Thrombocythemia 1	Pathogenic(Last reviewed: Dec 19, 2013)	no assertion criteria provided	VCV000097006	19	13054565 - 13054616	19	12943751 - 12943802	97006	102915	rs1555760738	
NM_014516.4(CNOT3):c.2080C>T (p.Gln694Ter)	CNOT3	Q694*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694673	19	54657494	19	54153757	694673	682792		NC_000019.10:54153756:C:T
NM_014516.4(CNOT3):c.1926_1927del (p.Cys643fs)	CNOT3	C643fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694672	19	54656625 - 54656626	19	54152888 - 54152889	694672	682791		
NM_014516.4(CNOT3):c.1866G>A (p.Trp622Ter)	CNOT3	W622*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694671	19	54656325	19	54152588	694671	682790		NC_000019.10:54152587:G:A
NM_014516.4(CNOT3):c.1473_1474del (p.Gly493fs)	CNOT3	G493fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694670	19	54653361 - 54653362	19	54149626 - 54149627	694670	682789		NC_000019.10:54149625:AG:
NM_014516.4(CNOT3):c.732dup (p.Ser245fs)	CNOT3		INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694669	19	54649671	19	54145930 - 54145931	694669	682788		NC_000019.10:54145930:CCCCCCCC:CCCCCCCCC
NM_004230.4(S1PR2):c.419A>G (p.Tyr140Cys)	S1PR2	Y140C	Deafness, autosomal recessive 68	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000219249	19	10335163	19	10224487	219249	217271	rs869312750	NC_000019.10:10224486:T:C
NM_004230.4(S1PR2):c.323G>C (p.Arg108Pro)	S1PR2	R108P	Deafness, autosomal recessive 68	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000219259	19	10335259	19	10224583	219259	217338	rs869312749	NC_000019.10:10224582:C:G
NM_015352.2(POFUT1):c.289C>T (p.Gln97Ter)	POFUT1	Q97*	Dowling-Degos disease 2	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000574378	20	30803114	20	32215311	574378	571182	rs1569152303	NC_000020.11:32215310:C:T
NM_002730.4(PRKACA):c.597_599dup (p.Cys200_Gly201insTrp)	PRKACA		Pigmented nodular adrenocortical disease, primary, 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000162471	19	14208434 - 14208436	19	14097621 - 14097622	162471	172145	rs724160013	NC_000019.10:14097621:CAC:CACCAC
NM_015352.2(POFUT1):c.482del (p.Lys161fs)	POFUT1	K161fs	Dowling-Degos disease 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000056809	20	30804463	20	32216660	56809	71436	rs886041033	NC_000020.11:32216659:AA:A
NM_015352.2(POFUT1):c.430G>T (p.Glu144Ter)	POFUT1	E144*	Dowling-Degos disease 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000056808	20	30804412	20	32216609	56808	71435	rs398123038	NC_000020.11:32216608:G:T
NM_139062.4(CSNK1D):c.137A>G (p.His46Arg)	CSNK1D	H46R	Advanced sleep phase syndrome, familial, 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050319	17	80223612	17	82265736	50319	59460	rs397514693	NC_000017.11:82265735:T:C
NM_207391.3(RGS9BP):c.193dup (p.Arg65fs)	RGS9BP		Bradyopsia	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000002831	19	33167360 - 33167361	19	32676454 - 32676455	2831	17870		NC_000019.10:32676454:CC:CCC
NM_139062.4(CSNK1D):c.130A>G (p.Thr44Ala)	CSNK1D	T44A	Advanced sleep phase syndrome, familial, 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000008741	17	80223619	17	82265743	8741	23780	rs104894561	NC_000017.11:82265742:T:C
NM_001466.4(FZD2):c.1644G>A (p.Trp548Ter)	FZD2	W548*	Robinow syndrome, autosomal dominant 2|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000617609	17	42636700	17	44559332	617609	609006	rs1568105666	NC_000017.11:44559331:G:A
NM_002816.5(PSMD12):c.526del (p.Ser176fs)	PSMD12	S156fs, S176fs, S117fs	not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000818024	17	65343586	17	67347470	818024	805980		NC_000017.11:67347469:A:
NM_002816.5(PSMD12):c.356del (p.Pro119fs)	PSMD12	P99fs, P119fs, P60fs	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000817952	17	65346394	17	67350278	817952	805981		NC_000017.11:67350277:GG:G
NM_002816.5(PSMD12):c.142_143CT[3] (p.Leu50fs)	PSMD12		Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000807474	17	65353654 - 65353655	17	67357538 - 67357539	807474	798723		NC_000017.11:67357537:AGAGAGAGA:AGAGAGA
NM_002816.5(PSMD12):c.316C>T (p.Gln106Ter)	PSMD12	Q106*, Q47*, Q86*	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000620497	17	65346434	17	67350318	620497	611876	rs1567955779	NC_000017.11:67350317:G:A
NM_002816.5(PSMD12):c.544C>T (p.Arg182Ter)	PSMD12	R182*, R123*, R162*	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000620300	17	65343568	17	67347452	620300	611875	rs1567954436	NC_000017.11:67347451:G:A
NM_001042631.2(SDHAF1):c.156C>A (p.Tyr52Ter)	SDHAF1	Y52*	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000280451	19	36486332	19	35995430	280451	265065	rs768768823	NC_000019.10:35995429:C:A
NM_002816.5(PSMD12):c.1033G>T (p.Glu345Ter)	PSMD12	E345*, E325*, E286*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000638584	17	65340772	17	67344656	638584	626376		NC_000017.11:67344655:C:A
NM_002816.5(PSMD12):c.909-2A>G	PSMD12		Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427782	17	65340898	17	67344782	427782	417871	rs1114167444	NC_000017.11:67344781:T:C
NM_002816.5(PSMD12):c.601C>T (p.Arg201Ter)	PSMD12	R201*, R181*, R142*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427781	17	65343511	17	67347395	427781	417870	rs895130488	NC_000017.11:67347394:G:A
NM_002816.5(PSMD12):c.1274T>G (p.Leu425Ter)	PSMD12	L425*, L366*, L405*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427780	17	65337056	17	67340940	427780	417869	rs1114167443	NC_000017.11:67340939:A:C
NM_002816.5(PSMD12):c.367C>T (p.Arg123Ter)	PSMD12	R123*, R64*, R103*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427779	17	65346383	17	67350267	427779	417868	rs1114167442	NC_000017.11:67350266:G:A
NM_001042631.2(SDHAF1):c.164G>C (p.Arg55Pro)	SDHAF1	R55P	Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000430	19	36486340	19	35995438	430	15469	rs137853193	NC_000019.10:35995437:G:C
NM_001042631.2(SDHAF1):c.169G>C (p.Gly57Arg)	SDHAF1	G57R	Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000429	19	36486345	19	35995443	429	15468	rs137853192	NC_000019.10:35995442:G:C
NM_001863.5(COX6B1):c.59G>A (p.Arg20His)	COX6B1	R19H, R20H	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000016875	19	36142204	19	35651302	16875	31914	rs121909602	NC_000019.10:35651301:G:A
NM_001863.5(COX6B1):c.58C>T (p.Arg20Cys)	COX6B1	R20C	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000217745	19	36142203	19	35651301	217745	214391	rs778740017	NC_000019.10:35651300:C:T
NM_002730.3(PRKACA):c.617T>G (p.Leu206Arg)	PRKACA	L206R, L198R, L282R	not provided|Pigmented nodular adrenocortical disease, primary, 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000091945	19	14208416	19	14097604	91945	97423	rs386352352	NC_000019.10:14097603:A:C
GINS1, -60A-G	GINS1		Combined immunodeficiency due to GINS1 deficiency	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000487512					487512	480563		
NM_021067.5(GINS1):c.-48C>G	GINS1		Combined immunodeficiency due to GINS1 deficiency	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000487510	20	25388409	20	25407773	487510	480561	rs974304393	NC_000020.11:25407772:C:G
NM_016077.5(PTRH2):c.324G>A (p.Trp108Ter)	PTRH2	W108*, W109*	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	Pathogenic(Last reviewed: Dec 3, 2019)	no assertion criteria provided	VCV000695110	17	57775016	17	59697655	695110	683214		NC_000017.11:59697654:C:T
NM_001143986.2(TLE6):c.1133del (p.Ala378fs)	TLE6	A255fs, A378fs	Preimplantation embryonic lethality 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000453260	19	2989672	19	2989674	453260	446855	rs776453307	NC_000019.10:2989673:C:
NM_016004.5(IFT52):c.424C>T (p.Arg142Ter)	IFT52	R142*	Short-rib thoracic dysplasia 16 with or without polydactyly	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000253306	20	42233652	20	43605012	253306	247749	rs748090019	NC_000020.11:43605011:C:T
NM_001143986.2(TLE6):c.1529C>A (p.Ser510Tyr)	TLE6	S510Y, S387Y	Preimplantation embryonic lethality 1	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000222026	19	2993572	19	2993574	222026	223717	rs767222404	NC_000019.10:2993573:C:A
NM_001015509.2(PTRH2):c.272_273del (p.Ala91fs)	PTRH2	A90fs, A91fs	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183428	17	57775070 - 57775071	17	59697709 - 59697710	183428	181534	rs786201017	NC_000017.11:59697708:AG:
NM_016004.5(IFT52):c.878del (p.Leu293fs)	IFT52	L293fs, L76fs, L117fs	Short-rib thoracic dysplasia 16 with or without polydactyly|Short Rib Polydactyly Syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000253308	20	42252640	20	43624000	253308	247751	rs886037870	NC_000020.11:43623999:T:
NM_016004.5(IFT52):c.595G>A (p.Ala199Thr)	IFT52	A199T, A23T	Short-rib thoracic dysplasia 16 with or without polydactyly|Short Rib Polydactyly Syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000253307	20	42242599	20	43613959	253307	247750	rs886037869	NC_000020.11:43613958:G:A
NM_005052.3(RAC3):c.182A>T (p.Gln61Leu)	RAC3	Q61L	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES|Intellectual disability|Abnormality of brain morphology	Pathogenic, association(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000585005	17	79990661	17	82032785	585005	576061	rs1568018920	NC_000017.11:82032784:A:T
NM_005052.3(RAC3):c.86C>T (p.Pro29Leu)	RAC3	P29L	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES|Intellectual disability|Abnormality of brain morphology	Pathogenic, association(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000585004	17	79990313	17	82032437	585004	576060	rs1568018697	NC_000017.11:82032436:C:T
NM_024298.5(MBOAT7):c.757_769del (p.Glu253fs)	MBOAT7	E180fs, E253fs	not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000817917	19	54684575 - 54684587	19	54180858 - 54180870	817917	806059		NC_000019.10:54180857:TGCAGCCGCACTC:
NM_001127.3(AP1B1):c.2374G>T (p.Glu792Ter)	AP1B1	E792*, E765*, E785*	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805798	22	29727841	22	29331852	805798	794118		NC_000022.11:29331851:C:A
NM_001127.3(AP1B1):c.2335del (p.Leu779fs)	AP1B1	L752fs, L772fs, L779fs	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805797	22	29727880	22	29331891	805797	794117		NC_000022.11:29331890:GGGGGG:GGGGG
NM_001127.3(AP1B1):c.430T>C (p.Cys144Arg)	AP1B1	C144R	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 17, 2020)	no assertion criteria provided	VCV000805796	22	29754810	22	29358821	805796	794116		NC_000022.11:29358820:A:G
NM_001127.3(AP1B1):c.38-1G>A	AP1B1		Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805795	22	29759096	22	29363107	805795	794115		NC_000022.11:29363106:C:T
NC_000022.10:g.29758984_29815476del	AP1B1		Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805794					805794	794114		
NM_024298.5(MBOAT7):c.820_826del (p.Gly274fs)	MBOAT7	G201fs, G274fs	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268115	19	54684518 - 54684524	19	54180801 - 54180807	268115	263641	rs886041061	NC_000019.10:54180800:GGCCGCC:
NM_024298.5(MBOAT7):c.854+1G>C	MBOAT7		Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000268114	19	54684489	19	54180772	268114	263640	rs886041060	NC_000019.10:54180771:C:G
NM_024298.5(MBOAT7):c.423del (p.Leu142fs)	MBOAT7	L69fs, L142fs	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268113	19	54687474	19	54183591	268113	263639	rs886041059	NC_000019.10:54183590:CCCC:CCC
NM_024298.5(MBOAT7):c.758_778del (p.Glu253_Ala259del)	MBOAT7		Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268112	19	54684566 - 54684586	19	54180849 - 54180869	268112	263638	rs750035706	NC_000019.10:54180848:CGGCGGCAATGCAGCCGCACTCGGCGGCAAT:CGGCGGCAAT
NM_024298.5(MBOAT7):c.126_145del (p.Leu43fs)	MBOAT7	L43fs, P12fs	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268111	19	54692132 - 54692151	19	54188278 - 54188297	268111	263637	rs886041058	NC_000019.10:54188277:GGGGGCCACAGGTGAACAGGG:G
NM_001305545.1(RNF43):c.-45C>T	RNF43	R113*	Sessile serrated polyposis cancer syndrome	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000254140	17	56448310	17	58370949	254140	248607	rs1567880628	NC_000017.11:58370948:G:A
NM_014740.4(EIF4A3):c.809A>G (p.Asp270Gly)	EIF4A3	D270G		Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101503	17	78111999	17	80138200	101503	107249	rs587777204	NC_000017.11:80138199:T:C
NM_014740.4(EIF4A3):c.-98_-81del18insTCGGCAGCGGCACAGCGAGG[10]	EIF4A3			Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101502	17	78120841 - 78120858	17	80147042 - 80147059	101502	107248		
EIF4A3, 15-REPEAT EXPANSION	EIF4A3			Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101501					101501	107247		
NM_032040.5(CCDC8):c.84dup (p.Lys29Ter)	CCDC8		Three M syndrome 3	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000031105	19	46915983 - 46915984	19	46412726 - 46412727	31105	40062	rs1568590155	NC_000019.10:46412726:A:AA
NM_032040.5(CCDC8):c.612dup (p.Lys205fs)	CCDC8		Three M syndrome 3	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000031104	19	46915455 - 46915456	19	46412198 - 46412199	31104	40061	rs752254407	NC_000019.10:46412198:CCCCC:CCCCCC
NM_017763.5(RNF43):c.394C>T (p.Arg132Ter)	RNF43	R132*, R5*	Colon Serrated Polyposis|Sessile serrated polyposis cancer syndrome	Pathogenic	criteria provided, single submitter	VCV000190226	17	56440943	17	58363582	190226	188056	rs786205215	NC_000017.11:58363581:G:A
GRCh37/hg19 17q22(chr17:56721367-56766202)x1	TEX14		not provided	Pathogenic(Last reviewed: Feb 9, 2018)	no assertion criteria provided	VCV000685922	17	56721367 - 56766202			685922	673514		
NM_004309.6(ARHGDIA):c.358C>T (p.Arg120Ter)	ARHGDIA	R120*, R165*	Nephrotic syndrome, type 8	Pathogenic(Last reviewed: Mar 10, 2015)	no assertion criteria provided	VCV000140594	17	79827106	17	81869230	140594	150286	rs587777553	NC_000017.11:81869229:G:A
NM_001201457.1(TEX14):c.254G>T (p.Arg85Leu)	TEX14	R85L	SPERMATOGENIC FAILURE 23	Pathogenic(Last reviewed: Jun 28, 2019)	no assertion criteria provided	VCV000635288	17	56700371	17	58623010	635288	623122		NC_000017.11:58623009:C:A
NM_001136191.3(KANK2):c.2027C>T (p.Ser676Phe)	KANK2	S684F, S676F	Nephrotic syndrome type 16	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000446388	19	11285190	19	11174514	446388	439843	rs1555816634	NC_000019.10:11174513:G:A
NM_001136191.3(KANK2):c.541A>G (p.Ser181Gly)	KANK2	S181G	Nephrotic syndrome type 16	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000446387	19	11304215	19	11193539	446387	439842	rs1555820663	NC_000019.10:11193538:T:C
NM_001201457.1(TEX14):c.2668_2678del (p.Ser890fs)	TEX14	S890fs, S884fs	SPERMATOGENIC FAILURE 23	Pathogenic(Last reviewed: Jun 28, 2019)	no assertion criteria provided	VCV000440758	17	56665299 - 56665309	17	58587938 - 58587948	440758	434385	rs1555568575	NC_000017.11:58587937:TGCCGGTGGCTTG:TG
NM_000894.2(LHB):c.183+1G>T	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000189293	19	49519803	19	49016546	189293	187179	rs786204822	NC_000019.10:49016545:C:A
NM_000894.2(LHB):c.28_39del (p.Leu10_Leu13del)	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000189292	19	49519948 - 49519959	19	49016691 - 49016702	189292	187178	rs769066903	NC_000019.10:49016690:CAGCAGCAGCAACAGCAGCAGC:CAGCAGCAGC
NM_000894.2(LHB):c.88_96del (p.His30_Ile32del)	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Nov 5, 2009)	no assertion criteria provided	VCV000189291	19	49519891 - 49519899	19	49016634 - 49016642	189291	187177	rs786204823	NC_000019.10:49016633:GATGGGGTGG:G
NM_000894.2(LHB):c.183+1G>C	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Aug 30, 2007)	no assertion criteria provided	VCV000189290	19	49519803	19	49016546	189290	187176	rs786204822	NC_000019.10:49016545:C:G
NM_001136191.3(KANK2):c.2009C>T (p.Ala670Val)	KANK2	A670V, A678V	Palmoplantar keratoderma and woolly hair	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000158088	19	11285208	19	11174532	158088	167939	rs606231303	NC_000019.10:11174531:G:A
NM_004309.6(ARHGDIA):c.518G>T (p.Gly173Val)	ARHGDIA	G173V, G218V	Nephrotic syndrome, type 8	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000140593	17	79826849	17	81868973	140593	150285	rs587777552	NC_000017.11:81868972:C:A
NM_004309.6(ARHGDIA):c.547_549GAC[2] (p.Asp185del)	ARHGDIA	D185del	Nephrotic syndrome, type 8	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050501	17	79826812 - 79826814	17	81868936 - 81868938	50501	59540	rs587776969	NC_000017.11:81868935:GTCGTCGTC:GTCGTC
NM_000894.2(LHB):c.167G>A (p.Gly56Asp)	LHB	G36D, G56D	Isolated lutropin deficiency	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000014416	19	49519820	19	49016563	14416	29455	rs121912517	NC_000019.10:49016562:C:T
NM_000894.2(LHB):c.221A>G (p.Gln74Arg)	LHB	Q54R, Q74R	Isolated lutropin deficiency	Pathogenic(Last reviewed: Jan 16, 1992)	no assertion criteria provided	VCV000014413	19	49519530	19	49016273	14413	29452	rs5030773	NC_000019.10:49016272:T:C
NM_177973.2(SULT2B1):c.71+2T>A	SULT2B1		ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14|Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426110	19	49055582	19	48552325	426110	414711	rs1114167426	NC_000019.10:48552324:T:A
NM_177973.2(SULT2B1):c.364dup (p.Met122fs)	SULT2B1		ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14|Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426109	19	49090634 - 49090635	19	48587377 - 48587378	426109	414712	rs1114167425	NC_000019.10:48587377:A:AA
NM_177973.2(SULT2B1):c.446C>T (p.Pro149Leu)	SULT2B1	P149L, P134L	Autosomal recessive congenital ichthyosis 1|ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426107	19	49094888	19	48591631	426107	414713	rs1114167424	NC_000019.10:48591630:C:T
NM_177973.2(SULT2B1):c.821G>A (p.Arg274Gln)	SULT2B1	R274Q, R259Q	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14|Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426108	19	49100171	19	48596914	426108	414714	rs762765702	NC_000019.10:48596913:G:A
NM_014740.4(EIF4A3):c.-98_-81del18insTCGGCAGCGGCACAGCGAGG[13]	EIF4A3			Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101500	17	78120841 - 78120858	17	80147042 - 80147059	101500	107246		
NM_001015509.2(PTRH2):c.257A>C (p.Gln86Pro)	PTRH2	Q85P, Q86P	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset|Global developmental delay|Cerebellar ataxia|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000183332	17	57775086	17	59697725	183332	181454	rs730882234	NC_000017.11:59697724:T:G
NM_002861.5(PCYT2):c.1075C>T (p.Arg359Ter)	PCYT2	R377*, R281*, R305*, R318*, R327*, R337*, R359*	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 17, 2020)	no assertion criteria provided	VCV000812573	17	79862804	17	81904928	812573	800821		NC_000017.11:81904927:G:A
NM_002861.5(PCYT2):c.676C>T (p.His226Tyr)	PCYT2	P307L, H148Y, H172Y, H185Y, H194Y, H226Y, H244Y	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812572	17	79864636	17	81906760	812572	800820		NC_000017.11:81906759:G:A
NM_002861.5(PCYT2):c.866C>T (p.Pro289Leu)	PCYT2	H244Y, P211L, P235L, P248L, P257L, P289L, P307L	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812571	17	79863583	17	81905707	812571	800819		NC_000017.11:81905706:G:A
NM_152513.4(MEI1):c.2206del (p.Val736fs)	MEI1	V736fs	HYDATIDIFORM MOLE, RECURRENT, 3	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000627578	22	42159262	22	41763258	627578	615933	rs759915989	NC_000022.11:41763257:GG:G
NM_152513.4(MEI1):c.1196+1G>A	MEI1		HYDATIDIFORM MOLE, RECURRENT, 3	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000627577	22	42128349	22	41732345	627577	615932	rs1569203272	NC_000022.11:41732344:G:A
HAMP, 4-BP DEL, ATGG	HAMP		Hemochromatosis, juvenile, digenic	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004285					4285	19324		
NM_013447.4(ADGRE2):c.1475G>A (p.Cys492Tyr)	ADGRE2	C492Y	Vibratory urticaria	Pathogenic(Last reviewed: Jun 24, 2016)	no assertion criteria provided	VCV000222005	19	14865881	19	14755069	222005	223695	rs199718602	NC_000019.10:14755068:C:T
TYROBP, 1-BP DEL, 141G	TYROBP		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005796					5796	20835		
TYROBP, EX1-4DEL	TYROBP		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005795					5795	20834		
HAMP, +14G-A, 5-PRIME UTR	HAMP		Hemochromatosis type 2B	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000004287					4287	19326		
NM_021175.4(HAMP):c.166C>T (p.Arg56Ter)	HAMP	R56*	Hemochromatosis type 2B	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004284	19	35775856	19	35284953	4284	19323	rs104894695	NC_000019.10:35284952:C:T
NM_021175.4(HAMP):c.95del (p.Gly32fs)	HAMP	G32fs	Hemochromatosis type 2B	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004283	19	35775694	19	35284791	4283	19322		NC_000019.10:35284790:GGG:GG
NG_009304.1:g.2160_7401del	TYROBP		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000192243	19	36396786 - 36402027	19	35905884 - 35911125	192243	190042		
NM_021175.4(HAMP):c.216C>A (p.Cys72Ter)	HAMP	C72*	Hemochromatosis type 1	Pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	VCV000188077	19	35775906	19	35285003	188077	186284	rs763369315	NC_000019.10:35285002:C:A
NM_003332.3(TYROBP):c.2T>C (p.Met1Thr)	TYROBP	M1T	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000005797	19	36399129	19	35908227	5797	20836	rs104894732	NC_000019.10:35908226:A:G
NM_138501.6(TECR):c.545C>T (p.Pro182Leu)	TECR	P182L, P197L	Mental retardation, autosomal recessive 14	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000030810	19	14675653	19	14564841	30810	39767	rs199469705	NC_000019.10:14564840:C:T
NM_001161748.2(LIM2):c.388C>T (p.Arg130Cys)	LIM2	R130C, R172C	Cataract (disease)	Pathogenic(Last reviewed: Nov 16, 2017)	no assertion criteria provided	VCV000625113	19	51883831	19	51380577	625113	613458	rs1568480054	NC_000019.10:51380576:G:A
NM_001161748.2(LIM2):c.461G>A (p.Gly154Glu)	LIM2	G154E, G196E	Cataract 19, multiple types	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000224327	19	51883516	19	51380262	224327	226063	rs869312732	NC_000019.10:51380261:C:T
NM_001161748.2(LIM2):c.313T>G (p.Phe105Val)	LIM2	F105V, F147V	Cataract 19, multiple types	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014356	19	51885684	19	51382430	14356	29395	rs121913555	NC_000019.10:51382429:A:C
NM_003332.3(TYROBP):c.141del (p.Met48fs)	TYROBP	M37fs, M48fs	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000056395	19	36398436	19	35907534	56395	71034	rs386833840	NC_000019.10:35907533:C:
NM_001080510.4(METTL23):c.282_286del (p.Gln94fs)	METTL23	Q27fs, Q90fs, Q94fs	Mental retardation, autosomal recessive 44	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144024	17	74729256 - 74729260	17	76733174 - 76733178	144024	153755	rs587777645	NC_000017.11:76733173:AAGATA:A
NM_023935.3(DDRGK1):c.408+1G>A	DDRGK1			Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000487527	20	3180987	20	3200341	487527	480578	rs1325869434	NC_000020.11:3200340:C:T
NM_001080510.4(METTL23):c.397C>T (p.Gln133Ter)	METTL23	Q133*, Q129*, Q66*	Mental retardation, autosomal recessive 44	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000144025	17	74729449	17	76733367	144025	153756	rs587777646	NC_000017.11:76733366:C:T
APOC2, 1-BP DEL, 2943G	APOC2		APOLIPOPROTEIN C-II (NIJMEGEN)|Apolipoprotein C2 deficiency	Pathogenic(Last reviewed: Dec 5, 1988)	no assertion criteria provided	VCV000002578					2578	17617		
APOC2, 1-BP INS	APOC2		APOLIPOPROTEIN C-II (ST. MICHAEL)|Apolipoprotein C2 deficiency	Pathogenic(Last reviewed: Dec 1, 1987)	no assertion criteria provided	VCV000002575					2575	17614		
NM_002490.6(NDUFA6):c.355del (p.Leu119fs)	NDUFA6	L119fs	Mitochondrial diseases|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000549666	22	42482219	22	42086215	549666	540434	rs781099275	NC_000022.11:42086214:GG:G
NM_002490.6(NDUFA6):c.309del (p.Met104fs)	NDUFA6	M104fs	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000549665	22	42482265	22	42086261	549665	540435	rs763006208	NC_000022.11:42086260:AA:A
NM_002490.6(NDUFA6):c.265G>T (p.Glu89Ter)	NDUFA6	E115*, E89*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487478	22	42482309	22	42086305	487478	480532	rs758833609	NC_000022.11:42086304:C:A
NM_002490.6(NDUFA6):c.191G>C (p.Arg64Pro)	NDUFA6	R90P, R64P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487477	22	42483128	22	42087124	487477	480533	rs750830935	NC_000022.11:42087123:C:G
NM_002490.6(NDUFA6):c.3G>A (p.Met1Ile)	NDUFA6	M27I, M1I	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487476	22	42486746	22	42090742	487476	480534	rs1023075742	NC_000022.11:42090741:C:T
NM_002490.6(NDUFA6):c.331_332del (p.Glu111fs)	NDUFA6	E111fs	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487475	22	42482242 - 42482243	22	42086238 - 42086239	487475	480531	rs1569463838	NC_000022.11:42086237:TCT:T
APOC2, 1-BP DEL	APOC2		APOLIPOPROTEIN C-II (TORONTO)|Apolipoprotein C2 deficiency	Pathogenic(Last reviewed: Oct 1, 1988)	no assertion criteria provided	VCV000002576					2576	17615		
NM_000878.5(IL2RB):c.286C>T (p.Gln96Ter)	IL2RB	Q96*	Ichthyosis (disease)	Pathogenic(Last reviewed: Apr 30, 2018)	no assertion criteria provided	VCV000545515	22	37535259	22	37139219	545515	536019	rs1569044747	NC_000022.11:37139218:G:A
NM_002608.4(PDGFB):c.2T>G (p.Met1Arg)	PDGFB	M1R	not provided	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000379331	22	39639967	22	39243962	379331	377492	rs1057520576	NC_000022.11:39243961:A:C
NM_000878.5(IL2RB):c.656_664CCTGGAGCC[1] (p.Pro222_Ser224del)	IL2RB		IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635832	22	37532298 - 37532306	22	37136258 - 37136266	635832	623647		NC_000022.11:37136257:GGCTCCAGGGGCTCCAGG:GGCTCCAGG
IL2RB, GLN96TER	IL2RB	Q96*	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635831					635831	623646		
IL2RB, SER40LEU	IL2RB	S40L	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635830					635830	623645		
IL2RB, LEU77PRO	IL2RB	L77P	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635829					635829	623644		
NM_002608.4(PDGFB):c.3G>A (p.Met1Ile)	PDGFB	M1I	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000075245	22	39639966	22	39243961	75245	86136	rs398122399	NC_000022.11:39243960:C:T
NM_002608.4(PDGFB):c.445C>T (p.Arg149Ter)	PDGFB	R149*, R134*	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000075243	22	39627638	22	39231633	75243	86134	rs397515633	NC_000022.11:39231632:G:A
NM_002608.4(PDGFB):c.726G>C (p.Ter242Tyr)	PDGFB	*242Y, *227Y	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000075241	22	39621728	22	39225723	75241	86132	rs398122398	NC_000022.11:39225722:C:G
NM_002608.4(PDGFB):c.356T>C (p.Leu119Pro)	PDGFB	L119P, L104P	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000075239	22	39627727	22	39231722	75239	86130	rs397515632	NC_000022.11:39231721:A:G
NM_002608.4(PDGFB):c.433C>T (p.Gln145Ter)	PDGFB	Q145*, Q130*	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000075237	22	39627650	22	39231645	75237	86128	rs397515631	NC_000022.11:39231644:G:A
PDGFB, PDGFB/COL1A1 FUSION	PDGFB		Dermatofibrosarcoma protuberans	Pathogenic(Last reviewed: May 24, 2001)	no assertion criteria provided	VCV000012599					12599	27638		
PDGFB, 135-BP DEL, IVS5	PDGFB		Meningioma	Pathogenic(Last reviewed: Oct 1, 1990)	no assertion criteria provided	VCV000012598					12598	27637		
NM_032045.5(KREMEN1):c.626T>C (p.Phe209Ser)	KREMEN1	F209S	Ectodermal dysplasia 13, hair/tooth type	Pathogenic(Last reviewed: Mar 13, 2017)	no assertion criteria provided	VCV000393469	22	29521399	22	29125411	393469	380291	rs1057524917	NC_000022.11:29125410:T:C
NM_003091.4(SNRPB):c.-72C>A	SNRPB		Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000183435	20	2451408	20	2470762	183435	181541	rs786201022	NC_000020.11:2470761:G:T
NM_003091.4(SNRPB):c.155+302G>T	SNRPB	G56W	Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000183433	20	2447951	20	2467305	183433	181539	rs786201020	NC_000020.11:2467304:C:A
NM_001015878.2(AURKC):c.436-2A>G	AURKC		Infertility associated with multi-tailed spermatozoa and excessive DNA	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000066088	19	57744826	19	57233458	66088	76990	rs397515484	NC_000019.10:57233457:A:G
NM_001015878.2(AURKC):c.686G>A (p.Cys229Tyr)	AURKC	C229Y, C210Y, C195Y	Infertility associated with multi-tailed spermatozoa and excessive DNA	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000006307	19	57746353	19	57234985	6307	21346	rs121908654	NC_000019.10:57234984:G:A
NM_003091.4(SNRPB):c.155+406C>A	SNRPB		Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183434	20	2447847	20	2467201	183434	181540	rs786201021	NC_000020.11:2467200:G:T
NM_001687.5(ATP5F1D):c.245C>T (p.Pro82Leu)	ATP5F1D	P82L	Decreased activity of mitochondrial ATP synthase complex|Mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000453296	19	1242558	19	1242559	453296	446893	rs867410737	NC_000019.10:1242558:C:T
NM_003091.4(SNRPB):c.155+302G>C	SNRPB	G56R	Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183432	20	2447951	20	2467305	183432	181538	rs786201020	NC_000020.11:2467304:C:G
NM_001015878.2(AURKC):c.145del (p.Leu49fs)	AURKC	L15fs, L30fs, L49fs	Infertility associated with multi-tailed spermatozoa and excessive DNA|not provided	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000006306	19	57743438	19	57232070	6306	21345	rs397515619	NC_000019.10:57232069:CCCC:CCC
NM_003091.4(SNRPB):c.155+301G>C	SNRPB	R55S	Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183431	20	2447952	20	2467306	183431	181537	rs786201019	NC_000020.11:2467305:C:G
NM_001687.5(ATP5F1D):c.317T>G (p.Val106Gly)	ATP5F1D	V106G	Mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5|Mitochondrial diseases	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000489386	19	1244117	19	1244118	489386	482269	rs1555745989	NC_000019.10:1244117:T:G
NM_002430.3:c.3846_3849del	MN1		CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812564	22	28147017 - 28147020	22	27751029 - 27751032	812564	800812		NC_000022.11:27751028:GACAGACAG:GACAG
NM_002430.3(MN1):c.3835C>T (p.Gln1279Ter)	MN1	Q1279*	CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812563	22	28147031	22	27751043	812563	800811		NC_000022.11:27751042:G:A
NM_002430.3(MN1):c.3870_3879dup (p.Ala1294Ter)	MN1		CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812561	22	28146986 - 28146987	22	27750998 - 27750999	812561	800809		NC_000022.11:27750998:CTTGGCGTCAC:CTTGGCGTCACTTGGCGTCAC
NM_002430.3(MN1):c.3817C>T (p.Gln1273Ter)	MN1	Q1273*	CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812559	22	28147049	22	27751061	812559	800807		NC_000022.11:27751060:G:A
NM_002430.3(MN1):c.3745G>T (p.Glu1249Ter)	MN1	E1249*	CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812558	22	28192787	22	27796799	812558	800806		NC_000022.11:27796798:C:A
NM_024417.5(FDXR):c.1A>G (p.Met1Val)	FDXR	M1V	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000489042	17	72869069	17	74872944	489042	482156	rs1323016653	NC_000017.11:74872943:T:C
NM_024417.5(FDXR):c.1429G>A (p.Glu477Lys)	FDXR	E477K, E508K, E437K, E425K, E469K, E483K, E520K	Auditory neuropathy-optic atrophy syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441240	17	72858986	17	74862864	441240	434872	rs997026784	NC_000017.11:74862863:C:T
NM_024417.5(FDXR):c.643C>G (p.Leu215Val)	FDXR	L215V, L221V, L246V, L207V, L163V, L175V, L258V	Auditory neuropathy-optic atrophy syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441239	17	72861020	17	74864898	441239	434871	rs1555620021	NC_000017.11:74864897:G:C
NM_024417.5(FDXR):c.1255C>T (p.Gln419Ter)	FDXR	Q419*, Q425*, Q462*, Q367*, Q411*, Q450*, Q379*	Auditory neuropathy-optic atrophy syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441238	17	72859288	17	74863166	441238	434870	rs1313895172	NC_000017.11:74863165:G:A
NM_000023.4(SGCA):c.790_791dup (p.Gly265fs)	SGCA		Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000847583	17	48247543 - 48247544	17	50170182 - 50170183	847583	845605		NC_000017.11:50170182:CCCC:CCCCCC
NM_005660.3(SLC35A2):c.837_843del (p.Phe280fs)	SLC35A2	F280fs, F293fs, F219fs, F308fs	SLC35A2-CDG	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000847377	X	48762343 - 48762349	X	48905066 - 48905072	847377	850112		NC_000023.11:48905065:GCCGAAGGCC:GCC
NM_000489.6(ATRX):c.4116_4119del (p.Arg1372_Lys1373insTer)	ATRX			Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000847375	X	76918872 - 76918875	X	77663383 - 77663386	847375	850300		NC_000023.11:77663382:CTTTCTT:CTT
NM_001399.5(EDA):c.673_706+2del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000847256	X	69247848 - 69247883	X	70027998 - 70028033	847256	853045		NC_000023.11:70027997:CTGGTCCTCAAGGACCCCCTGGCCTCCAGGGACCTTCTGGT:CTGGT
NC_000024.10:g.1290473C>T	CSF2RA	Q204*, Q71*	Surfactant metabolism dysfunction, pulmonary, 4	Pathogenic(Last reviewed: May 25, 2019)	criteria provided, single submitter	VCV000847249	X	1409366	X	1290473	847249	850357		NC_000024.10:1290472:C:T
NM_000026.4(ADSL):c.977G>A (p.Trp326Ter)	ADSL	W326*, W262*	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000846915	22	40757606	22	40361602	846915	849370		NC_000022.11:40361601:G:A
NM_003560.4(PLA2G6):c.1061T>C (p.Leu354Pro)	PLA2G6	L128P, L176P, L354P	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000846843	22	38528854	22	38132847	846843	849344		NC_000022.11:38132846:A:G
NM_001174089.2(SLC4A11):c.44-69del	SLC4A11	G8fs	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000846827	20	3218303	20	3237657	846827	848285		NC_000020.11:3237656:CCCC:CCC
NM_176787.5(PIGN):c.2397dup (p.Gly800fs)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000846655	18	59752470 - 59752471	18	62085237 - 62085238	846655	846991		NC_000018.10:62085237:AAAAAA:AAAAAAA
NM_152296.5(ATP1A3):c.2542+1G>C	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000846620	19	42474336	19	41970184	846620	852336		NC_000019.10:41970183:C:G
NM_000276.4(OCRL):c.1753_1755del (p.Glu585del)	OCRL	E586del, E585del	Lowe syndrome	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000846443	X	128709911 - 128709913	X	129575934 - 129575936	846443	849601		NC_000023.11:129575933:AGGAG:AG
NM_000052.7(ATP7A):c.4027del (p.Ala1343fs)	ATP7A	A1343fs, A1265fs	Distal spinal muscular atrophy, X-linked 3|Cutis laxa, X-linked|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000846390	X	77298835	X	78043337	846390	850338		NC_000023.11:78043336:GG:G
NM_001015877.2(PHF6):c.829del (p.Arg277fs)	PHF6	R277fs, R278fs	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000846281	X	133549141	X	134415111	846281	849662		NC_000023.11:134415110:AAAAA:AAAA
NM_000074.3(CD40LG):c.386del (p.Glu129fs)	CD40LG	E129fs		Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000846264	X	135738554	X	136656395	846264	849677		NC_000023.11:136656394:A:
NM_153638.3(PANK2):c.573del (p.Ser191fs)	PANK2	S191fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000846245	20	3870320	20	3889673	846245	848385		NC_000020.11:3889672:C:
NM_006306.4(SMC1A):c.2161C>T (p.Gln721Ter)	SMC1A	Q699*, Q721*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000845949	X	53431979	X	53405047	845949	850192		NC_000023.11:53405046:G:A
NM_002294.3(LAMP2):c.64+1G>C	LAMP2		Danon disease	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000845902	X	119602960	X	120469105	845902	852462		NC_000023.11:120469104:C:G
NM_033380.3(COL4A5):c.1517-1G>C	COL4A5		not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000845765	X	107840227	X	108596997	845765	852453		NC_000023.11:108596996:G:C
NM_004006.3(DMD):c.6290+2T>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000845533	X	32305644	X	32287527	845533	852500		NC_000023.11:32287526:A:T
NM_001323289.2(CDKL5):c.877_881dup (p.His294fs)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000845526	X	18616632 - 18616633	X	18598512 - 18598513	845526	849859		NC_000023.11:18598512:AATCA:AATCAAATCA
NM_004006.3(DMD):c.10297dup (p.Thr3433fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000845520	X	31191686 - 31191687	X	31173569 - 31173570	845520	849927		NC_000023.11:31173569:T:TT
NM_000444.6(PHEX):c.1400_1404del (p.Glu467fs)	PHEX	E467fs	not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000845434	X	22151733 - 22151737	X	22133616 - 22133620	845434	849903		NC_000023.11:22133615:AAAGAAAAG:AAAG
NM_033380.3(COL4A5):c.1989del (p.Lys664fs)	COL4A5	K664fs	not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000845398	X	107844660	X	108601430	845398	849549		NC_000023.11:108601429:GGGG:GGG
NM_006306.4(SMC1A):c.397T>G (p.Phe133Val)	SMC1A	F133V, F111V	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000845340	X	53441721	X	53414772	845340	850196		NC_000023.11:53414771:A:C
NM_001008537.3(NEXMIF):c.804_807del (p.Ser268fs)	NEXMIF	S268fs	not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000845041	X	73963585 - 73963588	X	74743750 - 74743753	845041	850290		NC_000023.11:74743749:CTTACTT:CTT
NM_000528.4(MAN2B1):c.426del (p.Val143fs)	MAN2B1	V143fs	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000844937	19	12776176	19	12665362	844937	847289		NC_000019.10:12665361:AA:A
NM_000061.3(BTK):c.1631+2T>C	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Mar 9, 2019)	criteria provided, single submitter	VCV000844931	X	100609616	X	101354628	844931	852955		NC_000023.11:101354627:A:G
NM_172107.4(KCNQ2):c.2276dup (p.Asn759fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000844836	20	62038339 - 62038340	20	63406986 - 63406987	844836	848513		NC_000020.11:63406986:TT:TTT
NM_020964.3(EPG5):c.1254del (p.Ser419fs)	EPG5	S419fs	Vici syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000844744	18	43531203	18	45951237	844744	846879		NC_000018.10:45951236:C:
NM_001184880.2(PCDH19):c.1300C>T (p.Gln434Ter)	PCDH19	Q434*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000844581	X	99662296	X	100407298	844581	849490		NC_000023.11:100407297:G:A
NM_001972.4(ELANE):c.301G>A (p.Val101Met)	ELANE	V101M	Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000844491	19	853338	19	853338	844491	848189		NC_000019.10:853337:G:A
NM_033380.3(COL4A5):c.1815del (p.Asn607fs)	COL4A5	N607fs	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000844422	X	107841967	X	108598737	844422	849548		NC_000023.11:108598736:T:
NM_000159.4(GCDH):c.1045G>A (p.Ala349Thr)	GCDH	A349T	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000844414	19	13008205	19	12897391	844414	847320		NC_000019.10:12897390:G:A
NM_000527.5(LDLR):c.1648del (p.Val550fs)	LDLR	V509fs, V550fs, V382fs, V423fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000844410	19	11226831	19	11116155	844410	847215		NC_000019.10:11116154:G:
NM_000527.5(LDLR):c.1490del (p.Thr497fs)	LDLR	T329fs, T456fs, T497fs, T370fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000844243	19	11224342	19	11113666	844243	847214		NC_000019.10:11113665:C:
NM_001184880.2(PCDH19):c.2113C>T (p.Arg705Ter)	PCDH19	R705*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000844229	X	99661483	X	100406485	844229	849483		NC_000023.11:100406484:G:A
NM_018486.3(HDAC8):c.295+2T>G	HDAC8		Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000844191	X	71788602	X	72568752	844191	852985		NC_000023.11:72568751:A:C
NM_000377.3(WAS):c.35dup (p.Arg13fs)	WAS		|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000843981	X	48542272 - 48542273	X	48683883 - 48683884	843981	850091		NC_000023.11:48683883:GGGGG:GGGGGG
NM_000061.3(BTK):c.441del (p.Phe146_Trp147insTer)	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000843969	X	100617628	X	101362640	843969	849518		NC_000023.11:101362639:CC:C
NM_015166.4(MLC1):c.701G>A (p.Trp234Ter)	MLC1	W182*, W200*, W204*, W234*, W155*	not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000843939	22	50512658	22	50074229	843939	849396		NC_000022.11:50074228:C:T
NM_000023.4(SGCA):c.26dup (p.Leu10fs)	SGCA		Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000843937	17	48243425 - 48243426	17	50166064 - 50166065	843937	845601		NC_000017.11:50166064:CC:CCC
NC_000018.10:g.46569636del	LOXHD1	R685fs	not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000843724	18	44149597	18	46569634	843724	846893		NC_000018.10:46569633:AAA:AA
NM_000444.6(PHEX):c.1116T>A (p.Tyr372Ter)	PHEX	Y372*	not provided	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000843703	X	22129621	X	22111503	843703	849897		NC_000023.11:22111502:T:A
NM_001174089.2(SLC4A11):c.625C>T (p.Gln209Ter)	SLC4A11	Q209*, Q225*, Q252*	not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000843673	20	3214264	20	3233618	843673	848284		NC_000020.11:3233617:G:A
NM_000397.4(CYBB):c.1245del (p.Phe416fs)	CYBB	F416fs	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV000843650	X	37664350	X	37805097	843650	850024		NC_000023.11:37805096:CCC:CC
NM_000444.6(PHEX):c.457dup (p.Ala153fs)	PHEX		not provided	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000843455	X	22095613 - 22095614	X	22077495 - 22077496	843455	849890		NC_000023.11:22077495:G:GG
NM_176787.5(PIGN):c.2439_2440CT[1] (p.Ser814fs)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000843074	18	59751824 - 59751825	18	62084591 - 62084592	843074	846989		NC_000018.10:62084590:AGAG:AG
NC_000019.10:g.35848334del	NPHS1	G412fs	not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000843023	19	36339235	19	35848333	843023	847547		NC_000019.10:35848332:CC:C
NM_000033.4(ABCD1):c.1081+1G>A	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000842966	X	152994868	X	153729413	842966	851942		NC_000023.11:153729412:G:A
NM_000397.4(CYBB):c.902_905TCAC[1] (p.His303fs)	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jan 12, 2020)	criteria provided, single submitter	VCV000842892	X	37663134 - 37663137	X	37803881 - 37803884	842892	850021		NC_000023.11:37803880:TCACTCAC:TCAC
NM_001429.4(EP300):c.4066C>T (p.Arg1356Ter)	EP300	R1356*, R1330*	Colorectal cancer|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000842871	22	41564765	22	41168761	842871	849377		NC_000022.11:41168760:C:T
NM_001008537.3(NEXMIF):c.746del (p.Ala249fs)	NEXMIF	A249fs	not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000842522	X	73963646	X	74743811	842522	850291		NC_000023.11:74743810:G:
NM_002501.4(NFIX):c.60_75dup (p.Phe26fs)	NFIX		Sotos syndrome 2|Marshall-Smith syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000842270	19	13135863 - 13135864	19	13025049 - 13025050	842270	847322		NC_000019.10:13025049:GCTGCCTCACGTCCGCGCT:GCTGCCTCACGTCCGCGCTGCCTCACGTCCGCGCT
NM_000284.4(PDHA1):c.874_881dup (p.Met294fs)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000842254	X	19375811 - 19375812	X	19357693 - 19357694	842254	849881		NC_000023.11:19357693:CACAGTAT:CACAGTATCACAGTAT
NM_001003787.4(STRADA):c.682C>T (p.Arg228Ter)	STRADA	R170*, R184*, R191*, R199*, R220*, R228*	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000842228	17	61784678	17	63707318	842228	845842		NC_000017.11:63707317:G:A
NM_001242896.3(DEPDC5):c.677dup (p.Tyr226Ter)	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000842113	22	32188070 - 32188071	22	31792084 - 31792085	842113	849257		NC_000022.11:31792084:A:AA
NM_005359.6(SMAD4):c.498del (p.Phe166fs)	SMAD4	F166fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000841903	18	48581192	18	51054822	841903	846906		NC_000018.10:51054821:TTT:TT
NM_198270.4(NHS):c.502C>T (p.Gln168Ter)	NHS	Q168*	Nance-Horan syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000841852	X	17394382	X	17376259	841852	849848		NC_000023.11:17376258:C:T
NM_000527.5(LDLR):c.469_470dup (p.Ser157fs)	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000841728	19	11216050 - 11216051	19	11105374 - 11105375	841728	847200		NC_000019.10:11105374:AG:AGAG
NM_033380.3(COL4A5):c.385-2A>G	COL4A5		not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000841674	X	107814641	X	108571411	841674	852959		NC_000023.11:108571410:A:G
NC_000018.10:g.46649169del	LOXHD1	Q78fs	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000841659	18	44229131	18	46649168	841659	846895		NC_000018.10:46649167:GG:G
NM_004655.4(AXIN2):c.2137C>T (p.Gln713Ter)	AXIN2	Q648*, Q713*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000841462	17	63532442	17	65536324	841462	845980		NC_000017.11:65536323:G:A
NM_000166.6(GJB1):c.199C>T (p.Gln67Ter)	GJB1	Q67*	Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000841323	X	70443756	X	71223906	841323	850245		NC_000023.11:71223905:C:T
NM_001184880.2(PCDH19):c.816_817del (p.Gln272fs)	PCDH19	Q272fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000841308	X	99662779 - 99662780	X	100407781 - 100407782	841308	849496		NC_000023.11:100407780:CC:
NM_031407.7(HUWE1):c.9209G>A (p.Arg3070His)	HUWE1	R3070H	not provided	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000841299	X	53578038	X	53551077	841299	850200		NC_000023.11:53551076:C:T
NM_000271.5(NPC1):c.1250_1253del (p.Lys417fs)	NPC1	K417fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000841247	18	21136280 - 21136283	18	23556316 - 23556319	841247	846704		NC_000018.10:23556315:TGTTTGT:TGT
NM_001145472.3(LOXHD1):c.2741del (p.Gly914fs)	LOXHD1	G264fs, G818fs, G914fs, G1963fs	not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000841246	18	44065090	18	46485127	841246	846886		NC_000018.10:46485126:CCC:CC
NM_172107.4(KCNQ2):c.667T>C (p.Ser223Pro)	KCNQ2	S223P	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000841056	20	62076035	20	63444682	841056	848543		NC_000020.11:63444681:A:G
NM_007254.4(PNKP):c.916_917del (p.Phe306fs)	PNKP	F306fs	Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000841020	19	50365814 - 50365815	19	49862557 - 49862558	841020	847898		NC_000019.10:49862556:AA:
NM_004247.4(EFTUD2):c.1150-2A>G	EFTUD2		not provided	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000840994	17	42942435	17	44865067	840994	851721		NC_000017.11:44865066:T:C
NM_000455.5(STK11):c.261_262dup (p.Ile88fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000840985	19	1207172 - 1207173	19	1207173 - 1207174	840985	847246		NC_000019.10:1207173:GA:GAGA
NM_001754.5(RUNX1):c.45dup (p.Cys16fs)	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000840868	21	36421151 - 36421152	21	35048854 - 35048855	840868	848783		NC_000021.9:35048854:C:CC
NM_004006.3(DMD):c.2804-1G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000840853	X	32490427	X	32472310	840853	851966		NC_000023.11:32472309:C:G
NM_033380.3(COL4A5):c.2041G>A (p.Gly681Ser)	COL4A5	G681S	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000840783	X	107844715	X	108601485	840783	849550		NC_000023.11:108601484:G:A
NM_000178.4(GSS):c.709C>T (p.Arg237Ter)	GSS	R237*	Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000840715	20	33524624	20	34936821	840715	848318		NC_000020.11:34936820:G:A
NM_004655.4(AXIN2):c.1206_1207AG[6] (p.Gly406fs)	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000840708	17	63533938 - 63533939	17	65537820 - 65537821	840708	846035		NC_000017.11:65537820:CTCTCTCTCT:CTCTCTCTCTCT
NM_000487.6(ARSA):c.855-1G>A	ARSA		Metachromatic leukodystrophy	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000840642	22	51064707	22	50626279	840642	851932		NC_000022.11:50626278:C:T
NM_001323289.2(CDKL5):c.1883del (p.Ser628fs)	CDKL5	S628fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000840609	X	18622927	X	18604807	840609	849863		NC_000023.11:18604806:G:
NM_000390.4(CHM):c.1718_1719del (p.Tyr573fs)	CHM	Y573fs, Y425fs	not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000840537	X	85128108 - 85128109	X	85873103 - 85873104	840537	850340		NC_000023.11:85873102:ATA:A
NM_000527.5(LDLR):c.966del (p.Asn322fs)	LDLR	N195fs, N322fs, N281fs, N154fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000840525	19	11221353	19	11110677	840525	847209		NC_000019.10:11110676:C:
NM_000159.4(GCDH):c.428_957-39del	GCDH		Glutaric aciduria, type 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000840282	19	13004385 - 13008073	19	12893571 - 12897259	840282	852308		
NM_000487.6(ARSA):c.433C>T (p.Arg145Ter)	ARSA	R59*, R145*	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000840281	22	51065626	22	50627198	840281	849467		NC_000022.11:50627197:G:A
NM_005359.6(SMAD4):c.1300_1301TA[4] (p.Lys436Ter)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000840266	18	48593547 - 48593548	18	51067177 - 51067178	840266	846926		NC_000018.10:51067177:ATATATA:ATATATATA
NM_004006.3(DMD):c.8596_8600del (p.Leu2866fs)	DMD	L2858fs, L2862fs, L406fs, L137fs, L1525fs, L1522fs, L2743fs, L2866fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000840099	X	31497168 - 31497172	X	31479051 - 31479055	840099	849945		NC_000023.11:31479050:TCAAG:
NM_000444.6(PHEX):c.1105A>T (p.Arg369Ter)	PHEX	R369*	not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000840089	X	22129610	X	22111492	840089	849895		NC_000023.11:22111491:A:T
NM_006915.3(RP2):c.515dup (p.Ser172fs)	RP2		not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000839997	X	46713322 - 46713323	X	46853887 - 46853888	839997	850068		NC_000023.11:46853887:G:GG
NM_001127221.1(CACNA1A):c.2360del (p.Leu787fs)	CACNA1A	L786fs, L790fs, L787fs	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000839990	19	13410090	19	13299276	839990	847371		NC_000019.10:13299275:AA:A
NM_000355.4(TCN2):c.86_87del (p.His29fs)	TCN2	H29fs	Transcobalamin II deficiency	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000839980	22	31006879 - 31006880	22	30610892 - 30610893	839980	849217		NC_000022.11:30610891:AT:
NM_000033.4(ABCD1):c.847C>G (p.His283Asp)	ABCD1	H283D	Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000839969	X	152991568	X	153726113	839969	849739		NC_000023.11:153726112:C:G
NM_000033.4(ABCD1):c.1961T>C (p.Leu654Pro)	ABCD1	L654P	Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000839877	X	153008770	X	153743316	839877	849762		NC_000023.11:153743315:T:C
NM_000377.3(WAS):c.1090C>T (p.Arg364Ter)	WAS	R364*	X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000839782	X	48547207	X	48688818	839782	850100		NC_000023.11:48688817:C:T
NM_000022.4(ADA):c.705del (p.Leu236fs)	ADA	L101fs, L212fs, L236fs	Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000839704	20	43251545	20	44622904	839704	848417		NC_000020.11:44622903:CC:C
NM_001242896.3(DEPDC5):c.319C>T (p.Gln107Ter)	DEPDC5	Q107*	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000839695	22	32162610	22	31766624	839695	849253		NC_000022.11:31766623:C:T
NM_000455.5(STK11):c.598-2A>C	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000839427	19	1220578	19	1220579	839427	852956		NC_000019.10:1220578:A:C
NC_000024.10:g.1288783_1288792del	CSF2RA	N123fs	Surfactant metabolism dysfunction, pulmonary, 4	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000839421	X	1407676 - 1407685	X	1288783 - 1288792	839421	850354		NC_000024.10:1288782:ATTTCTCCTG:
NM_020964.3(EPG5):c.2716C>T (p.Gln906Ter)	EPG5	Q906*	Vici syndrome	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000839415	18	43505706	18	45925740	839415	846866		NC_000018.10:45925739:G:A
NM_001184880.2(PCDH19):c.471dup (p.Ser158fs)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000839360	X	99663124 - 99663125	X	100408126 - 100408127	839360	849502		NC_000023.11:100408126:G:GG
NC_000019.10:g.11120137_11124409del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000839359					839359	851793		
NM_004006.3(DMD):c.2546del (p.Ala849fs)	DMD	A726fs, A845fs, A849fs, A841fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000839334	X	32509470	X	32491353	839334	849991		NC_000023.11:32491352:G:
NM_000159.4(GCDH):c.658G>A (p.Asp220Asn)	GCDH	D220N	Glutaric aciduria, type 1	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000839322	19	13007041	19	12896227	839322	847315		NC_000019.10:12896226:G:A
NM_000117.3(EMD):c.475_476del (p.Ser159fs)	EMD	S159fs	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000839321	X	153609267 - 153609268	X	154380907 - 154380908	839321	849831		NC_000023.11:154380906:AG:
NM_199242.3(UNC13D):c.1650del (p.Glu551fs)	UNC13D	E551fs		Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000839231	17	73831805	17	75835724	839231	846213		NC_000017.11:75835723:T:
NM_005359.6(SMAD4):c.547C>T (p.Gln183Ter)	SMAD4	Q183*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000839230	18	48581243	18	51054873	839230	846911		NC_000018.10:51054872:C:T
NM_000444.6(PHEX):c.68del (p.Leu23fs)	PHEX	L23fs	not provided	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000839198	X	22051191	X	22033073	839198	849886		NC_000023.11:22033072:T:
NM_000271.5(NPC1):c.81G>A (p.Trp27Ter)	NPC1	W27*	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000838982	18	21153515	18	23573551	838982	846709		NC_000018.10:23573550:C:T
NM_001195.5(BFSP1):c.898C>T (p.Gln300Ter)	BFSP1	Q189*, Q300*, Q161*, Q175*	Cataract 33, multiple types	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000838855	20	17479523	20	17498878	838855	848232		NC_000020.11:17498877:G:A
NM_017777.4(MKS1):c.458C>A (p.Ser153Ter)	MKS1	S153*, S143*	Meckel-Gruber syndrome|Joubert syndrome	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000838736	17	56292159	17	58214798	838736	845664		NC_000017.11:58214797:G:T
NM_000444.6(PHEX):c.1303-1G>A	PHEX		not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000838684	X	22151639	X	22133522	838684	853035		NC_000023.11:22133521:G:A
NM_000444.6(PHEX):c.304G>A (p.Gly102Arg)	PHEX	G102R	not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000838440	X	22065284	X	22047166	838440	849888		NC_000023.11:22047165:G:A
NM_004006.3(DMD):c.7378G>T (p.Glu2460Ter)	DMD	E1116*, E1119*, E2337*, E2456*, E2452*, E2460*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000838434	X	31792241	X	31774124	838434	849951		NC_000023.11:31774123:C:A
NM_004006.3(DMD):c.8821G>T (p.Glu2941Ter)	DMD	E212*, E1597*, E2818*, E2941*, E481*, E1600*, E2933*, E2937*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000838351	X	31496339	X	31478222	838351	849941		NC_000023.11:31478221:C:A
NM_006517.5(SLC16A2):c.695del (p.Asn232fs)	SLC16A2	N232fs	Spastic paraplegia	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000838287	X	73744312	X	74524477	838287	850262		NC_000023.11:74524476:AA:A
NM_000527.5(LDLR):c.699_708del (p.Thr235fs)	LDLR	T194fs, T108fs, T235fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000838240	19	11217241 - 11217250	19	11106565 - 11106574	838240	847204		NC_000019.10:11106564:CTGTGGCCACCTGT:CTGT
NM_005359.6(SMAD4):c.1348C>T (p.Gln450Ter)	SMAD4	Q450*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000838211	18	48603047	18	51076677	838211	846927		NC_000018.10:51076676:C:T
NM_000166.6(GJB1):c.504C>A (p.Cys168Ter)	GJB1	C168*	Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000838209	X	70444061	X	71224211	838209	850252		NC_000023.11:71224210:C:A
NM_000489.6(ATRX):c.1727C>A (p.Ser576Ter)	ATRX	S576*, S538*		Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000838105	X	76939021	X	77683529	838105	850314		NC_000023.11:77683528:G:T
NM_004006.3(DMD):c.10224-175_10238del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000838104	X	31196073 - 31196262	X	31177956 - 31178145	838104	852495		
NM_001323289.2(CDKL5):c.1485dup (p.Lys496fs)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000838071	X	18622527 - 18622528	X	18604407 - 18604408	838071	849861		NC_000023.11:18604407:CC:CCC
NM_001353921.2(ARHGEF9):c.945G>A (p.Glu315=)	ARHGEF9		Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000837954	X	62893918	X	63674038	837954	850204		NC_000023.11:63674037:C:T
NM_000152.5(GAA):c.759del (p.Ser254fs)	GAA	S254fs	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000837937	17	78081420	17	80107621	837937	846396		NC_000017.11:80107620:CCC:CC
NM_000390.4(CHM):c.190-2A>G	CHM		not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000837911	X	85233897	X	85978893	837911	852986		NC_000023.11:85978892:T:C
NM_000444.6(PHEX):c.942G>A (p.Trp314Ter)	PHEX	W314*	not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000837876	X	22117132	X	22099014	837876	849893		NC_000023.11:22099013:G:A
NM_001184880.2(PCDH19):c.533del (p.Ile178fs)	PCDH19	I178fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000837774	X	99663063	X	100408065	837774	849500		NC_000023.11:100408064:A:
NM_198270.4(NHS):c.3222del (p.His1074fs)	NHS	H918fs, H1074fs, H1095fs, H897fs	Nance-Horan syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000837673	X	17745511	X	17727391	837673	849850		NC_000023.11:17727390:T:
NM_001127221.1(CACNA1A):c.1650del (p.Phe551fs)	CACNA1A	F550fs, F551fs	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000837522	19	13423504	19	13312690	837522	847374		NC_000019.10:13312689:GG:G
NM_024422.6(DSC2):c.268G>T (p.Glu90Ter)	DSC2	E90*	Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000837489	18	28672150	18	31092187	837489	846763		NC_000018.10:31092186:C:A
NM_004006.3(DMD):c.10797+2T>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000837336	X	31165390	X	31147273	837336	853038		NC_000023.11:31147272:A:T
NM_000528.4(MAN2B1):c.1954G>T (p.Glu652Ter)	MAN2B1	E651*, E652*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000837291	19	12763059	19	12652245	837291	847285		NC_000019.10:12652244:C:A
NM_000528.4(MAN2B1):c.388C>T (p.Gln130Ter)	MAN2B1	Q130*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000836978	19	12776214	19	12665400	836978	847290		NC_000019.10:12665399:G:A
NM_006915.3(RP2):c.322dup (p.Cys108fs)	RP2		not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000836917	X	46713128 - 46713129	X	46853693 - 46853694	836917	850064		NC_000023.11:46853693:TT:TTT
NM_002734.5(PRKAR1A):c.431_440del (p.Asn144fs)	PRKAR1A	N144fs	Carney complex, type 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000836915	17	66519948 - 66519957	17	68523807 - 68523816	836915	846127		NC_000017.11:68523806:ATGAGAGAAG:
NM_000023.4(SGCA):c.658_659del (p.Ala220fs)	SGCA	A220fs	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000836857	17	48246525 - 48246526	17	50169164 - 50169165	836857	845604		NC_000017.11:50169163:CGC:C
NM_000455.5(STK11):c.291-2A>C	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000836771	19	1218414	19	1218415	836771	852846		NC_000019.10:1218414:A:C
NM_004655.4(AXIN2):c.1769_1800dup (p.Gly601fs)	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000836749	17	63533093 - 63533094	17	65536975 - 65536976	836749	845996		NC_000017.11:65536975:GGGGGCCCCTCCTTCCCTGGCGGGCAGGGCCAGG:GGGGGCCCCTCCTTCCCTGGCGGGCAGGGCCAGGGGGCCCCTCCTTCCCTGGCGGGCAGGGCCAGG
NM_000527.5(LDLR):c.579del (p.Asp193fs)	LDLR	D193fs, D152fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000836656	19	11216161	19	11105485	836656	847202		NC_000019.10:11105484:C:
NC_000019.10:g.35848398del	NPHS1		not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000836621	19	36339298	19	35848396	836621	847548		NC_000019.10:35848395:CCC:CC
NM_000152.5(GAA):c.1377dup (p.Glu460fs)	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000836467	17	78083793 - 78083794	17	80109994 - 80109995	836467	846406		NC_000017.11:80109994:C:CC
NM_005359.6(SMAD4):c.533C>A (p.Ser178Ter)	SMAD4	S178*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000836290	18	48581229	18	51054859	836290	846908		NC_000018.10:51054858:C:A
NM_020533.3(MCOLN1):c.192C>A (p.Cys64Ter)	MCOLN1	C64*	Mucolipidosis type IV	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000836263	19	7590007	19	7525121	836263	848129		NC_000019.10:7525120:C:A
NM_000475.5(NR0B1):c.1042del (p.Glu348fs)	NR0B1	E348fs	Congenital adrenal hypoplasia, X-linked|46,XY sex reversal, type 2	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000836245	X	30326439	X	30308322	836245	849921		NC_000023.11:30308321:CC:C
NM_007267.7(TMC6):c.967del (p.Leu323fs)	TMC6	L323fs	Epidermodysplasia verruciformis	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000836197	17	76120185	17	78124104	836197	846322		NC_000017.11:78124103:GGGGG:GGGG
NM_172107.4(KCNQ2):c.1688A>G (p.Asp563Gly)	KCNQ2	D532G, D535G, D545G, D563G	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000836158	20	62044878	20	63413525	836158	848523		NC_000020.11:63413524:T:C
NM_004006.3(DMD):c.3347del (p.Lys1116fs)	DMD	K1116fs, K1108fs, K1112fs, K993fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000836051	X	32481641	X	32463524	836051	849985		NC_000023.11:32463523:TTT:TT
NM_181882.3(PRX):c.607C>T (p.Gln203Ter)	PRX	Q203*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000836047	19	40903652	19	40397745	836047	847710		NC_000019.10:40397744:G:A
NM_007186.6(CEP250):c.5383dup (p.Glu1795fs)	CEP250		not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000835882	20	34091576 - 34091577	20	35503748 - 35503749	835882	848350		NC_000020.11:35503748:GGGG:GGGGG
NM_001256789.3(CACNA1F):c.1234G>T (p.Glu412Ter)	CACNA1F	E412*, E347*	not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000835858	X	49083474	X	49227012	835858	850147		NC_000023.11:49227011:C:A
NM_000527.5(LDLR):c.2113del (p.Ala705fs)	LDLR	A705fs, A537fs, A664fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000835638	19	11231170	19	11120494	835638	847218		NC_000019.10:11120493:GG:G
NM_000033.4(ABCD1):c.994C>T (p.Gln332Ter)	ABCD1	Q332*	Adrenoleukodystrophy	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000835571	X	152994780	X	153729325	835571	849746		NC_000023.11:153729324:C:T
NM_000527.5(LDLR):c.1447del (p.Trp483fs)	LDLR	W315fs, W356fs, W442fs, W483fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000835547	19	11224299	19	11113623	835547	847213		NC_000019.10:11113622:T:
NM_001848.3(COL6A1):c.804+1G>A	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000835438	21	47407569	21	45987655	835438	851863		NC_000021.9:45987654:G:A
NM_000054.6(AVPR2):c.500C>T (p.Ser167Leu)	AVPR2	S167L	not provided	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000835351	X	153171460	X	153906006	835351	849770		NC_000023.11:153906005:C:T
NM_004006.3(DMD):c.6611del (p.Lys2204fs)	DMD	K2081fs, K2196fs, K860fs, K2204fs, K863fs, K2200fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000835263	X	31986459	X	31968342	835263	849956		NC_000023.11:31968341:TTTTTT:TTTTT
NM_006282.5(STK4):c.733C>T (p.Arg245Ter)	STK4	R245*	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000835262	20	43625849	20	44997208	835262	848426		NC_000020.11:44997207:C:T
NM_001127221.1(CACNA1A):c.1638C>A (p.Tyr546Ter)	CACNA1A	Y546*, Y545*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000835237	19	13423516	19	13312702	835237	847375		NC_000019.10:13312701:G:T
NM_001008537.3(NEXMIF):c.635C>G (p.Ser212Ter)	NEXMIF	S212*	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000835200	X	73963757	X	74743922	835200	850292		NC_000023.11:74743921:G:C
NC_000018.10:g.46560479del	LOXHD1	S890fs	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000835121	18	44140440	18	46560477	835121	846892		NC_000018.10:46560476:GGG:GG
NM_014009.4(FOXP3):c.210+1G>A	FOXP3		Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000834992	X	49114752	X	49258295	834992	851974		NC_000023.11:49258294:C:T
NM_000355.4(TCN2):c.1139dup (p.Tyr380Ter)	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000834649	22	31018986 - 31018987	22	30622999 - 30623000	834649	849232		NC_000022.11:30622999:A:AA
NM_000202.8(IDS):c.1452_1453TA[1] (p.Ile485fs)	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000834637	X	148564475 - 148564476	X	149482944 - 149482945	834637	849703		NC_000023.11:149482943:TATAT:TAT
NM_000033.4(ABCD1):c.1172_1175del (p.Leu391fs)	ABCD1	L391fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000834461	X	153001656 - 153001659	X	153736202 - 153736205	834461	849751		NC_000023.11:153736201:TCCT:
NM_000211.5(ITGB2):c.2051_2055dup (p.Leu686fs)	ITGB2			Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000834432	21	46308632 - 46308633	21	44888717 - 44888718	834432	848882		NC_000021.9:44888717:GTAGCG:GTAGCGTAGCG
NM_018684.4(ZC4H2):c.67C>T (p.Gln23Ter)	ZC4H2	Q23*	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834100	X	64141855	X	64921975	834100	822350		NC_000023.11:64921974:G:A
NM_018684.4(ZC4H2):c.426G>A (p.Trp142Ter)	ZC4H2	W142*, W119*	WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834099	X	64139057	X	64919177	834099	822349		NC_000023.11:64919176:C:T
ZC4H2, 195-KB DEL	ZC4H2		WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834098					834098	822348		
NM_018684.4(ZC4H2):c.650A>G (p.Lys217Arg)	ZC4H2	K217R, K194R, S163G	Wieacker Wolff syndrome	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834097	X	64137688	X	64917808	834097	822347		NC_000023.11:64917807:T:C
NM_018684.3:c.274delAG	ZC4H2		WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834096					834096	822346		
NM_018684.4(ZC4H2):c.225+2T>C	ZC4H2		WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000834094	X	64141695	X	64921815	834094	822344		NC_000023.11:64921814:A:G
NM_002340.6(LSS):c.35G>A (p.Gly12Asp)	LSS	G12D	ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834068	21	47648493	21	46228579	834068	822319		NC_000021.9:46228578:C:T
NM_002340.6(LSS):c.1194+5G>A	LSS		ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834067	21	47630597	21	46210683	834067	822318		NC_000021.9:46210682:C:T
NM_002340.6(LSS):c.779G>C (p.Arg260Pro)	LSS	R260P, R180P, R249P	ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834066	21	47636307	21	46216393	834066	822317		NC_000021.9:46216392:C:G
NM_002340.6(LSS):c.2114C>A (p.Thr705Lys)	LSS	T705K, T625K, T694K	ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834065	21	47611103	21	46191189	834065	822316		NC_000021.9:46191188:G:T
NM_002340.6(LSS):c.1547A>G (p.Asn516Ser)	LSS	N516S, N505S, N436S	ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000834064	21	47626603	21	46206689	834064	822315		NC_000021.9:46206688:T:C
NM_001242896.3(DEPDC5):c.4066del (p.Leu1356fs)	DEPDC5	L1278fs, L1328fs, L1347fs, L1356fs, L1256fs, L1325fs, L1334fs	Epilepsy	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000834049	22	32289598	22	31893612	834049	822296		NC_000022.11:31893611:CCC:CC
NM_007363.5(NONO):c.457C>T (p.Arg153Ter)	NONO	R64*, R153*	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000833999	X	70514185	X	71294335	833999	822287		NC_000023.11:71294334:C:T
NC_000022.11:g.(?_31754902)_(31815449_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000833512	22	32150888 - 32211435			833512	821451		
NC_000023.11:g.(?_32545139)_(32645172_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000833501	X	32563256 - 32663289			833501	821739		
NC_000023.11:g.(?_31773950)_(31875383_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000833496	X	31792067 - 31893500			833496	821669		
NC_000023.11:g.(?_31609621)_(32365209_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000833493	X	31627738 - 32383326			833493	821642		
NC_000023.11:g.(?_31932070)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000833487	X	31950187 - 31950354			833487	821688		
NC_000018.10:g.(?_22168362)_(22172289_?)del	GATA6		Atrioventricular septal defect 5	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000833485	18	19748323 - 19752250			833485	821180		
NC_000023.11:g.(?_32644122)_(32651077_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000833459	X	32662239 - 32669194			833459	821756		
NC_000023.11:g.(?_31679365)_(31968524_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000833441	X	31697482 - 31986641			833441	821660		
NC_000022.11:g.(?_29603989)_(29636886_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000833432	22	29999978 - 30032875			833432	821438		
NC_000018.10:g.(?_55234528)_(55234703_?)del	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000833431	18	52901759 - 52901934			833431	821193		
NC_000023.11:g.(?_31773950)_(32573856_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000833410	X	31792067 - 32591973			833410	821673		
NC_000023.11:g.(?_31444471)_(31658154_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000833401	X	31462588 - 31676271			833401	821630		
NC_000023.11:g.(?_31932070)_(31968524_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000833396	X	31950187 - 31986641			833396	821689		
NC_000023.11:g.(?_40070953)_(40077949_?)dup	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000833394	X	39930206 - 39937202			833394	821790		
NC_000019.10:g.(?_11089282)_(11100355_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000833382	19	11199958 - 11211031			833382	821214		
NC_000023.11:g.(?_85864630)_(85911338_?)del	CHM		not provided	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000833335	X	85119635 - 85166343			833335	821804		
NC_000023.11:g.(?_32484909)_(32501852_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000833327	X	32503026 - 32519969			833327	821731		
NC_000020.11:g.(?_46709727)_(46733844_?)del	SLC2A10		Arterial tortuosity syndrome	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000833326	20	45338366 - 45362483			833326	821332		
NC_000023.11:g.(?_32809483)_(32823850_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000833308	X	32827600 - 32841967			833308	821763		
NC_000023.11:g.(?_32342090)_(32849830_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000833307	X	32360207 - 32867947			833307	821713		
NC_000022.11:g.(?_31760636)_(31760722_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000833301	22	32156622 - 32156708			833301	821452		
NC_000023.11:g.(?_8532975)_(8597276_?)del	ANOS1			Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000833273	X	8501016 - 8565317			833273	821801		
NC_000023.11:g.(?_32573520)_(32573856_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000833269	X	32591637 - 32591973			833269	821744		
NC_000023.11:g.(?_32216906)_(32573856_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000833262	X	32235023 - 32591973			833262	821697		
NC_000021.9:g.(?_32727926)_(32728060_?)del	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000833242	21	34100237 - 34100371			833242	821362		
NC_000019.10:g.(?_35835695)_(35835771_?)del	NPHS1		not provided	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, single submitter	VCV000833231	19	36326597 - 36326673			833231	821249		
NC_000023.11:g.(?_31314406)_(31820093_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000833222	X	31332523 - 31838210			833222	821624		
NC_000023.11:g.(?_31657980)_(31968524_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, single submitter	VCV000833190	X	31676097 - 31986641			833190	821654		
NC_000019.10:g.(?_13087969)_(13094669_?)del	NFIX		Sotos syndrome 2|Marshall-Smith syndrome	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000833187	19	13198783 - 13205483			833187	821239		
NC_000023.11:g.(?_32545149)_(32595886_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000833180	X	32563266 - 32614003			833180	821741		
NC_000023.11:g.(?_31609621)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000833176	X	31627738 - 31950354			833176	821639		
NC_000023.11:g.(?_32809483)_(32844870_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000833120	X	32827600 - 32862987			833120	821764		
NC_000021.9:g.(?_45986526)_(45987654_?)del	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000833097	21	47406440 - 47407568			833097	821381		
NC_000020.11:g.(?_63438605)_(63446857_?)del	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000833088	20	62069958 - 62078210			833088	821342		
NC_000023.11:g.(?_85878965)_(85903741_?)del	CHM		not provided	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000833081	X	85133970 - 85158746			833081	821805		
NC_000023.11:g.(?_31875178)_(32217073_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000833073	X	31893295 - 32235190			833073	821685		
NC_000021.9:g.(?_34880547)_(34880723_?)del	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000833071	21	36252844 - 36253020			833071	821368		
NC_000023.10:g.(?_46736940)_(46739204_?)del	RP2		not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000833065	X	46736940 - 46739204			833065	821505		
NC_000023.11:g.(?_31836708)_(31836829_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000833063	X	31854825 - 31854946			833063	821676		
NC_000023.11:g.(?_18929208)_(18983952_?)del	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000833058	X	18947326 - 19002070			833058	821579		
NC_000023.11:g.(?_31836708)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000833041	X	31854825 - 31950354			833041	821677		
NC_000023.11:g.(?_31657980)_(31679596_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 31, 2019)	criteria provided, single submitter	VCV000833040	X	31676097 - 31697713			833040	821647		
NC_000023.11:g.(?_31875178)_(31875383_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000833025	X	31893295 - 31893500			833025	821682		
NC_000023.11:g.(?_31657980)_(31729758_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000833017	X	31676097 - 31747875			833017	821648		
NC_000023.11:g.(?_32614283)_(32645172_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000833002	X	32632400 - 32663289			833002	821749		
NC_000023.11:g.(?_32461199)_(32849830_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000832986	X	32479316 - 32867947			832986	821727		
NC_000023.11:g.(?_31627663)_(31820093_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000832974	X	31645780 - 31838210			832974	821645		
NC_000017.11:g.(?_68512379)_(68524087_?)del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000832947	17	66508520 - 66520228			832947	821152		
NC_000017.11:g.(?_80213794)_(80215148_?)del	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000832945	17	78187593 - 78188947			832945	821175		
NC_000023.11:g.(?_32216906)_(32287711_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000832941	X	32235023 - 32305828			832941	821693		
NC_000023.11:g.(?_31496788)_(31627862_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832856	X	31514905 - 31645979			832856	821632		
NC_000023.11:g.(?_31348546)_(31507463_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000832853	X	31366663 - 31525580			832853	821628		
NC_000023.11:g.(?_31773950)_(31836829_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000832846	X	31792067 - 31854946			832846	821668		
NC_000023.11:g.(?_32501745)_(32501852_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000832831	X	32519862 - 32519969			832831	821734		
NC_000023.11:g.(?_32216906)_(32217073_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832830	X	32235023 - 32235190			832830	821692		
NC_000023.11:g.(?_31819965)_(31875383_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832826	X	31838082 - 31893500			832826	821674		
NC_000023.11:g.(?_31657980)_(31774202_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000832817	X	31676097 - 31792319			832817	821650		
NC_000019.10:g.(?_11123164)_(11131359_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000832800	19	11233840 - 11242035			832800	821228		
NC_000023.11:g.(?_32697860)_(32699303_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000832794	X	32715977 - 32717420			832794	821761		
NC_000023.11:g.(?_32461199)_(32844870_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000832786	X	32479316 - 32862987			832786	821726		
NC_000019.10:g.(?_11113268)_(11117013_?)dup	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000832779	19	11223944 - 11227689			832779	821221		
NC_000020.11:g.(?_44636217)_(44636298_?)del	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000832749	20	43264858 - 43264939			832749	821327		
NC_000023.11:g.(?_37780009)_(37810937_?)del	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000832747	X	37639262 - 37670190			832747	821780		
NC_000022.11:g.(?_38132114)_(38135084_?)del	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000832743	22	38528121 - 38531091			832743	821460		
NC_000023.11:g.(?_22168312)_(22247953_?)del	PHEX		not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000832733	X	22186429 - 22266070			832733	821600		
NC_000023.11:g.(?_31773950)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000832725	X	31792067 - 31950354			832725	821670		
NC_000023.11:g.(?_31965029)_(31968524_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000832721	X	31983146 - 31986641			832721	821690		
NC_000023.11:g.(?_32816458)_(32816650_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000832720	X	32834575 - 32834767			832720	821765		
NC_000023.11:g.(?_31819965)_(31965029_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000832703	X	31838082 - 31983146			832703	821675		
NC_000019.10:g.(?_11102654)_(11102796_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000832702	19	11213330 - 11213472			832702	821216		
NC_000023.11:g.(?_32595747)_(32651077_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV000832701	X	32613864 - 32669194			832701	821748		
NC_000020.11:g.(?_34457370)_(34457494_?)del	ITCH		Autoimmune disease, syndromic multisystem	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000832691	20	33045175 - 33045299			832691	821318		
NC_000023.10:g.(?_53448825)_(53449569_?)del	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000832686	X	53448825 - 53449569			832686	821513		
NC_000023.11:g.(?_32216906)_(32699303_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000832679	X	32235023 - 32717420			832679	821700		
NC_000023.10:g.(?_48542233)_(48542384_?)del	WAS		Wiskott-Aldrich syndrome|X-linked thrombocytopenia with normal platelets|	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000832668	X	48542233 - 48542384			832668	821507		
NC_000021.9:g.(?_34799291)_(35049298_?)del	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000832666	21	36171588 - 36421595			832666	821366		
NC_000023.11:g.(?_32380500)_(32699303_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000832662	X	32398617 - 32717420			832662	821714		
NC_000023.11:g.(?_22133523)_(22133624_?)del	PHEX		not provided	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000832656	X	22151640 - 22151741			832656	821595		
NC_000020.11:g.(?_63433725)_(63433923_?)del	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000832655	20	62065078 - 62065276			832655	821341		
NC_000023.11:g.(?_31729631)_(31932227_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000832653	X	31747748 - 31950344			832653	821665		
NC_000023.11:g.(?_22190444)_(22190502_?)del	PHEX		not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832638	X	22208561 - 22208619			832638	821605		
NC_000023.11:g.(?_32380500)_(32816650_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000832637	X	32398617 - 32834767			832637	821715		
NC_000023.11:g.(?_32342090)_(32699303_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832628	X	32360207 - 32717420			832628	821712		
NC_000023.11:g.(?_22178273)_(22178376_?)del	PHEX		not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000832616	X	22196390 - 22196493			832616	821602		
NC_000018.10:g.(?_2931236)_(2951376_?)del	LPIN2		Majeed syndrome	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832615	18	2931234 - 2951374			832615	821182		
NC_000023.11:g.(?_31773950)_(31774202_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000832608	X	31792067 - 31792319			832608	821666		
NC_000023.11:g.(?_31836718)_(31875373_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000832588	X	31854835 - 31893490			832588	821681		
NC_000019.10:g.(?_11089282)_(11131359_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000832568	19	11199958 - 11242035			832568	821215		
NC_000023.11:g.(?_32518008)_(32699293_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832561	X	32536125 - 32717410			832561	821738		
NC_000019.10:g.(?_11116849)_(11117013_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000832559	19	11227525 - 11227689			832559	821226		
NC_000023.11:g.(?_22033006)_(22077702_?)del	PHEX		not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000832549	X	22051124 - 22095820			832549	821586		
NC_000019.10:g.(?_11116084)_(11117013_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000832527	19	11226760 - 11227689			832527	821223		
NC_000017.11:g.(?_74274200)_(74289746_?)del	DNAI2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000832484	17	72270339 - 72285885			832484	821154		
NC_000019.10:g.(?_43506840)_(43527187_?)del	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000832480	19	44010992 - 44031339			832480	821262		
NC_000021.9:g.(?_34792125)_(34892973_?)del	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000832471	21	36164422 - 36265270			832471	821365		
NC_000023.11:g.(?_31323588)_(31323668_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832468	X	31341705 - 31341785			832468	821625		
NC_000022.11:g.(?_29603999)_(29642295_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000832466	22	29999988 - 30038284			832466	821444		
NC_000023.11:g.(?_31729621)_(31879410_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832462	X	31747738 - 31897527			832462	821663		
NC_000023.11:g.(?_31609621)_(31679596_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000832445	X	31627738 - 31697713			832445	821637		
NC_000023.11:g.(?_31679365)_(31679596_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000832439	X	31697482 - 31697713			832439	821655		
NC_000023.11:g.(?_32650983)_(32849830_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000832433	X	32669100 - 32867947			832433	821759		
NC_000023.11:g.(?_100402504)_(100408617_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832431	X	99657502 - 99663615			832431	821538		
NC_000023.11:g.(?_32697860)_(32699303_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000832430	X	32715977 - 32717420			832430	821760		
NC_000023.10:g.(?_132670132)_(132888223_?)del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000832421	X	132670132 - 132888223			832421	821476		
NC_000023.11:g.(?_31875178)_(31879410_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000832411	X	31893295 - 31897527			832411	821683		
NC_000023.11:g.(?_31729621)_(31820093_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000832397	X	31747738 - 31838210			832397	821662		
NC_000023.11:g.(?_32287519)_(32390191_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000832394	X	32305636 - 32408308			832394	821707		
NC_000023.11:g.(?_32411742)_(32472319_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000832393	X	32429859 - 32490436			832393	821717		
NC_000023.11:g.(?_31595570)_(31968524_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000832391	X	31613687 - 31986641			832391	821633		
NC_000023.10:g.(?_48932442)_(48935774_?)del	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000832368	X	48932442 - 48935774			832368	821510		
NC_000023.11:g.(?_31121823)_(32849830_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000832364	X	31139940 - 32867947			832364	821617		
NC_000019.10:g.(?_18073497)_(18073619_?)del	IL12RB1		Immunodeficiency 30	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000832339	19	18184307 - 18184429			832339	821244		
NC_000023.11:g.(?_153736092)_(153743755_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000832309	X	153001546 - 153009209			832309	821568		
NC_000023.11:g.(?_31729621)_(31729758_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000832306	X	31747738 - 31747875			832306	821661		
NC_000023.11:g.(?_22076388)_(22076474_?)del	PHEX		not provided	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832297	X	22094506 - 22094592			832297	821588		
NC_000023.11:g.(?_22047050)_(22047211_?)del	PHEX		not provided	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000832295	X	22065168 - 22065329			832295	821587		
NC_000023.11:g.(?_120431313)_(120470223_?)del	LAMP2		Danon disease	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000832269	X	119565168 - 119604078			832269	821549		
NC_000019.10:g.(?_11102654)_(11106697_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000832264	19	11213330 - 11217373			832264	821217		
NC_000023.11:g.(?_22076388)_(22077702_?)del	PHEX		not provided	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000832250	X	22094506 - 22095820			832250	821589		
NC_000023.11:g.(?_17687722)_(17692488_?)dup	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000832246	X	17705842 - 17710608			832246	821571		
NC_000023.11:g.(?_31836708)_(31968524_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000832226	X	31854825 - 31986641			832226	821679		
NC_000023.11:g.(?_101362153)_(101362709_?)dup	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000832224	X	100617141 - 100617697			832224	821541		
NC_000019.10:g.(?_13300530)_(13300676_?)del	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 23, 2019)	criteria provided, single submitter	VCV000832219	19	13411344 - 13411490			832219	821242		
NC_000023.11:g.(?_32816458)_(33211312_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000832216	X	32834575 - 33229429			832216	821768		
NC_000023.11:g.(?_2934812)_(2958455_?)del	ARSL			Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000832204	X	2852853 - 2876496			832204	821613		
NC_000023.11:g.(?_133753472)_(133754186_?)del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000832201	X	132887499 - 132888213			832201	821556		
NC_000023.11:g.(?_22114458)_(22114586_?)del	PHEX		not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000832195	X	22132576 - 22132704			832195	821594		
NC_000023.11:g.(?_32216906)_(32442157_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000832183	X	32235023 - 32460274			832183	821695		
NC_000023.11:g.(?_31729621)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000832182	X	31747738 - 31950354			832182	821664		
NC_000023.11:g.(?_31965029)_(32614463_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000832179	X	31983146 - 32632580			832179	821691		
NC_000023.11:g.(?_32216906)_(32699303_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000832171	X	32235023 - 32717420			832171	821701		
NC_000023.11:g.(?_18628351)_(18628607_?)del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000832153	X	18646471 - 18646727			832153	821576		
NC_000023.11:g.(?_32390061)_(32823850_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000832148	X	32408178 - 32841967			832148	821716		
NC_000019.10:g.(?_41397818)_(41414167_?)del	BCKDHA		Maple syrup urine disease	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000832142	19	41903723 - 41920072			832142	821257		
NC_000023.11:g.(?_32491267)_(32545344_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000832132	X	32509384 - 32563461			832132	821733		
NC_000023.11:g.(?_32644122)_(32645162_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000832129	X	32662239 - 32663279			832129	821755		
NC_000019.10:g.(?_11120086)_(11129676_?)dup	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000832107	19	11230762 - 11240352			832107	821227		
NC_000019.10:g.(?_13298534)_(13300666_?)del	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000832102	19	13409348 - 13411480			832102	821241		
NC_000023.11:g.(?_72644342)_(72676170_?)del	PHKA1		Glycogen storage disease IXd	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000832096	X	71864192 - 71896020			832096	821798		
NC_000023.11:g.(?_32452609)_(32699303_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000832095	X	32470726 - 32717420			832095	821723		
NC_000023.11:g.(?_69957017)_(69957142_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000832082	X	69176867 - 69176992			832082	821795		
NC_000017.11:g.(?_80109935)_(80113376_?)del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000832072	17	78083734 - 78087175			832072	821174		
NC_000023.11:g.(?_31879410)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000832063	X	31897527 - 31950354			832063	821686		
NC_000023.11:g.(?_32461199)_(32573856_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000832056	X	32479316 - 32591973			832056	821725		
NC_000023.11:g.(?_22219036)_(22247953_?)del	PHEX		not provided	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV000832049	X	22237153 - 22266070			832049	821610		
NC_000022.11:g.(?_41131368)_(41140277_?)del	EP300		Rubinstein-Taybi syndrome 2|Colorectal cancer	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832045	22	41527372 - 41536281			832045	821465		
NC_000023.10:g.(?_149831896)_(149832092_?)del	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000831990	X	149831896 - 149832092			831990	821483		
NC_000023.11:g.(?_100402504)_(100402871_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000831979	X	99657502 - 99657869			831979	821537		
NC_000023.11:g.(?_32573520)_(32849830_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000831978	X	32591637 - 32867947			831978	821745		
NC_000023.11:g.(?_18595328)_(18595448_?)del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000831965	X	18613448 - 18613568			831965	821575		
NC_000022.11:g.(?_19755901)_(19759687_?)del	TBX1		DiGeorge sequence	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000831941	22	19743424 - 19747210			831941	821399		
NC_000023.11:g.(?_38367271)_(38367449_?)del	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000831937	X	38226524 - 38226702			831937	821789		
NC_000023.11:g.(?_32287519)_(32823850_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000831932	X	32305636 - 32841967			831932	821708		
NC_000023.11:g.(?_32614293)_(32816650_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000831899	X	32632410 - 32834767			831899	821751		
NC_000022.11:g.(?_31754902)_(31784895_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831884	22	32150888 - 32180881			831884	821450		
NC_000023.11:g.(?_32438231)_(32573856_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000831870	X	32456348 - 32591973			831870	821720		
NC_000023.11:g.(?_31348546)_(31507463_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000831830	X	31366663 - 31525580			831830	821629		
NC_000023.11:g.(?_32565692)_(32626362_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000831817	X	32583809 - 32644479			831817	821743		
NC_000021.9:g.(?_36765002)_(36767295_?)del	HLCS		Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000831787	21	38137303 - 38139596			831787	821370		
NC_000019.10:g.(?_1218407)_(1222016_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000831774	19	1218406 - 1222015			831774	821234		
NC_000019.10:g.(?_11116084)_(11117013_?)dup	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000831771	19	11226760 - 11227689			831771	821224		
NC_000023.11:g.(?_74739385)_(74745670_?)del	NEXMIF		not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000831750	X	73959220 - 73965505			831750	821799		
NC_000019.10:g.(?_11110613)_(11117013_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000831736	19	11221289 - 11227689			831736	821219		
NC_000023.11:g.(?_31679365)_(31879410_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000831711	X	31697482 - 31897527			831711	821658		
NC_000023.11:g.(?_32595747)_(32595886_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000831707	X	32613864 - 32614003			831707	821747		
NC_000018.10:g.(?_2926703)_(2929178_?)del	LPIN2		Majeed syndrome	Pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000831706	18	2926701 - 2929176			831706	821181		
NC_000021.9:g.(?_36938822)_(36939004_?)del	HLCS		Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, single submitter	VCV000831691	21	38311122 - 38311304			831691	821372		
NC_000023.11:g.(?_22111467)_(22111560_?)del	PHEX		not provided	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000831666	X	22129585 - 22129678			831666	821592		
NC_000018.10:g.(?_51029921)_(51078477_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000831665	18	48556291 - 48604847			831665	821189		
NC_000019.10:g.(?_1218407)_(1226657_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000831632	19	1218406 - 1226656			831632	821237		
NC_000023.11:g.(?_136648058)_(136654450_?)del	CD40LG			Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000831629	X	135730217 - 135736609			831629	821561		
NC_000022.11:g.(?_40346510)_(40366542_?)del	ADSL		Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000831615	22	40742514 - 40762546			831615	821462		
NC_000018.10:g.(?_58671624)_(58747862_?)del	MALT1		Immunodeficiency 12	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831577	18	56338856 - 56415094			831577	821194		
NC_000023.11:g.(?_31679365)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000831575	X	31697482 - 31950354			831575	821659		
NC_000018.10:g.(?_51030213)_(51078467_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000831568	18	48556583 - 48604837			831568	821190		
NC_000017.11:g.(?_80108677)_(80113386_?)del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000831500	17	78082476 - 78087185			831500	821173		
NC_000020.10:g.(?_8113279)_(8352117_?)del	PLCB1		Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000831489	20	8113279 - 8352117			831489	821314		
NC_000023.11:g.(?_31609621)_(31836829_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000831464	X	31627738 - 31854946			831464	821638		
NC_000017.11:g.(?_74299708)_(74305452_?)del	DNAI2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000831419	17	72295847 - 72301591			831419	821155		
NC_000023.11:g.(?_22219036)_(22221743_?)del	PHEX		not provided	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000831408	X	22237153 - 22239860			831408	821609		
NC_000023.11:g.(?_32287519)_(32287711_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000831406	X	32305636 - 32305828			831406	821703		
NC_000019.10:g.(?_1218407)_(1223182_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000831395	19	1218406 - 1223181			831395	821235		
NC_000023.11:g.(?_32614293)_(32614463_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000831388	X	32632410 - 32632580			831388	821750		
NC_000023.11:g.(?_22033006)_(22047211_?)del	PHEX		not provided	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000831387	X	22051124 - 22065329			831387	821585		
NC_000019.10:g.(?_1206914)_(1226647_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000831379	19	1206913 - 1226646			831379	821233		
NC_000022.11:g.(?_31792013)_(31792122_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000831318	22	32187999 - 32188108			831318	821455		
NC_000023.11:g.(?_123885637)_(123907201_?)del	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000831298	X	123019487 - 123041051			831298	821552		
NC_000023.11:g.(?_32463429)_(32595886_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000831288	X	32481546 - 32614003			831288	821728		
NC_000019.10:g.(?_45584613)_(45584774_?)del	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000831267	19	46087871 - 46088032			831267	821265		
NC_000022.11:g.(?_41151813)_(41152370_?)del	EP300		Rubinstein-Taybi syndrome 2|Colorectal cancer	Pathogenic(Last reviewed: Apr 22, 2019)	criteria provided, single submitter	VCV000831260	22	41547817 - 41548374			831260	821466		
NC_000023.11:g.(?_22111467)_(22114586_?)del	PHEX		not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000831252	X	22129585 - 22132704			831252	821593		
NC_000023.11:g.(?_32644122)_(32823850_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000831235	X	32662239 - 32841967			831235	821758		
NC_000023.11:g.(?_32216906)_(32614463_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000831234	X	32235023 - 32632580			831234	821699		
NC_000023.11:g.(?_22212904)_(22212958_?)del	PHEX		not provided	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000831228	X	22231021 - 22231075			831228	821607		
NC_000022.11:g.(?_29671816)_(29678333_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000831227	22	30067805 - 30074322			831227	821449		
NC_000019.10:g.(?_11110613)_(11117013_?)dup	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000831219	19	11221289 - 11227689			831219	821220		
NC_000019.10:g.(?_11102654)_(11107528_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000831216	19	11213330 - 11218204			831216	821218		
NC_000023.11:g.(?_22190444)_(22227611_?)del	PHEX		not provided	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000831186	X	22208561 - 22245728			831186	821606		
NC_000017.11:g.(?_46923173)_(46940633_?)del	GOSR2		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000831185	17	45000539 - 45017999			831185	821100		
NC_000023.11:g.(?_31627663)_(31774202_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000831182	X	31645780 - 31792319			831182	821644		
NC_000019.10:g.(?_55025218)_(55038236_?)del	GP6		not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000831173	19	55536586 - 55549604			831173	821292		
NC_000023.11:g.(?_32287519)_(32386475_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000831164	X	32305636 - 32404592			831164	821706		
NC_000019.10:g.(?_11116084)_(11131359_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000831152	19	11226760 - 11242035			831152	821225		
NC_000020.11:g.(?_3227407)_(3239200_?)del	SLC4A11		not provided	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000831149	20	3208053 - 3219846			831149	821316		
NC_000023.11:g.(?_32545149)_(32573856_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000831132	X	32563266 - 32591973			831132	821740		
NC_000022.11:g.(?_29603999)_(29604122_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000831122	22	29999988 - 30000111			831122	821442		
NC_000023.11:g.(?_32626362)_(32849830_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000831116	X	32644479 - 32867947			831116	821753		
NC_000023.11:g.(?_18506933)_(18604888_?)del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000831097	X	18525053 - 18623008			831097	821573		
NC_000023.11:g.(?_33174335)_(33211366_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000831094	X	33192452 - 33229483			831094	821776		
NC_000023.11:g.(?_123885637)_(123888738_?)del	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000831093	X	123019487 - 123022588			831093	821551		
NC_000017.11:g.(?_68522746)_(68530459_?)del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000831062	17	66518887 - 66526600			831062	821153		
NC_000023.11:g.(?_31478096)_(31774202_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000831052	X	31496213 - 31792319			831052	821631		
NC_000023.11:g.(?_32468488)_(32849830_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000831022	X	32486605 - 32867947			831022	821729		
NC_000023.11:g.(?_32816458)_(32823850_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000831003	X	32834575 - 32841967			831003	821766		
NC_000023.11:g.(?_31323598)_(31836819_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000831002	X	31341715 - 31854936			831002	821626		
NC_000023.11:g.(?_18506933)_(18510874_?)del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000830999	X	18525053 - 18528994			830999	821572		
NC_000023.11:g.(?_31773950)_(31932237_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000830992	X	31792067 - 31950354			830992	821671		
NC_000023.11:g.(?_32844773)_(33020210_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000830991	X	32862890 - 33038327			830991	821770		
NC_000019.9:g.(?_11541499)_(11545857_?)del	CCDC151		Ciliary dyskinesia, primary, 30	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000830990	19	11541499 - 11545857			830990	821299		
NC_000023.10:g.(?_85115185)_(85303566_?)del	CHM		not provided	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000830989	X	85115185 - 85303566			830989	821530		
NC_000023.11:g.(?_153688555)_(153688856_?)del	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000830977	X	152954010 - 152954311			830977	821567		
NC_000019.10:g.(?_11116084)_(11116222_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000830959	19	11226760 - 11226898			830959	821222		
NC_000023.11:g.(?_108440116)_(108696388_?)del	COL4A5		not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000830937	X	107683346 - 107939618			830937	821544		
NC_000023.11:g.(?_31657980)_(31836829_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000830935	X	31676097 - 31854946			830935	821652		
NC_000023.10:g.(?_132670146)_(133119482_?)del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000830889	X	132670146 - 133119482			830889	821478		
NC_000019.10:g.(?_43511427)_(43511576_?)del	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000830887	19	44015579 - 44015728			830887	821263		
NC_000023.11:g.(?_32517998)_(32651077_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000830885	X	32536115 - 32669194			830885	821737		
NC_000023.11:g.(?_32411742)_(32651077_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000830882	X	32429859 - 32669194			830882	821718		
NC_000023.11:g.(?_86027491)_(86047532_?)del	CHM		not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000830879	X	85282495 - 85302536			830879	821808		
NC_000022.11:g.(?_29658157)_(29661364_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000830877	22	30054146 - 30057353			830877	821447		
NC_000023.11:g.(?_32644122)_(32644323_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000830845	X	32662239 - 32662440			830845	821754		
NC_000023.11:g.(?_32501745)_(32545344_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000830826	X	32519862 - 32563461			830826	821736		
NC_000023.11:g.(?_31260945)_(31261664_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000830818	X	31279062 - 31279781			830818	821623		
NC_000019.10:g.(?_40403696)_(40403872_?)del	PRX		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000830805	19	40909603 - 40909779			830805	821255		
NC_000023.11:g.(?_31348546)_(31364153_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000830801	X	31366663 - 31382270			830801	821627		
NC_000023.11:g.(?_22178273)_(22190502_?)del	PHEX		not provided	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000830800	X	22196390 - 22208619			830800	821603		
NC_000023.10:g.(?_132838213)_(132888223_?)del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000830784	X	132838213 - 132888223			830784	821479		
NC_000023.11:g.(?_37780009)_(37782203_?)del	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000830772	X	37639262 - 37641456			830772	821779		
NC_000023.11:g.(?_32287519)_(32310286_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000830762	X	32305636 - 32328403			830762	821704		
NC_000023.11:g.(?_134500010)_(134500097_?)del	HPRT1		Lesch-Nyhan syndrome|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830749	X	133634040 - 133634127			830749	821558		
NC_000023.11:g.(?_32816458)_(32844870_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000830715	X	32834575 - 32862987			830715	821767		
NC_000023.11:g.(?_31657980)_(31820093_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 28, 2019)	criteria provided, single submitter	VCV000830712	X	31676097 - 31838210			830712	821651		
NC_000023.11:g.(?_31836708)_(31965029_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000830691	X	31854825 - 31983146			830691	821678		
NC_000023.10:g.(?_153609093)_(153609182_?)del	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000830683	X	153609093 - 153609182			830683	821493		
NC_000023.11:g.(?_32216906)_(32595886_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000830677	X	32235023 - 32614003			830677	821698		
NC_000023.11:g.(?_153736102)_(153743735_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000830672	X	153001556 - 153009189			830672	821569		
NC_000023.11:g.(?_18657640)_(18657665_?)del	RS1		not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000830667	X	18675760 - 18675785			830667	821578		
NC_000023.11:g.(?_31609621)_(32217073_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000830664	X	31627738 - 32235190			830664	821641		
NC_000019.10:g.(?_1218407)_(1226647_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000830663	19	1218406 - 1226646			830663	821236		
NC_000023.11:g.(?_22033006)_(22033123_?)del	PHEX		not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000830652	X	22051124 - 22051241			830652	821583		
NC_000023.11:g.(?_153736102)_(153743745_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000830642	X	153001556 - 153009199			830642	821570		
NC_000023.11:g.(?_32216906)_(33211366_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000830622	X	32235023 - 33229483			830622	821702		
NC_000023.11:g.(?_22007157)_(22038537_?)del	PHEX		not provided	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000830617	X	22025275 - 22056655			830617	821582		
NC_000023.11:g.(?_38352331)_(38352793_?)del	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000830543	X	38211584 - 38212046			830543	821787		
NC_000023.10:g.(?_148577857)_(148579858_?)del	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000830530	X	148577857 - 148579858			830530	821480		
NC_000023.11:g.(?_31875178)_(32217073_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000830499	X	31893295 - 32235190			830499	821684		
NC_000023.11:g.(?_85956153)_(85956378_?)del	CHM		not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000830498	X	85211158 - 85211383			830498	821806		
NC_000020.11:g.(?_44651565)_(44651768_?)del	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Jun 23, 2019)	criteria provided, single submitter	VCV000830495	20	43280206 - 43280409			830495	821329		
NC_000017.11:g.(?_68512379)_(68515586_?)del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000830487	17	66508520 - 66511727			830487	821151		
NC_000023.11:g.(?_31657980)_(31932237_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000830485	X	31676097 - 31950354			830485	821653		
NC_000023.11:g.(?_69957007)_(69957152_?)dup	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000830481	X	69176857 - 69177002			830481	821794		
NC_000023.11:g.(?_22033006)_(22038537_?)del	PHEX		not provided	Pathogenic(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000830478	X	22051124 - 22056655			830478	821584		
NC_000019.10:g.(?_11127998)_(11131359_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000830441	19	11238674 - 11242035			830441	821229		
NC_000023.11:g.(?_31609621)_(31679596_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000830422	X	31627738 - 31697713			830422	821636		
NC_000023.11:g.(?_31169433)_(31507463_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000830419	X	31187550 - 31525580			830419	821620		
NM_001007228.2(SPOP):c.248A>G (p.Tyr83Cys)	SPOP	Y83C	NEURODEVELOPMENTAL DISORDER WITH RELATIVE MACROCEPHALY AND WITH OR WITHOUT CARDIAC OR ENDOCRINE ANOMALIES	Pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000830360	17	47696700	17	49619338	830360	818732		NC_000017.11:49619337:T:C
NM_001007228.2(SPOP):c.412C>T (p.Arg138Cys)	SPOP	R138C	NEURODEVELOPMENTAL DISORDER WITH RELATIVE MACROCEPHALY AND WITH OR WITHOUT CARDIAC OR ENDOCRINE ANOMALIES	Pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000830359	17	47696411	17	49619049	830359	818731		NC_000017.11:49619048:G:A
NM_001007228.2(SPOP):c.73A>G (p.Thr25Ala)	SPOP	T25A	NEURODEVELOPMENTAL DISORDER WITH RELATIVE MACROCEPHALY AND WITH OR WITHOUT CARDIAC OR ENDOCRINE ANOMALIES	Pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000830358	17	47700100	17	49622738	830358	818730		NC_000017.11:49622737:T:C
NM_001007228.2(SPOP):c.395G>T (p.Gly132Val)	SPOP	G132V	NEURODEVELOPMENTAL DISORDER WITH RELATIVE MACROCEPHALY AND WITH OR WITHOUT CARDIAC OR ENDOCRINE ANOMALIES	Pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000830357	17	47696428	17	49619066	830357	818729		NC_000017.11:49619065:C:A
NM_001007228.2(SPOP):c.430G>A (p.Asp144Asn)	SPOP	D144N	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000830356	17	47696393	17	49619031	830356	818728		NC_000017.11:49619030:C:T
NM_001007228.2(SPOP):c.362G>A (p.Arg121Gln)	SPOP	R121Q	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000830355	17	47696461	17	49619099	830355	818727		NC_000017.11:49619098:C:T
NM_000074.3(CD40LG):c.359del (p.Pro120fs)	CD40LG	P120fs		Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000830068	X	135738526	X	136656367	830068	818400		NC_000023.11:136656366:CC:C
NM_033380.3(COL4A5):c.1902del (p.Gly635fs)	COL4A5	G635fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000830035	X	107842050	X	108598820	830035	818352		NC_000023.11:108598819:AAAAA:AAAA
NM_000444.6(PHEX):c.135_136del (p.Leu47fs)	PHEX	L47fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 2, 2019)	no assertion criteria provided	VCV000829959	X	22056603 - 22056604	X	22038485 - 22038486	829959	818370		NC_000023.11:22038484:AA:
NM_033380.3(COL4A5):c.1933C>T (p.Gln645Ter)	COL4A5	Q645*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000829955	X	107842085	X	108598855	829955	818353		NC_000023.11:108598854:C:T
NM_033380.3(COL4A5):c.2510-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 25, 2019)	no assertion criteria provided	VCV000829947	X	107863488	X	108620258	829947	818355		NC_000023.11:108620257:G:T
NM_033380.3(COL4A5):c.4747_4748CA[1] (p.His1583fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 19, 2019)	no assertion criteria provided	VCV000829935	X	107938077 - 107938078	X	108694847 - 108694848	829935	818367		NC_000023.11:108694846:CACA:CA
NM_033380.3(COL4A5):c.3295del (p.Ser1099fs)	COL4A5	S1099fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000829918	X	107898608	X	108655378	829918	818361		NC_000023.11:108655377:TT:T
NM_033380.3(COL4A5):c.4197_4200delinsGGG (p.Pro1401fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 18, 2019)	no assertion criteria provided	VCV000829907	X	107925099 - 107925102	X	108681869 - 108681872	829907	818364		NC_000023.11:108681868:AGGA:GGG
NM_033380.3(COL4A5):c.4197del (p.Gly1400fs)	COL4A5	G1394fs, G1400fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 18, 2019)	no assertion criteria provided	VCV000829905	X	107925098	X	108681868	829905	818363		NC_000023.11:108681867:AA:A
NM_000377.3(WAS):c.1423C>T (p.Gln475Ter)	WAS	Q475*	X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000829893	X	48547793	X	48689404	829893	818375		NC_000023.11:48689403:C:T
NM_021219.4:c.177_180del	JAM2		BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829545					829545	818134		
NC_000021.9:g.25698676dup	JAM2		BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829543					829543	818133		
NM_021219.4(JAM2):c.685C>T (p.Arg229Ter)	JAM2	R229*, R193*	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829541	21	27074569	21	25702257	829541	818132		NC_000021.9:25702256:C:T
NM_021219.4(JAM2):c.323G>A (p.Arg108His)	JAM2	R108H, R72H	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829539	21	27066149	21	25693837	829539	818131		NC_000021.9:25693836:G:A
NM_021219.4:(67+1_68-1)_(394+1_395-1)del	JAM2		BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829537					829537	818130		
NM_021219.4(JAM2):c.504G>C (p.Trp168Cys)	JAM2	W168C, W132C	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 30, 2020)	no assertion criteria provided	VCV000829535	21	27071098	21	25698786	829535	818129		NC_000021.9:25698785:G:C
NM_021219.4(JAM2):c.1A>G (p.Met1Val)	JAM2	M1V	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829533	21	27012134	21	25639822	829533	818128		NC_000021.9:25639821:A:G
NM_021219.4:c.143del	JAM2		BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Mar 27, 2020)	no assertion criteria provided	VCV000829531					829531	818127		
NM_001284333.2(TLK2):c.968+1G>A	TLK2		MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000828197	17	60642499	17	62565138	828197	816534		NC_000017.11:62565137:G:A
NM_003688.3(CASK):c.1997dup (p.Asn666fs)	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV000828187	X	41413013 - 41413014	X	41553760 - 41553761	828187	816533		NC_000023.11:41553760:TTTTT:TTTTTT
NM_182641.4(BPTF):c.255del (p.Ser86fs)	BPTF	S86fs	NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000828184	17	65822088	17	67825972	828184	816529		NC_000017.11:67825971:CCCCCCCC:CCCCCCC
NM_024022.3(TMPRSS3):c.1195-1G>C	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828127	21	43795978	21	42375869	828127	816510		NC_000021.9:42375868:C:G
NM_004975.4(KCNB1):c.1528G>T (p.Gly510Ter)	KCNB1	G510*	Epileptic encephalopathy, early infantile, 26	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828102	20	47990569	20	49374032	828102	816494		NC_000020.11:49374031:C:A
NM_005450.6(NOG):c.64dup (p.Ala22fs)	NOG		Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000827845	17	54671645 - 54671646	17	56594284 - 56594285	827845	816042		NC_000017.11:56594284:GGG:GGGG
NM_001278116.2(L1CAM):c.1268-1G>A	L1CAM		X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000827844	X	153134408	X	153868953	827844	816043		NC_000023.11:153868952:C:T
NM_000328.3(RPGR):c.919del (p.Thr307fs)	RPGR	T306fs, T307fs, T317fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000827817	X	38163903	X	38304650	827817	816012		NC_000023.11:38304649:T:
NM_006950.3(SYN1):c.1001del (p.Asn334fs)	SYN1	N334fs	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: May 21, 2019)	no assertion criteria provided	VCV000827798	X	47435785	X	47576386	827798	816013		NC_000023.11:47576385:TT:T
NM_078629.4(MSL3):c.969_970AG[1] (p.Glu324fs)	MSL3		Global developmental delay	Pathogenic(Last reviewed: May 21, 2019)	no assertion criteria provided	VCV000827787	X	11783646 - 11783649	X	11765527 - 11765530	827787	816010		NC_000023.11:11765526:AGAGAG:AG
NM_138927.4(SON):c.6920G>A (p.Gly2307Glu)	SON	G2307E, G335E	ZTTK syndrome	Pathogenic	criteria provided, single submitter	VCV000827763	21	34945648	21	33573342	827763	815961		NC_000021.9:33573341:G:A
NM_005535.3(IL12RB1):c.962C>A (p.Ser321Ter)	IL12RB1	S361*, S321*	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827715	19	18182981	19	18072171	827715	815935		NC_000019.10:18072170:G:T
NM_001783.4(CD79A):c.323T>G (p.Val108Gly)	CD79A	V108G	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827697	19	42383303	19	41879233	827697	815938		NC_000019.10:41879232:T:G
NM_000061.3(BTK):c.837T>A (p.Tyr279Ter)	BTK	Y279*, Y313*	Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000827690	X	100615078	X	101360090	827690	815941		NC_000023.11:101360089:A:T
NM_005629.4(SLC6A8):c.1494C>G (p.Tyr498Ter)	SLC6A8	Y383*, Y488*, Y498*	Creatine transporter deficiency	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000827674	X	152959900	X	153694445	827674	815874		NC_000023.11:153694444:C:G
NM_024528.4(NKAP):c.1082G>A (p.Arg361Gln)	NKAP	R361Q	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827657	X	119059349	X	119925386	827657	815861		NC_000023.11:119925385:C:T
NM_024528.4(NKAP):c.1010T>C (p.Ile337Thr)	NKAP	I337T	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827656	X	119064042	X	119930079	827656	815860		NC_000023.11:119930078:A:G
NM_024528.4(NKAP):c.989G>A (p.Arg330His)	NKAP	R330H	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827655	X	119064063	X	119930100	827655	815859		NC_000023.11:119930099:C:T
NM_024528.4(NKAP):c.988C>T (p.Arg330Cys)	NKAP	R330C	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827654	X	119064064	X	119930101	827654	815858		NC_000023.11:119930100:G:A
NM_024528.4(NKAP):c.998G>A (p.Arg333Gln)	NKAP	R333Q	INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827653	X	119064054	X	119930091	827653	815857		NC_000023.11:119930090:C:T
NM_000398.7(CYB5R3):c.310G>T (p.Gly104Cys)	CYB5R3	G104C, G137C, G81C	Methemoglobinemia, type I	Pathogenic	no assertion criteria provided	VCV000827634	22	43026911	22	42630905	827634	815836		NC_000022.11:42630904:C:A
NM_000398.7(CYB5R3):c.190C>G (p.Leu64Val)	CYB5R3	L41V, L64V, L97V	Methemoglobinemia, type I	Pathogenic	no assertion criteria provided	VCV000827633	22	43027420	22	42631414	827633	815837		NC_000022.11:42631413:G:C
NM_000398.7(CYB5R3):c.103A>C (p.Thr35Pro)	CYB5R3	T12P, T35P, T68P	Methemoglobinemia, type I	Pathogenic	no assertion criteria provided	VCV000827632	22	43032771	22	42636765	827632	815838		NC_000022.11:42636764:T:G
NM_001429.4(EP300):c.7244A>G (p.Ter2415Trp)	EP300	*2389W, *2415W	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827631	22	41574959	22	41178955	827631	815835		NC_000022.11:41178954:A:G
NM_001429.4(EP300):c.5747dup (p.Pro1917fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827629	22	41573460 - 41573461	22	41177456 - 41177457	827629	815833		NC_000022.11:41177456:CC:CCC
NM_001429.4(EP300):c.5578_5584del (p.Gly1860fs)	EP300	G1834fs, G1860fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827628	22	41573293 - 41573299	22	41177289 - 41177295	827628	815832		NC_000022.11:41177288:GGCCAAC:
NM_001429.4(EP300):c.4390C>T (p.Gln1464Ter)	EP300	Q1438*, Q1464*	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827627	22	41566513	22	41170509	827627	815831		NC_000022.11:41170508:C:T
NM_001429.4(EP300):c.3438_3439del (p.Glu1147fs)	EP300	E1121fs, E1147fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827625	22	41553349 - 41553350	22	41157345 - 41157346	827625	815829		NC_000022.11:41157344:TG:
NM_001429.4(EP300):c.3367del (p.Met1124fs)	EP300	M1098fs, M1124fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827624	22	41553278	22	41157274	827624	815828		NC_000022.11:41157273:C:
NM_001429.4(EP300):c.2244_2250TATGGGC[1] (p.Tyr751fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827623	22	41545043 - 41545049	22	41149039 - 41149045	827623	815827		NC_000022.11:41149038:CTATGGGCTATGGGC:CTATGGGC
NM_001429.4(EP300):c.1957C>T (p.Gln653Ter)	EP300	Q653*	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827622	22	41537130	22	41141126	827622	815826		NC_000022.11:41141125:C:T
NM_001429.4(EP300):c.1606_1610delinsTATGTTGAGCCATAACTGCATGTTGAGCCCA (p.Ala536_Ile537delinsTyrValGluProTer)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827621	22	41531894 - 41531898	22	41135890 - 41135894	827621	815825		NC_000022.11:41135889:GCCAT:TATGTTGAGCCATAACTGCATGTTGAGCCCA
NM_001429.4(EP300):c.494_497del (p.Met165fs)	EP300	M165fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000827620	22	41513587 - 41513590	22	41117583 - 41117586	827620	815824		NC_000022.11:41117582:GAATGAA:GAA
NM_000455.5(STK11):c.830_836dup (p.Pro280fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000827570	19	1221305 - 1221306	19	1221306 - 1221307	827570	814887		NC_000019.10:1221306:GACTGTGG:GACTGTGGACTGTGG
NM_000455.5(STK11):c.806del (p.Lys269fs)	STK11	K269fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000827431	19	1221282	19	1221283	827431	814884		NC_000019.10:1221282:AA:A
NM_000455.5(STK11):c.792del (p.Phe264fs)	STK11	F264fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000827339	19	1221267	19	1221268	827339	814881		NC_000019.10:1221267:TTT:TT
NM_000455.5(STK11):c.526del (p.Asp176fs)	STK11	D176fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000825601	19	1220432	19	1220433	825601	814861		NC_000019.10:1220432:GG:G
NM_005359.6(SMAD4):c.505C>T (p.Gln169Ter)	SMAD4	Q169*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000825411	18	48581201	18	51054831	825411	814539		NC_000018.10:51054830:C:T
NM_005359.6(SMAD4):c.415_416del (p.Pro139fs)	SMAD4	P139fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000824629	18	48575221 - 48575222	18	51048851 - 51048852	824629	814536		NC_000018.10:51048850:CC:
NM_005359.6(SMAD4):c.413C>G (p.Ser138Ter)	SMAD4	S138*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000824618	18	48575219	18	51048849	824618	814535		NC_000018.10:51048848:C:G
NM_005359.6(SMAD4):c.399C>G (p.Tyr133Ter)	SMAD4	Y133*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000824470	18	48575205	18	51048835	824470	814534		NC_000018.10:51048834:C:G
NM_000455.5(STK11):c.388G>T (p.Glu130Ter)	STK11	E130*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000824343	19	1219336	19	1219337	824343	814856		NC_000019.10:1219336:G:T
NM_004655.4(AXIN2):c.355C>T (p.Gln119Ter)	AXIN2	Q119*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000823928	17	63554384	17	65558266	823928	814412		NC_000017.11:65558265:G:A
NM_000455.5(STK11):c.922_931delinsCC (p.Trp308fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV000823105	19	1222985 - 1222994	19	1222986 - 1222995	823105	814892		NC_000019.10:1222985:TGGTTCCGGA:CC
NM_005359.6(SMAD4):c.1028C>G (p.Ser343Ter)	SMAD4	S343*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000822036	18	48591865	18	51065495	822036	814565		NC_000018.10:51065494:C:G
NM_000455.5(STK11):c.291-1G>A	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000821978	19	1218415	19	1218416	821978	815738		NC_000019.10:1218415:G:A
NM_005359.6(SMAD4):c.250-1G>A	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000821380	18	48575055	18	51048685	821380	815714		NC_000018.10:51048684:G:A
NM_000455.5(STK11):c.242del (p.Lys81fs)	STK11	K81fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, single submitter	VCV000821260	19	1207153	19	1207154	821260	814849		NC_000019.10:1207153:AA:A
NM_005359.6(SMAD4):c.1381C>T (p.Gln461Ter)	SMAD4	Q461*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000819062	18	48603080	18	51076710	819062	814578		NC_000018.10:51076709:C:T
NM_005359.6(SMAD4):c.1311del (p.Phe438fs)	SMAD4	F438fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000818869	18	48603010	18	51076640	818869	814576		NC_000018.10:51076639:C:
NM_005359.6(SMAD4):c.1239C>G (p.Tyr413Ter)	SMAD4	Y413*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000818678	18	48593488	18	51067118	818678	814573		NC_000018.10:51067117:C:G
NM_172107.4(KCNQ2):c.1080G>A (p.Trp360Ter)	KCNQ2	W360*	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000818228	20	62065200	20	63433847	818228	806441		NC_000020.11:63433846:C:T
NM_001083961.2(WDR62):c.669del (p.Trp224fs)	WDR62	W224fs	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000818086	19	36558315	19	36067413	818086	806290		NC_000019.10:36067412:C:
NM_004006.3(DMD):c.9231dup (p.Thr3078fs)	DMD		not provided	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000818080	X	31279126 - 31279127	X	31261009 - 31261010	818080	806193		NC_000023.11:31261009:C:CC
NM_005676.5(RBM10):c.698del (p.Cys233fs)	RBM10	C156fs, C233fs, C298fs	not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000818058	X	47038536	X	47179137	818058	806221		NC_000023.11:47179136:G:
NM_004793.4(LONP1):c.798_804del (p.Pro267fs)	LONP1	P203fs, P71fs, P267fs	not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000818055	19	5711848 - 5711854	19	5711837 - 5711843	818055	806060		NC_000019.10:5711836:AGCCGGGAGC:AGC
NM_001356.5(DDX3X):c.751_752dup (p.Leu251fs)	DDX3X		not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000818047	X	41203059 - 41203060	X	41343806 - 41343807	818047	806214		NC_000023.11:41343806:TTT:TTTTT
NM_005257.6(GATA6):c.1070del (p.Pro357fs)	GATA6	P357fs	not provided	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000818043	18	19752172	18	22172211	818043	806003		NC_000018.10:22172210:CCCC:CCC
NM_138927.4(SON):c.6499dup (p.Ser2167fs)	SON		not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000818041	21	34931918 - 34931919	21	33559612 - 33559613	818041	806096		NC_000021.9:33559612:AAAAA:AAAAAA
NM_001008537.3(NEXMIF):c.2458del (p.Asp820fs)	NEXMIF	D820fs	not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000818040	X	73961934	X	74742099	818040	806257		NC_000023.11:74742098:C:
NM_002816.5(PSMD12):c.526del (p.Ser176fs)	PSMD12	S156fs, S176fs, S117fs	not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000818024	17	65343586	17	67347470	818024	805980		NC_000017.11:67347469:A:
NM_000328.3(RPGR):c.706del (p.Gln236fs)	RPGR	Q235fs, Q246fs, Q236fs	not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000818021	X	38169940	X	38310687	818021	806208		NC_000023.11:38310686:GGGG:GGG
NM_000268.4(NF2):c.30del (p.Phe11fs)	NF2	F11fs	not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000818007	22	30000017	22	29604028	818007	806115		NC_000022.11:29604027:C:
NM_001193466.2(KANSL1):c.2956_2957del (p.Gly986fs)	KANSL1	G985fs, G986fs	not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000818001	17	44109546 - 44109547	17	46032180 - 46032181	818001	805949		NC_000017.11:46032179:CC:
NM_001111125.3(IQSEC2):c.2645dup (p.Ile883fs)	IQSEC2		not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000817993	X	53276254 - 53276255	X	53247072 - 53247073	817993	806234		NC_000023.11:53247072:AA:AAA
NM_001356.5(DDX3X):c.373dup (p.Ser125fs)	DDX3X		not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000817971	X	41201835 - 41201836	X	41342582 - 41342583	817971	806213		NC_000023.11:41342582:A:AA
NM_001077488.4(GNAS):c.804_805dup (p.Glu269fs)	GNAS		not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000817970	20	57484820 - 57484821	20	58909765 - 58909766	817970	806082		NC_000020.11:58909765:GG:GGGG
NM_002501.4(NFIX):c.1204dup (p.Glu402fs)	NFIX		not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817968	19	13192617 - 13192618	19	13081803 - 13081804	817968	806034		NC_000019.10:13081803:GG:GGG
NM_005121.3(MED13):c.4685_4689dup (p.Met1564fs)	MED13		not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000817962	17	60042521 - 60042522	17	61965160 - 61965161	817962	805971		NC_000017.11:61965160:ACTGC:ACTGCACTGC
NM_030632.3(ASXL3):c.4336_4337del (p.Arg1446fs)	ASXL3	R1446fs	not provided	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000817954	18	31324148 - 31324149	18	33744184 - 33744185	817954	806013		NC_000018.10:33744183:AG:
NM_002816.5(PSMD12):c.356del (p.Pro119fs)	PSMD12	P99fs, P119fs, P60fs	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000817952	17	65346394	17	67350278	817952	805981		NC_000017.11:67350277:GG:G
NM_003906.5(MCM3AP):c.3789_3798CCCTGCTGCG[3] (p.Val1270fs)	MCM3AP		not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000817943	21	47676826 - 47676827	21	46256912 - 46256913	817943	806105		NC_000021.9:46256912:CGCAGCAGGGCGCAGCAGGG:CGCAGCAGGGCGCAGCAGGGCGCAGCAGGG
NM_030632.3(ASXL3):c.1579del (p.Gln527fs)	ASXL3	Q527fs	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000817942	18	31318944	18	33738980	817942	806008		NC_000018.10:33738979:CCCC:CCC
NM_138927.4(SON):c.4465del (p.Leu1489fs)	SON	L1489fs	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000817937	21	34926002	21	33553696	817937	806093		NC_000021.9:33553695:C:
NM_001111125.3(IQSEC2):c.3718dup (p.His1240fs)	IQSEC2		not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000817936	X	53264149 - 53264150	X	53234967 - 53234968	817936	806232		NC_000023.11:53234967:GG:GGG
NM_001429.4(EP300):c.4103del (p.Gly1368fs)	EP300	G1368fs, G1342fs	not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000817934	22	41564801	22	41168797	817934	806128		NC_000022.11:41168796:GG:G
NM_014727.3(KMT2B):c.648_649insA (p.Arg217fs)	KMT2B		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000817932	19	36210897 - 36210898	19	35719995 - 35719996	817932	806040		NC_000019.10:35719995::A
NM_000390.4(CHM):c.42_47delinsGGGAA (p.Ile14fs)	CHM		not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000817930	X	85302490 - 85302495	X	86047486 - 86047491	817930	806260		NC_000023.11:86047485:GTCCCT:TTCCC
NM_172107.4(KCNQ2):c.1080_1083del (p.Trp360fs)	KCNQ2	W360fs	not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000817919	20	62065197 - 62065200	20	63433844 - 63433847	817919	806085		NC_000020.11:63433843:CTGCC:C
NM_024298.5(MBOAT7):c.757_769del (p.Glu253fs)	MBOAT7	E180fs, E253fs	not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000817917	19	54684575 - 54684587	19	54180858 - 54180870	817917	806059		NC_000019.10:54180857:TGCAGCCGCACTC:
NM_015338.6(ASXL1):c.4196dup (p.Leu1399fs)	ASXL1		not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000817910	20	31024709 - 31024710	20	32436906 - 32436907	817910	806069		NC_000020.11:32436906:TT:TTT
NM_000308.4(CTSA):c.735del (p.Lys245fs)	CTSA	K245fs, K246fs	not provided	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000817909	20	44522669	20	45894030	817909	806073		NC_000020.11:45894029:G:
NM_002501.4(NFIX):c.424dup (p.Leu142fs)	NFIX		not provided	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000817902	19	13136226 - 13136227	19	13025412 - 13025413	817902	806032		NC_000019.10:13025412:CCCCC:CCCCCC
NM_001008537.3(NEXMIF):c.2031dup (p.Ala678fs)	NEXMIF		not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000817895	X	73962360 - 73962361	X	74742525 - 74742526	817895	806258		NC_000023.11:74742525:T:TT
NM_005121.3(MED13):c.3889del (p.Arg1297fs)	MED13	R1297fs	not provided	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000817887	17	60050166	17	61972805	817887	805972		NC_000017.11:61972804:TTTTTTT:TTTTTT
NM_001356.5(DDX3X):c.80_81AG[1] (p.Ser28fs)	DDX3X		not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000817882	X	41196695 - 41196696	X	41337442 - 41337443	817882	806211		NC_000023.11:41337441:AGAG:AG
NM_153638.3(PANK2):c.1514del (p.Ala505fs)	PANK2	A69fs, A214fs, A505fs	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000817881	20	3897675	20	3917028	817881	806072		NC_000020.11:3917027:C:
NM_000328.3(RPGR):c.1905+872_1905+873del	RPGR		not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000817877	X	38145474 - 38145475	X	38286221 - 38286222	817877	806206		NC_000023.11:38286220:CTCTC:CTC
NM_005559.4(LAMA1):c.56_57AG[2] (p.Gly21fs)	LAMA1		not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000817875	18	7117659 - 7117660	18	7117660 - 7117661	817875	806029		NC_000018.10:7117659:CTCTCT:CTCT
NM_001321120.2(TBX4):c.636del (p.Ala213fs)	TBX4	A213fs	not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000817874	17	59556074	17	61478713	817874	805969		NC_000017.11:61478712:T:
NM_014738.6(TMEM94):c.495_496dup (p.His166fs)	TMEM94		not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000817873	17	73484097 - 73484098	17	75488016 - 75488017	817873	805997		NC_000017.11:75488016:GC:GCGC
NM_002547.3(OPHN1):c.999_1000del (p.Phe333fs)	OPHN1	F333fs	not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000817870	X	67421486 - 67421487	X	68201644 - 68201645	817870	806249		NC_000023.11:68201643:AGA:A
NM_001347721.2(DYRK1A):c.606dup (p.Lys203fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000817869	21	38858884 - 38858885	21	37486582 - 37486583	817869	806097		NC_000021.9:37486582:C:CC
NM_001079872.2(CUL4B):c.1939dup (p.Tyr647fs)	CUL4B		not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000817868	X	119670888 - 119670889	X	120537033 - 120537034	817868	806154		NC_000023.11:120537033:A:AA
NM_000268.4(NF2):c.1056del (p.Arg353fs)	NF2	R270fs, R312fs, R311fs, R353fs	not provided	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000817865	22	30067871	22	29671882	817865	806116		NC_000022.11:29671881:G:
NM_001184880.2(PCDH19):c.49_62del (p.Thr17fs)	PCDH19	T17fs	not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000817864	X	99663534 - 99663547	X	100408536 - 100408549	817864	806146		NC_000023.11:100408535:GCGGCAGCCTGCGT:
NM_001127221.1(CACNA1A):c.4697dup (p.Pro1567fs)	CACNA1A		not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000817863	19	13365969 - 13365970	19	13255155 - 13255156	817863	806036		NC_000019.10:13255155:GG:GGG
NM_139058.3(ARX):c.1129del (p.Gln377fs)	ARX	Q377fs	not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000817843	X	25025547	X	25007430	817843	806191		NC_000023.11:25007429:GG:G
NM_001347721.2(DYRK1A):c.1343_1346dup (p.Arg449fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000817842	21	38877715 - 38877716	21	37505412 - 37505413	817842	806099		NC_000021.9:37505412:TAAG:TAAGTAAG
NM_005660.3(SLC35A2):c.7del (p.Ala3fs)	SLC35A2	A3fs	not provided	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000817834	X	48768907	X	48911630	817834	806226		NC_000023.11:48911629:C:
NM_001083962.2(TCF4):c.1244del (p.His415fs)	TCF4	H199fs, H254fs, H414fs, H421fs, H391fs, H255fs, H373fs, H390fs, H392fs, H285fs, H344fs, H412fs, H415fs, H517fs	not provided	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000817830	18	52921834	18	55254603	817830	806022		NC_000018.10:55254602:T:
NM_138927.4(SON):c.4237_4238del (p.Leu1413fs)	SON	L1413fs	not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000817821	21	34925774 - 34925775	21	33553468 - 33553469	817821	806092		NC_000021.9:33553467:CT:
NM_004859.4(CLTC):c.1307del (p.Cys436fs)	CLTC	C440fs, C436fs	not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000817819	17	57738943	17	59661582	817819	805962		NC_000017.11:59661581:G:
NM_172107.4(KCNQ2):c.204del (p.Lys69fs)	KCNQ2	K69fs	not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000817818	20	62103613	20	63472260	817818	806087		NC_000020.11:63472259:GGGGGG:GGGGG
NM_001291415.2(KDM6A):c.2067_2074del (p.Asn690fs)	KDM6A	N638fs, N342fs, N645fs, N593fs, N559fs, N690fs	not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000817807	X	44923050 - 44923057	X	45063805 - 45063812	817807	806219		NC_000023.11:45063804:TAACTCCA:
NM_203473.3(PORCN):c.1034del (p.Val345fs)	PORCN	V339fs, V344fs, V345fs, V268fs, V350fs	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000817801	X	48374303	X	48515915	817801	806223		NC_000023.11:48515914:T:
NM_000397.4(CYBB):c.865del (p.Trp289fs)	CYBB	W289fs	not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000817781	X	37660566	X	37801313	817781	806202		NC_000023.11:37801312:TTTT:TTT
NM_001323289.2(CDKL5):c.383del (p.Lys128fs)	CDKL5	K128fs	not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000817775	X	18598067	X	18579947	817775	806176		NC_000023.11:18579946:AA:A
NM_138927.4(SON):c.1533_1534AG[1] (p.Glu512fs)	SON		not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000817767	21	34923070 - 34923071	21	33550764 - 33550765	817767	806089		NC_000021.9:33550763:AGAG:AG
NM_015559.3(SETBP1):c.1827dup (p.Val610fs)	SETBP1		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000817764	18	42531128 - 42531129	18	44951163 - 44951164	817764	806017		NC_000018.10:44951163:CCCC:CCCCC
NM_004006.3(DMD):c.7771del (p.Glu2591fs)	DMD	E1247fs, E2468fs, E2587fs, E1250fs, E131fs, E2583fs, E2591fs	not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000817757	X	31697593	X	31679476	817757	806196		NC_000023.11:31679475:C:
NM_001126054.2(CASK):c.281_284TGGA[1] (p.Asp95fs)	CASK		not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000817740	X	41604845 - 41604848	X	41745592 - 41745595	817740	806218		NC_000023.11:41745591:TCCATCCAT:TCCAT
NM_001193466.2(KANSL1):c.608_611dup (p.Met205fs)	KANSL1		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000817727	17	44248898 - 44248899	17	46171532 - 46171533	817727	805952		NC_000017.11:46171532:CCCCCC:CCCCCCCCCC
NM_000346.4(SOX9):c.1031dup (p.Pro345fs)	SOX9		not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000817692	17	70120027 - 70120028	17	72123886 - 72123887	817692	805993		NC_000017.11:72123886:CC:CCC
NM_004006.3(DMD):c.9033_9040del (p.Tyr3012fs)	DMD	Y1671fs, Y2889fs, Y283fs, Y552fs, Y1668fs, Y3004fs, Y3008fs, Y3012fs	not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000817691	X	31462642 - 31462649	X	31444525 - 31444532	817691	806194		NC_000023.11:31444524:GGTTATACGGT:GGT
NM_000284.4(PDHA1):c.711_738dup (p.Asp247delinsSerGlnHisTer)	PDHA1		not provided	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000817680	X	19373570 - 19373571	X	19355452 - 19355453	817680	806182		NC_000023.11:19355452:GGCAGCCAGCACTGATTACTACAAGAGAGGC:GGCAGCCAGCACTGATTACTACAAGAGAGGCAGCCAGCACTGATTACTACAAGAGAGGC
NM_021120.4(DLG3):c.159del (p.Tyr54fs)	DLG3	Y54fs	not provided	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000817679	X	69665210	X	70445360	817679	806252		NC_000023.11:70445359:C:
NM_004187.5(KDM5C):c.3390_3391AG[1] (p.Glu1131fs)	KDM5C		not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000817677	X	53224158 - 53224159	X	53194976 - 53194977	817677	806228		NC_000023.11:53194975:CTCT:CT
NM_002501.4(NFIX):c.179dup (p.Leu61fs)	NFIX		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000817661	19	13135985 - 13135986	19	13025171 - 13025172	817661	806031		NC_000019.10:13025171:T:TT
NM_001184880.2(PCDH19):c.1288_1291del (p.Val430fs)	PCDH19	V430fs	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000817658	X	99662305 - 99662308	X	100407307 - 100407310	817658	806143		NC_000023.11:100407306:GCACGC:GC
NM_030632.3(ASXL3):c.4462_4465del (p.Thr1488fs)	ASXL3	T1488fs	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000817642	18	31324271 - 31324274	18	33744307 - 33744310	817642	806014		NC_000018.10:33744306:CTGACTG:CTG
NM_138927.4(SON):c.5721_5722dup (p.Arg1908fs)	SON		not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000817633	21	34927254 - 34927255	21	33554948 - 33554949	817633	806095		NC_000021.9:33554948:AAAAA:AAAAAAA
NM_003620.4(PPM1D):c.1535del (p.Asn512fs)	PPM1D	N512fs	not provided	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000817626	17	58740624	17	60663263	817626	805968		NC_000017.11:60663262:AAAAAAA:AAAAAA
NM_000033.4(ABCD1):c.1670_1671del (p.Val557fs)	ABCD1	V557fs	not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000817612	X	153006062 - 153006063	X	153740608 - 153740609	817612	806165		NC_000023.11:153740607:GTG:G
NM_000033.4(ABCD1):c.1359del (p.Gly454fs)	ABCD1	G454fs	not provided	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000817611	X	153001933	X	153736479	817611	806164		NC_000023.11:153736478:T:
NM_004586.3(RPS6KA3):c.645_649del (p.Ser215fs)	RPS6KA3	S215fs	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000817610	X	20206071 - 20206075	X	20187953 - 20187957	817610	806185		NC_000023.11:20187952:CTTTACTT:CTT
NM_000377.3(WAS):c.23del (p.Gly8fs)	WAS	G8fs	not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000817607	X	48542264	X	48683875	817607	806224		NC_000023.11:48683874:GG:G
NM_004006.3(DMD):c.1270del (p.Gln423_Met424insTer)	DMD		not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000817581	X	32662310	X	32644193	817581	806201		NC_000023.11:32644192:T:
NM_138927.4(SON):c.27dup (p.Arg10Ter)	SON		not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000817560	21	34915420 - 34915421	21	33543114 - 33543115	817560	806088		NC_000021.9:33543114:TTTTT:TTTTTT
NM_000216.4(ANOS1):c.494C>A (p.Ser165Ter)	ANOS1	S165*	not provided	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000817557	X	8565122	X	8597081	817557	806259		NC_000023.11:8597080:G:T
NM_001323289.2(CDKL5):c.1354C>T (p.Gln452Ter)	CDKL5	Q452*	not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000817555	X	18622398	X	18604278	817555	806179		NC_000023.11:18604277:C:T
NM_173630.4(RTTN):c.2753C>A (p.Ser918Ter)	RTTN	S6*, S918*	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000817544	18	67806870	18	70139634	817544	806027		NC_000018.10:70139633:G:T
NM_172107.4(KCNQ2):c.2092C>T (p.Gln698Ter)	KCNQ2	Q698*, Q667*, Q670*, Q680*	not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000817541	20	62038524	20	63407171	817541	806083		NC_000020.11:63407170:G:A
NM_001282531.3(ADNP):c.916C>T (p.Arg306Ter)	ADNP	R306*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000817538	20	49510335	20	50893798	817538	806080		NC_000020.11:50893797:G:A
NM_015107.3(PHF8):c.2713C>T (p.Gln905Ter)	PHF8	Q941*, Q804*, Q905*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000817530	X	53966886	X	53940453	817530	806237		NC_000023.11:53940452:G:A
NM_172107.4(KCNQ2):c.1041C>G (p.Tyr347Ter)	KCNQ2	Y347*	not provided	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000817529	20	62065239	20	63433886	817529	806086		NC_000020.11:63433885:G:C
NM_001353921.2(ARHGEF9):c.215G>A (p.Trp72Ter)	ARHGEF9	W44*, W5*, W12*, W65*, W72*, W78*	not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000817527	X	62926325	X	63706445	817527	806242		NC_000023.11:63706444:C:T
NM_004006.3(DMD):c.8362G>T (p.Glu2788Ter)	DMD	E1447*, E2780*, E2788*, E328*, E59*, E1444*, E2665*, E2784*	not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000817525	X	31525426	X	31507309	817525	806195		NC_000023.11:31507308:C:A
NM_001429.4(EP300):c.256C>T (p.Arg86Ter)	EP300	R86*	not provided	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000817520	22	41513352	22	41117348	817520	806124		NC_000022.11:41117347:C:T
NM_000397.4(CYBB):c.1275C>G (p.Tyr425Ter)	CYBB	Y425*	not provided	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000817514	X	37664382	X	37805129	817514	806204		NC_000023.11:37805128:C:G
NM_000284.4(PDHA1):c.724_727dup (p.Tyr243fs)	PDHA1		not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000817507	X	19373585 - 19373586	X	19355467 - 19355468	817507	806183		NC_000023.11:19355467:TTACT:TTACTTACT
NM_001083962.2(TCF4):c.1135_1136insGT (p.Leu379fs)	TCF4		not provided	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000817505	18	52924556 - 52924557	18	55257325 - 55257326	817505	806023		NC_000018.10:55257325:A:ACA
NM_001042472.3(ABHD12):c.258del (p.Pro87fs)	ABHD12	P87fs	not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000817503	20	25319921	20	25339285	817503	806068		NC_000020.11:25339284:AA:A
NM_078629.4(MSL3):c.1168_1169del (p.Lys390fs)	MSL3	K224fs, K241fs, K378fs, K390fs	not provided	Pathogenic(Last reviewed: Mar 24, 2019)	criteria provided, single submitter	VCV000817495	X	11783843 - 11783844	X	11765724 - 11765725	817495	806151		NC_000023.11:11765723:AAAA:AA
NM_015107.3(PHF8):c.368dup (p.Pro124fs)	PHF8		not provided	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000817490	X	54044179 - 54044180	X	54017746 - 54017747	817490	806239		NC_000023.11:54017746:A:AA
NM_001356.5(DDX3X):c.168_169del (p.Asp56fs)	DDX3X	D40fs, D56fs	not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000817485	X	41200752 - 41200753	X	41341499 - 41341500	817485	806212		NC_000023.11:41341498:ACA:A
NM_005650.4(TCF20):c.3004del (p.Arg1002fs)	TCF20	R1002fs	not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000817483	22	42608308	22	42212302	817483	806130		NC_000022.11:42212301:T:
NM_080647.1(TBX1):c.1187del (p.Pro396fs)	TBX1	P396fs	not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000817469	22	19754085	22	19766562	817469	806108		NC_000022.11:19766561:CCCCC:CCCC
NM_138927.4(SON):c.1744dup (p.Leu582fs)	SON		not provided	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000817466	21	34923280 - 34923281	21	33550974 - 33550975	817466	806090		NC_000021.9:33550974:C:CC
NM_015107.3(PHF8):c.1772dup (p.Ile592fs)	PHF8		not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000817465	X	54014335 - 54014336	X	53987902 - 53987903	817465	806238		NC_000023.11:53987902:TT:TTT
NM_000206.3(IL2RG):c.225_226insTGCT (p.Ser76delinsCysTer)	IL2RG		X-linked severe combined immunodeficiency|not provided	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817464	X	70330790 - 70330791	X	71110940 - 71110941	817464	806254		NC_000023.11:71110940::AGCA
NM_001347721.2(DYRK1A):c.814dup (p.Leu272fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000817461	21	38862652 - 38862653	21	37490350 - 37490351	817461	806098		NC_000021.9:37490350:C:CC
NM_030632.3(ASXL3):c.4087_4088delinsG (p.Met1363fs)	ASXL3		not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000817452	18	31323899 - 31323900	18	33743935 - 33743936	817452	806011		NC_000018.10:33743934:AT:G
NM_000252.3(MTM1):c.503del (p.Asn168fs)	MTM1	N131fs, N168fs	not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000817449	X	149807473	X	150639000	817449	806159		NC_000023.11:150638999:AA:A
NC_000023.11:g.129557325del	OCRL		not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000817444	X	128691301	X	129557324	817444	806155		NC_000023.11:129557323:GG:G
NM_001429.4(EP300):c.1517del (p.Met506fs)	EP300	M506fs	not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000817436	22	41527626	22	41131622	817436	806125		NC_000022.11:41131621:T:
NM_182641.4(BPTF):c.255dup (p.Ser86fs)	BPTF		not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000817433	17	65822087 - 65822088	17	67825971 - 67825972	817433	805982		NC_000017.11:67825971:CCCCCCCC:CCCCCCCCC
NM_014727.3(KMT2B):c.15_24dup (p.Ser9fs)	KMT2B		not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000817423	19	36208925 - 36208926	19	35718023 - 35718024	817423	806039		NC_000019.10:35718023:GGCGGCGGCGGGCGGCGGC:GGCGGCGGCGGGCGGCGGCGGGCGGCGGC
NM_000276.4(OCRL):c.533dup (p.Pro179fs)	OCRL		not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000817407	X	128692698 - 128692699	X	129558721 - 129558722	817407	806156		NC_000023.11:129558721:CCCCC:CCCCCC
NM_030632.3(ASXL3):c.2625dup (p.Val876fs)	ASXL3		not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000817406	18	31319985 - 31319986	18	33740021 - 33740022	817406	806010		NC_000018.10:33740021:AAAAAAAA:AAAAAAAAA
NM_001429.4(EP300):c.5720del (p.Pro1907fs)	EP300	P1881fs, P1907fs	not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000817399	22	41573432	22	41177428	817399	806129		NC_000022.11:41177427:CCCC:CCC
NM_177559.3(CSNK2A1):c.96del (p.Glu32fs)	CSNK2A1	E32fs	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000817389	20	489100	20	508456	817389	806079		NC_000020.11:508455:TT:T
NM_001184880.2(PCDH19):c.647del (p.Pro216fs)	PCDH19	P216fs	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000817379	X	99662949	X	100407951	817379	806144		NC_000023.11:100407950:GGG:GG
NM_000273.3(GPR143):c.461del (p.Ile154fs)	GPR143	I154fs	not provided	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000817370	X	9716701	X	9748661	817370	806261		NC_000023.11:9748660:A:
NM_006852.6(TLK2):c.1021del (p.Met341fs)	TLK2	M192fs, M355fs, M309fs, M341fs	not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000817367	17	60650625	17	62573264	817367	805977		NC_000017.11:62573263:AAAA:AAA
NM_001356.5(DDX3X):c.1503_1504insTGCT (p.Ala502fs)	DDX3X		not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000817366	X	41205763 - 41205764	X	41346510 - 41346511	817366	806216		NC_000023.11:41346510::TGCT
NM_001429.4(EP300):c.3039_3043del (p.Glu1014fs)	EP300	E988fs, E1014fs	not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000817350	22	41548248 - 41548252	22	41152244 - 41152248	817350	806127		NC_000022.11:41152243:AGAAGAGA:AGA
NM_005710.2(PQBP1):c.508del (p.Arg170fs)	PQBP1	R162fs, R170fs, R70fs	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000817349	X	48759724	X	48902447	817349	806225		NC_000023.11:48902446:CC:C
NM_018684.4(ZC4H2):c.125_129dup (p.His44fs)	ZC4H2		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000817348	X	64141792 - 64141793	X	64921912 - 64921913	817348	806245		NC_000023.11:64921912:CCTTTCCT:CCTTTCCTTTCCT
NM_004006.3(DMD):c.1693dup (p.Thr565fs)	DMD		not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000817345	X	32591872 - 32591873	X	32573755 - 32573756	817345	806199		NC_000023.11:32573755:T:TT
NM_182641.4(BPTF):c.3302del (p.Asn1101fs)	BPTF	N1227fs, N1101fs	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000817342	17	65907297	17	67911181	817342	805984		NC_000017.11:67911180:AAAAAA:AAAAA
NM_004247.4(EFTUD2):c.2544del (p.Val849fs)	EFTUD2	V849fs, V839fs, V814fs	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000817333	17	42930681	17	44853313	817333	805948		NC_000017.11:44853312:GG:G
NM_152906.7(TANGO2):c.35_36del (p.Pro12fs)	TANGO2	P12fs	not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000817318	22	20024356 - 20024357	22	20036833 - 20036834	817318	806109		NC_000022.11:20036832:CT:
NM_001111125.3(IQSEC2):c.886del (p.Ala296fs)	IQSEC2	A296fs, A91fs	not provided	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000817317	X	53285095	X	53255913	817317	806235		NC_000023.11:53255912:CCC:CC
NM_001429.4(EP300):c.2064del (p.Pro689fs)	EP300	P689fs	not provided	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000817316	22	41542753	22	41146749	817316	806126		NC_000022.11:41146748:A:
NM_004187.5(KDM5C):c.1501del (p.Trp501fs)	KDM5C	W500fs, W501fs, W434fs	not provided	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000817313	X	53239940	X	53210758	817313	806229		NC_000023.11:53210757:A:
NM_001323289.2(CDKL5):c.907_908insCC (p.Leu303fs)	CDKL5		not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000817286	X	18616662 - 18616663	X	18598542 - 18598543	817286	806178		NC_000023.11:18598542:C:CCC
NM_004586.3(RPS6KA3):c.442del (p.Asp148fs)	RPS6KA3	D148fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817284	X	20212351	X	20194233	817284	806186		NC_000023.11:20194232:CC:C
NM_001111125.3(IQSEC2):c.2983del (p.Arg995fs)	IQSEC2	R790fs, R995fs	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000817283	X	53270998	X	53241816	817283	806233		NC_000023.11:53241815:G:
NM_001242896.3(DEPDC5):c.191del (p.Lys64fs)	DEPDC5	K64fs	not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000817281	22	32156685	22	31760699	817281	806117		NC_000022.11:31760698:AA:A
NM_014927.5(CNKSR2):c.2020_2021AG[3] (p.Arg676fs)	CNKSR2		not provided	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000817278	X	21619443 - 21619444	X	21601325 - 21601326	817278	806187		NC_000023.11:21601324:AGAGAGAG:AGAGAG
NM_001399.5(EDA):c.11del (p.Pro4fs)	EDA	P4fs	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000817272	X	68836161	X	69616317	817272	806251		NC_000023.11:69616316:CCC:CC
NM_001193466.2(KANSL1):c.2902dup (p.Gln968fs)	KANSL1		not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000817270	17	44109600 - 44109601	17	46032234 - 46032235	817270	805950		NC_000017.11:46032234:GGGGGG:GGGGGGG
NM_182641.4(BPTF):c.5649del (p.Ile1883fs)	BPTF	I1883fs, I2009fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000817267	17	65919046	17	67922930	817267	805985		NC_000017.11:67922929:TT:T
NM_001291415.2(KDM6A):c.3626dup (p.Asn1210fs)	KDM6A		not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000817259	X	44945145 - 44945146	X	45085900 - 45085901	817259	806220		NC_000023.11:45085900:T:TT
NM_015107.3(PHF8):c.192dup (p.Arg65fs)	PHF8		not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000817250	X	54048792 - 54048793	X	54022359 - 54022360	817250	806240		NC_000023.11:54022359:TTTTTT:TTTTTTT
NM_001127898.4(CLCN5):c.845del (p.Gly282fs)	CLCN5	G232fs, G282fs, G212fs	not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000817241	X	49846414	X	50081757	817241	806227		NC_000023.11:50081756:GGG:GG
NM_030632.3(ASXL3):c.1095_1096del (p.Glu367fs)	ASXL3	E367fs	not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000817229	18	31318463 - 31318464	18	33738499 - 33738500	817229	806007		NC_000018.10:33738498:AA:
NM_006950.3(SYN1):c.288del (p.Ser96fs)	SYN1	S96fs	not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000817226	X	47478840	X	47619441	817226	806222		NC_000023.11:47619440:G:
NM_001278116.2(L1CAM):c.2593_2594del (p.His865fs)	L1CAM	H860fs, H865fs	not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000817222	X	153130909 - 153130910	X	153865454 - 153865455	817222	806167		NC_000023.11:153865453:TGT:T
NM_003688.3(CASK):c.543_548delinsTCCTACATAAATGACGTAGGTG (p.Thr182_Pro183delinsProThrTer)	CASK		not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000817203	X	41524690 - 41524695	X	41665437 - 41665442	817203	806217		NC_000023.11:41665436:GGTGTT:CACCTACGTCATTTATGTAGGA
NM_001127221.1(CACNA1A):c.5345del (p.Cys1782fs)	CACNA1A	C1787fs, C1784fs, C1781fs, C1782fs	not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000817192	19	13342582	19	13231768	817192	806035		NC_000019.10:13231767:C:
NM_001008537.3(NEXMIF):c.3584dup (p.Asn1195fs)	NEXMIF		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000817190	X	73960807 - 73960808	X	74740972 - 74740973	817190	806256		NC_000023.11:74740972:TTTTT:TTTTTT
NM_138927.4(SON):c.3653del (p.Ser1218fs)	SON	S1218fs	not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000817172	21	34925190	21	33552884	817172	806091		NC_000021.9:33552883:G:
NM_002501.4(NFIX):c.1013_1014del (p.Gln338fs)	NFIX	Q337fs, Q346fs, Q338fs, Q354fs, Q291fs, Q330fs	not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000817163	19	13189484 - 13189485	19	13078670 - 13078671	817163	806033		NC_000019.10:13078669:AG:
NM_001184880.2(PCDH19):c.1448del (p.Gly483fs)	PCDH19	G483fs	not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000817159	X	99662148	X	100407150	817159	806142		NC_000023.11:100407149:CCC:CC
NM_182641.4(BPTF):c.2245dup (p.Arg749fs)	BPTF		not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000817147	17	65889673 - 65889674	17	67893557 - 67893558	817147	805983		NC_000017.11:67893557:AA:AAA
NM_000252.3(MTM1):c.814del (p.Ser272fs)	MTM1	S272fs, S235fs	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000817134	X	149814289	X	150645816	817134	806160		NC_000023.11:150645815:TTT:TT
NM_004006.3(DMD):c.1323dup (p.Gln442fs)	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000817126	X	32662256 - 32662257	X	32644139 - 32644140	817126	806200		NC_000023.11:32644139:TTTTT:TTTTTT
NM_030632.3(ASXL3):c.1696_1697GA[1] (p.Glu566fs)	ASXL3		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000817120	18	31319063 - 31319064	18	33739099 - 33739100	817120	806009		NC_000018.10:33739098:AGAGA:AGA
NM_152424.4(AMER1):c.1100_1101insC (p.Gly368fs)	AMER1		not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000817104	X	63412066 - 63412067	X	64192186 - 64192187	817104	806244		NC_000023.11:64192186::G
NM_005629.4(SLC6A8):c.356del (p.Gly119fs)	SLC6A8	G4fs, G119fs	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000817103	X	152955922	X	153690467	817103	806163		NC_000023.11:153690466:GG:G
NM_015559.3(SETBP1):c.2269_2281del (p.Asp757fs)	SETBP1	D757fs	not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000817094	18	42531567 - 42531579	18	44951602 - 44951614	817094	806019		NC_000018.10:44951601:CCAGCCGGATGTTCCAGCCG:CCAGCCG
NM_080647.1(TBX1):c.983del (p.Pro328fs)	TBX1	P328fs	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000817078	22	19753496	22	19765973	817078	806107		NC_000022.11:19765972:CCCC:CCC
NM_001323289.2(CDKL5):c.663dup (p.Thr222fs)	CDKL5		not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000817077	X	18606177 - 18606178	X	18588057 - 18588058	817077	806177		NC_000023.11:18588057:TTTTT:TTTTTT
NM_015365.3(AMMECR1):c.454dup (p.Arg152fs)	AMMECR1		not provided	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000817076	X	109560845 - 109560846	X	110317617 - 110317618	817076	806149		NC_000023.11:110317617:GGGGGG:GGGGGGG
NM_005121.3(MED13):c.3001_3004CTTC[1] (p.Pro1002fs)	MED13		not provided	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000817075	17	60060356 - 60060359	17	61982995 - 61982998	817075	805973		NC_000017.11:61982994:GAAGGAAG:GAAG
NM_005121.3(MED13):c.125del (p.Pro42fs)	MED13	P42fs	not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000817068	17	60140604	17	62063243	817068	805974		NC_000017.11:62063242:GGGG:GGG
NM_078629.4(MSL3):c.1319dup (p.Gly441fs)	MSL3		not provided	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000817066	X	11790306 - 11790307	X	11772187 - 11772188	817066	806152		NC_000023.11:11772187:CCCCCC:CCCCCCC
NM_138927.4(SON):c.5565_5571del (p.Lys1855fs)	SON	K1855fs	not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000817058	21	34927102 - 34927108	21	33554796 - 33554802	817058	806094		NC_000021.9:33554795:GTCTCAT:
NM_001083961.2(WDR62):c.1821dup (p.Arg608fs)	WDR62		not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, single submitter	VCV000817049	19	36579989 - 36579990	19	36089087 - 36089088	817049	806043		NC_000019.10:36089087:TTT:TTTT
NM_000328.3(RPGR):c.219del (p.Ala74fs)	RPGR	A74fs, A84fs	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000817046	X	38182134	X	38322881	817046	806209		NC_000023.11:38322880:T:
NM_004429.5(EFNB1):c.324dup (p.Arg109fs)	EFNB1		not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000817042	X	68058654 - 68058655	X	68838811 - 68838812	817042	806250		NC_000023.11:68838811:A:AA
NM_004006.3(DMD):c.3478_3479del (p.Val1160fs)	DMD	V1160fs, V1037fs, V1152fs, V1156fs	not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000817035	X	32472903 - 32472904	X	32454786 - 32454787	817035	806198		NC_000023.11:32454785:ACA:A
NM_030632.3(ASXL3):c.4153_4154del (p.Val1385fs)	ASXL3	V1385fs	not provided	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000817028	18	31323964 - 31323965	18	33744000 - 33744001	817028	806012		NC_000018.10:33743999:TGT:T
NM_001278116.2(L1CAM):c.48del (p.Cys17fs)	L1CAM	C17fs	not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000817025	X	153141244	X	153875789	817025	806168		NC_000023.11:153875788:GGGG:GGG
NM_000213.5(ITGB4):c.4633_4634AG[1] (p.Arg1545fs)	ITGB4		not provided	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000817024	17	73751856 - 73751857	17	75755775 - 75755776	817024	805999		NC_000017.11:75755774:AGAG:AG
NM_001282531.3(ADNP):c.54_55TG[1] (p.Val19fs)	ADNP		not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000817018	20	49520477 - 49520478	20	50903940 - 50903941	817018	806081		NC_000020.11:50903939:CACA:CA
NM_004006.3(DMD):c.4568_4569dup (p.Lys1524Ter)	DMD		not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000817006	X	32404531 - 32404532	X	32386414 - 32386415	817006	806197		NC_000023.11:32386414:TAT:TATAT
NM_000444.6(PHEX):c.779del (p.Leu259_Leu260insTer)	PHEX		not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000817001	X	22112144	X	22094026	817001	806188		NC_000023.11:22094025:TTTT:TTT
NM_005650.4(TCF20):c.869dup (p.Tyr290Ter)	TCF20		not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000816998	22	42610442 - 42610443	22	42214436 - 42214437	816998	806131		NC_000022.11:42214436:T:TT
NM_001111125.3(IQSEC2):c.797_806dup (p.Tyr269Ter)	IQSEC2		not provided	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000816996	X	53285174 - 53285175	X	53255992 - 53255993	816996	806236		NC_000023.11:53255992:TAGGGGGGTT:TAGGGGGGTTTAGGGGGGTT
NM_006852.6(TLK2):c.367C>T (p.Arg123Ter)	TLK2	R91*, R123*, R137*	not provided	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000816982	17	60613534	17	62536173	816982	805975		NC_000017.11:62536172:C:T
NM_004187.5(KDM5C):c.157C>T (p.Gln53Ter)	KDM5C	Q53*	not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000816980	X	53250092	X	53220910	816980	806230		NC_000023.11:53220909:G:A
NM_004859.4(CLTC):c.187C>T (p.Arg63Ter)	CLTC	R63*	not provided	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000816974	17	57721781	17	59644420	816974	805961		NC_000017.11:59644419:C:T
NM_001356.5(DDX3X):c.1390G>T (p.Glu464Ter)	DDX3X	E448*, E278*, E464*	not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000816965	X	41205556	X	41346303	816965	806215		NC_000023.11:41346302:G:T
NM_000328.3(RPGR):c.1905+943G>T	RPGR	E950*	not provided	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000816960	X	38145404	X	38286151	816960	806205		NC_000023.11:38286150:C:A
NM_001015877.2(PHF6):c.955C>T (p.Arg319Ter)	PHF6	R319*	not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000816948	X	133551319	X	134417289	816948	806157		NC_000023.11:134417288:C:T
NM_004586.3(RPS6KA3):c.898C>T (p.Arg300Ter)	RPS6KA3	R300*	not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000816947	X	20195150	X	20177032	816947	806184		NC_000023.11:20177031:G:A
NC_000023.11:g.41131474del	USP9X		Mental retardation, X-linked 99	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000816935					816935	805130		
NC_000020.11:g.58909552C>T	GNAS		Pseudohypoparathyroidism	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000816910					816910	805116		
NC_000022.11:g.42214057G>A	TCF20		DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000816895					816895	805123		
NC_000022.11:g.41157392dup	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000816887					816887	805121		
NM_004750.5(CRLF1):c.985dup (p.Glu329fs)	CRLF1		Cold-induced sweating syndrome 1	Pathogenic	no assertion criteria provided	VCV000816854	19	18707470 - 18707471	19	18596660 - 18596661	816854	805031		NC_000019.10:18596660:C:CC
NM_005710.2(PQBP1):c.463C>T (p.Arg155Ter)	PQBP1	R147*, R155*	Renpenning syndrome 1	Pathogenic	no assertion criteria provided	VCV000816841	X	48759680	X	48902403	816841	805049		NC_000023.11:48902402:C:T
NC_000023.11:g.103787486C>G	PLP1		Pelizaeus-Merzbacher disease	Pathogenic(Last reviewed: Dec 11, 2019)	no assertion criteria provided	VCV000816707					816707	804913		
NC_000023.11:g.103786890G>A	PLP1		Pelizaeus-Merzbacher disease	Pathogenic(Last reviewed: Dec 11, 2019)	no assertion criteria provided	VCV000816706					816706	804912		
NC_000023.11:g.103786885G>A	PLP1		Pelizaeus-Merzbacher disease	Pathogenic(Last reviewed: Dec 11, 2019)	no assertion criteria provided	VCV000816705					816705	804911		
NM_001077488.4(GNAS):c.533+1G>T	GNAS		Pseudohypoparathyroidism	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000816649	20	57480536	20	58905481	816649	804855		NC_000020.11:58905480:G:T
NM_004595.5(SMS):c.388C>T (p.Arg130Cys)	SMS	R130C, R77C	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jan 30, 2020)	no assertion criteria provided	VCV000816629	X	21995237	X	21977119	816629	804834		NC_000023.11:21977118:C:T
GRCh37/hg19 Xq13.3(chrX:73917544-73988312)x1	NEXMIF		not provided	Pathogenic(Last reviewed: Jul 28, 2018)	no assertion criteria provided	VCV000816360	X	73917544 - 73988312			816360	804568		
GRCh37/hg19 Xp21.1(chrX:32458016-32593856)x1	DMD		not provided	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000816336	X	32458016 - 32593856			816336	804544		
GRCh37/hg19 Xp21.1(chrX:32455259-32791566)x0	DMD		not provided	Pathogenic(Last reviewed: Mar 11, 2019)	no assertion criteria provided	VCV000816335	X	32455259 - 32791566			816335	804543		
GRCh37/hg19 Xp21.1(chrX:31855684-32157553)x0	DMD		not provided	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000816332	X	31855684 - 32157553			816332	804540		
GRCh37/hg19 Xp21.1(chrX:31795363-31982230)x0	DMD		not provided	Pathogenic(Last reviewed: May 28, 2019)	no assertion criteria provided	VCV000816331	X	31795363 - 31982230			816331	804539		
GRCh37/hg19 Xp21.1(chrX:31766645-31923633)x1	DMD		not provided	Pathogenic(Last reviewed: Nov 1, 2018)	no assertion criteria provided	VCV000816330	X	31766645 - 31923633			816330	804538		
GRCh37/hg19 Xp21.1(chrX:31761311-31869309)x1	DMD		not provided	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000816329	X	31761311 - 31869309			816329	804537		
GRCh37/hg19 18q21.2(chr18:52956790-53108471)x1	TCF4		not provided	Pathogenic(Last reviewed: Oct 2, 2018)	no assertion criteria provided	VCV000816015	18	52956790 - 53108471			816015	804223		
GRCh37/hg19 18q12.3(chr18:42225174-42304325)x1	SETBP1		not provided	Pathogenic(Last reviewed: Apr 5, 2019)	no assertion criteria provided	VCV000816007	18	42225174 - 42304325			816007	804215		
NM_003688.3(CASK):c.1970G>A (p.Trp657Ter)	CASK	W628*, W634*, W657*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813943	X	41413041	X	41553788	813943	802235		NC_000023.11:41553787:C:T
NM_203473.3(PORCN):c.283C>T (p.Arg95Ter)	PORCN	R95*, R24*	Focal dermal hypoplasia	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813937	X	48369829	X	48511441	813937	802236		NC_000023.11:48511440:C:T
NM_001353921.2(ARHGEF9):c.1351C>T (p.Gln451Ter)	ARHGEF9	Q384*, Q423*, Q262*, Q400*, Q407*, Q342*, Q391*, Q444*, Q457*, Q379*, Q451*	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000813791	X	62863899	X	63644019	813791	802053		NC_000023.11:63644018:G:A
NM_172107.4(KCNQ2):c.2048_2049del (p.His683fs)	KCNQ2	H665fs, H683fs, H652fs, H655fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000813777	20	62038567 - 62038568	20	63407214 - 63407215	813777	802032		NC_000020.11:63407213:GTG:G
NM_001323289.2(CDKL5):c.898_899del (p.Gln300fs)	CDKL5	Q300fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000813762	X	18616654 - 18616655	X	18598534 - 18598535	813762	802048		NC_000023.11:18598533:CA:
NM_172107.4(KCNQ2):c.2425C>T (p.Gln809Ter)	KCNQ2	Q778*, Q809*, Q781*, Q791*	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000813752	20	62038191	20	63406838	813752	802031		NC_000020.11:63406837:G:A
NM_001184880.2(PCDH19):c.2531_2540del (p.Ser844fs)	PCDH19	S844fs, S797fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000813750	X	99657598 - 99657607	X	100402600 - 100402609	813750	802039		NC_000023.11:100402599:TGGTTAGCACTGGT:TGGT
NM_001184880.2(PCDH19):c.745del (p.Glu249fs)	PCDH19	E249fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000813748	X	99662851	X	100407853	813748	802041		NC_000023.11:100407852:C:
NM_001042537.1(SLC9A6):c.1148G>A (p.Gly383Asp)	SLC9A6	G383D, G299D, G331D, G351D	Christianson syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000813744	X	135095508	X	136013349	813744	802043		NC_000023.11:136013348:G:A
NM_001323289.2(CDKL5):c.1099C>T (p.Leu367=)	CDKL5		Early infantile epileptic encephalopathy 4	Pathogenic	criteria provided, single submitter	VCV000813743	X	18622143	X	18604023	813743	802049		NC_000023.11:18604022:C:T
NM_172107.4(KCNQ2):c.1411C>T (p.Gln471Ter)	KCNQ2	Q471*, Q443*, Q453*, Q441*	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000813737	20	62046370	20	63415017	813737	802035		NC_000020.11:63415016:G:A
NM_001323289.2(CDKL5):c.2276+1G>A	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	VCV000813729	X	18631396	X	18613276	813729	802066		NC_000023.11:18613275:G:A
NM_172107.4(KCNQ2):c.666_667CT[1] (p.Ser223fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000813728	20	62076033 - 62076034	20	63444680 - 63444681	813728	802037		NC_000020.11:63444679:AGAG:AG
NM_017653.6(DYM):c.95dup (p.Trp33fs)	DYM		Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: May 16, 2018)	no assertion criteria provided	VCV000813511	18	46956669 - 46956670	18	49430299 - 49430300	813511	801767		NC_000018.10:49430299:AA:AAA
NM_000071.3(CBS):c.1152G>C (p.Lys384Asn)	CBS	K279N, K384N	Classic homocystinuria	Pathogenic	criteria provided, single submitter	VCV000813502	21	44479407	21	43059297	813502	801742		NC_000021.9:43059296:C:G
NM_020533.3(MCOLN1):c.680+1G>A	MCOLN1		Mucolipidosis type IV	Pathogenic	criteria provided, single submitter	VCV000813499	19	7592515	19	7527629	813499	801739		NC_000019.10:7527628:G:A
NM_004646.3(NPHS1):c.740G>A (p.Trp247Ter)	NPHS1	W247*	Finnish congenital nephrotic syndrome	Pathogenic	criteria provided, single submitter	VCV000813498	19	36340238	19	35849336	813498	801738		NC_000019.10:35849335:C:T
NM_000109.4(DMD):c.2357-2A>C	DMD		Duchenne muscular dystrophy	Pathogenic	criteria provided, single submitter	VCV000813447	X	32509637	X	32491520	813447	801748		NC_000023.11:32491519:T:G
NM_000109.4(DMD):c.5898+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic	criteria provided, single submitter	VCV000813446	X	32360216	X	32342099	813446	801747		NC_000023.11:32342098:C:A
NM_000109.4(DMD):c.10371-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic	criteria provided, single submitter	VCV000813444	X	31187719	X	31169602	813444	801745		NC_000023.11:31169601:C:T
NM_003560.4(PLA2G6):c.1187-1G>A	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic	criteria provided, single submitter	VCV000813443	22	38524438	22	38128431	813443	801744		NC_000022.11:38128430:C:T
NM_003560.4(PLA2G6):c.1880-1G>C	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic	criteria provided, single submitter	VCV000813442	22	38511689	22	38115682	813442	801743		NC_000022.11:38115681:C:G
NM_000159.4(GCDH):c.896G>A (p.Trp299Ter)	GCDH	W299*	Glutaric aciduria, type 1	Pathogenic	criteria provided, single submitter	VCV000813441	19	13007767	19	12896953	813441	801737		NC_000019.10:12896952:G:A
GRCh37/hg19 20p13(chr20:3888573-3888925)	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000813319	20	3888573 - 3888925			813319	801568		
GRCh37/hg19 Xp21.2(chrX:29686547-29686621)	IL1RAPL1		Mental retardation 21, X-linked	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000813316	X	29686547 - 29686621			813316	801566		
GRCh37/hg19 Xp21.1(chrX:31792077-31893490)	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000813307	X	31792077 - 31893490			813307	801559		
GRCh37/hg19 Xq22.3(chrX:107683356-107683436)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000813306	X	107683356 - 107683436			813306	801558		
Single allele	EFTUD2		not provided	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000813276					813276	801520		
NM_000328.3(RPGR):c.29-1G>T	RPGR		Retinal dystrophy	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV000813233	X	38182778	X	38323525	813233	801491		NC_000023.11:38323524:C:A
NM_000328.3(RPGR):c.1217dup (p.Ser407fs)	RPGR		not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000813223	X	38158236 - 38158237	X	38298983 - 38298984	813223	801485		NC_000023.11:38298983:A:AA
NM_001029896.2(WDR45):c.69_75del (p.Cys23fs)	WDR45	C23fs	Basal ganglia calcification|Dystonia	Pathogenic	no assertion criteria provided	VCV000813007	X	48935551 - 48935557	X	49077892 - 49077898	813007	801228		NC_000023.11:49077891:CATGGCGCA:CA
NM_014727.3(KMT2B):c.6517_6518insA (p.Arg2173fs)	KMT2B		Dysarthria|Generalized dystonia	Pathogenic	no assertion criteria provided	VCV000813004	19	36223967 - 36223968	19	35733066 - 35733067	813004	801192		NC_000019.10:35733066::A
NM_014727.3(KMT2B):c.3143_3149del (p.Gly1048fs)	KMT2B	G1048fs	Abnormality of metabolism/homeostasis|Dysarthria|Specific learning disability|Myoclonus|Dystonia	Pathogenic	no assertion criteria provided	VCV000813003	19	36214713 - 36214719	19	35723812 - 35723818	813003	801191		NC_000019.10:35723811:CGGGGGGCGGG:CGGG
NM_014727.3(KMT2B):c.3024_3025AG[1] (p.Glu1009fs)	KMT2B		Dystonia	Pathogenic	no assertion criteria provided	VCV000813002	19	36214370 - 36214371	19	35723468 - 35723469	813002	801190		NC_000019.10:35723467:AGAG:AG
NC_000023.11:g.150583230_150648535del	MTM1		Abnormality of metabolism/homeostasis|Muscular Diseases|Central core regions in muscle fibers|Abnormality of the respiratory system	Pathogenic	no assertion criteria provided	VCV000812933	X	149751687 - 149817005			812933	801221		
NC_000022.11:g.20042177_20075233del	TANGO2		Global developmental delay|Episodic ataxia|Delayed speech and language development	Pathogenic	no assertion criteria provided	VCV000812930	22	20029700 - 20062756			812930	801216		
NC_000021.8:g.36284364_37074805del	RUNX1		Thrombocytopenia	Pathogenic	no assertion criteria provided	VCV000812916	21	36284364 - 37074805			812916	801206		
NC_000021.9:g.34791392_34804065del	RUNX1		Thrombocytopenia	Pathogenic	no assertion criteria provided	VCV000812915	21	36163689 - 36176362			812915	801209		
NM_015338.6(ASXL1):c.1900_1922del (p.Glu635fs)	ASXL1	E635fs, E574fs	Juvenile myelomonocytic leukemia|Cafe-au-lait spot	Pathogenic	no assertion criteria provided	VCV000812900	20	31022403 - 31022425	20	32434600 - 32434622	812900	801197		NC_000020.11:32434599:CACCACTGCCATAGAGAGGCGGCCACCACTGCCAT:CACCACTGCCAT
NM_139058.3(ARX):c.52dup (p.Ser18fs)	ARX		Abnormal synaptic transmission	Pathogenic	no assertion criteria provided	VCV000812792	X	25033802 - 25033803	X	25015685 - 25015686	812792	801224		NC_000023.11:25015685:TTTT:TTTTT
NM_172107.4(KCNQ2):c.845A>T (p.Asp282Val)	KCNQ2	D282V	Epileptic encephalopathy	Pathogenic	no assertion criteria provided	VCV000812789	20	62071033	20	63439680	812789	801202		NC_000020.11:63439679:T:A
NM_000219.6(KCNE1):c.94dup (p.Arg32fs)	KCNE1		Hereditary hearing loss and deafness|Long QT syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000812588	21	35821838 - 35821839	21	34449540 - 34449541	812588	800838		NC_000021.9:34449540:GGG:GGGG
NM_002861.5(PCYT2):c.1075C>T (p.Arg359Ter)	PCYT2	R377*, R281*, R305*, R318*, R327*, R337*, R359*	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 17, 2020)	no assertion criteria provided	VCV000812573	17	79862804	17	81904928	812573	800821		NC_000017.11:81904927:G:A
NM_002861.5(PCYT2):c.676C>T (p.His226Tyr)	PCYT2	P307L, H148Y, H172Y, H185Y, H194Y, H226Y, H244Y	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812572	17	79864636	17	81906760	812572	800820		NC_000017.11:81906759:G:A
NM_002861.5(PCYT2):c.866C>T (p.Pro289Leu)	PCYT2	H244Y, P211L, P235L, P248L, P257L, P289L, P307L	SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812571	17	79863583	17	81905707	812571	800819		NC_000017.11:81905706:G:A
NM_002430.3:c.3846_3849del	MN1		CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812564	22	28147017 - 28147020	22	27751029 - 27751032	812564	800812		NC_000022.11:27751028:GACAGACAG:GACAG
NM_002430.3(MN1):c.3835C>T (p.Gln1279Ter)	MN1	Q1279*	CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812563	22	28147031	22	27751043	812563	800811		NC_000022.11:27751042:G:A
NM_002430.3(MN1):c.3870_3879dup (p.Ala1294Ter)	MN1		CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812561	22	28146986 - 28146987	22	27750998 - 27750999	812561	800809		NC_000022.11:27750998:CTTGGCGTCAC:CTTGGCGTCACTTGGCGTCAC
NM_002430.3(MN1):c.3817C>T (p.Gln1273Ter)	MN1	Q1273*	CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812559	22	28147049	22	27751061	812559	800807		NC_000022.11:27751060:G:A
NM_002430.3(MN1):c.3745G>T (p.Glu1249Ter)	MN1	E1249*	CEBALID SYNDROME	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812558	22	28192787	22	27796799	812558	800806		NC_000022.11:27796798:C:A
NM_003681.5(PDXK):c.225T>A (p.Asn75Lys)	PDXK	N35K, N75K	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000812519	21	45161630	21	43741749	812519	800762		NC_000021.9:43741748:T:A
NM_172107.4(KCNQ2):c.626T>C (p.Ile209Thr)	KCNQ2	I209T	Seizures	Pathogenic(Last reviewed: Jan 28, 2020)	no assertion criteria provided	VCV000812512	20	62076076	20	63444723	812512	800755		NC_000020.11:63444722:A:G
NM_173477.5(USH1G):c.205dup (p.Leu69fs)	USH1G			Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812444	17	72916725 - 72916726	17	74920630 - 74920631	812444	800613		NC_000017.11:74920630:GGGG:GGGGG
NM_000328.3(RPGR):c.259G>T (p.Glu87Ter)	RPGR	E87*, E97*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812422	X	38180331	X	38321078	812422	800641		NC_000023.11:38321077:C:A
NM_000328.3(RPGR):c.592G>A (p.Gly198Arg)	RPGR	G197R, G198R, G208R	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812420	X	38176596	X	38317343	812420	800639		NC_000023.11:38317342:C:T
NM_000328.3(RPGR):c.897dup (p.Ile300fs)	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812419	X	38163924 - 38163925	X	38304671 - 38304672	812419	800638		NC_000023.11:38304671:A:AA
NM_000328.3(RPGR):c.1237_1238AG[3] (p.Arg415fs)	RPGR		Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000812418	X	38158210 - 38158211	X	38298957 - 38298958	812418	800637		NC_000023.11:38298956:CTCTCTCT:CTCTCT
NM_000328.3(RPGR):c.1334C>G (p.Ser445Ter)	RPGR	S383*, S444*, S445*, S455*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812417	X	38156617	X	38297364	812417	800636		NC_000023.11:38297363:G:C
NM_000328.3(RPGR):c.1572+1G>A	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812416	X	38150211	X	38290958	812416	800704		NC_000023.11:38290957:C:T
NM_000328.3(RPGR):c.1905+268C>T	RPGR	Q725*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812415	X	38146079	X	38286826	812415	800635		NC_000023.11:38286825:G:A
NM_000328.3(RPGR):c.1905+316_1905+319del	RPGR	E741fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812414	X	38146028 - 38146031	X	38286775 - 38286778	812414	800634		NC_000023.11:38286774:CCTC:
NM_000328.3(RPGR):c.1905+367G>T	RPGR	E758*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812413	X	38145980	X	38286727	812413	800633		NC_000023.11:38286726:C:A
NM_000328.3(RPGR):c.1905+867_1905+868dup	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812412	X	38145478 - 38145479	X	38286225 - 38286226	812412	800632		NC_000023.11:38286225:CT:CTCT
NM_000328.3(RPGR):c.1905+885_1905+886del	RPGR	E931fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812411	X	38145461 - 38145462	X	38286208 - 38286209	812411	800631		NC_000023.11:38286207:CCCC:CC
NM_000328.3(RPGR):c.1905+892del	RPGR	E933fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812410	X	38145455	X	38286202	812410	800630		NC_000023.11:38286201:CCCCC:CCCC
NM_000328.3(RPGR):c.1905+1059_1905+1060del	RPGR	E989fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812409	X	38145287 - 38145288	X	38286034 - 38286035	812409	800629		NC_000023.11:38286033:CCCC:CC
NM_006915.3(RP2):c.530_531del (p.Phe177fs)	RP2	F177fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812406	X	46713337 - 46713338	X	46853902 - 46853903	812406	800653		NC_000023.11:46853901:TTT:T
NM_006915.3(RP2):c.364del (p.Cys122fs)	RP2	C122fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812405	X	46713171	X	46853736	812405	800652		NC_000023.11:46853735:TT:T
NM_006915.3(RP2):c.102+1G>T	RP2		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812403	X	46696638	X	46837203	812403	800705		NC_000023.11:46837202:G:T
NM_006915.3(RP2):c.25_28del (p.Lys10fs)	RP2	K10fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812402	X	46696558 - 46696561	X	46837123 - 46837126	812402	800650		NC_000023.11:46837122:GACGGA:GA
NM_012469.4(PRPF6):c.2822_2824del (p.Phe941del)	PRPF6	F941del	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812381	20	62664340 - 62664342	20	64032987 - 64032989	812381	800624		NC_000020.11:64032986:CTTCT:CT
NM_015629.4(PRPF31):c.1108G>T (p.Glu370Ter)	PRPF31	E370*	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812380	19	54631714	19	54128339	812380	800623		NC_000019.10:54128338:G:T
NM_015629.4(PRPF31):c.697+1G>A	PRPF31		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812379	19	54627298	19	54123919	812379	800701		NC_000019.10:54123918:G:A
NM_015629.4(PRPF31):c.689del (p.Lys230fs)	PRPF31	K230fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812378	19	54627288	19	54123909	812378	800622		NC_000019.10:54123908:AA:A
NM_022567.2(NYX):c.1261_1262dup (p.Ala422fs)	NYX		Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812362	X	41333966 - 41333967	X	41474713 - 41474714	812362	800648		NC_000023.11:41474713:CT:CTCT
NC_000023.11:g.41474520_41474521GT[1]	NYX		Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812361	X	41333773 - 41333774	X	41474520 - 41474521	812361	800647		NC_000023.11:41474519:GTGT:GT
NM_022567.2(NYX):c.797T>C (p.Leu266Pro)	NYX	L266P	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812359	X	41333503	X	41474250	812359	800645		NC_000023.11:41474249:T:C
NM_000528.4(MAN2B1):c.2670_2671del (p.Gly891fs)	MAN2B1	G891fs, G890fs	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812348	19	12758406 - 12758407	19	12647592 - 12647593	812348	800621		NC_000019.10:12647591:CT:
NM_020964.3(EPG5):c.3447G>A (p.Trp1149Ter)	EPG5	W1149*		Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812308	18	43496109	18	45916144	812308	800619		NC_000018.10:45916143:C:T
NM_030582.4(COL18A1):c.969dup (p.Ala324fs)	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812292	21	46888477 - 46888478	21	45468563 - 45468564	812292	800626		NC_000021.9:45468563:T:TT
XM_024452331.1:c.-130_258del	CHM		Choroideremia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812270					812270	800663		
NM_000390.4(CHM):c.564_565del (p.Pro189fs)	CHM	P41fs, P189fs	Choroideremia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812269	X	85218807 - 85218808	X	85963802 - 85963803	812269	800662		NC_000023.11:85963801:GC:
NM_000390.4(CHM):c.819+1G>C	CHM		Choroideremia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812268	X	85213865	X	85958860	812268	800709		NC_000023.11:85958859:C:G
NM_000390.4(CHM):c.1314C>G (p.Tyr438Ter)	CHM	Y290*, Y438*	Choroideremia	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812267	X	85156124	X	85901119	812267	800661		NC_000023.11:85901118:G:C
NM_001256789.3(CACNA1F):c.187_193dup (p.Ala65fs)	CACNA1F		Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812252	X	49088221 - 49088222	X	49231759 - 49231760	812252	800660		NC_000023.11:49231759:CACTGGCCACTG:CACTGGCCACTGGCCACTG
NM_001256789.3(CACNA1F):c.1015-2A>G	CACNA1F		Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812251	X	49084603	X	49228141	812251	800708		NC_000023.11:49228140:T:C
NM_001256789.3(CACNA1F):c.1276+34G>A	CACNA1F		Cone-rod degeneration	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812250	X	49083398	X	49226936	812250	800707		NC_000023.11:49226935:C:T
NM_001256789.3(CACNA1F):c.2225T>G (p.Phe742Cys)	CACNA1F	F742C, F688C, F753C	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812249	X	49079044	X	49222585	812249	800659		NC_000023.11:49222584:A:C
NM_001256789.3(CACNA1F):c.2470G>T (p.Glu824Ter)	CACNA1F	E824*, E835*, E770*	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812248	X	49076166	X	49219707	812248	800658		NC_000023.11:49219706:C:A
NM_001256789.3(CACNA1F):c.2772del (p.Cys925fs)	CACNA1F	C925fs, C871fs, C936fs	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812247	X	49075156	X	49218697	812247	800657		NC_000023.11:49218696:G:
NM_001256789.3(CACNA1F):c.3921G>A (p.Trp1307Ter)	CACNA1F	W1318*, W1253*, W1307*	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812246	X	49069148	X	49212688	812246	800656		NC_000023.11:49212687:C:T
NM_001256789.3(CACNA1F):c.4051C>T (p.Arg1351Ter)	CACNA1F	R1297*, R1362*, R1351*	Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812245	X	49068407	X	49211947	812245	800655		NC_000023.11:49211946:G:A
NM_004928.3(CFAP410):c.643-2A>G	CFAP410		Leber congenital amaurosis	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812235	21	45750211	21	44330328	812235	800703		NC_000021.9:44330327:T:C
NM_004928.3(CFAP410):c.643-1G>C	CFAP410		Retinitis pigmentosa	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812234	21	45750210	21	44330327	812234	800702		NC_000021.9:44330326:C:G
NM_001195553.2(DCX):c.211G>A (p.Ala71Thr)	DCX	A152T, A71T	Lissencephaly, X-linked	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000812172	X	110653416	X	111410188	812172	800677		NC_000023.11:111410187:C:T
NM_033380.3(COL4A5):c.4316-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000812148	X	107930711	X	108687481	812148	800414		NC_000023.11:108687480:G:T
NM_000132.3(F8):c.302A>G (p.Asp101Gly)	F8	D101G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000812076	X	154225334	X	154997059	812076	800300		NC_000023.11:154997058:T:C
NM_000346.4(SOX9):c.1312_1330del (p.Ser438fs)	SOX9	S438fs	not specified	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000812008	17	70120310 - 70120328	17	72124169 - 72124187	812008	800060		NC_000017.11:72124168:TCACAGTACGACTACACCG:
NM_000132.3(F8):c.5301C>A (p.Tyr1767Ter)	F8	Y1767*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000811964	X	154134767	X	154906492	811964	800281		NC_000023.11:154906491:G:T
NM_000132.3(F8):c.601_602insC (p.Gly201fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000811848	X	154221210 - 154221211	X	154992935 - 154992936	811848	800296		NC_000023.11:154992935::G
NM_000109.4(DMD):c.1235dup (p.Gln413fs)	DMD		not specified	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000811835	X	32662320 - 32662321	X	32644203 - 32644204	811835	800315		NC_000023.11:32644203:A:AA
NM_000132.3(F8):c.1271+1G>A	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000811704	X	154194700	X	154966425	811704	800291		NC_000023.11:154966424:C:T
NM_000132.3(F8):c.5914_5915del (p.Ile1972fs)	F8	I1972fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000811466	X	154132264 - 154132265	X	154903989 - 154903990	811466	800276		NC_000023.11:154903988:AT:
NM_000132.3(F8):c.4870G>T (p.Glu1624Ter)	F8	E1624*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000811363	X	154157195	X	154928920	811363	800282		NC_000023.11:154928919:C:A
NM_000455.5(STK11):c.772del (p.Asp258fs)	STK11	D258fs	not specified	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000811295	19	1221246	19	1221247	811295	800098		NC_000019.10:1221246:GGGG:GGG
NM_000132.3(F8):c.6638C>T (p.Ser2213Phe)	F8	S2213F, S78F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000811281	X	154090078	X	154861803	811281	800269		NC_000023.11:154861802:G:A
NM_000132.3(F8):c.6622C>G (p.Gln2208Glu)	F8	Q2208E, Q73E	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000811219	X	154090094	X	154861819	811219	800270		NC_000023.11:154861818:G:C
NM_000109.4(DMD):c.9915dup (p.Asn3306Ter)	DMD		not specified	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000811187	X	31200889 - 31200890	X	31182772 - 31182773	811187	800306		NC_000023.11:31182772:A:AA
NM_000132.3(F8):c.5999G>T (p.Gly2000Val)	F8	G2000V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000811156	X	154130442	X	154902167	811156	800274		NC_000023.11:154902166:C:A
NM_000132.3(F8):c.3861_3867del (p.Phe1287fs)	F8	F1287fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000811155	X	154158198 - 154158204	X	154929923 - 154929929	811155	800283		NC_000023.11:154929922:TTTTGAG:
NM_000132.3(F8):c.2150G>A (p.Arg717Gln)	F8	R717Q	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 7, 2019)	criteria provided, single submitter	VCV000810977	X	154159915	X	154931640	810977	800285		NC_000023.11:154931639:C:T
NC_000019.10:g.11116889A>T	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: May 29, 2019)	no assertion criteria provided	VCV000810851					810851	799097		
NC_000019.10:g.11105546T>C	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: May 29, 2019)	no assertion criteria provided	VCV000810850					810850	799096		
NM_017414.4(USP18):c.1073+1G>A	USP18		Pseudo-TORCH syndrome 2	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000810842	22	18656610	22	18173843	810842	799090		NC_000022.11:18173842:G:A
NM_014009.4(FOXP3):c.691C>A (p.Gln231Lys)	FOXP3	Q196K, Q231K	Non-obstructive azoospermia	Pathogenic	no assertion criteria provided	VCV000810691	X	49112220	X	49255759	810691	798977		NC_000023.11:49255758:G:T
NM_005112.2:c.4487delC	MED13		INTELLECTUAL DEVELOPMENTAL DISORDER 61	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810684					810684	798970		
NM_005121.3:c.1745T>A	MED13	L582*	INTELLECTUAL DEVELOPMENTAL DISORDER 61	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810682					810682	798968		
NM_005121.3(MED13):c.977C>T (p.Thr326Ile)	MED13	T326I	INTELLECTUAL DEVELOPMENTAL DISORDER 61	Pathogenic(Last reviewed: Feb 1, 2020)	no assertion criteria provided	VCV000810681	17	60108837	17	62031476	810681	798967		NC_000017.11:62031475:G:A
NM_005112.2:c.392T>G	MED13	L131*	INTELLECTUAL DEVELOPMENTAL DISORDER 61	Pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000810680					810680	798966		
NM_000152.5(GAA):c.1910_1918del (p.Leu637_Val639del)	GAA		Glycogen storage disease, type II	Pathogenic	no assertion criteria provided	VCV000810667	17	78086693 - 78086701	17	80112894 - 80112902	810667	798952		NC_000017.11:80112893:TGCTGGGGGTGC:TGC
NM_000152.5(GAA):c.2074C>T (p.Gln692Ter)	GAA	Q692*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000810666	17	78087050	17	80113251	810666	798953		NC_000017.11:80113250:C:T
NM_000156.6(GAMT):c.491del (p.Gly164fs)	GAMT	G164fs	Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810628	19	1398994	19	1398995	810628	798921		NC_000019.10:1398994:CCCCCC:CCCCC
NM_001127221.1(CACNA1A):c.2554C>T (p.Gln852Ter)	CACNA1A	Q851*, Q852*, Q855*	not provided|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000808476	19	13409896	19	13299082	808476	797745		NC_000019.10:13299081:G:A
NM_001284333.2(TLK2):c.968+1G>C	TLK2		MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000807711	17	60642499	17	62565138	807711	798720		NC_000017.11:62565137:G:C
NM_006306.4(SMC1A):c.1781_1784TGAT[1] (p.Ile595fs)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000807692	X	53432548 - 53432551	X	53405616 - 53405619	807692	798818		NC_000023.11:53405615:ATCAATCA:ATCA
NM_006306.4(SMC1A):c.3497A>C (p.Asn1166Thr)	SMC1A	N1144T, N1166T	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000807691	X	53407949	X	53381028	807691	798817		NC_000023.11:53381027:T:G
NM_001042537.1(SLC9A6):c.1665_1669del (p.Arg556fs)	SLC9A6	R472fs, R556fs, R504fs, R524fs	Christianson syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000807688	X	135115588 - 135115592	X	136033429 - 136033433	807688	798807		NC_000023.11:136033428:GAAAGGA:GA
NM_015559.3(SETBP1):c.2425C>T (p.Gln809Ter)	SETBP1	Q809*	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807682	18	42531730	18	44951765	807682	798736		NC_000018.10:44951764:C:T
NM_000334.4(SCN4A):c.1201C>T (p.Arg401Cys)	SCN4A	R401C	Congenital myasthenic syndrome, acetazolamide-responsive	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807678	17	62043503	17	63966143	807678	798722		NC_000017.11:63966142:G:A
NM_000292.3(PHKA2):c.235C>T (p.Gln79Ter)	PHKA2	Q79*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000807651	X	18972374	X	18954256	807651	798810		NC_000023.11:18954255:G:A
NM_000285.4(PEPD):c.540del (p.Ile180fs)	PEPD	I116fs, I180fs	Prolidase deficiency	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807650	19	33968960	19	33478054	807650	798745		NC_000019.10:33478053:G:
NM_000285.4(PEPD):c.549-1G>A	PEPD		Prolidase deficiency	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807649	19	33954969	19	33464063	807649	798744		NC_000019.10:33464062:C:T
NM_153638.3(PANK2):c.1086C>A (p.Tyr362Ter)	PANK2	Y71*, Y362*	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000807648	20	3891328	20	3910681	807648	798764		NC_000020.11:3910680:C:A
NM_153638.3(PANK2):c.1085_1088del (p.Tyr362fs)	PANK2	Y362fs, Y71fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000807647	20	3891325 - 3891328	20	3910678 - 3910681	807647	798763		NC_000020.11:3910677:TTACTT:TT
NM_032608.7(MYO18B):c.6433C>T (p.Arg2145Ter)	MYO18B	R2145*, R2146*	Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000807635	22	26400784	22	26004818	807635	798769		NC_000022.11:26004817:C:T
NM_005461.5(MAFB):c.184A>G (p.Thr62Ala)	MAFB	T62A	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000807627	20	39317307	20	40688667	807627	798765		NC_000020.11:40688666:T:C
NM_006579.3(EBP):c.329G>A (p.Arg110Gln)	EBP	R110Q		Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000807598	X	48385404	X	48527016	807598	798815		NC_000023.11:48527015:G:A
NM_001347721.2(DYRK1A):c.1631_1632CA[2] (p.His545fs)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000807597	21	38878512 - 38878513	21	37506209 - 37506210	807597	798768		NC_000021.9:37506208:ACACACA:ACACA
NM_033380.3(COL4A5):c.2359G>A (p.Gly787Arg)	COL4A5	G787R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000807579	X	107850086	X	108606856	807579	798793		NC_000023.11:108606855:G:A
NM_033380.3(COL4A5):c.2314G>A (p.Gly772Ser)	COL4A5	G772S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000807578	X	107850041	X	108606811	807578	798792		NC_000023.11:108606810:G:A
NM_033380.3(COL4A5):c.2300dup (p.Lys768fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000807577	X	107850024 - 107850025	X	108606794 - 108606795	807577	798791		NC_000023.11:108606794:TTT:TTTT
NM_033380.3(COL4A5):c.2048_2050del (p.Pro683_Gly684delinsArg)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000807576	X	107845121 - 107845123	X	108601891 - 108601893	807576	798790		NC_000023.11:108601890:CTG:
NM_033380.3(COL4A5):c.1974_1975TA[1] (p.Ile659fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000807575	X	107844648 - 107844649	X	108601418 - 108601419	807575	798789		NC_000023.11:108601417:TATA:TA
NM_033380.3(COL4A5):c.1904G>T (p.Gly635Val)	COL4A5	G635V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807574	X	107842056	X	108598826	807574	798788		NC_000023.11:108598825:G:T
NM_033380.3(COL4A5):c.1807G>A (p.Gly603Ser)	COL4A5	G603S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000807573	X	107841959	X	108598729	807573	798787		NC_000023.11:108598728:G:A
NM_033380.3(COL4A5):c.1673G>A (p.Gly558Asp)	COL4A5	G558D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000807571	X	107840692	X	108597462	807571	798785		NC_000023.11:108597461:G:A
NM_033380.3(COL4A5):c.1424-2A>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000807570	X	107838737	X	108595507	807570	798784		NC_000023.11:108595506:A:C
NM_033380.3(COL4A5):c.1402C>T (p.Gln468Ter)	COL4A5	Q468*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000807569	X	107834853	X	108591623	807569	798783		NC_000023.11:108591622:C:T
NM_033380.3(COL4A5):c.973G>C (p.Gly325Arg)	COL4A5	G325R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807568	X	107826150	X	108582920	807568	798782		NC_000023.11:108582919:G:C
NM_030632.3(ASXL3):c.3827_3830dup (p.Asn1278fs)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000807546	18	31323636 - 31323637	18	33743672 - 33743673	807546	798735		NC_000018.10:33743672:TGCTTG:TGCTTGCTTG
NM_030632.3(ASXL3):c.3494_3495del (p.Asn1164_Cys1165insTer)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000807545	18	31323305 - 31323306	18	33743341 - 33743342	807545	798734		NC_000018.10:33743340:TGT:T
NM_015338.6(ASXL1):c.2036dup (p.Gly680fs)	ASXL1		Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000807543	20	31022547 - 31022548	20	32434744 - 32434745	807543	798762		NC_000020.11:32434744:GGGG:GGGGG
NM_000026.4(ADSL):c.268G>A (p.Ala90Thr)	ADSL	A90T, A26T	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000807536	22	40745950	22	40349946	807536	798771		NC_000022.11:40349945:G:A
NM_080632.3(UPF3B):c.575_578del (p.Glu191_Leu192insTer)	UPF3B		Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000807522	X	118977156 - 118977159	X	119843193 - 119843196	807522	798802		NC_000023.11:119843192:ATTAATT:ATT
NM_001083962.2(TCF4):c.795T>A (p.Tyr265Ter)	TCF4	Y105*, Y135*, Y194*, Y240*, Y241*, Y264*, Y367*, Y263*, Y223*, Y265*, Y271*, Y49*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000807513	18	52937189	18	55269958	807513	798737		NC_000018.10:55269957:A:T
NM_005650.3(TCF20):c.4441_4444dup (p.Ser1482fs)	TCF20		DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000807512	22	42606867 - 42606868	22	42210861 - 42210862	807512	798772		NC_000022.11:42210861:AACCA:AACCAACCA
NM_001321120.2(TBX4):c.281+1G>T	TBX4			Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000807511	17	59534993	17	61457632	807511	798719		NC_000017.11:61457631:G:T
NM_001042750.2(STAG2):c.352dup (p.Ile118fs)	STAG2		MULLEGAMA-KLEIN-MARTINEZ SYNDROME	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807501	X	123171439 - 123171440	X	124037589 - 124037590	807501	798804		NC_000023.11:124037589:A:AA
NM_002816.5(PSMD12):c.142_143CT[3] (p.Leu50fs)	PSMD12		Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000807474	17	65353654 - 65353655	17	67357538 - 67357539	807474	798723		NC_000017.11:67357537:AGAGAGAGA:AGAGAGA
NM_005710.2(PQBP1):c.597_598AG[1] (p.Glu200fs)	PQBP1		Renpenning syndrome 1	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000807471	X	48760028 - 48760029	X	48902751 - 48902752	807471	798816		NC_000023.11:48902750:AGAG:AG
NM_007254.4(PNKP):c.1261_1262insGGGTCGCCATCGACAAC (p.Ile421fs)	PNKP		Early infantile epileptic encephalopathy 10	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000807469	19	50365065 - 50365066	19	49861808 - 49861809	807469	798757		NC_000019.10:49861808::GTTGTCGATGGCGACCC
NM_000284.4(PDHA1):c.642G>T (p.Trp214Cys)	PDHA1	W214C, W183C, W252C, W221C	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000807461	X	19373505	X	19355387	807461	798811		NC_000023.11:19355386:G:T
NM_004646.3(NPHS1):c.3523_3524del (p.Leu1175fs)	NPHS1	L1175fs	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807454	19	36321816 - 36321817	19	35830914 - 35830915	807454	798751		NC_000019.10:35830913:AA:
NM_000271.5(NPC1):c.3027del (p.Lys1010fs)	NPC1	K1010fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000807453	18	21118520	18	23538556	807453	798732		NC_000018.10:23538555:GGGG:GGG
NM_007363.5(NONO):c.107del (p.Pro36fs)	NONO	P36fs	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000807452	X	70510593	X	71290743	807452	798822		NC_000023.11:71290742:CC:C
NM_014727.3(KMT2B):c.4549C>T (p.Arg1517Ter)	KMT2B	R1517*	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000807438	19	36219050	19	35728149	807438	798749		NC_000019.10:35728148:C:T
NM_014727.3(KMT2B):c.424C>T (p.Arg142Ter)	KMT2B	R142*	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807435	19	36210431	19	35719529	807435	798746		NC_000019.10:35719528:C:T
NM_001555.5(IGSF1):c.2407dup (p.His803fs)	IGSF1		Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000807432	X	130411113 - 130411114	X	131277139 - 131277140	807432	798806		NC_000023.11:131277139:GGGGGG:GGGGGGG
NM_000166.6(GJB1):c.783_784del (p.Ile262fs)	GJB1	I262fs	X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000807420	X	70444339 - 70444340	X	71224489 - 71224490	807420	798821		NC_000023.11:71224488:ACA:A
NM_001193416.3(DDX3X):c.1316-2A>G	DDX3X		Mental retardation, X-linked 102	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000807403	X	41205480	X	41346227	807403	798814		NC_000023.11:41346226:A:G
NM_001193416.3(DDX3X):c.1148C>G (p.Ala383Gly)	DDX3X	A197G, A383G, A367G	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000807402	X	41204555	X	41345302	807402	798813		NC_000023.11:41345301:C:G
NM_000095.3(COMP):c.1153G>T (p.Asp385Tyr)	COMP	D385Y	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000807400	19	18897443	19	18786633	807400	798743		NC_000019.10:18786632:C:A
NM_000095.3(COMP):c.1368_1370GGA[1] (p.Glu457del)	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807399	19	18896891 - 18896893	19	18786081 - 18786083	807399	798742		NC_000019.10:18786080:TCCTCCT:TCCT
NM_033380.3(COL4A5):c.4543_4544insTTAG (p.Cys1515fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807398	X	107935992 - 107935993	X	108692762 - 108692763	807398	798800		NC_000023.11:108692762::TTAG
NM_033380.3(COL4A5):c.4470T>G (p.Tyr1490Ter)	COL4A5	Y1484*, Y1490*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807397	X	107930866	X	108687636	807397	798799		NC_000023.11:108687635:T:G
NM_033380.3(COL4A5):c.3772G>A (p.Gly1258Ser)	COL4A5	G1258S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000807396	X	107911716	X	108668486	807396	798798		NC_000023.11:108668485:G:A
NM_033380.3(COL4A5):c.3197G>A (p.Gly1066Asp)	COL4A5	G1066D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807395	X	107869530	X	108626300	807395	798797		NC_000023.11:108626299:G:A
NM_033380.3(COL4A5):c.2606G>T (p.Gly869Val)	COL4A5	G869V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807394	X	107863585	X	108620355	807394	798796		NC_000023.11:108620354:G:T
NM_033380.3(COL4A5):c.225del (p.Gln76fs)	COL4A5	Q76fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000807392	X	107802377	X	108559147	807392	798780		NC_000023.11:108559146:A:
NM_033380.3(COL4A5):c.188dup (p.Phe64fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807391	X	107802338 - 107802339	X	108559108 - 108559109	807391	798779		NC_000023.11:108559108:GG:GGG
NM_001321120.2(TBX4):c.339T>A (p.Tyr113Ter)	TBX4	Y113*	Amelia, autosomal recessive|	Pathogenic(Last reviewed: Mar 23, 2020)	no assertion criteria provided	VCV000805945	17	59543237	17	61465876	805945	794273		NC_000017.11:61465875:T:A
NM_033380.3(COL4A5):c.4441C>T (p.Gln1481Ter)	COL4A5	Q1475*, Q1481*	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000805941	X	107930837	X	108687607	805941	794269		NC_000023.11:108687606:C:T
NM_004409.4:c.*224_*283CTG[(271_852)]CCG[1]CTG[17]CCG[1]CTG[29]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	no assertion criteria provided	VCV000805869					805869	794189		
NM_004409.4:c.*224_*283CTG[(510_860)]CCG[1]CTG[1]CCG[1]CTG[1]CCG[1]CTG[2]CCG[3]CTG[1]CCG[1]CTG[4]CCG[1]CTG[1]CCG[1]CTG[18]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	no assertion criteria provided	VCV000805868					805868	794188		
NM_004409.4:c.*224_*283CTG[329]NNN[(?)]CCG[1]CTG[1]CCG[1]CTG[1]CCG[1]CTG[4]CCG[1]CTG[1]CCG[1]CTG[1]CCG[1]CTG[4]CCG[1]CTG[1]CCG[1]CTG[18]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	no assertion criteria provided	VCV000805867					805867	794187		
NM_004409.4:c.*224_*283CTG[(192_602)]CCG[1]CTG[8]CCG[2]CTG[2]CCG[1]CTG[4]CCG[1]CTG[30]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Sep 13, 2019)	no assertion criteria provided	VCV000805866					805866	794186		
NM_001127.3(AP1B1):c.2374G>T (p.Glu792Ter)	AP1B1	E792*, E765*, E785*	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805798	22	29727841	22	29331852	805798	794118		NC_000022.11:29331851:C:A
NM_001127.3(AP1B1):c.2335del (p.Leu779fs)	AP1B1	L752fs, L772fs, L779fs	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805797	22	29727880	22	29331891	805797	794117		NC_000022.11:29331890:GGGGGG:GGGGG
NM_001127.3(AP1B1):c.430T>C (p.Cys144Arg)	AP1B1	C144R	Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 17, 2020)	no assertion criteria provided	VCV000805796	22	29754810	22	29358821	805796	794116		NC_000022.11:29358820:A:G
NM_001127.3(AP1B1):c.38-1G>A	AP1B1		Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805795	22	29759096	22	29363107	805795	794115		NC_000022.11:29363106:C:T
NC_000022.10:g.29758984_29815476del	AP1B1		Autosomal recessive keratitis-ichthyosis-deafness syndrome	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000805794					805794	794114		
NM_001127221.1(CACNA1A):c.4953+3662G>T	CACNA1A		not provided	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000805780	19	13352334	19	13241520	805780	794068		NC_000019.10:13241519:C:A
NM_000454.5(SOD1):c.346C>G (p.Arg116Gly)	SOD1	R116G	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000805495	21	33039677	21	31667364	805495	793852		NC_000021.9:31667363:C:G
NM_000451.3(SHOX):c.728del (p.Pro243fs)	SHOX	P243fs	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000805452	X	605215	X	644480	805452	793898		NC_000024.10:644479:CCCCCC:CCCCC
NM_006796.3(AFG3L2):c.1710_1711TG[1] (p.Val571fs)	AFG3L2		not provided	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV000805324	18	12344197 - 12344198	18	12344198 - 12344199	805324	793704		NC_000018.10:12344197:CACA:CA
NM_000444.6(PHEX):c.481dup (p.Arg161fs)	PHEX		not provided	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000805129	X	22095637 - 22095638	X	22077519 - 22077520	805129	793881		NC_000023.11:22077519:C:CC
NM_000444.6(PHEX):c.282del (p.Glu96fs)	PHEX	E96fs	not provided	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, single submitter	VCV000805127	X	22065261	X	22047143	805127	793880		NC_000023.11:22047142:TT:T
NM_000444.6(PHEX):c.1184_1185dup (p.Thr396fs)	PHEX		not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000805125	X	22132583 - 22132584	X	22114465 - 22114466	805125	793883		NC_000023.11:22114465:GGGG:GGGGGG
NM_000268.4(NF2):c.1006dup (p.Arg336fs)	NF2		not provided	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000805086	22	30067820 - 30067821	22	29671831 - 29671832	805086	793859		NC_000022.11:29671831:C:CC
NM_000109.4(DMD):c.5363dup (p.Leu1789fs)	DMD		not provided	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, single submitter	VCV000804747	X	32366583 - 32366584	X	32348466 - 32348467	804747	793885		NC_000023.11:32348466:GG:GGG
NM_000109.4(DMD):c.1949_1968+966del	DMD		not provided	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000804745	X	32582853 - 32583838	X	32564736 - 32565721	804745	794086		
NM_000109.4(DMD):c.1689dup (p.Ser564Ter)	DMD		not provided	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000804744	X	32591745 - 32591746	X	32573628 - 32573629	804744	793886		NC_000023.11:32573628:AAAAA:AAAAAA
NM_000166.6(GJB1):c.843_846del (p.Cys283fs)	GJB1	C283fs	not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000804723	X	70444399 - 70444402	X	71224549 - 71224552	804723	793894		NC_000023.11:71224548:CGGCC:C
NM_001127221.1(CACNA1A):c.1784del (p.Lys595fs)	CACNA1A	K595fs, K594fs	not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000804597	19	13419230	19	13308416	804597	793738		NC_000019.10:13308415:TTT:TT
NM_000495.5(COL4A5):c.781-1G>A	COL4A5		not provided	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000804591	X	107823762	X	108580532	804591	794080		NC_000023.11:108580531:G:A
NM_000495.5(COL4A5):c.3614G>A (p.Gly1205Asp)	COL4A5	G1205D	not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000804588	X	107911558	X	108668328	804588	793871		NC_000023.11:108668327:G:A
NM_000495.5(COL4A5):c.3197G>T (p.Gly1066Val)	COL4A5	G1066V	not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000804587	X	107869530	X	108626300	804587	793870		NC_000023.11:108626299:G:T
NM_000495.5(COL4A5):c.2767+1G>C	COL4A5		not provided	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000804586	X	107865123	X	108621893	804586	794081		NC_000023.11:108621892:G:C
NM_000495.5(COL4A5):c.2513T>G (p.Leu838Ter)	COL4A5	L838*	not provided	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000804585	X	107863492	X	108620262	804585	793869		NC_000023.11:108620261:T:G
NM_000495.5(COL4A5):c.2142dup (p.Lys715fs)	COL4A5		not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000804584	X	107845212 - 107845213	X	108601982 - 108601983	804584	793868		NC_000023.11:108601982:CCC:CCCC
NM_000054.6(AVPR2):c.441dup (p.Tyr148fs)	AVPR2		not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000804556	X	153171400 - 153171401	X	153905946 - 153905947	804556	793876		NC_000023.11:153905946:G:GG
NM_001011658.4(TRAPPC2):c.239_240AT[1] (p.Met81fs)	TRAPPC2		Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000804351	X	13734205 - 13734206	X	13716086 - 13716087	804351	792690		NC_000023.11:13716085:ATAT:AT
NM_000109.4(DMD):c.2506C>T (p.Gln836Ter)	DMD	Q721*, Q836*, Q840*, Q844*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000804333	X	32509486	X	32491369	804333	792688		NC_000023.11:32491368:G:A
NM_181672.3(OGT):c.1016A>G (p.Glu339Gly)	OGT	E329G, E339G	Intellectual disability, X-linked 106	Pathogenic	no assertion criteria provided	VCV000804284	X	70775895	X	71556045	804284	792640		NC_000023.11:71556044:A:G
NM_181672.3(OGT):c.762G>C (p.Leu254Phe)	OGT	L244F, L254F	Intellectual disability, X-linked 106	Pathogenic	no assertion criteria provided	VCV000804282	X	70775073	X	71555223	804282	792638		NC_000023.11:71555222:G:C
NM_001353921.2(ARHGEF9):c.1306del (p.Glu436fs)	ARHGEF9	E247fs, E327fs, E364fs, E369fs, E376fs, E385fs, E392fs, E408fs, E429fs, E436fs, E442fs	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000804241	X	62875389	X	63655509	804241	792611		NC_000023.11:63655508:CC:C
NM_031229.4(RBCK1):c.1411G>A (p.Glu471Lys)	RBCK1	E301K, E429K, E471K	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000804223	20	409697	20	429053	804223	792583		NC_000020.11:429052:G:A
Single allele	OCRL		not provided	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000804207					804207	792568		
NM_014270.5(SLC7A9):c.1201A>T (p.Lys401Ter)	SLC7A9	K401*	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804195	19	33333097	19	32842191	804195	792549		NC_000019.10:32842190:T:A
NM_014270.5(SLC7A9):c.151T>C (p.Ser51Pro)	SLC7A9	S51P	Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804194	19	33355619	19	32864713	804194	792554		NC_000019.10:32864712:A:G
NM_014270.5(SLC7A9):c.525del (p.Ser174_Tyr175insTer)	SLC7A9		Cystine urolithiasis	Pathogenic	no assertion criteria provided	VCV000804180	19	33353446	19	32862540	804180	792552		NC_000019.10:32862539:G:
NM_001303256.3(MORC2):c.79G>A (p.Glu27Lys)	MORC2	E27K	not provided	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000804164	22	31354670	22	30958684	804164	792534		NC_000022.11:30958683:C:T
NM_015629.4(PRPF31):c.856-1G>A	PRPF31		Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804159	19	54629902	19	54126527	804159	791959		NC_000019.10:54126526:G:A
NM_015629.4(PRPF31):c.573C>A (p.Cys191Ter)	PRPF31	C191*	Retinal dystrophy|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804158	19	54627173	19	54123794	804158	791958		NC_000019.10:54123793:C:A
NM_015629.4(PRPF31):c.335del (p.Lys112fs)	PRPF31	K112fs	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804157	19	54625887	19	54122508	804157	791957		NC_000019.10:54122507:AA:A
NM_015629.4(PRPF31):c.322+1G>A	PRPF31		Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804154	19	54625323	19	54121944	804154	791956		NC_000019.10:54121943:G:A
NM_015629.4(PRPF31):c.165G>A (p.Trp55Ter)	PRPF31	W55*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804153	19	54621823	19	54118443	804153	791955		NC_000019.10:54118442:G:A
NM_015629.4(PRPF31):c.89_92del (p.Pro30fs)	PRPF31	P30fs	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804152	19	54621744 - 54621747	19	54118364 - 54118367	804152	791954		NC_000019.10:54118363:AGCCAGC:AGC
NM_000132.3(F8):c.4936del (p.Ala1646fs)	F8	A1646fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804140	X	154157129	X	154928854	804140	792179		NC_000023.11:154928853:CCC:CC
NM_000117.3(EMD):c.12C>A (p.Tyr4Ter)	EMD	Y4*	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804132	X	153607856	X	154379496	804132	792171		NC_000023.11:154379495:C:A
NM_001278116.2(L1CAM):c.2440dup (p.Ala814fs)	L1CAM		X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804112	X	153131265 - 153131266	X	153865810 - 153865811	804112	792151		NC_000023.11:153865810:CC:CCC
NM_000033.4(ABCD1):c.1998C>G (p.Tyr666Ter)	ABCD1	Y666*	Adrenoleukodystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804111	X	153008949	X	153743495	804111	792150		NC_000023.11:153743494:C:G
NM_000033.4(ABCD1):c.1853del (p.Met618fs)	ABCD1	M618fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804110	X	153008513	X	153743059	804110	792149		NC_000023.11:153743058:T:
NM_000033.4(ABCD1):c.341T>C (p.Leu114Pro)	ABCD1	L114P	Adrenoleukodystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804104	X	152991062	X	153725607	804104	792143		NC_000023.11:153725606:T:C
NM_001256447.2(BCAP31):c.415C>T (p.Gln139Ter)	BCAP31	Q139*, Q206*	Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804102	X	152969476	X	153704021	804102	792141		NC_000023.11:153704020:G:A
NM_005629.4(SLC6A8):c.1396G>A (p.Gly466Arg)	SLC6A8	G466R, G351R, G456R	Creatine transporter deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804101	X	152959802	X	153694347	804101	792140		NC_000023.11:153694346:G:A
NM_000252.3(MTM1):c.482_485TGGA[2] (p.Trp164fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804098	X	149807453 - 149807456	X	150638980 - 150638983	804098	792135		NC_000023.11:150638979:TGGATGGATGGA:TGGATGGA
NM_000252.3(MTM1):c.136+1G>T	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804097	X	149765035	X	150596571	804097	792134		NC_000023.11:150596570:G:T
NM_000194.3(HPRT1):c.221T>G (p.Phe74Cys)	HPRT1	F74C	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804086	X	133609297	X	134475267	804086	792123		NC_000023.11:134475266:T:G
NM_001167.3(XIAP):c.1458del (p.Val487fs)	XIAP	V487fs	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804083	X	123040995	X	123907145	804083	792120		NC_000023.11:123907144:A:
NM_001167.3(XIAP):c.609dup (p.Gly204fs)	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804082	X	123020120 - 123020121	X	123886270 - 123886271	804082	792119		NC_000023.11:123886270:T:TT
NM_001079872.2(CUL4B):c.1386del (p.Phe462fs)	CUL4B	F284fs, F467fs, F462fs, F480fs	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804080	X	119675514	X	120541659	804080	792117		NC_000023.11:120541658:G:
NM_033380.3(COL4A5):c.4822-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804076	X	107938496	X	108695266	804076	792113		NC_000023.11:108695265:G:T
NM_033380.3(COL4A5):c.2395+2T>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804074	X	107850124	X	108606894	804074	792111		NC_000023.11:108606893:T:A
NM_033380.3(COL4A5):c.321+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804070	X	107811905	X	108568675	804070	792107		NC_000023.11:108568674:T:G
NM_000061.3(BTK):c.721dup (p.Tyr241fs)	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804064	X	100615610 - 100615611	X	101360622 - 101360623	804064	792101		NC_000023.11:101360622:A:AA
NM_000061.3(BTK):c.1784dup (p.Met596fs)	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804063	X	100608305 - 100608306	X	101353317 - 101353318	804063	792100		NC_000023.11:101353317:TT:TTT
NM_001184880.2(PCDH19):c.134_135del (p.Asp45fs)	PCDH19	D45fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804060	X	99663461 - 99663462	X	100408463 - 100408464	804060	792097		NC_000023.11:100408462:GT:
NM_001184880.2(PCDH19):c.937G>T (p.Glu313Ter)	PCDH19	E313*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804058	X	99662659	X	100407661	804058	792095		NC_000023.11:100407660:C:A
NM_001184880.2(PCDH19):c.1172del (p.Asn391fs)	PCDH19	N391fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804056	X	99662424	X	100407426	804056	792093		NC_000023.11:100407425:TT:T
NM_001184880.2(PCDH19):c.1623del (p.Ser542fs)	PCDH19	S542fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804054	X	99661973	X	100406975	804054	792091		NC_000023.11:100406974:GGG:GG
NM_001184880.2(PCDH19):c.2341dup (p.Ile781fs)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804051	X	99657796 - 99657797	X	100402798 - 100402799	804051	792088		NC_000023.11:100402798:TTTTTTT:TTTTTTTT
NM_001184880.2(PCDH19):c.2624del (p.Asn875fs)	PCDH19	N828fs, N875fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804050	X	99605695	X	100350697	804050	792087		NC_000023.11:100350696:TTTT:TTT
NM_001184880.2(PCDH19):c.2697dup (p.Glu900fs)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804049	X	99597051 - 99597052	X	100342053 - 100342054	804049	792086		NC_000023.11:100342053:T:TT
NM_000390.4(CHM):c.29_30del (p.Asp10fs)	CHM	D10fs	Choroideremia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804047	X	85302507 - 85302508	X	86047503 - 86047504	804047	792517		NC_000023.11:86047502:AT:
NM_000390.4(CHM):c.1053_1056dup (p.Asp353fs)	CHM		Choroideremia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804046	X	85211267 - 85211268	X	85956262 - 85956263	804046	792516		NC_000023.11:85956262:TATG:TATGTATG
NM_000390.4(CHM):c.1573C>T (p.Gln525Ter)	CHM	Q377*, Q525*	Choroideremia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804045	X	85134006	X	85879001	804045	792515		NC_000023.11:85879000:G:A
NM_001008537.3(NEXMIF):c.3689del (p.Ala1230fs)	NEXMIF	A1230fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804032	X	73960703	X	74740868	804032	792502		NC_000023.11:74740867:G:
NM_006517.5(SLC16A2):c.1373del (p.Pro458fs)	SLC16A2	P458fs	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804031	X	73749249	X	74529414	804031	792501		NC_000023.11:74529413:CC:C
NM_006517.5(SLC16A2):c.1262G>T (p.Gly421Val)	SLC16A2	G421V	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804030	X	73749139	X	74529304	804030	792500		NC_000023.11:74529303:G:T
NM_018486.3(HDAC8):c.738-1G>A	HDAC8		Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804029	X	71684582	X	72464732	804029	792499		NC_000023.11:72464731:C:T
NM_000166.6(GJB1):c.466_467CT[1] (p.Tyr157fs)	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804027	X	70444023 - 70444024	X	71224173 - 71224174	804027	792497		NC_000023.11:71224172:CTCT:CT
NM_002547.3(OPHN1):c.1138+1G>A	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804020	X	67414306	X	68194464	804020	792490		NC_000023.11:68194463:C:T
NM_001353921.2(ARHGEF9):c.178G>T (p.Glu60Ter)	ARHGEF9	E60*, E66*, E32*, E53*	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804015	X	62944444	X	63724564	804015	792485		NC_000023.11:63724563:C:A
NM_004463.3(FGD1):c.1452G>A (p.Trp484Ter)	FGD1	W484*	Aarskog syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804012	X	54492174	X	54465741	804012	792482		NC_000023.11:54465740:C:T
NM_004463.3(FGD1):c.1843-1G>A	FGD1		Aarskog syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804011	X	54482218	X	54455785	804011	792481		NC_000023.11:54455784:C:T
NM_006306.4(SMC1A):c.615+2T>C	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804008	X	53440180	X	53413230	804008	792478		NC_000023.11:53413229:A:G
NM_006306.4(SMC1A):c.2814dup (p.Lys939Ter)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804006	X	53423194 - 53423195	X	53396274 - 53396275	804006	792476		NC_000023.11:53396274:AA:AAA
NM_006306.4(SMC1A):c.3022C>T (p.Gln1008Ter)	SMC1A	Q1008*, Q986*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804005	X	53410126	X	53383205	804005	792475		NC_000023.11:53383204:G:A
NM_001111125.3(IQSEC2):c.938_939del (p.Ile313fs)	IQSEC2	I313fs, I108fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804004	X	53285042 - 53285043	X	53255860 - 53255861	804004	792474		NC_000023.11:53255859:TAT:T
NM_001111125.3(IQSEC2):c.1967del (p.Pro656fs)	IQSEC2	P451fs, P656fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804003	X	53279791	X	53250609	804003	792473		NC_000023.11:53250608:GGGG:GGG
NM_001029896.2(WDR45):c.235+2T>G	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803999	X	48935300	X	49077641	803999	792469		NC_000023.11:49077640:A:C
NM_001029896.2(WDR45):c.827+1G>T	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803997	X	48933022	X	49075363	803997	792467		NC_000023.11:49075362:C:A
NM_000377.3(WAS):c.734+5G>A	WAS			Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803992	X	48545349	X	48686960	803992	792462		NC_000023.11:48686959:G:A
NM_006579.3(EBP):c.504_505AG[1] (p.Glu169fs)	EBP			Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803991	X	48386656 - 48386657	X	48528268 - 48528269	803991	792461		NC_000023.11:48528267:AGAG:AG
NM_006579.3(EBP):c.261C>G (p.Tyr87Ter)	EBP	Y87*		Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803990	X	48382420	X	48524032	803990	792460		NC_000023.11:48524031:C:G
NM_006915.3(RP2):c.932del (p.Cys311fs)	RP2	C311fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803989	X	46736988	X	46877553	803989	792459		NC_000023.11:46877552:G:
NM_006915.3(RP2):c.158del (p.Leu53fs)	RP2	L53fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803987	X	46712965	X	46853530	803987	792457		NC_000023.11:46853529:TT:T
NM_003688.3(CASK):c.774_780del (p.Met258fs)	CASK	M258fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803986	X	41519743 - 41519749	X	41660490 - 41660496	803986	792456		NC_000023.11:41660489:ATCCAGCATC:ATC
NM_003688.3(CASK):c.1385_1394del (p.Pro462fs)	CASK	P462fs, P456fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803984	X	41437702 - 41437711	X	41578449 - 41578458	803984	792454		NC_000023.11:41578448:GAGGTGGGAGGAGGTG:GAGGTG
NM_001363819.1(DDX3X):c.-290dup	DDX3X		Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803982	X	41200853 - 41200854	X	41341600 - 41341601	803982	792452		NC_000023.11:41341600:G:GG
NM_001363819.1(DDX3X):c.-386C>G	DDX3X	S58*, S42*	Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803981	X	41200758	X	41341505	803981	792451		NC_000023.11:41341504:C:G
NM_001363819.1(DDX3X):c.-1809_-1806CAGC[3]	DDX3X		Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803980	X	41196709 - 41196710	X	41337456 - 41337457	803980	792450		NC_000023.11:41337456:CAGCCAGC:CAGCCAGCCAGC
NM_000531.6(OTC):c.387-1G>A	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803976	X	38260527	X	38401274	803976	792446		NC_000023.11:38401273:G:A
NM_000328.3(RPGR):c.310G>T (p.Glu104Ter)	RPGR	E104*, E114*, G104*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803973	X	38180280	X	38321027	803973	792443		NC_000023.11:38321026:C:A
NM_000328.3(RPGR):c.389_390del (p.Phe130fs)	RPGR	F130fs, F140fs, F129fs	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803971	X	38178161 - 38178162	X	38318908 - 38318909	803971	792441		NC_000023.11:38318907:AAAA:AA
NM_000328.3(RPGR):c.749G>A (p.Cys250Tyr)	RPGR	C250Y, C260Y, C249Y	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803970	X	38169897	X	38310644	803970	792440		NC_000023.11:38310643:C:T
NM_000328.3(RPGR):c.957del (p.Phe319fs)	RPGR	F318fs, F319fs, F329fs	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803969	X	38160602	X	38301349	803969	792439		NC_000023.11:38301348:AAAA:AAA
NM_000328.3(RPGR):c.1905+118G>T	RPGR	E675*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803968	X	38146229	X	38286976	803968	792438		NC_000023.11:38286975:C:A
NM_000328.3(RPGR):c.1905+280G>T	RPGR	E729*	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803967	X	38146067	X	38286814	803967	792437		NC_000023.11:38286813:C:A
NM_000328.3(RPGR):c.1905+617del	RPGR	E841fs	Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803966	X	38145730	X	38286477	803966	792436		NC_000023.11:38286476:T:
NM_000328.3(RPGR):c.1905+1199_1905+1200del	RPGR		Retinal dystrophy|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803964	X	38145147 - 38145148	X	38285894 - 38285895	803964	792434		NC_000023.11:38285893:CTCTC:CTC
NM_000397.4(CYBB):c.1326C>A (p.Tyr442Ter)	CYBB	Y442*	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803963	X	37665651	X	37806398	803963	792433		NC_000023.11:37806397:C:A
NM_000109.4(DMD):c.7+127978del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803962	X	33229398	X	33211281	803962	792432		NC_000023.11:33211280:C:
NM_000109.4(DMD):c.7+127982G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803961	X	33229394	X	33211277	803961	792431		NC_000023.11:33211276:C:T
NM_004010.3(DMD):c.-331del	DMD	E10fs, E14fs, E6fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803960	X	33038310	X	33020193	803960	792430		NC_000023.11:33020192:T:
NM_004010.3(DMD):c.-317del	DMD	K18fs, K10fs, K14fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803959	X	33038296	X	33020179	803959	792429		NC_000023.11:33020178:TTTT:TTT
NM_004010.3(DMD):c.-312del	DMD	T20fs, T12fs, T16fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803958	X	33038291	X	33020174	803958	792428		NC_000023.11:33020173:TTTT:TTT
NM_000109.4(DMD):c.69+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803957	X	33038255	X	33020138	803957	792427		NC_000023.11:33020137:C:A
NM_000109.4(DMD):c.69_69+14del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803956	X	33038242 - 33038256	X	33020125 - 33020139	803956	792426		NC_000023.11:33020124:CAAACCATTCTTACC:
NM_004010.3(DMD):c.-107_-106dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803953	X	32862899 - 32862900	X	32844782 - 32844783	803953	792423		NC_000023.11:32844782:AT:ATAT
NM_000109.4(DMD):c.240+5G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803952	X	32862895	X	32844778	803952	792422		NC_000023.11:32844777:C:T
NM_000109.4(DMD):c.241-463A>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803951	X	32841967	X	32823850	803951	792421		NC_000023.11:32823849:T:C
NM_000109.4(DMD):c.420del (p.Arg141fs)	DMD	R145fs, R141fs, R149fs, R26fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803949	X	32834671	X	32816554	803949	792419		NC_000023.11:32816553:A:
NM_000109.4(DMD):c.429T>G (p.Tyr143Ter)	DMD	Y143*, Y151*, Y147*, Y28*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803948	X	32834662	X	32816545	803948	792418		NC_000023.11:32816544:A:C
NM_000109.4(DMD):c.548C>A (p.Ser183Ter)	DMD	S187*, S183*, S191*, S68*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803946	X	32827687	X	32809570	803946	792416		NC_000023.11:32809569:G:T
NM_000109.4(DMD):c.611_612dup (p.Leu205fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803945	X	32827622 - 32827623	X	32809505 - 32809506	803945	792415		NC_000023.11:32809505:TA:TATA
NM_000109.4(DMD):c.642T>G (p.Tyr214Ter)	DMD	Y218*, Y222*, Y99*, Y214*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803944	X	32717394	X	32699277	803944	792414		NC_000023.11:32699276:A:C
NM_000109.4(DMD):c.669C>G (p.Tyr223Ter)	DMD	Y108*, Y223*, Y227*, Y231*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803943	X	32717367	X	32699250	803943	792413		NC_000023.11:32699249:G:C
NM_000109.4(DMD):c.685del (p.Gln229fs)	DMD	Q114fs, Q229fs, Q233fs, Q237fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803942	X	32717351	X	32699234	803942	792412		NC_000023.11:32699233:GG:G
NM_000109.4(DMD):c.750dup (p.Lys251Ter)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803941	X	32717285 - 32717286	X	32699168 - 32699169	803941	792411		NC_000023.11:32699168:A:AA
NM_000109.4(DMD):c.798T>A (p.Tyr266Ter)	DMD	Y151*, Y266*, Y270*, Y274*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803940	X	32717238	X	32699121	803940	792410		NC_000023.11:32699120:A:T
NM_000109.4(DMD):c.815del (p.Val272fs)	DMD	V157fs, V276fs, V280fs, V272fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803939	X	32716108	X	32697991	803939	792409		NC_000023.11:32697990:A:
NM_000109.4(DMD):c.937-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803938	X	32663270	X	32645153	803938	792408		NC_000023.11:32645152:C:T
NM_000109.4(DMD):c.947del (p.Ala316fs)	DMD	A316fs, A320fs, A324fs, A201fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803937	X	32663259	X	32645142	803937	792407		NC_000023.11:32645141:G:
NM_000109.4(DMD):c.974C>A (p.Ser325Ter)	DMD	S329*, S210*, S325*, S333*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803936	X	32663232	X	32645115	803936	792406		NC_000023.11:32645114:G:T
NM_000109.4(DMD):c.1120del (p.His374fs)	DMD	H259fs, H378fs, H374fs, H382fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803934	X	32663086	X	32644969	803934	792404		NC_000023.11:32644968:G:
NM_000109.4(DMD):c.1123G>T (p.Glu375Ter)	DMD	E375*, E383*, E260*, E379*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803933	X	32663083	X	32644966	803933	792403		NC_000023.11:32644965:C:A
NM_000109.4(DMD):c.1126-2A>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803932	X	32662432	X	32644315	803932	792402		NC_000023.11:32644314:T:A
NM_000109.4(DMD):c.1640_1643dup (p.Asp548fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803929	X	32591898 - 32591899	X	32573781 - 32573782	803929	792399		NC_000023.11:32573781:TCTT:TCTTTCTT
NM_000109.4(DMD):c.1710dup (p.Glu571fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803928	X	32591724 - 32591725	X	32573607 - 32573608	803928	792398		NC_000023.11:32573607:TTTTT:TTTTTT
NM_000109.4(DMD):c.1726A>T (p.Lys576Ter)	DMD	K461*, K576*, K580*, K584*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803927	X	32591709	X	32573592	803927	792397		NC_000023.11:32573591:T:A
NM_000109.4(DMD):c.1753C>T (p.Gln585Ter)	DMD	Q585*, Q593*, Q470*, Q589*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803926	X	32591682	X	32573565	803926	792396		NC_000023.11:32573564:G:A
NM_000109.4(DMD):c.1764del (p.Met588fs)	DMD	M588fs, M596fs, M473fs, M592fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803925	X	32591671	X	32573554	803925	792395		NC_000023.11:32573553:C:
NM_000109.4(DMD):c.1767dup (p.Ser590fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803924	X	32591667 - 32591668	X	32573550 - 32573551	803924	792394		NC_000023.11:32573550:T:TT
NM_000109.4(DMD):c.1942C>T (p.Gln648Ter)	DMD	Q533*, Q652*, Q656*, Q648*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803922	X	32583845	X	32565728	803922	792392		NC_000023.11:32565727:G:A
NM_000109.4(DMD):c.2040dup (p.Thr681fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803921	X	32563379 - 32563380	X	32545262 - 32545263	803921	792391		NC_000023.11:32545262:C:CC
NM_000109.4(DMD):c.2077del (p.Glu693fs)	DMD	E701fs, E693fs, E697fs, E578fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803920	X	32563343	X	32545226	803920	792390		NC_000023.11:32545225:C:
NM_000109.4(DMD):c.2090del (p.Pro697fs)	DMD	P705fs, P582fs, P697fs, P701fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803919	X	32563330	X	32545213	803919	792389		NC_000023.11:32545212:GG:G
NM_000109.4(DMD):c.2145-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803918	X	32536249	X	32518132	803918	792388		NC_000023.11:32518131:C:T
NM_000109.4(DMD):c.2263_2268+12del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803917	X	32536113 - 32536130	X	32517996 - 32518013	803917	792387		NC_000023.11:32517995:TGCATAACCTACATTGACT:T
NM_000109.4(DMD):c.2356+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803916	X	32519871	X	32501754	803916	792386		NC_000023.11:32501753:C:T
NM_000109.4(DMD):c.2383del (p.Gln795fs)	DMD	Q680fs, Q803fs, Q799fs, Q795fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803915	X	32509609	X	32491492	803915	792385		NC_000023.11:32491491:G:
NM_000109.4(DMD):c.2418del (p.Glu806fs)	DMD	E691fs, E810fs, E814fs, E806fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803914	X	32509574	X	32491457	803914	792384		NC_000023.11:32491456:TT:T
NM_000109.4(DMD):c.2424C>A (p.Cys808Ter)	DMD	C808*, C812*, C693*, C816*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803913	X	32509568	X	32491451	803913	792383		NC_000023.11:32491450:G:T
NM_000109.4(DMD):c.2437G>T (p.Glu813Ter)	DMD	E817*, E821*, E813*, E698*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803912	X	32509555	X	32491438	803912	792382		NC_000023.11:32491437:C:A
NM_000109.4(DMD):c.2548_2554del (p.Thr850fs)	DMD	T735fs, T854fs, T858fs, T850fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803908	X	32509438 - 32509444	X	32491321 - 32491327	803908	792378		NC_000023.11:32491320:GGGTGGTGGGT:GGGT
NM_000109.4(DMD):c.2598+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803907	X	32509393	X	32491276	803907	792377		NC_000023.11:32491275:C:A
NM_000109.4(DMD):c.2618C>A (p.Ser873Ter)	DMD	S877*, S881*, S758*, S873*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803906	X	32503197	X	32485080	803906	792376		NC_000023.11:32485079:G:T
NM_000109.4(DMD):c.2684del (p.Gly895fs)	DMD	G780fs, G899fs, G895fs, G903fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803904	X	32503131	X	32485014	803904	792374		NC_000023.11:32485013:CC:C
NM_000109.4(DMD):c.2766_2767AG[1] (p.Glu923fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803903	X	32503046 - 32503047	X	32484929 - 32484930	803903	792373		NC_000023.11:32484928:CTCT:CT
NM_000109.4(DMD):c.2829del (p.Arg944fs)	DMD	R948fs, R944fs, R952fs, R829fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803901	X	32490377	X	32472260	803901	792371		NC_000023.11:32472259:G:
NM_000109.4(DMD):c.2936del (p.Ser979fs)	DMD	S979fs, S864fs, S987fs, S983fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803900	X	32486817	X	32468700	803900	792370		NC_000023.11:32468699:C:
NM_000109.4(DMD):c.2989G>T (p.Glu997Ter)	DMD	E1001*, E997*, E882*, E1005*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803899	X	32486764	X	32468647	803899	792369		NC_000023.11:32468646:C:A
NM_000109.4(DMD):c.3086_3087del (p.Val1029fs)	DMD	V1029fs, V1033fs, V914fs, V1037fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803898	X	32486666 - 32486667	X	32468549 - 32468550	803898	792368		NC_000023.11:32468548:AA:
NM_000109.4(DMD):c.3133dup (p.Ile1045fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803897	X	32486619 - 32486620	X	32468502 - 32468503	803897	792367		NC_000023.11:32468502:TTTTT:TTTTTT
NM_000109.4(DMD):c.3169del (p.Ala1057fs)	DMD	A1057fs, A1065fs, A1061fs, A942fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803896	X	32482786	X	32464669	803896	792366		NC_000023.11:32464668:CC:C
NM_000109.4(DMD):c.3233del (p.Lys1078fs)	DMD	K1086fs, K1078fs, K1082fs, K963fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803895	X	32482722	X	32464605	803895	792365		NC_000023.11:32464604:TTTTTT:TTTTT
NM_000109.4(DMD):c.3271_3272del (p.Gln1091fs)	DMD	Q1095fs, Q1099fs, Q976fs, Q1091fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803894	X	32481692 - 32481693	X	32463575 - 32463576	803894	792364		NC_000023.11:32463574:TG:
NM_000109.4(DMD):c.3436G>T (p.Gly1146Ter)	DMD	G1150*, G1154*, G1146*, G1031*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803893	X	32472922	X	32454805	803893	792363		NC_000023.11:32454804:C:A
NM_000109.4(DMD):c.3509_3512del (p.Glu1170fs)	DMD	E1170fs, E1178fs, E1055fs, E1174fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803892	X	32472846 - 32472849	X	32454729 - 32454732	803892	792362		NC_000023.11:32454728:TCTT:
NM_000109.4(DMD):c.3615del (p.Lys1205_Val1206insTer)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803888	X	32466720	X	32448603	803888	792358		NC_000023.11:32448602:TTT:TT
NM_000109.4(DMD):c.3673C>T (p.Gln1225Ter)	DMD	Q1225*, Q1110*, Q1233*, Q1229*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803887	X	32466662	X	32448545	803887	792357		NC_000023.11:32448544:G:A
NM_000109.4(DMD):c.3771G>A (p.Trp1257Ter)	DMD	W1265*, W1142*, W1261*, W1257*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803886	X	32459423	X	32441306	803886	792356		NC_000023.11:32441305:C:T
NM_000109.4(DMD):c.3819G>A (p.Trp1273Ter)	DMD	W1273*, W1281*, W1158*, W1277*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803885	X	32459375	X	32441258	803885	792355		NC_000023.11:32441257:C:T
NM_000109.4(DMD):c.3956del (p.Ala1319fs)	DMD	A1204fs, A1319fs, A1327fs, A1323fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803884	X	32456449	X	32438332	803884	792354		NC_000023.11:32438331:G:
NM_000109.4(DMD):c.4270C>T (p.Gln1424Ter)	DMD	Q1424*, Q1432*, Q88*, Q1309*, Q1428*, Q91*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803881	X	32408238	X	32390121	803881	792351		NC_000023.11:32390120:G:A
NM_000109.4(DMD):c.4282_4285del (p.Ala1428fs)	DMD	A95fs, A92fs, A1428fs, A1436fs, A1313fs, A1432fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803880	X	32408223 - 32408226	X	32390106 - 32390109	803880	792350		NC_000023.11:32390105:CAGCC:C
NM_000109.4(DMD):c.4291del (p.Arg1431fs)	DMD	R1316fs, R1435fs, R95fs, R1431fs, R1439fs, R98fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803879	X	32408217	X	32390100	803879	792349		NC_000023.11:32390099:TTT:TT
NM_000109.4(DMD):c.4303C>T (p.Gln1435Ter)	DMD	Q102*, Q1439*, Q99*, Q1320*, Q1443*, Q1435*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803878	X	32408205	X	32390088	803878	792348		NC_000023.11:32390087:G:A
NM_000109.4(DMD):c.4326dup (p.Leu1443fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803877	X	32407785 - 32407786	X	32389668 - 32389669	803877	792347		NC_000023.11:32389668:TTTTTT:TTTTTTT
NM_000109.4(DMD):c.4328T>G (p.Leu1443Ter)	DMD	L110*, L1328*, L1447*, L1451*, L107*, L1443*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803876	X	32407784	X	32389667	803876	792346		NC_000023.11:32389666:A:C
NM_000109.4(DMD):c.4399A>T (p.Lys1467Ter)	DMD	K134*, K131*, K1467*, K1352*, K1471*, K1475*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803875	X	32407713	X	32389596	803875	792345		NC_000023.11:32389595:T:A
NM_000109.4(DMD):c.4414G>T (p.Glu1472Ter)	DMD	E1357*, E1472*, E1480*, E139*, E1476*, E136*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803874	X	32407698	X	32389581	803874	792344		NC_000023.11:32389580:C:A
NM_000109.4(DMD):c.4453_4469del (p.Val1485fs)	DMD	V1485fs, V1493fs, V152fs, V1370fs, V149fs, V1489fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803873	X	32407643 - 32407659	X	32389526 - 32389542	803873	792343		NC_000023.11:32389525:ACTACTTCCTGTTCCACACT:ACT
NM_000109.4(DMD):c.4512_4516del (p.Val1507_Lys1508insTer)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803872	X	32404561 - 32404565	X	32386444 - 32386448	803872	792342		NC_000023.11:32386443:CACTC:
NM_000109.4(DMD):c.4636G>T (p.Glu1546Ter)	DMD	E1546*, E1550*, E210*, E1554*, E213*, E1431*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803871	X	32404441	X	32386324	803871	792341		NC_000023.11:32386323:C:A
NM_000109.4(DMD):c.4660A>T (p.Arg1554Ter)	DMD	R1558*, R218*, R221*, R1439*, R1554*, R1562*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803870	X	32398788	X	32380671	803870	792340		NC_000023.11:32380670:T:A
NM_000109.4(DMD):c.4658_4661AAAG[1] (p.Arg1554fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803869	X	32398783 - 32398786	X	32380666 - 32380669	803869	792339		NC_000023.11:32380665:CTTTCTTTCT:CTTTCT
NM_000109.4(DMD):c.4669C>T (p.Gln1557Ter)	DMD	Q1561*, Q1442*, Q1557*, Q221*, Q1565*, Q224*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803868	X	32398779	X	32380662	803868	792338		NC_000023.11:32380661:G:A
NM_000109.4(DMD):c.4834_4835GA[1] (p.Glu1612fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803867	X	32383301 - 32383302	X	32365184 - 32365185	803867	792337		NC_000023.11:32365183:TCTCT:TCT
NM_000109.4(DMD):c.4956G>A (p.Trp1652Ter)	DMD	W1537*, W1656*, W319*, W1660*, W1652*, W316*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803866	X	32383182	X	32365065	803866	792336		NC_000023.11:32365064:C:T
NM_000109.4(DMD):c.5032C>T (p.Gln1678Ter)	DMD	Q1682*, Q342*, Q345*, Q1563*, Q1678*, Q1686*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803865	X	32382797	X	32364680	803865	792335		NC_000023.11:32364679:G:A
NM_000109.4(DMD):c.5143G>T (p.Glu1715Ter)	DMD	E1719*, E1715*, E382*, E1600*, E1723*, E379*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803864	X	32381063	X	32362946	803864	792334		NC_000023.11:32362945:C:A
NM_000109.4(DMD):c.5231T>G (p.Leu1744Ter)	DMD	L1629*, L408*, L1744*, L1748*, L1752*, L411*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803863	X	32380975	X	32362858	803863	792333		NC_000023.11:32362857:A:C
NM_000109.4(DMD):c.5334del (p.Phe1778fs)	DMD	F445fs, F1663fs, F1778fs, F1782fs, F1786fs, F442fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803861	X	32366613	X	32348496	803861	792331		NC_000023.11:32348495:AAA:AA
NM_000109.4(DMD):c.5352del (p.Lys1784fs)	DMD	K1669fs, K451fs, K1792fs, K448fs, K1788fs, K1784fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803860	X	32366595	X	32348478	803860	792330		NC_000023.11:32348477:TTTTT:TTTT
NM_000109.4(DMD):c.5612G>A (p.Trp1871Ter)	DMD	W1879*, W1756*, W1871*, W538*, W1875*, W535*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803859	X	32361354	X	32343237	803859	792329		NC_000023.11:32343236:C:T
NM_000109.4(DMD):c.5665G>T (p.Glu1889Ter)	DMD	E1774*, E1889*, E553*, E1897*, E1893*, E556*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803858	X	32361301	X	32343184	803858	792327		NC_000023.11:32343183:C:A
NM_000109.4(DMD):c.5665dup (p.Glu1889fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803857	X	32361300 - 32361301	X	32343183 - 32343184	803857	792328		NC_000023.11:32343183:C:CC
NM_000109.4(DMD):c.5797dup (p.Ala1933fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803856	X	32360317 - 32360318	X	32342200 - 32342201	803856	792326		NC_000023.11:32342200:CCCC:CCCCC
NM_000109.4(DMD):c.5999C>G (p.Ser2000Ter)	DMD	S2004*, S667*, S2000*, S2008*, S1885*, S664*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803855	X	32328293	X	32310176	803855	792325		NC_000023.11:32310175:G:C
NM_000109.4(DMD):c.6127del (p.Arg2043fs)	DMD	R1928fs, R707fs, R710fs, R2043fs, R2047fs, R2051fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803854	X	32305785	X	32287668	803854	792324		NC_000023.11:32287667:G:
NM_000109.4(DMD):c.6276del (p.Asp2092fs)	DMD	D756fs, D2100fs, D2092fs, D2096fs, D759fs, D1977fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803853	X	32235171	X	32217054	803853	792323		NC_000023.11:32217053:G:
NM_000109.4(DMD):c.6332G>A (p.Trp2111Ter)	DMD	W1996*, W2111*, W2119*, W778*, W2115*, W775*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803852	X	32235115	X	32216998	803852	792322		NC_000023.11:32216997:C:T
NM_000109.4(DMD):c.6333G>A (p.Trp2111Ter)	DMD	W1996*, W2111*, W2115*, W775*, W2119*, W778*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803851	X	32235114	X	32216997	803851	792321		NC_000023.11:32216996:C:T
NM_000109.4(DMD):c.6340_6341del (p.Glu2114fs)	DMD	E2114fs, E2118fs, E778fs, E2122fs, E1999fs, E781fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803850	X	32235106 - 32235107	X	32216989 - 32216990	803850	792320		NC_000023.11:32216988:TCT:T
NM_004013.2(DMD):c.-771_-770del	DMD	K860fs, K863fs, K2081fs, K2196fs, K2204fs, K2200fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803848	X	31986459 - 31986460	X	31968342 - 31968343	803848	792318		NC_000023.11:31968341:TTTTTT:TTTT
NM_004013.2(DMD):c.-627C>T	DMD	Q2244*, Q2252*, Q911*, Q2248*, Q2129*, Q908*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803847	X	31950205	X	31932088	803847	792317		NC_000023.11:31932087:G:A
NM_004013.2(DMD):c.-621A>T	DMD	K2254*, K910*, K2250*, K913*, K2131*, K2246*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803846	X	31950199	X	31932082	803846	792316		NC_000023.11:31932081:T:A
NM_000109.4(DMD):c.6889-2A>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803845	X	31893492	X	31875375	803845	792315		NC_000023.11:31875374:T:A
NM_000109.4(DMD):c.6889-1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803844	X	31893491	X	31875374	803844	792314		NC_000023.11:31875373:C:A
NM_004013.2(DMD):c.-354del	DMD	W2220fs, W999fs, W2335fs, W2339fs, W2343fs, W1002fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803843	X	31893376	X	31875259	803843	792313		NC_000023.11:31875258:A:
NM_004013.2(DMD):c.-353G>A	DMD	W1002*, W2220*, W2339*, W2335*, W999*, W2343*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803842	X	31893375	X	31875258	803842	792312		NC_000023.11:31875257:C:T
NM_004013.2(DMD):c.-352G>A	DMD	W1002*, W2220*, W999*, W2343*, W2335*, W2339*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803841	X	31893374	X	31875257	803841	792311		NC_000023.11:31875256:C:T
NM_004013.2(DMD):c.-313del	DMD	Q1012fs, Q2348fs, Q2356fs, Q1015fs, Q2352fs, Q2233fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803840	X	31893335	X	31875218	803840	792310		NC_000023.11:31875217:TT:T
NM_000109.4(DMD):c.7074+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803839	X	31893304	X	31875187	803839	792309		NC_000023.11:31875186:C:T
NM_000109.4(DMD):c.7285+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803838	X	31838091	X	31819974	803838	792307		NC_000023.11:31819973:C:A
NM_000109.4(DMD):c.7540C>T (p.Gln2514Ter)	DMD	Q1181*, Q62*, Q2522*, Q2399*, Q2514*, Q2518*, Q1178*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803836	X	31747844	X	31729727	803836	792306		NC_000023.11:31729726:G:A
NM_000109.4(DMD):c.7681C>T (p.Gln2561Ter)	DMD	Q1225*, Q2565*, Q109*, Q1228*, Q2446*, Q2561*, Q2569*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803835	X	31697659	X	31679542	803835	792305		NC_000023.11:31679541:G:A
NM_000109.4(DMD):c.7693C>T (p.Gln2565Ter)	DMD	Q1232*, Q2450*, Q1229*, Q2569*, Q113*, Q2565*, Q2573*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803834	X	31697647	X	31679530	803834	792304		NC_000023.11:31679529:G:A
NM_000109.4(DMD):c.7834dup (p.Ile2612fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803833	X	31697505 - 31697506	X	31679388 - 31679389	803833	792303		NC_000023.11:31679388:TTTT:TTTTT
NM_000109.4(DMD):c.7848+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803832	X	31697491	X	31679374	803832	792302		NC_000023.11:31679373:C:T
NM_000109.4(DMD):c.7848+2T>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803831	X	31697490	X	31679373	803831	792301		NC_000023.11:31679372:A:T
NM_000109.4(DMD):c.8003+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803830	X	31676106	X	31657989	803830	792300		NC_000023.11:31657988:C:A
NM_000109.4(DMD):c.8121dup (p.Gln2708fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803829	X	31645861 - 31645862	X	31627744 - 31627745	803829	792299		NC_000023.11:31627744:T:TT
NM_000109.4(DMD):c.8122C>T (p.Gln2708Ter)	DMD	Q256*, Q2708*, Q1375*, Q2712*, Q1372*, Q2593*, Q2716*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803828	X	31645861	X	31627744	803828	792298		NC_000023.11:31627743:G:A
NM_000109.4(DMD):c.8254C>T (p.Gln2752Ter)	DMD	Q1419*, Q2760*, Q1416*, Q2637*, Q2756*, Q2752*, Q300*, Q31*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803827	X	31525510	X	31507393	803827	792297		NC_000023.11:31507392:G:A
NM_000109.4(DMD):c.8275G>T (p.Glu2759Ter)	DMD	E1423*, E1426*, E2763*, E2759*, E307*, E38*, E2644*, E2767*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803826	X	31525489	X	31507372	803826	792296		NC_000023.11:31507371:C:A
NM_000109.4(DMD):c.8302del (p.Gln2768fs)	DMD	Q47fs, Q1435fs, Q2776fs, Q2772fs, Q316fs, Q1432fs, Q2653fs, Q2768fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803825	X	31525462	X	31507345	803825	792295		NC_000023.11:31507344:G:
NM_000109.4(DMD):c.8367-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803824	X	31515062	X	31496945	803824	792294		NC_000023.11:31496944:C:T
NM_000109.4(DMD):c.8393del (p.Gln2798fs)	DMD	Q346fs, Q77fs, Q1462fs, Q1465fs, Q2683fs, Q2798fs, Q2802fs, Q2806fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803823	X	31515035	X	31496918	803823	792293		NC_000023.11:31496917:T:
NM_000109.4(DMD):c.8427del (p.Leu2810fs)	DMD	L1477fs, L2810fs, L1474fs, L89fs, L2695fs, L2814fs, L2818fs, L358fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803822	X	31515001	X	31496884	803822	792292		NC_000023.11:31496883:AA:A
NM_000109.4(DMD):c.8436G>A (p.Trp2812Ter)	DMD	W2816*, W2820*, W360*, W91*, W1476*, W2812*, W1479*, W2697*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803821	X	31514992	X	31496875	803821	792291		NC_000023.11:31496874:C:T
NM_000109.4(DMD):c.8545del (p.Thr2849fs)	DMD	T1513fs, T2853fs, T1516fs, T2734fs, T397fs, T128fs, T2849fs, T2857fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803820	X	31497199	X	31479082	803820	792290		NC_000023.11:31479081:TTTT:TTT
NM_000109.4(DMD):c.8645-2A>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803818	X	31496493	X	31478376	803818	792288		NC_000023.11:31478375:T:A
NM_000109.4(DMD):c.8707del (p.Val2903fs)	DMD	V2788fs, V2903fs, V2911fs, V1567fs, V1570fs, V182fs, V2907fs, V451fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803816	X	31496429	X	31478312	803816	792286		NC_000023.11:31478311:CC:C
NM_000109.4(DMD):c.8720G>A (p.Trp2907Ter)	DMD	W2792*, W2915*, W1571*, W1574*, W186*, W2907*, W2911*, W455*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803815	X	31496416	X	31478299	803815	792285		NC_000023.11:31478298:C:T
NM_000109.4(DMD):c.8722del (p.Glu2908fs)	DMD	E2793fs, E456fs, E2908fs, E2912fs, E1572fs, E1575fs, E187fs, E2916fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803814	X	31496414	X	31478297	803814	792284		NC_000023.11:31478296:CCC:CC
NM_000109.4(DMD):c.8773del (p.Glu2926fs)	DMD	E1590fs, E2930fs, E2934fs, E205fs, E2811fs, E2926fs, E474fs, E1593fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803813	X	31496363	X	31478246	803813	792283		NC_000023.11:31478245:GGG:GG
NM_000109.4(DMD):c.8793del (p.Gln2932fs)	DMD	Q1596fs, Q211fs, Q2932fs, Q2936fs, Q1599fs, Q2817fs, Q2940fs, Q480fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803812	X	31496343	X	31478226	803812	792282		NC_000023.11:31478225:AA:A
NM_000109.4(DMD):c.8899del (p.Leu2967fs)	DMD	L1631fs, L515fs, L1634fs, L246fs, L2967fs, L2975fs, L2971fs, L2852fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803811	X	31496237	X	31478120	803811	792281		NC_000023.11:31478119:GG:G
NM_000109.4(DMD):c.8913+1G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803810	X	31496222	X	31478105	803810	792280		NC_000023.11:31478104:C:G
NM_000109.4(DMD):c.8998C>T (p.Gln3000Ter)	DMD	Q3000*, Q3008*, Q1664*, Q2885*, Q3004*, Q1667*, Q279*, Q548*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803809	X	31462660	X	31444543	803809	792279		NC_000023.11:31444542:G:A
NM_000109.4(DMD):c.9061_9062insA (p.Val3021fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803808	X	31366750 - 31366751	X	31348633 - 31348634	803808	792278		NC_000023.11:31348633::T
NM_000109.4(DMD):c.9161_9162AG[2] (p.Arg3055fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803807	X	31341749 - 31341750	X	31323632 - 31323633	803807	792277		NC_000023.11:31323631:CTCTCTC:CTCTC
NM_000109.4(DMD):c.9243_9244AG[1] (p.Glu3082fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803806	X	31279088 - 31279089	X	31260971 - 31260972	803806	792276		NC_000023.11:31260970:CTCT:CT
NM_000109.4(DMD):c.9320del (p.Leu3107fs)	DMD	L2992fs, L655fs, L1771fs, L1774fs, L3107fs, L3111fs, L3115fs, L386fs, L47fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803805	X	31241181	X	31223064	803805	792275		NC_000023.11:31223063:A:
NM_000109.4(DMD):c.9356C>A (p.Ser3119Ter)	DMD	S1783*, S3119*, S1786*, S398*, S667*, S3004*, S3123*, S3127*, S59*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803804	X	31227798	X	31209681	803804	792274		NC_000023.11:31209680:G:T
NM_000109.4(DMD):c.9539+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803802	X	31227614	X	31209497	803802	792272		NC_000023.11:31209496:C:A
NM_000109.4(DMD):c.9540-2A>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803801	X	31224786	X	31206669	803801	792271		NC_000023.11:31206668:T:C
NM_000109.4(DMD):c.9625+5G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803799	X	31224694	X	31206577	803799	792269		NC_000023.11:31206576:C:G
NM_000109.4(DMD):c.9706del (p.Ile3236fs)	DMD	I176fs, I3121fs, I3236fs, I784fs, I1903fs, I515fs, I3240fs, I3244fs, I1900fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803798	X	31222155	X	31204038	803798	792268		NC_000023.11:31204037:TTT:TT
NM_000109.4(DMD):c.9784-2A>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803796	X	31201023	X	31182906	803796	792266		NC_000023.11:31182905:T:A
NM_000109.4(DMD):c.9844del (p.Gln3282fs)	DMD	Q1949fs, Q222fs, Q3286fs, Q3290fs, Q561fs, Q1946fs, Q3167fs, Q3282fs, Q830fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803795	X	31200961	X	31182844	803795	792265		NC_000023.11:31182843:GGGG:GGG
NM_000109.4(DMD):c.9863_9884del (p.Pro3288fs)	DMD	P3288fs, P836fs, P1952fs, P3173fs, P3292fs, P1955fs, P228fs, P3296fs, P567fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803794	X	31200921 - 31200942	X	31182804 - 31182825	803794	792264		NC_000023.11:31182803:GCAGCCACTCTGTGCAGGACGGGCAGCCAC:GCAGCCAC
NM_000109.4(DMD):c.9926_9927del (p.Lys3309fs)	DMD	K3194fs, K3317fs, K1976fs, K3313fs, K1973fs, K249fs, K857fs, K3309fs, K588fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803793	X	31200878 - 31200879	X	31182761 - 31182762	803793	792263		NC_000023.11:31182760:TTT:T
NM_000109.4(DMD):c.10053T>G (p.Tyr3351Ter)	DMD	Y3359*, Y3351*, Y630*, Y3355*, Y899*, Y2015*, Y2018*, Y291*, Y3236*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803790	X	31198496	X	31180379	803790	792260		NC_000023.11:31180378:A:C
NM_000109.4(DMD):c.10063-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803789	X	31196923	X	31178806	803789	792259		NC_000023.11:31178805:C:T
NM_000109.4(DMD):c.10200-1dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803788	X	31196087 - 31196088	X	31177970 - 31177971	803788	792258		NC_000023.11:31177970:C:CC
NM_004020.3(DMD):c.2843+5106C>G	DMD	S3431*, S354*, S962*, S3427*, S975*, S2094*, S367*, S706*, S2091*, S3312*, S3435*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803787	X	31191680	X	31173563	803787	792257		NC_000023.11:31173562:G:C
NM_004020.3(DMD):c.2843+9102C>T	DMD	Q2133*, Q2136*, Q3354*, Q3477*, Q1004*, Q409*, Q396*, Q748*, Q1017*, Q3469*, Q3473*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803786	X	31187684	X	31169567	803786	792256		NC_000023.11:31169566:G:A
NM_004020.3(DMD):c.2843+9167AG[2]	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803785	X	31187614 - 31187615	X	31169497 - 31169498	803785	792255		NC_000023.11:31169496:CTCTCT:CTCT
NM_000109.4(DMD):c.10609_10610dup (p.Met3537fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803784	X	31165554 - 31165555	X	31147437 - 31147438	803784	792254		NC_000023.11:31147437:AT:ATAT
NM_139058.3(ARX):c.1369_1391del (p.Gly457fs)	ARX	G457fs	Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803782	X	25025285 - 25025307	X	25007168 - 25007190	803782	792252		NC_000023.11:25007167:GTGCTCAGGCCCAGCGGCGCCCCG:G
NM_139058.3(ARX):c.1414_1428del (p.Arg472_Phe476del)	ARX		Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803781	X	25025248 - 25025262	X	25007131 - 25007145	803781	792251		NC_000023.11:25007130:GAAAGCTGGGTGTCGGAA:GAA
NM_000444.6(PHEX):c.1496_1497insTCA (p.Glu499delinsAspGln)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803759	X	22196402 - 22196403	X	22178285 - 22178286	803759	792229		NC_000023.11:22178285:A:ATCA
NM_000444.6(PHEX):c.1402A>T (p.Lys468Ter)	PHEX	K468*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803757	X	22151739	X	22133622	803757	792227		NC_000023.11:22133621:A:T
NM_000444.6(PHEX):c.1324del (p.Val442fs)	PHEX	V442fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803756	X	22151661	X	22133544	803756	792226		NC_000023.11:22133543:G:
NM_000444.6(PHEX):c.1217G>A (p.Cys406Tyr)	PHEX	C406Y	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803755	X	22132619	X	22114501	803755	792225		NC_000023.11:22114500:G:A
NM_000444.6(PHEX):c.1215del (p.Lys405fs)	PHEX	K405fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803754	X	22132615	X	22114497	803754	792224		NC_000023.11:22114496:AAA:AA
NM_000444.6(PHEX):c.1208G>A (p.Trp403Ter)	PHEX	W403*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803753	X	22132610	X	22114492	803753	792223		NC_000023.11:22114491:G:A
NM_000444.6(PHEX):c.1157G>A (p.Trp386Ter)	PHEX	W386*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803752	X	22129662	X	22111544	803752	792222		NC_000023.11:22111543:G:A
NM_000444.6(PHEX):c.985del (p.His329fs)	PHEX	H329fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803750	X	22117171	X	22099053	803750	792220		NC_000023.11:22099052:CCCCC:CCCC
NM_000444.6(PHEX):c.934-1G>T	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000803749	X	22117123	X	22099005	803749	792219		NC_000023.11:22099004:G:T
NM_000444.6(PHEX):c.865G>T (p.Glu289Ter)	PHEX	E289*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803748	X	22115088	X	22096970	803748	792218		NC_000023.11:22096969:G:T
NM_000444.6(PHEX):c.849_849+2del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803747	X	22112217 - 22112219	X	22094099 - 22094101	803747	792217		NC_000023.11:22094098:GGT:
NM_000444.6(PHEX):c.593del (p.Tyr198fs)	PHEX	Y198fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803746	X	22095750	X	22077632	803746	792216		NC_000023.11:22077631:A:
NM_000444.6(PHEX):c.582del (p.Arg195fs)	PHEX	R195fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803745	X	22095737	X	22077619	803745	792215		NC_000023.11:22077618:TTT:TT
NM_000444.6(PHEX):c.559del (p.Leu187fs)	PHEX	L187fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803744	X	22095715	X	22077597	803744	792214		NC_000023.11:22077596:CC:C
NM_000444.6(PHEX):c.540G>A (p.Trp180Ter)	PHEX	W180*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803743	X	22095697	X	22077579	803743	792213		NC_000023.11:22077578:G:A
NM_000444.6(PHEX):c.349+1G>A	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803740	X	22065330	X	22047212	803740	792210		NC_000023.11:22047211:G:A
NM_000444.6(PHEX):c.185dup (p.Ala63fs)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803738	X	22056652 - 22056653	X	22038534 - 22038535	803738	792208		NC_000023.11:22038534:C:CC
NM_000444.6(PHEX):c.101del (p.Gly34fs)	PHEX	G34fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803737	X	22051222	X	22033104	803737	792207		NC_000023.11:22033103:GGG:GG
NM_000444.6(PHEX):c.20_21del (p.Ser7fs)	PHEX	S7fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803736	X	22051143 - 22051144	X	22033025 - 22033026	803736	792206		NC_000023.11:22033024:GC:
NM_000444.6(PHEX):c.7_8dup (p.Glu4fs)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803735	X	22051129 - 22051130	X	22033011 - 22033012	803735	792205		NC_000023.11:22033011:GC:GCGC
NM_004586.3(RPS6KA3):c.243+1G>A	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803734	X	20227405	X	20209287	803734	792204		NC_000023.11:20209286:C:T
NM_000284.4(PDHA1):c.822_826dup (p.Gly276fs)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803732	X	19373864 - 19373865	X	19355746 - 19355747	803732	792202		NC_000023.11:19355746:GATCTG:GATCTGATCTG
NM_000292.3(PHKA2):c.314_317del (p.Thr105fs)	PHKA2	T105fs	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803730	X	18969359 - 18969362	X	18951241 - 18951244	803730	792200		NC_000023.11:18951240:TGAGTG:TG
NM_000292.3(PHKA2):c.1138-2A>G	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803728	X	18949868	X	18931750	803728	792198		NC_000023.11:18931749:T:C
NM_001323289.2(CDKL5):c.2480C>G (p.Ser827Ter)	CDKL5	S827*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803724	X	18643351	X	18625231	803724	792194		NC_000023.11:18625230:C:G
NM_001323289.2(CDKL5):c.1816C>T (p.Gln606Ter)	CDKL5	Q606*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803723	X	18622860	X	18604740	803723	792193		NC_000023.11:18604739:C:T
NM_001323289.2(CDKL5):c.1742dup (p.His581fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803722	X	18622785 - 18622786	X	18604665 - 18604666	803722	792192		NC_000023.11:18604665:A:AA
NM_001323289.2(CDKL5):c.1431_1435dup (p.Ser479fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803720	X	18622474 - 18622475	X	18604354 - 18604355	803720	792190		NC_000023.11:18604354:TAGGA:TAGGATAGGA
NM_001323289.2(CDKL5):c.425T>G (p.Leu142Ter)	CDKL5	L142*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803718	X	18600032	X	18581912	803718	792188		NC_000023.11:18581911:T:G
NM_001323289.2(CDKL5):c.386del (p.Asn129fs)	CDKL5	N129fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803717	X	18598070	X	18579950	803717	792187		NC_000023.11:18579949:AA:A
NM_001323289.2(CDKL5):c.364G>A (p.Ala122Thr)	CDKL5	A122T	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803716	X	18598049	X	18579929	803716	792186		NC_000023.11:18579928:G:A
NM_001429.4(EP300):c.3707dup (p.Asn1236fs)	EP300		Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803700	22	41558756 - 41558757	22	41162752 - 41162753	803700	792075		NC_000022.11:41162752:AAAAAA:AAAAAAA
NM_000026.4(ADSL):c.725C>T (p.Thr242Ile)	ADSL	T242I, T178I	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803695	22	40756429	22	40360425	803695	792070		NC_000022.11:40360424:C:T
NM_003560.4(PLA2G6):c.164G>A (p.Trp55Ter)	PLA2G6	W55*	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803694	22	38565270	22	38169263	803694	792069		NC_000022.11:38169262:C:T
NM_003560.4(PLA2G6):c.1772G>A (p.Arg591Gln)	PLA2G6	R365Q, R413Q, R591Q, R359Q, R537Q	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803691	22	38512189	22	38116182	803691	792066		NC_000022.11:38116181:C:T
NM_003560.4(PLA2G6):c.2276+1G>A	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803689	22	38508510	22	38112503	803689	792064		NC_000022.11:38112502:C:T
NM_000343.4(SLC5A1):c.1695del (p.Asn565fs)	SLC5A1	N438fs, N565fs	Congenital glucose-galactose malabsorption	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803683	22	32500802	22	32104815	803683	792058		NC_000022.11:32104814:C:
NM_000343.4(SLC5A1):c.799C>T (p.Arg267Ter)	SLC5A1	R140*, R267*	Congenital glucose-galactose malabsorption	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803681	22	32480560	22	32084573	803681	792056		NC_000022.11:32084572:C:T
NM_000355.4(TCN2):c.249_255dup (p.Gly86fs)	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803677	22	31007041 - 31007042	22	30611054 - 30611055	803677	792052		NC_000022.11:30611054:CCTCCTA:CCTCCTACCTCCTA
NM_000268.4(NF2):c.1340+2T>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803675	22	30069477	22	29673488	803675	792050		NC_000022.11:29673487:T:G
NM_000268.4(NF2):c.1229del (p.Gln410fs)	NF2	Q369fs, Q368fs, Q327fs, Q410fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803674	22	30069364	22	29673375	803674	792049		NC_000022.11:29673374:A:
NM_000268.4(NF2):c.1060del (p.Asp354fs)	NF2	D354fs, D312fs, D313fs, D271fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803673	22	30067873	22	29671884	803673	792048		NC_000022.11:29671883:GGG:GG
NM_000268.4(NF2):c.933del (p.Ala313fs)	NF2	A272fs, A313fs, A271fs, A230fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803671	22	30064368	22	29668379	803671	792046		NC_000022.11:29668378:GG:G
NM_000268.4(NF2):c.810+2T>C	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803670	22	30057330	22	29661341	803670	792045		NC_000022.11:29661340:T:C
NM_000268.4(NF2):c.745_752del (p.Arg249fs)	NF2	R207fs, R249fs, R166fs, R208fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803669	22	30057261 - 30057268	22	29661272 - 29661279	803669	792044		NC_000022.11:29661271:ACAGACTGAC:AC
NM_000268.4(NF2):c.600-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803668	22	30054176	22	29658187	803668	792043		NC_000022.11:29658186:A:G
NM_000268.4(NF2):c.493C>T (p.Gln165Ter)	NF2	Q123*, Q124*, Q82*, Q165*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803666	22	30050691	22	29654702	803666	792041		NC_000022.11:29654701:C:T
NM_000268.4(NF2):c.179_185del (p.Trp60fs)	NF2	W60fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803663	22	30032803 - 30032809	22	29636814 - 29636820	803663	792038		NC_000022.11:29636813:TGGTTCTT:T
NM_001848.3(COL6A1):c.869G>A (p.Gly290Glu)	COL6A1	G290E	Bethlem myopathy 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803640	21	47409532	21	45989618	803640	792015		NC_000021.9:45989617:G:A
NM_001848.3(COL6A1):c.56_69dup (p.Glu24fs)	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803639	21	47401814 - 47401815	21	45981900 - 45981901	803639	792014		NC_000021.9:45981900:AGCCGCGCAGGATGAGCCG:AGCCGCGCAGGATGAGCCGCGCAGGATGAGCCG
NM_000383.4(AIRE):c.117del (p.Glu40fs)	AIRE	E40fs	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803632	21	45706003	21	44286120	803632	792009		NC_000021.9:44286119:CCCC:CCC
NM_001291412.2(SON):c.245-5006dup	SON		ZTTK syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803629	21	34924455 - 34924456	21	33552149 - 33552150	803629	792006		NC_000021.9:33552149:A:AA
NM_172107.4(KCNQ2):c.1956dup (p.Thr653fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803619	20	62038659 - 62038660	20	63407306 - 63407307	803619	791996		NC_000020.11:63407306:C:CC
NM_001282531.3(ADNP):c.-5-1G>C	ADNP		Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803615	20	49520539	20	50904002	803615	791990		NC_000020.11:50904001:C:G
NM_001282531.3(ADNP):c.2157_2159del (p.Tyr719_Glu720delinsTer)	ADNP		Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803614	20	49509092 - 49509094	20	50892555 - 50892557	803614	791989		NC_000020.11:50892554:TCGT:T
NM_006420.3(ARFGEF2):c.5254C>T (p.Arg1752Ter)	ARFGEF2	R1752*	Heterotopia, periventricular, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803611	20	47649632	20	49033095	803611	791986		NC_000020.11:49033094:C:T
NM_006420.3(ARFGEF2):c.1492del (p.Met498fs)	ARFGEF2	M498fs	Heterotopia, periventricular, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803610	20	47588929	20	48972392	803610	791985		NC_000020.11:48972391:A:
NM_005461.5(MAFB):c.185C>T (p.Thr62Ile)	MAFB	T62I	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803608	20	39317306	20	40688666	803608	791983		NC_000020.11:40688665:G:A
NM_006892.4(DNMT3B):c.2476C>T (p.Arg826Cys)	DNMT3B	R806C, R818C, R701C, R743C, R826C, R667C	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803606	20	31395623	20	32807817	803606	791978		NC_000020.11:32807816:C:T
NM_015338.6(ASXL1):c.1426_1427dup (p.Glu477fs)	ASXL1		Bohring-Opitz syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803604	20	31021426 - 31021427	20	32433623 - 32433624	803604	791976		NC_000020.11:32433623:CT:CTCT
NM_018848.3(MKKS):c.429_430del (p.Asp143_Phe144insTer)	MKKS			Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803600	20	10393733 - 10393734	20	10413085 - 10413086	803600	791969		NC_000020.11:10413084:AG:
NM_018848.3(MKKS):c.433_434del (p.Phe144_Ser145insTer)	MKKS			Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803599	20	10393729 - 10393730	20	10413081 - 10413082	803599	791968		NC_000020.11:10413080:CT:
NM_153638.3(PANK2):c.570_571del (p.Tyr190_Ser191delinsTer)	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803593	20	3870316 - 3870317	20	3889669 - 3889670	803593	791980		NC_000020.11:3889668:ACA:A
NM_000554.6(CRX):c.500_501del (p.Ala166_Ser167insTer)	CRX		Leber congenital amaurosis 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803571	19	48342824 - 48342825	19	47839567 - 47839568	803571	791942		NC_000019.10:47839566:CA:
NM_000095.3(COMP):c.1552G>C (p.Asp518His)	COMP	D518H	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803547	19	18896599	19	18785789	803547	791918		NC_000019.10:18785788:C:G
NM_005535.3(IL12RB1):c.1765del (p.Ala589fs)	IL12RB1	A629fs, A589fs	Immunodeficiency 30	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803545	19	18171958	19	18061148	803545	791916		NC_000019.10:18061147:C:
NC_000019.10:g.17837988G>A	JAK3	R549*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803542	19	17948797	19	17837988	803542	791913		NC_000019.10:17837987:G:A
NC_000019.10:g.17831273_17831274del	JAK3	K978fs	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803541	19	17942081 - 17942082	19	17831272 - 17831273	803541	791912		NC_000019.10:17831271:TTT:T
NM_001127221.1(CACNA1A):c.2134A>G (p.Ile712Val)	CACNA1A	I711V, I712V	Episodic ataxia type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803532	19	13414401	19	13303587	803532	791903		NC_000019.10:13303586:T:C
NM_001127221.1(CACNA1A):c.3581del (p.Pro1194fs)	CACNA1A	P1193fs, P1197fs, P1194fs	Episodic ataxia type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803531	19	13395996	19	13285182	803531	791902		NC_000019.10:13285181:GGG:GG
NM_002501.4(NFIX):c.799_812del (p.Thr267fs)	NFIX	T259fs, T275fs, T220fs, T267fs, T266fs	Marshall-Smith syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803529	19	13184819 - 13184832	19	13074005 - 13074018	803529	791900		NC_000019.10:13074004:TCACCTCCCCTCCTTC:TC
NM_002501.4(NFIX):c.327_340del (p.Gln110fs)	NFIX	Q109fs, Q63fs, Q102fs, Q110fs, Q118fs	Marshall-Smith syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803528	19	13136132 - 13136145	19	13025318 - 13025331	803528	791899		NC_000019.10:13025317:GACCAGAAGGGCAAGA:GA
NM_006087.4(TUBB4A):c.730G>C (p.Gly244Arg)	TUBB4A	G244R, G172R, G289R, G295R	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803516	19	6495780	19	6495769	803516	791961		NC_000019.10:6495768:C:G
NM_001972.4(ELANE):c.669C>A (p.Cys223Ter)	ELANE	C223*	Cyclical neutropenia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803509	19	856029	19	856029	803509	791966		NC_000019.10:856028:C:A
NM_000140.5(FECH):c.598+1G>T	FECH		Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803500	18	55233678	18	57566446	803500	791874		NC_000018.10:57566445:C:A
NM_001083962.2(TCF4):c.790-2A>G	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803496	18	52937196	18	55269965	803496	791870		NC_000018.10:55269964:T:C
NM_001083962.2(TCF4):c.918_922+8del	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803495	18	52937054 - 52937066	18	55269823 - 55269835	803495	791869		NC_000018.10:55269822:TGACTCACCCATT:
NM_001080467.3(MYO5B):c.656G>A (p.Arg219His)	MYO5B	R219H	Congenital microvillous atrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803491	18	47518758	18	49992388	803491	791865		NC_000018.10:49992387:C:T
NM_020964.3(EPG5):c.1252+1G>T	EPG5		Vici syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803490	18	43532365	18	45952399	803490	791864		NC_000018.10:45952398:C:A
NM_020964.3(EPG5):c.5870-2A>G	EPG5		Vici syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803489	18	43458415	18	45878450	803489	791863		NC_000018.10:45878449:T:C
NM_020964.3(EPG5):c.6577del (p.Val2193fs)	EPG5	V2193fs	Vici syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803488	18	43446807	18	45866842	803488	791862		NC_000018.10:45866841:C:
NM_030632.3(ASXL3):c.3330_3333dup (p.Ala1112fs)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803484	18	31323140 - 31323141	18	33743176 - 33743177	803484	791858		NC_000018.10:33743176:TCTTT:TCTTTCTTT
NM_030632.3(ASXL3):c.1884_1885del (p.Gly629fs)	ASXL3	G629fs	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803483	18	31319252 - 31319253	18	33739288 - 33739289	803483	791857		NC_000018.10:33739287:AG:
NM_000271.5(NPC1):c.2594C>T (p.Ser865Leu)	NPC1	S865L	Niemann-Pick disease type C1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803478	18	21120422	18	23540458	803478	791852		NC_000018.10:23540457:G:A
NM_000271.5(NPC1):c.2660C>T (p.Pro887Leu)	NPC1	P887L	Niemann-Pick disease type C1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803477	18	21119910	18	23539946	803477	791851		NC_000018.10:23539945:G:A
NM_018714.3(COG1):c.2665dup (p.Arg889fs)	COG1		COG1 congenital disorder of glycosylation	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803463	17	71202886 - 71202887	17	73206747 - 73206748	803463	791825		NC_000017.11:73206747:CCCCCC:CCCCCCC
NM_004247.4(EFTUD2):c.882del (p.Asp295fs)	EFTUD2	D260fs, D285fs, D295fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803428	17	42949926	17	44872558	803428	791782		NC_000017.11:44872557:A:
NM_000398.7(CYB5R3):c.226+2T>C	CYB5R3		Deficiency of cytochrome-b5 reductase	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801428	22	43027382	22	42631376	801428	789808		NC_000022.11:42631375:A:G
NM_007254.4(PNKP):c.1541_1548dup (p.Gln517fs)	PNKP		not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801423	19	50364522 - 50364523	19	49861265 - 49861266	801423	789803		NC_000019.10:49861265:GCAGTACAGC:GCAGTACAGCAGTACAGC
NM_000156.6(GAMT):c.521G>A (p.Trp174Ter)	GAMT	W174*	not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801414	19	1398964	19	1398965	801414	789796		NC_000019.10:1398964:C:T
NM_199242.2(UNC13D):c.1596+1G>C	UNC13D		not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801412	17	73831935	17	75835854	801412	789792		NC_000017.11:75835853:C:G
NM_001029896.2(WDR45):c.437-4_437-2delinsT	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jul 4, 2019)	no assertion criteria provided	VCV000801319	X	48933606 - 48933608	X	49075947 - 49075949	801319	789702		NC_000023.11:49075946:TAG:A
NM_000455.5(STK11):c.930del (p.Lys311fs)	STK11	K311fs	not provided	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000801287	19	1222992	19	1222993	801287	789653		NC_000019.10:1222992:GG:G
NM_005359.6(SMAD4):c.1045dup (p.Thr349fs)	SMAD4		not provided	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000801279	18	48591881 - 48591882	18	51065511 - 51065512	801279	789644		NC_000018.10:51065511:A:AA
NM_000159.4(GCDH):c.553_570del (p.Gly185_Ser190del)	GCDH		Glutaric aciduria, type 1	Pathogenic(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000801019	19	13006849 - 13006866	19	12896035 - 12896052	801019	789104		NC_000019.10:12896034:CAGCGGAAGTGACCCCAGCAGC:CAGC
NM_001242896.1:c.2958_2959insAlu	DEPDC5		not provided	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000801012					801012	789397		
NM_170784.2(MKKS):c.116C>T (p.Pro39Leu)	MKKS	P39L	Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800851	20	10394047	20	10413399	800851	788934		NC_000020.11:10413398:G:A
NM_001985.2:c.426_427insAlu	ETFB		not provided	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000800736					800736	789356		
NM_001321120.2(TBX4):c.792-1G>C	TBX4			Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000800705	17	59557450	17	61480089	800705	789312		NC_000017.11:61480088:G:C
NM_001321120.2(TBX4):c.1057C>T (p.Arg353Ter)	TBX4	R352*, R353*		Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000800704	17	59560293	17	61482932	800704	789311		NC_000017.11:61482931:C:T
NM_001321120.2(TBX4):c.251del (p.Gly84fs)	TBX4	G84fs		Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000800703	17	59534960	17	61457599	800703	789310		NC_000017.11:61457598:GGG:GG
NM_006192.5(PAX1):c.1104C>A (p.Cys368Ter)	PAX1	C368*	Otofaciocervical syndrome 2	Pathogenic(Last reviewed: Dec 17, 2019)	no assertion criteria provided	VCV000800553	20	21689904	20	21709266	800553	789154		NC_000020.11:21709265:C:A
NM_001184880.2(PCDH19):c.1952_1953CT[3] (p.Ser653fs)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800523	X	99661637 - 99661638	X	100406639 - 100406640	800523	789135		NC_000023.11:100406638:AGAGAGAGA:AGAGAGA
NM_001454.4(FOXJ1):c.967del (p.Glu323fs)	FOXJ1	E323fs	CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800281	17	74133733	17	76137652	800281	788387		NC_000017.11:76137651:CCCC:CCC
NM_001454.4(FOXJ1):c.826C>T (p.Gln276Ter)	FOXJ1	Q276*	CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800280	17	74133874	17	76137793	800280	788386		NC_000017.11:76137792:G:A
NM_001454.4(FOXJ1):c.868_871dup (p.Thr291fs)	FOXJ1		CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800279	17	74133828 - 74133829	17	76137747 - 76137748	800279	788385		NC_000017.11:76137747:TGCT:TGCTTGCT
NM_001454.4(FOXJ1):c.901G>T (p.Glu301Ter)	FOXJ1	E301*	CILIARY DYSKINESIA, PRIMARY, 43	Pathogenic(Last reviewed: Dec 13, 2019)	no assertion criteria provided	VCV000800278	17	74133799	17	76137718	800278	788384		NC_000017.11:76137717:C:A
NM_016077.5(PTRH2):c.324G>A (p.Trp108Ter)	PTRH2	W108*, W109*	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	Pathogenic(Last reviewed: Dec 3, 2019)	no assertion criteria provided	VCV000695110	17	57775016	17	59697655	695110	683214		NC_000017.11:59697654:C:T
NC_000021.9:g.31667335C>T	SOD1	S106L	Amyotrophic lateral sclerosis	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000695024	21	33039648	21	31667335	695024	683149		NC_000021.9:31667334:C:T
NM_001083962.2(TCF4):c.1067C>A (p.Ser356Ter)	TCF4	S332*, S355*, S362*, S196*, S331*, S356*, S285*, S314*, S354*, S458*, S140*, S226*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000695020	18	52927182	18	55259951	695020	683147		NC_000018.10:55259950:G:T
NM_000156.6(GAMT):c.145del (p.Tyr49fs)	GAMT	Y49fs	Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000695019	19	1401331	19	1401332	695019	683148		NC_000019.10:1401331:A:
NM_181882.3(PRX):c.458del (p.Pro153fs)	PRX	P153fs	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000694922	19	40903801	19	40397894	694922	683105		NC_000019.10:40397893:GGGG:GGG
NM_006907.4(PYCR1):c.722C>T (p.Ala241Val)	PYCR1	A210V, A241V, A268V	Autosomal recessive cutis laxa type 2B	Pathogenic	criteria provided, single submitter	VCV000694719	17	79892277	17	81934401	694719	682831		NC_000017.11:81934400:G:A
NM_006907.4(PYCR1):c.540+1G>A	PYCR1		Autosomal recessive cutis laxa type 2B	Pathogenic	criteria provided, single submitter	VCV000694712	17	79892801	17	81934925	694712	682842		NC_000017.11:81934924:C:T
NM_000489.5(ATRX):c.4558-3T>G	ATRX			Pathogenic	criteria provided, single submitter	VCV000694709	X	76891550	X	77636059	694709	682845		NC_000023.11:77636058:A:C
NM_001429.4(EP300):c.3070_3071insT (p.Lys1024fs)	EP300		Rubinstein-Taybi syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694700	22	41548282 - 41548283	22	41152278 - 41152279	694700	682835		NC_000022.11:41152278::T
NM_015338.6(ASXL1):c.2416_2417dup (p.Val807fs)	ASXL1		Bohring-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000694695	20	31022929 - 31022930	20	32435126 - 32435127	694695	682834		NC_000020.11:32435126:CAC:CACAC
NM_001356.4(DDX3X):c.1600C>G (p.Arg534Gly)	DDX3X	R348G, R518G, R534G	Mental retardation, X-linked 102	Pathogenic	criteria provided, single submitter	VCV000694687	X	41205860	X	41346607	694687	682836		NC_000023.11:41346606:C:G
NM_004463.3(FGD1):c.1590T>A (p.Tyr530Ter)	FGD1	Y530*	Aarskog syndrome	Pathogenic	criteria provided, single submitter	VCV000694686	X	54491930	X	54465497	694686	682837		NC_000023.11:54465496:A:T
NM_004247.4(EFTUD2):c.1414-2A>G	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic	criteria provided, single submitter	VCV000694683	17	42940276	17	44862908	694683	682841		NC_000017.11:44862907:T:C
NM_006907.4(PYCR1):c.11G>T (p.Gly4Val)	PYCR1	G31V, G4V	Autosomal recessive cutis laxa type 2B	Pathogenic	criteria provided, single submitter	VCV000694681	17	79894680	17	81936804	694681	682832		NC_000017.11:81936803:C:A
NM_004463.3(FGD1):c.1143_1145del (p.Leu382del)	FGD1	L382del	Aarskog syndrome	Pathogenic	criteria provided, single submitter	VCV000694679	X	54495266 - 54495268	X	54468833 - 54468835	694679	682838		NC_000023.11:54468832:AGGAG:AG
NM_018486.3(HDAC8):c.1112-4_1116del	HDAC8		Cornelia de Lange syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694678	X	71549922 - 71549930	X	72330072 - 72330080	694678	682844		NC_000023.11:72330071:ATTCCCTGCA:A
NM_014516.4(CNOT3):c.2080C>T (p.Gln694Ter)	CNOT3	Q694*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694673	19	54657494	19	54153757	694673	682792		NC_000019.10:54153756:C:T
NM_014516.4(CNOT3):c.1926_1927del (p.Cys643fs)	CNOT3	C643fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694672	19	54656625 - 54656626	19	54152888 - 54152889	694672	682791		
NM_014516.4(CNOT3):c.1866G>A (p.Trp622Ter)	CNOT3	W622*	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694671	19	54656325	19	54152588	694671	682790		NC_000019.10:54152587:G:A
NM_014516.4(CNOT3):c.1473_1474del (p.Gly493fs)	CNOT3	G493fs	INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694670	19	54653361 - 54653362	19	54149626 - 54149627	694670	682789		NC_000019.10:54149625:AG:
NM_014516.4(CNOT3):c.732dup (p.Ser245fs)	CNOT3		INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694669	19	54649671	19	54145930 - 54145931	694669	682788		NC_000019.10:54145930:CCCCCCCC:CCCCCCCCC
NM_000292.3(PHKA2):c.718-2A>G	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000694641	X	18959795	X	18941677	694641	682746		NC_000023.11:18941676:T:C
NM_000292.3(PHKA2):c.918+1G>A	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000694638	X	18958112	X	18939994	694638	682745		NC_000023.11:18939993:C:T
NM_000292.3(PHKA2):c.2268dup (p.Asp757Ter)	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Nov 11, 2019)	no assertion criteria provided	VCV000694636	X	18927010 - 18927011	X	18908892 - 18908893	694636	682742		NC_000023.11:18908892:A:AA
NM_001037.5(SCN1B):c.355T>G (p.Tyr119Asp)	SCN1B	Y119D, Y86D	Epileptic encephalopathy, early infantile, 52	Pathogenic(Last reviewed: Nov 25, 2019)	no assertion criteria provided	VCV000694618	19	35524550	19	35033646	694618	682722		NC_000019.10:35033645:T:G
NM_000152.5(GAA):c.1431del (p.Ile477fs)	GAA	I477fs	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jul 7, 2019)	criteria provided, single submitter	VCV000694453	17	78083847	17	80110048	694453	682392		NC_000017.11:80110047:TT:T
NM_000152.5(GAA):c.1193T>C (p.Leu398Pro)	GAA	L398P	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000694452	17	78082405	17	80108606	694452	682391		NC_000017.11:80108605:T:C
NM_024301.5(FKRP):c.960_970del (p.Ala321fs)	FKRP	A321fs	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000694028	19	47259664 - 47259674	19	46756407 - 46756417	694028	681847		NC_000019.10:46756406:GCGCGCGCTGCGCG:GCG
NM_001083961.2(WDR62):c.2788C>T (p.Gln930Ter)	WDR62	Q930*	Primary autosomal recessive microcephaly 2	Pathogenic	no assertion criteria provided	VCV000694008	19	36591698	19	36100796	694008	681832		NC_000019.10:36100795:C:T
NM_000033.4(ABCD1):c.1219A>T (p.Lys407Ter)	ABCD1	K407*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000693988	X	153001703	X	153736249	693988	681814		NC_000023.11:153736248:A:T
NM_173628.4(DNAH17):c.7994_8012del (p.Gly2665fs)	DNAH17	G2665fs	SPERMATOGENIC FAILURE 39	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000692268	17	76472796 - 76472814	17	78476714 - 78476732	692268	680080		NC_000017.11:78476713:GCTGTGGAAAATAAGAGTC:
NM_173628.4(DNAH17):c.1291_1292TA[1] (p.Tyr431_Lys432delinsTer)	DNAH17		SPERMATOGENIC FAILURE 39	Pathogenic(Last reviewed: Oct 25, 2019)	no assertion criteria provided	VCV000692267	17	76563239 - 76563240	17	78567157 - 78567158	692267	680079		NC_000017.11:78567156:TATA:TA
NM_033380.3(COL4A5):c.1648dup (p.Ile550fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000692245	X	107840666 - 107840667	X	108597436 - 108597437	692245	680061		NC_000023.11:108597436:A:AA
NM_033380.3(COL4A5):c.311del (p.Pro104fs)	COL4A5	P104fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000692237	X	107811892	X	108568662	692237	680060		NC_000023.11:108568661:CC:C
NM_001080472.4(FITM2):c.694G>A (p.Gly232Arg)	FITM2	G232R	SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692232	20	42935360	20	44306720	692232	680036		NC_000020.11:44306719:C:T
NM_001080472.4(FITM2):c.652C>T (p.Gln218Ter)	FITM2	Q218*	SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692231	20	42935402	20	44306762	692231	680035		NC_000020.11:44306761:G:A
NM_001080472.4(FITM2):c.39dup (p.Thr14fs)	FITM2		SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692230	20	42939750	20	44311109 - 44311110	692230	680034		NC_000020.11:44311109:CCCCC:CCCCCC
NM_001080472.4(FITM2):c.4G>T (p.Glu2Ter)	FITM2	E2*	SIDDIQI SYNDROME	Pathogenic(Last reviewed: Oct 24, 2019)	no assertion criteria provided	VCV000692229	20	42939785	20	44311145	692229	680033		NC_000020.11:44311144:C:A
NM_000216.4(ANOS1):c.773G>A (p.Trp258Ter)	ANOS1	W258*		Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000692191	X	8553391	X	8585350	692191	679937		NC_000023.11:8585349:C:T
NM_002501.4(NFIX):c.1131_1137dup (p.Ser380fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Jul 1, 2018)	no assertion criteria provided	VCV000692120	19	13192545 - 13192546	19	13081731 - 13081732	692120	679863		NC_000019.10:13081731:CCAGCAG:CCAGCAGCCAGCAG
NM_007254.4(PNKP):c.148C>G (p.Gln50Glu)	PNKP	Q50E	Ataxia-oculomotor apraxia 4	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000692103	19	50370314	19	49867057	692103	679847		NC_000019.10:49867056:G:C
NM_000346.4(SOX9):c.1177C>T (p.Gln393Ter)	SOX9	Q393*	Camptomelic dysplasia	Pathogenic(Last reviewed: Jul 1, 2019)	no assertion criteria provided	VCV000692094	17	70120175	17	72124034	692094	679838		NC_000017.11:72124033:C:T
NM_000346.4(SOX9):c.1234C>T (p.Gln412Ter)	SOX9	Q412*	Camptomelic dysplasia	Pathogenic(Last reviewed: Jul 1, 2019)	no assertion criteria provided	VCV000692093	17	70120232	17	72124091	692093	679839		NC_000017.11:72124090:C:T
NM_000346.4(SOX9):c.957C>G (p.Tyr319Ter)	SOX9	Y319*	Camptomelic dysplasia	Pathogenic(Last reviewed: Jul 1, 2019)	no assertion criteria provided	VCV000692092	17	70119955	17	72123814	692092	679837		NC_000017.11:72123813:C:G
NM_002501.4(NFIX):c.933_943del (p.Trp312fs)	NFIX	W265fs, W304fs, W311fs, W312fs, W320fs	Marshall-Smith syndrome	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000692076	19	13186462 - 13186472	19	13075648 - 13075658	692076	679805		NC_000019.10:13075647:GGTGGCCCAACG:G
NM_021140.3(KDM6A):c.3042del (p.Thr1015fs)	KDM6A	T1015fs, T1022fs, T1067fs, T719fs, T936fs, T970fs	Kabuki syndrome 2	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000692059	X	44938492	X	45079247	692059	679814		NC_000023.11:45079246:CCC:CC
NM_003560.4(PLA2G6):c.2035-2A>G	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000692050	22	38509663	22	38113656	692050	679833		NC_000022.11:38113655:T:C
NM_005993.5(TBCD):c.967C>T (p.Arg323Ter)	TBCD	R323*	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000692021	17	80763767	17	82805891	692021	679802		NC_000017.11:82805890:C:T
NM_000116.5(TAZ):c.811C>T (p.Gln271Ter)	TAZ	Q241*, Q257*, Q271*, Q227*, Q275*	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000692017	X	153649275	X	154420936	692017	574373		NC_000023.11:154420935:C:T
NM_021140.3(KDM6A):c.493C>T (p.Arg165Ter)	KDM6A	R165*	Kabuki syndrome 2	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000692010	X	44879904	X	45020659	692010	679813		NC_000023.11:45020658:C:T
NM_014009.4(FOXP3):c.-23+1G>T	FOXP3		Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000691990	X	49121122	X	49264660	691990	679834		NC_000023.11:49264659:C:A
NM_001077488.4(GNAS):c.274A>T (p.Lys92Ter)	GNAS	K32*, K734*, K76*, K77*, K91*, K92*	Pseudohypoparathyroidism	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000691981	20	57478599	20	58903544	691981	679724		NC_000020.11:58903543:A:T
GRCh37/hg19 Xq22.2(chrX:103029773-103036548)x1	PLP1		Spastic Paraplegia 2, mild, late onset	Pathogenic	no assertion criteria provided	VCV000691851	X	103029773 - 103036548			691851	679571		
GRCh37/hg19 Xq22.2(chrX:103029773-103036548)x0	PLP1		Hereditary spastic paraplegia 2	Pathogenic	no assertion criteria provided	VCV000691850	X	103029773 - 103036548			691850	679570		
NM_001086521.2(NDUFAF8):c.45_52dup (p.Phe18fs)	NDUFAF8		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000691644	17	79213202 - 79213203	17	81239402 - 81239403	691644	679357		NC_000017.11:81239402:CGCCTCCGCGCCT:CGCCTCCGCGCCTCCGCGCCT
NM_001086521.2(NDUFAF8):c.1A>G (p.Met1Val)	NDUFAF8	M1V	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000691643	17	79213164	17	81239364	691643	679356		NC_000017.11:81239363:A:G
NM_001086521.2(NDUFAF8):c.195+271C>T	NDUFAF8		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34|Mitochondrial diseases	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000691642	17	79213749	17	81239949	691642	679359		NC_000017.11:81239948:C:T
NM_001083899.2(GP6):c.584G>A (p.Ser195Asn)	GP6	S175N, S195N	Platelet-type bleeding disorder 11	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000691634	19	55538972	19	55027604	691634	679353		NC_000019.10:55027603:C:T
NM_001079858.3(ADGRG2):c.1731_1839+373del	ADGRG2		Congenital bilateral aplasia of vas deferens from CFTR mutation	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000691633	X	19023747 - 19024342	X	19005629 - 19006224	691633	679352		
NM_001079858.3(ADGRG2):c.1013del (p.Pro338fs)	ADGRG2	P300fs, P308fs, P314fs, P316fs, P322fs, P324fs, P335fs, P338fs	Congenital bilateral aplasia of vas deferens from CFTR mutation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000691632	X	19031890	X	19013772	691632	679350		NC_000023.11:19013771:GGGG:GGG
NM_001079858.3(ADGRG2):c.1460del (p.Gly487fs)	ADGRG2	G449fs, G457fs, G463fs, G465fs, G471fs, G473fs, G484fs, G487fs	Congenital bilateral aplasia of vas deferens from CFTR mutation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000691631	X	19026204	X	19008086	691631	679349		NC_000023.11:19008085:CC:C
NM_001079858.3(ADGRG2):c.251C>G (p.Ser84Ter)	ADGRG2	S60*, S68*, S76*, S81*, S84*	Congenital bilateral aplasia of vas deferens from CFTR mutation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000691630	X	19054071	X	19035953	691630	679351		NC_000023.11:19035952:G:C
NM_001079858.3(ADGRG2):c.2096dup (p.Phe700fs)	ADGRG2		Congenital bilateral aplasia of vas deferens from CFTR mutation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000691629	X	19021097 - 19021098	X	19002979 - 19002980	691629	679348		NC_000023.11:19002979:A:AA
NM_001079858.3(ADGRG2):c.2473C>T (p.Arg825Ter)	ADGRG2	R787*, R795*, R801*, R803*, R809*, R811*, R822*, R825*	Congenital bilateral aplasia of vas deferens from CFTR mutation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000691628	X	19017255	X	18999137	691628	679347		NC_000023.11:18999136:G:A
NM_007363.5(NONO):c.550C>T (p.Arg184Ter)	NONO	R184*, R95*	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000691621	X	70514278	X	71294428	691621	679342		NC_000023.11:71294427:C:T
NM_181672.3(OGT):c.1942A>T (p.Asn648Tyr)	OGT	N638Y, N648Y	Intellectual disability, X-linked 106	Pathogenic	no assertion criteria provided	VCV000691611	X	70781715	X	71561865	691611	679332		NC_000023.11:71561864:A:T
NM_001399.5(EDA):c.686dup (p.Gly230fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000691530	X	69247861 - 69247862	X	70028011 - 70028012	691530	679215		NC_000023.11:70028011:CCCCC:CCCCCC
NM_003604.2(IRS4):c.3161_3165del (p.Cys1054fs)	IRS4	C1054fs	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000691494	X	107976410 - 107976414	X	108733180 - 108733184	691494	679180		NC_000023.11:108733179:ACAGCAC:AC
NM_003604.2(IRS4):c.1772dup (p.Lys592fs)	IRS4		HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000691493	X	107977802 - 107977803	X	108734572 - 108734573	691493	679179		NC_000023.11:108734572:CCCCCCCC:CCCCCCCCC
NM_003604.2(IRS4):c.643G>T (p.Gly215Ter)	IRS4	G215*	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000691492	X	107978932	X	108735702	691492	679178		NC_000023.11:108735701:C:A
NM_005647.4(TBL1X):c.1015C>T (p.Arg339Ter)	TBL1X	R339*, R288*	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000691491	X	9661421	X	9693381	691491	679177		NC_000023.11:9693380:C:T
NM_005647.4(TBL1X):c.1526A>G (p.Tyr509Cys)	TBL1X	Y458C, Y509C	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8	Pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000691490	X	9679737	X	9711697	691490	679176		NC_000023.11:9711696:A:G
NM_005647.4(TBL1X):c.1510C>T (p.His504Tyr)	TBL1X	H453Y, H504Y	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691489	X	9679721	X	9711681	691489	679175		NC_000023.11:9711680:C:T
NM_005647.4(TBL1X):c.1246A>T (p.Asn416Tyr)	TBL1X	N365Y, N416Y	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691488	X	9677297	X	9709257	691488	679174		NC_000023.11:9709256:A:T
NM_001018113.3(FANCB):c.2249_2252del (p.Gly750fs)	FANCB	G750fs	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691316	X	14862017 - 14862020	X	14843895 - 14843898	691316	678983		NC_000023.11:14843894:CTTCCT:CT
NM_001018113.3(FANCB):c.2172_2175del (p.Thr725fs)	FANCB	T725fs	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691314	X	14862094 - 14862097	X	14843972 - 14843975	691314	678985		NC_000023.11:14843971:TGTTTG:TG
NM_001018113.3(FANCB):c.2165+1G>T	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Oct 10, 2011)	no assertion criteria provided	VCV000691311	X	14862624	X	14844502	691311	678988		NC_000023.11:14844501:C:A
NM_001018113.3(FANCB):c.1856_1857insT (p.Arg619fs)	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Jan 15, 2019)	no assertion criteria provided	VCV000691308	X	14863048 - 14863049	X	14844926 - 14844927	691308	678991		NC_000023.11:14844926::A
NM_001018113.3(FANCB):c.1807_1808GA[2] (p.Arg604fs)	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691307	X	14863091 - 14863094	X	14844969 - 14844972	691307	678992		NC_000023.11:14844968:TCTCTCTC:TCTC
NM_001018113.3(FANCB):c.1497_2580del (p.Ser500fs)	FANCB	S500fs	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691306	X	14861689 - 14863408	X	14843567 - 14845286	691306	678982		
NM_001018113.3(FANCB):c.1103C>A (p.Ser368Ter)	FANCB	S368*	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000691305	X	14877305	X	14859183	691305	678993		NC_000023.11:14859182:G:T
NM_001018113.3(FANCB):c.986T>C (p.Leu329Pro)	FANCB	L329P	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000691304	X	14877422	X	14859300	691304	678994		NC_000023.11:14859299:A:G
NM_001018113.3(FANCB):c.949C>T (p.Gln317Ter)	FANCB	Q317*	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000691302	X	14882684	X	14864562	691302	678996		NC_000023.11:14864561:G:A
NM_001018113.3(FANCB):c.829dup (p.Cys277fs)	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000691301	X	14882803 - 14882804	X	14864681 - 14864682	691301	678997		NC_000023.11:14864681:A:AA
NM_001018113.3(FANCB):c.755_767del (p.Leu252fs)	FANCB	L252fs	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000691300	X	14882866 - 14882878	X	14864744 - 14864756	691300	678998		NC_000023.11:14864743:AGAGATATTCTTAA:A
NM_001018113.3(FANCB):c.195dup (p.Thr66fs)	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000691299	X	14883437 - 14883438	X	14865315 - 14865316	691299	678999		NC_000023.11:14865315:AAAAAA:AAAAAAA
NM_001018113.3(FANCB):c.128T>C (p.Leu43Ser)	FANCB	L43S	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000691298	X	14883505	X	14865383	691298	679000		NC_000023.11:14865382:A:G
NC_000023.11:g.14843408_14873063del	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Aug 3, 2015)	no assertion criteria provided	VCV000691295					691295	678981		
NC_000022.11:g.41150384_41156982delinsTG	EP300		Postaxial polydactyly|Abnormal facial shape|Intellectual disability	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000691277					691277	678949		
NM_005629.4(SLC6A8):c.1142-2A>C	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000691273	X	152959358	X	153693903	691273	678963		NC_000023.11:153693902:A:C
NM_018486.3(HDAC8):c.562G>A (p.Ala188Thr)	HDAC8	A188T, A97T	Intellectual disability	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000691251	X	71710845	X	72490995	691251	678953		NC_000023.11:72490994:C:T
NM_001029896.2(WDR45):c.342-2A>C	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689799	X	48934185	X	49076526	689799	677472		NC_000023.11:49076525:T:G
NM_006852.4(TLK2):c.2107C>T (p.Arg703Ter)	TLK2	R554*, R703*, R725*, R671*	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689792	17	60689780	17	62612419	689792	677456		NC_000017.11:62612418:C:T
NM_005676.5(RBM10):c.724+2T>C	RBM10		TARP syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689781	X	47038564	X	47179165	689781	677471		NC_000023.11:47179164:T:C
NM_000444.6(PHEX):c.733-1G>C	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689777	X	22112100	X	22093982	689777	677468		NC_000023.11:22093981:G:C
NM_001193466.2(KANSL1):c.540del (p.Lys180fs)	KANSL1	K180fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689767	17	44248970	17	46171604	689767	677455		NC_000017.11:46171603:TTTT:TTT
NM_003688.3(CASK):c.913_914dup (p.Gly306fs)	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia|FG syndrome 4	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689749	X	41495831 - 41495832	X	41636578 - 41636579	689749	677470		NC_000023.11:41636578:TTT:TTTTT
NM_138270.4(ATRX):c.370+2746del	ATRX	K159fs	|Mental retardation-hypotonic facies syndrome X-linked, 1	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689744	X	76949320	X	77693831	689744	677477		NC_000023.11:77693830:TTTTTT:TTTTT
NM_152296.5(ATP1A3):c.2839G>T (p.Gly947Trp)	ATP1A3	G947W, G958W, G960W	Dystonia 12|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689735	19	42471896	19	41967744	689735	677461		NC_000019.10:41967743:C:A
NM_080476.4(PIGU):c.1149C>A (p.Asn383Lys)	PIGU	N383K	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 21	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000689724	20	33162953	20	34575149	689724	677402		NC_000020.11:34575148:G:T
NM_080476.4(PIGU):c.209T>A (p.Ile70Lys)	PIGU	I70K	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 21	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000689723	20	33233125	20	34645321	689723	677401		NC_000020.11:34645320:A:T
NM_001555.5(IGSF1):c.2303T>C (p.Leu768Pro)	IGSF1	L773P, L759P, L768P	Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000689655	X	130411847	X	131277873	689655	677333		NC_000023.11:131277872:A:G
NM_001555.5(IGSF1):c.2268dup (p.Arg757fs)	IGSF1		Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000689654	X	130411881 - 130411882	X	131277907 - 131277908	689654	677332		NC_000023.11:131277907:TTTTT:TTTTTT
NM_005984.5(SLC25A1):c.821+1G>A	SLC25A1		Combined d-2- and l-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000689643	22	19163933	22	19176420	689643	677322		NC_000022.11:19176419:C:T
NM_018684.4(ZC4H2):c.412C>T (p.Gln138Ter)	ZC4H2	Q115*, Q138*	Wieacker Wolff syndrome|not provided	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689619	X	64139071	X	64919191	689619	677298		NC_000023.11:64919190:G:A
NM_000109.4(DMD):c.7556T>A (p.Leu2519Ter)	DMD	L1183*, L1186*, L2404*, L2519*, L2523*, L2527*, L67*	Muscular Diseases	Pathogenic	no assertion criteria provided	VCV000689572	X	31747828	X	31729711	689572	677273		NC_000023.11:31729710:A:T
NM_015295.2(SMCHD1):c.4459C>T (p.Gln1487Ter)	SMCHD1	Q1487*	Scapulohumeral muscular dystrophy	Pathogenic	no assertion criteria provided	VCV000689561	18	2762127	18	2762129	689561	677264		NC_000018.10:2762128:C:T
NM_004006.2(DMD):c.8800G>T (p.Glu2934Ter)	DMD	E1590*, E1593*, E205*, E2811*, E2926*, E2930*, E2934*, E474*	Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000689489	X	31496360	X	31478243	689489	677126		NC_000023.11:31478242:C:A
NM_025219.3(DNAJC5):c.370_399dup (p.Cys124_Cys133dup)	DNAJC5		Neuronal ceroid lipofuscinosis 4B	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000689476	20	62562240 - 62562241	20	63930887 - 63930888	689476	677069		NC_000020.11:63930887:ACTGCTGCTGCTGTCTGTGCTGCTGCTTCAACTGCTGCTGC:ACTGCTGCTGCTGTCTGTGCTGCTGCTTCAACTGCTGCTGCTGTCTGTGCTGCTGCTTCAACTGCTGCTGC
NM_000276.4(OCRL):c.1907T>A (p.Val636Glu)	OCRL	V636E, V637E	Lowe syndrome	Pathogenic	no assertion criteria provided	VCV000689472	X	128710321	X	129576344	689472	677065		NC_000023.11:129576343:T:A
NM_000276.4(OCRL):c.1979A>C (p.His660Pro)	OCRL	H660P, H661P	Lowe syndrome	Pathogenic	no assertion criteria provided	VCV000689471	X	128710393	X	129576416	689471	677064		NC_000023.11:129576415:A:C
NM_000033.4(ABCD1):c.521A>C (p.Tyr174Ser)	ABCD1	Y174S	Adrenoleukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689462	X	152991242	X	153725787	689462	677061		NC_000023.11:153725786:A:C
NM_000033.4(ABCD1):c.1635-1G>A	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000689439	X	153006027	X	153740573	689439	677042		NC_000023.11:153740572:G:A
NM_032121.5(MAGT1):c.555dup (p.Tyr186fs)	MAGT1		Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000689410	X	77112925 - 77112926	X	77857428 - 77857429	689410	677002		NC_000023.11:77857428:T:TT
NM_032121.5(MAGT1):c.712C>T (p.Arg238Ter)	MAGT1	R238*, R206*	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000689409	X	77112286	X	77856789	689409	677001		NC_000023.11:77856788:G:A
NM_032121.5(MAGT1):c.598del (p.Arg200fs)	MAGT1	R168fs, R200fs	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000689408	X	77112883	X	77857386	689408	677000		NC_000023.11:77857385:GGG:GG
NM_139058.3(ARX):c.525C>G (p.Tyr175Ter)	ARX	Y175*	Lissencephaly 2, X-linked	Pathogenic	criteria provided, single submitter	VCV000689380	X	25031587	X	25013470	689380	676972		NC_000023.11:25013469:G:C
NM_001195803.2(LDLR):c.1606+287del	LDLR	T545fs, T672fs, T713fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000689352	19	11231196	19	11120520	689352	676944		NC_000019.10:11120519:C:
NM_001195798.2(LDLR):c.1594T>A (p.Tyr532Asn)	LDLR	Y364N, Y405N, Y491N, Y532N	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000689351	19	11226777	19	11116101	689351	676943		NC_000019.10:11116100:T:A
NM_001195798.2(LDLR):c.1049G>A (p.Arg350Gln)	LDLR	R182Q, R223Q, R309Q, R350Q	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000689349	19	11221436	19	11110760	689349	676941		NC_000019.10:11110759:G:A
NM_001195798.2(LDLR):c.926C>A (p.Pro309His)	LDLR	P141H, P182H, P268H, P309H	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000689348	19	11218176	19	11107500	689348	676940		NC_000019.10:11107499:C:A
NM_001195800.2(LDLR):c.314-1802G>T	LDLR	E187D, E228D	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000689346	19	11216266	19	11105590	689346	676938		NC_000019.10:11105589:G:T
NM_001195800.2(LDLR):c.314-1968G>C	LDLR	C132S, C173S	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000689345	19	11216100	19	11105424	689345	676937		NC_000019.10:11105423:G:C
GRCh37/hg19 22q11.21(chr22:20030822-20053554)x1	TANGO2		not provided	Pathogenic(Last reviewed: Mar 22, 2018)	no assertion criteria provided	VCV000689274	22	20030822 - 20053554			689274	676866		
GRCh37/hg19 22q12.3(chr22:33760603-33893824)x1	LARGE1		not provided	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000689212	22	33760603 - 33893824			689212	676804		
GRCh37/hg19 19q13.2(chr19:41907674-41923655)x1	BCKDHA		not provided	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000689061	19	41907674 - 41923655			689061	676653		
GRCh37/hg19 18q21.1(chr18:47389413-47419990)x1	MYO5B		not provided	Pathogenic(Last reviewed: Aug 10, 2018)	no assertion criteria provided	VCV000688948	18	47389413 - 47419990			688948	676540		
GRCh37/hg19 Xp11.4(chrX:38438500-38619112)x0	TSPAN7		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000688550	X	38438500 - 38619112			688550	676142		
GRCh37/hg19 22q11.21(chr22:20030822-20041691)x1	TANGO2		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000688031	22	20030822 - 20041691			688031	675623		
GRCh37/hg19 22q11.21(chr22:20030822-20053554)x1	TANGO2		not provided	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	VCV000687940	22	20030822 - 20053554			687940	675532		
GRCh37/hg19 22q12.1(chr22:26296892-26321051)x1	MYO18B		not provided	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000687925	22	26296892 - 26321051			687925	675517		
GRCh37/hg19 20p12.3(chr20:8843844-8880111)x1	PLCB1		not provided	Pathogenic(Last reviewed: Sep 13, 2017)	no assertion criteria provided	VCV000687733	20	8843844 - 8880111			687733	675325		
GRCh37/hg19 22q12.3(chr22:33983040-34200588)x1	LARGE1		not provided	Pathogenic(Last reviewed: Jul 9, 2018)	no assertion criteria provided	VCV000687489	22	33983040 - 34200588			687489	675081		
GRCh37/hg19 22q11.21(chr22:20030822-20053554)x1	TANGO2		not provided	Pathogenic(Last reviewed: Sep 28, 2017)	no assertion criteria provided	VCV000686862	22	20030822 - 20053554			686862	674454		
GRCh37/hg19 17q25.3(chr17:78058431-78074446)x1	CCDC40		not provided	Pathogenic(Last reviewed: Sep 15, 2017)	no assertion criteria provided	VCV000686764	17	78058431 - 78074446			686764	674356		
GRCh37/hg19 19q13.11(chr19:33963521-33975799)x1	PEPD		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	no assertion criteria provided	VCV000686349	19	33963521 - 33975799			686349	673941		
GRCh37/hg19 22q11.21(chr22:20030822-20053554)x1	TANGO2		not provided	Pathogenic(Last reviewed: Sep 5, 2018)	no assertion criteria provided	VCV000686235	22	20030822 - 20053554			686235	673827		
GRCh37/hg19 22q11.21(chr22:20028563-20053554)x1	TANGO2		not provided	Pathogenic(Last reviewed: Dec 4, 2017)	no assertion criteria provided	VCV000686157	22	20028563 - 20053554			686157	673749		
GRCh37/hg19 22q11.21(chr22:20030822-20053554)x1	TANGO2		not provided	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000686140	22	20030822 - 20053554			686140	673732		
GRCh37/hg19 18q21.33(chr18:59749354-59818707)x1	PIGN		not provided	Pathogenic(Last reviewed: Feb 16, 2018)	no assertion criteria provided	VCV000686030	18	59749354 - 59818707			686030	673622		
GRCh37/hg19 17q22(chr17:56721367-56766202)x1	TEX14		not provided	Pathogenic(Last reviewed: Feb 9, 2018)	no assertion criteria provided	VCV000685922	17	56721367 - 56766202			685922	673514		
GRCh37/hg19 Xp11.4(chrX:41708911-41713656)x1	CASK		not provided	Pathogenic(Last reviewed: Feb 14, 2018)	no assertion criteria provided	VCV000685469	X	41708911 - 41713656			685469	673061		
GRCh37/hg19 20p12.3(chr20:8089954-8572965)x1	PLCB1		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	no assertion criteria provided	VCV000685388	20	8089954 - 8572965			685388	672980		
GRCh37/hg19 20p12.3(chr20:8512966-8792352)x1	PLCB1		not provided	Pathogenic(Last reviewed: May 5, 2017)	no assertion criteria provided	VCV000685161	20	8512966 - 8792352			685161	672753		
GRCh37/hg19 21q22.3(chr21:47652184-47678774)x1	MCM3AP		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	no assertion criteria provided	VCV000684905	21	47652184 - 47678774			684905	672497		
NM_001366385.1(CARD14):c.470A>C (p.Gln157Pro)	CARD14	Q157P	Papulosquamous eruptions	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000684677	17	78157832	17	80184033	684677	672281		NC_000017.11:80184032:A:C
NM_001366385.1(CARD14):c.371T>C (p.Leu124Pro)	CARD14	L124P	Papulosquamous eruptions	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000684676	17	78157733	17	80183934	684676	672279		NC_000017.11:80183933:T:C
NM_001366385.1(CARD14):c.356T>G (p.Met119Arg)	CARD14	M119R	Papulosquamous eruptions	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000684675	17	78157718	17	80183919	684675	672278		NC_000017.11:80183918:T:G
NM_001366385.1(CARD14):c.349+5G>C	CARD14		Papulosquamous eruptions	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000684674	17	78156594	17	80182795	684674	672306		NC_000017.11:80182794:G:C
NM_001366385.1(CARD14):c.380G>C (p.Cys127Ser)	CARD14	C127S	Papulosquamous eruptions	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000684673	17	78157742	17	80183943	684673	672280		NC_000017.11:80183942:G:C
NM_000527.4(LDLR):c.2400dup (p.Phe801fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000684426	19	11240198 - 11240199	19	11129522 - 11129523	684426	672016		NC_000019.10:11129522:C:CC
NM_004737.6(LARGE1):c.2089G>T (p.Val697Leu)	LARGE1	V697L	Retinitis pigmentosa	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000684425	22	33670595	22	33274609	684425	672015		NC_000022.11:33274608:C:A
NM_002578.5(PAK3):c.976G>C (p.Val326Leu)	PAK3	V341L, V362L, V326L, V347L	Intellectual disability|Microcephaly	Pathogenic(Last reviewed: Mar 24, 2019)	criteria provided, single submitter	VCV000684413	X	110435830	X	111192602	684413	672009		NC_000023.11:111192601:G:C
NM_153638.3(PANK2):c.1351C>T (p.Arg451Ter)	PANK2	R15*, R160*, R451*	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000667397	20	3893220	20	3912573	667397	654901		NC_000020.11:3912572:C:T
NM_001174089.2(SLC4A11):c.1110C>A (p.Cys370Ter)	SLC4A11	C370*, C386*, C413*	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000666996	20	3211637	20	3230991	666996	654900		NC_000020.11:3230990:G:T
NM_005629.4(SLC6A8):c.1703C>A (p.Ser568Tyr)	SLC6A8	S453Y, S558Y, S568Y	Creatine transporter deficiency	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000666596	X	152960280	X	153694825	666596	654143		NC_000023.11:153694824:C:A
NM_033380.3(COL4A5):c.438+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000666560	X	107814697	X	108571467	666560	654151		NC_000023.11:108571466:G:A
NM_000276.4(OCRL):c.1498C>T (p.Arg500Ter)	OCRL	R501*, R500*	Lowe syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000666558	X	128703272	X	129569295	666558	654142		NC_000023.11:129569294:C:T
NM_000528.4(MAN2B1):c.2864_2879del (p.Thr955fs)	MAN2B1	T955fs, T954fs	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000666350	19	12758091 - 12758106	19	12647277 - 12647292	666350	653896		NC_000019.10:12647276:TGGTTGGCCACCAGCGTGGT:TGGT
NM_006517.5(SLC16A2):c.439G>A (p.Gly147Arg)	SLC16A2	G147R	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666343	X	73740833	X	74520998	666343	653909		NC_000023.11:74520997:G:A
NM_001347721.2(DYRK1A):c.673_674CT[1] (p.Cys226fs)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666311	21	38862511 - 38862512	21	37490209 - 37490210	666311	653898		NC_000021.9:37490208:TCTCT:TCT
NM_001429.4(EP300):c.3166C>T (p.Gln1056Ter)	EP300	Q1056*, Q1030*	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666310	22	41551022	22	41155018	666310	653900		NC_000022.11:41155017:C:T
NM_030662.3(MAP2K2):c.383C>T (p.Pro128Leu)	MAP2K2	P128L	TAFRO syndrome	Pathogenic(Last reviewed: Aug 12, 2019)	no assertion criteria provided	VCV000666272	19	4110574	19	4110576	666272	653829		NC_000019.10:4110575:G:A
NC_000019.9:g.(?_33321506)_(33359460_?)del	SLC7A9		not provided	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666217	19	33321506 - 33359460	19	32830600 - 32868554	666217	653573		
NM_000109.4(DMD):c.8968del (p.Ala2991fs)	DMD	A539fs, A1658fs, A2876fs, A2995fs, A2999fs, A1655fs, A270fs, A2991fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000666110	X	31462690	X	31444573	666110	649956		NC_000023.11:31444572:GG:G
NM_004655.4(AXIN2):c.2299_2302ACTT[1] (p.Tyr768fs)	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000666073	17	63530129 - 63530132	17	65534011 - 65534014	666073	646449		NC_000017.11:65534010:AAGTAAGT:AAGT
NM_000061.3(BTK):c.564del (p.Pro190fs)	BTK	P224fs, P190fs	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000666035	X	100617185	X	101362197	666035	649609		NC_000023.11:101362196:AA:A
NM_000033.4(ABCD1):c.346G>C (p.Gly116Arg)	ABCD1	G116R	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000665836	X	152991067	X	153725612	665836	649775		NC_000023.11:153725611:G:C
NM_000528.4(MAN2B1):c.2437-2A>G	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000665784	19	12759218	19	12648404	665784	653597		NC_000019.10:12648403:T:C
NC_000023.10:g.(?_31332523)_(31526374_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000665650	X	31332523 - 31526374	X	31314406 - 31508257	665650	653320		
NC_000023.10:g.(?_31854825)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000665639	X	31854825 - 31986641	X	31836708 - 31968524	665639	653754		
NC_000023.10:g.(?_31747738)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000665637	X	31747738 - 31986641	X	31729621 - 31968524	665637	653411		
NM_000455.5(STK11):c.964del (p.Ile322fs)	STK11	I322fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000665485	19	1223027	19	1223028	665485	647682		NC_000019.10:1223027:A:
NC_000019.9:g.(?_13186329)_(13189569_?)dup	NFIX		Sotos syndrome 2|Marshall-Smith syndrome	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000665055	19	13186329 - 13189569	19	13075515 - 13078755	665055	653449		
NC_000023.10:g.(?_41025125)_(41026830_?)del	USP9X		not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000665048	X	41025125 - 41026830	X	41165872 - 41167577	665048	653769		
NC_000023.10:g.(?_153008431)_(153009199_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000665037	X	153008431 - 153009199	X	153742977 - 153743745	665037	653308		
NC_000019.9:g.(?_11221289)_(11222326_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000665036	19	11221289 - 11222326	19	11110613 - 11111650	665036	652938		
NC_000022.10:g.(?_30032730)_(30035211_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000665033	22	30032730 - 30035211	22	29636741 - 29639222	665033	653205		
NC_000023.10:g.(?_32328189)_(32472959_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000665032	X	32328189 - 32472959	X	32310072 - 32454842	665032	653762		
NC_000023.10:g.(?_31947703)_(31950354_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000665027	X	31947703 - 31950354	X	31929586 - 31932237	665027	653440		
NM_004484.4(GPC3):c.513dup (p.Asp172Ter)	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000664988	X	132888027 - 132888028	X	133754000 - 133754001	664988	649698		NC_000023.11:133754000:AAA:AAAA
NM_001347721.2(DYRK1A):c.1069G>T (p.Glu357Ter)	DYRK1A	E328*, E357*, E366*	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000664970	21	38865463	21	37493161	664970	648995		NC_000021.9:37493160:G:T
NM_000202.8(IDS):c.418+1G>C	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000664872	X	148584841	X	149503311	664872	653691		NC_000023.11:149503310:C:G
NM_080860.4(RSPH1):c.196C>T (p.Arg66Ter)	RSPH1	R28*, R66*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000664828	21	43912946	21	42492836	664828	649004		NC_000021.9:42492835:G:A
NM_199242.2(UNC13D):c.520C>T (p.Gln174Ter)	UNC13D	Q174*		Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000664792	17	73838563	17	75842482	664792	646716		NC_000017.11:75842481:G:A
NM_001242897.2(DEPDC5):c.3907C>T (p.Gln1303Ter)	DEPDC5	Q1372*, Q1381*, Q1403*, Q1303*, Q1394*, Q1325*, Q1375*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000664598	22	32293471	22	31897485	664598	649445		NC_000022.11:31897484:C:T
NM_001174089.2(SLC4A11):c.2158G>T (p.Glu720Ter)	SLC4A11	E682*, E720*, E763*, E736*	not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000664579	20	3209518	20	3228872	664579	648608		NC_000020.11:3228871:C:A
NM_004655.4(AXIN2):c.333G>A (p.Trp111Ter)	AXIN2	W111*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000664578	17	63554406	17	65558288	664578	646567		NC_000017.11:65558287:C:T
NM_020964.3(EPG5):c.310_311dup (p.Glu105fs)	EPG5		Vici syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000664487	18	43535056 - 43535057	18	45955090 - 45955091	664487	647275		NC_000018.10:45955090:TTT:TTTTT
NC_000023.10:g.(?_32827600)_(32867947_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000664440	X	32827600 - 32867947	X	32809483 - 32849830	664440	653399		
NM_003140.3(SRY):c.169C>T (p.Gln57Ter)	SRY	Q57*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000664404	Y	2655476	Y	2787435	664404	650305		NC_000024.10:2787434:G:A
NM_000383.4(AIRE):c.489dup (p.Lys164fs)	AIRE		Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000664355	21	45707419 - 45707420	21	44287536 - 44287537	664355	649028		NC_000021.9:44287536:CCCCCC:CCCCCCC
NM_024301.5(FKRP):c.948del (p.Cys317fs)	FKRP	C317fs	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000664273	19	47259650	19	46756393	664273	648192		NC_000019.10:46756392:CCCCCC:CCCCC
NM_016418.5(NF2):c.1332_1333AG[1] (p.Glu445fs)	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000664255	22	30069467 - 30069470	22	29673478 - 29673481	664255	649355		NC_000022.11:29673477:AGAGAG:AG
NM_004655.4(AXIN2):c.1912C>T (p.Gln638Ter)	AXIN2	Q573*, Q638*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000664235	17	63532667	17	65536549	664235	646479		NC_000017.11:65536548:G:A
NM_153638.3(PANK2):c.851_855dup (p.Arg286fs)	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000664234	20	3888794 - 3888795	20	3908147 - 3908148	664234	648666		NC_000020.11:3908147:TTATA:TTATATTATA
NM_005359.5:c.1194G>A	SMAD4	W398*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000664189	18	48593443	18	51067073	664189	647314		NC_000018.10:51067072:G:A
NM_017950.4(CCDC40):c.2647C>T (p.Gln883Ter)	CCDC40	Q883*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000664142	17	78061837	17	80088038	664142	646853		NC_000017.11:80088037:C:T
NM_000527.4(LDLR):c.1987+2T>A	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000664087	19	11230911	19	11120235	664087	653478		NC_000019.10:11120234:T:A
NC_000023.10:g.(?_31893295)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000663956	X	31893295 - 31986641	X	31875178 - 31968524	663956	653651		
NM_001083962.2(TCF4):c.593_602delinsGCCGACTACAATAGGGAC (p.Ser198_Tyr201delinsCysArgLeuGlnTer)	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000663924	18	52946835 - 52946844	18	55279604 - 55279613	663924	647328		NC_000018.10:55279603:TAGCCTGGCG:GTCCCTATTGTAGTCGGC
NM_000152.5(GAA):c.1941C>A (p.Cys647Ter)	GAA	C647*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000663894	17	78086727	17	80112928	663894	646901		NC_000017.11:80112927:C:A
NM_000455.5(STK11):c.963del (p.Ile322fs)	STK11	I322fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000663824	19	1223024	19	1223025	663824	647681		NC_000019.10:1223024:CCC:CC
NM_172107.4(KCNQ2):c.106del (p.Arg36fs)	KCNQ2	R36fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000663758	20	62103711	20	63472358	663758	650468		NC_000020.11:63472357:GGG:GG
NM_000377.2(WAS):c.-37_132+35del	WAS		Wiskott-Aldrich syndrome||X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000663734	X	48542204 - 48542407	X	48683815 - 48684018	663734	653787		
NC_000019.9:g.(?_11210889)_(11213472_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000663429	19	11210889 - 11213472	19	11100213 - 11102796	663429	653102		
NM_005629.4(SLC6A8):c.1428C>A (p.Tyr476Ter)	SLC6A8	Y361*, Y466*, Y476*	Creatine transporter deficiency	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000663194	X	152959834	X	153694379	663194	649769		NC_000023.11:153694378:C:A
NM_001029896.2(WDR45):c.1005T>A (p.Tyr335Ter)	WDR45	Y335*, Y336*	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000663120	X	48932540	X	49074881	663120	650097		NC_000023.11:49074880:A:T
NM_024422.6(DSC2):c.2186del (p.Pro729fs)	DSC2	P729fs	Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000662906	18	28650756	18	31070790	662906	647134		NC_000018.10:31070789:GG:G
NM_001257988.1(TYMP):c.403del (p.Ala135fs)	TYMP	A135fs	not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000662890	22	50967579	22	50529150	662890	649545		NC_000022.11:50529149:CC:C
NC_000023.10:g.(?_32841402)_(32867947_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000662857	X	32841402 - 32867947	X	32823285 - 32849830	662857	653407		
NC_000023.10:g.(?_33032666)_(33038327_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000662853	X	33032666 - 33038327	X	33014549 - 33020210	662853	653412		
NC_000022.10:g.(?_20030878)_(20052185_?)del	TANGO2		not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000662837	22	20030878 - 20052185	22	20043355 - 20064662	662837	653685		
NC_000023.10:g.(?_31854825)_(31897527_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000662835	X	31854825 - 31897527	X	31836708 - 31879410	662835	653437		
NM_006785.4(MALT1):c.611dup (p.Gln205fs)	MALT1		Immunodeficiency 12	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000662739	18	56367784 - 56367785	18	58700552 - 58700553	662739	647356		NC_000018.10:58700552:C:CC
NM_006949.4(STXBP2):c.474_483delinsGA (p.Cys158fs)	STXBP2		Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000662726	19	7706635 - 7706644	19	7641749 - 7641758	662726	648531		NC_000019.10:7641748:CCCCTTCCGG:GA
NC_000023.10:g.(?_32715967)_(33146302_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000662295	X	32715967 - 33146302	X	32697850 - 33128185	662295	653668		
NM_000116.5(TAZ):c.697C>T (p.Gln233Ter)	TAZ	Q203*, Q233*, Q189*, Q219*, Q237*	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000662186	X	153648601	X	154420262	662186	649892		NC_000023.11:154420261:C:T
NM_032121.5(MAGT1):c.772_776del (p.Phe258fs)	MAGT1	F258fs, F226fs	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000662023	X	77111080 - 77111084	X	77855583 - 77855587	662023	650255		NC_000023.11:77855582:ACAAAACA:ACA
NM_001323289.2(CDKL5):c.2345C>G (p.Ser782Ter)	CDKL5	S782*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000662018	X	18638055	X	18619935	662018	649906		NC_000023.11:18619934:C:G
NM_005535.3(IL12RB1):c.169del (p.Ser57fs)	IL12RB1	S97fs, S57fs	Immunodeficiency 30	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000661930	19	18193030	19	18082220	661930	647838		NC_000019.10:18082219:T:
NM_017950.4(CCDC40):c.3004dup (p.Ile1002fs)	CCDC40		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000661903	17	78069229 - 78069230	17	80095430 - 80095431	661903	646856		NC_000017.11:80095430:AAAA:AAAAA
NM_004006.2(DMD):c.10182C>A (p.Tyr3394Ter)	DMD	Y665*, Y2050*, Y2053*, Y3386*, Y3394*, Y934*, Y326*, Y3271*, Y3390*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000661830	X	31196827	X	31178710	661830	649950		NC_000023.11:31178709:G:T
NC_000022.10:g.(?_29999978)_(30000111_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000661747	22	29999978 - 30000111	22	29603989 - 29604122	661747	653285		
NC_000023.10:g.(?_32305636)_(32328403_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000661740	X	32305636 - 32328403	X	32287519 - 32310286	661740	653355		
NC_000023.10:g.(?_32867835)_(32867947_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000661738	X	32867835 - 32867947	X	32849718 - 32849830	661738	653459		
NC_000023.10:g.(?_31747738)_(31838210_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000661732	X	31747738 - 31838210	X	31729621 - 31820093	661732	653409		
NC_000023.10:g.(?_31947707)_(31986637_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000661725	X	31947707 - 31986637	X	31929590 - 31968520	661725	653757		
NM_004006.2(DMD):c.2704C>T (p.Gln902Ter)	DMD	Q898*, Q902*, Q779*, Q894*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000661628	X	32503135	X	32485018	661628	650001		NC_000023.11:32485017:G:A
NM_000528.4(MAN2B1):c.1404dup (p.Trp469fs)	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000661591	19	12768274 - 12768275	19	12657460 - 12657461	661591	647700		NC_000019.10:12657460:G:GG
NM_000202.8(IDS):c.88_89insAT (p.Ala30fs)	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000661523	X	148586579 - 148586580	X	149505049 - 149505050	661523	649745		NC_000023.11:149505049::AT
NM_000159.4(GCDH):c.553G>A (p.Gly185Arg)	GCDH	G185R	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000661521	19	13006853	19	12896039	661521	647711		NC_000019.10:12896038:G:A
NM_020533.3(MCOLN1):c.445dup (p.Tyr149fs)	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000661439	19	7591685 - 7591686	19	7526799 - 7526800	661439	648518		NC_000019.10:7526799:T:TT
NM_000487.6(ARSA):c.1046del (p.Pro349fs)	ARSA	P263fs, P349fs	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000661357	22	51064425	22	50625997	661357	649556		NC_000022.11:50625996:GGGG:GGG
NM_000455.4(STK11):c.498C>G (p.Tyr166Ter)	STK11	Y166*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000661321	19	1220405	19	1220406	661321	647671		NC_000019.10:1220405:C:G
NM_023036.6(DNAI2):c.1132A>T (p.Lys378Ter)	DNAI2	K378*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000661289	17	72301502	17	74305363	661289	646671		NC_000017.11:74305362:A:T
NM_001083962.2(TCF4):c.1328C>G (p.Ser443Ter)	TCF4	S282*, S313*, S545*, S418*, S443*, S283*, S372*, S401*, S420*, S440*, S449*, S227*, S419*, S442*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000661273	18	52921750	18	55254519	661273	647325		NC_000018.10:55254518:G:C
NM_002501.4(NFIX):c.43_49dup (p.Glu17fs)	NFIX		Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000661035	19	13135847 - 13135848	19	13025033 - 13025034	661035	647719		NC_000019.10:13025033:CGTTCATCG:CGTTCATCGTTCATCG
NM_000377.2(WAS):c.355G>T (p.Gly119Ter)	WAS	G119*	X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000660964	X	48544017	X	48685628	660964	650079		NC_000023.11:48685627:G:T
NM_000527.4(LDLR):c.249delinsGG (p.Ile83fs)	LDLR		not provided|Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660717	19	11213398	19	11102722	660717	647615		NC_000019.10:11102721:T:GG
NC_000023.10:g.(?_31514885)_(31697723_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000660696	X	31514885 - 31697723	X	31496768 - 31679606	660696	653741		
NC_000023.10:g.(?_32613854)_(32614013_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000660695	X	32613854 - 32614013	X	32595737 - 32595896	660695	653767		
NC_000023.10:g.(?_69176857)_(69177002_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000660692	X	69176857 - 69177002	X	69957007 - 69957152	660692	653770		
NC_000019.9:g.(?_55652241)_(55658535_?)del	TNNT1		Nemaline myopathy 5	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000660688	19	55652241 - 55658535	19	55140873 - 55147167	660688	653586		
NC_000023.10:g.(?_31514895)_(31525580_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000660685	X	31514895 - 31525580	X	31496778 - 31507463	660685	653742		
NC_000023.10:g.(?_37639262)_(37642873_?)del	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000660681	X	37639262 - 37642873	X	37780009 - 37783620	660681	653677		
NM_144612.6(LOXHD1):c.734dup (p.Ser246fs)	LOXHD1		not provided	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000660612	18	44190763 - 44190764	18	46610800 - 46610801	660612	647283		NC_000018.10:46610800:CCCCCC:CCCCCCC
NM_001256715.2(DNAAF3):c.1135C>T (p.Arg379Ter)	DNAAF3	R426*, R325*, R446*, R379*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000660592	19	55671295	19	55159927	660592	648505		NC_000019.10:55159926:G:A
NM_002049.3(GATA1):c.5_8dup (p.Phe3fs)	GATA1		gene sequencing|Diamond-Blackfan anemia	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000660513	X	48649520 - 48649521	X	48791113 - 48791114	660513	650088		NC_000023.11:48791113:AGTT:AGTTAGTT
NM_001127221.1(CACNA1A):c.928_931del (p.Thr310fs)	CACNA1A	T310fs	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000660404	19	13470467 - 13470470	19	13359653 - 13359656	660404	647771		NC_000019.10:13359652:CAGTCAG:CAG
NM_001127221.1(CACNA1A):c.5059C>T (p.Gln1687Ter)	CACNA1A	Q1687*, Q1692*, Q1689*, Q1686*	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000660390	19	13346439	19	13235625	660390	647741		NC_000019.10:13235624:G:A
NM_000527.5(LDLR):c.1647dup (p.Val550fs)	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000660216	19	11226829 - 11226830	19	11116153 - 11116154	660216	647627		NC_000019.10:11116153:T:TT
NC_000023.10:g.(?_31341705)_(31341785_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000660160	X	31341705 - 31341785	X	31323588 - 31323668	660160	653739		
NC_000023.10:g.(?_135730217)_(135741594_?)del	CD40LG			Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000660153	X	135730217 - 135741594	X	136648058 - 136659435	660153	653301		
NC_000023.10:g.(?_103031893)_(103045536_?)dup	PLP1		Hereditary spastic paraplegia 2	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000660146	X	103031893 - 103045536			660146	653272		
NC_000023.10:g.(?_31697472)_(31792329_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000660142	X	31697472 - 31792329	X	31679355 - 31774212	660142	653396		
NC_000023.10:g.(?_148564267)_(148586894_?)del	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000660140	X	148564267 - 148586894			660140	653624		
NC_000023.10:g.(?_31838082)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000660139	X	31838082 - 31986641	X	31819965 - 31968524	660139	653337		
NM_001127221.1(CACNA1A):c.3536del (p.Leu1179fs)	CACNA1A	L1178fs, L1179fs, L1182fs	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000659920	19	13397337	19	13286523	659920	647747		NC_000019.10:13286522:A:
NM_013995.2(LAMP2):c.205_218del (p.His69fs)	LAMP2	H69fs	Danon disease	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000659852	X	119589391 - 119589404	X	120455536 - 120455549	659852	649654		NC_000023.11:120455535:GTCACAGTGCCATGGTC:GTC
NM_016418.5(NF2):c.1646T>A (p.Leu549Ter)	NF2	L508*, L466*, L549*, L507*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000659824	22	30077499	22	29681510	659824	649361		NC_000022.11:29681509:T:A
NM_004006.2(DMD):c.616C>T (p.Gln206Ter)	DMD	Q198*, Q202*, Q206*, Q83*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000659785	X	32827643	X	32809526	659785	650020		NC_000023.11:32809525:G:A
NM_000159.4(GCDH):c.1182T>G (p.Ile394Met)	GCDH	I394M	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000659769	19	13008616	19	12897802	659769	647717		NC_000019.10:12897801:T:G
NC_000018.9:g.(?_59821778)_(59825041_?)del	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000659593	18	59821778 - 59825041	18	62154545 - 62157808	659593	653377		
NM_001029896.2(WDR45):c.517-2A>G	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000659190	X	48933414	X	49075755	659190	653717		NC_000023.11:49075754:T:C
NM_000100.3(CSTB):c.200_203dup (p.Val69fs)	CSTB		Progressive myoclonic epilepsy	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000659184	21	45194176 - 45194177	21	43774295 - 43774296	659184	649021		NC_000021.9:43774295:CGCA:CGCACGCA
NM_000397.3(CYBB):c.1320C>G (p.Tyr440Ter)	CYBB	Y440*	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000659169	X	37665645	X	37806392	659169	650033		NC_000023.11:37806391:C:G
NM_000061.2(BTK):c.1262G>A (p.Trp421Ter)	BTK	W421*, W455*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Sep 22, 2018)	criteria provided, single submitter	VCV000659167	X	100611859	X	101356871	659167	649603		NC_000023.11:101356870:C:T
NC_000023.10:g.(?_149761067)_(149840078_?)del	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000658991	X	149761067 - 149840078			658991	653728		
NC_000023.10:g.(?_31627738)_(31792319_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000658986	X	31627738 - 31792319	X	31609621 - 31774202	658986	653641		
NC_000019.9:g.(?_11226750)_(11227694_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000658984	19	11226750 - 11227694	19	11116074 - 11117018	658984	653431		
NC_000023.10:g.(?_31947703)_(31947872_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000658973	X	31947703 - 31947872	X	31929586 - 31929755	658973	653755		
NM_176787.5(PIGN):c.1494dup (p.Leu499fs)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000658963	18	59777146 - 59777147	18	62109913 - 62109914	658963	647385		NC_000018.10:62109913:AAAAAA:AAAAAAA
NM_031229.4(RBCK1):c.582+1G>C	RBCK1		Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000658931	20	400113	20	419469	658931	653553		NC_000020.11:419468:G:C
NM_000206.2(IL2RG):c.956_957AG[1] (p.Leu321fs)	IL2RG		X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000658867	X	70327737 - 70327738	X	71107887 - 71107888	658867	650167		NC_000023.11:71107886:CTCTC:CTC
NM_000355.4(TCN2):c.428-2_428-1del	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000658845	22	31010334 - 31010335	22	30614347 - 30614348	658845	653254		NC_000022.11:30614346:AG:
NM_000528.4(MAN2B1):c.1928G>A (p.Trp643Ter)	MAN2B1	W643*, W642*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000658737	19	12763177	19	12652363	658737	647699		NC_000019.10:12652362:C:T
NM_001111125.3(IQSEC2):c.1078dup (p.Gln360fs)	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000658703	X	53284034 - 53284035	X	53254852 - 53254853	658703	650120		NC_000023.11:53254852:GG:GGG
NM_001184880.2(PCDH19):c.1755C>G (p.Tyr585Ter)	PCDH19	Y585*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000658664	X	99661841	X	100406843	658664	649574		NC_000023.11:100406842:G:C
NM_152468.5(TMC8):c.1746del (p.Leu583fs)	TMC8	L583fs	Epidermodysplasia verruciformis	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000658615	17	76134734	17	78138653	658615	646829		NC_000017.11:78138652:GGG:GG
NM_172107.4(KCNQ2):c.1424_1433del (p.Asp475fs)	KCNQ2	D445fs, D447fs, D457fs, D475fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000658549	20	62046348 - 62046357	20	63414995 - 63415004	658549	650428		NC_000020.11:63414994:CTGGGGCTGTC:C
NC_000019.9:g.(?_11215886)_(11218204_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000658446	19	11215886 - 11218204	19	11105210 - 11107528	658446	653560		
NC_000023.10:g.(?_32827600)_(32867947_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000658441	X	32827600 - 32867947	X	32809483 - 32849830	658441	653670		
NM_000455.5(STK11):c.965dup (p.Pro324fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000658358	19	1223027 - 1223028	19	1223028 - 1223029	658358	647683		NC_000019.10:1223028:T:TT
NM_000061.2(BTK):c.232C>T (p.Gln78Ter)	BTK	Q78*, Q112*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000658193	X	100629532	X	101374544	658193	649612		NC_000023.11:101374543:G:A
NM_004655.4(AXIN2):c.1036C>T (p.Gln346Ter)	AXIN2	Q346*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000658114	17	63537596	17	65541478	658114	646524		NC_000017.11:65541477:G:A
NM_005359.5:c.399C>A	SMAD4	Y133*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000658046	18	48575205	18	51048835	658046	647295		NC_000018.10:51048834:C:A
NM_000495.5(COL4A5):c.4488_4489del (p.Arg1497fs)	COL4A5	R1503fs, R1497fs	not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000657973	X	107930900 - 107930901	X	108687670 - 108687671	657973	649628		NC_000023.11:108687669:AAAA:AA
NM_005359.6(SMAD4):c.1067dup (p.Ser357fs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000657923	18	48591901 - 48591902	18	51065531 - 51065532	657923	647312		NC_000018.10:51065531:CCC:CCCC
NC_000023.10:g.(?_31792067)_(31897527_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000657921	X	31792067 - 31897527	X	31773950 - 31879410	657921	653751		
NC_000023.10:g.(?_2852853)_(2878461_?)del	ARSL			Pathogenic(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000657917	X	2852853 - 2878461	X	2934812 - 2960420	657917	653313		
NC_000023.10:g.(?_31838082)_(31838210_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000657913	X	31838082 - 31838210	X	31819965 - 31820093	657913	653649		
NC_000023.10:g.(?_31697482)_(31854946_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000657903	X	31697482 - 31854946	X	31679365 - 31836829	657903	653405		
NM_001943.5(DSG2):c.3G>A (p.Met1Ile)	DSG2	M1I	Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000657863	18	29078217	18	31498254	657863	647161		NC_000018.10:31498253:G:A
NM_000271.5(NPC1):c.3477+2T>C	NPC1		Niemann-Pick disease type C1	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000657686	18	21115431	18	23535467	657686	653379		NC_000018.10:23535466:A:G
NM_001127221.1(CACNA1A):c.1437C>G (p.Tyr479Ter)	CACNA1A	Y478*, Y479*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000657621	19	13428047	19	13317233	657621	647766		NC_000019.10:13317232:G:C
NM_001278116.2(L1CAM):c.1823del (p.Val608fs)	L1CAM	V603fs, V608fs	Spastic paraplegia	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000657401	X	153133458	X	153868003	657401	649798		NC_000023.11:153868002:A:
NC_000023.10:g.(?_32827600)_(32834767_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000657381	X	32827600 - 32834767	X	32809483 - 32816650	657381	653393		
NC_000023.10:g.(?_31792067)_(31983146_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000657380	X	31792067 - 31983146	X	31773950 - 31965029	657380	653413		
NC_000022.10:g.(?_34157348)_(34157473_?)del	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000657377	22	34157348 - 34157473	22	33761361 - 33761486	657377	653603		
NC_000023.10:g.(?_31986446)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000657374	X	31986446 - 31986641	X	31968329 - 31968524	657374	653652		
NM_000052.7(ATP7A):c.3868C>T (p.Gln1290Ter)	ATP7A	Q1212*, Q1290*	Distal spinal muscular atrophy, X-linked 3|Cutis laxa, X-linked|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000657355	X	77298149	X	78042651	657355	650283		NC_000023.11:78042650:C:T
NM_000152.5(GAA):c.1210G>A (p.Asp404Asn)	GAA	D404N	Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000657348	17	78082511	17	80108712	657348	646886		NC_000017.11:80108711:G:A
NM_000152.5(GAA):c.2481+110_2646+39del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000657307	17	78091650 - 78092187	17	80117851 - 80118388	657307	653062		
NM_001123383.1(BCOR):c.2858_2859del (p.Lys953fs)	BCOR	K953fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, single submitter	VCV000657302	X	39931740 - 39931741	X	40072487 - 40072488	657302	650045		NC_000023.11:40072486:TTT:T
NM_000334.4(SCN4A):c.808C>A (p.Gln270Lys)	SCN4A	Q270K	Hyperkalemic Periodic Paralysis Type 1	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000657169	17	62045611	17	63968251	657169	646438		NC_000017.11:63968250:G:T
NM_001848.2(COL6A1):c.887G>T (p.Gly296Val)	COL6A1	G296V	Bethlem myopathy 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000657156	21	47409550	21	45989636	657156	649077		NC_000021.9:45989635:G:T
NM_000033.4(ABCD1):c.408del (p.Gln136fs)	ABCD1	Q136fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000657046	X	152991129	X	153725674	657046	649777		NC_000023.11:153725673:G:
NC_000023.10:g.(?_31838082)_(31947872_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000656845	X	31838082 - 31947872	X	31819965 - 31929755	656845	653426		
NC_000023.10:g.(?_31792067)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000656844	X	31792067 - 31986641	X	31773950 - 31968524	656844	653752		
NC_000019.9:g.(?_11238674)_(11238771_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000656812	19	11238674 - 11238771	19	11127998 - 11128095	656812	653119		
NM_001083962.2(TCF4):c.923-2A>G	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000656789	18	52928766	18	55261535	656789	652892		NC_000018.10:55261534:T:C
NM_000033.4(ABCD1):c.1454C>G (p.Ser485Ter)	ABCD1	S485*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000656786	X	153002671	X	153737217	656786	649791		NC_000023.11:153737216:C:G
NM_004006.2(DMD):c.9563+2T>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000656754	X	31227613	X	31209496	656754	653783		NC_000023.11:31209495:A:T
NM_000061.2(BTK):c.1321G>T (p.Glu441Ter)	BTK	E475*, E441*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000656715	X	100611800	X	101356812	656715	649602		NC_000023.11:101356811:C:A
NM_000377.3(WAS):c.858del (p.Ser287fs)	WAS	S287fs	X-linked thrombocytopenia with normal platelets||Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000656534	X	48546768	X	48688379	656534	650086		NC_000023.11:48688378:CC:C
NM_004035.7(ACOX1):c.1717del (p.Asp573fs)	ACOX1	D573fs, D535fs		Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000656515	17	73945309	17	75949228	656515	646722		NC_000017.11:75949227:CCCCC:CCCC
NM_000033.4(ABCD1):c.36del (p.Asn13fs)	ABCD1	N13fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000656433	X	152990753	X	153725298	656433	649771		NC_000023.11:153725297:GGGGG:GGGG
NC_000023.10:g.(?_153008655)_(153009209_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000656289	X	153008655 - 153009209	X	153743201 - 153743755	656289	653310		
NC_000023.10:g.(?_31645780)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000656286	X	31645780 - 31986641	X	31627663 - 31968524	656286	653324		
NM_031229.4(RBCK1):c.325C>T (p.Arg109Ter)	RBCK1	R109*, R67*	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000656156	20	398439	20	417795	656156	648674		NC_000020.11:417794:C:T
NM_000152.5(GAA):c.806_830del (p.Leu269fs)	GAA	L269fs	Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000656144	17	78081468 - 78081492	17	80107669 - 80107693	656144	646880		NC_000017.11:80107668:CTCAGCACCAGCTGGACCAGGATCAC:C
NM_007254.4(PNKP):c.1203_1291del (p.Trp402fs)	PNKP	W402fs	Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000656086	19	50365036 - 50365124	19	49861779 - 49861867	656086	648289		
NM_000033.4(ABCD1):c.234_242dup (p.Arg80_Leu82dup)	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000656053	X	152990950 - 152990951	X	153725495 - 153725496	656053	649773		NC_000023.11:153725495:GGCTCCTGCGGCT:GGCTCCTGCGGCTCCTGCGGCT
NM_004484.4(GPC3):c.80dup (p.Pro28fs)	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000656012	X	133119396 - 133119397	X	133985369 - 133985370	656012	649708		NC_000023.11:133985369:GGGGG:GGGGGG
NM_001242896.3(DEPDC5):c.4446dup (p.Val1483fs)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000655956	22	32301976 - 32301977	22	31905990 - 31905991	655956	649447		NC_000022.11:31905990:TTT:TTTT
NM_006306.4(SMC1A):c.2872dup (p.Gln958fs)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000655878	X	53421798 - 53421799	X	53394878 - 53394879	655878	650126		NC_000023.11:53394878:GGG:GGGG
NM_000455.5(STK11):c.762dup (p.Phe255fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000655873	19	1221235 - 1221236	19	1221236 - 1221237	655873	647679		NC_000019.10:1221236:CCCC:CCCCC
NC_000023.10:g.(?_31332523)_(31382270_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000655764	X	31332523 - 31382270	X	31314406 - 31364153	655764	653315		
NC_000022.10:g.(?_41550979)_(41560154_?)del	EP300		Colorectal cancer|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000655763	22	41550979 - 41560154	22	41154975 - 41164150	655763	653288		
NC_000023.10:g.(?_32834575)_(32867947_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000655752	X	32834575 - 32867947	X	32816458 - 32849830	655752	653404		
NC_000023.10:g.(?_103031893)_(103045546_?)del	PLP1		Hereditary spastic paraplegia 2	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000655751	X	103031893 - 103045546			655751	653727		
NM_001127221.1(CACNA1A):c.5640del (p.Met1881fs)	CACNA1A	M1880fs, M1881fs, M1883fs, M1886fs	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000655727	19	13335575	19	13224761	655727	647735		NC_000019.10:13224760:CC:C
NM_000292.3(PHKA2):c.3331C>T (p.Arg1111Ter)	PHKA2	R1111*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000655569	X	18913261	X	18895143	655569	649914		NC_000023.11:18895142:G:A
NC_000023.10:g.(?_53430478)_(53432101_?)del	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000655221	X	53430478 - 53432101			655221	653294		
NM_001111125.3(IQSEC2):c.542del (p.Gly181fs)	IQSEC2	G181fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000655036	X	53349780	X	53320582	655036	650122		NC_000023.11:53320581:CCC:CC
NM_001242897.2(DEPDC5):c.788_792GAAGA[1] (p.Glu265fs)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000654814	22	32193603 - 32193607	22	31797617 - 31797621	654814	649410		NC_000022.11:31797616:AGAGAAGAGAAGA:AGAGAAGA
NM_001848.2(COL6A1):c.1003-1G>T	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, single submitter	VCV000654745	21	47410686	21	45990772	654745	653180		NC_000021.9:45990771:G:T
NM_004006.2(DMD):c.10765C>T (p.Gln3589Ter)	DMD	Q3585*, Q1019*, Q2245*, Q508*, Q860*, Q3589*, Q1116*, Q521*, Q1129*, Q2248*, Q3466*, Q3581*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000654722	X	31165424	X	31147307	654722	649949		NC_000023.11:31147306:G:A
NM_004655.4(AXIN2):c.761_762CT[1] (p.Leu255fs)	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Oct 6, 2018)	criteria provided, single submitter	VCV000654706	17	63553975 - 63553976	17	65557857 - 65557858	654706	646536		NC_000017.11:65557856:AGAG:AG
NC_000023.10:g.(?_31627738)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000654681	X	31627738 - 31986641	X	31609621 - 31968524	654681	653746		
NC_000019.9:g.(?_11230758)_(11231284_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000654664	19	11230758 - 11231284	19	11120082 - 11120608	654664	653435		
NM_002501.4(NFIX):c.303dup (p.Cys102fs)	NFIX		Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000654601	19	13136104 - 13136105	19	13025290 - 13025291	654601	647722		NC_000019.10:13025290:CCCCCC:CCCCCCC
NM_000411.8(HLCS):c.584dup (p.Tyr195Ter)	HLCS		Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000654583	21	38309160 - 38309161	21	36936860 - 36936861	654583	648989		NC_000021.9:36936860:T:TT
NM_000152.5(GAA):c.276C>A (p.Cys92Ter)	GAA	C92*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000654482	17	78078661	17	80104862	654482	646864		NC_000017.11:80104861:C:A
NM_000199.5(SGSH):c.490C>T (p.Gln164Ter)	SGSH	Q164*	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000654350	17	78188430	17	80214631	654350	646966		NC_000017.11:80214630:G:A
NM_016418.5(NF2):c.517-92_568del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000654267	22	30051485 - 30051628	22	29655496 - 29655639	654267	653616		
NM_001399.5(EDA):c.706+5G>T	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000654168	X	69247891	X	70028041	654168	653539		NC_000023.11:70028040:G:T
NC_000023.10:g.(?_69080668)_(69177002_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV000654113	X	69080668 - 69177002			654113	653372		
NC_000023.10:g.(?_32456338)_(32536268_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000654108	X	32456338 - 32536268	X	32438221 - 32518151	654108	653446		
NC_000023.10:g.(?_70443018)_(70444419_?)del	GJB1		Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000654107	X	70443018 - 70444419	X	71223168 - 71224569	654107	653679		
NC_000023.10:g.(?_31747738)_(31747875_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000654104	X	31747738 - 31747875	X	31729621 - 31729758	654104	653642		
NC_000023.10:g.(?_99551255)_(99663615_?)del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000654099	X	99551255 - 99663615	X	100296257 - 100408617	654099	653632		
NM_001242896.3(DEPDC5):c.1018del (p.Val340fs)	DEPDC5	V312fs, V340fs	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000654060	22	32198758	22	31802772	654060	649412		NC_000022.11:31802771:GGGG:GGG
NM_005359.5:c.1249_1250delGA	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000653799	18	48593495 - 48593496	18	51067125 - 51067126	653799	647316		NC_000018.10:51067124:AGAGA:AGA
NM_004006.2(DMD):c.831+1G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000653791	X	32717228	X	32699111	653791	653520		NC_000023.11:32699110:C:G
NM_014270.5(SLC7A9):c.511C>T (p.Arg171Trp)	SLC7A9	R171W	not provided	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, single submitter	VCV000653611	19	33353460	19	32862554	653611	647895		NC_000019.10:32862553:G:A
NM_001008537.3(NEXMIF):c.3458dup (p.Asn1153fs)	NEXMIF		not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000653605	X	73960933 - 73960934	X	74741098 - 74741099	653605	650210		NC_000023.11:74741098:TTTTTTT:TTTTTTTT
NM_198129.3(LAMA3):c.9397del (p.Leu3133fs)	LAMA3	L3077fs, L3133fs, L1524fs, L1468fs	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000653552	18	21529774	18	23949810	653552	647098		NC_000018.10:23949809:C:
NC_000022.10:g.(?_32160941)_(32162674_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000653533	22	32160941 - 32162674	22	31764955 - 31766688	653533	653286		
NC_000023.10:g.(?_41712348)_(41712500_?)del	CASK		Mental retardation, CASK-related, X-linked	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000653532	X	41712348 - 41712500	X	41853095 - 41853247	653532	653422		
NC_000022.10:g.(?_31008840)_(31011794_?)del	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000653526	22	31008840 - 31011794	22	30612853 - 30615807	653526	653602		
NC_000023.10:g.(?_31838082)_(31854946_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000653513	X	31838082 - 31854946	X	31819965 - 31836829	653513	653420		
NM_198129.3(LAMA3):c.9311C>T (p.Ala3104Val)	LAMA3	A3048V, A1439V, A3104V, A1495V	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000653457	18	21526208	18	23946244	653457	647097		NC_000018.10:23946243:C:T
NM_000116.5(TAZ):c.281G>A (p.Arg94His)	TAZ	R112H, R94H	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000653322	X	153641586	X	154413249	653322	649884		NC_000023.11:154413248:G:A
NM_181882.3(PRX):c.627del (p.Ala210fs)	PRX	A210fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000653288	19	40903632	19	40397725	653288	648129		NC_000019.10:40397724:GG:G
NM_001848.2(COL6A1):c.1003-2A>C	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000653239	21	47410685	21	45990771	653239	653176		NC_000021.9:45990770:A:C
NM_005257.5(GATA6):c.1477C>T (p.Arg493Ter)	GATA6	R493*	Atrioventricular septal defect 5	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000653141	18	19762766	18	22182805	653141	647090		NC_000018.10:22182804:C:T
NM_000166.6(GJB1):c.99_103dup (p.Val35fs)	GJB1		not provided|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000653090	X	70443655 - 70443656	X	71223805 - 71223806	653090	650193		NC_000023.11:71223805:CATGG:CATGGCATGG
NM_004006.2(DMD):c.1705-2A>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000653035	X	32591756	X	32573639	653035	653519		NC_000023.11:32573638:T:C
NC_000019.9:g.(?_13386644)_(13387962_?)del	CACNA1A		Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000652963	19	13386644 - 13387962	19	13275830 - 13277148	652963	652944		
NC_000022.10:g.(?_30069248)_(30069485_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000652949	22	30069248 - 30069485	22	29673259 - 29673496	652949	653697		
NM_003560.4(PLA2G6):c.1262del (p.Val421fs)	PLA2G6	V195fs, V421fs, V243fs	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000652932	22	38524362	22	38128355	652932	649499		NC_000022.11:38128354:A:
NM_004586.3(RPS6KA3):c.1996C>T (p.Gln666Ter)	RPS6KA3	Q666*	Mental retardation, X-linked 19|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000652883	X	20174331	X	20156213	652883	649929		NC_000023.11:20156212:G:A
NM_001323289.2(CDKL5):c.2326_2327del (p.Lys776fs)	CDKL5	K776fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000652635	X	18638036 - 18638037	X	18619916 - 18619917	652635	649905		NC_000023.11:18619915:AA:
NM_017636.4(TRPM4):c.3099C>G (p.Ile1033Met)	TRPM4	I1033M, I859M, I918M, I497M, I679M, I888M	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6	Pathogenic(Last reviewed: Aug 12, 2019)	no assertion criteria provided	VCV000652588	19	49705366	19	49202109	652588	653801		NC_000019.10:49202108:C:G
NM_017636.4(TRPM4):c.3119T>C (p.Ile1040Thr)	TRPM4	I1010T, I866T, I1040T, I504T, I686T, I895T, I925T	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000652587	19	49705386	19	49202129	652587	653800		NC_000019.10:49202128:T:C
NM_000377.2(WAS):c.803delinsTT (p.Arg268fs)	WAS		|Wiskott-Aldrich syndrome|X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000652576	X	48546714	X	48688325	652576	650085		NC_000023.11:48688324:G:TT
NC_000023.10:g.(?_68890034)_(69177002_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000652393	X	68890034 - 69177002			652393	653369		
NM_000527.4(LDLR):c.832G>T (p.Gly278Ter)	LDLR	G237*, G110*, G278*, G151*	Familial hypercholesterolemia	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000652345	19	11218082	19	11107406	652345	647617		NC_000019.10:11107405:G:T
NM_007254.4(PNKP):c.63del (p.Ile22fs)	PNKP	I22fs	Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000652248	19	50370399	19	49867142	652248	648306		NC_000019.10:49867141:GGGGGG:GGGGG
NM_020964.3(EPG5):c.6353_6356del (p.Val2118fs)	EPG5	V2118fs	Vici syndrome	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000652177	18	43447583 - 43447586	18	45867618 - 45867621	652177	647234		NC_000018.10:45867617:CAGACA:CA
NM_001399.5(EDA):c.599del (p.Pro200fs)	EDA	P200fs	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000651933	X	69247775	X	70027925	651933	650160		NC_000023.11:70027924:CCCCC:CCCC
NM_004586.3(RPS6KA3):c.727C>T (p.Arg243Ter)	RPS6KA3	R243*	Mental retardation, X-linked 19|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000651889	X	20205993	X	20187875	651889	649930		NC_000023.11:20187874:G:A
NM_000487.6(ARSA):c.157C>T (p.Gln53Ter)	ARSA	Q53*	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000651844	22	51066051	22	50627623	651844	649561		NC_000022.11:50627622:G:A
NC_000023.10:g.(?_31341705)_(31525580_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000651819	X	31341705 - 31525580	X	31323588 - 31507463	651819	653740		
NC_000023.10:g.(?_31332523)_(31525580_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000651818	X	31332523 - 31525580	X	31314406 - 31507463	651818	653390		
NC_000023.10:g.(?_31838082)_(32235190_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000651817	X	31838082 - 32235190	X	31819965 - 32217073	651817	653436		
NC_000023.10:g.(?_32536105)_(32536268_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000651813	X	32536105 - 32536268	X	32517988 - 32518151	651813	653765		
NC_000023.10:g.(?_85119615)_(85302556_?)del	CHM		not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000651805	X	85119615 - 85302556			651805	653297		
NM_005629.4(SLC6A8):c.457dup (p.Ala153fs)	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000651752	X	152956819 - 152956820	X	153691364 - 153691365	651752	649766		NC_000023.11:153691364:GG:GGG
NM_004655.4(AXIN2):c.730dup (p.Ser244fs)	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000651751	17	63554008 - 63554009	17	65557890 - 65557891	651751	646541		NC_000017.11:65557890:AAA:AAAA
NM_138927.3(SON):c.5964del (p.Ser1989fs)	SON	S1989fs	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000651689	21	34927501	21	33555195	651689	648943		NC_000021.9:33555194:T:
NM_000033.4(ABCD1):c.919C>T (p.Gln307Ter)	ABCD1	Q307*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000651649	X	152994705	X	153729250	651649	649787		NC_000023.11:153729249:C:T
NM_172107.4(KCNQ2):c.783_787dup (p.Thr263fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000651592	20	62073787 - 62073788	20	63442434 - 63442435	651592	650480		NC_000020.11:63442434:TGTCA:TGTCATGTCA
NM_001184880.2(PCDH19):c.1548C>A (p.Tyr516Ter)	PCDH19	Y516*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000651548	X	99662048	X	100407050	651548	649575		NC_000023.11:100407049:G:T
NM_000052.7(ATP7A):c.3250dup (p.Ser1084fs)	ATP7A		Cutis laxa, X-linked|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000651544	X	77287035 - 77287036	X	78031537 - 78031538	651544	650279		NC_000023.11:78031537:A:AA
NM_144612.6(LOXHD1):c.5777G>A (p.Trp1926Ter)	LOXHD1	W1926*, W877*, W227*, W781*	not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000651421	18	44069021	18	46489058	651421	647278		NC_000018.10:46489057:C:T
NC_000020.10:g.(?_62059700)_(62065276_?)del	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000651259	20	62059700 - 62065276	20	63428347 - 63433923	651259	653106		
NC_000019.9:g.(?_11210879)_(11218210_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000651247	19	11210879 - 11218210	19	11100203 - 11107534	651247	652916		
NM_198270.4(NHS):c.3595_3599del (p.Asn1199fs)	NHS	N1220fs, N1043fs, N1022fs, N1199fs	Nance-Horan syndrome	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000651020	X	17745884 - 17745888	X	17727764 - 17727768	651020	649895		NC_000023.11:17727763:AACTC:
NM_000061.3(BTK):c.680del (p.Pro227fs)	BTK	P227fs, P261fs	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000651001	X	100615652	X	101360664	651001	649607		NC_000023.11:101360663:GG:G
NM_001127221.1(CACNA1A):c.2411G>A (p.Trp804Ter)	CACNA1A	W803*, W804*, W807*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000650983	19	13410039	19	13299225	650983	647762		NC_000019.10:13299224:C:T
NM_000071.2(CBS):c.1223+1G>T	CBS		Classic homocystinuria	Pathogenic(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000650962	21	44479335	21	43059225	650962	653165		NC_000021.9:43059224:C:A
NM_000276.4(OCRL):c.1440_1441CT[1] (p.Asp480_Ser481insTer)	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000650887	X	128701314 - 128701315	X	129567337 - 129567338	650887	649666		NC_000023.11:129567336:CTCT:CT
NM_001174089.2(SLC4A11):c.670_671insA (p.Trp224Ter)	SLC4A11		not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000650848	20	3214218 - 3214219	20	3233572 - 3233573	650848	648609		NC_000020.11:3233572::T
NC_000022.10:g.(?_34000411)_(34000554_?)del	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000650725	22	34000411 - 34000554	22	33604425 - 33604568	650725	653698		
NC_000019.9:g.(?_42373091)_(42375455_?)del	RPS19		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Dec 15, 2018)	criteria provided, single submitter	VCV000650720	19	42373091 - 42375455			650720	653530		
NC_000023.10:g.(?_31893295)_(31950354_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000650719	X	31893295 - 31950354	X	31875178 - 31932237	650719	653439		
NC_000021.8:g.(?_36421129)_(36421595_?)del	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000650703	21	36421129 - 36421595	21	35048832 - 35049298	650703	653572		
NC_000019.9:g.(?_11210889)_(11218204_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000650699	19	11210889 - 11218204	19	11100213 - 11107528	650699	653558		
NM_001127221.1(CACNA1A):c.592C>T (p.Arg198Ter)	CACNA1A	R198*	not provided|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000650263	19	13482541	19	13371727	650263	647772		NC_000019.10:13371726:G:A
NM_004006.2(DMD):c.9094G>T (p.Glu3032Ter)	DMD	E3024*, E3032*, E3028*, E303*, E2909*, E572*, E1688*, E1691*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000650214	X	31366742	X	31348625	650214	649954		NC_000023.11:31348624:C:A
NC_000022.10:g.(?_32200128)_(32206647_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000650190	22	32200128 - 32206647	22	31804142 - 31810661	650190	653215		
NC_000023.10:g.(?_31627738)_(32519969_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000650182	X	31627738 - 32519969	X	31609621 - 32501852	650182	653747		
NM_006950.3(SYN1):c.1516C>T (p.Gln506Ter)	SYN1	Q506*	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000650148	X	47433867	X	47574468	650148	650075		NC_000023.11:47574467:G:A
NM_172107.4(KCNQ2):c.1680dup (p.Pro561fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000649870	20	62044885 - 62044886	20	63413532 - 63413533	649870	650436		NC_000020.11:63413532:CC:CCC
NM_001399.5(EDA):c.876_893del (p.Glu292_Val297del)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000649646	X	69253327 - 69253344	X	70033477 - 70033494	649646	650164		NC_000023.11:70033476:GGAGCTGGAGGTACTGGTGGA:GGA
NC_000019.9:g.(?_11240179)_(11242035_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000649634	19	11240179 - 11242035	19	11129503 - 11131359	649634	652940		
NC_000023.10:g.(?_31747748)_(31792309_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000649626	X	31747748 - 31792309	X	31729631 - 31774192	649626	653750		
NC_000023.10:g.(?_148578704)_(148586687_?)del	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000649624	X	148578704 - 148586687			649624	653625		
NM_001277126.1(NLRP12):c.1109_1112GGAA[1] (p.Lys371fs)	NLRP12		Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000649559	19	54313797 - 54313800	19	53810543 - 53810546	649559	648473		NC_000019.10:53810542:TTCCTTCCTT:TTCCTT
NM_004006.2(DMD):c.187-1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000649535	X	32862978	X	32844861	649535	653452		NC_000023.11:32844860:C:A
NM_014339.6(IL17RA):c.166_169dup (p.Cys57fs)	IL17RA		Immunodeficiency 51	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000649522	22	17578687 - 17578688	22	17097797 - 17097798	649522	649141		NC_000022.11:17097797:TACCT:TACCTACCT
NM_000206.2(IL2RG):c.430C>T (p.Gln144Ter)	IL2RG	Q144*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000649486	X	70330378	X	71110528	649486	650172		NC_000023.11:71110527:G:A
NM_001174089.2(SLC4A11):c.2215C>T (p.Arg739Trp)	SLC4A11	R755W, R782W, R701W, R739W	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000649470	20	3209331	20	3228685	649470	648607		NC_000020.11:3228684:G:A
NM_000292.3(PHKA2):c.1546C>T (p.Gln516Ter)	PHKA2	Q516*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000649460	X	18943809	X	18925691	649460	649917		NC_000023.11:18925690:G:A
NM_000215.3(JAK3):c.115del (p.Gln39fs)	JAK3	Q39fs	not provided|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000649414	19	17955112	19	17844303	649414	647819		NC_000019.10:17844302:GGGGGGG:GGGGGG
NM_020956.2(PRX):c.165_177dup (p.Gln60fs)	PRX		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000649369	19	40909619 - 40909620	19	40403712 - 40403713	649369	648135		NC_000019.10:40403712:CAGGCTGAGGCTCC:CAGGCTGAGGCTCCAGGCTGAGGCTCC
NM_004010.3(DMD):c.-76_-64del	DMD	D94fs, D90fs, D98fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000649355	X	32841463 - 32841475	X	32823346 - 32823358	649355	650024		NC_000023.11:32823345:TCCATCTACGATGTC:TC
NM_000152.5(GAA):c.2383G>T (p.Glu795Ter)	GAA	E795*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000649354	17	78091450	17	80117651	649354	646906		NC_000017.11:80117650:G:T
NM_000252.2(MTM1):c.64-2A>G	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000649278	X	149764960	X	150596496	649278	653776		NC_000023.11:150596495:A:G
NM_001848.2(COL6A1):c.58C>T (p.Gln20Ter)	COL6A1	Q20*	Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000649269	21	47401822	21	45981908	649269	649069		NC_000021.9:45981907:C:T
NM_144612.6(LOXHD1):c.1468C>T (p.Arg490Ter)	LOXHD1	R490*	not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000649221	18	44172511	18	46592548	649221	647282		NC_000018.10:46592547:G:A
NM_032121.5(MAGT1):c.737_738insGA (p.Phe246fs)	MAGT1		Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000649134	X	77112260 - 77112261	X	77856763 - 77856764	649134	650256		NC_000023.11:77856763::TC
NM_001184880.2(PCDH19):c.535A>T (p.Lys179Ter)	PCDH19	K179*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000649112	X	99663061	X	100408063	649112	649583		NC_000023.11:100408062:T:A
NC_000023.10:g.(?_32536115)_(32536267_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000649084	X	32536115 - 32536267	X	32517998 - 32518150	649084	653387		
NC_000023.10:g.(?_32827600)_(33038327_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000649074	X	32827600 - 33038327	X	32809483 - 33020210	649074	653673		
NC_000023.10:g.(?_32235023)_(32235190_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000649073	X	32235023 - 32235190	X	32216906 - 32217073	649073	653759		
NC_000023.10:g.(?_31838082)_(31897527_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000649052	X	31838082 - 31897527	X	31819965 - 31879410	649052	653753		
NM_172107.4(KCNQ2):c.2361dup (p.Ile788fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000648996	20	62038254 - 62038255	20	63406901 - 63406902	648996	650464		NC_000020.11:63406901:GG:GGG
NM_001323289.2(CDKL5):c.2785C>T (p.Gln929Ter)	CDKL5	Q929*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000648838	X	18646779	X	18628659	648838	649910		NC_000023.11:18628658:C:T
NM_000383.4(AIRE):c.1273C>T (p.Gln425Ter)	AIRE	Q425*	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000648772	21	45713053	21	44293170	648772	649040		NC_000021.9:44293169:C:T
NM_004646.3(NPHS1):c.2633dup (p.Asn878fs)	NPHS1		not provided	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000648643	19	36333055 - 36333056	19	35842153 - 35842154	648643	647949		NC_000019.10:35842153:TTTTTT:TTTTTTT
NC_000017.10:g.(?_78091982)_(78092166_?)del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000648526	17	78091982 - 78092166	17	80118183 - 80118367	648526	653183		
NC_000019.9:g.(?_11230758)_(11240356_?)dup	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000648525	19	11230758 - 11240356	19	11120082 - 11129680	648525	653442		
NM_000052.7(ATP7A):c.3294+1G>A	ATP7A		Cutis laxa, X-linked|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000648378	X	77287081	X	78031583	648378	653720		NC_000023.11:78031582:G:A
NM_153638.3(PANK2):c.1211A>T (p.Asn404Ile)	PANK2	N404I, N113I	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000648367	20	3891453	20	3910806	648367	648667		NC_000020.11:3910805:A:T
NM_144612.6(LOXHD1):c.4282C>T (p.Arg1428Ter)	LOXHD1	R221*, R317*, R1428*	not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000648364	18	44113218	18	46533255	648364	647280		NC_000018.10:46533254:G:A
NM_000411.8(HLCS):c.1055T>A (p.Leu352Ter)	HLCS	L352*, L499*	Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648263	21	38302675	21	36930375	648263	648986		NC_000021.9:36930374:A:T
NM_015192.4(PLCB1):c.1612G>T (p.Glu538Ter)	PLCB1	E538*	Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000648249	20	8705333	20	8724686	648249	648870		NC_000020.11:8724685:G:T
NM_001184880.2(PCDH19):c.2617-1G>A	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648240	X	99605703	X	100350705	648240	653771		NC_000023.11:100350704:C:T
NM_001184880.2(PCDH19):c.2676-6A>G	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000648238	X	99597079	X	100342081	648238	653428		NC_000023.11:100342080:T:C
NM_001127221.1(CACNA1A):c.1247_1248dup (p.Phe417fs)	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000648071	19	13443689 - 13443690	19	13332875 - 13332876	648071	647770		NC_000019.10:13332875:GGG:GGGGG
NM_005359.5:c.247C>T	SMAD4	Q83*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000648055	18	48573663	18	51047293	648055	647293		NC_000018.10:51047292:C:T
NC_000023.10:g.(?_32862890)_(32867947_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000647964	X	32862890 - 32867947	X	32844773 - 32849830	647964	653675		
NC_000023.10:g.(?_32509374)_(32509655_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000647959	X	32509374 - 32509655	X	32491257 - 32491538	647959	653383		
NC_000022.10:g.(?_32150888)_(32302503_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000647951	22	32150888 - 32302503	22	31754902 - 31906517	647951	653209		
NM_007363.5(NONO):c.245del (p.Pro82fs)	NONO	P82fs	not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000647910	X	70511718	X	71291868	647910	650198		NC_000023.11:71291867:CC:C
NM_000377.2(WAS):c.631C>T (p.Arg211Ter)	WAS	R211*	Wiskott-Aldrich syndrome|X-linked thrombocytopenia with normal platelets|	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000647830	X	48545241	X	48686852	647830	650082		NC_000023.11:48686851:C:T
NM_001184880.2(PCDH19):c.670del (p.Ser225fs)	PCDH19	S225fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000647772	X	99662926	X	100407928	647772	649581		NC_000023.11:100407927:GG:G
NM_001278116.2(L1CAM):c.3496C>T (p.Arg1166Ter)	L1CAM	R1161*, R1166*	Spastic paraplegia	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000647732	X	153128966	X	153863511	647732	649797		NC_000023.11:153863510:G:A
NM_000159.4(GCDH):c.91+5G>A	GCDH		Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000647712	19	13002214	19	12891400	647712	653601		NC_000019.10:12891399:G:A
NM_000146.4(FTL):c.-157G>A	FTL		|Neuroferritinopathy	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000647521	19	49468608	19	48965351	647521	648220		NC_000019.10:48965350:G:A
NM_001287344.1(BTK):c.1813_1814TA[3] (p.Ser606fs)	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000647370	X	100608893 - 100608894	X	101353905 - 101353906	647370	649595		NC_000023.11:101353905:TATA:TATATA
NM_000071.2(CBS):c.1126G>A (p.Asp376Asn)	CBS	D376N, D271N	Classic homocystinuria	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000647345	21	44480570	21	43060460	647345	649008		NC_000021.9:43060459:C:T
NM_000527.5(LDLR):c.1382del (p.Gly461fs)	LDLR	G293fs, G334fs, G420fs, G461fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000647342	19	11224233	19	11113557	647342	647622		NC_000019.10:11113556:GG:G
NM_000061.2(BTK):c.777-1G>A	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000647326	X	100615139	X	101360151	647326	653680		NC_000023.11:101360150:C:T
NM_145045.5(CCDC151):c.487C>T (p.Gln163Ter)	CCDC151	Q109*, Q137*, Q163*	Ciliary dyskinesia, primary, 30	Pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000647259	19	11537818	19	11426998	647259	647635		NC_000019.10:11426997:G:A
NM_000109.4(DMD):c.9444del (p.Ile3149fs)	DMD	I1816fs, I3153fs, I3157fs, I89fs, I3149fs, I1813fs, I3034fs, I428fs, I697fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000647196	X	31227710	X	31209593	647196	649952		NC_000023.11:31209592:A:
NM_002049.3(GATA1):c.166_187dup (p.Tyr63fs)	GATA1		gene sequencing|Diamond-Blackfan anemia	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000647140	X	48649679 - 48649680	X	48791272 - 48791273	647140	650089		NC_000023.11:48791272:CTGCAGCTGCGGCACTGGCCTACT:CTGCAGCTGCGGCACTGGCCTACTGCAGCTGCGGCACTGGCCTACT
NM_001754.4(RUNX1):c.289_299delinsCTCCTTCCGCTG (p.Phe97fs)	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000647118	21	36259192 - 36259202	21	34886895 - 34886905	647118	648970		NC_000021.9:34886894:GAGCAGAGGAA:CAGCGGAAGGAG
NM_000109.4(DMD):c.1230_1231dup (p.Glu411fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000647086	X	32662324 - 32662325	X	32644207 - 32644208	647086	650016		NC_000023.11:32644207:CA:CACA
NM_000527.4(LDLR):c.1092C>A (p.Cys364Ter)	LDLR	C196*, C237*, C364*, C323*	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000646922	19	11222221	19	11111545	646922	647620		NC_000019.10:11111544:C:A
NM_000061.2(BTK):c.1697C>G (p.Pro566Arg)	BTK	P390R, P566R, P600R	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000646878	X	100608911	X	101353923	646878	649596		NC_000023.11:101353922:G:C
NM_001242897.2(DEPDC5):c.1224C>A (p.Tyr408Ter)	DEPDC5	Y380*, Y408*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000646869	22	32202114	22	31806128	646869	649416		NC_000022.11:31806127:C:A
NM_172107.4(KCNQ2):c.1003C>G (p.Pro335Ala)	KCNQ2	P335A	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000646824	20	62069998	20	63438645	646824	650418		NC_000020.11:63438644:G:C
NM_016418.5(NF2):c.516+1G>A	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000646675	22	30050715	22	29654726	646675	653312		NC_000022.11:29654725:G:A
NM_001193416.3(DDX3X):c.397dup (p.Glu133fs)	DDX3X		not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000646639	X	41201859 - 41201860	X	41342606 - 41342607	646639	650049		NC_000023.11:41342606:G:GG
NM_000154.2(GALK1):c.766C>T (p.Arg256Trp)	GALK1	R256W	Deficiency of galactokinase	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000646613	17	73758812	17	75762731	646613	646696		NC_000017.11:75762730:G:A
NM_005359.5:c.1363C>T	SMAD4	Q455*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000646595	18	48603062	18	51076692	646595	647322		NC_000018.10:51076691:C:T
NM_015166.3(MLC1):c.218G>A (p.Gly73Glu)	MLC1	G73E	not provided	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000646457	22	50521562	22	50083133	646457	649543		NC_000022.11:50083132:C:T
NM_020956.2(PRX):c.*2894C>T	PRX	R897*	Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000646421	19	40901570	19	40395663	646421	648104		NC_000019.10:40395662:G:A
NC_000023.10:g.(?_31525388)_(31525580_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000646399	X	31525388 - 31525580	X	31507271 - 31507463	646399	653744		
NC_000023.10:g.(?_32717219)_(32717420_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000646387	X	32717219 - 32717420	X	32699102 - 32699303	646387	653768		
NM_023036.6(DNAI2):c.1459_1460delinsCATT (p.Thr487fs)	DNAI2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000646373	17	72306267 - 72306268	17	74310128 - 74310129	646373	646674		NC_000017.11:74310127:AC:CATT
NM_000109.4(DMD):c.7592dup (p.Asn2531fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000646368	X	31747791 - 31747792	X	31729674 - 31729675	646368	649965		NC_000023.11:31729674:TTTTT:TTTTTT
NM_005359.6(SMAD4):c.69del (p.Met24fs)	SMAD4	M24fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000646292	18	48573485	18	51047115	646292	647289		NC_000018.10:51047114:G:
NM_000199.5(SGSH):c.402dup (p.Asp135Ter)	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000646114	17	78188517 - 78188518	17	80214718 - 80214719	646114	646967		NC_000017.11:80214718:AAA:AAAA
NM_000397.4(CYBB):c.1313dup (p.Ile439fs)	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000646067	X	37664415 - 37664416	X	37805162 - 37805163	646067	650032		NC_000023.11:37805162:AAAAA:AAAAAA
NM_001257988.1(TYMP):c.11del (p.Ala3_Leu4insTer)	TYMP		not provided	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000646061	22	50968128	22	50529699	646061	649546		NC_000022.11:50529698:AA:A
NM_000194.3(HPRT1):c.319-2A>G	HPRT1		Lesch-Nyhan syndrome|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000645956	X	133620493	X	134486463	645956	653438		NC_000023.11:134486462:A:G
NC_000023.10:g.(?_153005536)_(153005701_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000645884	X	153005536 - 153005701	X	153740082 - 153740247	645884	653738		
NC_000023.10:g.(?_149831886)_(149840088_?)del	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, single submitter	VCV000645882	X	149831886 - 149840088			645882	653281		
NM_003413.4(ZIC3):c.571del (p.Glu191fs)	ZIC3	E191fs		Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000645837	X	136649418	X	137567259	645837	649731		NC_000023.11:137567258:GGGG:GGG
NM_001111125.3(IQSEC2):c.3074del (p.Phe1025fs)	IQSEC2	F1025fs, F820fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000645830	X	53268418	X	53239236	645830	650113		NC_000023.11:53239235:AAA:AA
NM_000061.2(BTK):c.1546C>T (p.Gln516Ter)	BTK	Q550*, Q516*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000645829	X	100611060	X	101356072	645829	649600		NC_000023.11:101356071:G:A
NM_000152.5(GAA):c.1585T>C (p.Ser529Pro)	GAA	S529P	Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645572	17	78084773	17	80110974	645572	646894		NC_000017.11:80110973:T:C
NM_000061.2(BTK):c.756G>A (p.Trp252Ter)	BTK	W252*, W286*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000645498	X	100615576	X	101360588	645498	649606		NC_000023.11:101360587:C:T
NM_001127221.1(CACNA1A):c.5118T>G (p.Tyr1706Ter)	CACNA1A	Y1708*, Y1711*, Y1705*, Y1706*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000645463	19	13346041	19	13235227	645463	647740		NC_000019.10:13235226:A:C
NC_000023.10:g.(?_31983146)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000645373	X	31983146 - 31986641	X	31965029 - 31968524	645373	653342		
NC_000023.10:g.(?_148579618)_(148586687_?)del	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000645359	X	148579618 - 148586687			645359	653344		
NC_000023.10:g.(?_32456348)_(32536267_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000645353	X	32456348 - 32536267	X	32438231 - 32518150	645353	653359		
NM_001242897.2(DEPDC5):c.4201C>T (p.Gln1401Ter)	DEPDC5	Q1470*, Q1501*, Q1401*, Q1423*, Q1492*, Q1479*, Q1473*	Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000645254	22	32302034	22	31906048	645254	649448		NC_000022.11:31906047:C:T
NM_000061.2(BTK):c.1763G>A (p.Trp588Ter)	BTK	W588*, W622*, W412*	X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000645226	X	100608327	X	101353339	645226	649592		NC_000023.11:101353338:C:T
NM_000271.5(NPC1):c.2096del (p.Val699fs)	NPC1	V699fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000645173	18	21124342	18	23544378	645173	647095		NC_000018.10:23544377:A:
NM_006306.4(SMC1A):c.1299del (p.Lys433fs)	SMC1A	K433fs, K411fs	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000645044	X	53436390	X	53409459	645044	650129		NC_000023.11:53409458:C:
NM_001123385.2(BCOR):c.3463del (p.Asp1155fs)	BCOR	D1137fs, D1155fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000644876	X	39923628	X	40064375	644876	650043		NC_000023.11:40064374:CC:C
NC_000019.9:g.(?_11226760)_(11231284_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000644845	19	11226760 - 11231284	19	11116084 - 11120608	644845	653108		
NC_000023.10:g.(?_69255188)_(69255479_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000644841	X	69255188 - 69255479	X	70035338 - 70035629	644841	653678		
NC_000019.9:g.(?_12767375)_(12772200_?)del	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000644824	19	12767375 - 12772200	19	12656561 - 12661386	644824	652941		
NM_000109.4(DMD):c.7+127975del	DMD	C10fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000644710	X	33229401	X	33211284	644710	650028		NC_000023.11:33211283:C:
NM_172107.4(KCNQ2):c.1117dup (p.Ser373fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000644680	20	62065162 - 62065163	20	63433809 - 63433810	644680	650422		NC_000020.11:63433809:T:TT
NM_021140.3(KDM6A):c.4051C>T (p.Arg1351Ter)	KDM6A	R1055*, R1306*, R1351*, R1272*, R1403*, R1358*	Kabuki syndrome 2	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000644617	X	44969369	X	45110124	644617	650058		NC_000023.11:45110123:C:T
NM_000268.4(NF2):c.69dup (p.Val24fs)	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000644553	22	30000054 - 30000055	22	29604065 - 29604066	644553	649331		NC_000022.11:29604065:CC:CCC
NM_001127221.1(CACNA1A):c.3535del (p.Leu1179fs)	CACNA1A	L1179fs, L1182fs, L1178fs	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000644525	19	13397338	19	13286524	644525	647749		NC_000019.10:13286523:GGGGGGG:GGGGGG
NM_000455.4(STK11):c.755_758dup (p.Pro254fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000644482	19	1221231 - 1221232	19	1221232 - 1221233	644482	647678		NC_000019.10:1221232:TGTA:TGTATGTA
NM_000061.2(BTK):c.1751-1G>C	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000644461	X	100608340	X	101353352	644461	653432		NC_000023.11:101353351:C:G
NM_001022.4(RPS19):c.173-2A>G	RPS19		Diamond-Blackfan anemia	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000644396	19	42373099	19	41869029	644396	653617		NC_000019.10:41869028:A:G
NM_000215.3(JAK3):c.1837C>T (p.Arg613Ter)	JAK3	R613*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000644288	19	17946810	19	17836001	644288	647807		NC_000019.10:17836000:G:A
NC_000023.10:g.(?_31676097)_(32305828_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000644278	X	31676097 - 32305828	X	31657980 - 32287711	644278	653749		
NM_000292.3(PHKA2):c.133C>T (p.Arg45Trp)	PHKA2	R45W	Glycogen storage disease type IXa1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000644261	X	18972476	X	18954358	644261	649922		NC_000023.11:18954357:G:A
NM_172107.4(KCNQ2):c.2326_2327delinsA (p.Pro776fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000644234	20	62038289 - 62038290	20	63406936 - 63406937	644234	650461		NC_000020.11:63406935:GG:T
NM_004006.2(DMD):c.8881C>T (p.Gln2961Ter)	DMD	Q1617*, Q1620*, Q2961*, Q232*, Q2838*, Q2953*, Q2957*, Q501*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000643851	X	31496279	X	31478162	643851	649958		NC_000023.11:31478161:G:A
NM_005359.6(SMAD4):c.443del (p.Leu148fs)	SMAD4	L148fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000643787	18	48575683	18	51049313	643787	647297		NC_000018.10:51049312:T:
NM_144612.6(LOXHD1):c.1506G>A (p.Trp502Ter)	LOXHD1	W502*	not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000643784	18	44172473	18	46592510	643784	647281		NC_000018.10:46592509:C:T
NM_004006.2(DMD):c.2869C>T (p.Gln957Ter)	DMD	Q953*, Q957*, Q834*, Q949*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000643749	X	32490361	X	32472244	643749	649998		NC_000023.11:32472243:G:A
NC_000023.10:g.(?_39911342)_(39937202_?)del	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000643718	X	39911342 - 39937202	X	40052089 - 40077949	643718	653421		
NC_000023.10:g.(?_32305636)_(32383326_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000643706	X	32305636 - 32383326	X	32287519 - 32365209	643706	653658		
NM_144612.6(LOXHD1):c.4212+1G>A	LOXHD1		not provided	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000643628	18	44114297	18	46534334	643628	653402		NC_000018.10:46534333:C:T
NM_000109.4(DMD):c.4586dup (p.Asn1529fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000643482	X	32404490 - 32404491	X	32386373 - 32386374	643482	649985		NC_000023.11:32386373:TTTT:TTTTT
NM_001323289.2(CDKL5):c.2821del (p.Tyr941fs)	CDKL5	Y941fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000643438	X	18646815	X	18628695	643438	649911		NC_000023.11:18628694:T:
NM_000215.3(JAK3):c.1688_1693delinsTGGAGGTGAGA (p.Lys563fs)	JAK3		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000643419	19	17948749 - 17948754	19	17837940 - 17837945	643419	647808		NC_000019.10:17837939:AGTTCT:TCTCACCTCCA
NM_000206.2(IL2RG):c.594+2_594+3del	IL2RG		X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000643411	X	70330003 - 70330004	X	71110153 - 71110154	643411	653470		NC_000023.11:71110152:CACA:CA
NM_000377.2(WAS):c.470_471del (p.Arg157fs)	WAS	R157fs	Wiskott-Aldrich syndrome||X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, single submitter	VCV000643344	X	48544340 - 48544341	X	48685951 - 48685952	643344	650081		NC_000023.11:48685950:CGC:C
NM_000109.4(DMD):c.2437_2438GA[1] (p.Glu813fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000643325	X	32509550 - 32509553	X	32491433 - 32491436	643325	650004		NC_000023.11:32491432:TCTCTC:TC
NM_000455.4(STK11):c.197_225del (p.Val66fs)	STK11	V66fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000643317	19	1207103 - 1207131	19	1207104 - 1207132	643317	647663		NC_000019.10:1207103:AGGAGGTGCTGGACTCGGAGACGCTGTGCAGGAGG:AGGAGG
NC_000018.9:g.(?_3447718)_(3457958_?)del	TGIF1		Holoprosencephaly 4	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000643155	18	3447718 - 3457958	18	3447720 - 3457960	643155	653071		
NC_000023.10:g.(?_133607369)_(133634127_?)del	HPRT1		Lesch-Nyhan syndrome|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000643153	X	133607369 - 133634127	X	134473339 - 134500097	643153	653299		
NM_016418.5(NF2):c.658A>T (p.Asn220Tyr)	NF2	N178Y, N220Y, N137Y, N179Y	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000643102	22	30054236	22	29658247	643102	649345		NC_000022.11:29658246:A:T
NM_000527.4(LDLR):c.1459_1472dup (p.Asp492fs)	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000643071	19	11224309 - 11224310	19	11113633 - 11113634	643071	647624		NC_000019.10:11113633:CAACATCTACTGGAC:CAACATCTACTGGACAACATCTACTGGAC
NM_153638.3(PANK2):c.126del (p.Arg44fs)	PANK2	R44fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000642965	20	3869873	20	3889226	642965	648662		NC_000020.11:3889225:G:
NM_000033.4(ABCD1):c.1784G>A (p.Trp595Ter)	ABCD1	W595*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000642905	X	153008444	X	153742990	642905	649793		NC_000023.11:153742989:G:A
NM_000052.7(ATP7A):c.453del (p.Thr152fs)	ATP7A	T152fs	Menkes kinky-hair syndrome|Cutis laxa, X-linked|Distal spinal muscular atrophy, X-linked 3	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000642741	X	77244068	X	77988572	642741	650266		NC_000023.11:77988571:GGG:GG
NM_001127221.1(CACNA1A):c.2025C>A (p.Tyr675Ter)	CACNA1A	Y674*, Y675*	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000642562	19	13414663	19	13303849	642562	647763		NC_000019.10:13303848:G:T
NM_000166.6(GJB1):c.265C>G (p.Leu89Val)	GJB1	L89V	Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000642558	X	70443822	X	71223972	642558	650194		NC_000023.11:71223971:C:G
NM_000033.4(ABCD1):c.723del (p.Trp242fs)	ABCD1	W242fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000642462	X	152991443	X	153725988	642462	649783		NC_000023.11:153725987:CC:C
NM_032620.4(GTPBP3):c.865G>T (p.Glu289Ter)	GTPBP3	E311*, E289*, E321*	not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000642459	19	17450299	19	17339490	642459	647795		NC_000019.10:17339489:G:T
NM_000061.3(BTK):c.270del (p.Glu90fs)	BTK	E124fs, E90fs	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000642455	X	100626660	X	101371672	642455	649611		NC_000023.11:101371671:C:
NM_018848.3(MKKS):c.172_175dup (p.Gln59fs)	MKKS		Bardet-Biedl syndrome|	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000642430	20	10393987 - 10393988	20	10413339 - 10413340	642430	648572		NC_000020.11:10413339:GTGAG:GTGAGTGAG
NM_004010.3(DMD):c.-336_-332del	DMD	E4fs, E12fs, E8fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000642306	X	33038311 - 33038315	X	33020194 - 33020198	642306	650027		NC_000023.11:33020193:CTTTC:
NM_000495.5(COL4A5):c.1177_1178dup (p.Met393fs)	COL4A5		not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000642234	X	107834297 - 107834298	X	108591067 - 108591068	642234	649626		NC_000023.11:108591067:TAT:TATAT
NM_001123385.2(BCOR):c.3467del (p.Pro1156fs)	BCOR	P1138fs, P1156fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000642113	X	39923624	X	40064371	642113	650042		NC_000023.11:40064370:GGG:GG
NC_000020.10:g.(?_50418798)_(50418967_?)del	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000642045	20	50418798 - 50418967	20	51802259 - 51802428	642045	653103		
NC_000019.9:g.(?_47258688)_(47260215_?)del	FKRP		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000642043	19	47258688 - 47260215	19	46755431 - 46756958	642043	653461		
NM_176787.5(PIGN):c.1688dup (p.Tyr564fs)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000641992	18	59774100 - 59774101	18	62106867 - 62106868	641992	647382		NC_000018.10:62106867:AAAAAA:AAAAAAA
NM_012179.4(FBXO7):c.1206_1207dup (p.Arg403fs)	FBXO7		Parkinson disease 15	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000641981	22	32894152 - 32894153	22	32498165 - 32498166	641981	649457		NC_000022.11:32498165:AAA:AAAAA
NM_000377.2(WAS):c.660_664del (p.Ser221_Pro222insTer)	WAS		X-linked thrombocytopenia with normal platelets||Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Nov 25, 2018)	criteria provided, single submitter	VCV000641614	X	48545268 - 48545272	X	48686879 - 48686883	641614	650083		NC_000023.11:48686878:CCTAGCC:CC
NC_000023.10:g.(?_31676087)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000641556	X	31676087 - 31986651	X	31657970 - 31968534	641556	653748		
NM_000276.4(OCRL):c.2464C>T (p.Arg822Ter)	OCRL	R814*, R822*, R823*	Lowe syndrome|	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000641377	X	128722985	X	129589008	641377	649667		NC_000023.11:129589007:C:T
NC_000023.10:g.(?_31747738)_(31792319_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000640999	X	31747738 - 31792319	X	31729621 - 31774202	640999	653328		
NC_000023.10:g.(?_31613687)_(31792319_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000640997	X	31613687 - 31792319	X	31595570 - 31774202	640997	653745		
NC_000022.10:g.(?_29999978)_(30077600_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000640993	22	29999978 - 30077600	22	29603989 - 29681611	640993	653696		
NC_000023.10:g.(?_31897527)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000640987	X	31897527 - 31986641	X	31879410 - 31968524	640987	653339		
NC_000023.10:g.(?_76944291)_(76972740_?)del	ATRX			Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000640984	X	76944291 - 76972740			640984	653630		
NM_000152.5(GAA):c.1798C>T (p.Arg600Cys)	GAA	R600C	Glycogen storage disease, type II	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000640911	17	78086420	17	80112621	640911	646900		NC_000017.11:80112620:C:T
NM_001167.3(XIAP):c.955C>T (p.Gln319Ter)	XIAP	Q319*	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000640819	X	123022546	X	123888696	640819	649662		NC_000023.11:123888695:C:T
NM_016418.5(NF2):c.1003G>T (p.Glu335Ter)	NF2	E252*, E293*, E294*, E335*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000640644	22	30067818	22	29671829	640644	649351		NC_000022.11:29671828:G:T
NC_000022.10:g.(?_19743473)_(19747220_?)del	TBX1		DiGeorge sequence	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000640457	22	19743473 - 19747220	22	19755950 - 19759697	640457	653267		
NC_000023.10:g.(?_31947703)_(31986641_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000640446	X	31947703 - 31986641	X	31929586 - 31968524	640446	653756		
NM_004006.2(DMD):c.4433T>G (p.Leu1478Ter)	DMD	L1355*, L134*, L137*, L1470*, L1474*, L1478*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000640379	X	32407703	X	32389586	640379	649986		NC_000023.11:32389585:A:C
NM_000527.5(LDLR):c.1023del (p.Asp342fs)	LDLR	D215fs, D342fs, D174fs, D301fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000640361	19	11221407	19	11110731	640361	647619		NC_000019.10:11110730:CCCC:CCC
NM_000033.4(ABCD1):c.1101_1108dup (p.Leu370fs)	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000640330	X	153001584 - 153001585	X	153736130 - 153736131	640330	649789		NC_000023.11:153736130:GGCAGCCT:GGCAGCCTGGCAGCCT
NM_004006.2(DMD):c.7066C>T (p.Gln2356Ter)	DMD	Q1012*, Q2348*, Q2356*, Q1015*, Q2352*, Q2233*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000640322	X	31893337	X	31875220	640322	649969		NC_000023.11:31875219:G:A
NM_000284.4(PDHA1):c.934_992dup (p.Ser331delinsArgValArgValThrLeuLeuCysPheSerArgThrGlyTrpTer)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000640193	X	19377067 - 19377068	X	19358949 - 19358950	640193	649927		
NM_004006.2(DMD):c.7454G>A (p.Trp2485Ter)	DMD	W2481*, W2485*, W25*, W2362*, W2477*, W1141*, W1144*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000640083	X	31792165	X	31774048	640083	649966		NC_000023.11:31774047:C:T
NM_014297.5(ETHE1):c.295C>T (p.Gln99Ter)	ETHE1	Q88*, Q99*	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000640004	19	44030433	19	43526281	640004	648172		NC_000019.10:43526280:G:A
NM_001943.5(DSG2):c.871dup (p.Thr291fs)	DSG2		Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000639905	18	29104707 - 29104708	18	31524744 - 31524745	639905	647167		NC_000018.10:31524744:A:AA
NC_000023.10:g.(?_135736512)_(135736609_?)del	CD40LG			Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000639868	X	135736512 - 135736609	X	136654353 - 136654450	639868	653378		
NC_000023.10:g.(?_31838082)_(31950354_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000639861	X	31838082 - 31950354	X	31819965 - 31932237	639861	653334		
NC_000019.9:g.(?_11227525)_(11231284_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000639860	19	11227525 - 11231284	19	11116849 - 11120608	639860	653561		
NM_004013.2(DMD):c.-333_-324del	DMD	Q2346fs, Q2350fs, Q1006fs, Q1009fs, Q2227fs, Q2342fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000639718	X	31893346 - 31893355	X	31875229 - 31875238	639718	649970		NC_000023.11:31875228:TTTCCAACTG:
NM_144612.6(LOXHD1):c.4921del (p.Ala1641fs)	LOXHD1	A1641fs, A530fs, A434fs	not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000639704	18	44102228	18	46522265	639704	647279		NC_000018.10:46522264:C:
NM_001008537.3(NEXMIF):c.507_511del (p.Asp169fs)	NEXMIF	D169fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000639644	X	73963881 - 73963885	X	74744046 - 74744050	639644	650225		NC_000023.11:74744045:TTAGAT:T
NM_001184880.2(PCDH19):c.132del (p.Asp45fs)	PCDH19	D45fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000639643	X	99663464	X	100408466	639643	649587		NC_000023.11:100408465:TTT:TT
NM_001848.2(COL6A1):c.878G>A (p.Gly293Glu)	COL6A1	G293E	Bethlem myopathy 1	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000639559	21	47409541	21	45989627	639559	649076		NC_000021.9:45989626:G:A
NM_004006.2(DMD):c.7400T>A (p.Leu2467Ter)	DMD	L2344*, L1123*, L2467*, L1126*, L2459*, L2463*, L7*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000639544	X	31792219	X	31774102	639544	649967		NC_000023.11:31774101:A:T
NM_000023.4(SGCA):c.233_234delinsGA (p.Tyr78Ter)	SGCA		Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000639468	17	48245018 - 48245019	17	50167657 - 50167658	639468	646177		NC_000017.11:50167656:AC:GA
NM_001008537.3(NEXMIF):c.842_845TGTC[1] (p.Val283fs)	NEXMIF		not provided	Pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000639428	X	73963543 - 73963546	X	74743708 - 74743711	639428	650224		NC_000023.11:74743707:GACAGACAG:GACAG
NC_000023.10:g.(?_31747738)_(31854946_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000639383	X	31747738 - 31854946	X	31729621 - 31836829	639383	653648		
NM_000211.5(ITGB2):c.786del (p.Thr263fs)	ITGB2	T194fs, T263fs		Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000639240	21	46320346	21	44900431	639240	649061		NC_000021.9:44900430:GG:G
NM_002501.4(NFIX):c.232A>T (p.Lys78Ter)	NFIX	K70*, K86*, K78*, K31*, K77*	Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000639180	19	13136039	19	13025225	639180	647721		NC_000019.10:13025224:A:T
NM_001123385.2(BCOR):c.3244dup (p.Tyr1082fs)	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000639148	X	39923846 - 39923847	X	40064593 - 40064594	639148	650044		NC_000023.11:40064593:A:AA
NM_001111125.3(IQSEC2):c.1186G>T (p.Glu396Ter)	IQSEC2	E396*, E191*	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000639042	X	53283927	X	53254745	639042	650119		NC_000023.11:53254744:C:A
NM_000109.4(DMD):c.353dup (p.Asn118fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000639041	X	32834737 - 32834738	X	32816620 - 32816621	639041	650022		NC_000023.11:32816620:TTTTT:TTTTTT
NM_000116.5(TAZ):c.370G>T (p.Gly124Ter)	TAZ	G142*, G124*	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000638931	X	153641904	X	154413567	638931	649885		NC_000023.11:154413566:G:T
NM_000276.4(OCRL):c.674_675AT[1] (p.Ile226fs)	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000638866	X	128692930 - 128692931	X	129558953 - 129558954	638866	649663		NC_000023.11:129558952:ATAT:AT
NM_003620.4(PPM1D):c.1259dup (p.Ser421fs)	PPM1D		Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Feb 5, 2019)	no assertion criteria provided	VCV000638685	17	58734199 - 58734200	17	60656838 - 60656839	638685	626462		NC_000017.11:60656838:AA:AAA
NM_000215.3(JAK3):c.1688_1696del (p.Lys563_Cys565del)	JAK3		NK-cell enteropathy	Pathogenic(Last reviewed: Jul 31, 2019)	no assertion criteria provided	VCV000638620	19	17948746 - 17948754	19	17837937 - 17837945	638620	626403		NC_000019.10:17837936:TGCAGTTCTTG:TG
NM_004006.2(DMD):c.9974+175T>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000638586	X	31200680	X	31182563	638586	626382		NC_000023.11:31182562:A:T
NM_002816.5(PSMD12):c.1033G>T (p.Glu345Ter)	PSMD12	E345*, E325*, E286*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000638584	17	65340772	17	67344656	638584	626376		NC_000017.11:67344655:C:A
NC_000023.11:g.48681722_48688043inv	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Feb 20, 2015)	no assertion criteria provided	VCV000638576			X	48681722 - 48688043	638576	626360		
NM_000377.2(WAS):c.735-2A>G	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Mar 25, 2013)	no assertion criteria provided	VCV000638575	X	48546441	X	48688052	638575	626361		NC_000023.11:48688051:A:G
NM_000377.2(WAS):c.1337_1338+9del	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Sep 23, 2015)	no assertion criteria provided	VCV000638574	X	48547451 - 48547461	X	48689062 - 48689072	638574	626363		NC_000023.11:48689061:ACAAGGTGAGGACA:ACA
NM_000377.2(WAS):c.1315_1453+204del	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Feb 15, 2012)	no assertion criteria provided	VCV000638573	X	48547432 - 48548027	X	48689043 - 48689638	638573	626362		
NM_006796.2(AFG3L2):c.1164+1G>A	AFG3L2			Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638488	18	12356692	18	12356693	638488	626320		NC_000018.10:12356692:C:T
NM_003688.3(CASK):c.824G>A (p.Trp275Ter)	CASK	W275*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638400	X	41519699	X	41660446	638400	626295		NC_000023.11:41660445:C:T
NM_000891.2(KCNJ2):c.1177G>T (p.Gly393Ter)	KCNJ2	G393*	Andersen Tawil syndrome	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638351	17	68172357	17	70176216	638351	626260		NC_000017.11:70176215:G:T
NM_021946.4(BCORL1):c.95C>T (p.Pro32Leu)	BCORL1	P32L	SHUKLA-VERNON SYNDROME	Pathogenic(Last reviewed: Jul 25, 2019)	no assertion criteria provided	VCV000638170	X	129146562	X	130012586	638170	625992		NC_000023.11:130012585:C:T
NM_021946.4(BCORL1):c.2345T>A (p.Val782Glu)	BCORL1	V782E	SHUKLA-VERNON SYNDROME	Pathogenic(Last reviewed: Jul 25, 2019)	no assertion criteria provided	VCV000638168	X	129149093	X	130015117	638168	625990		NC_000023.11:130015116:T:A
NM_001321120.2(TBX4):c.402G>A (p.Trp134Ter)	TBX4	W134*	Hypoplastic left heart syndrome|Hydronephrosis|Pulmonary hypoplasia|Aplasia/hypoplasia involving bones of the lower limbs|Absence of the sacrum|Hydroureter	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000638159	17	59544871	17	61467510	638159	625980		NC_000017.11:61467509:G:A
NM_000152.5(GAA):c.1538A>G (p.Asp513Gly)	GAA	D513G	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jul 10, 2019)	no assertion criteria provided	VCV000638014	17	78084626	17	80110827	638014	625835		NC_000017.11:80110826:A:G
NM_001356.4(DDX3X):c.1171-1G>C	DDX3X		Mental retardation, X-linked 102	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000638013	X	41204656	X	41345403	638013	625834		NC_000023.11:41345402:G:C
NM_000068.4(CACNA1A):c.2816_2826dup (p.Ser943fs)	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000637965	19	13409632 - 13409633	19	13298818 - 13298819	637965	625824		NC_000019.10:13298818:GCCCCCCTGCCG:GCCCCCCTGCCGCCCCCCTGCCG
NM_000152.5(GAA):c.1226_1227insG (p.Asp409fs)	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Jul 10, 2019)	no assertion criteria provided	VCV000637962	17	78082527 - 78082528	17	80108728 - 80108729	637962	625783		NC_000017.11:80108728::G
NM_000152.5(GAA):c.1895T>G (p.Leu632Arg)	GAA	L632R	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jul 10, 2019)	no assertion criteria provided	VCV000637961	17	78086681	17	80112882	637961	625782		NC_000017.11:80112881:T:G
NM_000152.5(GAA):c.876C>G (p.Tyr292Ter)	GAA	Y292*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jul 10, 2019)	no assertion criteria provided	VCV000637958	17	78081616	17	80107817	637958	625779		NC_000017.11:80107816:C:G
NM_000166.6(GJB1):c.191G>A (p.Cys64Tyr)	GJB1	C64Y	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000637608	X	70443748	X	71223898	637608	625522		NC_000023.11:71223897:G:A
NM_000166.6(GJB1):c.68T>C (p.Val23Ala)	GJB1	V23A	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000637585	X	70443625	X	71223775	637585	625474		NC_000023.11:71223774:T:C
NM_000166.6(GJB1):c.120_121AG[2] (p.Ser42fs)	GJB1		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000637569	X	70443677 - 70443678	X	71223827 - 71223828	637569	625500		NC_000023.11:71223826:AGAGAG:AGAG
NM_000166.6(GJB1):c.281A>G (p.His94Arg)	GJB1	H94R	Charcot-Marie-Tooth disease|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000637565	X	70443838	X	71223988	637565	625569		NC_000023.11:71223987:A:G
NM_000166.6(GJB1):c.238C>A (p.Gln80Lys)	GJB1	Q80K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000637563	X	70443795	X	71223945	637563	625541		NC_000023.11:71223944:C:A
NM_020956.2(PRX):c.*2069C>T	PRX	Q622*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000637509	19	40902395	19	40396488	637509	625424		NC_000019.10:40396487:G:A
NM_020956.2(PRX):c.*1295C>T	PRX	R364*	Charcot-Marie-Tooth disease, demyelinating, type 4F|Charcot-Marie-Tooth disease	Pathogenic	criteria provided, single submitter	VCV000637398	19	40903169	19	40397262	637398	625428		NC_000019.10:40397261:G:A
NM_020956.2(PRX):c.124_125dup (p.Phe43fs)	PRX		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637392	19	40909671 - 40909672	19	40403764 - 40403765	637392	625439		NC_000019.10:40403764:AT:ATAT
NM_181882.3(PRX):c.1173del (p.Arg392fs)	PRX	R392fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637391	19	40903086	19	40397179	637391	625427		NC_000019.10:40397178:AA:A
NM_000166.6(GJB1):c.785_786del (p.Ile262fs)	GJB1	I262fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637234	X	70444341 - 70444342	X	71224491 - 71224492	637234	625707		NC_000023.11:71224490:ATA:A
NM_000166.6(GJB1):c.89T>C (p.Ile30Thr)	GJB1	I30T	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000637215	X	70443646	X	71223796	637215	625484		NC_000023.11:71223795:T:C
NM_000166.6(GJB1):c.119C>T (p.Ala40Val)	GJB1	A40V	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000637200	X	70443676	X	71223826	637200	625499		NC_000023.11:71223825:C:T
NM_000166.6(GJB1):c.844dup (p.Ala282fs)	GJB1		Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637167	X	70444399 - 70444400	X	71224549 - 71224550	637167	625714		NC_000023.11:71224549:GG:GGG
NM_000166.6(GJB1):c.822del (p.Glu275fs)	GJB1	E275fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637166	X	70444379	X	71224529	637166	625711		NC_000023.11:71224528:T:
NM_000166.6(GJB1):c.800del (p.Pro267fs)	GJB1	P267fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637165	X	70444355	X	71224505	637165	625710		NC_000023.11:71224504:CCC:CC
NM_000166.6(GJB1):c.629_632del (p.Val210fs)	GJB1	V210fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637163	X	70444186 - 70444189	X	71224336 - 71224339	637163	625691		NC_000023.11:71224335:TGTA:
NM_000166.6(GJB1):c.576del (p.Phe193fs)	GJB1	F193fs	Charcot-Marie-Tooth disease	Pathogenic	no assertion criteria provided	VCV000637162	X	70444133	X	71224283	637162	625672		NC_000023.11:71224282:C:
NM_000166.6(GJB1):c.238C>T (p.Gln80Ter)	GJB1	Q80*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000637135	X	70443795	X	71223945	637135	625542		NC_000023.11:71223944:C:T
NM_004586.3(RPS6KA3):c.932T>G (p.Leu311Ter)	RPS6KA3	L311*	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000637053	X	20195116	X	20176998	637053	624874		NC_000023.11:20176997:A:C
NM_021140.3(KDM6A):c.2646_2647dup (p.Pro883fs)	KDM6A		Kabuki syndrome 2	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000637050	X	44929545 - 44929546	X	45070300 - 45070301	637050	624875		NC_000023.11:45070300:AC:ACAC
NM_001304815.1(CIC):c.3159_3160AG[2] (p.Glu1054_Ser1055insTer)	CIC		Intellectual disability, autosomal dominant 45	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000637047	19	42791372 - 42791373	19	42287220 - 42287221	637047	624868		NC_000019.10:42287219:AGAGAG:AGAG
NM_033380.3(COL4A5):c.4377del (p.Gly1460fs)	COL4A5	G1460fs, G1454fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000637042	X	107930773	X	108687543	637042	624871		NC_000023.11:108687542:T:
NM_002055.5(GFAP):c.242C>A (p.Ala81Asp)	GFAP	A81D	Alexander Disease	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000637027	17	42992613	17	44915245	637027	624864		NC_000017.11:44915244:G:T
NM_000211.5(ITGB2):c.562C>T (p.Arg188Ter)	ITGB2	R188*, R119*	not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000636972	21	46321586	21	44901671	636972	624694		NC_000021.9:44901670:G:A
NM_005535.3(IL12RB1):c.264C>G (p.Tyr88Ter)	IL12RB1	Y88*, Y128*	not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000636666	19	18191787	19	18080977	636666	624656		NC_000019.10:18080976:G:C
NM_000383.4(AIRE):c.21_43dup (p.Arg15delinsHisAlaGlyPheTer)	AIRE		Polyglandular autoimmune syndrome, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000636457	21	45705909 - 45705910	21	44286026 - 44286027	636457	624691		NC_000021.9:44286026:ACGCCGGCTTCTGAGGCTGCACC:ACGCCGGCTTCTGAGGCTGCACCACGCCGGCTTCTGAGGCTGCACC
NM_006397.3(RNASEH2A):c.589del (p.Glu197fs)	RNASEH2A	E197fs	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000636354	19	12921169	19	12810355	636354	624651		NC_000019.10:12810354:GG:G
NM_006785.4(MALT1):c.571C>T (p.Arg191Ter)	MALT1	R191*	Immunodeficiency 12|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000636343	18	56367745	18	58700513	636343	624647		NC_000018.10:58700512:C:T
NM_003681.5(PDXK):c.659G>A (p.Arg220Gln)	PDXK	R220Q, R180Q	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000636265	21	45173500	21	43753619	636265	624077		NC_000021.9:43753618:G:A
NM_003681.5(PDXK):c.682G>A (p.Ala228Thr)	PDXK	A228T, A188T	NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000636264	21	45173523	21	43753642	636264	624076		NC_000021.9:43753641:G:A
NM_152424.4(AMER1):c.565C>T (p.Gln189Ter)	AMER1	Q189*	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000636242	X	63412602	X	64192722	636242	624063		NC_000023.11:64192721:G:A
NM_015629.3(PRPF31):c.(238+1_239-1)_(420+1_421-1)dup	PRPF31		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636138					636138	624023		
NM_000328.2(RPGR):c.*644del	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636111	X	38128235	X	38268982	636111	623940		NC_000023.11:38268981:AA:A
NM_000328.3(RPGR):c.28+1G>C	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636110	X	38186592	X	38327339	636110	623943		NC_000023.11:38327338:C:G
NM_000328.3(RPGR):c.2426_2427del (p.Arg808_Ser809insTer)	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636109	X	38128900 - 38128901	X	38269647 - 38269648	636109	623908		NC_000023.11:38269646:TG:
NM_000328.3(RPGR):c.2405_2406del (p.Pro802fs)	RPGR	P690fs, P691fs, P701fs, P740fs, P801fs, P802fs, P629fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636108	X	38128921 - 38128922	X	38269668 - 38269669	636108	623909		NC_000023.11:38269667:TG:
NM_000328.3(RPGR):c.1234C>T (p.Arg412Ter)	RPGR	R412*, R422*, R411*	Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000636102	X	38158220	X	38298967	636102	623913		NC_000023.11:38298966:G:A
NM_015629.4(PRPF31):c.997del (p.Glu333fs)	PRPF31	E333fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000636072	19	54631498	19	54128123	636072	623902		NC_000019.10:54128122:GG:G
NC_000023.10:g.85296959_85303375inv	CHM		Choroideremia	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635965	X	85296959 - 85303375			635965	623779		
NM_000878.5(IL2RB):c.656_664CCTGGAGCC[1] (p.Pro222_Ser224del)	IL2RB		IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000635832	22	37532298 - 37532306	22	37136258 - 37136266	635832	623647		NC_000022.11:37136257:GGCTCCAGGGGCTCCAGG:GGCTCCAGG
IL2RB, GLN96TER	IL2RB	Q96*	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635831					635831	623646		
IL2RB, SER40LEU	IL2RB	S40L	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635830					635830	623645		
IL2RB, LEU77PRO	IL2RB	L77P	IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY	Pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635829					635829	623644		
NM_000033.4(ABCD1):c.1628del (p.Pro543fs)	ABCD1	P543fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000635562	X	153005683	X	153740229	635562	623388		NC_000023.11:153740228:CCC:CC
NM_001077488.4(GNAS):c.280C>T (p.Gln94Ter)	GNAS	Q93*, Q94*, Q34*, Q736*, Q78*, Q79*	Pseudohypoparathyroidism	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000635558	20	57478605	20	58903550	635558	623387		NC_000020.11:58903549:C:T
NM_033380.3(COL4A5):c.3319G>T (p.Gly1107Ter)	COL4A5	G1107*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 11, 2019)	no assertion criteria provided	VCV000635552	X	107898633	X	108655403	635552	623361		NC_000023.11:108655402:G:T
NM_000390.4(CHM):c.660del (p.Ile221fs)	CHM	I73fs, I221fs	Choroideremia	Pathogenic(Last reviewed: Mar 11, 2019)	no assertion criteria provided	VCV000635551	X	85218712	X	85963707	635551	623370		NC_000023.11:85963706:AA:A
NM_033380.3(COL4A5):c.3482G>A (p.Gly1161Glu)	COL4A5	G1161E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 27, 2018)	no assertion criteria provided	VCV000635536	X	107909753	X	108666523	635536	623364		NC_000023.11:108666522:G:A
NM_033380.3(COL4A5):c.3481G>C (p.Gly1161Arg)	COL4A5	G1161R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 21, 2018)	no assertion criteria provided	VCV000635512	X	107909752	X	108666522	635512	623363		NC_000023.11:108666521:G:C
NM_033380.3(COL4A5):c.3475C>T (p.Gln1159Ter)	COL4A5	Q1159*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 9, 2018)	no assertion criteria provided	VCV000635495	X	107909746	X	108666516	635495	623362		NC_000023.11:108666515:C:T
NM_005629.4(SLC6A8):c.626_627del (p.Pro209fs)	SLC6A8	P94fs, P209fs	Creatine transporter deficiency	Pathogenic(Last reviewed: Dec 12, 2018)	no assertion criteria provided	VCV000635461	X	152956990 - 152956991	X	153691535 - 153691536	635461	623366		NC_000023.11:153691534:CT:
NM_004586.3(RPS6KA3):c.2196del (p.Ile735fs)	RPS6KA3	I735fs	Coffin-Lowry syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635336	X	20173543	X	20155425	635336	623170		NC_000023.11:20155424:AA:A
NM_001278116.2(L1CAM):c.749del (p.Ser250fs)	L1CAM	S245fs, S250fs	L1 syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635332	X	153135900	X	153870445	635332	623169		NC_000023.11:153870444:C:
NM_001278116.2(L1CAM):c.3166+1G>A	L1CAM		L1 syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635331	X	153130039	X	153864584	635331	623180		NC_000023.11:153864583:C:T
NM_001201457.1(TEX14):c.254G>T (p.Arg85Leu)	TEX14	R85L	SPERMATOGENIC FAILURE 23	Pathogenic(Last reviewed: Jun 28, 2019)	no assertion criteria provided	VCV000635288	17	56700371	17	58623010	635288	623122		NC_000017.11:58623009:C:A
NM_021102.4(SPINT2):c.447G>A (p.Trp149Ter)	SPINT2	W149*, W92*	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Jun 27, 2019)	no assertion criteria provided	VCV000635284	19	38780814	19	38290174	635284	623118		NC_000019.10:38290173:G:A
NM_000109.4(DMD):c.1694del (p.Ala565fs)	DMD	A450fs, A573fs, A569fs, A565fs	not provided	Pathogenic(Last reviewed: Aug 8, 2011)	no assertion criteria provided	VCV000635239	X	32591741	X	32573624	635239	623080	rs1569229528	NC_000023.11:32573623:G:
NM_000154.2(GALK1):c.678del (p.Asn226fs)	GALK1	N226fs	Galactokinase deficiency with cataracts	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000635166	17	73758900	17	75762819	635166	623001	rs1568395061	NC_000017.11:75762818:A:
NM_005660.3(SLC35A2):c.630_631TC[2] (p.Ser212fs)	SLC35A2		SLC35A2-CDG	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000635117	X	48762551 - 48762552	X	48905274 - 48905275	635117	622952		NC_000023.11:48905273:GAGAGA:GAGA
NM_033380.3(COL4A5):c.1147G>C (p.Gly383Arg)	COL4A5	G383R	Alport syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000635111	X	107829959	X	108586729	635111	622948	rs1569492161	NC_000023.11:108586728:G:C
NM_004187.5(KDM5C):c.807del (p.Thr270fs)	KDM5C	T203fs, T269fs, T270fs	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635109	X	53245133	X	53215951	635109	622946	rs1569278313	NC_000023.11:53215950:GGGGGG:GGGGG
NM_030632.3(ASXL3):c.1847_1848AG[1] (p.Ser617fs)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000635047	18	31319214 - 31319215	18	33739250 - 33739251	635047	622920		NC_000018.10:33739249:GAGAG:GAG
NM_014927.5(CNKSR2):c.1734G>A (p.Trp578Ter)	CNKSR2	W578*, W499*, W529*, W548*	Intellectual disability, X-linked, syndromic, Houge type	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634608	X	21609216	X	21591098	634608	622491	rs1569261319	NC_000023.11:21591097:G:A
NM_000709.4(BCKDHA):c.1069C>T (p.Gln357Ter)	BCKDHA	Q357*, Q356*	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634552	19	41928976	19	41423071	634552	622463	rs762199542	NC_000019.10:41423070:C:T
NM_000199.5(SGSH):c.89-2A>G	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634541	17	78190993	17	80217194	634541	622512	rs1369704445	NC_000017.11:80217193:T:C
NM_020956.2(PRX):c.*1184del	PRX	D327fs	Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634532	19	40903280	19	40397373	634532	622461	rs1568708792	NC_000019.10:40397372:CC:C
NM_033380.3(COL4A5):c.2509+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000633835	X	107858256	X	108615026	633835	622267	rs1569497030	NC_000023.11:108615025:T:G
NM_000489.5(ATRX):c.7205del (p.Ile2402fs)	ATRX	I2402fs, I2364fs	Global developmental delay	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000633696	X	76764103	X	77508625	633696	622128	rs1569513017	NC_000023.11:77508624:A:
NM_004975.4(KCNB1):c.1747C>T (p.Arg583Ter)	KCNB1	R583*	Epileptic encephalopathy, early infantile, 26|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633637	20	47990350	20	49373813	633637	622051	rs781663444	NC_000020.11:49373812:G:A
NM_004975.4(KCNB1):c.1248C>A (p.Phe416Leu)	KCNB1	F416L	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633635	20	47990849	20	49374312	633635	622053	rs1569017015	NC_000020.11:49374311:G:T
NM_004975.4(KCNB1):c.1201G>A (p.Gly401Arg)	KCNB1	G401R	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633633	20	47990896	20	49374359	633633	622055	rs1569017045	NC_000020.11:49374358:C:T
NM_004975.4(KCNB1):c.1139A>G (p.Tyr380Cys)	KCNB1	Y380C	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633630	20	47990958	20	49374421	633630	622058	rs1569017123	NC_000020.11:49374420:T:C
NM_004975.4(KCNB1):c.1132G>C (p.Val378Leu)	KCNB1	V378L	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633629	20	47990965	20	49374428	633629	622059	rs1569017143	NC_000020.11:49374427:C:G
NM_004975.4(KCNB1):c.1130C>A (p.Thr377Asn)	KCNB1	T377N	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633628	20	47990967	20	49374430	633628	622060	rs1569017148	NC_000020.11:49374429:G:T
NM_004975.4(KCNB1):c.1115C>T (p.Thr372Ile)	KCNB1	T372I	Intellectual disability	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633626	20	47990982	20	49374445	633626	622061	rs1569017160	NC_000020.11:49374444:G:A
NM_004975.4(KCNB1):c.1045G>T (p.Val349Phe)	KCNB1	V349F	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633624	20	47991052	20	49374515	633624	622064	rs1569017205	NC_000020.11:49374514:C:A
NM_004975.4(KCNB1):c.984C>G (p.Tyr328Ter)	KCNB1	Y328*	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633623	20	47991113	20	49374576	633623	622065	rs1179351306	NC_000020.11:49374575:G:C
NM_004975.4(KCNB1):c.857del (p.Val286fs)	KCNB1	V286fs	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633621	20	47991240	20	49374703	633621	622067	rs1569017337	NC_000020.11:49374702:A:
NM_004975.4(KCNB1):c.629C>G (p.Thr210Arg)	KCNB1	T210R	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633620	20	47991468	20	49374931	633620	622068	rs1555889162	NC_000020.11:49374930:G:C
NM_001321120.2(TBX4):c.355dup (p.Ile119fs)	TBX4			Pathogenic(Last reviewed: Dec 27, 2019)	no assertion criteria provided	VCV000633610	17	59543252 - 59543253	17	61465891 - 61465892	633610	622042	rs1569036773	NC_000017.11:61465891:A:AA
NM_001172646.1(PLCB4):c.1924G>T (p.Asp642Tyr)	PLCB4	D630Y, D642Y	Ocular melanocytosis|Uveal melanoma	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000633597	20	9389753	20	9409106	633597	622029	rs1568763104	NC_000020.11:9409105:G:T
NM_005629.4(SLC6A8):c.940_944TTCTT[1] (p.Phe315fs)	SLC6A8		not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000633583	X	152958743 - 152958747	X	153693288 - 153693292	633583	621994		NC_000023.11:153693287:TTTTCTTTTCTT:TTTTCTT
NM_001008537.3(NEXMIF):c.2984C>A (p.Ser995Ter)	NEXMIF	S995*	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000633537	X	73961408	X	74741573	633537	622005	rs1569335235	NC_000023.11:74741572:G:T
NM_001304815.1(CIC):c.2795-3881_5255del	CIC		not provided	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000633530	19	42787042 - 42795448	19	42282890 - 42291296	633530	622011		
NM_004187.4(KDM5C):c.1243-2A>G	KDM5C		not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000633505	X	53240839	X	53211657	633505	622015	rs1569274606	NC_000023.11:53211656:T:C
NM_000252.2(MTM1):c.593A>C (p.Tyr198Ser)	MTM1	Y198S	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Sep 27, 2010)	no assertion criteria provided	VCV000633473	X	149809806	X	150641333	633473	621917	rs1569565497	NC_000023.11:150641332:A:C
NM_000252.2(MTM1):c.1053+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Nov 29, 2007)	no assertion criteria provided	VCV000633472	X	149818375	X	150649902	633472	621918	rs587783751	NC_000023.11:150649901:G:A
NM_000252.2(MTM1):c.1381C>T (p.Gln461Ter)	MTM1	Q461*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Aug 2, 2007)	no assertion criteria provided	VCV000633470	X	149828871	X	150660398	633470	621920	rs782234944	NC_000023.11:150660397:C:T
NM_002351.4(SH2D1A):c.20A>G (p.Tyr7Cys)	SH2D1A	Y7C	X-Linked Lymphoproliferative Syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000633415	X	123480512	X	124346662	633415	621676	rs1569527111	NC_000023.11:124346661:A:G
NM_000528.4(MAN2B1):c.562C>T (p.Arg188Ter)	MAN2B1	R188*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	VCV000633292	19	12775674	19	12664860	633292	621629	rs1429239930	NC_000019.10:12664859:G:A
NM_000202.8(IDS):c.238C>T (p.Gln80Ter)	IDS	Q80*	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633269	X	148585689	X	149504159	633269	621680	rs1569560527	NC_000023.11:149504158:G:A
NM_000152.5(GAA):c.148_859-11del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000633223	17	78078528 - 78081583	17	80104729 - 80107784	633223	621866		
NM_000071.2(CBS):c.526G>A (p.Glu176Lys)	CBS	E176K, E71K	Homocystinuria	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000633144	21	44485731	21	43065621	633144	621647	rs762065361	NC_000021.9:43065620:C:T
NM_004646.3(NPHS1):c.2479C>T (p.Arg827Ter)	NPHS1	R827*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000632927	19	36333308	19	35842406	632927	621631	rs140018064	NC_000019.10:35842405:G:A
NM_000152.5(GAA):c.1905C>A (p.Asn635Lys)	GAA	N635K	Glycogen storage disease, type II	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000632823	17	78086691	17	80112892	632823	621607	rs1414146587	NC_000017.11:80112891:C:A
NM_000152.3(GAA):c.1195-19_2190-17del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000632821	17	78082477 - 78090750	17	80108678 - 80116951	632821	621867		
NM_000071.2(CBS):c.209+1G>A	CBS		Homocystinuria	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000632738	21	44492094	21	43071984	632738	621874	rs751464024	NC_000021.9:43071983:C:T
NM_000061.2(BTK):c.1138C>T (p.Gln380Ter)	BTK	Q380*, Q414*	X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632732	X	100612536	X	101357548	632732	621657	rs1569292021	NC_000023.11:101357547:G:A
NM_000061.3(BTK):c.655del (p.Val219fs)	BTK	V219fs, V253fs	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000632731	X	100615677	X	101360689	632731	621658	rs1569292810	NC_000023.11:101360688:CC:C
NM_000061.2(BTK):c.588+1G>T	BTK		X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632729	X	100617160	X	101362172	632729	621875	rs1569293252	NC_000023.11:101362171:C:A
NM_001287344.1(BTK):c.278_280AGA[1] (p.Lys94del)	BTK		X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000632728	X	100629583 - 100629585	X	101374595 - 101374597	632728	621660		NC_000023.11:101374594:TCTTCT:TCT
NM_015338.5(ASXL1):c.4060G>T (p.Glu1354Ter)	ASXL1	E1354*, E1293*	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000632646	20	31024575	20	32436772	632646	621640	rs1569339085	NC_000020.11:32436771:G:T
NM_001356.4(DDX3X):c.1439G>C (p.Arg480Thr)	DDX3X	R480T, R294T, R464T	Cerebellar vermis hypoplasia|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632603	X	41205605	X	41346352	632603	621036	rs1569240005	NC_000023.11:41346351:G:C
NM_003688.3(CASK):c.2120dup (p.Tyr708fs)	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632602	X	41401978 - 41401979	X	41542725 - 41542726	632602	621037	rs1569295677	NC_000023.11:41542725:T:TT
NM_003688.3(CASK):c.533-2A>G	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632601	X	41524707	X	41665454	632601	621041	rs1569380062	NC_000023.11:41665453:T:C
NM_001042545.2(LTBP4):c.1828C>T (p.Gln610Ter)	LTBP4	Q610*, Q640*, Q677*	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000632581	19	41117075	19	40611169	632581	621015	rs1568406407	NC_000019.10:40611168:C:T
NM_000782.5(CYP24A1):c.443T>C (p.Leu148Pro)	CYP24A1	L148P	Hypercalcemia, infantile, 1	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000631878	20	52789454	20	54172915	631878	620664	rs139763321	NC_000020.11:54172914:A:G
NM_014270.5(SLC7A9):c.671C>T (p.Ala224Val)	SLC7A9	A224V	Cystinuria	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000631809	19	33353057	19	32862151	631809	620632	rs140873167	NC_000019.10:32862150:G:A
NM_000140.4(FECH):c.820G>A (p.Asp274Asn)	FECH	D274N, D280N	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000631802	18	55222169	18	57554937	631802	620623	rs146269992	NC_000018.10:57554936:C:T
NM_001291412.2(SON):c.244+3236del	SON	K128fs	ZTTK syndrome|not provided	Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000631519	21	34921914	21	33549608	631519	619906	rs778418096	NC_000021.9:33549607:AAAAAAAA:AAAAAAA
NM_000455.5(STK11):c.152dup (p.Met51fs)	STK11	M51Ifs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631515	19	1207063 - 1207064	19	1207064 - 1207065	631515	619902	rs1568690161	NC_000019.10:1207064:T:TT
NM_005650.3(TCF20):c.1520del (p.Pro507fs)	TCF20	P507fs	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631508	22	42609792	22	42213786	631508	619895	rs1569151886	NC_000022.11:42213785:GG:G
NM_005650.3(TCF20):c.594dup (p.Gly199fs)	TCF20		DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631507	22	42610717 - 42610718	22	42214711 - 42214712	631507	619894	rs1569153986	NC_000022.11:42214711:A:AA
NM_005650.3(TCF20):c.310_313dup (p.Gln105fs)	TCF20		DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631506	22	42610998 - 42610999	22	42214992 - 42214993	631506	619893	rs1569154591	NC_000022.11:42214992:GTGGG:GTGGGTGGG
NM_005650.3(TCF20):c.3837del (p.Asp1280fs)	TCF20	D1280fs	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631505	22	42607475	22	42211469	631505	619892	rs1569146455	NC_000022.11:42211468:TT:T
NM_005650.3(TCF20):c.955C>T (p.Gln319Ter)	TCF20	Q319*	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631504	22	42610357	22	42214351	631504	619891	rs1569153066	NC_000022.11:42214350:G:A
NM_005650.3(TCF20):c.3518del (p.Lys1173fs)	TCF20	K1173fs	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES	Pathogenic(Last reviewed: May 20, 2019)	no assertion criteria provided	VCV000631503	22	42607794	22	42211788	631503	619890	rs1569147202	NC_000022.11:42211787:TT:T
NM_000527.4(LDLR):c.922G>T (p.Glu308Ter)	LDLR	E308*, E140*, E267*, E181*	Familial hypercholesterolemia	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000631318	19	11218172	19	11107496	631318	618940	rs879254721	NC_000019.10:11107495:G:T
NM_001195803.2(LDLR):c.1606+150_1606+151del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000630543	19	11231056 - 11231057	19	11120380 - 11120381	630543	618955		NC_000019.10:11120379:GTGTG:GTG
NM_000527.4(LDLR):c.505_511del (p.Asn169fs)	LDLR	N169fs, N128fs	Familial hypercholesterolemia	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000629644	19	11216086 - 11216092	19	11105410 - 11105416	629644	618938	rs1568594903	NC_000019.10:11105409:CAACGACC:C
NM_016937.4(POLA1):c.328G>A (p.Gly110Arg)	POLA1	G110R, G116R	VAN ESCH-O''''DRISCOLL SYNDROME|X-linked intellectual disability, Van Esch type	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627636	X	24722586	X	24704469	627636	615988	rs1569271892	NC_000023.11:24704468:G:A
NM_016937.3(POLA1):c.445_507del (p.Lys149_Glu169del)	POLA1		VAN ESCH-O''''DRISCOLL SYNDROME|X-linked intellectual disability, Van Esch type	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627635	X	24733256 - 24733318	X	24715139 - 24715201	627635	615990	rs1569277866	
NM_016937.4(POLA1):c.507+1G>A	POLA1		VAN ESCH-O''''DRISCOLL SYNDROME|X-linked intellectual disability, Van Esch type	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627634	X	24733321	X	24715204	627634	615991	rs1569277899	NC_000023.11:24715203:G:A
NM_016937.4(POLA1):c.4142C>T (p.Pro1381Leu)	POLA1	P1381L, P1387L	VAN ESCH-O''''DRISCOLL SYNDROME|X-linked intellectual disability, Van Esch type	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627633	X	24906235	X	24888118	627633	615989	rs1569350993	NC_000023.11:24888117:C:T
NM_016937.4(POLA1):c.236T>G (p.Ile79Ser)	POLA1	I79S, I85S	VAN ESCH-O''''DRISCOLL SYNDROME|X-linked intellectual disability, Van Esch type	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627632	X	24721453	X	24703336	627632	615987	rs1569271378	NC_000023.11:24703335:T:G
NM_006359.3(SLC9A6):c.478_479AT[1] (p.Phe161fs)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000627623	X	135080315 - 135080316	X	135998156 - 135998157	627623	615978		NC_000023.11:135998155:ATAT:AT
NM_153609.3(TMPRSS6):c.2161C>T (p.Gln721Ter)	TMPRSS6	Q721*, Q712*, Q734*	Microcytic anemia	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000627580	22	37462982	22	37066942	627580	615947	rs775869554	NC_000022.11:37066941:G:A
NM_152513.4(MEI1):c.2206del (p.Val736fs)	MEI1	V736fs	HYDATIDIFORM MOLE, RECURRENT, 3	Pathogenic(Last reviewed: May 15, 2019)	no assertion criteria provided	VCV000627578	22	42159262	22	41763258	627578	615933	rs759915989	NC_000022.11:41763257:GG:G
NM_152513.4(MEI1):c.1196+1G>A	MEI1		HYDATIDIFORM MOLE, RECURRENT, 3	Pathogenic(Last reviewed: May 14, 2019)	no assertion criteria provided	VCV000627577	22	42128349	22	41732345	627577	615932	rs1569203272	NC_000022.11:41732344:G:A
NM_000284.4(PDHA1):c.225G>T (p.Glu75Asp)	PDHA1	E75D, E113D	Pyruvate dehydrogenase complex deficiency	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000627558	X	19368162	X	19350044	627558	615914	rs1569190079	NC_000023.11:19350043:G:T
NM_178526.5(SLC25A42):c.380+2T>A	SLC25A42		METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION	Pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000627557	19	19216538	19	19105729	627557	615912	rs1247424432	NC_000019.10:19105728:T:A
NM_173477.5(USH1G):c.1060G>T (p.Asp354Tyr)	USH1G	D354Y, D251Y	Usher syndrome, type 1G	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627491	17	72915871	17	74919776	627491	615827	rs1316299165	NC_000017.11:74919775:C:A
NM_001039141.3(TRIOBP):c.3524C>A (p.Ser1175Ter)	TRIOBP	S1175*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627486	22	38122087	22	37726080	627486	615833	rs1569042693	NC_000022.11:37726079:C:A
NM_001039141.3(TRIOBP):c.4291G>T (p.Glu1431Ter)	TRIOBP	E1431*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627485	22	38130634	22	37734627	627485	615834	rs1569046250	NC_000022.11:37734626:G:T
NM_024022.3(TMPRSS3):c.1048+1G>A	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627482	21	43800225	21	42380116	627482	615847	rs1429442821	NC_000021.9:42380115:C:T
NM_000307.5(POU3F4):c.170G>A (p.Trp57Ter)	POU3F4	W57*	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627470	X	82763502	X	83508494	627470	615835	rs1454033665	NC_000023.11:83508493:G:A
NM_133261.3(GIPC3):c.724G>T (p.Glu242Ter)	GIPC3	E242*	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000627446	19	3589847	19	3589849	627446	615828	rs1568278651	NC_000019.10:3589848:G:T
NM_031407.7(HUWE1):c.12188G>A (p.Arg4063Gln)	HUWE1	R4063Q	Mental retardation, X-linked, syndromic, Turner type	Pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000627417	X	53563578	X	53536617	627417	615772	rs1569399945	NC_000023.11:53536616:C:T
NM_002473.5(MYH9):c.99G>C (p.Trp33Cys)	MYH9	W33C	MYH9-related disorder	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627409	22	36745183	22	36349138	627409	615662		NC_000022.11:36349137:C:G
NM_000132.3(F8):c.6685C>T (p.Leu2229Phe)	F8	L2229F, L94F	Abnormality of coagulation	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627359	X	154090031	X	154861756	627359	615680		NC_000023.11:154861755:G:A
NM_000132.3(F8):c.6104T>C (p.Val2035Ala)	F8	V2035A	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627347	X	154130337	X	154902062	627347	615685		NC_000023.11:154902061:A:G
NM_000132.3(F8):c.6082G>A (p.Gly2028Arg)	F8	G2028R	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627346	X	154130359	X	154902084	627346	615686		NC_000023.11:154902083:C:T
NM_000132.3(F8):c.5918A>T (p.His1973Leu)	F8	H1973L	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627340	X	154132261	X	154903986	627340	615687		NC_000023.11:154903985:T:A
NM_000132.3(F8):c.1804C>G (p.Arg602Gly)	F8	R602G	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627259	X	154182266	X	154953991	627259	615699		NC_000023.11:154953990:G:C
NM_000132.3(F8):c.1621A>T (p.Thr541Ser)	F8	T541S	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627254	X	154185363	X	154957088	627254	615702		NC_000023.11:154957087:T:A
NM_000132.3(F8):c.1020A>C (p.Glu340Asp)	F8	E340D	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627191	X	154194952	X	154966677	627191	615707		NC_000023.11:154966676:T:G
NM_000132.3(F8):c.979C>G (p.Leu327Val)	F8	L327V	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627165	X	154197636	X	154969361	627165	615708		NC_000023.11:154969360:G:C
NM_000132.3(F8):c.6434T>G (p.Phe2145Cys)	F8	F2145C, F10C	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627109	X	154091498	X	154863223	627109	615684		NC_000023.11:154863222:A:C
NM_000132.3(F8):c.2043G>C (p.Met681Ile)	F8	M681I	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000627033	X	154176043	X	154947768	627033	615696		NC_000023.11:154947767:C:G
NM_000132.3(F8):c.1364T>G (p.Phe455Cys)	F8	F455C	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626992	X	154194324	X	154966049	626992	615703		NC_000023.11:154966048:A:C
NM_000132.3(F8):c.6686T>C (p.Leu2229Pro)	F8	L2229P, L94P	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626935	X	154090030	X	154861755	626935	615679		NC_000023.11:154861754:A:G
NM_000132.3(F8):c.6547A>G (p.Met2183Val)	F8	M2183V, M48V	Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000626933	X	154091385	X	154863110	626933	615682		NC_000023.11:154863109:T:C
NM_004595.5(SMS):c.908_911del (p.Met303fs)	SMS	M303fs, M250fs	Syndromic X-linked intellectual disability Snyder type	Pathogenic	criteria provided, single submitter	VCV000626916	X	22003302 - 22003305	X	21985184 - 21985187	626916	615269		NC_000023.11:21985183:AATGAA:AA
NM_000116.5(TAZ):c.688del (p.Arg230fs)	TAZ	R230fs, R234fs, R200fs, R186fs, R216fs	Cardiomyopathy	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000626857	X	153648588	X	154420249	626857	615183	rs1569552936	NC_000023.11:154420248:CCCCC:CCCC
NM_001448.3(GPC4):c.742del (p.Leu248fs)	GPC4	L248fs	Keipert syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	no assertion criteria provided	VCV000626361	X	132445421	X	133311393	626361	614693	rs1569341521	NC_000023.11:133311392:GGG:GG
NM_001448.3(GPC4):c.1518_1521dup (p.Pro508fs)	GPC4		Keipert syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	no assertion criteria provided	VCV000626360	X	132437044 - 132437045	X	133303016 - 133303017	626360	614692	rs1569339879	NC_000023.11:133303016:GCAC:GCACGCAC
ARX, ARG2085HIS	ARX	R2085H	Mental retardation, with or without seizures, ARX-related, X-linked	Pathogenic(Last reviewed: Jul 30, 1999)	no assertion criteria provided	VCV000626338					626338	614670		
NM_182978.4(GNAL):c.964C>T (p.Arg322Ter)	GNAL	R245*, R322*, R38*	Dystonia 25	Pathogenic(Last reviewed: Jul 13, 2018)	no assertion criteria provided	VCV000626333	18	11868595	18	11868596	626333	614664	rs1252185897	NC_000018.10:11868595:C:T
NM_182978.4(GNAL):c.505-5T>C	GNAL		Dystonia 25	Pathogenic(Last reviewed: Jul 13, 2018)	no assertion criteria provided	VCV000626332	18	11753820	18	11753821	626332	614663	rs766177601	NC_000018.10:11753820:T:C
NM_001039213.4(CEACAM16):c.37G>T (p.Ala13Ser)	CEACAM16	A13S	DEAFNESS, AUTOSOMAL RECESSIVE 113	Pathogenic(Last reviewed: May 1, 2019)	no assertion criteria provided	VCV000626323	19	45204763	19	44701493	626323	614655	rs1198256157	NC_000019.10:44701492:G:T
NM_001039213.4(CEACAM16):c.662-1G>C	CEACAM16		DEAFNESS, AUTOSOMAL RECESSIVE 113	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000626322	19	45208859	19	44705589	626322	614654	rs1568528171	NC_000019.10:44705588:G:C
NM_001242896.3(DEPDC5):c.1936dup (p.Ser646fs)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic	no assertion criteria provided	VCV000626285	22	32217552 - 32217553	22	31821566 - 31821567	626285	614608	rs1569012755	NC_000022.11:31821566:A:AA
NM_001083962.2(TCF4):c.1486+2T>G	TCF4		Pitt-Hopkins syndrome	Pathogenic	no assertion criteria provided	VCV000626271	18	52901777	18	55234546	626271	614614	rs1555721921	NC_000018.10:55234545:A:C
NM_020964.3(EPG5):c.895C>T (p.Arg299Ter)	EPG5	R299*	Vici syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000626237	18	43534473	18	45954507	626237	614539	rs767638289	NC_000018.10:45954506:G:A
NM_000351.6(STS):c.287G>A (p.Trp96Ter)	STS	W96*, W91*, W103*	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000625856	X	7175519	X	7257478	625856	614160		NC_000023.11:7257477:G:A
NM_032121.5(MAGT1):c.938T>G (p.Leu313Ter)	MAGT1	L313*, L281*	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625838	X	77096802	X	77841305	625838	614142	rs1569547878	NC_000023.11:77841304:A:C
NM_032121.5(MAGT1):c.991C>T (p.Arg331Ter)	MAGT1	R331*, R299*	Congenital disorder of glycosylation|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625837	X	77096749	X	77841252	625837	614141	rs1569547876	NC_000023.11:77841251:G:A
NM_032121.5(MAGT1):c.1068A>C (p.Lys356Asn)	MAGT1	K356N, K324N	Congenital disorder of glycosylation|CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000625836	X	77086322	X	77830825	625836	614140	rs373260156	NC_000023.11:77830824:T:G
GRCh37/hg19 Xq28(chrX:147642893-147870805)	AFF2		FRAXE	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625801	X	147642893 - 147870805			625801	614105		
GRCh37/hg19 Xq25(chrX:122970459-123034511)	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625799	X	122970459 - 123034511			625799	614103		
GRCh37/hg19 Xq24(chrX:118714474-118718137)	UBE2A		Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625798	X	118714474 - 118718137			625798	614102		
GRCh37/hg19 Xq22.3(chrX:107802035-107802303)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625795	X	107802035 - 107802303			625795	614099		
GRCh37/hg19 Xq21.1(chrX:77244108-77244998)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625793	X	77244108 - 77244998			625793	614097		
GRCh37/hg19 Xq13.2(chrX:71801020-71804146)	PHKA1		Glycogen storage disease IXd	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625792	X	71801020 - 71804146			625792	614096		
GRCh37/hg19 Xp11.23(chrX:47039376-47040521)	RBM10		TARP syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625791	X	47039376 - 47040521			625791	614095		
GRCh37/hg19 Xp11.4(chrX:38144822-38164037)	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625790	X	38144822 - 38164037			625790	614094		
GRCh37/hg19 Xp21.1(chrX:32587530-32719171)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625789	X	32587530 - 32719171			625789	614093		
GRCh37/hg19 Xp21.1(chrX:32466518-32928163)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625788	X	32466518 - 32928163			625788	614092		
GRCh37/hg19 20q13.12(chr20:43264839-43265435)	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625690	20	43264839 - 43265435			625690	613994		
GRCh37/hg19 Xp21.1(chrX:32235149-32459424)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625644	X	32235149 - 32459424			625644	613948		
GRCh37/hg19 Xp21.1(chrX:31853996-31855256)	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625643	X	31853996 - 31855256			625643	613947		
GRCh37/hg19 20q13.32(chr20:57244540-57246216)	STX16		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625617	20	57244540 - 57246216			625617	613921		
NM_003620.3(PPM1D):c.1248_1252del (p.Pro417fs)	PPM1D	P417fs	Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000625529	17	58734188 - 58734192	17	60656827 - 60656831	625529	613832	rs1567977657	NC_000017.11:60656826:ACACCAC:AC
NM_001077488.4(GNAS):c.127_129CTG[5] (p.Leu46dup)	GNAS		GNAS-related disorder	Pathogenic(Last reviewed: Aug 21, 2018)	no assertion criteria provided	VCV000625528	20	57466907 - 57466908	20	58891852 - 58891853	625528	613833		NC_000020.11:58891852:CTGCTGCTGCTG:CTGCTGCTGCTGCTG
NM_022829.6(SLC13A3):c.1016+3A>G	SLC13A3		LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625426	20	45217796	20	46589157	625426	613740	rs199961976	NC_000020.11:46589156:T:C
NM_022829.6(SLC13A3):c.1642G>A (p.Gly548Ser)	SLC13A3	G548S, G501S, G498S, G466S, G450S	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625425	20	45188828	20	46560189	625425	613739	rs1568904872	NC_000020.11:46560188:C:T
NM_022829.6(SLC13A3):c.761C>A (p.Ala254Asp)	SLC13A3	A254D, A207D, A156D, P232T	LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625424	20	45224829	20	46596190	625424	613738	rs1568927501	NC_000020.11:46596189:G:T
NM_000159.4(GCDH):c.1240G>T (p.Glu414Ter)	GCDH	E414*	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Jun 23, 2015)	no assertion criteria provided	VCV000625295	19	13008674	19	12897860	625295	613628	rs147611168	NC_000019.10:12897859:G:T
NM_000159.4(GCDH):c.1114A>G (p.Arg372Gly)	GCDH	R372G	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000625294	19	13008548	19	12897734	625294	613626	rs771924230	NC_000019.10:12897733:A:G
NM_000159.4(GCDH):c.701G>C (p.Arg234Pro)	GCDH	R234P	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000625293	19	13007084	19	12896270	625293	613625	rs1203022386	NC_000019.10:12896269:G:C
NM_000159.4(GCDH):c.296A>G (p.Glu99Gly)	GCDH	E99G	Glutaric aciduria, type 1	Pathogenic(Last reviewed: May 18, 2016)	no assertion criteria provided	VCV000625292	19	13002954	19	12892140	625292	613624	rs1294124984	NC_000019.10:12892139:A:G
NM_153252.5(BRWD3):c.3791del (p.Ser1264fs)	BRWD3	S1264fs	Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625218	X	79945283	X	80689784	625218	613548		NC_000023.11:80689783:C:
NM_001145073.3(USP27X):c.306_307GA[2] (p.Asp104fs)	USP27X		Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625216	X	49645216 - 49645217	X	49880613 - 49880614	625216	613546		NC_000023.11:49880612:GAGAGA:GAGA
NM_139058.3(ARX):c.1446_1448+1dup	ARX		Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625215	X	25025226 - 25025227	X	25007109 - 25007110	625215	613545		NC_000023.11:25007109:CCTGCC:CCTGCCTGCC
NM_002025.4(AFF2):c.3229C>T (p.Gln1077Ter)	AFF2	Q1077*, Q1042*, Q1067*, Q718*, Q1038*	Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625213	X	148049184	X	148967654	625213	613543		NC_000023.11:148967653:C:T
NM_001042537.1(SLC9A6):c.793+1G>A	SLC9A6		Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625212	X	135081128	X	135998969	625212	613551		NC_000023.11:135998968:G:A
NM_007325.5(GRIA3):c.2327C>T (p.Thr776Met)	GRIA3	T776M	Spasticity|Infantile spasms|Neurodegeneration|Generalized hypotonia|Focal seizures|Severe global developmental delay|Dystonia|Epileptic encephalopathy|Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625211	X	122613916	X	123480065	625211	613542		NC_000023.11:123480064:C:T
NM_001042537.1(SLC9A6):c.1463-1G>A	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000625179	X	135106488	X	136024329	625179	613522		NC_000023.11:136024328:G:A
NM_001161748.2(LIM2):c.388C>T (p.Arg130Cys)	LIM2	R130C, R172C	Cataract (disease)	Pathogenic(Last reviewed: Nov 16, 2017)	no assertion criteria provided	VCV000625113	19	51883831	19	51380577	625113	613458	rs1568480054	NC_000019.10:51380576:G:A
RTTN, ARG985GLY	RTTN	R985G	Microcephaly, short stature, and polymicrogyria with or without seizures	Pathogenic(Last reviewed: Apr 3, 2019)	no assertion criteria provided	VCV000624635					624635	613454		
NM_001167.3(XIAP):c.566T>C (p.Leu189Pro)	XIAP	L189P	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000624588	X	123020078	X	123886228	624588	613424	rs1569477871	NC_000023.11:123886227:T:C
NM_000206.2(IL2RG):c.455T>G (p.Val152Gly)	IL2RG	V152G	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000624584	X	70330145	X	71110295	624584	613425	rs193922348	NC_000023.11:71110294:A:C
NM_024656.4(COLGALT1):c.1129G>C (p.Gly377Arg)	COLGALT1	G377R	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000623641	19	17688272	19	17577463	623641	612466	rs1568481244	NC_000019.10:17577462:G:C
NM_024656.4(COLGALT1):c.460G>C (p.Ala154Pro)	COLGALT1	A154P	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000623640	19	17671245	19	17560436	623640	612465	rs181844791	NC_000019.10:17560435:G:C
NM_024656.4(COLGALT1):c.1096del (p.Glu366fs)	COLGALT1	E366fs	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Mar 21, 2019)	no assertion criteria provided	VCV000623639	19	17688238	19	17577429	623639	612464	rs1568481204	NC_000019.10:17577428:GG:G
NM_024656.4(COLGALT1):c.452T>G (p.Leu151Arg)	COLGALT1	L151R	BRAIN SMALL VESSEL DISEASE 3	Pathogenic(Last reviewed: Mar 21, 2019)	no assertion criteria provided	VCV000623638	19	17671237	19	17560428	623638	612463	rs1478523191	NC_000019.10:17560427:T:G
NM_001011658.4(TRAPPC2):c.40del (p.Asp14fs)	TRAPPC2	D14fs, D48fs	Spondyloepiphyseal dysplasia tarda	Pathogenic	no assertion criteria provided	VCV000623472	X	13738043	X	13719924	623472	612434		NC_000023.11:13719923:C:
NM_001011658.4(TRAPPC2):c.1A>T (p.Met1Leu)	TRAPPC2	M1L, M35L	Spondyloepiphyseal dysplasia tarda	Pathogenic	no assertion criteria provided	VCV000623471	X	13738082	X	13719963	623471	612433		NC_000023.11:13719962:T:A
NM_002024.5(FMR1):c.-128GGC[>200]	FMR1		Fragile X syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623468					623468	612431		
NM_003560.4(PLA2G6):c.1880-9del	PLA2G6		Neurodegeneration with brain iron accumulation 2b	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623393	22	38511697	22	38115690	623393	612360	rs1569243771	NC_000022.11:38115689:GGGG:GGG
NM_015294.6(TRIM37):c.181C>T (p.Arg61Ter)	TRIM37	R61*, R27*	Mulibrey nanism syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623386	17	57165752	17	59088391	623386	612321	rs373520509	NC_000017.11:59088390:G:A
NM_000709.4(BCKDHA):c.332T>C (p.Leu111Pro)	BCKDHA	L111P	Maple syrup urine disease	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623384	19	41916871	19	41410966	623384	612330	rs1568503938	NC_000019.10:41410965:T:C
NM_153252.5(BRWD3):c.3198_3199TG[1] (p.Val1067fs)	BRWD3		Mental retardation, X-linked 93	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623359	X	79948501 - 79948502	X	80693002 - 80693003	623359	612340		NC_000023.11:80693001:CACA:CA
NM_000528.4(MAN2B1):c.1203C>G (p.Tyr401Ter)	MAN2B1	Y401*, Y400*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623335	19	12769065	19	12658251	623335	612329	rs781291011	NC_000019.10:12658250:G:C
NM_000709.4(BCKDHA):c.554del (p.Leu185fs)	BCKDHA	L185fs	Maple syrup urine disease	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623332	19	41925108	19	41419203	623332	612331	rs1568506608	NC_000019.10:41419202:TT:T
NM_000475.5(NR0B1):c.851_856TGGTGC[1] (p.284_285LV[1])	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000623314	X	30326619 - 30326624	X	30308502 - 30308507	623314	612339		NC_000023.11:30308501:GCACCAGCACCAGC:GCACCAGC
NM_000527.5(LDLR):c.272del (p.Gly91fs)	LDLR	G91fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000623312	19	11213420	19	11102744	623312	612328	rs1568592055	NC_000019.10:11102743:GG:G
NM_020964.3(EPG5):c.6084G>A (p.Trp2028Ter)	EPG5	W2028*	Vici syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623301	18	43450673	18	45870708	623301	612326	rs1568107449	NC_000018.10:45870707:C:T
NM_001042750.2(STAG2):c.3097C>T (p.Arg1033Ter)	STAG2	R1033*	HOLOPROSENCEPHALY 13, X-LINKED	Pathogenic(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000623246	X	123220440	X	124086590	623246	612209	rs1569520709	NC_000023.11:124086589:C:T
NM_001042750.2(STAG2):c.2229G>A (p.Trp743Ter)	STAG2	W743*	MULLEGAMA-KLEIN-MARTINEZ SYNDROME	Pathogenic(Last reviewed: Oct 23, 2019)	no assertion criteria provided	VCV000623245	X	123200250	X	124066400	623245	612208	rs1569516580	NC_000023.11:124066399:G:A
NM_001042750.2(STAG2):c.3027A>T (p.Lys1009Asn)	STAG2	K1009N	MULLEGAMA-KLEIN-MARTINEZ SYNDROME	Pathogenic(Last reviewed: Oct 23, 2019)	no assertion criteria provided	VCV000623241	X	123217373	X	124083523	623241	612204	rs1374370833	NC_000023.11:124083522:A:T
NM_001042750.2(STAG2):c.980G>A (p.Ser327Asn)	STAG2	S327N	MULLEGAMA-KLEIN-MARTINEZ SYNDROME	Pathogenic(Last reviewed: Oct 23, 2019)	no assertion criteria provided	VCV000623240	X	123184122	X	124050272	623240	612203	rs1569512722	NC_000023.11:124050271:G:A
NM_001042750.2(STAG2):c.205C>T (p.Arg69Ter)	STAG2	R69*	HOLOPROSENCEPHALY 13, X-LINKED|MULLEGAMA-KLEIN-MARTINEZ SYNDROME	Pathogenic(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000623239	X	123164892	X	124031042	623239	612202	rs1569507848	NC_000023.11:124031041:C:T
NM_000216.4(ANOS1):c.21_22CG[1] (p.Ala8fs)	ANOS1			Pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000623176	X	8700054 - 8700055	X	8732013 - 8732014	623176	612201		NC_000023.11:8732012:CGCGC:CGC
NM_001111125.3(IQSEC2):c.3875del (p.Pro1292fs)	IQSEC2	P1292fs	Mental retardation, X-linked 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000623140	X	53263993	X	53234811	623140	612123	rs1569291627	NC_000023.11:53234810:GGGGG:GGGG
NM_002473.5(MYH9):c.5770_5779del (p.Gly1924fs)	MYH9	G1924fs	MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000623110	22	36678818 - 36678827	22	36282772 - 36282781	623110	612059		NC_000022.11:36282771:GCAGGTCCCCGC:GC
NM_002473.5(MYH9):c.2152C>T (p.Arg718Trp)	MYH9	R718W	MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000623108	22	36701983	22	36305937	623108	612069		NC_000022.11:36305936:G:A
NM_002473.5(MYH9):c.283G>A (p.Ala95Thr)	MYH9	A95T	MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000623106	22	36744999	22	36348954	623106	612071		NC_000022.11:36348953:C:T
NM_001390.4(DTNA):c.146A>G (p.Asn49Ser)	DTNA	N49S	Left ventricular noncompaction 1	Pathogenic(Last reviewed: Mar 18, 2019)	no assertion criteria provided	VCV000623092	18	32346003	18	34766039	623092	612055	rs775975702	NC_000018.10:34766038:A:G
NM_007186.6(CEP250):c.4006C>T (p.Arg1336Ter)	CEP250	R1336*, R704*	Cone-rod dystrophy and hearing loss 2	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620662	20	34089779	20	35501952	620662	612048	rs774702094	NC_000020.11:35501951:C:T
NM_007186.6(CEP250):c.3337A>T (p.Lys1113Ter)	CEP250	K1113*, K481*	Cone-rod dystrophy and hearing loss 2	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620661	20	34085578	20	35497749	620661	612047	rs1568820302	NC_000020.11:35497748:A:T
NM_007186.6(CEP250):c.562C>T (p.Arg188Ter)	CEP250	R188*	Cone-rod dystrophy and hearing loss 2	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620660	20	34054860	20	35467035	620660	612046	rs1369076411	NC_000020.11:35467034:C:T
NM_007186.6(CEP250):c.361C>T (p.Arg121Ter)	CEP250	R121*	Cone-rod dystrophy and hearing loss 2	Pathogenic(Last reviewed: Mar 14, 2019)	no assertion criteria provided	VCV000620659	20	34053898	20	35466073	620659	612045	rs1341298773	NC_000020.11:35466072:C:T
NM_007186.6(CEP250):c.3463C>T (p.Arg1155Ter)	CEP250	R1155*, R523*	Usher syndrome|Cone-rod dystrophy and hearing loss 2	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000620658	20	34085704	20	35497875	620658	612044	rs749314857	NC_000020.11:35497874:C:T
NM_000328.3(RPGR):c.1905+600_1905+601del	RPGR	E836fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000620583	X	38145746 - 38145747	X	38286493 - 38286494	620583	611982	rs1569236971	NC_000023.11:38286492:CCCCC:CCC
NM_000328.3(RPGR):c.1905+537_1905+540del	RPGR	G817fs	Retinal dystrophy|Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000620582	X	38145807 - 38145810	X	38286554 - 38286557	620582	611983	rs1569237077	NC_000023.11:38286553:CTCT:
NM_001256447.2(BCAP31):c.91A>T (p.Arg31Ter)	BCAP31	R31*, R98*	not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000620572	X	152988609	X	153723154	620572	611935	rs1569540524	NC_000023.11:153723153:T:A
NM_015559.3(SETBP1):c.1630C>T (p.Arg544Ter)	SETBP1	R544*	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000620563	18	42530935	18	44950970	620563	611890	rs1568234874	NC_000018.10:44950969:C:T
NM_000346.4(SOX9):c.522C>A (p.Tyr174Ter)	SOX9	Y174*	not provided	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000620560	17	70118950	17	72122809	620560	611879	rs373719106	NC_000017.11:72122808:C:A
NM_014727.2(KMT2B):c.3885G>A (p.Trp1295Ter)	KMT2B	W1295*	not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000620543	19	36216719	19	35725818	620543	611971	rs1568374482	NC_000019.10:35725817:G:A
NM_001008537.3(NEXMIF):c.1300G>T (p.Glu434Ter)	NEXMIF	E434*	not provided	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000620527	X	73963092	X	74743257	620527	611958	rs1569335738	NC_000023.11:74743256:C:A
NM_004782.4(SNAP29):c.250C>T (p.Gln84Ter)	SNAP29	Q84*	not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000620507	22	21224637	22	20870349	620507	611919	rs1315355162	NC_000022.11:20870348:C:T
NM_002816.5(PSMD12):c.316C>T (p.Gln106Ter)	PSMD12	Q106*, Q47*, Q86*	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000620497	17	65346434	17	67350318	620497	611876	rs1567955779	NC_000017.11:67350317:G:A
NM_015192.4(PLCB1):c.1332T>A (p.Tyr444Ter)	PLCB1	Y444*	not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000620493	20	8696992	20	8716345	620493	611914	rs1568571093	NC_000020.11:8716344:T:A
NM_001323289.2(CDKL5):c.697G>T (p.Glu233Ter)	CDKL5	E233*	not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000620492	X	18606216	X	18588096	620492	611937	rs1569215664	NC_000023.11:18588095:G:T
NM_020964.3(EPG5):c.1381C>T (p.Gln461Ter)	EPG5	Q461*	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000620484	18	43531076	18	45951110	620484	611894	rs1568183567	NC_000018.10:45951109:G:A
NM_004247.4(EFTUD2):c.1060C>T (p.Arg354Ter)	EFTUD2	R354*, R319*, R344*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000620475	17	42945264	17	44867896	620475	611859	rs996949678	NC_000017.11:44867895:G:A
NM_020812.4(DOCK6):c.387C>G (p.Tyr129Ter)	DOCK6	Y129*	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000620466	19	11362915	19	11252239	620466	611898	rs752015120	NC_000019.10:11252238:G:C
NM_020812.4(DOCK6):c.1462C>T (p.Arg488Ter)	DOCK6	R488*	not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000620465	19	11353753	19	11243077	620465	611897	rs369389970	NC_000019.10:11243076:G:A
NM_153252.5(BRWD3):c.4015G>T (p.Glu1339Ter)	BRWD3	E1339*	not provided	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000620459	X	79941026	X	80685527	620459	611962	rs1569245569	NC_000023.11:80685526:C:A
NM_015338.5(ASXL1):c.2790G>A (p.Trp930Ter)	ASXL1	W930*, W869*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000620453	20	31023305	20	32435502	620453	611910	rs1569333361	NC_000020.11:32435501:G:A
NM_005120.3(MED12):c.5920C>T (p.Gln1974Ter)	MED12	Q1974*	not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000620451	X	70357669	X	71137819	620451	611954	rs1569482431	NC_000023.11:71137818:C:T
NM_004429.4(EFNB1):c.640C>T (p.Gln214Ter)	EFNB1	Q214*	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000620450	X	68060096	X	68840253	620450	611953	rs1569398276	NC_000023.11:68840252:C:T
NM_030632.3(ASXL3):c.1535T>A (p.Leu512Ter)	ASXL3	L512*	not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000620449	18	31318903	18	33738939	620449	611883	rs1568359816	NC_000018.10:33738938:T:A
NM_021140.3(KDM6A):c.1972C>T (p.Arg658Ter)	KDM6A	R658*, R710*, R665*, R579*, R362*, R613*	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000620434	X	44928872	X	45069627	620434	611948	rs755440519	NC_000023.11:45069626:C:T
NM_001083961.2(WDR62):c.1157G>A (p.Trp386Ter)	WDR62	W386*	not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000620430	19	36564357	19	36073455	620430	611903	rs1265252597	NC_000019.10:36073454:G:A
NM_015559.3(SETBP1):c.1765C>T (p.Arg589Ter)	SETBP1	R589*	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000620410	18	42531070	18	44951105	620410	611891	rs1568235086	NC_000018.10:44951104:C:T
NM_001184880.2(PCDH19):c.955A>T (p.Lys319Ter)	PCDH19	K319*	not provided	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000620397	X	99662641	X	100407643	620397	611929	rs1569315186	NC_000023.11:100407642:T:A
NM_015559.3(SETBP1):c.265C>T (p.Gln89Ter)	SETBP1	Q89*	not provided	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000620362	18	42281576	18	44701611	620362	611888	rs1568097623	NC_000018.10:44701610:C:T
NM_001029896.2(WDR45):c.52C>T (p.Gln18Ter)	WDR45	Q18*	not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000620358	X	48935703	X	49078044	620358	611949	rs1569523562	NC_000023.11:49078043:G:A
NM_001321120.2(TBX4):c.1018C>T (p.Arg340Ter)	TBX4	R340*	not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000620312	17	59557677	17	61480316	620312	611864	rs1569044884	NC_000017.11:61480315:C:T
NM_001123383.1(BCOR):c.3079G>T (p.Glu1027Ter)	BCOR	E1027*, E1009*	not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000620307	X	39930385	X	40071132	620307	611946	rs1569153948	NC_000023.11:40071131:C:A
NM_015559.3(SETBP1):c.666G>A (p.Trp222Ter)	SETBP1	W222*	not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000620306	18	42529971	18	44950006	620306	611889	rs1391600900	NC_000018.10:44950005:G:A
NM_020964.3(EPG5):c.263T>G (p.Leu88Ter)	EPG5	L88*	not provided	Pathogenic(Last reviewed: Aug 5, 2018)	criteria provided, single submitter	VCV000620301	18	43535105	18	45955139	620301	611895	rs183478189	NC_000018.10:45955138:A:C
NM_002816.5(PSMD12):c.544C>T (p.Arg182Ter)	PSMD12	R182*, R123*, R162*	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000620300	17	65343568	17	67347452	620300	611875	rs1567954436	NC_000017.11:67347451:G:A
NM_015338.5(ASXL1):c.2077C>T (p.Arg693Ter)	ASXL1	R693*, R632*	not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000620281	20	31022592	20	32434789	620281	611909	rs373221034	NC_000020.11:32434788:C:T
NM_001008537.3(NEXMIF):c.682G>T (p.Glu228Ter)	NEXMIF	E228*	not provided	Pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000620268	X	73963710	X	74743875	620268	611959	rs1569335893	NC_000023.11:74743874:C:A
NM_001347721.2(DYRK1A):c.151C>T (p.Gln51Ter)	DYRK1A	Q51*, Q22*	not provided	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000620262	21	38845126	21	37472824	620262	611917	rs1555977077	NC_000021.9:37472823:C:T
NM_003588.3(CUL4B):c.1405C>T (p.Arg469Ter)	CUL4B	R469*, R451*, R456*, R273*	not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000620257	X	119675549	X	120541694	620257	611932	rs1569390220	NC_000023.11:120541693:G:A
NM_004006.2(DMD):c.4546A>T (p.Lys1516Ter)	DMD	K1516*, K172*, K1393*, K1508*, K1512*, K175*	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000620249	X	32404555	X	32386438	620249	611944	rs1569560626	NC_000023.11:32386437:T:A
NM_080647.1(TBX1):c.908G>A (p.Trp303Ter)	TBX1	W303*	not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000620242	22	19753348	22	19765825	620242	611972	rs1569022780	NC_000022.11:19765824:G:A
NM_138927.3(SON):c.5473C>T (p.Arg1825Ter)	SON	R1825*	not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620241	21	34927010	21	33554704	620241	611915	rs1569058837	NC_000021.9:33554703:C:T
NM_006852.4(TLK2):c.2089C>T (p.Arg697Ter)	TLK2	R697*, R719*, R548*, R665*	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620238	17	60689762	17	62612401	620238	611871	rs1568027692	NC_000017.11:62612400:C:T
NM_015338.5(ASXL1):c.1762C>T (p.Gln588Ter)	ASXL1	Q588*, Q527*	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000620227	20	31022277	20	32434474	620227	611908	rs1486082302	NC_000020.11:32434473:C:T
NM_001127221.1(CACNA1A):c.3157C>T (p.Gln1053Ter)	CACNA1A	Q1053*, Q1056*, Q1052*	not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000620224	19	13397716	19	13286902	620224	611899	rs1568495944	NC_000019.10:13286901:G:A
NM_014271.4(IL1RAPL1):c.1054C>T (p.Arg352Ter)	IL1RAPL1	R352*	not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000620223	X	29938208	X	29920091	620223	611942	rs1569203705	NC_000023.11:29920090:C:T
NM_153252.5(BRWD3):c.4054A>T (p.Arg1352Ter)	BRWD3	R1352*	not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000620222	X	79940987	X	80685488	620222	611961	rs758800773	NC_000023.11:80685487:T:A
NM_030632.3(ASXL3):c.1585G>T (p.Glu529Ter)	ASXL3	E529*	not provided	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000620218	18	31318953	18	33738989	620218	611884	rs1568359887	NC_000018.10:33738988:G:T
NM_001347721.2(DYRK1A):c.1378C>T (p.Gln460Ter)	DYRK1A	Q469*, Q460*, Q431*	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000620200	21	38877751	21	37505448	620200	611918	rs1555990955	NC_000021.9:37505447:C:T
NM_001039141.3(TRIOBP):c.2968C>T (p.Arg990Ter)	TRIOBP	R990*	not provided	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000620199	22	38121531	22	37725524	620199	611922	rs1228392408	NC_000022.11:37725523:C:T
NM_004006.2(DMD):c.5082G>A (p.Trp1694Ter)	DMD	W1694*, W1571*, W353*, W1686*, W350*, W1690*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000620196	X	32382771	X	32364654	620196	611943	rs1295394996	NC_000023.11:32364653:C:T
NM_030632.3(ASXL3):c.1783C>T (p.Gln595Ter)	ASXL3	Q595*	not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000620192	18	31319151	18	33739187	620192	611885	rs1568360291	NC_000018.10:33739186:C:T
NM_001111125.3(IQSEC2):c.3856C>T (p.Gln1286Ter)	IQSEC2	Q1286*	not provided	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000620190	X	53264012	X	53234830	620190	611951	rs1569291654	NC_000023.11:53234829:G:A
NM_002637.4(PHKA1):c.1174C>T (p.Arg392Ter)	PHKA1	R392*	not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000620183	X	71872465	X	72652615	620183	611956	rs1556299510	NC_000023.11:72652614:G:A
NM_006517.5(SLC16A2):c.154C>T (p.Gln52Ter)	SLC16A2	Q52*	not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000620181	X	73641626	X	74421791	620181	611957	rs1569281085	NC_000023.11:74421790:C:T
NM_005121.3(MED13):c.5161C>T (p.Gln1721Ter)	MED13	Q1721*	not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000620179	17	60039044	17	61961683	620179	611866	rs1044065786	NC_000017.11:61961682:G:A
NM_005121.3(MED13):c.5627G>A (p.Trp1876Ter)	MED13	W1876*	not provided	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000620178	17	60033196	17	61955835	620178	611865	rs1567940265	NC_000017.11:61955834:C:T
NM_005121.3(MED13):c.1864A>T (p.Lys622Ter)	MED13	K622*	not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000620177	17	60088014	17	62010653	620177	611867	rs1567975588	NC_000017.11:62010652:T:A
NM_005121.3(MED13):c.1745T>A (p.Leu582Ter)	MED13	L582*	not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000620176	17	60088133	17	62010772	620176	611868	rs780070113	NC_000017.11:62010771:A:T
NM_000285.4(PEPD):c.977G>A (p.Trp326Ter)	PEPD	W326*, W262*, W285*	not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620168	19	33882376	19	33391470	620168	611902	rs529315200	NC_000019.10:33391469:C:T
NM_006852.4(TLK2):c.1910C>G (p.Ser637Ter)	TLK2	S637*, S605*, S659*, S488*	not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000620167	17	60683541	17	62606180	620167	611869	rs1568015106	NC_000017.11:62606179:C:G
NM_000308.3(CTSA):c.249G>A (p.Trp83Ter)	CTSA	W83*, W65*	not provided	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000620166	20	44520555	20	45891916	620166	611911	rs1568761792	NC_000020.11:45891915:G:A
NM_006852.4(TLK2):c.1928G>A (p.Trp643Ter)	TLK2	W643*, W494*, W665*, W611*	not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000620161	17	60683559	17	62606198	620161	611870	rs1568015131	NC_000017.11:62606197:G:A
NM_001193416.3(DDX3X):c.136C>T (p.Arg46Ter)	DDX3X	R46*	Mental retardation, X-linked 102|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620156	X	41198321	X	41339068	620156	611947	rs1569234653	NC_000023.11:41339067:C:T
NM_002547.3(OPHN1):c.1489C>T (p.Arg497Ter)	OPHN1	R497*	not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000620153	X	67331733	X	68111891	620153	611952	rs1569215382	NC_000023.11:68111890:G:A
NM_015629.4(PRPF31):c.220C>T (p.Gln74Ter)	PRPF31	Q74*	not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000620140	19	54621995	19	54118615	620140	611907	rs1389305246	NC_000019.10:54118614:C:T
NM_001077488.4(GNAS):c.529C>T (p.Gln177Ter)	GNAS	Q176*, Q177*, Q117*, Q819*, Q162*, Q161*	not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000620119	20	57480531	20	58905476	620119	611912	rs1569020396	NC_000020.11:58905475:C:T
NM_198270.4(NHS):c.742C>T (p.Arg248Ter)	NHS	R248*, R71*	Nance-Horan syndrome|not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620118	X	17710478	X	17692358	620118	611936	rs1569310232	NC_000023.11:17692357:C:T
NM_000166.6(GJB1):c.633C>A (p.Tyr211Ter)	GJB1	Y211*	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000620115	X	70444190	X	71224340	620115	611955	rs1569215443	NC_000023.11:71224339:C:A
NM_000194.3(HPRT1):c.454C>T (p.Gln152Ter)	HPRT1	Q152*	not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000620112	X	133627589	X	134493559	620112	611934	rs1569359021	NC_000023.11:134493558:C:T
NM_006852.4(TLK2):c.364C>T (p.Arg122Ter)	TLK2	R122*, R90*	not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620099	17	60613531	17	62536170	620099	611969	rs1567870541	NC_000017.11:62536169:C:T
NM_001193466.2(KANSL1):c.449del (p.Pro150fs)	KANSL1	P150fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000620068	17	44249061	17	46171695	620068	611427	rs1567764119	NC_000017.11:46171694:GG:G
NM_001008537.3(NEXMIF):c.280dup (p.Ala94fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000620056	X	73964111 - 73964112	X	74744276 - 74744277	620056	611459	rs1569336024	NC_000023.11:74744276:C:CC
NM_001282531.3(ADNP):c.177_178dup (p.Asp60fs)	ADNP		Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000620048	20	49518576 - 49518577	20	50902039 - 50902040	620048	611434	rs1568722170	NC_000020.11:50902039:CCC:CCCCC
NM_014271.4(IL1RAPL1):c.1191_1201+6del	IL1RAPL1		Mental retardation 21, X-linked	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000620044	X	29959899 - 29959915	X	29941782 - 29941798	620044	611470	rs1569208908	NC_000023.11:29941781:GAGCTCGATGGAGGTAGGA:GA
NM_004187.4(KDM5C):c.3570_3573del (p.Gly1191fs)	KDM5C	G1191fs, G1124fs, G1190fs	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000620032	X	53223786 - 53223789	X	53194604 - 53194607	620032	611453	rs1569258293	NC_000023.11:53194603:CCCAC:C
NM_001184880.2(PCDH19):c.971del (p.Asn324fs)	PCDH19	N324fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000620031	X	99662625	X	100407627	620031	611437	rs1569315169	NC_000023.11:100407626:TT:T
NM_001193466.2(KANSL1):c.2938_2939del (p.Leu980fs)	KANSL1	L979fs, L980fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000620029	17	44109564 - 44109565	17	46032198 - 46032199	620029	611426	rs1568366050	NC_000017.11:46032197:AAA:A
NM_001083962.2(TCF4):c.1705C>T (p.Arg569Trp)	TCF4	R569W, R498W, R523W, R540W, R541W, R353W, R404W, R405W, R409W, R439W, R544W, R545W, R562W, R435W, R494W, R527W, R546W, R564W, R568W, R575W, R565W, R671W	Pitt-Hopkins syndrome|Corneal dystrophy, Fuchs endothelial, 3	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000620020	18	52896252	18	55229021	620020	611428	rs1568305976	NC_000018.10:55229020:G:A
NM_002501.4(NFIX):c.136A>T (p.Lys46Ter)	NFIX	K46*, K54*, K38*, K45*	Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000620018	19	13135943	19	13025129	620018	611430	rs1568268397	NC_000019.10:13025128:A:T
NM_001347721.2(DYRK1A):c.334C>T (p.Gln112Ter)	DYRK1A	Q121*, Q112*, Q83*	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000620014	21	38852973	21	37480671	620014	611436	rs1555980234	NC_000021.9:37480670:C:T
NM_001111125.3(IQSEC2):c.3278C>G (p.Ser1093Trp)	IQSEC2	S1093W, S888W	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000620013	X	53265677	X	53236495	620013	611471	rs1556859744	NC_000023.11:53236494:G:C
NM_001282531.3(ADNP):c.733G>T (p.Glu245Ter)	ADNP	E245*	Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000619999	20	49510518	20	50893981	619999	611433	rs1568710501	NC_000020.11:50893980:C:A
NM_001282531.3(ADNP):c.1932_1933AG[2] (p.Arg646fs)	ADNP		Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000619994	20	49509314 - 49509315	20	50892777 - 50892778	619994	611432		NC_000020.11:50892776:CTCTCTC:CTCTC
NM_001111125.3(IQSEC2):c.854del (p.Pro285fs)	IQSEC2	P80fs, P285fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000619985	X	53285127	X	53255945	619985	611456	rs782460038	NC_000023.11:53255944:GGGGGG:GGGGG
NM_001195553.2(DCX):c.226C>G (p.Arg76Gly)	DCX	R157G, R76G	Lissencephaly, X-linked	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000619981	X	110653401	X	111410173	619981	611440	rs587783534	NC_000023.11:111410172:G:C
NM_000273.3(GPR143):c.731del (p.Ile244fs)	GPR143	I244fs	Nystagmus 6, congenital, X-linked	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000619966	X	9711641	X	9743601	619966	611358	rs1569118851	NC_000023.11:9743600:A:
NM_033380.3(COL4A5):c.3177del (p.Gly1060fs)	COL4A5	G1060fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000619957	X	107869510	X	108626280	619957	611357	rs1569499015	NC_000023.11:108626279:T:
NM_001178011.2(CDC45):c.205-1051TA[4]	CDC45		Meier-gorlin syndrome 7	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000619950	22	19470333 - 19470334	22	19482810 - 19482811	619950	611347		NC_000022.11:19482810:TATA:TATATATA
NM_018669.6(WDR4):c.454-2A>C	WDR4		GALLOWAY-MOWAT SYNDROME 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000619605	21	44282506	21	42862396	619605	611003	rs779449710	NC_000021.9:42862395:T:G
NM_018669.6(WDR4):c.911_927dup (p.Gln310fs)	WDR4		GALLOWAY-MOWAT SYNDROME 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000619602	21	44273726 - 44273727	21	42853616 - 42853617	619602	611000	rs1569314907	NC_000021.9:42853616:GCAGTCCTGGAGCACCC:GCAGTCCTGGAGCACCCGCAGTCCTGGAGCACCC
NM_018669.6(WDR4):c.509G>A (p.Arg170Gln)	WDR4	R170Q, R24Q	GALLOWAY-MOWAT SYNDROME 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000619601	21	44282449	21	42862339	619601	610999	rs1292041526	NC_000021.9:42862338:C:T
NM_018669.6(WDR4):c.509G>T (p.Arg170Leu)	WDR4	R170L, R24L	MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000619600	21	44282449	21	42862339	619600	610998	rs1292041526	NC_000021.9:42862338:C:A
NM_006031.6(PCNT):c.3465-1G>A	PCNT			Pathogenic	no assertion criteria provided	VCV000619502	21	47808656	21	46388741	619502	610899	rs755084205	NC_000021.9:46388740:G:A
NM_006003.3(UQCRFS1):c.41T>A (p.Val14Asp)	UQCRFS1	V14D	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10|Propionicacidemia|Lactic acidosis|Cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000619501	19	29703985	19	29213078	619501	610898	rs1568346416	NC_000019.10:29213077:A:T
NM_006003.3(UQCRFS1):c.610C>T (p.Arg204Ter)	UQCRFS1	R204*	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10|Propionicacidemia|Lactic acidosis|Cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000619499	19	29698670	19	29207763	619499	610896	rs1242465339	NC_000019.10:29207762:G:A
NM_006003.3(UQCRFS1):c.215-1G>C	UQCRFS1		MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10|Propionicacidemia|Lactic acidosis|Cardiomyopathy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000619297	19	29699066	19	29208159	619297	610695	rs1568344751	NC_000019.10:29208158:C:G
NM_000033.4(ABCD1):c.1225-7_1239del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000619288	X	153001790 - 153001811	X	153736336 - 153736357	619288	610689	rs1569541009	NC_000023.11:153736335:CTCCCTCAGGTGACGGAGCTGGCT:CT
NM_032134.2(QRICH2):c.3037C>T (p.Arg1013Ter)	QRICH2	R1013*	SPERMATOGENIC FAILURE 35	Pathogenic(Last reviewed: Oct 7, 2019)	no assertion criteria provided	VCV000619118	17	74287273	17	76291192	619118	610513	rs777214459	NC_000017.11:76291191:G:A
NM_032134.2(QRICH2):c.192G>A (p.Trp64Ter)	QRICH2	L64*, W64*	SPERMATOGENIC FAILURE 35	Pathogenic(Last reviewed: Oct 7, 2019)	no assertion criteria provided	VCV000619117	17	74300511	17	76304430	619117	610512	rs1567790522	NC_000017.11:76304429:C:T
NM_205767.2(MICOS13):c.30-1G>A	MICOS13		Combined oxidative phosphorylation deficiency 37	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000619099	19	5679775	19	5679764	619099	610497	rs1568293849	NC_000019.10:5679763:C:T
NM_001429.4(EP300):c.5489_5491GGA[1] (p.Arg1831del)	EP300	R1831del	Menke-Hennekam syndrome 2	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000619096	22	41573203 - 41573205	22	41177199 - 41177201	619096	610494	rs1569120910	NC_000022.11:41177198:AGGAGGA:AGGA
NM_001429.4(EP300):c.5471A>C (p.Gln1824Pro)	EP300	Q1824P, Q1798P	Menke-Hennekam syndrome 2	Pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000619095	22	41573186	22	41177182	619095	610493	rs1569120903	NC_000022.11:41177181:A:C
NM_001281463.1(SMC1A):c.1969G>T (p.Glu657Ter)	SMC1A	E657*, E679*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000619027	X	53432200	X	53405268	619027	610425	rs1569356968	NC_000023.11:53405267:C:A
NM_000061.2(BTK):c.1004T>A (p.Val335Asp)	BTK	V335D, V369D	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000619022	X	100613396	X	101358408	619022	610420	rs1569292214	NC_000023.11:101358407:A:T
IKBKG, IVS4DS, C-T, +866	IKBKG		Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Feb 20, 2019)	no assertion criteria provided	VCV000619016					619016	610414		
NM_177559.3(CSNK2A1):c.1A>G (p.Met1Val)	CSNK2A1	M1V	Okur-chung neurodevelopmental syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000619015	20	489195	20	508551	619015	610413	rs1568532361	NC_000020.11:508550:T:C
NM_177559.3(CSNK2A1):c.466G>C (p.Asp156His)	CSNK2A1	D156H, D20H	Okur-chung neurodevelopmental syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000619014	20	476407	20	495763	619014	610412	rs1568512728	NC_000020.11:495762:C:G
NM_000206.2(IL2RG):c.87del (p.Asn31fs)	IL2RG	N31fs	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Feb 14, 2019)	no assertion criteria provided	VCV000619010	X	70331303	X	71111453	619010	610408		NC_000023.11:71111452:C:
NM_022095.4(ZNF335):c.1505A>G (p.Tyr502Cys)	ZNF335	Y502C	Primary autosomal recessive microcephaly 10	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000619007	20	44592140	20	45963501	619007	610405	rs753888773	NC_000020.11:45963500:T:C
NM_022095.4(ZNF335):c.1399T>C (p.Cys467Arg)	ZNF335	C467R	Primary autosomal recessive microcephaly 10	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000619006	20	44592246	20	45963607	619006	610404	rs1568822376	NC_000020.11:45963606:A:G
NM_001754.4(RUNX1):c.958C>T (p.Arg320Ter)	RUNX1	R320*, R293*	not provided|Thrombocytopenia	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618862	21	36171607	21	34799310	618862	610162	rs1569008655	NC_000021.9:34799309:G:A
NM_000132.3(F8):c.379del (p.Ala127fs)	F8	A127fs	not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000618641	X	154225257	X	154996982	618641	610230	rs1454692506	NC_000023.11:154996981:C:
NM_000132.3(F8):c.5605G>A (p.Gly1869Ser)	F8	G1869S	not provided	Pathogenic(Last reviewed: Apr 22, 2018)	criteria provided, single submitter	VCV000618640	X	154132781	X	154904506	618640	610217	rs1417520379	NC_000023.11:154904505:C:T
NM_000132.3(F8):c.575T>C (p.Ile192Thr)	F8	I192T	not provided	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000618637	X	154221237	X	154992962	618637	610229	rs1448187077	NC_000023.11:154992961:A:G
NM_001399.5(EDA):c.252del (p.Gly85fs)	EDA	G85fs	not provided|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000618616	X	68836404	X	69616560	618616	610258	rs1569272328	NC_000023.11:69616559:T:
NM_004006.2(DMD):c.6874G>T (p.Glu2292Ter)	DMD	E2292*, E2169*, E2288*, E951*, E948*, E2284*	not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000618600	X	31947751	X	31929634	618600	610243	rs1569515486	NC_000023.11:31929633:C:A
NM_004006.2(DMD):c.9634G>T (p.Glu3212Ter)	DMD	E3212*, E3204*, E1871*, E3208*, E3089*, E483*, E144*, E1868*, E752*	not provided	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000618599	X	31224714	X	31206597	618599	610240	rs1569463953	NC_000023.11:31206596:C:A
NM_004006.2(DMD):c.6276C>G (p.Tyr2092Ter)	DMD	Y2092*, Y751*, Y2084*, Y2088*, Y748*, Y1969*	not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000618598	X	32305660	X	32287543	618598	610244	rs1569555987	NC_000023.11:32287542:G:C
NM_004006.2(DMD):c.1638G>A (p.Trp546Ter)	DMD	W546*, W542*, W538*, W423*	not provided	Pathogenic(Last reviewed: May 14, 2017)	criteria provided, single submitter	VCV000618597	X	32591928	X	32573811	618597	610248	rs1569230293	NC_000023.11:32573810:C:T
NM_000052.7(ATP7A):c.1435C>T (p.Gln479Ter)	ATP7A	Q479*	not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000618540	X	77254073	X	77998576	618540	610260	rs1569549695	NC_000023.11:77998575:C:T
NM_152424.4(AMER1):c.768dup (p.Asp257fs)	AMER1		not provided	Pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000618525	X	63412398 - 63412399	X	64192518 - 64192519	618525	610257	rs1569192258	NC_000023.11:64192518:TTT:TTTT
NM_000132.3(F8):c.4042A>T (p.Lys1348Ter)	F8	K1348*	not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000618114	X	154158023	X	154929748	618114	610219	rs1297584118	NC_000023.11:154929747:T:A
NM_000132.3(F8):c.2945del (p.Asn982fs)	F8	N982fs	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000618108	X	154159120	X	154930845	618108	610220	rs387906447	NC_000023.11:154930844:TTTTTT:TTTTT
NM_000132.3(F8):c.766T>A (p.Tyr256Asn)	F8	Y256N	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000618107	X	154212983	X	154984708	618107	610228	rs1569559955	NC_000023.11:154984707:A:T
NM_000132.3(F8):c.5954del (p.Arg1985fs)	F8	R1985fs	not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000618105	X	154132225	X	154903950	618105	610214	rs1215569190	NC_000023.11:154903949:C:
NM_000132.3(F8):c.1094A>G (p.Tyr365Cys)	F8	Y365C	Hereditary factor IX deficiency disease|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618104	X	154194878	X	154966603	618104	610226	rs375241473	NC_000023.11:154966602:T:C
NM_000132.3(F8):c.1350_1351CA[1] (p.Thr451fs)	F8		not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000618101	X	154194335 - 154194336	X	154966060 - 154966061	618101	610224		NC_000023.11:154966059:TGTGT:TGT
NM_000132.3(F8):c.5960_5964del (p.Lys1987fs)	F8	K1987fs	not provided	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000618100	X	154132215 - 154132219	X	154903940 - 154903944	618100	610213	rs1569559514	NC_000023.11:154903939:CTCTT:
NM_000132.3(F8):c.5954G>A (p.Arg1985Gln)	F8	R1985Q	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000618098	X	154132225	X	154903950	618098	610215	rs1490417405	NC_000023.11:154903949:C:T
NM_004006.2(DMD):c.3856G>T (p.Glu1286Ter)	DMD	E1286*, E1163*, E1278*, E1282*	not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000618065	X	32459362	X	32441245	618065	610247	rs1569562570	NC_000023.11:32441244:C:A
NM_000109.4(DMD):c.9156del (p.Trp3053fs)	DMD	W2938fs, W3061fs, W1717fs, W3053fs, W601fs, W1720fs, W332fs, W3057fs	not specified	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000618064	X	31341759	X	31323642	618064	610241	rs1569526156	NC_000023.11:31323641:GGG:GG
NM_004006.2(DMD):c.8524C>T (p.Gln2842Ter)	DMD	Q2842*, Q113*, Q1501*, Q2719*, Q1498*, Q2834*, Q2838*, Q382*	not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000618063	X	31514928	X	31496811	618063	610242	rs1569547229	NC_000023.11:31496810:G:A
NM_000033.4(ABCD1):c.1621_1628del (p.Tyr541fs)	ABCD1	Y541fs	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000617947	X	153005677 - 153005684	X	153740223 - 153740230	617947	610199	rs1569541093	NC_000023.11:153740222:CTACATCCC:C
NM_006852.4(TLK2):c.1651C>T (p.Gln551Ter)	TLK2	Q402*, Q519*, Q551*, Q573*	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617937	17	60678112	17	62600751	617937	609329	rs1568003569	NC_000017.11:62600750:C:T
NM_001330418.2(TLK2):c.-461C>T	TLK2	Q13*	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617935	17	60558523	17	62481162	617935	609317	rs1567758622	NC_000017.11:62481161:C:T
NM_006852.4(TLK2):c.907C>T (p.Arg303Ter)	TLK2	R154*, R271*, R303*	not provided|MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617933	17	60642437	17	62565076	617933	609322	rs138247472	NC_000017.11:62565075:C:T
NM_001330418.2(TLK2):c.-171C>T	TLK2	R61*	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617928	17	60599592	17	62522231	617928	609318	rs1567844041	NC_000017.11:62522230:C:T
NM_001330418.2(TLK2):c.-150G>T	TLK2	E68*	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617923	17	60599613	17	62522252	617923	609319	rs1567844114	NC_000017.11:62522251:G:T
NM_001284333.2(TLK2):c.777C>A (p.Tyr259Ter)	TLK2	Y110*, Y227*, Y259*	not provided|MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617921	17	60637433	17	62560072	617921	609320	rs1567920106	NC_000017.11:62560071:C:A
NM_006852.4(TLK2):c.784C>T (p.Arg262Ter)	TLK2	R113*, R230*, R262*	not provided|MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617919	17	60637440	17	62560079	617919	609321	rs1567920209	NC_000017.11:62560078:C:T
NM_138927.3(SON):c.6087del (p.Ser2029fs)	SON	S2029fs	not provided|ZTTK syndrome	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000617864	21	34927624	21	33555318	617864	609250	rs1569059792	NC_000021.9:33555317:C:
NM_014297.5(ETHE1):c.79C>A (p.Gln27Lys)	ETHE1	Q27K	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, single submitter	VCV000617791	19	44031251	19	43527099	617791	609188	rs749803238	NC_000019.10:43527098:G:T
NM_000117.2(EMD):c.101dup (p.Tyr34Ter)	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000617762	X	153608067 - 153608068	X	154379707 - 154379708	617762	609159	rs1569552079	NC_000023.11:154379707:A:AA
NM_001127221.1(CACNA1A):c.3846C>G (p.Tyr1282Ter)	CACNA1A	Y1282*, Y1285*, Y1281*	Episodic ataxia type 2	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000617754	19	13387922	19	13277108	617754	609152	rs774224202	NC_000019.10:13277107:G:C
NM_014738.6(TMEM94):c.3998+5G>A	TMEM94		Intellectual developmental disorder with cardiac defects and dysmorphic facies	Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617671	17	73495168	17	75499087	617671	609074	rs1567985127	NC_000017.11:75499086:G:A
NM_014738.6(TMEM94):c.810del (p.Asp270fs)	TMEM94	D270fs, D280fs	Intellectual developmental disorder with cardiac defects and dysmorphic facies	Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617668	17	73485392	17	75489311	617668	609071	rs1567950778	NC_000017.11:75489310:C:
NM_014738.6(TMEM94):c.2734C>T (p.Arg912Ter)	TMEM94	R922*, R912*, R921*, R896*, R916*	Intellectual developmental disorder with cardiac defects and dysmorphic facies	Pathogenic(Last reviewed: Feb 6, 2019)	no assertion criteria provided	VCV000617667	17	73491370	17	75495289	617667	609070	rs557746506	NC_000017.11:75495288:C:T
NM_033290.4(MID1):c.1917del (p.Thr640fs)	MID1	T602fs, T640fs	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617627	X	10417495	X	10449455	617627	609027	rs1569265497	NC_000023.11:10449454:GGGG:GGG
NM_000346.4(SOX9):c.491A>C (p.Gln164Pro)	SOX9	Q164P	Camptomelic dysplasia	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617626	17	70118919	17	72122778	617626	609024	rs1567910689	NC_000017.11:72122777:A:C
NM_001466.4(FZD2):c.1644G>A (p.Trp548Ter)	FZD2	W548*	Robinow syndrome, autosomal dominant 2|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000617609	17	42636700	17	44559332	617609	609006	rs1568105666	NC_000017.11:44559331:G:A
NM_017722.4(TRMT1):c.1332_1333del (p.Tyr445fs)	TRMT1	Y409fs, Y416fs, Y445fs, Y184fs	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000617604	19	13220259 - 13220260	19	13109445 - 13109446	617604	609001	rs1203487591	NC_000019.10:13109444:ACA:A
NM_017722.4(TRMT1):c.1506+1G>T	TRMT1		INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000617603	19	13218564	19	13107750	617603	609000	rs1568361011	NC_000019.10:13107749:C:A
NM_001351762.2(TRMT1):c.-114_-83del	TRMT1	Q183fs, Q219fs	INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000617602	19	13223779 - 13223810	19	13112965 - 13112996	617602	608999	rs746572548	NC_000019.10:13112964:TGACGTCAAACCTCTCCGACACCCTCTGGTGCTG:TG
NM_153609.3(TMPRSS6):c.234C>G (p.Tyr78Ter)	TMPRSS6	Y78*, Y69*	Microcytic anemia	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000617552	22	37494585	22	37098545	617552	608921	rs1569024289	NC_000022.11:37098544:G:C
NM_152906.7(TANGO2):c.256C>T (p.Arg86Ter)	TANGO2	R86*, R127*, P26L	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000617515	22	20040098	22	20052575	617515	608879	rs1162037663	NC_000022.11:20052574:C:T
NM_172107.4(KCNQ2):c.958_993dup (p.Val320_Lys331dup)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Oct 24, 2018)	no assertion criteria provided	VCV000617505	20	62070007 - 62070008	20	63438654 - 63438655	617505	608865	rs1568925507	NC_000020.11:63438654:CTTCTCAAAGTGCTTCTGCCTGTGCTGCTCCTGAACCTTC:CTTCTCAAAGTGCTTCTGCCTGTGCTGCTCCTGAACCTTCTCAAAGTGCTTCTGCCTGTGCTGCTCCTGAACCTTC
NM_000334.4(SCN4A):c.2009C>A (p.Ser670Tyr)	SCN4A	S670Y	Potassium aggravated myotonia	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000617484	17	62036635	17	63959275	617484	608846	rs914586984	NC_000017.11:63959274:G:T
GRCh37/hg19 Xq26.2(chrX:132815787-132973332)x0	GPC3		not provided	Pathogenic(Last reviewed: Mar 7, 2016)	no assertion criteria provided	VCV000617153	X	132815787 - 132973332			617153	608489		
GRCh37/hg19 Xp11.3(chrX:43807135-43845720)x0	NDP		not provided	Pathogenic(Last reviewed: Aug 29, 2012)	no assertion criteria provided	VCV000616888	X	43807135 - 43845720			616888	608224		
GRCh37/hg19 Xp21.1(chrX:32041580-32556252)x1	DMD		not provided	Pathogenic(Last reviewed: Jun 20, 2016)	no assertion criteria provided	VCV000616830	X	32041580 - 32556252			616830	608166		
GRCh37/hg19 Xp21.1(chrX:31764087-31864634)x1	DMD		not provided	Pathogenic(Last reviewed: Dec 16, 2016)	no assertion criteria provided	VCV000616828	X	31764087 - 31864634			616828	608164		
GRCh37/hg19 Xp21.1(chrX:31533207-31983162)x0	DMD		not provided	Pathogenic(Last reviewed: Sep 24, 2012)	no assertion criteria provided	VCV000616825	X	31533207 - 31983162			616825	608161		
GRCh37/hg19 Xp22.13(chrX:18444908-18505130)x1	CDKL5		not provided	Pathogenic(Last reviewed: Nov 23, 2015)	no assertion criteria provided	VCV000616769	X	18444908 - 18505130			616769	608105		
GRCh37/hg19 21q22.12(chr21:36394632-36517454)x1	RUNX1		not provided	Pathogenic(Last reviewed: Jun 24, 2016)	no assertion criteria provided	VCV000604915	21	36394632 - 36517454			604915	596251		
NM_005650.3(TCF20):c.4786C>T (p.Arg1596Ter)	TCF20	R1596*	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599647	22	42606526	22	42210520	599647	590983	rs1569144264	NC_000022.11:42210519:G:A
NM_005650.3(TCF20):c.2883C>G (p.Tyr961Ter)	TCF20	Y961*	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599645	22	42608429	22	42212423	599645	590981	rs1208949378	NC_000022.11:42212422:G:C
NM_005650.3(TCF20):c.3486dup (p.Cys1163fs)	TCF20		Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599644	22	42607825 - 42607826	22	42211819 - 42211820	599644	590980	rs1569147315	NC_000022.11:42211819:G:GG
NM_005650.3(TCF20):c.4739_4740AG[1] (p.Arg1581fs)	TCF20		Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599643	22	42606570 - 42606571	22	42210564 - 42210565	599643	590979	rs1569144348	NC_000022.11:42210563:CTCT:CT
NM_005650.3(TCF20):c.2155C>T (p.Arg719Ter)	TCF20	R719*	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599642	22	42609157	22	42213151	599642	590978	rs1569150452	NC_000022.11:42213150:G:A
NM_005650.3(TCF20):c.1960C>T (p.Gln654Ter)	TCF20	Q654*	Neurodevelopmental abnormality|DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599641	22	42609352	22	42213346	599641	590977	rs1569150885	NC_000022.11:42213345:G:A
NM_005650.3(TCF20):c.364dup (p.Gln122fs)	TCF20		Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599640	22	42610947 - 42610948	22	42214941 - 42214942	599640	590976	rs777979354	NC_000022.11:42214941:GGGGGGG:GGGGGGGG
NM_005650.3(TCF20):c.622del (p.Leu208fs)	TCF20	L208fs	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599639	22	42610690	22	42214684	599639	590975	rs1569153915	NC_000022.11:42214683:G:
NM_005650.3(TCF20):c.697C>T (p.Gln233Ter)	TCF20	Q233*	Neurodevelopmental abnormality|DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599638	22	42610615	22	42214609	599638	590974	rs751610641	NC_000022.11:42214608:G:A
NM_005650.3(TCF20):c.932_933del (p.Gln311fs)	TCF20	Q311fs	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599637	22	42610379 - 42610380	22	42214373 - 42214374	599637	590973	rs1569153159	NC_000022.11:42214372:CT:
NM_005650.3(TCF20):c.2088_2089del (p.Glu697fs)	TCF20	E697fs	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000599636	22	42609223 - 42609224	22	42213217 - 42213218	599636	590972	rs1569150635	NC_000022.11:42213216:CA:
NM_015365.3(AMMECR1):c.454del (p.Arg152fs)	AMMECR1	R152fs, R29fs	Short stature	Pathogenic(Last reviewed: Nov 18, 2001)	no assertion criteria provided	VCV000599546	X	109560846	X	110317618	599546	590926	rs1569405174	NC_000023.11:110317617:GGGGGG:GGGGG
NM_001111125.3(IQSEC2):c.4419del (p.Ser1474fs)	IQSEC2	S1474fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000599453	X	53263449	X	53234267	599453	590809	rs1569290954	NC_000023.11:53234266:GGGGGGG:GGGGGG
NM_001111125.3(IQSEC2):c.2582+2T>C	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000599451	X	53277294	X	53248112	599451	590811	rs1569300277	NC_000023.11:53248111:A:G
NM_001282933.2(ZNF341):c.583C>T (p.Gln195Ter)	ZNF341	Q195*, Q105*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599414	20	32341071	20	33753265	599414	590751	rs1568940507	NC_000020.11:33753264:C:T
NM_001282933.2(ZNF341):c.1647C>G (p.Tyr549Ter)	ZNF341	Y542*, Y549*, Y459*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599413	20	32369121	20	33781315	599413	590750	rs376598954	NC_000020.11:33781314:C:G
NM_001282933.2(ZNF341):c.1083del (p.Lys362fs)	ZNF341	K272fs, K355fs, K362fs	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000599412	20	32349722	20	33761916	599412	590749	rs1568945329	NC_000020.11:33761915:G:
NM_001282933.2(ZNF341):c.1156C>T (p.Arg386Ter)	ZNF341	R386*, R379*, R296*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599411	20	32349795	20	33761989	599411	590748	rs982121798	NC_000020.11:33761988:C:T
NM_001282933.2(ZNF341):c.904C>T (p.Arg302Ter)	ZNF341	R302*, R212*	HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000599410	20	32345116	20	33757310	599410	590747	rs746141726	NC_000020.11:33757309:C:T
NM_005650.3(TCF20):c.4774C>T (p.Gln1592Ter)	TCF20	Q1592*	Intellectual disability|Hypotelorism|Generalized hypotonia	Pathogenic(Last reviewed: Nov 6, 2018)	no assertion criteria provided	VCV000599400	22	42606538	22	42210532	599400	590736		NC_000022.11:42210531:G:A
NM_000836.2(GRIN2D):c.1345G>A (p.Asp449Asn)	GRIN2D	D449N	Epileptic encephalopathy, early infantile, 46	Pathogenic(Last reviewed: Jan 15, 2019)	no assertion criteria provided	VCV000599390	19	48917774	19	48414517	599390	590726	rs1569064110	NC_000019.10:48414516:G:A
NM_000836.2(GRIN2D):c.2080A>C (p.Ser694Arg)	GRIN2D	S694R	Epileptic encephalopathy, early infantile, 46	Pathogenic(Last reviewed: Jan 15, 2019)	no assertion criteria provided	VCV000599389	19	48923060	19	48419803	599389	590725	rs1569065866	NC_000019.10:48419802:A:C
NM_000836.2(GRIN2D):c.2043G>C (p.Met681Ile)	GRIN2D	M681I	Epileptic encephalopathy, early infantile, 46	Pathogenic(Last reviewed: Jan 16, 2019)	no assertion criteria provided	VCV000599388	19	48923023	19	48419766	599388	590724	rs1569065861	NC_000019.10:48419765:G:C
NM_014975.3(MAST1):c.1549G>A (p.Gly517Ser)	MAST1	G517S	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599361	19	12975903	19	12865089	599361	590669	rs1568413207	NC_000019.10:12865088:G:A
NM_014975.3(MAST1):c.832_834del (p.Leu279del)	MAST1	L279del	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599360	19	12962804 - 12962806	19	12851990 - 12851992	599360	590668	rs1568409502	NC_000019.10:12851989:GTTG:G
NM_014975.3(MAST1):c.826_828AAG[1] (p.Lys277del)	MAST1	K277del	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599359	19	12962798 - 12962800	19	12851984 - 12851986	599359	590667	rs1568409494	NC_000019.10:12851983:GAAGAAG:GAAG
NM_014975.3(MAST1):c.580_582GAG[1] (p.Glu195del)	MAST1	E195del	MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599358	19	12958676 - 12958678	19	12847862 - 12847864	599358	590666	rs1568408280	NC_000019.10:12847861:GGAGGAG:GGAG
GRCh37/hg19 17q24.3(chr17:69475275-69499520)x3	SOX9		46,XX sex reversal 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000599356	17	69458943 - 69499834			599356	590650		
GRCh37/hg19 17q24.3(chr17:69458883-69482850)x3	SOX9		46,XX sex reversal 2	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000599355	17	69393372 - 69483073			599355	590649		
NM_000307.5(POU3F4):c.975G>A (p.Trp325Ter)	POU3F4	W325*	Deafness, X-linked 2	Pathogenic(Last reviewed: Sep 10, 2017)	criteria provided, single submitter	VCV000599350	X	82764307	X	83509299	599350	590644	rs1569280385	NC_000023.11:83509298:G:A
NM_001252.5(CD70):c.552_554CTT[1] (p.Phe186del)	CD70	F186del	Severe combined immunodeficiency due to CD70 deficiency	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599339	19	6586056 - 6586058	19	6586045 - 6586047	599339	590636	rs1568431102	NC_000019.10:6586044:AAGAAG:AAG
NM_001252.5(CD70):c.250del (p.Ser84fs)	CD70	S84fs	Severe combined immunodeficiency due to CD70 deficiency	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599338	19	6586363	19	6586352	599338	590635	rs1568431262	NC_000019.10:6586351:A:
NM_001252.5(CD70):c.535C>T (p.Arg179Ter)	CD70	R179*	Severe combined immunodeficiency due to CD70 deficiency	Pathogenic(Last reviewed: Jan 10, 2019)	no assertion criteria provided	VCV000599337	19	6586078	19	6586067	599337	590634	rs368303189	NC_000019.10:6586066:G:A
NM_004655.4(AXIN2):c.1460_1472dup (p.Pro494fs)	AXIN2		Colorectal cancer|Oligodontia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000599333	17	63533681 - 63533682	17	65537563 - 65537564	599333	590610	rs1567755946	NC_000017.11:65537563:GCCGCGGGAGGCAGC:GCCGCGGGAGGCAGCCGCGGGAGGCAGC
NM_002340.6(LSS):c.625A>T (p.Asn209Tyr)	LSS	N209Y, N129Y, N198Y	ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000599323	21	47639412	21	46219498	599323	590598	rs754230211	NC_000021.9:46219497:T:A
NM_002340.6(LSS):c.423G>A (p.Trp141Ter)	LSS	W141*, W61*	ALOPECIA-MENTAL RETARDATION SYNDROME 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000599322	21	47642549	21	46222635	599322	590597	rs1569036540	NC_000021.9:46222634:C:T
NM_002340.6(LSS):c.304C>G (p.Leu102Val)	LSS	L102V, L22V	HYPOTRICHOSIS 14	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599321	21	47647481	21	46227567	599321	590596	rs1569039353	NC_000021.9:46227566:G:C
NM_002340.6(LSS):c.743T>C (p.Leu248Pro)	LSS	L248P, L168P, L237P	HYPOTRICHOSIS 14	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599320	21	47636343	21	46216429	599320	590595	rs1260995701	NC_000021.9:46216428:A:G
NM_002340.6(LSS):c.1172T>C (p.Phe391Ser)	LSS	F391S, F311S, F380S	HYPOTRICHOSIS 14	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599319	21	47630624	21	46210710	599319	590594	rs1249530918	NC_000021.9:46210709:A:G
NM_002340.6(LSS):c.1887G>T (p.Trp629Cys)	LSS	W629C, W549C, W618C	Cataract 44	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599318	21	47614506	21	46194592	599318	590593	rs764098604	NC_000021.9:46194591:C:A
NM_002340.6(LSS):c.1025T>G (p.Ile342Ser)	LSS	I342S, I262S, I331S	Cataract 44	Pathogenic(Last reviewed: Jan 8, 2019)	no assertion criteria provided	VCV000599317	21	47633736	21	46213822	599317	590592	rs749141857	NC_000021.9:46213821:A:C
NM_004606.4(TAF1):c.3568C>T (p.Arg1190Cys)	TAF1	R1190C, R1169C	Mental retardation, X-linked, syndromic 33	Pathogenic	criteria provided, single submitter	VCV000599303	X	70617204	X	71397354	599303	590565	rs1569301036	NC_000023.11:71397353:C:T
NM_014728.3(FRMPD4):c.856C>T (p.Arg286Ter)	FRMPD4	R286*, R278*, R246*, R288*, R323*, R283*	Mental retardation, X-linked 104	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000599280	X	12712496	X	12694377	599280	590542	rs1569057837	NC_000023.11:12694376:C:T
NC_000023.10:g.12515801_12581900del	FRMPD4		Mental retardation, X-linked 104	Pathogenic(Last reviewed: Jan 7, 2019)	no assertion criteria provided	VCV000599279	X	12515801 - 12581900			599279	590541		
NM_033380.3(COL4A5):c.1132_1138del (p.Ile378fs)	COL4A5	I378fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000599160	X	107829944 - 107829950	X	108586714 - 108586720	599160	590344	rs1569492147	NC_000023.11:108586713:ATACAGG:
NM_033380.3(COL4A5):c.3604+2T>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000599120	X	107910415	X	108667185	599120	590353	rs1569505613	NC_000023.11:108667184:T:A
NM_033380.3(COL4A5):c.834+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 17, 2018)	no assertion criteria provided	VCV000599107	X	107823818	X	108580588	599107	590343	rs1569490932	NC_000023.11:108580587:T:G
NM_033380.3(COL4A5):c.1843G>A (p.Gly615Arg)	COL4A5	G615R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000599064	X	107841995	X	108598765	599064	590347	rs1569494304	NC_000023.11:108598764:G:A
NM_033380.3(COL4A5):c.3247-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 19, 2017)	no assertion criteria provided	VCV000599056	X	107898560	X	108655330	599056	590351	rs1569504056	NC_000023.11:108655329:G:A
NM_000252.2(MTM1):c.1262G>T (p.Arg421Leu)	MTM1	R421L	High palate|Congenital microcephaly|Generalized neonatal hypotonia|Abnormality of the nares|Enlarged naris|Generalized hypotonia|Toe clinodactyly|Postnatal microcephaly|Neonatal hypotonia|Decreased fetal movement|Polyhydramnios|Abnormality of the cerebral white matter|Diffuse white matter abnormalities	Pathogenic	criteria provided, single submitter	VCV000599006	X	149828138	X	150659665	599006	590097	rs587783772	NC_000023.11:150659664:G:T
NM_182641.4(BPTF):c.5337_5338del (p.Val1780fs)	BPTF	V1780fs, V1906fs	Joint laxity|Cafe-au-lait spot|Seizures|Autistic disorder of childhood onset	Pathogenic	criteria provided, single submitter	VCV000598947	17	65914862 - 65914863	17	67918746 - 67918747	598947	590084	rs1568070621	NC_000017.11:67918745:GAG:G
NM_030632.3(ASXL3):c.1351C>T (p.Gln451Ter)	ASXL3	Q451*	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000598774	18	31318719	18	33738755	598774	589844	rs1179499890	NC_000018.10:33738754:C:T
Single allele	ZC4H2		Wieacker Wolff syndrome	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000598761	X	64171841 - 64267316			598761	589822		
NM_001347721.2(DYRK1A):c.197_200TAAC[1] (p.Asn68fs)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000598757	21	38845171 - 38845174	21	37472869 - 37472872	598757	589813	rs1569355102	NC_000021.9:37472868:CTAACTAAC:CTAAC
NM_015338.5(ASXL1):c.1283_1284del (p.Gln428fs)	ASXL1	Q428fs, Q367fs	Bohring-Opitz syndrome	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000598750	20	31021284 - 31021285	20	32433481 - 32433482	598750	589812	rs1569324457	NC_000020.11:32433480:AG:
NM_014738.6(TMEM94):c.765-1G>C	TMEM94		Intellectual developmental disorder with cardiac defects and dysmorphic facies|TMEM94-related condition	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000598744	17	73485346	17	75489265	598744	589808	rs1352010373	NC_000017.11:75489264:G:C
NM_014738.6(TMEM94):c.2605dup (p.Met869fs)	TMEM94		Intellectual developmental disorder with cardiac defects and dysmorphic facies|TMEM94-related condition	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000598743	17	73490986 - 73490987	17	75494905 - 75494906	598743	589809	rs1163944538	NC_000017.11:75494905:AAAAAA:AAAAAAA
NM_000109.4(DMD):c.3350C>A (p.Ser1117Ter)	DMD	S1125*, S1117*, S1002*, S1121*	not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000598713	X	32481614	X	32463497	598713	589774	rs374744331	NC_000023.11:32463496:G:T
NM_001429.4(EP300):c.2540dup (p.Ser848fs)	EP300		not provided	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000598616	22	41545920 - 41545921	22	41149916 - 41149917	598616	589677	rs1569107391	NC_000022.11:41149916:CCCCC:CCCCCC
NM_001039141.3(TRIOBP):c.3487_3533del (p.Pro1163fs)	TRIOBP	P1163fs	not provided	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000598439	22	38122040 - 38122086	22	37726033 - 37726079	598439	589500	rs1569042640	NC_000022.11:37726032:CATCCCCACCCCTGTGTGCATTGGGCACCGGGATGCACCCTCCTTCTCATCCCCACC:CATCCCCACC
NM_001008537.3(NEXMIF):c.773G>A (p.Trp258Ter)	NEXMIF	W258*	not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000598239	X	73963619	X	74743784	598239	589300	rs1569335877	NC_000023.11:74743783:C:T
NM_176787.5(PIGN):c.981dup (p.Met328fs)	PIGN		not provided|Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000598225	18	59807694 - 59807695	18	62140461 - 62140462	598225	589286	rs776697598	NC_000018.10:62140461:C:CC
NM_172107.4(KCNQ2):c.102del (p.Thr35fs)	KCNQ2	T35fs	not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000598155	20	62103715	20	63472362	598155	589216	rs1568986619	NC_000020.11:63472361:GG:G
NM_000152.5(GAA):c.1326+1G>A	GAA		not provided	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000597944	17	78082628	17	80108829	597944	589005	rs1205507761	NC_000017.11:80108828:G:A
NM_001184880.2(PCDH19):c.841del (p.Val281fs)	PCDH19	V281fs	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000597883	X	99662755	X	100407757	597883	588944	rs1569315381	NC_000023.11:100407756:C:
NM_004013.2(DMD):c.-732C>T	DMD	Q2217*, Q2209*, Q873*, Q2094*, Q2213*, Q876*	not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000597691	X	31950310	X	31932193	597691	588752	rs1569516166	NC_000023.11:31932192:G:A
NM_000109.4(DMD):c.752_753del (p.Lys251fs)	DMD	K259fs, K251fs, K136fs, K255fs	not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000597634	X	32717283 - 32717284	X	32699166 - 32699167	597634	588695	rs1569469138	NC_000023.11:32699165:TTT:T
NM_001083961.2(WDR62):c.1677_1680dup (p.Ile561fs)	WDR62		not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000597606	19	36577621 - 36577622	19	36086719 - 36086720	597606	588667	rs1568351433	NC_000019.10:36086719:GGCTG:GGCTGGCTG
NM_024301.5(FKRP):c.740del (p.Pro247fs)	FKRP	P247fs	not provided	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000597598	19	47259443	19	46756186	597598	588659	rs1568418845	NC_000019.10:46756185:CCCCC:CCCC
NM_001848.2(COL6A1):c.2122C>T (p.Gln708Ter)	COL6A1	Q708*	not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000597567	21	47422187	21	46002273	597567	588628	rs1569519109	NC_000021.9:46002272:C:T
NM_024301.5(FKRP):c.264C>G (p.Tyr88Ter)	FKRP	Y88*	not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000597390	19	47258971	19	46755714	597390	588451	rs1057520771	NC_000019.10:46755713:C:G
NM_000531.6(OTC):c.391_397dup (p.Ser133delinsIleValTer)	OTC		not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000597358	X	38260529 - 38260530	X	38401276 - 38401277	597358	588419	rs1569279343	NC_000023.11:38401276:TATTGTCTA:TATTGTCTATTGTCTA
NM_015295.2(SMCHD1):c.1872_1873del (p.Phe624fs)	SMCHD1	F624fs	not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000597334	18	2705719 - 2705720	18	2705721 - 2705722	597334	588395	rs1568188407	NC_000018.10:2705720:TTTT:TT
NM_000109.4(DMD):c.1596G>A (p.Trp532Ter)	DMD	W540*, W536*, W417*, W532*	not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000597288	X	32591946	X	32573829	597288	588349	rs1569230389	NC_000023.11:32573828:C:T
NM_000023.4(SGCA):c.676C>T (p.Gln226Ter)	SGCA	Q226*	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000597232	17	48246544	17	50169183	597232	588293	rs1567741398	NC_000017.11:50169182:C:T
NM_001366385.1(CARD14):c.412G>A (p.Glu138Lys)	CARD14	E138K	Papulosquamous eruptions|not provided	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000597197	17	78157774	17	80183975	597197	588258	rs1567872320	NC_000017.11:80183974:G:A
NM_000152.5(GAA):c.1030_1031del (p.Gly344fs)	GAA	G344fs	not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000597147	17	78082162 - 78082163	17	80108363 - 80108364	597147	588208	rs1567829962	NC_000017.11:80108362:GGG:G
NM_000023.4(SGCA):c.315_316CA[1] (p.Thr106fs)	SGCA		not provided	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000597055	17	48245310 - 48245311	17	50167949 - 50167950	597055	588116	rs1567739735	NC_000017.11:50167948:CACA:CA
NM_000109.4(DMD):c.5673dup (p.Leu1892fs)	DMD		not provided|not specified|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597052	X	32361292 - 32361293	X	32343175 - 32343176	597052	588113	rs794727661	NC_000023.11:32343175:TTTTTTTT:TTTTTTTTT
NM_006517.5(SLC16A2):c.46C>T (p.Gln16Ter)	SLC16A2	Q16*	not provided	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000597045	X	73641518	X	74421683	597045	588106	rs1569280986	NC_000023.11:74421682:C:T
NM_000109.4(DMD):c.3233dup (p.Gln1079fs)	DMD		not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000597011	X	32482721 - 32482722	X	32464604 - 32464605	597011	588072	rs1569563740	NC_000023.11:32464604:TTTTTT:TTTTTTT
NM_000152.5(GAA):c.2655_2656del (p.Val886fs)	GAA	V886fs	not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000597005	17	78092460 - 78092461	17	80118661 - 80118662	597005	588066	rs1555603219	NC_000017.11:80118660:CG:
NM_000109.4(DMD):c.1954_1955del (p.Lys652fs)	DMD	K652fs, K656fs, K537fs, K660fs	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000596932	X	32583832 - 32583833	X	32565715 - 32565716	596932	587993	rs1569213903	NC_000023.11:32565714:TTTT:TT
NM_000109.4(DMD):c.1745_1748dup (p.Lys583delinsAsnTer)	DMD		not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000596922	X	32591686 - 32591687	X	32573569 - 32573570	596922	587983	rs1569229221	NC_000023.11:32573569:TTAA:TTAATTAA
NM_004006.2(DMD):c.10087-2A>G	DMD		not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000596803	X	31196924	X	31178807	596803	587864	rs1569420861	NC_000023.11:31178806:T:C
NM_000213.5(ITGB4):c.4642_4645del (p.Trp1548fs)	ITGB4	W1548fs, W1478fs, W1531fs	not provided	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000596771	17	73751863 - 73751866	17	75755782 - 75755785	596771	587832	rs1568385656	NC_000017.11:75755781:GCTGGC:GC
NM_001848.2(COL6A1):c.1693C>T (p.Arg565Ter)	COL6A1	R565*	not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000596692	21	47419085	21	45999171	596692	587753	rs1304888945	NC_000021.9:45999170:C:T
NM_001165927.1(MKS1):c.1219del (p.Ala407fs)	MKS1	A214fs, A407fs, A417fs	not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000596505	17	56285279	17	58207918	596505	587566	rs1567796331	NC_000017.11:58207917:CCCC:CCC
NM_000109.4(DMD):c.5656del (p.Asp1886fs)	DMD	D1890fs, D550fs, D1886fs, D1894fs, D553fs, D1771fs	not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000596413	X	32361310	X	32343193	596413	587474	rs1569558964	NC_000023.11:32343192:CC:C
NM_000109.4(DMD):c.6001C>T (p.Gln2001Ter)	DMD	Q2009*, Q2001*, Q2005*, Q665*, Q1886*, Q668*	not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000596350	X	32328291	X	32310174	596350	587411	rs1569556943	NC_000023.11:32310173:G:A
NM_000033.4(ABCD1):c.1074_1075AG[1] (p.Glu359fs)	ABCD1		not provided	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000596275	X	152994860 - 152994861	X	153729405 - 153729406	596275	587336	rs1569540883	NC_000023.11:153729404:AGAG:AG
NM_005603.6(ATP8B1):c.614dup (p.Asn205fs)	ATP8B1		not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000596167	18	55365039 - 55365040	18	57697807 - 57697808	596167	587228	rs761784230	NC_000018.10:57697807:TTTTTTTT:TTTTTTTTT
NM_000152.5(GAA):c.482_483del (p.Pro161fs)	GAA	P161fs	not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000596146	17	78078865 - 78078866	17	80105066 - 80105067	596146	587207	rs764750389	NC_000017.11:80105065:CCCC:CC
NM_001848.2(COL6A1):c.903+1G>T	COL6A1		not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000596078	21	47409567	21	45989653	596078	587139	rs1569518119	NC_000021.9:45989652:G:T
NM_015295.2(SMCHD1):c.3197del (p.Met1066fs)	SMCHD1	M1066fs	not provided	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000596075	18	2732411	18	2732413	596075	587136	rs1568261067	NC_000018.10:2732412:T:
NM_000109.4(DMD):c.9703C>T (p.Gln3235Ter)	DMD	Q3243*, Q3120*, Q1899*, Q3239*, Q514*, Q783*, Q175*, Q1902*, Q3235*	not provided	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000595953	X	31222158	X	31204041	595953	587014	rs1569460722	NC_000023.11:31204040:G:A
NM_000109.4(DMD):c.1579-2A>C	DMD		not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000595916	X	32591965	X	32573848	595916	586977	rs773779441	NC_000023.11:32573847:T:G
NM_000109.4(DMD):c.1038G>A (p.Trp346Ter)	DMD	W354*, W350*, W231*, W346*	not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000595844	X	32663168	X	32645051	595844	586906	rs1569376447	NC_000023.11:32645050:C:T
NM_000109.4(DMD):c.2532G>A (p.Trp844Ter)	DMD	W852*, W844*, W848*, W729*	not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000595843	X	32509460	X	32491343	595843	586905	rs1429329309	NC_000023.11:32491342:C:T
NM_000109.4(DMD):c.3476C>G (p.Ser1159Ter)	DMD	S1167*, S1159*, S1163*, S1044*	not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000595842	X	32472882	X	32454765	595842	586904	rs1569563278	NC_000023.11:32454764:G:C
NM_004013.2(DMD):c.-801G>T	DMD	E2194*, E2071*, E850*, E2190*, E2186*, E853*	not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000595841	X	31986490	X	31968373	595841	586903	rs1304218104	NC_000023.11:31968372:C:A
NM_020956.2(PRX):c.*3058dup	PRX		Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000595695	19	40901405 - 40901406	19	40395498 - 40395499	595695	586757	rs1568704829	NC_000019.10:40395498:A:AA
NM_015295.2(SMCHD1):c.1186C>T (p.Gln396Ter)	SMCHD1	Q396*	not provided	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000595554	18	2697883	18	2697885	595554	586616	rs377471712	NC_000018.10:2697884:C:T
NM_000109.4(DMD):c.2105del (p.Lys702fs)	DMD	K587fs, K702fs, K710fs, K706fs	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000595522	X	32563315	X	32545198	595522	586584	rs1569169560	NC_000023.11:32545197:TTTT:TTT
NM_000109.4(DMD):c.4762_4763del (p.Lys1588fs)	DMD	K1473fs, K252fs, K1592fs, K1596fs, K1588fs, K255fs	not provided	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000595496	X	32398685 - 32398686	X	32380568 - 32380569	595496	586558	rs1569560475	NC_000023.11:32380567:TTT:T
NM_000152.5(GAA):c.1134C>G (p.Tyr378Ter)	GAA	Y378*	not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000595469	17	78082346	17	80108547	595469	586531	rs1567830317	NC_000017.11:80108546:C:G
NM_001848.2(COL6A1):c.1641_1642del (p.Asp548fs)	COL6A1	D548fs	not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000595434	21	47418837 - 47418838	21	45998923 - 45998924	595434	586496	rs1569518771	NC_000021.9:45998922:GGGGG:GGG
NM_000023.4(SGCA):c.1039_1042dup (p.Ala348fs)	SGCA		not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000595224	17	48252671 - 48252672	17	50175310 - 50175311	595224	586286	rs1567746537	NC_000017.11:50175310:GATGG:GATGGATGG
NM_000074.2(CD40LG):c.347-2A>G	CD40LG		not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000595194	X	135738513	X	136656354	595194	586256	rs1569377237	NC_000023.11:136656353:A:G
NM_000109.4(DMD):c.3899C>A (p.Ser1300Ter)	DMD	S1308*, S1185*, S1304*, S1300*	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000595153	X	32456506	X	32438389	595153	586215	rs1569562466	NC_000023.11:32438388:G:T
NM_004006.2(DMD):c.831+1G>T	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595152	X	32717228	X	32699111	595152	586214	rs1239018406	NC_000023.11:32699110:C:A
NM_015295.2(SMCHD1):c.1670_1671GA[1] (p.Glu558fs)	SMCHD1		not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000595045	18	2703711 - 2703712	18	2703713 - 2703714	595045	586107	rs1568183325	NC_000018.10:2703712:AGAGA:AGA
NM_000109.4(DMD):c.2890del (p.Tyr964fs)	DMD	Y964fs, Y972fs, Y849fs, Y968fs	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000594994	X	32490316	X	32472199	594994	586056	rs1569564281	NC_000023.11:32472198:A:
NM_000117.2(EMD):c.468_471del (p.Arg157fs)	EMD	R157fs	not provided	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000594972	X	153609257 - 153609260	X	154380897 - 154380900	594972	586034	rs1569552102	NC_000023.11:154380896:CGGCCGG:CGG
NM_000109.4(DMD):c.8366+1G>C	DMD		not provided	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000594953	X	31525397	X	31507280	594953	586015	rs1064794569	NC_000023.11:31507279:C:G
NM_000271.5(NPC1):c.2830G>A (p.Asp944Asn)	NPC1	D944N	not provided	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000594885	18	21119400	18	23539436	594885	585947	rs748837410	NC_000018.10:23539435:C:T
NM_144612.6(LOXHD1):c.2870C>A (p.Ser957Ter)	LOXHD1	S957*	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000594870	18	44140237	18	46560274	594870	585932	rs1440105492	NC_000018.10:46560273:G:T
NM_000033.4(ABCD1):c.1203del (p.Ile402fs)	ABCD1	I402fs	not provided	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000594664	X	153001686	X	153736232	594664	585727	rs1569541007	NC_000023.11:153736231:GG:G
NM_000023.4(SGCA):c.203del (p.Gly68fs)	SGCA	G68fs	not provided	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000594552	17	48244986	17	50167625	594552	585615	rs1567739228	NC_000017.11:50167624:GGG:GG
NM_000109.4(DMD):c.5539C>T (p.Gln1847Ter)	DMD	Q1855*, Q1732*, Q1847*, Q511*, Q1851*, Q514*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000594248	X	32364083	X	32345966	594248	585311	rs1569559097	NC_000023.11:32345965:G:A
NM_000276.4(OCRL):c.2428C>T (p.Arg810Ter)	OCRL	R810*, R802*, R811*	Lowe syndrome|not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000594148	X	128722949	X	129588972	594148	585211	rs1569463775	NC_000023.11:129588971:C:T
NM_000213.5(ITGB4):c.2763C>A (p.Tyr921Ter)	ITGB4	Y921*	not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000594018	17	73738551	17	75742470	594018	585081	rs1568366397	NC_000017.11:75742469:C:A
NM_000109.4(DMD):c.8037del (p.His2680fs)	DMD	H2565fs, H1344fs, H2688fs, H1347fs, H2680fs, H2684fs, H228fs	not provided	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000593897	X	31645946	X	31627829	593897	584960	rs1569140330	NC_000023.11:31627828:A:
NM_000328.3(RPGR):c.154G>A (p.Gly52Arg)	RPGR	G52R, G62R	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000593841	X	38182652	X	38323399	593841	584904	rs281865296	NC_000023.11:38323398:C:T
NM_000109.4(DMD):c.5948del (p.Leu1983fs)	DMD	L1987fs, L650fs, L1983fs, L647fs, L1868fs, L1991fs	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000593816	X	32328344	X	32310227	593816	584879	rs1569556948	NC_000023.11:32310226:AAA:AA
NM_004006.2(DMD):c.264+1G>A	DMD		not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000593815	X	32862899	X	32844782	593815	584878	rs1569533147	NC_000023.11:32844781:C:T
NM_004006.2(DMD):c.5867G>A (p.Trp1956Ter)	DMD	W1956*, W1833*, W612*, W1948*, W1952*, W615*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000593723	X	32360272	X	32342155	593723	584786	rs1569558906	NC_000023.11:32342154:C:T
NM_000109.4(DMD):c.498_499del (p.His166fs)	DMD	H166fs, H170fs, H51fs, H174fs	not provided	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000593722	X	32834592 - 32834593	X	32816475 - 32816476	593722	584785	rs1569528090	NC_000023.11:32816474:TAT:T
NM_005559.4(LAMA1):c.1942_1948del (p.Phe648fs)	LAMA1	F648fs	not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000593704	18	7034581 - 7034587	18	7034582 - 7034588	593704	584767	rs754361205	NC_000018.10:7034581:TGTGAAA:
NM_006012.4(CLPP):c.367+2T>C	CLPP		not provided	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000593703	19	6362555	19	6362544	593703	584766	rs909909437	NC_000019.10:6362543:T:C
NM_000152.5(GAA):c.1802C>A (p.Ser601Ter)	GAA	S601*	not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000593486	17	78086424	17	80112625	593486	584550	rs374470794	NC_000017.11:80112624:C:A
NM_000109.4(DMD):c.5366_5387del (p.Leu1789fs)	DMD	L1789fs, L1674fs, L453fs, L456fs, L1793fs, L1797fs	not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000593482	X	32366560 - 32366581	X	32348443 - 32348464	593482	584546	rs1569559198	NC_000023.11:32348442:CCCTGCTGAATTTCAGCCTCCA:
NM_000109.4(DMD):c.7986G>A (p.Trp2662Ter)	DMD	W2670*, W210*, W2547*, W2662*, W1329*, W1326*, W2666*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000593328	X	31676124	X	31658007	593328	584392	rs1569186252	NC_000023.11:31658006:C:T
NM_004006.2(DMD):c.5371C>T (p.Gln1791Ter)	DMD	Q1791*, Q1668*, Q1787*, Q447*, Q1783*, Q450*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000593327	X	32366600	X	32348483	593327	584391	rs1569559204	NC_000023.11:32348482:G:A
NM_000109.4(DMD):c.2171dup (p.His724fs)	DMD		not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000593296	X	32536221 - 32536222	X	32518104 - 32518105	593296	584360	rs1569565192	NC_000023.11:32518104:T:TT
NM_000109.4(DMD):c.3196G>T (p.Glu1066Ter)	DMD	E1074*, E1066*, E1070*, E951*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000593295	X	32482759	X	32464642	593295	584359	rs1569563751	NC_000023.11:32464641:C:A
NM_004006.2(DMD):c.9807+1G>T	DMD		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000593221	X	31222077	X	31203960	593221	584285	rs1569460610	NC_000023.11:31203959:C:A
NM_000023.4(SGCA):c.115_116insT (p.Thr39fs)	SGCA		not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000593203	17	48244806 - 48244807	17	50167445 - 50167446	593203	584267	rs1567738897	NC_000017.11:50167445::T
NM_000109.4(DMD):c.4127del (p.Glu1376fs)	DMD	E1380fs, E40fs, E1261fs, E1384fs, E1376fs, E43fs	not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000593200	X	32429951	X	32411834	593200	584264	rs1569561687	NC_000023.11:32411833:T:
NM_000292.3(PHKA2):c.2746C>T (p.Arg916Trp)	PHKA2	R916W	not provided|Glycogen storage disease type IXa1	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000593082	X	18924673	X	18906555	593082	584146	rs1569297427	NC_000023.11:18906554:G:A
NM_004006.2(DMD):c.1652G>A (p.Trp551Ter)	DMD	W551*, W547*, W428*, W543*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000593031	X	32591914	X	32573797	593031	584095	rs1569230215	NC_000023.11:32573796:C:T
NM_000109.4(DMD):c.5705_5709del (p.Arg1902fs)	DMD	R1787fs, R1906fs, R1910fs, R1902fs, R566fs, R569fs	not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000593021	X	32361257 - 32361261	X	32343140 - 32343144	593021	584085	rs1569558953	NC_000023.11:32343139:TTTCCTTTC:TTTC
NM_020964.3(EPG5):c.6608_6609insTCAG (p.Lys2205fs)	EPG5		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000593013	18	43446775 - 43446776	18	45866810 - 45866811	593013	584077	rs1568103027	NC_000018.10:45866810:CTG:CTGACTG
NM_138927.3(SON):c.1579_1613del (p.His527fs)	SON	H527fs	not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000592963	21	34923111 - 34923145	21	33550805 - 33550839	592963	584027	rs1569052840	NC_000021.9:33550804:CTGGGCATCCTGAGGTGACAACGGCAACAGGGTTGCTGGG:CTGGG
NM_004006.2(DMD):c.8775G>A (p.Trp2925Ter)	DMD	W2925*, W1581*, W2917*, W196*, W2802*, W2921*, W465*, W1584*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000592600	X	31496385	X	31478268	592600	583665	rs868688877	NC_000023.11:31478267:C:T
NM_006517.5(SLC16A2):c.327G>A (p.Trp109Ter)	SLC16A2	W109*	not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000592273	X	73641799	X	74421964	592273	583311	rs1569281190	NC_000023.11:74421963:G:A
NM_000109.4(DMD):c.9743dup (p.Ser3249fs)	DMD		not provided	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000592244	X	31222117 - 31222118	X	31204000 - 31204001	592244	100760	rs398124103	NC_000023.11:31204000:CCCCC:CCCCCC
NM_001278116.2(L1CAM):c.3201T>G (p.Tyr1067Ter)	L1CAM	Y1067*, Y1062*	not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000592224	X	153129898	X	153864443	592224	583262	rs1569544629	NC_000023.11:153864442:A:C
NM_000271.5(NPC1):c.1138_1139CT[1] (p.Trp381fs)	NPC1		not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000592188	18	21136392 - 21136393	18	23556428 - 23556429	592188	583226	rs1567965488	NC_000018.10:23556427:AGAG:AG
NM_000202.8(IDS):c.1265G>T (p.Cys422Phe)	IDS	C422F, C332F	not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000592185	X	148564665	X	149483134	592185	583223	rs886044835	NC_000023.11:149483133:C:A
t(X;3)(q13.3;q11.2)dn	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000592173			3	96297926 - 96297934	592173	583209		
NM_000132.3(F8):c.2044G>T (p.Val682Phe)	F8	V682F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000592086	X	154176042	X	154947767	592086	583136	rs1569559755	NC_000023.11:154947766:C:A
NM_005984.5(SLC25A1):c.740G>A (p.Arg247Gln)	SLC25A1	R247Q, R144Q, R254Q	MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000590940	22	19164098	22	19176585	590940	581884	rs781908532	NC_000022.11:19176584:C:T
NM_173477.5(USH1G):c.854dup (p.Ala286fs)	USH1G		Hearing impairment	Pathogenic(Last reviewed: Oct 8, 2018)	no assertion criteria provided	VCV000590930	17	72916076 - 72916077	17	74919981 - 74919982	590930	581876	rs1567939718	NC_000017.11:74919981:C:CC
NM_004006.2(DMD):c.4486G>T (p.Glu1496Ter)	DMD	E1496*, E1488*, E1373*, E152*, E155*, E1492*	MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD|Duchenne muscular dystrophy	Pathogenic	criteria provided, single submitter	VCV000590902	X	32407650	X	32389533	590902	581847	rs1569560739	NC_000023.11:32389532:C:A
NM_001242897.2(DEPDC5):c.2278C>T (p.Arg760Ter)	DEPDC5	R760*, R838*, R810*, R829*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000590901	22	32234828	22	31838842	590901	581846	rs1569067939	NC_000022.11:31838841:C:T
NM_000475.5(NR0B1):c.919G>T (p.Glu307Ter)	NR0B1	E307*	Congenital adrenal hypoplasia, X-linked|Congenital adrenal hypoplasia, X-linked|46,XY sex reversal, type 2	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000590884	X	30326562	X	30308445	590884	581824	rs1324519932	NC_000023.11:30308444:C:A
NM_014727.2(KMT2B):c.5336G>A (p.Arg1779Gln)	KMT2B	R1779Q	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000590881	19	36221667	19	35730766	590881	581822	rs779863547	NC_000019.10:35730765:G:A
NM_014727.2(KMT2B):c.4622C>T (p.Ala1541Val)	KMT2B	A1541V	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000590880	19	36219725	19	35728824	590880	581821	rs1568377293	NC_000019.10:35728823:C:T
NM_000528.4(MAN2B1):c.729_730insTT (p.Ser244fs)	MAN2B1		Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency	Pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000590807	19	12774550 - 12774551	19	12663736 - 12663737	590807	581776	rs1568307275	NC_000019.10:12663736::AA
NM_005650.3(TCF20):c.3760dup (p.Arg1254fs)	TCF20		Intellectual disability	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000590792	22	42607551 - 42607552	22	42211545 - 42211546	590792	581731	rs1569146649	NC_000022.11:42211545:T:TT
NM_005650.3(TCF20):c.5725C>T (p.His1909Tyr)	TCF20	H1909Y	Autistic behavior|Muscular hypotonia|Attention deficit hyperactivity disorder|Neurodevelopmental delay|Neurodevelopmental abnormality	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590780	22	42575639	22	42179633	590780	581716	rs1569110700	NC_000022.11:42179632:G:A
NM_005650.3(TCF20):c.1810_1811del (p.Val604fs)	TCF20	V604fs	Intellectual disability, mild|Autistic disorder of childhood onset	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000590779	22	42609501 - 42609502	22	42213495 - 42213496	590779	581715	rs1569151204	NC_000022.11:42213494:ACA:A
NM_005650.3(TCF20):c.2594C>G (p.Ser865Ter)	TCF20	S865*	Myoclonus|Intellectual disability, mild|Autistic disorder of childhood onset	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000590778	22	42608718	22	42212712	590778	581714	rs1569149539	NC_000022.11:42212711:G:C
NM_005650.3(TCF20):c.3605dup (p.Pro1203fs)	TCF20		Pectus excavatum|Intellectual disability, moderate|Failure to thrive|Ptosis|Generalized hypotonia	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000590777	22	42607706 - 42607707	22	42211700 - 42211701	590777	581713	rs1569146993	NC_000022.11:42211700:CC:CCC
NM_001915.4(CYB561):c.131G>A (p.Trp44Ter)	CYB561	W44*, W51*	ORTHOSTATIC HYPOTENSION 2	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590764	17	61514778	17	63437417	590764	581701	rs1437737028	NC_000017.11:63437416:C:T
NM_001915.4(CYB561):c.262G>A (p.Gly88Arg)	CYB561	G88R, G95R	ORTHOSTATIC HYPOTENSION 2	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590763	17	61513454	17	63436093	590763	581700	rs772361572	NC_000017.11:63436092:C:T
NM_031310.3(PLVAP):c.101T>C (p.Leu34Pro)	PLVAP	L34P	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Pathogenic(Last reviewed: Nov 14, 2018)	no assertion criteria provided	VCV000590328	19	17487997	19	17377188	590328	581267	rs1568378665	NC_000019.10:17377187:A:G
NM_031310.3(PLVAP):c.988C>T (p.Gln330Ter)	PLVAP	Q330*	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000590327	19	17476286	19	17365477	590327	581266	rs199712527	NC_000019.10:17365476:G:A
NM_031310.3(PLVAP):c.1072C>T (p.Arg358Ter)	PLVAP	R358*	DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000590326	19	17476202	19	17365393	590326	581265	rs761158492	NC_000019.10:17365392:G:A
NM_024844.5(NUP85):c.405+1G>A	NUP85		NEPHROTIC SYNDROME, TYPE 17	Pathogenic(Last reviewed: Nov 12, 2018)	no assertion criteria provided	VCV000590317	17	73209215	17	75213120	590317	581256	rs1568070817	NC_000017.11:75213119:G:A
NM_005650.3(TCF20):c.3801_3802GA[1] (p.Arg1268fs)	TCF20		TCF20-related condition|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590288	22	42607508 - 42607509	22	42211502 - 42211503	590288	581229	rs1569146542	NC_000022.11:42211501:TCTCT:TCT
CLCN4, ARG718TRP	CLCN4	R718W	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000590286					590286	581227		
NM_000495.5(COL4A5):c.3769C>T (p.Gln1257Ter)	COL4A5	Q1257*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000590263	X	107911713	X	108668483	590263	581206	rs1569505812	NC_000023.11:108668482:C:T
NM_001323289.2(CDKL5):c.1165C>T (p.Gln389Ter)	CDKL5	Q389*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000590188	X	18622209	X	18604089	590188	580914	rs1569219346	NC_000023.11:18604088:C:T
NM_001242897.2(DEPDC5):c.3987C>G (p.Tyr1329Ter)	DEPDC5	Y1329*, Y1429*, Y1351*, Y1398*, Y1401*, Y1420*, Y1407*	Seizures	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000590153	22	32293551	22	31897565	590153	580495	rs1569232705	NC_000022.11:31897564:C:G
NM_001184880.2(PCDH19):c.1091del (p.Pro364fs)	PCDH19	P364fs	History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589939	X	99662505	X	100407507	589939	580706	rs758946412	NC_000023.11:100407506:GGGGGGG:GGGGGG
NM_001184880.2(PCDH19):c.498C>A (p.Tyr166Ter)	PCDH19	Y166*	History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589938	X	99663098	X	100408100	589938	580592	rs796052837	NC_000023.11:100408099:G:T
NM_001184880.2(PCDH19):c.372_373dup (p.Asn125fs)	PCDH19		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000589933	X	99663222 - 99663223	X	100408224 - 100408225	589933	580709	rs1569315950	NC_000023.11:100408224:TGT:TGTGT
NM_001184880.2(PCDH19):c.994del (p.Val332fs)	PCDH19	V332fs	History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000589901	X	99662602	X	100407604	589901	580724	rs1569315156	NC_000023.11:100407603:CC:C
NM_001008537.3(NEXMIF):c.3493C>T (p.Gln1165Ter)	NEXMIF	Q1165*	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Nov 25, 2016)	criteria provided, single submitter	VCV000589459	X	73960899	X	74741064	589459	581135	rs1569335056	NC_000023.11:74741063:G:A
NM_007254.4(PNKP):c.1255_1258dup (p.Ala420fs)	PNKP		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000589380	19	50365068 - 50365069	19	49861811 - 49861812	589380	580511	rs768847609	NC_000019.10:49861811:CGACC:CGACCGACC
NM_001083962.2(TCF4):c.469del (p.Arg157fs)	TCF4	R157fs, R259fs, R156fs, R115fs, R155fs, R27fs, R132fs, R133fs, R86fs	Pitt-Hopkins syndrome|History of neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589268	18	53018135	18	55350904	589268	580319	rs1569138023	NC_000018.10:55350903:GGGG:GGG
NM_001242897.2(DEPDC5):c.1870+2370_1870+2371del	DEPDC5		Seizures	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000589219	22	32217579 - 32217580	22	31821593 - 31821594	589219	580770	rs1372605067	NC_000022.11:31821592:CTCT:CT
NM_001127221.1(CACNA1A):c.1637dup (p.Tyr546Ter)	CACNA1A		History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 27, 2017)	criteria provided, single submitter	VCV000589171	19	13423516 - 13423517	19	13312702 - 13312703	589171	580504	rs1568523843	NC_000019.10:13312702:T:TT
NM_001184880.2(PCDH19):c.768dup (p.Val257fs)	PCDH19		History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000589045	X	99662827 - 99662828	X	100407829 - 100407830	589045	580728	rs1569315508	NC_000023.11:100407829:GGG:GGGG
NM_001127221.1(CACNA1A):c.1925del (p.Phe642fs)	CACNA1A	F641fs, F642fs	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000588860	19	13418660	19	13307846	588860	580337	rs1568518139	NC_000019.10:13307845:AAA:AA
NM_006950.3(SYN1):c.1310del (p.Pro437fs)	SYN1	P437fs	History of neurodevelopmental disorder	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000588529	X	47434170	X	47574771	588529	581110	rs1569322834	NC_000023.11:47574770:GG:G
NM_004463.3(FGD1):c.1636+1G>A	FGD1		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000588329	X	54491883	X	54465450	588329	581090	rs1569541211	NC_000023.11:54465449:C:T
NM_001008537.3(NEXMIF):c.1567dup (p.Trp523fs)	NEXMIF		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000588255	X	73962824 - 73962825	X	74742989 - 74742990	588255	581143	rs1569335666	NC_000023.11:74742989:A:AA
NM_000052.7(ATP7A):c.31dup (p.Thr11fs)	ATP7A		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000588061	X	77227168 - 77227169	X	77971671 - 77971672	588061	581085	rs1569549376	NC_000023.11:77971671:A:AA
NM_003688.3(CASK):c.1015+1G>C	CASK		History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000587865	X	41485856	X	41626603	587865	581104	rs1569350501	NC_000023.11:41626602:C:G
NM_001323289.2(CDKL5):c.666del (p.Ile223fs)	CDKL5	I223fs	History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000587758	X	18606185	X	18588065	587758	580892	rs1569215645	NC_000023.11:18588064:T:
NM_001022.4(RPS19):c.367_368dup (p.Leu123_Thr124insTer)	RPS19		Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Sep 18, 2018)	no assertion criteria provided	VCV000587695	19	42373778 - 42373779	19	41869708 - 41869709	587695	578653	rs1568796003	NC_000019.10:41869708:CT:CTCT
NM_017613.4(DONSON):c.1563+1G>T	DONSON		MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587636	21	34951655	21	33579349	587636	578579	rs534299298	NC_000021.9:33579348:C:A
NM_000475.5(NR0B1):c.1267del (p.His423fs)	NR0B1	H423fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587537	X	30322842	X	30304725	587537	578591	rs1569268048	NC_000023.11:30304724:GGGG:GGG
NM_004409.5(DMPK):c.931C>T (p.Arg311Ter)	DMPK	R311*, R321*, R337*, R222*	Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587521	19	46280800	19	45777542	587521	578567	rs762280354	NC_000019.10:45777541:G:A
NM_004006.2(DMD):c.3358G>T (p.Glu1120Ter)	DMD	E1120*, E997*, E1116*, E1112*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587510	X	32481630	X	32463513	587510	578592	rs1569563678	NC_000023.11:32463512:C:A
NM_001256789.3(CACNA1F):c.4471C>T (p.Arg1491Ter)	CACNA1F	R1502*, R1437*, R1491*	Congenital stationary night blindness, type 2A	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000587382	X	49067064	X	49210604	587382	578351	rs782581701	NC_000023.11:49210603:G:A
NM_033380.3(COL4A5):c.4532_4545delinsTTTCAT (p.Thr1511fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587353	X	107935981 - 107935994	X	108692751 - 108692764	587353	578272	rs1569508938	NC_000023.11:108692750:CGGCTGGCAGCTGC:TTTCAT
NM_033380.3(COL4A5):c.4531del (p.Thr1511fs)	COL4A5	T1511fs, T1505fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587352	X	107935980	X	108692750	587352	578271	rs281874742	NC_000023.11:108692749:A:
NM_033380.3(COL4A5):c.4456del (p.Thr1486fs)	COL4A5	T1486fs, T1480fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587351	X	107930851	X	108687621	587351	578266	rs104886281	NC_000023.11:108687620:AA:A
NM_033380.3(COL4A5):c.4507_4508AG[1] (p.Arg1503fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587350	X	107930903 - 107930904	X	108687673 - 108687674	587350	578268	rs104886421	NC_000023.11:108687672:AGAG:AG
NM_033380.3(COL4A5):c.4367del (p.Pro1456fs)	COL4A5	P1456fs, P1450fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587349	X	107930759	X	108687529	587349	578261	rs104886275	NC_000023.11:108687528:CCCCC:CCCC
NM_033380.3(COL4A5):c.5052del (p.Gln1685fs)	COL4A5	Q1679fs, Q1685fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587348	X	107939584	X	108696354	587348	578300	rs104886307	NC_000023.11:108696353:T:
NM_033380.3(COL4A5):c.5012_5019del (p.Thr1671fs)	COL4A5	T1665fs, T1671fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587347	X	107939540 - 107939547	X	108696310 - 108696317	587347	578299	rs104886426	NC_000023.11:108696309:GAAACGCTGAAA:GAAA
NM_033380.3(COL4A5):c.4986del (p.Asp1662fs)	COL4A5	D1656fs, D1662fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587346	X	107938661	X	108695431	587346	578296	rs104886304	NC_000023.11:108695430:C:
NM_033380.3(COL4A5):c.4850del (p.Gly1617fs)	COL4A5	G1617fs, G1611fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587345	X	107938524	X	108695294	587345	578290	rs104886301	NC_000023.11:108695293:GG:G
NM_033380.3(COL4A5):c.4796_4797TG[1] (p.Trp1600fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587344	X	107938126 - 107938127	X	108694896 - 108694897	587344	578284	rs281874749	NC_000023.11:108694895:TGTG:TG
NM_033380.3(COL4A5):c.4768_4774del (p.Pro1590fs)	COL4A5	P1584fs, P1590fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587343	X	107938095 - 107938101	X	108694865 - 108694871	587343	578283	rs606231374	NC_000023.11:108694864:ATTCCCCATT:ATT
NM_033380.3(COL4A5):c.4707-3_4735del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587342	X	107938034 - 107938065	X	108694804 - 108694835	587342	578276	rs1556462911	NC_000023.11:108694803:CAGATGTGCAGTATGTGAAGCTCCAGCTGTGG:
NM_033380.3(COL4A5):c.4454_4455del (p.Gly1485fs)	COL4A5	G1485fs, G1479fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587341	X	107930850 - 107930851	X	108687620 - 108687621	587341	578265	rs104886420	NC_000023.11:108687619:GA:
NM_033380.3(COL4A5):c.4362dup (p.Pro1455fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587340	X	107930757 - 107930758	X	108687527 - 108687528	587340	578260	rs606231373	NC_000023.11:108687527:T:TT
NM_033380.3(COL4A5):c.4347_4373del (p.Asp1450_Pro1458del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587339	X	107930738 - 107930764	X	108687508 - 108687534	587339	578258	rs606231372	NC_000023.11:108687507:GGTCCAGATGGATTGCAAGGTCCCCCAGGTCC:GGTCC
NM_033380.3(COL4A5):c.4344_4379dup (p.Pro1449_Gly1460dup)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587338	X	107930728 - 107930729	X	108687498 - 108687499	587338	578257	rs281874736	NC_000023.11:108687498:GGTCCCCCTGGTCCAGATGGATTGCAAGGTCCCCCAGGTCCCCCTGG:GGTCCCCCTGGTCCAGATGGATTGCAAGGTCCCCCAGGTCCCCCTGGTCCAGATGGATTGCAAGGTCCCCCAGGTCCCCCTGG
NM_033380.3(COL4A5):c.4253del (p.Gly1418fs)	COL4A5	G1418fs, G1412fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587337	X	107929296	X	108686066	587337	578255	rs281874732	NC_000023.11:108686065:GG:G
NM_033380.3(COL4A5):c.4118_4119AG[1] (p.Ser1374fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587335	X	107925020 - 107925021	X	108681790 - 108681791	587335	578251	rs104886403	NC_000023.11:108681789:AGAG:AG
NM_033380.3(COL4A5):c.4089del (p.Pro1364fs)	COL4A5	P1358fs, P1364fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587334	X	107924991	X	108681761	587334	578250	rs104886268	NC_000023.11:108681760:T:
NM_033380.3(COL4A5):c.4010del (p.Phe1337fs)	COL4A5	F1331fs, F1337fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587333	X	107923975	X	108680745	587333	578246	rs104886265	NC_000023.11:108680744:TT:T
NM_033380.3(COL4A5):c.3938del (p.Leu1313fs)	COL4A5	L1307fs, L1313fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587332	X	107920859	X	108677629	587332	578245	rs104886259	NC_000023.11:108677628:T:
NM_033380.3(COL4A5):c.3884_3887dup (p.Gly1297fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587331	X	107920802 - 107920803	X	108677572 - 108677573	587331	578243	rs606231370	NC_000023.11:108677572:CCAACC:CCAACCAACC
NM_033380.3(COL4A5):c.3833del (p.Pro1278fs)	COL4A5	P1278fs, P1272fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587329	X	107920753	X	108677523	587329	578240	rs104886258	NC_000023.11:108677522:CC:C
NM_033380.3(COL4A5):c.3754_3757dup (p.Asn1253fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587328	X	107911696 - 107911697	X	108668466 - 108668467	587328	578238	rs104886394	NC_000023.11:108668466:AGGCA:AGGCAGGCA
NM_033380.3(COL4A5):c.3709_3710dup (p.Gly1238fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587327	X	107911649 - 107911650	X	108668419 - 108668420	587327	578234	rs104886392	NC_000023.11:108668419:CCCCC:CCCCCCC
NM_000495.4(COL4A5):c.610_628del (p.Gly204Aspfs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587326	X	107821180 - 107821198	X	108577950 - 108577968	587326	578076	rs104886435	NC_000023.11:108577949:AGGGCCCTCCTGGTCCACCAGG:AGG
NM_033380.3(COL4A5):c.573_574dup (p.Gly192fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587325	X	107819165 - 107819166	X	108575935 - 108575936	587325	578072	rs281874757	NC_000023.11:108575935:AG:AGAG
NM_033380.3(COL4A5):c.550dup (p.Leu184fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587324	X	107819141 - 107819142	X	108575911 - 108575912	587324	578070	rs104886433	NC_000023.11:108575911:CC:CCC
NM_033380.3(COL4A5):c.544_546+4del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587323	X	107816881 - 107816887	X	108573651 - 108573657	587323	578068	rs1569489339	NC_000023.11:108573650:ACAAGTAA:A
NM_033380.3(COL4A5):c.533del (p.Pro178fs)	COL4A5	P178fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587322	X	107816870	X	108573640	587322	578066	rs104886058	NC_000023.11:108573639:CC:C
NM_033380.3(COL4A5):c.446del (p.Pro149fs)	COL4A5	P149fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000587321	X	107815044	X	108571814	587321	578063	rs104886054	NC_000023.11:108571813:CCCCC:CCCC
NM_033380.3(COL4A5):c.446dup (p.Gly150fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587320	X	107815043 - 107815044	X	108571813 - 108571814	587320	578064	rs104886054	NC_000023.11:108571813:CCCCC:CCCCCC
NM_000495.4(COL4A5):c.440del (p.Gly147Aspfs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587319	X	107815040	X	108571810	587319	578062	rs104886053	NC_000023.11:108571809:GGG:GG
NM_033380.3(COL4A5):c.368del (p.Gly123fs)	COL4A5	G123fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587318	X	107812034	X	108568804	587318	578058	rs104886046	NC_000023.11:108568803:GG:G
NM_033380.3(COL4A5):c.293del (p.Pro98fs)	COL4A5	P98fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587317	X	107811874	X	108568644	587317	578052	rs104886045	NC_000023.11:108568643:CC:C
NM_033380.3(COL4A5):c.252del (p.Pro85fs)	COL4A5	P85fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587316	X	107807130	X	108563900	587316	578049	rs104886044	NC_000023.11:108563899:GGG:GG
NM_000495.5(COL4A5):c.3710_3761del (p.Pro1237fs)	COL4A5	P1237fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587315	X	107911651 - 107911702	X	108668421 - 108668472	587315	578235	rs104886393	
NM_033380.3(COL4A5):c.3647del (p.Pro1216fs)	COL4A5	P1216fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587314	X	107911590	X	108668360	587314	578230	rs104886249	NC_000023.11:108668359:CC:C
NM_033380.3(COL4A5):c.3618_3622del (p.Asp1206fs)	COL4A5	D1206fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587313	X	107911562 - 107911566	X	108668332 - 108668336	587313	578229	rs1569505747	NC_000023.11:108668331:TGGAG:
NM_033380.3(COL4A5):c.3604+3A>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587312	X	107910416	X	108667186	587312	578228	rs1569505614	NC_000023.11:108667185:A:T
NM_033380.3(COL4A5):c.3543_3549del (p.Lys1181fs)	COL4A5	K1181fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587311	X	107909811 - 107909817	X	108666581 - 108666587	587311	578226	rs281874716	NC_000023.11:108666580:GAAGGGTGAA:GAA
NM_033380.3(COL4A5):c.3527del (p.Gly1176fs)	COL4A5	G1176fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587310	X	107909797	X	108666567	587310	578225	rs104886239	NC_000023.11:108666566:GG:G
NM_033380.3(COL4A5):c.3509del (p.Gly1170fs)	COL4A5	G1170fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587309	X	107909779	X	108666549	587309	578223	rs104886238	NC_000023.11:108666548:GG:G
NM_033380.3(COL4A5):c.3474del (p.Gln1159fs)	COL4A5	Q1159fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587308	X	107909743	X	108666513	587308	578222	rs104886234	NC_000023.11:108666512:GGG:GG
NM_033380.3(COL4A5):c.3413del (p.Pro1138fs)	COL4A5	P1138fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587307	X	107908774	X	108665544	587307	578219	rs104886227	NC_000023.11:108665543:CCC:CC
NM_033380.3(COL4A5):c.3334_3337dup (p.Gly1113fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587306	X	107898647 - 107898648	X	108655417 - 108655418	587306	578218	rs104886380	NC_000023.11:108655417:CCTG:CCTGCCTG
NM_033380.3(COL4A5):c.3331del (p.Thr1111fs)	COL4A5	T1111fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587305	X	107898644	X	108655414	587305	578217	rs104886226	NC_000023.11:108655413:AA:A
NM_033380.3(COL4A5):c.3167del (p.Pro1056fs)	COL4A5	P1056fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587304	X	107869497	X	108626267	587304	578213	rs281874711	NC_000023.11:108626266:CCCC:CCC
NM_033380.3(COL4A5):c.3057del (p.Leu1019_Ile1020insTer)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587303	X	107868974	X	108625744	587303	578209	rs104886208	NC_000023.11:108625743:TT:T
NM_033380.3(COL4A5):c.3046del (p.Gln1016fs)	COL4A5	Q1016fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587302	X	107868964	X	108625734	587302	578207	rs281874710	NC_000023.11:108625733:C:
NM_033380.3(COL4A5):c.2965del (p.Asp989fs)	COL4A5	D989fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587301	X	107867513	X	108624283	587301	578205	rs104886206	NC_000023.11:108624282:G:
NM_033380.3(COL4A5):c.2928_2929del (p.Val977fs)	COL4A5	V977fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587298	X	107867475 - 107867476	X	108624245 - 108624246	587298	578202	rs104886373	NC_000023.11:108624244:GAG:G
NM_033380.3(COL4A5):c.2846del (p.Pro949fs)	COL4A5	P949fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587297	X	107865983	X	108622753	587297	578197	rs104886197	NC_000023.11:108622752:CC:C
NM_033380.3(COL4A5):c.2822_2824GTA[1] (p.Ser942del)	COL4A5	S942del	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587296	X	107865960 - 107865962	X	108622730 - 108622732	587296	578195	rs104886369	NC_000023.11:108622729:GTAGTA:GTA
NM_033380.3(COL4A5):c.2802dup (p.Gly935fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587295	X	107865939 - 107865940	X	108622709 - 108622710	587295	578192	rs104886368	NC_000023.11:108622709:T:TT
NM_033380.3(COL4A5):c.2747_2758delinsT (p.Ser916fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587294	X	107865102 - 107865113	X	108621872 - 108621883	587294	578189	rs1569498133	NC_000023.11:108621871:GTGGTGTACCTG:T
NM_033380.3(COL4A5):c.2687del (p.Gly896fs)	COL4A5	G896fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587293	X	107865041	X	108621811	587293	578186	rs281874700	NC_000023.11:108621810:GG:G
NM_033380.3(COL4A5):c.2643del (p.Leu882fs)	COL4A5	L882fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587292	X	107863620	X	108620390	587292	578183	rs104886200	NC_000023.11:108620389:GGG:GG
NM_033380.3(COL4A5):c.2625del (p.Pro876fs)	COL4A5	P876fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587291	X	107863604	X	108620374	587291	578181	rs104886198	NC_000023.11:108620373:A:
NM_033380.3(COL4A5):c.2595_2612del (p.Ile867_Gly872del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587290	X	107863572 - 107863589	X	108620342 - 108620359	587290	578180	rs104886355	NC_000023.11:108620341:CCAGGGATCCCCGGAGCACC:CC
NM_033380.3(COL4A5):c.2590_2625del (p.Ser864_Gly875del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587289	X	107863569 - 107863604	X	108620339 - 108620374	587289	578179	rs104886354	NC_000023.11:108620338:AGTCCAGGGATCCCCGGAGCACCTGGTCCTATAGGA:
NM_000495.4(COL4A5):c.2510del (p.Gly837Valfs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587288	X	107863488	X	108620258	587288	578175	rs104886181	NC_000023.11:108620257:GG:G
NM_033380.3(COL4A5):c.2477del (p.Pro826fs)	COL4A5	P826fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587287	X	107858221	X	108614991	587287	578171	rs281874694	NC_000023.11:108614990:CC:C
NM_033380.3(COL4A5):c.119del (p.Cys40fs)	COL4A5	C40fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587285	X	107783013	X	108539783	587285	578047	rs104886042	NC_000023.11:108539782:G:
NM_033380.3(COL4A5):c.2_3del (p.Met1fs)	COL4A5	M1fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587284	X	107683357 - 107683358	X	108440127 - 108440128	587284	578042	rs104886376	NC_000023.11:108440126:TG:
NM_033380.3(COL4A5):c.2452_2454delinsT (p.Ile818fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587283	X	107858197 - 107858199	X	108614967 - 108614969	587283	578169	rs1569497013	NC_000023.11:108614966:ATA:T
NM_033380.3(COL4A5):c.2395+2750A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587282	X	107852872	X	108609642	587282	578166	rs104886352	NC_000023.11:108609641:A:G
NM_033380.3(COL4A5):c.2322dup (p.Gly775fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587281	X	107850045 - 107850046	X	108606815 - 108606816	587281	578164	rs104886351	NC_000023.11:108606815:AAAA:AAAAA
NM_033380.3(COL4A5):c.1567del (p.Thr523fs)	COL4A5	T523fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587277	X	107840277	X	108597047	587277	578129	rs104886123	NC_000023.11:108597046:AA:A
NM_033380.3(COL4A5):c.1542_1543del (p.Glu516fs)	COL4A5	E516fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587276	X	107840253 - 107840254	X	108597023 - 108597024	587276	578128	rs104886333	NC_000023.11:108597022:AG:
NM_033380.3(COL4A5):c.1423+57dup	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587275	X	107834930 - 107834931	X	108591700 - 108591701	587275	578124	rs104886328	NC_000023.11:108591700:C:CC
NM_033380.3(COL4A5):c.1348_1349AT[1] (p.Ile450fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587274	X	107834799 - 107834800	X	108591569 - 108591570	587274	578122	rs104886320	NC_000023.11:108591568:ATAT:AT
NM_033380.3(COL4A5):c.1288dup (p.Ala430fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587273	X	107834406 - 107834407	X	108591176 - 108591177	587273	578119	rs104886318	NC_000023.11:108591176:GGGG:GGGGG
NM_033380.3(COL4A5):c.1280dup (p.Pro428fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587272	X	107834401 - 107834402	X	108591171 - 108591172	587272	578118	rs104886327	NC_000023.11:108591171:A:AA
NM_033380.3(COL4A5):c.1265del (p.Pro422fs)	COL4A5	P422fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587271	X	107834386	X	108591156	587271	578117	rs104886109	NC_000023.11:108591155:CC:C
NM_033380.3(COL4A5):c.38_41dup (p.Leu14fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587269	X	107683391 - 107683392	X	108440161 - 108440162	587269	578043	rs104886408	NC_000023.11:108440161:TTCTT:TTCTTTCTT
NM_033380.3(COL4A5):c.1254del (p.Pro419fs)	COL4A5	P419fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587268	X	107834375	X	108591145	587268	578115	rs104886104	NC_000023.11:108591144:TT:T
NM_033380.3(COL4A5):c.1214_1217dup (p.Gln407fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587267	X	107834335 - 107834336	X	108591105 - 108591106	587267	578113	rs104886326	NC_000023.11:108591105:GGGG:GGGGGGGG
NM_033380.3(COL4A5):c.1074del (p.Gly359fs)	COL4A5	G359fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587266	X	107829882	X	108586652	587266	578108	rs104886095	NC_000023.11:108586651:AAAAA:AAAA
NM_033380.3(COL4A5):c.945dup (p.Gly316fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587265	X	107826121 - 107826122	X	108582891 - 108582892	587265	578100	rs104886449	NC_000023.11:108582891:T:TT
NM_033380.3(COL4A5):c.873del (p.Gly292fs)	COL4A5	G292fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587263	X	107823949	X	108580719	587263	578093	rs281874767	NC_000023.11:108580718:AA:A
NM_033380.3(COL4A5):c.866del (p.Gly289fs)	COL4A5	G289fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587262	X	107823941	X	108580711	587262	578091	rs281874766	NC_000023.11:108580710:GGG:GG
NM_033380.3(COL4A5):c.812del (p.Pro271fs)	COL4A5	P271fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587261	X	107823793	X	108580563	587261	578088	rs104886072	NC_000023.11:108580562:CC:C
NM_033380.3(COL4A5):c.788del (p.Pro263fs)	COL4A5	P263fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587260	X	107823769	X	108580539	587260	578086	rs281874764	NC_000023.11:108580538:CC:C
NM_033380.3(COL4A5):c.759_760AG[1] (p.Glu254fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000587259	X	107821592 - 107821593	X	108578362 - 108578363	587259	578084	rs104886443	NC_000023.11:108578361:AGAG:AG
NM_000495.4(COL4A5):c.689del (p.Gly230Valfs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587258	X	107821520	X	108578290	587258	578081	rs104886077	NC_000023.11:108578289:GGG:GG
NM_033380.3(COL4A5):c.646-12_646-11del	COL4A5	G216_K229del	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587257	X	107821296 - 107821297	X	108578066 - 108578067	587257	578078	rs104886436	NC_000023.11:108578065:TT:
NM_033380.3(COL4A5):c.2822G>A (p.Gly941Asp)	COL4A5	G941D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587255	X	107865960	X	108622730	587255	578194	rs1569498254	NC_000023.11:108622729:G:A
NM_033380.3(COL4A5):c.2245-40A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587254	X	107849932	X	108606702	587254	578158	rs1569495747	NC_000023.11:108606701:A:G
NM_033380.3(COL4A5):c.780+5G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587253	X	107821618	X	108578388	587253	578085	rs1569490635	NC_000023.11:108578387:G:A
NM_033380.3(COL4A5):c.1780-6T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587252	X	107841926	X	108598696	587252	578132	rs1569494262	NC_000023.11:108598695:T:G
NM_033380.3(COL4A5):c.2767G>C (p.Gly923Arg)	COL4A5	G923R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587251	X	107865122	X	108621892	587251	578191	rs1569498140	NC_000023.11:108621891:G:C
NM_033380.3(COL4A5):c.991-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587250	X	107827713	X	108584483	587250	578104	rs1569491718	NC_000023.11:108584482:G:A
NM_033380.3(COL4A5):c.4719T>A (p.Cys1573Ter)	COL4A5	C1567*, C1573*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587249	X	107938049	X	108694819	587249	578279	rs1569509203	NC_000023.11:108694818:T:A
NM_033380.3(COL4A5):c.3809-2A>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587248	X	107920728	X	108677498	587248	578239	rs1569506917	NC_000023.11:108677497:A:T
NM_033380.3(COL4A5):c.1078_1113del (p.Asn360_Gly371del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587247	X	107829878 - 107829913	X	108586648 - 108586683	587247	578110	rs1569492113	NC_000023.11:108586647:GGAGAAAAAGGAAACATTGGGTTGCCTGGGTTGCCTGGAGAAAAAGGA:GGAGAAAAAGGA
NM_033380.3(COL4A5):c.1347_1355del (p.Ile450_Glu452del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587246	X	107834795 - 107834803	X	108591565 - 108591573	587246	578121	rs1569493132	NC_000023.11:108591564:TGAGATATGTGA:TGA
NM_033380.3(COL4A5):c.929G>A (p.Gly310Glu)	COL4A5	G310E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587245	X	107824250	X	108581020	587245	578098	rs1556407064	NC_000023.11:108581019:G:A
NM_033380.3(COL4A5):c.893G>A (p.Gly298Asp)	COL4A5	G298D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587244	X	107824214	X	108580984	587244	578097	rs1569491068	NC_000023.11:108580983:G:A
NM_033380.3(COL4A5):c.609+875G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587243	X	107820077	X	108576847	587243	578074	rs1569490148	NC_000023.11:108576846:G:T
NM_033380.3(COL4A5):c.4994+2T>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587242	X	107938671	X	108695441	587242	578297	rs1569509371	NC_000023.11:108695440:T:C
NM_033380.3(COL4A5):c.1948+894C>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587241	X	107842994	X	108599764	587241	578145	rs5973838	NC_000023.11:108599763:C:G
NM_033380.3(COL4A5):c.610-2A>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587240	X	107821180	X	108577950	587240	578075	rs281874758	NC_000023.11:108577949:A:T
NM_033380.3(COL4A5):c.2589del (p.Ser864fs)	COL4A5	S864fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587239	X	107863568	X	108620338	587239	578178	rs1569497723	NC_000023.11:108620337:C:
NM_033380.3(COL4A5):c.4743del (p.Val1582fs)	COL4A5	V1576fs, V1582fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587238	X	107938073	X	108694843	587238	578280	rs1569509210	NC_000023.11:108694842:A:
NM_033380.3(COL4A5):c.4583del (p.Asn1528fs)	COL4A5	N1522fs, N1528fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587237	X	107936031	X	108692801	587237	578273	rs1569508951	NC_000023.11:108692800:AA:A
NM_033380.3(COL4A5):c.1411_1414dup (p.Gly472fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587236	X	107834861 - 107834862	X	108591631 - 108591632	587236	578123	rs1569493161	NC_000023.11:108591631:CAAG:CAAGCAAG
NM_033380.3(COL4A5):c.331_332insCA (p.Gly111fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587235	X	107811998 - 107811999	X	108568768 - 108568769	587235	578054	rs1569488415	NC_000023.11:108568768::CA
NM_033380.3(COL4A5):c.2903_2904insG (p.Pro969fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587234	X	107866041 - 107866042	X	108622811 - 108622812	587234	578198	rs1569498271	NC_000023.11:108622811::G
NM_033380.3(COL4A5):c.3450_3451insAC (p.Val1151fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587233	X	107908813 - 107908814	X	108665583 - 108665584	587233	578220	rs1569505385	NC_000023.11:108665583::AC
NM_033380.3(COL4A5):c.4837dup (p.Ala1613fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587232	X	107938508 - 107938509	X	108695278 - 108695279	587232	578289	rs1569509307	NC_000023.11:108695278:GGGG:GGGGG
NM_033380.3(COL4A5):c.4754_4755insT (p.Gln1585fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587231	X	107938084 - 107938085	X	108694854 - 108694855	587231	578281	rs1569509214	NC_000023.11:108694854::T
NM_033380.3(COL4A5):c.1652_1653insTC (p.Thr552fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587230	X	107840671 - 107840672	X	108597441 - 108597442	587230	578131	rs1569494000	NC_000023.11:108597441::TC
NM_033380.3(COL4A5):c.871C>T (p.Gln291Ter)	COL4A5	Q291*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587229	X	107823948	X	108580718	587229	578092	rs1569490975	NC_000023.11:108580717:C:T
NM_033380.3(COL4A5):c.3053G>A (p.Gly1018Asp)	COL4A5	G1018D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587228	X	107868971	X	108625741	587228	578208	rs1569498896	NC_000023.11:108625740:G:A
NM_033380.3(COL4A5):c.3206G>A (p.Gly1069Asp)	COL4A5	G1069D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587227	X	107869539	X	108626309	587227	578214	rs281874712	NC_000023.11:108626308:G:A
NM_033380.3(COL4A5):c.1781G>A (p.Gly594Asp)	COL4A5	G594D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587226	X	107841933	X	108598703	587226	578133	rs1569494267	NC_000023.11:108598702:G:A
NM_033380.3(COL4A5):c.4475G>A (p.Gly1492Asp)	COL4A5	G1486D, G1492D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587225	X	107930871	X	108687641	587225	578267	rs104886282	NC_000023.11:108687640:G:A
NM_033380.3(COL4A5):c.2288G>T (p.Gly763Val)	COL4A5	G763V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587224	X	107850015	X	108606785	587224	578161	rs281874689	NC_000023.11:108606784:G:T
NM_033380.3(COL4A5):c.1000G>A (p.Gly334Ser)	COL4A5	G334S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587223	X	107827723	X	108584493	587223	578105	rs1569491729	NC_000023.11:108584492:G:A
NM_000495.4(COL4A5):c.3791-?_4198+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587222					587222	578038		
NM_033380.3(COL4A5):c.5059T>G (p.Cys1687Gly)	COL4A5	C1681G, C1687G	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587221	X	107939591	X	108696361	587221	578302	rs1569509494	NC_000023.11:108696360:T:G
NM_033380.3(COL4A5):c.4949C>G (p.Ser1650Cys)	COL4A5	S1644C, S1650C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587220	X	107938624	X	108695394	587220	578295	rs1569509352	NC_000023.11:108695393:C:G
NM_033380.3(COL4A5):c.4931G>C (p.Cys1644Ser)	COL4A5	C1638S, C1644S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587219	X	107938606	X	108695376	587219	578294	rs104886302	NC_000023.11:108695375:G:C
NM_033380.3(COL4A5):c.4913G>A (p.Cys1638Tyr)	COL4A5	C1632Y, C1638Y	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587218	X	107938588	X	108695358	587218	578292	rs1569509333	NC_000023.11:108695357:G:A
NM_033380.3(COL4A5):c.4811C>T (p.Ser1604Phe)	COL4A5	S1598F, S1604F	Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	no assertion criteria provided	VCV000587217	X	107938141	X	108694911	587217	578287	rs1569509257	NC_000023.11:108694910:C:T
NM_033380.3(COL4A5):c.4805G>T (p.Gly1602Val)	COL4A5	G1596V, G1602V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587216	X	107938135	X	108694905	587216	578286	rs104886297	NC_000023.11:108694904:G:T
NM_033380.3(COL4A5):c.4706+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587215	X	107936156	X	108692926	587215	578274	rs1569508998	NC_000023.11:108692925:G:A
NM_033380.3(COL4A5):c.4528+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587214	X	107930925	X	108687695	587214	578269	rs104886413	NC_000023.11:108687694:G:T
NM_033380.3(COL4A5):c.4078G>T (p.Gly1360Cys)	COL4A5	G1354C, G1360C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587213	X	107924177	X	108680947	587213	578249	rs1569507409	NC_000023.11:108680946:G:T
NM_033380.3(COL4A5):c.3545G>T (p.Gly1182Val)	COL4A5	G1182V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587212	X	107909816	X	108666586	587212	578227	rs1569505535	NC_000023.11:108666585:G:T
NM_033380.3(COL4A5):c.3227del (p.Pro1076fs)	COL4A5	P1076fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587211	X	107869559	X	108626329	587211	578215	rs1569499057	NC_000023.11:108626328:CC:C
NM_033380.3(COL4A5):c.2976_2982del (p.Gln992fs)	COL4A5	Q992fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587210	X	107867523 - 107867529	X	108624293 - 108624299	587210	578206	rs1569498624	NC_000023.11:108624292:AACCTGGA:A
NM_033380.3(COL4A5):c.2918-1G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587209	X	107867465	X	108624235	587209	578200	rs104886372	NC_000023.11:108624234:G:C
NM_033380.3(COL4A5):c.2297G>T (p.Gly766Val)	COL4A5	G766V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587208	X	107850024	X	108606794	587208	578162	rs104886172	NC_000023.11:108606793:G:T
NM_033380.3(COL4A5):c.1949-2A>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587205	X	107844621	X	108601391	587205	578147	rs1569494852	NC_000023.11:108601390:A:T
NM_033380.3(COL4A5):c.1799G>A (p.Gly600Asp)	COL4A5	G600D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587204	X	107841951	X	108598721	587204	578134	rs1569494281	NC_000023.11:108598720:G:A
NM_033380.3(COL4A5):c.1246_1269del (p.Ile416_Gly423del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587203	X	107834362 - 107834385	X	108591132 - 108591155	587203	578114	rs1569492996	NC_000023.11:108591131:CCTGGAATTTCCATTCCTGGACCTCCTGGA:CCTGGA
NM_033380.3(COL4A5):c.1165G>A (p.Gly389Arg)	COL4A5	G389R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587202	X	107829977	X	108586747	587202	578111	rs1569492172	NC_000023.11:108586746:G:A
NM_033380.3(COL4A5):c.1073_1074insC (p.Lys358fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587201	X	107829885 - 107829886	X	108586655 - 108586656	587201	578107	rs1569492120	NC_000023.11:108586655::C
NM_033380.3(COL4A5):c.965G>T (p.Gly322Val)	COL4A5	G322V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587200	X	107826142	X	108582912	587200	578103	rs1569491399	NC_000023.11:108582911:G:T
NM_033380.3(COL4A5):c.936+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587199	X	107824258	X	108581028	587199	578099	rs1569491107	NC_000023.11:108581027:G:A
NM_033380.3(COL4A5):c.680G>A (p.Gly227Asp)	COL4A5	G227D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587197	X	107821342	X	108578112	587197	578079	rs1569490446	NC_000023.11:108578111:G:A
NM_033380.3(COL4A5):c.560_561dup (p.Thr188fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587196	X	107819151 - 107819152	X	108575921 - 108575922	587196	578071	rs1569489828	NC_000023.11:108575921:CCC:CCCCC
NM_033380.3(COL4A5):c.876A>T (p.Gly292=)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587194	X	107823953	X	108580723	587194	578095	rs1569490985	NC_000023.11:108580722:A:T
NM_033380.3(COL4A5):c.547-3C>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587193	X	107819137	X	108575907	587193	578069	rs1569489799	NC_000023.11:108575906:C:A
NM_033380.3(COL4A5):c.1922G>A (p.Gly641Glu)	COL4A5	G641E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587191	X	107842074	X	108598844	587191	578142	rs1569494378	NC_000023.11:108598843:G:A
NM_033380.3(COL4A5):c.5069G>A (p.Arg1690Lys)	COL4A5	R1684K, R1690K	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587190	X	107939601	X	108696371	587190	578303	rs1360698598	NC_000023.11:108696370:G:A
NM_033380.3(COL4A5):c.4370G>A (p.Gly1457Asp)	COL4A5	G1451D, G1457D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587189	X	107930766	X	108687536	587189	578262	rs1569508352	NC_000023.11:108687535:G:A
NM_033380.3(COL4A5):c.3917del (p.Gly1306fs)	COL4A5	G1306fs, G1300fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587187	X	107920837	X	108677607	587187	578244	rs1569506954	NC_000023.11:108677606:GG:G
NM_033380.3(COL4A5):c.3685G>T (p.Gly1229Cys)	COL4A5	G1229C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587186	X	107911629	X	108668399	587186	578233	rs1569505771	NC_000023.11:108668398:G:T
NM_033380.3(COL4A5):c.3154C>T (p.Gln1052Ter)	COL4A5	Q1052*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587185	X	107869487	X	108626257	587185	578212	rs1569499001	NC_000023.11:108626256:C:T
NM_033380.3(COL4A5):c.3071G>A (p.Gly1024Glu)	COL4A5	G1024E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587184	X	107868989	X	108625759	587184	578210	rs1569498904	NC_000023.11:108625758:G:A
NM_033380.3(COL4A5):c.2918G>A (p.Gly973Asp)	COL4A5	G973D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587183	X	107867466	X	108624236	587183	578201	rs1569498606	NC_000023.11:108624235:G:A
NM_033380.3(COL4A5):c.2918-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000587182	X	107867465	X	108624235	587182	578199	rs104886372	NC_000023.11:108624234:G:A
NM_033380.3(COL4A5):c.2765_2766inv (p.Lys922Ile)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587181	X	107865120 - 107865121	X	108621890 - 108621891	587181	578190		NC_000023.11:108621889:AA:TT
NM_033380.3(COL4A5):c.2589_2660del (p.Ser864_Gly887del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587180	X	107863565 - 107863636	X	108620335 - 108620406	587180	578177	rs1569497722	
NM_033380.3(COL4A5):c.2264T>G (p.Leu755Ter)	COL4A5	L755*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587179	X	107849991	X	108606761	587179	578160	rs1569495758	NC_000023.11:108606760:T:G
NM_033380.3(COL4A5):c.1931G>A (p.Gly644Asp)	COL4A5	G644D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587178	X	107842083	X	108598853	587178	578143	rs1569494386	NC_000023.11:108598852:G:A
NM_033380.3(COL4A5):c.1894G>C (p.Gly632Arg)	COL4A5	G632R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587177	X	107842046	X	108598816	587177	578140	rs1569494351	NC_000023.11:108598815:G:C
NM_033380.3(COL4A5):c.1846_1854del (p.Asn616_Gly618del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587176	X	107841994 - 107842002	X	108598764 - 108598772	587176	578137	rs1569494302	NC_000023.11:108598763:AGGGAATATAGGG:AGGG
NM_033380.3(COL4A5):c.1826G>A (p.Gly609Asp)	COL4A5	G609D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587175	X	107841978	X	108598748	587175	578135	rs104886140	NC_000023.11:108598747:G:A
NM_033380.3(COL4A5):c.947G>A (p.Gly316Asp)	COL4A5	G316D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587173	X	107826124	X	108582894	587173	578101	rs1569491387	NC_000023.11:108582893:G:A
NM_033380.3(COL4A5):c.321+1_321+2dup	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587172	X	107811902 - 107811903	X	108568672 - 108568673	587172	578053	rs1569488388	NC_000023.11:108568672:TGT:TGTGT
NM_000495.4(COL4A5):c.82-?_1516+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587170					587170	578036		
NM_000495.4(COL4A5):c.3925-?_4198+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587169					587169	578040		
NM_000495.4(COL4A5):c.2510-1_2554del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587168	X	107863488 - 107863533	X	108620258 - 108620303	587168	578174	rs1569497680	NC_000023.11:108620257:GGTTTACATGGAATACCAGGAGAGAAGGGGGATCCAGGACCTCCTGG:G
NM_000495.4(COL4A5):c.82-?_2395+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587167					587167	578037		
NM_033380.3(COL4A5):c.2510-1_2525del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587166	X	107863488 - 107863504	X	108620258 - 108620274	587166	578173	rs1569497679	NC_000023.11:108620257:GGTTTACATGGAATACC:
NM_033380.3(COL4A5):c.2423del (p.Gly808fs)	COL4A5	G808fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587165	X	107858167	X	108614937	587165	578168	rs1569496997	NC_000023.11:108614936:GG:G
NM_033380.3(COL4A5):c.590del (p.Pro197fs)	COL4A5	P197fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587164	X	107819179	X	108575949	587164	578073	rs1569489856	NC_000023.11:108575948:CCCCC:CCCC
NM_033380.3(COL4A5):c.1339+6C>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587163	X	107834467	X	108591237	587163	578120	rs1569493051	NC_000023.11:108591236:C:G
NM_033380.3(COL4A5):c.2815G>T (p.Glu939Ter)	COL4A5	E939*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587162	X	107865953	X	108622723	587162	578193	rs1569498249	NC_000023.11:108622722:G:T
NM_033380.3(COL4A5):c.4360G>C (p.Gly1454Arg)	COL4A5	G1448R, G1454R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587161	X	107930756	X	108687526	587161	578259	rs104886279	NC_000023.11:108687525:G:C
NM_033380.3(COL4A5):c.1009G>A (p.Gly337Ser)	COL4A5	G337S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587160	X	107827732	X	108584502	587160	578106	rs1210495852	NC_000023.11:108584501:G:A
NM_033380.3(COL4A5):c.458G>A (p.Gly153Asp)	COL4A5	G153D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587159	X	107815060	X	108571830	587159	578065	rs1569488946	NC_000023.11:108571829:G:A
NM_033380.3(COL4A5):c.2396-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587158	X	107858140	X	108614910	587158	578167	rs886041509	NC_000023.11:108614909:G:A
NM_033380.3(COL4A5):c.2677G>C (p.Gly893Arg)	COL4A5	G893R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587157	X	107863656	X	108620426	587157	578185	rs1569497776	NC_000023.11:108620425:G:C
NM_033380.3(COL4A5):c.384+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587156	X	107812052	X	108568822	587156	578060	rs1569488437	NC_000023.11:108568821:G:A
NM_033380.3(COL4A5):c.4822-2A>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587153	X	107938495	X	108695265	587153	578288	rs1569509301	NC_000023.11:108695264:A:C
NM_033380.3(COL4A5):c.4767dup (p.Pro1590fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587152	X	107938095 - 107938096	X	108694865 - 108694866	587152	578282	rs1569509224	NC_000023.11:108694865:TT:TTT
NM_033380.3(COL4A5):c.3721G>C (p.Gly1241Arg)	COL4A5	G1241R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587151	X	107911665	X	108668435	587151	578236	rs104886255	NC_000023.11:108668434:G:C
NM_033380.3(COL4A5):c.3246+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587150	X	107869580	X	108626350	587150	578216	rs1569499064	NC_000023.11:108626349:G:A
NM_033380.3(COL4A5):c.2831del (p.Gly944fs)	COL4A5	G944fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587149	X	107865968	X	108622738	587149	578196	rs1569498258	NC_000023.11:108622737:GG:G
NM_033380.3(COL4A5):c.2546G>A (p.Gly849Glu)	COL4A5	G849E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587148	X	107863525	X	108620295	587148	578176	rs1569497695	NC_000023.11:108620294:G:A
NM_033380.3(COL4A5):c.2482G>A (p.Gly828Arg)	COL4A5	G828R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587147	X	107858227	X	108614997	587147	578172	rs1569497022	NC_000023.11:108614996:G:A
NM_033380.3(COL4A5):c.2237G>A (p.Gly746Glu)	COL4A5	G746E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587146	X	107846284	X	108603054	587146	578157	rs867625069	NC_000023.11:108603053:G:A
NM_033380.3(COL4A5):c.2077G>A (p.Gly693Arg)	COL4A5	G693R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587145	X	107845150	X	108601920	587145	578150	rs1569495038	NC_000023.11:108601919:G:A
NM_033380.3(COL4A5):c.1862G>T (p.Gly621Val)	COL4A5	G621V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587144	X	107842014	X	108598784	587144	578139	rs1569494322	NC_000023.11:108598783:G:T
NM_033380.3(COL4A5):c.1526G>A (p.Gly509Asp)	COL4A5	G509D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587143	X	107840237	X	108597007	587143	578127	rs867721264	NC_000023.11:108597006:G:A
NM_033380.3(COL4A5):c.1075G>A (p.Gly359Arg)	COL4A5	G359R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587142	X	107829887	X	108586657	587142	578109	rs1569492122	NC_000023.11:108586656:G:A
NM_033380.3(COL4A5):c.801dup (p.Pro268fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587141	X	107823780 - 107823781	X	108580550 - 108580551	587141	578087	rs1569490913	NC_000023.11:108580550:GGG:GGGG
NM_033380.3(COL4A5):c.698G>T (p.Gly233Val)	COL4A5	G233V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587140	X	107821531	X	108578301	587140	578082	rs1569490592	NC_000023.11:108578300:G:T
NM_033380.3(COL4A5):c.412G>A (p.Gly138Ser)	COL4A5	G138S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587139	X	107814670	X	108571440	587139	578061	rs767619131	NC_000023.11:108571439:G:A
NM_033380.3(COL4A5):c.152G>T (p.Gly51Val)	COL4A5	G51V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587138	X	107802304	X	108559074	587138	578048	rs755038747	NC_000023.11:108559073:G:T
NM_033380.3(COL4A5):c.2T>A (p.Met1Lys)	COL4A5	M1K	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587137	X	107683357	X	108440127	587137	578041	rs1569469409	NC_000023.11:108440126:T:A
NM_033380.3(COL4A5):c.368G>A (p.Gly123Glu)	COL4A5	G123E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587136	X	107812035	X	108568805	587136	578057	rs1569488429	NC_000023.11:108568804:G:A
NM_033380.3(COL4A5):c.359_363delinsATAC (p.Gly120fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587135	X	107812026 - 107812030	X	108568796 - 108568800	587135	578055	rs1569488424	NC_000023.11:108568795:GTATT:ATAC
NM_033380.3(COL4A5):c.4713del (p.Val1572fs)	COL4A5	V1572fs, V1566fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587134	X	107938043	X	108694813	587134	578277	rs1569509196	NC_000023.11:108694812:A:
NM_033380.3(COL4A5):c.4417_4418CA[3] (p.Ser1474fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587133	X	107930812 - 107930813	X	108687582 - 108687583	587133	578263	rs1569508366	NC_000023.11:108687582:CACA:CACACA
NM_033380.3(COL4A5):c.4202del (p.Pro1401fs)	COL4A5	P1395fs, P1401fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587132	X	107925103	X	108681873	587132	578253	rs1569507572	NC_000023.11:108681872:CC:C
NM_033380.3(COL4A5):c.3746del (p.Gly1249fs)	COL4A5	G1249fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587131	X	107911689	X	108668459	587131	578237	rs1569505800	NC_000023.11:108668458:GG:G
NM_033380.3(COL4A5):c.1992_2009del (p.Lys664_Gly669del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587130	X	107844664 - 107844681	X	108601434 - 108601451	587130	578148	rs1569494882	NC_000023.11:108601433:AAGCCTGGCTTGCCTGGTAA:AA
NM_033380.3(COL4A5):c.1442dup (p.Cys481fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587129	X	107838756 - 107838757	X	108595526 - 108595527	587129	578125	rs1569493656	NC_000023.11:108595526:G:GG
NM_033380.3(COL4A5):c.863del (p.Lys288fs)	COL4A5	K288fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587128	X	107823939	X	108580709	587128	578090	rs1569490970	NC_000023.11:108580708:AA:A
NM_033380.3(COL4A5):c.4800G>A (p.Trp1600Ter)	COL4A5	W1594*, W1600*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587127	X	107938130	X	108694900	587127	578285	rs1569509236	NC_000023.11:108694899:G:A
NM_033380.3(COL4A5):c.2632G>T (p.Gly878Ter)	COL4A5	G878*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587126	X	107863611	X	108620381	587126	578182	rs1569497759	NC_000023.11:108620380:G:T
NM_033380.3(COL4A5):c.544C>T (p.Gln182Ter)	COL4A5	Q182*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587125	X	107816882	X	108573652	587125	578067	rs1569489341	NC_000023.11:108573651:C:T
NM_033380.3(COL4A5):c.107C>G (p.Ser36Ter)	COL4A5	S36*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587124	X	107783001	X	108539771	587124	578046	rs759512115	NC_000023.11:108539770:C:G
NM_033380.3(COL4A5):c.4706+4A>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587123	X	107936159	X	108692929	587123	578275	rs1569508999	NC_000023.11:108692928:A:T
NM_033380.3(COL4A5):c.4529-345A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587122	X	107935633	X	108692403	587122	578270	rs1569508899	NC_000023.11:108692402:A:G
NM_033380.3(COL4A5):c.1949-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587121	X	107844621	X	108601391	587121	578146	rs1569494852	NC_000023.11:108601390:A:G
NM_033380.3(COL4A5):c.1166-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587120	X	107834287	X	108591057	587120	578112	rs1569492951	NC_000023.11:108591056:G:A
NM_033380.3(COL4A5):c.834+5G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587119	X	107823821	X	108580591	587119	578089	rs104886442	NC_000023.11:108580590:G:A
NM_033380.3(COL4A5):c.687+2T>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587118	X	107821351	X	108578121	587118	578080	rs1569490465	NC_000023.11:108578120:T:C
NM_033380.3(COL4A5):c.276+5G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587117	X	107807161	X	108563931	587117	578051	rs104886365	NC_000023.11:108563930:G:T
NM_033380.3(COL4A5):c.4216_4216+1del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587116	X	107925118 - 107925119	X	108681888 - 108681889	587116	578254	rs1569507577	NC_000023.11:108681887:GG:
NM_033380.3(COL4A5):c.2677G>A (p.Gly893Ser)	COL4A5	G893S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587115	X	107863656	X	108620426	587115	578184	rs1569497776	NC_000023.11:108620425:G:A
NM_033380.3(COL4A5):c.2306G>T (p.Gly769Val)	COL4A5	G769V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587114	X	107850033	X	108606803	587114	578163	rs1437633065	NC_000023.11:108606802:G:T
NM_033380.3(COL4A5):c.384G>A (p.Lys128=)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587113	X	107812051	X	108568821	587113	578059	rs1569488434	NC_000023.11:108568820:G:A
NM_033380.3(COL4A5):c.2387G>T (p.Gly796Val)	COL4A5	G796V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587112	X	107850114	X	108606884	587112	578165	rs1569495819	NC_000023.11:108606883:G:T
NM_033380.3(COL4A5):c.5054A>C (p.Gln1685Pro)	COL4A5	Q1679P, Q1685P	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587111	X	107939586	X	108696356	587111	578301	rs1569509492	NC_000023.11:108696355:A:C
NM_033380.3(COL4A5):c.4880T>C (p.Leu1627Ser)	COL4A5	L1621S, L1627S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587110	X	107938555	X	108695325	587110	578291	rs1569509315	NC_000023.11:108695324:T:C
NM_033380.3(COL4A5):c.4718G>C (p.Cys1573Ser)	COL4A5	C1567S, C1573S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587109	X	107938048	X	108694818	587109	578278	rs1569509201	NC_000023.11:108694817:G:C
NM_033380.3(COL4A5):c.4445G>T (p.Cys1482Phe)	COL4A5	C1476F, C1482F	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587108	X	107930841	X	108687611	587108	578264	rs1569508382	NC_000023.11:108687610:G:T
NM_033380.3(COL4A5):c.4042G>A (p.Gly1348Arg)	COL4A5	G1342R, G1348R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587107	X	107924141	X	108680911	587107	578247	rs1569507398	NC_000023.11:108680910:G:A
NM_033380.3(COL4A5):c.3668G>A (p.Gly1223Asp)	COL4A5	G1223D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587106	X	107911612	X	108668382	587106	578232	rs104886252	NC_000023.11:108668381:G:A
NM_033380.3(COL4A5):c.3650G>A (p.Gly1217Asp)	COL4A5	G1217D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587105	X	107911594	X	108668364	587105	578231	rs1569505758	NC_000023.11:108668363:G:A
NM_033380.3(COL4A5):c.3526G>A (p.Gly1176Arg)	COL4A5	G1176R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587104	X	107909797	X	108666567	587104	578224	rs1569505525	NC_000023.11:108666566:G:A
NM_033380.3(COL4A5):c.2714G>A (p.Gly905Asp)	COL4A5	G905D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587103	X	107865069	X	108621839	587103	578188	rs1569498110	NC_000023.11:108621838:G:A
NM_033380.3(COL4A5):c.2156G>T (p.Gly719Val)	COL4A5	G719V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587101	X	107846203	X	108602973	587101	578154	rs868580411	NC_000023.11:108602972:G:T
NM_033380.3(COL4A5):c.2095G>A (p.Gly699Arg)	COL4A5	G699R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587100	X	107845168	X	108601938	587100	578151	rs1569495049	NC_000023.11:108601937:G:A
NM_033380.3(COL4A5):c.1948G>A (p.Gly650Ser)	COL4A5	G650S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587099	X	107842100	X	108598870	587099	578144	rs1569494393	NC_000023.11:108598869:G:A
NM_033380.3(COL4A5):c.1913G>A (p.Gly638Asp)	COL4A5	G638D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587098	X	107842065	X	108598835	587098	578141	rs104886134	NC_000023.11:108598834:G:A
NM_033380.3(COL4A5):c.1843G>C (p.Gly615Arg)	COL4A5	G615R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587097	X	107841995	X	108598765	587097	578136	rs1569494304	NC_000023.11:108598764:G:C
NM_033380.3(COL4A5):c.1579G>A (p.Gly527Arg)	COL4A5	G527R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587096	X	107840290	X	108597060	587096	578130	rs1569493892	NC_000023.11:108597059:G:A
NM_033380.3(COL4A5):c.965G>A (p.Gly322Asp)	COL4A5	G322D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587095	X	107826142	X	108582912	587095	578102	rs1569491399	NC_000023.11:108582911:G:A
NM_033380.3(COL4A5):c.715G>A (p.Gly239Arg)	COL4A5	G239R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587094	X	107821548	X	108578318	587094	578083	rs1569490603	NC_000023.11:108578317:G:A
NM_033380.3(COL4A5):c.367G>A (p.Gly123Arg)	COL4A5	G123R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587093	X	107812034	X	108568804	587093	578056	rs1569488426	NC_000023.11:108568803:G:A
NM_000495.4(COL4A5):c.3791-?_4510+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587091					587091	578039		
NM_033380.3(COL4A5):c.3472G>A (p.Gly1158Arg)	COL4A5	G1158R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587090	X	107909743	X	108666513	587090	578221	rs104886389	NC_000023.11:108666512:G:A
NM_033380.3(COL4A5):c.2705G>T (p.Gly902Val)	COL4A5	G902V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000587089	X	107865060	X	108621830	587089	578187	rs104886361	NC_000023.11:108621829:G:T
NM_033380.3(COL4A5):c.1259G>T (p.Gly420Val)	COL4A5	G420V	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000587088	X	107834381	X	108591151	587088	578116	rs281874663	NC_000023.11:108591150:G:T
NM_000328.3(RPGR):c.578_588del (p.Ser193fs)	RPGR	S192fs, S193fs, S203fs	Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 11, 2018)	no assertion criteria provided	VCV000586984	X	38176600 - 38176610	X	38317347 - 38317357	586984	578030	rs1569257917	NC_000023.11:38317346:AGAGATCCAGGAGA:AGA
NM_001127898.4(CLCN5):c.1396G>C (p.Asp466His)	CLCN5	D396H, D466H, D416H		Pathogenic	no assertion criteria provided	VCV000586983	X	49851366	X	50086709	586983	578029	rs1569540369	NC_000023.11:50086708:G:C
NM_030773.3(TUBB1):c.35del (p.Cys12fs)	TUBB1	C12fs	Congenital hypothyroidism	Pathogenic(Last reviewed: Oct 18, 2016)	no assertion criteria provided	VCV000586966	20	57594612	20	59019557	586966	578009	rs773248042	NC_000020.11:59019556:G:
NM_030773.3(TUBB1):c.318C>G (p.Tyr106Ter)	TUBB1	Y106*	Congenital hypothyroidism	Pathogenic(Last reviewed: Oct 18, 2016)	no assertion criteria provided	VCV000586965	20	57598800	20	59023745	586965	578010	rs560702757	NC_000020.11:59023744:C:G
NM_030773.3(TUBB1):c.479C>T (p.Pro160Leu)	TUBB1	P160L	Congenital hypothyroidism	Pathogenic(Last reviewed: Oct 18, 2016)	no assertion criteria provided	VCV000586964	20	57598961	20	59023906	586964	578011	rs759117911	NC_000020.11:59023905:C:T
NM_005660.3(SLC35A2):c.233A>G (p.Lys78Arg)	SLC35A2	K78R, K54R, K106R, K91R	SLC35A2-CDG	Pathogenic(Last reviewed: Oct 5, 2018)	no assertion criteria provided	VCV000586961	X	48767132	X	48909855	586961	578006	rs1569511572	NC_000023.11:48909854:T:C
NM_000454.4(SOD1):c.435G>C (p.Leu145Phe)	SOD1	L145F	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586637	21	33040861	21	31668548	586637	577887	rs1482760341	NC_000021.9:31668547:G:C
NM_000454.4(SOD1):c.420C>A (p.Asn140Lys)	SOD1	N140K	not provided	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000586635	21	33040846	21	31668533	586635	577885	rs1804449	NC_000021.9:31668532:C:A
NM_000444.6(PHEX):c.263G>A (p.Trp88Ter)	PHEX	W88*	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000586224	X	22065243	X	22047125	586224	577949	rs1569369653	NC_000023.11:22047124:G:A
NM_000444.6(PHEX):c.15_16del (p.Gly6fs)	PHEX	G6fs	not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000586223	X	22051138 - 22051139	X	22033020 - 22033021	586223	577948	rs1569364701	NC_000023.11:22033019:AG:
NM_000444.6(PHEX):c.1033C>T (p.Gln345Ter)	PHEX	Q345*	not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000586222	X	22117223	X	22099105	586222	577951	rs1569391212	NC_000023.11:22099104:C:T
NM_001184880.2(PCDH19):c.2122A>T (p.Lys708Ter)	PCDH19	K708*	not provided	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000586210	X	99661474	X	100406476	586210	577910	rs1569314119	NC_000023.11:100406475:T:A
NM_000475.5(NR0B1):c.99del (p.Leu34fs)	NR0B1	L34fs	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000586189	X	30327382	X	30309265	586189	577954	rs1569269195	NC_000023.11:30309264:CC:C
NM_000475.5(NR0B1):c.625C>T (p.Gln209Ter)	NR0B1	Q209*	not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000586188	X	30326856	X	30308739	586188	577952	rs1569268878	NC_000023.11:30308738:G:A
NM_016418.5(NF2):c.461_479dup (p.Gly161fs)	NF2		not provided	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000586175	22	30050656 - 30050657	22	29654667 - 29654668	586175	577905	rs1569293373	NC_000022.11:29654667:CGACCCCAGTGTTCACAAGCG:CGACCCCAGTGTTCACAAGCGACCCCAGTGTTCACAAGCG
NM_000117.2(EMD):c.116_143del (p.Phe39fs)	EMD	F39fs	not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000585847	X	153608081 - 153608108	X	154379721 - 154379748	585847	577946	rs1569552080	NC_000023.11:154379720:CTTCGAGTACGAGACCCAGAGGCGGCGGCT:CT
NM_000109.4(DMD):c.9854_9855TG[3] (p.Trp3286fs)	DMD		not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000585788	X	31200947 - 31200948	X	31182830 - 31182831	585788	577956	rs1569427535	NC_000023.11:31182830:CACAC:CACACAC
NM_004006.2(DMD):c.4758G>A (p.Trp1586Ter)	DMD	W1586*, W1463*, W1582*, W242*, W1578*, W245*	not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000585785	X	32398714	X	32380597	585785	577959	rs1569560477	NC_000023.11:32380596:C:T
NM_004006.2(DMD):c.3804G>A (p.Trp1268Ter)	DMD	W1268*, W1264*, W1260*, W1145*	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000585783	X	32459414	X	32441297	585783	577961	rs1569562573	NC_000023.11:32441296:C:T
NM_004006.2(DMD):c.3606_3607del	DMD		not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000585782	X	32466752 - 32466753	X	32448635 - 32448636	585782	577962	rs1569562951	NC_000023.11:32448634:CTCTCT:CTCT
NM_004006.2(DMD):c.2111del (p.Pro704fs)	DMD	P696fs, P704fs, P581fs, P700fs	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000585780	X	32563333	X	32545216	585780	577964	rs1569169736	NC_000023.11:32545215:GG:G
NM_004006.2(DMD):c.10546G>T (p.Glu3516Ter)	DMD	E3516*, E2172*, E3512*, E1056*, E2175*, E435*, E787*, E1043*, E3393*, E3508*, E448*	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000585779	X	31187567	X	31169450	585779	577955	rs1569401103	NC_000023.11:31169449:C:A
NM_004006.2(DMD):c.100A>T (p.Lys34Ter)	DMD	K34*, K30*, K26*	not provided	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000585778	X	32867931	X	32849814	585778	577965	rs1557084280	NC_000023.11:32849813:T:A
NM_000166.6(GJB1):c.319del (p.Arg107fs)	GJB1	R107fs	not provided	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000585742	X	70443876	X	71224026	585742	577978	rs1569215212	NC_000023.11:71224025:C:
NM_001127221.1(CACNA1A):c.439G>A (p.Glu147Lys)	CACNA1A	E147K	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000585573	19	13563790	19	13452976	585573	577737	rs1568659847	NC_000019.10:13452975:C:T
NM_001127221.1(CACNA1A):c.4036C>T (p.Arg1346Ter)	CACNA1A	R1346*, R1349*, R1345*	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000585570	19	13373604	19	13262790	585570	577718	rs1568473233	NC_000019.10:13262789:G:A
NM_001127221.1(CACNA1A):c.3928dup (p.Arg1310fs)	CACNA1A		not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000585568	19	13386727 - 13386728	19	13275913 - 13275914	585568	577720	rs1568485109	NC_000019.10:13275913:GG:GGG
NM_001127221.1(CACNA1A):c.3695+1G>A	CACNA1A		not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000585567	19	13395881	19	13285067	585567	577721	rs1315533129	NC_000019.10:13285066:C:T
NM_001127221.1(CACNA1A):c.3697dup (p.Leu1233fs)	CACNA1A		not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000585566	19	13395881 - 13395882	19	13285067 - 13285068	585566	577722	rs1568493323	NC_000019.10:13285067:GGG:GGGG
NM_000495.5(COL4A5):c.4088del (p.Gly1363fs)	COL4A5	G1369fs, G1363fs	not provided	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000585544	X	107925007	X	108681777	585544	577923	rs1569507535	NC_000023.11:108681776:GG:G
NM_000495.5(COL4A5):c.3585del (p.Gly1196fs)	COL4A5	G1196fs	not provided	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000585543	X	107910394	X	108667164	585543	577922	rs1569505604	NC_000023.11:108667163:T:
NM_000495.5(COL4A5):c.3368del (p.Phe1123fs)	COL4A5	F1123fs	not provided	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000585542	X	107898681	X	108655451	585542	577921	rs1569504092	NC_000023.11:108655450:TT:T
NM_000495.5(COL4A5):c.2095G>T (p.Gly699Ter)	COL4A5	G699*	not provided	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000585541	X	107845168	X	108601938	585541	577920	rs1569495049	NC_000023.11:108601937:G:T
NM_033380.3(COL4A5):c.1779+1G>A	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585538	X	107840799	X	108597569	585538	577917	rs104886337	NC_000023.11:108597568:G:A
NM_000495.5(COL4A5):c.1032+1G>C	COL4A5		not provided	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000585536	X	107827756	X	108584526	585536	577915	rs1569491753	NC_000023.11:108584525:G:C
NM_000054.6(AVPR2):c.911-2A>G	AVPR2		not provided	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000585475	X	153171975	X	153906521	585475	577944	rs1569545567	NC_000023.11:153906520:A:G
NM_000054.6(AVPR2):c.383A>C (p.Tyr128Ser)	AVPR2	Y128S	not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000585474	X	153171343	X	153905889	585474	577943	rs781950164	NC_000023.11:153905888:A:C
NM_000383.4(AIRE):c.1295_1296insA (p.Arg433fs)	AIRE		Polyglandular autoimmune syndrome, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585381	21	45713688 - 45713689	21	44293805 - 44293806	585381	577902	rs763695515	NC_000021.9:44293805::A
NM_016418.5(NF2):c.583_589del (p.His195fs)	NF2	H112fs, H154fs, H153fs, H195fs	Spindle cell sarcoma	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000585330	22	30051646 - 30051652	22	29655657 - 29655663	585330	576379	rs1569294187	NC_000022.11:29655656:GAGCACCGAG:GAG
NM_000033.4(ABCD1):c.1978C>T (p.Arg660Trp)	ABCD1	R660W	Adrenoleukodystrophy	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585302	X	153008787	X	153743333	585302	576358	rs1569541203	NC_000023.11:153743332:C:T
NM_000033.4(ABCD1):c.1534G>A (p.Gly512Ser)	ABCD1	G512S	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585301	X	153005591	X	153740137	585301	576357	rs1569541088	NC_000023.11:153740136:G:A
NM_000033.4(ABCD1):c.1096A>T (p.Lys366Ter)	ABCD1	K366*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000585300	X	153001580	X	153736126	585300	576356	rs1569541000	NC_000023.11:153736125:A:T
NM_020639.3(RIPK4):c.1074dup (p.Glu359Ter)	RIPK4			Pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000585265	21	43164162 - 43164163	21	41744002 - 41744003	585265	576315	rs1569100177	NC_000021.9:41744002:A:AA
NM_020639.3(RIPK4):c.850G>A (p.Glu284Lys)	RIPK4	E284K	Curly hair, ankyloblepharon, nail dysplasia syndrome	Pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000585264	21	43166005	21	41745845	585264	576314	rs199835696	NC_000021.9:41745844:C:T
NM_014960.5(ARSG):c.133G>T (p.Asp45Tyr)	ARSG	D45Y	Usher syndrome|	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000585252	17	66303767	17	68307626	585252	576301	rs1568445893	NC_000017.11:68307625:G:T
NM_016120.4(RLIM):c.1831C>T (p.Arg611Cys)	RLIM	R611C	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000585245	X	73811319	X	74591484	585245	576294	rs1569309449	NC_000023.11:74591483:G:A
NM_016120.4(RLIM):c.1093C>T (p.Arg365Cys)	RLIM	R365C	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000585244	X	73812057	X	74592222	585244	576293	rs1569309816	NC_000023.11:74592221:G:A
NM_016120.4(RLIM):c.1792G>A (p.Asp598Asn)	RLIM	D598N	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000585243	X	73811358	X	74591523	585243	576292	rs1569309460	NC_000023.11:74591522:C:T
NM_139284.3(LGI4):c.2T>C (p.Met1Thr)	LGI4	M1T		Pathogenic	criteria provided, single submitter	VCV000585241	19	35625583	19	35134679	585241	576291	rs1207534366	NC_000019.10:35134678:A:G
NM_001943.5(DSG2):c.512_516del (p.Leu171fs)	DSG2	L171fs	Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585218	18	29101191 - 29101195	18	31521228 - 31521232	585218	576268	rs1568105371	NC_000018.10:31521227:GAGTTGAGT:GAGT
NM_001127221.1(CACNA1A):c.4054C>T (p.Arg1352Ter)	CACNA1A	R1352*, R1355*, R1351*	Episodic ataxia type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585212	19	13373586	19	13262772	585212	576271	rs1568473171	NC_000019.10:13262771:G:A
NM_018848.3(MKKS):c.792T>G (p.Tyr264Ter)	MKKS	Y264*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585168	20	10393371	20	10412723	585168	576245	rs74315397	NC_000020.11:10412722:A:C
NM_018848.3(MKKS):c.492T>A (p.Cys164Ter)	MKKS	C164*	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585167	20	10393671	20	10413023	585167	576246	rs1568666460	NC_000020.11:10413022:A:T
NM_018848.3(MKKS):c.295T>C (p.Cys99Arg)	MKKS	C99R	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585166	20	10393868	20	10413220	585166	576247	rs1297985227	NC_000020.11:10413219:A:G
NM_018848.3(MKKS):c.1478del (p.Leu493fs)	MKKS	L493fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585165	20	10386130	20	10405482	585165	576243	rs1568662687	NC_000020.11:10405481:AAA:AA
NM_018848.3(MKKS):c.1239_1242dup (p.Thr415Ter)	MKKS		Progressive cone dystrophy (without rod involvement)|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585164	20	10388293 - 10388294	20	10407645 - 10407646	585164	576244	rs1306231185	NC_000020.11:10407645:TTCA:TTCATTCA
NM_005052.3(RAC3):c.182A>T (p.Gln61Leu)	RAC3	Q61L	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES|Intellectual disability|Abnormality of brain morphology	Pathogenic, association(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000585005	17	79990661	17	82032785	585005	576061	rs1568018920	NC_000017.11:82032784:A:T
NM_005052.3(RAC3):c.86C>T (p.Pro29Leu)	RAC3	P29L	NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES|Intellectual disability|Abnormality of brain morphology	Pathogenic, association(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000585004	17	79990313	17	82032437	585004	576060	rs1568018697	NC_000017.11:82032436:C:T
NM_000455.4(STK11):c.82dup (p.Arg28fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000584980	19	1206992 - 1206993	19	1206993 - 1206994	584980	576036	rs1568689930	NC_000019.10:1206993:CC:CCC
NM_005559.4(LAMA1):c.5407C>T (p.Gln1803Ter)	LAMA1	Q1803*	Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Apr 29, 2018)	criteria provided, single submitter	VCV000584439	18	6985615	18	6985616	584439	575504	rs1568019012	NC_000018.10:6985615:G:A
NC_000021.8:g.(?_38792657)_(38884854_?)del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000584409	21	38792657 - 38884854			584409	573716		
NC_000023.10:g.(?_32827590)_(33038337_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000584399	X	32827590 - 33038337	X	32809473 - 33020220	584399	573479		
NC_000019.9:g.(?_11226750)_(11242035_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000584371	19	11226750 - 11242035	19	11116074 - 11131359	584371	572701		
NC_000023.10:g.(?_31222078)_(31241238_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000584367	X	31222078 - 31241238	X	31203961 - 31223121	584367	575288		
NC_000022.10:g.(?_34022208)_(34157483_?)del	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000584360	22	34022208 - 34157483			584360	573909		
NC_000023.10:g.(?_32715967)_(32717430_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000584343	X	32715967 - 32717430	X	32697850 - 32699313	584343	573471		
NC_000023.10:g.(?_123019487)_(123026643_?)del	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000584339	X	123019487 - 123026643	X	123885637 - 123892793	584339	575283		
NC_000020.10:g.(?_10385875)_(10394182_?)del	MKKS		Bardet-Biedl syndrome|	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000584330	20	10385875 - 10394182	20	10405227 - 10413534	584330	575074		
NC_000022.10:g.(?_32154512)_(32154639_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000584322	22	32154512 - 32154639	22	31758526 - 31758653	584322	573228		
NC_000023.10:g.(?_31332523)_(31627738_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000584308	X	31332523 - 31627738	X	31314406 - 31609621	584308	575291		
NC_000021.8:g.(?_47408978)_(47409071_?)del	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000584291	21	47408978 - 47409071	21	45989064 - 45989157	584291	573019		
NC_000023.10:g.(?_32235013)_(32490446_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000584282	X	32235013 - 32490446	X	32216896 - 32472329	584282	573460		
NC_000023.10:g.(?_31224679)_(31382270_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000584270	X	31224679 - 31382270	X	31206562 - 31364153	584270	572086		
NC_000023.10:g.(?_31950177)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000584249	X	31950177 - 31986651	X	31932060 - 31968534	584249	575297		
NC_000023.10:g.(?_31645770)_(31697723_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000584245	X	31645770 - 31697723	X	31627653 - 31679606	584245	574203		
NC_000023.10:g.(?_31697472)_(31697723_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000584206	X	31697472 - 31697723	X	31679355 - 31679606	584206	575295		
NC_000023.10:g.(?_31645770)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000584202	X	31645770 - 31950364	X	31627653 - 31932247	584202	572098		
NC_000017.10:g.(?_72295837)_(72301601_?)del	DNAI2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000584187	17	72295837 - 72301601	17	74299698 - 74305462	584187	568668		
NC_000023.10:g.(?_38260508)_(38260946_?)del	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000584165	X	38260508 - 38260946	X	38401255 - 38401693	584165	575304		
NC_000023.10:g.(?_31627738)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	VCV000584157	X	31627738 - 31986651	X	31609621 - 31968534	584157	574201		
NC_000023.10:g.(?_123499591)_(123505261_?)del	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000584122	X	123499591 - 123505261	X	124365741 - 124371411	584122	575284		
NC_000017.10:g.(?_66511525)_(66525142_?)del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000584116	17	66511525 - 66525142	17	68515384 - 68529001	584116	574279		
NC_000023.10:g.(?_31747728)_(31792329_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000584110	X	31747728 - 31792329	X	31729611 - 31774212	584110	574205		
NC_000023.10:g.(?_31947693)_(31947882_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000584109	X	31947693 - 31947882	X	31929576 - 31929765	584109	572102		
NC_000019.9:g.(?_11213320)_(11218210_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000584079	19	11213320 - 11218210	19	11102644 - 11107534	584079	572695		
NC_000019.9:g.(?_11233830)_(11242035_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000584070	19	11233830 - 11242035	19	11123154 - 11131359	584070	570267		
NC_000023.10:g.(?_17393861)_(17753592_?)del	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000584066	X	17393861 - 17753592			584066	575279		
NC_000023.10:g.(?_32827590)_(32841967_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000584064	X	32827590 - 32841967	X	32809473 - 32823850	584064	573475		
NC_000017.10:g.(?_44108822)_(44159928_?)del	KANSL1		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000584056	17	44108822 - 44159928	17	46031456 - 46082562	584056	574273		
NC_000019.9:g.(?_42874853)_(42874983_?)del	MEGF8		Carpenter syndrome 2	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000584047	19	42874853 - 42874983	19	42370701 - 42370831	584047	574785		
NC_000019.9:g.(?_11230748)_(11231284_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000584042	19	11230748 - 11231284	19	11120072 - 11120608	584042	570262		
NC_000023.10:g.(?_31627738)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000584039	X	31627738 - 31893510	X	31609621 - 31875393	584039	574199		
NC_000023.10:g.(?_31332523)_(31462764_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000584029	X	31332523 - 31462764	X	31314406 - 31444647	584029	573446		
NC_000023.10:g.(?_32235013)_(32383336_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000584026	X	32235013 - 32383336	X	32216896 - 32365219	584026	575299		
NC_000023.10:g.(?_31627738)_(31792329_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000584013	X	31627738 - 31792329	X	31609621 - 31774212	584013	575293		
NC_000017.10:g.(?_63532432)_(63532677_?)del	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000584012	17	63532432 - 63532677	17	65536314 - 65536559	584012	570724		
NC_000023.10:g.(?_31514885)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000584009	X	31514885 - 31893510	X	31496768 - 31875393	584009	572091		
NC_000018.9:g.(?_48602998)_(48604847_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000583985	18	48602998 - 48604847	18	51076628 - 51078477	583985	574708		
NC_000023.10:g.(?_32827590)_(32834777_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000583965	X	32827590 - 32834777	X	32809473 - 32816660	583965	574218		
NC_000018.9:g.(?_59755969)_(59810599_?)del	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000583957	18	59755969 - 59810599	18	62088736 - 62143366	583957	572535		
NC_000019.9:g.(?_11238664)_(11238781_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000583946	19	11238664 - 11238781	19	11127988 - 11128105	583946	570268		
NC_000019.9:g.(?_55652231)_(55658545_?)del	TNNT1		Nemaline myopathy 5	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000583940	19	55652231 - 55658545	19	55140863 - 55147177	583940	570286		
NC_000023.10:g.(?_31341695)_(31526374_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000583919	X	31341695 - 31526374	X	31323578 - 31508257	583919	574195		
NC_000023.10:g.(?_153607825)_(153609577_?)del	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000583878	X	153607825 - 153609577			583878	573442		
NC_000022.10:g.(?_30038185)_(30038280_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000583855	22	30038185 - 30038280	22	29642196 - 29642291	583855	573218		
NC_000023.10:g.(?_123025068)_(123026643_?)del	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000583839	X	123025068 - 123026643	X	123891218 - 123892793	583839	574191		
NC_000023.10:g.(?_31514885)_(31697723_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000583837	X	31514885 - 31697723	X	31496768 - 31679606	583837	575292		
NC_000023.10:g.(?_31627701)_(31986631_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000583834	X	31627701 - 31986631	X	31609584 - 31968514	583834	574197		
NC_000019.9:g.(?_1221938)_(1222015_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000583799	19	1221938 - 1222015	19	1221939 - 1222016	583799	572710		
NC_000019.9:g.(?_13470400)_(13470633_?)del	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000583770	19	13470400 - 13470633	19	13359586 - 13359819	583770	574784		
NC_000018.9:g.(?_48556583)_(48604847_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000583710	18	48556583 - 48604847	18	51030213 - 51078477	583710	570044		
NC_000023.10:g.(?_31747728)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000583700	X	31747728 - 31950364	X	31729611 - 31932247	583700	575296		
NC_000023.10:g.(?_132795738)_(133119496_?)del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Mar 10, 2018)	criteria provided, single submitter	VCV000583690	X	132795738 - 133119496			583690	573436		
NC_000022.10:g.(?_38565205)_(38565453_?)del	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000583663	22	38565205 - 38565453	22	38169198 - 38169446	583663	575208		
NC_000023.10:g.(?_31241144)_(31241258_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000583653	X	31241144 - 31241258	X	31223027 - 31223141	583653	575289		
NC_000023.10:g.(?_32305626)_(32381095_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000583636	X	32305626 - 32381095	X	32287509 - 32362978	583636	573465		
NC_000023.10:g.(?_18938130)_(18938339_?)del	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000583617	X	18938130 - 18938339	X	18920012 - 18920221	583617	575285		
NC_000018.9:g.(?_2920271)_(2960858_?)del	LPIN2		Majeed syndrome	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000583606	18	2920271 - 2960858	18	2920273 - 2960860	583606	572524		
NC_000017.10:g.(?_73969686)_(73975174_?)del	ACOX1			Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000583563	17	73969686 - 73975174	17	75973605 - 75979093	583563	568672		
NC_000023.10:g.(?_32305626)_(32408318_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000583557	X	32305626 - 32408318	X	32287509 - 32390201	583557	575300		
NC_000020.10:g.(?_62044803)_(62045546_?)del	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000583554	20	62044803 - 62045546	20	63413450 - 63414193	583554	575075		
NC_000023.10:g.(?_31792077)_(31854936_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000583546	X	31792077 - 31854936	X	31773960 - 31836819	583546	573451		
NC_000023.10:g.(?_32235013)_(32472969_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000583545	X	32235013 - 32472969	X	32216896 - 32454852	583545	574207		
NC_000023.10:g.(?_33038236)_(33038337_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000583538	X	33038236 - 33038337	X	33020119 - 33020220	583538	573486		
NC_000023.10:g.(?_32827590)_(32867957_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000583527	X	32827590 - 32867957	X	32809473 - 32849840	583527	573476		
NC_000022.10:g.(?_30032730)_(30057338_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000583523	22	30032730 - 30057338	22	29636741 - 29661349	583523	573936		
NC_000022.10:g.(?_34157338)_(34157483_?)del	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000583522	22	34157338 - 34157483	22	33761351 - 33761496	583522	573232		
NC_000023.10:g.(?_123480147)_(123505261_?)del	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000583520	X	123480147 - 123505261	X	124346297 - 124371411	583520	574193		
NC_000023.10:g.(?_31986436)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000583518	X	31986436 - 31986651	X	31968319 - 31968534	583518	575298		
NC_000020.10:g.(?_45338356)_(45362493_?)del	SLC2A10		Arterial tortuosity syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000583508	20	45338356 - 45362493	20	46709717 - 46733854	583508	571139		
NC_000023.10:g.(?_32662229)_(32669194_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000583494	X	32662229 - 32669194	X	32644112 - 32651077	583494	572124		
NC_000023.10:g.(?_32563256)_(32591983_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000583478	X	32563256 - 32591983	X	32545139 - 32573866	583478	575302		
NC_000019.9:g.(?_13186349)_(13189549_?)del	NFIX		Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000583425	19	13186349 - 13189549	19	13075535 - 13078735	583425	572021		
NC_000023.10:g.(?_38240575)_(38272343_?)del	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000583414	X	38240575 - 38272343	X	38381322 - 38413090	583414	572127		
NM_001127221.1(CACNA1A):c.6205C>T (p.Arg2069Ter)	CACNA1A	R2069*, R2068*, R2074*, R2071*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000583270	19	13323018	19	13212204	583270	572936	rs779221807	NC_000019.10:13212203:G:A
NM_001399.5(EDA):c.1133C>T (p.Thr378Met)	EDA	T378M, T373M, T376M	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000583138	X	69255416	X	70035566	583138	575441	rs1569407346	NC_000023.11:70035565:C:T
NM_000026.4(ADSL):c.550C>T (p.Gln184Ter)	ADSL	Q184*, Q120*	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000583132	22	40754935	22	40358931	583132	574139	rs1569096551	NC_000022.11:40358930:C:T
NM_006494.4(ERF):c.-44_22+11del	ERF		Craniosynostosis 1	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000583126	19	42759119 - 42759195	19	42254967 - 42255043	583126	570836	rs1568475667	
NM_000455.4(STK11):c.105_106del (p.Tyr36fs)	STK11	Y36fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000583088	19	1207016 - 1207017	19	1207017 - 1207018	583088	572188	rs1568689994	NC_000019.10:1207016:TCT:T
NM_016418.5(NF2):c.999+1G>A	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000583001	22	30064436	22	29668447	583001	573347	rs1569302393	NC_000022.11:29668446:G:A
NM_004006.2(DMD):c.7252C>T (p.Gln2418Ter)	DMD	Q2418*, Q1074*, Q2295*, Q2410*, Q1077*, Q2414*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582905	X	31838149	X	31820032	582905	572419	rs1569451994	NC_000023.11:31820031:G:A
NM_000411.8(HLCS):c.604G>T (p.Glu202Ter)	HLCS	E202*, E349*	Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000582885	21	38309141	21	36936841	582885	575164	rs148324626	NC_000021.9:36936840:C:A
NM_004655.4(AXIN2):c.1822del (p.Leu608fs)	AXIN2	L608fs	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Mar 4, 2018)	criteria provided, single submitter	VCV000582788	17	63533072	17	65536954	582788	569578	rs1567754914	NC_000017.11:65536953:G:
NM_000527.4(LDLR):c.1851del (p.Val618fs)	LDLR	V577fs, V450fs, V618fs, V491fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Feb 18, 2018)	criteria provided, single submitter	VCV000582591	19	11230771	19	11120095	582591	572871	rs1568610747	NC_000019.10:11120094:AAA:AA
NM_007267.7(TMC6):c.748_1082+56del	TMC6		EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000582588	17	76120014 - 76120748	17	78123933 - 78124667	582588	569801	rs1567997496	
NM_000117.2(EMD):c.607del (p.Arg203fs)	EMD	R203fs	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000582473	X	153609397	X	154381037	582473	574371	rs1569552106	NC_000023.11:154381036:CCC:CC
NM_000194.3(HPRT1):c.368C>G (p.Ser123Ter)	HPRT1	S123*	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000582293	X	133620544	X	134486514	582293	574292	rs369065223	NC_000023.11:134486513:C:G
NM_000023.4(SGCA):c.186C>G (p.Tyr62Ter)	SGCA	Y62*	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000582221	17	48244971	17	50167610	582221	574512	rs766400853	NC_000017.11:50167609:C:G
NM_001165927.1(MKS1):c.1357C>G (p.Arg453Gly)	MKS1	R463G, R453G, R260G	Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000582164	17	56284466	17	58207105	582164	574534	rs766392300	NC_000017.11:58207104:G:C
NM_006494.4(ERF):c.223C>T (p.Gln75Ter)	ERF	Q75*	Craniosynostosis 1	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000582072	19	42754517	19	42250365	582072	574986	rs1568472771	NC_000019.10:42250364:G:A
NM_001323289.2(CDKL5):c.282+1G>T	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000582020	X	18593611	X	18575491	582020	572370	rs1569213054	NC_000023.11:18575490:G:T
NM_001848.2(COL6A1):c.814G>C (p.Gly272Arg)	COL6A1	G272R	Bethlem myopathy 1	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000581961	21	47409007	21	45989093	581961	575191	rs398123640	NC_000021.9:45989092:G:C
NM_020964.3(EPG5):c.5938G>T (p.Glu1980Ter)	EPG5	E1980*	Vici syndrome	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000581925	18	43458345	18	45878380	581925	572643	rs763614919	NC_000018.10:45878379:C:A
NM_020964.3(EPG5):c.1253-1G>A	EPG5		Vici syndrome	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000581923	18	43531205	18	45951239	581923	574757	rs1470797555	NC_000018.10:45951238:C:T
NM_001083962.2(TCF4):c.1841C>T (p.Ala614Val)	TCF4	A614V, A398V, A449V, A450V, A454V, A480V, A539V, A543V, A585V, A590V, A607V, A609V, A620V, A716V, A484V, A572V, A591V, A613V, A568V, A586V, A589V, A610V	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000581714	18	52896116	18	55228885	581714	571970	rs1568303352	NC_000018.10:55228884:G:A
NM_005629.4(SLC6A8):c.1104dup (p.Glu369fs)	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000581613	X	152959003 - 152959004	X	153693548 - 153693549	581613	573650	rs1569539381	NC_000023.11:153693548:A:AA
NM_000159.4(GCDH):c.914C>T (p.Ser305Leu)	GCDH	S305L	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000581598	19	13007785	19	12896971	581598	570510	rs1260580183	NC_000019.10:12896970:C:T
NM_004006.2(DMD):c.650-1827_771del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000581591	X	32717289 - 32719237	X	32699172 - 32701120	581591	575406		
NM_017950.4(CCDC40):c.1416del (p.Ile473fs)	CCDC40	I473fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000581475	17	78032754	17	80058955	581475	571693	rs764011276	NC_000017.11:80058954:GG:G
NM_000023.4(SGCA):c.236_237insA (p.Gln80fs)	SGCA		Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000581361	17	48245021 - 48245022	17	50167660 - 50167661	581361	571260	rs1567739339	NC_000017.11:50167660::A
NM_001256715.2(DNAAF3):c.363_373del (p.Leu122fs)	DNAAF3	L169fs, L68fs, L190fs, L122fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000581286	19	55673608 - 55673618	19	55162240 - 55162250	581286	571104	rs1159887305	NC_000019.10:55162239:GCGGGCGCAGC:
NM_176787.5(PIGN):c.1759C>T (p.Arg587Ter)	PIGN	R587*	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000581123	18	59774030	18	62106797	581123	574777	rs376226764	NC_000018.10:62106796:G:A
NM_001008537.3(NEXMIF):c.3334del (p.Ile1112fs)	NEXMIF	I1112fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000581020	X	73961058	X	74741223	581020	574899	rs1569335135	NC_000023.11:74741222:TTTTTT:TTTTT
NM_000052.7(ATP7A):c.1537G>T (p.Glu513Ter)	ATP7A	E513*	Cutis laxa, X-linked|Menkes kinky-hair syndrome|Distal spinal muscular atrophy, X-linked 3	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000581017	X	77254175	X	77998678	581017	575082	rs1569549699	NC_000023.11:77998677:G:T
NM_024301.5(FKRP):c.1077_1078dup (p.Asp360fs)	FKRP		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000580998	19	47259782 - 47259783	19	46756525 - 46756526	580998	570873	rs1568419860	NC_000019.10:46756525:GGG:GGGGG
NM_007254.4(PNKP):c.143del (p.Arg48fs)	PNKP	R48fs	Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000580950	19	50370319	19	49867062	580950	573276	rs766530579	NC_000019.10:49867061:C:
NM_144687.3(NLRP12):c.1170C>A (p.Tyr390Ter)	NLRP12	Y390*	Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000580902	19	54313743	19	53810489	580902	575054	rs146245368	NC_000019.10:53810488:G:T
NM_005535.3(IL12RB1):c.251_254del (p.Gly84fs)	IL12RB1	G124fs, G84fs	Immunodeficiency 30	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000580899	19	18191797 - 18191800	19	18080987 - 18080990	580899	572990	rs1568515222	NC_000019.10:18080986:CGCCCG:CG
NM_005629.4(SLC6A8):c.1659C>G (p.Tyr553Ter)	SLC6A8	Y553*, Y543*, Y438*	Creatine transporter deficiency	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000580873	X	152960236	X	153694781	580873	575353	rs1569539466	NC_000023.11:153694780:C:G
NM_000527.4(LDLR):c.1595_1596dup (p.Trp533fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000580835	19	11226777 - 11226778	19	11116101 - 11116102	580835	572867	rs1568606711	NC_000019.10:11116101:AC:ACAC
NM_199242.2(UNC13D):c.2293G>T (p.Glu765Ter)	UNC13D	E765*		Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000580834	17	73830411	17	75834330	580834	569747	rs763117746	NC_000017.11:75834329:C:A
NM_020436.5(SALL4):c.1232del (p.Val411fs)	SALL4	V411fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000580810	20	50407790	20	51791251	580810	571309	rs1568864697	NC_000020.11:51791250:A:
NM_014339.6(IL17RA):c.787C>T (p.Arg263Ter)	IL17RA	R263*	Immunodeficiency 51	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV000580706	22	17584408	22	17103518	580706	575210	rs778624945	NC_000022.11:17103517:C:T
NM_020964.3(EPG5):c.1431_1434CTTC[1] (p.Phe478_Leu479insTer)	EPG5		Vici syndrome	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000580542	18	43529509 - 43529512	18	45949543 - 45949546	580542	570190	rs762639913	NC_000018.10:45949542:GAAGGAAG:GAAG
NM_020964.3(EPG5):c.4286del (p.His1429fs)	EPG5	H1429fs	Vici syndrome	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000580540	18	43487966	18	45908001	580540	570166	rs1568142333	NC_000018.10:45908000:T:
NM_000061.2(BTK):c.278C>A (p.Ser93Ter)	BTK	S93*, S127*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000580394	X	100626652	X	101371664	580394	573515	rs1569295678	NC_000023.11:101371663:G:T
NM_020956.2(PRX):c.*1595C>T	PRX	R464*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000580375	19	40902869	19	40396962	580375	573125	rs574861276	NC_000019.10:40396961:G:A
NM_001127221.1(CACNA1A):c.1415dup (p.Glu473fs)	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000580312	19	13428068 - 13428069	19	13317254 - 13317255	580312	572265	rs1568528298	NC_000019.10:13317254:TTTTT:TTTTTT
NM_001364171.2(CCDC114):c.1514dup (p.Phe507_Glu508insTer)	CCDC114		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000580269	19	48800913 - 48800914	19	48297656 - 48297657	580269	570897	rs753915759	NC_000019.10:48297656:GGGGGG:GGGGGGG
NM_172107.4(KCNQ2):c.780_781dup (p.Phe261fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000580204	20	62073793 - 62073794	20	63442440 - 63442441	580204	571355	rs1568932480	NC_000020.11:63442440:AG:AGAG
NM_031229.4(RBCK1):c.1054C>T (p.Arg352Ter)	RBCK1	R352*, R310*, R182*	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000580166	20	407981	20	427337	580166	572889	rs780854072	NC_000020.11:427336:C:T
NM_004006.2(DMD):c.1619G>A (p.Trp540Ter)	DMD	W540*, W536*, W417*, W532*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000580058	X	32591947	X	32573830	580058	573826	rs1569230406	NC_000023.11:32573829:C:T
NM_001022.4(RPS19):c.384_385del (p.Asp130fs)	RPS19	K133fs, D130fs	Diamond-Blackfan anemia	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000580015	19	42373795 - 42373796	19	41869725 - 41869726	580015	573141	rs869066130	NC_000019.10:41869724:AAA:A
NM_000109.4(DMD):c.1553del (p.Thr518fs)	DMD	T403fs, T526fs, T518fs, T522fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000579974	X	32613899	X	32595782	579974	572454	rs1569273905	NC_000023.11:32595781:G:
NM_153638.3(PANK2):c.909del (p.Phe304fs)	PANK2	F13fs, F304fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000579971	20	3888853	20	3908206	579971	571214	rs1568569941	NC_000020.11:3908205:C:
NM_005629.4(SLC6A8):c.1455G>A (p.Trp485Ter)	SLC6A8	W485*, W370*, W475*	Creatine transporter deficiency	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000579906	X	152959861	X	153694406	579906	572253	rs1569539443	NC_000023.11:153694405:G:A
NM_000475.5(NR0B1):c.528C>G (p.Tyr176Ter)	NR0B1	Y176*	Congenital adrenal hypoplasia, X-linked|46,XY sex reversal, type 2	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000579771	X	30326953	X	30308836	579771	573780	rs767828388	NC_000023.11:30308835:G:C
NM_000061.2(BTK):c.1688G>A (p.Trp563Ter)	BTK	W563*, W387*, W597*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000579604	X	100608920	X	101353932	579604	574234	rs1555977474	NC_000023.11:101353931:C:T
NM_000271.5(NPC1):c.306T>G (p.Tyr102Ter)	NPC1	Y102*	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000579540	18	21148944	18	23568980	579540	571849	rs751249367	NC_000018.10:23568979:A:C
NM_172107.3(KCNQ2):c.1872del (p.Lys625Argfs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000579390	20	62039781	20	63408428	579390	573599	rs1568864658	NC_000020.11:63408427:CCC:CC
NM_005535.3(IL12RB1):c.1791+2T>G	IL12RB1		Immunodeficiency 30|not provided	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000579038	19	18171930	19	18061120	579038	572287	rs554063682	NC_000019.10:18061119:A:C
NM_001008537.3(NEXMIF):c.2251del (p.Glu751fs)	NEXMIF	E751fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000578993	X	73962141	X	74742306	578993	574903	rs1569335485	NC_000023.11:74742305:CC:C
NM_030662.3(MAP2K2):c.171T>A (p.Phe57Leu)	MAP2K2	F57L	Rasopathy	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000578970	19	4117549	19	4117551	578970	574980	rs1057519910	NC_000019.10:4117550:A:T
NM_000411.8(HLCS):c.250G>T (p.Glu84Ter)	HLCS	E84*, E231*	Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000578930	21	38309495	21	36937195	578930	573790	rs1569218416	NC_000021.9:36937194:C:A
NM_004035.7(ACOX1):c.139del (p.Gln47fs)	ACOX1	Q47fs, Q9fs		Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000578920	17	73974745	17	75978664	578920	571606	rs1567892272	NC_000017.11:75978663:GG:G
NM_032121.5(MAGT1):c.444dup (p.Ala149fs)	MAGT1		Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000578831	X	77126346 - 77126347	X	77870849 - 77870850	578831	574029	rs1569548146	NC_000023.11:77870849:AAAAAA:AAAAAAA
NM_002637.4(PHKA1):c.892C>T (p.Arg298Ter)	PHKA1	R298*	Glycogen storage disease IXd	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000578746	X	71877464	X	72657614	578746	575448	rs1256371424	NC_000023.11:72657613:G:A
NM_000109.4(DMD):c.5431_5435dup (p.Asn1812fs)	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578631	X	32364186 - 32364187	X	32346069 - 32346070	578631	575396	rs1569559110	NC_000023.11:32346069:TTGTCTT:TTGTCTTGTCTT
NM_000152.5(GAA):c.2662G>T (p.Glu888Ter)	GAA	E888*	Glycogen storage disease, type II	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000578595	17	78092467	17	80118668	578595	571734	rs765718882	NC_000017.11:80118667:G:T
NM_000292.3(PHKA2):c.2465del (p.Leu822fs)	PHKA2	L822fs	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000578458	X	18926070	X	18907952	578458	573764	rs1569298646	NC_000023.11:18907951:A:
NM_004006.2(DMD):c.3604-1G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 4, 2018)	criteria provided, single submitter	VCV000578444	X	32466756	X	32448639	578444	575401	rs1569562952	NC_000023.11:32448638:C:G
NM_000527.4(LDLR):c.694+1G>C	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000578041	19	11216277	19	11105601	578041	574858	rs879254646	NC_000019.10:11105600:G:C
NM_004655.4(AXIN2):c.234G>A (p.Trp78Ter)	AXIN2	W78*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000577956	17	63554505	17	65558387	577956	569663	rs1567769335	NC_000017.11:65558386:C:T
NM_000159.4(GCDH):c.751C>T (p.Gln251Ter)	GCDH	Q251*	Glutaric aciduria, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000577874	19	13007134	19	12896320	577874	570509	rs1008834111	NC_000019.10:12896319:C:T
NM_001083962.2(TCF4):c.1552G>T (p.Glu518Ter)	TCF4	E518*, E388*, E495*, E517*, E357*, E493*, E524*, E620*, E358*, E447*, E494*, E515*, E302*, E476*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000577819	18	52899837	18	55232606	577819	574765	rs1555718063	NC_000018.10:55232605:C:A
NM_004006.2(DMD):c.8655C>A (p.Tyr2885Ter)	DMD	Y2885*, Y1544*, Y2881*, Y2762*, Y1541*, Y2877*, Y156*, Y425*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000577742	X	31497113	X	31478996	577742	575389	rs1569546174	NC_000023.11:31478995:G:T
NM_013995.2(LAMP2):c.137G>A (p.Trp46Ter)	LAMP2	W46*	Danon disease	Pathogenic(Last reviewed: May 20, 2018)	criteria provided, single submitter	VCV000577660	X	119590552	X	120456697	577660	574266	rs1569371591	NC_000023.11:120456696:C:T
NM_000377.2(WAS):c.734+2T>A	WAS		X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000577637	X	48545346	X	48686957	577637	575424	rs1569493877	NC_000023.11:48686956:T:A
NM_001347721.2(DYRK1A):c.507dup (p.Arg170fs)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000577532	21	38858785 - 38858786	21	37486483 - 37486484	577532	573129	rs1569370887	NC_000021.9:37486483:T:TT
NM_000033.4(ABCD1):c.454C>T (p.Arg152Cys)	ABCD1	R152C	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000577418	X	152991175	X	153725720	577418	572284	rs1569540693	NC_000023.11:153725719:C:T
NM_001242897.2(DEPDC5):c.1453C>T (p.Arg485Ter)	DEPDC5	R485*, R457*	Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000577194	22	32210985	22	31814999	577194	575262	rs1568991466	NC_000022.11:31814998:C:T
NM_001323289.2(CDKL5):c.638G>A (p.Gly213Glu)	CDKL5	G213E	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000577127	X	18606157	X	18588037	577127	572376	rs1569215629	NC_000023.11:18588036:G:A
NM_020956.2(PRX):c.353del (p.Lys118fs)	PRX	K118fs	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000577125	19	40904555	19	40398648	577125	574976	rs1568710514	NC_000019.10:40398647:TT:T
NM_198270.4(NHS):c.814C>T (p.Gln272Ter)	NHS	Q272*, Q95*	Nance-Horan syndrome	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000577103	X	17710550	X	17692430	577103	575375	rs1569310288	NC_000023.11:17692429:C:T
NM_004975.4(KCNB1):c.1142G>A (p.Gly381Glu)	KCNB1	G381E	Epileptic encephalopathy, early infantile, 26	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000576946	20	47990955	20	49374418	576946	572937	rs1569017114	NC_000020.11:49374417:C:T
NM_000033.4(ABCD1):c.1876G>A (p.Ala626Thr)	ABCD1	A626T	not specified|Adrenoleukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000576910	X	153008685	X	153743231	576910	572300	rs1557055316	NC_000023.11:153743230:G:A
NM_005359.5(SMAD4):c.939dup (p.Ile314Hisfs)	SMAD4		Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000576856	18	48586267 - 48586268	18	51059897 - 51059898	576856	570226	rs1568206602	NC_000018.10:51059897:CCC:CCCC
NM_000455.4(STK11):c.-1115_290del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000576830	19	1205798 - 1207202	19	1205799 - 1207203	576830	572181		
NM_001184880.2(PCDH19):c.1121_1122del (p.Val373_Ser374insTer)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000576806	X	99662474 - 99662475	X	100407476 - 100407477	576806	572137	rs1569315042	NC_000023.11:100407475:AGA:A
NM_000033.4(ABCD1):c.1660dup (p.Arg554fs)	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 30, 2018)	criteria provided, single submitter	VCV000576680	X	153006052 - 153006053	X	153740598 - 153740599	576680	573666	rs1569541115	NC_000023.11:153740598:C:CC
NM_005535.3(IL12RB1):c.559G>T (p.Gly187Ter)	IL12RB1	G187*, G227*	Immunodeficiency 30	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000576660	19	18187128	19	18076318	576660	574916	rs564884307	NC_000019.10:18076317:C:A
NM_001323289.2(CDKL5):c.2142del (p.Tyr716fs)	CDKL5	Y716fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000576176	X	18627680	X	18609560	576176	573755	rs1569220925	NC_000023.11:18609559:C:
NM_017950.4(CCDC40):c.415C>T (p.Gln139Ter)	CCDC40	Q139*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000576151	17	78013932	17	80040133	576151	572366	rs764551914	NC_000017.11:80040132:C:T
NM_004006.2(DMD):c.9224+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000576087	X	31341714	X	31323597	576087	573781	rs1569526122	NC_000023.11:31323596:C:T
NM_024422.6(DSC2):c.2463C>A (p.Tyr821Ter)	DSC2	Y821*	Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000575762	18	28648905	18	31068939	575762	571862	rs1567971476	NC_000018.10:31068938:G:T
NM_004006.2(DMD):c.1006G>T (p.Glu336Ter)	DMD	E336*, E332*, E328*, E213*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000575704	X	32663224	X	32645107	575704	575404	rs1057522454	NC_000023.11:32645106:C:A
NM_000292.3(PHKA2):c.2209C>T (p.Gln737Ter)	PHKA2	Q737*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000575608	X	18929007	X	18910889	575608	575380	rs1569300538	NC_000023.11:18910888:G:A
NM_004484.3(GPC3):c.1307del (p.Ala436fs)	GPC3	A420fs, A436fs, A459fs, A382fs	Wilms tumor 1	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000575598	X	132795864	X	133661836	575598	573537	rs1569408743	NC_000023.11:133661835:G:
NM_017950.4(CCDC40):c.3157del (p.Arg1053fs)	CCDC40	R1053fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000575559	17	78071177	17	80097378	575559	569837	rs1567818236	NC_000017.11:80097377:CCC:CC
NM_013995.2(LAMP2):c.843T>G (p.Tyr281Ter)	LAMP2	Y281*	Danon disease	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV000575405	X	119580181	X	120446326	575405	575322	rs1569369194	NC_000023.11:120446325:A:C
NM_003895.3(SYNJ1):c.24G>A (p.Trp8Ter)	SYNJ1	W8*	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000575322	21	34100328	21	32728017	575322	571505	rs1569147057	NC_000021.9:32728016:C:T
NM_004006.2(DMD):c.918T>A (p.Tyr306Ter)	DMD	Y306*, Y183*, Y302*, Y298*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000575175	X	32716029	X	32697912	575175	575405	rs149106712	NC_000023.11:32697911:A:T
NM_000100.3(CSTB):c.64C>T (p.Gln22Ter)	CSTB	Q22*	Progressive myoclonic epilepsy	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000575156	21	45196087	21	43776206	575156	575178	rs1569006250	NC_000021.9:43776205:G:A
NM_001242897.2(DEPDC5):c.3568C>T (p.Gln1190Ter)	DEPDC5	Q1290*, Q1190*, Q1212*, Q1259*, Q1268*, Q1281*, Q1262*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000575135	22	32275573	22	31879587	575135	575265	rs1569186093	NC_000022.11:31879586:C:T
NM_212472.2(PRKAR1A):c.671G>A (p.Trp224Ter)	PRKAR1A	W224*	Carney complex, type 1	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000575134	17	66522016	17	68525875	575134	574608	rs1568698504	NC_000017.11:68525874:G:A
NM_001242897.2(DEPDC5):c.784_785GA[2] (p.Arg263fs)	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000575084	22	32193602 - 32193603	22	31797616 - 31797617	575084	575260	rs1569523728	NC_000022.11:31797615:GAGAGA:GAGA
NM_000109.4(DMD):c.670_674ATCAC[3] (p.Leu227fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000575031	X	32717356 - 32717357	X	32699239 - 32699240	575031	575407	rs1569469298	NC_000023.11:32699239:GTGATGTGATGT:GTGATGTGATGTGATGT
NM_004006.2(DMD):c.3742C>T (p.Gln1248Ter)	DMD	Q1248*, Q1125*, Q1240*, Q1244*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000575026	X	32466617	X	32448500	575026	575400	rs1569562936	NC_000023.11:32448499:G:A
NM_001399.5(EDA):c.396+4dup	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000574959	X	68836551 - 68836552	X	69616707 - 69616708	574959	574870	rs1569272528	NC_000023.11:69616707:A:AA
NM_000455.4(STK11):c.291-1G>T	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000574932	19	1218415	19	1218416	574932	572895	rs112675807	NC_000019.10:1218415:G:T
NM_001083962.2(TCF4):c.1527del (p.Ser510fs)	TCF4	S349fs, S380fs, S439fs, S487fs, S509fs, S510fs, S516fs, S485fs, S486fs, S612fs, S294fs, S350fs, S468fs, S507fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000574899	18	52899862	18	55232631	574899	572665	rs1568331766	NC_000018.10:55232630:G:
NM_001429.4(EP300):c.4585C>T (p.Arg1529Ter)	EP300	R1529*, R1503*	Colorectal cancer|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000574856	22	41568635	22	41172631	574856	574142	rs1569118537	NC_000022.11:41172630:C:T
NM_020956.2(PRX):c.231C>G (p.Tyr77Ter)	PRX	Y77*	Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000574671	19	40904677	19	40398770	574671	570797	rs752192677	NC_000019.10:40398769:G:C
NM_212472.2(PRKAR1A):c.812dup (p.Leu271fs)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000574526	17	66525051 - 66525052	17	68528910 - 68528911	574526	574609	rs1568701362	NC_000017.11:68528910:TT:TTT
NM_001887.4(CRYBB1):c.585del (p.Tyr196fs)	CRYBB1	Y196fs	Cataract, congenital nuclear, autosomal recessive 3	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000574493	22	26995628	22	26599664	574493	571755	rs1569203234	NC_000022.11:26599663:G:
NM_144687.3(NLRP12):c.2574_2585+13del	NLRP12		Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000574410	19	54307193 - 54307217	19	53803939 - 53803963	574410	571072	rs1302931500	NC_000019.10:53803938:AGGAAGAACTCACCACAAAGTCCGTAG:AG
NM_015352.2(POFUT1):c.289C>T (p.Gln97Ter)	POFUT1	Q97*	Dowling-Degos disease 2	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000574378	20	30803114	20	32215311	574378	571182	rs1569152303	NC_000020.11:32215310:C:T
NM_001111125.3(IQSEC2):c.1579C>T (p.Gln527Ter)	IQSEC2	Q527*, Q322*	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000574377	X	53280179	X	53250997	574377	573922	rs1569302816	NC_000023.11:53250996:G:A
NM_000377.2(WAS):c.1001del (p.Gly334fs)	WAS	G334fs	|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000574368	X	48547113	X	48688724	574368	572514	rs1569494025	NC_000023.11:48688723:GGGGGG:GGGGG
NM_000454.4(SOD1):c.301G>A (p.Glu101Lys)	SOD1	E101K	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000574319	21	33039632	21	31667319	574319	573721	rs76731700	NC_000021.9:31667318:G:A
NM_172107.4(KCNQ2):c.845del (p.Asp282fs)	KCNQ2	D282fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000574311	20	62071033	20	63439680	574311	575132	rs1568927747	NC_000020.11:63439679:T:
NM_001008537.3(NEXMIF):c.3800del (p.Pro1267fs)	NEXMIF	P1267fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000574310	X	73960592	X	74740757	574310	574897	rs1569334937	NC_000023.11:74740756:GGG:GG
NM_015295.2(SMCHD1):c.4821dup (p.Ile1608fs)	SMCHD1		Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000574293	18	2769792 - 2769793	18	2769794 - 2769795	574293	574713	rs1568350731	NC_000018.10:2769794:T:TT
NM_004006.2(DMD):c.3020C>A (p.Ser1007Ter)	DMD	S1007*, S1003*, S999*, S884*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000574223	X	32486757	X	32468640	574223	572440	rs144732570	NC_000023.11:32468639:G:T
NM_000397.3(CYBB):c.1466_1467del (p.Asn489fs)	CYBB	N489fs	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000574178	X	37668824 - 37668825	X	37809571 - 37809572	574178	574726	rs1569480333	NC_000023.11:37809570:AT:
NM_001111125.3(IQSEC2):c.848del (p.Gly283fs)	IQSEC2	G283fs, G78fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV000573936	X	53285133	X	53255951	573936	573923	rs782660318	NC_000023.11:53255950:CCCCCC:CCCCC
NM_001029896.2(WDR45):c.827+1G>C	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000573902	X	48933022	X	49075363	573902	572515	rs1557083958	NC_000023.11:49075362:C:G
NM_003721.4(RFXANK):c.271_271+1insCTGCC	RFXANK		Bare lymphocyte syndrome 2	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000573785	19	19307855 - 19307856	19	19197046 - 19197047	573785	574922	rs1568578781	NC_000019.10:19197046::CTGCC
NM_001242897.2(DEPDC5):c.1133del (p.Pro378fs)	DEPDC5	P350fs, P378fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000573709	22	32200197	22	31804211	573709	573377	rs1568955379	NC_000022.11:31804210:CCC:CC
NM_000397.3(CYBB):c.1011G>A (p.Trp337Ter)	CYBB	W337*	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, single submitter	VCV000573596	X	37663243	X	37803990	573596	573852	rs1569479943	NC_000023.11:37803989:G:A
NM_199242.2(UNC13D):c.1768C>T (p.Gln590Ter)	UNC13D	Q590*		Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000573522	17	73831570	17	75835489	573522	569752	rs1567818774	NC_000017.11:75835488:G:A
NM_000383.4(AIRE):c.958del (p.Leu320fs)	AIRE	L320fs	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000573407	21	45711055	21	44291172	573407	571603	rs1568928525	NC_000021.9:44291171:CC:C
NM_017950.4(CCDC40):c.3129del (p.Phe1044fs)	CCDC40	F1044fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000573257	17	78071151	17	80097352	573257	569836	rs1418585908	NC_000017.11:80097351:C:
NM_001127221.1(CACNA1A):c.1472G>A (p.Trp491Ter)	CACNA1A	W491*, W490*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000573195	19	13428012	19	13317198	573195	574893	rs1568528144	NC_000019.10:13317197:C:T
NM_153638.3(PANK2):c.1257del (p.Phe419fs)	PANK2	F128fs, F419fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000573171	20	3893120	20	3912473	573171	571232	rs1568574931	NC_000020.11:3912472:TTTTTTT:TTTTTT
NM_032121.5(MAGT1):c.65_66del (p.Lys22fs)	MAGT1	K22fs	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000573122	X	77150938 - 77150939	X	77895441 - 77895442	573122	574993	rs782474570	NC_000023.11:77895440:TTT:T
NM_001242897.2(DEPDC5):c.4201_4202dup (p.Gln1401fs)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000572846	22	32302033 - 32302034	22	31906047 - 31906048	572846	575267	rs1569254004	NC_000022.11:31906047:CA:CACA
NM_001242897.2(DEPDC5):c.3247del (p.Ala1083fs)	DEPDC5	A1083fs, A1105fs, A1174fs, A1152fs, A1155fs, A1161fs, A1183fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000572795	22	32269302	22	31873316	572795	571963	rs1569166925	NC_000022.11:31873315:G:
NM_005359.5(SMAD4):c.1343_1367delAGCAGCAGGCGGCTACTGCACAAGC (p.Gln448Leufs)	SMAD4	Q448fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Sep 2, 2018)	criteria provided, single submitter	VCV000572588	18	48603040 - 48603064	18	51076670 - 51076694	572588	570232	rs1568211187	NC_000018.10:51076669:GCAGCAGCAGGCGGCTACTGCACAAGC:GC
NM_144687.3(NLRP12):c.815G>A (p.Trp272Ter)	NLRP12	W272*	Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000572583	19	54314098	19	53810844	572583	571077	rs752809784	NC_000019.10:53810843:C:T
NM_004006.2(DMD):c.3679C>T (p.Gln1227Ter)	DMD	Q1227*, Q1104*, Q1223*, Q1219*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000572550	X	32466680	X	32448563	572550	573800	rs1569562941	NC_000023.11:32448562:G:A
NM_000215.3(JAK3):c.2989G>T (p.Glu997Ter)	JAK3	E997*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000572507	19	17941419	19	17830610	572507	572974	rs1568400897	NC_000019.10:17830609:C:A
NM_001256715.2(DNAAF3):c.350G>A (p.Trp117Ter)	DNAAF3	W185*, W164*, W117*, W63*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 2	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572342	19	55673631	19	55162263	572342	571106	rs770403610	NC_000019.10:55162262:C:T
NM_017950.4(CCDC40):c.424C>T (p.Gln142Ter)	CCDC40	Q142*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000572208	17	78013941	17	80040142	572208	574657	rs1568667609	NC_000017.11:80040141:C:T
NM_020436.5(SALL4):c.827dup (p.Ser276fs)	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000571934	20	50408194 - 50408195	20	51791655 - 51791656	571934	575119	rs1568865283	NC_000020.11:51791655:C:CC
NM_001278116.2(L1CAM):c.400+5G>A	L1CAM		Spastic paraplegia	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000571917	X	153137602	X	153872147	571917	572317	rs1569544908	NC_000023.11:153872146:C:T
NM_001165927.1(MKS1):c.615-2A>T	MKS1		Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000571828	17	56291232	17	58213871	571828	571722	rs773036963	NC_000017.11:58213870:T:A
NM_172107.4(KCNQ2):c.788C>T (p.Thr263Ile)	KCNQ2	T263I	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000571819	20	62073787	20	63442434	571819	573613	rs1568932462	NC_000020.11:63442433:G:A
NM_004006.2(DMD):c.531-1G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000571814	X	32827729	X	32809612	571814	574716	rs1569526579	NC_000023.11:32809611:C:G
NM_001193466.2(KANSL1):c.1046del (p.Lys349fs)	KANSL1	K349fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000571768	17	44248464	17	46171098	571768	571552	rs1567761585	NC_000017.11:46171097:TTT:TT
NM_000061.2(BTK):c.1526T>C (p.Met509Thr)	BTK	M509T, M543T	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000571649	X	100611080	X	101356092	571649	574241	rs1569291644	NC_000023.11:101356091:A:G
NM_001242897.2(DEPDC5):c.2091T>A (p.Tyr697Ter)	DEPDC5	Y697*, Y775*, Y766*, Y747*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000571591	22	32233112	22	31837126	571591	574112	rs374158137	NC_000022.11:31837125:T:A
NM_001754.4(RUNX1):c.166_193dup (p.Ala65fs)	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000571388	21	36259297 - 36259298	21	34887000 - 34887001	571388	573118	rs1569084530	NC_000021.9:34887000:CGCCGGCGTCCGGGGCGCCCAGCGGCAACGCC:CGCCGGCGTCCGGGGCGCCCAGCGGCAACGCCGGCGTCCGGGGCGCCCAGCGGCAACGCC
NM_000071.2(CBS):c.452-153_624dup	CBS		Classic homocystinuria	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000571387	21	44485538 - 44485539	21	43065428 - 43065429	571387	573136	rs1568932440	
NM_001195798.2(LDLR):c.996_1009delinsGCA (p.Lys333fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000571377	19	11221383 - 11221396	19	11110707 - 11110720	571377	572855	rs1568600415	NC_000019.10:11110706:TAAGATCGGCTACG:GCA
NM_001281463.1(SMC1A):c.3085C>T (p.Arg1029Ter)	SMC1A	R1051*, R1029*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000571206	X	53409561	X	53382640	571206	574809	rs1569351907	NC_000023.11:53382639:G:A
NM_000052.7(ATP7A):c.2467del (p.Ile822_Val823insTer)	ATP7A		Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome|Cutis laxa, X-linked	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000571199	X	77270219	X	78014722	571199	572609	rs1569549974	NC_000023.11:78014721:G:
NM_001347721.2(DYRK1A):c.637+2T>C	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000571196	21	38858918	21	37486616	571196	575165	rs1569371303	NC_000021.9:37486615:T:C
NM_004006.2(DMD):c.5026-2A>G	DMD		Duchenne muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570910	X	32382829	X	32364712	570910	575398	rs1569559849	NC_000023.11:32364711:T:C
NM_003895.3(SYNJ1):c.2910_2914del (p.Arg971fs)	SYNJ1	R971fs, R927fs, R932fs	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000570902	21	34028997 - 34029001	21	32656687 - 32656691	570902	571490	rs778394516	NC_000021.9:32656686:CTTAT:
NM_002103.5(GYS1):c.1615G>T (p.Glu539Ter)	GYS1	E539*, E475*	Glycogen storage disease 0, muscle	Pathogenic(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000570876	19	49474215	19	48970958	570876	575003	rs561646250	NC_000019.10:48970957:C:A
NM_003859.2(DPM1):c.331_343del (p.Gly111fs)	DPM1	G111fs	Congenital disorder of glycosylation type 1E	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000570864	20	49562413 - 49562425	20	50945876 - 50945888	570864	571306	rs1272097668	NC_000020.11:50945875:TGATGTAGTTTCCTG:TG
NM_003688.3(CASK):c.1641_1644del (p.Thr548fs)	CASK	T542fs, T548fs	Mental retardation, CASK-related, X-linked	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000570810	X	41420836 - 41420839	X	41561583 - 41561586	570810	574730	rs1569306724	NC_000023.11:41561582:TGTTTG:TG
NM_145045.5(CCDC151):c.583_595dup (p.His199fs)	CCDC151		Ciliary dyskinesia, primary, 30	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000570784	19	11537709 - 11537710	19	11426889 - 11426890	570784	574861	rs750658321	NC_000019.10:11426889:GTCTGTTTTGCGC:GTCTGTTTTGCGCGTCTGTTTTGCGC
NM_001783.3(CD79A):c.198G>A (p.Trp66Ter)	CD79A	W66*	Agammaglobulinemia 3, autosomal recessive	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000570771	19	42383178	19	41879108	570771	573150	rs1568801716	NC_000019.10:41879107:G:A
NM_212472.2(PRKAR1A):c.660_661TG[1] (p.Val221fs)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000570680	17	66522005 - 66522006	17	68525864 - 68525865	570680	571565	rs1568698487	NC_000017.11:68525863:TGTG:TG
NM_003413.4(ZIC3):c.535dup (p.Val179fs)	ZIC3			Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000570392	X	136649384 - 136649385	X	137567225 - 137567226	570392	573607	rs1569345723	NC_000023.11:137567225:G:GG
NM_003560.4(PLA2G6):c.1931del (p.Phe644fs)	PLA2G6	F644fs, F418fs, F412fs, F466fs, F590fs	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000570347	22	38511637	22	38115630	570347	571997	rs1569243565	NC_000022.11:38115629:AA:A
NM_000033.4(ABCD1):c.1126G>T (p.Glu376Ter)	ABCD1	E376*	Adrenoleukodystrophy	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000570327	X	153001610	X	153736156	570327	572295	rs782266592	NC_000023.11:153736155:G:T
NM_198270.4(NHS):c.2414G>A (p.Trp805Ter)	NHS	W805*, W628*, W649*, W826*	Nance-Horan syndrome	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000570303	X	17744703	X	17726583	570303	573752	rs1569319773	NC_000023.11:17726582:G:A
NM_020964.3(EPG5):c.3614del (p.Leu1205fs)	EPG5	L1205fs	Vici syndrome	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000570260	18	43495555	18	45915590	570260	570174	rs1568150793	NC_000018.10:45915589:A:
NM_005359.5(SMAD4):c.1572G>A (p.Trp524Ter)	SMAD4	W524*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000570229	18	48604750	18	51078380	570229	571962	rs1568211588	NC_000018.10:51078379:G:A
NM_020964.3(EPG5):c.424G>T (p.Glu142Ter)	EPG5	E142*	Vici syndrome	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000570219	18	43534944	18	45954978	570219	574758	rs190673127	NC_000018.10:45954977:C:A
NM_020964.3(EPG5):c.7333C>T (p.Arg2445Ter)	EPG5	R2445*	Vici syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570218	18	43437927	18	45857962	570218	571946	rs780889226	NC_000018.10:45857961:G:A
NM_001364171.2(CCDC114):c.1517dup (p.Phe507_Glu508insTer)	CCDC114		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000570116	19	48800910 - 48800911	19	48297653 - 48297654	570116	570893	rs766394527	NC_000019.10:48297653:CCC:CCCC
NM_199242.2(UNC13D):c.3011_3014dup (p.Tyr1006fs)	UNC13D			Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000569875	17	73825004 - 73825005	17	75828923 - 75828924	569875	571594	rs1567816070	NC_000017.11:75828923:TCCA:TCCATCCA
NM_004006.2(DMD):c.9100C>T (p.Arg3034Ter)	DMD	R3034*, R1690*, R1693*, R305*, R2911*, R3026*, R3030*, R574*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569802	X	31366736	X	31348619	569802	572399	rs1569530432	NC_000023.11:31348618:G:A
NM_001399.5(EDA):c.459dup (p.Val154fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000569609	X	69176938 - 69176939	X	69957088 - 69957089	569609	574871	rs1569384962	NC_000023.11:69957088:T:TT
NM_000206.2(IL2RG):c.270G>A (p.Trp90Ter)	IL2RG	W90*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000569485	X	70330538	X	71110688	569485	575443	rs1569480047	NC_000023.11:71110687:C:T
NM_000891.2(KCNJ2):c.1102del (p.Leu368fs)	KCNJ2	L368fs	Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000569363	17	68172281	17	70176140	569363	571569	rs1567823248	NC_000017.11:70176139:CC:C
NM_017950.4(CCDC40):c.2440C>T (p.Arg814Ter)	CCDC40	R814*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000569156	17	78060006	17	80086207	569156	574663	rs747233125	NC_000017.11:80086206:C:T
NM_001083962.2(TCF4):c.740dup (p.His247fs)	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000569100	18	52942898 - 52942899	18	55275667 - 55275668	569100	574767	rs1568620774	NC_000018.10:55275667:T:TT
NM_004006.2(DMD):c.7247T>A (p.Leu2416Ter)	DMD	L2416*, L2293*, L2412*, L1072*, L1075*, L2408*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000568924	X	31838154	X	31820037	568924	572421	rs1569452000	NC_000023.11:31820036:A:T
NM_001399.5(EDA):c.527-2A>T	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000568794	X	69247705	X	70027855	568794	573970	rs1569404780	NC_000023.11:70027854:A:T
NM_000292.3(PHKA2):c.2772_2782del (p.Met924fs)	PHKA2	M924fs	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000568551	X	18924637 - 18924647	X	18906519 - 18906529	568551	575377	rs1569297379	NC_000023.11:18906518:GCTCCGTGGCC:
NM_001353921.2(ARHGEF9):c.922C>T (p.Gln308Ter)	ARHGEF9	Q301*, Q248*, Q308*, Q163*, Q241*, Q280*, Q199*, Q314*	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000568396	X	62893941	X	63674061	568396	574815	rs1569458475	NC_000023.11:63674060:G:A
NM_001167.3(XIAP):c.712C>T (p.Arg238Ter)	XIAP	R238*	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000568305	X	123020224	X	123886374	568305	572186	rs111978474	NC_000023.11:123886373:C:T
NM_024422.6(DSC2):c.2200C>T (p.Gln734Ter)	DSC2	Q734*	Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000568186	18	28650742	18	31070776	568186	571867	rs769022411	NC_000018.10:31070775:G:A
NM_000166.6(GJB1):c.524dup (p.Asn175fs)	GJB1		Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000567945	X	70444079 - 70444080	X	71224229 - 71224230	567945	574883	rs1569215346	NC_000023.11:71224229:AA:AAA
NM_000284.4(PDHA1):c.58-1G>A	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000567912	X	19367429	X	19349311	567912	574444	rs1569189834	NC_000023.11:19349310:G:A
NM_144687.3(NLRP12):c.2791G>T (p.Glu931Ter)	NLRP12	E931*, E932*	Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000567880	19	54301633	19	53798379	567880	571071	rs1404302953	NC_000019.10:53798378:C:A
NM_001127221.1(CACNA1A):c.4953+1G>T	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000567724	19	13355995	19	13245181	567724	572238	rs1568457080	NC_000019.10:13245180:C:A
NM_023036.6(DNAI2):c.1422del (p.Thr475fs)	DNAI2	T463fs, T475fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000567508	17	72306227	17	74310088	567508	571584	rs1240172375	NC_000017.11:74310087:GGGG:GGG
NM_000276.4(OCRL):c.2389G>C (p.Ala797Pro)	OCRL	A797P, A798P, A789P	Lowe syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000567454	X	128722910	X	129588933	567454	574268	rs935956958	NC_000023.11:129588932:G:C
NM_005359.5(SMAD4):c.585C>G (p.Tyr195Ter)	SMAD4	Y195*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000567396	18	48581281	18	51054911	567396	572649	rs1316902116	NC_000018.10:51054910:C:G
NM_001323289.2(CDKL5):c.583T>G (p.Trp195Gly)	CDKL5	W195G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000567323	X	18606102	X	18587982	567323	572373	rs1569215594	NC_000023.11:18587981:T:G
NM_000215.3(JAK3):c.1561_1564delinsTGAC (p.Leu521_Glu522delinsTer)	JAK3		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000567299	19	17949077 - 17949080	19	17838268 - 17838271	567299	574910	rs1568404443	NC_000019.10:17838267:CCAG:GTCA
NM_001029896.2(WDR45):c.210_213dup (p.Pro72Ter)	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000567282	X	48935323 - 48935324	X	49077664 - 49077665	567282	572523	rs1569523537	NC_000023.11:49077664:ACTA:ACTAACTA
NM_014646.2(LPIN2):c.589C>T (p.Arg197Ter)	LPIN2	R197*	Majeed syndrome	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000567272	18	2951054	18	2951056	567272	570061	rs750126005	NC_000018.10:2951055:G:A
NM_000383.4(AIRE):c.469C>T (p.Gln157Ter)	AIRE	Q157*	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000567249	21	45707405	21	44287522	567249	573848	rs1488613451	NC_000021.9:44287521:C:T
NM_000109.4(DMD):c.5463_5464del (p.Gly1823fs)	DMD	G1827fs, G487fs, G490fs, G1823fs, G1708fs, G1831fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000567065	X	32364158 - 32364159	X	32346041 - 32346042	567065	572436	rs1569559106	NC_000023.11:32346040:TTT:T
NM_002103.5(GYS1):c.1204del (p.Arg402fs)	GYS1	R402fs, R338fs	Glycogen storage disease 0, muscle	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000567037	19	49481380	19	48978123	567037	572594	rs1568619900	NC_000019.10:48978122:T:
NM_001111125.3(IQSEC2):c.3387C>A (p.Tyr1129Ter)	IQSEC2	Y1129*, Y924*	Mental retardation, X-linked 1	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000566884	X	53265568	X	53236386	566884	573915	rs374220843	NC_000023.11:53236385:G:T
NM_004586.3(RPS6KA3):c.1845del (p.Gly614_Tyr615insTer)	RPS6KA3		Coffin-Lowry syndrome|Mental retardation, X-linked 19	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000566835	X	20179876	X	20161758	566835	573769	rs1569190602	NC_000023.11:20161757:G:
NM_004655.4(AXIN2):c.1206_1207AG[4] (p.Glu405fs)	AXIN2		Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000566626	17	63533939 - 63533940	17	65537821 - 65537822	566626	574593	rs771001164	NC_000017.11:65537820:CTCTCTCTCT:CTCTCTCT
NM_000156.6(GAMT):c.316C>T (p.Gln106Ter)	GAMT	Q106*	Cerebral creatine deficiency syndrome|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566624	19	1399803	19	1399804	566624	572281	rs1369786965	NC_000019.10:1399803:G:A
NM_000033.4(ABCD1):c.146_159del (p.Pro49fs)	ABCD1	P49fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000566603	X	152990866 - 152990879	X	153725411 - 153725424	566603	573654	rs1569540676	NC_000023.11:153725410:CCCGCCGGGGAGCCC:C
NM_199242.2(UNC13D):c.2258_2267delinsTACCTTGTCCGA (p.Gly753fs)	UNC13D			Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000566475	17	73830437 - 73830446	17	75834356 - 75834365	566475	574618	rs1567818219	NC_000017.11:75834355:ATCTCATGGC:TCGGACAAGGTA
NM_023036.6(DNAI2):c.546C>A (p.Tyr182Ter)	DNAI2	Y182*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000566298	17	72285811	17	74289672	566298	572236	rs770946088	NC_000017.11:74289671:C:A
NM_000074.2(CD40LG):c.304_314del (p.Lys102fs)	CD40LG	K102fs		Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000566114	X	135736545 - 135736555	X	136654386 - 136654396	566114	574313	rs1569376925	NC_000023.11:136654385:ACAAAGAGGAGAC:AC
NM_002049.3(GATA1):c.94dup (p.Val32fs)	GATA1		GATA-1-related thrombocytopenia with dyserythropoiesis|Diamond-Blackfan anemia	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000566070	X	48649606 - 48649607	X	48791199 - 48791200	566070	575425	rs1569499310	NC_000023.11:48791199:GGGG:GGGGG
NM_001184880.2(PCDH19):c.918C>G (p.Tyr306Ter)	PCDH19	Y306*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000566069	X	99662678	X	100407680	566069	575311	rs1569315231	NC_000023.11:100407679:G:C
NM_013995.2(LAMP2):c.415_469dup (p.Ser157Ter)	LAMP2		Danon disease	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000566028	X	119582911 - 119582912	X	120449056 - 120449057	566028	572180	rs1569369940	
NM_001127221.1(CACNA1A):c.4294C>T (p.Arg1432Ter)	CACNA1A	R1432*, R1431*, R1435*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000565995	19	13370475	19	13259661	565995	572946	rs1568470104	NC_000019.10:13259660:G:A
NM_000166.6(GJB1):c.35G>A (p.Gly12Asp)	GJB1	G12D	Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000565953	X	70443592	X	71223742	565953	575444	rs1569214985	NC_000023.11:71223741:G:A
NM_001278116.2(L1CAM):c.2014C>T (p.Gln672Ter)	L1CAM	Q672*, Q667*	Spastic paraplegia	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000565824	X	153132934	X	153867479	565824	575359	rs1569544723	NC_000023.11:153867478:G:A
NM_001184880.1(PCDH19):c.1657_2616+3340del	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000565718	X	99654184 - 99661941	X	100399184 - 100406941	565718	575309		
NM_001083962.2(TCF4):c.1146+3A>G	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000565600	18	52924543	18	55257312	565600	572668	rs1568490874	NC_000018.10:55257311:T:C
NM_000527.4(LDLR):c.1209C>A (p.Phe403Leu)	LDLR	F403L, F235L, F276L, F362L	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000565474	19	11223976	19	11113300	565474	572864	rs777903106	NC_000019.10:11113299:C:A
NM_000159.4(GCDH):c.386A>C (p.Glu129Ala)	GCDH	E129A	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000565448	19	13004348	19	12893534	565448	572922	rs1568425945	NC_000019.10:12893533:A:C
NM_004010.3(DMD):c.-229dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000565437	X	32867889 - 32867890	X	32849772 - 32849773	565437	574721	rs1569533965	NC_000023.11:32849772:CCC:CCCC
NM_000166.6(GJB1):c.100A>G (p.Met34Val)	GJB1	M34V	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000565409	X	70443657	X	71223807	565409	573989	rs1569215061	NC_000023.11:71223806:A:G
NM_001083962.2(TCF4):c.740_741AT[1] (p.Ile248fs)	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000565375	18	52942896 - 52942897	18	55275665 - 55275666	565375	570243	rs1568620706	NC_000018.10:55275664:ATAT:AT
NM_153638.3(PANK2):c.1097del (p.Pro366fs)	PANK2	P75fs, P366fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000565372	20	3891337	20	3910690	565372	575097	rs753400880	NC_000020.11:3910689:CCC:CC
NM_004484.3(GPC3):c.1471G>T (p.Glu491Ter)	GPC3	E491*, E437*, E514*, E475*	Wilms tumor 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000565351	X	132730570	X	133596542	565351	572199	rs1569392947	NC_000023.11:133596541:C:A
NM_006949.4(STXBP2):c.134del (p.Cys45fs)	STXBP2	C45fs	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000565320	19	7703951	19	7639065	565320	575067	rs1568463402	NC_000019.10:7639064:G:
NM_006796.2(AFG3L2):c.1402C>T (p.Arg468Cys)	AFG3L2	R468C	Optic atrophy	Pathogenic(Last reviewed: Aug 6, 2018)	no assertion criteria provided	VCV000565275	18	12351329	18	12351330	565275	556459	rs1020764190	NC_000018.10:12351329:G:A
GRCh37/hg19 Xq13.1(chrX:68001279-68138241)x1	EFNB1		not provided	Pathogenic(Last reviewed: Mar 19, 2018)	no assertion criteria provided	VCV000564854	X	68001279 - 68138241			564854	556038		
GRCh37/hg19 Xp11.3(chrX:44773319-44909637)x1	KDM6A		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000564836	X	44773319 - 44909637			564836	556020		
GRCh37/hg19 Xp21.1(chrX:32765462-32891720)x0	DMD		not provided	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000564822	X	32765462 - 32891720			564822	556006		
GRCh37/hg19 Xp21.1(chrX:31880951-32082537)x0	DMD		not provided	Pathogenic(Last reviewed: Nov 17, 2017)	no assertion criteria provided	VCV000564819	X	31880951 - 32082537			564819	556003		
GRCh37/hg19 Xp21.1(chrX:31684915-31723599)x0	DMD		not provided	Pathogenic(Last reviewed: Jan 14, 2018)	no assertion criteria provided	VCV000564817	X	31684915 - 31723599			564817	556001		
GRCh37/hg19 Xp21.2(chrX:29400224-29721917)x0	IL1RAPL1		not provided	Pathogenic(Last reviewed: Nov 15, 2017)	no assertion criteria provided	VCV000564812	X	29400224 - 29721917			564812	555996		
GRCh37/hg19 Xp21.3-21.2(chrX:29154202-29881444)x1	IL1RAPL1		not provided	Pathogenic(Last reviewed: May 14, 2018)	no assertion criteria provided	VCV000564810	X	29154202 - 29881444			564810	555994		
GRCh37/hg19 Xp22.31(chrX:7143912-7185127)x0	STS		not provided	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000564770	X	7143912 - 7185127			564770	555954		
GRCh37/hg19 18q21.2(chr18:53011022-53131802)x1	TCF4		not provided	Pathogenic(Last reviewed: May 31, 2018)	no assertion criteria provided	VCV000564487	18	53011022 - 53131802			564487	555671		
NM_000495.5(COL4A5):c.4297+1G>C	COL4A5		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562440	X	107929360	X	108686130	562440	553624	rs587776403	NC_000023.11:108686129:G:C
NM_033380.3(COL4A5):c.546+2dup	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000562420	X	107816885 - 107816886	X	108573655 - 108573656	562420	553604	rs1569489353	NC_000023.11:108573655:T:TT
NM_033380.3(COL4A5):c.647G>A (p.Gly216Glu)	COL4A5	G216E	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562417	X	107821309	X	108578079	562417	553601	rs104886074	NC_000023.11:108578078:G:A
NM_000495.5(COL4A5):c.4510+1G>A	COL4A5		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562410	X	107930925	X	108687695	562410	553594	rs104886413	NC_000023.11:108687694:G:A
NM_000495.5(COL4A5):c.2510-2A>G	COL4A5		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562406	X	107863487	X	108620257	562406	553590	rs760109866	NC_000023.11:108620256:A:G
NM_033380.3(COL4A5):c.3685G>A (p.Gly1229Ser)	COL4A5	G1229S	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000562403	X	107911629	X	108668399	562403	553587	rs1569505771	NC_000023.11:108668398:G:A
NM_001127898.4(CLCN5):c.415+1G>A	CLCN5		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562399	X	49837244	X	50072589	562399	553583	rs1569540051	NC_000023.11:50072588:G:A
NM_001018113.3(FANCB):c.1668del (p.Asp557fs)	FANCB	D557fs	not provided|Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562389	X	14863237	X	14845115	562389	553573	rs1569083679	NC_000023.11:14845114:A:
NM_000495.5(COL4A5):c.2395+1G>C	COL4A5		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562340	X	107850123	X	108606893	562340	553524	rs869025331	NC_000023.11:108606892:G:C
NM_000495.5(COL4A5):c.594dup (p.Pro199fs)	COL4A5		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562251	X	107819186 - 107819187	X	108575956 - 108575957	562251	553435	rs1569489863	NC_000023.11:108575956:A:AA
NM_000490.5(AVP):c.322+2T>G	AVP		not provided	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000562238	20	3063621	20	3082975	562238	553422	rs1568733815	NC_000020.11:3082974:A:C
NM_000061.2(BTK):c.726dup (p.Ile243fs)	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Sep 26, 2018)	no assertion criteria provided	VCV000562232	X	100615605 - 100615606	X	101360617 - 101360618	562232	553416	rs1569292774	NC_000023.11:101360617:AAAA:AAAAA
NM_000208.4(INSR):c.3601C>T (p.Arg1201Trp)	INSR	R1201W, R1189W	Insulin resistance	Pathogenic(Last reviewed: Oct 4, 2017)	no assertion criteria provided	VCV000562225	19	7120689	19	7120678	562225	553409	rs1568426700	NC_000019.10:7120677:G:A
NM_001127221.1(CACNA1A):c.3695+1G>T	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000562220	19	13395881	19	13285067	562220	553399	rs1315533129	NC_000019.10:13285066:C:A
NM_001083962.2(TCF4):c.696del (p.Gly232_Met233insTer)	TCF4		Corneal dystrophy, Fuchs endothelial, 3|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000562214	18	52942943	18	55275712	562214	553397	rs1568622225	NC_000018.10:55275711:CCC:CC
NM_173630.4(RTTN):c.5648-5T>A	RTTN		Microcephaly, short stature, and polymicrogyria with or without seizures	Pathogenic(Last reviewed: Sep 3, 2018)	criteria provided, single submitter	VCV000562178	18	67697350	18	70030114	562178	553352	rs1256028809	NC_000018.10:70030113:A:T
NM_000307.5(POU3F4):c.478C>T (p.Gln160Ter)	POU3F4	Q160*	Autosomal recessive sensorineural hearing loss	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562096	X	82763810	X	83508802	562096	553274	rs1569280235	NC_000023.11:83508801:C:T
NM_024022.3(TMPRSS3):c.783-1G>T	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562094	21	43802344	21	42382235	562094	553272	rs1237955948	NC_000021.9:42382234:C:A
NM_001039141.3(TRIOBP):c.3634_3646del (p.Leu1212fs)	TRIOBP	L1212fs	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jul 5, 2018)	no assertion criteria provided	VCV000562075	22	38122196 - 38122208	22	37726189 - 37726201	562075	553273	rs1569042782	NC_000022.11:37726188:GCTGATCCCCCAAG:G
NM_003906.5(MCM3AP):c.2609T>C (p.Leu870Ser)	MCM3AP	L870S	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562054	21	47690334	21	46270420	562054	553230	rs1569074977	NC_000021.9:46270419:A:G
NM_003906.5(MCM3AP):c.2851T>C (p.Ser951Pro)	MCM3AP	S951P	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562053	21	47686019	21	46266105	562053	553229	rs1569072024	NC_000021.9:46266104:A:G
NM_003906.5(MCM3AP):c.2633G>A (p.Arg878His)	MCM3AP	R878H	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562052	21	47687052	21	46267138	562052	553228	rs373674344	NC_000021.9:46267137:C:T
NM_003906.5(MCM3AP):c.2600C>A (p.Ala867Asp)	MCM3AP	A867D	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562051	21	47690343	21	46270429	562051	553227	rs1569074992	NC_000021.9:46270428:G:T
NM_003906.5(MCM3AP):c.2667C>A (p.Tyr889Ter)	MCM3AP	Y889*	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562050	21	47687018	21	46267104	562050	553226	rs1569073058	NC_000021.9:46267103:G:T
NM_003906.5(MCM3AP):c.443del (p.Pro148fs)	MCM3AP	P148fs	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562049	21	47704758	21	46284844	562049	553225	rs1569086477	NC_000021.9:46284843:GG:G
NM_003906.5(MCM3AP):c.3814G>A (p.Val1272Met)	MCM3AP	V272M, V1272M	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Sep 21, 2018)	no assertion criteria provided	VCV000562048	21	47676821	21	46256907	562048	553224	rs779248881	NC_000021.9:46256906:C:T
NM_001754.4(RUNX1):c.611G>A (p.Arg204Gln)	RUNX1	R204Q, R177Q	Thrombocytopenia|not provided	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000561253	21	36231773	21	34859476	561253	552368	rs1569061762	NC_000021.9:34859475:C:T
NM_001754.4(RUNX1):c.610C>T (p.Arg204Ter)	RUNX1	R204*, R177*	Thrombocytopenia|not provided|Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000561252	21	36231774	21	34859477	561252	552369	rs1569061768	NC_000021.9:34859476:G:A
NM_001754.4(RUNX1):c.567C>G (p.Tyr189Ter)	RUNX1	Y189*, Y162*	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000561248	21	36231817	21	34859520	561248	552372	rs1569061831	NC_000021.9:34859519:G:C
NM_001754.4(RUNX1):c.351+1G>A	RUNX1		not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000561236	21	36259139	21	34886842	561236	552384	rs1060502579	NC_000021.9:34886841:C:T
NM_001754.4(RUNX1):c.330G>C (p.Lys110Asn)	RUNX1	K110N, K83N	not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000561234	21	36259161	21	34886864	561234	552386	rs1569084082	NC_000021.9:34886863:C:G
NM_001754.4(RUNX1):c.292del (p.Leu98fs)	RUNX1	L71fs, L98fs	not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000561231	21	36259199	21	34886902	561231	552389	rs1569084170	NC_000021.9:34886901:GG:G
NM_001083962.2(TCF4):c.937_941del (p.Gly313fs)	TCF4	G242fs, G289fs, G311fs, G183fs, G312fs, G313fs, G319fs, G97fs, G153fs, G271fs, G288fs, G415fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561128	18	52928746 - 52928750	18	55261515 - 55261519	561128	552212	rs1568523662	NC_000018.10:55261514:GCCCCGC:GC
NM_001083962.2(TCF4):c.1292del (p.Gly431fs)	TCF4	G215fs, G270fs, G301fs, G360fs, G533fs, G408fs, G431fs, G406fs, G271fs, G389fs, G407fs, G428fs, G430fs, G437fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561127	18	52921786	18	55254555	561127	552210	rs1568471940	NC_000018.10:55254554:CCC:CC
NM_001083962.2(TCF4):c.1034del (p.Pro345fs)	TCF4	P185fs, P344fs, P321fs, P343fs, P351fs, P274fs, P345fs, P129fs, P215fs, P303fs, P320fs, P447fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561126	18	52927215	18	55259984	561126	552211	rs1568509890	NC_000018.10:55259983:GGG:GG
NM_003560.4(PLA2G6):c.1592-2A>C	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561085	22	38516918	22	38120911	561085	552230	rs1465629909	NC_000022.11:38120910:T:G
NM_000284.4(PDHA1):c.523G>A (p.Ala175Thr)	PDHA1	A175T, A213T, A182T	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561078	X	19372621	X	19354503	561078	552256	rs1569191372	NC_000023.11:19354502:G:A
NM_006031.6(PCNT):c.1032+1G>A	PCNT			Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561076	21	47767427	21	46347513	561076	552227	rs1569178877	NC_000021.9:46347512:G:A
NM_001184880.2(PCDH19):c.1676del (p.Asn559fs)	PCDH19	N559fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561073	X	99661920	X	100406922	561073	552236	rs1569314475	NC_000023.11:100406921:TT:T
NM_001271938.2(MEGF8):c.1788+1G>C	MEGF8		Carpenter syndrome 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561058	19	42848226	19	42344074	561058	552219	rs1206116606	NC_000019.10:42344073:G:C
NM_001008537.3(NEXMIF):c.2886_2887CT[1] (p.Ser963fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561042	X	73961503 - 73961504	X	74741668 - 74741669	561042	552265	rs1569335265	NC_000023.11:74741667:AGAG:AG
NM_001323289.2(CDKL5):c.868C>T (p.Gln290Ter)	CDKL5	Q290*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560971	X	18616624	X	18598504	560971	552253	rs1569218019	NC_000023.11:18598503:C:T
NM_001127898.4(CLCN5):c.344G>A (p.Trp115Ter)	CLCN5	W115*, W45*, W65*		Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560969	X	49837172	X	50072517	560969	552262	rs1569540047	NC_000023.11:50072516:G:A
NM_015338.5(ASXL1):c.3700C>T (p.Gln1234Ter)	ASXL1	Q1234*, Q1173*	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560957	20	31024215	20	32436412	560957	552222	rs1569337452	NC_000020.11:32436411:C:T
NM_024105.4(ALG12):c.930_931del (p.Arg311fs)	ALG12	R311fs	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560937	22	50301430 - 50301431	22	49907782 - 49907783	560937	552234	rs1569174722	NC_000022.11:49907781:GT:
NM_000489.5(ATRX):c.4317G>A (p.Lys1439=)	ATRX			Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560933	X	76909588	X	77654098	560933	552266	rs1569535642	NC_000023.11:77654097:C:T
NM_001029896.2(WDR45):c.131-11_145del	WDR45		Cerebral-cerebellar-coloboma syndrome, X-linked	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560932	X	48935392 - 48935417	X	49077733 - 49077758	560932	552261	rs1569523544	NC_000023.11:49077732:CCACCTGCTCGTGGTCTGGACAGGGACCA:CCA
NM_000284.4(PDHA1):c.1026_1039del (p.Arg343fs)	PDHA1	R312fs, R343fs, R350fs, R381fs	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560930	X	19377624 - 19377637	X	19359506 - 19359519	560930	552257	rs1569194036	NC_000023.11:19359505:GAGGAAGGAGATTG:
NM_000284.4(PDHA1):c.482A>G (p.Tyr161Cys)	PDHA1	Y161C, Y199C, Y168C	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560929	X	19371263	X	19353145	560929	552255	rs1569190962	NC_000023.11:19353144:A:G
NM_013995.2(LAMP2):c.138G>A (p.Trp46Ter)	LAMP2	W46*	Danon disease	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560927	X	119590551	X	120456696	560927	552241	rs1271031981	NC_000023.11:120456695:C:T
NM_173477.5(USH1G):c.511G>T (p.Glu171Ter)	USH1G	E171*, E68*	Usher syndrome, type 1G|Deafness	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000560918	17	72916420	17	74920325	560918	552027	rs201866631	NC_000017.11:74920324:C:A
NM_173477.5(USH1G):c.812del (p.Pro271fs)	USH1G	P168fs, P271fs	Deafness	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560917	17	72916119	17	74920024	560917	552026	rs1567939793	NC_000017.11:74920023:GGGG:GGG
RFXANK, LEU195PRO	RFXANK	L195P	Bare lymphocyte syndrome, type II, complementation group B	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000560882					560882	551989		
NM_000307.5(POU3F4):c.249dup (p.Gly84fs)	POU3F4		Deafness, X-linked 2	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000560726	X	82763578 - 82763579	X	83508570 - 83508571	560726	551802	rs1569280138	NC_000023.11:83508570:CCC:CCCC
NM_001127221.1(CACNA1A):c.5559_5560del (p.Tyr1853_Ser1854delinsTer)	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2|Cerebellar ataxia	Pathogenic(Last reviewed: May 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000560724	19	13339581 - 13339582	19	13228767 - 13228768	560724	551795	rs1568440440	NC_000019.10:13228766:TGT:T
NM_033380.3(COL4A5):c.4789del (p.Asp1597fs)	COL4A5	D1591fs, D1597fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000560705	X	107938117	X	108694887	560705	551799	rs1569509234	NC_000023.11:108694886:GGG:GG
NM_001323289.2(CDKL5):c.1921_1922del (p.Ser641fs)	CDKL5	S641fs	Epileptic encephalopathy	Pathogenic(Last reviewed: Mar 29, 2017)	no assertion criteria provided	VCV000560636	X	18622965 - 18622966	X	18604845 - 18604846	560636	551754	rs1569219844	NC_000023.11:18604844:AG:
NM_000116.5(TAZ):c.367C>T (p.Arg123Ter)	TAZ	R123*, R141*	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000560626	X	153641901	X	154413564	560626	551752	rs1569552731	NC_000023.11:154413563:C:T
NM_000328.3(RPGR):c.423del (p.Ile142fs)	RPGR	I141fs, I152fs, I142fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560504	X	38178128	X	38318875	560504	551599	rs1569258901	NC_000023.11:38318874:C:
NM_000328.3(RPGR):c.1905+1088_1905+1091del	RPGR	E998fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560503	X	38145256 - 38145259	X	38286003 - 38286006	560503	551593	rs1569235677	NC_000023.11:38286002:CCTTC:C
NM_000328.3(RPGR):c.1905+1042G>T	RPGR	E983*	Retinal dystrophy	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560502	X	38145305	X	38286052	560502	551594	rs1569235803	NC_000023.11:38286051:C:A
NM_000328.3(RPGR):c.1905+479del	RPGR	E795fs	Retinitis pigmentosa 15|Retinitis pigmentosa|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560500	X	38145868	X	38286615	560500	551595	rs1569237206	NC_000023.11:38286614:T:
NM_000328.3(RPGR):c.1671del (p.Ala558fs)	RPGR	A496fs, A557fs, A558fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560498	X	38147196	X	38287943	560498	551597	rs1569238659	NC_000023.11:38287942:TTT:TT
NM_006915.3(RP2):c.486_490del (p.Gly163fs)	RP2	G163fs	Leber congenital amaurosis	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560495	X	46713292 - 46713296	X	46853857 - 46853861	560495	551601	rs1569531639	NC_000023.11:46853856:GCAGGGC:GC
NM_015629.4(PRPF31):c.1291C>T (p.Gln431Ter)	PRPF31	Q431*	Retinitis pigmentosa 11	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560487	19	54632662	19	54129287	560487	551589	rs1568600184	NC_000019.10:54129286:C:T
NM_153638.3(PANK2):c.1317del (p.Arg440fs)	PANK2	R440fs, R149fs, R4fs	Cone-rod dystrophy	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560475	20	3893186	20	3912539	560475	551592	rs544616523	NC_000020.11:3912538:T:
NM_000554.6(CRX):c.205C>T (p.Arg69Cys)	CRX	R69C	Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000560444	19	48339604	19	47836347	560444	551587	rs771551785	NC_000019.10:47836346:C:T
NM_001042472.3(ABHD12):c.447G>A (p.Trp149Ter)	ABHD12	W149*	Cone/cone-rod dystrophy	Pathogenic(Last reviewed: Sep 1, 2016)	no assertion criteria provided	VCV000560424	20	25300930	20	25320294	560424	551590	rs1568725951	NC_000020.11:25320293:C:T
NM_000152.5(GAA):c.4G>T (p.Gly2Ter)	GAA	G2*	Elevated serum creatine phosphokinase	Pathogenic	no assertion criteria provided	VCV000560377	17	78078389	17	80104590	560377	551432	rs1567825175	NC_000017.11:80104589:G:T
NM_173483.3(CYP4F22):c.1138del (p.Asp380Thrfs)	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560339	19	15658918	19	15548107	560339	551383	rs1568364107	NC_000019.10:15548106:GGG:GG
NM_173483.4(CYP4F22):c.549+5G>C	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560338	19	15648478	19	15537667	560338	551365	rs1568360387	NC_000019.10:15537666:G:C
NM_173483.4(CYP4F22):c.1085G>A (p.Arg362Gln)	CYP4F22	R362Q	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560337	19	15655039	19	15544228	560337	551380	rs769229606	NC_000019.10:15544227:G:A
NM_173483.4(CYP4F22):c.367+1G>A	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560336	19	15640665	19	15529854	560336	551359	rs1568357749	NC_000019.10:15529853:G:A
NM_173483.4(CYP4F22):c.429dup (p.Leu144fs)	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560333	19	15648350 - 15648351	19	15537539 - 15537540	560333	551361	rs1382435790	NC_000019.10:15537539:GGG:GGGG
NM_173483.4(CYP4F22):c.1563G>A (p.Trp521Ter)	CYP4F22	W521*	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560332	19	15662249	19	15551438	560332	551389	rs1360295659	NC_000019.10:15551437:G:A
NM_173483.4(CYP4F22):c.466C>T (p.Arg156Cys)	CYP4F22	R156C	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560331	19	15648390	19	15537579	560331	551362	rs770500550	NC_000019.10:15537578:C:T
NM_173483.4(CYP4F22):c.727C>T (p.Arg243Cys)	CYP4F22	R243C	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560330	19	15651316	19	15540505	560330	551372	rs768098854	NC_000019.10:15540504:C:T
NM_173483.4(CYP4F22):c.1114C>T (p.Arg372Trp)	CYP4F22	R372W	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560328	19	15655068	19	15544257	560328	551381	rs201129618	NC_000019.10:15544256:C:T
NM_173483.4(CYP4F22):c.981del (p.Glu328fs)	CYP4F22	E328fs	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560327	19	15654822	19	15544011	560327	551378	rs1568362644	NC_000019.10:15544010:CC:C
NM_173483.4(CYP4F22):c.177C>G (p.Phe59Leu)	CYP4F22	F59L	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000560326	19	15636324	19	15525513	560326	551357	rs118091316	NC_000019.10:15525512:C:G
NM_173483.4(CYP4F22):c.1084C>G (p.Arg362Gly)	CYP4F22	R362G	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560325	19	15655038	19	15544227	560325	551379	rs745368359	NC_000019.10:15544226:C:G
NM_173483.4(CYP4F22):c.1137-18_1137-4del	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560324	19	15658901 - 15658915	19	15548090 - 15548104	560324	551382	rs1568364101	NC_000019.10:15548089:TATCTCCATTCTCCC:
NM_173483.4(CYP4F22):c.912C>A (p.Asp304Glu)	CYP4F22	D304E	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560323	19	15651501	19	15540690	560323	551375	rs1159994392	NC_000019.10:15540689:C:A
NM_173483.4(CYP4F22):c.1163C>A (p.Thr388Lys)	CYP4F22	T388K	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560322	19	15658945	19	15548134	560322	551384	rs1568364117	NC_000019.10:15548133:C:A
NM_173483.4(CYP4F22):c.697A>C (p.Ile233Leu)	CYP4F22	I233L	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560321	19	15651286	19	15540475	560321	551369	rs1568361250	NC_000019.10:15540474:A:C
NM_173483.4(CYP4F22):c.467G>A (p.Arg156His)	CYP4F22	R156H	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560320	19	15648391	19	15537580	560320	551363	rs776275777	NC_000019.10:15537579:G:A
NM_173483.4(CYP4F22):c.421+1G>A	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560319	19	15648226	19	15537415	560319	551360	rs773886415	NC_000019.10:15537414:G:A
NM_173483.4(CYP4F22):c.940-1G>A	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560318	19	15654781	19	15543970	560318	551377	rs1568362605	NC_000019.10:15543969:G:A
NM_173483.4(CYP4F22):c.1352G>C (p.Arg451Pro)	CYP4F22	R451P	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560317	19	15661501	19	15550690	560317	551386	rs144961059	NC_000019.10:15550689:G:C
NM_173483.4(CYP4F22):c.716_719TGTC[1] (p.Val241fs)	CYP4F22		Autosomal recessive congenital ichthyosis 5|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000560316	19	15651303 - 15651306	19	15540492 - 15540495	560316	551371	rs751937099	NC_000019.10:15540491:TCTGTCTGTC:TCTGTC
NM_173483.4(CYP4F22):c.1532A>G (p.Glu511Gly)	CYP4F22	E511G	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560315	19	15662218	19	15551407	560315	551388	rs1167473603	NC_000019.10:15551406:A:G
NM_173483.4(CYP4F22):c.1488C>G (p.Phe496Leu)	CYP4F22	F496L	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560314	19	15662174	19	15551363	560314	551387	rs1568365205	NC_000019.10:15551362:C:G
NM_173483.4(CYP4F22):c.1351C>T (p.Arg451Cys)	CYP4F22	R451C	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560313	19	15661500	19	15550689	560313	551385	rs200581968	NC_000019.10:15550688:C:T
NM_173483.4(CYP4F22):c.917T>C (p.Ile306Thr)	CYP4F22	I306T	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560312	19	15651506	19	15540695	560312	551376	rs370734976	NC_000019.10:15540694:T:C
NM_173483.4(CYP4F22):c.847C>T (p.Arg283Trp)	CYP4F22	R283W	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560311	19	15651436	19	15540625	560311	551374	rs755885838	NC_000019.10:15540624:C:T
NM_173483.4(CYP4F22):c.641_642GT[1] (p.Val215fs)	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560310	19	15648773 - 15648774	19	15537962 - 15537963	560310	551368	rs1568360554	NC_000019.10:15537961:TGTGT:TGT
NM_173483.4(CYP4F22):c.592G>T (p.Asp198Tyr)	CYP4F22	D198Y	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560309	19	15648725	19	15537914	560309	551367	rs1568360526	NC_000019.10:15537913:G:T
NM_173483.4(CYP4F22):c.550-2A>T	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560308	19	15648681	19	15537870	560308	551366	rs1568360475	NC_000019.10:15537869:A:T
NM_173483.4(CYP4F22):c.493_499delinsCTTGATT (p.Phe165_Ile167delinsLeuAspPhe)	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560307	19	15648417 - 15648423	19	15537606 - 15537612	560307	551364	rs1568360348	NC_000019.10:15537605:TTTGACA:CTTGATT
NM_173483.4(CYP4F22):c.242G>A (p.Gly81Asp)	CYP4F22	G81D	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000560306	19	15640539	19	15529728	560306	551358	rs369811073	NC_000019.10:15529727:G:A
NM_030632.3(ASXL3):c.1500del (p.Glu500fs)	ASXL3	E500fs	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000560241	18	31318867	18	33738903	560241	551327	rs1568359734	NC_000018.10:33738902:AA:A
Single allele	DMD		Becker muscular dystrophy|Duchenne muscular dystrophy|Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000560062	X	31947471 - 31972601			560062	550778		
Single allele	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000560054	X	31697480 - 31766673	X	31679364 - 31748557	560054	550770		
NM_000346.4(SOX9):c.508C>T (p.Pro170Ser)	SOX9	P170S	Camptomelic dysplasia|Campomelic dysplasia with autosomal sex reversal	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000559879	17	70118936	17	72122795	559879	550632	rs866706988	NC_000017.11:72122794:C:T
NM_001347721.2(DYRK1A):c.910C>T (p.Gln304Ter)	DYRK1A	Q313*, Q275*, Q304*	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 30, 2018)	no assertion criteria provided	VCV000559653	21	38862749	21	37490447	559653	550373	rs1555984433	NC_000021.9:37490446:C:T
NM_021140.3(KDM6A):c.1392_1395TCAT[3] (p.Trp467fs)	KDM6A		Kabuki syndrome 2	Pathogenic(Last reviewed: Mar 15, 2013)	no assertion criteria provided	VCV000559639	X	44920630 - 44920631	X	45061385 - 45061386	559639	550379	rs1556311265	NC_000023.11:45061385:TCATTCAT:TCATTCATTCAT
NM_003688.3(CASK):c.2040-1G>A	CASK		CASK-Related Disorder	Pathogenic(Last reviewed: Jan 30, 2018)	no assertion criteria provided	VCV000559631	X	41402060	X	41542807	559631	550378	rs1555977269	NC_000023.11:41542806:C:T
NM_001356.4(DDX3X):c.1429C>G (p.Gln477Glu)	DDX3X	Q477E, Q461E, Q291E	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	VCV000559627	X	41205595	X	41346342	559627	550377	rs1555954105	NC_000023.11:41346341:C:G
NM_018896.5(CACNA1G):c.4591A>G (p.Met1531Val)	CACNA1G	M1531V, M1508V, M1506V	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS	Pathogenic(Last reviewed: Aug 14, 2018)	no assertion criteria provided	VCV000559581	17	48685266	17	50607905	559581	550304	rs1555558553	NC_000017.11:50607904:A:G
NM_020971.3(SPTBN4):c.7453del (p.Ala2485fs)	SPTBN4	A2485fs	Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000559549	19	41078057	19	40572151	559549	550272	rs1555721549	NC_000019.10:40572150:GG:G
NM_020971.3(SPTBN4):c.7303C>T (p.Arg2435Cys)	SPTBN4	R2435C	Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000559548	19	41076618	19	40570712	559548	550271	rs777273785	NC_000019.10:40570711:C:T
NM_020971.3(SPTBN4):c.1511G>A (p.Arg504Gln)	SPTBN4	R504Q	Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000559547	19	41009885	19	40503978	559547	550270	rs765087147	NC_000019.10:40503977:G:A
NM_020971.3(SPTBN4):c.3820G>T (p.Glu1274Ter)	SPTBN4	E1274*	not provided|Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000559545	19	41029509	19	40523602	559545	550268	rs1555818396	NC_000019.10:40523601:G:T
NM_001001563.5(TIMM50):c.26C>A (p.Ser9Ter)	TIMM50	S112*, S9*	Mitochondrial encephalopathy	Pathogenic	criteria provided, single submitter	VCV000559480	19	39971519	19	39480879	559480	550204	rs35135520	NC_000019.10:39480878:C:A
NM_001001563.5(TIMM50):c.260G>C (p.Gly87Ala)	TIMM50	G190A, G87A	Mitochondrial encephalopathy	Pathogenic	criteria provided, single submitter	VCV000559479	19	39973525	19	39482885	559479	550203	rs776019250	NC_000019.10:39482884:G:C
NM_000116.5(TAZ):c.583G>T (p.Gly195Ter)	TAZ	G195*, G165*	not provided	Pathogenic(Last reviewed: Feb 22, 2016)	no assertion criteria provided	VCV000559336	X	153648085	X	154419746	559336	550110	rs878853656	NC_000023.11:154419745:G:T
NM_000116.5(TAZ):c.207C>G (p.His69Gln)	TAZ	H69Q, H87Q	not provided	Pathogenic(Last reviewed: Mar 4, 2016)	no assertion criteria provided	VCV000559335	X	153640520	X	154412183	559335	550109	rs1557191125	NC_000023.11:154412182:C:G
NM_000199.5(SGSH):c.1129C>T (p.Arg377Cys)	SGSH	R377C	not provided	Pathogenic(Last reviewed: May 15, 2017)	no assertion criteria provided	VCV000559103	17	78184631	17	80210832	559103	549765	rs772311757	NC_000017.11:80210831:G:A
NM_000202.8(IDS):c.309C>G (p.Tyr103Ter)	IDS	Y103*, Y13*	not provided	Pathogenic(Last reviewed: Dec 30, 2016)	no assertion criteria provided	VCV000558998	X	148584951	X	149503421	558998	549823	rs1174495581	NC_000023.11:149503420:G:C
NM_024301.5(FKRP):c.1168_1169CG[1] (p.Gly391fs)	FKRP		Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000558649	19	47259874 - 47259875	19	46756617 - 46756618	558649	548935	rs748087383	NC_000019.10:46756616:GCGCG:GCG
NM_000152.5(GAA):c.1978C>T (p.Arg660Cys)	GAA	R660C	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558604	17	78086764	17	80112965	558604	549174	rs759518659	NC_000017.11:80112964:C:T
NM_000152.5(GAA):c.2367dup (p.Pro790fs)	GAA		Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558571	17	78091433 - 78091434	17	80117634 - 80117635	558571	549194	rs1555602860	NC_000017.11:80117634:A:AA
NM_000154.2(GALK1):c.410dup (p.Gly138fs)	GALK1		Deficiency of galactokinase	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558402	17	73759465 - 73759466	17	75763384 - 75763385	558402	549131	rs767329054	NC_000017.11:75763384:CCCCCC:CCCCCCC
NM_000709.4(BCKDHA):c.718del (p.Ala240fs)	BCKDHA	A240fs	Maple syrup urine disease	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000558389	19	41928136	19	41422231	558389	548820	rs1555766993	NC_000019.10:41422230:GGGGG:GGGG
NM_000271.5(NPC1):c.449_450AG[1] (p.Ser151fs)	NPC1		Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558159	18	21148797 - 21148799	18	23568834 - 23568835	558159	548561	rs749012588	NC_000018.10:23568833:CTCT:CT
NM_000199.5(SGSH):c.582T>A (p.Cys194Ter)	SGSH	C194*	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000557068	17	78188052	17	80214253	557068	548485	rs1555621659	NC_000017.11:80214252:A:T
NM_000071.2(CBS):c.828+1G>A	CBS		Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556952	21	44484009	21	43063899	556952	549273	rs763290176	NC_000021.9:43063898:C:T
NM_198129.3(LAMA3):c.6567del (p.Glu2190fs)	LAMA3	E2134fs, E581fs, E2190fs, E525fs	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556752	18	21484609	18	23904645	556752	549300	rs1555732939	NC_000018.10:23904644:CC:C
NM_024301.5(FKRP):c.1141dup (p.Ala381fs)	FKRP		Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556419	19	47259842 - 47259843	19	46756585 - 46756586	556419	549376	rs754403441	NC_000019.10:46756585:GGGGGG:GGGGGGG
NM_015166.3(MLC1):c.448del (p.Leu150fs)	MLC1	L150fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000556409	22	50515907	22	50077478	556409	549442	rs1555967227	NC_000022.11:50077477:G:
NM_000271.5(NPC1):c.1628del (p.Pro543fs)	NPC1	P543fs	Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556403	18	21131617	18	23551653	556403	549256	rs1555635957	NC_000018.10:23551652:GGG:GG
NM_004646.3(NPHS1):c.928G>A (p.Asp310Asn)	NPHS1	D310N	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556151	19	36339962	19	35849060	556151	548766	rs763972372	NC_000019.10:35849059:C:T
NM_024301.5(FKRP):c.77G>A (p.Trp26Ter)	FKRP	W26*	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556052	19	47258784	19	46755527	556052	548876	rs752731569	NC_000019.10:46755526:G:A
NM_000152.5(GAA):c.1551+1G>T	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000555986	17	78084640	17	80110841	555986	548423	rs770780848	NC_000017.11:80110840:G:T
NM_004646.3(NPHS1):c.2536_2539CTAA[1] (p.Thr847fs)	NPHS1		Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000555946	19	36333146 - 36333149	19	35842244 - 35842247	555946	548762	rs1244884053	NC_000019.10:35842243:TTAGTTAG:TTAG
NM_000152.5(GAA):c.1437+1G>A	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000555864	17	78083855	17	80110056	555864	548419	rs1555600575	NC_000017.11:80110055:G:A
NM_000227.5(LAMA3):c.1403_1404AG[1] (p.Gln468_Ser469insTer)	LAMA3		Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000555742	18	21483001 - 21483002	18	23903037 - 23903038	555742	548621	rs1158945258	NC_000018.10:23903036:AGAG:AG
NM_000152.5(GAA):c.1551+1G>C	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000554983	17	78084640	17	80110841	554983	548786	rs770780848	NC_000017.11:80110840:G:C
NM_000383.4(AIRE):c.931del (p.Cys311fs)	AIRE	C311fs	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000554933	21	45711029	21	44291146	554933	549432	rs1555872755	NC_000021.9:44291145:T:
NM_004646.3(NPHS1):c.3548dup (p.Tyr1183Ter)	NPHS1		not provided|Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554827	19	36321791 - 36321792	19	35830889 - 35830890	554827	548744	rs756436580	NC_000019.10:35830889:T:TT
NM_001165927.1(MKS1):c.799G>T (p.Glu267Ter)	MKS1	E277*, E267*, E74*	Bardet-Biedl syndrome 13|Joubert syndrome 28|Meckel syndrome type 1|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554581	17	56290372	17	58213011	554581	548273	rs1555599412	NC_000017.11:58213010:C:A
NM_000159.4(GCDH):c.1054C>T (p.Gln352Ter)	GCDH	Q352*	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000554539	19	13008214	19	12897400	554539	549340	rs1555751089	NC_000019.10:12897399:C:T
NM_144612.6(LOXHD1):c.5002C>T (p.Arg1668Ter)	LOXHD1	R1668*, R461*, R557*	Deafness, autosomal recessive 77|Rare genetic deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000554146	18	44102147	18	46522184	554146	549036	rs961865375	NC_000018.10:46522183:G:A
NM_000528.4(MAN2B1):c.2355G>A (p.Thr785=)	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000554100	19	12760155	19	12649341	554100	548687	rs1008745697	NC_000019.10:12649340:C:T
NM_000709.4(BCKDHA):c.859C>T (p.Arg287Ter)	BCKDHA	R287*, R286*	Maple syrup urine disease	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000553989	19	41928539	19	41422634	553989	548802	rs764247545	NC_000019.10:41422633:C:T
NM_000271.5(NPC1):c.1554-1009G>A	NPC1		Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553804	18	21132700	18	23552736	553804	548915	rs1055204017	NC_000018.10:23552735:C:T
NM_004646.3(NPHS1):c.3027C>G (p.Tyr1009Ter)	NPHS1	Y1009*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000553429	19	36330221	19	35839319	553429	549349	rs762184939	NC_000019.10:35839318:G:C
NM_000199.5(SGSH):c.703G>A (p.Asp235Asn)	SGSH	D235N	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000553004	17	78187645	17	80213846	553004	548861	rs753472891	NC_000017.11:80213845:C:T
NM_000271.5(NPC1):c.2842G>A (p.Asp948Asn)	NPC1	D948N	Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552987	18	21119388	18	23539424	552987	549245	rs1261939149	NC_000018.10:23539423:C:T
NM_000022.4(ADA):c.424C>T (p.Arg142Ter)	ADA	R142*	Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000552928	20	43254264	20	44625623	552928	548898	rs780014431	NC_000020.11:44625622:G:A
NM_000528.4(MAN2B1):c.2669C>G (p.Ser890Ter)	MAN2B1	S890*, S889*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552770	19	12758408	19	12647594	552770	548669	rs1406466561	NC_000019.10:12647593:G:C
NM_000152.5(GAA):c.379_380del (p.Cys127fs)	GAA	C127fs	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552747	17	78078763 - 78078764	17	80104964 - 80104965	552747	549144	rs1207988953	NC_000017.11:80104963:GTG:G
NM_004646.3(NPHS1):c.3549C>A (p.Tyr1183Ter)	NPHS1	Y1183*	not provided|Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552390	19	36321791	19	35830889	552390	548742	rs767887213	NC_000019.10:35830888:G:T
NM_000152.5(GAA):c.2407C>T (p.Gln803Ter)	GAA	Q803*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000552368	17	78091474	17	80117675	552368	548817	rs1344266804	NC_000017.11:80117674:C:T
NM_000271.5(NPC1):c.3562del (p.Glu1188fs)	NPC1	E1188fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000552331	18	21114439	18	23534475	552331	548517	rs758231839	NC_000018.10:23534474:CC:C
NM_198129.3(LAMA3):c.9511+1G>A	LAMA3		Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000552174	18	21529889	18	23949925	552174	549317	rs1296034886	NC_000018.10:23949924:G:A
NM_000199.5(SGSH):c.376dup (p.Val126fs)	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000552173	17	78188543 - 78188544	17	80214744 - 80214745	552173	548865	rs1555621971	NC_000017.11:80214744:C:CC
NM_000152.5(GAA):c.1292_1295dup (p.Gln433fs)	GAA		Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552165	17	78082592 - 78082593	17	80108793 - 80108794	552165	548415	rs996798292	NC_000017.11:80108793:TGCA:TGCATGCA
NM_000383.4(AIRE):c.1567-2A>G	AIRE		Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000551748	21	45717537	21	44297654	551748	549436	rs1555873650	NC_000021.9:44297653:A:G
NM_000383.4(AIRE):c.1193del (p.Pro398fs)	AIRE	P398fs	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000551697	21	45712972	21	44293089	551697	549147	rs1555872988	NC_000021.9:44293088:CC:C
NM_000227.5(LAMA3):c.2248C>T (p.Gln750Ter)	LAMA3	Q750*, Q2359*, Q2303*, Q694*	Junctional epidermolysis bullosa gravis of Herlitz|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551628	18	21489176	18	23909212	551628	548647	rs1555735252	NC_000018.10:23909211:C:T
NM_000383.4(AIRE):c.1096-1G>A	AIRE		Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000551625	21	45712875	21	44292992	551625	549068	rs780906602	NC_000021.9:44292991:G:A
NM_000152.5(GAA):c.1432G>A (p.Gly478Arg)	GAA	G478R	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551295	17	78083849	17	80110050	551295	548784	rs778068209	NC_000017.11:80110049:G:A
NM_000528.4(MAN2B1):c.2299C>T (p.Gln767Ter)	MAN2B1	Q767*, Q766*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000551140	19	12760211	19	12649397	551140	549322	rs779769525	NC_000019.10:12649396:G:A
NM_000383.4(AIRE):c.1A>G (p.Met1Val)	AIRE	M1V	Inherited Immunodeficiency Diseases|Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551136	21	45705890	21	44286007	551136	549127	rs121434258	NC_000021.9:44286006:A:G
NM_000199.5(SGSH):c.1297C>T (p.Arg433Trp)	SGSH	R433W	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000551014	17	78184463	17	80210664	551014	548846	rs777267343	NC_000017.11:80210663:G:A
NM_024301.5(FKRP):c.266C>T (p.Pro89Leu)	FKRP	P89L	Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	Pathogenic/Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000551007	19	47258973	19	46755716	551007	549195	rs770711331	NC_000019.10:46755715:C:T
NM_000022.4(ADA):c.396dup (p.Val133fs)	ADA		Severe combined immunodeficiency due to ADA deficiency|Severe combined immunodeficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550821	20	43254291 - 43254292	20	44625650 - 44625651	550821	549388	rs1555844617	NC_000020.11:44625650:T:TT
NM_000199.5(SGSH):c.221G>A (p.Arg74His)	SGSH	R74H	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550504	17	78190859	17	80217060	550504	548867	rs778336949	NC_000017.11:80217059:C:T
NM_024301.5(FKRP):c.928G>T (p.Glu310Ter)	FKRP	E310*	Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550361	19	47259635	19	46756378	550361	548879	rs765885747	NC_000019.10:46756377:G:T
NM_000023.4(SGCA):c.92T>C (p.Leu31Pro)	SGCA	L31P	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550333	17	48244783	17	50167422	550333	548534	rs903823830	NC_000017.11:50167421:T:C
NM_000152.5(GAA):c.1941C>G (p.Cys647Trp)	GAA	C647W	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550327	17	78086727	17	80112928	550327	548439	rs776948121	NC_000017.11:80112927:C:G
NM_000199.5(SGSH):c.1166A>G (p.Asn389Ser)	SGSH	N389S	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000550252	17	78184594	17	80210795	550252	549212	rs1555620214	NC_000017.11:80210794:T:C
NM_000022.4(ADA):c.736C>T (p.Gln246Ter)	ADA	Q246*, Q222*, Q111*	Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000549915	20	43251514	20	44622873	549915	548972	rs1555844120	NC_000020.11:44622872:G:A
NM_000227.5(LAMA3):c.1214del (p.Gln405fs)	LAMA3	Q1958fs, Q2014fs, Q349fs, Q405fs	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000549906	18	21481127	18	23901163	549906	548619	rs1555731178	NC_000018.10:23901162:A:
NM_020956.2(PRX):c.*3908G>T	PRX	E1235*	Charcot-Marie-Tooth disease, demyelinating, type 4F	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549686	19	40900556	19	40394649	549686	540469	rs1385904344	NC_000019.10:40394648:C:A
NM_139284.3(LGI4):c.1153C>T (p.Gln385Ter)	LGI4	Q385*	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549679	19	35617320	19	35126416	549679	540467	rs1366269616	NC_000019.10:35126415:G:A
NM_000454.4(SOD1):c.112G>C (p.Gly38Arg)	SOD1	G38R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549678	21	33036142	21	31663829	549678	540470	rs121912431	NC_000021.9:31663828:G:C
NM_002490.6(NDUFA6):c.355del (p.Leu119fs)	NDUFA6	L119fs	Mitochondrial diseases|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000549666	22	42482219	22	42086215	549666	540434	rs781099275	NC_000022.11:42086214:GG:G
NM_002490.6(NDUFA6):c.309del (p.Met104fs)	NDUFA6	M104fs	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000549665	22	42482265	22	42086261	549665	540435	rs763006208	NC_000022.11:42086260:AA:A
NC_000023.10:g.50653777_50689335del35559	BMP15		Primary amenorrhea	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000549656	X	50653777 - 50689335	X	50910779 - 50946337	549656	540134		
NM_203446.2(SYNJ1):c.512G>A (p.Trp171Ter)	SYNJ1	W171*, W132*	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000549503	21	34072232	21	32699922	549503	539985	rs1555907463	NC_000021.9:32699921:C:T
GRCh37/hg19 Xq23(chrX:108919564-108929311)	ACSL4		Ischemic stroke|Global developmental delay	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000548953	X	108915663 - 108933582			548953	539435		
NM_006852.4(TLK2):c.1460+2T>G	TLK2		MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548936	17	60663589	17	62586228	548936	539423	rs1555651572	NC_000017.11:62586227:T:G
NM_006852.4(TLK2):c.989C>A (p.Ser330Ter)	TLK2	S330*, S181*, S298*	MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000548935	17	60650596	17	62573235	548935	539422	rs1555644480	NC_000017.11:62573234:C:A
NM_006852.4(TLK2):c.1720+1G>T	TLK2		MENTAL RETARDATION, AUTOSOMAL DOMINANT 57	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548933	17	60678182	17	62600821	548933	539420	rs1555660806	NC_000017.11:62600820:G:T
NM_000377.2(WAS):c.360+1G>C	WAS		Wiskott-Aldrich syndrome	Pathogenic	no assertion criteria provided	VCV000548704	X	48544023	X	48685634	548704	539188	rs1057520700	NC_000023.11:48685633:G:C
NM_030582.4(COL18A1):c.1610dup (p.Gly538fs)	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Sep 4, 2014)	no assertion criteria provided	VCV000548656	21	46897722 - 46897723	21	45477808 - 45477809	548656	539163	rs1555860555	NC_000021.9:45477808:CCCCCC:CCCCCCC
NM_080860.4(RSPH1):c.315C>G (p.Tyr105Ter)	RSPH1	Y105*, Y67*	Primary ciliary dyskinesia 24	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548598	21	43906531	21	42486421	548598	539100	rs144037391	NC_000021.9:42486420:G:C
NM_005359.5(SMAD4):c.1308+2T>C	SMAD4		Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Myhre syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548563	18	48593559	18	51067189	548563	539082	rs1555686624	NC_000018.10:51067188:T:C
NM_001323289.2(CDKL5):c.2452_2459del (p.Pro818fs)	CDKL5	P818fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548518	X	18643321 - 18643328	X	18625201 - 18625208	548518	539112	rs1555954737	NC_000023.11:18625200:GACCAAAGGA:GA
NM_014646.2(LPIN2):c.469C>T (p.Arg157Ter)	LPIN2	R157*	Majeed syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548484	18	2951174	18	2951176	548484	539079	rs916009547	NC_000018.10:2951175:G:A
NM_001184880.2(PCDH19):c.489_490delinsAT (p.Gln164Ter)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000548139	X	99663106 - 99663107	X	100408108 - 100408109	548139	538624	rs1555985639	NC_000023.11:100408107:GC:AT
NM_015338.5(ASXL1):c.2100T>A (p.Tyr700Ter)	ASXL1	Y700*, Y639*	Myelodysplasia	Pathogenic	criteria provided, single submitter	VCV000548120	20	31022615	20	32434812	548120	538607	rs1261178797	NC_000020.11:32434811:T:A
GRCh38/hg38 19p13.2(chr19:11100222-11102787)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548101	19	11210898 - 11213463	19	11100222 - 11102787	548101	538597		
GRCh38/hg38 19p13.2(chr19:11102663-11107515)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548100	19	11213339 - 11218191	19	11102663 - 11107515	548100	538596		
GRCh38/hg38 19p13.2(chr19:11128007-11133830)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548098	19	11238683 - 11244506	19	11128007 - 11133830	548098	538594		
GRCh38/hg38 19p13.2(chr19:11129512-11133830)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548096	19	11240188 - 11244506	19	11129512 - 11133830	548096	538592		
GRCh38/hg38 19p13.2(chr19:11100222-11107515)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548093	19	11210898 - 11218191	19	11100222 - 11107515	548093	538589		
GRCh38/hg38 19p13.2(chr19:11106564-11107515)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548092	19	11217240 - 11218191	19	11106564 - 11107515	548092	538588		
GRCh38/hg38 19p13.2(chr19:11120091-11120523)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548091	19	11230767 - 11231199	19	11120091 - 11120523	548091	538587		
GRCh38/hg38 19p13.2(chr19:11120091-11123345)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548090	19	11230767 - 11234021	19	11120091 - 11123345	548090	538586		
GRCh38/hg38 19p13.2(chr19:11116093-11116999)x1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548088	19	11226769 - 11227675	19	11116093 - 11116999	548088	538584		
NM_000527.4(LDLR):c.1693_1696del (p.Gly565fs)	LDLR	G438fs, G397fs, G524fs, G565fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000548079	19	11226876 - 11226879	19	11116200 - 11116203	548079	538576	rs1555806088	NC_000019.10:11116199:GGCA:
NM_138927.3(SON):c.3556C>T (p.Gln1186Ter)	SON	Q1186*	ZTTK syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000548026	21	34925093	21	33552787	548026	538493	rs1275312464	NC_000021.9:33552786:C:T
NM_018684.4(ZC4H2):c.427C>T (p.Gln143Ter)	ZC4H2	Q143*, Q120*	Wieacker Wolff syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548020	X	64139056	X	64919176	548020	538517	rs1260869746	NC_000023.11:64919175:G:A
NM_001039591.3(USP9X):c.44del (p.Asn15fs)	USP9X	N15fs	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000547925	X	40982924	X	41123671	547925	538510	rs1555917927	NC_000023.11:41123670:AA:A
NM_002351.4(SH2D1A):c.192G>A (p.Trp64Ter)	SH2D1A	W64*	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547772	X	123499665	X	124365815	547772	538285	rs1556620706	NC_000023.11:124365814:G:A
NM_004586.3(RPS6KA3):c.2185C>T (p.Arg729Trp)	RPS6KA3	R729W	Coffin-Lowry syndrome|Mental retardation, X-linked 19	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547768	X	20173554	X	20155436	547768	538304	rs1555924331	NC_000023.11:20155435:G:A
NM_004586.3(RPS6KA3):c.334C>T (p.Arg112Ter)	RPS6KA3	R112*	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547762	X	20213255	X	20195137	547762	538310	rs1555943479	NC_000023.11:20195136:G:A
NM_004586.3(RPS6KA3):c.328C>T (p.Arg110Ter)	RPS6KA3	R110*	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547761	X	20213261	X	20195143	547761	538311	rs1555943484	NC_000023.11:20195142:G:A
NM_016418.5(NF2):c.1550T>C (p.Leu517Pro)	NF2	L517P, L475P, L434P, L476P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547709	22	30074288	22	29678299	547709	538259	rs1556002568	NC_000022.11:29678298:T:C
NM_016418.5(NF2):c.1447-2del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547707	22	30074183	22	29678194	547707	538257	rs1556002457	NC_000022.11:29678193:A:
NM_033290.4(MID1):c.1663A>G (p.Ile555Val)	MID1	I555V, I517V	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547526	X	10417749	X	10449709	547526	538277	rs398123341	NC_000023.11:10449708:T:C
NM_033290.4(MID1):c.1608_1611dup (p.Ser538Ter)	MID1		Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547525	X	10422953 - 10422954	X	10454913 - 10454914	547525	538278	rs1556003095	NC_000023.11:10454913:ATCAAT:ATCAATCAAT
NM_033290.4(MID1):c.1393G>C (p.Ala465Pro)	MID1	A465P, A427P	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547523	X	10427740	X	10459700	547523	538280	rs1556004366	NC_000023.11:10459699:C:G
NM_033290.4(MID1):c.829C>T (p.Arg277Ter)	MID1	R277*, R239*, R328*	not provided|Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547521	X	10463659	X	10495619	547521	538282	rs1555895704	NC_000023.11:10495618:G:A
NM_033290.4(MID1):c.757-1G>C	MID1		Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547520	X	10463732	X	10495692	547520	538283	rs1555895725	NC_000023.11:10495691:C:G
NM_000489.5(ATRX):c.5039T>C (p.Ile1680Thr)	ATRX	I1680T, I1642T		Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547182	X	76888790	X	77633302	547182	538323	rs1557106482	NC_000023.11:77633301:A:G
NM_001448.3(GPC4):c.316del (p.Asp106fs)	GPC4	D106fs	Keipert syndrome	Pathogenic(Last reviewed: Jun 14, 2019)	no assertion criteria provided	VCV000547178	X	132473214	X	133339186	547178	537665	rs1556028269	NC_000023.11:133339185:C:
NM_001448.3(GPC4):c.1486G>T (p.Glu496Ter)	GPC4	E496*	Keipert syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000547177	X	132437080	X	133303052	547177	537663	rs1556022644	NC_000023.11:133303051:C:A
NM_001448.3(GPC4):c.701dup (p.Val235fs)	GPC4		Keipert syndrome	Pathogenic(Last reviewed: Jun 14, 2019)	no assertion criteria provided	VCV000547176	X	132458182 - 132458183	X	133324154 - 133324155	547176	537664	rs1556025980	NC_000023.11:133324154:TT:TTT
NM_001448.3(GPC4):c.1516C>T (p.Gln506Ter)	GPC4	Q506*	Keipert syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000547175	X	132437050	X	133303022	547175	537662	rs1556022641	NC_000023.11:133303021:G:A
NM_000219.6(KCNE1):c.51G>A (p.Trp17Ter)	KCNE1	W17*	Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000547164	21	35821882	21	34449584	547164	537652	rs1244688796	NC_000021.9:34449583:C:T
NM_000219.6(KCNE1):c.50G>A (p.Trp17Ter)	KCNE1	W17*	Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000547163	21	35821883	21	34449585	547163	537653	rs779124360	NC_000021.9:34449584:C:T
NM_000219.6(KCNE1):c.138C>A (p.Tyr46Ter)	KCNE1	Y46*	Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Jun 21, 2018)	no assertion criteria provided	VCV000547162	21	35821795	21	34449497	547162	537651	rs758346045	NC_000021.9:34449496:G:T
NM_000346.4(SOX9):c.628del (p.Asp210fs)	SOX9	D210fs	not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000546497	17	70119056	17	72122915	546497	536958	rs1555629195	NC_000017.11:72122914:G:
NM_002547.3(OPHN1):c.1834+1G>T	OPHN1		not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000546456	X	67292993	X	68073151	546456	537060	rs1253923818	NC_000023.11:68073150:C:A
NM_198270.4(NHS):c.397del (p.Ala133fs)	NHS	A133fs	not provided	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000546440	X	17394276	X	17376153	546440	537043	rs1555981408	NC_000023.11:17376152:GG:G
NM_198270.4(NHS):c.1190del (p.Ser397fs)	NHS	S241fs, S418fs, S220fs, S397fs	not provided	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000546439	X	17743479	X	17725359	546439	537044	rs1556038232	NC_000023.11:17725358:C:
NM_001323289.2(CDKL5):c.555-2A>G	CDKL5		not provided	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000546421	X	18606072	X	18587952	546421	537045	rs1555950455	NC_000023.11:18587951:A:G
NM_001127221.1(CACNA1A):c.2542C>T (p.Gln848Ter)	CACNA1A	Q848*, Q847*, Q851*	not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000546157	19	13409908	19	13299094	546157	536979	rs1420078244	NC_000019.10:13299093:G:A
NM_001015877.2(PHF6):c.1000_1005delinsT (p.Asp333_Glu334insTer)	PHF6		not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000546065	X	133559262 - 133559267	X	134425232 - 134425237	546065	536547	rs1556020616	NC_000023.11:134425231:GAGAGA:T
NM_004006.2(DMD):c.5024T>A (p.Leu1675Ter)	DMD	L1675*, L334*, L1552*, L331*, L1667*, L1671*	not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000546041	X	32383138	X	32365021	546041	536552	rs1557305418	NC_000023.11:32365020:A:T
NM_015629.4(PRPF31):c.992G>A (p.Trp331Ter)	PRPF31	W331*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546035	19	54631494	19	54128119	546035	536532	rs1555794205	NC_000019.10:54128118:G:A
NM_001184880.2(PCDH19):c.499G>T (p.Glu167Ter)	PCDH19	E167*	not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000546029	X	99663097	X	100408099	546029	536545	rs1555985623	NC_000023.11:100408098:C:A
NM_004859.4(CLTC):c.2259C>A (p.Cys753Ter)	CLTC	C757*, C753*	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000546022	17	57746268	17	59668907	546022	536504	rs1454289985	NC_000017.11:59668906:C:A
NM_001278116.2(L1CAM):c.26G>A (p.Trp9Ter)	L1CAM	W9*	not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000546020	X	153141266	X	153875811	546020	536549	rs1557094409	NC_000023.11:153875810:C:T
NM_021140.3(KDM6A):c.3904C>T (p.Gln1302Ter)	KDM6A	Q1302*, Q1354*, Q1223*, Q1257*, Q1006*, Q1309*	not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000546019	X	44966680	X	45107435	546019	536557	rs1556375815	NC_000023.11:45107434:C:T
NM_005629.4(SLC6A8):c.1668G>A (p.Trp556Ter)	SLC6A8	W556*, W546*, W441*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000546017	X	152960245	X	153694790	546017	536548	rs1557045704	NC_000023.11:153694789:G:A
NM_004006.2(DMD):c.2257G>T (p.Glu753Ter)	DMD	E753*, E745*, E749*, E630*	not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545973	X	32536160	X	32518043	545973	536553	rs1557396632	NC_000023.11:32518042:C:A
NM_001429.4(EP300):c.3934C>T (p.Arg1312Ter)	EP300	R1312*, R1286*	not provided	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000545969	22	41564512	22	41168508	545969	536543	rs1555911075	NC_000022.11:41168507:C:T
NM_004006.2(DMD):c.5533G>T (p.Glu1845Ter)	DMD	E1845*, E1841*, E504*, E1722*, E1837*, E501*	not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000545963	X	32364113	X	32345996	545963	536551	rs1354256883	NC_000023.11:32345995:C:A
NM_015338.5(ASXL1):c.1433del (p.Gly478fs)	ASXL1	G417fs, G478fs	not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000545944	20	31021432	20	32433629	545944	536533	rs1555911508	NC_000020.11:32433628:GGG:GG
NM_172107.4(KCNQ2):c.1709del (p.Gln570fs)	KCNQ2	Q570fs, Q552fs, Q542fs, Q539fs	not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000545940	20	62044857	20	63413504	545940	536534	rs1555853549	NC_000020.11:63413503:T:
NM_001356.4(DDX3X):c.1284dup (p.Ser429fs)	DDX3X		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000545936	X	41204768 - 41204769	X	41345515 - 41345516	545936	536555	rs1555953894	NC_000023.11:41345515:GG:GGG
NM_000109.4(DMD):c.444delinsGG (p.Ile149fs)	DMD		not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000545934	X	32834647	X	32816530	545934	536554	rs1557052599	NC_000023.11:32816529:T:CC
NM_001193466.2(KANSL1):c.779del (p.Gly260fs)	KANSL1	G260fs	not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000545909	17	44248731	17	46171365	545909	536501	rs748018297	NC_000017.11:46171364:CCCCCC:CCCCC
NM_003688.3(CASK):c.21dup (p.Phe8fs)	CASK		not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000545907	X	41782220 - 41782221	X	41922967 - 41922968	545907	536556	rs1556313509	NC_000023.11:41922967:C:CC
NM_144612.6(LOXHD1):c.4683dup (p.Arg1562fs)	LOXHD1		not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000545905	18	44104727 - 44104728	18	46524764 - 46524765	545905	536520	rs1409994676	NC_000018.10:46524764:CCC:CCCC
NM_005359.5(SMAD4):c.1134_1135delAG (p.Arg378Serfs)	SMAD4		not provided|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545822	18	48591966 - 48591967	18	51065596 - 51065597	545822	536521	rs1555686503	NC_000018.10:51065595:GAGAGAG:GAGAG
NM_005359.5(SMAD4):c.1549_1550delAG (p.Ser517Hisfs)	SMAD4		Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545806	18	48604725 - 48604726	18	51078355 - 51078356	545806	536522	rs377767373	NC_000018.10:51078354:AGAG:AG
NM_000455.4(STK11):c.540del (p.Asn181fs)	STK11	N181fs	not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000545746	19	1220444	19	1220445	545746	536527	rs1131690939	NC_000019.10:1220444:GGGG:GGG
NM_004655.4(AXIN2):c.1994dup (p.Asn666fs)	AXIN2		Oligodontia-colorectal cancer syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545741	17	63532584 - 63532585	17	65536466 - 65536467	545741	536512	rs267606674	NC_000017.11:65536466:CCCCCCC:CCCCCCCC
NM_001029896.2(WDR45):c.870C>G (p.Tyr290Ter)	WDR45	Y291*, Y290*	Neurodegeneration with brain iron accumulation 5|not provided	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000545700	X	48932898	X	49075239	545700	536192	rs782557596	NC_000023.11:49075238:G:C
NM_001083962.2(TCF4):c.919_922+2delinsGTCCC	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, single submitter	VCV000545571	18	52937060 - 52937065	18	55269829 - 55269834	545571	536070	rs1555789019	NC_000018.10:55269828:ACCCAT:GGGAC
NM_003413.4(ZIC3):c.593_609del (p.Pro198fs)	ZIC3	P198fs		Pathogenic(Last reviewed: May 28, 2018)	no assertion criteria provided	VCV000545555	X	136649441 - 136649457	X	137567282 - 137567298	545555	536057	rs1569345742	NC_000023.11:137567281:CCCATACCGCCCAGTGGCC:CC
NM_003413.4(ZIC3):c.128C>A (p.Ser43Ter)	ZIC3	S43*		Pathogenic(Last reviewed: May 28, 2018)	no assertion criteria provided	VCV000545554	X	136648978	X	137566819	545554	536056	rs1569345504	NC_000023.11:137566818:C:A
NM_003413.4(ZIC3):c.757T>A (p.Cys253Ser)	ZIC3	C253S		Pathogenic(Last reviewed: May 28, 2018)	no assertion criteria provided	VCV000545553	X	136649607	X	137567448	545553	536055	rs122463167	NC_000023.11:137567447:T:A
NM_003413.4(ZIC3):c.755C>A (p.Ser252Ter)	ZIC3	S252*		Pathogenic(Last reviewed: May 28, 2018)	no assertion criteria provided	VCV000545552	X	136649605	X	137567446	545552	536054	rs1203069392	NC_000023.11:137567445:C:A
NM_001001890.3(RUNX1):c.598G>T (p.Glu200Ter)	RUNX1	E200*, E227*	Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 29, 2019)	reviewed by expert panel	VCV000545522	21	36206833	21	34834536	545522	536024	rs1555889984	NC_000021.9:34834535:C:A
NM_000878.5(IL2RB):c.286C>T (p.Gln96Ter)	IL2RB	Q96*	Ichthyosis (disease)	Pathogenic(Last reviewed: Apr 30, 2018)	no assertion criteria provided	VCV000545515	22	37535259	22	37139219	545515	536019	rs1569044747	NC_000022.11:37139218:G:A
NM_006012.4(CLPP):c.624C>G (p.Ile208Met)	CLPP	I208M	Perrault syndrome 3	Pathogenic(Last reviewed: Jun 13, 2018)	no assertion criteria provided	VCV000545503	19	6366337	19	6366326	545503	536008	rs1555719766	NC_000019.10:6366325:C:G
NM_001353921.2(ARHGEF9):c.920G>A (p.Trp307Ter)	ARHGEF9	W198*, W300*, W307*, W162*, W247*, W279*, W240*, W313*	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000545451	X	62893943	X	63674063	545451	535714	rs1556358991	NC_000023.11:63674062:C:T
NM_001111125.3(IQSEC2):c.55_151delinsAT (p.Ala19fs)	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000545445	X	53350171 - 53350267	X	53320973 - 53321069	545445	535713	rs1556880284	
NM_001193466.2(KANSL1):c.878del (p.Asp293fs)	KANSL1	D293fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000545439	17	44248632	17	46171266	545439	535708	rs1555575405	NC_000017.11:46171265:T:
NM_018486.3(HDAC8):c.104_105del (p.Pro35fs)	HDAC8	P35fs	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000545414	X	71792507 - 71792508	X	72572657 - 72572658	545414	535678	rs1556165162	NC_000023.11:72572656:GGGG:GG
NM_005710.2(PQBP1):c.586C>T (p.Arg196Ter)	PQBP1	R196*, R188*, R101*, R195*, R96*	Renpenning syndrome 1|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000545093	X	48760017	X	48902740	545093	535359	rs1557041672	NC_000023.11:48902739:C:T
NM_001083962.2(TCF4):c.913_920del (p.Ser305fs)	TCF4	S145fs, S234fs, S263fs, S281fs, S89fs, S303fs, S305fs, S407fs, S175fs, S280fs, S304fs, S311fs	not provided	Pathogenic(Last reviewed: Aug 11, 2017)	no assertion criteria provided	VCV000545086	18	52937064 - 52937071	18	55269833 - 55269840	545086	535335	rs1555789026	NC_000018.10:55269832:ATTATACT:
NM_001029896.2(WDR45):c.516+1G>A	WDR45		Neurodegeneration with brain iron accumulation 5|not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000545080	X	48933524	X	49075865	545080	535360	rs797046102	NC_000023.11:49075864:C:T
NM_001347721.2(DYRK1A):c.1306dup (p.Thr436fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Apr 13, 2017)	no assertion criteria provided	VCV000545070	21	38877678 - 38877679	21	37505375 - 37505376	545070	535346	rs1555990855	NC_000021.9:37505375:A:AA
NM_021140.3(KDM6A):c.2832+1G>A	KDM6A		Kabuki syndrome 2|not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000545065	X	44936072	X	45076827	545065	535357	rs1135401809	NC_000023.11:45076826:G:A
NM_001281463.1(SMC1A):c.2496+1G>A	SMC1A		not provided	Pathogenic(Last reviewed: Apr 6, 2017)	no assertion criteria provided	VCV000545064	X	53426510	X	53399588	545064	535361	rs1556888550	NC_000023.11:53399587:C:T
NM_177559.3(CSNK2A1):c.526T>C (p.Trp176Arg)	CSNK2A1	W176R, W40R	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	no assertion criteria provided	VCV000545062	20	472993	20	492349	545062	535342	rs1555762737	NC_000020.11:492348:A:G
NM_138927.3(SON):c.3848del (p.Cys1283fs)	SON	C1283fs	not provided	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000545055	21	34925385	21	33553079	545055	535345	rs1555898930	NC_000021.9:33553078:G:
NM_030632.3(ASXL3):c.1534_1535del (p.Leu512fs)	ASXL3	L512fs	not provided	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000545054	18	31318901 - 31318902	18	33738937 - 33738938	545054	535333	rs1555742212	NC_000018.10:33738936:TTT:T
NM_001039591.3(USP9X):c.5273T>A (p.Val1758Asp)	USP9X	V1758D	not provided	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000545053	X	41073904	X	41214651	545053	535355	rs1555933732	NC_000023.11:41214650:T:A
NM_005650.3(TCF20):c.5352del (p.Arg1785fs)	TCF20	R1785fs	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	no assertion criteria provided	VCV000545052	22	42605960	22	42209954	545052	535349	rs1555923508	NC_000022.11:42209953:GGGG:GGG
NM_004977.2(KCNC3):c.1344C>G (p.Phe448Leu)	KCNC3	F448L	not provided	Pathogenic(Last reviewed: Nov 3, 2016)	no assertion criteria provided	VCV000545048	19	50826866	19	50323609	545048	535339	rs104894700	NC_000019.10:50323608:G:C
NM_173630.4(RTTN):c.5469_5470del (p.Val1824fs)	RTTN	V912fs, V1824fs	not provided	Pathogenic(Last reviewed: Oct 5, 2016)	no assertion criteria provided	VCV000545043	18	67715278 - 67715279	18	70048042 - 70048043	545043	535336	rs1555704436	NC_000018.10:70048041:CT:
NM_001356.4(DDX3X):c.749_750insGCCTC (p.Leu251fs)	DDX3X		not provided	Pathogenic(Last reviewed: May 4, 2016)	no assertion criteria provided	VCV000545029	X	41203058 - 41203059	X	41343805 - 41343806	545029	535356	rs1555953333	NC_000023.11:41343805:C:CGCCTC
NM_000166.6(GJB1):c.8G>A (p.Trp3Ter)	GJB1	W3*	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000543927	X	70443565	X	71223715	543927	534951	rs1555936989	NC_000023.11:71223714:G:A
NM_000166.6(GJB1):c.491G>A (p.Arg164Gln)	GJB1	R164Q	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, single submitter	VCV000543920	X	70444048	X	71224198	543920	535194	rs1241595912	NC_000023.11:71224197:G:A
NC_000019.9:g.(?_40909593)_(40909789_?)del	PRX		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000543513	19	40909593 - 40909789	19	40403686 - 40403882	543513	532368		
NM_020956.2(PRX):c.*3219_*3220insT	PRX		Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000543308	19	40901244 - 40901245	19	40395337 - 40395338	543308	533494	rs1301129751	NC_000019.10:40395337::A
NM_006494.4(ERF):c.566_567del (p.Asp188_Cys189insTer)	ERF		Craniosynostosis 1	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000543070	19	42753697 - 42753698	19	42249545 - 42249546	543070	533147	rs1555750816	NC_000019.10:42249544:ACA:A
NM_001848.2(COL6A1):c.930+189C>T	COL6A1		not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000542998	21	47409881	21	45989967	542998	534026	rs1556425596	NC_000021.9:45989966:C:T
NM_001848.2(COL6A1):c.905G>A (p.Gly302Glu)	COL6A1	G302E	Bethlem myopathy 1	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000542988	21	47409667	21	45989753	542988	534512	rs1556425566	NC_000021.9:45989752:G:A
NM_001848.2(COL6A1):c.2431_2434+36del	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000542987	21	47422610 - 47422649	21	46002696 - 46002735	542987	534526	rs759918870	NC_000021.9:46002695:CCCAGATCTGCATAGGTGCGCATGGGGCCACCCGGGCAGTCCCAGATCTGC:CCCAGATCTGC
NM_000068.4(CACNA1A):c.2329_2331delinsAC (p.Val777fs)	CACNA1A		Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000542835	19	13410128 - 13410130	19	13299314 - 13299316	542835	532729	rs1555756461	NC_000019.10:13299313:CAC:GT
NM_001127221.1(CACNA1A):c.2758G>T (p.Glu920Ter)	CACNA1A	E920*, E919*, E923*	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000542828	19	13409692	19	13298878	542828	532737	rs1555756130	NC_000019.10:13298877:C:A
NM_001127221.1(CACNA1A):c.2194G>T (p.Glu732Ter)	CACNA1A	E732*, E735*, E731*	Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000542827	19	13411452	19	13300638	542827	532730	rs1555756737	NC_000019.10:13300637:C:A
NM_004975.4(KCNB1):c.629C>T (p.Thr210Met)	KCNB1	T210M	KCNB1-related disorder|Epileptic encephalopathy, early infantile, 26	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000542057	20	47991468	20	49374931	542057	533574	rs1555889162	NC_000020.11:49374930:G:A
NM_001008537.3(NEXMIF):c.3230del (p.Pro1077fs)	NEXMIF	P1077fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000541125	X	73961162	X	74741327	541125	535197	rs1556016350	NC_000023.11:74741326:GGGG:GGG
NM_001008537.3(NEXMIF):c.3226del (p.Thr1076fs)	NEXMIF	T1076fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000541124	X	73961166	X	74741331	541124	534969	rs1556016352	NC_000023.11:74741330:T:
NM_005660.3(SLC35A2):c.348del (p.Val117fs)	SLC35A2	V130fs, V145fs, V56fs, V117fs, V93fs	SLC35A2-CDG	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000541105	X	48763747	X	48906470	541105	535180	rs1557043131	NC_000023.11:48906469:T:
NM_002501.4(NFIX):c.358del (p.Leu120fs)	NFIX	L112fs, L128fs, L119fs, L120fs, L73fs	Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000540464	19	13136164	19	13025350	540464	533138	rs1555696611	NC_000019.10:13025349:CC:C
NM_001029896.2(WDR45):c.408dup (p.Glu137Ter)	WDR45		History of neurodevelopmental disorder|Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000540345	X	48934116 - 48934117	X	49076457 - 49076458	540345	534894	rs1557084239	NC_000023.11:49076457:AAA:AAAA
NM_021140.3(KDM6A):c.2462_2463del (p.Ser821fs)	KDM6A	S873fs, S525fs, S742fs, S821fs, S776fs, S828fs	Kabuki syndrome 2	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000539319	X	44929362 - 44929363	X	45070117 - 45070118	539319	535170	rs1556330304	NC_000023.11:45070116:CA:
NM_032121.5(MAGT1):c.223C>T (p.Gln75Ter)	MAGT1	Q75*, Q43*	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000539316	X	77131070	X	77875573	539316	535088	rs1557217723	NC_000023.11:77875572:G:A
NM_000271.5(NPC1):c.2973_2974delinsAT (p.Gly992Trp)	NPC1		not provided|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000539309	18	21118573 - 21118574	18	23538609 - 23538610	539309	532541	rs1555632971	NC_000018.10:23538608:CC:AT
NM_001429.4(EP300):c.2983G>T (p.Glu995Ter)	EP300	E995*, E969*	Carcinoma of colon|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000538873	22	41548002	22	41151998	538873	534326	rs1555909666	NC_000022.11:41151997:G:T
NM_001111125.3(IQSEC2):c.1551_1558del (p.Leu518fs)	IQSEC2	L313fs, L518fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000538603	X	53280200 - 53280207	X	53251018 - 53251025	538603	535036	rs1556863492	NC_000023.11:53251017:GGTAGAGGGG:GG
NM_006949.4(STXBP2):c.212_213del (p.Leu71fs)	STXBP2	L71fs	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000538150	19	7704659 - 7704660	19	7639773 - 7639774	538150	533961	rs1555769166	NC_000019.10:7639772:TG:
NM_006949.4(STXBP2):c.1214G>A (p.Arg405Gln)	STXBP2	R405Q, R402Q, R416Q	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000538148	19	7709606	19	7644720	538148	533963	rs773360200	NC_000019.10:7644719:G:A
NM_003140.3(SRY):c.263C>A (p.Ser88Ter)	SRY	S88*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000537739	Y	2655382	Y	2787341	537739	535213	rs1556370558	NC_000024.10:2787340:G:T
NM_003140.3(SRY):c.288C>G (p.Tyr96Ter)	SRY	Y96*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000537738	Y	2655357	Y	2787316	537738	535003	rs1556370548	NC_000024.10:2787315:G:C
NM_212472.2(PRKAR1A):c.764_768del (p.Ile255fs)	PRKAR1A	I255fs	Carney complex, type 1	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000536897	17	66524034 - 66524038	17	68527893 - 68527897	536897	531722	rs1555814477	NC_000017.11:68527892:TATTTTA:TA
NM_212472.2(PRKAR1A):c.177+1G>A	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Aug 19, 2018)	criteria provided, single submitter	VCV000536896	17	66511718	17	68515577	536896	532076	rs1555811753	NC_000017.11:68515576:G:A
NM_001003787.4(STRADA):c.1036C>T (p.Arg346Ter)	STRADA	R346*, R309*, R317*, R288*, R338*	Polyhydramnios, megalencephaly, and symptomatic epilepsy	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000536756	17	61781765	17	63704405	536756	531675	rs748855607	NC_000017.11:63704404:G:A
NC_000018.9:g.(?_28654629)_(28673626_?)dup	DSC2		Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000536290	18	28654629 - 28673626			536290	532385		
NC_000018.9:g.(?_28650672)_(28650836_?)del	DSC2		Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000536289	18	28650672 - 28650836	18	31070706 - 31070870	536289	532235		
NM_001972.4(ELANE):c.452G>A (p.Cys151Tyr)	ELANE	C151Y	Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000535843	19	855649	19	855649	535843	533974	rs57246956	NC_000019.10:855648:G:A
NC_000022.10:g.(?_32205577)_(32211218_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000534830	22	32205577 - 32211218	22	31809591 - 31815232	534830	534014		
NC_000022.10:g.(?_32150888)_(32211218_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000534829	22	32150888 - 32211218	22	31754902 - 31815232	534829	534563		
NM_001242897.2(DEPDC5):c.346C>T (p.Arg116Ter)	DEPDC5	R116*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000534806	22	32162637	22	31766651	534806	534234	rs1315483224	NC_000022.11:31766650:C:T
NM_001242897.2(DEPDC5):c.865C>T (p.Gln289Ter)	DEPDC5	Q289*, Q261*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000534791	22	32193683	22	31797697	534791	534739	rs759952667	NC_000022.11:31797696:C:T
NM_003283.6(TNNT1):c.120dup (p.Lys41fs)	TNNT1		Nemaline myopathy 5	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000534399	19	55656919 - 55656920	19	55145551 - 55145552	534399	533388	rs1555859304	NC_000019.10:55145551:GGGG:GGGGG
NM_001184880.2(PCDH19):c.1183C>T (p.Arg395Ter)	PCDH19	R395*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Nov 19, 2017)	criteria provided, single submitter	VCV000533856	X	99662413	X	100407415	533856	534561	rs769967221	NC_000023.11:100407414:G:A
NM_001184880.2(PCDH19):c.1521dup (p.Ile508fs)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV000533849	X	99662074 - 99662075	X	100407076 - 100407077	533849	534422	rs1131691646	NC_000023.11:100407076:GG:GGG
NM_001184880.2(PCDH19):c.1555C>T (p.Arg519Ter)	PCDH19	R519*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000533844	X	99662041	X	100407043	533844	534418	rs1555985105	NC_000023.11:100407042:G:A
NM_005629.4(SLC6A8):c.53_137delinsCCGTGT (p.Lys18fs)	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000533702	X	152954082 - 152954166	X	153688627 - 153688711	533702	534616	rs1557043770	
NC_000023.10:g.(?_77271231)_(77271398_?)del	ATP7A		Cutis laxa, X-linked|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000533690	X	77271231 - 77271398			533690	534393		
NM_001167.3(XIAP):c.664C>T (p.Arg222Ter)	XIAP	R222*	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000533655	X	123020176	X	123886326	533655	535013	rs1556404684	NC_000023.11:123886325:C:T
NM_001167.3(XIAP):c.389_392del (p.Asp130fs)	XIAP	D130fs	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000533654	X	123019899 - 123019902	X	123886049 - 123886052	533654	534496	rs1556404575	NC_000023.11:123886048:AGACAG:AG
NM_000397.3(CYBB):c.781C>T (p.Gln261Ter)	CYBB	Q261*	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000533558	X	37658314	X	37799061	533558	535161	rs1556469197	NC_000023.11:37799060:C:T
NM_000397.3(CYBB):c.1702G>A (p.Glu568Lys)	CYBB	E568K	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000533556	X	37670159	X	37810906	533556	534794	rs1556473119	NC_000023.11:37810905:G:A
NM_001611.5(ACP5):c.738C>A (p.Tyr246Ter)	ACP5	Y246*	Spondyloenchondrodysplasia with immune dysregulation	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000533474	19	11686065	19	11575250	533474	532691	rs761798208	NC_000019.10:11575249:G:T
NC_000023.10:g.(?_18582577)_(18600090_?)del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000533400	X	18582577 - 18600090	X	18564457 - 18581970	533400	534520		
NM_001323289.2(CDKL5):c.725del (p.Pro242fs)	CDKL5	P242fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000533390	X	18606243	X	18588123	533390	535120	rs1555950494	NC_000023.11:18588122:CC:C
NM_001323289.2(CDKL5):c.614_617dup (p.Asp206fs)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000533389	X	18606131 - 18606132	X	18588011 - 18588012	533389	535119	rs1555950465	NC_000023.11:18588011:AGCGA:AGCGAGCGA
NM_001323289.2(CDKL5):c.198_199TC[1] (p.Leu67fs)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000533386	X	18593525 - 18593526	X	18575405 - 18575406	533386	534765	rs1555949011	NC_000023.11:18575404:CTCTC:CTC
NC_000023.10:g.(?_103031893)_(103045546_?)dup	PLP1		Hereditary spastic paraplegia 2	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000533385	X	103031893 - 103045546			533385	534374		
NM_001323289.2(CDKL5):c.508G>T (p.Glu170Ter)	CDKL5	E170*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000533384	X	18602427	X	18584307	533384	535118	rs1555950066	NC_000023.11:18584306:G:T
NM_004655.4(AXIN2):c.1642G>T (p.Glu548Ter)	AXIN2	E548*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000533194	17	63533512	17	65537394	533194	531665	rs367624903	NC_000017.11:65537393:C:A
NM_004655.4(AXIN2):c.2309del (p.Phe770fs)	AXIN2	F770fs, F705fs	Oligodontia-colorectal cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533178	17	63530126	17	65534008	533178	531723	rs1299440644	NC_000017.11:65534007:AAAAA:AAAA
NM_004655.4(AXIN2):c.1646del (p.Tyr549fs)	AXIN2	Y549fs	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000533177	17	63533508	17	65537390	533177	531663	rs1555577613	NC_000017.11:65537389:T:
NM_199242.2(UNC13D):c.118-308C>T	UNC13D			Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000533095	17	73839908	17	75843827	533095	531855	rs959968589	NC_000017.11:75843826:G:A
NM_199242.2(UNC13D):c.1472T>A (p.Leu491Ter)	UNC13D	L491*		Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000533091	17	73832165	17	75836084	533091	532157	rs1555601754	NC_000017.11:75836083:A:T
NM_015295.2(SMCHD1):c.3484C>T (p.Gln1162Ter)	SMCHD1	Q1162*	Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000532808	18	2739488	18	2739490	532808	532172	rs1555644339	NC_000018.10:2739489:C:T
NM_015295.2(SMCHD1):c.4104del (p.Val1369fs)	SMCHD1	V1369fs	Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000532807	18	2750442	18	2750444	532807	532179	rs1555647265	NC_000018.10:2750443:CCC:CC
NM_001754.4(RUNX1):c.1408_1409GC[4] (p.Leu472fs)	RUNX1		Familial platelet disorder with associated myeloid malignancy|not provided	Pathogenic(Last reviewed: Jul 26, 2019)	reviewed by expert panel	VCV000532664	21	36164461 - 36164462	21	34792164 - 34792165	532664	533817	rs1555884790	NC_000021.9:34792164:GCGCGCG:GCGCGCGCG
NM_001281463.1(SMC1A):c.521G>A (p.Arg174His)	SMC1A	R174H, R196H	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000532572	X	53440210	X	53413260	532572	534886	rs1556890815	NC_000023.11:53413259:C:T
NM_001281463.1(SMC1A):c.3037C>T (p.Arg1013Ter)	SMC1A	R1035*, R1013*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000532569	X	53410045	X	53383124	532569	535184	rs1556886124	NC_000023.11:53383123:G:A
NM_000206.2(IL2RG):c.548del (p.Leu183fs)	IL2RG	L183fs	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000532190	X	70330052	X	71110202	532190	535189	rs1556330562	NC_000023.11:71110201:AAA:AA
NM_000206.2(IL2RG):c.522G>A (p.Trp174Ter)	IL2RG	W174*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000532189	X	70330078	X	71110228	532189	535190	rs1556330568	NC_000023.11:71110227:C:T
NC_000023.10:g.(?_119562319)_(119603044_?)del	LAMP2		Danon disease	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000532015	X	119562319 - 119603044	X	120428464 - 120469189	532015	534395		
NC_000023.10:g.(?_17393861)_(17653740_?)del	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000531902	X	17393861 - 17653740			531902	534359		
NM_000117.2(EMD):c.581_582del (p.Ser194fs)	EMD	S194fs	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000531738	X	153609373 - 153609374	X	154381013 - 154381014	531738	535112	rs1557182654	NC_000023.11:154381012:CA:
NM_000117.2(EMD):c.215_216AT[3] (p.Met73fs)	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000531732	X	153608328 - 153608329	X	154379968 - 154379969	531732	534740	rs1557182364	NC_000023.11:154379968:ATAT:ATATAT
NM_000117.2(EMD):c.135dup (p.Arg46fs)	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000531731	X	153608100 - 153608101	X	154379740 - 154379741	531731	535110	rs1557182301	NC_000023.11:154379740:GG:GGG
NM_000252.2(MTM1):c.1210G>A (p.Glu404Lys)	MTM1	E404K	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000530855	X	149826450	X	150657977	530855	535062	rs781933660	NC_000023.11:150657976:G:A
NC_000020.10:g.(?_62062673)_(62065276_?)del	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000530656	20	62062673 - 62065276	20	63431320 - 63433923	530656	533982		
NM_172107.4(KCNQ2):c.848del (p.Lys283fs)	KCNQ2	K283fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000530425	20	62071030	20	63439677	530425	533624	rs1555870506	NC_000020.11:63439676:TT:T
NM_172107.4(KCNQ2):c.1086C>G (p.Tyr362Ter)	KCNQ2	Y362*	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000530424	20	62065194	20	63433841	530424	533688	rs747376305	NC_000020.11:63433840:G:C
NM_172107.4(KCNQ2):c.687del (p.Ser229fs)	KCNQ2	S229fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000530407	20	62076015	20	63444662	530407	533692	rs1555873656	NC_000020.11:63444661:G:
NM_172107.4(KCNQ2):c.439del (p.Ala147fs)	KCNQ2	A147fs	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000530406	20	62076666	20	63445313	530406	533697	rs1555873981	NC_000020.11:63445312:CCC:CC
NM_005359.5(SMAD4):c.1409delC (p.Pro470Leufs)	SMAD4	P470fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000529954	18	48603106	18	51076736	529954	532339	rs1555687387	NC_000018.10:51076735:CCC:CC
NM_005359.5(SMAD4):c.1407_1410dup (p.Gly471Profs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000529945	18	48603104 - 48603105	18	51076734 - 51076735	529945	532337	rs1555687386	NC_000018.10:51076734:TCCCT:TCCCTCCCT
NM_005359.5(SMAD4):c.1324C>T (p.Gln442Ter)	SMAD4	Q442*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000529907	18	48603023	18	51076653	529907	532335	rs1555687378	NC_000018.10:51076652:C:T
NM_000159.4(GCDH):c.262C>A (p.Arg88Ser)	GCDH	R88S	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000529444	19	13002779	19	12891965	529444	533135	rs142967670	NC_000019.10:12891964:C:A
NM_000159.4(GCDH):c.770G>A (p.Arg257Gln)	GCDH	R257Q	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000529442	19	13007153	19	12896339	529442	533136	rs751583656	NC_000019.10:12896338:G:A
NC_000019.9:g.(?_7587617)_(7593163_?)del	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000528767	19	7587617 - 7593163	19	7522731 - 7528277	528767	532832		
NC_000023.10:g.(?_68890034)_(69177002_?)dup	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000528365	X	68890034 - 69177002			528365	534391		
NC_000023.10:g.(?_68836133)_(68890124_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000528364	X	68836133 - 68890124	X	69616289 - 69670280	528364	534942		
NC_000023.10:g.(?_68836133)_(69255479_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000528363	X	68836133 - 69255479			528363	534513		
NM_001399.5(EDA):c.741G>A (p.Gln247=)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000528357	X	69249388	X	70029538	528357	534936	rs886042183	NC_000023.11:70029537:G:A
NM_001399.5(EDA):c.239dup (p.Ser81fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000528355	X	68836389 - 68836390	X	69616545 - 69616546	528355	535048	rs1555972071	NC_000023.11:69616545:GG:GGG
NM_001399.5(EDA):c.681_697del (p.Pro228fs)	EDA	P228fs	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000528354	X	69247858 - 69247874	X	70028008 - 70028024	528354	534912	rs1556098978	NC_000023.11:70028007:AGGACCCCCTGGCCTCCAGG:AGG
NC_000023.10:g.(?_153008421)_(153009209_?)del	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000528353	X	153008421 - 153009209			528353	534499		
NM_000033.4(ABCD1):c.1532G>A (p.Cys511Tyr)	ABCD1	C511Y	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	VCV000528344	X	153005589	X	153740135	528344	534629	rs1557054745	NC_000023.11:153740134:G:A
NM_000033.4(ABCD1):c.1628C>T (p.Pro543Leu)	ABCD1	P543L	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000528341	X	153005685	X	153740231	528341	534632	rs1557054776	NC_000023.11:153740230:C:T
NM_000033.4(ABCD1):c.16_22delinsCT (p.Arg6fs)	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000528340	X	152990737 - 152990743	X	153725282 - 153725288	528340	534587	rs1557052133	NC_000023.11:153725281:AGGCCCC:CT
NM_000033.4(ABCD1):c.1820_1823del (p.Gly607fs)	ABCD1	G607fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000528339	X	153008478 - 153008481	X	153743024 - 153743027	528339	534678	rs1557055253	NC_000023.11:153743023:GGGTGG:GG
NM_000033.4(ABCD1):c.1567C>T (p.Leu523Phe)	ABCD1	L523F	Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000528338	X	153005624	X	153740170	528338	534597	rs1159943880	NC_000023.11:153740169:C:T
NM_000033.4(ABCD1):c.1552C>G (p.Arg518Gly)	ABCD1	R518G	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000528337	X	153005609	X	153740155	528337	534675	rs128624224	NC_000023.11:153740154:C:G
NM_000377.2(WAS):c.91G>A (p.Glu31Lys)	WAS	E31K	not provided|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000528222	X	48542333	X	48683944	528222	535002	rs1557006239	NC_000023.11:48683943:G:A
NM_000377.2(WAS):c.271C>T (p.Gln91Ter)	WAS	Q91*	X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, single submitter	VCV000528221	X	48542810	X	48684421	528221	534824	rs1557006354	NC_000023.11:48684420:C:T
NC_000023.10:g.(?_153132791)_(153141311_?)del	L1CAM		Spastic paraplegia	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000528038	X	153132791 - 153141311			528038	534353		
NM_000455.4(STK11):c.793_794GA[3] (p.Asn266fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527838	19	1221269 - 1221270	19	1221270 - 1221271	527838	532698	rs1555738656	NC_000019.10:1221270:GAGA:GAGAGA
NM_000455.4(STK11):c.256C>T (p.Arg86Ter)	STK11	R86*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000527834	19	1207168	19	1207169	527834	532683	rs1057520039	NC_000019.10:1207168:C:T
NM_000455.4(STK11):c.1097_1108+1232del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000527833	19	1223158 - 1224401	19	1223159 - 1224402	527833	532735		
NM_000455.4(STK11):c.157dup (p.Asp53fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000527822	19	1207064 - 1207065	19	1207065 - 1207066	527822	532661	rs1131690917	NC_000019.10:1207065:GGGGG:GGGGGG
NM_000455.4(STK11):c.468C>G (p.Tyr156Ter)	STK11	Y156*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000527815	19	1220375	19	1220376	527815	532684	rs786201349	NC_000019.10:1220375:C:G
NM_000455.4(STK11):c.895_901dup (p.Arg301fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000527814	19	1221978 - 1221979	19	1221979 - 1221980	527814	532692	rs1555738874	NC_000019.10:1221979:CTCCATCC:CTCCATCCTCCATCC
NM_000455.4(STK11):c.918_919delinsTCC (p.Ser307fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000527812	19	1222003 - 1222004	19	1222004 - 1222005	527812	532720	rs1555738899	NC_000019.10:1222003:CA:TCC
NM_000455.4(STK11):c.821delinsAC (p.Ile274fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527811	19	1221298	19	1221299	527811	532712	rs1555738683	NC_000019.10:1221298:T:AC
NC_000022.10:g.(?_30064316)_(30074318_?)del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000527725	22	30064316 - 30074318	22	29668327 - 29678329	527725	534011		
NM_016418.5(NF2):c.563_564del (p.Ile188fs)	NF2	I105fs, I146fs, I147fs, I188fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000527703	22	30051629 - 30051630	22	29655640 - 29655641	527703	534709	rs1555993313	NC_000022.11:29655639:TT:
NM_016418.5(NF2):c.970del (p.Gln324fs)	NF2	Q324fs, Q241fs, Q282fs, Q283fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000527702	22	30064404	22	29668415	527702	534186	rs1555998851	NC_000022.11:29668414:CCC:CC
NM_016418.5(NF2):c.798C>G (p.Tyr266Ter)	NF2	Y266*, Y224*, Y225*, Y183*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000527692	22	30057316	22	29661327	527692	534168	rs917257652	NC_000022.11:29661326:C:G
NM_000202.8(IDS):c.257C>T (p.Pro86Leu)	IDS	P86L	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000527322	X	148585003	X	149503473	527322	534573	rs1557340280	NC_000023.11:149503472:G:A
NC_000022.10:g.(?_51063553)_(51066227_?)del	ARSA		Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000526831	22	51063553 - 51066227	22	50625125 - 50627799	526831	534023		
NC_000019.9:g.(?_11215876)_(11218210_?)del	LDLR		Familial hypercholesterolemia	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000526767	19	11215876 - 11218210	19	11105200 - 11107534	526767	532485		
NM_000527.4(LDLR):c.274C>T (p.Gln92Ter)	LDLR	Q92*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000526754	19	11213423	19	11102747	526754	532657	rs774467219	NC_000019.10:11102746:C:T
NC_000020.10:g.(?_3869728)_(3893301_?)del	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000526631	20	3869728 - 3893301	20	3889081 - 3912654	526631	533507		
NM_153638.3(PANK2):c.1250_1251dup (p.Phe418fs)	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000526628	20	3893118 - 3893119	20	3912471 - 3912472	526628	534089	rs1555788619	NC_000020.11:3912471:CT:CTCT
NM_153638.3(PANK2):c.1236-2A>C	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000526627	20	3893103	20	3912456	526627	533598	rs1261714833	NC_000020.11:3912455:A:C
NM_000292.3(PHKA2):c.1054C>T (p.Arg352Ter)	PHKA2	R352*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000526624	X	18954256	X	18936138	526624	534785	rs1556007472	NC_000023.11:18936137:G:A
NM_000292.3(PHKA2):c.1794-8_1812del	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000526623	X	18938301 - 18938327	X	18920183 - 18920209	526623	534775	rs1556000892	NC_000023.11:18920182:AAGGTTCCCTAATTTTACTCTGCCAAGAAG:AAG
NC_000017.10:g.(?_78078341)_(78079713_?)del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000526556	17	78078341 - 78079713	17	80104542 - 80105914	526556	530557		
NM_000152.5(GAA):c.342del (p.Lys114fs)	GAA	K114fs	Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000526523	17	78078727	17	80104928	526523	532292	rs1555598796	NC_000017.11:80104927:G:
NM_000152.5(GAA):c.1438-2A>G	GAA		Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000526521	17	78084524	17	80110725	526521	531972	rs1555600730	NC_000017.11:80110724:A:G
NM_007267.7(TMC6):c.1325dup (p.Thr444fs)	TMC6		EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000526234	17	76117694 - 76117695	17	78121613 - 78121614	526234	532241	rs1555655146	NC_000017.11:78121613:A:AA
NC_000023.10:g.(?_32235013)_(32235200_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000526178	X	32235013 - 32235200	X	32216896 - 32217083	526178	534417		
NC_000023.10:g.(?_31747742)_(31792315_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000526173	X	31747742 - 31792315	X	31729625 - 31774198	526173	534551		
NC_000023.10:g.(?_31645770)_(31838220_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 21, 2017)	criteria provided, single submitter	VCV000526170	X	31645770 - 31838220	X	31627653 - 31820103	526170	534545		
NC_000023.10:g.(?_31950177)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000526168	X	31950177 - 31950364	X	31932060 - 31932247	526168	534415		
NC_000023.10:g.(?_31792057)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000526166	X	31792057 - 31986651	X	31773940 - 31968534	526166	534407		
NC_000023.10:g.(?_31838072)_(31838220_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000526165	X	31838072 - 31838220	X	31819955 - 31820103	526165	534386		
NC_000023.10:g.(?_31627738)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000526164	X	31627738 - 31950364	X	31609621 - 31932247	526164	534404		
NC_000023.10:g.(?_31893285)_(32235200_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000526163	X	31893285 - 32235200	X	31875168 - 32217083	526163	534555		
NC_000023.10:g.(?_31854815)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000526161	X	31854815 - 31950364	X	31836698 - 31932247	526161	534553		
NC_000023.10:g.(?_32429849)_(32591983_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000526160	X	32429849 - 32591983	X	32411732 - 32573866	526160	534426		
NC_000023.10:g.(?_32834565)_(32867957_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 11, 2017)	criteria provided, single submitter	VCV000526159	X	32834565 - 32867957	X	32816448 - 32849840	526159	534437		
NC_000023.10:g.(?_31676087)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000526158	X	31676087 - 31950364	X	31657970 - 31932247	526158	534549		
NC_000023.10:g.(?_32519852)_(32519979_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 6, 2018)	criteria provided, single submitter	VCV000526155	X	32519852 - 32519979	X	32501735 - 32501862	526155	534401		
NC_000023.10:g.(?_31279052)_(31747885_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000526154	X	31279052 - 31747885	X	31260935 - 31729768	526154	534538		
NC_000023.10:g.(?_32827590)_(32867957_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000526150	X	32827590 - 32867957	X	32809473 - 32849840	526150	534926		
NC_000023.10:g.(?_31854815)_(32383336_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000526148	X	31854815 - 32383336	X	31836698 - 32365219	526148	534914		
NC_000023.10:g.(?_31947693)_(32235200_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000526147	X	31947693 - 32235200	X	31929576 - 32217083	526147	534557		
NC_000023.10:g.(?_31366653)_(31747885_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000526146	X	31366653 - 31747885	X	31348536 - 31729768	526146	534400		
NC_000023.10:g.(?_31341695)_(31341795_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000526144	X	31341695 - 31341795	X	31323578 - 31323678	526144	534378		
NC_000023.10:g.(?_31893285)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000526142	X	31893285 - 31893510	X	31875168 - 31875393	526142	534389		
NC_000023.10:g.(?_31676087)_(31792329_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000526141	X	31676087 - 31792329	X	31657970 - 31774212	526141	534879		
NC_000023.10:g.(?_31697472)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000526140	X	31697472 - 31986651	X	31679355 - 31968534	526140	534381		
NC_000023.10:g.(?_31838072)_(31838220_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000526139	X	31838072 - 31838220	X	31819955 - 31820103	526139	534896		
NM_004006.2(DMD):c.1992+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000526103	X	32583818	X	32565701	526103	534893	rs1556802319	NC_000023.11:32565700:C:A
NM_004010.3(DMD):c.-14del	DMD	Q111fs, Q115fs, Q119fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526099	X	32841413	X	32823296	526099	534941	rs1557058308	NC_000023.11:32823295:T:
NM_000109.4(DMD):c.3793del (p.Ser1265fs)	DMD	S1150fs, S1265fs, S1269fs, S1273fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000526098	X	32459401	X	32441284	526098	535149	rs1557359217	NC_000023.11:32441283:A:
NM_004006.2(DMD):c.5266C>T (p.Gln1756Ter)	DMD	Q1756*, Q1752*, Q1748*, Q415*, Q1633*, Q412*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000526093	X	32380964	X	32362847	526093	534848	rs1557303544	NC_000023.11:32362846:G:A
NM_004006.2(DMD):c.8027+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526091	X	31676106	X	31657989	526091	535141	rs1556789913	NC_000023.11:31657988:C:T
NM_000109.4(DMD):c.632dup (p.Asp211fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000526090	X	32717403 - 32717404	X	32699286 - 32699287	526090	534843	rs1556930839	NC_000023.11:32699286:T:TT
NM_004006.2(DMD):c.3268C>T (p.Gln1090Ter)	DMD	Q1090*, Q967*, Q1082*, Q1086*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000526089	X	32482711	X	32464594	526089	534768	rs1557369991	NC_000023.11:32464593:G:A
NM_004006.2(DMD):c.9183G>A (p.Trp3061Ter)	DMD	W3061*, W3057*, W332*, W3053*, W1720*, W601*, W1717*, W2938*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000526087	X	31341756	X	31323639	526087	535136	rs1556503937	NC_000023.11:31323638:C:T
NM_004006.2(DMD):c.1075G>T (p.Glu359Ter)	DMD	E359*, E351*, E236*, E355*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000526084	X	32663155	X	32645038	526084	535158	rs1556876346	NC_000023.11:32645037:C:A
NM_004006.2(DMD):c.5602A>T (p.Arg1868Ter)	DMD	R1868*, R1864*, R1745*, R524*, R527*, R1860*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000526083	X	32361388	X	32343271	526083	534804	rs1557291229	NC_000023.11:32343270:T:A
NM_004006.2(DMD):c.9975-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000526079	X	31198599	X	31180482	526079	534797	rs1556040444	NC_000023.11:31180481:C:T
NM_000109.4(DMD):c.1771del (p.Ser591fs)	DMD	S476fs, S595fs, S599fs, S591fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	VCV000526077	X	32591664	X	32573547	526077	534898	rs1556809704	NC_000023.11:32573546:TT:T
NM_004006.2(DMD):c.6408G>A (p.Trp2136Ter)	DMD	W2136*, W2128*, W792*, W795*, W2013*, W2132*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000526076	X	32235063	X	32216946	526076	534742	rs1557218131	NC_000023.11:32216945:C:T
NM_000109.4(DMD):c.2614del (p.Leu872fs)	DMD	L757fs, L872fs, L876fs, L880fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000526074	X	32503201	X	32485084	526074	534884	rs1557380685	NC_000023.11:32485083:G:
NM_004006.2(DMD):c.2776C>T (p.Gln926Ter)	DMD	Q926*, Q803*, Q918*, Q922*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000526072	X	32503063	X	32484946	526072	534776	rs1055371114	NC_000023.11:32484945:G:A
NM_000109.4(DMD):c.3364_3365dup (p.Leu1123fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526071	X	32481598 - 32481599	X	32463481 - 32463482	526071	534762	rs1557369413	NC_000023.11:32463481:TCT:TCTCT
NM_004006.2(DMD):c.1366A>T (p.Lys456Ter)	DMD	K456*, K333*, K452*, K448*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000526066	X	32632536	X	32614419	526066	535155	rs1556853298	NC_000023.11:32614418:T:A
NM_004006.2(DMD):c.4501C>T (p.Gln1501Ter)	DMD	Q1501*, Q1493*, Q157*, Q160*, Q1378*, Q1497*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000526064	X	32407635	X	32389518	526064	535146	rs1557322201	NC_000023.11:32389517:G:A
NM_000109.4(DMD):c.833dup (p.Tyr278Ter)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526063	X	32716089 - 32716090	X	32697972 - 32697973	526063	534838	rs1556929259	NC_000023.11:32697972:T:TT
NM_004006.2(DMD):c.1292G>A (p.Trp431Ter)	DMD	W431*, W308*, W423*, W427*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000526062	X	32662288	X	32644171	526062	535156	rs1556875224	NC_000023.11:32644170:C:T
NM_004006.2(DMD):c.2949+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000526061	X	32490280	X	32472163	526061	534774	rs1557374482	NC_000023.11:32472162:C:T
NM_004006.2(DMD):c.6251_6290+12981del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000526055	X	32292665 - 32305685	X	32274548 - 32287568	526055	534753		
NM_004006.2(DMD):c.10224-175_10230del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000526054	X	31196081 - 31196262	X	31177964 - 31178145	526054	535132	rs1556035817	
NM_004006.2(DMD):c.10783C>T (p.Gln3595Ter)	DMD	Q3595*, Q1135*, Q514*, Q1025*, Q1122*, Q2251*, Q2254*, Q3472*, Q866*, Q3587*, Q3591*, Q527*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000526051	X	31165406	X	31147289	526051	535130	rs1385794215	NC_000023.11:31147288:G:A
NM_000109.4(DMD):c.8072_8088del (p.Glu2691fs)	DMD	E2576fs, E2695fs, E1358fs, E2691fs, E239fs, E1355fs, E2699fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000526050	X	31645895 - 31645911	X	31627778 - 31627794	526050	535140	rs1556764880	NC_000023.11:31627777:CCAGGCAAGAAACTTTTCCAGG:CCAGG
NM_004020.3(DMD):c.2843+6294del	DMD	N3333fs, N3452fs, N2112fs, N3448fs, N375fs, N727fs, N983fs, N996fs, N3456fs, N2115fs, N388fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526049	X	31190492	X	31172375	526049	534815	rs1556028034	NC_000023.11:31172374:TTT:TT
NM_000109.4(DMD):c.8659dup (p.Glu2887fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000526048	X	31496476 - 31496477	X	31478359 - 31478360	526048	535138	rs1556656456	NC_000023.11:31478359:CC:CCC
NM_004006.2(DMD):c.4231C>T (p.Gln1411Ter)	DMD	Q1411*, Q1288*, Q1403*, Q1407*, Q67*, Q70*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526046	X	32429871	X	32411754	526046	534813	rs1010666282	NC_000023.11:32411753:G:A
NM_000109.4(DMD):c.8555del (p.Pro2852fs)	DMD	P1516fs, P131fs, P2860fs, P400fs, P1519fs, P2737fs, P2852fs, P2856fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000526045	X	31497189	X	31479072	526045	534720	rs1556656847	NC_000023.11:31479071:GG:G
NM_000109.4(DMD):c.3689del (p.Lys1230fs)	DMD	K1234fs, K1115fs, K1230fs, K1238fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000526040	X	32466646	X	32448529	526040	535150	rs1557362198	NC_000023.11:32448528:TTTTTT:TTTTT
NM_080647.1(TBX1):c.292A>T (p.Lys98Ter)	TBX1	K98*	DiGeorge sequence	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000526036	22	19748685	22	19761162	526036	534153	rs1555895466	NC_000022.11:19761161:A:T
NM_023036.6(DNAI2):c.718C>T (p.Gln240Ter)	DNAI2	Q240*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000525359	17	72287266	17	74291127	525359	532144	rs780116486	NC_000017.11:74291126:C:T
NM_001364171.2(CCDC114):c.398del (p.Lys133fs)	CCDC114	K96fs, K133fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000525210	19	48815336	19	48312079	525210	533627	rs1421531868	NC_000019.10:48312078:TT:T
NM_138927.3(SON):c.1414_1423delinsTTGCGTCTGTGG (p.Pro472fs)	SON		not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000524167	21	34922951 - 34922960	21	33550645 - 33550654	524167	514775	rs1555898264	NC_000021.9:33550644:CCACCTGTGA:TTGCGTCTGTGG
NM_003688.3(CASK):c.1195del (p.Arg399fs)	CASK	R393fs, R399fs	not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000524165	X	41448806	X	41589553	524165	514806	rs1555989338	NC_000023.11:41589552:T:
NM_004859.4(CLTC):c.2793_2794del (p.Asn932fs)	CLTC	N932fs, N936fs	not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000524163	17	57754546 - 57754547	17	59677185 - 59677186	524163	514726	rs1555606652	NC_000017.11:59677184:TA:
NM_004859.4(CLTC):c.2651_2652del (p.Ile884fs)	CLTC	I884fs, I888fs	not provided	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000524162	17	57754403 - 57754404	17	59677042 - 59677043	524162	514725	rs1555606630	NC_000017.11:59677041:ATA:A
NM_004859.4(CLTC):c.4568dup (p.Ser1524fs)	CLTC		not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000524157	17	57762549 - 57762550	17	59685188 - 59685189	524157	514728	rs1555607616	NC_000017.11:59685188:A:AA
NM_001029896.2(WDR45):c.680_689del (p.Lys227fs)	WDR45	K228fs, K227fs	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000524156	X	48933240 - 48933249	X	49075581 - 49075590	524156	514810	rs1557084036	NC_000023.11:49075580:TCCACCAGTTTC:TC
NM_001323289.2(CDKL5):c.629del (p.Leu210fs)	CDKL5	L210fs	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000524152	X	18606146	X	18588026	524152	514794	rs1555950470	NC_000023.11:18588025:TTT:TT
NM_001123383.1(BCOR):c.524_527del (p.Lys175fs)	BCOR	K175fs	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000524141	X	39934072 - 39934075	X	40074819 - 40074822	524141	514802	rs1555919843	NC_000023.11:40074818:TGTTTGT:TGT
NM_002547.2(OPHN1):c.2159_2171delGGGATGCTGACAG (p.Gly720Valfs)	OPHN1		not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000524115	X	67273640 - 67273652	X	68053798 - 68053810	524115	514815	rs1556076981	NC_000023.11:68053797:CTGTCAGCATCCCCTG:CTG
NM_001347721.2(DYRK1A):c.220dup (p.Gln74fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000524106	21	38850518 - 38850519	21	37478216 - 37478217	524106	514776	rs1555979106	NC_000021.9:37478216:CCCC:CCCCC
NM_000109.4(DMD):c.10530-1dup	DMD		not provided	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000524098	X	31165634 - 31165635	X	31147517 - 31147518	524098	514797	rs1555998436	NC_000023.11:31147517:CC:CCC
NM_005257.5(GATA6):c.925del (p.Gln309fs)	GATA6	Q309fs	not provided	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000524082	18	19752027	18	22172066	524082	514737	rs1555628831	NC_000018.10:22172065:CCCC:CCC
NM_000328.3(RPGR):c.1054_1058del (p.Lys352fs)	RPGR	K352fs, K351fs, K362fs	not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000524070	X	38160501 - 38160505	X	38301248 - 38301252	524070	514801	rs1555965081	NC_000023.11:38301247:AATTTAA:AA
NM_016032.4(ZDHHC9):c.717_738del (p.Val240fs)	ZDHHC9	V240fs	not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000524052	X	128946733 - 128946754	X	129812757 - 129812778	524052	514791	rs1556004792	NC_000023.11:129812756:ATGAAATCCAGTCAGTCCCACGA:A
NM_030582.4(COL18A1):c.1377dup (p.Val460fs)	COL18A1		not provided	Pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000524047	21	46896297 - 46896298	21	45476383 - 45476384	524047	514778	rs760175310	NC_000021.9:45476383:CCCCCC:CCCCCCC
NM_015559.3(SETBP1):c.1661del (p.Leu554fs)	SETBP1	L554fs	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000524046	18	42530966	18	44951001	524046	514743	rs1555706499	NC_000018.10:44951000:T:
NM_006852.4(TLK2):c.947del (p.Tyr316fs)	TLK2	Y316fs, Y167fs, Y284fs	not provided	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000524042	17	60642477	17	62565116	524042	514731	rs1555639317	NC_000017.11:62565115:A:
NM_001363734.1(ASXL1):c.3450_3453CTCC[1] (p.Leu1152fs)	ASXL1		not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000524036	20	31024148 - 31024151	20	32436345 - 32436348	524036	514769	rs1555912648	NC_000020.11:32436344:CTCCCTCC:CTCC
NM_001111125.3(IQSEC2):c.1925dup (p.Ile643fs)	IQSEC2		not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000524027	X	53279832 - 53279833	X	53250650 - 53250651	524027	514814	rs1556863165	NC_000023.11:53250650:GGGG:GGGGG
NM_000276.4(OCRL):c.970_986del (p.Leu324fs)	OCRL	L324fs, L325fs	not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000524022	X	128696390 - 128696406	X	129562413 - 129562429	524022	514790	rs1556346271	NC_000023.11:129562412:GCTTCTTATATTTGCCAG:G
NM_198270.4(NHS):c.975del (p.Thr326fs)	NHS	T326fs, T149fs, T170fs, T347fs	not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000524021	X	17739683	X	17721563	524021	514793	rs1556037290	NC_000023.11:17721562:G:
NM_001356.4(DDX3X):c.1454dup (p.His485fs)	DDX3X		not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000524010	X	41205619 - 41205620	X	41346366 - 41346367	524010	514804	rs1555954122	NC_000023.11:41346366:A:AA
NM_003620.3(PPM1D):c.1246_1247AC[4] (p.Pro417fs)	PPM1D		not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000524006	17	58734187 - 58734188	17	60656826 - 60656827	524006	514730	rs1555648570	NC_000017.11:60656826:ACAC:ACACACAC
NM_177559.3(CSNK2A1):c.503del (p.His168fs)	CSNK2A1	H32fs, H168fs	not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000523999	20	476370	20	495726	523999	514771	rs1555763444	NC_000020.11:495725:T:
NM_001347721.2(DYRK1A):c.317del (p.Lys106fs)	DYRK1A	K106fs, K115fs, K77fs	not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000523995	21	38852951	21	37480649	523995	514777	rs1555980192	NC_000021.9:37480648:AAAAAA:AAAAA
NM_003688.3(CASK):c.553_565del (p.Phe185fs)	CASK	F185fs	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000523973	X	41524673 - 41524685	X	41665420 - 41665432	523973	514807	rs1556014805	NC_000023.11:41665419:CTGGTGCCATAAA:
NM_004586.3(RPS6KA3):c.1463_1464del (p.Tyr488fs)	RPS6KA3	Y488fs	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000523940	X	20185845 - 20185846	X	20167727 - 20167728	523940	514796	rs1555928736	NC_000023.11:20167726:ATA:A
NM_004187.4(KDM5C):c.1802dup (p.Tyr601Ter)	KDM5C		not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000523921	X	53231099 - 53231100	X	53201917 - 53201918	523921	514812	rs1556842137	NC_000023.11:53201917:T:TT
NM_004006.2(DMD):c.8077C>T (p.Gln2693Ter)	DMD	Q2693*, Q233*, Q2685*, Q2689*, Q1352*, Q2570*, Q1349*	not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000523910	X	31645930	X	31627813	523910	514799	rs1556764922	NC_000023.11:31627812:G:A
NM_000033.4(ABCD1):c.843C>A (p.Tyr281Ter)	ABCD1	Y281*	not specified|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523894	X	152991564	X	153726109	523894	514792	rs1557052555	NC_000023.11:153726108:C:A
NM_005559.4(LAMA1):c.8931G>A (p.Trp2977Ter)	LAMA1	W2977*	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000523892	18	6943315	18	6943316	523892	514745	rs1236564978	NC_000018.10:6943315:C:T
NM_005559.4(LAMA1):c.295C>T (p.Gln99Ter)	LAMA1	Q99*	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000523891	18	7080024	18	7080025	523891	514748	rs1178073729	NC_000018.10:7080024:G:A
NM_018486.3(HDAC8):c.951C>A (p.Tyr317Ter)	HDAC8	Y317*, Y226*	not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000523882	X	71681908	X	72462058	523882	514816	rs1555991936	NC_000023.11:72462057:G:T
NM_001111125.3(IQSEC2):c.3679C>T (p.Gln1227Ter)	IQSEC2	Q1227*	not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000523861	X	53264189	X	53235007	523861	514813	rs1556859257	NC_000023.11:53235006:G:A
NM_005559.4(LAMA1):c.2344C>T (p.Arg782Ter)	LAMA1	R782*	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000523859	18	7026036	18	7026037	523859	514747	rs374851540	NC_000018.10:7026036:G:A
NM_005559.4(LAMA1):c.5512C>T (p.Gln1838Ter)	LAMA1	Q1838*	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000523858	18	6985384	18	6985385	523858	514746	rs376548651	NC_000018.10:6985384:G:A
NM_000061.2(BTK):c.46C>T (p.Gln16Ter)	BTK	Q16*, Q50*	not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000523855	X	100630227	X	101375239	523855	514787	rs1555980888	NC_000023.11:101375238:G:A
NM_004187.4(KDM5C):c.2332C>T (p.Arg778Ter)	KDM5C	R778*, R711*, R777*	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000523819	X	53227982	X	53198800	523819	514811	rs1556840029	NC_000023.11:53198799:G:A
NM_014727.2(KMT2B):c.5113C>T (p.Arg1705Ter)	KMT2B	R1705*	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000523817	19	36221279	19	35730378	523817	514757	rs1555731976	NC_000019.10:35730377:C:T
NM_004247.4(EFTUD2):c.523C>T (p.Gln175Ter)	EFTUD2	Q175*, Q140*, Q165*	not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000523812	17	42959060	17	44881692	523812	514719	rs1555569283	NC_000017.11:44881691:G:A
NM_015559.3(SETBP1):c.1633G>T (p.Glu545Ter)	SETBP1	E545*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000523811	18	42530938	18	44950973	523811	514742	rs1555706476	NC_000018.10:44950972:G:T
NM_021140.3(KDM6A):c.3797C>A (p.Ser1266Ter)	KDM6A	S1266*, S1318*, S970*, S1273*, S1221*, S1187*	not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000523806	X	44950028	X	45090783	523806	514809	rs1556357314	NC_000023.11:45090782:C:A
NM_000397.3(CYBB):c.1006G>T (p.Glu336Ter)	CYBB	E336*	not provided	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000523790	X	37663238	X	37803985	523790	514800	rs1556470794	NC_000023.11:37803984:G:T
NM_001127221.1(CACNA1A):c.4990C>T (p.Arg1664Ter)	CACNA1A	R1664*, R1669*, R1663*, R1666*	not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000523785	19	13346508	19	13235694	523785	514750	rs1555738369	NC_000019.10:13235693:G:A
NM_004006.2(DMD):c.9691C>T (p.Gln3231Ter)	DMD	Q3231*, Q1887*, Q3108*, Q502*, Q1890*, Q3223*, Q163*, Q3227*, Q771*	not provided	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000523784	X	31222194	X	31204077	523784	514798	rs1556235825	NC_000023.11:31204076:G:A
NM_033290.4(MID1):c.1483C>T (p.Arg495Ter)	MID1	R495*, R457*	not provided|Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523781	X	10423082	X	10455042	523781	514789	rs745554420	NC_000023.11:10455041:G:A
NM_001429.4(EP300):c.3841C>T (p.Arg1281Ter)	EP300	R1281*, R1255*	not provided	Pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000523774	22	41562637	22	41166633	523774	514784	rs1555910814	NC_000022.11:41166632:C:T
NM_212472.2(PRKAR1A):c.289C>T (p.Arg97Ter)	PRKAR1A	R97*	not provided|Carney complex, type 1	Pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523771	17	66519008	17	68522867	523771	514732	rs1555813217	NC_000017.11:68522866:C:T
NM_003688.3(CASK):c.2742G>A (p.Trp914Ter)	CASK	W914*, W891*, W890*, W919*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000523767	X	41379697	X	41520444	523767	514805	rs1555971887	NC_000023.11:41520443:C:T
NM_030632.3(ASXL3):c.1582G>T (p.Glu528Ter)	ASXL3	E528*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000523766	18	31318950	18	33738986	523766	514739	rs1555742232	NC_000018.10:33738985:G:T
NM_004409.4:c.*224_*283CTG[(260_320)]CCGCTGCTG[(10_14)]CTG[(15_23)]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	VCV000523756					523756	514412		
NM_004409.4:c.*224_*283CTG[(200_300)]CCG[1]CTG[(41_59)]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	VCV000523755					523755	514411		
NM_004409.4:c.*224_*283CTG[(180_240)]CCGCTG[(53_67)]CTG[(53_67)]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	no assertion criteria provided	VCV000523754					523754	514410		
NM_000527.4(LDLR):c.1462_1463insC (p.Ile488fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000523735	19	11224314 - 11224315	19	11113638 - 11113639	523735	514385	rs1555805413	NC_000019.10:11113638::C
NM_000527.4(LDLR):c.1461dup (p.Ile488fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000523734	19	11224312 - 11224313	19	11113636 - 11113637	523734	514384	rs1555805409	NC_000019.10:11113636:C:CC
NM_000527.4(LDLR):c.954C>A (p.Cys318Ter)	LDLR	C318*, C150*, C277*, C191*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000523733	19	11221341	19	11110665	523733	514381	rs1323416354	NC_000019.10:11110664:C:A
NM_000527.4(LDLR):c.68-?_1586+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000523721	19	11200292 - 11226769			523721	514373		
NM_019613.4(WDR45B):c.799C>T (p.Gln267Ter)	WDR45B	Q267*	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES	Pathogenic(Last reviewed: May 16, 2018)	no assertion criteria provided	VCV000523671	17	80575179	17	82617303	523671	514319	rs1555647262	NC_000017.11:82617302:G:A
NM_144687.3(NLRP12):c.1223G>A (p.Trp408Ter)	NLRP12	W408*	Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000523656	19	54313690	19	53810436	523656	514304	rs774895361	NC_000019.10:53810435:C:T
NM_144687.3(NLRP12):c.882C>G (p.Asp294Glu)	NLRP12	D294E	Familial cold autoinflammatory syndrome 2	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000523653	19	54314031	19	53810777	523653	514301	rs147080557	NC_000019.10:53810776:G:C
NM_001323289.2(CDKL5):c.751delinsTC (p.Ala251fs)	CDKL5		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000523629	X	18613474	X	18595354	523629	514279	rs1555951141	NC_000023.11:18595353:G:TC
NM_001029896.2(WDR45):c.974-1G>A	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000523624	X	48932572	X	49074913	523624	514280	rs1557083830	NC_000023.11:49074912:C:T
NM_144612.6(LOXHD1):c.3061+1G>A	LOXHD1		not provided|Autosomal recessive non-syndromic sensorineural deafness type DFNB	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523622	18	44140045	18	46560082	523622	514275	rs537227442	NC_000018.10:46560081:C:T
NM_003588.3(CUL4B):c.1458_1459del (p.Val487fs)	CUL4B	V291fs, V474fs, V469fs, V487fs	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000523617	X	119675495 - 119675496	X	120541640 - 120541641	523617	514278	rs1556206910	NC_000023.11:120541639:CTC:C
NM_172107.4(KCNQ2):c.869G>T (p.Gly290Val)	KCNQ2	G290V	Generalized hypotonia|Seizures	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523563	20	62071009	20	63439656	523563	514107	rs397514582	NC_000020.11:63439655:C:A
NM_000495.5(COL4A5):c.3614G>T (p.Gly1205Val)	COL4A5	G1205V	Elevated mean arterial pressure|Microscopic hematuria|Chronic kidney disease	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523547	X	107911558	X	108668328	523547	514117	rs1556446493	NC_000023.11:108668327:G:T
NM_033380.3(COL4A5):c.3588A>G (p.Gly1196=)	COL4A5		Global glomerulosclerosis|Proteinuria|Hearing impairment|Bilateral sensorineural hearing impairment|Nephritis	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523546	X	107910397	X	108667167	523546	514116	rs1556445736	NC_000023.11:108667166:A:G
NM_033380.2(COL4A5):c.1424-2_1430delAGGTGACAA	COL4A5		Proteinuria|Nephropathy|Hematuria|Downslanted palpebral fissures	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523544	X	107838737 - 107838745	X	108595507 - 108595515	523544	514114	rs1556411578	NC_000023.11:108595506:AGGTGACAAAGGTGACA:AGGTGACA
NM_001165927.1(MKS1):c.1136-2A>C	MKS1		Nystagmus|Polydactyly|Muscular hypotonia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523519	17	56285364	17	58208003	523519	514086	rs1488635637	NC_000017.11:58208002:T:G
NM_004975.4(KCNB1):c.935G>A (p.Arg312His)	KCNB1	R312H	Epileptic encephalopathy|Difficulty walking|Generalized hypotonia|Seizures|Delayed speech and language development|Intellectual disability|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523478	20	47991162	20	49374625	523478	514105	rs1555889127	NC_000020.11:49374624:C:T
NM_004586.3(RPS6KA3):c.1522C>T (p.Gln508Ter)	RPS6KA3	Q508*	Macrocephalus|Motor delay|Dolichocephaly|Global developmental delay|Thick vermilion border|Delayed speech and language development|Muscular hypotonia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523475	X	20185787	X	20167669	523475	514129	rs1555928716	NC_000023.11:20167668:G:A
NM_004006.2(DMD):c.93+1G>C	DMD		Elevated serum creatine phosphokinase|Atrial septal defect	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523470	X	33038255	X	33020138	523470	514135	rs886042604	NC_000023.11:33020137:C:G
NM_004006.2(DMD):c.4838G>A (p.Trp1613Ter)	DMD	W1613*, W1609*, W269*, W272*, W1490*, W1605*	Primary dilated cardiomyopathy|Progressive muscle weakness|Calf muscle hypertrophy|Abnormal muscle fiber dystrophin expression	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523468	X	32398634	X	32380517	523468	514133	rs1557315928	NC_000023.11:32380516:C:T
NM_001167.3(XIAP):c.1141C>T (p.Arg381Ter)	XIAP	R381*	not provided|Lymphoproliferative syndrome 2, X-linked|Sepsis|Recurrent infections	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523420	X	123034384	X	123900534	523420	514119	rs1556408009	NC_000023.11:123900533:C:T
NM_000117.2(EMD):c.184dup (p.Ser62fs)	EMD		Muscular Diseases|Flexion contracture|Failure to thrive	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523333	X	153608150 - 153608151	X	154379790 - 154379791	523333	514128	rs1557182317	NC_000023.11:154379790:T:TT
GRCh37/hg19 Xq13.1(chrX:68058460-68059931)	EFNB1		Frontal bossing|Hypertelorism|Facial asymmetry	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523309	X	68058460 - 68059931			523309	514221		
NM_018486.3(HDAC8):c.937C>T (p.Arg313Ter)	HDAC8	R313*, R222*	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000523222	X	71681922	X	72462072	523222	513841	rs1569316085	NC_000023.11:72462071:G:A
NM_001281463.1(SMC1A):c.1048-2A>G	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000523213	X	53438853	X	53411903	523213	513835	rs1569358628	NC_000023.11:53411902:T:C
NM_001281463.1(SMC1A):c.2328dup (p.Arg777fs)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000523209	X	53430523 - 53430524	X	53403591 - 53403592	523209	513834	rs1569356555	NC_000023.11:53403591:TTT:TTTT
NM_001281463.1(SMC1A):c.589del (p.Ala197fs)	SMC1A	A219fs, A197fs	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000523208	X	53440049	X	53413099	523208	513836	rs1569359048	NC_000023.11:53413098:CCC:CC
NM_006517.5(SLC16A2):c.1170+4_1170+7del	SLC16A2		Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523037	X	73745729 - 73745732	X	74525894 - 74525897	523037	513694	rs1555989846	NC_000023.11:74525893:GTGAGTG:GTG
NM_003560.4(PLA2G6):c.1547_1548dup (p.Gly517fs)	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523033	22	38519144 - 38519145	22	38123137 - 38123138	523033	513669	rs1555988204	NC_000022.11:38123137:CGC:CGCGC
NM_000199.5(SGSH):c.578T>C (p.Phe193Ser)	SGSH	F193S	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523016	17	78188056	17	80214257	523016	513648	rs1555621662	NC_000017.11:80214256:A:G
NM_000199.5(SGSH):c.544C>T (p.Arg182Cys)	SGSH	R182C	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523015	17	78188090	17	80214291	523015	513649	rs529855742	NC_000017.11:80214290:G:A
NM_000487.6(ARSA):c.245G>A (p.Arg82Gln)	ARSA	R82Q	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522999	22	51065814	22	50627386	522999	513675	rs769892461	NC_000022.11:50627385:C:T
NM_139202.2(MLC1):c.1087G>A (p.Asp363Asn)	MLC1	D363N	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522910	22	50500059	22	50061630	522910	513673	rs779971307	NC_000022.11:50061629:C:T
NM_000052.7(ATP7A):c.3049G>A (p.Gly1017Arg)	ATP7A	G1017R, G939R	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522907	X	77284879	X	78029382	522907	513695	rs1557236754	NC_000023.11:78029381:G:A
NM_004247.4(EFTUD2):c.1567del (p.Gln523fs)	EFTUD2	Q488fs, Q523fs, Q513fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000522863	17	42940121	17	44862753	522863	513468	rs1555565774	NC_000017.11:44862752:GGG:GG
NM_005994.4(TBX2):c.59G>A (p.Arg20Gln)	TBX2	R20Q	VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION|TBX2-related condition	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	VCV000522826	17	59477596	17	61400235	522826	513470	rs1364709483	NC_000017.11:61400234:G:A
NM_030632.3(ASXL3):c.3039+1G>A	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000522818	18	31320408	18	33740444	522818	513473	rs1555743003	NC_000018.10:33740443:G:A
NM_001195553.2(DCX):c.288C>A (p.Asn96Lys)	DCX	N96K, N177K	Fucosidosis	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522790	X	110653339	X	111410111	522790	513388	rs1556405057	NC_000023.11:111410110:G:T
NM_000202.8(IDS):c.196C>T (p.Gln66Ter)	IDS	Q66*	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522777	X	148585731	X	149504201	522777	513390	rs1557340403	NC_000023.11:149504200:G:A
NM_000271.5(NPC1):c.1171G>T (p.Glu391Ter)	NPC1	E391*	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522757	18	21136362	18	23556398	522757	513372	rs1555637139	NC_000018.10:23556397:C:A
NM_018684.4(ZC4H2):c.375_377AGA[1] (p.Glu128del)	ZC4H2	E105del, E128del	Wieacker Wolff syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522752	X	64139979 - 64139981	X	64920099 - 64920101	522752	513399	rs750367160	NC_000023.11:64920098:TCTTCTTC:TCTTC
NM_003560.4(PLA2G6):c.834G>C (p.Gln278His)	PLA2G6	Q278H, Q52H, Q100H	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522674	22	38531055	22	38135048	522674	513385	rs1556010444	NC_000022.11:38135047:C:G
NM_000709.4(BCKDHA):c.143del (p.Leu48fs)	BCKDHA	L48fs	Maple syrup urine disease	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522650	19	41916576	19	41410671	522650	513375	rs1555765593	NC_000019.10:41410670:T:
NM_002972.4(SBF1):c.4378T>G (p.Leu1460Val)	SBF1	L1460V, L1435V	Charcot-Marie-Tooth disease, type 4B3	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522645	22	50893829	22	50455400	522645	513386	rs1404020990	NC_000022.11:50455399:A:C
NM_000159.4(GCDH):c.541G>C (p.Glu181Gln)	GCDH	E181Q	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522644	19	13006841	19	12896027	522644	513374	rs745852738	NC_000019.10:12896026:G:C
NM_001146702.1(KDM5C):c.3241G>A (p.Val1081Met)	KDM5C	V1081M, V1148M, V1147M	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522629	X	53223917	X	53194735	522629	513397	rs782205045	NC_000023.11:53194734:C:T
NM_004977.2(KCNC3):c.11_12del (p.Ser4fs)	KCNC3	S4fs		Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522615	19	50832328 - 50832329	19	50329071 - 50329072	522615	513379	rs1555781806	NC_000019.10:50329070:TG:
NM_033380.3(COL4A5):c.567_568TA[1] (p.Ile190fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 27, 2017)	no assertion criteria provided	VCV000522497	X	107819160 - 107819161	X	108575930 - 108575931	522497	513151	rs1556405010	NC_000023.11:108575929:TATA:TA
NM_000444.6(PHEX):c.501G>A (p.Trp167Ter)	PHEX	W167*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522470	X	22095658	X	22077540	522470	513164	rs1556020770	NC_000023.11:22077539:G:A
NM_033380.3(COL4A5):c.3314T>A (p.Leu1105Ter)	COL4A5	L1105*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522457	X	107898628	X	108655398	522457	513161	rs1556439394	NC_000023.11:108655397:T:A
NM_000328.3(RPGR):c.983del (p.Gly328fs)	RPGR	G338fs, G327fs, G328fs	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522451	X	38160576	X	38301323	522451	513165	rs1555965107	NC_000023.11:38301322:CC:C
NM_033380.3(COL4A5):c.687del (p.Gly230fs)	COL4A5	G230fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000522445	X	107821345	X	108578115	522445	513152	rs1556405926	NC_000023.11:108578114:AAAAA:AAAA
NM_018848.3(MKKS):c.613A>T (p.Lys205Ter)	MKKS	K205*	Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Sep 18, 2017)	no assertion criteria provided	VCV000522402	20	10393550	20	10412902	522402	513146	rs1555802009	NC_000020.11:10412901:T:A
NM_022835.3(PLEKHG2):c.610C>T (p.Arg204Trp)	PLEKHG2	R204W, R145W	Leukodystrophy and acquired microcephaly with or without dystonia	Pathogenic(Last reviewed: Apr 17, 2018)	no assertion criteria provided	VCV000522394	19	39907506	19	39416866	522394	513006	rs201201843	NC_000019.10:39416865:C:T
NM_030632.3(ASXL3):c.4144C>T (p.Gln1382Ter)	ASXL3	Q1382*	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	no assertion criteria provided	VCV000522179	18	31323956	18	33743992	522179	512784	rs1555744086	NC_000018.10:33743991:C:T
NM_030632.3(ASXL3):c.1448dup (p.Thr484fs)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Apr 12, 2018)	no assertion criteria provided	VCV000522176	18	31318815 - 31318816	18	33738851 - 33738852	522176	512781	rs1555742167	NC_000018.10:33738851:T:TT
NM_139058.3(ARX):c.922G>T (p.Glu308Ter)	ARX	E308*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000522170	X	25031190	X	25013073	522170	512646	rs1556055108	NC_000023.11:25013072:C:A
NM_001347721.2(DYRK1A):c.1008G>A (p.Trp336Ter)	DYRK1A	W345*, W336*, W307*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000522162	21	38865402	21	37493100	522162	512490	rs1555985642	NC_000021.9:37493099:G:A
NM_001429.4(EP300):c.4579_4589del (p.Arg1527fs)	EP300	R1527fs, R1501fs	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000522153	22	41568629 - 41568639	22	41172625 - 41172635	522153	512530	rs1555911580	NC_000022.11:41172624:AGAAAACGAGA:
NM_000284.4(PDHA1):c.832-1G>A	PDHA1		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000522146	X	19375769	X	19357651	522146	512636	rs1555934843	NC_000023.11:19357650:G:A
NM_001008537.3(NEXMIF):c.1518_1522del (p.Arg507fs)	NEXMIF	R507fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000522076	X	73962870 - 73962874	X	74743035 - 74743039	522076	512761	rs1556016642	NC_000023.11:74743034:TCCTCTC:TC
NM_001356.4(DDX3X):c.865-1G>C	DDX3X		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000522074	X	41203491	X	41344238	522074	512672	rs1255183431	NC_000023.11:41344237:G:C
NM_005676.5(RBM10):c.1471_1472GT[1] (p.Ser492fs)	RBM10		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000522056	X	47040940 - 47040941	X	47181541 - 47181542	522056	512686	rs1556779417	NC_000023.11:47181540:TGTGT:TGT
NM_001029896.2(WDR45):c.508C>T (p.Gln170Ter)	WDR45	Q171*, Q170*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000522050	X	48933533	X	49075874	522050	512697	rs1557084120	NC_000023.11:49075873:G:A
NM_004586.3(RPS6KA3):c.712G>T (p.Glu238Ter)	RPS6KA3	E238*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 10, 2017)	criteria provided, single submitter	VCV000522031	X	20206008	X	20187890	522031	512639	rs1555939377	NC_000023.11:20187889:C:A
NM_001282531.3(ADNP):c.2287dup (p.Ser763fs)	ADNP		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000522015	20	49508963 - 49508964	20	50892426 - 50892427	522015	512462	rs1555809919	NC_000020.11:50892426:AA:AAA
NM_004247.4(EFTUD2):c.2352dup (p.Arg785fs)	EFTUD2		Inborn genetic diseases	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000522000	17	42930998 - 42930999	17	44853630 - 44853631	522000	512288	rs1555564175	NC_000017.11:44853630:AA:AAA
NM_001347721.2(DYRK1A):c.1003dup (p.Met335fs)	DYRK1A		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000521993	21	38865396 - 38865397	21	37493094 - 37493095	521993	512489	rs1555985620	NC_000021.9:37493094:A:AA
NM_015125.4(CIC):c.4319dup (p.Asp1440fs)	CIC		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000521984	19	42798447 - 42798448	19	42294295 - 42294296	521984	512425	rs1555773554	NC_000019.10:42294295:A:AA
NM_001193466.2(KANSL1):c.1269del (p.Glu424fs)	KANSL1	E424fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000521981	17	44248241	17	46170875	521981	512296	rs1555574888	NC_000017.11:46170874:GGG:GG
NM_001281463.1(SMC1A):c.3131G>A (p.Arg1044His)	SMC1A	R1044H, R1066H	Congenital muscular hypertrophy-cerebral syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521979	X	53409515	X	53382594	521979	512703	rs1556886034	NC_000023.11:53382593:C:T
NM_015338.5(ASXL1):c.2791del (p.Glu931fs)	ASXL1	E870fs, E931fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000521974	20	31023304	20	32435501	521974	512446	rs1555912296	NC_000020.11:32435500:GGG:GG
NM_002351.4(SH2D1A):c.150C>A (p.Tyr50Ter)	SH2D1A	Y50*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000521960	X	123499623	X	124365773	521960	512584	rs1556620698	NC_000023.11:124365772:C:A
NM_001323289.2(CDKL5):c.2152+1G>A	CDKL5		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000521911	X	18627691	X	18609571	521911	512633	rs1555952732	NC_000023.11:18609570:G:A
NM_021120.4(DLG3):c.631C>T (p.Arg211Ter)	DLG3	R211*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000521892	X	69669637	X	70449787	521892	512732	rs1213060424	NC_000023.11:70449786:C:T
NM_015107.3(PHF8):c.2225dup (p.Ser742fs)	PHF8		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000521817	X	54011564 - 54011565	X	53985131 - 53985132	521817	512714	rs1557099144	NC_000023.11:53985131:C:CC
NM_000054.6(AVPR2):c.382_384del (p.Tyr128del)	AVPR2	Y128del	Nephrogenic diabetes insipidus, X-linked|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521815	X	153171341 - 153171343	X	153905887 - 153905889	521815	512609	rs1557100594	NC_000023.11:153905886:CTAC:C
NM_000166.6(GJB1):c.392_393TG[1] (p.Trp132fs)	GJB1		Inborn genetic diseases|X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521808	X	70443951 - 70443952	X	71224099 - 71224100	521808	512742	rs1555937168	NC_000023.11:71224098:TGTG:TG
NM_001127898.4(CLCN5):c.1374del (p.Phe459fs)	CLCN5	F389fs, F409fs, F459fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000521801	X	49851344	X	50086687	521801	512699	rs1557194018	NC_000023.11:50086686:G:
NM_005650.3(TCF20):c.2224C>T (p.Arg742Ter)	TCF20	R742*	DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES|Neurodevelopmental abnormality|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521787	22	42609088	22	42213082	521787	512539	rs1555926209	NC_000022.11:42213081:G:A
NM_001282531.3(ADNP):c.1337G>A (p.Trp446Ter)	ADNP	W446*	Inborn genetic diseases	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000521765	20	49509914	20	50893377	521765	512463	rs1555810308	NC_000020.11:50893376:C:T
NM_001356.4(DDX3X):c.3G>C (p.Met1Ile)	DDX3X	M1I	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000521712	X	41193508	X	41334255	521712	512667	rs1555950665	NC_000023.11:41334254:G:C
NM_145045.5(CCDC151):c.1060C>T (p.Gln354Ter)	CCDC151	Q354*, Q300*, Q294*	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000521708	19	11534602	19	11423933	521708	512378	rs1555721837	NC_000019.10:11423932:G:A
NM_001193466.2(KANSL1):c.1042C>T (p.Arg348Ter)	KANSL1	R348*	Inborn genetic diseases|Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521688	17	44248468	17	46171102	521688	512297	rs1427624649	NC_000017.11:46171101:G:A
NM_001356.4(DDX3X):c.284+1G>C	DDX3X		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000521636	X	41200870	X	41341617	521636	512668	rs1555952710	NC_000023.11:41341616:G:C
NM_017613.4(DONSON):c.1254dup (p.Lys419Ter)	DONSON		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000521608	21	34953703 - 34953704	21	33581397 - 33581398	521608	512484	rs765112107	NC_000021.9:33581397:A:AA
NM_138927.3(SON):c.4774_4777del (p.Thr1592fs)	SON	T1592fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000521599	21	34926311 - 34926314	21	33554005 - 33554008	521599	512481	rs1555899177	NC_000021.9:33554004:ACTC:
NM_016032.4(ZDHHC9):c.679del (p.Val226_Leu227insTer)	ZDHHC9		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000521595	X	128946792	X	129812816	521595	512587	rs1556004813	NC_000023.11:129812815:G:
NM_000273.3(GPR143):c.768-1G>A	GPR143		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000521594	X	9709496	X	9741456	521594	512778	rs1555914303	NC_000023.11:9741455:C:T
NM_001127221.1(CACNA1A):c.2788_2789insT (p.His930fs)	CACNA1A		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000521593	19	13409661 - 13409662	19	13298847 - 13298848	521593	512391	rs1555756091	NC_000019.10:13298847::A
NM_006031.6(PCNT):c.4702G>T (p.Glu1568Ter)	PCNT	E1568*, E1450*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000521591	21	47819621	21	46399707	521591	512503	rs1217566598	NC_000021.9:46399706:G:T
NM_006031.6(PCNT):c.1507C>T (p.Gln503Ter)	PCNT	Q503*, Q385*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000521590	21	47773068	21	46353154	521590	512502	rs1555954069	NC_000021.9:46353153:C:T
NM_006907.4(PYCR1):c.138+1G>A	PYCR1		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000521586	17	79893998	17	81936122	521586	512339	rs755867227	NC_000017.11:81936121:C:T
NM_001356.4(DDX3X):c.976C>T (p.Arg326Cys)	DDX3X	R326C, R140C, R310C	Mental retardation, X-linked 102|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521573	X	41203603	X	41344350	521573	512673	rs1555953548	NC_000023.11:41344349:C:T
NM_004586.3(RPS6KA3):c.1699C>T (p.Gln567Ter)	RPS6KA3	Q567*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000521533	X	20183082	X	20164964	521533	512637	rs1555927554	NC_000023.11:20164963:G:A
NM_014727.2(KMT2B):c.7759C>T (p.Arg2587Ter)	KMT2B	R2587*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000521527	19	36228979	19	35738078	521527	512407	rs1555734923	NC_000019.10:35738077:C:T
NM_000216.4(ANOS1):c.90_100dup (p.Arg34fs)	ANOS1		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000521518	X	8699977 - 8699978	X	8731936 - 8731937	521518	512777	rs1555904596	NC_000023.11:8731936:GCCGCGCAGCAGCCGCGC:GCCGCGCAGCAGCCGCGCAGCAGCCGCGC
NM_022095.4(ZNF335):c.757dup (p.Arg253fs)	ZNF335		Inborn genetic diseases	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000521497	20	44596429 - 44596430	20	45967790 - 45967791	521497	512455	rs1555851216	NC_000020.11:45967790:GG:GGG
NM_004859.4(CLTC):c.4420G>T (p.Glu1474Ter)	CLTC	E1474*, E1478*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000521468	17	57761332	17	59683971	521468	512306	rs1555607504	NC_000017.11:59683970:G:T
NM_015338.5(ASXL1):c.2763_2770delinsCAA (p.Val922fs)	ASXL1		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000521462	20	31023278 - 31023285	20	32435475 - 32435482	521462	512445	rs1555912285	NC_000020.11:32435474:TGTTGAGC:CAA
NM_001347721.2(DYRK1A):c.1275dup (p.Gly426fs)	DYRK1A		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000521452	21	38877647 - 38877648	21	37505344 - 37505345	521452	512492	rs1555990816	NC_000021.9:37505344:T:TT
NM_001015877.2(PHF6):c.820C>T (p.Arg274Ter)	PHF6	R274*, R275*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000521446	X	133549136	X	134415106	521446	512591	rs1556019107	NC_000023.11:134415105:C:T
NM_000489.5(ATRX):c.6003G>A (p.Trp2001Ter)	ATRX	W2001*, W1963*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000521442	X	76849273	X	77593803	521442	512765	rs1557082399	NC_000023.11:77593802:C:T
NM_005650.3(TCF20):c.2685del (p.Arg896fs)	TCF20	R896fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000521438	22	42608627	22	42212621	521438	512538	rs1555925903	NC_000022.11:42212620:CCC:CC
NM_015338.5(ASXL1):c.4127dup (p.Pro1377fs)	ASXL1		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000521420	20	31024636 - 31024637	20	32436833 - 32436834	521420	512448	rs1555912897	NC_000020.11:32436833:GGGGGG:GGGGGGG
NM_138927.3(SON):c.5495_5497del (p.Ser1832_Glu1833delinsTer)	SON		Inborn genetic diseases	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000521396	21	34927032 - 34927034	21	33554726 - 33554728	521396	512483	rs1555899379	NC_000021.9:33554725:CTG:
NM_000074.2(CD40LG):c.559del (p.Ala187fs)	CD40LG	A187fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000521393	X	135741347	X	136659188	521393	512593	rs1556143529	NC_000023.11:136659187:G:
NM_014727.2(KMT2B):c.2425C>T (p.Gln809Ter)	KMT2B	Q809*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000521392	19	36212674	19	35721772	521392	512402	rs1555729045	NC_000019.10:35721771:C:T
NM_001347721.2(DYRK1A):c.803del (p.Ala268fs)	DYRK1A	A277fs, A268fs, A239fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000521368	21	38862642	21	37490340	521368	512487	rs1555984304	NC_000021.9:37490339:C:
NM_001184880.2(PCDH19):c.1006dup (p.Val336fs)	PCDH19		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000521360	X	99662589 - 99662590	X	100407591 - 100407592	521360	512551	rs1555985372	NC_000023.11:100407591:C:CC
NM_002025.4(AFF2):c.76A>T (p.Lys26Ter)	AFF2	K26*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000521344	X	147733548	X	148652027	521344	512599	rs1557256416	NC_000023.11:148652026:A:T
NM_005559.4(LAMA1):c.3397C>T (p.Arg1133Ter)	LAMA1	R1133*	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000521310	18	7012104	18	7012105	521310	512371	rs767889331	NC_000018.10:7012104:G:A
NM_005650.3(TCF20):c.4368del (p.Gly1457fs)	TCF20	G1457fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000521280	22	42606944	22	42210938	521280	512537	rs1555924435	NC_000022.11:42210937:GG:G
NM_176787.5(PIGN):c.1940del (p.Lys647fs)	PIGN	K647fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000521276	18	59770055	18	62102822	521276	512370	rs1555682938	NC_000018.10:62102821:TTT:TT
NM_001029871.4(RSPO4):c.79+1G>A	RSPO4		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000521270	20	982728	20	1002085	521270	512439	rs775644973	NC_000020.11:1002084:C:T
NM_001356.4(DDX3X):c.616G>A (p.Val206Met)	DDX3X	V206M, V20M, V190M	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000521268	X	41202541	X	41343288	521268	512670	rs1555953166	NC_000023.11:41343287:G:A
NM_030632.3(ASXL3):c.1354del (p.Glu452fs)	ASXL3	E452fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000521261	18	31318721	18	33738757	521261	512349	rs1555742087	NC_000018.10:33738756:GG:G
NM_018848.3(MKKS):c.845dup (p.Leu283fs)	MKKS		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000521251	20	10393317 - 10393318	20	10412669 - 10412670	521251	512440	rs1555801973	NC_000020.11:10412669:T:TT
NM_021120.4(DLG3):c.351T>A (p.Tyr117Ter)	DLG3	Y117*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000521239	X	69665402	X	70445552	521239	512731	rs1241142887	NC_000023.11:70445551:T:A
NM_080647.1(TBX1):c.909-2A>G	TBX1		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000521234	22	19753423	22	19765900	521234	512508	rs1555896474	NC_000022.11:19765899:A:G
NM_001347721.2(DYRK1A):c.531_532dup (p.Ile178fs)	DYRK1A		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000521202	21	38858809 - 38858810	21	37486507 - 37486508	521202	512485	rs1555982591	NC_000021.9:37486507:CA:CACA
NM_006517.5(SLC16A2):c.644C>A (p.Pro215Gln)	SLC16A2	P215Q	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000521200	X	73744262	X	74524427	521200	512755	rs759410438	NC_000023.11:74524426:C:A
NM_015338.5(ASXL1):c.3111G>A (p.Trp1037Ter)	ASXL1	W1037*, W976*	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000521186	20	31023626	20	32435823	521186	512447	rs1555912419	NC_000020.11:32435822:G:A
NM_018486.2(HDAC8):c.911delG (p.Gly304Glufs)	HDAC8		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000521181	X	71681948	X	72462098	521181	512749	rs1555991965	NC_000023.11:72462097:CC:C
NM_001282531.3(ADNP):c.2287del (p.Ser763fs)	ADNP	S763fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000521175	20	49508964	20	50892427	521175	512461	rs1555809919	NC_000020.11:50892426:AA:A
NM_004187.4(KDM5C):c.2770C>T (p.Gln924Ter)	KDM5C	Q924*, Q923*, Q857*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000521151	X	53226079	X	53196897	521151	512700	rs1556837420	NC_000023.11:53196896:G:A
NM_001356.4(DDX3X):c.1601dup (p.Val535fs)	DDX3X		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000521145	X	41205860 - 41205861	X	41346607 - 41346608	521145	512675	rs1555954287	NC_000023.11:41346607:G:GG
NM_014727.2(KMT2B):c.3400C>T (p.Gln1134Ter)	KMT2B	Q1134*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000521143	19	36215603	19	35724702	521143	512403	rs1555730069	NC_000019.10:35724701:C:T
NM_004247.4(EFTUD2):c.2562-1G>A	EFTUD2		Inborn genetic diseases	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000521130	17	42929931	17	44852563	521130	512287	rs1555564006	NC_000017.11:44852562:C:T
NM_001281463.1(SMC1A):c.2263T>C (p.Phe755Leu)	SMC1A	F755L, F777L	Inborn genetic diseases	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000521126	X	53430589	X	53403657	521126	512704	rs1556889236	NC_000023.11:53403656:A:G
NM_000284.4(PDHA1):c.735A>C (p.Arg245Ser)	PDHA1	R245S, R283S, R252S, R214S	Inborn genetic diseases	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000521121	X	19373598	X	19355480	521121	512635	rs1555934376	NC_000023.11:19355479:A:C
NM_003588.3(CUL4B):c.1219G>T (p.Glu407Ter)	CUL4B	E407*, E211*, E394*, E389*	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000521119	X	119677977	X	120544122	521119	512572	rs1556213001	NC_000023.11:120544121:C:A
NM_000276.4(OCRL):c.1621C>T (p.Arg541Ter)	OCRL	R541*, R542*	Inborn genetic diseases|Lowe syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000521093	X	128709135	X	129575158	521093	512586	rs1182741031	NC_000023.11:129575157:C:T
NM_021140.3(KDM6A):c.2075_2076del (p.Gln692fs)	KDM6A	Q613fs, Q744fs, Q396fs, Q692fs, Q699fs, Q647fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000521092	X	44928975 - 44928976	X	45069730 - 45069731	521092	512684	rs1556328723	NC_000023.11:45069729:AG:
NM_003688.3(CASK):c.845dup (p.Tyr282Ter)	CASK		Inborn genetic diseases	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000521079	X	41495900 - 41495901	X	41636647 - 41636648	521079	512678	rs1556004104	NC_000023.11:41636647:T:TT
NM_015338.5(ASXL1):c.1446dup (p.Val483fs)	ASXL1		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000521071	20	31021446 - 31021447	20	32433643 - 32433644	521071	512444	rs1555911515	NC_000020.11:32433643:A:AA
NM_004247.4(EFTUD2):c.2595dup (p.Ser866fs)	EFTUD2		Inborn genetic diseases	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000521038	17	42929896 - 42929897	17	44852528 - 44852529	521038	512286	rs1555563998	NC_000017.11:44852528:G:GG
NM_004429.4(EFNB1):c.142A>T (p.Lys48Ter)	EFNB1	K48*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	VCV000521026	X	68058473	X	68838630	521026	512729	rs1556105875	NC_000023.11:68838629:A:T
NM_000394.4(CRYAA):c.346C>A (p.Arg116Ser)	CRYAA	R116S, R79S	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 20, 2016)	criteria provided, single submitter	VCV000521018	21	44592214	21	43172104	521018	512494	rs74315439	NC_000021.9:43172103:C:A
NM_001123383.1(BCOR):c.2428C>T (p.Arg810Ter)	BCOR	R810*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000521011	X	39932171	X	40072918	521011	512657	rs1555918056	NC_000023.11:40072917:G:A
NM_002501.4(NFIX):c.1180del (p.His394fs)	NFIX	H394fs, H402fs, H347fs, H353fs, H386fs, H393fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000521006	19	13192594	19	13081780	521006	512384	rs1555707363	NC_000019.10:13081779:CC:C
NM_001282531.3(ADNP):c.2499del (p.Val834fs)	ADNP	V834fs	Inborn genetic diseases	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000520984	20	49508752	20	50892215	520984	512460	rs1555809836	NC_000020.11:50892214:TTT:TT
NM_001083962.2(TCF4):c.680G>A (p.Trp227Ter)	TCF4	W227*, W329*, W67*, W11*, W156*, W185*, W202*, W225*, W97*, W203*, W226*, W233*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000520978	18	52942959	18	55275728	520978	512367	rs1555797231	NC_000018.10:55275727:C:T
NM_000152.5(GAA):c.1692del (p.Leu565fs)	GAA	L565fs	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	VCV000520974	17	78085835	17	80112036	520974	512334	rs1555601234	NC_000017.11:80112035:TTT:TT
NM_006517.5(SLC16A2):c.383T>C (p.Leu128Pro)	SLC16A2	L128P	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000520969	X	73641855	X	74422020	520969	512753	rs1555979604	NC_000023.11:74422019:T:C
NM_198270.4(NHS):c.3182del (p.Pro1061fs)	NHS	P1082fs, P905fs, P1061fs, P884fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000520960	X	17745470	X	17727350	520960	512630	rs1556039406	NC_000023.11:17727349:CC:C
NM_001429.4(EP300):c.1508dup (p.Met503fs)	EP300		Inborn genetic diseases	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000520954	22	41527616 - 41527617	22	41131612 - 41131613	520954	512528	rs1555907749	NC_000022.11:41131612:T:TT
NM_198270.4(NHS):c.1168C>T (p.Gln390Ter)	NHS	Q390*, Q411*, Q213*, Q234*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000520943	X	17742541	X	17724421	520943	512629	rs1556038028	NC_000023.11:17724420:C:T
NM_018486.3(HDAC8):c.755_761del (p.Tyr252fs)	HDAC8	Y161fs, Y252fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000520939	X	71684558 - 71684564	X	72464708 - 72464714	520939	512750	rs1555993215	NC_000023.11:72464707:GCTTGGT:
NM_018684.4(ZC4H2):c.450dup (p.Ile151fs)	ZC4H2		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000520928	X	64139032 - 64139033	X	64919152 - 64919153	520928	512724	rs1555933851	NC_000023.11:64919152:GGGGGG:GGGGGGG
NM_001083962.2(TCF4):c.1304C>G (p.Ser435Ter)	TCF4	S435*, S274*, S411*, S432*, S219*, S305*, S364*, S393*, S410*, S412*, S275*, S434*, S441*, S537*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 15, 2016)	criteria provided, single submitter	VCV000520926	18	52921774	18	55254543	520926	512364	rs1555763998	NC_000018.10:55254542:G:C
NM_001127221.1(CACNA1A):c.6371del (p.Arg2124fs)	CACNA1A	R2123fs, R2124fs, R2126fs, R2129fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000520922	19	13320284	19	13209470	520922	512387	rs1555730902	NC_000019.10:13209469:C:
NM_002764.3(PRPS1):c.307-2A>G	PRPS1		Inborn genetic diseases	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000520913	X	106884130	X	107640900	520913	512559	rs1556299881	NC_000023.11:107640899:A:G
NM_003588.3(CUL4B):c.775C>T (p.Gln259Ter)	CUL4B	Q259*, Q63*, Q241*, Q246*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000520903	X	119681046	X	120547191	520903	512573	rs1556220623	NC_000023.11:120547190:G:A
NM_021140.3(KDM6A):c.1015C>T (p.Gln339Ter)	KDM6A	Q339*, Q88*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	VCV000520881	X	44918532	X	45059287	520881	512681	rs1556308480	NC_000023.11:45059286:C:T
NM_001206985.2(METTL23):c.-52dup	METTL23		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 25, 2015)	criteria provided, single submitter	VCV000520871	17	74729124 - 74729125	17	76733042 - 76733043	520871	512324	rs1462161137	NC_000017.11:76733042:A:AA
NM_001281463.1(SMC1A):c.1543del (p.Val515fs)	SMC1A	V515fs, V537fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	VCV000520863	X	53432825	X	53405893	520863	512707	rs1556889640	NC_000023.11:53405892:CC:C
NM_005660.3(SLC35A2):c.795del (p.Phe265fs)	SLC35A2	F204fs, F293fs, F265fs, F278fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	VCV000520858	X	48762391	X	48905114	520858	512696	rs1557042808	NC_000023.11:48905113:AAAAAA:AAAAA
NM_001347721.2(DYRK1A):c.658_659del (p.Met220fs)	DYRK1A	M220fs, M229fs, M191fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	VCV000520853	21	38862496 - 38862497	21	37490194 - 37490195	520853	512486	rs1555984102	NC_000021.9:37490193:TAT:T
NM_001347721.2(DYRK1A):c.1239del (p.Lys413fs)	DYRK1A	K413fs, K384fs, K422fs	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000520852	21	38877610	21	37505307	520852	512491	rs1555990751	NC_000021.9:37505306:AAA:AA
NM_001323289.2(CDKL5):c.1107_1120del (p.Gly369_Asn370insTer)	CDKL5		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000520850	X	18622150 - 18622163	X	18604030 - 18604043	520850	512632	rs1555951954	NC_000023.11:18604029:GAAACCTTGCTGGAG:G
NM_001083962.2(TCF4):c.931G>T (p.Gly311Ter)	TCF4	G311*, G181*, G413*, G151*, G269*, G310*, G95*, G240*, G286*, G309*, G317*, G287*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 20, 2015)	criteria provided, single submitter	VCV000520842	18	52928756	18	55261525	520842	512366	rs1555778204	NC_000018.10:55261524:C:A
NM_001127221.1(CACNA1A):c.2809C>T (p.Gln937Ter)	CACNA1A	Q937*, Q936*, Q940*	Inborn genetic diseases	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000520831	19	13409641	19	13298827	520831	512390	rs1318353774	NC_000019.10:13298826:G:A
NM_015559.3(SETBP1):c.1408del (p.Lys469_Met470insTer)	SETBP1		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	VCV000520830	18	42530710	18	44950745	520830	512352	rs1555706391	NC_000018.10:44950744:AAAA:AAA
NM_000528.4(MAN2B1):c.2212del (p.Glu738fs)	MAN2B1	E737fs, E738fs	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	VCV000520823	19	12760782	19	12649968	520823	512380	rs1555706706	NC_000019.10:12649967:CC:C
NM_001083961.2(WDR62):c.2575C>T (p.Gln859Ter)	WDR62	Q859*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	VCV000520801	19	36590355	19	36099453	520801	512408	rs1006898944	NC_000019.10:36099452:C:T
NM_001281463.1(SMC1A):c.1924del (p.Arg642fs)	SMC1A	R642fs, R664fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000520787	X	53432245	X	53405313	520787	512706	rs1556889534	NC_000023.11:53405312:G:
NM_001083962.2(TCF4):c.673del (p.Asp225fs)	TCF4	D65fs, D9fs, D154fs, D200fs, D201fs, D225fs, D327fs, D231fs, D183fs, D223fs, D224fs, D95fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000520783	18	52942966	18	55275735	520783	512368	rs1555797248	NC_000018.10:55275734:C:
NM_001429.4(EP300):c.272del (p.Pro91fs)	EP300	P91fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, single submitter	VCV000520753	22	41513365	22	41117361	520753	512525	rs1555905780	NC_000022.11:41117360:CCCC:CCC
NM_005650.3(TCF20):c.5069dup (p.Pro1692fs)	TCF20		Inborn genetic diseases	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000520742	22	42606242 - 42606243	22	42210236 - 42210237	520742	512536	rs1555923822	NC_000022.11:42210236:T:TT
NM_001429.4(EP300):c.1066C>T (p.Gln356Ter)	EP300	Q356*	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000520726	22	41523650	22	41127646	520726	512527	rs1555907278	NC_000022.11:41127645:C:T
NM_014727.2(KMT2B):c.6245_6266dup (p.Val2090fs)	KMT2B		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000520719	19	36223683 - 36223684	19	35732782 - 35732783	520719	512406	rs1555732987	NC_000019.10:35732782:TCGGGGCCAGGGCACGCCTCCTTCGGGGCCAGG:TCGGGGCCAGGGCACGCCTCCTTCGGGGCCAGGGCACGCCTCCTTCGGGGCCAGG
NM_006494.4(ERF):c.785del (p.Pro262fs)	ERF	P262fs, P187fs	Inborn genetic diseases	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000520696	19	42753479	19	42249327	520696	512423	rs1555750721	NC_000019.10:42249326:GGGGG:GGGG
NM_001184880.2(PCDH19):c.1018A>T (p.Asn340Tyr)	PCDH19	N340Y	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 5, 2015)	criteria provided, single submitter	VCV000520677	X	99662578	X	100407580	520677	512550	rs1555985368	NC_000023.11:100407579:T:A
NM_172107.4(KCNQ2):c.2114del (p.Pro705fs)	KCNQ2	P674fs, P705fs, P687fs, P677fs	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000520670	20	62038502	20	63407149	520670	512473	rs1555850868	NC_000020.11:63407148:GGGGG:GGGG
NM_006517.5(SLC16A2):c.357_358CT[1] (p.Ser120fs)	SLC16A2		Inborn genetic diseases|Spastic paraplegia	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520656	X	73641829 - 73641830	X	74421994 - 74421995	520656	512752	rs1555979596	NC_000023.11:74421993:CTCT:CT
NM_001614.5(ACTG1):c.1004G>A (p.Arg335His)	ACTG1	R335H	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000520655	17	79477840	17	81510814	520655	512336	rs1555666392	NC_000017.11:81510813:C:T
NM_001127221.1(CACNA1A):c.1915C>T (p.Gln639Ter)	CACNA1A	Q639*, Q638*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000520652	19	13418935	19	13308121	520652	512392	rs1555758842	NC_000019.10:13308120:G:A
NM_001206985.2(METTL23):c.-24del	METTL23	E56fs, E60fs	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000520640	17	74729152	17	76733070	520640	512325	rs1382444181	NC_000017.11:76733069:GG:G
NM_004463.3(FGD1):c.997C>T (p.Gln333Ter)	FGD1	Q333*	Inborn genetic diseases	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000520638	X	54496553	X	54470120	520638	512719	rs1557189592	NC_000023.11:54470119:G:A
NM_003688.3(CASK):c.2065A>T (p.Lys689Ter)	CASK	K689*, K660*, K666*	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 12, 2015)	criteria provided, single submitter	VCV000520620	X	41402034	X	41542781	520620	512676	rs1555977248	NC_000023.11:41542780:T:A
NM_033380.3(COL4A5):c.2958_2975del (p.Asp989_Gly994del)	COL4A5		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 26, 2014)	criteria provided, single submitter	VCV000520604	X	107867506 - 107867523	X	108624276 - 108624293	520604	512561	rs1556421106	NC_000023.11:108624275:GCCTGGAGACCCAGGGCA:
NM_015338.5(ASXL1):c.1117C>T (p.Gln373Ter)	ASXL1	Q373*, Q312*	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 5, 2015)	criteria provided, single submitter	VCV000520587	20	31021118	20	32433315	520587	512443	rs1427299519	NC_000020.11:32433314:C:T
NM_001083962.2(TCF4):c.1267_1268del (p.Gly423fs)	TCF4	G263fs, G293fs, G398fs, G423fs, G429fs, G420fs, G207fs, G422fs, G525fs, G262fs, G352fs, G381fs, G399fs, G400fs	Inborn genetic diseases	Pathogenic(Last reviewed: Aug 6, 2014)	criteria provided, single submitter	VCV000520568	18	52921810 - 52921811	18	55254579 - 55254580	520568	512365	rs1555764170	NC_000018.10:55254578:CC:
NM_182641.4(BPTF):c.2598dup (p.Glu867fs)	BPTF		Inborn genetic diseases	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000520550	17	65899950 - 65899951	17	67903834 - 67903835	520550	512314	rs753044214	NC_000017.11:67903834:AAAAAAAAA:AAAAAAAAAA
NM_001356.4(DDX3X):c.1276_1279del (p.Asp426fs)	DDX3X	D410fs, D426fs, D240fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000520543	X	41204760 - 41204763	X	41345507 - 41345510	520543	512674	rs1555953882	NC_000023.11:41345506:CAGACA:CA
NM_004187.4(KDM5C):c.595C>T (p.Gln199Ter)	KDM5C	Q199*, Q132*, Q198*	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000520414	X	53246387	X	53217205	520414	511020	rs1556852362	NC_000023.11:53217204:G:A
NM_172107.4(KCNQ2):c.2378_2391del (p.Val793fs)	KCNQ2	V793fs, V765fs, V775fs, V762fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000520409	20	62038225 - 62038238	20	63406872 - 63406885	520409	511018	rs1555850403	NC_000020.11:63406871:CTCCTCGTGGTCCAC:C
NM_013995.2(LAMP2):c.64+4delinsGT	LAMP2		Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000520366	X	119602957	X	120469102	520366	510896	rs1556123906	NC_000023.11:120469101:T:AC
NM_005359.5(SMAD4):c.1308+1G>A	SMAD4		Juvenile polyposis syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520190	18	48593558	18	51067188	520190	510796	rs587781618	NC_000018.10:51067187:G:A
NM_000116.5(TAZ):c.145del (p.Val49fs)	TAZ	V67fs, V49fs	Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000518893	X	153640457	X	154412120	518893	510930	rs1557191074	NC_000023.11:154412119:GG:G
NM_001042472.3(ABHD12):c.249C>G (p.Tyr83Ter)	ABHD12	Y83*	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic	criteria provided, single submitter	VCV000518455	20	25319930	20	25339294	518455	509045	rs1303044966	NC_000020.11:25339293:G:C
NM_000199.5(SGSH):c.364G>A (p.Gly122Arg)	SGSH	G122R	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000518269	17	78188556	17	80214757	518269	508894	rs761607612	NC_000017.11:80214756:C:T
NM_000199.5(SGSH):c.1080del (p.Val361fs)	SGSH	V361fs	not provided|Mucopolysaccharidosis, MPS-III-A|Mucopolysaccharidosis	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000518268	17	78184680	17	80210881	518268	508893	rs770947426	NC_000017.11:80210880:GG:G
NM_000709.4(BCKDHA):c.511del (p.Leu171fs)	BCKDHA	L171fs	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000517592	19	41925062	19	41419157	517592	497317	rs762084007	NC_000019.10:41419156:CCCCC:CCCC
NM_024022.3(TMPRSS3):c.579dup (p.Cys194fs)	TMPRSS3		Rare genetic deafness	Pathogenic(Last reviewed: May 25, 2010)	criteria provided, single submitter	VCV000517148	21	43804115 - 43804116	21	42384006 - 42384007	517148	497344	rs397517376	NC_000021.9:42384006:T:TT
NM_000398.7(CYB5R3):c.757G>A (p.Val253Met)	CYB5R3	V253M, V286M, V230M	Hereditary methemoglobinemia	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000505719	22	43015928	22	42619922	505719	497548	rs144071404	NC_000022.11:42619921:C:T
NM_000022.4(ADA):c.532del (p.Val177_Val178insTer)	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000505549	20	43252917	20	44624276	505549	497336	rs886041796	NC_000020.11:44624275:CC:C
NM_144612.6(LOXHD1):c.3148G>T (p.Glu1050Ter)	LOXHD1	E1050*	Rare genetic deafness	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000505330	18	44139479	18	46559516	505330	497581	rs1555679863	NC_000018.10:46559515:C:A
NM_004006.2(DMD):c.(?_32)_(649_?)del	DMD		Muscular dystrophy	Pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000505317	X	32827610 - 33038317	X	32809493 - 33020200	505317	497353		
NM_020964.3(EPG5):c.3698G>A (p.Trp1233Ter)	EPG5	W1233*	Vici syndrome	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000505026	18	43493789	18	45913824	505026	497296	rs1555673917	NC_000018.10:45913823:C:T
NM_000271.5(NPC1):c.3614C>G (p.Thr1205Arg)	NPC1	T1205R	Niemann-Pick disease type C1|Niemann-Pick disease, type C	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000505018	18	21113459	18	23533495	505018	497495	rs758902805	NC_000018.10:23533494:G:C
NM_006031.6(PCNT):c.7126C>T (p.Gln2376Ter)	PCNT	Q2376*, Q2258*		Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	VCV000504880	21	47841985	21	46422071	504880	497345	rs1555993038	NC_000021.9:46422070:C:T
NM_014297.5(ETHE1):c.604dup (p.Val202fs)	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504504	19	44012203 - 44012204	19	43508051 - 43508052	504504	496128	rs1555761934	NC_000019.10:43508051:C:CC
NM_014297.5(ETHE1):c.592dup (p.His198fs)	ETHE1		Ethylmalonic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000504503	19	44012929 - 44012930	19	43508777 - 43508778	504503	496127	rs1555762070	NC_000019.10:43508777:GG:GGG
NM_014297.5(ETHE1):c.505+1G>T	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504502	19	44015588	19	43511436	504502	496126	rs935855792	NC_000019.10:43511435:C:A
NM_014297.5(ETHE1):c.491C>A (p.Thr164Lys)	ETHE1	T164K, T153K, T41K, T66K	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504501	19	44015603	19	43511451	504501	496125	rs1268640442	NC_000019.10:43511450:G:T
NM_014297.5(ETHE1):c.487C>G (p.Arg163Gly)	ETHE1	R163G, R65G, R152G, R40G	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504500	19	44015607	19	43511455	504500	496124	rs28940289	NC_000019.10:43511454:G:C
NM_014297.5(ETHE1):c.455C>T (p.Thr152Ile)	ETHE1	T152I, T141I, T29I, T54I	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504499	19	44015639	19	43511487	504499	496123	rs1317633085	NC_000019.10:43511486:G:A
NM_014297.5(ETHE1):c.440_450del (p.His147fs)	ETHE1	H136fs, H147fs, H24fs, H49fs	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504498	19	44015644 - 44015654	19	43511492 - 43511502	504498	496122	rs1555762753	NC_000019.10:43511491:GGCCATGCTGTGG:GG
NM_014297.5(ETHE1):c.230del (p.Asn77fs)	ETHE1	N77fs	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504497	19	44030498	19	43526346	504497	496121	rs1555765481	NC_000019.10:43526345:TT:T
NM_014297.5(ETHE1):c.222_223insA (p.Ala75fs)	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504496	19	44030670 - 44030671	19	43526518 - 43526519	504496	496120	rs1555765528	NC_000019.10:43526518::T
NM_014297.5(ETHE1):c.187C>T (p.Gln63Ter)	ETHE1	Q63*	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504495	19	44030706	19	43526554	504495	496119	rs368778231	NC_000019.10:43526553:G:A
NM_014297.5(ETHE1):c.164T>C (p.Leu55Pro)	ETHE1	L55P	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504494	19	44030729	19	43526577	504494	496118	rs182983506	NC_000019.10:43526576:A:G
NM_014297.5(ETHE1):c.127_128AG[2] (p.Glu44fs)	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000504493	19	44030761 - 44030762	19	43526609 - 43526610	504493	496117	rs761827730	NC_000019.10:43526608:CTCTCT:CTCT
NM_014297.5(ETHE1):c.113A>G (p.Tyr38Cys)	ETHE1	Y38C	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504492	19	44030780	19	43526628	504492	496116	rs1555765564	NC_000019.10:43526627:T:C
NM_014297.5(ETHE1):c.66del (p.Ile23fs)	ETHE1	I23fs	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504491	19	44031264	19	43527112	504491	496115	rs1555765689	NC_000019.10:43527111:GGGGG:GGGG
NM_014297.5(ETHE1):c.34C>T (p.Gln12Ter)	ETHE1	Q12*	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504490	19	44031296	19	43527144	504490	496114	rs1555765701	NC_000019.10:43527143:G:A
NM_014297.4(ETHE1):c.-67-16_-67-12delCGCCC	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	VCV000504489	19	44031408 - 44031412	19	43527256 - 43527260	504489	496113	rs1211555765	
NM_007059.4(KPTN):c.665dup (p.Ser223fs)	KPTN		Mental retardation, autosomal recessive 41	Pathogenic(Last reviewed: Mar 30, 2018)	no assertion criteria provided	VCV000504486	19	47983598 - 47983599	19	47480341 - 47480342	504486	496111	rs1295123083	NC_000019.10:47480341:T:TT
NM_000208.4(INSR):c.3003_3012delinsGGAAG (p.Ser1001fs)	INSR		Leprechaunism syndrome	Pathogenic(Last reviewed: Mar 6, 2017)	no assertion criteria provided	VCV000504475	19	7126596 - 7126605	19	7126585 - 7126594	504475	495915	rs1555735951	NC_000019.10:7126584:ATCACTGGCA:CTTCC
NM_000208.4(INSR):c.167T>C (p.Ile56Thr)	INSR	I56T	Leprechaunism syndrome	Pathogenic(Last reviewed: Mar 6, 2017)	no assertion criteria provided	VCV000504474	19	7267841	19	7267830	504474	495914	rs1555689937	NC_000019.10:7267829:A:G
NM_004187.4(KDM5C):c.1773_1774AG[1] (p.Glu592fs)	KDM5C		not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000504453	X	53231126 - 53231127	X	53201944 - 53201945	504453	495829	rs1556842268	NC_000023.11:53201943:CTCTC:CTC
NM_001022.4(RPS19):c.128_129del (p.Lys43fs)	RPS19	K43fs	not provided	Pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000504400	19	42365236 - 42365237	19	41861167 - 41861168	504400	495866	rs1555839161	NC_000019.10:41861166:AAA:A
NM_000116.5(TAZ):c.639G>A (p.Trp213Ter)	TAZ	W213*, W199*, W217*, W169*, W183*	not provided	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000504385	X	153648426	X	154420087	504385	495811	rs1557194077	NC_000023.11:154420086:G:A
NM_001039591.3(USP9X):c.2224C>T (p.Arg742Ter)	USP9X	R742*	not provided	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000504343	X	41025363	X	41166110	504343	495897	rs1555924860	NC_000023.11:41166109:C:T
NM_001039591.3(USP9X):c.5606_5607dup (p.Val1870fs)	USP9X		not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000504340	X	41075424 - 41075425	X	41216171 - 41216172	504340	495806	rs1555933972	NC_000023.11:41216171:CTC:CTCTC
NM_001008537.3(NEXMIF):c.991del (p.Glu331fs)	NEXMIF	E331fs	not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504323	X	73963401	X	74743566	504323	495646	rs1556016724	NC_000023.11:74743565:CC:C
NM_001083962.2(TCF4):c.1711del (p.Met571fs)	TCF4	M407fs, M564fs, M571fs, M355fs, M406fs, M437fs, M441fs, M525fs, M529fs, M542fs, M547fs, M577fs, M411fs, M546fs, M570fs, M496fs, M500fs, M543fs, M548fs, M566fs, M567fs, M673fs	not provided	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000504319	18	52896246	18	55229015	504319	495494	rs1555710866	NC_000018.10:55229014:T:
NM_172107.4(KCNQ2):c.769G>T (p.Glu257Ter)	KCNQ2	E257*	not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504313	20	62073806	20	63442453	504313	495878	rs1555871853	NC_000020.11:63442452:C:A
NM_005650.3(TCF20):c.1707del (p.Arg570fs)	TCF20	R570fs	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000504312	22	42609605	22	42213599	504312	495885	rs1555926655	NC_000022.11:42213598:GGGGGG:GGGGG
NM_172107.4(KCNQ2):c.1816A>T (p.Lys606Ter)	KCNQ2	K606*, K578*, K575*, K588*	not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000504307	20	62039837	20	63408484	504307	495754	rs1555851516	NC_000020.11:63408483:T:A
NM_001184880.2(PCDH19):c.875_879dup (p.His294fs)	PCDH19		not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504290	X	99662716 - 99662717	X	100407718 - 100407719	504290	495779	rs1555985416	NC_000023.11:100407718:CGGGTCG:CGGGTCGGGTCG
NM_001127221.1(CACNA1A):c.6158dup (p.Thr2054fs)	CACNA1A		not provided	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000504277	19	13323231 - 13323232	19	13212417 - 13212418	504277	495709	rs1158454977	NC_000019.10:13212417:GGGGGG:GGGGGGG
NM_001356.4(DDX3X):c.869C>G (p.Ser290Ter)	DDX3X	S290*, S274*, S104*	not provided	Pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	VCV000504273	X	41203496	X	41344243	504273	495817	rs1555953482	NC_000023.11:41344242:C:G
NM_001356.4(DDX3X):c.40C>T (p.Gln14Ter)	DDX3X	Q14*	not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000504264	X	41193545	X	41334292	504264	495809	rs1555950676	NC_000023.11:41334291:C:T
NM_001193466.2(KANSL1):c.808del (p.Leu270fs)	KANSL1	L270fs	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000504263	17	44248702	17	46171336	504263	495428	rs1555575489	NC_000017.11:46171335:GGGG:GGG
NM_182641.4(BPTF):c.6622C>T (p.Arg2208Ter)	BPTF	R2334*, R2208*	not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000504258	17	65940410	17	67944294	504258	495850	rs1158151918	NC_000017.11:67944293:C:T
NM_002501.4(NFIX):c.772C>T (p.Gln258Ter)	NFIX	Q258*, Q266*, Q211*, Q250*, Q257*	not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000504244	19	13184794	19	13073980	504244	495698	rs1555705276	NC_000019.10:13073979:C:T
NM_016032.4(ZDHHC9):c.328+1G>A	ZDHHC9		not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000504233	X	128962956	X	129828980	504233	495785	rs1556007364	NC_000023.11:129828979:C:T
NM_138927.3(SON):c.1834_1843del (p.Ser612fs)	SON	S612fs	not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000504228	21	34923364 - 34923373	21	33551058 - 33551067	504228	495755	rs1555898374	NC_000021.9:33551057:GGGGCAGTCTGGGGCAG:GGGGCAG
NM_001399.5(EDA):c.390del (p.His131fs)	EDA	H131fs	not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000504227	X	68836540	X	69616696	504227	495643	rs1555972137	NC_000023.11:69616695:GGG:GG
NM_030632.3(ASXL3):c.1738G>T (p.Glu580Ter)	ASXL3	E580*	not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000504223	18	31319106	18	33739142	504223	495692	rs1555742333	NC_000018.10:33739141:G:T
NM_153638.3(PANK2):c.505_512del (p.Ser169fs)	PANK2	S169fs	Pigmentary pallidal degeneration|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504213	20	3870251 - 3870258	20	3889604 - 3889611	504213	495744	rs755653150	NC_000020.11:3889603:CAGCGCGTC:C
NM_015125.4(CIC):c.2154dup (p.Gly719fs)	CIC		not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504201	19	42795073 - 42795074	19	42290921 - 42290922	504201	495868	rs1555769289	NC_000019.10:42290921:T:TT
NM_030632.3(ASXL3):c.4509_4513dup (p.Val1505fs)	ASXL3		not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504200	18	31324317 - 31324318	18	33744353 - 33744354	504200	495485	rs1555744396	NC_000018.10:33744353:CAGACCAG:CAGACCAGACCAG
NM_001272071.2(AP1S2):c.40C>T (p.Arg14Ter)	AP1S2	R14*	not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504198	X	15870608	X	15852485	504198	495627	rs1555904878	NC_000023.11:15852484:G:A
NM_001083961.2(WDR62):c.4226dup (p.Ser1410fs)	WDR62		not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	VCV000504193	19	36595487 - 36595488	19	36104585 - 36104586	504193	495711	rs1555725014	NC_000019.10:36104585:CCCCC:CCCCCC
NM_002547.3(OPHN1):c.5dup (p.His3fs)	OPHN1		not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000504169	X	67652857 - 67652858	X	68433015 - 68433016	504169	495904	rs1555988317	NC_000023.11:68433015:CCC:CCCC
NM_001356.4(DDX3X):c.241_242insCTT (p.Lys81delinsThrTer)	DDX3X		not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000504166	X	41200826 - 41200827	X	41341573 - 41341574	504166	495813	rs1555952685	NC_000023.11:41341573::CTT
NM_001111125.3(IQSEC2):c.1676del (p.Pro559fs)	IQSEC2	P354fs, P559fs	Mental retardation, X-linked 1|not provided	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504163	X	53280082	X	53250900	504163	495828	rs1556863340	NC_000023.11:53250899:GG:G
NM_021140.3(KDM6A):c.3185_3188del (p.Asp1062fs)	KDM6A	D1114fs, D983fs, D1069fs, D766fs, D1017fs, D1062fs	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000504162	X	44941859 - 44941862	X	45082614 - 45082617	504162	495640	rs1556346208	NC_000023.11:45082613:AGATAG:AG
NM_004187.4(KDM5C):c.2553_2554del (p.Glu852fs)	KDM5C	E851fs, E785fs, E852fs	not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000504157	X	53227021 - 53227022	X	53197839 - 53197840	504157	495826	rs1556838673	NC_000023.11:53197838:CA:
NM_005461.5(MAFB):c.135del (p.Cys46fs)	MAFB	C46fs	not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000504138	20	39317356	20	40688716	504138	495555	rs1555826446	NC_000020.11:40688715:GGG:GG
NM_004859.4(CLTC):c.3637_3639GCT[1] (p.Ala1214del)	CLTC	A1218del	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000504135	17	57760025 - 57760027	17	59682664 - 59682666	504135	495686	rs1555607332	NC_000017.11:59682663:TGCTGCT:TGCT
NM_138927.3(SON):c.416_417insT (p.Lys139fs)	SON		not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000504111	21	34921953 - 34921954	21	33549647 - 33549648	504111	495564	rs1555898000	NC_000021.9:33549647::T
NM_001429.4(EP300):c.4190_4191dup (p.Leu1398fs)	EP300		not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000504110	22	41565523 - 41565524	22	41169519 - 41169520	504110	495774	rs1555911201	NC_000022.11:41169519:AC:ACAC
NM_001356.4(DDX3X):c.819delinsCT (p.Pro274fs)	DDX3X		not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000504082	X	41203336	X	41344083	504082	495898	rs1555953420	NC_000023.11:41344082:A:CT
NM_001008537.3(NEXMIF):c.1014dup (p.Pro339fs)	NEXMIF		not provided	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000504074	X	73963377 - 73963378	X	74743542 - 74743543	504074	495910	rs1556016723	NC_000023.11:74743542:AAAAAA:AAAAAAA
NM_138927.3(SON):c.58_59insGC (p.Ile20fs)	SON		not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000504070	21	34915456 - 34915457	21	33543150 - 33543151	504070	495561	rs1555896735	NC_000021.9:33543150::GC
NM_001278116.2(L1CAM):c.2918_2919del (p.Pro973fs)	L1CAM	P968fs, P973fs	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000504061	X	153130403 - 153130404	X	153864948 - 153864949	504061	495624	rs1557090314	NC_000023.11:153864947:GGGG:GG
NM_001347721.2(DYRK1A):c.765_767del (p.Lys255_Phe256delinsAsn)	DYRK1A		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000504059	21	38862604 - 38862606	21	37490302 - 37490304	504059	495576	rs1555984238	NC_000021.9:37490301:GTT:
NM_004247.4(EFTUD2):c.1901_1902insAA (p.Leu635fs)	EFTUD2		not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000504058	17	42936508 - 42936509	17	44859140 - 44859141	504058	495679	rs1555565162	NC_000017.11:44859140:T:TTT
NM_001039876.3(SYNE4):c.511_526del (p.Arg171fs)	SYNE4	R171fs	not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000504047	19	36497744 - 36497759	19	36006842 - 36006857	504047	495718	rs1555785625	NC_000019.10:36006841:GGGCTGCCCAGGCCCTGGGCT:GGGCT
NM_001039876.3(SYNE4):c.119_120AG[3] (p.Ser41fs)	SYNE4		not provided	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000504046	19	36499461 - 36499462	19	36008559 - 36008560	504046	495527	rs758800042	NC_000019.10:36008559:CTCTC:CTCTCTC
NM_002547.3(OPHN1):c.961del (p.Cys321fs)	OPHN1	C321fs	not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000504026	X	67421525	X	68201683	504026	495841	rs1555952648	NC_000023.11:68201682:A:
NM_030632.3(ASXL3):c.1206_1212delinsTCACAT (p.Glu402fs)	ASXL3		not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000504003	18	31318574 - 31318580	18	33738610 - 33738616	504003	495700	rs1555742010	NC_000018.10:33738609:ACAACAG:TCACAT
NM_138927.3(SON):c.2616_2623del (p.Ser873fs)	SON	S873fs	not provided	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000503985	21	34924152 - 34924159	21	33551846 - 33551853	503985	495879	rs1555898622	NC_000021.9:33551845:ACTCTCAAA:A
NM_004975.4(KCNB1):c.1310_1311AG[2] (p.Arg438fs)	KCNB1		not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000503975	20	47990782 - 47990783	20	49374245 - 49374246	503975	495876	rs1555889069	NC_000020.11:49374244:CTCTCTC:CTCTC
NM_020533.3(MCOLN1):c.1017_1020del (p.Arg340fs)	MCOLN1	R340fs	not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000503973	19	7593737 - 7593740	19	7528851 - 7528854	503973	495741	rs1555742120	NC_000019.10:7528850:GGACGG:GG
NM_004586.3(RPS6KA3):c.593+2_593+5del	RPS6KA3		not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000503966	X	20211600 - 20211603	X	20193482 - 20193485	503966	495818	rs1555942692	NC_000023.11:20193481:CTTACTT:CTT
NM_000206.2(IL2RG):c.427del (p.Thr143fs)	IL2RG	T143fs	not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000503952	X	70330381	X	71110531	503952	495907	rs1556330710	NC_000023.11:71110530:T:
NM_004975.4(KCNB1):c.661delinsAT (p.Gly221fs)	KCNB1		not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000503951	20	47991436	20	49374899	503951	495747	rs1555889157	NC_000020.11:49374898:C:AT
NM_002501.4(NFIX):c.324dup (p.Asp109fs)	NFIX		not provided	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000503947	19	13136127 - 13136128	19	13025313 - 13025314	503947	495512	rs1555696587	NC_000019.10:13025313:CCCC:CCCCC
NM_005120.3(MED12):c.5135_5138dup (p.Val1714fs)	MED12		not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000503941	X	70356239 - 70356240	X	71136389 - 71136390	503941	495844	rs1556338764	NC_000023.11:71136389:GGCG:GGCGGGCG
NM_001029896.2(WDR45):c.599dup (p.Asn201fs)	WDR45		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000503923	X	48933329 - 48933330	X	49075670 - 49075671	503923	495900	rs1557084066	NC_000023.11:49075670:A:AA
NM_001167.3(XIAP):c.108del (p.Pro37fs)	XIAP	P37fs	Lymphoproliferative syndrome 2, X-linked|not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503904	X	123019617	X	123885767	503904	495793	rs1556404455	NC_000023.11:123885766:TTTT:TTT
NM_020461.4(TUBGCP6):c.1587del (p.Cys529fs)	TUBGCP6	C529fs	not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000503899	22	50665176	22	50226747	503899	495886	rs1555908577	NC_000022.11:50226746:G:
NM_198270.4(NHS):c.3384del (p.Glu1129fs)	NHS	E1150fs, E1129fs, E952fs, E973fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503897	X	17745673	X	17727553	503897	495631	rs1556039548	NC_000023.11:17727552:T:
NM_000116.5(TAZ):c.487dup (p.Asp163fs)	TAZ		not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000503896	X	153647906 - 153647907	X	154419567 - 154419568	503896	495808	rs1557193821	NC_000023.11:154419567:GG:GGG
NM_001127221.1(CACNA1A):c.2906del (p.Gly969fs)	CACNA1A	G969fs, G972fs, G968fs	not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000503887	19	13409544	19	13298730	503887	495518	rs1555755926	NC_000019.10:13298729:CCC:CC
NM_001282531.3(ADNP):c.1876_1892del (p.Leu626fs)	ADNP	L626fs	not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000503886	20	49509359 - 49509375	20	50892822 - 50892838	503886	495736	rs1555810093	NC_000020.11:50892821:AGGATTGAAAAGCAAAGAGGA:AGGA
NM_172107.4(KCNQ2):c.518dup (p.Met174fs)	KCNQ2		not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000503884	20	62076183 - 62076184	20	63444830 - 63444831	503884	495749	rs1555873813	NC_000020.11:63444830:A:AA
NM_000109.4(DMD):c.1953_1957del (p.Lys652fs)	DMD	K660fs, K537fs, K652fs, K656fs	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000503875	X	32583830 - 32583834	X	32565713 - 32565717	503875	495634	rs1556802365	NC_000023.11:32565712:TCTTTTC:TC
NM_001323289.2(CDKL5):c.1546del (p.Tyr516fs)	CDKL5	Y516fs	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000503833	X	18622590	X	18604470	503833	495794	rs1555952063	NC_000023.11:18604469:T:
NM_001347721.2(DYRK1A):c.143dup (p.Ser49fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000503817	21	38845117 - 38845118	21	37472815 - 37472816	503817	495759	rs1555977071	NC_000021.9:37472815:T:TT
NM_003620.3(PPM1D):c.1212del (p.Glu405fs)	PPM1D	E405fs	not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000503784	17	58734153	17	60656792	503784	495848	rs1555648558	NC_000017.11:60656791:AA:A
NM_138927.3(SON):c.5717_5720del (p.Arg1906fs)	SON	R1906fs	not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000503761	21	34927251 - 34927254	21	33554945 - 33554948	503761	495880	rs1382415023	NC_000021.9:33554944:AAAGAAA:AAA
NM_000397.3(CYBB):c.1462-56_1586+68dup249	CYBB		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000503744	X	37668762 - 37668763	X	37809509 - 37809510	503744	495803	rs1556472628	
NM_001356.4(DDX3X):c.1675_1677CTT[1] (p.Leu560del)	DDX3X	L560del	not provided	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000503738	X	41206170 - 41206172	X	41346917 - 41346919	503738	495899	rs1555954380	NC_000023.11:41346916:TCTTCTT:TCTT
NM_006915.3(RP2):c.76_77dup (p.Gln26fs)	RP2		not provided	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000503713	X	46696610 - 46696611	X	46837175 - 46837176	503713	495827	rs1556313530	NC_000023.11:46837175:CA:CACA
NM_003639.4(IKBKG):c.519-3_519dup	IKBKG		not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000503711	X	153788618 - 153788619	X	154560403 - 154560404	503711	495814	rs1557236445	NC_000023.11:154560403:CAGG:CAGGCAGG
NM_000061.2(BTK):c.1489C>T (p.Gln497Ter)	BTK	Q497*, Q531*	not provided	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000503706	X	100611117	X	101356129	503706	495887	rs1555977811	NC_000023.11:101356128:G:A
NM_000475.5(NR0B1):c.548del (p.Gly183fs)	NR0B1	G183fs	not provided	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000503698	X	30326933	X	30308816	503698	495825	rs1555973117	NC_000023.11:30308815:CCCCC:CCCC
NM_001278116.2(L1CAM):c.1704-1G>A	L1CAM		not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000503684	X	153133578	X	153868123	503684	495799	rs1557091678	NC_000023.11:153868122:C:T
NM_000206.2(IL2RG):c.703C>T (p.Gln235Ter)	IL2RG	Q235*	not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000503682	X	70329132	X	71109282	503682	495906	rs1556330249	NC_000023.11:71109281:G:A
NM_000455.4(STK11):c.180del (p.Ser59_Tyr60insTer)	STK11		not provided|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503650	19	1207092	19	1207093	503650	495509	rs1555735008	NC_000019.10:1207092:C:
NM_000284.4(PDHA1):c.929_932del (p.Val310fs)	PDHA1	V279fs, V317fs, V348fs, V310fs	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000503637	X	19377060 - 19377063	X	19358942 - 19358945	503637	495895	rs1555935216	NC_000023.11:19358941:AAGTAAG:AAG
NM_000271.5(NPC1):c.423_424dup (p.Lys142fs)	NPC1		Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000503633	18	21148825 - 21148826	18	23568861 - 23568862	503633	495854	rs773941375	NC_000018.10:23568861:TC:TCTC
NM_000397.3(CYBB):c.960del (p.Val321fs)	CYBB	V321fs	not provided	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000503616	X	37663191	X	37803938	503616	495896	rs1556470775	NC_000023.11:37803937:AA:A
NM_001323289.2(CDKL5):c.766C>T (p.Gln256Ter)	CDKL5	Q256*	not provided	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000503610	X	18613489	X	18595369	503610	495894	rs1555951142	NC_000023.11:18595368:C:T
NM_003688.3(CASK):c.1609C>T (p.Arg537Ter)	CASK	R537*, R531*	not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503609	X	41420871	X	41561618	503609	495820	rs1555981717	NC_000023.11:41561617:G:A
NM_001282631.2(ARSL):c.23+2045_23+2047del	ARSL	L43del	not provided	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000503608	X	2876372 - 2876374	X	2958331 - 2958333	503608	495800	rs1555910687	NC_000023.11:2958330:AGAAGAAG:AGAAG
NM_001323289.2(CDKL5):c.1942_1944+2delinsA	CDKL5		not provided	Pathogenic(Last reviewed: May 20, 2015)	criteria provided, single submitter	VCV000503508	X	18622986 - 18622990	X	18604866 - 18604870	503508	494944	rs1555952163	NC_000023.11:18604865:CAGGT:A
NM_000132.3(F8):c.2113+461_2113+473del	F8			Pathogenic(Last reviewed: Mar 27, 2018)	no assertion criteria provided	VCV000503494	X	154175500 - 154175512	X	154947225 - 154947237	503494	494917		NC_000023.11:154947224:AAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAA
NM_004586.3(RPS6KA3):c.632-1G>A	RPS6KA3		not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000502775	X	20206089	X	20187971	502775	494198	rs398124177	NC_000023.11:20187970:C:T
NM_004020.3(DMD):c.2843+9192G>T	DMD	E3507*, E2163*, E2166*, E1047*, E3384*, E426*, E439*, E1034*, E3499*, E3503*, E778*	not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000502556	X	31187594	X	31169477	502556	493980	rs1556024095	NC_000023.11:31169476:C:A
NM_000202.8(IDS):c.252C>A (p.Cys84Ter)	IDS	C84*	not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000502523	X	148585008	X	149503478	502523	493947	rs1557340286	NC_000023.11:149503477:G:T
NM_000109.4(DMD):c.8042_8046del (p.Arg2681fs)	DMD	R2685fs, R1348fs, R2566fs, R2681fs, R2689fs, R1345fs, R229fs	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000502441	X	31645937 - 31645941	X	31627820 - 31627824	502441	493865	rs1556764934	NC_000023.11:31627819:TAATCTA:TA
NM_000109.4(DMD):c.571_574dup (p.Phe192fs)	DMD		not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000502440	X	32827660 - 32827661	X	32809543 - 32809544	502440	493864	rs1557047875	NC_000023.11:32809543:ATGCATG:ATGCATGCATG
NM_005603.6(ATP8B1):c.1799G>A (p.Arg600Gln)	ATP8B1	R600Q	not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000502324	18	55342086	18	57674854	502324	493748	rs1202682161	NC_000018.10:57674853:C:T
NM_001323289.2(CDKL5):c.1111del (p.Ala372fs)	CDKL5	A372fs	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000502250	X	18622154	X	18604034	502250	493674	rs1555951958	NC_000023.11:18604033:CC:C
NM_000109.4(DMD):c.3285_3289del (p.Ser1096fs)	DMD	S981fs, S1096fs, S1100fs, S1104fs	not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000502225	X	32481675 - 32481679	X	32463558 - 32463562	502225	493649	rs1557369493	NC_000023.11:32463557:GACTGG:G
NM_001347721.2(DYRK1A):c.542_545del (p.Ile181fs)	DYRK1A	I152fs, I190fs, I181fs	not provided	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000502025	21	38858819 - 38858822	21	37486517 - 37486520	502025	493449	rs1555982601	NC_000021.9:37486516:AATAAA:AA
NM_004006.2(DMD):c.3433-2_3433-1delinsCC	DMD		not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000502013	X	32472950 - 32472951	X	32454833 - 32454834	502013	493437	rs1557365503	NC_000023.11:32454832:CT:GG
NM_004013.2(DMD):c.-222C>T	DMD	Q2387*, Q1043*, Q1046*, Q2264*, Q2379*, Q2383*	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000502009	X	31854876	X	31836759	502009	493433	rs1556930579	NC_000023.11:31836758:G:A
NM_000023.4(SGCA):c.37+2C>G	SGCA		not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000501790	17	48243440	17	50166079	501790	493214	rs112500642	NC_000017.11:50166078:C:G
NM_015295.2(SMCHD1):c.2142dup (p.Ile715Tyrfs)	SMCHD1		not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000501782	18	2707638 - 2707639	18	2707640 - 2707641	501782	493206	rs1555635144	NC_000018.10:2707640:T:TT
NM_004006.2(DMD):c.1812+2T>A	DMD		not provided	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000501780	X	32591645	X	32573528	501780	493204	rs1556809625	NC_000023.11:32573527:A:T
NM_000109.4(DMD):c.3861del (p.Pro1288fs)	DMD	P1173fs, P1288fs, P1292fs, P1296fs	not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000501633	X	32459333	X	32441216	501633	493057	rs1557359155	NC_000023.11:32441215:AA:A
NM_000109.4(DMD):c.2108del (p.Lys703fs)	DMD	K707fs, K588fs, K703fs, K711fs	not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000501567	X	32563312	X	32545195	501567	492991	rs1556780579	NC_000023.11:32545194:TT:T
NM_004006.2(DMD):c.649+5G>T	DMD		not provided	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000501566	X	32827605	X	32809488	501566	492990	rs1557047808	NC_000023.11:32809487:C:A
NM_005559.4(LAMA1):c.505C>T (p.Arg169Ter)	LAMA1	R169*	not provided	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000501474	18	7050776	18	7050777	501474	492898	rs752872595	NC_000018.10:7050776:G:A
NM_004010.3(DMD):c.-87G>T	DMD	G95*, G87*, G91*	not provided	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000501437	X	32841486	X	32823369	501437	492861	rs1557058415	NC_000023.11:32823368:C:A
NM_000271.5(NPC1):c.2604+1G>A	NPC1		Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501356	18	21120411	18	23540447	501356	492780	rs1555633454	NC_000018.10:23540446:C:T
NM_004006.2(DMD):c.4295del (p.Gln1432fs)	DMD	Q1432fs, Q1309fs, Q1424fs, Q1428fs, Q91fs, Q88fs	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501338	X	32408237	X	32390120	501338	492762	rs1557322834	NC_000023.11:32390119:T:
NM_000109.4(DMD):c.8623A>T (p.Lys2875Ter)	DMD	K2883*, K1539*, K1542*, K2760*, K2879*, K2875*, K423*, K154*	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000501337	X	31497121	X	31479004	501337	492761	rs1556656767	NC_000023.11:31479003:T:A
NM_000152.5(GAA):c.1153del (p.Arg385fs)	GAA	R385fs	not provided	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000501294	17	78082363	17	80108564	501294	492718	rs1555600102	NC_000017.11:80108563:CCC:CC
NM_000109.4(DMD):c.1231G>T (p.Glu411Ter)	DMD	E419*, E411*, E415*, E296*	not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000501260	X	32662325	X	32644208	501260	492684	rs1220963408	NC_000023.11:32644207:C:A
NM_000109.4(DMD):c.5524_5528del (p.Lys1842fs)	DMD	K506fs, K1846fs, K1727fs, K1850fs, K1842fs, K509fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501218	X	32364094 - 32364098	X	32345977 - 32345981	501218	492642	rs1557292678	NC_000023.11:32345976:TGTTTT:T
NM_004013.2(DMD):c.-329_-328del	DMD		not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000501131	X	31893350 - 31893351	X	31875233 - 31875234	501131	492555	rs1556962326	NC_000023.11:31875232:CA:
NM_000109.4(DMD):c.10062+1G>T	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501095	X	31198486	X	31180369	501095	492519	rs398123828	NC_000023.11:31180368:C:A
NM_172107.4(KCNQ2):c.144del (p.Lys49fs)	KCNQ2	K49fs	not provided	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000501059	20	62103673	20	63472320	501059	492483	rs1555881809	NC_000020.11:63472319:GGGGG:GGGG
NM_001323289.2(CDKL5):c.713del (p.Phe238fs)	CDKL5	F238fs	not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000501058	X	18606229	X	18588109	501058	492482	rs1555950486	NC_000023.11:18588108:TTTT:TTT
NM_000109.4(DMD):c.5571del (p.Arg1857fs)	DMD	R524fs, R1742fs, R1865fs, R521fs, R1857fs, R1861fs	not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000500802	X	32361395	X	32343278	500802	492226	rs1557291242	NC_000023.11:32343277:CC:C
NM_000709.4(BCKDHA):c.854-2A>G	BCKDHA		not provided	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000500713	19	41928532	19	41422627	500713	492137	rs760494152	NC_000019.10:41422626:A:G
NM_004006.2(DMD):c.8937+1G>T	DMD		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000500710	X	31496222	X	31478105	500710	492134	rs1556656077	NC_000023.11:31478104:C:A
NM_004013.2(DMD):c.-716_-713del	DMD	E2222fs, E878fs, E881fs, E2099fs, E2214fs, E2218fs	not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000500709	X	31950291 - 31950294	X	31932174 - 31932177	500709	492133	rs1557011872	NC_000023.11:31932173:AATT:
NM_000109.4(DMD):c.5310del (p.Pro1771fs)	DMD	P1771fs, P438fs, P1656fs, P1775fs, P1779fs, P435fs	not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000500707	X	32366637	X	32348520	500707	492131	rs1557294341	NC_000023.11:32348519:AA:A
NM_000276.4(OCRL):c.1000C>T (p.Arg334Ter)	OCRL	R334*, R335*	not provided|Lowe syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000500705	X	128696421	X	129562444	500705	492129	rs1556346316	NC_000023.11:129562443:C:T
NM_004006.2(DMD):c.3276+2del	DMD		not provided	Pathogenic(Last reviewed: Mar 5, 2017)	criteria provided, single submitter	VCV000500695	X	32482701	X	32464584	500695	492119	rs1557369964	NC_000023.11:32464583:A:
NM_015295.2(SMCHD1):c.3276_3276+4delAGTAA	SMCHD1		not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000500665	18	2732490 - 2732494	18	2732489 - 2732493	500665	492089	rs1555642277	
NM_015295.2(SMCHD1):c.4733_4736dup (p.Glu1579fs)	SMCHD1		not provided	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000500659	18	2769704 - 2769705	18	2769706 - 2769707	500659	492083	rs1555651730	NC_000018.10:2769706:CAGA:CAGACAGA
NM_001848.2(COL6A1):c.2435-2A>G	COL6A1		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000500615	21	47423032	21	46003118	500615	492039	rs940473416	NC_000021.9:46003117:A:G
NM_015295.2(SMCHD1):c.5547+1G>C	SMCHD1		not provided	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000500529	18	2778238	18	2778240	500529	491953	rs1555654127	NC_000018.10:2778239:G:C
NM_001848.2(COL6A1):c.2160dup (p.Asn721fs)	COL6A1		not provided	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000500479	21	47422224 - 47422225	21	46002310 - 46002311	500479	491903	rs1249738773	NC_000021.9:46002310:C:CC
NM_000109.4(DMD):c.3339_3340AG[1] (p.Glu1114fs)	DMD		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000500255	X	32481622 - 32481623	X	32463505 - 32463506	500255	491679	rs1057518284	NC_000023.11:32463504:CTCT:CT
NM_015629.4(PRPF31):c.973G>T (p.Glu325Ter)	PRPF31	E325*	not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000500129	19	54631475	19	54128100	500129	491553	rs1555794201	NC_000019.10:54128099:G:T
NM_000208.4(INSR):c.350_353del (p.Asn117fs)	INSR	N117fs	not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000500119	19	7267655 - 7267658	19	7267644 - 7267647	500119	491543	rs1347163319	NC_000019.10:7267643:TAGTTA:TA
NM_000109.4(DMD):c.4266_4267del (p.His1422fs)	DMD	H1422fs, H1426fs, H1430fs, H86fs, H1307fs, H89fs	not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000500046	X	32408241 - 32408242	X	32390124 - 32390125	500046	491470	rs1557322838	NC_000023.11:32390123:TAT:T
NM_000109.4(DMD):c.5689G>T (p.Glu1897Ter)	DMD	E1905*, E1897*, E1782*, E1901*, E561*, E564*	not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000499880	X	32361277	X	32343160	499880	491304	rs1557291003	NC_000023.11:32343159:C:A
NM_001848.2(COL6A1):c.1056+1del	COL6A1		not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000499871	21	47410741	21	45990827	499871	491295	rs1556425853	NC_000021.9:45990826:G:
NM_000071.2(CBS):c.1496_1497TC[1] (p.Ser500fs)	CBS		not provided|Classic homocystinuria	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000499845	21	44476966 - 44476967	21	43056856 - 43056857	499845	491269	rs1555871188	NC_000021.9:43056855:GAGAG:GAG
NM_172107.4(KCNQ2):c.1820del (p.Gly607fs)	KCNQ2	G576fs, G607fs, G579fs, G589fs	not provided	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000499739	20	62039833	20	63408480	499739	491163	rs1555851513	NC_000020.11:63408479:CCC:CC
NM_000109.4(DMD):c.4471C>T (p.Gln1491Ter)	DMD	Q1499*, Q1491*, Q1495*, Q1376*, Q155*, Q158*	not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000499729	X	32407641	X	32389524	499729	491153	rs755686224	NC_000023.11:32389523:G:A
NM_004013.2(DMD):c.-730_-729del	DMD	D2096fs, D2211fs, D2219fs, D875fs, D878fs, D2215fs	not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000499728	X	31950307 - 31950308	X	31932190 - 31932191	499728	491152	rs1557011929	NC_000023.11:31932189:TTT:T
NM_000109.4(DMD):c.5383C>T (p.Gln1795Ter)	DMD	Q1803*, Q1680*, Q1799*, Q462*, Q1795*, Q459*	not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000499610	X	32366564	X	32348447	499610	491034	rs1557294228	NC_000023.11:32348446:G:A
NM_001123383.1(BCOR):c.3267_3270dup (p.Pro1091Ter)	BCOR		not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000499579	X	39923820 - 39923821	X	40064567 - 40064568	499579	491003	rs1555915852	NC_000023.11:40064567:ATCA:ATCAATCA
NM_000202.8(IDS):c.404_405del (p.Lys135fs)	IDS	K135fs, K45fs	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000499561	X	148584855 - 148584856	X	149503325 - 149503326	499561	490985	rs1557340221	NC_000023.11:149503324:TTTT:TT
NM_000109.4(DMD):c.2944C>T (p.Gln982Ter)	DMD	Q990*, Q986*, Q867*, Q982*	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000499537	X	32486809	X	32468692	499537	490961	rs1233380601	NC_000023.11:32468691:G:A
NM_152841.2(HPS4):c.431dup (p.Asn144fs)	HPS4		not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000499399	22	26868322 - 26868323	22	26472356 - 26472357	499399	490823	rs1555907536	NC_000022.11:26472356:TTTTT:TTTTTT
NM_000271.5(NPC1):c.423_424insGA (p.Lys142fs)	NPC1		not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000499393	18	21148826 - 21148827	18	23568862 - 23568863	499393	490817	rs1555641037	NC_000018.10:23568862::TC
NM_198129.3(LAMA3):c.8644del (p.Arg2882fs)	LAMA3	R2882fs, R1217fs, R1273fs, R2826fs	not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, single submitter	VCV000499362	18	21512189	18	23932225	499362	490786	rs1555745215	NC_000018.10:23932224:CCC:CC
NM_004013.2(DMD):c.-909_-908del	DMD	V2150fs, V2158fs, V2035fs, V814fs, V817fs, V2154fs	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000499304	X	31986597 - 31986598	X	31968480 - 31968481	499304	490728	rs1557038198	NC_000023.11:31968479:ACA:A
NM_004006.2(DMD):c.4591C>T (p.Gln1531Ter)	DMD	Q1531*, Q1527*, Q190*, Q1523*, Q1408*, Q187*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000499188	X	32404510	X	32386393	499188	490612	rs1557320194	NC_000023.11:32386392:G:A
NM_000109.4(DMD):c.5776G>T (p.Glu1926Ter)	DMD	E1934*, E1930*, E593*, E1811*, E1926*, E590*	not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000499187	X	32360339	X	32342222	499187	490611	rs1557290355	NC_000023.11:32342221:C:A
NM_001077488.4(GNAS):c.2T>C (p.Met1Thr)	GNAS	M1T	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000499177	20	57466783	20	58891728	499177	490601	rs1555883949	NC_000020.11:58891727:T:C
NM_001848.2(COL6A1):c.1002+2T>G	COL6A1		not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000499176	21	47410338	21	45990424	499176	490600	rs1322590833	NC_000021.9:45990423:T:G
NM_001039141.3(TRIOBP):c.251_254+22del	TRIOBP		not provided	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000499105	22	38106560 - 38106585	22	37710553 - 37710578	499105	490529	rs1555894574	NC_000022.11:37710552:CCAGGGCCCAAGAGGTGGGTAGAGTCCCAGGGCCCA:CCAGGGCCCA
NM_000117.2(EMD):c.484C>T (p.Gln162Ter)	EMD	Q162*	Emery-Dreifuss muscular dystrophy 1, X-linked|not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000498989	X	153609276	X	154380916	498989	490413	rs1557182611	NC_000023.11:154380915:C:T
NM_004013.2(DMD):c.-837C>T	DMD	Q2182*, Q838*, Q841*, Q2174*, Q2059*, Q2178*	not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000498985	X	31986526	X	31968409	498985	490409	rs1557038061	NC_000023.11:31968408:G:A
NM_020436.5(SALL4):c.1311_1321del (p.Asn438fs)	SALL4	N438fs	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000498781	20	50407701 - 50407711	20	51791162 - 51791172	498781	490205	rs1555850609	NC_000020.11:51791161:GCTGGGGGTTTGC:GC
NM_006031.6(PCNT):c.3757G>T (p.Glu1253Ter)	PCNT	E1253*, E1135*	not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000498776	21	47809263	21	46389348	498776	490200	rs1555973872	NC_000021.9:46389347:G:T
NM_000109.4(DMD):c.6399del (p.Lys2132_Tyr2133insTer)	DMD		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000498586	X	32235048	X	32216931	498586	490010	rs1557218093	NC_000023.11:32216930:G:
NM_000109.4(DMD):c.1635_1636insGTAA (p.Leu546fs)	DMD		not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000498585	X	32591906 - 32591907	X	32573789 - 32573790	498585	490009	rs1556810362	NC_000023.11:32573789::TTAC
NM_015295.2(SMCHD1):c.120del (p.Asp42fs)	SMCHD1	D42fs	not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000498564	18	2656194	18	2656195	498564	489988	rs1555622310	NC_000018.10:2656194:C:
NM_000109.4(DMD):c.454_455insAC (p.Thr152fs)	DMD		not provided	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000498355	X	32834636 - 32834637	X	32816519 - 32816520	498355	489779	rs1557052560	NC_000023.11:32816519::GT
NM_144612.6(LOXHD1):c.1535_1536CT[1] (p.Leu513fs)	LOXHD1		not provided	Pathogenic(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000498162	18	44172012 - 44172013	18	46592049 - 46592050	498162	489586	rs1555683951	NC_000018.10:46592048:AGAG:AG
NM_000271.5(NPC1):c.1219C>T (p.Gln407Ter)	NPC1	Q407*	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000498154	18	21136314	18	23556350	498154	489578	rs775629081	NC_000018.10:23556349:G:A
NM_004013.2(DMD):c.-211C>G	DMD	Y2390*, Y1049*, Y2382*, Y2386*, Y1046*, Y2267*	not provided	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000497971	X	31854865	X	31836748	497971	489395	rs770183212	NC_000023.11:31836747:G:C
NM_172107.3(KCNQ2):c.2T>A (p.Met1Lys)	KCNQ2	M1K	Early infantile epileptic encephalopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000497690	20	62103815	20	63472462	497690	489114	rs118192186	NC_000020.11:63472461:A:T
NM_000023.4(SGCA):c.585-1G>A	SGCA		not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000497672	17	48246452	17	50169091	497672	489096	rs1342189589	NC_000017.11:50169090:G:A
NM_004020.3(DMD):c.2843+9177del	DMD	E1042fs, E2161fs, E3379fs, E3494fs, E773fs, E1029fs, E2158fs, E3498fs, E3502fs, E421fs, E434fs	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000497641	X	31187609	X	31169492	497641	489065	rs1556024147	NC_000023.11:31169491:CC:C
NM_015295.2(SMCHD1):c.424+1G>A	SMCHD1		not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000497570	18	2667031	18	2667032	497570	488994	rs1555625396	NC_000018.10:2667031:G:A
NM_000109.4(DMD):c.5886del (p.Phe1963fs)	DMD	F1971fs, F630fs, F1848fs, F1967fs, F627fs, F1963fs	not provided	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000497527	X	32360229	X	32342112	497527	488951	rs1557290181	NC_000023.11:32342111:G:
NM_004010.3(DMD):c.-5del	DMD	N122fs, N114fs, N118fs	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000497502	X	32834750	X	32816633	497502	488926	rs1557052797	NC_000023.11:32816632:TTTTT:TTTT
NM_000109.4(DMD):c.5115del (p.Glu1706fs)	DMD	E1706fs, E1710fs, E1714fs, E373fs, E1591fs, E370fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000497488	X	32382714	X	32364597	497488	488912	rs1557304860	NC_000023.11:32364596:TTTTT:TTTT
NM_144612.6(LOXHD1):c.5944C>T (p.Arg1982Ter)	LOXHD1	R1982*, R283*, R837*, R933*	not provided	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000497393	18	44065034	18	46485071	497393	488817	rs1306586204	NC_000018.10:46485070:G:A
NM_001848.2(COL6A1):c.811C>T (p.Arg271Ter)	COL6A1	R271*	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000497373	21	47409004	21	45989090	497373	488797	rs1391624796	NC_000021.9:45989089:C:T
NM_000109.4(DMD):c.4096G>T (p.Glu1366Ter)	DMD	E1374*, E33*, E1366*, E1251*, E1370*, E30*	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000497353	X	32429982	X	32411865	497353	488777	rs1557340452	NC_000023.11:32411864:C:A
NM_004006.2(DMD):c.10453dup (p.Leu3485Profs)	DMD		not provided|Duchenne muscular dystrophy|Becker muscular dystrophy	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497301	X	31187659 - 31187660	X	31169542 - 31169543	497301	488725	rs886043375	NC_000023.11:31169542:GGGGGG:GGGGGGG
NM_000346.4(SOX9):c.781G>T (p.Glu261Ter)	SOX9	E261*	not provided	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000497284	17	70119779	17	72123638	497284	488708	rs1555629290	NC_000017.11:72123637:G:T
NM_004006.2(DMD):c.7661-1G>C	DMD		not provided	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000497229	X	31697704	X	31679587	497229	488653	rs1556806346	NC_000023.11:31679586:C:G
NM_000109.4(DMD):c.5999_6000CA[1] (p.Gln2001fs)	DMD		not provided	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000497228	X	32328290 - 32328291	X	32310173 - 32310174	497228	488652	rs1557272125	NC_000023.11:32310172:TGTG:TG
NM_001256789.3(CACNA1F):c.1504C>T (p.Arg502Ter)	CACNA1F	R513*, R448*, R502*	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497205	X	49082518	X	49226056	497205	488629	rs1365490247	NC_000023.11:49226055:G:A
NM_000023.4(SGCA):c.892del (p.Leu298fs)	SGCA	L298fs	not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000497197	17	48247645	17	50170284	497197	274861	rs886044512	NC_000017.11:50170283:CCCC:CCC
NM_004006.2(DMD):c.1602+1G>T	DMD		not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000497183	X	32613873	X	32595756	497183	488607	rs1057517960	NC_000023.11:32595755:C:A
NM_000023.4(SGCA):c.168del (p.Ala57fs)	SGCA	A57fs	not provided	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000497173	17	48244951	17	50167590	497173	488597	rs1555568264	NC_000017.11:50167589:CCC:CC
NM_004006.2(DMD):c.4618G>T (p.Glu1540Ter)	DMD	E1540*, E1417*, E196*, E1536*, E199*, E1532*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000497172	X	32404483	X	32386366	497172	488596	rs1557320151	NC_000023.11:32386365:C:A
NM_001848.2(COL6A1):c.859-1G>C	COL6A1		not provided|Bethlem myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497161	21	47409521	21	45989607	497161	488585	rs1556425531	NC_000021.9:45989606:G:C
NM_000109.4(DMD):c.3579+2dup	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497147	X	32472776 - 32472777	X	32454659 - 32454660	497147	488571	rs796523999	NC_000023.11:32454659:A:AA
NM_000023.4(SGCA):c.322_325dup (p.Asn109fs)	SGCA		not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000497103	17	48245316 - 48245317	17	50167955 - 50167956	497103	488527	rs1555568518	NC_000017.11:50167955:TACA:TACATACA
NM_000109.4(DMD):c.8239del (p.Leu2747fs)	DMD	L1414fs, L2632fs, L2751fs, L295fs, L1411fs, L26fs, L2747fs, L2755fs	not provided	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000497078	X	31525525	X	31507408	497078	488502	rs1556669914	NC_000023.11:31507407:GG:G
NM_001848.2(COL6A1):c.1003-12_1006delinsGGA	COL6A1		not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000497056	21	47410675 - 47410690	21	45990761 - 45990776	497056	488480	rs1556425832	NC_000021.9:45990760:TCCTCTTTCCAGGGGG:GGA
NM_001848.2(COL6A1):c.98-2_103delAGACTGCC	COL6A1		not provided|Bethlem myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000497044	21	47402546 - 47402553	21	45982629 - 45982636	497044	488468	rs1556423703	
NM_000152.5(GAA):c.1129G>C (p.Gly377Arg)	GAA	G377R	not provided	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000497033	17	78082341	17	80108542	497033	488457	rs752002666	NC_000017.11:80108541:G:C
NM_000152.5(GAA):c.1130del (p.Gly377fs)	GAA	G377fs	not provided	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000497032	17	78082339	17	80108540	497032	488456	rs754134578	NC_000017.11:80108539:GGGG:GGG
NM_000194.3(HPRT1):c.643_*7del (p.Lys215fs)	HPRT1	K215fs	not provided	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000496971	X	133634092 - 133634113	X	134500062 - 134500083	496971	488395	rs1556030344	NC_000023.11:134500061:AAAATACAAAGCCTAAGATGAGA:A
NM_022567.2(NYX):c.38-1_38delinsTT	NYX		not provided	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000496942	X	41332743 - 41332744	X	41473490 - 41473491	496942	488366	rs1555967031	NC_000023.11:41473489:GC:TT
NM_033290.3(MID1):c.1656-8_1657delTTCCGCAGGT	MID1		not provided	Pathogenic(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	VCV000496926	X	10417755 - 10417764	X	10449715 - 10449724	496926	488350	rs1556002004	
NM_004006.2(DMD):c.2950-2A>T	DMD		not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	VCV000496923	X	32486829	X	32468712	496923	488347	rs398123915	NC_000023.11:32468711:T:A
NM_001037811.2(HSD17B10):c.650G>A (p.Arg217Gln)	HSD17B10	R217Q, R226Q	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496894	X	53458461	X	53431513	496894	488318	rs1556894502	NC_000023.11:53431512:C:T
NM_006517.5(SLC16A2):c.434G>A (p.Trp145Ter)	SLC16A2	W145*	not provided|Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496891	X	73740828	X	74520993	496891	488315	rs1555989364	NC_000023.11:74520992:G:A
NM_000528.4(MAN2B1):c.384G>A (p.Trp128Ter)	MAN2B1	W128*	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496890	19	12776218	19	12665404	496890	488314	rs1555709972	NC_000019.10:12665403:C:T
NM_004463.3(FGD1):c.577C>T (p.Arg193Ter)	FGD1	R193*	not provided	Pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496830	X	54497098	X	54470665	496830	488254	rs1557189664	NC_000023.11:54470664:G:A
NM_000052.7(ATP7A):c.3915_3921del (p.Asp1305fs)	ATP7A	D1227fs, D1305fs	not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000496826	X	77298195 - 77298201	X	78042697 - 78042703	496826	488250	rs1557238590	NC_000023.11:78042696:ACTCCCCA:A
NM_198129.3(LAMA3):c.7654C>T (p.Arg2552Ter)	LAMA3	R2552*, R943*, R2496*, R887*	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Jun 21, 2017)	no assertion criteria provided	VCV000496811	18	21495262	18	23915298	496811	488235	rs1181742615	NC_000018.10:23915297:C:T
NM_001008537.3(NEXMIF):c.4075dup (p.Ser1359fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000496670	X	73960316 - 73960317	X	74740481 - 74740482	496670	488165	rs1556016224	NC_000023.11:74740481:A:AA
NM_000109.4(DMD):c.2780-1del	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000496616	X	32490427	X	32472310	496616	488102	rs1557374667	NC_000023.11:32472309:C:
NM_080473.5(GATA5):c.46T>G (p.Tyr16Asp)	GATA5	Y16D	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5	Pathogenic(Last reviewed: Mar 16, 2018)	no assertion criteria provided	VCV000496602	20	61050532	20	62475476	496602	488094	rs1555897088	NC_000020.11:62475475:A:C
NM_080473.5(GATA5):c.598T>G (p.Trp200Gly)	GATA5	W200G	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5	Pathogenic(Last reviewed: Mar 16, 2018)	no assertion criteria provided	VCV000496601	20	61048560	20	62473504	496601	488093	rs1555896778	NC_000020.11:62473503:A:C
NM_080473.5(GATA5):c.595C>G (p.Leu199Val)	GATA5	L199V	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5	Pathogenic(Last reviewed: Mar 16, 2018)	no assertion criteria provided	VCV000496600	20	61048563	20	62473507	496600	488092	rs1555896779	NC_000020.11:62473506:G:C
NM_080473.5(GATA5):c.569T>C (p.Val190Ala)	GATA5	V190A	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5	Pathogenic(Last reviewed: Mar 16, 2018)	no assertion criteria provided	VCV000496599	20	61048589	20	62473533	496599	488091	rs782051102	NC_000020.11:62473532:A:G
NM_014297.5(ETHE1):c.406A>G (p.Thr136Ala)	ETHE1	T136A, T13A, T38A, T125A	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000496426	19	44015688	19	43511536	496426	487823	rs1284200516	NC_000019.10:43511535:T:C
NM_004646.3(NPHS1):c.802C>T (p.Arg268Ter)	NPHS1	R268*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000496273	19	36340176	19	35849274	496273	488000	rs749341977	NC_000019.10:35849273:G:A
NM_004646.3(NPHS1):c.2663+2T>G	NPHS1		not provided|Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000496271	19	36333024	19	35842122	496271	488046	rs762392183	NC_000019.10:35842121:A:C
NM_000487.6(ARSA):c.960G>A (p.Trp320Ter)	ARSA	W320*, W234*	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000495883	22	51064601	22	50626173	495883	488065	rs1375757476	NC_000022.11:50626172:C:T
NM_000411.8(HLCS):c.1135C>T (p.Gln379Ter)	HLCS	Q379*, Q526*	Holocarboxylase synthetase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495865	21	38302595	21	36930295	495865	487964	rs1393866282	NC_000021.9:36930294:G:A
NM_000397.3(CYBB):c.80_83del (p.Val27fs)	CYBB	V27fs	Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000495863	X	37641373 - 37641376	X	37782120 - 37782123	495863	488042	rs1556464554	NC_000023.11:37782119:TGTCTG:TG
NM_000377.2(WAS):c.413G>C (p.Arg138Pro)	WAS	R138P	X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000495847	X	48544175	X	48685786	495847	487890	rs139265251	NC_000023.11:48685785:G:C
NM_000377.3(WAS):c.1266_1267insG	WAS		Wiskott-Aldrich syndrome|X-linked thrombocytopenia with normal platelets|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495844	X	48547383 - 48547384	X	48688994 - 48688995	495844	488054	rs1557007312	NC_000023.11:48688994:GGGGG:GGGGGG
NM_000178.4(GSS):c.-9+5G>A	GSS		Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000495702	20	33543525	20	34955722	495702	488009	rs1555889738	NC_000020.11:34955721:C:T
NM_000156.6(GAMT):c.491dup (p.Val165fs)	GAMT		Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000495685	19	1398993 - 1398994	19	1398994 - 1398995	495685	488043	rs749390953	NC_000019.10:1398994:CCCCCC:CCCCCCC
NM_000152.5(GAA):c.2188G>T (p.Glu730Ter)	GAA	E730*	Glycogen storage disease, type II	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000495665	17	78087164	17	80113365	495665	487782	rs1555601828	NC_000017.11:80113364:G:T
NM_000152.5(GAA):c.1735G>A (p.Glu579Lys)	GAA	E579K	Glycogen storage disease, type II	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000495664	17	78085880	17	80112081	495664	487917	rs991082382	NC_000017.11:80112080:G:A
NM_000071.2(CBS):c.494G>A (p.Cys165Tyr)	CBS	C165Y, C60Y	Cardiovascular phenotype|Homocystinuria|Classic homocystinuria	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000495531	21	44485763	21	43065653	495531	488016	rs1347651454	NC_000021.9:43065652:C:T
NM_000071.2(CBS):c.1221del (p.Trp408fs)	CBS	W303fs, W408fs	Classic homocystinuria|Homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495530	21	44479338	21	43059228	495530	488011	rs1361324844	NC_000021.9:43059227:GGG:GG
NM_002144.4(HOXB1):c.66C>G (p.Tyr22Ter)	HOXB1	Y22*	Hereditary congenital facial paresis 3	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000495206	17	46608201	17	48530839	495206	486705	rs1247386618	NC_000017.11:48530838:G:C
NM_002144.4(HOXB1):c.620G>A (p.Arg207His)	HOXB1	R207H	Hereditary congenital facial paresis 3	Pathogenic(Last reviewed: Mar 6, 2018)	no assertion criteria provided	VCV000495205	17	46607195	17	48529833	495205	486704	rs1555632121	NC_000017.11:48529832:C:T
NM_004737.6(LARGE1):c.283C>T (p.Arg95Ter)	LARGE1	R95*	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000495057	22	34046478	22	33650492	495057	486618	rs761071115	NC_000022.11:33650491:G:A
NM_001256715.2(DNAAF3):c.1271dup (p.Phe426fs)	DNAAF3		Ciliary dyskinesia, primary, 2|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000495054	19	55670784 - 55670785	19	55159416 - 55159417	495054	486617	rs1349668884	NC_000019.10:55159416:T:TT
NM_002743.3(PRKCSH):c.1395T>G (p.Tyr465Ter)	PRKCSH	Y462*, Y465*, Y472*	Polycystic liver disease 1	Pathogenic(Last reviewed: Feb 21, 2018)	no assertion criteria provided	VCV000492970	19	11559945	19	11449130	492970	485920	rs1555728990	NC_000019.10:11449129:T:G
NM_003140.3(SRY):c.89G>T (p.Arg30Ile)	SRY	R30I	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jul 14, 2010)	no assertion criteria provided	VCV000492908	Y	2655556	Y	2787515	492908	485861	rs1556370576	NC_000024.10:2787514:C:A
NM_016418.5(NF2):c.180G>A (p.Trp60Ter)	NF2	W60*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 29, 2016)	no assertion criteria provided	VCV000492893	22	30032805	22	29636816	492893	485797	rs780872661	NC_000022.11:29636815:G:A
NM_016418.5(NF2):c.43A>T (p.Lys15Ter)	NF2	K15*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 13, 2014)	no assertion criteria provided	VCV000492891	22	30000030	22	29604041	492891	485796	rs1555978356	NC_000022.11:29604040:A:T
NM_000529.2(MC2R):c.634del (p.Arg212fs)	MC2R	R212fs	Glucocorticoid Deficiency	Pathogenic(Last reviewed: Jan 15, 2013)	no assertion criteria provided	VCV000492870	18	13884884	18	13884885	492870	485783	rs1226345778	NC_000018.10:13884884:T:
NM_000529.2(MC2R):c.573C>A (p.Cys191Ter)	MC2R	C191*	Glucocorticoid Deficiency	Pathogenic(Last reviewed: Jun 5, 2009)	no assertion criteria provided	VCV000492869	18	13884945	18	13884946	492869	485784	rs762692123	NC_000018.10:13884945:G:T
NM_000529.2(MC2R):c.560del (p.Val187fs)	MC2R	V187fs	Glucocorticoid Deficiency	Pathogenic(Last reviewed: Dec 10, 2015)	no assertion criteria provided	VCV000492868	18	13884958	18	13884959	492868	485785	rs1555619406	NC_000018.10:13884958:A:
NM_000529.2(MC2R):c.433C>T (p.Arg145Cys)	MC2R	R145C	Glucocorticoid Deficiency	Pathogenic(Last reviewed: Feb 8, 2013)	no assertion criteria provided	VCV000492866	18	13885085	18	13885086	492866	485787	rs139218324	NC_000018.10:13885085:G:A
NM_000529.2(MC2R):c.410G>C (p.Arg137Pro)	MC2R	R137P	Glucocorticoid Deficiency	Pathogenic(Last reviewed: Jan 23, 2009)	no assertion criteria provided	VCV000492865	18	13885108	18	13885109	492865	485788	rs1208417750	NC_000018.10:13885108:C:G
NM_000475.5(NR0B1):c.1362_1363CA[1] (p.Thr455fs)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Mar 5, 2009)	no assertion criteria provided	VCV000492859	X	30322744 - 30322745	X	30304627 - 30304628	492859	485815	rs1555972640	NC_000023.11:30304626:TGTG:TG
NM_000475.5(NR0B1):c.1340T>C (p.Leu447Pro)	NR0B1	L447P	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: May 18, 2016)	no assertion criteria provided	VCV000492858	X	30322769	X	30304652	492858	485816	rs1555972641	NC_000023.11:30304651:A:G
NM_000475.5(NR0B1):c.1168+1_1168+20del	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000492857	X	30326293 - 30326312	X	30308176 - 30308195	492857	485817	rs1555972943	NC_000023.11:30308175:CCTAAGGCCAGTACCCTTACCC:CC
NM_000475.5(NR0B1):c.1123_1124insT (p.Thr375fs)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Nov 28, 2011)	no assertion criteria provided	VCV000492855	X	30326357 - 30326358	X	30308240 - 30308241	492855	485819	rs1555972957	NC_000023.11:30308240::A
NM_000475.5(NR0B1):c.952C>T (p.Gln318Ter)	NR0B1	Q318*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Jan 6, 2009)	no assertion criteria provided	VCV000492854	X	30326529	X	30308412	492854	485820	rs1555972994	NC_000023.11:30308411:G:A
NM_000475.5(NR0B1):c.806T>A (p.Val269Asp)	NR0B1	V269D	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Mar 16, 2011)	no assertion criteria provided	VCV000492853	X	30326675	X	30308558	492853	485821	rs1555973045	NC_000023.11:30308557:A:T
NM_000475.5(NR0B1):c.754del (p.Gln252fs)	NR0B1	Q252fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 26, 2011)	no assertion criteria provided	VCV000492852	X	30326727	X	30308610	492852	485822	rs1555973063	NC_000023.11:30308609:G:
NM_000475.5(NR0B1):c.277del (p.Ala93fs)	NR0B1	A93fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 18, 2013)	no assertion criteria provided	VCV000492851	X	30327204	X	30309087	492851	485823	rs1555973189	NC_000023.11:30309086:CC:C
NM_004006.2(DMD):c.7310-1G>A	DMD		Becker muscular dystrophy|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000492825	X	31792310	X	31774193	492825	485824	rs1556880354	NC_000023.11:31774192:C:T
NM_004006.2(DMD):c.2669T>A (p.Leu890Ter)	DMD	L890*, L767*, L886*, L882*	Duchenne muscular dystrophy|Becker muscular dystrophy	Pathogenic(Last reviewed: May 23, 2014)	no assertion criteria provided	VCV000492823	X	32503170	X	32485053	492823	485826	rs1557380616	NC_000023.11:32485052:A:T
NM_000109.4(DMD):c.606del (p.Lys203fs)	DMD	K203fs, K211fs, K88fs, K207fs	Becker muscular dystrophy|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 19, 2014)	no assertion criteria provided	VCV000492822	X	32827629	X	32809512	492822	485827	rs1557047827	NC_000023.11:32809511:C:
NM_000061.2(BTK):c.1946del (p.Ser649fs)	BTK	S683fs, S649fs, S473fs	Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Mar 23, 2016)	no assertion criteria provided	VCV000492821	X	100604907	X	101349919	492821	485798	rs1555976766	NC_000023.11:101349918:C:
NM_000061.2(BTK):c.1706T>C (p.Leu569Pro)	BTK	L569P, L603P, L393P	Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Sep 25, 2007)	no assertion criteria provided	VCV000492820	X	100608902	X	101353914	492820	485799	rs1555977461	NC_000023.11:101353913:A:G
NM_000061.2(BTK):c.1630_1631+3delinsGAAA	BTK		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Feb 27, 2010)	no assertion criteria provided	VCV000492819	X	100609615 - 100609619	X	101354627 - 101354631	492819	485800	rs1555977580	NC_000023.11:101354626:CACCT:TTTC
NM_000061.2(BTK):c.1581_1584del (p.Cys527fs)	BTK	C351fs, C527fs, C561fs	not provided|Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Aug 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000492818	X	100609665 - 100609668	X	101354677 - 101354680	492818	485801	rs1555977592	NC_000023.11:101354676:CAAACA:CA
NM_000061.2(BTK):c.1567-2A>T	BTK		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Jul 30, 2009)	no assertion criteria provided	VCV000492817	X	100609684	X	101354696	492817	485802	rs1555977598	NC_000023.11:101354695:T:A
NM_000061.2(BTK):c.1116G>C (p.Arg372Ser)	BTK	R372S, R406S	Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Aug 15, 2012)	no assertion criteria provided	VCV000492815	X	100612558	X	101357570	492815	485804	rs1555978024	NC_000023.11:101357569:C:G
NM_000061.2(BTK):c.953C>T (p.Ser318Phe)	BTK	S318F, S352F	Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Sep 29, 2015)	no assertion criteria provided	VCV000492814	X	100613626	X	101358638	492814	485805	rs1555978197	NC_000023.11:101358637:G:A
NM_000061.2(BTK):c.863G>A (p.Arg288Gln)	BTK	R288Q, R322Q	not provided|not specified|Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492813	X	100614312	X	101359324	492813	485806	rs1555978277	NC_000023.11:101359323:C:T
NM_000061.2(BTK):c.435C>A (p.Cys145Ter)	BTK	C145*, C179*	Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000492812	X	100617634	X	101362646	492812	485807	rs1555978891	NC_000023.11:101362645:G:T
NM_000061.2(BTK):c.161del (p.Gly54fs)	BTK	G54fs, G88fs	Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Jul 10, 2009)	no assertion criteria provided	VCV000492810	X	100629603	X	101374615	492810	485809	rs1555980799	NC_000023.11:101374614:CCC:CC
NM_000061.2(BTK):c.141+3_141+6del	BTK		Agammaglobulinemia, non-Bruton type	Pathogenic(Last reviewed: Mar 29, 2005)	no assertion criteria provided	VCV000492809	X	100630126 - 100630129	X	101375138 - 101375141	492809	485810	rs1555980866	NC_000023.11:101375137:ACTTAC:AC
NM_000455.4(STK11):c.923G>A (p.Trp308Ter)	STK11	W308*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000492567	19	1222986	19	1222987	492567	485309	rs864622488	NC_000019.10:1222986:G:A
NM_001687.5(ATP5F1D):c.317T>G (p.Val106Gly)	ATP5F1D	V106G	Mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5|Mitochondrial diseases	Pathogenic(Last reviewed: Sep 17, 2018)	no assertion criteria provided	VCV000489386	19	1244117	19	1244118	489386	482269	rs1555745989	NC_000019.10:1244117:T:G
NM_001983.4(ERCC1):c.525+2T>C	ERCC1		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000489383	19	45922354	19	45419096	489383	482194	rs1555787722	NC_000019.10:45419095:A:G
NM_004928.3(CFAP410):c.355C>T (p.Gln119Ter)	CFAP410	Q119*, Q78*	not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000489375	21	45752934	21	44333051	489375	482220	rs1457263136	NC_000021.9:44333050:G:A
NM_015559.3(SETBP1):c.1264C>T (p.Gln422Ter)	SETBP1	Q422*	not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000489374	18	42530569	18	44950604	489374	482172	rs1555706333	NC_000018.10:44950603:C:T
NM_021140.3(KDM6A):c.398T>G (p.Leu133Ter)	KDM6A	L133*	not provided	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000489348	X	44870219	X	45010974	489348	482254	rs1556115974	NC_000023.11:45010973:T:G
NM_004187.4(KDM5C):c.3058C>T (p.Gln1020Ter)	KDM5C	Q1020*, Q1019*, Q953*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000489301	X	53225160	X	53195978	489301	482260	rs1556836399	NC_000023.11:53195977:G:A
NM_033290.4(MID1):c.756+5G>A	MID1		not provided	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000489249	X	10491127	X	10523087	489249	482230	rs1555899082	NC_000023.11:10523086:C:T
NM_001282531.3(ADNP):c.2230G>T (p.Glu744Ter)	ADNP	E744*	not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000489245	20	49509021	20	50892484	489245	482211	rs1555809957	NC_000020.11:50892483:C:A
NM_172107.4(KCNQ2):c.927+1G>A	KCNQ2		not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000489239	20	62070950	20	63439597	489239	482213	rs1555870346	NC_000020.11:63439596:C:T
NM_004859.4(CLTC):c.769C>T (p.Gln257Ter)	CLTC	Q261*, Q257*	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000489236	17	57728651	17	59651290	489236	482145	rs1555603752	NC_000017.11:59651289:C:T
NM_178152.3(DCX):c.192C>G (p.Tyr64Ter)	DCX	Y64*, Y145*	not provided	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000489234	X	110653435	X	111410207	489234	482231	rs764964209	NC_000023.11:111410206:G:C
NM_000455.4(STK11):c.393C>G (p.Tyr131Ter)	STK11	Y131*	not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000489222	19	1219341	19	1219342	489222	482184	rs760399253	NC_000019.10:1219341:C:G
NM_020964.3(EPG5):c.772G>T (p.Glu258Ter)	EPG5	E258*	not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000489218	18	43534596	18	45954630	489218	482173	rs1555681647	NC_000018.10:45954629:C:A
NM_138927.3(SON):c.5767C>T (p.Arg1923Ter)	SON	R1923*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000489214	21	34927304	21	33554998	489214	482217	rs1033229812	NC_000021.9:33554997:C:T
NM_000355.4(TCN2):c.871C>T (p.Gln291Ter)	TCN2	Q291*, Q264*	not provided	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000489213	22	31011705	22	30615718	489213	482226	rs1461973241	NC_000022.11:30615717:C:T
NM_014646.2(LPIN2):c.1594C>T (p.Gln532Ter)	LPIN2	Q532*	not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000489197	18	2928615	18	2928617	489197	482170	rs1175109245	NC_000018.10:2928616:G:A
NM_005215.4(DCC):c.1911+1G>C	DCC		not provided	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000489193	18	50741968	18	53215598	489193	482177	rs1555732204	NC_000018.10:53215597:G:C
NM_004859.4(CLTC):c.2050C>T (p.Gln684Ter)	CLTC	Q688*, Q684*	not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000489191	17	57744260	17	59666899	489191	482146	rs1555605497	NC_000017.11:59666898:C:T
NM_001022.4(RPS19):c.411+2T>C	RPS19		not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000489187	19	42373825	19	41869755	489187	482193	rs1555841598	NC_000019.10:41869754:T:C
NM_001323289.2(CDKL5):c.786C>A (p.Tyr262Ter)	CDKL5	Y262*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489166	X	18613509	X	18595389	489166	482246	rs1555951146	NC_000023.11:18595388:C:A
NM_003688.3(CASK):c.1A>T (p.Met1Leu)	CASK	M1L	not provided	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000489154	X	41782241	X	41922988	489154	482253	rs1556313516	NC_000023.11:41922987:T:A
NM_005993.5(TBCD):c.988C>T (p.Gln330Ter)	TBCD	Q330*	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000489140	17	80763788	17	82805912	489140	482160	rs1419604407	NC_000017.11:82805911:C:T
NM_001356.4(DDX3X):c.543+5G>A	DDX3X		not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000489129	X	41202094	X	41342841	489129	482250	rs1555953039	NC_000023.11:41342840:G:A
NM_015559.3(SETBP1):c.821G>A (p.Trp274Ter)	SETBP1	W274*	not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000489124	18	42530126	18	44950161	489124	482171	rs1555705966	NC_000018.10:44950160:G:A
NM_003573.2(LTBP4):c.4119T>G (p.Tyr1373Ter)	LTBP4	Y1343*, Y1373*, Y1410*	not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000489109	19	41132923	19	40627018	489109	482192	rs1555744253	NC_000019.10:40627017:T:G
NM_138927.3(SON):c.403G>T (p.Glu135Ter)	SON	E135*	not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000489105	21	34921940	21	33549634	489105	482216	rs1555897997	NC_000021.9:33549633:G:T
NM_001184880.2(PCDH19):c.2147+1G>A	PCDH19		not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000489093	X	99661448	X	100406450	489093	482227	rs1555984947	NC_000023.11:100406449:C:T
NM_003688.3(CASK):c.846C>A (p.Tyr282Ter)	CASK	Y282*	not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000489049	X	41495900	X	41636647	489049	482252	rs886128077	NC_000023.11:41636646:G:T
NM_001282531.3(ADNP):c.2239G>T (p.Glu747Ter)	ADNP	E747*	not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000489048	20	49509012	20	50892475	489048	482210	rs1555809953	NC_000020.11:50892474:C:A
NM_001029896.2(WDR45):c.574C>T (p.Gln192Ter)	WDR45	Q193*, Q192*	not provided	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000489044	X	48933355	X	49075696	489044	482257	rs1557084077	NC_000023.11:49075695:G:A
NM_024417.5(FDXR):c.1A>G (p.Met1Val)	FDXR	M1V	not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000489042	17	72869069	17	74872944	489042	482156	rs1323016653	NC_000017.11:74872943:T:C
NM_001029896.2(WDR45):c.307A>T (p.Lys103Ter)	WDR45	K104*, K103*	not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000489040	X	48934338	X	49076679	489040	482258	rs1557084310	NC_000023.11:49076678:T:A
NM_171998.4(RAB39B):c.2T>C (p.Met1Thr)	RAB39B	M1T	not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000489029	X	154493572	X	155264287	489029	482245	rs1557314544	NC_000023.11:155264286:A:G
NM_001083962.2(TCF4):c.1726C>T (p.Arg576Ter)	TCF4	R576*, R678*, R360*, R411*, R416*, R446*, R530*, R534*, R547*, R548*, R551*, R553*, R571*, R552*, R575*, R582*, R412*, R442*, R501*, R505*, R569*, R572*	not provided|Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488988	18	52896231	18	55229000	488988	482178	rs1555710726	NC_000018.10:55228999:G:A
NM_013995.2(LAMP2):c.718C>T (p.Gln240Ter)	LAMP2	Q240*	not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000488987	X	119581719	X	120447864	488987	482232	rs1556101420	NC_000023.11:120447863:G:A
NM_015338.5(ASXL1):c.4243C>T (p.Arg1415Ter)	ASXL1	R1415*, R1354*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488969	20	31024758	20	32436955	488969	482203	rs754129466	NC_000020.11:32436954:C:T
NM_032620.4(GTPBP3):c.2T>A (p.Met1Lys)	GTPBP3	M1K	not provided	Pathogenic(Last reviewed: Nov 28, 2015)	criteria provided, single submitter	VCV000488854	19	17448422	19	17337613	488854	482186	rs1019249439	NC_000019.10:17337612:T:A
NM_000330.3(RS1):c.1A>T (p.Met1Leu)	RS1	M1L	not provided	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000488837	X	18690188	X	18672068	488837	482248	rs281865332	NC_000023.11:18672067:T:A
NM_005535.3(IL12RB1):c.913A>T (p.Lys305Ter)	IL12RB1	K305*, K345*	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000488832	19	18183030	19	18072220	488832	482188	rs1555782866	NC_000019.10:18072219:T:A
NM_003639.4(IKBKG):c.868C>T (p.Gln290Ter)	IKBKG	Q290*, Q289*, Q358*	not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000488830	X	153791124	X	154562909	488830	482243	rs1156900338	NC_000023.11:154562908:C:T
NM_000444.6(PHEX):c.1218T>A (p.Cys406Ter)	PHEX	C406*	not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000488751	X	22132620	X	22114502	488751	482249	rs1416252114	NC_000023.11:22114501:T:A
NM_198129.3(LAMA3):c.5016C>A (p.Tyr1672Ter)	LAMA3	Y1672*, Y63*	not provided	Pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, single submitter	VCV000488702	18	21456275	18	23876311	488702	482169	rs1169182678	NC_000018.10:23876310:C:A
NM_001278116.2(L1CAM):c.3071C>G (p.Ser1024Ter)	L1CAM	S1024*, S1019*	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000488701	X	153130135	X	153864680	488701	482240	rs1557090143	NC_000023.11:153864679:G:C
NM_001278116.2(L1CAM):c.1672C>T (p.Arg558Ter)	L1CAM	R558*, R553*	Spastic paraplegia|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488700	X	153133788	X	153868333	488700	482241	rs1557091773	NC_000023.11:153868332:G:A
NM_001278116.2(L1CAM):c.1379G>A (p.Trp460Ter)	L1CAM	W460*, W455*	not provided	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000488699	X	153134296	X	153868841	488699	482242	rs1557092042	NC_000023.11:153868840:C:T
NM_000216.4(ANOS1):c.1267C>T (p.Arg423Ter)	ANOS1	R423*	|not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488697	X	8522080	X	8554039	488697	482267	rs1555893221	NC_000023.11:8554038:G:A
NM_000206.2(IL2RG):c.281C>A (p.Ser94Ter)	IL2RG	S94*	not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000488696	X	70330527	X	71110677	488696	482264	rs775704953	NC_000023.11:71110676:G:T
NM_001127898.4(CLCN5):c.292C>T (p.Arg98Ter)	CLCN5	R28*, R98*, R48*	not provided|	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488682	X	49834662	X	50070007	488682	482259	rs1049618423	NC_000023.11:50070006:C:T
NM_000390.4(CHM):c.1218C>A (p.Cys406Ter)	CHM	C406*, C258*	not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000488681	X	85166292	X	85911287	488681	482268	rs1556277815	NC_000023.11:85911286:G:T
NM_018684.4(ZC4H2):c.22_23del (p.Met8fs)	ZC4H2	M8fs	Wieacker Wolff syndrome	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000488641	X	64196235 - 64196236	X	64976355 - 64976356	488641	481509	rs1555945816	NC_000023.11:64976354:AT:
NM_001039591.3(USP9X):c.4756del (p.Ala1587fs)	USP9X	A1587fs	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488635	X	41060465	X	41201212	488635	481503	rs1555930128	NC_000023.11:41201211:C:
NM_023010.3(UPF3B):c.1312del (p.Arg438fs)	UPF3B	R451fs, R438fs	Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000488634	X	118968942	X	119834979	488634	481502	rs1556377028	NC_000023.11:119834978:G:
NM_001001563.5(TIMM50):c.715C>T (p.Arg239Trp)	TIMM50	R342W, R239W, R126W		Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000488623	19	39978719	19	39488079	488623	481491	rs1449758112	NC_000019.10:39488078:C:T
NM_001001563.5(TIMM50):c.664G>A (p.Ala222Thr)	TIMM50	A325T, A222T, A109T		Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000488622	19	39977103	19	39486463	488622	481490	rs1305711807	NC_000019.10:39486462:G:A
NM_000346.4(SOX9):c.1372C>T (p.Gln458Ter)	SOX9	Q458*	Camptomelic dysplasia	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488604	17	70120370	17	72124229	488604	481472	rs1555629443	NC_000017.11:72124228:C:T
NM_176787.5(PIGN):c.1717dup (p.Thr573fs)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000488578	18	59774071 - 59774072	18	62106838 - 62106839	488578	481446	rs1555683948	NC_000018.10:62106838:T:TT
NM_001015877.2(PHF6):c.29_30dup (p.Pro11fs)	PHF6		Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000488575	X	133511674 - 133511675	X	134377644 - 134377645	488575	481443	rs1556013203	NC_000023.11:134377644:GGG:GGGGG
NM_000284.4(PDHA1):c.930_932AAG[1] (p.Arg311del)	PDHA1	R311del	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000488571	X	19377064 - 19377066	X	19358946 - 19358948	488571	481439	rs1555935223	NC_000023.11:19358945:AAGAAG:AAG
NM_000284.4(PDHA1):c.491A>G (p.Asn164Ser)	PDHA1	N164S, N202S, N171S	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000488569	X	19371272	X	19353154	488569	481437	rs1555933963	NC_000023.11:19353153:A:G
NM_002361.4(MAG):c.512_516AGCTG[3] (p.Trp174Ter)	MAG		Spastic paraplegia 75, autosomal recessive	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488543	19	35790549 - 35790550	19	35299646 - 35299647	488543	481411	rs771777424	NC_000019.10:35299646:CTGAGCTGAGCTG:CTGAGCTGAGCTGAGCTG
NM_014727.2(KMT2B):c.521dup (p.Thr176fs)	KMT2B		Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000488539	19	36210763 - 36210764	19	35719861 - 35719862	488539	481407	rs763183959	NC_000019.10:35719861:CCCCCCC:CCCCCCCC
NM_032620.4(GTPBP3):c.643G>T (p.Glu215Ter)	GTPBP3	E237*, E215*	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000488527	19	17449814	19	17339005	488527	481395	rs1555726849	NC_000019.10:17339004:G:T
NM_012179.4(FBXO7):c.152del (p.Asn51fs)	FBXO7	N51fs	Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488517	22	32874996	22	32479009	488517	481385	rs1228608709	NC_000022.11:32479008:AA:A
NM_014297.5(ETHE1):c.375+5G>A	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488509	19	44030348	19	43526196	488509	481377	rs769259233	NC_000019.10:43526195:C:T
NM_014297.5(ETHE1):c.586G>A (p.Asp196Asn)	ETHE1	D196N, D98N, D185N, D73N	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488508	19	44012936	19	43508784	488508	481376	rs763799125	NC_000019.10:43508783:C:T
NM_020964.3(EPG5):c.1501A>T (p.Lys501Ter)	EPG5	K501*	Vici syndrome	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000488507	18	43528539	18	45948573	488507	481375	rs1203870830	NC_000018.10:45948572:T:A
NM_020964.3(EPG5):c.1924C>T (p.Arg642Ter)	EPG5	R642*	Vici syndrome	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000488506	18	43523146	18	45943180	488506	481374	rs912986968	NC_000018.10:45943179:G:A
NM_017613.4(DONSON):c.683G>A (p.Trp228Ter)	DONSON	W228*	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000488493	21	34956998	21	33584692	488493	481361	rs777061964	NC_000021.9:33584691:C:T
NM_001127898.4(CLCN5):c.575G>A (p.Trp192Ter)	CLCN5	W192*, W122*, W142*		Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000488483	X	49840609	X	50075954	488483	481351	rs1557192084	NC_000023.11:50075953:G:A
NM_001323289.2(CDKL5):c.554+1G>A	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488478	X	18602474	X	18584354	488478	481346	rs1555950083	NC_000023.11:18584353:G:A
NM_001323289.2(CDKL5):c.453del (p.Cys152fs)	CDKL5	C152fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000488477	X	18600060	X	18581940	488477	481345	rs1555949763	NC_000023.11:18581939:G:
NM_001256447.2(BCAP31):c.363_364TC[1] (p.Leu122fs)	BCAP31		Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000488474	X	152969525 - 152969526	X	153704070 - 153704071	488474	481342	rs1557047954	NC_000023.11:153704069:GAGAG:GAG
NM_001164603.1(ASXL1):c.217A>T (p.Lys73Ter)	ASXL1	K73*, K63*	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000488471	20	30956891	20	32369088	488471	481339	rs1555901138	NC_000020.11:32369087:A:T
NM_006907.4(PYCR1):c.59dup (p.Ala21fs)	PYCR1		Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Jul 24, 2017)	no assertion criteria provided	VCV000488457	17	79894631 - 79894632	17	81936755 - 81936756	488457	481325	rs762218403	NC_000017.11:81936755:G:GG
NM_006907.4(PYCR1):c.355C>T (p.Arg119Cys)	PYCR1	R119C, R146C	Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Jul 28, 2017)	no assertion criteria provided	VCV000488456	17	79892987	17	81935111	488456	481324	rs121918376	NC_000017.11:81935110:G:A
NM_004586.3(RPS6KA3):c.327del (p.Arg110fs)	RPS6KA3	R110fs	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jun 22, 2017)	no assertion criteria provided	VCV000488448	X	20213262	X	20195144	488448	481327	rs1555943492	NC_000023.11:20195143:AA:A
NM_015338.5(ASXL1):c.3754_3758del (p.Gln1251_Asp1252insTer)	ASXL1		Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 20, 2017)	no assertion criteria provided	VCV000488446	20	31024265 - 31024269	20	32436462 - 32436466	488446	481326	rs1555912709	NC_000020.11:32436461:ACAGGACAG:ACAG
NM_001081550.2(THOC2):c.2138G>A (p.Gly713Asp)	THOC2	G713D	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488431	X	122766890	X	123633039	488431	481304	rs1556023928	NC_000023.11:123633038:C:T
NM_004859.4(CLTC):c.4663C>T (p.Gln1555Ter)	CLTC	Q1555*, Q1559*	Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488420	17	57763005	17	59685644	488420	481276	rs1555607682	NC_000017.11:59685643:C:T
NM_004859.4(CLTC):c.3140T>C (p.Leu1047Pro)	CLTC	L1047P, L1051P	Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488419	17	57758730	17	59681369	488419	481275	rs1555607159	NC_000017.11:59681368:T:C
NM_004859.4(CLTC):c.977_980del (p.Ser326fs)	CLTC	S326fs, S330fs	Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488417	17	57737757 - 57737760	17	59660396 - 59660399	488417	481273	rs1555604778	NC_000017.11:59660395:GTCAGT:GT
NM_004859.4(CLTC):c.4575dup (p.Glu1526fs)	CLTC		Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 5, 2018)	no assertion criteria provided	VCV000488416	17	57762556 - 57762557	17	59685195 - 59685196	488416	481272	rs1555607621	NC_000017.11:59685195:A:AA
NM_001015877.2(PHF6):c.673C>T (p.Arg225Ter)	PHF6	R225*, R226*	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000488410	X	133547940	X	134413910	488410	481264	rs1556018932	NC_000023.11:134413909:C:T
NM_000033.4(ABCD1):c.1201C>T (p.Arg401Trp)	ABCD1	R401W	Adrenoleukodystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000488393	X	153001685	X	153736231	488393	481244	rs727503786	NC_000023.11:153736230:C:T
NM_001429.4(EP300):c.3262-2A>G	EP300		Rubinstein-Taybi syndrome 1|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488375	22	41553171	22	41157167	488375	481223	rs1555910114	NC_000022.11:41157166:A:G
NM_203473.3(PORCN):c.1008+2T>A	PORCN		Focal dermal hypoplasia	Pathogenic(Last reviewed: May 27, 2017)	no assertion criteria provided	VCV000487811	X	48374183	X	48515795	487811	480819	rs1556975151	NC_000023.11:48515794:T:A
NM_023935.3(DDRGK1):c.408+1G>A	DDRGK1			Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000487527	20	3180987	20	3200341	487527	480578	rs1325869434	NC_000020.11:3200340:C:T
NM_002501.4(NFIX):c.416G>A (p.Gly139Glu)	NFIX	G139E, G147E, G131E, G92E, G138E	Marshall-Smith syndrome	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000487523	19	13136223	19	13025409	487523	480574	rs1555696625	NC_000019.10:13025408:G:A
GINS1, -60A-G	GINS1		Combined immunodeficiency due to GINS1 deficiency	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000487512					487512	480563		
NM_021067.5(GINS1):c.-48C>G	GINS1		Combined immunodeficiency due to GINS1 deficiency	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000487510	20	25388409	20	25407773	487510	480561	rs974304393	NC_000020.11:25407772:C:G
NM_002490.6(NDUFA6):c.265G>T (p.Glu89Ter)	NDUFA6	E115*, E89*	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487478	22	42482309	22	42086305	487478	480532	rs758833609	NC_000022.11:42086304:C:A
NM_002490.6(NDUFA6):c.191G>C (p.Arg64Pro)	NDUFA6	R90P, R64P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487477	22	42483128	22	42087124	487477	480533	rs750830935	NC_000022.11:42087123:C:G
NM_002490.6(NDUFA6):c.3G>A (p.Met1Ile)	NDUFA6	M27I, M1I	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487476	22	42486746	22	42090742	487476	480534	rs1023075742	NC_000022.11:42090741:C:T
NM_002490.6(NDUFA6):c.331_332del (p.Glu111fs)	NDUFA6	E111fs	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33|Mitochondrial diseases	Pathogenic(Last reviewed: Dec 13, 2018)	no assertion criteria provided	VCV000487475	22	42482242 - 42482243	22	42086238 - 42086239	487475	480531	rs1569463838	NC_000022.11:42086237:TCT:T
NM_000271.5(NPC1):c.3742_3745del (p.Leu1248fs)	NPC1	L1248fs	Niemann-Pick disease type C1|Niemann-Pick disease, type C	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487441	18	21113328 - 21113331	18	23533364 - 23533367	487441	480509	rs774943545	NC_000018.10:23533363:TGAGT:T
NM_001193466.2(KANSL1):c.572del (p.Gly191fs)	KANSL1	G191fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000487349	17	44248938	17	46171572	487349	480418	rs1555575816	NC_000017.11:46171571:CCCCC:CCCC
NM_001347721.2(DYRK1A):c.638-9_638-5del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000487250	21	38862466 - 38862470	21	37490164 - 37490168	487250	471646	rs1555984064	NC_000021.9:37490163:TTCTCTT:TT
NM_001429.4(EP300):c.3684_3687del (p.Lys1228fs)	EP300	K1228fs, K1202fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000487228	22	41558737 - 41558740	22	41162733 - 41162736	487228	470318	rs1555910482	NC_000022.11:41162732:AAAGAA:AA
NM_001429.4(EP300):c.3070_3074del (p.Lys1024fs)	EP300	K1024fs, K998fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000487227	22	41548281 - 41548285	22	41152277 - 41152281	487227	470316	rs1555909697	NC_000022.11:41152276:AAAAGA:A
NM_000455.4(STK11):c.108C>G (p.Tyr36Ter)	STK11	Y36*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000486996	19	1207020	19	1207021	486996	479835	rs137853079	NC_000019.10:1207020:C:G
NM_000455.4(STK11):c.67del (p.Asp23fs)	STK11	D23fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000486995	19	1206978	19	1206979	486995	479831	rs1555734904	NC_000019.10:1206978:GG:G
NM_005359.5(SMAD4):c.275_276delAT (p.His92Argfs)	SMAD4	H92fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000486989	18	48575081 - 48575082	18	51048711 - 51048712	486989	480129	rs1555685156	NC_000018.10:51048710:AT:
NM_005359.5(SMAD4):c.905G>A (p.Trp302Ter)	SMAD4	W302*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000486988	18	48586236	18	51059866	486988	479406	rs1555686071	NC_000018.10:51059865:G:A
NM_005359.5(SMAD4):c.1239_1241delCTT (p.Tyr413_Asp552del)	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000486987	18	48593488 - 48593490	18	51067118 - 51067120	486987	480171	rs1555686610	NC_000018.10:51067117:CTT:
NM_005359.5(SMAD4):c.1201dup (p.Cys401Leufs)	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 17, 2016)	criteria provided, single submitter	VCV000486983	18	48593449 - 48593450	18	51067079 - 51067080	486983	479441	rs1555686604	NC_000018.10:51067079:T:TT
NM_005359.5(SMAD4):c.903delC (p.Trp302Glyfs)	SMAD4	W302fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000486981	18	48584825	18	51058455	486981	479414	rs1555685978	NC_000018.10:51058454:C:
NM_005359.5(SMAD4):c.752delA (p.Asn251Metfs)	SMAD4	N251fs	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000486978	18	48584578	18	51058208	486978	479361	rs1555685925	NC_000018.10:51058207:AA:A
NM_005359.5(SMAD4):c.1418delG (p.Gly473Aspfs)	SMAD4	G473fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000486454	18	48603116	18	51076746	486454	479410	rs1555687388	NC_000018.10:51076745:GG:G
NM_005359.5(SMAD4):c.1349_1376del28 (p.Gln450Leufs)	SMAD4	Q450fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000486450	18	48603039 - 48603066	18	51076669 - 51076696	486450	479398	rs876660720	NC_000018.10:51076668:TGCAGCAGCAGGCGGCTACTGCACAAGCTGCAGCAGC:TGCAGCAGC
NM_005359.5(SMAD4):c.1023delT (p.Pro342Leufs)	SMAD4	P342fs	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000486447	18	48591859	18	51065489	486447	479430	rs1555686469	NC_000018.10:51065488:TT:T
NM_000455.4(STK11):c.357del (p.Asn119fs)	STK11	N119fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000485010	19	1218482	19	1218483	485010	479783	rs1555737444	NC_000019.10:1218482:C:
NM_004312.3(ARR3):c.239T>C (p.Leu80Pro)	ARR3	L80P	MYOPIA 26, X-LINKED, FEMALE-LIMITED	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000478826	X	69496025	X	70276175	478826	472252	rs1555941116	NC_000023.11:70276174:T:C
NM_004312.3(ARR3):c.298C>T (p.Arg100Ter)	ARR3	R100*	MYOPIA 26, X-LINKED, FEMALE-LIMITED	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000478825	X	69496084	X	70276234	478825	472251	rs1555941129	NC_000023.11:70276233:C:T
NM_004312.3(ARR3):c.893C>A (p.Ala298Asp)	ARR3	A298D	MYOPIA 26, X-LINKED, FEMALE-LIMITED	Pathogenic(Last reviewed: Dec 22, 2017)	no assertion criteria provided	VCV000478824	X	69498479	X	70278629	478824	472250	rs765658563	NC_000023.11:70278628:C:A
NM_145045.5(CCDC151):c.267dup (p.Glu90Ter)	CCDC151		Ciliary dyskinesia, primary, 30	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000477980	19	11541817 - 11541818	19	11430997 - 11430998	477980	470361	rs1555723797	NC_000019.10:11430997:AAAAAAA:AAAAAAAA
NM_000166.6(GJB1):c.77C>G (p.Ser26Trp)	GJB1	S26W	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000477604	X	70443634	X	71223784	477604	472198	rs587777876	NC_000023.11:71223783:C:G
NM_000166.6(GJB1):c.515C>T (p.Pro172Leu)	GJB1	P172L	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000477599	X	70444072	X	71224222	477599	471000	rs1555937218	NC_000023.11:71224221:C:T
NM_000166.6(GJB1):c.304_306del (p.Glu102del)	GJB1	E102del	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000477594	X	70443861 - 70443863	X	71224011 - 71224013	477594	470989	rs1555937135	NC_000023.11:71224010:GAG:
NM_000166.6(GJB1):c.183dup (p.Ser62fs)	GJB1		Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000477590	X	70443739 - 70443740	X	71223889 - 71223890	477590	470976	rs1555937084	NC_000023.11:71223889:C:CC
NC_000023.10:g.(?_70443018)_(70444429_?)del	GJB1		Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000477588	X	70443018 - 70444429	X	71223168 - 71224579	477588	472031		
NM_001164617.2(GPC3):c.629_654delinsCTTGCA (p.Asn210fs)	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000476661	X	132887887 - 132887912	X	133753860 - 133753885	476661	472060	rs1556297749	NC_000023.11:133753859:CTGGGTCATAATAAGCTTGGGGAAAT:TGCAAG
NM_006494.4(ERF):c.733del (p.Leu245fs)	ERF	L245fs, L170fs	Craniosynostosis 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000476628	19	42753531	19	42249379	476628	468850	rs1555750741	NC_000019.10:42249378:GGGG:GGG
NM_006494.4(ERF):c.619C>T (p.Arg207Ter)	ERF	R207*, R132*	Craniosynostosis 1	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000476627	19	42753645	19	42249493	476627	470963	rs1555750795	NC_000019.10:42249492:G:A
NM_001848.2(COL6A1):c.957_957+7del	COL6A1		Bethlem myopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000476443	21	47410198 - 47410205	21	45990284 - 45990291	476443	471265	rs1556425687	NC_000021.9:45990283:GGTGAGCG:
NM_001848.2(COL6A1):c.868G>T (p.Gly290Trp)	COL6A1	G290W	Bethlem myopathy 1	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000476441	21	47409531	21	45989617	476441	471258	rs121912939	NC_000021.9:45989616:G:T
NM_001848.2(COL6A1):c.823G>T (p.Gly275Trp)	COL6A1	G275W	Bethlem myopathy 1	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000476439	21	47409016	21	45989102	476439	471255	rs1556425467	NC_000021.9:45989101:G:T
NM_001848.2(COL6A1):c.148del (p.Ala49_Leu50insTer)	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000476414	21	47402596	21	45982682	476414	471716	rs1556423728	NC_000021.9:45982681:CCC:CC
NM_001848.2(COL6A1):c.1003-2del	COL6A1		Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000476406	21	47410685	21	45990771	476406	469719	rs1556425835	NC_000021.9:45990770:A:
NM_001127221.1(CACNA1A):c.4429C>T (p.Gln1477Ter)	CACNA1A	Q1477*, Q1476*, Q1480*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000476259	19	13368328	19	13257514	476259	469414	rs1555743942	NC_000019.10:13257513:G:A
NM_001127221.1(CACNA1A):c.2907_2932del (p.Pro970fs)	CACNA1A	P969fs, P970fs, P973fs	not provided|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000476244	19	13409518 - 13409543	19	13298704 - 13298729	476244	469846	rs1555755909	NC_000019.10:13298703:CCCTCCGCTCCGCCTTGTCCTCCGGACCCTCC:CCCTCC
NM_001127221.1(CACNA1A):c.2042del (p.Gln681fs)	CACNA1A	Q680fs, Q681fs	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000476239	19	13414646	19	13303832	476239	469437	rs1555757523	NC_000019.10:13303831:T:
NM_001127221.1(CACNA1A):c.1704G>A (p.Trp568Ter)	CACNA1A	W568*, W567*	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000476236	19	13419310	19	13308496	476236	469861	rs1555759066	NC_000019.10:13308495:C:T
NM_001127221.1(CACNA1A):c.1442del (p.Arg481fs)	CACNA1A	R481fs, R480fs	not provided|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000476235	19	13428042	19	13317228	476235	469868	rs1555762908	NC_000019.10:13317227:C:
NM_001127221.1(CACNA1A):c.1082+1G>A	CACNA1A		Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000476232	19	13446619	19	13335805	476232	468530	rs1272886269	NC_000019.10:13335804:C:T
NM_004975.4(KCNB1):c.1041C>G (p.Ser347Arg)	KCNB1	S347R	Epileptic encephalopathy|Epileptic encephalopathy, early infantile, 26	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000475255	20	47991056	20	49374519	475255	470956	rs587777848	NC_000020.11:49374518:G:C
NM_001008537.3(NEXMIF):c.3595_3611del (p.Lys1199fs)	NEXMIF	K1199fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000474070	X	73960781 - 73960797	X	74740946 - 74740962	474070	471980	rs1556016292	NC_000023.11:74740945:TTACCTTTGAGGGATTTTT:TT
NM_001008537.3(NEXMIF):c.3011_3014del (p.Ser1004fs)	NEXMIF	S1004fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000474068	X	73961378 - 73961381	X	74741543 - 74741546	474068	471006	rs1556016381	NC_000023.11:74741542:TTACTT:TT
NM_001008537.3(NEXMIF):c.2673del (p.Asn891fs)	NEXMIF	N891fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000474064	X	73961719	X	74741884	474064	471013	rs1556016438	NC_000023.11:74741883:G:
NM_001008537.3(NEXMIF):c.2166_2168delinsAC (p.Phe722fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000474060	X	73962224 - 73962226	X	74742389 - 74742391	474060	471993	rs1556016529	NC_000023.11:74742388:TTA:GT
NM_001029896.2(WDR45):c.437-2A>C	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000473122	X	48933606	X	49075947	473122	471614	rs886041693	NC_000023.11:49075946:T:G
NM_001347721.2(DYRK1A):c.284dup (p.Tyr95Ter)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000472250	21	38850585 - 38850586	21	37478283 - 37478284	472250	470660	rs1555979158	NC_000021.9:37478283:A:AA
NM_176787.5(PIGN):c.1258del (p.Leu420fs)	PIGN	L420fs	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000472207	18	59780543	18	62113310	472207	469898	rs1555685797	NC_000018.10:62113309:GGG:GG
NM_021140.3(KDM6A):c.3016C>T (p.Gln1006Ter)	KDM6A	Q1058*, Q1006*, Q961*, Q927*, Q1013*, Q710*	Kabuki syndrome 2	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000471948	X	44938468	X	45079223	471948	472154	rs1556341546	NC_000023.11:45079222:C:T
NM_021140.3(KDM6A):c.2101_2102TC[4] (p.His702fs)	KDM6A		Kabuki syndrome 2	Pathogenic(Last reviewed: Apr 16, 2017)	criteria provided, single submitter	VCV000471947	X	44928999 - 44929000	X	45069754 - 45069755	471947	470828	rs1556328781	NC_000023.11:45069754:CTCTC:CTCTCTCTC
NM_000271.5(NPC1):c.3517dup (p.Arg1173fs)	NPC1		Niemann-Pick disease type C1	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000471943	18	21114483 - 21114484	18	23534519 - 23534520	471943	467901	rs1555631982	NC_000018.10:23534519:T:TT
NM_000071.2(CBS):c.737-1G>C	CBS		Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000471366	21	44484102	21	43063992	471366	471223	rs757428597	NC_000021.9:43063991:C:G
NC_000021.8:g.(?_44478235)_(44485825_?)del	CBS		Classic homocystinuria	Pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000471352	21	44478235 - 44485825	21	43058125 - 43065715	471352	471079		
NM_000023.4(SGCA):c.724G>T (p.Val242Phe)	SGCA	V242F	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000471337	17	48246592	17	50169231	471337	468175	rs200166783	NC_000017.11:50169230:G:T
NM_000023.4(SGCA):c.348_352dup (p.Gln118fs)	SGCA		Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000471332	17	48245341 - 48245342	17	50167980 - 50167981	471332	467925	rs752640127	NC_000017.11:50167980:CTCGGC:CTCGGCTCGGC
NM_001111125.3(IQSEC2):c.863del (p.Val288fs)	IQSEC2	V83fs, V288fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000471277	X	53285118	X	53255936	471277	471910	rs1556865060	NC_000023.11:53255935:A:
NM_001111125.3(IQSEC2):c.4434_4438dup (p.Lys1480fs)	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000471275	X	53263429 - 53263430	X	53234247 - 53234248	471275	472164	rs1556858912	NC_000023.11:53234247:TGGCCT:TGGCCTGGCCT
NM_001111125.3(IQSEC2):c.1649dup (p.Leu551fs)	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000471265	X	53280108 - 53280109	X	53250926 - 53250927	471265	471903	rs1556863398	NC_000023.11:53250926:GGGG:GGGGG
NM_003140.3(SRY):c.380A>G (p.Tyr127Cys)	SRY	Y127C	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000470196	Y	2655265	Y	2787224	470196	472023	rs104894973	NC_000024.10:2787223:T:C
NM_003140.3(SRY):c.264dup (p.Glu89fs)	SRY		46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000470195	Y	2655380 - 2655381	Y	2787339 - 2787340	470195	472025	rs1556370556	NC_000024.10:2787339:T:TT
NM_212472.2(PRKAR1A):c.502+1G>A	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000469066	17	66520219	17	68524078	469066	468302	rs1555813578	NC_000017.11:68524077:G:A
NM_001083962.2(TCF4):c.1557del (p.Asp520fs)	TCF4	D304fs, D495fs, D526fs, D359fs, D478fs, D519fs, D622fs, D360fs, D496fs, D520fs, D390fs, D449fs, D497fs, D517fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000468949	18	52899832	18	55232601	468949	469826	rs1555717982	NC_000018.10:55232600:A:
NM_001083962.2(TCF4):c.1504del (p.Gln502fs)	TCF4	Q460fs, Q604fs, Q286fs, Q341fs, Q477fs, Q478fs, Q508fs, Q342fs, Q372fs, Q431fs, Q479fs, Q499fs, Q501fs, Q502fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000468948	18	52899885	18	55232654	468948	468078	rs1555718426	NC_000018.10:55232653:G:
NM_152296.5(ATP1A3):c.2408G>A (p.Gly803Asp)	ATP1A3	G803D, G816D, G814D	Dystonia 12	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000468598	19	42474550	19	41970398	468598	469865	rs1555859571	NC_000019.10:41970397:C:T
NM_001193466.2(KANSL1):c.808_809del (p.Leu270fs)	KANSL1	L270fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000468412	17	44248701 - 44248702	17	46171335 - 46171336	468412	468132	rs551541795	NC_000017.11:46171334:AG:
NM_001193466.2(KANSL1):c.2132dup (p.Met711fs)	KANSL1		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000468402	17	44117138 - 44117139	17	46039772 - 46039773	468402	467813	rs1555734136	NC_000017.11:46039772:A:AA
NM_024422.6(DSC2):c.996T>G (p.Tyr332Ter)	DSC2	Y332*	Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000468388	18	28662973	18	31083007	468388	469690	rs1555639134	NC_000018.10:31083006:A:C
NM_000022.4(ADA):c.703C>T (p.Arg235Trp)	ADA	R235W, R211W, R100W	Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468281	20	43251547	20	44622906	468281	470393	rs778809577	NC_000020.11:44622905:G:A
NM_030777.4(SLC2A10):c.648C>G (p.Tyr216Ter)	SLC2A10	Y216*	Thoracic aortic aneurysm and aortic dissection|Arterial tortuosity syndrome	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000467819	20	45354323	20	46725684	467819	469401	rs1015798796	NC_000020.11:46725683:C:G
NM_001242897.2(DEPDC5):c.2660_2685del (p.His887fs)	DEPDC5	H887fs, H956fs, H937fs, H965fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000466477	22	32241090 - 32241115	22	31845104 - 31845129	466477	471543	rs1555900914	NC_000022.11:31845103:AGGCCCACTGCGACATCTATGGGGACAGGCCC:AGGCCC
NM_001242897.2(DEPDC5):c.1385_1386del (p.Ala461_Tyr462insTer)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000466450	22	32206566 - 32206567	22	31810580 - 31810581	466450	471094	rs1555882921	NC_000022.11:31810579:TAT:T
NC_000022.10:g.(?_32154512)_(32174174_?)del	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000466446	22	32154512 - 32174174			466446	470889		
NC_000022.10:g.(?_32150888)_(32150985_?)del	DEPDC5		Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000466445	22	32150888 - 32150985	22	31754902 - 31754999	466445	470887		
NM_001943.5(DSG2):c.621_626del (p.Tyr207_Pro209delinsTer)	DSG2		Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000466348	18	29102143 - 29102148	18	31522180 - 31522185	466348	468900	rs1555671331	NC_000018.10:31522179:TCCTCC:
NM_020964.3(EPG5):c.3762_3789dup (p.Ala1264delinsTyrTer)	EPG5		Vici syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000466248	18	43493697 - 43493698	18	45913732 - 45913733	466248	469361	rs1555673890	NC_000018.10:45913732:AGAGTTTATCACCAATTCCCCTTCAATAA:AGAGTTTATCACCAATTCCCCTTCAATAAGAGTTTATCACCAATTCCCCTTCAATAA
NM_001184880.2(PCDH19):c.619del (p.Arg207fs)	PCDH19	R207fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000465307	X	99662977	X	100407979	465307	472038	rs1555985543	NC_000023.11:100407978:GG:G
NM_001184880.2(PCDH19):c.2453del (p.Gln818fs)	PCDH19	Q818fs, Q771fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000465300	X	99657685	X	100402687	465300	471657	rs1555984453	NC_000023.11:100402686:T:
NM_001184880.2(PCDH19):c.1442_1448del (p.Asp481fs)	PCDH19	D481fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000465297	X	99662148 - 99662154	X	100407150 - 100407156	465297	472034	rs1555985163	NC_000023.11:100407149:CCCAGGTC:C
NM_001005360.2(DNM2):c.1853C>A (p.Ala618Asp)	DNM2	A618D, A614D	Charcot-Marie-Tooth disease, dominant intermediate B	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000465283	19	10934535	19	10823859	465283	469097	rs1555715869	NC_000019.10:10823858:C:A
NM_001123383.1(BCOR):c.3410_3411del (p.Lys1137fs)	BCOR	K1119fs, K1137fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000465159	X	39923680 - 39923681	X	40064427 - 40064428	465159	472149	rs1555915763	NC_000023.11:40064426:TTT:T
NM_001123383.1(BCOR):c.3388dup (p.Leu1130fs)	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000465158	X	39923702 - 39923703	X	40064449 - 40064450	465158	471551	rs1555915785	NC_000023.11:40064449:GGG:GGGG
NM_002049.3(GATA1):c.89C>G (p.Ser30Ter)	GATA1	S30*	Diamond-Blackfan anemia|GATA-1-related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000465134	X	48649605	X	48791198	465134	471606	rs1557020021	NC_000023.11:48791197:C:G
NM_002049.3(GATA1):c.21del (p.Ser8fs)	GATA1	S8fs	Diamond-Blackfan anemia|GATA-1-related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000465133	X	48649534	X	48791127	465133	472161	rs1557020001	NC_000023.11:48791126:GGGG:GGG
NM_003413.4(ZIC3):c.476_479del (p.Tyr159fs)	ZIC3	Y159fs		Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000464967	X	136649325 - 136649328	X	137567166 - 137567169	464967	471742	rs1556029841	NC_000023.11:137567165:TACTT:T
NM_002872.5(RAC2):c.184G>A (p.Glu62Lys)	RAC2	E62K	Neutrophil immunodeficiency syndrome|Abnormality of cellular immune system|Immunodeficiency|Abnormality of T cell physiology|Lymphopenia|Severe combined immunodeficiency disease|Congenital combined immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000464885	22	37628882	22	37232842	464885	471580	rs1555908409	NC_000022.11:37232841:C:T
NM_001323289.2(CDKL5):c.244del (p.Arg82fs)	CDKL5	R82fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000464813	X	18593572	X	18575452	464813	471428	rs1555949041	NC_000023.11:18575451:A:
NM_001323289.2(CDKL5):c.2345C>A (p.Ser782Ter)	CDKL5	S782*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000464812	X	18638055	X	18619935	464812	471434	rs1555954074	NC_000023.11:18619934:C:A
NM_001323289.2(CDKL5):c.1519C>T (p.Gln507Ter)	CDKL5	Q507*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000464809	X	18622563	X	18604443	464809	471431	rs1555952052	NC_000023.11:18604442:C:T
NM_001323289.2(CDKL5):c.1246G>T (p.Glu416Ter)	CDKL5	E416*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000464808	X	18622290	X	18604170	464808	470650	rs1555951991	NC_000023.11:18604169:G:T
NM_004655.4(AXIN2):c.194_195del (p.Pro65fs)	AXIN2	P65fs	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000464585	17	63554544 - 63554545	17	65558426 - 65558427	464585	468710	rs1555583659	NC_000017.11:65558425:CG:
NM_004655.4(AXIN2):c.1637del (p.Gly546fs)	AXIN2	G546fs	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000464561	17	63533517	17	65537399	464561	468612	rs1555577625	NC_000017.11:65537398:CCCCC:CCCC
NM_015295.2(SMCHD1):c.1040+1G>A	SMCHD1		Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000464158	18	2694692	18	2694694	464158	468787	rs1245372794	NC_000018.10:2694693:G:A
NM_001754.4(RUNX1):c.215_216dup (p.Ser73fs)	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 1, 2019)	reviewed by expert panel	VCV000463988	21	36259274 - 36259275	21	34886977 - 34886978	463988	471192	rs1555899813	NC_000021.9:34886977:CC:CCCC
NC_000021.9:g.(?_35048836)_(35048905_?)del	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 6, 2019)	reviewed by expert panel	VCV000463975	21	36421133 - 36421202	21	35048836 - 35048905	463975	471077		
NM_020436.5(SALL4):c.563del (p.Gly188fs)	SALL4	G188fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000463530	20	50408459	20	51791920	463530	470471	rs1555850961	NC_000020.11:51791919:CCCC:CCC
NM_000216.4(ANOS1):c.1A>T (p.Met1Leu)	ANOS1	M1L		Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000463527	X	8700077	X	8732036	463527	471784	rs606231409	NC_000023.11:8732035:T:A
NM_000891.2(KCNJ2):c.715G>T (p.Glu239Ter)	KCNJ2	E239*	Andersen Tawil syndrome	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000463523	17	68171895	17	70175754	463523	468303	rs1555603974	NC_000017.11:70175753:G:T
NM_000206.2(IL2RG):c.903_910del (p.Glu302fs)	IL2RG	E302fs	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000463387	X	70328141 - 70328148	X	71108291 - 71108298	463387	471671	rs1556329779	NC_000023.11:71108290:GGTATTCAG:G
NM_000206.2(IL2RG):c.720G>A (p.Trp240Ter)	IL2RG	W240*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000463384	X	70329115	X	71109265	463384	470931	rs1556330234	NC_000023.11:71109264:C:T
NM_000206.2(IL2RG):c.602C>G (p.Ser201Ter)	IL2RG	S201*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000463382	X	70329233	X	71109383	463382	471964	rs1556330286	NC_000023.11:71109382:G:C
NM_000206.2(IL2RG):c.562C>T (p.Gln188Ter)	IL2RG	Q188*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000463379	X	70330038	X	71110188	463379	471672	rs1556330552	NC_000023.11:71110187:G:A
NM_000206.2(IL2RG):c.100G>T (p.Glu34Ter)	IL2RG	E34*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000463378	X	70331290	X	71111440	463378	472189	rs1556331272	NC_000023.11:71111439:C:A
NC_000023.10:g.(?_70328127)_(70328196_?)del	IL2RG		X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Dec 26, 2016)	criteria provided, single submitter	VCV000463377	X	70328127 - 70328196	X	71108277 - 71108346	463377	472030		
NM_001022.4(RPS19):c.294_295TG[3] (p.Ala100fs)	RPS19		Diamond-Blackfan anemia	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000463373	19	42373220 - 42373221	19	41869150 - 41869151	463373	468838	rs1555841356	NC_000019.10:41869150:GTGTG:GTGTGTG
NM_001022.4(RPS19):c.185G>A (p.Arg62Gln)	RPS19	R62Q	Diamond-Blackfan anemia	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000463372	19	42373113	19	41869043	463372	468836	rs1555841301	NC_000019.10:41869042:G:A
NM_013995.2(LAMP2):c.696T>A (p.Cys232Ter)	LAMP2	C232*	Danon disease	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000463159	X	119581741	X	120447886	463159	472048	rs1556101523	NC_000023.11:120447885:A:T
NM_198270.4(NHS):c.4093A>T (p.Lys1365Ter)	NHS	K1365*, K1386*, K1209*, K1188*	Nance-Horan syndrome	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000463042	X	17746382	X	17728262	463042	472111	rs1556039901	NC_000023.11:17728261:A:T
NM_198270.4(NHS):c.277G>T (p.Glu93Ter)	NHS	E93*	Nance-Horan syndrome	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000463040	X	17394157	X	17376034	463040	471426	rs1341004065	NC_000023.11:17376033:G:T
NM_198270.4(NHS):c.1399_1402del (p.Asp467fs)	NHS	D311fs, D488fs, D467fs, D290fs	Nance-Horan syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000463037	X	17743686 - 17743689	X	17725566 - 17725569	463037	470640	rs1556038355	NC_000023.11:17725565:CAGACA:CA
NC_000023.10:g.(?_17710435)_(17710608_?)del	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000463036	X	17710435 - 17710608	X	17692315 - 17692488	463036	471608		
NM_000117.2(EMD):c.430G>T (p.Glu144Ter)	EMD	E144*	not provided|Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000462824	X	153609143	X	154380783	462824	471411	rs1557182560	NC_000023.11:154380782:G:T
NM_000117.2(EMD):c.12C>G (p.Tyr4Ter)	EMD	Y4*	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000462823	X	153607856	X	154379496	462823	472104	rs782011714	NC_000023.11:154379495:C:G
NM_172107.4(KCNQ2):c.915C>G (p.Phe305Leu)	KCNQ2	F305L	Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000461423	20	62070963	20	63439610	461423	470995	rs775918190	NC_000020.11:63439609:G:C
Single allele	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000461212			20	63419599 - 63439728	461212	470845		
Single allele	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jun 3, 2017)	criteria provided, single submitter	VCV000461211			20	63406624 - 63439728	461211	470839		
NM_005359.5(SMAD4):c.461C>G (p.Ser154Ter)	SMAD4	S154*	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000460552	18	48581157	18	51054787	460552	468010	rs1555685624	NC_000018.10:51054786:C:G
NM_005359.5(SMAD4):c.1228_1229delCA (p.Gln410Glufs)	SMAD4	Q410fs	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000460532	18	48593476 - 48593477	18	51067106 - 51067107	460532	468990	rs1555686608	NC_000018.10:51067105:ACA:A
NM_005359.5(SMAD4):c.1166_1167delTG (p.Leu389Terfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000460529	18	48593415 - 48593416	18	51067045 - 51067046	460529	468057	rs1555686600	NC_000018.10:51067044:TG:
NM_005359.5(SMAD4):c.1138delA (p.Arg380Glyfs)	SMAD4	R380fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000460526	18	48591974	18	51065604	460526	468050	rs1555686506	NC_000018.10:51065603:AA:A
Single allele	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000460469			18	51065417 - 51067193	460469	469225		
NC_000018.9:g.(?_48573411)_(48604843_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000460460	18	48573411 - 48604843			460460	467889		
NM_000355.4(TCN2):c.766dup (p.Ser256fs)	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000460319	22	31011598 - 31011599	22	30615611 - 30615612	460319	470139	rs1555895066	NC_000022.11:30615611:TT:TTT
NM_000475.5(NR0B1):c.901C>T (p.Gln301Ter)	NR0B1	Q301*	46,XY sex reversal, type 2|Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000460312	X	30326580	X	30308463	460312	471455	rs1555973010	NC_000023.11:30308462:G:A
NM_000475.5(NR0B1):c.552del (p.Glu185fs)	NR0B1	E185fs	46,XY sex reversal, type 2|Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000460311	X	30326929	X	30308812	460311	472119	rs1555973115	NC_000023.11:30308811:TTT:TT
NM_000475.5(NR0B1):c.516G>A (p.Trp172Ter)	NR0B1	W172*	46,XY sex reversal, type 2|Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000460310	X	30326965	X	30308848	460310	471847	rs1555973131	NC_000023.11:30308847:C:T
NM_000159.4(GCDH):c.1189G>A (p.Glu397Lys)	GCDH	E397K	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000459948	19	13008623	19	12897809	459948	468501	rs1555751336	NC_000019.10:12897808:G:A
NM_000159.4(GCDH):c.1064G>A (p.Arg355His)	GCDH	R355H	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000459947	19	13008224	19	12897410	459947	469404	rs748275416	NC_000019.10:12897409:G:A
NM_000052.7(ATP7A):c.3473C>A (p.Ser1158Ter)	ATP7A	S1158*, S1080*	Menkes kinky-hair syndrome|Distal spinal muscular atrophy, X-linked 3|Cutis laxa, X-linked	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000459840	X	77289281	X	78033783	459840	471066	rs1557237451	NC_000023.11:78033782:C:A
NM_024301.5(FKRP):c.158_162dup (p.Glu55fs)	FKRP		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000459232	19	47258862 - 47258863	19	46755605 - 46755606	459232	468909	rs1290836394	NC_000019.10:46755605:GGTGCGG:GGTGCGGTGCGG
NM_024301.5(FKRP):c.142del (p.Arg48fs)	FKRP	R48fs	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000459229	19	47258845	19	46755588	459229	470334	rs1555738103	NC_000019.10:46755587:CCCCC:CCCC
NM_001399.5(EDA):c.970G>A (p.Val324Met)	EDA	V324M, V322M, V319M	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000458662	X	69255253	X	70035403	458662	472187	rs1556110308	NC_000023.11:70035402:G:A
NM_001399.5(EDA):c.628G>T (p.Gly210Ter)	EDA	G210*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000458660	X	69247808	X	70027958	458660	472186	rs1556098733	NC_000023.11:70027957:G:T
NM_001399.5(EDA):c.599dup (p.Gly201fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000458659	X	69247774 - 69247775	X	70027924 - 70027925	458659	471959	rs1556098570	NC_000023.11:70027924:CCCCC:CCCCCC
NM_001399.5(EDA):c.560dup (p.Pro188fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000458658	X	69247737 - 69247738	X	70027887 - 70027888	458658	471958	rs1556098384	NC_000023.11:70027887:CCC:CCCC
NM_001399.5(EDA):c.521_522delinsT (p.Lys174fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000458655	X	69243086 - 69243087	X	70023236 - 70023237	458655	471957	rs1556092261	NC_000023.11:70023235:AA:T
NM_001399.5(EDA):c.228_234delinsAA (p.Leu78fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000458654	X	68836380 - 68836386	X	69616536 - 69616542	458654	470922	rs1555972067	NC_000023.11:69616535:CCGCCTT:AA
NC_000023.10:g.(?_69243048)_(69255479_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000458652	X	69243048 - 69255479			458652	470433		
NC_000023.10:g.(?_69080668)_(69177002_?)dup	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000458651	X	69080668 - 69177002			458651	470380		
Single allele	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000458650			X	69616289 - 69616724	458650	471201		
NM_000033.4(ABCD1):c.766_769dup (p.Val257fs)	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000458649	X	152991486 - 152991487	X	153726031 - 153726032	458649	471351	rs1557052530	NC_000023.11:153726031:AACG:AACGAACG
NM_000033.4(ABCD1):c.70del (p.Leu24fs)	ABCD1	L24fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000458648	X	152990789	X	153725334	458648	471798	rs1557052171	NC_000023.11:153725333:CCC:CC
NM_000033.4(ABCD1):c.537_544dup (p.Arg182fs)	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000458647	X	152991256 - 152991257	X	153725801 - 153725802	458647	472084	rs1557052397	NC_000023.11:153725801:CCTACTACC:CCTACTACCCTACTACC
NM_000033.4(ABCD1):c.521A>G (p.Tyr174Cys)	ABCD1	Y174C	Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000458646	X	152991242	X	153725787	458646	472083	rs1557052390	NC_000023.11:153725786:A:G
NM_000033.4(ABCD1):c.311G>A (p.Arg104His)	ABCD1	R104H	Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000458642	X	152991032	X	153725577	458642	470545	rs1557052302	NC_000023.11:153725576:G:A
NM_000033.4(ABCD1):c.293C>T (p.Ser98Leu)	ABCD1	S98L	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000458641	X	152991014	X	153725559	458641	472082	rs1557052294	NC_000023.11:153725558:C:T
NM_000033.4(ABCD1):c.1998C>A (p.Tyr666Ter)	ABCD1	Y666*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000458639	X	153008949	X	153743495	458639	472086	rs1170974058	NC_000023.11:153743494:C:A
NM_000033.4(ABCD1):c.1780+2T>G	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000458636	X	153006175	X	153740721	458636	471808	rs1557054875	NC_000023.11:153740720:T:G
NM_000033.4(ABCD1):c.1772G>A (p.Arg591Gln)	ABCD1	R591Q	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000458635	X	153006165	X	153740711	458635	470574	rs1557054873	NC_000023.11:153740710:G:A
NM_000033.4(ABCD1):c.1270C>T (p.Gln424Ter)	ABCD1	Q424*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000458629	X	153001844	X	153736390	458629	472085	rs1557054210	NC_000023.11:153736389:C:T
NC_000021.8:g.(?_45705870)_(45717630_?)del	AIRE		Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000458611	21	45705870 - 45717630	21	44285987 - 44297747	458611	471557		
NC_000023.10:g.(?_153128098)_(153141311_?)del	L1CAM		Spastic paraplegia	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000458209	X	153128098 - 153141311			458209	471988		
NM_000455.4(STK11):c.884_888del (p.Ala295fs)	STK11	A295fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000458070	19	1221968 - 1221972	19	1221969 - 1221973	458070	468468	rs1555738863	NC_000019.10:1221968:GCCAAG:G
NM_000455.4(STK11):c.816del (p.Ser271_Tyr272insTer)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000458065	19	1221293	19	1221294	458065	469776	rs1555738667	NC_000019.10:1221293:C:
NM_000455.4(STK11):c.525_532dup (p.Lys178fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000458050	19	1220430 - 1220431	19	1220431 - 1220432	458050	469353	rs1555738219	NC_000019.10:1220431:AGGACATCA:AGGACATCAGGACATCA
NM_000455.4(STK11):c.179_180dup (p.Gly61fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000458034	19	1207090 - 1207091	19	1207091 - 1207092	458034	468455	rs1555735001	NC_000019.10:1207091:AC:ACAC
NC_000019.9:g.(?_1219317)_(1221345_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000458008	19	1219317 - 1221345			458008	469084		
NM_000276.4(OCRL):c.860dup (p.Tyr288fs)	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000457993	X	128695189 - 128695190	X	129561212 - 129561213	457993	470469	rs1556345889	NC_000023.11:129561212:TT:TTT
NM_016418.5(NF2):c.656_657insA (p.Asn220fs)	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000457925	22	30054234 - 30054235	22	29658245 - 29658246	457925	470115	rs1555994819	NC_000022.11:29658245::A
NM_016418.5(NF2):c.592C>T (p.Arg198Ter)	NF2	R198*, R156*, R115*, R157*	not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000457922	22	30051658	22	29655669	457922	470104	rs1555993345	NC_000022.11:29655668:C:T
NM_016418.5(NF2):c.586C>T (p.Arg196Ter)	NF2	R196*, R113*, R154*, R155*	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000457921	22	30051652	22	29655663	457921	471030	rs1555993336	NC_000022.11:29655662:C:T
NM_016418.5(NF2):c.273del (p.Val92fs)	NF2	V50fs, V92fs	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000457911	22	30035111	22	29639122	457911	471883	rs1555987647	NC_000022.11:29639121:A:
NM_016418.5(NF2):c.1737+1G>T	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000457907	22	30077591	22	29681602	457907	471907	rs1556003799	NC_000022.11:29681601:G:T
NC_000023.10:g.(?_148564257)_(148586687_?)del	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000457352	X	148564257 - 148586687			457352	470358		
NM_001195798.2(LDLR):c.1811delinsCT (p.Arg604fs)	LDLR		Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000456651	19	11227640	19	11116964	456651	469713	rs1555806529	NC_000019.10:11116963:G:CT
NC_000019.9:g.(?_11210879)_(11222335_?)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000456644	19	11210879 - 11222335	19	11100203 - 11111659	456644	469072		
NC_000019.9:g.(?_11210879)_(11213482_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000456642	19	11210879 - 11213482	19	11100203 - 11102806	456642	468135		
NM_153638.3(PANK2):c.680A>G (p.Tyr227Cys)	PANK2	Y227C	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000456525	20	3888624	20	3907977	456525	471386	rs1555787646	NC_000020.11:3907976:A:G
NM_153638.3(PANK2):c.1176_1177del (p.Gly393_Val394insTer)	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000456524	20	3891418 - 3891419	20	3910771 - 3910772	456524	470368	rs778550409	NC_000020.11:3910770:AG:
NM_000152.5(GAA):c.2740C>T (p.Gln914Ter)	GAA	Q914*	Glycogen storage disease, type II	Pathogenic(Last reviewed: May 29, 2017)	criteria provided, single submitter	VCV000456415	17	78092545	17	80118746	456415	468575	rs1555603264	NC_000017.11:80118745:C:T
NC_000017.10:g.(?_78091992)_(78092156_?)del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000456368	17	78091992 - 78092156	17	80118193 - 80118357	456368	466300		
NC_000017.10:g.(?_76133778)_(76133915_?)del	TMC8		EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000456001	17	76133778 - 76133915	17	78137697 - 78137834	456001	467383		
NM_004006.2(DMD):c.9928C>T (p.Gln3310Ter)	DMD	Q3310*, Q3306*, Q850*, Q242*, Q3302*, Q1966*, Q1969*, Q3187*, Q581*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000455949	X	31200901	X	31182784	455949	471457	rs104894789	NC_000023.11:31182783:G:A
NM_000109.4(DMD):c.9857_9866del (p.Trp3286fs)	DMD	W1950fs, W226fs, W3286fs, W3290fs, W3294fs, W3171fs, W834fs, W565fs, W1953fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000455948	X	31200939 - 31200948	X	31182822 - 31182831	455948	470679	rs1556046080	NC_000023.11:31182821:ACGGGCAGCCAC:AC
NM_004006.2(DMD):c.9649+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000455947	X	31224698	X	31206581	455947	470684	rs1556256329	NC_000023.11:31206580:C:T
NM_000109.4(DMD):c.8651del (p.Pro2884fs)	DMD	P1551fs, P2884fs, P2888fs, P1548fs, P2769fs, P432fs, P163fs, P2892fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000455939	X	31496485	X	31478368	455939	470693	rs1556656487	NC_000023.11:31478367:GG:G
NM_000109.4(DMD):c.8580dup (p.Val2861fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000455936	X	31497163 - 31497164	X	31479046 - 31479047	455936	471852	rs1556656818	NC_000023.11:31479046:A:AA
NM_004006.2(DMD):c.831+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000455934	X	32717228	X	32699111	455934	471869	rs1239018406	NC_000023.11:32699110:C:T
NM_004013.2(DMD):c.-113del	DMD	K1082fs, K2419fs, K1079fs, K2415fs, K2300fs, K2423fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000455931	X	31838133	X	31820016	455931	471479	rs1556917057	NC_000023.11:31820015:TTT:TT
NM_004006.2(DMD):c.7098+1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000455929	X	31893304	X	31875187	455929	470701	rs1556962223	NC_000023.11:31875186:C:A
NM_004013.2(DMD):c.-395del	DMD	K2321fs, K2206fs, K988fs, K2325fs, K2329fs, K985fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000455927	X	31893417	X	31875300	455927	471483	rs398124040	NC_000023.11:31875299:TTTTTTT:TTTTTT
NM_004006.2(DMD):c.686T>G (p.Leu229Ter)	DMD	L229*, L106*, L221*, L225*	Duchenne muscular dystrophy|not specified	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000455925	X	32717374	X	32699257	455925	470771	rs1556930769	NC_000023.11:32699256:A:C
NM_004006.2(DMD):c.6615-2A>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000455923	X	31950346	X	31932229	455923	470737	rs1557011973	NC_000023.11:31932228:T:A
NM_004006.2(DMD):c.6424A>T (p.Lys2142Ter)	DMD	K2142*, K801*, K2134*, K2138*, K798*, K2019*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000455919	X	32235047	X	32216930	455919	471853	rs1557218076	NC_000023.11:32216929:T:A
NM_000109.4(DMD):c.5589_5616del (p.Lys1863fs)	DMD	K1867fs, K527fs, K530fs, K1748fs, K1863fs, K1871fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000455913	X	32361350 - 32361377	X	32343233 - 32343260	455913	470743	rs1557291170	NC_000023.11:32343232:ATACCACTGATGAGAAATTTCTAGAGCC:
NM_000109.4(DMD):c.4894_4895delinsTG (p.Thr1632Ter)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000455902	X	32383243 - 32383244	X	32365126 - 32365127	455902	471510	rs1557305645	NC_000023.11:32365125:GT:CA
NM_004006.2(DMD):c.2804-1G>T	DMD		not provided|Dilated cardiomyopathy 3B|Becker muscular dystrophy|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000455886	X	32490427	X	32472310	455886	470754	rs398123909	NC_000023.11:32472309:C:A
NM_000109.4(DMD):c.7+127965del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000455874	X	33229411	X	33211294	455874	471872	rs1557300135	NC_000023.11:33211293:C:
NM_004006.2(DMD):c.1865C>A (p.Ser622Ter)	DMD	S622*, S499*, S614*, S618*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000455871	X	32583946	X	32565829	455871	471533	rs886041344	NC_000023.11:32565828:G:T
NM_004006.2(DMD):c.186+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000455870	X	32867844	X	32849727	455870	471871	rs1557084067	NC_000023.11:32849726:C:T
NM_000109.4(DMD):c.1452del (p.Gln484fs)	DMD	Q488fs, Q369fs, Q484fs, Q492fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000455863	X	32632426	X	32614309	455863	472139	rs1556853039	NC_000023.11:32614308:TT:T
NM_004006.2(DMD):c.10238del (p.Ile3413fs)	DMD	I2069fs, I345fs, I684fs, I2072fs, I3290fs, I3413fs, I3405fs, I3409fs, I953fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000455853	X	31196073	X	31177956	455853	472121	rs1556035795	NC_000023.11:31177955:A:
Single allele	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000455849			X	33211262 - 33211366	455849	471647		
NC_000023.10:g.(?_33032666)_(33038337_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000455848	X	33032666 - 33038337	X	33014549 - 33020220	455848	472029		
NC_000023.10:g.(?_32841392)_(32867957_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000455846	X	32841392 - 32867957	X	32823275 - 32849840	455846	471196		
NC_000023.10:g.(?_32841392)_(32841967_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 11, 2017)	criteria provided, single submitter	VCV000455845	X	32841392 - 32841967	X	32823275 - 32823850	455845	470424		
NC_000023.10:g.(?_32827590)_(32841967_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000455843	X	32827590 - 32841967	X	32809473 - 32823850	455843	472028		
NC_000023.10:g.(?_32662229)_(32669194_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000455840			X	32644112 - 32651077	455840	471191		
NC_000023.10:g.(?_32632400)_(32632590_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000455839	X	32632400 - 32632590			455839	471641		
NC_000023.10:g.(?_32429849)_(33038337_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000455835	X	32429849 - 33038337			455835	472027		
NC_000023.10:g.(?_32360197)_(32536268_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000455831	X	32360197 - 32536268	X	32342080 - 32518151	455831	470414		
NC_000023.10:g.(?_32305626)_(32509655_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000455830	X	32305626 - 32509655	X	32287509 - 32491538	455830	472022		
NC_000023.10:g.(?_32305626)_(32305838_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000455829	X	32305626 - 32305838	X	32287509 - 32287721	455829	472021		
Single allele	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000455827			X	32216896 - 32501862	455827	471181		
NC_000023.10:g.(?_32235013)_(32490446_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000455826	X	32235013 - 32490446	X	32216896 - 32472329	455826	472010		
NC_000023.10:g.(?_31947693)_(32383336_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000455824	X	31947693 - 32383336	X	31929576 - 32365219	455824	471180		
NC_000023.10:g.(?_31947693)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000455823	X	31947693 - 31986651			455823	471624		
NC_000023.10:g.(?_31893285)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000455821	X	31893285 - 31986651	X	31875168 - 31968534	455821	471172		
NC_000023.10:g.(?_31947693)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000455820	X	31947693 - 31950364			455820	470410		
NC_000023.10:g.(?_31893285)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000455819	X	31893285 - 31950364	X	31875168 - 31932247	455819	471169		
NC_000023.10:g.(?_31854815)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000455818	X	31854815 - 31986651			455818	472008		
NC_000023.10:g.(?_31854815)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000455817	X	31854815 - 31893510	X	31836698 - 31875393	455817	471163		
NC_000023.10:g.(?_31838072)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000455816	X	31838072 - 31986651			455816	472005		
NC_000023.10:g.(?_31838072)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000455815	X	31838072 - 31950364	X	31819955 - 31932247	455815	471622		
NC_000023.10:g.(?_31838072)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000455814	X	31838072 - 31893510			455814	472004		
NC_000023.10:g.(?_31792057)_(32235200_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000455813	X	31792057 - 32235200	X	31773940 - 32217083	455813	472003		
NC_000023.10:g.(?_31792057)_(31950364_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000455812	X	31792057 - 31950364			455812	470409		
NC_000023.10:g.(?_31792057)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000455811	X	31792057 - 31893510			455811	470406		
Single allele	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000455809			X	31773940 - 31836839	455809	471161		
NC_000023.10:g.(?_31747728)_(31986651_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000455808	X	31747728 - 31986651			455808	471621		
NC_000023.10:g.(?_31747728)_(31893510_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 1, 2017)	criteria provided, single submitter	VCV000455807	X	31747728 - 31893510	X	31729611 - 31875393	455807	471619		
NC_000023.10:g.(?_31697472)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000455805	X	31697472 - 31893510	X	31679355 - 31875393	455805	470398		
Single allele	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000455803			X	31627653 - 31968534	455803	471996		
NC_000023.10:g.(?_31627738)_(31854956_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000455802	X	31627738 - 31854956	X	31609621 - 31836839	455802	470397		
NC_000023.10:g.(?_31627738)_(31838220_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000455801	X	31627738 - 31838220			455801	471615		
NC_000023.10:g.(?_31747728)_(31893510_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000455800	X	31747728 - 31893510			455800	470400		
NC_000023.10:g.(?_31627738)_(31747885_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000455799	X	31627738 - 31747885			455799	471613		
Single allele	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000455797			X	31444461 - 31679606	455797	471995		
Single allele	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000455796			X	31348536 - 31479123	455796	471160		
NC_000023.10:g.(?_31196029)_(31201041_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000455795	X	31196029 - 31201041	X	31177912 - 31182924	455795	471992		
NM_080860.4(RSPH1):c.727_727+138del	RSPH1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000454950	21	43897263 - 43897401	21	42477153 - 42477291	454950	469626	rs1555875358	
NM_080860.4(RSPH1):c.680dup (p.Pro228fs)	RSPH1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000454946	21	43897447 - 43897448	21	42477337 - 42477338	454946	469642	rs556286752	NC_000021.9:42477337:TTTTT:TTTTTT
NM_023036.6(DNAI2):c.1414C>T (p.Gln472Ter)	DNAI2	Q472*, Q460*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000454933	17	72306222	17	74310083	454933	468818	rs756868374	NC_000017.11:74310082:C:T
NM_023036.6(DNAI2):c.1357dup (p.Glu453fs)	DNAI2		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000454932	17	72306164 - 72306165	17	74310025 - 74310026	454932	468325	rs1555614910	NC_000017.11:74310025:G:GG
NM_017950.4(CCDC40):c.2712-1G>A	CCDC40		Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000454885	17	78063562	17	80089763	454885	468962	rs370706991	NC_000017.11:80089762:G:A
NM_017950.4(CCDC40):c.2671G>T (p.Glu891Ter)	CCDC40	E891*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000454884	17	78061861	17	80088062	454884	468958	rs773796940	NC_000017.11:80088061:G:T
NM_017950.4(CCDC40):c.2183_2184del (p.Gly728fs)	CCDC40	G728fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000454883	17	78058734 - 78058735	17	80084935 - 80084936	454883	468465	rs751191119	NC_000017.11:80084934:GGG:G
NM_001256715.2(DNAAF3):c.155dup (p.Ser54fs)	DNAAF3		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000454617	19	55677298 - 55677299	19	55165930 - 55165931	454617	470813	rs745465871	NC_000019.10:55165930:A:AA
NC_000017.10:g.(?_78032273)_(78032799_?)del	CCDC40		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000454504	17	78032273 - 78032799	17	80058474 - 80059000	454504	466294		
NM_001687.5(ATP5F1D):c.245C>T (p.Pro82Leu)	ATP5F1D	P82L	Decreased activity of mitochondrial ATP synthase complex|Mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5	Pathogenic(Last reviewed: Sep 14, 2018)	no assertion criteria provided	VCV000453296	19	1242558	19	1242559	453296	446893	rs867410737	NC_000019.10:1242558:C:T
NM_001142966.2(GREB1L):c.983G>A (p.Arg328Gln)	GREB1L	R328Q	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453285	18	19020263	18	21440302	453285	446879	rs1311814599	NC_000018.10:21440301:G:A
NM_001142966.2(GREB1L):c.2251C>T (p.Arg751Cys)	GREB1L	R751C	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453284	18	19053060	18	21473099	453284	446878	rs1555654020	NC_000018.10:21473098:C:T
NM_001142966.2(GREB1L):c.4607A>G (p.His1536Arg)	GREB1L	H1536R	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453283	18	19088424	18	21508463	453283	446877	rs1555662027	NC_000018.10:21508462:A:G
NM_001142966.2(GREB1L):c.1780G>T (p.Glu594Ter)	GREB1L	E594*	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453282	18	19031043	18	21451082	453282	446876	rs1555650110	NC_000018.10:21451081:G:T
NM_001142966.2(GREB1L):c.4369-1G>C	GREB1L		Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453281	18	19088078	18	21508117	453281	446875	rs1555661907	NC_000018.10:21508116:G:C
NM_001142966.2(GREB1L):c.1582del (p.Gln528fs)	GREB1L	Q528fs	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453280	18	19029657	18	21449696	453280	446874	rs1555649811	NC_000018.10:21449695:CCC:CC
NM_001142966.2(GREB1L):c.3295C>T (p.Gln1099Ter)	GREB1L	Q1099*	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453279	18	19076563	18	21496602	453279	446873	rs1555659101	NC_000018.10:21496601:C:T
NM_001142966.2(GREB1L):c.5068G>A (p.Val1690Met)	GREB1L	V1690M	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453278	18	19095544	18	21515583	453278	446872	rs1555663997	NC_000018.10:21515582:G:A
NM_001142966.2(GREB1L):c.4700T>C (p.Leu1567Pro)	GREB1L	L1567P	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453277	18	19088517	18	21508556	453277	446871	rs1555662061	NC_000018.10:21508555:T:C
NM_001142966.2(GREB1L):c.4680C>A (p.Tyr1560Ter)	GREB1L	Y1560*	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453276	18	19088497	18	21508536	453276	446870	rs1555662052	NC_000018.10:21508535:C:A
NM_001142966.2(GREB1L):c.4000dup (p.Leu1334fs)	GREB1L		Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453275	18	19080529 - 19080530	18	21500568 - 21500569	453275	446869	rs1555660209	NC_000018.10:21500568:CC:CCC
NM_001142966.2(GREB1L):c.5608+1del	GREB1L		Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453274	18	19100784	18	21520823	453274	446868	rs1555665627	NC_000018.10:21520822:GG:G
NM_001142966.2(GREB1L):c.5378T>G (p.Leu1793Arg)	GREB1L	L1793R	Renal hypodysplasia/aplasia 3	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453273	18	19098101	18	21518140	453273	446867	rs1555664772	NC_000018.10:21518139:T:G
NM_001143986.2(TLE6):c.1133del (p.Ala378fs)	TLE6	A255fs, A378fs	Preimplantation embryonic lethality 1	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000453260	19	2989672	19	2989674	453260	446855	rs776453307	NC_000019.10:2989673:C:
NM_004218.4(RAB11B):c.202G>A (p.Ala68Thr)	RAB11B	A68T	NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000453255	19	8464908	19	8400024	453255	446837	rs1555690804	NC_000019.10:8400023:G:A
NM_016418.5(NF2):c.1346_1347del (p.Lys449fs)	NF2	K366fs, K408fs, K407fs, K449fs	not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000453214	22	30070829 - 30070830	22	29674840 - 29674841	453214	446398	rs1556001351	NC_000022.11:29674839:AAA:A
NM_000527.4(LDLR):c.932_939delinsGAGAGTGG (p.Lys311_Cys313delinsArgGluTrp)	LDLR		not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000453194	19	11218182 - 11218189	19	11107506 - 11107513	453194	446030	rs1555803913	NC_000019.10:11107505:AAGAGTGC:GAGAGTGG
NM_001127221.1(CACNA1A):c.6400C>T (p.Arg2134Ter)	CACNA1A	R2134*, R2136*, R2133*, R2139*	not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000453193	19	13320255	19	13209441	453193	446041	rs1555730878	NC_000019.10:13209440:G:A
NM_000215.3(JAK3):c.1432dup (p.Arg478fs)	JAK3		not provided	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000453184	19	17950294 - 17950295	19	17839485 - 17839486	453184	446071	rs769633203	NC_000019.10:17839485:T:TT
NM_178152.3(DCX):c.270_273TCTG[1] (p.Ser92fs)	DCX		not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000453171	X	110653350 - 110653353	X	111410122 - 111410125	453171	446471	rs1556405065	NC_000023.11:111410121:CAGACAGA:CAGA
NM_000351.6(STS):c.184G>T (p.Gly62Ter)	STS	G62*, G69*, G57*	not provided	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000453154	X	7175314	X	7257273	453154	446761	rs1555956229	NC_000023.11:7257272:G:T
NM_172107.4(KCNQ2):c.1357_1373del (p.Lys453fs)	KCNQ2	K423fs, K425fs, K435fs, K453fs	not provided	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000453053	20	62046408 - 62046424	20	63415055 - 63415071	453053	446285	rs1555854643	NC_000020.11:63415054:GGGGACCCCTTCCCCTTGG:GG
NM_172107.4(KCNQ2):c.981_985delinsCCCGGCAGCAGG (p.Lys327fs)	KCNQ2		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000453040	20	62070016 - 62070020	20	63438663 - 63438667	453040	446289	rs1555869796	NC_000020.11:63438662:AGTGC:CCTGCTGCCGGG
NM_138927.3(SON):c.6022C>T (p.Arg2008Ter)	SON	R2008*	not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	VCV000453018	21	34927559	21	33555253	453018	446312	rs1555899560	NC_000021.9:33555252:C:T
NM_001039591.3(USP9X):c.1374G>A (p.Trp458Ter)	USP9X	W458*	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000452886	X	41003834	X	41144581	452886	446650	rs1555921455	NC_000023.11:41144580:G:A
NM_001008537.3(NEXMIF):c.942T>G (p.Tyr314Ter)	NEXMIF	Y314*	not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000452798	X	73963450	X	74743615	452798	446771	rs1556016735	NC_000023.11:74743614:A:C
NM_002637.4(PHKA1):c.2606+1G>A	PHKA1		not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000452732	X	71829473	X	72609623	452732	446763	rs373517016	NC_000023.11:72609622:C:T
NM_000495.5(COL4A5):c.1570G>T (p.Gly524Cys)	COL4A5	G524C	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452626	X	107840281	X	108597051	452626	446465	rs1170254952	NC_000023.11:108597050:G:T
NM_001282531.3(ADNP):c.2194_2197del (p.Leu732fs)	ADNP	L732fs	Helsmoortel-Van der Aa Syndrome|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000452597	20	49509054 - 49509057	20	50892517 - 50892520	452597	446267	rs1555809984	NC_000020.11:50892516:CTAACT:CT
NM_030632.3(ASXL3):c.4399C>T (p.Arg1467Ter)	ASXL3	R1467*	not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000452589	18	31324211	18	33744247	452589	445963	rs1204482456	NC_000018.10:33744246:C:T
NM_005993.4(TBCD):c.2009delG (p.Gly670Valfs)	TBCD		not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000452576	17	80869633	17	82911757	452576	445927	rs1555649346	NC_000017.11:82911756:GGGG:GGG
NM_003336.4(UBE2A):c.125+2T>C	UBE2A		not provided	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000452557	X	118708946	X	119574983	452557	446478	rs1556235612	NC_000023.11:119574982:T:C
NM_001042537.1(SLC9A6):c.1380_1386delinsGTCTTGGGAAGAGCT (p.Asn460fs)	SLC9A6		not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000452555	X	135104774 - 135104780	X	136022615 - 136022621	452555	446505	rs1556620027	NC_000023.11:136022614:TATTTAC:GTCTTGGGAAGAGCT
NM_030632.3(ASXL3):c.1808C>G (p.Ser603Ter)	ASXL3	S603*	not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000452513	18	31319176	18	33739212	452513	445959	rs762650572	NC_000018.10:33739211:C:G
NM_001356.4(DDX3X):c.544-1G>T	DDX3X		not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000452512	X	41202468	X	41343215	452512	446652	rs1555953149	NC_000023.11:41343214:G:T
NM_172107.4(KCNQ2):c.430C>T (p.Arg144Trp)	KCNQ2	R144W	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000452487	20	62076675	20	63445322	452487	446292	rs1555873985	NC_000020.11:63445321:G:A
NM_001347721.2(DYRK1A):c.285C>A (p.Tyr95Ter)	DYRK1A	Y104*, Y66*, Y95*	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452476	21	38850587	21	37478285	452476	446318	rs797044519	NC_000021.9:37478284:C:A
NM_001111125.3(IQSEC2):c.2098G>T (p.Glu700Ter)	IQSEC2	E700*, E495*	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452424	X	53279660	X	53250478	452424	446700	rs1556863043	NC_000023.11:53250477:C:A
NM_001321120.2(TBX4):c.281+1G>A	TBX4		not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452418	17	59534993	17	61457632	452418	445847	rs1555881112	NC_000017.11:61457631:G:A
NM_005629.4(SLC6A8):c.746_747GT[1] (p.Val250fs)	SLC6A8		not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000452407	X	152957530 - 152957531	X	153692075 - 153692076	452407	446528	rs1557044569	NC_000023.11:153692074:TGTGT:TGT
NM_001347721.2(DYRK1A):c.187C>T (p.Gln63Ter)	DYRK1A	Q63*, Q34*	not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000452388	21	38845162	21	37472860	452388	446317	rs373178770	NC_000021.9:37472859:C:T
NM_000284.4(PDHA1):c.1034_1037dup (p.Glu347fs)	PDHA1		not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000452363	X	19377631 - 19377632	X	19359513 - 19359514	452363	446608	rs1555935473	NC_000023.11:19359513:AGAT:AGATAGAT
NM_001111125.3(IQSEC2):c.2889+1G>A	IQSEC2		not provided|Mental retardation, X-linked 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000452339	X	53272513	X	53243331	452339	446698	rs1556861311	NC_000023.11:53243330:C:T
NM_001356.4(DDX3X):c.1423C>T (p.Arg475Cys)	DDX3X	R475C, R289C, R459C	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000452283	X	41205589	X	41346336	452283	446659	rs1064794574	NC_000023.11:41346335:C:T
NM_001042472.3(ABHD12):c.874C>T (p.Arg292Ter)	ABHD12	R292*	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000452247	20	25287545	20	25306909	452247	446212	rs776800006	NC_000020.11:25306908:G:A
NM_001356.4(DDX3X):c.874C>T (p.Arg292Ter)	DDX3X	R292*, R276*, R106*	History of neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000452201	X	41203501	X	41344248	452201	446655	rs1555953488	NC_000023.11:41344247:C:T
NM_000284.4(PDHA1):c.900-2A>G	PDHA1		not provided	Pathogenic(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000452159	X	19377032	X	19358914	452159	446607	rs1555935197	NC_000023.11:19358913:A:G
NM_020964.3(EPG5):c.5375_5378dup (p.Leu1794fs)	EPG5		not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000452021	18	43462378 - 43462379	18	45882413 - 45882414	452021	445973	rs1555667231	NC_000018.10:45882413:TGAATG:TGAATGAATG
NM_000054.6(AVPR2):c.359_426dup (p.Arg143delinsTrpTrpAlaCysMetProProProThrTer)	AVPR2		not provided	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000451934	X	153171318 - 153171319	X	153905864 - 153905865	451934	446553	rs1557100580	
NM_005629.4(SLC6A8):c.263-1G>A	SLC6A8		not provided	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000451902	X	152955829	X	153690374	451902	446525	rs1557044165	NC_000023.11:153690373:G:A
NM_033380.3(COL4A5):c.584G>T (p.Gly195Val)	COL4A5	G195V	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000451889	X	107819177	X	108575947	451889	446463	rs104886061	NC_000023.11:108575946:G:T
NM_001281463.1(SMC1A):c.2807del (p.Gln936fs)	SMC1A	Q936fs, Q958fs	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000451879	X	53421798	X	53394878	451879	446705	rs1556887777	NC_000023.11:53394877:T:
NM_015107.3(PHF8):c.122dup (p.Ala42fs)	PHF8		not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000451824	X	54049252 - 54049253	X	54022819 - 54022820	451824	446720	rs1557110385	NC_000023.11:54022819:TT:TTT
NM_001356.4(DDX3X):c.1769+1G>A	DDX3X		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451776	X	41206266	X	41347013	451776	446660	rs1555954414	NC_000023.11:41347012:G:A
NM_000531.6(OTC):c.298+2T>G	OTC		Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451770	X	38229132	X	38369879	451770	446640	rs1555972538	NC_000023.11:38369878:T:G
NM_030632.3(ASXL3):c.3964C>T (p.Gln1322Ter)	ASXL3	Q1322*	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000451766	18	31323776	18	33743812	451766	445961	rs1555743954	NC_000018.10:33743811:C:T
NM_004006.2(DMD):c.6317G>A (p.Trp2106Ter)	DMD	W2106*, W1983*, W762*, W765*, W2098*, W2102*	not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000451763	X	32235154	X	32217037	451763	446627	rs1557218269	NC_000023.11:32217036:C:T
NM_001127221.1(CACNA1A):c.6492dup (p.Glu2165Ter)	CACNA1A		not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000451719	19	13320162 - 13320163	19	13209348 - 13209349	451719	446040	rs1555730801	NC_000019.10:13209348:A:AA
NM_172107.4(KCNQ2):c.654G>A (p.Trp218Ter)	KCNQ2	W218*	not provided	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000451602	20	62076048	20	63444695	451602	446290	rs1555873683	NC_000020.11:63444694:C:T
NM_001555.5(IGSF1):c.2896+1del	IGSF1		not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000451530	X	130409934	X	131275960	451530	446499	rs1556177186	NC_000023.11:131275959:CC:C
NM_000495.5(COL4A5):c.990+1G>T	COL4A5		not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000451503	X	107826168	X	108582938	451503	446464	rs1556407701	NC_000023.11:108582937:G:T
NM_004247.4(EFTUD2):c.2674del (p.Gln892fs)	EFTUD2	Q857fs, Q882fs, Q892fs	not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000451365	17	42929818	17	44852450	451365	445785	rs1555563981	NC_000017.11:44852449:GGG:GG
NM_001323289.2(CDKL5):c.2593_2616delinsG (p.Gln865fs)	CDKL5		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000451340	X	18646587 - 18646610	X	18628467 - 18628490	451340	446601	rs1555955237	NC_000023.11:18628466:CAACAAACCAAAAATTCCTTCTCA:G
NM_001281463.1(SMC1A):c.2703dup (p.Ser902fs)	SMC1A		not provided	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000451244	X	53423239 - 53423240	X	53396319 - 53396320	451244	446706	rs1556888010	NC_000023.11:53396319:G:GG
NM_001127221.1(CACNA1A):c.2961_2962dup (p.Arg988fs)	CACNA1A		not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000451238	19	13409487 - 13409488	19	13298673 - 13298674	451238	446056	rs1555755878	NC_000019.10:13298673:GGG:GGGGG
NM_006949.4(STXBP2):c.169+2T>G	STXBP2		not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000451232	19	7703988	19	7639102	451232	446200	rs1555768979	NC_000019.10:7639101:T:G
NM_001282531.3(ADNP):c.1287dup (p.Ala430fs)	ADNP		not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000451210	20	49509963 - 49509964	20	50893426 - 50893427	451210	446268	rs1555810335	NC_000020.11:50893426:A:AA
NM_001356.4(DDX3X):c.959_961TAG[1] (p.Val321del)	DDX3X	V321del	not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000451203	X	41203586 - 41203588	X	41344333 - 41344335	451203	446656	rs1555953527	NC_000023.11:41344332:TAGTAG:TAG
NM_003688.3(CASK):c.2155+2T>C	CASK		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, single submitter	VCV000451175	X	41401942	X	41542689	451175	446664	rs1555977195	NC_000023.11:41542688:A:G
NM_152296.5(ATP1A3):c.2806C>T (p.Gln936Ter)	ATP1A3	Q936*, Q949*, Q947*	not provided	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000451130	19	42472950	19	41968798	451130	446139	rs1555859144	NC_000019.10:41968797:G:A
NM_018486.3(HDAC8):c.738-1del	HDAC8		not provided	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000451066	X	71684582	X	72464732	451066	446760	rs1555993243	NC_000023.11:72464731:C:
NM_004975.4(KCNB1):c.1144G>C (p.Asp382His)	KCNB1	D382H	not provided	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000451018	20	47990953	20	49374416	451018	446263	rs1555889090	NC_000020.11:49374415:C:G
NM_015338.5(ASXL1):c.1773C>G (p.Tyr591Ter)	ASXL1	Y591*, Y530*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000451016	20	31022288	20	32434485	451016	446216	rs371369583	NC_000020.11:32434484:C:G
NM_000495.5(COL4A5):c.2604del (p.Gly869fs)	COL4A5	G869fs	not provided	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000450980	X	107863580	X	108620350	450980	446466	rs1556419850	NC_000023.11:108620349:CCCC:CCC
NM_004187.4(KDM5C):c.2982-1G>C	KDM5C		not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000450907	X	53225237	X	53196055	450907	446692	rs1556836552	NC_000023.11:53196054:C:G
NM_176787.5(PIGN):c.661C>T (p.Arg221Ter)	PIGN	R221*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000450902	18	59815460	18	62148227	450902	446003	rs1382897257	NC_000018.10:62148226:G:A
NM_014727.2(KMT2B):c.12_24dup (p.Ser9fs)	KMT2B		not provided|Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000450816	19	36208922 - 36208923	19	35718020 - 35718021	450816	446086	rs1555727493	NC_000019.10:35718020:GGCGGCGGCGGCGGGCGGCGGC:GGCGGCGGCGGCGGGCGGCGGCGGCGGGCGGCGGC
NM_004006.2(DMD):c.8575G>T (p.Glu2859Ter)	DMD	E2859*, E1515*, E130*, E2851*, E1518*, E2855*, E399*, E2736*	not provided	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000450806	X	31497193	X	31479076	450806	446624	rs1556656851	NC_000023.11:31479075:C:A
NM_014727.2(KMT2B):c.4204C>T (p.Arg1402Ter)	KMT2B	R1402*	not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000450691	19	36218425	19	35727524	450691	446089	rs1555730957	NC_000019.10:35727523:C:T
NM_001039141.3(TRIOBP):c.1195C>T (p.Arg399Ter)	TRIOBP	R399*	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000450619	22	38119758	22	37723751	450619	446411	rs750078356	NC_000022.11:37723750:C:T
NM_000213.5(ITGB4):c.175_207del (p.Arg59_Ala69del)	ITGB4		not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000450544	17	73723496 - 73723528	17	75727415 - 75727447	450544	445898	rs1480399395	NC_000017.11:75727414:CCGGCGCTGCAACACCCAGGCGGAGCTGCTGGCC:C
NM_003688.3(CASK):c.184del (p.Glu62fs)	CASK	E62fs	not provided	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000450510	X	41646525	X	41787272	450510	446665	rs1556121448	NC_000023.11:41787271:CCC:CC
NM_001083962.2(TCF4):c.1239dup (p.Gly414fs)	TCF4		not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000450498	18	52921838 - 52921839	18	55254607 - 55254608	450498	445987	rs1555764460	NC_000018.10:55254607:A:AA
NM_001077488.4(GNAS):c.901A>T (p.Lys301Ter)	GNAS	K300*, K301*, K285*, K286*, K241*, K943*	not provided	Pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000450479	20	57485064	20	58910009	450479	446272	rs1555891743	NC_000020.11:58910008:A:T
NM_001321120.2(TBX4):c.709C>T (p.Gln237Ter)	TBX4	Q237*	not provided	Pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000450470	17	59557248	17	61479887	450470	445848	rs1555883466	NC_000017.11:61479886:C:T
NM_015338.5(ASXL1):c.4198G>T (p.Glu1400Ter)	ASXL1	E1400*, E1339*	not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000450465	20	31024713	20	32436910	450465	446217	rs1555912930	NC_000020.11:32436909:G:T
NM_138927.3(SON):c.3396C>A (p.Tyr1132Ter)	SON	Y1132*	not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000450464	21	34924933	21	33552627	450464	446310	rs1555898806	NC_000021.9:33552626:C:A
NM_212472.2(PRKAR1A):c.695dup (p.Arg233fs)	PRKAR1A		not provided	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000450406	17	66522039 - 66522040	17	68525898 - 68525899	450406	445875	rs1555814115	NC_000017.11:68525898:G:GG
NM_000268.3(NF2):c.675+1G>C	NF2		not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000450205	22	30054254	22	29658265	450205	446397	rs1555994854	NC_000022.11:29658264:G:C
NM_001347721.2(DYRK1A):c.940C>T (p.Gln314Ter)	DYRK1A	Q323*, Q285*, Q314*	not provided	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000450203	21	38865334	21	37493032	450203	446320	rs1555985532	NC_000021.9:37493031:C:T
NM_001282531.3(ADNP):c.337_340del (p.Thr113fs)	ADNP	T113fs	not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000450110	20	49510911 - 49510914	20	50894374 - 50894377	450110	446269	rs1555810794	NC_000020.11:50894373:AGGTA:A
NM_020964.3(EPG5):c.4740del (p.Thr1581fs)	EPG5	T1581fs	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000450105	18	43479438	18	45899473	450105	445974	rs1555671254	NC_000018.10:45899472:GG:G
NM_030632.3(ASXL3):c.4209_4210CA[1] (p.Thr1404fs)	ASXL3		not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000450046	18	31324021 - 31324022	18	33744057 - 33744058	450046	445962	rs1555744175	NC_000018.10:33744056:CACA:CA
NM_001193466.2(KANSL1):c.1006G>T (p.Glu336Ter)	KANSL1	E336*	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000450042	17	44248504	17	46171138	450042	445791	rs1555575197	NC_000017.11:46171137:C:A
NM_001083962.2(TCF4):c.1069+1G>A	TCF4	G333D	not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000450041	18	52927179	18	55259948	450041	445988	rs797045072	NC_000018.10:55259947:C:T
NM_014727.2(KMT2B):c.7271dup (p.Ser2425fs)	KMT2B		not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000450023	19	36227700 - 36227701	19	35736799 - 35736800	450023	446090	rs1555734445	NC_000019.10:35736799:TT:TTT
NM_006517.5(SLC16A2):c.889C>A (p.Arg297Ser)	SLC16A2	R297S	not provided	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000449964	X	73744507	X	74524672	449964	446767	rs1555989715	NC_000023.11:74524671:C:A
NM_004006.2(DMD):c.531-2A>G	DMD		not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000449832	X	32827730	X	32809613	449832	446634	rs398123985	NC_000023.11:32809612:T:C
NM_001272071.2(AP1S2):c.289-2A>G	AP1S2		not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000449725	X	15863641	X	15845518	449725	446597	rs1555904148	NC_000023.11:15845517:T:C
NM_001278116.2(L1CAM):c.2209-42_2229del	L1CAM		not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000449707	X	153132306 - 153132368	X	153866851 - 153866913	449707	446545	rs1557091079	
NM_000444.6(PHEX):c.436+1G>A	PHEX		not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000449698	X	22094593	X	22076475	449698	446611	rs1057517788	NC_000023.11:22076474:G:A
NM_004975.4(KCNB1):c.916C>T (p.Arg306Cys)	KCNB1	R306C	Myoclonic absences|Epileptic encephalopathy|Epileptic encephalopathy, early infantile, 26|not provided	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449693	20	47991181	20	49374644	449693	446266	rs1555889130	NC_000020.11:49374643:G:A
NM_001111125.3(IQSEC2):c.2749+1G>A	IQSEC2		not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000449680	X	53276150	X	53246968	449680	446699	rs1556862167	NC_000023.11:53246967:C:T
NM_000531.6(OTC):c.540+1G>T	OTC		not provided	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000449675	X	38260682	X	38401429	449675	446642	rs72556288	NC_000023.11:38401428:G:T
NM_000390.4(CHM):c.1609+2T>A	CHM		not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000449646	X	85133968	X	85878963	449646	446802	rs1556217900	NC_000023.11:85878962:A:T
NM_005359.5(SMAD4):c.1140-1G>A	SMAD4		not provided	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000449645	18	48593388	18	51067018	449645	445983	rs1555686594	NC_000018.10:51067017:G:A
NM_001083962.2(TCF4):c.1650-2A>G	TCF4		not provided	Pathogenic(Last reviewed: Dec 8, 2015)	criteria provided, single submitter	VCV000449629	18	52896309	18	55229078	449629	445985	rs1555711245	NC_000018.10:55229077:T:C
NM_003639.4(IKBKG):c.188-1G>A	IKBKG		not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000449621	X	153784379	X	154556164	449621	446588	rs1557236015	NC_000023.11:154556163:G:A
NM_005984.5(SLC25A1):c.302+1G>T	SLC25A1		not provided	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	VCV000449593	22	19165454	22	19177941	449593	446354	rs1555923089	NC_000022.11:19177940:C:A
NM_017653.5(DYM):c.208C>T (p.Arg70Ter)	DYM	R70*, R69*	not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000449561	18	46906114	18	49379744	449561	445981	rs768509996	NC_000018.10:49379743:G:A
NM_001184880.2(PCDH19):c.2147+2T>C	PCDH19		not provided	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000449522	X	99661447	X	100406449	449522	446439	rs1555984946	NC_000023.11:100406448:A:G
NM_000377.2(WAS):c.1058del (p.Pro353fs)	WAS	P353fs	|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449516	X	48547171	X	48688782	449516	446681	rs1557007165	NC_000023.11:48688781:CCCCC:CCCC
NM_000377.2(WAS):c.961C>T (p.Arg321Ter)	WAS	R321*	not provided|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449515	X	48547078	X	48688689	449515	446680	rs1557007123	NC_000023.11:48688688:C:T
NM_000330.3(RS1):c.184+2T>G	RS1		not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000449510	X	18674771	X	18656651	449510	446603	rs1555959367	NC_000023.11:18656650:A:C
NM_015629.4(PRPF31):c.758_767del (p.Gly253fs)	PRPF31	G253fs	not provided	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000449506	19	54627936 - 54627945	19	54124557 - 54124566	449506	446187	rs1555793170	NC_000019.10:54124556:CGGGGCCCAGCG:CG
NM_000444.6(PHEX):c.663+1G>A	PHEX		not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000449505	X	22095821	X	22077703	449505	446612	rs1556020845	NC_000023.11:22077702:G:A
NM_003639.4(IKBKG):c.792dup (p.Gln265fs)	IKBKG		not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000449492	X	153791045 - 153791046	X	154562830 - 154562831	449492	446590	rs1237384577	NC_000023.11:154562830:AAA:AAAA
NM_194277.2(FRMD7):c.685C>T (p.Arg229Cys)	FRMD7	R229C, R214C	not provided	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000449483	X	131218574	X	132084546	449483	446500	rs137852212	NC_000023.11:132084545:G:A
NM_000390.4(CHM):c.820-2A>G	CHM		not provided|Choroideremia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449468	X	85212982	X	85957977	449468	446803	rs1556307713	NC_000023.11:85957976:T:C
NM_000390.4(CHM):c.1771-1G>A	CHM		not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449467	X	85119827	X	85864822	449467	446801	rs1556191599	NC_000023.11:85864821:C:T
NM_000074.2(CD40LG):c.346+1delG	CD40LG		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000449466	X	135736589	X	136654430	449466	446507	rs1556139575	NC_000023.11:136654429:GG:G
NM_000074.2(CD40LG):c.216C>A (p.Cys72Ter)	CD40LG	C72*	not provided	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000449464	X	135732484	X	136650325	449464	446506	rs1556136635	NC_000023.11:136650324:C:A
NM_212472.2(PRKAR1A):c.672G>A (p.Trp224Ter)	PRKAR1A	W224*	not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000449447	17	66522017	17	68525876	449447	445874	rs1555814100	NC_000017.11:68525875:G:A
NM_016418.5(NF2):c.122G>A (p.Trp41Ter)	NF2	W41*	not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449433	22	30032747	22	29636758	449433	446394	rs1555986860	NC_000022.11:29636757:G:A
NM_000531.6(OTC):c.540+265G>A	OTC		not provided|Ornithine carbamoyltransferase deficiency|Hyperammonemia|Protein avoidance|Abnormality of ornithine metabolism	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449382	X	38260946	X	38401693	449382	446643	rs1555975756	NC_000023.11:38401692:G:A
NM_000132.3(F8):c.4473C>A (p.Tyr1491Ter)	F8	Y1491*	not provided	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000449368	X	154157592	X	154929317	449368	446594	rs1557278411	NC_000023.11:154929316:G:T
NM_005629.4(SLC6A8):c.1411C>T (p.Gln471Ter)	SLC6A8	Q471*, Q461*, Q356*	not provided	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000449367	X	152959817	X	153694362	449367	446533	rs1557045475	NC_000023.11:153694361:C:T
NM_005629.4(SLC6A8):c.568_569TG[1] (p.Ala191fs)	SLC6A8		not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000449366	X	152956932 - 152956933	X	153691477 - 153691478	449366	446527	rs1557044442	NC_000023.11:153691476:TGTG:TG
NM_001278116.2(L1CAM):c.1780del (p.Ser594fs)	L1CAM	S594fs, S589fs	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000449365	X	153133501	X	153868046	449365	446547	rs1557091629	NC_000023.11:153868045:T:
NM_000252.2(MTM1):c.137-11T>A	MTM1		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000449364	X	149767045	X	150598581	449364	446518	rs1557412659	NC_000023.11:150598580:T:A
NM_001184880.2(PCDH19):c.1700C>T (p.Pro567Leu)	PCDH19	P567L	not provided|Early infantile epileptic encephalopathy 9	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449356	X	99661896	X	100406898	449356	446440	rs201989363	NC_000023.11:100406897:G:A
NM_000206.2(IL2RG):c.421C>T (p.Gln141Ter)	IL2RG	Q141*	not provided|X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449330	X	70330387	X	71110537	449330	446742	rs1556330713	NC_000023.11:71110536:G:A
NM_001005360.2(DNM2):c.1852G>A (p.Ala618Thr)	DNM2	A618T, A614T	not provided	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000449326	19	10934534	19	10823858	449326	446020	rs773598203	NC_000019.10:10823857:G:A
NM_001193375.2(NDUFA11):c.97+5G>A	NDUFA11		not provided|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000449316	19	5903618	19	5903607	449316	446193	rs1348957889	NC_000019.10:5903606:C:T
NM_198129.3(LAMA3):c.8708+1G>A	LAMA3		not provided	Pathogenic(Last reviewed: Nov 23, 2015)	no assertion criteria provided	VCV000449300	18	21512256	18	23932292	449300	445946	rs754558574	NC_000018.10:23932291:G:A
NM_000023.4(SGCA):c.585-1G>C	SGCA		not provided	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000449294	17	48246452	17	50169091	449294	445805	rs1342189589	NC_000017.11:50169090:G:C
NM_003639.4(IKBKG):c.768+2T>G	IKBKG		not provided	Pathogenic(Last reviewed: Oct 26, 2015)	criteria provided, single submitter	VCV000449291	X	153790001	X	154561786	449291	446589	rs1557236571	NC_000023.11:154561785:T:G
NM_176787.5(PIGN):c.2672+1G>T	PIGN		not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000449284	18	59739905	18	62072672	449284	445997	rs1287655964	NC_000018.10:62072671:C:A
NM_000061.2(BTK):c.119A>G (p.Tyr40Cys)	BTK	Y40C, Y74C	not provided|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449226	X	100630154	X	101375166	449226	446452	rs1555980875	NC_000023.11:101375165:T:C
NM_005629.4(SLC6A8):c.1254+1G>A	SLC6A8		not provided	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000449187	X	152959473	X	153694018	449187	446531	rs1557045333	NC_000023.11:153694017:G:A
NM_013995.2(LAMP2):c.929-2A>G	LAMP2		not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000449156	X	119575751	X	120441896	449156	446482	rs1556092556	NC_000023.11:120441895:T:C
NM_000206.2(IL2RG):c.846G>A (p.Trp282Ter)	IL2RG	W282*	not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000449136	X	70328457	X	71108607	449136	446741	rs1556329954	NC_000023.11:71108606:C:T
NM_000377.2(WAS):c.778-6G>A	WAS		not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000449116	X	48546683	X	48688294	449116	446679	rs1557007011	NC_000023.11:48688293:G:A
NM_006915.3(RP2):c.243_246dup (p.Ile83fs)	RP2		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000449092	X	46713050 - 46713051	X	46853615 - 46853616	449092	446671	rs1556318579	NC_000023.11:46853615:TACC:TACCTACC
NM_006907.4(PYCR1):c.535G>A (p.Ala179Thr)	PYCR1	A179T, A206T	Autosomal recessive cutis laxa type 2B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449091	17	79892807	17	81934931	449091	445922	rs139751598	NC_000017.11:81934930:C:T
NM_003620.3(PPM1D):c.1210C>T (p.Gln404Ter)	PPM1D	Q404*	not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000449085	17	58734152	17	60656791	449085	445843	rs768126695	NC_000017.11:60656790:C:T
NM_000227.5(LAMA3):c.4114C>T (p.Gln1372Ter)	LAMA3	Q1372*, Q2981*, Q1316*, Q2925*	Junctional epidermolysis bullosa gravis of Herlitz|Adult junctional epidermolysis bullosa||not provided|Adult junctional epidermolysis bullosa|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449049	18	21519265	18	23939301	449049	445947	rs772038362	NC_000018.10:23939300:C:T
NM_001278116.2(L1CAM):c.1983del (p.Lys661fs)	L1CAM	K656fs, K661fs	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000449048	X	153132965	X	153867510	449048	446546	rs1557091377	NC_000023.11:153867509:TTTTT:TTTT
NM_001278116.2(L1CAM):c.1267C>T (p.Gln423Ter)	L1CAM	Q423*, Q418*	Spastic paraplegia|not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000449046	X	153134975	X	153869520	449046	446549	rs1557092248	NC_000023.11:153869519:G:A
NM_001399.5(EDA):c.593del (p.Gly198fs)	EDA	G198fs	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000449013	X	69247771	X	70027921	449013	446736	rs1556098553	NC_000023.11:70027920:GGG:GG
NM_000397.3(CYBB):c.210dup (p.Val71fs)	CYBB		not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000449009	X	37642810 - 37642811	X	37783557 - 37783558	449009	446636	rs1556464882	NC_000023.11:37783557:A:AA
NM_001127221.1(CACNA1A):c.4075C>T (p.Arg1359Trp)	CACNA1A	R1359W, R1362W, R1358W	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448996	19	13373565	19	13262751	448996	446049	rs1555745461	NC_000019.10:13262750:G:A
NM_001123383.1(BCOR):c.2484_2485AG[2] (p.Ser830fs)	BCOR		not provided|Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000448990	X	39932110 - 39932111	X	40072857 - 40072858	448990	446645	rs1555918014	NC_000023.11:40072856:CTCTCT:CTCT
NM_144612.6(LOXHD1):c.746G>A (p.Trp249Ter)	LOXHD1	W249*	Deafness	Pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	VCV000448957	18	44190752	18	46610789	448957	442564	rs1248889536	NC_000018.10:46610788:C:T
NM_006883.2(SHOX):c.633+3382_633+3384delinsAG	SHOX		not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000448378	X	605204 - 605206	X	644469 - 644471	448378	442468	rs1556468777	NC_000024.10:644468:TAC:AG
NM_020956.2(PRX):c.*3816del	PRX	L1204fs	not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000448140	19	40900648	19	40394741	448140	442225	rs776887800	NC_000019.10:40394740:A:
NM_020956.2(PRX):c.*3491_*3561del	PRX	I1096fs	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000448139	19	40900903 - 40900973	19	40394996 - 40395066	448139	442226	rs1555800610	
NM_000444.6(PHEX):c.187+1G>A	PHEX		not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000447936	X	22056656	X	22038538	447936	442405	rs1556012100	NC_000023.11:22038537:G:A
NM_001184880.2(PCDH19):c.859G>T (p.Glu287Ter)	PCDH19	E287*	not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000447921	X	99662737	X	100407739	447921	442360	rs1555985427	NC_000023.11:100407738:C:A
NM_001184880.2(PCDH19):c.207_208AC[1] (p.His70fs)	PCDH19		not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000447918	X	99663386 - 99663387	X	100408388 - 100408389	447918	442362	rs1555985799	NC_000023.11:100408387:GTGTG:GTG
NM_001184880.2(PCDH19):c.169C>T (p.Gln57Ter)	PCDH19	Q57*	not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000447917	X	99663427	X	100408429	447917	442363	rs1367823627	NC_000023.11:100408428:G:A
NM_001184880.2(PCDH19):c.1133C>G (p.Ser378Ter)	PCDH19	S378*	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447916	X	99662463	X	100407465	447916	442357	rs1555985301	NC_000023.11:100407464:G:C
NM_001184880.2(PCDH19):c.1098C>G (p.Tyr366Ter)	PCDH19	Y366*	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000447915	X	99662498	X	100407500	447915	442358	rs1239794408	NC_000023.11:100407499:G:C
NM_000475.5(NR0B1):c.463_467delinsTGAGCTCCG (p.Gln155_Thr156delinsTer)	NR0B1		not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000447885	X	30327014 - 30327018	X	30308897 - 30308901	447885	442410	rs1555973147	NC_000023.11:30308896:GTTTG:CGGAGCTCA
NM_016418.5(NF2):c.738_756del (p.Glu247fs)	NF2	E205fs, E164fs, E206fs, E247fs	not provided	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000447764	22	30057253 - 30057271	22	29661264 - 29661282	447764	442347	rs1555996156	NC_000022.11:29661263:CCCTGAGAACAGACTGACCCCC:CCC
NM_000216.4(ANOS1):c.1270C>T (p.Arg424Ter)	ANOS1	R424*	not provided	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000447606	X	8522077	X	8554036	447606	442461	rs747010865	NC_000023.11:8554035:G:A
NM_000166.6(GJB1):c.64C>T (p.Arg22Ter)	GJB1	R22*	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447441	X	70443621	X	71223771	447441	442441	rs1555937020	NC_000023.11:71223770:C:T
NM_000166.6(GJB1):c.622G>A (p.Glu208Lys)	GJB1	E208K	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447439	X	70444179	X	71224329	447439	442454	rs1555937270	NC_000023.11:71224328:G:A
NM_000166.6(GJB1):c.548G>A (p.Arg183His)	GJB1	R183H	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447435	X	70444105	X	71224255	447435	442450	rs1555937233	NC_000023.11:71224254:G:A
NM_000166.6(GJB1):c.266T>C (p.Leu89Pro)	GJB1	L89P	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447428	X	70443823	X	71223973	447428	442443	rs1555937122	NC_000023.11:71223972:T:C
NM_004006.2(DMD):c.9163+2T>G	DMD		not provided	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000447268	X	31366671	X	31348554	447268	442412	rs1556539065	NC_000023.11:31348553:A:C
NM_004006.2(DMD):c.8196del (p.Glu2733fs)	DMD	E2729fs, E1389fs, E2610fs, E2733fs, E1392fs, E2725fs, E273fs	not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000447267	X	31645811	X	31627694	447267	442413	rs1556764753	NC_000023.11:31627693:TTTT:TTT
NM_004006.2(DMD):c.7661-2A>G	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447265	X	31697705	X	31679588	447265	442415	rs1556806356	NC_000023.11:31679587:T:C
NM_004006.2(DMD):c.6423C>A (p.Tyr2141Ter)	DMD	Y2141*, Y2137*, Y800*, Y2133*, Y797*, Y2018*	not provided	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447262	X	32235048	X	32216931	447262	442417	rs1425702864	NC_000023.11:32216930:G:T
NM_004006.2(DMD):c.589G>T (p.Glu197Ter)	DMD	E197*, E189*, E74*, E193*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447261	X	32827670	X	32809553	447261	442429	rs1340365803	NC_000023.11:32809552:C:A
NM_004006.2(DMD):c.5851C>T (p.Gln1951Ter)	DMD	Q1951*, Q607*, Q610*, Q1828*, Q1943*, Q1947*	not specified|not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447260	X	32360288	X	32342171	447260	442418	rs773643220	NC_000023.11:32342170:G:A
NM_004006.2(DMD):c.3217G>T (p.Glu1073Ter)	DMD	E1073*, E950*, E1065*, E1069*	not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000447256	X	32482762	X	32464645	447256	442421	rs398123931	NC_000023.11:32464644:C:A
NM_000109.4(DMD):c.2620del (p.Asp874fs)	DMD	G759fs, G878fs, G882fs, D874fs	not provided	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000447255	X	32503195	X	32485078	447255	442422	rs1557380670	NC_000023.11:32485077:C:
NM_004006.2(DMD):c.2423_2424insA (p.Asn809fs)	DMD		not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000447254	X	32509592 - 32509593	X	32491475 - 32491476	447254	442423	rs1557383751	NC_000023.11:32491475::T
NM_004006.2(DMD):c.10121del (p.Lys3374fs)	DMD	K306fs, K3251fs, K3370fs, K2033fs, K3366fs, K645fs, K2030fs, K3374fs, K914fs	not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000447248	X	31196888	X	31178771	447248	442411	rs1556037429	NC_000023.11:31178770:TT:T
NM_000495.5(COL4A5):c.935del (p.Pro312fs)	COL4A5	P312fs	not provided	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000447214	X	107824255	X	108581025	447214	442368	rs1556407078	NC_000023.11:108581024:CC:C
NM_000495.5(COL4A5):c.511G>C (p.Gly171Arg)	COL4A5	G171R	not provided	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000447213	X	107816849	X	108573619	447213	442367	rs1556404027	NC_000023.11:108573618:G:C
NM_000495.5(COL4A5):c.4689-1G>C	COL4A5		not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000447212	X	107938036	X	108694806	447212	442383	rs1556462917	NC_000023.11:108694805:G:C
NM_000495.5(COL4A5):c.465+1_465+5del	COL4A5		not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000447211	X	107815065 - 107815069	X	108571835 - 108571839	447211	442366	rs1556403276	NC_000023.11:108571834:AAGGTAAG:AAG
NM_000495.5(COL4A5):c.4045del (p.Glu1349fs)	COL4A5	E1355fs, E1349fs	not provided	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000447210	X	107924158	X	108680928	447210	442382	rs1556453276	NC_000023.11:108680927:GGGGG:GGGG
NM_000495.5(COL4A5):c.404G>A (p.Gly135Asp)	COL4A5	G135D	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000447209	X	107814662	X	108571432	447209	442365	rs1556403086	NC_000023.11:108571431:G:A
NM_000495.5(COL4A5):c.3695del (p.Gly1232fs)	COL4A5	G1232fs	not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000447206	X	107911638	X	108668408	447206	442379	rs1556446657	NC_000023.11:108668407:GG:G
NM_000495.5(COL4A5):c.2538_2539dup (p.Asp847fs)	COL4A5		not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000447203	X	107863513 - 107863514	X	108620283 - 108620284	447203	442376	rs1556419800	NC_000023.11:108620283:GGGGG:GGGGGGG
NM_000495.5(COL4A5):c.2509+1G>A	COL4A5		not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000447201	X	107858255	X	108615025	447201	442374	rs1556418287	NC_000023.11:108615024:G:A
NM_000495.5(COL4A5):c.2414G>A (p.Gly805Glu)	COL4A5	G805E	not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447200	X	107858159	X	108614929	447200	442373	rs1556418210	NC_000023.11:108614928:G:A
NM_000495.5(COL4A5):c.1258G>A (p.Gly420Arg)	COL4A5	G420R	not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000447199	X	107834380	X	108591150	447199	442372	rs1556410266	NC_000023.11:108591149:G:A
NM_001127221.1(CACNA1A):c.6031C>T (p.Gln2011Ter)	CACNA1A	Q2011*, Q2016*, Q2010*, Q2013*	not provided	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000446937	19	13323467	19	13212653	446937	442050	rs1355062450	NC_000019.10:13212652:G:A
NM_001127221.1(CACNA1A):c.41del (p.Gly14fs)	CACNA1A	G14fs	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000446923	19	13616998	19	13506184	446923	442089	rs1555797179	NC_000019.10:13506183:CCCCC:CCCC
NM_001127221.1(CACNA1A):c.3218del (p.Lys1073fs)	CACNA1A	K1072fs, K1073fs, K1076fs	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000446916	19	13397655	19	13286841	446916	442067	rs1555753042	NC_000019.10:13286840:TT:T
NM_001127221.1(CACNA1A):c.2737C>T (p.Gln913Ter)	CACNA1A	Q913*, Q916*, Q912*	not provided	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000446911	19	13409713	19	13298899	446911	442072	rs1555756161	NC_000019.10:13298898:G:A
NM_001127221.1(CACNA1A):c.2009G>A (p.Trp670Ter)	CACNA1A	W670*, W669*	not provided	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000446905	19	13414679	19	13303865	446905	442078	rs1555757537	NC_000019.10:13303864:C:T
NM_001127221.1(CACNA1A):c.1503_1524del (p.Leu502fs)	CACNA1A	L502fs, L501fs	not provided|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446903	19	13427960 - 13427981	19	13317146 - 13317167	446903	442080	rs1555762855	NC_000019.10:13317145:GTGAACAATAGCAACACACAGCGTG:GTG
NM_000383.4(AIRE):c.1365G>A (p.Trp455Ter)	AIRE	W455*	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000446815	21	45713758	21	44293875	446815	442313	rs1555873118	NC_000021.9:44293874:G:A
Single allele	DCC		Developmental Split Brain Syndrome	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000446759	18	49867184 - 49874866	18	52340818 - 52348500	446759	440335		
NM_005215.4(DCC):c.788_794del (p.Val263fs)	DCC	V263fs	Developmental Split Brain Syndrome	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000446724	18	50450166 - 50450172	18	52923796 - 52923802	446724	440258	rs1555682265	NC_000018.10:52923795:GTTTCTGG:G
NM_014927.5(CNKSR2):c.2134C>T (p.Arg712Ter)	CNKSR2	R712*, R633*, R682*, R663*	Intellectual disability, X-linked, syndromic, Houge type	Pathogenic(Last reviewed: Dec 9, 2017)	no assertion criteria provided	VCV000446716	X	21624986	X	21606868	446716	440249	rs904072058	NC_000023.11:21606867:C:T
NM_001142966.2(GREB1L):c.4368G>T (p.Gln1456His)	GREB1L	Q1456H	Inner ear Malformation	Pathogenic(Last reviewed: Nov 25, 2017)	no assertion criteria provided	VCV000446527	18	19085910	18	21505949	446527	440045	rs1555661490	NC_000018.10:21505948:G:T
NM_001142966.2(GREB1L):c.982C>T (p.Arg328Ter)	GREB1L	R328*	Inner ear Malformation	Pathogenic(Last reviewed: Nov 25, 2017)	no assertion criteria provided	VCV000446526	18	19020262	18	21440301	446526	440044	rs1555648043	NC_000018.10:21440300:C:T
NM_001167.3(XIAP):c.672dup (p.Pro225fs)	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446510	X	123020181 - 123020182	X	123886331 - 123886332	446510	440028	rs1556404697	NC_000023.11:123886331:TTT:TTTT
NM_001167.3(XIAP):c.651del (p.Trp217fs)	XIAP	W217fs	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446509	X	123020162	X	123886312	446509	440027	rs1556404673	NC_000023.11:123886311:GG:G
NM_001167.3(XIAP):c.1021_1022del (p.Asn341fs)	XIAP	N341fs	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446508	X	123025131 - 123025132	X	123891281 - 123891282	446508	440026	rs1556406033	NC_000023.11:123891280:AA:
NM_001077488.4(GNAS):c.435+1G>A	GNAS		Inborn genetic diseases|Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000446491	20	57478847	20	58903792	446491	440007	rs1555889131	NC_000020.11:58903791:G:A
NM_172341.4(PSENEN):c.62-1G>C	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446486	19	36237319	19	35746418	446486	440001	rs1555738836	NC_000019.10:35746417:G:C
NM_172341.4(PSENEN):c.167-2A>G	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446485	19	36237607	19	35746706	446485	440000	rs1555738903	NC_000019.10:35746705:A:G
NM_172341.4(PSENEN):c.194T>G (p.Leu65Arg)	PSENEN	L65R	Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446484	19	36237636	19	35746735	446484	439999	rs1555738906	NC_000019.10:35746734:T:G
NM_172341.4(PSENEN):c.35T>A (p.Leu12Ter)	PSENEN	L12*	Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446483	19	36236866	19	35745965	446483	439998	rs1555738763	NC_000019.10:35745964:T:A
NM_172341.3(PSENEN):c.66dup (p.Phe23Valfs)	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Dec 1, 2017)	no assertion criteria provided	VCV000446482	19	36237318 - 36237319	19	35746417 - 35746418	446482	439997	rs1555738837	NC_000019.10:35746417:GGGGGG:GGGGGGG
NM_001184880.2(PCDH19):c.138_139delinsTT (p.Arg47Ter)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000446433	X	99663457 - 99663458	X	100408459 - 100408460	446433	439889	rs1555985820	NC_000023.11:100408458:GC:AA
NM_001136191.3(KANK2):c.2027C>T (p.Ser676Phe)	KANK2	S684F, S676F	Nephrotic syndrome type 16	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000446388	19	11285190	19	11174514	446388	439843	rs1555816634	NC_000019.10:11174513:G:A
NM_001136191.3(KANK2):c.541A>G (p.Ser181Gly)	KANK2	S181G	Nephrotic syndrome type 16	Pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	VCV000446387	19	11304215	19	11193539	446387	439842	rs1555820663	NC_000019.10:11193538:T:C
NM_001363.5(DKC1):c.203A>G (p.His68Arg)	DKC1	H68R		Pathogenic(Last reviewed: Nov 23, 2017)	criteria provided, single submitter	VCV000446380	X	153994213	X	154765938	446380	439831	rs1557264102	NC_000023.11:154765937:A:G
NM_018486.3(HDAC8):c.522C>A (p.Tyr174Ter)	HDAC8	Y174*, Y83*	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Nov 30, 2016)	no assertion criteria provided	VCV000446297	X	71715034	X	72495184	446297	439701	rs146015223	NC_000023.11:72495183:G:T
NM_003688.3(CASK):c.2302+1G>A	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000446289	X	41393958	X	41534705	446289	439692	rs1555975458	NC_000023.11:41534704:C:T
NM_003688.3(CASK):c.109C>T (p.Gln37Ter)	CASK	Q37*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000446288	X	41712431	X	41853178	446288	439694	rs1556254569	NC_000023.11:41853177:G:A
NM_003688.3(CASK):c.1315-7A>G	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000446287	X	41437788	X	41578535	446287	439693	rs1555986221	NC_000023.11:41578534:T:C
NM_000455.4(STK11):c.727del (p.Val243fs)	STK11	V243fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446257	19	1220706	19	1220707	446257	439636	rs1555738475	NC_000019.10:1220706:GGGG:GGG
NM_033380.3(COL4A5):c.1483dup (p.Gln495fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000446217	X	107838797 - 107838798	X	108595567 - 108595568	446217	439581	rs1556411631	NC_000023.11:108595567:C:CC
NM_000527.4(LDLR):c.(1586+1_1587-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000446149					446149	439496		
NM_015365.3(AMMECR1):c.429T>A (p.Tyr143Ter)	AMMECR1	Y143*, Y20*	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	Pathogenic	no assertion criteria provided	VCV000446130	X	109560871	X	110317643	446130	439477	rs765498367	NC_000023.11:110317642:A:T
Single allele	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 17, 2007)	no assertion criteria provided	VCV000446120	18	59819870 - 59824934	18	62152637 - 62157701	446120	439467		
NM_176787.5(PIGN):c.421dup (p.Ile141fs)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 17, 2007)	no assertion criteria provided	VCV000446119	18	59824382 - 59824383	18	62157149 - 62157150	446119	439466	rs1555696769	NC_000018.10:62157149:T:TT
NM_016327.3(UPB1):c.917-1G>A	UPB1		Deficiency of beta-ureidopropionase|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000445946	22	24919586	22	24523618	445946	439218	rs143493067	NC_000022.11:24523617:G:A
NM_001039591.3(USP9X):c.5395C>T (p.Arg1799Ter)	USP9X	R1799*	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000445770	X	41075215	X	41215962	445770	439042	rs1555933937	NC_000023.11:41215961:C:T
NM_199242.2(UNC13D):c.1847A>G (p.Glu616Gly)	UNC13D	E616G	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000445606	17	73831491	17	75835410	445606	438878	rs754621494	NC_000017.11:75835409:T:C
NM_001077488.4(GNAS):c.352G>A (p.Val118Met)	GNAS	V118M, V58M, V102M, V103M, V117M, V760M	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000445504	20	57478763	20	58903708	445504	438776	rs1555889031	NC_000020.11:58903707:G:A
NM_000206.2(IL2RG):c.258_261dup (p.His88fs)	IL2RG		not provided	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000445479	X	70330754 - 70330755	X	71110904 - 71110905	445479	438751	rs1556330940	NC_000023.11:71110904:CAGA:CAGACAGA
NM_033550.4(TP53RK):c.728G>T (p.Arg243Leu)	TP53RK	R243L	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444883	20	45315426	20	46686787	444883	438525	rs776588426	NC_000020.11:46686786:C:A
NM_033550.4(TP53RK):c.125G>A (p.Gly42Asp)	TP53RK	G42D	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444882	20	45317929	20	46689290	444882	438524	rs773814837	NC_000020.11:46689289:C:T
NM_033550.4(TP53RK):c.242C>G (p.Thr81Arg)	TP53RK	T81R	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444881	20	45317812	20	46689173	444881	438523	rs1432218739	NC_000020.11:46689172:G:C
NM_033550.4(TP53RK):c.179del (p.Lys60fs)	TP53RK	K60fs	GALLOWAY-MOWAT SYNDROME 4	Pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000444880	20	45317875	20	46689236	444880	438522	rs1431526147	NC_000020.11:46689235:TT:T
NM_006014.4(LAGE3):c.188+1G>A	LAGE3		GALLOWAY-MOWAT SYNDROME 2, X-LINKED	Pathogenic(Last reviewed: Oct 25, 2017)	no assertion criteria provided	VCV000444873	X	153707066	X	154478727	444873	438514	rs1557211410	NC_000023.11:154478726:C:T
NM_006014.4(LAGE3):c.410T>C (p.Phe137Ser)	LAGE3	F137S	GALLOWAY-MOWAT SYNDROME 2, X-LINKED	Pathogenic(Last reviewed: Oct 25, 2017)	no assertion criteria provided	VCV000444872	X	153706305	X	154477966	444872	438513	rs1557211209	NC_000023.11:154477965:A:G
NM_006014.4(LAGE3):c.316G>T (p.Val106Phe)	LAGE3	V106F	GALLOWAY-MOWAT SYNDROME 2, X-LINKED	Pathogenic(Last reviewed: Oct 25, 2017)	no assertion criteria provided	VCV000444871	X	153706623	X	154478284	444871	438512	rs1557211306	NC_000023.11:154478283:C:A
NM_000475.5(NR0B1):c.315G>A (p.Trp105Ter)	NR0B1	W105*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000444091	X	30327166	X	30309049	444091	437734	rs132630327	NC_000023.11:30309048:C:T
NM_000475.5(NR0B1):c.327C>A (p.Cys109Ter)	NR0B1	C109*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000444090	X	30327154	X	30309037	444090	437733	rs1555973172	NC_000023.11:30309036:G:T
NM_000475.5(NR0B1):c.515G>A (p.Trp172Ter)	NR0B1	W172*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000444089	X	30326966	X	30308849	444089	437732	rs1555973132	NC_000023.11:30308848:C:T
NM_000475.5(NR0B1):c.543del (p.Gly183fs)	NR0B1	G183fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000444088	X	30326938	X	30308821	444088	437731	rs1555973120	NC_000023.11:30308820:T:
NM_000475.5(NR0B1):c.545_546insCCCA (p.Gly183fs)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000444087	X	30326935 - 30326936	X	30308818 - 30308819	444087	437730	rs1555973119	NC_000023.11:30308818::TGGG
NM_000475.5(NR0B1):c.548dup (p.Gly183_Lys184insTer)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000444086	X	30326932 - 30326933	X	30308815 - 30308816	444086	437729	rs1555973117	NC_000023.11:30308815:CCCCC:CCCCCC
NM_000475.5(NR0B1):c.551_552del (p.Lys184fs)	NR0B1	K184fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444085	X	30326929 - 30326930	X	30308812 - 30308813	444085	437728	rs1555973115	NC_000023.11:30308811:TTT:T
NM_000475.5(NR0B1):c.652dup (p.Thr218fs)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444084	X	30326828 - 30326829	X	30308711 - 30308712	444084	437727	rs1555973092	NC_000023.11:30308711:T:TT
NM_000475.5(NR0B1):c.638_654delinsCATC (p.Leu213fs)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444083	X	30326827 - 30326843	X	30308710 - 30308726	444083	437726	rs1555973091	NC_000023.11:30308709:CGTGGGCACGCAGTAGA:GATG
NM_000475.5(NR0B1):c.765C>A (p.Cys255Ter)	NR0B1	C255*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444082	X	30326716	X	30308599	444082	437725	rs1311271225	NC_000023.11:30308598:G:T
NM_000475.5(NR0B1):c.773C>A (p.Ala258Asp)	NR0B1	A258D	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444081	X	30326708	X	30308591	444081	437724	rs1555973058	NC_000023.11:30308590:G:T
NM_000475.5(NR0B1):c.822C>A (p.Cys274Ter)	NR0B1	C274*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000444080	X	30326659	X	30308542	444080	437723	rs753734546	NC_000023.11:30308541:G:T
NM_000475.5(NR0B1):c.844C>T (p.Gln282Ter)	NR0B1	Q282*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000444079	X	30326637	X	30308520	444079	437722	rs1555973031	NC_000023.11:30308519:G:A
NM_000475.5(NR0B1):c.871T>C (p.Trp291Arg)	NR0B1	W291R	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444078	X	30326610	X	30308493	444078	437721	rs1555973021	NC_000023.11:30308492:A:G
NM_000475.5(NR0B1):c.872G>C (p.Trp291Ser)	NR0B1	W291S	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444077	X	30326609	X	30308492	444077	437720	rs1489209061	NC_000023.11:30308491:C:G
NM_000475.5(NR0B1):c.1169-1G>A	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000444075	X	30322941	X	30304824	444075	437718	rs1555972666	NC_000023.11:30304823:C:T
NM_000475.5(NR0B1):c.1234_1235del (p.Leu411_Ser412insTer)	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000444074	X	30322874 - 30322875	X	30304757 - 30304758	444074	437717	rs1555972655	NC_000023.11:30304756:CT:
NM_000475.5(NR0B1):c.1169-112_*17delinsTG	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000444073	X	30322679 - 30323052	X	30304562 - 30304935	444073	437716	rs1555972632	
NC_000023.10:g.(?_30322696)_(30327480_?)del	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000444072	X	30322696 - 30327480	X	30304579 - 30309363	444072	437715		
NM_206898.1(MRAP):c.106+1del	MRAP		ACTH resistance	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000444068	21	33671389	21	32299078	444068	437711	rs1476574441	NC_000021.9:32299077:G:
NM_206898.1(MRAP):c.1A>G (p.Met1Val)	MRAP	M1V	ACTH resistance	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, single submitter	VCV000444067	21	33671283	21	32298972	444067	437710	rs1555897462	NC_000021.9:32298971:A:G
NM_000529.2(MC2R):c.424G>T (p.Val142Leu)	MC2R	V142L	ACTH resistance	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000444066	18	13885094	18	13885095	444066	437709	rs199950178	NC_000018.10:13885094:C:A
NM_000529.2(MC2R):c.459dup (p.Ile154fs)	MC2R		Glucocorticoid Deficiency|ACTH resistance	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000444065	18	13885058 - 13885059	18	13885059 - 13885060	444065	437708	rs1555619430	NC_000018.10:13885059:G:GG
NM_000529.2(MC2R):c.674T>G (p.Leu225Arg)	MC2R	L225R	ACTH resistance	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000444064	18	13884844	18	13884845	444064	437707	rs1555619377	NC_000018.10:13884844:A:C
NM_000529.2(MC2R):c.702del (p.Phe235fs)	MC2R	F235fs	ACTH resistance	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000444063	18	13884816	18	13884817	444063	437735	rs1555619372	NC_000018.10:13884816:GGGGG:GGGG
NM_014332.3(SMPX):c.87dup (p.Gly30fs)	SMPX		Deafness, X-linked	Pathogenic(Last reviewed: Oct 1, 2017)	no assertion criteria provided	VCV000444056	X	21761912 - 21761913	X	21743794 - 21743795	444056	437698	rs1569308571	NC_000023.11:21743794:T:TT
GRCh37/hg19 Xp21.1(chrX:31637969-31894898)x0	DMD		See cases	Pathogenic(Last reviewed: Aug 15, 2014)	no assertion criteria provided	VCV000443949	X	31637969 - 31894898			443949	437611		
GRCh37/hg19 Xp21.1(chrX:31923771-32043955)x0	DMD		See cases	Pathogenic(Last reviewed: Feb 1, 2016)	no assertion criteria provided	VCV000443414	X	31923771 - 32043955			443414	437076		
GRCh37/hg19 Xp21.1(chrX:32077637-32237871)x0	DMD		See cases	Pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	VCV000443384	X	32077637 - 32237871			443384	437046		
GRCh37/hg19 Xp11.4(chrX:41708906-41713659)x1	CASK		See cases	Pathogenic(Last reviewed: Dec 8, 2014)	no assertion criteria provided	VCV000443361	X	41708906 - 41713659			443361	437023		
GRCh37/hg19 Xp21.1(chrX:32644702-32681484)x2	DMD		See cases	Pathogenic(Last reviewed: Apr 22, 2014)	no assertion criteria provided	VCV000442727	X	32644702 - 32681484			442727	436389		
GRCh37/hg19 Xp21.1(chrX:31951570-32096169)x0	DMD		See cases	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000442714	X	31951570 - 32096169			442714	436376		
GRCh37/hg19 Xp22.2(chrX:10533428-10669918)x0	MID1		See cases	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000442083	X	10533428 - 10669918			442083	435745		
NM_001323289.2(CDKL5):c.2828_2829del (p.Arg943fs)	CDKL5	R943fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Sep 5, 2017)	no assertion criteria provided	VCV000441534	X	18646821 - 18646822	X	18628701 - 18628702	441534	435196	rs1555955290	NC_000023.11:18628700:AGA:A
NM_001159773.2(CANT1):c.511A>T (p.Ile171Phe)	CANT1	I171F	EPIPHYSEAL DYSPLASIA, MULTIPLE, 7	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441248	17	76993194	17	78997112	441248	434881	rs1014317450	NC_000017.11:78997111:T:A
NM_024417.5(FDXR):c.1429G>A (p.Glu477Lys)	FDXR	E477K, E508K, E437K, E425K, E469K, E483K, E520K	Auditory neuropathy-optic atrophy syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441240	17	72858986	17	74862864	441240	434872	rs997026784	NC_000017.11:74862863:C:T
NM_024417.5(FDXR):c.643C>G (p.Leu215Val)	FDXR	L215V, L221V, L246V, L207V, L163V, L175V, L258V	Auditory neuropathy-optic atrophy syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441239	17	72861020	17	74864898	441239	434871	rs1555620021	NC_000017.11:74864897:G:C
NM_024417.5(FDXR):c.1255C>T (p.Gln419Ter)	FDXR	Q419*, Q425*, Q462*, Q367*, Q411*, Q450*, Q379*	Auditory neuropathy-optic atrophy syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000441238	17	72859288	17	74863166	441238	434870	rs1313895172	NC_000017.11:74863165:G:A
NM_000527.4(LDLR):c.2282_2309del (p.Thr761fs)	LDLR	T593fs, T583fs, T720fs, T761fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441230	19	11233984 - 11234011	19	11123308 - 11123335	441230	434853	rs1555808143	NC_000019.10:11123307:CTCACCACGGTGGAGATAGTGACAATGTCTCACCA:CTCACCA
NM_001195803.2(LDLR):c.1606+160del	LDLR	T503fs, T671fs, T630fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441226	19	11231069	19	11120393	441226	434849	rs1555807356	NC_000019.10:11120392:A:
NM_000527.4(LDLR):c.1757C>G (p.Ser586Ter)	LDLR	S586*, S418*, S459*, S545*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000441221	19	11227586	19	11116910	441221	434846	rs1555806455	NC_000019.10:11116909:C:G
NM_000527.4(LDLR):c.1705+1del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000441217	19	11226888	19	11116212	441217	434844	rs879254992	NC_000019.10:11116211:GG:G
NM_000527.4(LDLR):c.1596C>G (p.Tyr532Ter)	LDLR	Y532*, Y364*, Y405*, Y491*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441216	19	11226779	19	11116103	441216	434843	rs1555805947	NC_000019.10:11116102:C:G
NM_000527.4(LDLR):c.1587-5_1618del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441215	19	11226765 - 11226801	19	11116089 - 11116125	441215	434858	rs1555805930	NC_000019.10:11116088:ACCAGCTTCATGTACTGGACTGACTGGGGAACTCCCG:
NM_000527.4(LDLR):c.1046dup (p.Arg350fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441209	19	11221432 - 11221433	19	11110756 - 11110757	441209	434841	rs1555804545	NC_000019.10:11110756:A:AA
NM_000527.4(LDLR):c.987C>A (p.Cys329Ter)	LDLR	C329*, C202*, C161*, C288*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441206	19	11221374	19	11110698	441206	434838	rs1555804467	NC_000019.10:11110697:C:A
NM_000527.4(LDLR):c.928dup (p.Ile310fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441200	19	11218177 - 11218178	19	11107501 - 11107502	441200	434837	rs1555803912	NC_000019.10:11107501:A:AA
NM_000527.4(LDLR):c.817+2T>G	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441193	19	11217365	19	11106689	441193	434831	rs879254686	NC_000019.10:11106688:T:G
NM_001195800.2(LDLR):c.314-1815_314-1811del	LDLR	D183fs, D224fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441188	19	11216253 - 11216257	19	11105577 - 11105581	441188	434826	rs1555803455	NC_000019.10:11105576:ACAAA:
NM_001195800.2(LDLR):c.314-2046_314-2036dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441185	19	11216021 - 11216022	19	11105345 - 11105346	441185	434823	rs1555803254	NC_000019.10:11105345:CCTGTGGTCCC:CCTGTGGTCCCCCTGTGGTCCC
NM_000527.4(LDLR):c.314-?_940+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441182	19	11213463 - 11218191			441182	434801		
NM_000527.4(LDLR):c.140_153del (p.Asp47fs)	LDLR	D47fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441179	19	11210970 - 11210983	19	11100294 - 11100307	441179	434821	rs1555802291	NC_000019.10:11100293:GATGGCAGCGCTGAG:G
NM_000527.4(LDLR):c.91_104del (p.Glu31fs)	LDLR	E31fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000441176	19	11210922 - 11210935	19	11100246 - 11100259	441176	434818	rs1555802259	NC_000019.10:11100245:GAGTTCCAGTGCCA:
NM_015559.3(SETBP1):c.2612T>G (p.Ile871Ser)	SETBP1	I871S	Schinzel-Giedion syndrome|not provided	Pathogenic(Last reviewed: Feb 25, 2020)	no assertion criteria provided	VCV000441093	18	42531917	18	44951952	441093	434668	rs267607038	NC_000018.10:44951951:T:G
NM_030632.3(ASXL3):c.1978_1981del (p.Asp660fs)	ASXL3	D660fs	Inborn genetic diseases|Bainbridge-Ropers syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000441020	18	31319343 - 31319346	18	33739379 - 33739382	441020	434666	rs1555742500	NC_000018.10:33739378:ACAGACA:ACA
NM_001291412.2(SON):c.244+5217del	SON	S789fs	ZTTK syndrome|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000440941	21	34923902	21	33551596	440941	434679	rs1555898531	NC_000021.9:33551595:A:
NM_000032.5(ALAS2):c.508C>A (p.Arg170Ser)	ALAS2	R170S, R157S, R133S	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Aug 7, 2017)	no assertion criteria provided	VCV000440879	X	55047615	X	55021182	440879	434515	rs1557248142	NC_000023.11:55021181:G:T
NM_001429.4(EP300):c.4363C>T (p.Gln1455Ter)	EP300	Q1455*, Q1429*	Inborn genetic diseases|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000440864	22	41566486	22	41170482	440864	434511	rs1555911313	NC_000022.11:41170481:C:T
NM_000455.4(STK11):c.921-2A>C	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 5, 2017)	no assertion criteria provided	VCV000440861	19	1222982	19	1222983	440861	434508	rs727504172	NC_000019.10:1222982:A:C
NM_000390.4(CHM):c.280del (p.Thr94fs)	CHM	T94fs	Choroideremia	Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000440813	X	85233805	X	85978801	440813	434442	rs1555958073	NC_000023.11:85978800:TTTT:TTT
NM_001001563.5(TIMM50):c.340C>T (p.Arg114Trp)	TIMM50	R217W, R114W		Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000440793	19	39976210	19	39485570	440793	434422	rs1300848445	NC_000019.10:39485569:C:T
NM_001001563.5(TIMM50):c.446C>T (p.Thr149Met)	TIMM50	T252M, T149M, T36M		Pathogenic(Last reviewed: Oct 3, 2017)	no assertion criteria provided	VCV000440792	19	39976401	19	39485761	440792	434421	rs1244226820	NC_000019.10:39485760:C:T
NM_001201457.1(TEX14):c.2668_2678del (p.Ser890fs)	TEX14	S890fs, S884fs	SPERMATOGENIC FAILURE 23	Pathogenic(Last reviewed: Jun 28, 2019)	no assertion criteria provided	VCV000440758	17	56665299 - 56665309	17	58587938 - 58587948	440758	434385	rs1555568575	NC_000017.11:58587937:TGCCGGTGGCTTG:TG
NM_000527.5(LDLR):c.814_818del (p.Asn272fs)	LDLR	N231fs, N145fs, N272fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440726	19	11217360 - 11218068	19	11106683 - 11107391	440726	434254	rs1555803722	
NM_000527.4(LDLR):c.2547+5G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440702	19	11240351	19	11129675	440702	434353	rs879255226	NC_000019.10:11129674:G:A
NM_000527.4(LDLR):c.2530G>A (p.Gly844Ser)	LDLR	G844S, G666S, G803S, G676S	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440701	19	11240329	19	11129653	440701	434352	rs1555809614	NC_000019.10:11129652:G:A
NM_000527.4(LDLR):c.2500del (p.Asp834fs)	LDLR	D666fs, D834fs, D656fs, D793fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440700	19	11240298	19	11129622	440700	434351	rs1555809594	NC_000019.10:11129621:GG:G
NM_000527.4(LDLR):c.2476C>T (p.Pro826Ser)	LDLR	P826S, P785S, P648S, P658S	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440699	19	11240275	19	11129599	440699	434350	rs879255217	NC_000019.10:11129598:C:T
NM_000527.4(LDLR):c.2446A>C (p.Lys816Gln)	LDLR	K816Q, K775Q, K638Q, K648Q	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440697	19	11240245	19	11129569	440697	434348	rs879255213	NC_000019.10:11129568:A:C
NM_001195798.2(LDLR):c.2418_2421CTTC[1] (p.Leu808fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440695	19	11240217 - 11240220	19	11129541 - 11129544	440695	434346	rs1555809520	NC_000019.10:11129540:CTTCCTTC:CTTC
NM_000527.4(LDLR):c.2413G>C (p.Gly805Arg)	LDLR	G805R, G627R, G637R, G764R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440694	19	11240212	19	11129536	440694	434345	rs879255204	NC_000019.10:11129535:G:C
NM_000527.4(LDLR):c.2402del (p.Phe801fs)	LDLR	F760fs, F633fs, F623fs, F801fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440693	19	11240200	19	11129524	440693	434344	rs1555809490	NC_000019.10:11129523:TT:T
NM_000527.4(LDLR):c.2394_2401del (p.Leu799fs)	LDLR	L621fs, L631fs, L799fs, L758fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440692	19	11240191 - 11240198	19	11129515 - 11129522	440692	434343	rs1555809471	NC_000019.10:11129514:CTCCTCGTCT:CT
NM_000527.4(LDLR):c.2312-3C>T	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440690	19	11238681	19	11128005	440690	434341	rs875989942	NC_000019.10:11128004:C:T
NM_000527.4(LDLR):c.2274del (p.Leu759fs)	LDLR	L718fs, L581fs, L591fs, L759fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440689	19	11233981	19	11123305	440689	434340	rs1555808139	NC_000019.10:11123304:GGG:GG
NM_000527.4(LDLR):c.2263del (p.Ala755fs)	LDLR	A577fs, A714fs, A755fs, A587fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440688	19	11233969	19	11123293	440688	434339	rs1555808120	NC_000019.10:11123292:GGGG:GGG
NM_000527.4(LDLR):c.2259dup (p.Gly754fs)	LDLR		Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000440686	19	11233967 - 11233968	19	11123291 - 11123292	440686	434337	rs1555808118	NC_000019.10:11123291:T:TT
NM_000527.4(LDLR):c.2253G>A (p.Arg751=)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440685	19	11233962	19	11123286	440685	434336	rs1555808114	NC_000019.10:11123285:G:A
NM_000527.4(LDLR):c.2251del (p.Arg751fs)	LDLR	R710fs, R583fs, R573fs, R751fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440684	19	11233958	19	11123282	440684	434335	rs1555808107	NC_000019.10:11123281:CCC:CC
NM_000527.4(LDLR):c.2141_2311del171 (p.Glu714_Gln770del)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440683	19	11233848 - 11234018	19	11123172 - 11123342	440683	434334	rs1555808008	
NM_000527.4(LDLR):c.2140+1_2140+12del	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440681	19	11231198 - 11231209	19	11120522 - 11120533	440681	434332	rs1555807475	NC_000019.10:11120521:GGTGTGGCACACG:G
NM_000527.4(LDLR):c.2131T>G (p.Cys711Gly)	LDLR	C711G, C543G, C670G	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440680	19	11231189	19	11120513	440680	434331	rs879255144	NC_000019.10:11120512:T:G
NM_000527.4(LDLR):c.2116_2117insC (p.Arg706fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440679	19	11231174 - 11231175	19	11120498 - 11120499	440679	434330	rs1555807465	NC_000019.10:11120498::C
NM_000527.4(LDLR):c.2089G>A (p.Ala697Thr)	LDLR	A697T, A529T, A656T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440678	19	11231147	19	11120471	440678	434329	rs776217028	NC_000019.10:11120470:G:A
NM_000527.4(LDLR):c.2062_2063insC (p.Asn688fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440677	19	11231120 - 11231121	19	11120444 - 11120445	440677	434328	rs1555807421	NC_000019.10:11120444::C
NM_000527.4(LDLR):c.2050del (p.Ala684fs)	LDLR	A643fs, A516fs, A684fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440676	19	11231108	19	11120432	440676	434327	rs1555807388	NC_000019.10:11120431:G:
NM_001195803.2(LDLR):c.1606+199_1606+212delinsC	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440675	19	11231108 - 11231121	19	11120432 - 11120445	440675	434326	rs1555807390	NC_000019.10:11120431:GCCCCGCAGATCAA:C
NM_000527.4(LDLR):c.2026G>T (p.Gly676Cys)	LDLR	G676C, G508C, G635C	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440673	19	11231084	19	11120408	440673	434324	rs745753810	NC_000019.10:11120407:G:T
NM_000527.4(LDLR):c.1988-1G>C	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440672	19	11231045	19	11120369	440672	434323	rs1555807335	NC_000019.10:11120368:G:C
NM_000527.4(LDLR):c.1943C>T (p.Ser648Phe)	LDLR	S648F, S480F, S607F, S521F	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440670	19	11230865	19	11120189	440670	434321	rs1555807266	NC_000019.10:11120188:C:T
NM_000527.4(LDLR):c.1937T>A (p.Leu646Gln)	LDLR	L646Q, L478Q, L605Q, L519Q	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440669	19	11230859	19	11120183	440669	434320	rs1555807261	NC_000019.10:11120182:T:A
NM_000527.4(LDLR):c.1845+2T>A	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440667	19	11227676	19	11117000	440667	434318	rs778408161	NC_000019.10:11116999:T:A
NM_000527.4(LDLR):c.1842_1845+2del	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440666	19	11227670 - 11227675	19	11116994 - 11116999	440666	434317	rs1555806582	NC_000019.10:11116993:TTGAGGT:T
NM_000527.4(LDLR):c.1835C>T (p.Ala612Val)	LDLR	A612V, A485V, A444V, A571V	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440664	19	11227664	19	11116988	440664	434315	rs377449975	NC_000019.10:11116987:C:T
NM_000527.4(LDLR):c.1817C>A (p.Ala606Asp)	LDLR	A606D, A565D, A438D, A479D	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440663	19	11227646	19	11116970	440663	434314	rs1410295777	NC_000019.10:11116969:C:A
NM_000527.4(LDLR):c.1769_1774del (p.Val590_Asn591del)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440660	19	11227597 - 11227602	19	11116921 - 11116926	440660	434311	rs1555806467	NC_000019.10:11116920:GTCAACG:G
NM_000527.4(LDLR):c.1753del (p.Ile585fs)	LDLR	I417fs, I458fs, I544fs, I585fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440659	19	11227582	19	11116906	440659	434310	rs1555806448	NC_000019.10:11116905:A:
NM_000527.4(LDLR):c.1743A>T (p.Lys581Asn)	LDLR	K581N, K413N, K454N, K540N	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440658	19	11227572	19	11116896	440658	434309	rs1555806428	NC_000019.10:11116895:A:T
NM_000527.4(LDLR):c.1705+2T>C	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440656	19	11226890	19	11116214	440656	434307	rs1555806110	NC_000019.10:11116213:T:C
NM_000527.4(LDLR):c.1620dup (p.Lys541fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440654	19	11226801 - 11226802	19	11116125 - 11116126	440654	434305	rs1555805985	NC_000019.10:11116125:CC:CCC
NM_000527.4(LDLR):c.1603G>A (p.Asp535Asn)	LDLR	D535N, D367N, D408N, D494N	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440653	19	11226786	19	11116110	440653	434304	rs879254955	NC_000019.10:11116109:G:A
NM_000527.4(LDLR):c.1571_1586+3dup	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440651	19	11224421 - 11224422	19	11113745 - 11113746	440651	434302	rs1555805531	NC_000019.10:11113745:GTGGATCCTGTTCATGGGTG:GTGGATCCTGTTCATGGGTGTGGATCCTGTTCATGGGTG
NM_000527.4(LDLR):c.1570_1579del (p.Val524fs)	LDLR	V397fs, V524fs, V356fs, V483fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440650	19	11224420 - 11224429	19	11113744 - 11113753	440650	434301	rs1555805530	NC_000019.10:11113743:TGGTGGATCCTG:TG
NM_000527.4(LDLR):c.1521G>C (p.Lys507Asn)	LDLR	K507N, K339N, K380N, K466N	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440649	19	11224373	19	11113697	440649	434300	rs1555805490	NC_000019.10:11113696:G:C
NM_000527.4(LDLR):c.1467C>A (p.Tyr489Ter)	LDLR	Y489*, Y362*, Y321*, Y448*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440647	19	11224319	19	11113643	440647	434298	rs370777955	NC_000019.10:11113642:C:A
NM_000527.4(LDLR):c.1449G>C (p.Trp483Cys)	LDLR	W483C, W315C, W356C, W442C	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000440646	19	11224301	19	11113625	440646	434297	rs879254907	NC_000019.10:11113624:G:C
NM_000527.4(LDLR):c.1448G>T (p.Trp483Leu)	LDLR	W483L, W442L, W315L, W356L	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440645	19	11224300	19	11113624	440645	434296	rs875989921	NC_000019.10:11113623:G:T
NM_000527.4(LDLR):c.1438G>A (p.Ala480Thr)	LDLR	A480T, A439T, A312T, A353T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440644	19	11224290	19	11113614	440644	434295	rs879254901	NC_000019.10:11113613:G:A
NM_000527.4(LDLR):c.1433G>A (p.Gly478Glu)	LDLR	G478E, G310E, G351E, G437E	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440642	19	11224285	19	11113609	440642	434293	rs1555805380	NC_000019.10:11113608:G:A
NM_001195798.2(LDLR):c.1413_1414delinsGGACAT (p.Gln474fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440640	19	11224265 - 11224266	19	11113589 - 11113590	440640	434291	rs1555805360	NC_000019.10:11113588:AG:GGACAT
NM_000527.4(LDLR):c.1393del (p.Tyr465fs)	LDLR	Y465fs, Y297fs, Y338fs, Y424fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440639	19	11224245	19	11113569	440639	434290	rs1555805348	NC_000019.10:11113568:T:
NM_001195798.2(LDLR):c.1379_1394delinsCAGCT (p.His460fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440638	19	11224231 - 11224246	19	11113555 - 11113570	440638	434289	rs1555805337	NC_000019.10:11113554:ACGGCGTCTCTTCCTA:CAGCT
NM_000527.4(LDLR):c.1342C>A (p.Gln448Lys)	LDLR	Q448K, Q407K, Q321K, Q280K	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440635	19	11224109	19	11113433	440635	434286	rs879254871	NC_000019.10:11113432:C:A
NM_000527.4(LDLR):c.1234A>C (p.Met412Leu)	LDLR	M412L, M371L, M285L, M244L	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440633	19	11224001	19	11113325	440633	434284	rs1225797407	NC_000019.10:11113324:A:C
NM_000527.4(LDLR):c.1195G>T (p.Ala399Ser)	LDLR	A399S, A358S, A272S, A231S	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440632	19	11223962	19	11113286	440632	434283	rs730882099	NC_000019.10:11113285:G:T
NM_000527.4(LDLR):c.1187G>A (p.Gly396Asp)	LDLR	G396D, G269D, G228D, G355D	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440630	19	11223954	19	11113278	440630	434282	rs766474188	NC_000019.10:11113277:G:A
NM_000527.4(LDLR):c.1154T>C (p.Leu385Pro)	LDLR	L385P, L217P, L344P, L258P	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440626	19	11222283	19	11111607	440626	434277	rs879254809	NC_000019.10:11111606:T:C
NM_000527.4(LDLR):c.1067A>T (p.Asp356Val)	LDLR	D356V, D315V, D188V, D229V	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440623	19	11222196	19	11111520	440623	434274	rs879254777	NC_000019.10:11111519:A:T
NM_000527.4(LDLR):c.1064dup (p.Asp356fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440622	19	11222192 - 11222193	19	11111516 - 11111517	440622	434273	rs1555804700	NC_000019.10:11111516:T:TT
NM_000527.4(LDLR):c.1028G>T (p.Gly343Val)	LDLR	G343V, G302V, G216V, G175V	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440618	19	11221415	19	11110739	440618	434269	rs879254760	NC_000019.10:11110738:G:T
NM_000527.4(LDLR):c.948del (p.Asn316fs)	LDLR	N275fs, N316fs, N148fs, N189fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440615	19	11221335	19	11110659	440615	434266	rs1555804443	NC_000019.10:11110658:C:
NM_000527.4(LDLR):c.940+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440614	19	11218191	19	11107515	440614	434265	rs879254729	NC_000019.10:11107514:G:T
NM_000527.4(LDLR):c.911A>T (p.Asp304Val)	LDLR	D304V, D263V, D136V, D177V	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440613	19	11218161	19	11107485	440613	434264	rs1555803898	NC_000019.10:11107484:A:T
NM_000527.4(LDLR):c.904T>C (p.Cys302Arg)	LDLR	C302R, C175R, C134R, C261R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440611	19	11218154	19	11107478	440611	434262	rs1555803891	NC_000019.10:11107477:T:C
NM_000527.4(LDLR):c.886T>C (p.Cys296Arg)	LDLR	C296R, C255R, C169R, C128R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440610	19	11218136	19	11107460	440610	434261	rs1555803879	NC_000019.10:11107459:T:C
NM_000527.4(LDLR):c.840_841insT (p.Lys281Ter)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440608	19	11218090 - 11218091	19	11107414 - 11107415	440608	434259	rs1555803841	NC_000019.10:11107414::T
NM_000527.4(LDLR):c.839_848dup (p.Cys284fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440607	19	11218087 - 11218088	19	11107411 - 11107412	440607	434258	rs1555803837	NC_000019.10:11107411:AACAAGTTCAA:AACAAGTTCAAACAAGTTCAA
NM_000527.4(LDLR):c.817+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440604	19	11217364	19	11106688	440604	434255	rs879254685	NC_000019.10:11106687:G:T
NM_000527.4(LDLR):c.796_800del (p.Asp266fs)	LDLR	D139fs, D266fs, D225fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440603	19	11217342 - 11217346	19	11106666 - 11106670	440603	434253	rs1555803701	NC_000019.10:11106665:GATGA:
NM_000527.4(LDLR):c.770G>C (p.Arg257Pro)	LDLR	R257P, R130P, R216P	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440602	19	11217316	19	11106640	440602	434252	rs757808215	NC_000019.10:11106639:G:C
NM_000527.4(LDLR):c.737G>T (p.Gly246Val)	LDLR	G246V, G119V, G205V	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440600	19	11217283	19	11106607	440600	434250	rs879254661	NC_000019.10:11106606:G:T
NM_000527.4(LDLR):c.731C>G (p.Ser244Cys)	LDLR	S244C, S117C, S203C	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440599	19	11217277	19	11106601	440599	434249	rs1208667598	NC_000019.10:11106600:C:G
NM_000527.4(LDLR):c.722T>G (p.Phe241Cys)	LDLR	F241C, F200C, F114C	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440598	19	11217268	19	11106592	440598	434248	rs748131256	NC_000019.10:11106591:T:G
NM_000527.4(LDLR):c.702del (p.Thr235fs)	LDLR	T194fs, T108fs, T235fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440597	19	11217247	19	11106571	440597	434247	rs1555803641	NC_000019.10:11106570:CC:C
NM_000527.4(LDLR):c.682_683insGACAAATCTGAG (p.Glu228delinsGlyGlnIleTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440596	19	11216263 - 11216264	19	11105587 - 11105588	440596	434246	rs879254641	NC_000019.10:11105587:G:GGACAAATCTGAG
NM_000527.4(LDLR):c.680_692delACGAGGAAAACTGins24 (p.?)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440594	19	11216262 - 11216274	19	11105586 - 11105598	440594	434244		
NM_000527.4(LDLR):c.669_676del (p.Lys223fs)	LDLR	K182fs, K223fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440593	19	11216251 - 11216258	19	11105575 - 11105582	440593	434243	rs1555803449	NC_000019.10:11105574:GGACAAAT:
NM_000527.4(LDLR):c.666C>T (p.Cys222=)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440592	19	11216248	19	11105572	440592	434242	rs756613387	NC_000019.10:11105571:C:T
NM_000527.4(LDLR):c.662_681dup (p.Glu228fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440591	19	11216243 - 11216244	19	11105567 - 11105568	440591	434241	rs1555803432	NC_000019.10:11105567:ACTGCAAGGACAAATCTGAC:ACTGCAAGGACAAATCTGACACTGCAAGGACAAATCTGAC
NM_000527.4(LDLR):c.658_663del (p.Pro220_Asp221del)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440589	19	11216239 - 11216244	19	11105563 - 11105568	440589	434239	rs1555803409	NC_000019.10:11105562:CCCCGAC:C
NM_000527.4(LDLR):c.644G>A (p.Arg215His)	LDLR	R215H, R174H	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440588	19	11216226	19	11105550	440588	434238	rs753319170	NC_000019.10:11105549:G:A
NM_000527.4(LDLR):c.643C>T (p.Arg215Cys)	LDLR	R215C, R174C	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440587	19	11216225	19	11105549	440587	434237	rs764042910	NC_000019.10:11105548:C:T
NM_000527.4(LDLR):c.628A>C (p.Ile210Leu)	LDLR	I210L, I169L	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440586	19	11216210	19	11105534	440586	434236	rs1555803391	NC_000019.10:11105533:A:C
NM_000527.4(LDLR):c.612C>A (p.Cys204Ter)	LDLR	C204*, C163*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440585	19	11216194	19	11105518	440585	434235	rs1555803383	NC_000019.10:11105517:C:A
NM_000527.4(LDLR):c.586C>A (p.Pro196Thr)	LDLR	P196T, P155T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440584	19	11216168	19	11105492	440584	434234	rs1013147010	NC_000019.10:11105491:C:A
NM_000527.4(LDLR):c.565del (p.Val189fs)	LDLR	V148fs, V189fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440582	19	11216147	19	11105471	440582	434232	rs1555803354	NC_000019.10:11105470:G:
NM_000527.4(LDLR):c.557dup (p.Leu187fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440581	19	11216135 - 11216136	19	11105459 - 11105460	440581	434231	rs879254573	NC_000019.10:11105459:GGGG:GGGGG
NM_000527.4(LDLR):c.535_536insGCTCGGAG (p.Glu179fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440578	19	11216116 - 11216117	19	11105440 - 11105441	440578	434228	rs1555803337	NC_000019.10:11105440:G:GGCTCGGAG
NM_000527.4(LDLR):c.532del (p.Asp178fs)	LDLR	D137fs, D178fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440577	19	11216113	19	11105437	440577	434227	rs1555803327	NC_000019.10:11105436:GG:G
NM_000527.4(LDLR):c.482T>C (p.Ile161Thr)	LDLR	I161T, I120T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440575	19	11216064	19	11105388	440575	434225	rs754933794	NC_000019.10:11105387:T:C
NM_000527.4(LDLR):c.445G>C (p.Gly149Arg)	LDLR	G149R, G108R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440573	19	11216027	19	11105351	440573	434223	rs879254529	NC_000019.10:11105350:G:C
NM_000527.4(LDLR):c.431C>T (p.Pro144Leu)	LDLR	P144L, P103L	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440572	19	11216013	19	11105337	440572	434222	rs912448894	NC_000019.10:11105336:C:T
NM_000527.4(LDLR):c.400T>G (p.Cys134Gly)	LDLR	C134G, C93G	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440567	19	11215982	19	11105306	440567	434217	rs875989900	NC_000019.10:11105305:T:G
NM_000527.4(LDLR):c.380T>G (p.Val127Gly)	LDLR	V127G, V86G	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440566	19	11215962	19	11105286	440566	434216	rs879254503	NC_000019.10:11105285:T:G
NM_000527.4(LDLR):c.378del (p.Phe126fs)	LDLR	F85fs, F126fs	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440565	19	11215960	19	11105284	440565	434215	rs1555803213	NC_000019.10:11105283:C:
NM_000527.4(LDLR):c.363C>G (p.Cys121Trp)	LDLR	C121W, C80W	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440563	19	11215945	19	11105269	440563	434213	rs1555803191	NC_000019.10:11105268:C:G
NM_000527.4(LDLR):c.337dup (p.Glu113fs)	LDLR		Familial hypercholesterolemia 1|Hypercholesterolemia|not provided	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000440560	19	11215918 - 11215919	19	11105242 - 11105243	440560	434210	rs752191968	NC_000019.10:11105242:G:GG
NM_000527.4(LDLR):c.313+4_313+16del	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440557	19	11213466 - 11213478	19	11102790 - 11102802	440557	434207	rs1555802822	NC_000019.10:11102789:AGTGTGGCCCTGC:
NM_000527.4(LDLR):c.300C>G (p.Asp100Glu)	LDLR	D100E	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440556	19	11213449	19	11102773	440556	434206	rs766709484	NC_000019.10:11102772:C:G
NM_000527.4(LDLR):c.269A>C (p.Asp90Ala)	LDLR	D90A	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440555	19	11213418	19	11102742	440555	434205	rs771019366	NC_000019.10:11102741:A:C
NM_000527.4(LDLR):c.263G>A (p.Arg88Lys)	LDLR	R88K	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440554	19	11213412	19	11102736	440554	434204	rs1398808477	NC_000019.10:11102735:G:A
NM_000527.4(LDLR):c.262A>G (p.Arg88Gly)	LDLR	R88G	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440553	19	11213411	19	11102735	440553	434203	rs200660051	NC_000019.10:11102734:A:G
NM_000527.4(LDLR):c.259T>C (p.Trp87Arg)	LDLR	W87R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440552	19	11213408	19	11102732	440552	434202	rs121908025	NC_000019.10:11102731:T:C
NM_000527.4(LDLR):c.248T>C (p.Ile83Thr)	LDLR	I83T	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440551	19	11213397	19	11102721	440551	434201	rs1555802745	NC_000019.10:11102720:T:C
NM_000527.4(LDLR):c.191-1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440550	19	11213339	19	11102663	440550	434200	rs879254433	NC_000019.10:11102662:G:T
NM_000527.4(LDLR):c.188G>T (p.Cys63Phe)	LDLR	C63F	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440548	19	11211019	19	11100343	440548	434198	rs879254427	NC_000019.10:11100342:G:T
NM_000527.4(LDLR):c.172G>T (p.Glu58Ter)	LDLR	E58*	Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000440547	19	11211003	19	11100327	440547	434197	rs879254423	NC_000019.10:11100326:G:T
NM_000527.4(LDLR):c.139G>C (p.Asp47His)	LDLR	D47H	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440546	19	11210970	19	11100294	440546	434196	rs778284147	NC_000019.10:11100293:G:C
NM_000527.4(LDLR):c.132G>A (p.Trp44Ter)	LDLR	W44*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440545	19	11210963	19	11100287	440545	434195	rs1555802287	NC_000019.10:11100286:G:A
NM_000527.4(LDLR):c.115T>C (p.Cys39Arg)	LDLR	C39R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440543	19	11210946	19	11100270	440543	434193	rs1555802275	NC_000019.10:11100269:T:C
NM_000527.4(LDLR):c.90_91insTGTGTTT (p.Glu31delinsCysValTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440541	19	11210921 - 11210922	19	11100245 - 11100246	440541	434191	rs1555802258	NC_000019.10:11100245::TGTGTTT
NM_000527.4(LDLR):c.79T>C (p.Cys27Arg)	LDLR	C27R	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440540	19	11210910	19	11100234	440540	434190	rs1555802245	NC_000019.10:11100233:T:C
NM_001195798.2(LDLR):c.70_192del (p.Gly24_Leu64del)	LDLR		Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000440539	19	11210899 - 11211021	19	11100223 - 11100345	440539	434189	rs1555802242	
NM_001257988.1(TYMP):c.763_765del (p.Leu255del)	TYMP	L255del	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000440503	22	50965594 - 50965596	22	50527165 - 50527167	440503	434129	rs1556488264	NC_000022.11:50527164:CAGC:C
NM_001257988.1(TYMP):c.628A>C (p.Ser210Arg)	TYMP	S210R	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000440502	22	50966035	22	50527606	440502	434130	rs761665644	NC_000022.11:50527605:T:G
NM_000527.4(LDLR):c.1070del (p.Glu357fs)	LDLR	E230fs, E357fs, E189fs, E316fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000440486	19	11222199	19	11111523	440486	434113	rs1555804717	NC_000019.10:11111522:A:
NM_000116.5(TAZ):c.483del (p.Met162fs)	TAZ	M162fs, M180fs, M132fs	not specified	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000440320	X	153647901	X	154419562	440320	433956	rs1557193815	NC_000023.11:154419561:GGGG:GGG
NM_000346.4(SOX9):c.1099_1100delinsG (p.Pro367fs)	SOX9		not specified	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000440293	17	70120097 - 70120098	17	72123956 - 72123957	440293	433936	rs1555629374	NC_000017.11:72123955:CC:G
NM_000132.3(F8):c.6089G>A (p.Ser2030Asn)	F8	S2030N	Hereditary factor IX deficiency disease|not specified	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439683	X	154130352	X	154902077	439683	433314	rs369414658	NC_000023.11:154902076:C:T
NM_000132.3(F8):c.270del (p.Leu90_Leu91insTer)	F8		not specified	Pathogenic(Last reviewed: Dec 12, 2016)	criteria provided, single submitter	VCV000439682	X	154225366	X	154997091	439682	433325	rs1557285171	NC_000023.11:154997090:C:
NM_000132.3(F8):c.1569G>T (p.Leu523=)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000439678	X	154185415	X	154957140	439678	433321	rs782733685	NC_000023.11:154957139:C:A
NM_000132.3(F8):c.5186G>A (p.Gly1729Glu)	F8	G1729E	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000439677	X	154156879	X	154928604	439677	433316	rs1557278259	NC_000023.11:154928603:C:T
NM_000132.3(F8):c.1589A>G (p.Tyr530Cys)	F8	Y530C	not specified	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000439676	X	154185395	X	154957120	439676	433320	rs1557281265	NC_000023.11:154957119:T:C
NM_000132.3(F8):c.1350C>A (p.Tyr450Ter)	F8	Y450*	not specified	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000439675	X	154194338	X	154966063	439675	433323	rs1557281954	NC_000023.11:154966062:G:T
NM_000109.4(DMD):c.1457del (p.Lys486fs)	DMD	K371fs, K486fs, K490fs, K494fs	not specified	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000439619	X	32632421	X	32614304	439619	433330	rs1556853022	NC_000023.11:32614303:TT:T
NM_000109.4(DMD):c.8173G>T (p.Glu2725Ter)	DMD	E2733*, E2725*, E1392*, E2610*, E273*, E2729*, E1389*	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000439618	X	31645810	X	31627693	439618	433503	rs1556764743	NC_000023.11:31627692:C:A
NM_000109.4(DMD):c.2461C>T (p.Gln821Ter)	DMD	Q821*, Q829*, Q706*, Q825*	not specified	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000439617	X	32509531	X	32491414	439617	433328	rs753662330	NC_000023.11:32491413:G:A
NM_000109.4(DMD):c.8758A>T (p.Lys2920Ter)	DMD	K2920*, K2928*, K199*, K468*, K2924*, K1584*, K1587*, K2805*	not specified	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000439616	X	31496378	X	31478261	439616	433326	rs1556656298	NC_000023.11:31478260:T:A
NM_000109.4(DMD):c.2392G>T (p.Glu798Ter)	DMD	E798*, E806*, E802*, E683*	not specified|not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000439615	X	32509600	X	32491483	439615	433329	rs1557383761	NC_000023.11:32491482:C:A
NM_000109.4(DMD):c.4036del (p.Leu1346fs)	DMD	L1346fs, L1350fs, L1231fs, L1354fs	not specified	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000439614	X	32456369	X	32438252	439614	433502	rs1557357445	NC_000023.11:32438251:G:
NM_000109.4(DMD):c.8367-2A>G	DMD		Duchenne muscular dystrophy|not specified	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000439613	X	31515063	X	31496946	439613	433327	rs1556665303	NC_000023.11:31496945:T:C
NM_000109.4(DMD):c.8856G>A (p.Trp2952Ter)	DMD	W2960*, W1616*, W2952*, W2956*, W1619*, W2837*, W231*, W500*	not specified|not provided	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439612	X	31496280	X	31478163	439612	433501	rs1556656184	NC_000023.11:31478162:C:T
NM_000109.4(DMD):c.7875G>A (p.Trp2625Ter)	DMD	W2633*, W1289*, W1292*, W173*, W2510*, W2625*, W2629*	not specified	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000439610	X	31676235	X	31658118	439610	433499	rs1556790316	NC_000023.11:31658117:C:T
NM_000109.4(DMD):c.9536A>G (p.Asp3179Gly)	DMD	D3187G, D3179G, D1846G, D3183G, D119G, D458G, D727G, D1843G, D3064G	not provided	Pathogenic(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000439608	X	31227618	X	31209501	439608	433497	rs1556280638	NC_000023.11:31209500:T:C
NM_004006.2(DMD):c.4845+2T>G	DMD		not specified	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000439607	X	32398625	X	32380508	439607	433496	rs1557315881	NC_000023.11:32380507:A:C
NM_000109.4(DMD):c.2077G>T (p.Glu693Ter)	DMD	E701*, E697*, E578*, E693*	not specified	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000439606	X	32563343	X	32545226	439606	433495	rs1556780711	NC_000023.11:32545225:C:A
NM_000495.5(COL4A5):c.2696G>A (p.Gly899Asp)	COL4A5	G899D	not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000439521	X	107865051	X	108621821	439521	433304	rs281874702	NC_000023.11:108621820:G:A
NM_001250.6(CD40):c.256+2T>C	CD40		not specified	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000439466	20	44750999	20	46122360	439466	433398	rs774195387	NC_000020.11:46122359:T:C
NM_000071.2(CBS):c.816T>A (p.Cys272Ter)	CBS	C272*, C167*	not provided|Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439461	21	44484022	21	43063912	439461	433393	rs528689432	NC_000021.9:43063911:A:T
NM_000061.2(BTK):c.1780G>A (p.Gly594Arg)	BTK	G594R, G628R, G418R	not specified	Pathogenic(Last reviewed: Dec 15, 2016)	criteria provided, single submitter	VCV000439452	X	100608310	X	101353322	439452	433384	rs1555977339	NC_000023.11:101353321:C:T
NM_000033.4(ABCD1):c.1440del (p.Ile481fs)	ABCD1	I481fs	not specified|not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439349	X	153002654	X	153737200	439349	433309	rs1557054318	NC_000023.11:153737199:CCCC:CCC
NM_000455.4(STK11):c.199del (p.Leu67fs)	STK11	L67fs	not provided|Peutz-Jeghers syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000439304	19	1207111	19	1207112	439304	432949	rs1555735014	NC_000019.10:1207111:C:
NM_001127898.4(CLCN5):c.1676G>A (p.Trp559Ter)	CLCN5	W559*, W509*, W489*		Pathogenic(Last reviewed: Oct 28, 2013)	no assertion criteria provided	VCV000438798	X	49853473	X	50088816	438798	432424	rs1557194353	NC_000023.11:50088815:G:A
NM_018669.6(WDR4):c.940dup (p.Leu314fs)	WDR4		GALLOWAY-MOWAT SYNDROME 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000438742	21	44273713 - 44273714	21	42853603 - 42853604	438742	432368	rs776760122	NC_000021.9:42853603:GGGGGG:GGGGGGG
NM_018669.6(WDR4):c.491A>C (p.Asp164Ala)	WDR4	D164A, D18A	GALLOWAY-MOWAT SYNDROME 6	Pathogenic(Last reviewed: Mar 8, 2019)	no assertion criteria provided	VCV000438741	21	44282467	21	42862357	438741	432369	rs1555976610	NC_000021.9:42862356:T:G
NM_001126121.2(SLC25A19):c.550G>C (p.Ala184Pro)	SLC25A19	A184P	Striatal necrosis, bilateral, and progressive polyneuropathy	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438733	17	73274326	17	75278245	438733	432359	rs769187207	NC_000017.11:75278244:C:G
NM_001126121.2(SLC25A19):c.481G>A (p.Ala161Thr)	SLC25A19	A161T	Striatal necrosis, bilateral, and progressive polyneuropathy	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438732	17	73274395	17	75278314	438732	432360	rs1208990609	NC_000017.11:75278313:C:T
NM_001126121.2(SLC25A19):c.454C>A (p.Pro152Thr)	SLC25A19	P152T	Striatal necrosis, bilateral, and progressive polyneuropathy	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438731	17	73279509	17	75283428	438731	432361	rs1555603796	NC_000017.11:75283427:G:T
NM_001126121.2(SLC25A19):c.194C>T (p.Ala65Val)	SLC25A19	A65V	Striatal necrosis, bilateral, and progressive polyneuropathy	Pathogenic(Last reviewed: Sep 14, 2017)	no assertion criteria provided	VCV000438730	17	73282479	17	75286398	438730	432362	rs1555604541	NC_000017.11:75286397:G:A
NM_001195800.2(LDLR):c.314-1803del	LDLR	E228fs, E187fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438696	19	11216265	19	11105589	438696	432341	rs1555803481	NC_000019.10:11105588:A:
NM_000054.6(AVPR2):c.24del (p.Ala9fs)	AVPR2	A9fs	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438660	X	153170622	X	153905168	438660	432347	rs1557100304	NC_000023.11:153905167:CC:C
NM_000444.6(PHEX):c.1022T>A (p.Val341Asp)	PHEX	V341D	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 28, 2013)	criteria provided, single submitter	VCV000438577	X	22117212	X	22099094	438577	432145	rs1556026027	NC_000023.11:22099093:T:A
NM_000444.6(PHEX):c.1269del (p.Asp424fs)	PHEX	D424fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438576	X	22132671	X	22114553	438576	432152	rs1556030487	NC_000023.11:22114552:A:
NC_000023.10:g.(22115157_22117149)_(22117270_22129584)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438572	X	22115157 - 22129584	X	22097039 - 22111466	438572	432112		
NM_000444.6(PHEX):c.467T>C (p.Leu156Pro)	PHEX	L156P	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000438570	X	22095624	X	22077506	438570	432132	rs1556020752	NC_000023.11:22077505:T:C
NM_000444.6(PHEX):c.732+5G>C	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000438569	X	22108620	X	22090502	438569	432140	rs1556023528	NC_000023.11:22090501:G:C
Single allele	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438567	X	22114640 - 22150788			438567	432107		
NM_000444.6(PHEX):c.1216T>C (p.Cys406Arg)	PHEX	C406R	Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438566	X	22132618	X	22114500	438566	432151	rs1556030465	NC_000023.11:22114499:T:C
NC_000023.10:g.(22117270_22129584)_(22132705_22151639)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438565	X	22117270 - 22151639	X	22099152 - 22123572	438565	432113		
NM_000444.6(PHEX):c.1572dup (p.Val525fs)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438564	X	22196477 - 22196478	X	22178360 - 22178361	438564	432164	rs1556071138	NC_000023.11:22178360:CC:CCC
NM_000444.6(PHEX):c.1359A>C (p.Glu453Asp)	PHEX	E453D	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438560	X	22151696	X	22133579	438560	432156	rs202164519	NC_000023.11:22133578:A:C
NM_000444.6(PHEX):c.1103G>A (p.Trp368Ter)	PHEX	W368*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438559	X	22129608	X	22111490	438559	432148	rs1556029499	NC_000023.11:22111489:G:A
NM_000444.6(PHEX):c.679C>A (p.Leu227Ile)	PHEX	L227I	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438556	X	22108562	X	22090444	438556	432136	rs1556023495	NC_000023.11:22090443:C:A
NM_000444.6(PHEX):c.707T>C (p.Leu236Pro)	PHEX	L236P	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438555	X	22108590	X	22090472	438555	432138	rs1556023505	NC_000023.11:22090471:T:C
NM_000444.6(PHEX):c.1297G>T (p.Glu433Ter)	PHEX	E433*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438554	X	22132699	X	22114581	438554	432153	rs1556030502	NC_000023.11:22114580:G:T
NM_000444.6(PHEX):c.934-3_934-1delinsTCA	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438552	X	22117121 - 22117123	X	22099003 - 22099005	438552	432143	rs1556025936	NC_000023.11:22099002:CAG:TCA
NM_000444.6(PHEX):c.253T>C (p.Cys85Arg)	PHEX	C85R	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 28, 2013)	criteria provided, single submitter	VCV000438549	X	22065233	X	22047115	438549	432128	rs1556014287	NC_000023.11:22047114:T:C
NC_000023.10:g.(22065330_22094505)_(22095821_22108546)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438546	X	22065330 - 22108546	X	22047212 - 22090428	438546	432109		
NM_000444.6(PHEX):c.1560del (p.Trp520fs)	PHEX	W520fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438545	X	22196466	X	22178349	438545	432162	rs1556071086	NC_000023.11:22178348:GG:G
NM_000444.6(PHEX):c.591A>G (p.Gln197=)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438544	X	22095748	X	22077630	438544	432134	rs1556020818	NC_000023.11:22077629:A:G
NM_000444.6(PHEX):c.1568_1569insT (p.Lys523fs)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438543	X	22196475 - 22196476	X	22178358 - 22178359	438543	432163	rs1556071123	NC_000023.11:22178358::T
NC_000023.10:g.(22132705_22151639)_(22151742_22186428)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438541	X	22132705 - 22186428			438541	432106		
NM_000444.6(PHEX):c.1483-2A>G	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438540	X	22196388	X	22178271	438540	432160	rs1556070724	NC_000023.11:22178270:A:G
NM_000444.6(PHEX):c.187+1del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438539	X	22056654	X	22038536	438539	432126	rs1556012094	NC_000023.11:22038535:GGG:GG
NM_000444.6(PHEX):c.1523A>C (p.Gln508Pro)	PHEX	Q508P	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438538	X	22196430	X	22178313	438538	432161	rs1556070890	NC_000023.11:22178312:A:C
NM_000444.6(PHEX):c.187+1G>T	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000438537	X	22056656	X	22038538	438537	432125	rs1556012100	NC_000023.11:22038537:G:T
NM_000444.6(PHEX):c.621T>G (p.Tyr207Ter)	PHEX	Y207*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438536	X	22095778	X	22077660	438536	432135	rs771208171	NC_000023.11:22077659:T:G
NM_000444.6(PHEX):c.1586+1G>A	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438534	X	22196494	X	22178377	438534	432165	rs1064796928	NC_000023.11:22178376:G:A
NM_000444.6(PHEX):c.424del (p.Cys142fs)	PHEX	C142fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438533	X	22094580	X	22076462	438533	432130	rs1556020474	NC_000023.11:22076461:T:
NM_000444.6(PHEX):c.1404G>C (p.Lys468Asn)	PHEX	K468N	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438531	X	22151741	X	22133624	438531	432157	rs754449807	NC_000023.11:22133623:G:C
NM_000444.6(PHEX):c.78dup (p.Val27fs)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438526	X	22051198 - 22051199	X	22033080 - 22033081	438526	432121	rs1556010757	NC_000023.11:22033080:TTT:TTTT
NM_000444.6(PHEX):c.142C>T (p.Gln48Ter)	PHEX	Q48*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000438523	X	22056610	X	22038492	438523	432123	rs202074612	NC_000023.11:22038491:C:T
NM_000444.6(PHEX):c.1137_1138delinsAT (p.Ser379_Arg380delinsArgTrp)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438522	X	22129642 - 22129643	X	22111524 - 22111525	438522	432150	rs1556029519	NC_000023.11:22111523:CA:AT
NM_000444.6(PHEX):c.415T>A (p.Tyr139Asn)	PHEX	Y139N	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000438518	X	22094571	X	22076453	438518	432129	rs1556020460	NC_000023.11:22076452:T:A
NM_000444.6(PHEX):c.1134del (p.Ser379fs)	PHEX	S379fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438517	X	22129638	X	22111520	438517	432149	rs1556029516	NC_000023.11:22111519:TT:T
NM_000444.6(PHEX):c.119-3C>G	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000438515	X	22056584	X	22038466	438515	432122	rs1556012055	NC_000023.11:22038465:C:G
NC_000023.10:g.(22095821_22108546)_(22108616_22112100)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438514	X	22095821 - 22112100	X	22077703 - 22093982	438514	432111		
NC_000023.10:g.(?_22051124)_(22051242_22056586)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438512	X	22051124 - 22056586	X	22033006 - 22038468	438512	432120		
NM_000444.6(PHEX):c.1044del (p.Asp349fs)	PHEX	D349fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438508	X	22117232	X	22099114	438508	432146	rs1556026042	NC_000023.11:22099113:AAA:AA
NM_000444.6(PHEX):c.436+6T>C	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 17, 2015)	criteria provided, single submitter	VCV000438507	X	22094598	X	22076480	438507	432131	rs1556020485	NC_000023.11:22076479:T:C
NM_000444.6(PHEX):c.1303-1G>C	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 14, 2015)	criteria provided, single submitter	VCV000438505	X	22151639	X	22133522	438505	432155	rs1556036014	NC_000023.11:22133521:G:C
NM_000444.6(PHEX):c.732+5G>A	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000438504	X	22108620	X	22090502	438504	432139	rs1556023528	NC_000023.11:22090501:G:A
NM_000444.6(PHEX):c.230G>T (p.Cys77Phe)	PHEX	C77F	Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438501	X	22065210	X	22047092	438501	432127	rs1556014263	NC_000023.11:22047091:G:T
NC_000023.10:g.(22051242_22056586)_(22056656_22065167)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438497	X	22051242 - 22065167	X	22033124 - 22047049	438497	432108		
NC_000023.10:g.(22094593_22095593)_(22095821_22108546)del	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438496	X	22094593 - 22108546	X	22076475 - 22090428	438496	432110		
NM_000444.6(PHEX):c.181G>T (p.Glu61Ter)	PHEX	E61*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000438495	X	22056649	X	22038531	438495	432124	rs770630990	NC_000023.11:22038530:G:T
NM_000444.6(PHEX):c.544_545GA[1] (p.Arg183fs)	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438494	X	22095700 - 22095703	X	22077582 - 22077585	438494	432133	rs1556020798	NC_000023.11:22077581:AGAGAGA:AGA
NM_000444.6(PHEX):c.704del (p.Tyr235fs)	PHEX	Y235fs	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000438493	X	22108587	X	22090469	438493	432137	rs1556023503	NC_000023.11:22090468:A:
NM_000444.6(PHEX):c.955_957AAG[1] (p.Lys320del)	PHEX	K320del	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 28, 2013)	criteria provided, single submitter	VCV000438490	X	22117145 - 22117147	X	22099027 - 22099029	438490	432144	rs1556025968	NC_000023.11:22099026:AAGAAG:AAG
NM_000444.6(PHEX):c.933+1G>T	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 6, 2013)	criteria provided, single submitter	VCV000438489	X	22115157	X	22097039	438489	432142	rs1556025314	NC_000023.11:22097038:G:T
NM_000444.6(PHEX):c.832G>T (p.Glu278Ter)	PHEX	E278*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000438488	X	22112200	X	22094082	438488	432141	rs1556024541	NC_000023.11:22094081:G:T
NM_000444.6(PHEX):c.1590G>C (p.Trp530Cys)	PHEX	W530C	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000438486	X	22208564	X	22190447	438486	432167	rs1556091855	NC_000023.11:22190446:G:C
NM_001008537.3(NEXMIF):c.2042del (p.Gly681fs)	NEXMIF	G681fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Sep 13, 2017)	no assertion criteria provided	VCV000438479	X	73962350	X	74742515	438479	432101	rs1556016555	NC_000023.11:74742514:CCC:CC
NM_001008537.3(NEXMIF):c.964C>T (p.Arg322Ter)	NEXMIF	R322*	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Sep 13, 2017)	no assertion criteria provided	VCV000438478	X	73963428	X	74743593	438478	432100	rs1556016731	NC_000023.11:74743592:G:A
NM_001008537.3(NEXMIF):c.438C>A (p.Cys146Ter)	NEXMIF	C146*	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Sep 13, 2017)	no assertion criteria provided	VCV000438477	X	73963954	X	74744119	438477	432099	rs1556016802	NC_000023.11:74744118:G:T
NM_022482.5(GZF1):c.1054dup (p.Thr352fs)	GZF1		JOINT LAXITY, SHORT STATURE, AND MYOPIA	Pathogenic(Last reviewed: Sep 11, 2017)	no assertion criteria provided	VCV000438349	20	23346073 - 23346074	20	23365436 - 23365437	438349	431980	rs1555786729	NC_000020.11:23365436:A:AA
NM_022482.5(GZF1):c.865G>T (p.Glu289Ter)	GZF1	E289*	JOINT LAXITY, SHORT STATURE, AND MYOPIA	Pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000438348	20	23345885	20	23365248	438348	431979	rs1555786618	NC_000020.11:23365247:G:T
NM_000527.4(LDLR):c.1988-1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000438329	19	11231045	19	11120369	438329	431959	rs1555807335	NC_000019.10:11120368:G:A
NM_000527.4(LDLR):c.1757C>A (p.Ser586Ter)	LDLR	S586*, S418*, S459*, S545*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000438326	19	11227586	19	11116910	438326	431957	rs1555806455	NC_000019.10:11116909:C:A
Single allele	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000438319	19	11211022 - 11224439			438319	431964		
Single allele	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000438318	19	11211022 - 11217364			438318	431963		
Single allele	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000438317	19	11211022 - 11216277			438317	431962		
Single allele	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000438315	19	11200292 - 11227675			438315	431961		
NM_001356.4(DDX3X):c.770dup (p.Asn257fs)	DDX3X		Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 25, 2016)	no assertion criteria provided	VCV000438286	X	41203283 - 41203284	X	41344030 - 41344031	438286	431935	rs1555953398	NC_000023.11:41344030:AAAA:AAAAA
NM_001356.4(DDX3X):c.1099dup (p.Gln367fs)	DDX3X		Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 12, 2016)	no assertion criteria provided	VCV000438285	X	41204505 - 41204506	X	41345252 - 41345253	438285	431936	rs1555953819	NC_000023.11:41345252:C:CC
NM_001123383.1(BCOR):c.3268del (p.Asp1090fs)	BCOR	D1072fs, D1090fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Aug 31, 2016)	no assertion criteria provided	VCV000438284	X	39923823	X	40064570	438284	431933	rs1555915854	NC_000023.11:40064569:C:
NM_004928.3(CFAP410):c.33_34insAGCTGCACAGCGTGCA (p.Ala12fs)	CFAP410		Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438159	21	45759044 - 45759045	21	44339161 - 44339162	438159	431813	rs748531024	NC_000021.9:44339161::TGCACGCTGTGCAGCT
NM_000328.3(RPGR):c.1905+414AG[2]	RPGR		Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438144	X	38145928 - 38145929	X	38286675 - 38286676	438144	431819	rs1555961832	NC_000023.11:38286674:CTCTCTC:CTCTC
NM_000328.3(RPGR):c.1905+331_1905+332del	RPGR		Retinitis pigmentosa 15|Retinal dystrophy|Retinitis pigmentosa|not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000438142	X	38146015 - 38146016	X	38286762 - 38286763	438142	431821	rs1555961852	NC_000023.11:38286761:TCTCT:TCT
NM_000328.3(RPGR):c.1368_1369AG[2] (p.Ser458fs)	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438138	X	38156578 - 38156579	X	38297325 - 38297326	438138	431825	rs1555964133	NC_000023.11:38297324:CTCTCT:CTCT
NM_001042472.3(ABHD12):c.193C>T (p.Arg65Ter)	ABHD12	R65*	Retinal dystrophy	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438130	20	25319986	20	25339350	438130	431811	rs758316679	NC_000020.11:25339349:G:A
NM_001256789.3(CACNA1F):c.3853C>T (p.Arg1285Cys)	CACNA1F	R1296C, R1285C, R1231C	Retinal dystrophy|Progressive cone dystrophy (without rod involvement)	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000438126	X	49069216	X	49212756	438126	431838	rs1557106557	NC_000023.11:49212755:G:A
NM_001256789.3(CACNA1F):c.1218del (p.Trp407fs)	CACNA1F	W407fs, W342fs	Congenital stationary night blindness	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000438118	X	49083490	X	49227028	438118	431846	rs1557110192	NC_000023.11:49227027:G:
NM_006915.3(RP2):c.352C>T (p.Arg118Cys)	RP2	R118C	Retinitis pigmentosa|Retinal dystrophy	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000437944	X	46713160	X	46853725	437944	431836	rs1556318633	NC_000023.11:46853724:C:T
NM_001183.6(ATP6AP1):c.542T>G (p.Leu181Arg)	ATP6AP1	L181R	Immunodeficiency 47	Pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000437913	X	153660790	X	154432444	437913	431541	rs1557196978	NC_000023.11:154432443:T:G
NM_015125.4(CIC):c.1474C>T (p.Arg492Trp)	CIC	R492W, R1401W	Intellectual disability, autosomal dominant 45	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000437890	19	42794394	19	42290242	437890	431511	rs373584239	NC_000019.10:42290241:C:T
NM_012478.4(WBP2):c.487A>C (p.Met163Leu)	WBP2	M163L	DEAFNESS, AUTOSOMAL RECESSIVE 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437833	17	73843922	17	75847841	437833	431408	rs1555604710	NC_000017.11:75847840:T:G
NM_012478.4(WBP2):c.671C>T (p.Ala224Val)	WBP2	A224V, A179V	DEAFNESS, AUTOSOMAL RECESSIVE 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437832	17	73843050	17	75846969	437832	431407	rs1555604549	NC_000017.11:75846968:G:A
NM_012478.4(WBP2):c.478G>A (p.Ala160Thr)	WBP2	A160T	DEAFNESS, AUTOSOMAL RECESSIVE 107	Pathogenic(Last reviewed: Aug 24, 2017)	no assertion criteria provided	VCV000437831	17	73843931	17	75847850	437831	431406	rs202022024	NC_000017.11:75847849:C:T
NM_003560.4(PLA2G6):c.1427+1G>A	PLA2G6		Infantile neuroaxonal dystrophy|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437465	22	38522377	22	38126370	437465	431023	rs750939090	NC_000022.11:38126369:C:T
NM_153638.3(PANK2):c.936T>A (p.Cys312Ter)	PANK2	C312*, C21*	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437451	20	3888880	20	3908233	437451	431003	rs1555787799	NC_000020.11:3908232:T:A
NM_000199.5(SGSH):c.763del (p.Gln255fs)	SGSH	Q255fs	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437445	17	78186056	17	80212257	437445	431001	rs1555620827	NC_000017.11:80212256:GG:G
NM_000271.5(NPC1):c.881+1G>T	NPC1		Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437442	18	21140194	18	23560230	437442	431002	rs1555638409	NC_000018.10:23560229:C:A
NM_006031.6(PCNT):c.7804G>T (p.Glu2602Ter)	PCNT	E2602*, E2484*		Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000437418	21	47850037	21	46430123	437418	430971	rs1555999948	NC_000021.9:46430122:G:T
NM_001347721.2(DYRK1A):c.833A>T (p.Asp278Val)	DYRK1A	D287V, D249V, D278V	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000437414	21	38862672	21	37490370	437414	430970	rs1555984343	NC_000021.9:37490369:A:T
NM_001323289.2(CDKL5):c.2359_2363del (p.Lys787fs)	CDKL5	K787fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000437405	X	18638067 - 18638071	X	18619947 - 18619951	437405	430972	rs1555954078	NC_000023.11:18619946:AAAAGAA:AA
NM_001083961.2(WDR62):c.3012_3034dup (p.Pro1012fs)	WDR62		Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000437292	19	36592602 - 36592603	19	36101700 - 36101701	437292	430187	rs1555723585	NC_000019.10:36101700:CGCAGCCATCCACTCCCCAGCTCCGC:CGCAGCCATCCACTCCCCAGCTCCGCAGCCATCCACTCCCCAGCTCCGC
NM_001083961.2(WDR62):c.3514+1G>A	WDR62		Primary autosomal recessive microcephaly 2|not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437291	19	36594110	19	36103208	437291	430189	rs199736219	NC_000019.10:36103207:G:A
NM_003336.4(UBE2A):c.67G>A (p.Gly23Arg)	UBE2A	G23R	not provided|Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000437188	X	118708886	X	119574923	437188	430634	rs1556235551	NC_000023.11:119574922:G:A
NM_001083962.2(TCF4):c.1834del (p.His612fs)	TCF4	H396fs, H482fs, H541fs, H570fs, H584fs, H588fs, H607fs, H447fs, H478fs, H589fs, H611fs, H612fs, H448fs, H452fs, H618fs, H537fs, H566fs, H583fs, H587fs, H605fs, H608fs, H714fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000436963	18	52896123	18	55228892	436963	430066	rs1555710069	NC_000018.10:55228891:GG:G
NM_003140.3(SRY):c.331C>T (p.Gln111Ter)	SRY	Q111*	46,XX sex reversal, type 1|46,XY sex reversal, type 1	Pathogenic(Last reviewed: Nov 3, 2015)	criteria provided, single submitter	VCV000436871	Y	2655314	Y	2787273	436871	430955	rs1556370543	NC_000024.10:2787272:G:A
NM_005629.4(SLC6A8):c.1583del (p.Pro528fs)	SLC6A8	P518fs, P528fs, P413fs	Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000436772	X	152960072	X	153694617	436772	430688	rs1557045581	NC_000023.11:153694616:CCCC:CCC
NM_006517.5(SLC16A2):c.532del (p.Ala178fs)	SLC16A2	A178fs	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000436739	X	73740922	X	74521087	436739	430913	rs1555989375	NC_000023.11:74521086:GGGGG:GGGG
NM_006517.5(SLC16A2):c.1026+1G>T	SLC16A2		Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000436736	X	73744645	X	74524810	436736	430916	rs1555989729	NC_000023.11:74524809:G:T
NM_001754.4(RUNX1):c.352-1G>A	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 1, 2019)	reviewed by expert panel	VCV000436616	21	36253011	21	34880714	436616	430421	rs587776809	NC_000021.9:34880713:C:T
NM_173630.4(RTTN):c.5185+1G>A	RTTN		MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH SEIZURES	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000436607	18	67721366	18	70054130	436607	430082	rs1555707336	NC_000018.10:70054129:C:T
NM_005676.5(RBM10):c.1249-1G>A	RBM10		TARP syndrome	Pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000436516	X	47040613	X	47181214	436516	430797	rs1556778986	NC_000023.11:47181213:G:A
NM_171998.4(RAB39B):c.559G>T (p.Glu187Ter)	RAB39B	E187*	Mental retardation, X-linked 72	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000436462	X	154490171	X	155260886	436462	430743	rs1557314191	NC_000023.11:155260885:C:A
NM_007254.4(PNKP):c.636+1G>T	PNKP		Early infantile epileptic encephalopathy 10	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000436354	19	50367435	19	49864178	436354	430258	rs1247055716	NC_000019.10:49864177:C:A
NM_006031.6(PCNT):c.5482G>T (p.Glu1828Ter)	PCNT	E1828*, E1710*		Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000436277	21	47831469	21	46411555	436277	430489	rs1315359733	NC_000021.9:46411554:G:T
NM_006031.6(PCNT):c.5992C>T (p.Gln1998Ter)	PCNT	Q1998*, Q1880*		Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000436268	21	47831979	21	46412065	436268	430497	rs757577162	NC_000021.9:46412064:C:T
NM_006031.6(PCNT):c.3880G>T (p.Glu1294Ter)	PCNT	E1294*, E1176*		Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000436263	21	47810624	21	46390709	436263	430475	rs1359618876	NC_000021.9:46390708:G:T
NM_006031.6(PCNT):c.3058A>T (p.Lys1020Ter)	PCNT	K1020*, K902*		Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000436261	21	47786947	21	46367032	436261	430468	rs1555962301	NC_000021.9:46367031:A:T
NM_006031.6(PCNT):c.1975dup (p.Asp659fs)	PCNT			Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000436258	21	47776923 - 47776924	21	46357008 - 46357009	436258	430457	rs1555956600	NC_000021.9:46357008:GGGG:GGGGG
NM_006031.6(PCNT):c.1680-2A>G	PCNT			Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000436254	21	47773899	21	46353985	436254	430452	rs1555954786	NC_000021.9:46353984:A:G
NM_002501.4(NFIX):c.927dup (p.Ser310fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	VCV000435981	19	13186455 - 13186456	19	13075641 - 13075642	435981	430127	rs1555705733	NC_000019.10:13075641:CC:CCC
NM_000252.2(MTM1):c.342+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000435903	X	149783173	X	150614700	435903	430678	rs1557413092	NC_000023.11:150614699:G:A
NM_000252.2(MTM1):c.1178dup (p.Leu393fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000435902	X	149826416 - 149826417	X	150657943 - 150657944	435902	430680	rs1557414513	NC_000023.11:150657943:TT:TTT
NM_000252.2(MTM1):c.465del (p.Asn155fs)	MTM1	N155fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000435901	X	149807436	X	150638963	435901	430679	rs1557413783	NC_000023.11:150638962:T:
NM_001165927.1(MKS1):c.1378-1dup	MKS1		Meckel-Gruber syndrome|Joubert syndrome|Meckel syndrome type 1	Pathogenic(Last reviewed: Jan 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000435876	17	56283904 - 56283905	17	58206543 - 58206544	435876	429991	rs762668200	NC_000017.11:58206543:CCCCC:CCCCCC
NM_001278116.2(L1CAM):c.3053C>G (p.Ser1018Ter)	L1CAM	S1018*, S1013*	Hydrocephalus due to aqueductal stenosis	Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	VCV000435689	X	153130153	X	153864698	435689	430694	rs1557090161	NC_000023.11:153864697:G:C
NM_001008537.3(NEXMIF):c.1597del (p.Arg533fs)	NEXMIF	R533fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000435602	X	73962795	X	74742960	435602	430926	rs1556016632	NC_000023.11:74742959:GGG:GG
NM_000216.4(ANOS1):c.109G>T (p.Glu37Ter)	ANOS1	E37*		Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000435540	X	8699969	X	8731928	435540	430951	rs1555904591	NC_000023.11:8731927:C:A
NM_001111125.3(IQSEC2):c.1626_1630del (p.Pro543fs)	IQSEC2	P338fs, P543fs	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000435526	X	53280128 - 53280132	X	53250946 - 53250950	435526	430836	rs1556863435	NC_000023.11:53250945:CGGGCCGG:CGG
NM_004247.4(EFTUD2):c.2198G>A (p.Trp733Ter)	EFTUD2	W733*, W698*, W723*	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000435033	17	42931985	17	44854617	435033	429977	rs1555564341	NC_000017.11:44854616:C:T
NM_004429.4(EFNB1):c.560_561AC[1] (p.Thr188fs)	EFNB1			Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000435028	X	68059863 - 68059864	X	68840020 - 68840021	435028	430895	rs1556107925	NC_000023.11:68840019:ACAC:AC
NM_004429.4(EFNB1):c.128+2T>A	EFNB1			Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000435026	X	68049749	X	68829906	435026	430892	rs1556096780	NC_000023.11:68829905:T:A
NM_001347721.2(DYRK1A):c.924+4_924+7del	DYRK1A		Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000435011	21	38862764 - 38862767	21	37490462 - 37490465	435011	430428	rs1555984461	NC_000021.9:37490461:GTAAGTA:GTA
NM_178152.3(DCX):c.705+1del	DCX		Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000434903	X	110644217	X	111400989	434903	430629	rs1556401725	NC_000023.11:111400988:CC:C
NM_178152.3(DCX):c.355_356del (p.Leu119fs)	DCX	L200fs, L119fs	Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000434902	X	110653271 - 110653272	X	111410043 - 111410044	434902	430632	rs1556404991	NC_000023.11:111410042:AG:
NM_001195553.2(DCX):c.544G>T (p.Val182Phe)	DCX	V182F, V263F	Lissencephaly, X-linked	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000434901	X	110644379	X	111401151	434901	430631	rs1556401951	NC_000023.11:111401150:C:A
NM_001195553.2(DCX):c.682_683CT[1] (p.Tyr229fs)	DCX		Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000434900	X	110644238 - 110644239	X	111401010 - 111401011	434900	430630	rs1556401744	NC_000023.11:111401009:AGAG:AG
NM_001323289.2(CDKL5):c.1684_1687del (p.Thr562fs)	CDKL5	T562fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000434665	X	18622726 - 18622729	X	18604606 - 18604609	434665	430761	rs1555952101	NC_000023.11:18604605:CAACCA:CA
NM_001323289.2(CDKL5):c.1345G>T (p.Glu449Ter)	CDKL5	E449*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000434663	X	18622389	X	18604269	434663	430758	rs1555952015	NC_000023.11:18604268:G:T
NM_003688.3(CASK):c.846C>G (p.Tyr282Ter)	CASK	Y282*	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Mental retardation and microcephaly with pontine and cerebellar hypoplasia|FG syndrome 4|not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000434588	X	41495900	X	41636647	434588	430790	rs886128077	NC_000023.11:41636646:G:C
NM_003688.3(CASK):c.1864G>T (p.Glu622Ter)	CASK	E622*, E593*, E599*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000434587	X	41413147	X	41553894	434587	430788	rs1555980033	NC_000023.11:41553893:C:A
NM_003688.3(CASK):c.2534_2535del (p.Phe845fs)	CASK	F822fs, F845fs, F850fs, F821fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000434586	X	41383258 - 41383259	X	41524005 - 41524006	434586	430786	rs1555972628	NC_000023.11:41524004:AAA:A
NM_001127221.1(CACNA1A):c.1482_1483del (p.Ser495fs)	CACNA1A	S494fs, S495fs	Episodic ataxia type 2	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000434558	19	13428001 - 13428002	19	13317187 - 13317188	434558	430130	rs1555762869	NC_000019.10:13317186:TG:
NM_001127221.1(CACNA1A):c.3414del (p.Lys1139fs)	CACNA1A	K1139fs, K1142fs, K1138fs	not provided|Episodic ataxia type 2	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000434556	19	13397459	19	13286645	434556	430128	rs746790849	NC_000019.10:13286644:GGGGGGG:GGGGGG
NM_139058.3(ARX):c.1535_1549delinsGGCGCAG (p.Val512fs)	ARX		Hydranencephaly with abnormal genitalia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000434399	X	25022927 - 25022941	X	25004810 - 25004824	434399	430769	rs1556046720	NC_000023.11:25004809:GGGCGCCCGATGCCA:CTGCGCC
NM_139058.3(ARX):c.1141del (p.Ala381fs)	ARX	A381fs	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000434396	X	25025535	X	25007418	434396	430771	rs1556049694	NC_000023.11:25007417:CCC:CC
NM_000487.6(ARSA):c.937C>T (p.Arg313Ter)	ARSA	R313*, R227*	Metachromatic leukodystrophy|not provided	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434394	22	51064624	22	50626196	434394	430596	rs551472773	NC_000022.11:50626195:G:A
NM_006420.3(ARFGEF2):c.2638_2639delinsT (p.Pro880fs)	ARFGEF2		Heterotopia, periventricular, autosomal recessive	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000434297	20	47605926 - 47605927	20	48989389 - 48989390	434297	430351	rs1555811929	NC_000020.11:48989388:CC:T
NM_001272071.2(AP1S2):c.281del (p.Phe94fs)	AP1S2	F94fs	Pettigrew syndrome	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000434219	X	15864033	X	15845910	434219	430748	rs1555904182	NC_000023.11:15845909:AAA:AA
NM_020956.2(PRX):c.*1217del	PRX	A338fs	Dejerine-Sottas disease	Pathogenic	no assertion criteria provided	VCV000433553	19	40903247	19	40397340	433553	427125	rs1555801290	NC_000019.10:40397339:CC:C
NM_003688.3(CASK):c.2589+1G>T	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000433537	X	41383203	X	41523950	433537	427111	rs1555972599	NC_000023.11:41523949:C:A
NM_172107.4(KCNQ2):c.1610_1615del (p.Lys537_Val538del)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000433180	20	62045457 - 62045462	20	63414104 - 63414109	433180	426752	rs1555853977	NC_000020.11:63414103:TGACTTTGA:TGA
NM_000117.2(EMD):c.600G>A (p.Trp200Ter)	EMD	W200*	not provided|Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433174	X	153609392	X	154381032	433174	426731	rs1557182661	NC_000023.11:154381031:G:A
NC_000023.10:g.(?_154379237)_(154381523_?)del	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000433172	X	154379237 - 154381523			433172	426729		
NM_000117.2(EMD):c.621del (p.Pro208fs)	EMD	P208fs	not provided|Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000433171	X	153609412	X	154381052	433171	426732	rs1557182670	NC_000023.11:154381051:GG:G
NM_000117.2(EMD):c.674_678del (p.Leu225fs)	EMD	L225fs	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000433169	X	153609466 - 153609470	X	154381106 - 154381110	433169	426734	rs1557182692	NC_000023.11:154381105:TCTGG:
NM_000117.2(EMD):c.121_155del (p.Tyr41fs)	EMD	Y41fs	not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000433167	X	153608086 - 153608120	X	154379726 - 154379760	433167	426730	rs1557182286	NC_000023.11:154379725:AGTACGAGACCCAGAGGCGGCGGCTCTCGCCCCCCAG:AG
NM_000117.3(EMD):c.82+1G>T	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000433166	X	153607927	X	154379567	433166	426737	rs1557182214	NC_000023.11:154379566:G:T
NM_005676.5(RBM10):c.159del (p.Lys54fs)	RBM10	K54fs, K119fs	TARP syndrome	Pathogenic(Last reviewed: Nov 17, 2011)	criteria provided, single submitter	VCV000433146	X	47028855	X	47169456	433146	426736	rs1556770954	NC_000023.11:47169455:C:
NM_001242897.2(DEPDC5):c.2258_2259insAGA (p.Ser753delinsArgAsp)	DEPDC5		Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433143	22	32234808 - 32234809	22	31838822 - 31838823	433143	426706	rs1555897392	NC_000022.11:31838822::AGA
NM_001242897.2(DEPDC5):c.-57G>C	DEPDC5		Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433141	22	32150851	22	31754865	433141	426704	rs1383795440	NC_000022.11:31754864:G:C
NM_015192.4(PLCB1):c.3382C>T (p.His1128Tyr)	PLCB1	H1128Y	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433139	20	8770867	20	8790220	433139	426702	rs1555790846	NC_000020.11:8790219:C:T
NM_001037.5(SCN1B):c.472G>C (p.Val158Leu)	SCN1B	V158L, V125L	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433138	19	35530044	19	35039140	433138	426701	rs138450474	NC_000019.10:35039139:G:C
NM_001003787.4(STRADA):c.179G>T (p.Ser60Ile)	STRADA	S60I, S23I, S2I, S31I, S52I	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433135	17	61791413	17	63714053	433135	426698	rs56271007	NC_000017.11:63714052:C:A
NM_001003787.4(STRADA):c.190C>T (p.Pro64Ser)	STRADA	P64S, P27S, P56S, P6S, P35S	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433134	17	61791402	17	63714042	433134	426697	rs55695051	NC_000017.11:63714041:G:A
NM_001003787.4(STRADA):c.403G>A (p.Ala135Thr)	STRADA	A135T, A91T, A106T, A127T, A98T, A77T	Rolandic epilepsy	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000433133	17	61788142	17	63710782	433133	426696	rs1555699052	NC_000017.11:63710781:C:T
NM_030632.3(ASXL3):c.1032_1035dup (p.Thr346fs)	ASXL3		not provided	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000432991	18	31314325 - 31314326	18	33734361 - 33734362	432991	426269	rs1555741188	NC_000018.10:33734361:AAAGAAA:AAAGAAAGAAA
NM_001282531.3(ADNP):c.2175del (p.Leu726fs)	ADNP	L726fs	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000432980	20	49509076	20	50892539	432980	426345	rs1555810001	NC_000020.11:50892538:GGG:GG
NM_000397.3(CYBB):c.54_79del (p.Trp18fs)	CYBB	W18fs	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000432965	X	37641345 - 37641370	X	37782092 - 37782117	432965	426456	rs1556464542	NC_000023.11:37782091:TTTGGCTGGGGTTGAACGTCTTCCTCTTTG:TTTG
NM_001356.4(DDX3X):c.1334T>G (p.Leu445Ter)	DDX3X	L445*, L259*, L429*	not provided	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000432923	X	41205500	X	41346247	432923	426461	rs1555954081	NC_000023.11:41346246:T:G
NM_001111125.3(IQSEC2):c.2021del (p.Gly674fs)	IQSEC2	G469fs, G674fs	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000432909	X	53279737	X	53250555	432909	426474	rs1556863090	NC_000023.11:53250554:CC:C
NM_001042537.1(SLC9A6):c.899+1G>A	SLC9A6		Christianson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432837	X	135084373	X	136002214	432837	426407	rs1556617455	NC_000023.11:136002213:G:A
NM_003688.3(CASK):c.626T>C (p.Leu209Pro)	CASK	L209P	not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000432816	X	41524612	X	41665359	432816	426464	rs1556014749	NC_000023.11:41665358:A:G
NM_003588.3(CUL4B):c.923dup (p.Leu308fs)	CUL4B		not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000432812	X	119679349 - 119679350	X	120545494 - 120545495	432812	426402	rs1556216330	NC_000023.11:120545494:AAAAAAA:AAAAAAAA
NM_000328.3(RPGR):c.1187dup (p.Leu396fs)	RPGR		not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000432806	X	38158266 - 38158267	X	38299013 - 38299014	432806	426458	rs1555964576	NC_000023.11:38299013:AAA:AAAA
NM_001356.4(DDX3X):c.623del (p.Lys208fs)	DDX3X	K192fs, K22fs, K208fs	not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000432784	X	41202545	X	41343292	432784	426460	rs1555953169	NC_000023.11:41343291:AAAA:AAA
NM_000390.4(CHM):c.866_867dup (p.Val290fs)	CHM		not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000432763	X	85212932 - 85212933	X	85957927 - 85957928	432763	426499	rs1556307648	NC_000023.11:85957927:CA:CACA
NM_005120.3(MED12):c.473G>A (p.Trp158Ter)	MED12	W158*	not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000432691	X	70339940	X	71120090	432691	426488	rs1556334114	NC_000023.11:71120089:G:A
NM_177559.3(CSNK2A1):c.149A>G (p.Tyr50Cys)	CSNK2A1	Y50C	not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000432689	20	485826	20	505182	432689	426344	rs869312849	NC_000020.11:505181:T:C
NM_001111125.1(IQSEC2):c.3016dupG (p.Val1006Glyfs)	IQSEC2		not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000432658	X	53268476	X	53239293 - 53239294	432658	426471	rs1556860401	
NM_001323289.2(CDKL5):c.427dup (p.Ile143fs)	CDKL5		not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000432570	X	18600032 - 18600033	X	18581912 - 18581913	432570	426444	rs1555949752	NC_000023.11:18581912:AA:AAA
NM_198270.4(NHS):c.553C>T (p.Gln185Ter)	NHS	Q185*	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432524	X	17394433	X	17376310	432524	426440	rs1555981433	NC_000023.11:17376309:C:T
NM_001257988.1(TYMP):c.709G>T (p.Gly237Ter)	TYMP	G237*	not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000432522	22	50965650	22	50527221	432522	426383	rs1556488369	NC_000022.11:50527220:C:A
NM_001281463.1(SMC1A):c.2206C>T (p.Arg736Ter)	SMC1A	R736*, R758*	not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000432458	X	53430750	X	53403818	432458	426477	rs1556889269	NC_000023.11:53403817:G:A
NM_000527.4(LDLR):c.1540G>T (p.Glu514Ter)	LDLR	E514*, E346*, E387*, E473*	not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000432366	19	11224392	19	11113716	432366	426279	rs1555805507	NC_000019.10:11113715:G:T
NM_018684.4(ZC4H2):c.592C>T (p.Arg198Trp)	ZC4H2	R198W, R175W	Wieacker Wolff syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432364	X	64137746	X	64917866	432364	426484	rs137962226	NC_000023.11:64917865:G:A
NM_007363.5(NONO):c.217C>T (p.Arg73Ter)	NONO	R73*	not provided	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000432295	X	70511691	X	71291841	432295	426490	rs1555949215	NC_000023.11:71291840:C:T
NM_001347721.2(DYRK1A):c.574C>T (p.Gln192Ter)	DYRK1A	Q201*, Q192*, Q163*	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000432268	21	38858853	21	37486551	432268	426360	rs1555982630	NC_000021.9:37486550:C:T
NM_003688.3(CASK):c.660C>G (p.Tyr220Ter)	CASK	Y220*	not provided	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, single submitter	VCV000432242	X	41524578	X	41665325	432242	426463	rs747587301	NC_000023.11:41665324:G:C
NM_001323289.2(CDKL5):c.65-1G>A	CDKL5		not provided	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000432220	X	18528939	X	18510819	432220	426441	rs1555940533	NC_000023.11:18510818:G:A
NM_001353921.2(ARHGEF9):c.332G>A (p.Arg111Gln)	ARHGEF9	R104Q, R83Q, R2Q, R117Q, R111Q, R44Q, R51Q	Early infantile epileptic encephalopathy 8|not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000432195	X	62926208	X	63706328	432195	426483	rs1556401714	NC_000023.11:63706327:C:T
NM_000284.4(PDHA1):c.738C>T (p.Gly246=)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432160	X	19373601	X	19355483	432160	426447	rs1555934379	NC_000023.11:19355482:C:T
NM_003639.4(IKBKG):c.723C>G (p.Tyr241Ter)	IKBKG	Y241*, Y309*, Y190*, Y240*	not provided	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000431997	X	153789954	X	154561739	431997	426439	rs1557236565	NC_000023.11:154561738:C:G
NM_000709.4(BCKDHA):c.647-1G>C	BCKDHA		not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431985	19	41928068	19	41422163	431985	426316	rs753216964	NC_000019.10:41422162:G:C
NM_016418.5(NF2):c.1228C>T (p.Gln410Ter)	NF2	Q410*, Q368*, Q369*, Q327*	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000431979	22	30069363	22	29673374	431979	426372	rs1556000842	NC_000022.11:29673373:C:T
NM_000206.2(IL2RG):c.207_211dup (p.Asn71delinsThrTer)	IL2RG		not provided	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000431930	X	70330804 - 70330805	X	71110954 - 71110955	431930	426487	rs1556330963	NC_000023.11:71110954:TCATGT:TCATGTCATGT
NM_000444.6(PHEX):c.397C>T (p.Gln133Ter)	PHEX	Q133*	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431828	X	22094553	X	22076435	431828	426451	rs151306376	NC_000023.11:22076434:C:T
NM_001278116.2(L1CAM):c.502del (p.Arg168fs)	L1CAM	R163fs, R168fs	not provided	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000431824	X	153136533	X	153871078	431824	426419	rs1557092994	NC_000023.11:153871077:GG:G
NM_004187.4(KDM5C):c.89A>G (p.Tyr30Cys)	KDM5C	Y30C	not provided	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000431823	X	53253983	X	53224801	431823	426469	rs1556856142	NC_000023.11:53224800:T:C
NM_000398.7(CYB5R3):c.250C>T (p.Arg84Ter)	CYB5R3	R84*, R117*, R61*	not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431812	22	43026971	22	42630965	431812	426381	rs1210302322	NC_000022.11:42630964:G:A
NM_033380.3(COL4A5):c.679G>A (p.Gly227Ser)	COL4A5	G227S	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000431809	X	107821341	X	108578111	431809	426396	rs1556405916	NC_000023.11:108578110:G:A
NM_015338.5(ASXL1):c.3202C>T (p.Arg1068Ter)	ASXL1	R1068*, R1007*	Bohring-Opitz syndrome	Pathogenic	criteria provided, single submitter	VCV000431709	20	31023717	20	32435914	431709	425230	rs764651405	NC_000020.11:32435913:C:T
NM_000527.4(LDLR):c.2376del (p.Ile792fs)	LDLR	I614fs, I624fs, I751fs, I792fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431550	19	11238747	19	11128071	431550	425061	rs1135402785	NC_000019.10:11128070:TT:T
NM_001195798.2(LDLR):c.2366_2367CT[3] (p.Ser791fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431549	19	11238737 - 11238738	19	11128061 - 11128062	431549	425060	rs1135402784	NC_000019.10:11128061:CTCT:CTCTCT
NM_000527.4(LDLR):c.2312-?_2389+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000431546	19	11236353 - 11239475			431546	425021		
NM_000527.4(LDLR):c.2141-2A>G	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431542	19	11233848	19	11123172	431542	425055	rs1135402780	NC_000019.10:11123171:A:G
NM_000527.4(LDLR):c.2141-?_2389+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431541	19	11233850 - 11239475			431541	425020		
NM_000527.4(LDLR):c.1885_1886insA (p.Phe629fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431537	19	11230807 - 11230808	19	11120131 - 11120132	431537	425051	rs1135402779	NC_000019.10:11120131::A
NM_000527.4(LDLR):c.1804G>T (p.Glu602Ter)	LDLR	E602*, E434*, E475*, E561*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431536	19	11227633	19	11116957	431536	425050	rs1135402778	NC_000019.10:11116956:G:T
NM_000527.4(LDLR):c.1673_1676del (p.Glu558fs)	LDLR	E390fs, E558fs, E517fs, E431fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431534	19	11226856 - 11226859	19	11116180 - 11116183	431534	425048	rs1135402777	NC_000019.10:11116179:AAAA:
NM_000527.4(LDLR):c.1573_1586+5del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431530	19	11224424 - 11224442	19	11113748 - 11113766	431530	425044	rs1135402776	NC_000019.10:11113747:GGATCCTGTTCATGGGTGCG:G
NM_000527.4(LDLR):c.1474del (p.Asp492fs)	LDLR	D324fs, D365fs, D451fs, D492fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431528	19	11224326	19	11113650	431528	425042	rs1135402774	NC_000019.10:11113649:G:
NM_000527.4(LDLR):c.1162dup (p.His388fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431522	19	11222286 - 11222287	19	11111610 - 11111611	431522	425036	rs875989917	NC_000019.10:11111610:CCCCC:CCCCCC
NM_000527.4(LDLR):c.1158_1162dup (p.His388fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431521	19	11222286 - 11222287	19	11111610 - 11111611	431521	425035	rs875989917	NC_000019.10:11111610:CCCCC:CCCCCCCCCC
NM_000527.4(LDLR):c.949dup (p.Glu317fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431517	19	11221335 - 11221336	19	11110659 - 11110660	431517	425031	rs1135402769	NC_000019.10:11110659:G:GG
NM_001195800.2(LDLR):c.314-1999C>T	LDLR	Q163*, Q122*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000431511	19	11216069	19	11105393	431511	425027	rs1135402768	NC_000019.10:11105392:C:T
NM_015295.2(SMCHD1):c.1571A>G (p.Asn524Ser)	SMCHD1	N524S	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431470	18	2700840	18	2700842	431470	424983	rs1135402745	NC_000018.10:2700841:A:G
NM_015295.2(SMCHD1):c.1568C>A (p.Thr523Lys)	SMCHD1	T523K	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431469	18	2700837	18	2700839	431469	424982	rs1135402744	NC_000018.10:2700838:C:A
NM_015295.2(SMCHD1):c.1417G>C (p.Glu473Gln)	SMCHD1	E473Q	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431468	18	2700611	18	2700613	431468	424981	rs1135402743	NC_000018.10:2700612:G:C
NM_015295.2(SMCHD1):c.1259A>T (p.Asp420Val)	SMCHD1	D420V	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431467	18	2697956	18	2697958	431467	424980	rs1135402742	NC_000018.10:2697957:A:T
NM_015295.2(SMCHD1):c.725C>G (p.Ala242Gly)	SMCHD1	A242G	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431466	18	2688478	18	2688480	431466	424979	rs1135402741	NC_000018.10:2688479:C:G
NM_015295.2(SMCHD1):c.511T>G (p.Phe171Val)	SMCHD1	F171V	Cryptorchidism|Microphallus|Short nose|Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431465	18	2674017	18	2674018	431465	424978	rs1135402740	NC_000018.10:2674017:T:G
NM_015295.2(SMCHD1):c.423G>T (p.Leu141Phe)	SMCHD1	L141F	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431464	18	2667029	18	2667030	431464	424977	rs1057519641	NC_000018.10:2667029:G:T
NM_015295.2(SMCHD1):c.415A>C (p.Asn139His)	SMCHD1	N139H	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431463	18	2667021	18	2667022	431463	424976	rs1135402739	NC_000018.10:2667021:A:C
NM_015295.2(SMCHD1):c.386T>A (p.Met129Lys)	SMCHD1	M129K	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431462	18	2666992	18	2666993	431462	424975	rs1135402738	NC_000018.10:2666992:T:A
NM_015295.2(SMCHD1):c.320T>C (p.Leu107Pro)	SMCHD1	L107P	Arhinia choanal atresia microphthalmia	Pathogenic	no assertion criteria provided	VCV000431461	18	2666926	18	2666927	431461	424974	rs1135402737	NC_000018.10:2666926:T:C
NM_005032.7(PLS3):c.256del (p.Ser86fs)	PLS3	S41fs, S86fs, S59fs, S64fs	Bone mineral density quantitative trait locus 18	Pathogenic	no assertion criteria provided	VCV000431450	X	114863524	X	115629212	431450	424966	rs1135402748	NC_000023.11:115629211:AAAAA:AAAA
NM_001177465.3(MAMLD1):c.319G>T (p.Glu107Ter)	MAMLD1	E132*, E107*	Hypospadias 2, X-linked	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000431447	X	149638239	X	150469967	431447	424963	rs1135402752	NC_000023.11:150469966:G:T
NM_017613.4(DONSON):c.876C>G (p.Phe292Leu)	DONSON	F292L	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 4, 2017)	no assertion criteria provided	VCV000431420	21	34955882	21	33583576	431420	424943	rs779803447	NC_000021.9:33583575:G:C
NM_017613.4(DONSON):c.1282C>T (p.Gln428Ter)	DONSON	Q428*	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 5, 2017)	no assertion criteria provided	VCV000431419	21	34953676	21	33581370	431419	424942	rs993687029	NC_000021.9:33581369:G:A
NM_017613.4(DONSON):c.1251_1256del (p.Asn417_Ser418del)	DONSON		MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 4, 2017)	no assertion criteria provided	VCV000431418	21	34953702 - 34953707	21	33581396 - 33581401	431418	424941	rs1135401961	NC_000021.9:33581395:TTAGAGTTA:TTA
NM_017613.4(DONSON):c.786-22A>G	DONSON		MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 4, 2017)	no assertion criteria provided	VCV000431416	21	34955994	21	33583688	431416	424939	rs1135401960	NC_000021.9:33583687:T:C
NM_017613.4(DONSON):c.1337T>C (p.Met446Thr)	DONSON	M446T	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 4, 2017)	no assertion criteria provided	VCV000431415	21	34953621	21	33581315	431415	424938	rs1135401959	NC_000021.9:33581314:A:G
NM_017613.4(DONSON):c.1047-9A>G	DONSON		Microcephaly-micromelia syndrome|MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	Pathogenic(Last reviewed: Aug 5, 2017)	no assertion criteria provided	VCV000431414	21	34954370	21	33582064	431414	424937	rs779149681	NC_000021.9:33582063:T:C
NM_003688.3(CASK):c.68del (p.Phe23fs)	CASK	F23fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431176	X	41712472	X	41853219	431176	424699	rs1135401762	NC_000023.11:41853218:AA:A
NM_015125.4(CIC):c.2571_2586del (p.Pro858fs)	CIC	P858fs, P1767fs	Intellectual disability, autosomal dominant 45	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000431170	19	42795490 - 42795505	19	42291338 - 42291353	431170	424693	rs1555769968	NC_000019.10:42291337:CACCCACCACCAGCATC:C
NM_015125.4(CIC):c.1801_1808dup (p.Glu604fs)	CIC		Intellectual disability, autosomal dominant 45	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000431169	19	42794719 - 42794720	19	42290567 - 42290568	431169	424692	rs1135401824	NC_000019.10:42290567:CAAGAGACC:CAAGAGACCAAGAGACC
NM_015125.4(CIC):c.1057C>T (p.Arg353Ter)	CIC	R353*, R1262*	Intellectual disability, autosomal dominant 45|not provided	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000431168	19	42793165	19	42289013	431168	424691	rs1135401823	NC_000019.10:42289012:C:T
NM_212550.4(BLOC1S3):c.131C>A (p.Ser44Ter)	BLOC1S3	S44*	Hermansky-Pudlak syndrome 8	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	VCV000431167	19	45682685	19	45179427	431167	424690	rs281865115	NC_000019.10:45179426:C:A
NM_004247.4(EFTUD2):c.1775_1779del (p.Val592fs)	EFTUD2	V557fs, V582fs, V592fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431142	17	42937354 - 42937358	17	44859986 - 44859990	431142	424666	rs1135401812	NC_000017.11:44859985:CTCCAC:C
NM_001291415.1(KDM6A):c.2988+1G>C	KDM6A		Kabuki syndrome 2	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431139	X	44936072	X	45076827	431139	424676	rs1135401809	NC_000023.11:45076826:G:C
NM_001083962.2(TCF4):c.1953_1954TC[2] (p.Ser653fs)	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431137	18	52895514 - 52895515	18	55228283 - 55228284	431137	424667	rs1135401807	NC_000018.10:55228282:GAGAGAG:GAGAG
NM_002501.4(NFIX):c.73del (p.Ala25fs)	NFIX	A25fs, A33fs, A24fs, A17fs	Sotos syndrome 2	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431130	19	13135880	19	13025066	431130	424668	rs1135401802	NC_000019.10:13025065:G:
NM_000194.3(HPRT1):c.47G>T (p.Gly16Val)	HPRT1	G16V	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431129	X	133607408	X	134473378	431129	424675	rs1135401801	NC_000023.11:134473377:G:T
NM_004187.4(KDM5C):c.2482C>T (p.Arg828Ter)	KDM5C	R828*, R761*, R827*	Inborn genetic diseases|Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431128	X	53227706	X	53198524	431128	424677	rs1135401800	NC_000023.11:53198523:G:A
NM_001353921.2(ARHGEF9):c.886C>T (p.Arg296Ter)	ARHGEF9	R289*, R187*, R236*, R268*, R151*, R229*, R296*, R302*	not provided|Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431121	X	62893977	X	63674097	431121	424678	rs1135401795	NC_000023.11:63674096:G:A
NM_000489.5(ATRX):c.4865C>T (p.Ala1622Val)	ATRX	A1622V, A1584V		Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431119	X	76889145	X	77633657	431119	424679	rs1135401793	NC_000023.11:77633656:G:A
NM_001282531.3(ADNP):c.517C>T (p.Arg173Ter)	ADNP	R173*	not provided|Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431117	20	49510734	20	50894197	431117	424673	rs1135401791	NC_000020.11:50894196:G:A
NM_153638.3(PANK2):c.1235+1G>T	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431115	20	3891478	20	3910831	431115	424671	rs1135401789	NC_000020.11:3910830:G:T
NM_007325.5(GRIA3):c.1964T>C (p.Phe655Ser)	GRIA3	F655S	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431114	X	122561878	X	123428027	431114	424674	rs1135401788	NC_000023.11:123428026:T:C
NM_172107.4(KCNQ2):c.902G>A (p.Gly301Asp)	KCNQ2	G301D	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431095	20	62070976	20	63439623	431095	424618	rs1131691936	NC_000020.11:63439622:C:T
NM_000487.6(ARSA):c.1274A>G (p.His425Arg)	ARSA	H425R, H339R	Metachromatic leukodystrophy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000431090	22	51063829	22	50625401	431090	424607	rs1135401757	NC_000022.11:50625400:T:C
NM_000487.6(ARSA):c.852T>A (p.Asn284Lys)	ARSA	N284K, N198K	Metachromatic leukodystrophy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000431089	22	51065021	22	50626593	431089	424608	rs1135401756	NC_000022.11:50626592:A:T
NM_000487.6(ARSA):c.545C>G (p.Pro182Arg)	ARSA	P182R, P96R	Metachromatic leukodystrophy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000431086	22	51065401	22	50626973	431086	424611	rs1135401755	NC_000022.11:50626972:G:C
NM_000487.6(ARSA):c.229G>C (p.Ala77Pro)	ARSA	A77P	Metachromatic leukodystrophy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000431085	22	51065830	22	50627402	431085	424612	rs763880042	NC_000022.11:50627401:C:G
NM_000487.6(ARSA):c.98T>C (p.Leu33Pro)	ARSA	L33P	Metachromatic leukodystrophy	Pathogenic(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000431084	22	51066110	22	50627682	431084	424613	rs1135401754	NC_000022.11:50627681:A:G
NM_182641.4(BPTF):c.989del (p.Leu330fs)	BPTF	L330fs	Global developmental delay|Expressive language delay|Postnatal microcephaly|Intellectual disability|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431072	17	65850431	17	67854315	431072	424588	rs1135401778	NC_000017.11:67854314:T:
NM_182641.4(BPTF):c.8609T>G (p.Met2870Arg)	BPTF	M2853R, M2870R	Global developmental delay|Expressive language delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000431071	17	65971957	17	67975841	431071	424594	rs782736894	NC_000017.11:67975840:T:G
NM_182641.4(BPTF):c.2982_2992+1del	BPTF		Global developmental delay|Postnatal microcephaly|Expressive language delay	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000431069	17	65905867 - 65905878	17	67909751 - 67909762	431069	424591	rs1555649483	NC_000017.11:67909750:GAAGGACCAAGG:
Single allele	BPTF		Postnatal microcephaly|Expressive language delay|Global developmental delay	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000431068	17	65898399 - 65986986			431068	424597		
NM_182641.4(BPTF):c.8701A>T (p.Lys2901Ter)	BPTF	K2884*, K2901*	Global developmental delay|Expressive language delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000431066	17	65972049	17	67975933	431066	424595	rs1555693714	NC_000017.11:67975932:A:T
NM_182641.4(BPTF):c.4836_4837TG[1] (p.Val1613fs)	BPTF		Global developmental delay|Expressive language delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000431065	17	65908836 - 65908837	17	67912720 - 67912721	431065	424592	rs1555652383	NC_000017.11:67912719:TGTG:TG
NM_182641.4(BPTF):c.2482dup (p.Glu828fs)	BPTF		Global developmental delay|Expressive language delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000431064	17	65890218 - 65890219	17	67894102 - 67894103	431064	424590	rs1555639411	NC_000017.11:67894102:GG:GGG
NM_000074.2(CD40LG):c.421G>C (p.Ala141Pro)	CD40LG	A141P		Pathogenic	criteria provided, single submitter	VCV000430909	X	135741209	X	136659050	430909	424451	rs1387503550	NC_000023.11:136659049:G:C
NM_031229.4(RBCK1):c.1112G>T (p.Cys371Phe)	RBCK1	C371F, C329F, C201F	Glycogen storage disease, type IV|Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000430898	20	408039	20	427395	430898	424441	rs1555787599	NC_000020.11:427394:G:T
NM_004646.3(NPHS1):c.2206G>A (p.Val736Met)	NPHS1	V736M	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	no assertion criteria provided	VCV000430877	19	36335011	19	35844109	430877	424418	rs1131692245	NC_000019.10:35844108:C:T
NM_024301.5(FKRP):c.679G>C (p.Ala227Pro)	FKRP	A227P	Fukuyama congenital muscular dystrophy	Pathogenic	no assertion criteria provided	VCV000430845	19	47259386	19	46756129	430845	424236	rs775681117	NC_000019.10:46756128:G:C
NM_004187.4(KDM5C):c.3597_3601del (p.Leu1200fs)	KDM5C	L1200fs, L1133fs, L1199fs	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000430803	X	53223758 - 53223762	X	53194576 - 53194580	430803	424348	rs1131692227	NC_000023.11:53194575:GCAGAGC:GC
NM_000527.4(LDLR):c.2422C>G (p.Leu808Val)	LDLR	L808V, L630V, L767V, L640V	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430802	19	11240221	19	11129545	430802	424346	rs1131692226	NC_000019.10:11129544:C:G
NM_000527.4(LDLR):c.2393_2409del (p.Leu798fs)	LDLR	L757fs, L798fs, L620fs, L630fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430801	19	11240189 - 11240205	19	11129513 - 11129529	430801	424345	rs1131692225	NC_000019.10:11129512:TGCTCCTCGTCTTCCTTTGC:TGC
NM_000527.4(LDLR):c.2323_2352del (p.Val775_Pro784del)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430799	19	11238694 - 11238723	19	11128018 - 11128047	430799	424343	rs1131692224	NC_000019.10:11128017:CGTTGCTGGCAGAGGAAATGAGAAGAAGCCC:C
NM_000527.4(LDLR):c.2270del (p.Pro757fs)	LDLR	P579fs, P716fs, P589fs, P757fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430798	19	11233976	19	11123300	430798	424342	rs1131692223	NC_000019.10:11123299:CCCC:CCC
NM_000527.4(LDLR):c.2230C>T (p.Arg744Ter)	LDLR	R744*, R566*, R576*, R703*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430795	19	11233939	19	11123263	430795	424340	rs200793488	NC_000019.10:11123262:C:T
NM_000527.4(LDLR):c.2061del (p.Asn688fs)	LDLR	N647fs, N520fs, N688fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430793	19	11231119	19	11120443	430793	424337	rs1131692221	NC_000019.10:11120442:C:
NM_000527.4(LDLR):c.2044C>T (p.Leu682Phe)	LDLR	L682F, L641F, L514F	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430792	19	11231102	19	11120426	430792	424336	rs1131692220	NC_000019.10:11120425:C:T
NM_000527.4(LDLR):c.1988G>C (p.Gly663Ala)	LDLR	G663A, G622A, G495A	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430791	19	11231046	19	11120370	430791	424335	rs879255102	NC_000019.10:11120369:G:C
NM_000527.4(LDLR):c.1846_1865del (p.Asp616fs)	LDLR	D448fs, D575fs, D616fs, D489fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430789	19	11230768 - 11230787	19	11120092 - 11120111	430789	424333	rs1131692219	NC_000019.10:11120091:GACAAAGTATTTTGGACAGA:
NM_000527.4(LDLR):c.1829_1840dup (p.Ser610_Val613dup)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430788	19	11227654 - 11227655	19	11116978 - 11116979	430788	424332	rs1555806546	NC_000019.10:11116978:TCTCCTTGGCCGTCT:TCTCCTTGGCCGTCTCCTTGGCCGTCT
NM_000527.4(LDLR):c.1744_1745insA (p.Leu582fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430787	19	11227573 - 11227574	19	11116897 - 11116898	430787	424331	rs1131692217	NC_000019.10:11116897::A
NM_000527.4(LDLR):c.1744C>T (p.Leu582Phe)	LDLR	L582F, L414F, L455F, L541F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430786	19	11227573	19	11116897	430786	424330	rs1131692216	NC_000019.10:11116896:C:T
NM_000527.4(LDLR):c.1738_1739insTGT (p.Ser580_Lys581insLeu)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430785	19	11227566 - 11227567	19	11116890 - 11116891	430785	424329	rs1131692215	NC_000019.10:11116890:T:TTGT
NM_001195798.2(LDLR):c.1736_1737delinsT (p.Asp579fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430784	19	11227565 - 11227566	19	11116889 - 11116890	430784	424328	rs1131692214	NC_000019.10:11116888:AC:T
NM_000527.4(LDLR):c.1733T>C (p.Val578Ala)	LDLR	V578A, V410A, V451A, V537A	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430783	19	11227562	19	11116886	430783	424327	rs72658864	NC_000019.10:11116885:T:C
NM_000527.4(LDLR):c.1678A>T (p.Ile560Phe)	LDLR	I560F, I433F, I519F, I392F	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430782	19	11226861	19	11116185	430782	424326	rs1131692213	NC_000019.10:11116184:A:T
NM_001195798.2(LDLR):c.1568_1570TGG[1] (p.Val524del)	LDLR	V524del	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430781	19	11224419 - 11224421	19	11113743 - 11113745	430781	424325	rs1131692212	NC_000019.10:11113742:GTGGTGG:GTGG
NM_000527.4(LDLR):c.1566del (p.Ile522fs)	LDLR	I481fs, I522fs, I354fs, I395fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430780	19	11224418	19	11113742	430780	424324	rs1131692211	NC_000019.10:11113741:C:
NM_000527.4(LDLR):c.1530del (p.Leu511fs)	LDLR	L511fs, L343fs, L384fs, L470fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430779	19	11224382	19	11113706	430779	424323	rs1131692210	NC_000019.10:11113705:G:
NM_000527.4(LDLR):c.1456del (p.Ser486fs)	LDLR	S486fs, S359fs, S445fs, S318fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430778	19	11224308	19	11113632	430778	424322	rs1131692209	NC_000019.10:11113631:A:
NM_000527.4(LDLR):c.1427C>T (p.Pro476Leu)	LDLR	P476L, P435L, P308L, P349L	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430777	19	11224279	19	11113603	430777	424321	rs1131692208	NC_000019.10:11113602:C:T
NM_000527.4(LDLR):c.1130del (p.Cys377fs)	LDLR	C250fs, C336fs, C377fs, C209fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430773	19	11222259	19	11111583	430773	424317	rs1131692205	NC_000019.10:11111582:G:
NM_000527.4(LDLR):c.1114G>T (p.Glu372Ter)	LDLR	E372*, E204*, E331*, E245*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430772	19	11222243	19	11111567	430772	424316	rs1131692204	NC_000019.10:11111566:G:T
NM_000527.4(LDLR):c.1081C>T (p.Pro361Ser)	LDLR	P361S, P193S, P320S, P234S	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430771	19	11222210	19	11111534	430771	424315	rs1131692203	NC_000019.10:11111533:C:T
NM_000527.4(LDLR):c.1057G>T (p.Glu353Ter)	LDLR	E353*, E312*, E185*, E226*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430770	19	11221444	19	11110768	430770	424314	rs370471092	NC_000019.10:11110767:G:T
NM_000527.4(LDLR):c.905G>T (p.Cys302Phe)	LDLR	C302F, C134F, C175F, C261F	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430768	19	11218155	19	11107479	430768	424313	rs879254715	NC_000019.10:11107478:G:T
NM_000527.4(LDLR):c.882_883del (p.Lys294fs)	LDLR	K253fs, K294fs, K126fs, K167fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430767	19	11218132 - 11218133	19	11107456 - 11107457	430767	424312	rs1131692202	NC_000019.10:11107455:AG:
NM_000527.4(LDLR):c.860del (p.Gly287fs)	LDLR	G287fs, G119fs, G160fs, G246fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430766	19	11218109	19	11107433	430766	424311	rs1131692201	NC_000019.10:11107432:GG:G
NM_000527.4(LDLR):c.829G>T (p.Glu277Ter)	LDLR	E277*, E109*, E236*, E150*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430764	19	11218079	19	11107403	430764	424310	rs148698650	NC_000019.10:11107402:G:T
NM_000527.4(LDLR):c.805G>A (p.Gly269Ser)	LDLR	G269S, G142S, G228S	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430763	19	11217351	19	11106675	430763	424309	rs1131692200	NC_000019.10:11106674:G:A
NM_001195800.2(LDLR):c.314-1806_314-1804delinsCA	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430762	19	11216262 - 11216264	19	11105586 - 11105588	430762	424308	rs879254637	NC_000019.10:11105585:ACG:CA
NM_001195800.2(LDLR):c.314-1817_314-1803delinsAACTGCGGTAAACTGCGGTAAACT	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430761	19	11216251 - 11216265	19	11105575 - 11105589	430761	424307	rs1131692198	NC_000019.10:11105574:GGACAAATCTGACGA:AACTGCGGTAAACTGCGGTAAACT
NM_000527.4(LDLR):c.666_688del (p.Cys222_Asn230delinsTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430760	19	11216248 - 11216270	19	11105572 - 11105594	430760	424306	rs1131692197	NC_000019.10:11105571:CAAGGACAAATCTGACGAGGAAA:
NM_001195800.2(LDLR):c.314-1921_314-1918delinsTG	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430758	19	11216147 - 11216150	19	11105471 - 11105474	430758	424304	rs1131692195	NC_000019.10:11105470:GTGT:TG
NM_000527.4(LDLR):c.519_532del (p.Cys173_Asp178delinsTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430755	19	11216100 - 11216113	19	11105424 - 11105437	430755	424301	rs1131692193	NC_000019.10:11105423:GCGAAGATGGCTCGG:G
NM_001195800.2(LDLR):c.314-2044_314-1982delinsA	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430754	19	11216024 - 11216086	19	11105348 - 11105410	430754	424300	rs1555803259	
NM_000527.4(LDLR):c.417C>A (p.Asp139Glu)	LDLR	D139E, D98E	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430753	19	11215999	19	11105323	430753	424299	rs537484504	NC_000019.10:11105322:C:A
NM_000527.4(LDLR):c.318_336del (p.Lys107fs)	LDLR	K107fs, K66fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430752	19	11215899 - 11215917	19	11105223 - 11105241	430752	424298	rs1131692192	NC_000019.10:11105222:CCAAGACGTGCTCCCAGGAC:C
NM_000527.4(LDLR):c.314-1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430751	19	11215895	19	11105219	430751	424297	rs879254471	NC_000019.10:11105218:G:T
NM_000527.4(LDLR):c.311G>C (p.Cys104Ser)	LDLR	C104S	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430750	19	11213460	19	11102784	430750	424296	rs875989895	NC_000019.10:11102783:G:C
NM_000527.4(LDLR):c.251_252insCATTCTG (p.Gln85fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430749	19	11213400 - 11213401	19	11102724 - 11102725	430749	424295	rs1131692191	NC_000019.10:11102724::CATTCTG
NM_000527.4(LDLR):c.178del (p.Gln60fs)	LDLR	Q60fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430747	19	11211007	19	11100331	430747	424293	rs1555802312	NC_000019.10:11100330:CCC:CC
NM_000527.4(LDLR):c.116G>T (p.Cys39Phe)	LDLR	C39F	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000430746	19	11210947	19	11100271	430746	424292	rs1131692189	NC_000019.10:11100270:G:T
NM_014297.5(ETHE1):c.505+1G>C	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Jul 10, 2017)	no assertion criteria provided	VCV000430736	19	44015588	19	43511436	430736	424283	rs935855792	NC_000019.10:43511435:C:G
NM_000531.6(OTC):c.517C>G (p.Leu173Val)	OTC	L173V	Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Apr 25, 2017)	no assertion criteria provided	VCV000430717	X	38260658	X	38401405	430717	424256	rs1131692152	NC_000023.11:38401404:C:G
NM_001042472.3(ABHD12):c.211_223del (p.Arg71fs)	ABHD12	R71fs	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Jun 30, 2017)	no assertion criteria provided	VCV000430695	20	25319956 - 25319968	20	25339320 - 25339332	430695	424226	rs1555817157	NC_000020.11:25339319:TCTTCCTCAGGCG:
NM_005220.3(DLX3):c.476G>T (p.Arg159Leu)	DLX3	R159L	Amelogenesis imperfecta, type IV|Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000430609	17	48070804	17	49993440	430609	423257	rs1555617226	NC_000017.11:49993439:C:A
NM_005220.3(DLX3):c.574del (p.Glu192fs)	DLX3	E192fs	Amelogenesis imperfecta, type IV|Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000430607	17	48069171	17	49991807	430607	423255	rs1057518764	NC_000017.11:49991806:CCCC:CCC
NM_000208.4(INSR):c.2030_2267+1del	INSR		Pineal hyperplasia AND diabetes mellitus syndrome	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000430587	19	7150507 - 7152938	19	7150496 - 7152927	430587	423235		
DCC, 7-BP DEL, NT788	DCC		Gaze palsy, familial horizontal, with progressive scoliosis, 2	Pathogenic(Last reviewed: Apr 2, 2019)	no assertion criteria provided	VCV000430581					430581	423088		
DCC, 7,682-BP DEL	DCC		Gaze palsy, familial horizontal, with progressive scoliosis, 2	Pathogenic(Last reviewed: Apr 2, 2019)	no assertion criteria provided	VCV000430580					430580	423087		
NM_001399.5(EDA):c.180C>A (p.Cys60Ter)	EDA	C60*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 28, 2017)	no assertion criteria provided	VCV000430575	X	68836332	X	69616488	430575	422942	rs1131692034	NC_000023.11:69616487:C:A
NM_001278116.2(L1CAM):c.1485C>G (p.Tyr495Ter)	L1CAM	Y495*, Y490*	not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000430438	X	153134077	X	153868622	430438	422432	rs1131691964	NC_000023.11:153868621:G:C
NM_001278116.2(L1CAM):c.1767C>A (p.Tyr589Ter)	L1CAM	Y589*, Y584*	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000430437	X	153133514	X	153868059	430437	422431	rs377470679	NC_000023.11:153868058:G:T
NM_001347721.2(DYRK1A):c.678_680delinsAC (p.Cys226_Leu227delinsTer)	DYRK1A		not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000430402	21	38862517 - 38862519	21	37490215 - 37490217	430402	422357	rs1131691946	NC_000021.9:37490214:TTT:AC
NM_001323289.2(CDKL5):c.768dup (p.Ser257fs)	CDKL5		not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000430365	X	18613490 - 18613491	X	18595370 - 18595371	430365	422445	rs1131691926	NC_000023.11:18595370:G:GG
NM_138927.3(SON):c.4865_4869del (p.Ser1621_Leu1622insTer)	SON		not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000430335	21	34926398 - 34926402	21	33554092 - 33554096	430335	422351	rs1131691911	NC_000021.9:33554091:AGTTTAGTT:AGTT
NM_000216.4(ANOS1):c.3G>A (p.Met1Ile)	ANOS1	M1I	not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000430254	X	8700075	X	8732034	430254	422522	rs1131691863	NC_000023.11:8732033:C:T
NM_000159.4(GCDH):c.1063C>T (p.Arg355Cys)	GCDH	R355C	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430222	19	13008223	19	12897409	430222	422238	rs781477694	NC_000019.10:12897408:C:T
NM_000397.3(CYBB):c.483+1G>T	CYBB		not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000430197	X	37653064	X	37793811	430197	422469	rs1131691828	NC_000023.11:37793810:G:T
NM_000444.6(PHEX):c.682dup (p.Ser228fs)	PHEX		not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000430170	X	22108564 - 22108565	X	22090446 - 22090447	430170	422453	rs1131691812	NC_000023.11:22090446:T:TT
NM_033380.3(COL4A5):c.3410G>A (p.Gly1137Asp)	COL4A5	G1137D	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000430135	X	107908773	X	108665543	430135	422402	rs1131691795	NC_000023.11:108665542:G:A
NM_000284.4(PDHA1):c.650C>T (p.Pro217Leu)	PDHA1	P217L, P255L, P186L, P224L	not provided	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000430118	X	19373513	X	19355395	430118	422448	rs1131691792	NC_000023.11:19355394:C:T
NM_005559.4(LAMA1):c.6299del (p.Leu2099_Ser2100insTer)	LAMA1		not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000430114	18	6977772	18	6977773	430114	422229	rs1131691789	NC_000018.10:6977772:G:
NM_001282531.3(ADNP):c.2195del (p.Lys731_Leu732insTer)	ADNP		not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000430071	20	49509056	20	50892519	430071	422325	rs1131691770	NC_000020.11:50892518:AA:A
NM_001356.4(DDX3X):c.152-1G>C	DDX3X		not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000430070	X	41200736	X	41341483	430070	422477	rs1131691769	NC_000023.11:41341482:G:C
NM_000211.5(ITGB2):c.741+1G>A	ITGB2		not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	VCV000430061	21	46321406	21	44901491	430061	422366	rs1131691763	NC_000021.9:44901490:C:T
NM_000219.6(KCNE1):c.12dup (p.Asn5Ter)	KCNE1		Long QT syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430060	21	35821920 - 35821921	21	34449622 - 34449623	430060	422353	rs1131691762	NC_000021.9:34449622:A:AA
NM_001278116.2(L1CAM):c.266C>A (p.Ser89Ter)	L1CAM	S89*, S84*	not provided	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000430059	X	153137741	X	153872286	430059	422434	rs782178366	NC_000023.11:153872285:G:T
NM_000216.4(ANOS1):c.1615G>T (p.Glu539Ter)	ANOS1	E539*	not provided	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, single submitter	VCV000430035	X	8504818	X	8536777	430035	422521	rs144586521	NC_000023.11:8536776:C:A
NM_000033.4(ABCD1):c.761C>T (p.Thr254Met)	ABCD1	T254M	Adrenoleukodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430026	X	152991482	X	153726027	430026	422427	rs1131691743	NC_000023.11:153726026:C:T
NM_173483.4(CYP4F22):c.1007-2A>G	CYP4F22		not provided	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000430019	19	15654959	19	15544148	430019	422252	rs1045109000	NC_000019.10:15544147:A:G
NM_001083962.2(TCF4):c.1876C>T (p.Arg626Ter)	TCF4	R626*, R462*, R551*, R584*, R597*, R601*, R603*, R625*, R632*, R728*, R466*, R619*, R621*, R622*, R410*, R496*, R580*, R602*, R461*, R492*, R555*, R598*	Pitt-Hopkins syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000430016	18	52896081	18	55228850	430016	422225	rs1131691735	NC_000018.10:55228849:G:A
NM_172107.4(KCNQ2):c.1508C>G (p.Ser503Ter)	KCNQ2	S503*, S485*, S473*, S475*	not provided	Pathogenic(Last reviewed: Sep 28, 2015)	criteria provided, single submitter	VCV000430015	20	62046273	20	63414920	430015	422339	rs1131691734	NC_000020.11:63414919:G:C
NM_000444.6(PHEX):c.118+1G>T	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430012	X	22051242	X	22033124	430012	422451	rs1131691731	NC_000023.11:22033123:G:T
NM_001127221.1(CACNA1A):c.3106dup (p.Ser1036fs)	CACNA1A		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429987	19	13397766 - 13397767	19	13286952 - 13286953	429987	422244	rs1131691712	NC_000019.10:13286952:A:AA
NM_001029896.2(WDR45):c.884G>A (p.Trp295Ter)	WDR45	W296*, W295*	not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000429970	X	48932884	X	49075225	429970	422488	rs1131691703	NC_000023.11:49075224:C:T
NM_023010.3(UPF3B):c.690_697del (p.Arg233fs)	UPF3B	R233fs	not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000429957	X	118975149 - 118975156	X	119841186 - 119841193	429957	422406	rs1131691699	NC_000023.11:119841185:TCTCTTCTTCTCTT:TCTCTT
NM_006087.4(TUBB4A):c.286G>A (p.Gly96Arg)	TUBB4A	G147R, G96R, G141R, G24R	not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429952	19	6496224	19	6496213	429952	422301	rs1131691696	NC_000019.10:6496212:C:T
NM_030632.3(ASXL3):c.3106C>T (p.Arg1036Ter)	ASXL3	R1036*	Bainbridge-Ropers syndrome|not provided	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429913	18	31322918	18	33742954	429913	422219	rs1131691668	NC_000018.10:33742953:C:T
NM_001278116.2(L1CAM):c.2438dup (p.Ala814fs)	L1CAM		not provided	Pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000429911	X	153131267 - 153131268	X	153865812 - 153865813	429911	422429	rs1131691666	NC_000023.11:153865812:T:TT
NM_001347721.2(DYRK1A):c.1357dup (p.Tyr453fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Oct 29, 2015)	criteria provided, single submitter	VCV000429904	21	38877728 - 38877729	21	37505425 - 37505426	429904	422360	rs1131691661	NC_000021.9:37505425:TT:TTT
NM_172107.4(KCNQ2):c.2085del (p.Thr696fs)	KCNQ2	T668fs, T696fs, T665fs, T678fs	not provided	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000429899	20	62038531	20	63407178	429899	422335	rs1131691658	NC_000020.11:63407177:GG:G
NM_004247.4(EFTUD2):c.1542C>A (p.Tyr514Ter)	EFTUD2	Y514*, Y504*, Y479*	not provided	Pathogenic(Last reviewed: Sep 30, 2015)	criteria provided, single submitter	VCV000429890	17	42940146	17	44862778	429890	422172	rs749855263	NC_000017.11:44862777:G:T
NM_001083962.2(TCF4):c.986_990+3del	TCF4		not provided	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000429889	18	52928694 - 52928701	18	55261463 - 55261470	429889	422226	rs1131691653	NC_000018.10:55261462:CACCGAAGCA:CA
NM_000206.2(IL2RG):c.391C>T (p.Gln131Ter)	IL2RG	Q131*	not provided	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000429886	X	70330417	X	71110567	429886	422506	rs1131691652	NC_000023.11:71110566:G:A
NM_001111125.3(IQSEC2):c.3502-2del	IQSEC2		not provided	Pathogenic(Last reviewed: Oct 5, 2015)	criteria provided, single submitter	VCV000429884	X	53264368	X	53235186	429884	422493	rs1131691650	NC_000023.11:53235185:T:
NM_152424.4(AMER1):c.705del (p.Pro237fs)	AMER1	P237fs	not provided	Pathogenic(Last reviewed: Oct 27, 2015)	criteria provided, single submitter	VCV000429881	X	63412462	X	64192582	429881	422498	rs1131691649	NC_000023.11:64192581:A:
NM_001184880.2(PCDH19):c.1521del (p.Ile508fs)	PCDH19	I508fs	not provided	Pathogenic(Last reviewed: Sep 23, 2015)	criteria provided, single submitter	VCV000429878	X	99662075	X	100407077	429878	422392	rs1131691646	NC_000023.11:100407076:GG:G
NM_000156.6(GAMT):c.503A>C (p.Tyr168Ser)	GAMT	Y168S	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429874	19	1398982	19	1398983	429874	422247	rs1131691644	NC_000019.10:1398982:T:G
NM_018684.4(ZC4H2):c.199C>T (p.Arg67Ter)	ZC4H2	R67*, R44*	Wieacker Wolff syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429826	X	64141723	X	64921843	429826	422499	rs1131691616	NC_000023.11:64921842:G:A
NM_001356.4(DDX3X):c.1498-2A>G	DDX3X		Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, multiple submitters, no conflicts	VCV000429815	X	41205756	X	41346503	429815	422482	rs1131691608	NC_000023.11:41346502:A:G
NM_001184880.2(PCDH19):c.595G>T (p.Glu199Ter)	PCDH19	E199*	not provided	Pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	VCV000429806	X	99663001	X	100408003	429806	422397	rs1131691603	NC_000023.11:100408002:C:A
NM_001356.4(DDX3X):c.641_643delinsCC (p.Ile214fs)	DDX3X		not provided	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000429756	X	41202566 - 41202568	X	41343313 - 41343315	429756	422479	rs1131691571	NC_000023.11:41343312:TCA:CC
NM_001399.5(EDA):c.922G>T (p.Glu308Ter)	EDA	E308*	not provided	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000429747	X	69253376	X	70033526	429747	422505	rs1131691566	NC_000023.11:70033525:G:T
NM_003639.4(IKBKG):c.672-2A>T	IKBKG		not provided	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	VCV000429745	X	153789901	X	154561686	429745	422444	rs1057517746	NC_000023.11:154561685:A:T
NM_000475.5(NR0B1):c.708G>A (p.Trp236Ter)	NR0B1	W236*	not provided|Congenital adrenal hypoplasia, X-linked|46,XY sex reversal, type 2|Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429744	X	30326773	X	30308656	429744	422461	rs1131691564	NC_000023.11:30308655:C:T
NM_000216.4(ANOS1):c.1887_1888del (p.Tyr630fs)	ANOS1	Y630fs	not provided	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000429739	X	8502456 - 8502457	X	8534415 - 8534416	429739	422520	rs1131691560	NC_000023.11:8534414:AAA:A
NM_000271.5(NPC1):c.526del (p.Leu176fs)	NPC1	L176fs	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000429737	18	21141429	18	23561465	429737	422214	rs1131691558	NC_000018.10:23561464:GG:G
NM_000346.4(SOX9):c.509C>T (p.Pro170Leu)	SOX9	P170L	not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000429733	17	70118937	17	72122796	429733	422193	rs1131691554	NC_000017.11:72122795:C:T
NM_000152.5(GAA):c.2269C>T (p.Gln757Ter)	GAA	Q757*	not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429727	17	78090846	17	80117047	429727	422208	rs200483245	NC_000017.11:80117046:C:T
NM_000159.4(GCDH):c.892G>A (p.Ala298Thr)	GCDH	A298T	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429706	19	13007763	19	12896949	429706	422236	rs761765983	NC_000019.10:12896948:G:A
NM_020436.5(SALL4):c.1375del (p.Leu459fs)	SALL4	L459fs	not provided	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	VCV000429698	20	50407647	20	51791108	429698	422328	rs1131691536	NC_000020.11:51791107:G:
NM_001184880.2(PCDH19):c.976_981delinsTTCCC (p.Ile326fs)	PCDH19		not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000429648	X	99662615 - 99662620	X	100407617 - 100407622	429648	422395	rs1131691509	NC_000023.11:100407616:CGGGAT:GGGAA
NM_006031.6(PCNT):c.398del (p.Phe133fs)	PCNT	F15fs, F133fs	not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000429602	21	47754440	21	46334526	429602	422370	rs1131691484	NC_000021.9:46334525:TT:T
NM_005676.5(RBM10):c.2214_2217del (p.Ser738fs)	RBM10	S738fs, S660fs, S661fs, S803fs, S737fs	not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000429505	X	47044886 - 47044889	X	47185487 - 47185490	429505	422485	rs1131691421	NC_000023.11:47185486:AGTGAG:AG
NM_001127221.1(CACNA1A):c.4504_4506del (p.Phe1502del)	CACNA1A	F1502del, F1501del, F1505del	not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000429427	19	13368251 - 13368253	19	13257437 - 13257439	429427	422241	rs1131691374	NC_000019.10:13257436:AAA:
NM_172107.4(KCNQ2):c.1687G>T (p.Asp563Tyr)	KCNQ2	D563Y, D535Y, D545Y, D532Y	not provided	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000429424	20	62044879	20	63413526	429424	422338	rs796052653	NC_000020.11:63413525:C:A
NM_003639.4(IKBKG):c.652_662dup (p.Glu222fs)	IKBKG		not provided	Pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000429392	X	153788753 - 153788754	X	154560538 - 154560539	429392	422443	rs1557236517	NC_000023.11:154560538:CCAGGCCGCCTC:CCAGGCCGCCTCCAGGCCGCCTC
NM_001356.4(DDX3X):c.864+1delinsTTC	DDX3X		not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000429312	X	41203382	X	41344129	429312	422481	rs1131691314	NC_000023.11:41344128:G:TTC
NM_001123383.1(BCOR):c.1024C>T (p.Arg342Ter)	BCOR	R342*	not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000429288	X	39933575	X	40074322	429288	422474	rs151177114	NC_000023.11:40074321:G:A
NM_001363819.1(DDX3X):c.-304del	DDX3X	F69fs, F85fs	Mental retardation, X-linked 102|not provided	Pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000429287	X	41200840	X	41341587	429287	422478	rs1131691299	NC_000023.11:41341586:C:
NM_000109.4(DMD):c.5960del (p.Tyr1987fs)	DMD	Y1872fs, Y1995fs, Y654fs, Y1987fs, Y1991fs, Y651fs	not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000429274	X	32328332	X	32310215	429274	422466	rs1131691292	NC_000023.11:32310214:T:
NM_001282531.3(ADNP):c.57dup (p.Lys20fs)	ADNP		not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000429255	20	49520476 - 49520477	20	50903939 - 50903940	429255	422326	rs1131691281	NC_000020.11:50903939:C:CC
NM_016032.4(ZDHHC9):c.286C>T (p.Arg96Trp)	ZDHHC9	R96W	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: Apr 4, 2017)	no assertion criteria provided	VCV000429192	X	128962999	X	129829023	429192	421144	rs1131690786	NC_000023.11:129829022:G:A
NM_003560.4(PLA2G6):c.3G>T (p.Met1Ile)	PLA2G6	M1I	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000429031	22	38565431	22	38169424	429031	420984	rs764959600	NC_000022.11:38169423:C:A
NM_000455.4(STK11):c.734+1G>C	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000428792	19	1220717	19	1220718	428792	420715	rs587782018	NC_000019.10:1220717:G:C
NM_000455.4(STK11):c.373dup (p.Met125fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000428791	19	1218494 - 1218495	19	1218495 - 1218496	428791	420698	rs1131690952	NC_000019.10:1218495:AAAA:AAAAA
NM_000455.4(STK11):c.374+1A>G	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	VCV000428788	19	1218500	19	1218501	428788	420699	rs1131690951	NC_000019.10:1218500:A:G
NM_000455.4(STK11):c.290+1G>A	STK11		Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428787	19	1207203	19	1207204	428787	420695	rs1131690950	NC_000019.10:1207203:G:A
NM_000455.4(STK11):c.843dup (p.Leu282fs)	STK11		Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428786	19	1221319 - 1221320	19	1221320 - 1221321	428786	420719	rs1131690949	NC_000019.10:1221320:G:GG
NM_000455.4(STK11):c.752del (p.Gly251fs)	STK11	G251fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	VCV000428785	19	1221227	19	1221228	428785	420717	rs1131690948	NC_000019.10:1221227:GGG:GG
NM_000455.4(STK11):c.876del (p.Glu291_Tyr292insTer)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	VCV000428784	19	1221961	19	1221962	428784	420722	rs1131690947	NC_000019.10:1221961:C:
NM_000455.4(STK11):c.911G>C (p.Arg304Pro)	STK11	R304P	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 22, 2015)	criteria provided, single submitter	VCV000428783	19	1221996	19	1221997	428783	420724	rs376280361	NC_000019.10:1221996:G:C
NM_000455.4(STK11):c.608dup (p.Phe204fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	VCV000428782	19	1220587 - 1220588	19	1220588 - 1220589	428782	420709	rs1131690946	NC_000019.10:1220588:CCC:CCCC
NM_000455.4(STK11):c.913C>T (p.Gln305Ter)	STK11	Q305*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428781	19	1221998	19	1221999	428781	420725	rs1131690945	NC_000019.10:1221998:C:T
NM_000455.4(STK11):c.658C>T (p.Gln220Ter)	STK11	Q220*	Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428776	19	1220640	19	1220641	428776	420711	rs1131690940	NC_000019.10:1220640:C:T
NM_000455.4(STK11):c.540dup (p.Asn181fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000428775	19	1220443 - 1220444	19	1220444 - 1220445	428775	420705	rs1131690939	NC_000019.10:1220444:GGGG:GGGGG
NM_000455.4(STK11):c.195_198del (p.Glu65fs)	STK11	E65fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000428772	19	1207107 - 1207110	19	1207108 - 1207111	428772	420692	rs1131690936	NC_000019.10:1207107:GGTG:
NM_000455.4(STK11):c.598-2A>G	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000428770	19	1220578	19	1220579	428770	420708	rs1131690934	NC_000019.10:1220578:A:G
NM_000455.4(STK11):c.363_367dup (p.Gln123fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000428769	19	1218487 - 1218488	19	1218488 - 1218489	428769	420696	rs1131690933	NC_000019.10:1218488:GAAGC:GAAGCGAAGC
NM_000455.4(STK11):c.487delGins19 (p.?)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	VCV000428768	19	1220394	19	1220395	428768	420703		
NM_000455.4(STK11):c.93dup (p.Thr32fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2013)	criteria provided, single submitter	VCV000428766	19	1207003 - 1207004	19	1207004 - 1207005	428766	420682	rs1131690930	NC_000019.10:1207004:CC:CCC
NM_000455.4(STK11):c.209dup (p.Thr71fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	VCV000428765	19	1207120 - 1207121	19	1207121 - 1207122	428765	420693	rs1131690929	NC_000019.10:1207121:A:AA
NM_000455.4(STK11):c.446del (p.Pro149fs)	STK11	P149fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	VCV000428762	19	1219392	19	1219393	428762	420700	rs1131690926	NC_000019.10:1219392:CCC:CC
NM_000455.4(STK11):c.367C>T (p.Gln123Ter)	STK11	Q123*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	VCV000428761	19	1218492	19	1218493	428761	420697	rs1131690925	NC_000019.10:1218492:C:T
NM_000455.4(STK11):c.106del (p.Tyr36fs)	STK11	Y36fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	VCV000428760	19	1207018	19	1207019	428760	420683	rs1131690924	NC_000019.10:1207018:T:
NM_000455.4(STK11):c.640C>T (p.Gln214Ter)	STK11	Q214*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 29, 2012)	criteria provided, single submitter	VCV000428759	19	1220622	19	1220623	428759	420710	rs1131690923	NC_000019.10:1220622:C:T
NM_000455.4(STK11):c.497_500dup (p.His168fs)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000428758	19	1220402 - 1220403	19	1220403 - 1220404	428758	420704	rs1131690922	NC_000019.10:1220403:TACCT:TACCTACCT
NM_000455.4(STK11):c.543C>G (p.Asn181Lys)	STK11	N181K	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428757	19	1220450	19	1220451	428757	420706	rs730881973	NC_000019.10:1220450:C:G
NM_000455.4(STK11):c.862+1G>T	STK11		Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428756	19	1221340	19	1221341	428756	420720	rs1131690921	NC_000019.10:1221340:G:T
NM_000455.5(STK11):c.920+1G>A	STK11		Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428755	19	1222006	19	1222007	428755	420726	rs1131690920	NC_000019.10:1222006:G:A
NM_000455.4(STK11):c.156_157del (p.Asp53fs)	STK11	D53fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 4, 2012)	criteria provided, single submitter	VCV000428753	19	1207065 - 1207066	19	1207066 - 1207067	428753	420686	rs1131690917	NC_000019.10:1207065:GGGGG:GGG
NM_000455.4(STK11):c.180C>A (p.Tyr60Ter)	STK11	Y60*	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428750	19	1207092	19	1207093	428750	420690	rs778376925	NC_000019.10:1207092:C:A
NM_000455.4(STK11):c.180C>G (p.Tyr60Ter)	STK11	Y60*	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428749	19	1207092	19	1207093	428749	420691	rs778376925	NC_000019.10:1207092:C:G
NM_000455.4(STK11):c.816C>G (p.Tyr272Ter)	STK11	Y272*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	VCV000428747	19	1221293	19	1221294	428747	420718	rs9282859	NC_000019.10:1221293:C:G
NM_005676.5(RBM10):c.1350_1351AG[1] (p.Glu451fs)	RBM10		Inborn genetic diseases	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000428617	X	47040715 - 47040716	X	47181316 - 47181317	428617	420436	rs1131690789	NC_000023.11:47181315:AGAG:AG
NM_052865.4(MGME1):c.359del (p.Pro120fs)	MGME1	P120fs	Mitochondrial DNA depletion syndrome 11	Pathogenic(Last reviewed: May 7, 2017)	no assertion criteria provided	VCV000428588	20	17950860	20	17970217	428588	420146	rs1555789140	NC_000020.11:17970216:CC:C
NM_004928.3(CFAP410):c.320A>G (p.Tyr107Cys)	CFAP410	Y107C, Y66C	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000428583	21	45752969	21	44333086	428583	420017	rs1131690801	NC_000021.9:44333085:T:C
NM_004928.3(CFAP410):c.331G>A (p.Val111Met)	CFAP410	V111M, V70M	|Retinal dystrophy	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000428582	21	45752958	21	44333075	428582	420016	rs555164150	NC_000021.9:44333074:C:T
NM_004928.3(CFAP410):c.347C>T (p.Pro116Leu)	CFAP410	P116L, P75L		Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000428581	21	45752942	21	44333059	428581	420015	rs922930539	NC_000021.9:44333058:G:A
NM_004928.3(CFAP410):c.319T>C (p.Tyr107His)	CFAP410	Y107H, Y66H		Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000428580	21	45752970	21	44333087	428580	420014	rs763623409	NC_000021.9:44333086:A:G
NM_004928.3(CFAP410):c.643-23A>T	CFAP410			Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000428579	21	45750232	21	44330349	428579	420013	rs1131690800	NC_000021.9:44330348:T:A
NM_004928.3(CFAP410):c.545+1G>A	CFAP410			Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000428578	21	45751725	21	44331842	428578	420012	rs778222701	NC_000021.9:44331841:C:T
NM_004928.3(CFAP410):c.436_466del (p.Glu146fs)	CFAP410	E146fs, E105fs	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	Pathogenic(Last reviewed: Jul 17, 2018)	no assertion criteria provided	VCV000428576	21	45751805 - 45751835	21	44331922 - 44331952	428576	420010	rs746633371	NC_000021.9:44331921:TGGGGCCGCCGTGGCCTGTGCCCTCTCTCTCTGGGGCCGC:TGGGGCCGC
NM_004928.3(CFAP410):c.103del (p.Ile35fs)	CFAP410	I35fs		Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000428575	21	45755681	21	44335798	428575	420009	rs1114167893	NC_000021.9:44335797:T:
NM_004928.3(CFAP410):c.671T>C (p.Leu224Pro)	CFAP410	L224P, L223P, L343P, L182P		Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000428574	21	45750181	21	44330298	428574	420008	rs1114167892	NC_000021.9:44330297:A:G
NM_004928.3(CFAP410):c.218G>C (p.Arg73Pro)	CFAP410	R73P, R32P	Cone/cone-rod dystrophy|Retinitis pigmentosa||Retinal dystrophy	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000428573	21	45753071	21	44333188	428573	420007	rs140451304	NC_000021.9:44333187:C:G
NM_181672.3(OGT):c.463-6T>G	OGT		Intellectual disability, X-linked 106	Pathogenic(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000428572	X	70764411	X	71544561	428572	420006	rs943295842	NC_000023.11:71544560:T:G
NM_181672.3(OGT):c.851G>C (p.Arg284Pro)	OGT	R284P, R274P	Intellectual disability, X-linked 106	Pathogenic(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000428571	X	70775162	X	71555312	428571	420005	rs1114167891	NC_000023.11:71555311:G:C
NM_181672.3(OGT):c.762G>T (p.Leu254Phe)	OGT	L254F, L244F	Intellectual disability, X-linked 106	Pathogenic(Last reviewed: Aug 8, 2017)	no assertion criteria provided	VCV000428570	X	70775073	X	71555223	428570	420004	rs1131692155	NC_000023.11:71555222:G:T
NM_006915.3(RP2):c.102+3A>C	RP2		Leber congenital amaurosis	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427871	X	46696640	X	46837205	427871	418831	rs1556313557	NC_000023.11:46837204:A:C
NM_000328.3(RPGR):c.1572+3A>T	RPGR		Retinitis pigmentosa	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000427866	X	38150209	X	38290956	427866	418828	rs1555962831	NC_000023.11:38290955:T:A
NM_002035.4(KDSR):c.557A>T (p.Tyr186Phe)	KDSR	Y186F	Erythrokeratodermia variabilis et progressiva 4	Pathogenic(Last reviewed: Jun 13, 2017)	no assertion criteria provided	VCV000427792	18	61018173	18	63350940	427792	418322	rs1114167452	NC_000018.10:63350939:T:A
NM_002035.4(KDSR):c.879G>A (p.Gln293=)	KDSR	Q293Q	Erythrokeratodermia variabilis et progressiva 4	Pathogenic(Last reviewed: Jun 13, 2017)	no assertion criteria provided	VCV000427791	18	61002490	18	63335257	427791	418321	rs752611378	NC_000018.10:63335256:C:T
NM_002035.4(KDSR):c.256-2A>C	KDSR		Erythrokeratodermia variabilis et progressiva 4	Pathogenic(Last reviewed: Jun 13, 2017)	no assertion criteria provided	VCV000427790	18	61022798	18	63355565	427790	418320	rs1114167451	NC_000018.10:63355564:T:G
NM_002035.4(KDSR):c.164_166del (p.Gln55_Gly56delinsArg)	KDSR		Erythrokeratodermia variabilis et progressiva 4	Pathogenic(Last reviewed: Jun 13, 2017)	no assertion criteria provided	VCV000427789	18	61030044 - 61030046	18	63362811 - 63362813	427789	418319	rs1114167450	NC_000018.10:63362810:CTT:
NM_002816.5(PSMD12):c.909-2A>G	PSMD12		Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427782	17	65340898	17	67344782	427782	417871	rs1114167444	NC_000017.11:67344781:T:C
NM_002816.5(PSMD12):c.601C>T (p.Arg201Ter)	PSMD12	R201*, R181*, R142*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427781	17	65343511	17	67347395	427781	417870	rs895130488	NC_000017.11:67347394:G:A
NM_002816.5(PSMD12):c.1274T>G (p.Leu425Ter)	PSMD12	L425*, L366*, L405*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427780	17	65337056	17	67340940	427780	417869	rs1114167443	NC_000017.11:67340939:A:C
NM_002816.5(PSMD12):c.367C>T (p.Arg123Ter)	PSMD12	R123*, R64*, R103*	Stankiewicz-Isidor syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427779	17	65346383	17	67350267	427779	417868	rs1114167442	NC_000017.11:67350266:G:A
NM_007363.5(NONO):c.1171G>T (p.Gly391Cys)	NONO	G391C, G302C	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000427778	X	70518358	X	71298508	427778	417867	rs1114167441	NC_000023.11:71298507:G:T
NM_001887.4(CRYBB1):c.387C>A (p.Ser129Arg)	CRYBB1	S129R	Cataract, congenital nuclear, autosomal recessive 3	Pathogenic(Last reviewed: Jun 5, 2017)	no assertion criteria provided	VCV000427749	22	27003898	22	26607934	427749	417543	rs1114167433	NC_000022.11:26607933:G:T
NM_001887.4(CRYBB1):c.757T>C (p.Ter253Arg)	CRYBB1	*253R	Cataract, congenital nuclear, autosomal recessive 3	Pathogenic(Last reviewed: Jun 5, 2017)	no assertion criteria provided	VCV000427748	22	26995456	22	26599492	427748	417542	rs1114167432	NC_000022.11:26599491:A:G
NM_020964.3(EPG5):c.2353dup (p.Ala785fs)	EPG5		Vici syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	no assertion criteria provided	VCV000427732	18	43510700 - 43510701	18	45930734 - 45930735	427732	417345	rs1085308062	NC_000018.10:45930734:CC:CCC
NM_001886.3(CRYBA4):c.190G>T (p.Gly64Trp)	CRYBA4	G64W	Cataract 23, multiple types	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	VCV000427575	22	27021476	22	26625512	427575	416851	rs1114167427	NC_000022.11:26625511:G:T
NM_000444.6(PHEX):c.1366T>C (p.Trp456Arg)	PHEX	W456R	not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000427188	X	22151703	X	22133586	427188	415766	rs1085308012	NC_000023.11:22133585:T:C
NM_172107.4(KCNQ2):c.286dup (p.His96fs)	KCNQ2		not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000427025	20	62103530 - 62103531	20	63472177 - 63472178	427025	415698	rs1085307905	NC_000020.11:63472177:GG:GGG
NM_176787.5(PIGN):c.932T>G (p.Leu311Trp)	PIGN	L311W	Inborn genetic diseases|not provided|Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426983	18	59810570	18	62143337	426983	415608	rs746882521	NC_000018.10:62143336:A:C
NM_003639.4(IKBKG):c.766C>T (p.Arg256Ter)	IKBKG	R256*, R205*, R255*, R324*	not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000426975	X	153789997	X	154561782	426975	415756	rs1085307883	NC_000023.11:154561781:C:T
NM_001184880.2(PCDH19):c.1417_1418CT[1] (p.Ser474fs)	PCDH19		not provided	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000426961	X	99662174 - 99662177	X	100407176 - 100407179	426961	415727	rs1085307873	NC_000023.11:100407175:AGAGAG:AG
NM_007363.5(NONO):c.1009C>T (p.Arg337Ter)	NONO	R337*, R248*	not provided	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000426955	X	70517292	X	71297442	426955	415815	rs1085307870	NC_000023.11:71297441:C:T
NM_015338.5(ASXL1):c.1934dup (p.Gly646fs)	ASXL1		not provided|Bohring-Opitz syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426927	20	31022441 - 31022442	20	32434638 - 32434639	426927	415680	rs750318549	NC_000020.11:32434638:GGGGGGGG:GGGGGGGGG
NM_178152.3(DCX):c.30_31del (p.Arg11_Asp12insTer)	DCX		not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000426911	X	110653596 - 110653597	X	111410368 - 111410369	426911	415735	rs1085307851	NC_000023.11:111410367:TTT:T
NM_001356.4(DDX3X):c.1493C>T (p.Thr498Ile)	DDX3X	T498I, T482I, T312I	not provided	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000426897	X	41205659	X	41346406	426897	415785	rs200427211	NC_000023.11:41346405:C:T
NM_001127221.1(CACNA1A):c.526G>A (p.Val176Met)	CACNA1A	V176M	not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000426878	19	13563703	19	13452889	426878	415635	rs1057521920	NC_000019.10:13452888:C:T
NM_000495.5(COL4A5):c.1869del (p.Gly624fs)	COL4A5	G624fs	not provided	Pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000426808	X	107842021	X	108598791	426808	415732	rs1085307808	NC_000023.11:108598790:T:
NM_000116.5(TAZ):c.646G>A (p.Gly216Arg)	TAZ	G216R, G172R, G186R, G202R, G220R	not provided|3-Methylglutaconic aciduria type 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426783	X	153648433	X	154420094	426783	415753	rs1085307797	NC_000023.11:154420093:G:A
NM_003588.3(CUL4B):c.1007_1011del (p.Ile336fs)	CUL4B	I318fs, I323fs, I336fs, I140fs	Syndromic X-linked mental retardation, Cabezas type|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426723	X	119678462 - 119678466	X	120544607 - 120544611	426723	415736	rs1085307760	NC_000023.11:120544606:TATAATAT:TAT
NM_000074.2(CD40LG):c.658C>T (p.Gln220Ter)	CD40LG	Q220*	not provided	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000426663	X	135741446	X	136659287	426663	415742	rs1085307733	NC_000023.11:136659286:C:T
NM_001077488.4(GNAS):c.-4_2del (p.Met1del)	GNAS	M1del	not provided	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000426629	20	57466778 - 57466783	20	58891723 - 58891728	426629	415687	rs1085307719	NC_000020.11:58891722:CGCCAT:
NM_001271043.2(NFIX):c.1104delG	NFIX		not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000426620	19	13192493	19	13081679	426620	415622	rs1085307714	NC_000019.10:13081678:GGG:GG
NM_000152.5(GAA):c.118C>T (p.Arg40Ter)	GAA	R40*	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Nov 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426593	17	78078503	17	80104704	426593	415589	rs767409395	NC_000017.11:80104703:C:T
NM_000377.2(WAS):c.390del (p.Asp130fs)	WAS	D130fs	not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000426548	X	48544152	X	48685763	426548	415791	rs1085307678	NC_000023.11:48685762:C:
NM_000475.5(NR0B1):c.348_388delinsAGAA (p.Arg117fs)	NR0B1		not provided	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000426547	X	30327093 - 30327133	X	30308976 - 30309016	426547	415772	rs1085307677	NC_000023.11:30308975:ACAGGAGTGCCACGGGCCGCCCACCCGGAAGCCCCGCTCTG:TTCT
NM_212472.2(PRKAR1A):c.806A>G (p.Asp269Gly)	PRKAR1A	D269G	not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000426532	17	66525047	17	68528906	426532	415583	rs1085307672	NC_000017.11:68528905:A:G
NM_030632.3(ASXL3):c.3464C>A (p.Ser1155Ter)	ASXL3	S1155*	not provided|Decreased activity of mitochondrial complex I|Gastrostomy tube feeding in infancy|Absent speech|Global developmental delay|Generalized hypotonia|Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000426517	18	31323276	18	33743312	426517	415601	rs377619533	NC_000018.10:33743311:C:A
NM_004187.4(KDM5C):c.2319G>A (p.Trp773Ter)	KDM5C	W773*, W772*, W706*	not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000426496	X	53227995	X	53198813	426496	415797	rs1085307655	NC_000023.11:53198812:C:T
NM_000411.8(HLCS):c.1693C>T (p.Arg565Ter)	HLCS	R565*, R712*	Holocarboxylase synthetase deficiency|not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426486	21	38132130	21	36759829	426486	415700	rs772791252	NC_000021.9:36759828:G:A
NM_004247.4(EFTUD2):c.1058+1G>A	EFTUD2		not provided|Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426481	17	42945654	17	44868286	426481	415565	rs1085307647	NC_000017.11:44868285:C:T
NM_000444.6(PHEX):c.312T>G (p.Tyr104Ter)	PHEX	Y104*	not provided	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000426473	X	22065292	X	22047174	426473	415764	rs1085307642	NC_000023.11:22047173:T:G
NM_030632.3(ASXL3):c.1623_1624CT[2] (p.Leu543fs)	ASXL3		not provided	Pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000426466	18	31318991 - 31318992	18	33739027 - 33739028	426466	415600	rs1085307640	NC_000018.10:33739026:CTCTCT:CTCT
NM_004586.3(RPS6KA3):c.1894C>T (p.Arg632Ter)	RPS6KA3	R632*	not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000426465	X	20179827	X	20161709	426465	415762	rs1085307639	NC_000023.11:20161708:G:A
NM_000167.5(GK):c.889_890insC (p.Asp297fs)	GK		not provided	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000426447	X	30726183 - 30726184	X	30708066 - 30708067	426447	415773	rs1085307629	NC_000023.11:30708066::C
NM_000152.5(GAA):c.2105G>A (p.Arg702His)	GAA	R702H	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426278	17	78087081	17	80113282	426278	415590	rs398123172	NC_000017.11:80113281:G:A
NM_176787.5(PIGN):c.2284-1G>C	PIGN		not provided|Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426235	18	59756076	18	62088843	426235	415607	rs760977825	NC_000018.10:62088842:C:G
NM_000307.5(POU3F4):c.232C>T (p.Gln78Ter)	POU3F4	Q78*	not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, single submitter	VCV000426228	X	82763564	X	83508556	426228	415818	rs1085307512	NC_000023.11:83508555:C:T
NM_001323289.2(CDKL5):c.258C>G (p.Tyr86Ter)	CDKL5	Y86*	not provided	Pathogenic(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000426143	X	18593586	X	18575466	426143	415757	rs1085307470	NC_000023.11:18575465:C:G
NM_000455.4(STK11):c.904C>T (p.Gln302Ter)	STK11	Q302*	not provided	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000426137	19	1221989	19	1221990	426137	415621	rs1085307466	NC_000019.10:1221989:C:T
NM_172107.4(KCNQ2):c.1093C>T (p.Arg365Ter)	KCNQ2	R365*	Benign familial neonatal seizures 1|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426132	20	62065187	20	63433834	426132	415696	rs1085307463	NC_000020.11:63433833:G:A
NM_004187.4(KDM5C):c.1557G>A (p.Trp519Ter)	KDM5C	W519*, W518*, W452*	not provided	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000426131	X	53239884	X	53210702	426131	415798	rs1085307462	NC_000023.11:53210701:C:T
NM_004247.4(EFTUD2):c.702+1G>T	EFTUD2		Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426124	17	42956923	17	44879555	426124	415566	rs1085307457	NC_000017.11:44879554:C:A
NM_001242897.2(DEPDC5):c.336_337del (p.Asp113fs)	DEPDC5	D113fs	not provided	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426117	22	32162625 - 32162626	22	31766639 - 31766640	426117	415711	rs1085307452	NC_000022.11:31766638:GGGG:GG
NM_177973.2(SULT2B1):c.71+2T>A	SULT2B1		ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14|Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426110	19	49055582	19	48552325	426110	414711	rs1114167426	NC_000019.10:48552324:T:A
NM_177973.2(SULT2B1):c.364dup (p.Met122fs)	SULT2B1		ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14|Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426109	19	49090634 - 49090635	19	48587377 - 48587378	426109	414712	rs1114167425	NC_000019.10:48587377:A:AA
NM_177973.2(SULT2B1):c.821G>A (p.Arg274Gln)	SULT2B1	R274Q, R259Q	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14|Autosomal recessive congenital ichthyosis 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426108	19	49100171	19	48596914	426108	414714	rs762765702	NC_000019.10:48596913:G:A
NM_177973.2(SULT2B1):c.446C>T (p.Pro149Leu)	SULT2B1	P149L, P134L	Autosomal recessive congenital ichthyosis 1|ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000426107	19	49094888	19	48591631	426107	414713	rs1114167424	NC_000019.10:48591630:C:T
NM_001195.5(BFSP1):c.1042+3A>G	BFSP1		Cataract 33, multiple types	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000425559	20	17477580	20	17496935	425559	413914	rs1085307127	NC_000020.11:17496934:T:C
NM_001195.5(BFSP1):c.1042G>A (p.Asp348Asn)	BFSP1	D348N, D209N, D237N, D223N	Cataract 33, multiple types	Pathogenic(Last reviewed: May 9, 2017)	no assertion criteria provided	VCV000425558	20	17477583	20	17496938	425558	413913	rs1085307126	NC_000020.11:17496937:C:T
NM_152296.5(ATP1A3):c.2266C>T (p.Arg756Cys)	ATP1A3	R756C, R767C, R769C	Dystonia 12|Inborn genetic diseases|not provided|Alternating hemiplegia of childhood 2|Alternating hemiplegia of childhood 2|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000425189	19	42474692	19	41970540	425189	413523	rs1064797245	NC_000019.10:41970539:G:A
NM_003620.3(PPM1D):c.1250dup (p.Pro418fs)	PPM1D		Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Jun 17, 2019)	no assertion criteria provided	VCV000424879	17	58734190 - 58734191	17	60656829 - 60656830	424879	413213	rs1064797100	NC_000017.11:60656829:CC:CCC
NM_003620.3(PPM1D):c.1281G>A (p.Trp427Ter)	PPM1D	W427*	Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Jun 17, 2019)	no assertion criteria provided	VCV000424878	17	58740376	17	60663015	424878	413212	rs1064797099	NC_000017.11:60663014:G:A
NM_003620.3(PPM1D):c.1270dup (p.Glu424fs)	PPM1D		Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Jun 17, 2019)	no assertion criteria provided	VCV000424877	17	58740363 - 58740364	17	60663002 - 60663003	424877	413211	rs1064797098	NC_000017.11:60663002:GG:GGG
NM_003620.3(PPM1D):c.1216del (p.Thr406fs)	PPM1D	T406fs	Inborn genetic diseases|Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000424876	17	58734156	17	60656795	424876	413210	rs747947002	NC_000017.11:60656794:AAA:AA
NM_003620.3(PPM1D):c.1221T>A (p.Cys407Ter)	PPM1D	C407*	Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold	Pathogenic(Last reviewed: Jun 17, 2019)	no assertion criteria provided	VCV000424875	17	58734163	17	60656802	424875	413209	rs189669693	NC_000017.11:60656801:T:A
NM_139284.3(LGI4):c.773G>C (p.Arg258Pro)	LGI4	R258P	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000424870	19	35617777	19	35126873	424870	413204	rs755500591	NC_000019.10:35126872:C:G
NM_139284.3(LGI4):c.1299+5G>T	LGI4		Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: May 3, 2017)	no assertion criteria provided	VCV000424869	19	35617169	19	35126265	424869	413203	rs1064797095	NC_000019.10:35126264:C:A
NM_139284.3(LGI4):c.1301T>A (p.Val434Asp)	LGI4	V434D	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000424868	19	35616410	19	35125506	424868	413202	rs1064797094	NC_000019.10:35125505:A:T
NM_139284.3(LGI4):c.793+5G>C	LGI4		Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000424867	19	35617752	19	35126848	424867	413201	rs1064797093	NC_000019.10:35126847:C:G
NM_139284.3(LGI4):c.863G>A (p.Trp288Ter)	LGI4	W288*	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000424866	19	35617610	19	35126706	424866	413200	rs775997446	NC_000019.10:35126705:C:T
NM_139284.3(LGI4):c.793G>A (p.Ala265Thr)	LGI4	A265T	Arthrogryposis multiplex congenita, neurogenic, with myelin defect	Pathogenic(Last reviewed: May 2, 2017)	no assertion criteria provided	VCV000424865	19	35617757	19	35126853	424865	413199	rs779232987	NC_000019.10:35126852:C:T
NM_000054.6(AVPR2):c.878G>A (p.Trp293Ter)	AVPR2	W293*	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000424624	X	153171838	X	153906384	424624	411518	rs1064797077	NC_000023.11:153906383:G:A
NM_004247.4(EFTUD2):c.579del (p.Gly195fs)	EFTUD2	G160fs, G185fs, G195fs	not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000424610	17	42957962	17	44880594	424610	410044	rs1064797069	NC_000017.11:44880593:GG:G
NM_001429.4(EP300):c.319C>T (p.Gln107Ter)	EP300	Q107*	not provided	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000424555	22	41513415	22	41117411	424555	411021	rs1064797038	NC_000022.11:41117410:C:T
NM_005027.4(PIK3R2):c.1669G>C (p.Asp557His)	PIK3R2	D557H	not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000424553	19	18278049	19	18167239	424553	410554	rs372272045	NC_000019.10:18167238:G:C
NM_212472.2(PRKAR1A):c.488del (p.Thr163fs)	PRKAR1A	T163fs	not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000424516	17	66520204	17	68524063	424516	410230	rs1064797015	NC_000017.11:68524062:C:
NM_030632.3(ASXL3):c.4360C>T (p.Gln1454Ter)	ASXL3	Q1454*	not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000424448	18	31324172	18	33744208	424448	410364	rs1064796972	NC_000018.10:33744207:C:T
NM_000487.6(ARSA):c.302del (p.Gly101fs)	ARSA	G101fs, G15fs	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424445	22	51065757	22	50627329	424445	411049	rs761606317	NC_000022.11:50627328:CCCCCCC:CCCCCC
NM_001127221.1(CACNA1A):c.2847_2856del (p.Ala952fs)	CACNA1A	A952fs, A955fs, A951fs	not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000424375	19	13409594 - 13409603	19	13298780 - 13298789	424375	410523	rs1555755977	NC_000019.10:13298779:CGCGCCCGTGCGCG:CGCG
NM_000444.6(PHEX):c.1147C>T (p.Gln383Ter)	PHEX	Q383*	not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000424372	X	22129652	X	22111534	424372	411272	rs1064796942	NC_000023.11:22111533:C:T
NM_001347721.2(DYRK1A):c.490-1G>A	DYRK1A		not provided	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000424369	21	38858768	21	37486466	424369	410859	rs1064796939	NC_000021.9:37486465:G:A
NM_000377.2(WAS):c.249C>A (p.Tyr83Ter)	WAS	Y83*	not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000424355	X	48542788	X	48684399	424355	411385	rs368151220	NC_000023.11:48684398:C:A
NM_000444.6(PHEX):c.1586+1G>T	PHEX		not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000424354	X	22196494	X	22178377	424354	411279	rs1064796928	NC_000023.11:22178376:G:T
NM_000444.6(PHEX):c.1174-2A>G	PHEX		not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424353	X	22132574	X	22114456	424353	411274	rs1064796927	NC_000023.11:22114455:A:G
NM_004247.4(EFTUD2):c.2466+1G>A	EFTUD2		not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424276	17	42930884	17	44853516	424276	410041	rs1064796893	NC_000017.11:44853515:C:T
NM_001008537.3(NEXMIF):c.766C>T (p.Gln256Ter)	NEXMIF	Q256*	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424256	X	73963626	X	74743791	424256	411485	rs1064796882	NC_000023.11:74743790:G:A
NM_003688.3(CASK):c.1480C>T (p.Gln494Ter)	CASK	Q494*, Q488*	CASK-Related Disorder|not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424249	X	41437616	X	41578363	424249	411366	rs1064796879	NC_000023.11:41578362:G:A
NM_080647.1(TBX1):c.796G>T (p.Glu266Ter)	TBX1	E266*	not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424199	22	19752592	22	19765069	424199	410914	rs144848597	NC_000022.11:19765068:G:T
NM_001039591.3(USP9X):c.7207C>T (p.Gln2403Ter)	USP9X	Q2403*	not provided	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000424197	X	41088651	X	41229398	424197	411338	rs1064796854	NC_000023.11:41229397:C:T
NM_001083962.2(TCF4):c.652C>T (p.Gln218Ter)	TCF4	Q218*, Q176*, Q217*, Q320*, Q2*, Q147*, Q193*, Q216*, Q224*, Q58*, Q88*, Q194*	not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000424196	18	52946785	18	55279554	424196	410400	rs1064796853	NC_000018.10:55279553:G:A
NM_000061.2(BTK):c.1185G>A (p.Trp395Ter)	BTK	W395*, W429*	not provided	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000424170	X	100611936	X	101356948	424170	411071	rs1064796836	NC_000023.11:101356947:C:T
NM_030777.4(SLC2A10):c.1278_1287delinsCC (p.Phe427fs)	SLC2A10		not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000424159	20	45354953 - 45354962	20	46726314 - 46726323	424159	410761	rs1064796832	NC_000020.11:46726313:GTTTGGGCCA:CC
NM_000455.4(STK11):c.841_842del (p.Pro281fs)	STK11	P281fs	not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000424156	19	1221314 - 1221315	19	1221315 - 1221316	424156	410452	rs121913321	NC_000019.10:1221314:CCCCCC:CCCC
NM_001356.4(DDX3X):c.1438A>G (p.Arg480Gly)	DDX3X	R480G, R294G, R464G	not provided	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000424151	X	41205604	X	41346351	424151	411352	rs1064796827	NC_000023.11:41346350:A:G
NM_001356.4(DDX3X):c.862A>G (p.Lys288Glu)	DDX3X	K288E, K102E, K272E	not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424139	X	41203379	X	41344126	424139	411346	rs1064796820	NC_000023.11:41344125:A:G
NM_005710.2(PQBP1):c.641+1G>A	PQBP1		not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000424138	X	48760073	X	48902796	424138	411392	rs1064796819	NC_000023.11:48902795:G:A
NM_002025.4(AFF2):c.3575del (p.Asn1192fs)	AFF2	N1182fs, N1192fs, N1157fs, N1153fs, N833fs	not provided	Pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000424137	X	148062269	X	148980739	424137	411144	rs1064796818	NC_000023.11:148980738:AAAA:AAA
NM_007363.5(NONO):c.1289del (p.Pro430fs)	NONO	P341fs, P430fs	not provided	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000424120	X	70519798	X	71299948	424120	411475	rs1064796806	NC_000023.11:71299947:CC:C
NM_212472.2(PRKAR1A):c.15dup (p.Thr6fs)	PRKAR1A		not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000424087	17	66511554 - 66511555	17	68515413 - 68515414	424087	410224	rs1555811666	NC_000017.11:68515413:T:TT
NM_000383.4(AIRE):c.510_522dup (p.Leu175fs)	AIRE		not provided	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000424080	21	45707437 - 45707438	21	44287554 - 44287555	424080	410884	rs940485051	NC_000021.9:44287554:AGCAGCGCAGAGCAGCAGCGC:AGCAGCGCAGAGCAGCAGCGCAGAGCAGCAGCGC
NM_000216.4(ANOS1):c.580G>T (p.Glu194Ter)	ANOS1	E194*	not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000424064	X	8555981	X	8587940	424064	411505	rs1064796777	NC_000023.11:8587939:C:A
NM_001363734.1(ASXL1):c.2781_2782CT[1] (p.Asp927_Ser928insTer)	ASXL1		not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000424055	20	31023479 - 31023480	20	32435676 - 32435677	424055	410744	rs1064796772	NC_000020.11:32435675:CTCT:CT
NM_030632.3(ASXL3):c.3325_3326del (p.Lys1109fs)	ASXL3	K1109fs	not provided	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000424009	18	31323137 - 31323138	18	33743173 - 33743174	424009	410362	rs1064796742	NC_000018.10:33743172:AA:
NM_006579.3(EBP):c.128_140del (p.Val43fs)	EBP	V43fs	not provided	Pathogenic(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000423969	X	48382286 - 48382298	X	48523898 - 48523910	423969	411382	rs1064796721	NC_000023.11:48523897:GTCGTGACCACATG:G
NM_001347721.2(DYRK1A):c.1445_1446delinsTCTACA (p.Asn482fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000423948	21	38877818 - 38877819	21	37505515 - 37505516	423948	410869	rs1064796713	NC_000021.9:37505514:AT:TCTACA
NM_000152.5(GAA):c.1062C>A (p.Tyr354Ter)	GAA	Y354*	not provided	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000423925	17	78082195	17	80108396	423925	410291	rs1064796703	NC_000017.11:80108395:C:A
NM_000268.3(NF2):c.517-1G>A	NF2		not provided	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000423789	22	30051582	22	29655593	423789	410982	rs1064796632	NC_000022.11:29655592:G:A
NM_001111125.3(IQSEC2):c.3250C>T (p.Gln1084Ter)	IQSEC2	Q1084*, Q879*	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000423760	X	53267354	X	53238172	423760	411417	rs1064796614	NC_000023.11:53238171:G:A
NM_001083962.2(TCF4):c.873C>G (p.Tyr291Ter)	TCF4	Y291*, Y220*, Y131*, Y249*, Y267*, Y393*, Y75*, Y161*, Y266*, Y289*, Y290*, Y297*	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000423631	18	52937111	18	55269880	423631	410399	rs1064796538	NC_000018.10:55269879:G:C
NM_001429.4(EP300):c.3412dup (p.Val1138fs)	EP300		not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000423581	22	41553320 - 41553321	22	41157316 - 41157317	423581	411022	rs1555910122	NC_000022.11:41157316:GGG:GGGG
NM_001323289.2(CDKL5):c.2231_2265del (p.Ser744fs)	CDKL5	S744fs	not provided	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000423577	X	18631346 - 18631380	X	18613226 - 18613260	423577	411229	rs1064796503	NC_000023.11:18613225:AGCAGTTCTGGAACCAACCACTCAAAAAGACAACCAGCA:AGCA
NM_001126054.2(CASK):c.2107_2109GTA[1] (p.Val704del)	CASK	V727del	not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000423552	X	41394186 - 41394188	X	41534933 - 41534935	423552	411360	rs1064796488	NC_000023.11:41534932:TACTACT:TACT
NM_138927.3(SON):c.3334C>T (p.Arg1112Ter)	SON	R1112*	Inborn genetic diseases|not provided|ZTTK syndrome	Pathogenic(Last reviewed: Feb 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000423520	21	34924871	21	33552565	423520	410844	rs1064796472	NC_000021.9:33552564:C:T
NM_001347721.2(DYRK1A):c.664C>T (p.Arg222Ter)	DYRK1A	R231*, R193*, R222*	Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423502	21	38862503	21	37490201	423502	410863	rs780441716	NC_000021.9:37490200:C:T
NM_001193466.2(KANSL1):c.2311_2323delinsATG (p.Leu771fs)	KANSL1		not provided	Pathogenic(Last reviewed: Feb 8, 2017)	criteria provided, single submitter	VCV000423448	17	44116462 - 44116474	17	46039096 - 46039108	423448	410048	rs1064796433	NC_000017.11:46039095:GTGGGTTGAGCAA:CAT
NM_001356.4(DDX3X):c.659T>C (p.Leu220Ser)	DDX3X	L220S, L204S, L34S	not provided	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000423442	X	41202584	X	41343331	423442	411345	rs1064796429	NC_000023.11:41343330:T:C
NM_001356.4(DDX3X):c.148A>T (p.Lys50Ter)	DDX3X	K50*	not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000423362	X	41198333	X	41339080	423362	411342	rs1064796382	NC_000023.11:41339079:A:T
NM_001347721.2(DYRK1A):c.545_548del (p.Lys182fs)	DYRK1A	K153fs, K191fs, K182fs	not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000423335	21	38858822 - 38858825	21	37486520 - 37486523	423335	410861	rs1064796367	NC_000021.9:37486519:AAAGAA:AA
NM_001356.4(DDX3X):c.1256del (p.Val419fs)	DDX3X	V403fs, V233fs, V419fs	not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000423331	X	41204742	X	41345489	423331	411350	rs1064796364	NC_000023.11:41345488:T:
NM_003688.3(CASK):c.59+2T>C	CASK		not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000423284	X	41782181	X	41922928	423284	411373	rs1064796344	NC_000023.11:41922927:A:G
NM_001282531.3(ADNP):c.845del (p.Gly282fs)	ADNP	G282fs	not provided	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000423279	20	49510406	20	50893869	423279	410770	rs1064796339	NC_000020.11:50893868:CCC:CC
NM_001347721.2(DYRK1A):c.1519+1G>A	DYRK1A		not provided	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000423237	21	38877893	21	37505590	423237	410870	rs1064796316	NC_000021.9:37505589:G:A
NM_000444.6(PHEX):c.663+1_663+45del	PHEX		not provided	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000423220	X	22095819 - 22095863	X	22077701 - 22077745	423220	411265	rs1064796303	NC_000023.11:22077700:AGGTATAATGAGGACCCATTCATCTTCTTTGCTCAGTCCTAGATTAG:AG
NM_001193466.2(KANSL1):c.2830_2837+13del	KANSL1		not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423195	17	44110433 - 44110453	17	46033067 - 46033087	423195	410047	rs1064796289	NC_000017.11:46033066:CCTGCCCCATCACCTGCTGCCCC:CC
NM_002501.4(NFIX):c.267_268delinsC (p.Glu89fs)	NFIX		not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000423194	19	13136074 - 13136075	19	13025260 - 13025261	423194	410476	rs1064796288	NC_000019.10:13025259:GG:C
NM_015559.3(SETBP1):c.1676del (p.Pro559fs)	SETBP1	P559fs	not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423032	18	42530977	18	44951012	423032	410368	rs1064796181	NC_000018.10:44951011:CCCCC:CCCC
NM_001323289.2(CDKL5):c.1209_1210AC[3] (p.Leu405fs)	CDKL5		Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000423029	X	18622251 - 18622252	X	18604131 - 18604132	423029	411222	rs1555951981	NC_000023.11:18604131:CACAC:CACACAC
NM_172107.4(KCNQ2):c.325_328CTGT[1] (p.Ser110fs)	KCNQ2		Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422997	20	62078155 - 62078158	20	63446802 - 63446805	422997	410834	rs1064796151	NC_000020.11:63446801:ACAGACAG:ACAG
NM_001195800.2(LDLR):c.314-1806_314-1804delinsCGGTATGGACTGCA	LDLR		not provided	Pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000422951	19	11216262 - 11216264	19	11105586 - 11105588	422951	410433	rs879254637	NC_000019.10:11105585:ACG:CGGTATGGACTGCA
NM_015338.5(ASXL1):c.2477del (p.Gly826fs)	ASXL1	G826fs, G765fs	not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000422927	20	31022991	20	32435188	422927	410742	rs1064796100	NC_000020.11:32435187:GG:G
NM_004586.3(RPS6KA3):c.1959+2del	RPS6KA3		not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000422804	X	20179760	X	20161642	422804	411243	rs1064796008	NC_000023.11:20161641:A:
NM_005359.5(SMAD4):c.903C>G (p.Tyr301Ter)	SMAD4	Y301*	not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000422800	18	48584825	18	51058455	422800	410387	rs746084369	NC_000018.10:51058454:C:G
NM_172107.4(KCNQ2):c.1229dup (p.Pro411fs)	KCNQ2		Early infantile epileptic encephalopathy|not provided|Seizures	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000422786	20	62055547 - 62055548	20	63424194 - 63424195	422786	410821	rs886041339	NC_000020.11:63424194:GGGGGG:GGGGGGG
NM_001323289.2(CDKL5):c.1776_1777del (p.Ser593fs)	CDKL5	S593fs	not provided	Pathogenic(Last reviewed: Dec 23, 2016)	criteria provided, single submitter	VCV000422734	X	18622817 - 18622818	X	18604697 - 18604698	422734	411224	rs1064793376	NC_000023.11:18604696:TTTTT:TTT
NM_015125.4(CIC):c.2694dup (p.Lys899fs)	CIC		not provided	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000422592	19	42795608 - 42795609	19	42291456 - 42291457	422592	410628	rs1555770200	NC_000019.10:42291456:CCCCCC:CCCCCCC
NM_000271.5(NPC1):c.721C>T (p.Gln241Ter)	NPC1	Q241*	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422340	18	21140355	18	23560391	422340	410331	rs1064795718	NC_000018.10:23560390:G:A
NM_001111125.3(IQSEC2):c.4039dup (p.Ala1347fs)	IQSEC2		not provided|Mental retardation, X-linked 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422032	X	53263828 - 53263829	X	53234646 - 53234647	422032	411411	rs1064795512	NC_000023.11:53234646:CCCCCC:CCCCCCC
NM_001356.4(DDX3X):c.1595C>T (p.Thr532Met)	DDX3X	T532M, T346M, T516M	not provided	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000421830	X	41205855	X	41346602	421830	411356	rs1064795387	NC_000023.11:41346601:C:T
NM_006359.2(SLC9A6):c.509_510delGA (p.Arg170Thrfs)	SLC9A6		not provided	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000421511	X	135080639 - 135080640	X	135998480 - 135998481	421511	411131	rs1064795183	NC_000023.11:135998479:AGAGA:AGA
NM_000455.4(STK11):c.358G>T (p.Glu120Ter)	STK11	E120*	Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000421459	19	1218483	19	1218484	421459	410442	rs775595174	NC_000019.10:1218483:G:T
NM_000489.5(ATRX):c.517G>A (p.Ala173Thr)	ATRX	A173T, A135T	not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000421368	X	76944388	X	77688895	421368	411492	rs1064795090	NC_000023.11:77688894:C:T
NM_003688.3(CASK):c.763C>T (p.Arg255Cys)	CASK	R255C	not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000421141	X	41519760	X	41660507	421141	411369	rs1064794937	NC_000023.11:41660506:G:A
NM_000455.4(STK11):c.630C>A (p.Cys210Ter)	STK11	C210*	Peutz-Jeghers syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421017	19	1220612	19	1220613	421017	410448	rs786201213	NC_000019.10:1220612:C:A
NM_004187.4(KDM5C):c.2785C>T (p.Arg929Ter)	KDM5C	R929*, R928*, R862*	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000421004	X	53226064	X	53196882	421004	411406	rs782405999	NC_000023.11:53196881:G:A
NM_001278116.2(L1CAM):c.1028_1032dup (p.Gly345fs)	L1CAM		not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000420891	X	153135348 - 153135349	X	153869893 - 153869894	420891	411166	rs1557092418	NC_000023.11:153869893:ATATA:ATATAATATA
NM_004975.4(KCNB1):c.1297C>T (p.Arg433Ter)	KCNB1	R433*	Epileptic encephalopathy, early infantile, 26|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420881	20	47990800	20	49374263	420881	410766	rs1064794764	NC_000020.11:49374262:G:A
NM_001429.4(EP300):c.4188_4189insCCTATGTATATCTCCTATACATATCTCCTATCGAACA (p.Tyr1397fs)	EP300		not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000420668	22	41565522 - 41565523	22	41169518 - 41169519	420668	411024	rs1064794624	NC_000022.11:41169518::CCTATGTATATCTCCTATACATATCTCCTATCGAACA
NM_000444.6(PHEX):c.1593dup (p.Thr532fs)	PHEX		not provided	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000420634	X	22208564 - 22208565	X	22190447 - 22190448	420634	411280	rs1556091873	NC_000023.11:22190447:TTT:TTTT
NM_000527.4(LDLR):c.1706-1G>C	LDLR		not provided	Pathogenic(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000420598	19	11227534	19	11116858	420598	410435	rs879254996	NC_000019.10:11116857:G:C
NM_173483.4(CYP4F22):c.976C>T (p.Arg326Ter)	CYP4F22	R326*	not provided|Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000420584	19	15654818	19	15544007	420584	410546	rs762667660	NC_000019.10:15544006:C:T
NM_004006.2(DMD):c.8390+1G>A	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420583	X	31525397	X	31507280	420583	411313	rs1064794569	NC_000023.11:31507279:C:T
NM_003639.4(IKBKG):c.1105_1106insG (p.Pro369fs)	IKBKG		not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000420195	X	153792223 - 153792224	X	154564008 - 154564009	420195	411204	rs1064794340	NC_000023.11:154564008::G
NM_199242.2(UNC13D):c.2346_2349del (p.Arg782fs)	UNC13D	R782fs	|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420155	17	73830174 - 73830177	17	75834093 - 75834096	420155	410246	rs764196809	NC_000017.11:75834092:CTCCCT:CT
NM_000444.6(PHEX):c.985dup (p.His329fs)	PHEX		not provided	Pathogenic(Last reviewed: Feb 20, 2017)	criteria provided, single submitter	VCV000420128	X	22117170 - 22117171	X	22099052 - 22099053	420128	411271	rs1556025994	NC_000023.11:22099052:CCCCC:CCCCCC
NM_000444.6(PHEX):c.670C>T (p.Gln224Ter)	PHEX	Q224*	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000420127	X	22108553	X	22090435	420127	411266	rs948246694	NC_000023.11:22090434:C:T
NM_000444.6(PHEX):c.151C>T (p.Gln51Ter)	PHEX	Q51*	not provided	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000420126	X	22056619	X	22038501	420126	411258	rs1064794303	NC_000023.11:22038500:C:T
NM_000271.5(NPC1):c.973_974dup (p.Asp325fs)	NPC1		Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000420124	18	21136558 - 21136559	18	23556594 - 23556595	420124	410330	rs886044580	NC_000018.10:23556594:TC:TCTC
NM_000152.5(GAA):c.2297A>C (p.Tyr766Ser)	GAA	Y766S	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420102	17	78090874	17	80117075	420102	410298	rs144016984	NC_000017.11:80117074:A:C
NM_000152.5(GAA):c.1075G>T (p.Gly359Ter)	GAA	G359*	not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000420101	17	78082208	17	80108409	420101	410292	rs1064794288	NC_000017.11:80108408:G:T
NM_212472.2(PRKAR1A):c.405_406TG[1] (p.Val136fs)	PRKAR1A		not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000420084	17	66519922 - 66519923	17	68523781 - 68523782	420084	410229	rs1064794280	NC_000017.11:68523780:TGTG:TG
NM_001127221.1(CACNA1A):c.2042_2043del (p.Gln681fs)	CACNA1A	Q680fs, Q681fs	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2|not provided|Recurrent respiratory infections|Epileptic encephalopathy|Bulbar palsy	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420056	19	13414645 - 13414646	19	13303831 - 13303832	420056	410530	rs1064794262	NC_000019.10:13303830:CT:
NM_001127221.1(CACNA1A):c.5396C>T (p.Ser1799Leu)	CACNA1A	S1799L, S1804L, S1798L, S1801L	Epileptic encephalopathy, early infantile, 42|not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420055	19	13342531	19	13231717	420055	410503	rs1064794261	NC_000019.10:13231716:G:A
NM_000527.4(LDLR):c.1439C>T (p.Ala480Val)	LDLR	A480V, A312V, A353V, A439V	not provided|Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420052	19	11224291	19	11113615	420052	410434	rs1064794259	NC_000019.10:11113614:C:T
NM_023010.3(UPF3B):c.693_694AG[2] (p.Arg233fs)	UPF3B		not provided|Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000420043	X	118975148 - 118975149	X	119841185 - 119841186	420043	411112	rs1064794254	NC_000023.11:119841184:CTCTCT:CTCT
NM_178152.3(DCX):c.505C>T (p.Gln169Ter)	DCX	Q169*, Q250*	not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000419990	X	110644418	X	111401190	419990	411097	rs1064794223	NC_000023.11:111401189:G:A
NM_000284.4(PDHA1):c.905G>A (p.Arg302His)	PDHA1	R302H, R340H, R271H, R309H	not provided	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000419850	X	19377039	X	19358921	419850	411240	rs1064794149	NC_000023.11:19358920:G:A
NM_003639.4(IKBKG):c.662del (p.Ser221fs)	IKBKG	S220fs, S289fs, S221fs	not provided	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000419829	X	153788765	X	154560550	419829	411203	rs1064794135	NC_000023.11:154560549:C:
NM_001356.4(DDX3X):c.1203_1205CTT[1] (p.Phe402del)	DDX3X	F402del	not provided	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000419827	X	41204688 - 41204690	X	41345435 - 41345437	419827	411349	rs1064794133	NC_000023.11:41345434:TCTTCTT:TCTT
NM_020533.3(MCOLN1):c.405+1G>A	MCOLN1		not provided	Pathogenic(Last reviewed: Sep 20, 2015)	criteria provided, single submitter	VCV000419813	19	7591493	19	7526607	419813	410721	rs148748724	NC_000019.10:7526606:G:A
NM_024422.6(DSC2):c.943-1G>A	DSC2		Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy, type 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419777	18	28663027	18	31083061	419777	410338	rs796756333	NC_000018.10:31083060:C:T
NM_000397.3(CYBB):c.85del (p.Tyr29fs)	CYBB	Y29fs	not provided	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000419755	X	37641380	X	37782127	419755	411323	rs1064794086	NC_000023.11:37782126:T:
NM_000377.2(WAS):c.273+1G>A	WAS		not provided	Pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	VCV000419739	X	48542813	X	48684424	419739	411386	rs1064794076	NC_000023.11:48684423:G:A
NM_000211.5(ITGB2):c.991G>T (p.Glu331Ter)	ITGB2	E331*, E262*	not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000419728	21	46318984	21	44899069	419728	410888	rs755600323	NC_000021.9:44899068:C:A
NM_001356.4(DDX3X):c.1144A>C (p.Ser382Arg)	DDX3X	S382R, S196R, S366R	not provided	Pathogenic(Last reviewed: Sep 7, 2015)	criteria provided, single submitter	VCV000419725	X	41204551	X	41345298	419725	411348	rs1064794068	NC_000023.11:41345297:A:C
NM_000152.5(GAA):c.1552-3C>G	GAA		not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419722	17	78084737	17	80110938	419722	410294	rs375470378	NC_000017.11:80110937:C:G
NM_172107.4(KCNQ2):c.691G>C (p.Glu231Gln)	KCNQ2	E231Q	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000419718	20	62073884	20	63442531	419718	410830	rs1064794063	NC_000020.11:63442530:C:G
NM_001256447.2(BCAP31):c.341+2T>G	BCAP31		not provided|Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000419708	X	152980995	X	153715540	419708	411155	rs1064794057	NC_000023.11:153715539:A:C
NM_016941.4(DLL3):c.621C>A (p.Cys207Ter)	DLL3	C207*	not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000419705	19	39993666	19	39503026	419705	410605	rs771875570	NC_000019.10:39503025:C:A
NM_006087.4(TUBB4A):c.1172G>T (p.Arg391Leu)	TUBB4A	R391L, R442L, R436L, R319L	not provided|Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419697	19	6495338	19	6495327	419697	410718	rs886041021	NC_000019.10:6495326:C:A
NM_001077488.4(GNAS):c.8G>C (p.Cys3Ser)	GNAS	C3S	not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419690	20	57466789	20	58891734	419690	410778	rs1064794045	NC_000020.11:58891733:G:C
NM_000531.6(OTC):c.634G>T (p.Gly212Ter)	OTC	G212*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419686	X	38262964	X	38403711	419686	411327	rs772049322	NC_000023.11:38403710:G:T
NM_001193466.2(KANSL1):c.536_537dup (p.Lys180fs)	KANSL1		not provided	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000419679	17	44248972 - 44248973	17	46171606 - 46171607	419679	410052	rs1064794038	NC_000017.11:46171606:TC:TCTC
NM_001039591.3(USP9X):c.6365_6366del (p.Phe2122fs)	USP9X	F2122fs	not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000419674	X	41077779 - 41077780	X	41218526 - 41218527	419674	411337	rs1064794035	NC_000023.11:41218525:TTT:T
NM_000495.5(COL4A5):c.2510-1_2523del	COL4A5		not provided	Pathogenic(Last reviewed: Aug 4, 2015)	criteria provided, single submitter	VCV000419666	X	107863486 - 107863500	X	108620256 - 108620270	419666	411089	rs1064794029	NC_000023.11:108620255:TAGGTTTACATGGAATA:TA
NM_014927.5(CNKSR2):c.1282C>T (p.Arg428Ter)	CNKSR2	R428*, R379*	not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419657	X	21550164	X	21532046	419657	411249	rs1064794022	NC_000023.11:21532045:C:T
NM_000271.5(NPC1):c.3734_3735del (p.Pro1245fs)	NPC1	P1245fs	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000419641	18	21113338 - 21113339	18	23533374 - 23533375	419641	410326	rs1064794009	NC_000018.10:23533373:AG:
NM_000211.5(ITGB2):c.2013G>A (p.Trp671Ter)	ITGB2	W671*, W602*	not provided	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000419640	21	46308675	21	44888760	419640	410886	rs942375725	NC_000021.9:44888759:C:T
NM_001347721.2(DYRK1A):c.1221del (p.Lys407fs)	DYRK1A	K378fs, K407fs, K416fs	not provided	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000419635	21	38877592	21	37505289	419635	410868	rs1064794006	NC_000021.9:37505288:AAA:AA
NM_172107.4(KCNQ2):c.1204G>T (p.Gly402Ter)	KCNQ2	G402*, G392*	not provided	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000419629	20	62059733	20	63428380	419629	410822	rs1064794001	NC_000020.11:63428379:C:A
NM_001323289.2(CDKL5):c.858C>A (p.Tyr286Ter)	CDKL5	Y286*	not provided	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000419625	X	18616614	X	18598494	419625	411216	rs766511365	NC_000023.11:18598493:C:A
NM_000346.4(SOX9):c.522C>G (p.Tyr174Ter)	SOX9	Y174*	not provided	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000419613	17	70118950	17	72122809	419613	410232	rs373719106	NC_000017.11:72122808:C:G
NM_015338.5(ASXL1):c.2810del (p.Pro937fs)	ASXL1	P876fs, P937fs	not provided	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, single submitter	VCV000419609	20	31023322	20	32435519	419609	410743	rs1064793988	NC_000020.11:32435518:CCCC:CCC
NM_004006.2(DMD):c.3487C>T (p.Gln1163Ter)	DMD	Q1163*, Q1155*, Q1159*, Q1040*	not provided	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000419607	X	32472895	X	32454778	419607	411318	rs1064793986	NC_000023.11:32454777:G:A
NM_006031.6(PCNT):c.6364_6365AT[1] (p.Ser2123fs)	PCNT		not provided	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000419606	21	47836196 - 47836197	21	46416282 - 46416283	419606	410906	rs1064793985	NC_000021.9:46416281:ATAT:AT
NM_017671.4(FERMT1):c.1371+4A>G	FERMT1		not provided	Pathogenic(Last reviewed: Aug 19, 2015)	criteria provided, single submitter	VCV000419594	20	6068420	20	6087773	419594	410781	rs1064793979	NC_000020.11:6087772:T:C
NM_017671.4(FERMT1):c.676dup (p.Gln226fs)	FERMT1		not provided|Kindler's syndrome	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419593	20	6091014 - 6091015	20	6110367 - 6110368	419593	410782	rs748240859	NC_000020.11:6110367:GGGGGGG:GGGGGGGG
NM_004187.4(KDM5C):c.1541A>T (p.His514Leu)	KDM5C	H514L, H447L, H513L	not provided	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	VCV000419589	X	53239900	X	53210718	419589	411408	rs1064793975	NC_000023.11:53210717:T:A
NM_000377.2(WAS):c.19G>T (p.Gly7Ter)	WAS	G7*	not provided	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000419588	X	48542261	X	48683872	419588	411383	rs1064793974	NC_000023.11:48683871:G:T
NM_000397.3(CYBB):c.602_605dup (p.Phe202fs)	CYBB		not provided	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000419587	X	37655318 - 37655319	X	37796065 - 37796066	419587	411325	rs1556468363	NC_000023.11:37796065:CTTACTT:CTTACTTACTT
NM_004247.4(EFTUD2):c.1963-1G>T	EFTUD2		not provided	Pathogenic(Last reviewed: Aug 22, 2015)	criteria provided, single submitter	VCV000419585	17	42934526	17	44857158	419585	410043	rs765835040	NC_000017.11:44857157:C:A
NM_004006.2(DMD):c.2555G>A (p.Trp852Ter)	DMD	W852*, W729*, W848*, W844*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419572	X	32509461	X	32491344	419572	411320	rs1064793964	NC_000023.11:32491343:C:T
NM_001123383.1(BCOR):c.678dup (p.Tyr227fs)	BCOR		not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419569	X	39933920 - 39933921	X	40074667 - 40074668	419569	411332	rs1555919695	NC_000023.11:40074667:GG:GGG
NM_000444.6(PHEX):c.680_681TC[1] (p.Ser228fs)	PHEX		not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, multiple submitters, no conflicts	VCV000419563	X	22108562 - 22108563	X	22090444 - 22090445	419563	411267	rs1064793956	NC_000023.11:22090443:CTCTC:CTC
NM_000528.4(MAN2B1):c.2356-2A>G	MAN2B1		not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000419533	19	12760032	19	12649218	419533	410474	rs1064793936	NC_000019.10:12649217:T:C
NM_001278116.2(L1CAM):c.806+1G>C	L1CAM		not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000419506	X	153135842	X	153870387	419506	411168	rs1064793920	NC_000023.11:153870386:C:G
NM_000033.4(ABCD1):c.1895C>T (p.Thr632Ile)	ABCD1	T632I	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419446	X	153008704	X	153743250	419446	411157	rs1064793877	NC_000023.11:153743249:C:T
NM_000444.6(PHEX):c.419C>G (p.Ser140Ter)	PHEX	S140*	not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419416	X	22094575	X	22076457	419416	411261	rs140678356	NC_000023.11:22076456:C:G
NM_000061.2(BTK):c.894+1G>A	BTK		not provided	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000419415	X	100614280	X	101359292	419415	411073	rs1064793859	NC_000023.11:101359291:C:T
NM_001356.4(DDX3X):c.119C>G (p.Pro40Arg)	DDX3X	P40R	not provided	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000419413	X	41198304	X	41339051	419413	411340	rs1064793858	NC_000023.11:41339050:C:G
NM_018486.3(HDAC8):c.165-2A>G	HDAC8		not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000419411	X	71788736	X	72568886	419411	411478	rs1064793856	NC_000023.11:72568885:T:C
NM_172107.4(KCNQ2):c.2401del (p.Ser801fs)	KCNQ2	S773fs, S783fs, S770fs, S801fs	not provided	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000419407	20	62038215	20	63406862	419407	410813	rs1064793852	NC_000020.11:63406861:AA:A
NM_000444.6(PHEX):c.1202del (p.Pro401fs)	PHEX	P401fs	not provided	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000419401	X	22132603	X	22114485	419401	411275	rs1064793847	NC_000023.11:22114484:CC:C
NM_001848.2(COL6A1):c.815G>A (p.Gly272Asp)	COL6A1	G272D	not provided	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000419392	21	47409008	21	45989094	419392	410890	rs1064793840	NC_000021.9:45989093:G:A
NM_001077488.4(GNAS):c.1A>T (p.Met1Leu)	GNAS	M1L	not provided	Pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	VCV000419339	20	57466782	20	58891727	419339	410777	rs137854530	NC_000020.11:58891726:A:T
NM_001278116.2(L1CAM):c.1939+1G>A	L1CAM		not provided	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000419337	X	153133254	X	153867799	419337	411162	rs1064793801	NC_000023.11:153867798:C:T
NM_000527.4(LDLR):c.313+3A>C	LDLR		not provided	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000419334	19	11213465	19	11102789	419334	410432	rs1064793799	NC_000019.10:11102788:A:C
NM_001356.4(DDX3X):c.121C>T (p.Pro41Ser)	DDX3X	P41S	not provided	Pathogenic(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	VCV000419328	X	41198306	X	41339053	419328	411341	rs1064793796	NC_000023.11:41339052:C:T
NM_000271.5(NPC1):c.3570_3573dup (p.Ala1192fs)	NPC1		not provided|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419323	18	21114427 - 21114428	18	23534463 - 23534464	419323	410327	rs750323164	NC_000018.10:23534463:AAGT:AAGTAAGT
NM_000271.5(NPC1):c.1298C>T (p.Pro433Leu)	NPC1	P433L	not provided	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000419321	18	21136235	18	23556271	419321	410329	rs1064793791	NC_000018.10:23556270:G:A
NM_032121.5(MAGT1):c.110G>A (p.Trp37Ter)	MAGT1	W37*, W5*	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia|not provided	Pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000419298	X	77150894	X	77895397	419298	411494	rs200934080	NC_000023.11:77895396:C:T
NM_030632.3(ASXL3):c.3364C>T (p.Gln1122Ter)	ASXL3	Q1122*	Bainbridge-Ropers syndrome|not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000419279	18	31323176	18	33743212	419279	410363	rs1064793765	NC_000018.10:33743211:C:T
NM_001018113.3(FANCB):c.1691_1694TTGT[1] (p.Cys566fs)	FANCB		not provided	Pathogenic(Last reviewed: Jul 19, 2015)	criteria provided, single submitter	VCV000419268	X	14863207 - 14863210	X	14845085 - 14845088	419268	411142	rs1064793758	NC_000023.11:14845084:ACAAACAAA:ACAAA
NM_002547.3(OPHN1):c.155-2A>C	OPHN1		not provided	Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	VCV000419263	X	67518940	X	68299098	419263	411446	rs1064793755	NC_000023.11:68299097:T:G
NM_004006.2(DMD):c.10651C>T (p.Gln3551Ter)	DMD	Q3551*, Q1078*, Q3543*, Q3428*, Q483*, Q1091*, Q2207*, Q2210*, Q3547*, Q470*, Q822*, Q981*	not provided	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000419240	X	31165538	X	31147421	419240	411311	rs1064793742	NC_000023.11:31147420:G:A
NM_178152.3(DCX):c.364+1del	DCX		not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000419226	X	110653262	X	111410034	419226	411099	rs1064793735	NC_000023.11:111410033:CC:C
NM_024422.6(DSC2):c.2250+2T>C	DSC2		not provided	Pathogenic(Last reviewed: Jun 26, 2015)	criteria provided, single submitter	VCV000419220	18	28650690	18	31070724	419220	410334	rs1064793731	NC_000018.10:31070723:A:G
NM_014927.5(CNKSR2):c.2145+1G>A	CNKSR2		not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000419218	X	21624998	X	21606880	419218	411251	rs1064793729	NC_000023.11:21606879:G:A
NM_018848.3(MKKS):c.1070_1071delinsAA (p.Ser357Ter)	MKKS		not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000419200	20	10389366 - 10389367	20	10408718 - 10408719	419200	410729	rs1064793714	NC_000020.11:10408717:GG:TT
NM_212472.2(PRKAR1A):c.213_247del (p.Gly72fs)	PRKAR1A	G72fs	not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000419198	17	66518932 - 66518966	17	68522791 - 68522825	419198	410227	rs1064793712	NC_000017.11:68522790:AGGCACTCGTACAGACTCAAGGGAGGATGAGATTT:
NM_212472.2(PRKAR1A):c.69_70dup (p.Lys24fs)	PRKAR1A		not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000419193	17	66511607 - 66511608	17	68515466 - 68515467	419193	410225	rs1064793709	NC_000017.11:68515466:AGA:AGAGA
NM_000071.2(CBS):c.1005_1006delinsTT (p.Arg336Cys)	CBS		not provided	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000419185	21	44482454 - 44482455	21	43062344 - 43062345	419185	410878	rs1064793703	NC_000021.9:43062343:GG:AA
NM_001282531.3(ADNP):c.70del (p.Ser24fs)	ADNP	S24fs	not provided	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000419147	20	49520464	20	50903927	419147	410772	rs1064793677	NC_000020.11:50903926:T:
NM_000109.4(DMD):c.9346_9347del (p.Leu3116fs)	DMD	L1780fs, L1783fs, L3001fs, L395fs, L56fs, L3124fs, L3116fs, L3120fs, L664fs	not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000419101	X	31227807 - 31227808	X	31209690 - 31209691	419101	411312	rs1064793644	NC_000023.11:31209689:AA:
NM_005559.4(LAMA1):c.1243del (p.His415fs)	LAMA1	H415fs	not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000419085	18	7042162	18	7042163	419085	410412	rs1064793632	NC_000018.10:7042162:GG:G
NM_031407.7(HUWE1):c.12691T>C (p.Tyr4231His)	HUWE1	Y4231H	not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000419084	X	53561617	X	53534656	419084	411427	rs1064793631	NC_000023.11:53534655:A:G
NM_004586.3(RPS6KA3):c.814del (p.Asp272fs)	RPS6KA3	D272fs	not provided	Pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000419033	X	20204445	X	20186327	419033	411246	rs1064793597	NC_000023.11:20186326:C:
NM_001042537.1(SLC9A6):c.1299_1300del (p.Phe434fs)	SLC9A6	F350fs, F382fs, F402fs, F434fs	Seizures|Recurrent respiratory infections|Sleep disturbance|Gastrostomy tube feeding in infancy|Scoliosis|Global developmental delay|not provided	Pathogenic(Last reviewed: May 6, 2015)	criteria provided, single submitter	VCV000418996	X	135098865 - 135098866	X	136016706 - 136016707	418996	411132	rs1064793575	NC_000023.11:136016705:TGT:T
NM_000023.4(SGCA):c.391del (p.Leu131fs)	SGCA	L131fs	Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418990	17	48245736	17	50168375	418990	410065	rs144356125	NC_000017.11:50168374:CCCCC:CCCC
NM_001111125.3(IQSEC2):c.4027_4030dup (p.Arg1344fs)	IQSEC2		not provided	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000418989	X	53263837 - 53263838	X	53234655 - 53234656	418989	411412	rs1064793569	NC_000023.11:53234655:TGGGTG:TGGGTGGGTG
NM_212472.2(PRKAR1A):c.385dup (p.Ala129fs)	PRKAR1A		not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000418988	17	66519901 - 66519902	17	68523760 - 68523761	418988	410228	rs1555813434	NC_000017.11:68523760:G:GG
NM_003639.4(IKBKG):c.1258T>C (p.Ter420Gln)	IKBKG	*420Q, *321Q, *488Q, *419Q	not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000418983	X	153792674	X	154564459	418983	411205	rs1064793564	NC_000023.11:154564458:T:C
NM_000346.4(SOX9):c.738del (p.Gln246fs)	SOX9	Q246fs	not provided	Pathogenic(Last reviewed: May 14, 2015)	criteria provided, single submitter	VCV000418969	17	70119736	17	72123595	418969	410233	rs1064793556	NC_000017.11:72123594:G:
NM_001347721.2(DYRK1A):c.263_264del (p.Ser88fs)	DYRK1A	S59fs, S88fs, S97fs	not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000418949	21	38850564 - 38850565	21	37478262 - 37478263	418949	410857	rs1064793546	NC_000021.9:37478261:TCT:T
NM_000444.6(PHEX):c.152_162del (p.Gln51fs)	PHEX	Q51fs	not provided	Pathogenic(Last reviewed: May 1, 2015)	criteria provided, single submitter	VCV000418922	X	22056619 - 22056629	X	22038501 - 22038511	418922	411259	rs1064793526	NC_000023.11:22038500:CAGGAGTACTGC:C
NM_172107.4(KCNQ2):c.2126dup (p.Val710fs)	KCNQ2		not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000418894	20	62038489 - 62038490	20	63407136 - 63407137	418894	410815	rs1555850842	NC_000020.11:63407136:GGGGG:GGGGGG
NM_000109.4(DMD):c.4514_4517del (p.Ser1505fs)	DMD	S1505fs, S1513fs, S1390fs, S1509fs, S169fs, S172fs	not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418861	X	32404560 - 32404563	X	32386443 - 32386446	418861	411317	rs1064793479	NC_000023.11:32386442:TCACTCA:TCA
NM_000475.5(NR0B1):c.745_746del (p.Lys249fs)	NR0B1	K249fs	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000418850	X	30326735 - 30326736	X	30308618 - 30308619	418850	411309	rs1064793475	NC_000023.11:30308617:TT:
NM_001083961.2(WDR62):c.4264_4265delinsGTGGTCTGAG (p.His1422delinsValValTer)	WDR62		not provided	Pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, single submitter	VCV000418831	19	36595530 - 36595531	19	36104628 - 36104629	418831	410569	rs1064793462	NC_000019.10:36104627:CA:GTGGTCTGAG
NM_000444.6(PHEX):c.1525del (p.Thr509fs)	PHEX	T509fs	not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000418829	X	22196430	X	22178313	418829	411278	rs1064793461	NC_000023.11:22178312:AAA:AA
NM_015338.5(ASXL1):c.1406dup (p.Ser470fs)	ASXL1		not provided	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000418797	20	31021406 - 31021407	20	32433603 - 32433604	418797	410741	rs1555911496	NC_000020.11:32433603:C:CC
NM_004429.4(EFNB1):c.258_266del (p.Ala87_Cys89del)	EFNB1		not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000418794	X	68058589 - 68058597	X	68838746 - 68838754	418794	411447	rs1064793438	NC_000023.11:68838745:AGCTGCCTG:
NM_001193466.2(KANSL1):c.2058del (p.Lys686fs)	KANSL1	K686fs	not provided	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000418786	17	44117213	17	46039847	418786	410049	rs1064793433	NC_000017.11:46039846:TTT:TT
NM_000455.4(STK11):c.910del (p.Arg304fs)	STK11	R304fs	not provided	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000418779	19	1221994	19	1221995	418779	410456	rs1064793427	NC_000019.10:1221994:CC:C
NM_000390.4(CHM):c.41dup (p.Gly15fs)	CHM		not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000418773	X	85302495 - 85302496	X	86047491 - 86047492	418773	411506	rs1555972050	NC_000023.11:86047491:A:AA
NM_001323289.2(CDKL5):c.1007_1014del (p.Gln336fs)	CDKL5	Q336fs	not provided	Pathogenic(Last reviewed: Mar 17, 2015)	criteria provided, single submitter	VCV000418707	X	18622050 - 18622057	X	18603930 - 18603937	418707	411219	rs1064793381	NC_000023.11:18603929:CAGTCTCAC:C
NM_001323289.2(CDKL5):c.1777del (p.Ser593fs)	CDKL5	S593fs	not provided	Pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	VCV000418699	X	18622817	X	18604697	418699	411225	rs1064793376	NC_000023.11:18604696:TTTTT:TTTT
NM_001022.4(RPS19):c.105dup (p.Thr36fs)	RPS19		not provided	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000418695	19	42365213 - 42365214	19	41861144 - 41861145	418695	410620	rs1555839154	NC_000019.10:41861144:T:TT
NM_004750.5(CRLF1):c.983dup (p.Ser328fs)	CRLF1		not provided	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	VCV000418665	19	18707472 - 18707473	19	18596662 - 18596663	418665	410555	rs1555758035	NC_000019.10:18596662:C:CC
NM_021140.3(KDM6A):c.3978_3981del (p.Pro1327fs)	KDM6A	P1282fs, P1327fs, P1379fs, P1031fs, P1248fs, P1334fs	not provided	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000418661	X	44966753 - 44966756	X	45107508 - 45107511	418661	411376	rs1064793351	NC_000023.11:45107507:AACCA:A
NM_000206.2(IL2RG):c.328del (p.Glu110fs)	IL2RG	E110fs	not provided	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	VCV000418645	X	70330480	X	71110630	418645	411462	rs1064793338	NC_000023.11:71110629:C:
NM_172107.4(KCNQ2):c.2555del (p.Pro852fs)	KCNQ2	P824fs, P821fs, P852fs, P834fs	not provided	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000418594	20	62038061	20	63406708	418594	410812	rs1064793317	NC_000020.11:63406707:GGGGG:GGGG
NM_001029896.2(WDR45):c.746_748CCT[1] (p.Ser250del)	WDR45	S251del	not provided	Pathogenic(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000418542	X	48933099 - 48933101	X	49075440 - 49075442	418542	411396	rs1064793294	NC_000023.11:49075439:AGGAGGAG:AGGAG
NM_000377.2(WAS):c.1453G>A (p.Asp485Asn)	WAS	D485N	|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|not provided|Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418541	X	48547823	X	48689434	418541	411388	rs1064793293	NC_000023.11:48689433:G:A
NM_000377.3(WAS):c.1219_1235dup (p.Pro413fs)	WAS		not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000418540	X	48547333 - 48547334	X	48688944 - 48688945	418540	411387	rs1064793292	NC_000023.11:48688944:CCGGGAATGGACCAGCCCC:CCGGGAATGGACCAGCCCCGGGAATGGACCAGCCCC
NM_005359.5(SMAD4):c.669_691delTCAGCCTGCCAGTATACTGGGGG (p.Ser223Argfs)	SMAD4		not provided	Pathogenic(Last reviewed: Dec 19, 2014)	criteria provided, single submitter	VCV000418499	18	48584494 - 48584516	18	51058124 - 51058146	418499	410383	rs1064793271	NC_000018.10:51058123:GGTCAGCCTGCCAGTATACTGGGGG:GG
NM_000444.6(PHEX):c.1173+1G>C	PHEX		not provided	Pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000418406	X	22129679	X	22111561	418406	411273	rs1064793227	NC_000023.11:22111560:G:C
NM_198129.3(LAMA3):c.5099C>G (p.Ser1700Ter)	LAMA3	S1700*, S91*	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000418280	18	21456358	18	23876394	418280	410332	rs754323928	NC_000018.10:23876393:C:G
NM_001278116.2(L1CAM):c.1408C>T (p.Gln470Ter)	L1CAM	Q470*, Q465*	not provided	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000418278	X	153134154	X	153868699	418278	411165	rs1064793163	NC_000023.11:153868698:G:A
NM_001278116.2(L1CAM):c.998C>G (p.Pro333Arg)	L1CAM	P333R, P328R	not provided	Pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	VCV000418277	X	153135383	X	153869928	418277	411167	rs1064793162	NC_000023.11:153869927:G:C
NM_001111125.3(IQSEC2):c.296del (p.His99fs)	IQSEC2	H99fs	not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000418255	X	53350026	X	53320828	418255	411422	rs1064793152	NC_000023.11:53320827:T:
NM_001399.5(EDA):c.612_629del (p.202_204IPG[1])	EDA		not provided|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418170	X	69247781 - 69247798	X	70027931 - 70027948	418170	411448	rs1064793104	NC_000023.11:70027930:GGAATTCCAGGGATTCCTGGAATTCCAGG:GGAATTCCAGG
NM_000397.3(CYBB):c.1662dup (p.Glu555Ter)	CYBB		not provided	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000418153	X	37670118 - 37670119	X	37810865 - 37810866	418153	411326	rs1453468510	NC_000023.11:37810865:T:TT
NM_003688.3(CASK):c.1837C>T (p.Arg613Ter)	CASK	R613*, R584*, R590*	not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418109	X	41414858	X	41555605	418109	411363	rs779508996	NC_000023.11:41555604:G:A
NM_001754.4(RUNX1):c.497G>A (p.Arg166Gln)	RUNX1	R166Q, R139Q	Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 30, 2019)	reviewed by expert panel	VCV000417961	21	36252865	21	34880568	417961	404848	rs1060499616	NC_000021.9:34880567:C:T
NM_030632.3(ASXL3):c.1471C>T (p.Gln491Ter)	ASXL3	Q491*	Bainbridge-Ropers syndrome|not provided	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000417928	18	31318839	18	33738875	417928	404836	rs1060499602	NC_000018.10:33738874:C:T
NM_052876.4(NACC1):c.892C>T (p.Arg298Trp)	NACC1	R298W	not provided|Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000417784	19	13246913	19	13136099	417784	404685	rs1060505041	NC_000019.10:13136098:C:T
USP18, 3-PRIME DEL	USP18		Pseudo-TORCH syndrome 2	Pathogenic(Last reviewed: Mar 26, 2017)	no assertion criteria provided	VCV000417775					417775	404676		
NM_017414.4(USP18):c.652C>T (p.Gln218Ter)	USP18	Q218*	Pseudo-TORCH syndrome 2	Pathogenic(Last reviewed: Mar 26, 2017)	no assertion criteria provided	VCV000417774	22	18652635	22	18169868	417774	404675	rs1085307118	NC_000022.11:18169867:C:T
NM_021998.5(ZNF711):c.2054del (p.Phe685fs)	ZNF711	F731fs, F685fs	ZNF711-Related X-linked Mental Retardation	Pathogenic(Last reviewed: Dec 20, 2017)	no assertion criteria provided	VCV000417761	X	84526601	X	85271595	417761	404662	rs1060505032	NC_000023.11:85271594:TT:T
NM_001696.4(ATP6V1E1):c.634C>T (p.Arg212Trp)	ATP6V1E1	R212W, R182W, R190W		Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000417760	22	18075487	22	17592721	417760	404661	rs1028534806	NC_000022.11:17592720:G:A
NM_001696.4(ATP6V1E1):c.383T>C (p.Leu128Pro)	ATP6V1E1	L128P, L106P, L98P		Pathogenic(Last reviewed: Mar 22, 2019)	no assertion criteria provided	VCV000417759	22	18082845	22	17600079	417759	404660	rs1060505031	NC_000022.11:17600078:A:G
NM_015318.4(ARHGEF18):c.1143+5G>A	ARHGEF18		Retinitis pigmentosa 78	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000417758	19	7521294	19	7456408	417758	404659	rs1064793002	NC_000019.10:7456407:G:A
NM_015318.4(ARHGEF18):c.2158G>T (p.Glu720Ter)	ARHGEF18	E878*, E720*, E1066*, E824*	Retinitis pigmentosa 78	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000417757	19	7532286	19	7467400	417757	404658	rs767689418	NC_000019.10:7467399:G:T
NM_015318.4(ARHGEF18):c.2264_2287del (p.Arg755_Glu762del)	ARHGEF18		Retinitis pigmentosa 78	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000417756	19	7532387 - 7532410	19	7467501 - 7467524	417756	404657	rs1064793001	NC_000019.10:7467500:CGAGCGGCTGGAGCAGGAGCGGGCCGAGC:CGAGC
NM_015318.4(ARHGEF18):c.1522C>T (p.Arg508Ter)	ARHGEF18	R666*, R508*, R854*, R612*	Retinitis pigmentosa 78	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000417755	19	7527145	19	7462259	417755	404656	rs1064793000	NC_000019.10:7462258:C:T
NM_015318.4(ARHGEF18):c.334A>G (p.Thr112Ala)	ARHGEF18	T270A, T112A, T216A, T458A	Retinitis pigmentosa 78	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000417754	19	7509101	19	7444215	417754	404655	rs987233144	NC_000019.10:7444214:A:G
NM_000271.5(NPC1):c.2713C>T (p.Gln905Ter)	NPC1	Q905*	Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000417625	18	21119857	18	23539893	417625	404603	rs917070773	NC_000018.10:23539892:G:A
NM_000307.5(POU3F4):c.877C>G (p.Leu293Val)	POU3F4	L293V	Deafness, X-linked 2	Pathogenic(Last reviewed: Mar 4, 2017)	no assertion criteria provided	VCV000417622	X	82764209	X	83509201	417622	404600	rs780027419	NC_000023.11:83509200:C:G
NM_153638.3(PANK2):c.1426_1429del (p.Met476fs)	PANK2	M185fs, M40fs, M476fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Nov 5, 2016)	no assertion criteria provided	VCV000417619	20	3897587 - 3897590	20	3916940 - 3916943	417619	404597	rs1555789557	NC_000020.11:3916939:ATGA:
NC_000018.9:g.(?_48593389)_(48611412_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000417583	18	48593389 - 48611412	18	51067019 - 51085042	417583	403153		
NC_000023.10:g.(?_39916408)_(39937222_?)del	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000417570	X	39916408 - 39937222	X	40057155 - 40077969	417570	404451		
NC_000023.10:g.(?_31676107)_(31854936_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000417508	X	31676107 - 31854936	X	31657990 - 31836819	417508	403993		
NC_000023.10:g.(?_31462598)_(31515061_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000417505	X	31462598 - 31515061	X	31444481 - 31496944	417505	403992		
NC_000023.10:g.(?_32456358)_(32509635_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000417504	X	32456358 - 32509635	X	32438241 - 32491518	417504	404430		
NC_000023.10:g.(?_32827610)_(33038317_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000417503	X	32827610 - 33038317	X	32809493 - 33020200	417503	404449		
NC_000023.10:g.(?_32305646)_(32328393_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 23, 2016)	criteria provided, single submitter	VCV000417501	X	32305646 - 32328393	X	32287529 - 32310276	417501	404411		
NC_000023.10:g.(?_31279072)_(31279133_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000417500	X	31279072 - 31279133	X	31260955 - 31261016	417500	404401		
NC_000023.10:g.(?_31341715)_(31497220_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000417498	X	31341715 - 31497220	X	31323598 - 31479103	417498	403991		
NC_000023.10:g.(?_31838092)_(31854936_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000417497	X	31838092 - 31854936	X	31819975 - 31836819	417497	403997		
NC_000023.10:g.(?_32481556)_(32509635_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000417495	X	32481556 - 32509635	X	32463439 - 32491518	417495	404433		
NC_000023.10:g.(?_32862900)_(32867937_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, single submitter	VCV000417494	X	32862900 - 32867937	X	32844783 - 32849820	417494	404416		
NC_000023.10:g.(?_31676107)_(31838200_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 12, 2016)	criteria provided, single submitter	VCV000417493	X	31676107 - 31838200	X	31657990 - 31820083	417493	404029		
NC_000023.10:g.(?_32305646)_(32328393_?)dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000417491	X	32305646 - 32328393	X	32287529 - 32310276	417491	404000		
NC_000023.10:g.(?_31514905)_(31893490_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000417490	X	31514905 - 31893490	X	31496788 - 31875373	417490	404023		
NC_000023.10:g.(?_31747748)_(31747865_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, single submitter	VCV000417489	X	31747748 - 31747865	X	31729631 - 31729748	417489	404408		
NC_000023.10:g.(?_31986456)_(31986631_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000417488	X	31986456 - 31986631	X	31968339 - 31968514	417488	404428		
NC_000023.10:g.(?_31792077)_(31792309_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000417487	X	31792077 - 31792309	X	31773960 - 31774192	417487	403995		
NC_000023.10:g.(?_32662249)_(32867937_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000417484	X	32662249 - 32867937	X	32644132 - 32849820	417484	404413		
NC_000023.10:g.(?_31496223)_(31950344_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000417483	X	31496223 - 31950344	X	31478106 - 31932227	417483	404404		
NC_000023.10:g.(?_31747748)_(31838200_?)del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000417482	X	31747748 - 31838200	X	31729631 - 31820083	417482	404426		
NC_000023.10:g.(?_132795758)_(132888203_?)del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000417449	X	132795758 - 132888203			417449	404008		
NC_000019.9:g.(?_11240189)_(11244506_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000417373	19	11240189 - 11244506	19	11129513 - 11133830	417373	402822		
NM_000527.4(LDLR):c.1846-?_2311+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000417369	19	11230768 - 11234020	19	11120092 - 11123344	417369	402817		
NC_000023.10:g.(?_103031754)_(103047548_?)dup	PLP1		Hereditary spastic paraplegia 2	Pathogenic(Last reviewed: May 22, 2016)	criteria provided, single submitter	VCV000417363	X	103031754 - 103047548			417363	404425		
NC_000023.10:g.(?_153129338)_(153131274_?)del	L1CAM		Spastic paraplegia	Pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000417318	X	153129338 - 153131274			417318	403987		
NC_000019.9:g.(?_1218416)_(1219412_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000417315	19	1218416 - 1219412	19	1218417 - 1219413	417315	402826		
NC_000019.9:g.(?_1221948)_(1222005_?)del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000417312	19	1221948 - 1222005	19	1221949 - 1222006	417312	403365		
NM_005660.3(SLC35A2):c.426+287_775del	SLC35A2		SLC35A2-CDG	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000412239	X	48762411 - 48763382	X	48905134 - 48906105	412239	404397	rs1557042824	
NM_016418.5(NF2):c.517-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000412207	22	30051581	22	29655592	412207	403906	rs1060503670	NC_000022.11:29655591:A:G
NM_016418.5(NF2):c.432C>G (p.Tyr144Ter)	NF2	Y144*, Y102*, Y61*, Y103*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000412201	22	30038259	22	29642270	412201	403903	rs1060503667	NC_000022.11:29642269:C:G
NM_016418.5(NF2):c.676-2A>G	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 25, 2016)	criteria provided, single submitter	VCV000412199	22	30057192	22	29661203	412199	403919	rs1060503666	NC_000022.11:29661202:A:G
NM_213607.3(CCDC103):c.115C>T (p.Gln39Ter)	CCDC103	Q39*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000411696	17	42978481	17	44901113	411696	402157	rs1060503433	NC_000017.11:44901112:C:T
NM_024422.6(DSC2):c.882dup (p.Phe295fs)	DSC2		Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	VCV000410650	18	28666598 - 28666599	18	31086635 - 31086636	410650	403195	rs1060502989	NC_000018.10:31086635:T:TT
NM_001256715.2(DNAAF3):c.607_611dup (p.Arg205fs)	DNAAF3		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000410288	19	55673062 - 55673063	19	55161694 - 55161695	410288	404089	rs1060502831	NC_000019.10:55161694:GCGTCG:GCGTCGCGTCG
NM_005629.4(SLC6A8):c.972_973CA[1] (p.Thr325fs)	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000410218	X	152958777 - 152958778	X	153693322 - 153693323	410218	404502	rs1060502808	NC_000023.11:153693321:CACA:CA
NM_004006.2(DMD):c.2077C>T (p.Gln693Ter)	DMD	Q693*, Q570*, Q685*, Q689*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000409942	X	32563367	X	32545250	409942	404261	rs1060502661	NC_000023.11:32545249:G:A
NM_004013.2(DMD):c.-313_-312del	DMD	Q1015fs, Q2233fs, Q2352fs, Q1012fs, Q2348fs, Q2356fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000409940	X	31893334 - 31893335	X	31875217 - 31875218	409940	404225	rs1060502659	NC_000023.11:31875216:GT:
NM_004006.2(DMD):c.6118-1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000409937	X	32305819	X	32287702	409937	404541	rs1060502656	NC_000023.11:32287701:C:T
NM_000109.4(DMD):c.2709dup (p.Val904fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 11, 2016)	criteria provided, single submitter	VCV000409936	X	32503105 - 32503106	X	32484988 - 32484989	409936	404554	rs1557380496	NC_000023.11:32484988:AAA:AAAA
NM_004010.3(DMD):c.-332_-331GA[1]	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000409931	X	33038308 - 33038309	X	33020191 - 33020192	409931	404576	rs1060502652	NC_000023.11:33020190:TCTCT:TCT
NM_004010.3(DMD):c.-132dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000409930	X	32862925 - 32862926	X	32844808 - 32844809	409930	404293	rs1557079469	NC_000023.11:32844808:CC:CCC
NM_004010.3(DMD):c.-217dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000409928	X	32867877 - 32867878	X	32849760 - 32849761	409928	404574	rs1557084128	NC_000023.11:32849760:T:TT
NM_000109.4(DMD):c.9410del (p.Met3137fs)	DMD	M416fs, M1801fs, M3141fs, M685fs, M77fs, M1804fs, M3022fs, M3137fs, M3145fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000409926	X	31227744	X	31209627	409926	404542	rs1060502648	NC_000023.11:31209626:A:
NM_000109.4(DMD):c.5072_5073AC[2] (p.Leu1693fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000409925	X	32382752 - 32382753	X	32364635 - 32364636	409925	404557	rs1060502647	NC_000023.11:32364634:GTGTGT:GTGT
NM_004006.2(DMD):c.5110G>T (p.Glu1704Ter)	DMD	E1704*, E1696*, E1581*, E1700*, E360*, E363*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000409924	X	32382743	X	32364626	409924	404214	rs765445866	NC_000023.11:32364625:C:A
NM_000109.4(DMD):c.5860_5867del (p.Lys1954fs)	DMD	K1958fs, K1962fs, K1839fs, K618fs, K621fs, K1954fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, single submitter	VCV000409923	X	32360248 - 32360255	X	32342131 - 32342138	409923	404546	rs1060502646	NC_000023.11:32342130:GCAAATTTGC:GC
NM_004006.2(DMD):c.4858G>T (p.Glu1620Ter)	DMD	E1620*, E1497*, E279*, E1616*, E276*, E1612*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000409919	X	32383304	X	32365187	409919	404218	rs1060502645	NC_000023.11:32365186:C:A
NM_004006.2(DMD):c.1061G>A (p.Trp354Ter)	DMD	W354*, W346*, W231*, W350*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000409918	X	32663169	X	32645052	409918	404277	rs1060502644	NC_000023.11:32645051:C:T
NM_004006.2(DMD):c.4071+1G>A	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000409917	X	32456357	X	32438240	409917	404229	rs1060502643	NC_000023.11:32438239:C:T
NM_004006.2(DMD):c.6614+2T>C	DMD		Duchenne muscular dystrophy|not specified	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000409914	X	31986454	X	31968337	409914	404231	rs1060502641	NC_000023.11:31968336:A:G
NM_000109.4(DMD):c.6181del (p.Val2061fs)	DMD	V2065fs, V2061fs, V725fs, V728fs, V1946fs, V2069fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000409913	X	32305731	X	32287614	409913	404550	rs1060502640	NC_000023.11:32287613:C:
NM_004013.2(DMD):c.-140_-138delinsGTTT	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000409912	X	31838158 - 31838160	X	31820041 - 31820043	409912	404224	rs1064792967	NC_000023.11:31820040:GGT:AAAC
NM_004006.2(DMD):c.2665C>T (p.Arg889Ter)	DMD	R889*, R881*, R885*, R766*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000409911	X	32503174	X	32485057	409911	404245	rs1060502639	NC_000023.11:32485056:G:A
NM_004006.2(DMD):c.2202G>A (p.Trp734Ter)	DMD	W734*, W611*, W726*, W730*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV000409907	X	32536215	X	32518098	409907	404248	rs1060502636	NC_000023.11:32518097:C:T
NM_000109.4(DMD):c.2052dup (p.Gln685fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000409906	X	32563367 - 32563368	X	32545250 - 32545251	409906	404273	rs1060502635	NC_000023.11:32545250:TT:TTT
NM_004006.2(DMD):c.8914C>T (p.Gln2972Ter)	DMD	Q2972*, Q2968*, Q1631*, Q2964*, Q1628*, Q243*, Q2849*, Q512*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000409903	X	31496246	X	31478129	409903	404533	rs1060502633	NC_000023.11:31478128:G:A
NM_000109.4(DMD):c.4910_4913del (p.Lys1637fs)	DMD	K1637fs, K301fs, K304fs, K1522fs, K1645fs, K1641fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000409902	X	32383225 - 32383228	X	32365108 - 32365111	409902	404549	rs1060502632	NC_000023.11:32365107:TCCTTC:TC
NM_004006.2(DMD):c.10406_10407insAA (p.His3469fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000409900	X	31187706 - 31187707	X	31169589 - 31169590	409900	404525	rs1060502630	NC_000023.11:31169589:T:TTT
NM_004006.2(DMD):c.1653G>A (p.Trp551Ter)	DMD	W551*, W428*, W543*, W547*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409899	X	32591913	X	32573796	409899	404274	rs1060502629	NC_000023.11:32573795:C:T
NM_004006.2(DMD):c.2276T>A (p.Leu759Ter)	DMD	L759*, L636*, L751*, L755*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000409897	X	32536141	X	32518024	409897	404569	rs1060502627	NC_000023.11:32518023:A:T
NM_004006.2(DMD):c.10797+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000409896	X	31165391	X	31147274	409896	404521	rs1060502626	NC_000023.11:31147273:C:T
NM_000109.4(DMD):c.10701del (p.Met3568fs)	DMD	M3568fs, M3576fs, M495fs, M508fs, M847fs, M1103fs, M3572fs, M1006fs, M1116fs, M2232fs, M2235fs, M3453fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 13, 2016)	criteria provided, single submitter	VCV000409894	X	31165464	X	31147347	409894	404522	rs1060502625	NC_000023.11:31147346:CC:C
NM_000109.4(DMD):c.9214_9217del (p.Thr3072fs)	DMD	T3076fs, T3080fs, T620fs, T1739fs, T2957fs, T3072fs, T12fs, T1736fs, T351fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000409893	X	31279117 - 31279120	X	31261000 - 31261003	409893	404200	rs1060502624	NC_000023.11:31260999:TTGTTTG:TTG
NM_004006.2(DMD):c.5647A>T (p.Lys1883Ter)	DMD	K1883*, K1760*, K1879*, K542*, K1875*, K539*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 24, 2016)	criteria provided, single submitter	VCV000409892	X	32361343	X	32343226	409892	404547	rs1060502623	NC_000023.11:32343225:T:A
NM_004006.2(DMD):c.9621T>A (p.Cys3207Ter)	DMD	C3207*, C1866*, C3084*, C139*, C3203*, C1863*, C3199*, C478*, C747*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000409890	X	31224727	X	31206610	409890	404530	rs1057524037	NC_000023.11:31206609:A:T
NM_004006.2(DMD):c.8209C>T (p.Gln2737Ter)	DMD	Q2737*, Q2729*, Q1396*, Q2614*, Q2733*, Q277*, Q1393*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000409889	X	31645798	X	31627681	409889	404209	rs1060502621	NC_000023.11:31627680:G:A
NM_004013.2(DMD):c.-719del	DMD	N2217fs, N2098fs, N880fs, N2213fs, N2221fs, N877fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000409888	X	31950297	X	31932180	409888	404228	rs1060502620	NC_000023.11:31932179:TTT:TT
NM_000109.4(DMD):c.9016dup (p.Leu3006fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000409885	X	31462641 - 31462642	X	31444524 - 31444525	409885	404189	rs1556641290	NC_000023.11:31444524:GG:GGG
NM_004006.2(DMD):c.3603+3A>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000409882	X	32472776	X	32454659	409882	404564	rs1060502615	NC_000023.11:32454658:T:A
NM_000117.2(EMD):c.123C>A (p.Tyr41Ter)	EMD	Y41*	Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic(Last reviewed: Jun 11, 2016)	criteria provided, single submitter	VCV000409877	X	153608090	X	154379730	409877	404492	rs1060502612	NC_000023.11:154379729:C:A
NM_013995.2(LAMP2):c.962G>A (p.Trp321Ter)	LAMP2	W321*	Danon disease	Pathogenic(Last reviewed: Apr 16, 2016)	criteria provided, single submitter	VCV000409227	X	119575716	X	120441861	409227	404054	rs1060502306	NC_000023.11:120441860:C:T
NM_013995.2(LAMP2):c.1013C>G (p.Ser338Ter)	LAMP2	S338*	Danon disease	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000409225	X	119575665	X	120441810	409225	404085	rs1060502305	NC_000023.11:120441809:G:C
NM_013995.2(LAMP2):c.973dup (p.Leu325fs)	LAMP2		Danon disease	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, single submitter	VCV000409224	X	119575704 - 119575705	X	120441849 - 120441850	409224	404436	rs1556092459	NC_000023.11:120441849:GGGGGG:GGGGGGG
NM_013995.2(LAMP2):c.788del (p.Gly263fs)	LAMP2	G263fs	Danon disease	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000409222	X	119580236	X	120446381	409222	404088	rs1060502303	NC_000023.11:120446380:CC:C
NM_013995.2(LAMP2):c.546_548delinsTA (p.Ser183fs)	LAMP2		Danon disease	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000409221	X	119582833 - 119582835	X	120448978 - 120448980	409221	404092	rs1060502302	NC_000023.11:120448977:CTC:TA
NM_023036.6(DNAI2):c.876G>A (p.Trp292Ter)	DNAI2	W292*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000408970	17	72297196	17	74301057	408970	402515	rs1060502202	NC_000017.11:74301056:G:A
NM_023036.6(DNAI2):c.1516C>T (p.Arg506Ter)	DNAI2	R506*, R494*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000408962	17	72308163	17	74312024	408962	402988	rs141581673	NC_000017.11:74312023:C:T
NM_023036.6(DNAI2):c.883C>T (p.Arg295Ter)	DNAI2	R295*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000408961	17	72297203	17	74301064	408961	402521	rs200708870	NC_000017.11:74301063:C:T
NM_001184880.2(PCDH19):c.2341del (p.Ile781fs)	PCDH19	I734fs, I781fs	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000408902	X	99657797	X	100402799	408902	404418	rs1060502175	NC_000023.11:100402798:TTTTTTT:TTTTTT
NM_024301.5(FKRP):c.1083C>A (p.Tyr361Ter)	FKRP	Y361*	Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	VCV000408721	19	47259790	19	46756533	408721	403765	rs1060502109	NC_000019.10:46756532:C:A
NM_024301.5(FKRP):c.-39-2934_564del	FKRP		Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	VCV000408658	19	47255735 - 47259271	19	46752478 - 46756014	408658	403756		
NM_080860.4(RSPH1):c.573+1_573+17del	RSPH1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000408130	21	43902730 - 43902746	21	42482620 - 42482636	408130	403766	rs1064792947	NC_000021.9:42482619:CATGCTCCGCAACTTACCAT:CAT
NM_080860.4(RSPH1):c.287dup (p.Asn96fs)	RSPH1		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000408124	21	43906558 - 43906559	21	42486448 - 42486449	408124	403775	rs1060501861	NC_000021.9:42486448:TTT:TTTT
NM_001323289.2(CDKL5):c.2022del (p.Phe675fs)	CDKL5	F675fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000408123	X	18627007	X	18608887	408123	404163	rs1060501860	NC_000023.11:18608886:CC:C
NM_017950.4(CCDC40):c.1276G>T (p.Glu426Ter)	CCDC40	E426*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000407770	17	78032409	17	80058610	407770	402576	rs775299709	NC_000017.11:80058609:G:T
NM_017950.4(CCDC40):c.2712-1G>T	CCDC40		Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 15	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000407769	17	78063562	17	80089763	407769	402587	rs370706991	NC_000017.11:80089762:G:T
NM_017950.4(CCDC40):c.2591_2592delinsACCG (p.Thr864fs)	CCDC40		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000407761	17	78061547 - 78061548	17	80087748 - 80087749	407761	403201	rs1060501719	NC_000017.11:80087747:CA:ACCG
NM_001242897.2(DEPDC5):c.434G>A (p.Trp145Ter)	DEPDC5	W145*, W117*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000407346	22	32174105	22	31778119	407346	404370	rs1060501488	NC_000022.11:31778118:G:A
NM_001242897.2(DEPDC5):c.1845del (p.Arg615fs)	DEPDC5	R587fs, R615fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: May 8, 2016)	criteria provided, single submitter	VCV000407342	22	32215185	22	31819199	407342	404380	rs1060501487	NC_000022.11:31819198:GG:G
NM_000328.3(RPGR):c.1366C>T (p.Gln456Ter)	RPGR	Q456*, Q455*, Q466*, Q394*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000406540	X	38156585	X	38297332	406540	404297	rs1060501181	NC_000023.11:38297331:G:A
NM_000166.6(GJB1):c.65G>A (p.Arg22Gln)	GJB1	R22Q	Charcot-Marie-Tooth Neuropathy X|not provided|X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000406228	X	70443622	X	71223772	406228	404289	rs1060501002	NC_000023.11:71223771:G:A
NM_000166.6(GJB1):c.343dup (p.Leu115fs)	GJB1		Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000406225	X	70443895 - 70443896	X	71224045 - 71224046	406225	404292	rs1555937150	NC_000023.11:71224045:CCCCC:CCCCCC
NM_000166.6(GJB1):c.101T>C (p.Met34Thr)	GJB1	M34T	Charcot-Marie-Tooth Neuropathy X|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000406224	X	70443658	X	71223808	406224	404290	rs1060500998	NC_000023.11:71223807:T:C
NM_001195803.2(LDLR):c.1606+150del	LDLR	C499fs, C626fs, C667fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000406170	19	11231059	19	11120383	406170	403593	rs1060500988	NC_000019.10:11120382:T:
NM_000527.4(LDLR):c.1272del (p.Asn425fs)	LDLR	N298fs, N384fs, N257fs, N425fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000406168	19	11224036	19	11113360	406168	403615	rs1060500987	NC_000019.10:11113359:CCCC:CCC
NM_000527.4(LDLR):c.1731G>C (p.Trp577Cys)	LDLR	W577C, W409C, W450C, W536C	Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000406163	19	11227560	19	11116884	406163	403135	rs875989928	NC_000019.10:11116883:G:C
NM_005359.5(SMAD4):c.1529delG (p.Gly510Aspfs)	SMAD4	G510fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000405502	18	48604704	18	51078334	405502	402788	rs1060500744	NC_000018.10:51078333:GGGG:GGG
NM_005359.5(SMAD4):c.728_735delGGCCTCAG (p.Gly243Alafs)	SMAD4	G243fs	Juvenile polyposis syndrome|not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000405500	18	48584551 - 48584558	18	51058181 - 51058188	405500	403303	rs1060500742	NC_000018.10:51058180:TCAGGGCCTCAG:TCAG
NM_005359.5(SMAD4):c.263_267delAAGGA (p.Lys88Ilefs)	SMAD4	K88fs	Juvenile polyposis syndrome|not provided	Pathogenic(Last reviewed: Dec 24, 2016)	criteria provided, single submitter	VCV000405496	18	48575066 - 48575070	18	51048696 - 51048700	405496	402807	rs1060500739	NC_000018.10:51048695:GGAAAGGA:GGA
NM_005359.5(SMAD4):c.1198delA (p.Arg400Glyfs)	SMAD4	R400fs	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000405491	18	48593447	18	51067077	405491	402759	rs1060500734	NC_000018.10:51067076:A:
NM_005359.5(SMAD4):c.1096C>T (p.Gln366Ter)	SMAD4	Q366*	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000405490	18	48591933	18	51065563	405490	403329	rs1060500733	NC_000018.10:51065562:C:T
NM_000891.2(KCNJ2):c.682C>T (p.Arg228Ter)	KCNJ2	R228*	Andersen Tawil syndrome	Pathogenic(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000403974	17	68171862	17	70175721	403974	403123	rs1060500053	NC_000017.11:70175720:C:T
NM_000116.5(TAZ):c.281G>T (p.Arg94Leu)	TAZ	R94L, R112L	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000403954	X	153641586	X	154413249	403954	404531	rs1060500044	NC_000023.11:154413248:G:T
NM_000455.4(STK11):c.935_936del (p.Lys312fs)	STK11	K312fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Nov 13, 2016)	criteria provided, single submitter	VCV000403780	19	1222997 - 1222998	19	1222998 - 1222999	403780	403179	rs397518443	NC_000019.10:1222997:AAA:A
NM_000455.4(STK11):c.129del (p.Lys44fs)	STK11	K44fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000403779	19	1207040	19	1207041	403779	403630	rs1060499961	NC_000019.10:1207040:CC:C
NM_000455.4(STK11):c.989_996del (p.Asp330fs)	STK11	D330fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000403776	19	1223050 - 1223057	19	1223051 - 1223058	403776	403645	rs1060499960	NC_000019.10:1223050:GGACCGGTGG:GG
NM_000455.4(STK11):c.842dup (p.Leu282fs)	STK11		Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Mar 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000403750	19	1221313 - 1221314	19	1221314 - 1221315	403750	403194	rs121913321	NC_000019.10:1221314:CCCCCC:CCCCCCC
NM_030582.4(COL18A1):c.3213dup (p.Gly1072fs)	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000403722	21	46917558 - 46917559	21	45497644 - 45497645	403722	390699	rs749009747	NC_000021.9:45497644:CCCCCCC:CCCCCCCC
NM_000152.5(GAA):c.1082C>T (p.Pro361Leu)	GAA	P361L	Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000403712	17	78082294	17	80108495	403712	390687	rs755253527	NC_000017.11:80108494:C:T
NM_000527.4(LDLR):c.(2389+1_2390-1)_(*_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403661					403661	390645		
NM_000527.4(LDLR):c.(2311+1_2312-1)_(2547+1_2548-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403660					403660	390644		
NM_000527.4(LDLR):c.(1845+1_1846-1)_(*_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403659					403659	390643		
NM_000527.4(LDLR):c.(1845+1_1846-1)_(2140+1_2141-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403658					403658	390642		
NM_000527.4(LDLR):c.(1586+1_1587-1)_(2547+1_2548-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403657					403657	390641		
NM_000527.4(LDLR):c.(940+1_941-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403656					403656	390640		
NM_000527.4(LDLR):c.(940+1_941-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403655					403655	390639		
NM_000527.4(LDLR):c.(940+1_941-1)_(1186+1_1187-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403654					403654	390638		
NM_000527.4(LDLR):c.(313+1_314-1)_(940+1_941-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403653					403653	390637		
NM_000527.4(LDLR):c.(313+1_314-1)_(1586+1_1587-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403652					403652	390636		
NM_000527.4(LDLR):c.(67+1_68-1)_(2311+1_2312-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403651					403651	390635		
NM_000527.4(LDLR):c.(?_-1)_(1845+1_1846-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403650					403650	390634		
NM_000527.4(LDLR):c.(?_-1)_(67+1_68-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403649					403649	390633		
NM_000527.4(LDLR):c.2253_2256dup (p.Pro753fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403647	19	11233960 - 11233961	19	11123284 - 11123285	403647	390629	rs1555808111	NC_000019.10:11123284:GGCTG:GGCTGGCTG
NM_000527.4(LDLR):c.2180_2184dup (p.Leu729fs)	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000403646	19	11233887 - 11233888	19	11123211 - 11123212	403646	390628	rs1555808044	NC_000019.10:11123211:GTCAGG:GTCAGGTCAGG
NM_000527.4(LDLR):c.(67+1_68-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403645					403645	390632		
NM_000527.4(LDLR):c.1741A>T (p.Lys581Ter)	LDLR	K581*, K413*, K454*, K540*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403643	19	11227570	19	11116894	403643	390625	rs1060499927	NC_000019.10:11116893:A:T
NM_000527.4(LDLR):c.1632_1633del (p.Gly546fs)	LDLR	G419fs, G378fs, G546fs, G505fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403642	19	11226815 - 11226816	19	11116139 - 11116140	403642	390624	rs1060499926	NC_000019.10:11116138:AG:
NM_000527.4(LDLR):c.1358+5G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403640	19	11224130	19	11113454	403640	390622	rs1060499924	NC_000019.10:11113453:G:T
NM_000527.4(LDLR):c.1204_1205del (p.Phe402fs)	LDLR	F234fs, F275fs, F361fs, F402fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403638	19	11223971 - 11223972	19	11113295 - 11113296	403638	390621	rs1060499923	NC_000019.10:11113294:TT:
NM_001195798.2(LDLR):c.1182_1183TG[1] (p.Val395fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403637	19	11222311 - 11222312	19	11111635 - 11111636	403637	390619	rs1060499922	NC_000019.10:11111634:TGTG:TG
NM_001195800.2(LDLR):c.314-1803_314-1792del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000403633	19	11216263 - 11216274	19	11105587 - 11105598	403633	390614	rs1064792905	NC_000019.10:11105586:CGAGGAAAACTGCG:CG
NM_000527.4(LDLR):c.681C>A (p.Asp227Glu)	LDLR	D227E, D186E	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	VCV000403632	19	11216263	19	11105587	403632	390613	rs121908028	NC_000019.10:11105586:C:A
NM_002473.5(MYH9):c.5137A>G (p.Ser1713Gly)	MYH9	S1713G	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402285	22	36681924	22	36285878	402285	389253	rs764139009	NC_000022.11:36285877:T:C
NM_024022.3(TMPRSS3):c.582T>A (p.Cys194Ter)	TMPRSS3	C194*, C67*	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402283	21	43804113	21	42384004	402283	389252	rs1060499811	NC_000021.9:42384003:A:T
NM_001039141.3(TRIOBP):c.3055G>A (p.Gly1019Arg)	TRIOBP	G1019R	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402281	22	38121618	22	37725611	402281	389255	rs549095193	NC_000022.11:37725610:G:A
NM_001039141.3(TRIOBP):c.1447C>T (p.Gln483Ter)	TRIOBP	Q483*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402280	22	38120010	22	37724003	402280	389254	rs1060499809	NC_000022.11:37724002:C:T
NM_144612.6(LOXHD1):c.4843G>A (p.Gly1615Arg)	LOXHD1	G1615R, G408R, G504R	Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Jun 4, 2016)	no assertion criteria provided	VCV000402259	18	44104462	18	46524499	402259	389251	rs768835732	NC_000018.10:46524498:C:T
NM_176787.5(PIGN):c.996T>G (p.Ile332Met)	PIGN	I332M	Multiple congenital anomalies-hypotonia-seizures syndrome 1|Abnormality of brain morphology	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000402190	18	59807680	18	62140447	402190	389175	rs1060499763	NC_000018.10:62140446:A:C
NM_033380.3(COL4A5):c.3819_3881del (p.Pro1274_Gly1294del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000397580	X	107920735 - 107920797	X	108677505 - 108677567	397580	384507	rs1556451235	
NM_033380.3(COL4A5):c.2048del (p.Pro683fs)	COL4A5	P683fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000397579	X	107845119	X	108601889	397579	384505	rs1060499694	NC_000023.11:108601888:CCC:CC
NM_016430.3(PIGP):c.306del (p.Glu103fs)	PIGP	E103fs, E129fs, E153fs	Early infantile epileptic encephalopathy 55|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000397552	21	38437903	21	37065603	397552	384446	rs778481061	NC_000021.9:37065602:TTT:TT
NM_001272071.2(AP1S2):c.1-3C>A	AP1S2		Pettigrew syndrome	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000397541	X	15870650	X	15852527	397541	384444	rs1060499672	NC_000023.11:15852526:G:T
NM_004187.4(KDM5C):c.767_768CT[1] (p.Leu257fs)	KDM5C		Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	VCV000397527	X	53245267 - 53245268	X	53216085 - 53216086	397527	384427	rs1060499661	NC_000023.11:53216084:AGAG:AG
NM_001111125.3(IQSEC2):c.2477T>C (p.Met826Thr)	IQSEC2	M826T, M621T	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000397526	X	53277401	X	53248219	397526	384428	rs1060499660	NC_000023.11:53248218:A:G
NM_000489.5(ATRX):c.6122G>A (p.Ser2041Asn)	ATRX	S2041N, S2003N		Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	VCV000397524	X	76845399	X	77589929	397524	384429	rs1060499658	NC_000023.11:77589928:C:T
NC_000022.10:g.(41537227_41542742)_(41560135_41562602)dup	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000397516	22	41537227 - 41562602	22	41141223 - 41166598	397516	384415		
NM_001008537.3(NEXMIF):c.3470C>A (p.Ser1157Ter)	NEXMIF	S1157*	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000397512	X	73960922	X	74741087	397512	384417	rs1060499652	NC_000023.11:74741086:G:T
GRCh37/hg19 Xq12(chrX:67497166-67594258)x0	OPHN1		See cases	Pathogenic	no assertion criteria provided	VCV000396985	X	67497166 - 67594258			396985	383878		
GRCh37/hg19 Xq28(chrX:147573612-147620560)x0	AFF2		See cases	Pathogenic	no assertion criteria provided	VCV000396647	X	147573612 - 147620560			396647	383540		
GRCh37/hg19 Xp21.1(chrX:32684174-32719596)x0	DMD		See cases	Pathogenic	no assertion criteria provided	VCV000396506	X	32684174 - 32719596			396506	383399		
GRCh37/hg19 Xq11.2(chrX:64174689-64450154)x1	ZC4H2		See cases	Pathogenic	no assertion criteria provided	VCV000396258	X	64174689 - 64450154			396258	383151		
GRCh37/hg19 18q21.2(chr18:53214922-53346803)x1	TCF4		See cases	Pathogenic	no assertion criteria provided	VCV000396087	18	53214922 - 53346803			396087	382980		
GRCh37/hg19 Xp21.1(chrX:31942461-32104259)x1	DMD		See cases	Pathogenic	no assertion criteria provided	VCV000395895	X	31942461 - 32104259			395895	382788		
GRCh37/hg19 Xp22.11(chrX:22166967-22219901)x2	PHEX		See cases	Pathogenic	no assertion criteria provided	VCV000395516	X	22166967 - 22219901			395516	382409		
GRCh37/hg19 Xq28(chrX:153126942-153143271)x1	L1CAM		See cases	Pathogenic	no assertion criteria provided	VCV000395221	X	153126942 - 153143271			395221	382114		
GRCh37/hg19 Xp21.1(chrX:31683623-31766614)x0	DMD		See cases	Pathogenic	no assertion criteria provided	VCV000394556	X	31683623 - 31766614			394556	381449		
GRCh37/hg19 Xp21.1(chrX:32349168-32534563)x0	DMD		See cases	Pathogenic	no assertion criteria provided	VCV000393835	X	32349168 - 32534563			393835	380728		
NM_000216.4(ANOS1):c.33_34insA (p.Leu12fs)	ANOS1			Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	VCV000393472	X	8700044 - 8700045	X	8732003 - 8732004	393472	380294	rs1057520210	NC_000023.11:8732003::T
NM_032045.5(KREMEN1):c.626T>C (p.Phe209Ser)	KREMEN1	F209S	Ectodermal dysplasia 13, hair/tooth type	Pathogenic(Last reviewed: Mar 13, 2017)	no assertion criteria provided	VCV000393469	22	29521399	22	29125411	393469	380291	rs1057524917	NC_000022.11:29125410:T:C
NM_003895.3(SYNJ1):c.3365-2A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000393360	21	34018101	21	32645791	393360	380180	rs1057524880	NC_000021.9:32645790:T:C
NM_003895.3(SYNJ1):c.1938del (p.Gln647fs)	SYNJ1	Q603fs, Q608fs, Q647fs	Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000393359	21	34038874	21	32666564	393359	380179	rs1057524879	NC_000021.9:32666563:A:
NM_003895.3(SYNJ1):c.2528G>A (p.Trp843Ter)	SYNJ1	W843*, W799*, W804*	Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000393358	21	34030076	21	32657766	393358	380178	rs1057524878	NC_000021.9:32657765:C:T
NM_003895.3(SYNJ1):c.2663A>G (p.Tyr888Cys)	SYNJ1	Y888C, Y844C, Y849C	Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jan 17, 2018)	no assertion criteria provided	VCV000393357	21	34029346	21	32657036	393357	380177	rs1057524877	NC_000021.9:32657035:T:C
NM_003895.3(SYNJ1):c.1376G>C (p.Arg459Pro)	SYNJ1	R459P, R420P	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Mar 8, 2017)	no assertion criteria provided	VCV000393356	21	34053900	21	32681590	393356	380176	rs1060499619	NC_000021.9:32681589:C:G
NM_000117.2(EMD):c.419T>A (p.Leu140Ter)	EMD	L140*	not provided	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393234	X	153609132	X	154380772	393234	379235	rs1057524848	NC_000023.11:154380771:T:A
NM_004006.2(DMD):c.5872G>T (p.Glu1958Ter)	DMD	E1958*, E1835*, E1950*, E617*, E1954*, E614*	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000393178	X	32360267	X	32342150	393178	379347	rs1057524825	NC_000023.11:32342149:C:A
NM_144612.6(LOXHD1):c.4741-1G>A	LOXHD1		not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000393044	18	44104565	18	46524602	393044	375940	rs1057524755	NC_000018.10:46524601:C:T
NM_001184880.2(PCDH19):c.799G>T (p.Glu267Ter)	PCDH19	E267*	not provided	Pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000393037	X	99662797	X	100407799	393037	378877	rs1057524751	NC_000023.11:100407798:C:A
NM_001323289.2(CDKL5):c.419A>G (p.Asn140Ser)	CDKL5	N140S	not provided	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000392860	X	18600026	X	18581906	392860	378016	rs1057524663	NC_000023.11:18581905:A:G
NM_203473.3(PORCN):c.705-2A>C	PORCN		not provided	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000392684	X	48372626	X	48514238	392684	379425	rs1057524593	NC_000023.11:48514237:A:C
NM_004247.4(EFTUD2):c.2347+1G>T	EFTUD2		not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000392673	17	42931636	17	44854268	392673	376066	rs1057524588	NC_000017.11:44854267:C:A
NM_003688.3(CASK):c.1504-2A>C	CASK		not provided	Pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000392425	X	41429001	X	41569748	392425	379415	rs1057524485	NC_000023.11:41569747:T:G
NM_007363.5(NONO):c.103C>T (p.Gln35Ter)	NONO	Q35*	not provided	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000392246	X	70510590	X	71290740	392246	379411	rs1057524408	NC_000023.11:71290739:C:T
NM_004586.3(RPS6KA3):c.1606G>T (p.Val536Phe)	RPS6KA3	V536F	not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000391985	X	20183175	X	20165057	391985	380017	rs1057524314	NC_000023.11:20165056:C:A
NM_016941.4(DLL3):c.661C>T (p.Arg221Ter)	DLL3	R221*	not provided	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000391971	19	39994719	19	39504079	391971	377641	rs200275281	NC_000019.10:39504078:C:T
NM_001039591.3(USP9X):c.643C>T (p.Arg215Ter)	USP9X	R215*	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000391824	X	40996264	X	41137011	391824	378303	rs1057524248	NC_000023.11:41137010:C:T
NM_001242897.2(DEPDC5):c.562+1G>A	DEPDC5		not provided|Familial focal epilepsy with variable foci	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391802	22	32179972	22	31783986	391802	378785	rs1057524233	NC_000022.11:31783985:G:A
NM_001282531.3(ADNP):c.2213C>G (p.Ser738Ter)	ADNP	S738*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000391218	20	49509038	20	50892501	391218	378330	rs779340209	NC_000020.11:50892500:G:C
NM_001281463.1(SMC1A):c.1438G>A (p.Glu480Lys)	SMC1A	E480K, E502K	not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000384752	X	53436034	X	53409103	384752	378480	rs1057522040	NC_000023.11:53409102:C:T
NM_000199.5(SGSH):c.673T>C (p.Phe225Leu)	SGSH	F225L	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000383967	17	78187675	17	80213876	383967	375756	rs1057521801	NC_000017.11:80213875:A:G
NM_001429.4(EP300):c.4763T>C (p.Met1588Thr)	EP300	M1588T, M1562T	not provided|Colorectal cancer|Rubinstein-Taybi syndrome 2|Rubinstein-Taybi syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000383803	22	41569772	22	41173768	383803	379858	rs1057521737	NC_000022.11:41173767:T:C
NM_001111125.3(IQSEC2):c.2983C>T (p.Arg995Trp)	IQSEC2	R995W, R790W	Mental retardation, X-linked 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000383534	X	53270998	X	53241816	383534	380077	rs1057521657	NC_000023.11:53241815:G:A
NM_000377.2(WAS):c.360+1G>A	WAS		not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000381690	X	48544023	X	48685634	381690	380065	rs1057520700	NC_000023.11:48685633:G:A
NM_020436.5(SALL4):c.2491C>T (p.Arg831Ter)	SALL4	R831*, R394*	not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000381683	20	50405651	20	51789112	381683	379729	rs1057521145	NC_000020.11:51789111:G:A
NM_000444.6(PHEX):c.849+1G>A	PHEX		not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000381681	X	22112218	X	22094100	381681	379200	rs1057521144	NC_000023.11:22094099:G:A
NM_000444.6(PHEX):c.565C>T (p.Gln189Ter)	PHEX	Q189*	not provided	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000381680	X	22095722	X	22077604	381680	379199	rs1057521143	NC_000023.11:22077603:C:T
NM_000211.5(ITGB2):c.79A>T (p.Lys27Ter)	ITGB2	K27*	not provided	Pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000381673	21	46330267	21	44910352	381673	378569	rs189250711	NC_000021.9:44910351:T:A
NM_003639.4(IKBKG):c.502C>T (p.Gln168Ter)	IKBKG	Q168*, Q167*, Q236*	not provided	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000381670	X	153786849	X	154558634	381670	379245	rs1057521138	NC_000023.11:154558633:C:T
NM_001347721.2(DYRK1A):c.905C>T (p.Ser302Phe)	DYRK1A	S311F, S302F, S273F	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000381574	21	38862744	21	37490442	381574	377246	rs1039571136	NC_000021.9:37490441:C:T
NM_000132.3(F8):c.6103G>A (p.Val2035Met)	F8	V2035M	not provided	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000381561	X	154130338	X	154902063	381561	380000	rs1057521074	NC_000023.11:154902062:C:T
NM_001083962.2(TCF4):c.1727G>A (p.Arg576Gln)	TCF4	R576Q, R553Q, R360Q, R411Q, R501Q, R505Q, R530Q, R548Q, R582Q, R678Q, R416Q, R534Q, R547Q, R551Q, R552Q, R571Q, R575Q, R412Q, R442Q, R446Q, R569Q, R572Q	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381549	18	52896230	18	55228999	381549	375991	rs1057521070	NC_000018.10:55228998:C:T
NM_001127221.1(CACNA1A):c.4046G>A (p.Arg1349Gln)	CACNA1A	R1349Q, R1352Q, R1348Q	Inborn genetic diseases|not provided|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2|Familial hemiplegic migraine type 1|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2||Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000380972	19	13373594	19	13262780	380972	376243	rs1057520918	NC_000019.10:13262779:C:T
NM_001111125.3(IQSEC2):c.2776C>T (p.Arg926Ter)	IQSEC2	R926*, R721*	Mental retardation, X-linked 1|not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000380487	X	53272627	X	53243445	380487	379449	rs1057520858	NC_000023.11:53243444:G:A
NM_212472.2(PRKAR1A):c.535C>T (p.Gln179Ter)	PRKAR1A	Q179*	not provided|Carney complex	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000379923	17	66521085	17	68524944	379923	376530	rs141913727	NC_000017.11:68524943:C:T
NM_000167.5(GK):c.259+2T>C	GK		not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000379913	X	30686237	X	30668120	379913	379314	rs1057520781	NC_000023.11:30668119:T:C
NM_001278116.2(L1CAM):c.2433C>A (p.Tyr811Ter)	L1CAM	Y811*, Y806*	not provided	Pathogenic(Last reviewed: Jun 1, 2015)	criteria provided, single submitter	VCV000379893	X	153131273	X	153865818	379893	379000	rs782553641	NC_000023.11:153865817:G:T
NM_172107.4(KCNQ2):c.1686C>A (p.Tyr562Ter)	KCNQ2	Y562*, Y544*, Y531*, Y534*	not provided	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	VCV000379891	20	62044880	20	63413527	379891	377139	rs1057520773	NC_000020.11:63413526:G:T
NM_024301.5(FKRP):c.1394A>C (p.Tyr465Ser)	FKRP	Y465S	not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000379888	19	47260101	19	46756844	379888	377797	rs1057520772	NC_000019.10:46756843:A:C
NM_024301.5(FKRP):c.264C>A (p.Tyr88Ter)	FKRP	Y88*	not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000379887	19	47258971	19	46755714	379887	376619	rs1057520771	NC_000019.10:46755713:C:A
NM_000159.4(GCDH):c.1156C>G (p.Arg386Gly)	GCDH	R386G	not provided|Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379878	19	13008590	19	12897776	379878	377199	rs752127949	NC_000019.10:12897775:C:G
NM_000390.4(CHM):c.133G>T (p.Gly45Ter)	CHM	G45*	not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000379873	X	85236797	X	85981793	379873	378697	rs1057520765	NC_000023.11:85981792:C:A
NM_004006.2(DMD):c.5758C>T (p.Gln1920Ter)	DMD	Q1920*, Q1797*, Q1912*, Q576*, Q579*, Q1916*	Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000379872	X	32360381	X	32342264	379872	378246	rs1057520764	NC_000023.11:32342263:G:A
NM_001184880.2(PCDH19):c.825C>A (p.Tyr275Ter)	PCDH19	Y275*	not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000379858	X	99662771	X	100407773	379858	378875	rs1057520761	NC_000023.11:100407772:G:T
NM_015629.4(PRPF31):c.855+1G>A	PRPF31		not provided	Pathogenic(Last reviewed: May 22, 2015)	criteria provided, single submitter	VCV000379837	19	54628036	19	54124657	379837	377842	rs1057520752	NC_000019.10:54124656:G:A
NM_003560.4(PLA2G6):c.1501G>A (p.Glu501Lys)	PLA2G6	E501K, E275K, E323K, E447K, E269K	not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000379833	22	38519192	22	38123185	379833	379852	rs587784332	NC_000022.11:38123184:C:T
NM_001127221.1(CACNA1A):c.4099T>A (p.Phe1367Ile)	CACNA1A	F1367I, F1366I, F1370I	not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000379829	19	13372418	19	13261604	379829	379387	rs1057520749	NC_000019.10:13261603:A:T
NM_007254.4(PNKP):c.1315C>T (p.Arg439Ter)	PNKP	R439*	Early infantile epileptic encephalopathy 12|not provided	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379820	19	50364936	19	49861679	379820	377868	rs539286945	NC_000019.10:49861678:G:A
NM_001399.5(EDA):c.617C>T (p.Pro206Leu)	EDA	P206L	Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000379815	X	69247797	X	70027947	379815	379504	rs1057520742	NC_000023.11:70027946:C:T
NM_002547.3(OPHN1):c.1246C>T (p.Gln416Ter)	OPHN1	Q416*	not provided	Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	VCV000379804	X	67412791	X	68192949	379804	379501	rs1057520737	NC_000023.11:68192948:G:A
NM_004247.4(EFTUD2):c.1096C>T (p.Gln366Ter)	EFTUD2	Q366*, Q356*, Q331*	not provided	Pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	VCV000379737	17	42945228	17	44867860	379737	376069	rs1057520720	NC_000017.11:44867859:G:A
NM_001363.5(DKC1):c.1133G>A (p.Arg378Gln)	DKC1	R378Q	|not provided	Pathogenic(Last reviewed: May 8, 2015)	criteria provided, single submitter	VCV000379736	X	154001502	X	154773227	379736	379257	rs1057520719	NC_000023.11:154773226:G:A
NM_001077488.4(GNAS):c.125G>A (p.Arg42His)	GNAS	R42H	not provided	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000379730	20	57466906	20	58891851	379730	378336	rs1057520715	NC_000020.11:58891850:G:A
NM_000377.2(WAS):c.360+1G>T	WAS		not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000379705	X	48544023	X	48685634	379705	378352	rs1057520700	NC_000023.11:48685633:G:T
NM_000061.2(BTK):c.41C>A (p.Ser14Tyr)	BTK	S14Y, S48Y	not provided	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000379662	X	100630232	X	101375244	379662	377658	rs1057520682	NC_000023.11:101375243:G:T
NM_004247.4(EFTUD2):c.103G>T (p.Glu35Ter)	EFTUD2	E35*	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000379627	17	42971787	17	44894419	379627	376154	rs1057520674	NC_000017.11:44894418:C:A
NM_004247.4(EFTUD2):c.1732C>T (p.Arg578Ter)	EFTUD2	R578*, R568*, R543*	not provided|Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379625	17	42937401	17	44860033	379625	375142	rs1057520673	NC_000017.11:44860032:G:A
NM_000152.5(GAA):c.1478C>T (p.Pro493Leu)	GAA	P493L	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379593	17	78084566	17	80110767	379593	378821	rs148842275	NC_000017.11:80110766:C:T
NM_198129.3(LAMA3):c.4683+2T>G	LAMA3		not provided	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000379570	18	21444849	18	23864885	379570	376752	rs765943112	NC_000018.10:23864884:T:G
NM_000167.5(GK):c.514C>T (p.Arg172Ter)	GK	R172*	not provided	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000379569	X	30712616	X	30694499	379569	378193	rs1057520647	NC_000023.11:30694498:C:T
NM_000206.2(IL2RG):c.202G>A (p.Glu68Lys)	IL2RG	E68K	not provided|X-linked severe combined immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379561	X	70330814	X	71110964	379561	379505	rs1057520644	NC_000023.11:71110963:C:T
NM_173483.4(CYP4F22):c.1084C>T (p.Arg362Ter)	CYP4F22	R362*	Autosomal recessive congenital ichthyosis 5|not provided	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000379536	19	15655038	19	15544227	379536	377333	rs745368359	NC_000019.10:15544226:C:T
NM_007254.4(PNKP):c.1386+1G>A	PNKP		not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000379531	19	50364864	19	49861607	379531	376667	rs1057520630	NC_000019.10:49861606:C:T
NM_000390.4(CHM):c.1334C>G (p.Ser445Ter)	CHM	S445*, S297*	not provided	Pathogenic(Last reviewed: Apr 8, 2015)	criteria provided, single submitter	VCV000379530	X	85156104	X	85901099	379530	379557	rs1057520629	NC_000023.11:85901098:G:C
NM_000159.4(GCDH):c.937C>T (p.Arg313Trp)	GCDH	R313W	not provided|Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379529	19	13007808	19	12896994	379529	377194	rs779315456	NC_000019.10:12896993:C:T
NM_001848.2(COL6A1):c.957G>T (p.Lys319Asn)	COL6A1	K319N	not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000379510	21	47410198	21	45990284	379510	377319	rs1057520625	NC_000021.9:45990283:G:T
NM_000444.6(PHEX):c.58C>T (p.Arg20Ter)	PHEX	R20*	Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379502	X	22051181	X	22033063	379502	378102	rs770573978	NC_000023.11:22033062:C:T
NM_000276.4(OCRL):c.1573A>C (p.Lys525Gln)	OCRL	K525Q, K526Q	not provided	Pathogenic(Last reviewed: Apr 21, 2015)	criteria provided, single submitter	VCV000379480	X	128703347	X	129569370	379480	377736	rs1057520613	NC_000023.11:129569369:A:C
NM_000061.2(BTK):c.669T>A (p.Tyr223Ter)	BTK	Y223*, Y257*	not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000379478	X	100615663	X	101360675	379478	378784	rs1057520612	NC_000023.11:101360674:A:T
NM_152424.4(AMER1):c.571G>T (p.Glu191Ter)	AMER1	E191*	not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000379474	X	63412596	X	64192716	379474	378541	rs1057520610	NC_000023.11:64192715:C:A
NM_000455.4(STK11):c.766G>T (p.Glu256Ter)	STK11	E256*	not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000379470	19	1221243	19	1221244	379470	379230	rs1057520606	NC_000019.10:1221243:G:T
NM_000061.2(BTK):c.1580G>C (p.Cys527Ser)	BTK	C527S, C351S, C561S	not provided	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000379335	X	100609669	X	101354681	379335	378897	rs1057520578	NC_000023.11:101354680:C:G
NM_002608.4(PDGFB):c.2T>G (p.Met1Arg)	PDGFB	M1R	not provided	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000379331	22	39639967	22	39243962	379331	377492	rs1057520576	NC_000022.11:39243961:A:C
NM_000383.4(AIRE):c.274C>T (p.Arg92Trp)	AIRE	R92W	Polyglandular autoimmune syndrome, type 1|not provided	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379319	21	45706581	21	44286698	379319	378471	rs140630532	NC_000021.9:44286697:C:T
NM_000444.6(PHEX):c.617T>G (p.Leu206Trp)	PHEX	L206W	not provided	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	VCV000379283	X	22095774	X	22077656	379283	378115	rs886041694	NC_000023.11:22077655:T:G
NM_004586.3(RPS6KA3):c.204T>G (p.Phe68Leu)	RPS6KA3	F68L	not provided	Pathogenic(Last reviewed: Mar 21, 2015)	criteria provided, single submitter	VCV000379241	X	20227445	X	20209327	379241	380018	rs1057520540	NC_000023.11:20209326:A:C
NM_014009.3(FOXP3):c.1190G>A (p.Arg397Gln)	FOXP3	R397Q, R362Q	not provided|Bone marrow hypocellularity|Anemia|Pneumonia|Pancytopenia	Pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	VCV000379222	X	49107901	X	49251440	379222	378413	rs1057520529	NC_000023.11:49251439:C:T
NM_000026.4(ADSL):c.253C>T (p.Arg85Ter)	ADSL	R85*, R21*	not provided|Adenylosuccinate lyase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379129	22	40745935	22	40349931	379129	377516	rs1036185928	NC_000022.11:40349930:C:T
NM_152906.7(TANGO2):c.94C>T (p.Arg32Ter)	TANGO2	R32*, R73*	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION|not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000378700	22	20030915	22	20043392	378700	378630	rs199801224	NC_000022.11:20043391:C:T
NM_001281463.1(SMC1A):c.556C>G (p.Arg186Gly)	SMC1A	R186G, R208G	not provided	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000378628	X	53440082	X	53413132	378628	379330	rs1057520375	NC_000023.11:53413131:G:C
NM_005619.5(RTN2):c.939del (p.Thr314fs)	RTN2	T314fs	Hereditary spastic paraplegia 12	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378054	19	45996512	19	45493254	378054	380145	rs768449676	NC_000019.10:45493253:A:
NM_001429.3(EP300):c.3857A>G	EP300	N1286S, N1260S	Rubinstein-Taybi syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000378053	22	41562653	22	41166649	378053	380144	rs1555910821	NC_000022.11:41166648:A:G
NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)	ZC4H2	R18K	Wieacker Wolff syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378045	X	64196205	X	64976325	378045	380137	rs1057520299	NC_000023.11:64976324:C:T
NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)	ZC4H2	L66H, L43H	Wieacker Wolff syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378042	X	64141725	X	64921845	378042	380135	rs1057520297	NC_000023.11:64921844:A:T
NM_000159.4(GCDH):c.395G>A (p.Arg132Gln)	GCDH	R132Q	not provided|Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000377917	19	13004357	19	12893543	377917	377186	rs200639270	NC_000019.10:12893542:G:A
NM_000022.4(ADA):c.7C>T (p.Gln3Ter)	ADA	Q3*	Severe combined immunodeficiency due to ADA deficiency|not provided	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377441	20	43280242	20	44651601	377441	377038	rs1057520217	NC_000020.11:44651600:G:A
NM_000273.3(GPR143):c.2T>C (p.Met1Thr)	GPR143	M1T	not provided	Pathogenic(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000377335	X	9733856	X	9765816	377335	364213	rs1057520200	NC_000023.11:9765815:A:G
NM_001127221.1(CACNA1A):c.2313_2340dup (p.Glu781delinsGlnValArgValGlyAlaAlaAspGlnTer)	CACNA1A		not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000377185	19	13410109 - 13410110	19	13299295 - 13299296	377185	364063	rs1057520154	NC_000019.10:13299295:ACTGGTCCGCTGCTCCCACACGGACTTG:ACTGGTCCGCTGCTCCCACACGGACTTGACTGGTCCGCTGCTCCCACACGGACTTG
NM_000052.7(ATP7A):c.2867G>A (p.Trp956Ter)	ATP7A	W956*, W878*	not provided	Pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000377175	X	77276527	X	78021030	377175	364053	rs67273048	NC_000023.11:78021029:G:A
NM_001972.4(ELANE):c.170C>T (p.Ala57Val)	ELANE	A57V	not provided	Pathogenic(Last reviewed: Dec 2, 2016)	criteria provided, single submitter	VCV000377028	19	852978	19	852978	377028	363906	rs1057520110	NC_000019.10:852977:C:T
NM_000276.4(OCRL):c.1095del (p.His365fs)	OCRL	H366fs, H365fs	not provided	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000376875	X	128696614	X	129562637	376875	363753	rs1057520078	NC_000023.11:129562636:C:
NM_000455.4(STK11):c.109C>T (p.Gln37Ter)	STK11	Q37*	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000376334	19	1207021	19	1207022	376334	363213	rs121913324	NC_000019.10:1207021:C:T
NM_030662.3(MAP2K2):c.376A>G (p.Asn126Asp)	MAP2K2	N126D	Cardio-facio-cutaneous syndrome|Cutaneous melanoma|Cardiofaciocutaneous syndrome 4	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000376176	19	4110581	19	4110583	376176	363055	rs1057519806	NC_000019.10:4110582:T:C
NM_001754.4(RUNX1):c.601C>T (p.Arg201Ter)	RUNX1	R201*, R174*	Acute myeloid leukemia|Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 29, 2019)	reviewed by expert panel	VCV000376018	21	36231783	21	34859486	376018	362897	rs1057519748	NC_000021.9:34859485:G:A
NM_002067.5(GNA11):c.626A>T (p.Gln209Leu)	GNA11	Q209L	Susceptibility to uveal melanoma|Cutaneous melanoma|Malignant melanoma of skin	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000376002	19	3118942	19	3118944	376002	362881	rs1057519742	NC_000019.10:3118943:A:T
NM_002067.5(GNA11):c.626A>C (p.Gln209Pro)	GNA11	Q209P	Cutaneous melanoma|Susceptibility to uveal melanoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000376001	19	3118942	19	3118944	376001	362880	rs1057519742	NC_000019.10:3118943:A:C
NM_005359.5(SMAD4):c.1609G>T (p.Asp537Tyr)	SMAD4	D537Y	Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000376000	18	48604787	18	51078417	376000	362879	rs1057519741	NC_000018.10:51078416:G:T
NM_005359.5(SMAD4):c.1065C>A (p.Asp355Glu)	SMAD4	D355E	Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375999	18	48591902	18	51065532	375999	362878	rs1057519740	NC_000018.10:51065531:C:A
NM_005359.5(SMAD4):c.1051G>C (p.Asp351His)	SMAD4	D351H	Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375998	18	48591888	18	51065518	375998	362877	rs1057519739	NC_000018.10:51065517:G:C
NM_005359.5(SMAD4):c.1051G>A (p.Asp351Asn)	SMAD4	D351N	Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375997	18	48591888	18	51065518	375997	362876	rs1057519739	NC_000018.10:51065517:G:A
NM_005359.5(SMAD4):c.989A>C (p.Glu330Ala)	SMAD4	E330A	Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000375996	18	48591826	18	51065456	375996	362875	rs281875324	NC_000018.10:51065455:A:C
NM_001029896.2(WDR45):c.55+2_55+3del	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic	no assertion criteria provided	VCV000375868	X	48935697 - 48935698	X	49078038 - 49078039	375868	362749	rs1057519622	NC_000023.11:49078037:CAC:C
NM_000527.4(LDLR):c.2482dup (p.Tyr828fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375841	19	11240280 - 11240281	19	11129604 - 11129605	375841	362733	rs1057519690	NC_000019.10:11129604:T:TT
NM_000527.4(LDLR):c.2295_2302del (p.Thr766fs)	LDLR	T588fs, T598fs, T725fs, T766fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375837	19	11234002 - 11234009	19	11123326 - 11123333	375837	362729	rs1057519687	NC_000019.10:11123325:GTGACAATGT:GT
NM_000527.4(LDLR):c.2134dup (p.Leu712fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375834	19	11231190 - 11231191	19	11120514 - 11120515	375834	362726	rs1057519685	NC_000019.10:11120514:CC:CCC
NM_000527.4(LDLR):c.2085del (p.Cys696fs)	LDLR	C528fs, C696fs, C655fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375832	19	11231142	19	11120466	375832	362724	rs1057519683	NC_000019.10:11120465:CC:C
NM_000527.4(LDLR):c.2078dup (p.Phe694fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375831	19	11231134 - 11231135	19	11120458 - 11120459	375831	362723	rs1057519682	NC_000019.10:11120458:AA:AAA
NM_000527.4(LDLR):c.2068dup (p.His690fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000375830	19	11231121 - 11231122	19	11120445 - 11120446	375830	362722	rs879255130	NC_000019.10:11120445:CCCCC:CCCCCC
NM_000527.4(LDLR):c.1988-2A>G	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375828	19	11231044	19	11120368	375828	362720	rs879255101	NC_000019.10:11120367:A:G
NM_000527.4(LDLR):c.1980_1983del (p.Pro661fs)	LDLR	P620fs, P534fs, P661fs, P493fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375826	19	11230899 - 11230902	19	11120223 - 11120226	375826	362718	rs1057519679	NC_000019.10:11120222:CCAGCCA:CCA
NM_000527.4(LDLR):c.1853T>G (p.Val618Gly)	LDLR	V618G, V450G, V491G, V577G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375824	19	11230775	19	11120099	375824	362716	rs1057519677	NC_000019.10:11120098:T:G
NM_001195798.2(LDLR):c.1773_1774delinsT (p.Gly593fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375823	19	11227602 - 11227603	19	11116926 - 11116927	375823	362715	rs1057519676	NC_000019.10:11116925:CG:T
NM_000527.4(LDLR):c.1730G>A (p.Trp577Ter)	LDLR	W577*, W409*, W536*, W450*	Familial hypercholesterolemia 1|not provided|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375821	19	11227559	19	11116883	375821	362713	rs138947766	NC_000019.10:11116882:G:A
NM_000527.4(LDLR):c.1571_1572del (p.Val524fs)	LDLR	V356fs, V397fs, V483fs, V524fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375818	19	11224422 - 11224423	19	11113746 - 11113747	375818	362710	rs1057519674	NC_000019.10:11113745:GTG:G
NM_000527.4(LDLR):c.1529del (p.Thr510fs)	LDLR	T383fs, T469fs, T510fs, T342fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375817	19	11224381	19	11113705	375817	362709	rs1057519673	NC_000019.10:11113704:C:
NM_000527.4(LDLR):c.1478del (p.Ser493fs)	LDLR	S325fs, S366fs, S452fs, S493fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375816	19	11224330	19	11113654	375816	362708	rs1057519672	NC_000019.10:11113653:C:
NM_000527.4(LDLR):c.1330del (p.Ser444fs)	LDLR	S317fs, S276fs, S444fs, S403fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375814	19	11224097	19	11113421	375814	362706	rs1057519671	NC_000019.10:11113420:T:
NM_000527.4(LDLR):c.1187del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375810	19	11223953	19	11113277	375810	362702	rs1057519667	NC_000019.10:11113276:GG:G
NM_000527.4(LDLR):c.967G>T (p.Gly323Cys)	LDLR	G323C, G155C, G196C, G282C	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375806	19	11221354	19	11110678	375806	362698	rs373869746	NC_000019.10:11110677:G:T
NM_000527.4(LDLR):c.940+2T>G	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375805	19	11218192	19	11107516	375805	362697	rs875989912	NC_000019.10:11107515:T:G
NM_000527.4(LDLR):c.940+1dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375804	19	11218189 - 11218190	19	11107513 - 11107514	375804	362696	rs1057519666	NC_000019.10:11107513:GG:GGG
NM_000527.4(LDLR):c.940_940+14del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000375803	19	11218186 - 11218200	19	11107510 - 11107524	375803	362695	rs1057519665	NC_000019.10:11107509:GTGCGGTGAGTCTCGGTGC:GTGC
NM_000527.4(LDLR):c.783C>A (p.Cys261Ter)	LDLR	C261*, C134*, C220*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375801	19	11217329	19	11106653	375801	362693	rs1057519663	NC_000019.10:11106652:C:A
NM_000527.4(LDLR):c.683A>G (p.Glu228Gly)	LDLR	E228G, E187G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375796	19	11216265	19	11105589	375796	362688	rs879254642	NC_000019.10:11105588:A:G
NM_000527.4(LDLR):c.666_682dup (p.Glu228fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375795	19	11216246 - 11216247	19	11105570 - 11105571	375795	362682	rs1057519662	NC_000019.10:11105570:GCAAGGACAAATCTGACG:GCAAGGACAAATCTGACGCAAGGACAAATCTGACG
NM_000527.4(LDLR):c.681del (p.Asp227fs)	LDLR	D227fs, D186fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375794	19	11216263	19	11105587	375794	362687	rs1057519661	NC_000019.10:11105586:C:
NM_000527.4(LDLR):c.680_692del (p.Asp227fs)	LDLR	D227fs, D186fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375793	19	11216259 - 11216271	19	11105583 - 11105595	375793	362686	rs1057519660	NC_000019.10:11105582:CTGACGAGGAAAACTG:CTG
NM_000527.4(LDLR):c.383G>A (p.Cys128Tyr)	LDLR	C128Y, C87Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375783	19	11215965	19	11105289	375783	362675	rs879254506	NC_000019.10:11105288:G:A
NM_000527.4(LDLR):c.377T>C (p.Phe126Ser)	LDLR	F126S, F85S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375782	19	11215959	19	11105283	375782	362674	rs879254502	NC_000019.10:11105282:T:C
NM_000527.4(LDLR):c.327C>A (p.Cys109Ter)	LDLR	C109*, C68*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375781	19	11215909	19	11105233	375781	362673	rs1057519654	NC_000019.10:11105232:C:A
NM_000527.4(LDLR):c.314-2A>T	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375780	19	11215894	19	11105218	375780	362672	rs879254470	NC_000019.10:11105217:A:T
NM_000527.4(LDLR):c.244_250dup (p.Pro84fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375779	19	11213391 - 11213392	19	11102715 - 11102716	375779	362671	rs1057519653	NC_000019.10:11102715:CTGCATTC:CTGCATTCTGCATTC
NM_000527.4(LDLR):c.191T>A (p.Leu64Ter)	LDLR	L64*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375776	19	11213340	19	11102664	375776	362668	rs774016801	NC_000019.10:11102663:T:A
NM_000527.4(LDLR):c.126C>G (p.Tyr42Ter)	LDLR	Y42*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000375774	19	11210957	19	11100281	375774	362666	rs751317621	NC_000019.10:11100280:C:G
NM_015295.2(SMCHD1):c.404G>T (p.Ser135Ile)	SMCHD1	S135I	Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375768	18	2667010	18	2667011	375768	362649	rs1057519646	NC_000018.10:2667010:G:T
NM_015295.2(SMCHD1):c.404G>A (p.Ser135Asn)	SMCHD1	S135N	Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375767	18	2667010	18	2667011	375767	362648	rs1057519646	NC_000018.10:2667010:G:A
NM_015295.2(SMCHD1):c.403A>T (p.Ser135Cys)	SMCHD1	S135C	Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375766	18	2667009	18	2667010	375766	362647	rs1057519645	NC_000018.10:2667009:A:T
NM_015295.2(SMCHD1):c.410G>A (p.Gly137Glu)	SMCHD1	G137E	Facioscapulohumeral muscular dystrophy 2|Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000375765	18	2667016	18	2667017	375765	362646	rs1057519644	NC_000018.10:2667016:G:A
NM_015295.2(SMCHD1):c.408A>C (p.Glu136Asp)	SMCHD1	E136D	Facioscapulohumeral muscular dystrophy 2|Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375764	18	2667014	18	2667015	375764	362645	rs1057519643	NC_000018.10:2667014:A:C
NM_015295.2(SMCHD1):c.1199A>T (p.Gln400Leu)	SMCHD1	Q400L	Short nose|Anosmia|Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375763	18	2697896	18	2697898	375763	362644	rs1057519642	NC_000018.10:2697897:A:T
NM_015295.2(SMCHD1):c.423G>C (p.Leu141Phe)	SMCHD1	L141F	Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375762	18	2667029	18	2667030	375762	362643	rs1057519641	NC_000018.10:2667029:G:C
NM_015295.2(SMCHD1):c.1043A>G (p.His348Arg)	SMCHD1	H348R	Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375761	18	2697032	18	2697034	375761	362642	rs1057519640	NC_000018.10:2697033:A:G
NM_015295.2(SMCHD1):c.1034A>G (p.Gln345Arg)	SMCHD1	Q345R	Anosmia|Arhinia choanal atresia microphthalmia	Pathogenic(Last reviewed: Feb 27, 2017)	no assertion criteria provided	VCV000375760	18	2694685	18	2694687	375760	362641	rs1057519639	NC_000018.10:2694686:A:G
NM_031407.7(HUWE1):c.12928G>C (p.Gly4310Arg)	HUWE1	G4310R	Mental retardation, X-linked, syndromic, Turner type	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375725	X	53561062	X	53534101	375725	362599	rs1556909287	NC_000023.11:53534100:C:G
NM_031407.7(HUWE1):c.567+1G>C	HUWE1		Mental retardation, X-linked, syndromic, Turner type	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375711	X	53661187	X	53634235	375711	362613	rs1557024919	NC_000023.11:53634234:C:G
NM_031407.7(HUWE1):c.329G>A (p.Arg110Gln)	HUWE1	R110Q	Mental retardation, X-linked, syndromic, Turner type	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375709	X	53674333	X	53647390	375709	362615	rs1557036768	NC_000023.11:53647389:C:T
NM_198270.4(NHS):c.4385C>G (p.Ser1462Cys)	NHS	S1462C, S1306C, S1483C, S1285C	Syndromic intellectual disability, X-linked|Nance-Horan syndrome	Pathogenic(Last reviewed: Feb 12, 2017)	criteria provided, single submitter	VCV000375706	X	17750076	X	17731956	375706	362596	rs1481421967	NC_000023.11:17731955:C:G
NM_033068.3(ACP4):c.428C>T (p.Thr143Met)	ACP4	T143M	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Oct 28, 2016)	no assertion criteria provided	VCV000375700	19	51295037	19	50791780	375700	362590	rs546603773	NC_000019.10:50791779:C:T
NM_033068.3(ACP4):c.746C>T (p.Pro249Leu)	ACP4	P249L	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Oct 28, 2016)	no assertion criteria provided	VCV000375694	19	51297041	19	50793784	375694	362584	rs1085307111	NC_000019.10:50793783:C:T
NM_001037.5(SCN1B):c.316A>T (p.Ile106Phe)	SCN1B	I106F, I73F	Epileptic encephalopathy, early infantile, 52	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000375687	19	35524511	19	35033607	375687	362556	rs931949929	NC_000019.10:35033606:A:T
NM_001037.5(SCN1B):c.373C>T (p.Arg125Cys)	SCN1B	R125C, R92C	Epileptic encephalopathy, early infantile, 52	Pathogenic(Last reviewed: Feb 17, 2017)	no assertion criteria provided	VCV000375686	19	35524568	19	35033664	375686	362555	rs1135401736	NC_000019.10:35033663:C:T
NM_015559.3(SETBP1):c.2016_2017insT (p.Lys673Ter)	SETBP1		Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000375633	18	42531321 - 42531322	18	44951356 - 44951357	375633	362448	rs1057519594	NC_000018.10:44951356::T
NM_001347721.2(DYRK1A):c.1464del (p.Ala489fs)	DYRK1A	A460fs, A498fs, A489fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 23, 2015)	criteria provided, single submitter	VCV000375629	21	38877834	21	37505531	375629	362451	rs1057519628	NC_000021.9:37505530:CCCC:CCC
NM_001347721.2(DYRK1A):c.270_274del (p.Leu91fs)	DYRK1A	L100fs, L62fs, L91fs	Mental retardation, autosomal dominant 7	Pathogenic	no assertion criteria provided	VCV000375618	21	38850568 - 38850572	21	37478266 - 37478270	375618	362432	rs1057519402	NC_000021.9:37478265:TTGACTTGA:TTGA
NM_001281463.1(SMC1A):c.1322_1323insC (p.Glu442fs)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic	no assertion criteria provided	VCV000375616	X	53436149 - 53436150	X	53409218 - 53409219	375616	362430	rs1057519398	NC_000023.11:53409218::G
NM_003588.3(CUL4B):c.1736_1737del (p.Thr579fs)	CUL4B	T561fs, T383fs, T566fs, T579fs	Syndromic X-linked mental retardation, Cabezas type	Pathogenic	no assertion criteria provided	VCV000375587	X	119673181 - 119673182	X	120539326 - 120539327	375587	362397	rs1057519396	NC_000023.11:120539325:TGT:T
NM_001042537.1(SLC9A6):c.882del (p.Ala295fs)	SLC9A6	A243fs, A263fs, A211fs, A295fs	Christianson syndrome	Pathogenic	no assertion criteria provided	VCV000375585	X	135084354	X	136002195	375585	362395	rs1057519394	NC_000023.11:136002194:TT:T
NM_004187.4(KDM5C):c.2622+2dup	KDM5C		Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic	no assertion criteria provided	VCV000375584	X	53226950 - 53226951	X	53197768 - 53197769	375584	362394	rs1057519393	NC_000023.11:53197768:A:AA
NM_173494.2(DNAAF6):c.355C>T (p.Gln119Ter)	DNAAF6	Q119*	Ciliary dyskinesia, primary, 36, X-linked	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000375563	X	106465997	X	107222767	375563	362373	rs1057519569	NC_000023.11:107222766:C:T
NM_173494.2(DNAAF6):c.357_363del (p.Val120fs)	DNAAF6	V120fs	Ciliary dyskinesia, primary, 36, X-linked	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000375562	X	106465998 - 106466004	X	107222768 - 107222774	375562	362372	rs1057519568	NC_000023.11:107222767:AGGTGGGA:A
NM_001323289.2(CDKL5):c.1449_1452dup (p.Lys485fs)	CDKL5		Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375524	X	18622492 - 18622493	X	18604372 - 18604373	375524	362352	rs1057519542	NC_000023.11:18604372:GACC:GACCGACC
NM_001323289.2(CDKL5):c.2641C>T (p.Gln881Ter)	CDKL5	Q881*	Focal epilepsy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375523	X	18646635	X	18628515	375523	362353	rs1057519541	NC_000023.11:18628514:C:T
NM_172107.4(KCNQ2):c.798T>A (p.Asp266Glu)	KCNQ2	D266E	Epileptic encephalopathy	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375518	20	62073777	20	63442424	375518	362349	rs1057519536	NC_000020.11:63442423:A:T
NM_001127649.3(PEX26):c.296G>A (p.Trp99Ter)	PEX26	W99*	Peroxisome biogenesis disorder 7A	Pathogenic(Last reviewed: Feb 7, 2017)	no assertion criteria provided	VCV000375504	22	18562705	22	18079939	375504	362314	rs62641229	NC_000022.11:18079938:G:A
NM_030632.3(ASXL3):c.1961dup (p.Ser654_Ser655insTer)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000375461	18	31319328 - 31319329	18	33739364 - 33739365	375461	362232	rs1057519498	NC_000018.10:33739364:C:CC
NM_000455.4(STK11):c.440_441del (p.Arg147fs)	STK11	R147fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Dec 16, 2016)	no assertion criteria provided	VCV000375445	19	1219388 - 1219389	19	1219389 - 1219390	375445	362212	rs1555737814	NC_000019.10:1219388:GT:
NM_001037.5(SCN1B):c.308A>T (p.Asp103Val)	SCN1B	D103V, D70V	Cardiomyopathy	Pathogenic	no assertion criteria provided	VCV000375404	19	35524503	19	35033599	375404	362162	rs1057519457	NC_000019.10:35033598:A:T
NM_022095.4(ZNF335):c.2740_2743GTGA[1] (p.Ser915fs)	ZNF335		Primary autosomal recessive microcephaly 10|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000375393	20	44581304 - 44581307	20	45952665 - 45952668	375393	362164	rs753460205	NC_000020.11:45952664:TCACTCAC:TCAC
NM_022095.4(ZNF335):c.3787G>T (p.Glu1263Ter)	ZNF335	E1263*	Primary autosomal recessive microcephaly 10	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000375392	20	44578004	20	45949365	375392	362163	rs749190523	NC_000020.11:45949364:C:A
NM_001356.4(DDX3X):c.362G>T (p.Arg121Leu)	DDX3X	R121L, R105L	Mental retardation, X-linked 102	Pathogenic	no assertion criteria provided	VCV000375386	X	41201825	X	41342572	375386	362168	rs1057519446	NC_000023.11:41342571:G:T
NM_001363819.1(DDX3X):c.-367dup	DDX3X		Mental retardation, X-linked 102	Pathogenic	no assertion criteria provided	VCV000375368	X	41200774 - 41200775	X	41341521 - 41341522	375368	362167	rs1057519431	NC_000023.11:41341521:AAA:AAAA
NM_001356.4(DDX3X):c.1703C>T (p.Pro568Leu)	DDX3X	P568L, P382L, P552L	Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000375367	X	41206199	X	41346946	375367	362169	rs1057519430	NC_000023.11:41346945:C:T
NM_001127221.1(CACNA1A):c.5018G>C (p.Arg1673Pro)	CACNA1A	R1672P, R1673P, R1675P, R1678P	Cerebellar ataxia|Cerebellar atrophy|Intellectual disability|Cerebellar ataxia	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2015)	no assertion criteria provided	VCV000375366	19	13346480	19	13235666	375366	362161	rs1057519429	NC_000019.10:13235665:C:G
NM_024876.4(COQ8B):c.1430G>A (p.Arg477Gln)	COQ8B	R477Q, R436Q	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375337	19	41198145	19	40692240	375337	362110	rs1057519347	NC_000019.10:40692239:C:T
NM_024876.4(COQ8B):c.645del (p.Phe215fs)	COQ8B	F174fs, F215fs	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375336	19	41209692	19	40703787	375336	362112	rs764587648	NC_000019.10:40703786:AAA:AA
NM_001142555.3(COQ8B):c.831_833dup (p.Thr278dup)	COQ8B		Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375335	19	41206293 - 41206294	19	40700388 - 40700389	375335	362111	rs1057519346	NC_000019.10:40700388:GTCGT:GTCGTCGT
NM_024876.4(COQ8B):c.101G>A (p.Trp34Ter)	COQ8B	W34*	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000375334	19	41220437	19	40714532	375334	362113	rs1057519345	NC_000019.10:40714531:C:T
NM_138393.4(REEP6):c.448del (p.Ala150fs)	REEP6	A150fs	Retinitis pigmentosa 77	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000375312	19	1496380	19	1496381	375312	362088	rs1057519341	NC_000019.10:1496380:GGGG:GGG
NM_015692.5(CPAMD8):c.4408-1G>A	CPAMD8		Anterior segment dysgenesis 8	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000375311	19	17014434	19	16903624	375311	362087	rs369858688	NC_000019.10:16903623:C:T
NM_015692.5(CPAMD8):c.2211dup (p.Arg738fs)	CPAMD8		Anterior segment dysgenesis 8	Pathogenic(Last reviewed: Dec 18, 2019)	no assertion criteria provided	VCV000375310	19	17081702 - 17081703	19	16970892 - 16970893	375310	362086	rs756064750	NC_000019.10:16970892:GGGGGGG:GGGGGGGG
NM_015692.5(CPAMD8):c.4210T>C (p.Ser1404Pro)	CPAMD8	S1451P, S1404P	Anterior segment dysgenesis 8	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000375309	19	17015077	19	16904267	375309	362085	rs1057519340	NC_000019.10:16904266:A:G
NM_015365.3(AMMECR1):c.502C>T (p.Arg168Ter)	AMMECR1	R45*, R168*	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	Pathogenic(Last reviewed: Jan 25, 2018)	no assertion criteria provided	VCV000375305	X	109507799	X	110264571	375305	362081	rs1057519338	NC_000023.11:110264570:G:A
NM_015365.3(AMMECR1):c.530G>A (p.Gly177Asp)	AMMECR1	G177D, G54D	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	Pathogenic(Last reviewed: May 17, 2017)	no assertion criteria provided	VCV000375304	X	109507771	X	110264543	375304	362080	rs1057519337	NC_000023.11:110264542:C:T
NM_005215.4(DCC):c.2677G>A (p.Ala893Thr)	DCC	A893T		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375287	18	50918246	18	53391876	375287	362058	rs1057519057	NC_000018.10:53391875:G:A
NM_005215.4(DCC):c.2260G>A (p.Val754Met)	DCC	V754M		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375286	18	50866178	18	53339808	375286	362055	rs775565634	NC_000018.10:53339807:G:A
NM_005215.4(DCC):c.2227A>T (p.Met743Leu)	DCC	M743L		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375285	18	50866145	18	53339775	375285	362054	rs199651452	NC_000018.10:53339774:A:T
NM_005215.4(DCC):c.1790G>C (p.Arg597Pro)	DCC	R597P		Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375284	18	50734116	18	53207746	375284	362053	rs1057519056	NC_000018.10:53207745:G:C
NM_005215.4(DCC):c.2414G>A (p.Gly805Glu)	DCC	G805E	Mirror movements 1|	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000375283	18	50912467	18	53386097	375283	362057	rs1057519055	NC_000018.10:53386096:G:A
NM_005215.4(DCC):c.2378T>G (p.Val793Gly)	DCC	V793G	Mirror movements 1|	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000375282	18	50912431	18	53386061	375282	362056	rs1057519054	NC_000018.10:53386060:T:G
NM_005215.4(DCC):c.925del (p.Thr309fs)	DCC	T309fs	Mirror movements 1|	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000375281	18	50451680	18	52925310	375281	362052	rs1057519053	NC_000018.10:52925309:A:
NM_020971.3(SPTBN4):c.1597C>T (p.Gln533Ter)	SPTBN4	Q533*	not provided|Myopathy, congenital, with neuropathy and deafness	Pathogenic(Last reviewed: Aug 13, 2018)	no assertion criteria provided	VCV000375254	19	41009971	19	40504064	375254	361955	rs1114167445	NC_000019.10:40504063:C:T
NM_172107.4(KCNQ2):c.1680_1684dup (p.Tyr562fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000375002	20	62044881 - 62044882	20	63413528 - 63413529	375002	361908	rs118192231	NC_000020.11:63413528:AGGGC:AGGGCAGGGC
NM_172107.4(KCNQ2):c.1569_1581del (p.Cys523fs)	KCNQ2	C495fs, C523fs, C492fs, C505fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000374999	20	62045491 - 62045503	20	63414138 - 63414150	374999	361690	rs1555854036	NC_000020.11:63414137:AAACTCGCAGGGG:
NM_138393.4(REEP6):c.383C>T (p.Pro128Leu)	REEP6	P128L	Retinitis pigmentosa 77	Pathogenic(Last reviewed: Jan 19, 2017)	no assertion criteria provided	VCV000374992	19	1496318	19	1496319	374992	361900	rs1057519317	NC_000019.10:1496318:C:T
NM_138393.4(REEP6):c.517+177dup	REEP6		Retinitis pigmentosa 77	Pathogenic(Last reviewed: Jan 19, 2017)	no assertion criteria provided	VCV000374991	19	1496625 - 1496626	19	1496626 - 1496627	374991	361899	rs1057519427	NC_000019.10:1496626:CCCC:CCCCC
NM_138393.4(REEP6):c.404T>C (p.Leu135Pro)	REEP6	L135P	Retinitis pigmentosa 77	Pathogenic(Last reviewed: Jan 19, 2017)	no assertion criteria provided	VCV000374989	19	1496339	19	1496340	374989	361897	rs1057519316	NC_000019.10:1496339:T:C
NM_000709.4(BCKDHA):c.399delinsAA (p.Asn134fs)	BCKDHA		Maple syrup urine disease	Pathogenic	no assertion criteria provided	VCV000374929	19	41919977	19	41414072	374929	361834	rs1057519059	NC_000019.10:41414071:C:AA
NM_018255.4(ELP2):c.1385G>T (p.Arg462Leu)	ELP2	R462L, R527L, R392L, R418L, R313L, R412L, R436L, R501L, R457L	Mental retardation, autosomal recessive 58	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000374912	18	33736538	18	36156575	374912	361817	rs371310428	NC_000018.10:36156574:G:T
NM_018255.4(ELP2):c.1663A>C (p.Thr555Pro)	ELP2	T555P, T620P, T594P, T485P, T505P, T550P, T406P, T511P, T529P	Mental retardation, autosomal recessive 58	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000374911	18	33739953	18	36159990	374911	361816	rs772450541	NC_000018.10:36159989:A:C
NM_014727.2(KMT2B):c.402dup (p.Ser135fs)	KMT2B		Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000374874	19	36210404 - 36210405	19	35719502 - 35719503	374874	361779	rs1057519282	NC_000019.10:35719502:CCCCC:CCCCCC
NM_014727.2(KMT2B):c.7050-2A>G	KMT2B		Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000374872	19	36224662	19	35733761	374872	361777	rs1057519280	NC_000019.10:35733760:A:G
NM_014727.2(KMT2B):c.1633C>T (p.Arg545Ter)	KMT2B	R545*	Dystonia 28, childhood-onset	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374871	19	36211882	19	35720980	374871	361776	rs1057519279	NC_000019.10:35720979:C:T
NM_014727.2(KMT2B):c.6406del (p.Leu2136fs)	KMT2B	L2136fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000374870	19	36223856	19	35732955	374870	361775	rs1057519278	NC_000019.10:35732954:C:
NM_033068.3(ACP4):c.397G>A (p.Glu133Lys)	ACP4	E133K	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374866	19	51295006	19	50791749	374866	361771	rs779823931	NC_000019.10:50791748:G:A
NM_033068.3(ACP4):c.382G>C (p.Ala128Pro)	ACP4	A128P	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374865	19	51294991	19	50791734	374865	361770	rs767907487	NC_000019.10:50791733:G:C
NM_033068.3(ACP4):c.226C>T (p.Arg76Cys)	ACP4	R76C	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374864	19	51294040	19	50790783	374864	361769	rs1057519277	NC_000019.10:50790782:C:T
NM_033068.3(ACP4):c.331C>T (p.Arg111Cys)	ACP4	R111C	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374863	19	51294940	19	50791683	374863	361768	rs202073531	NC_000019.10:50791682:C:T
NM_033068.3(ACP4):c.713C>T (p.Ser238Leu)	ACP4	S238L	Amelogenesis imperfecta, type IJ	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000374862	19	51297008	19	50793751	374862	361767	rs763573828	NC_000019.10:50793750:C:T
NM_004429.4(EFNB1):c.561del (p.Asn187fs)	EFNB1	N187fs		Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000374806	X	68059864	X	68840021	374806	361730	rs1057519035	NC_000023.11:68840020:C:
NM_003688.3:c.116_117delCA	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV000374802					374802	361732		
NM_001848.2(COL6A1):c.904-2A>G	COL6A1		not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374620	21	47409664	21	45989750	374620	361506	rs1057519174	NC_000021.9:45989749:A:G
NM_000159.4(GCDH):c.764C>T (p.Ser255Leu)	GCDH	S255L	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374435	19	13007147	19	12896333	374435	361321	rs758503371	NC_000019.10:12896332:C:T
NM_001008537.3(NEXMIF):c.1376_1377del (p.Asp458_Cys459insTer)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000374404	X	73963015 - 73963016	X	74743180 - 74743181	374404	361254	rs1057518730	NC_000023.11:74743179:ACA:A
NM_001008537.3(NEXMIF):c.4248dup (p.Gly1417fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Apr 18, 2014)	no assertion criteria provided	VCV000374403	X	73960143 - 73960144	X	74740308 - 74740309	374403	361253	rs1057518728	NC_000023.11:74740308:A:AA
NM_015107.3(PHF8):c.377del (p.Leu126fs)	PHF8	L162fs, L126fs	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Apr 18, 2014)	no assertion criteria provided	VCV000374402	X	54044171	X	54017738	374402	361248	rs1057518729	NC_000023.11:54017737:A:
NM_001256447.2(BCAP31):c.-44-270C>A	BCAP31	S36*	Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Jun 17, 2014)	no assertion criteria provided	VCV000374401	X	152989013	X	153723558	374401	361238	rs1057518721	NC_000023.11:153723557:G:T
NM_001281463.1(SMC1A):c.50C>G (p.Ser17Ter)	SMC1A	S17*, S39*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374391	X	53442112	X	53415163	374391	361246	rs1057518670	NC_000023.11:53415162:G:C
NM_172107.4(KCNQ2):c.2296del (p.Leu766fs)	KCNQ2	L748fs, L735fs, L738fs, L766fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374390	20	62038320	20	63406967	374390	361236	rs1057518668	NC_000020.11:63406966:GG:G
Single allele	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Dec 7, 2015)	no assertion criteria provided	VCV000374373	22	38565225 - 38565478			374373	361274		
Single allele	DMD		Duchenne muscular dystrophy|Becker muscular dystrophy	Pathogenic(Last reviewed: Sep 5, 2015)	no assertion criteria provided	VCV000374372	X	31792077 - 31854939			374372	361273		
NM_005660.3(SLC35A2):c.617_620del (p.Val206fs)	SLC35A2	V219fs, V145fs, V206fs, V234fs	SLC35A2-CDG	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000374354	X	48762566 - 48762569	X	48905289 - 48905292	374354	361244	rs1057518719	NC_000023.11:48905288:ACGA:
Single allele	DMD		Duchenne muscular dystrophy|Becker muscular dystrophy	Pathogenic(Last reviewed: Sep 5, 2015)	no assertion criteria provided	VCV000374332	X	31838467 - 31867499			374332	361267		
NM_000284.4(PDHA1):c.292-23A>G	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Jan 25, 2015)	no assertion criteria provided	VCV000374330	X	19369376	X	19351258	374330	361266	rs1057518702	NC_000023.11:19351257:A:G
NM_004463.3(FGD1):c.527del (p.Pro176fs)	FGD1	P176fs	Aarskog syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000374329	X	54497148	X	54470715	374329	361249	rs756586058	NC_000023.11:54470714:GGGGGGGG:GGGGGGG
NM_000451.3(SHOX):c.544+1G>A	SHOX		Short stature, idiopathic, X-linked	Pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	VCV000374328	X	601614	X	640879	374328	361265	rs1057518701	NC_000024.10:640878:G:A
NM_004187.4(KDM5C):c.1439C>T (p.Pro480Leu)	KDM5C	P480L, P413L, P479L	Mental retardation, syndromic, Claes-Jensen type, X-linked|Spastic paraplegia|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374324	X	53240002	X	53210820	374324	361245	rs1057518697	NC_000023.11:53210819:G:A
NM_000109.4(DMD):c.5628del (p.Arg1876fs)	DMD	R1884fs, R543fs, R1761fs, R540fs, R1876fs, R1880fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000374319	X	32361338	X	32343221	374319	361242	rs1057518692	NC_000023.11:32343220:CC:C
NC_000019.9:g.(?_44015589)_(44015719_?)del	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Dec 4, 2015)	no assertion criteria provided	VCV000374299	19	44015589 - 44015719			374299	361262		
NM_172107.4(KCNQ2):c.2425del (p.Gln809fs)	KCNQ2	Q791fs, Q781fs, Q778fs, Q809fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374272	20	62038191	20	63406838	374272	361235	rs1057518662	NC_000020.11:63406837:GGG:GG
NM_153252.5(BRWD3):c.568C>T (p.Arg190Ter)	BRWD3	R190*	Mental retardation, X-linked 93	Pathogenic(Last reviewed: Feb 17, 2015)	no assertion criteria provided	VCV000374258	X	80001091	X	80745592	374258	361256	rs1057518650	NC_000023.11:80745591:G:A
NM_001282531.3(ADNP):c.2318dup (p.Tyr774fs)	ADNP		Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000374212	20	49508932 - 49508933	20	50892395 - 50892396	374212	361112	rs1057518978	NC_000020.11:50892395:TTT:TTTT
NM_004006.2(DMD):c.1637G>A (p.Trp546Ter)	DMD	W546*, W538*, W423*, W542*	Muscle weakness|Calf muscle hypertrophy|EMG: myopathic abnormalities|Motor delay|EMG abnormality|Muscle cramps	Pathogenic(Last reviewed: Jun 11, 2014)	criteria provided, single submitter	VCV000374191	X	32591929	X	32573812	374191	361095	rs1057518962	NC_000023.11:32573811:C:T
NM_004006.2(DMD):c.10247G>A (p.Trp3416Ter)	DMD	W3416*, W3412*, W687*, W2075*, W3293*, W2072*, W3408*, W956*, W348*	Duchenne muscular dystrophy|Duchenne muscular dystrophy|Dilated cardiomyopathy 3B|Becker muscular dystrophy|Cardiomyopathy|Pectus excavatum|Ptosis|Clinodactyly of the 5th finger|Proptosis	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374132	X	31196064	X	31177947	374132	361092	rs201217593	NC_000023.11:31177946:C:T
NM_153638.3(PANK2):c.1069C>T (p.Arg357Trp)	PANK2	R357W, R66W	Neurodegeneration	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000374127	20	3891311	20	3910664	374127	361064	rs753376100	NC_000020.11:3910663:C:T
NM_153638.3(PANK2):c.894G>A (p.Met298Ile)	PANK2	M298I, M7I	Neurodegeneration	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000374126	20	3888838	20	3908191	374126	361063	rs1057518915	NC_000020.11:3908190:G:A
NM_001077488.4(GNAS):c.85C>T (p.Gln29Ter)	GNAS	Q29*	Cushing's syndrome|PITUITARY ADENOMA 3, MULTIPLE TYPES|Progressive osseous heteroplasia|Pseudohypoparathyroidism|McCune-Albright syndrome|Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism type 1C|Pseudohypoparathyroidism type 1B|Round face|Brachydactyly|Cognitive impairment|Obesity|Tetany|Short stature|Subcutaneous nodule|Hypocalcemia|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374113	20	57466866	20	58891811	374113	361065	rs1057518907	NC_000020.11:58891810:C:T
NM_004006.2(DMD):c.5699T>G (p.Leu1900Ter)	DMD	L1900*, L1892*, L1896*, L559*, L1777*, L556*	Muscular Diseases	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, single submitter	VCV000374059	X	32361291	X	32343174	374059	361093	rs1057518866	NC_000023.11:32343173:A:C
NM_001083962.2(TCF4):c.500-1G>A	TCF4		Global developmental delay|Epicanthus|Short nose|Anteverted nares|Stereotypy|Drooling|Feeding difficulties in infancy	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000374054	18	53017640	18	55350409	374054	361037	rs1057518864	NC_000018.10:55350408:C:T
NM_000271.5(NPC1):c.1421C>T (p.Pro474Leu)	NPC1	P474L	Headache|Cognitive impairment|Postural instability|Cerebellar ataxia|Cataplexy|Speech apraxia|Niemann-Pick disease type C1	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374049	18	21134854	18	23554890	374049	361031	rs372445155	NC_000018.10:23554889:G:A
NM_001083962.2(TCF4):c.1719_1722dup (p.Ala575fs)	TCF4		Global developmental delay|Cerebral hypoplasia|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jun 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000374031	18	52896234 - 52896235	18	55229003 - 55229004	374031	361036	rs1057518848	NC_000018.10:55229003:ATTG:ATTGATTG
NM_000377.2(WAS):c.1183_1190dup (p.Pro398fs)	WAS		not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000373820	X	48547299 - 48547300	X	48688910 - 48688911	373820	360645	rs1057518633	NC_000023.11:48688910:CCACCACC:CCACCACCCCACCACC
NM_000271.5(NPC1):c.2280_2281CT[3] (p.Phe763fs)	NPC1		not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000373793	18	21121356 - 21121357	18	23541392 - 23541393	373793	360314	rs1057518613	NC_000018.10:23541391:AGAGAGAGA:AGAGAGA
NM_000527.4(LDLR):c.1774G>A (p.Gly592Arg)	LDLR	G592R, G551R, G424R, G465R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373769	19	11227603	19	11116927	373769	360376	rs763147599	NC_000019.10:11116926:G:A
NM_001347721.2(DYRK1A):c.550_552delinsTTCTT (p.Lys184fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000373735	21	38858829 - 38858831	21	37486527 - 37486529	373735	360488	rs1057518580	NC_000021.9:37486526:AAG:TTCTT
NM_000397.3(CYBB):c.898-2A>C	CYBB		not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000373734	X	37663128	X	37803875	373734	360635	rs1057518579	NC_000023.11:37803874:A:C
NM_007363.5(NONO):c.230_231del (p.Phe77fs)	NONO	F77fs	not provided	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, single submitter	VCV000373550	X	70511701 - 70511702	X	71291851 - 71291852	373550	360650	rs1057518476	NC_000023.11:71291850:TTTTT:TTT
NM_001347721.2(DYRK1A):c.638-2A>G	DYRK1A		not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000373544	21	38862475	21	37490173	373544	360443	rs1057518474	NC_000021.9:37490172:A:G
NM_015338.5(ASXL1):c.3894_3897dup (p.Gln1300fs)	ASXL1		not provided	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000373517	20	31024407 - 31024408	20	32436604 - 32436605	373517	360568	rs1057518458	NC_000020.11:32436604:CAGGC:CAGGCAGGC
NM_000116.5(TAZ):c.699+1G>A	TAZ		not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000373434	X	153648604	X	154420265	373434	360548	rs1057518416	NC_000023.11:154420264:G:A
NM_000444.6(PHEX):c.1586+2T>A	PHEX		not provided	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000373371	X	22196495	X	22178378	373371	360571	rs1057518377	NC_000023.11:22178377:T:A
NM_000444.6(PHEX):c.663+2T>A	PHEX		not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000373319	X	22095822	X	22077704	373319	360612	rs1057518348	NC_000023.11:22077703:T:A
NM_001282531.3(ADNP):c.539_542del (p.Val180fs)	ADNP	V180fs	Helsmoortel-Van der Aa Syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373314	20	49510709 - 49510712	20	50894172 - 50894175	373314	360425	rs1057518345	NC_000020.11:50894171:CTAACTA:CTA
NM_001083962.2(TCF4):c.1037C>G (p.Ser346Ter)	TCF4	S346*, S345*, S130*, S216*, S186*, S275*, S344*, S352*, S448*, S304*, S321*, S322*	not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000373305	18	52927212	18	55259981	373305	360490	rs1057518339	NC_000018.10:55259980:G:C
NM_000109.4(DMD):c.3339_3340AG[3] (p.Phe1115fs)	DMD		not provided	Pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000373208	X	32481621 - 32481622	X	32463504 - 32463505	373208	360686	rs1057518284	NC_000023.11:32463504:CTCT:CTCTCT
NM_003688.3(CASK):c.2368C>T (p.Gln790Ter)	CASK	Q790*, Q767*, Q766*, Q795*	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000373139	X	41390397	X	41531144	373139	360639	rs1057518245	NC_000023.11:41531143:G:A
NM_001077488.4(GNAS):c.1096del (p.Cys366fs)	GNAS	C1008fs, C351fs, C366fs, C365fs, C306fs, C350fs	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000373111	20	57485792	20	58910737	373111	360431	rs1057518224	NC_000020.11:58910736:T:
NM_000346.4(SOX9):c.1180C>T (p.Arg394Ter)	SOX9	R394*	Camptomelic dysplasia|not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373101	17	70120178	17	72124037	373101	360346	rs1057518216	NC_000017.11:72124036:C:T
NM_004006.2(DMD):c.2168+1G>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373091	X	32563275	X	32545158	373091	360687	rs1057518207	NC_000023.11:32545157:C:T
NM_001347721.2(DYRK1A):c.322C>T (p.Arg108Ter)	DYRK1A	R117*, R108*, R79*	Mental retardation, autosomal dominant 7|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373087	21	38852961	21	37480659	373087	360481	rs1057518204	NC_000021.9:37480658:C:T
NM_001323289.2(CDKL5):c.1006C>T (p.Gln336Ter)	CDKL5	Q336*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373086	X	18622050	X	18603930	373086	360565	rs1057518203	NC_000023.11:18603929:C:T
NM_153252.5(BRWD3):c.2598_2601dup (p.Leu868fs)	BRWD3		not provided	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000373083	X	79960296 - 79960297	X	80704797 - 80704798	373083	360695	rs1057518202	NC_000023.11:80704797:ATTTATT:ATTTATTTATT
NM_005660.3(SLC35A2):c.634_636TCC[1] (p.Ser213del)	SLC35A2	S213del	not provided	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000373073	X	48762547 - 48762549	X	48905270 - 48905272	373073	360694	rs1057518194	NC_000023.11:48905269:GGAGGAG:GGAG
NM_001972.3(ELANE):c.600_601dupGG (p.Asp201Glyfs)	ELANE		not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000373070	19	855956 - 855957	19	855956 - 855957	373070	360416	rs1057518191	NC_000019.10:855956:GGGGG:GGGGGGG
NM_001193466.2(KANSL1):c.1579_1582del (p.Ile527fs)	KANSL1	I527fs	not provided	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000373061	17	44144985 - 44144988	17	46067619 - 46067622	373061	360248	rs1057518182	NC_000017.11:46067618:CAAT:
NM_006892.4(DNMT3B):c.562dup (p.Tyr188fs)	DNMT3B		not provided	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000373054	20	31375164 - 31375165	20	32787358 - 32787359	373054	360466	rs1057518176	NC_000020.11:32787358:T:TT
NM_001039591.3(USP9X):c.2876C>A (p.Ser959Ter)	USP9X	S959*	not provided	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000373052	X	41029487	X	41170234	373052	360642	rs1057518174	NC_000023.11:41170233:C:A
NM_000284.4(PDHA1):c.921_932dup (p.Arg311_Ser312insSerGlnGluVal)	PDHA1		not provided	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000373051	X	19377054 - 19377055	X	19358936 - 19358937	373051	360671	rs1057518173	NC_000023.11:19358936:TCAGGAAGTAAG:TCAGGAAGTAAGTCAGGAAGTAAG
NM_004187.4(KDM5C):c.3404dup (p.Ser1136fs)	KDM5C		not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000373050	X	53224146 - 53224147	X	53194964 - 53194965	373050	360633	rs1057518172	NC_000023.11:53194964:A:AA
NM_001363819.1(DDX3X):c.-187_-186del	DDX3X	N108fs, N124fs	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000373049	X	41201834 - 41201835	X	41342581 - 41342582	373049	360643	rs1057518171	NC_000023.11:41342580:ACA:A
NM_080647.1(TBX1):c.1176_1195dup (p.Glu399fs)	TBX1		not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000373046	22	19754074 - 19754075	22	19766551 - 19766552	373046	360504	rs1057518168	NC_000022.11:19766551:CCGGCCCAGTCCCCCGAACCCCG:CCGGCCCAGTCCCCCGAACCCCGGCCCAGTCCCCCGAACCCCG
NM_000273.3(GPR143):c.163_170del (p.Ala55fs)	GPR143	A55fs	not provided	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, single submitter	VCV000373042	X	9733688 - 9733695	X	9765648 - 9765655	373042	360697	rs1057518164	NC_000023.11:9765647:GGGCCCGCGGGCC:GGGCC
NM_176787.5(PIGN):c.181G>T (p.Glu61Ter)	PIGN	E61*	not provided	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373038	18	59828406	18	62161173	373038	360497	rs200199765	NC_000018.10:62161172:C:A
NM_002501.4(NFIX):c.559+1G>A	NFIX		not provided	Pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000373027	19	13136367	19	13025553	373027	360380	rs1057518152	NC_000019.10:13025552:G:A
NM_001127221.1(CACNA1A):c.3535dup (p.Leu1179fs)	CACNA1A		not provided	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000372975	19	13397337 - 13397338	19	13286523 - 13286524	372975	360374	rs757953057	NC_000019.10:13286523:GGGGGGG:GGGGGGGG
NM_030773.3(TUBB1):c.779T>C (p.Phe260Ser)	TUBB1	F260S	not provided|	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372810	20	57599261	20	59024206	372810	360473	rs1057517996	NC_000020.11:59024205:T:C
NM_000479.5(AMH):c.208dup (p.Leu70fs)	AMH		not provided	Pathogenic(Last reviewed: Oct 28, 2016)	criteria provided, single submitter	VCV000372806	19	2249533 - 2249534	19	2249534 - 2249535	372806	360383	rs769922506	NC_000019.10:2249534:CCCCCC:CCCCCCC
NM_152296.5(ATP1A3):c.2116G>A (p.Gly706Arg)	ATP1A3	G706R, G717R, G719R	not provided|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372799	19	42479928	19	41975776	372799	360446	rs782175860	NC_000019.10:41975775:C:T
NM_006087.4(TUBB4A):c.535G>C (p.Val179Leu)	TUBB4A	V179L, V230L, V224L, V107L	not provided	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000372789	19	6495975	19	6495964	372789	360447	rs1057517986	NC_000019.10:6495963:C:G
NM_015629.4(PRPF31):c.527+1G>T	PRPF31		Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372779	19	54626940	19	54123561	372779	360464	rs1057517982	NC_000019.10:54123560:G:T
NM_000271.5(NPC1):c.2201G>T (p.Ser734Ile)	NPC1	S734I	not provided|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372775	18	21123463	18	23543499	372775	360321	rs757475924	NC_000018.10:23543498:C:A
NM_001399.5(EDA):c.245del (p.Gly82fs)	EDA	G82fs	not provided	Pathogenic(Last reviewed: Nov 9, 2016)	criteria provided, single submitter	VCV000372765	X	68836395	X	69616551	372765	360670	rs1057517971	NC_000023.11:69616550:GGG:GG
NM_002049.3(GATA1):c.622G>A (p.Gly208Arg)	GATA1	G208R	not provided	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000372762	X	48650753	X	48792346	372762	360619	rs587776454	NC_000023.11:48792345:G:A
NM_004006.2(DMD):c.1602+1G>A	DMD		not provided	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000372742	X	32613873	X	32595756	372742	360601	rs1057517960	NC_000023.11:32595755:C:T
NM_203473.3(PORCN):c.1235T>C (p.Phe412Ser)	PORCN	F412S, F417S, F406S, F335S, F411S	not provided	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000372731	X	48375647	X	48517259	372731	360691	rs1057517951	NC_000023.11:48517258:T:C
NM_000284.4(PDHA1):c.858_861dup (p.Arg288fs)	PDHA1		not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000372714	X	19375793 - 19375794	X	19357675 - 19357676	372714	360606	rs1555934859	NC_000023.11:19357675:ACTTAC:ACTTACTTAC
NM_000199.5(SGSH):c.356-2A>G	SGSH		not provided	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	VCV000372692	17	78188566	17	80214767	372692	360477	rs1057517927	NC_000017.11:80214766:T:C
NM_000444.6(PHEX):c.1173+2T>C	PHEX		not provided	Pathogenic(Last reviewed: Oct 20, 2016)	criteria provided, single submitter	VCV000372631	X	22129680	X	22111562	372631	360621	rs1057517896	NC_000023.11:22111561:T:C
NM_031407.7(HUWE1):c.12680T>C (p.Leu4227Ser)	HUWE1	L4227S	not provided	Pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000372628	X	53561628	X	53534667	372628	360637	rs1057517893	NC_000023.11:53534666:A:G
NM_003639.4(IKBKG):c.220del (p.Glu74fs)	IKBKG	E74fs, E142fs	not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	VCV000372591	X	153784410	X	154556195	372591	360550	rs1057517874	NC_000023.11:154556194:GGG:GG
NM_000377.2(WAS):c.777+1G>A	WAS		not provided|Wiskott-Aldrich syndrome||X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372546	X	48546486	X	48688097	372546	360647	rs1057517845	NC_000023.11:48688096:G:A
NM_000377.2(WAS):c.559+5G>A	WAS		not provided	Pathogenic(Last reviewed: Dec 24, 2015)	criteria provided, single submitter	VCV000372545	X	48544528	X	48686139	372545	360692	rs886039451	NC_000023.11:48686138:G:A
NM_003244.3(TGIF1):c.269G>A (p.Arg90His)	TGIF1	R219H, R90H, R104H, R70H, R93H	not provided	Pathogenic(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	VCV000372529	18	3457388	18	3457390	372529	360353	rs1057517835	NC_000018.10:3457389:G:A
NM_000455.4(STK11):c.921-1G>C	STK11		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000372524	19	1222983	19	1222984	372524	360361	rs398123406	NC_000019.10:1222983:G:C
NM_000455.4(STK11):c.790_793del (p.Phe264fs)	STK11	F264fs	Hereditary cancer-predisposing syndrome|not provided|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372523	19	1221264 - 1221267	19	1221265 - 1221268	372523	360512	rs121913320	NC_000019.10:1221264:TTGTTTG:TTG
NM_000455.4(STK11):c.735-1G>A	STK11		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, multiple submitters, no conflicts	VCV000372522	19	1221211	19	1221212	372522	360507	rs1057517830	NC_000019.10:1221211:G:A
NM_000346.4(SOX9):c.1262_1278del (p.Ser421fs)	SOX9	S421fs	not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000372514	17	70120258 - 70120274	17	72124117 - 72124133	372514	360272	rs1057517827	NC_000017.11:72124116:CAGCCCCTTCAACCTCCCA:CA
NM_001022.4(RPS19):c.406G>T (p.Gly136Ter)	RPS19	G136*, R140L	not provided	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000372495	19	42373818	19	41869748	372495	360439	rs144337183	NC_000019.10:41869747:G:T
NM_001022.4(RPS19):c.3G>T (p.Met1Ile)	RPS19	M1I	not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000372494	19	42364847	19	41860777	372494	360563	rs138938035	NC_000019.10:41860776:G:T
NM_212472.2(PRKAR1A):c.951del (p.Arg317fs)	PRKAR1A	R317fs	not provided	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000372475	17	66526120	17	68529979	372475	360318	rs1057517805	NC_000017.11:68529978:A:
NM_000444.6(PHEX):c.1483-1G>A	PHEX		not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000372458	X	22196389	X	22178272	372458	360559	rs1057517794	NC_000023.11:22178271:G:A
NM_000444.6(PHEX):c.1180C>T (p.Gln394Ter)	PHEX	Q394*	not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000372457	X	22132582	X	22114464	372457	360587	rs1057517793	NC_000023.11:22114463:C:T
NM_000444.6(PHEX):c.1046dup (p.Asp349fs)	PHEX		not provided	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000372456	X	22117235 - 22117236	X	22099117 - 22099118	372456	360679	rs1057517792	NC_000023.11:22099117:A:AA
NM_000444.6(PHEX):c.883del (p.Ala295fs)	PHEX	A295fs	not provided	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000372455	X	22115105	X	22096987	372455	360678	rs1057517791	NC_000023.11:22096986:GG:G
NM_000444.6(PHEX):c.871C>T (p.Arg291Ter)	PHEX	R291*	not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372454	X	22115094	X	22096976	372454	360620	rs866429868	NC_000023.11:22096975:C:T
NM_000444.6(PHEX):c.503C>T (p.Pro168Leu)	PHEX	P168L	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372453	X	22095660	X	22077542	372453	360677	rs1057517790	NC_000023.11:22077541:C:T
NM_000444.6(PHEX):c.500G>A (p.Trp167Ter)	PHEX	W167*	not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000372452	X	22095657	X	22077539	372452	360585	rs1057517789	NC_000023.11:22077538:G:A
NM_000444.6(PHEX):c.426C>A (p.Cys142Ter)	PHEX	C142*	not provided	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000372450	X	22094582	X	22076464	372450	360581	rs1057517787	NC_000023.11:22076463:C:A
NM_000475.5(NR0B1):c.580del (p.Ala194fs)	NR0B1	A194fs	not provided	Pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, single submitter	VCV000372436	X	30326901	X	30308784	372436	360630	rs1057517778	NC_000023.11:30308783:CC:C
NM_003639.4(IKBKG):c.1167dup (p.Glu390fs)	IKBKG		not provided|Ectodermal dysplasia and immunodeficiency 1|Incontinentia pigmenti, atypical	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000372387	X	153792576 - 153792577	X	154564361 - 154564362	372387	360602	rs782178147	NC_000023.11:154564361:CCCCCCC:CCCCCCCC
NM_000206.2(IL2RG):c.43C>T (p.Gln15Ter)	IL2RG	Q15*	not provided	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000372386	X	70331347	X	71111497	372386	360655	rs1057517747	NC_000023.11:71111496:G:A
NM_003639.4(IKBKG):c.672-2A>G	IKBKG		not provided	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, single submitter	VCV000372385	X	153789901	X	154561686	372385	360669	rs1057517746	NC_000023.11:154561685:A:G
NM_004484.3(GPC3):c.175G>T (p.Gly59Ter)	GPC3	G59*, E59*	not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000372372	X	133119302	X	133985275	372372	360574	rs1057517739	NC_000023.11:133985274:C:A
NM_014009.3(FOXP3):c.1009C>T (p.Arg337Ter)	FOXP3	R337*, R302*	not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000372368	X	49109622	X	49253161	372368	360624	rs1057517736	NC_000023.11:49253160:G:A
NM_001972.4(ELANE):c.137C>T (p.Ser46Phe)	ELANE	S46F	not provided	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000372362	19	852945	19	852945	372362	360456	rs878855320	NC_000019.10:852944:C:T
NM_000397.3(CYBB):c.674+4_674+7delAGTG	CYBB		not provided	Pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, single submitter	VCV000372353	X	37655392 - 37655395	X	37796139 - 37796142	372353	360631	rs1057517730	NC_000023.11:37796138:TGAGTGAGTG:TGAGTG
NM_000390.4(CHM):c.1437dup (p.Glu480fs)	CHM		not provided	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000372324	X	85149265 - 85149266	X	85894260 - 85894261	372324	360696	rs1057517717	NC_000023.11:85894260:T:TT
NM_000390.4(CHM):c.1342C>T (p.Gln448Ter)	CHM	Q448*, Q300*	not provided	Pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000372323	X	85156096	X	85901091	372323	360708	rs1057517716	NC_000023.11:85901090:G:A
NM_000390.4(CHM):c.1213C>T (p.Gln405Ter)	CHM	Q405*, Q257*	not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000372322	X	85166297	X	85911292	372322	360672	rs1057517715	NC_000023.11:85911291:G:A
NM_000390.4(CHM):c.1019C>A (p.Ser340Ter)	CHM	S340*, S192*	not provided	Pathogenic(Last reviewed: Aug 5, 2015)	criteria provided, single submitter	VCV000372321	X	85211305	X	85956300	372321	360709	rs1057517714	NC_000023.11:85956299:G:T
NM_005183.4(CACNA1F):c.3433G>T (p.Glu1145Ter)	CACNA1F	E1145*, E1080*, E1134*	not provided	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000372314	X	49071840	X	49215380	372314	360699	rs138447882	NC_000023.11:49215379:C:A
NM_000061.2(BTK):c.1103G>A (p.Gly368Glu)	BTK	G368E, G402E	not provided	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000372312	X	100612571	X	101357583	372312	360547	rs1057517710	NC_000023.11:101357582:C:T
NM_000061.2(BTK):c.1064T>A (p.Ile355Asn)	BTK	I355N, I389N	not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000372311	X	100613336	X	101358348	372311	360510	rs1057517709	NC_000023.11:101358347:A:T
NM_139058.3(ARX):c.1593_1599dup (p.Ala534fs)	ARX		not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000372305	X	25022876 - 25022877	X	25004759 - 25004760	372305	360636	rs1057517705	NC_000023.11:25004759:GGCTATG:GGCTATGGGCTATG
NM_000487.6(ARSA):c.979G>A (p.Gly327Ser)	ARSA	G327S, G241S	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000372303	22	51064582	22	50626154	372303	360618	rs148092995	NC_000022.11:50626153:C:T
NM_000383.4(AIRE):c.823del (p.Gln275fs)	AIRE	Q275fs	not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000372300	21	45709894	21	44290011	372300	360492	rs764819068	NC_000021.9:44290010:CC:C
NM_024120.5(NDUFAF5):c.749G>T (p.Gly250Val)	NDUFAF5	G250V, G222V, G93V, G63V	not provided|Mitochondrial complex I deficiency|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372253	20	13789519	20	13808873	372253	359158	rs757043077	NC_000020.11:13808872:G:T
NM_001289905.1(IL17RA):c.764_768CCAGA[1] (p.Pro257fs)	IL17RA		Immunodeficiency 51	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372208	22	17584385 - 17584389	22	17103495 - 17103499	372208	359113	rs1057518747	NC_000022.11:17103494:CCAGACCAGA:CCAGA
NM_014339.6(IL17RA):c.268del (p.Leu90fs)	IL17RA	L90fs	Immunodeficiency 51	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372207	22	17578790	22	17097900	372207	359112	rs1057518746	NC_000022.11:17097899:CC:C
NM_014339.6(IL17RA):c.196C>T (p.Arg66Ter)	IL17RA	R66*	Immunodeficiency 51	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV000372206	22	17578719	22	17097829	372206	359111	rs1057518745	NC_000022.11:17097828:C:T
NM_014339.6(IL17RA):c.1159G>A (p.Asp387Asn)	IL17RA	D387N, D353N	Immunodeficiency 51	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372205	22	17589268	22	17108378	372205	359110	rs1057519079	NC_000022.11:17108377:G:A
NM_014339.6(IL17RA):c.1302_1318dup (p.Asn440fs)	IL17RA		Immunodeficiency 51	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372204	22	17589406 - 17589407	22	17108516 - 17108517	372204	359109	rs1057518744	NC_000022.11:17108516:AGCAGGAGATGGTGGAGAGCA:AGCAGGAGATGGTGGAGAGCAGGAGATGGTGGAGAGCA
NM_002250.3(KCNN4):c.845T>A (p.Val282Glu)	KCNN4	V282E	Dehydrated hereditary stomatocytosis 2	Pathogenic(Last reviewed: Dec 11, 2015)	no assertion criteria provided	VCV000372186	19	44273956	19	43769804	372186	359091	rs1057519077	NC_000019.10:43769803:A:T
NM_002250.3(KCNN4):c.844G>A (p.Val282Met)	KCNN4	V282M	Dehydrated hereditary stomatocytosis 2	Pathogenic(Last reviewed: Dec 11, 2015)	no assertion criteria provided	VCV000372185	19	44273957	19	43769805	372185	359090	rs1057519076	NC_000019.10:43769804:C:T
NM_002444.3(MSN):c.1657C>T (p.Arg553Ter)	MSN	R553*	Immunodeficiency 50	Pathogenic(Last reviewed: Dec 20, 2016)	no assertion criteria provided	VCV000372155	X	64959678	X	65739816	372155	359060	rs1057519075	NC_000023.11:65739815:C:T
NM_002444.3(MSN):c.511C>T (p.Arg171Trp)	MSN	R171W	Immunodeficiency 50	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000372154	X	64951012	X	65731150	372154	359059	rs1057519074	NC_000023.11:65731149:C:T
NM_006280.3(SSR4):c.418-1G>A	SSR4		Congenital disorder of glycosylation type 1y	Pathogenic(Last reviewed: Nov 28, 2016)	no assertion criteria provided	VCV000372146	X	153063783	X	153798328	372146	359051	rs1057518736	NC_000023.11:153798327:G:A
NM_006280.3(SSR4):c.417+1G>A	SSR4		Congenital disorder of glycosylation type 1y	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000372145	X	153063592	X	153798137	372145	359050	rs1057518735	NC_000023.11:153798136:G:A
NM_006280.3(SSR4):c.356_357AG[1] (p.Arg120fs)	SSR4		Congenital disorder of glycosylation type 1y	Pathogenic/Likely pathogenic(Last reviewed: Nov 28, 2016)	no assertion criteria provided	VCV000372144	X	153063530 - 153063531	X	153798075 - 153798076	372144	359049	rs794729223	NC_000023.11:153798074:AGAG:AG
NM_006280.3(SSR4):c.187-301_352-15del	SSR4		Congenital disorder of glycosylation type 1y	Pathogenic(Last reviewed: Nov 28, 2016)	no assertion criteria provided	VCV000372143	X	153062612 - 153063511	X	153797129 - 153798028	372143	359048	rs1557072752	
NM_000527.4:c.5-kb del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372122					372122	359029		
NM_000527.4:c.>15-kb del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372121					372121	359028		
NM_000487.6(ARSA):c.526C>T (p.Gln176Ter)	ARSA	Q176*, Q90*	Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371662	22	51065420	22	50626992	371662	358682	rs762284875	NC_000022.11:50626991:G:A
NM_000487.6(ARSA):c.495_501del (p.Pro166fs)	ARSA	P166fs, P80fs	not provided|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371638	22	51065445 - 51065451	22	50627017 - 50627023	371638	358683	rs1057517429	NC_000022.11:50627016:GGCCGGCGG:GG
NM_000071.2(CBS):c.954+1G>A	CBS		Classic homocystinuria	Pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000371568	21	44483062	21	43062952	371568	358637	rs1057517373	NC_000021.9:43062951:C:T
NM_000071.2(CBS):c.442G>A (p.Gly148Arg)	CBS	G148R, G43R	Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371512	21	44486362	21	43066252	371512	358643	rs755952006	NC_000021.9:43066251:C:T
NM_000152.5(GAA):c.2813_2814GT[1] (p.Val939fs)	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000371481	17	78093083 - 78093084	17	80119284 - 80119285	371481	358523	rs763359208	NC_000017.11:80119283:TGTGT:TGT
NM_000152.5(GAA):c.1193del (p.Leu398fs)	GAA	L398fs	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371457	17	78082405	17	80108606	371457	358498	rs1057517286	NC_000017.11:80108605:T:
NM_000528.4(MAN2B1):c.422del (p.Asp141fs)	MAN2B1	D141fs	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371425	19	12776180	19	12665366	371425	358581	rs778399351	NC_000019.10:12665365:T:
NM_000383.4(AIRE):c.517C>T (p.Gln173Ter)	AIRE	Q173*	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000371397	21	45707453	21	44287570	371397	358654	rs1057517241	NC_000021.9:44287569:C:T
NM_000071.2(CBS):c.19dup (p.Gln7fs)	CBS		not provided|Classic homocystinuria	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371345	21	44492284 - 44492285	21	43072174 - 43072175	371345	358648	rs748695461	NC_000021.9:43072174:GGGGGG:GGGGGGG
NM_000152.5(GAA):c.1316T>A (p.Met439Lys)	GAA	M439K	Glycogen storage disease, type II|Glycogen storage disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371305	17	78082617	17	80108818	371305	358501	rs747610090	NC_000017.11:80108817:T:A
NM_000152.5(GAA):c.236_246del (p.Pro79fs)	GAA	P79fs	Glycogen storage disease, type II	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000371302	17	78078615 - 78078625	17	80104816 - 80104826	371302	358485	rs1057517165	NC_000017.11:80104815:CAGTGCCCACACAGTGC:CAGTGC
NM_000152.5(GAA):c.2331+2T>A	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000371281	17	78090910	17	80117111	371281	358520	rs1057517148	NC_000017.11:80117110:T:A
NM_000152.5(GAA):c.1564C>G (p.Pro522Ala)	GAA	P522A	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371277	17	78084752	17	80110953	371277	358502	rs892129065	NC_000017.11:80110952:C:G
NM_000159.4(GCDH):c.532G>A (p.Gly178Arg)	GCDH	G178R	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371271	19	13006832	19	12896018	371271	358596	rs749452002	NC_000019.10:12896017:G:A
NM_015166.3(MLC1):c.449_455del (p.Leu150fs)	MLC1	L150fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000371207	22	50515900 - 50515906	22	50077471 - 50077477	371207	358668	rs1057517090	NC_000022.11:50077470:AGCAGGA:
NM_000271.5(NPC1):c.852del (p.Phe284fs)	NPC1	F284fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371187	18	21140224	18	23560260	371187	358539	rs762124334	NC_000018.10:23560259:AAAAAA:AAAAA
NM_000159.4(GCDH):c.382C>T (p.Arg128Ter)	GCDH	R128*	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000371176	19	13004344	19	12893530	371176	358593	rs752334462	NC_000019.10:12893529:C:T
NM_000071.2(CBS):c.1007G>A (p.Arg336His)	CBS	R336H, R231H	Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371147	21	44482453	21	43062343	371147	358635	rs760417941	NC_000021.9:43062342:C:T
NM_000152.5(GAA):c.2015G>A (p.Arg672Gln)	GAA	R672Q	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000371126	17	78086801	17	80113002	371126	358509	rs778418246	NC_000017.11:80113001:G:A
NM_000071.2(CBS):c.959T>C (p.Val320Ala)	CBS	V320A, V215A	not specified|Homocystinuria|Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371028	21	44482501	21	43062391	371028	358636	rs781567152	NC_000021.9:43062390:A:G
NM_020533.3(MCOLN1):c.984+1G>A	MCOLN1		Mucolipidosis type IV	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371019	19	7593590	19	7528704	371019	358625	rs767950930	NC_000019.10:7528703:G:A
NM_000528.4(MAN2B1):c.1687G>T (p.Glu563Ter)	MAN2B1	E563*, E562*	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370997	19	12766651	19	12655837	370997	358573	rs1057516927	NC_000019.10:12655836:C:A
NM_000152.5(GAA):c.2281delinsAT (p.Ala761fs)	GAA		Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370993	17	78090858	17	80117059	370993	358519	rs1057516924	NC_000017.11:80117058:G:AT
NM_000487.6(ARSA):c.545del (p.Pro182fs)	ARSA	P96fs, P182fs	Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370973	22	51065401	22	50626973	370973	358681	rs1057516907	NC_000022.11:50626972:GGG:GG
NM_020533.3(MCOLN1):c.1047dup (p.Phe350fs)	MCOLN1		Inborn genetic diseases|not provided|Mucolipidosis type IV	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370970	19	7593767 - 7593768	19	7528881 - 7528882	370970	358626	rs1057516904	NC_000019.10:7528881:AA:AAA
NM_000528.4(MAN2B1):c.2802dup (p.Val935fs)	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370914	19	12758274 - 12758275	19	12647460 - 12647461	370914	358567	rs1057516864	NC_000019.10:12647460:GGGGG:GGGGGG
NM_000152.5(GAA):c.2238G>A (p.Trp746Ter)	GAA	W746*	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370904	17	78090815	17	80117016	370904	358515	rs1800312	NC_000017.11:80117015:G:A
NM_000199.5(SGSH):c.697C>T (p.Arg233Ter)	SGSH	R233*	Mucopolysaccharidosis, MPS-III-A|Sanfilippo syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370732	17	78187651	17	80213852	370732	358524	rs374621913	NC_000017.11:80213851:G:A
NM_000159.4(GCDH):c.848del (p.Leu283fs)	GCDH	L283fs	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370672	19	13007231	19	12896417	370672	358599	rs761491320	NC_000019.10:12896416:T:
NM_000152.5(GAA):c.2242dup (p.Glu748fs)	GAA		not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370651	17	78090813 - 78090814	17	80117014 - 80117015	370651	358518	rs777275355	NC_000017.11:80117014:GGGGGG:GGGGGGG
NM_000271.5(NPC1):c.1990G>A (p.Val664Met)	NPC1	V664M	Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370601	18	21124448	18	23544484	370601	358532	rs376213990	NC_000018.10:23544483:C:T
NM_000152.5(GAA):c.875A>G (p.Tyr292Cys)	GAA	Y292C	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370577	17	78081615	17	80107816	370577	358491	rs1057516600	NC_000017.11:80107815:A:G
NM_000152.5(GAA):c.2185del (p.Leu729fs)	GAA	L729fs	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370552	17	78087160	17	80113361	370552	358511	rs1057516581	NC_000017.11:80113360:CC:C
NM_000159.4(GCDH):c.219del (p.Tyr74fs)	GCDH	Y74fs	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370484	19	13002735	19	12891921	370484	358590	rs1057516521	NC_000019.10:12891920:CC:C
NM_000227.5(LAMA3):c.1678del (p.Val560fs)	LAMA3	V504fs, V560fs, V2113fs, V2169fs	not provided|Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370424	18	21484547	18	23904583	370424	358557	rs1057516476	NC_000018.10:23904582:GG:G
NM_000487.6(ARSA):c.418dup (p.His140fs)	ARSA		not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000370305	22	51065640 - 51065641	22	50627212 - 50627213	370305	358688	rs745884435	NC_000022.11:50627212:GGGGGGG:GGGGGGGG
NM_000152.5(GAA):c.1076-22T>G	GAA		Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370278	17	78082266	17	80108467	370278	358492	rs762260678	NC_000017.11:80108466:T:G
NM_000152.5(GAA):c.1143del (p.Ala382fs)	GAA	A382fs	not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	VCV000370263	17	78082354	17	80108555	370263	358496	rs757458607	NC_000017.11:80108554:CC:C
NM_000152.5(GAA):c.2214G>A (p.Trp738Ter)	GAA	W738*	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370223	17	78090791	17	80116992	370223	358513	rs1057516328	NC_000017.11:80116991:G:A
NM_000152.5(GAA):c.2227C>T (p.Gln743Ter)	GAA	Q743*	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000370157	17	78090804	17	80117005	370157	358514	rs1057516277	NC_000017.11:80117004:C:T
NM_000271.5(NPC1):c.350_351AG[1] (p.Gln119fs)	NPC1		Niemann-Pick disease, type C|Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000370143	18	21148897 - 21148898	18	23568933 - 23568934	370143	358545	rs759075595	NC_000018.10:23568932:CTCT:CT
NM_000152.5(GAA):c.1799G>A (p.Arg600His)	GAA	R600H	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000370130	17	78086421	17	80112622	370130	358505	rs377544304	NC_000017.11:80112621:G:A
NM_000152.5(GAA):c.169C>T (p.Gln57Ter)	GAA	Q57*	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370124	17	78078554	17	80104755	370124	358484	rs1057516251	NC_000017.11:80104754:C:T
NM_000159.4(GCDH):c.1173del (p.Asn392fs)	GCDH	N392fs	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370106	19	13008601	19	12897787	370106	358603	rs754002357	NC_000019.10:12897786:GGGGGGG:GGGGGG
NM_000071.2(CBS):c.738delG	CBS		Classic homocystinuria	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000370105	21	44484100	21	43063990	370105	358639	rs766453711	NC_000021.9:43063989:CCC:CC
NM_000159.4(GCDH):c.226C>T (p.Gln76Ter)	GCDH	Q76*	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370102	19	13002743	19	12891929	370102	358591	rs898043081	NC_000019.10:12891928:C:T
NM_000276.4(OCRL):c.239-4023A>G	OCRL		Lowe syndrome	Pathogenic	criteria provided, single submitter	VCV000370030	X	128687279	X	129553302	370030	354269	rs1057515577	NC_000023.11:129553301:A:G
NM_033380.3(COL4A5):c.4763del (p.Gln1588fs)	COL4A5	Q1582fs, Q1588fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000369963	X	107938093	X	108694863	369963	354185	rs1057516203	NC_000023.11:108694862:A:
NM_000152.5(GAA):c.2704_2716dup (p.Val906fs)	GAA		Glycogen storage disease, type II	Pathogenic	no assertion criteria provided	VCV000369944	17	78092505 - 78092506	17	80118706 - 80118707	369944	354180	rs1057516189	NC_000017.11:80118706:CTGCAGAAGGTGACTG:CTGCAGAAGGTGACTGCAGAAGGTGACTG
NM_000152.3(GAA):c.1636+460_2672del	GAA		Glycogen storage disease, type II	Pathogenic	no assertion criteria provided	VCV000369943	17	78085284 - 78092477	17	80111485 - 80118678	369943	354179		
NM_033380.3(COL4A5):c.3487_3488delinsG (p.Pro1163fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000369940	X	107909758 - 107909759	X	108666528 - 108666529	369940	354184	rs1057516187	NC_000023.11:108666527:CC:G
NM_001195800.2(LDLR):c.314-2019del	LDLR	N115fs, N156fs	not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369873	19	11216048	19	11105372	369873	354084	rs1057516135	NC_000019.10:11105371:AA:A
NM_001195798.2(LDLR):c.1878del (p.Ala627fs)	LDLR	A500fs, A459fs, A627fs, A586fs	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000369872	19	11230799	19	11120123	369872	354098	rs1057516134	NC_000019.10:11120122:AA:A
NM_001195800.2(LDLR):c.314-2146_314-2142del	LDLR	F114fs, F73fs	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000369870	19	11215921 - 11215925	19	11105245 - 11105249	369870	354081	rs1057516132	NC_000019.10:11105244:GTTTCG:G
NM_000527.4(LDLR):c.1911delC (p.Asp638Metfs)	LDLR	D638fs, D470fs, D511fs, D597fs	Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|not provided|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369869	19	11230832	19	11120156	369869	354099	rs867272973	NC_000019.10:11120155:CC:C
NM_001195798.2(LDLR):c.820del (p.Thr274fs)	LDLR	T106fs, T147fs, T274fs, T233fs	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369863	19	11218070	19	11107394	369863	354088	rs751122998	NC_000019.10:11107393:A:
NM_000527.4(LDLR):c.68-1G>A	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369858	19	11210898	19	11100222	369858	354077	rs879254397	NC_000019.10:11100221:G:A
NM_000527.4(LDLR):c.428G>C (p.Cys143Ser)	LDLR	C143S, C102S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000369851	19	11216010	19	11105334	369851	354083	rs879254522	NC_000019.10:11105333:G:C
NM_000527.4(LDLR):c.2167G>T (p.Glu723Ter)	LDLR	E545*, E555*, E682*, E723*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000369849	19	11233876	19	11123200	369849	354100	rs1057516127	NC_000019.10:11123199:G:T
NM_000527.4(LDLR):c.1102T>C (p.Cys368Arg)	LDLR	C368R, C200R, C327R, C241R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369848	19	11222231	19	11111555	369848	354093	rs879254791	NC_000019.10:11111554:T:C
NM_170784.2(MKKS):c.1334T>G (p.Leu445Ter)	MKKS	L445*		Pathogenic	no assertion criteria provided	VCV000369846	20	10386274	20	10405626	369846	354064	rs1057516054	NC_000020.11:10405625:A:C
NM_172107.4(KCNQ2):c.2318dup (p.Cys774fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369814	20	62038297 - 62038298	20	63406944 - 63406945	369814	354043	rs1555850512	NC_000020.11:63406944:CCC:CCCC
NM_172107.4(KCNQ2):c.1856_1886del (p.Met619fs)	KCNQ2	M591fs, M619fs, M588fs, M601fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369812	20	62039767 - 62039797	20	63408414 - 63408444	369812	353972	rs1555851445	NC_000020.11:63408413:TGCTTCTCCACCTTCCCGAGCCGTCCCATCATGCT:TGCT
NM_172107.4(KCNQ2):c.1783C>T (p.Arg595Trp)	KCNQ2	R595W, R567W, R577W, R564W	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369811	20	62039870	20	63408517	369811	353973	rs1555851550	NC_000020.11:63408516:G:A
NM_172107.4(KCNQ2):c.1776C>G (p.Ile592Met)	KCNQ2	I592M, I561M, I574M, I564M	Benign Rolandic epilepsy	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369810	20	62039877	20	63408524	369810	353974	rs201868078	NC_000020.11:63408523:G:C
NM_172107.3(KCNQ2):c.1764-?_*(455_?)del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369809	20	62037542 - 62039889	20	63406189 - 63408536	369809	353967		
NM_172107.4(KCNQ2):c.1689C>G (p.Asp563Glu)	KCNQ2	D563E, D532E, D535E, D545E	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369806	20	62044877	20	63413524	369806	353976	rs35450031	NC_000020.11:63413523:G:C
NM_172107.4(KCNQ2):c.1658G>T (p.Arg553Leu)	KCNQ2	R553L, R522L, R535L, R525L	Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000369805	20	62044908	20	63413555	369805	353977	rs118192234	NC_000020.11:63413554:C:A
NM_172107.4(KCNQ2):c.1655A>C (p.Lys552Thr)	KCNQ2	K552T, K521T, K524T, K534T	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369804	20	62044911	20	63413558	369804	353978	rs1555853613	NC_000020.11:63413557:T:G
NM_172107.4(KCNQ2):c.1631+1G>A	KCNQ2		Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000369801	20	62045440	20	63414087	369801	353980	rs1057516121	NC_000020.11:63414086:C:T
NM_172107.4(KCNQ2):c.1621A>G (p.Arg541Gly)	KCNQ2	R541G, R513G, R523G, R510G	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369800	20	62045451	20	63414098	369800	353981	rs1555853971	NC_000020.11:63414097:T:C
NM_172107.4(KCNQ2):c.1609A>T (p.Lys537Ter)	KCNQ2	K537*, K509*, K519*, K506*	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369799	20	62045463	20	63414110	369799	353982	rs1555853983	NC_000020.11:63414109:T:A
NM_172107.4(KCNQ2):c.1501G>C (p.Ala501Pro)	KCNQ2	A501P, A471P, A473P, A483P	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369797	20	62046280	20	63414927	369797	353984	rs1057516118	NC_000020.11:63414926:C:G
NC_000020.11:g.(?_63413450)_(63415126_?)del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369796			20	63413450 - 63415126	369796	354040		
NM_172107.4(KCNQ2):c.1418_1419del (p.Leu473fs)	KCNQ2	L455fs, L445fs, L443fs, L473fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369795	20	62046362 - 62046363	20	63415009 - 63415010	369795	353985	rs1057516117	NC_000020.11:63415008:GAG:G
NM_172107.4(KCNQ2):c.1382A>C (p.Gln461Pro)	KCNQ2	Q461P, Q433P, Q443P, Q431P	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369794	20	62046399	20	63415046	369794	353986	rs1057516116	NC_000020.11:63415045:T:G
NM_172107.3(KCNQ2):c.1248-?_*(455_?)del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369792	20	62037542 - 62051025	20	63406189 - 63419672	369792	353968		
NM_172107.4(KCNQ2):c.1247+1G>A	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369791	20	62055529	20	63424176	369791	353987	rs1057516115	NC_000020.11:63424175:C:T
NM_172107.4(KCNQ2):c.1228_1230CCG[1] (p.Pro411del)	KCNQ2	P411del	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369790	20	62055544 - 62055546	20	63424191 - 63424193	369790	354038	rs1060499544	NC_000020.11:63424190:CGGCGG:CGG
NM_172107.4(KCNQ2):c.1203T>C (p.Ser401=)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369789	20	62059734	20	63428381	369789	353988	rs756007198	NC_000020.11:63428380:A:G
NM_172107.4(KCNQ2):c.1193_1194AG[1] (p.Lys398_Ser399insTer)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369788	20	62059741 - 62059742	20	63428388 - 63428389	369788	353989	rs1057516114	NC_000020.11:63428387:CTCT:CT
NM_172107.2(KCNQ2):c.1119-?_*382del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369787					369787	354037		
NM_172107.4(KCNQ2):c.1126del (p.Thr376fs)	KCNQ2	T376fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369786	20	62062715	20	63431362	369786	353990	rs1057516113	NC_000020.11:63431361:TTT:TT
NM_172107.4(KCNQ2):c.1118+3A>G	KCNQ2	Y374C	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369785	20	62065159	20	63433806	369785	353991	rs1057516112	NC_000020.11:63433805:T:C
NM_172107.4(KCNQ2):c.1085A>G (p.Tyr362Cys)	KCNQ2	Y362C	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369784	20	62065195	20	63433842	369784	353992	rs1057516111	NC_000020.11:63433841:T:C
NM_172107.4(KCNQ2):c.1073C>T (p.Ser358Phe)	KCNQ2	S358F	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369783	20	62065207	20	63433854	369783	353993	rs1057516110	NC_000020.11:63433853:G:A
NM_172107.4(KCNQ2):c.1066C>G (p.Leu356Val)	KCNQ2	L356V	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369782	20	62065214	20	63433861	369782	353994	rs1057516109	NC_000020.11:63433860:G:C
NM_172107.4(KCNQ2):c.1054T>C (p.Ser352Pro)	KCNQ2	S352P	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369781	20	62065226	20	63433873	369781	353995	rs1057516108	NC_000020.11:63433872:A:G
NM_172107.4(KCNQ2):c.1051C>T (p.Leu351Phe)	KCNQ2	L351F	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369779	20	62065229	20	63433876	369779	353997	rs1057516106	NC_000020.11:63433875:G:A
NM_172107.4(KCNQ2):c.1030T>C (p.Trp344Arg)	KCNQ2	W344R	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369777	20	62065250	20	63433897	369777	353999	rs1057516105	NC_000020.11:63433896:A:G
NM_172107.4(KCNQ2):c.1024-2A>G	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369776	20	62065258	20	63433905	369776	354000	rs1057516104	NC_000020.11:63433904:T:C
NM_172107.4(KCNQ2):c.973A>G (p.Arg325Gly)	KCNQ2	R325G	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369775	20	62070028	20	63438675	369775	354001	rs1057516103	NC_000020.11:63438674:T:C
NM_172107.4(KCNQ2):c.973A>C (p.Arg325=)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369774	20	62070028	20	63438675	369774	354002	rs1057516103	NC_000020.11:63438674:T:G
NM_172107.4(KCNQ2):c.928-1G>C	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369773	20	62070074	20	63438721	369773	354003	rs1057516102	NC_000020.11:63438720:C:G
NM_172107.4(KCNQ2):c.926C>T (p.Ala309Val)	KCNQ2	A309V	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000369772	20	62070952	20	63439599	369772	354004	rs1057516101	NC_000020.11:63439598:G:A
NM_172107.4(KCNQ2):c.911T>C (p.Phe304Ser)	KCNQ2	F304S	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369771	20	62070967	20	63439614	369771	354005	rs1057516100	NC_000020.11:63439613:A:G
NM_172107.4(KCNQ2):c.886A>C (p.Thr296Pro)	KCNQ2	T296P	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369769	20	62070992	20	63439639	369769	354007	rs756921902	NC_000020.11:63439638:T:G
NM_172107.4(KCNQ2):c.868G>A (p.Gly290Ser)	KCNQ2	G290S	Early infantile epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000369768	20	62071010	20	63439657	369768	354008	rs1057516098	NC_000020.11:63439656:C:T
NM_172107.4(KCNQ2):c.860C>A (p.Thr287Asn)	KCNQ2	T287N	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369767	20	62071018	20	63439665	369767	354009	rs727503973	NC_000020.11:63439664:G:T
NM_172107.4(KCNQ2):c.854C>A (p.Pro285His)	KCNQ2	P285H	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369766	20	62071024	20	63439671	369766	354010	rs1057516097	NC_000020.11:63439670:G:T
NM_172107.4(KCNQ2):c.835G>T (p.Gly279Cys)	KCNQ2	G279C	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369765	20	62071043	20	63439690	369765	354011	rs1057516096	NC_000020.11:63439689:C:A
NM_172107.4(KCNQ2):c.827C>T (p.Thr276Ile)	KCNQ2	T276I	Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000369764	20	62071051	20	63439698	369764	354012	rs1057516095	NC_000020.11:63439697:G:A
NM_172107.4(KCNQ2):c.793G>C (p.Ala265Pro)	KCNQ2	A265P	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369762	20	62073782	20	63442429	369762	354014	rs794727740	NC_000020.11:63442428:C:G
NM_172107.4(KCNQ2):c.757G>A (p.Ala253Thr)	KCNQ2	A253T	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369761	20	62073818	20	63442465	369761	354015	rs1057516093	NC_000020.11:63442464:C:T
NM_172107.4(KCNQ2):c.715G>C (p.Gly239Arg)	KCNQ2	G239R	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369760	20	62073860	20	63442507	369760	354016	rs1057516092	NC_000020.11:63442506:C:G
NM_172107.4(KCNQ2):c.700A>C (p.Thr234Pro)	KCNQ2	T234P	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369759	20	62073875	20	63442522	369759	354017	rs1057516091	NC_000020.11:63442521:T:G
NM_172107.4(KCNQ2):c.650C>A (p.Thr217Asn)	KCNQ2	T217N	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369758	20	62076052	20	63444699	369758	354018	rs1057516090	NC_000020.11:63444698:G:T
NM_172107.4(KCNQ2):c.649A>G (p.Thr217Ala)	KCNQ2	T217A	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369757	20	62076053	20	63444700	369757	354019	rs1057516089	NC_000020.11:63444699:T:C
NM_172107.4(KCNQ2):c.643G>A (p.Gly215Arg)	KCNQ2	G215R	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369756	20	62076059	20	63444706	369756	354020	rs1057516088	NC_000020.11:63444705:C:T
NM_172107.4(KCNQ2):c.613A>G (p.Ile205Val)	KCNQ2	I205V	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369755	20	62076089	20	63444736	369755	354021	rs1057516087	NC_000020.11:63444735:T:C
NM_172107.4(KCNQ2):c.608T>C (p.Leu203Pro)	KCNQ2	L203P	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369754	20	62076094	20	63444741	369754	354022	rs1057516086	NC_000020.11:63444740:A:G
NM_172107.3(KCNQ2):c.602G>A (p.Arg201His)	KCNQ2	R201H	Severe intellectual deficiency|Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000369753	20	62076100	20	63444747	369753	354023	rs1057516085	NC_000020.11:63444746:C:T
NM_172107.4(KCNQ2):c.592_594delinsA (p.Arg198fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369752	20	62076108 - 62076110	20	63444755 - 63444757	369752	354024	rs1057516084	NC_000020.11:63444754:CCG:T
NM_172107.4(KCNQ2):c.566G>T (p.Gly189Val)	KCNQ2	G189V	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369751	20	62076136	20	63444783	369751	354025	rs1057516083	NC_000020.11:63444782:C:A
NM_172107.2(KCNQ2):c.388-?_1301+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369750					369750	354036		
NM_172107.2(KCNQ2):c.388-682_1118+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369749					369749	354035		
NM_172107.4(KCNQ2):c.523G>C (p.Val175Leu)	KCNQ2	V175L	Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000369748	20	62076179	20	63444826	369748	354026	rs1057516082	NC_000020.11:63444825:C:G
NM_172107.4(KCNQ2):c.476G>A (p.Gly159Glu)	KCNQ2	G159E	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369747	20	62076629	20	63445276	369747	354027	rs1057516081	NC_000020.11:63445275:C:T
NM_172107.4(KCNQ2):c.475G>A (p.Gly159Arg)	KCNQ2	G159R	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369746	20	62076630	20	63445277	369746	354028	rs1057516080	NC_000020.11:63445276:C:T
NM_172107.2(KCNQ2):c.297-?_1247+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369745					369745	354034		
NM_172107.4(KCNQ2):c.471G>A (p.Trp157Ter)	KCNQ2	W157*	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369744	20	62076634	20	63445281	369744	354029	rs1057516079	NC_000020.11:63445280:C:T
NM_172107.4(KCNQ2):c.460T>G (p.Tyr154Asp)	KCNQ2	Y154D	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369743	20	62076645	20	63445292	369743	354030	rs1057516078	NC_000020.11:63445291:A:C
NM_172107.4(KCNQ2):c.341C>T (p.Thr114Ile)	KCNQ2	T114I	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369742	20	62078146	20	63446793	369742	354031	rs1057516077	NC_000020.11:63446792:G:A
NM_172107.4(KCNQ2):c.340A>G (p.Thr114Ala)	KCNQ2	T114A	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369741	20	62078147	20	63446794	369741	354032	rs1057516076	NC_000020.11:63446793:T:C
NM_172107.2:c.1-?c.993+?del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000369740					369740	354033		
NM_001098426.2(SMARCD2):c.401+2T>C	SMARCD2		Specific granule deficiency 2|Specific granule deficiency 1|Autosomal recessive severe congenital neutropenia	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000369731	17	61914799	17	63837439	369731	353957	rs1057518733	NC_000017.11:63837438:A:G
NM_001098426.2(SMARCD2):c.414_438dup (p.Gln147delinsGluAspGlyArgTer)	SMARCD2		Specific granule deficiency 2|Specific granule deficiency 1|Autosomal recessive severe congenital neutropenia	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000369730	17	61914560 - 61914561	17	63837200 - 63837201	369730	353956	rs1555580263	NC_000017.11:63837200:AGGTAGAACCTTATCTGCCATCTTC:AGGTAGAACCTTATCTGCCATCTTCAGGTAGAACCTTATCTGCCATCTTC
NM_001098426.2(SMARCD2):c.1181+1G>A	SMARCD2		Specific granule deficiency 2|Specific granule deficiency 1|Autosomal recessive severe congenital neutropenia	Pathogenic(Last reviewed: May 25, 2017)	no assertion criteria provided	VCV000369729	17	61911268	17	63833908	369729	353955	rs1057518731	NC_000017.11:63833907:C:T
NM_000033.4(ABCD1):c.529C>T (p.Gln177Ter)	ABCD1	Q177*	not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000369726	X	152991250	X	153725795	369726	353952	rs1057516052	NC_000023.11:153725794:C:T
NM_000132.3(F8):c.3091_3094del (p.Lys1031fs)	F8	K1031fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 15, 2016)	no assertion criteria provided	VCV000369689	X	154158971 - 154158974	X	154930696 - 154930699	369689	353915	rs1375894900	NC_000023.11:154930695:TCTTTCT:TCT
NM_000132.3(F8):c.2734_2735del (p.Asn912fs)	F8	N912fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000369688	X	154159330 - 154159331	X	154931055 - 154931056	369688	353916	rs1557278778	NC_000023.11:154931054:TT:
NM_001143981.2(CHRDL1):c.520dup (p.Ser174fs)	CHRDL1		Megalocornea	Pathogenic(Last reviewed: Nov 3, 2014)	criteria provided, single submitter	VCV000369678	X	109963083 - 109963084	X	110719855 - 110719856	369678	353912	rs1057516043	NC_000023.11:110719855:AA:AAA
NM_152296.5(ATP1A3):c.2512_2516delinsTC (p.Arg838_Leu839delinsSer)	ATP1A3		Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000369662	19	42474363 - 42474367	19	41970211 - 41970215	369662	353910	rs1057516032	NC_000019.10:41970210:AGTCT:GA
NM_000252.2(MTM1):c.226G>T (p.Glu76Ter)	MTM1	E76*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000369659	X	149767145	X	150598681	369659	353913	rs1057516031	NC_000023.11:150598680:G:T
NM_001347721.2(DYRK1A):c.449dup (p.Tyr150Ter)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000369658	21	38853087 - 38853088	21	37480785 - 37480786	369658	353886	rs1057516030	NC_000021.9:37480785:A:AA
NM_004006.3(DMD):c.6139C>T (p.Gln2047Ter)	DMD	Q2047*, Q1924*, Q703*, Q706*, Q2039*, Q2043*	Elevated serum creatine phosphokinase	Pathogenic	no assertion criteria provided	VCV000369655	X	32305797	X	32287680	369655	353883	rs1057516028	NC_000023.11:32287679:G:A
NM_006949.4(STXBP2):c.1247-1G>C	STXBP2		Familial hemophagocytic lymphohistiocytosis|Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000330555	19	7710082	19	7645196	330555	349580	rs140148806	NC_000019.10:7645195:G:C
NM_000285.4(PEPD):c.692_694del (p.Tyr231del)	PEPD	Y231del, Y167del, Y190del	not provided|Prolidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000328810	19	33904527 - 33904529	19	33413621 - 33413623	328810	333120	rs745834191	NC_000019.10:33413620:AGTAG:AG
NM_000156.6(GAMT):c.133T>A (p.Trp45Arg)	GAMT	W45R	Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000328352	19	1401343	19	1401344	328352	348225	rs886054247	NC_000019.10:1401343:A:T
NM_000528.4(MAN2B1):c.418C>T (p.Arg140Ter)	MAN2B1	R140*	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000328281	19	12776184	19	12665370	328281	342838	rs370803545	NC_000019.10:12665369:G:A
NM_006907.4(PYCR1):c.633+1G>C	PYCR1		Cutis laxa|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000325904	17	79892528	17	81934652	325904	347796	rs144346996	NC_000017.11:81934651:C:G
NM_000023.4(SGCA):c.183dup (p.Tyr62fs)	SGCA		not provided	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000291210	17	48244966 - 48244967	17	50167605 - 50167606	291210	275447	rs886044688	NC_000017.11:50167605:CC:CCC
NM_144612.6(LOXHD1):c.442A>T (p.Lys148Ter)	LOXHD1	K148*	Deafness, autosomal recessive 77|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291140	18	44219648	18	46639685	291140	275377	rs886044666	NC_000018.10:46639684:T:A
NM_000109.4(DMD):c.1104dup (p.Asp369fs)	DMD		not provided	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000291018	X	32663101 - 32663102	X	32644984 - 32644985	291018	275255	rs886044624	NC_000023.11:32644984:TTT:TTTT
NM_004006.2(DMD):c.358-1G>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000290909	X	32834758	X	32816641	290909	275146	rs886044582	NC_000023.11:32816640:C:T
NM_001848.2(COL6A1):c.957+1G>A	COL6A1		not provided	Pathogenic(Last reviewed: Sep 3, 2016)	criteria provided, single submitter	VCV000290695	21	47410199	21	45990285	290695	274932	rs886044535	NC_000021.9:45990284:G:A
NM_000023.4(SGCA):c.161del (p.Val54fs)	SGCA	V54fs	not provided	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000290641	17	48244946	17	50167585	290641	274878	rs886044516	NC_000017.11:50167584:T:
NM_000023.4(SGCA):c.489del (p.Leu164fs)	SGCA	L164fs	Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000290625	17	48245838	17	50168477	290625	274862	rs753650776	NC_000017.11:50168476:A:
NM_004006.2(DMD):c.9975-2A>C	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290604	X	31198600	X	31180483	290604	274841	rs886044502	NC_000023.11:31180482:T:G
NM_004006.2(DMD):c.4845+1G>T	DMD		not provided	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000290599	X	32398626	X	32380509	290599	274836	rs886044501	NC_000023.11:32380508:C:A
NM_002547.3(OPHN1):c.772del (p.Gln258fs)	OPHN1	Q258fs	not provided	Pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, single submitter	VCV000290595	X	67430055	X	68210213	290595	274832	rs886044499	NC_000023.11:68210212:GGGG:GGG
NM_004006.2(DMD):c.93+1_93+5delGTAAG	DMD		not provided	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000290586	X	33038251 - 33038255	X	33020134 - 33020138	290586	274823	rs886044495	
NM_004013.2(DMD):c.-577_-574del	DMD	K2268fs, K2145fs, K2264fs, K924fs, K2260fs, K927fs	not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000290564	X	31947818 - 31947821	X	31929701 - 31929704	290564	274801	rs886044490	NC_000023.11:31929700:TTGTTTG:TTG
NM_001848.2(COL6A1):c.931-1G>C	COL6A1		not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000290490	21	47410171	21	45990257	290490	274727	rs886042354	NC_000021.9:45990256:G:C
NM_004006.2(DMD):c.5344G>T (p.Glu1782Ter)	DMD	E1782*, E1778*, E441*, E1774*, E438*, E1659*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000290445	X	32366627	X	32348510	290445	274682	rs886044455	NC_000023.11:32348509:C:A
NM_000109.4(DMD):c.1509_1510dup (p.His504fs)	DMD		not provided	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000290395	X	32613941 - 32613942	X	32595824 - 32595825	290395	274632	rs886044440	NC_000023.11:32595824:GAG:GAGAG
NM_001323289.2(CDKL5):c.1365_1366insA (p.Gly456fs)	CDKL5		not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000290315	X	18622409 - 18622410	X	18604289 - 18604290	290315	274552	rs886044424	NC_000023.11:18604289::A
NM_015295.2(SMCHD1):c.4898T>G (p.Leu1633Ter)	SMCHD1	L1633*	not provided	Pathogenic(Last reviewed: Sep 17, 2016)	criteria provided, single submitter	VCV000290300	18	2770038	18	2770040	290300	274537	rs886044419	NC_000018.10:2770039:T:G
NM_000109.4(DMD):c.3389G>A (p.Trp1130Ter)	DMD	W1138*, W1015*, W1130*, W1134*	not provided	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000290270	X	32481575	X	32463458	290270	274507	rs886044406	NC_000023.11:32463457:C:T
NM_000109.4(DMD):c.4288C>T (p.Gln1430Ter)	DMD	Q1438*, Q94*, Q1434*, Q1315*, Q1430*, Q97*	not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000290261	X	32408220	X	32390103	290261	274498	rs886044402	NC_000023.11:32390102:G:A
NM_000117.2(EMD):c.512C>A (p.Ser171Ter)	EMD	S171*	not provided	Pathogenic(Last reviewed: Sep 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000290259	X	153609304	X	154380944	290259	274496	rs886044901	NC_000023.11:154380943:C:A
NM_000489.5(ATRX):c.1753G>T (p.Glu585Ter)	ATRX	E585*, E547*	not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000290044	X	76938995	X	77683503	290044	274281	rs886044898	NC_000023.11:77683502:C:A
NM_000109.4(DMD):c.10626_10627dup (p.Gln3543fs)	DMD		not provided	Pathogenic(Last reviewed: Aug 12, 2016)	criteria provided, single submitter	VCV000289993	X	31165537 - 31165538	X	31147420 - 31147421	289993	274230	rs886044325	NC_000023.11:31147420:GGGG:GGGGGG
NM_004006.2(DMD):c.8669-1G>C	DMD		not provided	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000289992	X	31496492	X	31478375	289992	274229	rs886044324	NC_000023.11:31478374:C:G
NM_006915.3(RP2):c.593_594del (p.Tyr198fs)	RP2	Y198fs	not provided	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000289957	X	46713400 - 46713401	X	46853965 - 46853966	289957	274194	rs886044897	NC_000023.11:46853964:TAT:T
NM_000328.3(RPGR):c.1387C>T (p.Gln463Ter)	RPGR	Q463*, Q473*, Q401*, Q462*	not provided|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000289902	X	38156564	X	38297311	289902	274139	rs886044302	NC_000023.11:38297310:G:A
NM_001848.2(COL6A1):c.932G>A (p.Gly311Asp)	COL6A1	G311D	not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000289651	21	47410173	21	45990259	289651	273888	rs886044231	NC_000021.9:45990258:G:A
NM_005603.6(ATP8B1):c.279G>A (p.Ala93=)	ATP8B1		not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000289530	18	55373722	18	57706490	289530	273767	rs761575295	NC_000018.10:57706489:C:T
NM_000109.4(DMD):c.5855_5856AG[1] (p.Ser1953fs)	DMD		not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000289506	X	32360257 - 32360258	X	32342140 - 32342141	289506	273743	rs886044193	NC_000023.11:32342139:CTCTC:CTC
NM_000117.2(EMD):c.251_255del (p.Leu84fs)	EMD	L84fs	not provided	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000289486	X	153608362 - 153608366	X	154380002 - 154380006	289486	273723	rs782452523	NC_000023.11:154380001:TACTCTAC:TAC
NM_024301.5(FKRP):c.970G>T (p.Glu324Ter)	FKRP	E324*	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000289473	19	47259677	19	46756420	289473	273710	rs886044183	NC_000019.10:46756419:G:T
NM_000026.4(ADSL):c.907C>T (p.Arg303Cys)	ADSL	R303C, R239C	not provided|Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000289379	22	40757536	22	40361532	289379	273616	rs373458753	NC_000022.11:40361531:C:T
NM_001184880.2(PCDH19):c.1101del (p.Ile368fs)	PCDH19	I368fs	not provided	Pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000289376	X	99662495	X	100407497	289376	273613	rs886044166	NC_000023.11:100407496:C:
NM_000271.5(NPC1):c.3229C>T (p.Arg1077Ter)	NPC1	R1077*	Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000289257	18	21116653	18	23536689	289257	273494	rs750095738	NC_000018.10:23536688:G:A
NM_024301.5(FKRP):c.1141del (p.Ala381fs)	FKRP	A381fs	not provided	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000289250	19	47259843	19	46756586	289250	273487	rs754403441	NC_000019.10:46756585:GGGGGG:GGGGG
NM_015295.2(SMCHD1):c.5020del (p.Ile1674fs)	SMCHD1	I1674fs	not provided	Pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000289243	18	2771580	18	2771582	289243	273480	rs886044129	NC_000018.10:2771581:AAAAA:AAAA
NM_000554.6(CRX):c.448del (p.Ser150fs)	CRX	S150fs	not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000289219	19	48342772	19	47839515	289219	273456	rs886044121	NC_000019.10:47839514:T:
NM_024301.5(FKRP):c.1267del (p.Arg423fs)	FKRP	R423fs	not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000289096	19	47259970	19	46756713	289096	273333	rs886044083	NC_000019.10:46756712:CCCCC:CCCC
NM_024301.5(FKRP):c.1269_1270insT (p.Asn424Ter)	FKRP		not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000289093	19	47259976 - 47259977	19	46756719 - 46756720	289093	273330	rs772950604	NC_000019.10:46756719::T
NM_004006.2(DMD):c.4483C>T (p.Gln1495Ter)	DMD	Q1495*, Q1487*, Q1491*, Q151*, Q1372*, Q154*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000288923	X	32407653	X	32389536	288923	273160	rs748769566	NC_000023.11:32389535:G:A
NM_001363734.1(ASXL1):c.975_976GT[2] (p.Val327fs)	ASXL1		Bohring-Opitz syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000288745	20	31021158 - 31021159	20	32433355 - 32433356	288745	272982	rs886043994	NC_000020.11:32433354:TGTGTGT:TGTGT
NM_004006.2(DMD):c.9563+1G>A	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288725	X	31227614	X	31209497	288725	272962	rs886043989	NC_000023.11:31209496:C:T
NM_000023.4(SGCA):c.770del (p.Pro257fs)	SGCA	P257fs	not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000288637	17	48247525	17	50170164	288637	272874	rs886043962	NC_000017.11:50170163:CC:C
NM_024301.5(FKRP):c.1256_1257del (p.Pro419fs)	FKRP	P419fs	not provided	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000288628	19	47259962 - 47259963	19	46756705 - 46756706	288628	272865	rs886043959	NC_000019.10:46756704:CCC:C
NM_000052.7(ATP7A):c.2694del (p.Ser899fs)	ATP7A	S821fs, S899fs	not provided	Pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	VCV000288581	X	77275806	X	78020309	288581	272818	rs886044881	NC_000023.11:78020308:GGG:GG
NM_000152.5(GAA):c.736del (p.Leu246fs)	GAA	L246fs	not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000288505	17	78081398	17	80107599	288505	272742	rs886043920	NC_000017.11:80107598:CC:C
NM_000109.4(DMD):c.2837G>A (p.Trp946Ter)	DMD	W954*, W946*, W950*, W831*	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000288476	X	32490369	X	32472252	288476	272713	rs886043909	NC_000023.11:32472251:C:T
NM_000271.5(NPC1):c.1065del (p.Phe356fs)	NPC1	F356fs	not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000288351	18	21136468	18	23556504	288351	272588	rs886043871	NC_000018.10:23556503:G:
NM_023036.6(DNAI2):c.1697del (p.Asp566fs)	DNAI2	D566fs, D554fs	not provided	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000288257	17	72308344	17	74312205	288257	272494	rs764971993	NC_000017.11:74312204:A:
NM_000346.4(SOX9):c.1249C>T (p.Gln417Ter)	SOX9	Q417*	not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000288215	17	70120247	17	72124106	288215	272452	rs886043831	NC_000017.11:72124105:C:T
NM_014270.5(SLC7A9):c.614dup (p.Asn206fs)	SLC7A9		not provided|Cystinuria	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288197	19	33353113 - 33353114	19	32862207 - 32862208	288197	272434	rs745319034	NC_000019.10:32862207:TTT:TTTT
NM_004006.2(DMD):c.186+2T>A	DMD		not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000288177	X	32867843	X	32849726	288177	272414	rs886043822	NC_000023.11:32849725:A:T
NM_000109.4(DMD):c.10548T>A (p.Tyr3516Ter)	DMD	Y3524*, Y3516*, Y954*, Y1051*, Y2183*, Y3401*, Y2180*, Y443*, Y1064*, Y3520*, Y456*, Y795*	not provided	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000288164	X	31165617	X	31147500	288164	272401	rs886043817	NC_000023.11:31147499:A:T
NM_030582.4(COL18A1):c.2596del (p.Arg866fs)	COL18A1	R1101fs, R686fs, R866fs	not provided	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000288111	21	46910773	21	45490859	288111	272348	rs886043809	NC_000021.9:45490858:CC:C
NM_004917.4(KLK4):c.632del (p.Leu211fs)	KLK4	L116fs, L211fs	not provided|Amelogenesis imperfecta, hypomaturation type, IIA1	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000288110	19	51410323	19	50907067	288110	272347	rs556734208	NC_000019.10:50907066:A:
NM_000109.4(DMD):c.5336dup (p.Asn1779fs)	DMD		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000288070	X	32366610 - 32366611	X	32348493 - 32348494	288070	272307	rs1557294296	NC_000023.11:32348493:TT:TTT
NM_001848.2(COL6A1):c.1002+1G>A	COL6A1		not provided	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000287971	21	47410337	21	45990423	287971	272208	rs886043700	NC_000021.9:45990422:G:A
NM_000271.5(NPC1):c.2872C>T (p.Arg958Ter)	NPC1	R958*	Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000287837	18	21119358	18	23539394	287837	272074	rs759826138	NC_000018.10:23539393:G:A
NM_001323289.2(CDKL5):c.1108_1109dup (p.Asn370fs)	CDKL5		not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000287828	X	18622150 - 18622151	X	18604030 - 18604031	287828	272065	rs886043742	NC_000023.11:18604030:AAA:AAAAA
NM_139058.3(ARX):c.614_642del (p.Leu205fs)	ARX	L205fs	not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000287784	X	25031470 - 25031498	X	25013353 - 25013381	287784	272021	rs886043728	NC_000023.11:25013352:GGCGCTGCCCGGGCCGCCGGCCACGCCGAGGCGCT:GGCGCT
NM_000390.4(CHM):c.645_648TACT[1] (p.Tyr217fs)	CHM		not provided	Pathogenic(Last reviewed: Jun 4, 2016)	criteria provided, single submitter	VCV000287749	X	85218720 - 85218723	X	85963715 - 85963718	287749	271986	rs886043716	NC_000023.11:85963714:AGTAAGTAA:AGTAA
NM_024301.5(FKRP):c.675del (p.Thr226fs)	FKRP	T226fs	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000287717	19	47259382	19	46756125	287717	271954	rs886043706	NC_000019.10:46756124:G:
NM_001848.2(COL6A1):c.1002+1G>T	COL6A1		not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000287695	21	47410337	21	45990423	287695	271932	rs886043700	NC_000021.9:45990422:G:T
NM_000109.4(DMD):c.2028_2029del (p.Val677fs)	DMD	V685fs, V562fs, V677fs, V681fs	not provided	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000287693	X	32563391 - 32563392	X	32545274 - 32545275	287693	271930	rs886043699	NC_000023.11:32545273:CT:
NM_000109.4(DMD):c.10102del (p.Val3367_Leu3368insTer)	DMD		not provided|Proximal muscle weakness in lower limbs|Motor delay|Calf muscle hypertrophy	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000287624	X	31196883	X	31178766	287624	271861	rs886043676	NC_000023.11:31178765:G:
NM_001083899.2(GP6):c.479G>A (p.Trp160Ter)	GP6	W160*	not provided	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000287607	19	55539077	19	55027709	287607	271844	rs886043669	NC_000019.10:55027708:C:T
NM_000109.4(DMD):c.1932del (p.Asp644fs)	DMD	D644fs, D648fs, D652fs, D529fs	not provided	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000287457	X	32583855	X	32565738	287457	271694	rs886043640	NC_000023.11:32565737:A:
NM_001848.2(COL6A1):c.904G>A (p.Gly302Arg)	COL6A1	G302R	not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000287445	21	47409666	21	45989752	287445	271682	rs794727028	NC_000021.9:45989751:G:A
NM_000109.4(DMD):c.3723G>A (p.Trp1241Ter)	DMD	W1249*, W1126*, W1245*, W1241*	not provided	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000287438	X	32466612	X	32448495	287438	271675	rs886043635	NC_000023.11:32448494:C:T
NM_144612.6(LOXHD1):c.4376-2A>G	LOXHD1		not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000287284	18	44109296	18	46529333	287284	271521	rs886043616	NC_000018.10:46529332:T:C
NM_001429.4(EP300):c.4065C>A (p.Tyr1355Ter)	EP300	Y1355*, Y1329*	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000287229	22	41564764	22	41168760	287229	271466	rs886043598	NC_000022.11:41168759:C:A
NM_000444.6(PHEX):c.67del (p.Leu23fs)	PHEX	L23fs	not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000287159	X	22051188	X	22033070	287159	271396	rs886043584	NC_000023.11:22033069:CCC:CC
NM_001184880.2(PCDH19):c.1263_1264CA[1] (p.Thr422fs)	PCDH19		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000287127	X	99662330 - 99662331	X	100407332 - 100407333	287127	271364	rs886043572	NC_000023.11:100407331:TGTG:TG
NM_000199.5(SGSH):c.1272_1282del (p.Tyr424_Arg428delinsTer)	SGSH		Retinal dystrophy|Global developmental delay|Nystagmus|Gastrointestinal dysmotility|Developmental regression|Severe visual impairment|Diarrhea|Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000287037	17	78184478 - 78184488	17	80210679 - 80210689	287037	271274	rs752914124	NC_000017.11:80210678:GGAGGTCCTTG:
NM_139058.3(ARX):c.790del (p.Arg264fs)	ARX	R264fs	Lissencephaly 2, X-linked|not provided	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000287023	X	25031322	X	25013205	287023	271260	rs886043552	NC_000023.11:25013204:GGGG:GGG
NC_000023.10:g.32472914_32472915delCCinsG	DMD		not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000286921	X	32472914 - 32472915			286921	271158		
NM_000109.4(DMD):c.4150C>T (p.Gln1384Ter)	DMD	Q1392*, Q1269*, Q1384*, Q51*, Q1388*, Q48*	not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000286833	X	32429928	X	32411811	286833	271070	rs886043496	NC_000023.11:32411810:G:A
NM_030632.3(ASXL3):c.1484del (p.Pro495fs)	ASXL3	P495fs	not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000286814	18	31318851	18	33738887	286814	271051	rs886043487	NC_000018.10:33738886:CC:C
NM_001291421.1(KDM6A):c.-482G>T	KDM6A	G51*	not provided	Pathogenic(Last reviewed: Apr 3, 2016)	criteria provided, single submitter	VCV000286785	X	44732948	X	44873702	286785	271022	rs886043476	NC_000023.11:44873701:G:T
NM_015295.2(SMCHD1):c.4799dup (p.Leu1600fs)	SMCHD1		not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000286741	18	2769767 - 2769768	18	2769769 - 2769770	286741	270978	rs867598503	NC_000018.10:2769769:TTTT:TTTTT
NM_144612.6(LOXHD1):c.894T>G (p.Tyr298Ter)	LOXHD1	Y298*	not provided	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000286635	18	44181420	18	46601457	286635	270872	rs886043441	NC_000018.10:46601456:A:C
NM_000109.4(DMD):c.6199C>T (p.Gln2067Ter)	DMD	Q2075*, Q734*, Q1952*, Q2071*, Q731*, Q2067*	not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000286577	X	32305713	X	32287596	286577	270814	rs886043428	NC_000023.11:32287595:G:A
NM_000152.5(GAA):c.1754+1G>A	GAA		not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000286458	17	78085900	17	80112101	286458	270695	rs886043399	NC_000017.11:80112100:G:A
NM_000023.4(SGCA):c.747+1G>A	SGCA		not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000286436	17	48246616	17	50169255	286436	270673	rs886043392	NC_000017.11:50169254:G:A
NM_000109.4(DMD):c.1506dup (p.Thr503fs)	DMD		not provided	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	VCV000286398	X	32613945 - 32613946	X	32595828 - 32595829	286398	270635	rs886043376	NC_000023.11:32595828:G:GG
NM_004020.3(DMD):c.2843+9126del	DMD		not provided	Pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	VCV000286396	X	31187660	X	31169543	286396	270633	rs886043375	NC_000023.11:31169542:GGGGGG:GGGGG
NM_001848.2(COL6A1):c.774_781TCCGGGGC[1] (p.Leu261fs)	COL6A1		not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000286267	21	47407537 - 47407544	21	45987623 - 45987630	286267	270504	rs886043354	NC_000021.9:45987622:CTCCGGGGCTCCGGGGC:CTCCGGGGC
NM_000109.4(DMD):c.4526_4532del (p.Ser1509fs)	DMD	S1394fs, S1513fs, S1517fs, S173fs, S1509fs, S176fs	not provided	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000286245	X	32404545 - 32404551	X	32386428 - 32386434	286245	270482	rs886043348	NC_000023.11:32386427:ACTTCAGACTTCA:ACTTCA
NM_000152.5(GAA):c.2499_2500CA[1] (p.Thr834fs)	GAA		Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286229	17	78092009 - 78092010	17	80118210 - 80118211	286229	270466	rs886043343	NC_000017.11:80118209:CACA:CA
NM_001848.2(COL6A1):c.1003-1G>A	COL6A1		Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286179	21	47410686	21	45990772	286179	270416	rs886043330	NC_000021.9:45990771:G:A
NM_004006.2(DMD):c.1482+1G>C	DMD		not provided	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000286155	X	32632419	X	32614302	286155	270392	rs398123862	NC_000023.11:32614301:C:G
NM_001848.2(COL6A1):c.1021G>T (p.Gly341Cys)	COL6A1	G341C	Bethlem myopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000286146	21	47410705	21	45990791	286146	270383	rs886043321	NC_000021.9:45990790:G:T
NM_001323289.2(CDKL5):c.212del (p.Asn71fs)	CDKL5	N71fs	not provided	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000286056	X	18593537	X	18575417	286056	270293	rs886043296	NC_000023.11:18575416:AAAA:AAA
NM_004586.3(RPS6KA3):c.1539_1542del (p.Glu515fs)	RPS6KA3	E515fs	not provided	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000286052	X	20185767 - 20185770	X	20167649 - 20167652	286052	270289	rs886043293	NC_000023.11:20167648:TCGTTC:TC
NM_000023.4(SGCA):c.409G>A (p.Glu137Lys)	SGCA	E137K	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000286049	17	48245758	17	50168397	286049	270286	rs372210292	NC_000017.11:50168396:G:A
NM_001848.2(COL6A1):c.1039_1052del (p.Lys346_Gly347insTer)	COL6A1		not provided	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000286047	21	47410723 - 47410736	21	45990809 - 45990822	286047	270284	rs886043291	NC_000021.9:45990808:GGCTCGCCCGGGTT:
NM_004010.3(DMD):c.-195_-191dup	DMD		not provided	Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	VCV000286039	X	32867851 - 32867852	X	32849734 - 32849735	286039	270276	rs886043288	NC_000023.11:32849734:TGCCCTG:TGCCCTGCCCTG
NM_004006.2(DMD):c.1150-1G>A	DMD		not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000285921	X	32662431	X	32644314	285921	270158	rs886043251	NC_000023.11:32644313:C:T
NM_020964.3(EPG5):c.1497+1G>T	EPG5		not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000285882	18	43529449	18	45949483	285882	270119	rs886043244	NC_000018.10:45949482:C:A
NM_000023.4(SGCA):c.403C>T (p.Gln135Ter)	SGCA	Q135*	Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000285818	17	48245752	17	50168391	285818	270055	rs886043221	NC_000017.11:50168390:C:T
NM_000109.4(DMD):c.1570C>T (p.Gln524Ter)	DMD	Q532*, Q524*, Q409*, Q528*	not provided	Pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000285784	X	32613882	X	32595765	285784	270021	rs763936813	NC_000023.11:32595764:G:A
NM_000390.4(CHM):c.715C>T (p.Arg239Ter)	CHM	R239*, R91*	Choroideremia|not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285756	X	85213970	X	85958965	285756	269993	rs776256380	NC_000023.11:85958964:G:A
NM_015295.2(SMCHD1):c.3236_3237GA[1] (p.Glu1080fs)	SMCHD1		not provided	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000285698	18	2732449 - 2732450	18	2732451 - 2732452	285698	269935	rs886043182	NC_000018.10:2732450:AGAGA:AGA
NM_000109.4(DMD):c.6369_6370insCA (p.Ile2124fs)	DMD		not provided	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000285617	X	32235077 - 32235078	X	32216960 - 32216961	285617	269854	rs886043157	NC_000023.11:32216960:T:TGT
NM_004010.3(DMD):c.-51dup	DMD		not provided	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000285616	X	32841449 - 32841450	X	32823332 - 32823333	285616	269853	rs1557058353	NC_000023.11:32823332:T:TT
NM_001848.2(COL6A1):c.315_349del (p.Met106fs)	COL6A1	M106fs	not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000285588	21	47404267 - 47404301	21	45984353 - 45984387	285588	269825	rs886043147	NC_000021.9:45984352:GCGCATGCCTGGCGGCCGCGACGCACTCAAAAGCAGCG:GCG
NM_015295.2(SMCHD1):c.1843-1G>A	SMCHD1		not provided	Pathogenic(Last reviewed: Jan 8, 2016)	criteria provided, single submitter	VCV000285586	18	2705691	18	2705693	285586	269823	rs886043146	NC_000018.10:2705692:G:A
NM_000271.5(NPC1):c.67del (p.Gln23fs)	NPC1	Q23fs	not provided	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000285543	18	21153529	18	23573565	285543	269780	rs886043131	NC_000018.10:23573564:G:
NM_001848.2(COL6A1):c.928_930del (p.Lys310del)	COL6A1	K310del	not provided	Pathogenic(Last reviewed: Dec 31, 2015)	criteria provided, multiple submitters, no conflicts	VCV000285482	21	47409688 - 47409690	21	45989774 - 45989776	285482	269719	rs886043114	NC_000021.9:45989773:AGAAG:AG
NM_001256789.3(CACNA1F):c.2543+1G>A	CACNA1F		not provided	Pathogenic(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000285396	X	49076092	X	49219633	285396	269633	rs886044841	NC_000023.11:49219632:C:T
NM_004020.3(DMD):c.2843+6288del	DMD	Y2113fs, Y3454fs, Y981fs, Y2110fs, Y373fs, Y994fs, Y3331fs, Y3450fs, Y3446fs, Y386fs, Y725fs	not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000285350	X	31190498	X	31172381	285350	269587	rs886043084	NC_000023.11:31172380:T:
NM_000252.2(MTM1):c.444+1G>A	MTM1		not provided	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000285246	X	149787613	X	150619140	285246	269483	rs886044840	NC_000023.11:150619139:G:A
NM_000109.4(DMD):c.3214del (p.Asp1072fs)	DMD	D1072fs, D957fs, D1076fs, D1080fs	not provided	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000285232	X	32482741	X	32464624	285232	269469	rs886043052	NC_000023.11:32464623:CCCC:CCC
NM_000109.4(DMD):c.5715+1G>T	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000285195	X	32361250	X	32343133	285195	269432	rs886043041	NC_000023.11:32343132:C:A
NM_000202.8(IDS):c.1591C>T (p.Gln531Ter)	IDS	Q531*, Q441*	not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000285082	X	148564339	X	149482808	285082	269319	rs886044837	NC_000023.11:149482807:G:A
NM_000109.4(DMD):c.433C>T (p.Gln145Ter)	DMD	Q153*, Q30*, Q149*, Q145*	not provided	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000284924	X	32834658	X	32816541	284924	269161	rs886042983	NC_000023.11:32816540:G:A
NM_004006.2(DMD):c.649+1G>T	DMD		not provided	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000284862	X	32827609	X	32809492	284862	269099	rs398124032	NC_000023.11:32809491:C:A
NM_000202.8(IDS):c.1265G>A (p.Cys422Tyr)	IDS	C422Y, C332Y	not provided|Mucopolysaccharidosis, MPS-II	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000284860	X	148564665	X	149483134	284860	269097	rs886044835	NC_000023.11:149483133:C:T
NM_000023.4(SGCA):c.292C>T (p.Arg98Cys)	SGCA	R98C	Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000284708	17	48245077	17	50167716	284708	268945	rs138945081	NC_000017.11:50167715:C:T
NM_153638.3(PANK2):c.310G>T (p.Glu104Ter)	PANK2	E104*	not provided	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000284671	20	3870057	20	3889410	284671	268908	rs780551883	NC_000020.11:3889409:G:T
NM_024301.5(FKRP):c.313C>T (p.Gln105Ter)	FKRP	Q105*	not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000284644	19	47259020	19	46755763	284644	268881	rs761821795	NC_000019.10:46755762:C:T
NM_001848.2(COL6A1):c.930+1G>A	COL6A1		not provided	Pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000284560	21	47409693	21	45989779	284560	268797	rs886042902	NC_000021.9:45989778:G:A
NM_001323289.2(CDKL5):c.1553del (p.Pro518fs)	CDKL5	P518fs	not provided	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000284540	X	18622595	X	18604475	284540	268777	rs886042899	NC_000023.11:18604474:CCC:CC
NM_004187.4(KDM5C):c.410_411dup (p.Ala138Ter)	KDM5C		not provided	Pathogenic(Last reviewed: Nov 13, 2015)	criteria provided, single submitter	VCV000284507	X	53247088 - 53247089	X	53217906 - 53217907	284507	268744	rs1057515581	NC_000023.11:53217906:TA:TATA
NM_000109.4(DMD):c.10038T>A (p.Tyr3346Ter)	DMD	Y3354*, Y2010*, Y3350*, Y2013*, Y3231*, Y3346*, Y894*, Y286*, Y625*	not provided	Pathogenic(Last reviewed: Oct 28, 2015)	criteria provided, single submitter	VCV000284461	X	31198511	X	31180394	284461	268698	rs886042875	NC_000023.11:31180393:A:T
NM_001123383.1(BCOR):c.3779_3780AG[1] (p.Leu1262fs)	BCOR		Glioblastoma|not provided	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	VCV000284290	X	39922288 - 39922289	X	40063035 - 40063036	284290	268527	rs886042842	NC_000023.11:40063034:CTCT:CT
NM_000109.4(DMD):c.10074_10076AGA[1] (p.Glu3359del)	DMD	E3367del	Duchenne muscular dystrophy|not provided|Becker muscular dystrophy	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	VCV000284288	X	31196906 - 31196908	X	31178789 - 31178791	284288	268525	rs886042840	NC_000023.11:31178788:TCTTCT:TCT
NM_005710.2(PQBP1):c.450_453del (p.Asp150fs)	PQBP1	D150fs, D142fs	not provided	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000284240	X	48759664 - 48759667	X	48902387 - 48902390	284240	268477	rs886044823	NC_000023.11:48902386:AGACAGA:AGA
NM_000194.3(HPRT1):c.580G>C (p.Asp194His)	HPRT1	D194H	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000284173	X	133632685	X	134498655	284173	268410	rs267606863	NC_000023.11:134498654:G:C
NM_000109.4(DMD):c.1023dup (p.Glu342fs)	DMD		not provided	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000284138	X	32663182 - 32663183	X	32645065 - 32645066	284138	268375	rs1556876421	NC_000023.11:32645065:TT:TTT
NM_000152.5(GAA):c.1064T>C (p.Leu355Pro)	GAA	L355P	not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000284093	17	78082197	17	80108398	284093	268330	rs766074609	NC_000017.11:80108397:T:C
NM_001848.2(COL6A1):c.1611+1G>A	COL6A1		not provided	Pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000283950	21	47418348	21	45998434	283950	268187	rs886042748	NC_000021.9:45998433:G:A
NM_004006.2(DMD):c.5140G>T (p.Glu1714Ter)	DMD	E1714*, E1591*, E1710*, E1706*, E370*, E373*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000283945	X	32382713	X	32364596	283945	268182	rs886042747	NC_000023.11:32364595:C:A
NM_004020.3(DMD):c.2843+5081C>T	DMD	Q3427*, Q3304*, Q2083*, Q3423*, Q954*, Q2086*, Q346*, Q359*, Q698*, Q3419*, Q967*	not provided	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000283713	X	31191705	X	31173588	283713	267950	rs886042691	NC_000023.11:31173587:G:A
NM_003413.4(ZIC3):c.1025del (p.Ser342fs)	ZIC3	S342fs	not provided	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000283617	X	136649875	X	137567716	283617	267854	rs886042663	NC_000023.11:137567715:C:
NM_017950.4(CCDC40):c.1440+1G>C	CCDC40		not provided	Pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000283423	17	78032780	17	80058981	283423	267660	rs886042621	NC_000017.11:80058980:G:C
NM_004006.2(DMD):c.2168+2T>G	DMD		not provided	Pathogenic(Last reviewed: Oct 6, 2015)	criteria provided, single submitter	VCV000283413	X	32563274	X	32545157	283413	267650	rs886042618	NC_000023.11:32545156:A:C
NM_000109.4(DMD):c.1363_1384del (p.Trp455fs)	DMD	W455fs, W459fs, W463fs, W340fs	not provided	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	VCV000283396	X	32632494 - 32632515	X	32614377 - 32614398	283396	267633	rs886042616	NC_000023.11:32614376:TTTCTTCTGTTTTTGTTAGCCA:
NM_172107.4(KCNQ2):c.1118+2T>C	KCNQ2	Y374H	not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283350	20	62065160	20	63433807	283350	267587	rs886042605	NC_000020.11:63433806:A:G
NM_004006.2(DMD):c.93+1G>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000283346	X	33038255	X	33020138	283346	267583	rs886042604	NC_000023.11:33020137:C:T
NM_000152.5(GAA):c.1124G>T (p.Arg375Leu)	GAA	R375L	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000283230	17	78082336	17	80108537	283230	267467	rs142752477	NC_000017.11:80108536:G:T
NM_004646.3(NPHS1):c.2847_2853del (p.Val949_Val950insTer)	NPHS1		not provided	Pathogenic(Last reviewed: Aug 30, 2015)	criteria provided, single submitter	VCV000282911	19	36330472 - 36330478	19	35839570 - 35839576	282911	267148	rs886042517	NC_000019.10:35839569:ACTCACAAC:AC
NM_024301.5(FKRP):c.162_165dup (p.Phe56fs)	FKRP		Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282866	19	47258867 - 47258868	19	46755610 - 46755611	282866	267103	rs886042506	NC_000019.10:46755610:GGGAG:GGGAGGGAG
NM_000109.4(DMD):c.1393A>T (p.Lys465Ter)	DMD	K473*, K469*, K465*, K350*	not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000282849	X	32632485	X	32614368	282849	267086	rs886042499	NC_000023.11:32614367:T:A
NM_000152.5(GAA):c.258dup (p.Asn87fs)	GAA		not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282842	17	78078636 - 78078637	17	80104837 - 80104838	282842	267079	rs761317813	NC_000017.11:80104837:CCCCCCC:CCCCCCCC
NM_004006.2(DMD):c.10477C>T (p.Gln3493Ter)	DMD	Q3493*, Q764*, Q1033*, Q3489*, Q412*, Q425*, Q3370*, Q3485*, Q1020*, Q2149*, Q2152*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282841	X	31187636	X	31169519	282841	267078	rs886042495	NC_000023.11:31169518:G:A
NM_006950.3(SYN1):c.377G>A (p.Trp126Ter)	SYN1	W126*	not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000282790	X	47478751	X	47619352	282790	267027	rs886042481	NC_000023.11:47619351:C:T
NM_000109.4(DMD):c.2290_2291GA[1] (p.Lys765fs)	DMD		not provided	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000282614	X	32519935 - 32519936	X	32501818 - 32501819	282614	266851	rs886042437	NC_000023.11:32501817:TCTC:TC
NM_001848.2(COL6A1):c.1022G>T (p.Gly341Val)	COL6A1	G341V	Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000282533	21	47410706	21	45990792	282533	266770	rs121912935	NC_000021.9:45990791:G:T
NM_015295.2(SMCHD1):c.3801+1G>A	SMCHD1		not provided	Pathogenic(Last reviewed: Sep 10, 2015)	criteria provided, single submitter	VCV000282530	18	2743927	18	2743929	282530	266767	rs886042417	NC_000018.10:2743928:G:A
NM_000109.4(DMD):c.8081_8087dup (p.Trp2696fs)	DMD		not provided	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000282293	X	31645895 - 31645896	X	31627778 - 31627779	282293	266530	rs886042373	NC_000023.11:31627778:CAGGCAA:CAGGCAACAGGCAA
NM_000152.5(GAA):c.934del (p.Leu312fs)	GAA	L312fs	not provided	Pathogenic(Last reviewed: Aug 7, 2015)	criteria provided, single submitter	VCV000282254	17	78081673	17	80107874	282254	266491	rs886042358	NC_000017.11:80107873:CC:C
NM_024301.5(FKRP):c.545A>G (p.Tyr182Cys)	FKRP	Y182C	Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282247	19	47259252	19	46755995	282247	266484	rs543163491	NC_000019.10:46755994:A:G
NM_000109.4(DMD):c.2488C>T (p.Gln830Ter)	DMD	Q838*, Q715*, Q834*, Q830*	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000282233	X	32509504	X	32491387	282233	266470	rs886042351	NC_000023.11:32491386:G:A
NM_000109.4(DMD):c.2579del (p.Ser860fs)	DMD	S860fs, S868fs, S864fs, S745fs	not provided	Pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, single submitter	VCV000282230	X	32509413	X	32491296	282230	266467	rs886042348	NC_000023.11:32491295:C:
NM_000109.4(DMD):c.5065C>T (p.Gln1689Ter)	DMD	Q1697*, Q1689*, Q353*, Q1574*, Q1693*, Q356*	not provided	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000282229	X	32382764	X	32364647	282229	266466	rs886042347	NC_000023.11:32364646:G:A
NM_000271.5(NPC1):c.1920del (p.His641fs)	NPC1	H641fs	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000281941	18	21124951	18	23544987	281941	266178	rs886042270	NC_000018.10:23544986:CCCC:CCC
NM_000271.5(NPC1):c.3246-2A>G	NPC1		Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Nov 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000281939	18	21115666	18	23535702	281939	266176	rs886042268	NC_000018.10:23535701:T:C
NM_006517.5(SLC16A2):c.576-1G>A	SLC16A2		not provided	Pathogenic(Last reviewed: Jul 9, 2015)	criteria provided, single submitter	VCV000281817	X	73744193	X	74524358	281817	266054	rs886042238	NC_000023.11:74524357:G:A
NM_001318510.2(ACSL4):c.845_846del (p.His282fs)	ACSL4	H323fs, H282fs	not provided	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	VCV000281523	X	108921301 - 108921302	X	109678072 - 109678073	281523	265760	rs886042180	NC_000023.11:109678071:AT:
NM_001008537.3(NEXMIF):c.640del (p.Ala214fs)	NEXMIF	A214fs	not provided	Pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	VCV000281434	X	73963752	X	74743917	281434	265671	rs886042158	NC_000023.11:74743916:CCC:CC
NM_000109.4(DMD):c.5008C>T (p.Gln1670Ter)	DMD	Q1678*, Q1670*, Q334*, Q1674*, Q1555*, Q337*	not provided	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000281412	X	32382821	X	32364704	281412	265649	rs886042154	NC_000023.11:32364703:G:A
NM_000033.4(ABCD1):c.1166G>A (p.Arg389His)	ABCD1	R389H	not provided|Adrenoleukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281336	X	153001650	X	153736196	281336	265573	rs886044777	NC_000023.11:153736195:G:A
NM_004006.2(DMD):c.31+36947G>A	DMD		not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000281179	X	33192452	X	33174335	281179	265416	rs886042106	NC_000023.11:33174334:C:T
NM_000528.4(MAN2B1):c.1383C>A (p.Tyr461Ter)	MAN2B1	Y461*, Y460*	Deficiency of alpha-mannosidase|not provided	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000281152	19	12768296	19	12657482	281152	265389	rs775200333	NC_000019.10:12657481:G:T
NM_000117.2(EMD):c.3G>A (p.Met1Ile)	EMD	M1I	Emery-Dreifuss muscular dystrophy 1, X-linked|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281087	X	153607847	X	154379487	281087	265324	rs886044771	NC_000023.11:154379486:G:A
NM_000252.2(MTM1):c.19del (p.Ser7fs)	MTM1	S7fs	not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000281079	X	149761094	X	150592632	281079	265316	rs886044770	NC_000023.11:150592631:TT:T
NM_000152.5(GAA):c.546G>C (p.Thr182=)	GAA		not provided	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	VCV000281056	17	78078931	17	80105132	281056	265293	rs143523371	NC_000017.11:80105131:G:C
NM_000023.4(SGCA):c.518T>C (p.Leu173Pro)	SGCA	L173P	not provided	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000281027	17	48245867	17	50168506	281027	265264	rs143962150	NC_000017.11:50168505:T:C
NM_000071.2(CBS):c.28del (p.Val10fs)	CBS	V10fs	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000281010	21	44492276	21	43072166	281010	265247	rs779250698	NC_000021.9:43072165:C:
NM_000052.7(ATP7A):c.1974_1977dup (p.Phe660fs)	ATP7A		not provided	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	VCV000281009	X	77266971 - 77266972	X	78011474 - 78011475	281009	265246	rs886044769	NC_000023.11:78011474:TGTTT:TGTTTGTTT
NM_000199.5(SGSH):c.1135del (p.Val379fs)	SGSH	V379fs	not provided|Sanfilippo syndrome	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280988	17	78184625	17	80210826	280988	265225	rs777956287	NC_000017.11:80210825:C:
NM_000152.5(GAA):c.546G>A (p.Thr182=)	GAA		not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280955	17	78078931	17	80105132	280955	265192	rs143523371	NC_000017.11:80105131:G:A
NM_000152.5(GAA):c.1912G>T (p.Gly638Trp)	GAA	G638W	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000280954	17	78086698	17	80112899	280954	265191	rs757617999	NC_000017.11:80112898:G:T
NM_000487.6(ARSA):c.346C>T (p.Arg116Ter)	ARSA	R116*, R30*	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000280950	22	51065713	22	50627285	280950	265187	rs761860059	NC_000022.11:50627284:G:A
NM_000206.2(IL2RG):c.758-1G>A	IL2RG		X-linked severe combined immunodeficiency|not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280937	X	70328546	X	71108696	280937	264921	rs886042051	NC_000023.11:71108695:C:T
NM_080647.1(TBX1):c.498_501dup (p.Lys168delinsArgTer)	TBX1		not provided	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000280935	22	19750850 - 19750851	22	19763327 - 19763328	280935	265120	rs886042049	NC_000022.11:19763327:CGAT:CGATCGAT
NM_001958.4(EEF1A2):c.370G>A (p.Glu124Lys)	EEF1A2	E124K	not provided|Epileptic encephalopathy, early infantile, 33	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280924	20	62126409	20	63495056	280924	264765	rs886042041	NC_000020.11:63495055:C:T
NM_001282531.3(ADNP):c.2268dup (p.Lys757fs)	ADNP		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000280907	20	49508982 - 49508983	20	50892445 - 50892446	280907	265100	rs886042026	NC_000020.11:50892445:GGGG:GGGGG
NM_000444.6(PHEX):c.448A>T (p.Lys150Ter)	PHEX	K150*	not provided	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000280906	X	22095605	X	22077487	280906	265054	rs886042025	NC_000023.11:22077486:A:T
NM_001008537.3(NEXMIF):c.1493C>A (p.Ser498Ter)	NEXMIF	S498*	not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280904	X	73962899	X	74743064	280904	265128	rs886042023	NC_000023.11:74743063:G:T
NM_001399.5(EDA):c.872G>A (p.Gly291Glu)	EDA	G291E, G288E	not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280902	X	69253326	X	70033476	280902	265171	rs886042021	NC_000023.11:70033475:G:A
NM_001323289.2(CDKL5):c.2522dup (p.Leu842fs)	CDKL5		not provided	Pathogenic(Last reviewed: Sep 28, 2016)	criteria provided, single submitter	VCV000280890	X	18646514 - 18646515	X	18628394 - 18628395	280890	264824	rs886042014	NC_000023.11:18628394:AA:AAA
NM_000495.5(COL4A5):c.2722G>T (p.Gly908Ter)	COL4A5	G908*	not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000280889	X	107865077	X	108621847	280889	264942	rs281874703	NC_000023.11:108621846:G:T
NM_172107.4(KCNQ2):c.992del (p.Lys331fs)	KCNQ2	K331fs	not provided	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000280885	20	62070009	20	63438656	280885	264884	rs886042010	NC_000020.11:63438655:TT:T
NM_005629.4(SLC6A8):c.1255-2A>G	SLC6A8		not provided	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000280878	X	152959583	X	153694128	280878	265141	rs886042005	NC_000023.11:153694127:A:G
NM_001282531.3(ADNP):c.330dup (p.Tyr111fs)	ADNP		not provided	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000280876	20	49510920 - 49510921	20	50894383 - 50894384	280876	265106	rs886042003	NC_000020.11:50894383:GGGG:GGGGG
NM_001282531.3(ADNP):c.2378T>G (p.Leu793Ter)	ADNP	L793*	not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000280874	20	49508873	20	50892336	280874	264759	rs886042001	NC_000020.11:50892335:A:C
NM_000455.4(STK11):c.326del (p.Asn109fs)	STK11	N109fs	not provided	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000280868	19	1218447	19	1218448	280868	264728	rs886041996	NC_000019.10:1218447:AAAAA:AAAA
NM_001029896.2(WDR45):c.663_664CA[2] (p.Gln223fs)	WDR45		not provided	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000280866	X	48933261 - 48933262	X	49075602 - 49075603	280866	264899	rs886041994	NC_000023.11:49075601:TGTGTGT:TGTGT
NM_001347721.2(DYRK1A):c.1351_1354del (p.Leu451fs)	DYRK1A	L422fs, L451fs, L460fs	not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280864	21	38877722 - 38877725	21	37505419 - 37505422	280864	265115	rs886041993	NC_000021.9:37505418:TGCTTG:TG
NM_001142730.3(KCTD1):c.1921C>T (p.His641Tyr)	KCTD1	H33Y, H41Y, H641Y	not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280853	18	24081103	18	26501139	280853	264815	rs886041986	NC_000018.10:26501138:G:A
NM_000292.3(PHKA2):c.2782_2783delinsATGGCACGGAGCC (p.Leu928fs)	PHKA2		not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000280852	X	18924636 - 18924637	X	18906518 - 18906519	280852	265146	rs886041985	NC_000023.11:18906517:AG:GGCTCCGTGCCAT
NM_015338.5(ASXL1):c.1282C>T (p.Gln428Ter)	ASXL1	Q428*, Q367*	not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000280841	20	31021283	20	32433480	280841	264866	rs886041975	NC_000020.11:32433479:C:T
NM_004782.4(SNAP29):c.85C>T (p.Arg29Ter)	SNAP29	R29*	not provided	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000280840	22	21213483	22	20859195	280840	264774	rs749633059	NC_000022.11:20859194:C:T
NM_001037811.2(HSD17B10):c.607A>G (p.Lys203Glu)	HSD17B10	K212E, K203E	not provided|HSD10 disease	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000280839	X	53458504	X	53431556	280839	265040	rs886041974	NC_000023.11:53431555:T:C
NM_004750.5(CRLF1):c.322C>T (p.Gln108Ter)	CRLF1	Q108*	not provided	Pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000280836	19	18710450	19	18599640	280836	264946	rs886041972	NC_000019.10:18599639:G:A
NM_001008537.3(NEXMIF):c.1042C>T (p.Arg348Ter)	NEXMIF	R348*	not provided|Mental retardation, X-linked 98	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280835	X	73963350	X	74743515	280835	265174	rs886041971	NC_000023.11:74743514:G:A
NM_138927.3(SON):c.1136C>A (p.Ser379Ter)	SON	S379*	not provided	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000280834	21	34922673	21	33550367	280834	264965	rs886041970	NC_000021.9:33550366:C:A
NM_001272071.2(AP1S2):c.92del (p.Thr31fs)	AP1S2	T31fs	not provided	Pathogenic(Last reviewed: Sep 9, 2016)	criteria provided, single submitter	VCV000280826	X	15870556	X	15852433	280826	264961	rs886041964	NC_000023.11:15852432:G:
NM_001356.4(DDX3X):c.1462del (p.Arg488fs)	DDX3X	R472fs, R488fs, R302fs	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000280825	X	41205627	X	41346374	280825	265012	rs886041963	NC_000023.11:41346373:CC:C
NM_177559.3(CSNK2A1):c.139C>G (p.Arg47Gly)	CSNK2A1	R47G	not provided	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000280816	20	485836	20	505192	280816	264757	rs886041956	NC_000020.11:505191:G:C
NM_021140.3(KDM6A):c.4005+5_4005+8del	KDM6A		not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000280806	X	44966780 - 44966783	X	45107535 - 45107538	280806	265020	rs886041946	NC_000023.11:45107534:AAGTAAGTAA:AAGTAA
NM_018486.3(HDAC8):c.496C>T (p.Arg166Ter)	HDAC8	R166*, R75*	not provided|Delayed speech and language development|Intrauterine growth retardation|Microcephaly|Global developmental delay|Abnormal facial shape|Sparse scalp hair|Cornelia de Lange syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280793	X	71715060	X	72495210	280793	265061	rs886041936	NC_000023.11:72495209:G:A
NM_000194.3(HPRT1):c.202C>T (p.Leu68Phe)	HPRT1	L68F	not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000280785	X	133609278	X	134475248	280785	265138	rs886041930	NC_000023.11:134475247:C:T
NM_015295.2(SMCHD1):c.848A>G (p.Tyr283Cys)	SMCHD1	Y283C	not provided	Pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000280776	18	2688720	18	2688722	280776	264901	rs886041921	NC_000018.10:2688721:A:G
NM_001127221.1(CACNA1A):c.4177G>C (p.Val1393Leu)	CACNA1A	V1393L, V1396L, V1392L	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000280773	19	13372340	19	13261526	280773	265051	rs794727411	NC_000019.10:13261525:C:G
NM_015295.2(SMCHD1):c.1030C>T (p.Arg344Ter)	SMCHD1	R344*	Facioscapulohumeral muscular dystrophy 2|not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280772	18	2694681	18	2694683	280772	264720	rs886041918	NC_000018.10:2694682:C:T
NM_000487.6(ARSA):c.854+1G>T	ARSA		not provided	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, single submitter	VCV000280764	22	51065018	22	50626590	280764	264934	rs886041911	NC_000022.11:50626589:C:A
NM_001083962.2(TCF4):c.1031del (p.Asn344fs)	TCF4	N214fs, N302fs, N350fs, N446fs, N184fs, N273fs, N319fs, N342fs, N343fs, N344fs, N128fs, N320fs	not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000280763	18	52927218	18	55259987	280763	264916	rs886041910	NC_000018.10:55259986:TTT:TT
NM_000489.5(ATRX):c.5957-1G>A	ATRX		not provided	Pathogenic(Last reviewed: Jul 26, 2016)	criteria provided, single submitter	VCV000280755	X	76849320	X	77593850	280755	264923	rs886041903	NC_000023.11:77593849:C:T
NM_001281463.1(SMC1A):c.1126C>T (p.Arg376Ter)	SMC1A	R376*, R398*	not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000280754	X	53438773	X	53411823	280754	265036	rs886041902	NC_000023.11:53411822:G:A
NM_021140.3(KDM6A):c.2830dup (p.Tyr944fs)	KDM6A		not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000280751	X	44936066 - 44936067	X	45076821 - 45076822	280751	265163	rs886041899	NC_000023.11:45076821:TTT:TTTT
NM_001256447.2(BCAP31):c.307_308CT[1] (p.Tyr104fs)	BCAP31		not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	VCV000280742	X	152981028 - 152981029	X	153715573 - 153715574	280742	264948	rs886041892	NC_000023.11:153715572:AGAGA:AGA
NM_172107.4(KCNQ2):c.274dup (p.Ala92fs)	KCNQ2		not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000280740	20	62103542 - 62103543	20	63472189 - 63472190	280740	265112	rs886041890	NC_000020.11:63472189:CCC:CCCC
NM_000276.4(OCRL):c.2470-2A>G	OCRL		not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000280729	X	128723820	X	129589843	280729	264801	rs886041880	NC_000023.11:129589842:A:G
NM_000276.4(OCRL):c.2582-1G>T	OCRL		not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000280725	X	128724122	X	129590145	280725	265137	rs398123289	NC_000023.11:129590144:G:T
NM_031407.7(HUWE1):c.9208C>T (p.Arg3070Cys)	HUWE1	R3070C	Mental retardation, X-linked, syndromic, Turner type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280723	X	53578039	X	53551078	280723	265043	rs886041876	NC_000023.11:53551077:G:A
NM_001323289.2(CDKL5):c.2305G>T (p.Glu769Ter)	CDKL5	E769*	not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000280719	X	18638015	X	18619895	280719	264971	rs886041872	NC_000023.11:18619894:G:T
NM_001083961.2(WDR62):c.2467+2T>G	WDR62		not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000280706	19	36585068	19	36094166	280706	264845	rs886041863	NC_000019.10:36094165:T:G
NM_172107.4(KCNQ2):c.1637T>C (p.Met546Thr)	KCNQ2	M546T, M515T, M518T, M528T	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000280703	20	62044929	20	63413576	280703	265109	rs886041860	NC_000020.11:63413575:A:G
NM_004187.4(KDM5C):c.1402-2A>G	KDM5C		not provided	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000280698	X	53240041	X	53210859	280698	265166	rs886041855	NC_000023.11:53210858:T:C
NM_000117.2(EMD):c.60del (p.Asn20fs)	EMD	N20fs	not provided|Emery-Dreifuss muscular dystrophy 1, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280697	X	153607904	X	154379544	280697	264819	rs886041854	NC_000023.11:154379543:C:
NM_000444.6(PHEX):c.941G>A (p.Trp314Ter)	PHEX	W314*	not provided	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, single submitter	VCV000280696	X	22117131	X	22099013	280696	265064	rs886041853	NC_000023.11:22099012:G:A
NM_030632.3(ASXL3):c.4020_4021TG[1] (p.Val1341fs)	ASXL3		not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000280684	18	31323832 - 31323833	18	33743868 - 33743869	280684	265045	rs886041846	NC_000018.10:33743867:TGTG:TG
NM_005629.4(SLC6A8):c.1422_1434delinsTTGACTACTACTACAG (p.Tyr475_Ala478delinsTer)	SLC6A8		not provided	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000280683	X	152959828 - 152959840	X	153694373 - 153694385	280683	265142	rs886041845	NC_000023.11:153694372:CTACTACTCGGCC:TTGACTACTACTACAG
NM_001111125.3(IQSEC2):c.2329G>T (p.Glu777Ter)	IQSEC2	E777*, E572*	not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000280678	X	53278033	X	53248851	280678	264913	rs782517076	NC_000023.11:53248850:C:A
NM_000444.6(PHEX):c.1587-1G>A	PHEX		not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280672	X	22208560	X	22190443	280672	265078	rs886041839	NC_000023.11:22190442:G:A
NM_018486.3(HDAC8):c.787C>T (p.Gln263Ter)	HDAC8	Q263*, Q172*	Cornelia de Lange syndrome 5|not provided	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280671	X	71684532	X	72464682	280671	265124	rs886041838	NC_000023.11:72464681:G:A
NM_001347721.2(DYRK1A):c.341del (p.Gln114fs)	DYRK1A	Q123fs, Q114fs, Q85fs	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000280666	21	38852980	21	37480678	280666	265113	rs886041833	NC_000021.9:37480677:A:
NM_004247.4(EFTUD2):c.1669C>T (p.Gln557Ter)	EFTUD2	Q557*, Q522*, Q547*	not provided	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000280664	17	42937850	17	44860482	280664	264848	rs886041831	NC_000017.11:44860481:G:A
NM_002501.4(NFIX):c.905del (p.Pro302fs)	NFIX	P310fs, P301fs, P302fs, P255fs, P294fs	not provided	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000280662	19	13186432	19	13075618	280662	264933	rs886041828	NC_000019.10:13075617:CCCC:CCC
NM_005629.4(SLC6A8):c.1290_1309del (p.Asp431fs)	SLC6A8	D316fs, D431fs, D421fs	not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000280650	X	152959610 - 152959629	X	153694155 - 153694174	280650	265029	rs886041818	NC_000023.11:153694154:CCGGCCTCCTCGACCTCCTCCCGGCCTCCT:CCGGCCTCCT
NM_000117.2(EMD):c.103G>T (p.Glu35Ter)	EMD	E35*	not provided	Pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000280644	X	153608070	X	154379710	280644	264820	rs782222974	NC_000023.11:154379709:G:T
NM_004429.4(EFNB1):c.85dup (p.Ala29fs)	EFNB1		not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000280643	X	68049702 - 68049703	X	68829859 - 68829860	280643	265170	rs886041811	NC_000023.11:68829859:GG:GGG
NM_001083961.2(WDR62):c.1941C>A (p.Cys647Ter)	WDR62	C647*	not provided|Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280634	19	36580191	19	36089289	280634	265067	rs769688376	NC_000019.10:36089288:C:A
NM_004006.2(DMD):c.1288A>T (p.Arg430Ter)	DMD	R430*, R422*, R426*, R307*	not provided	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000280633	X	32662292	X	32644175	280633	264887	rs886041802	NC_000023.11:32644174:T:A
NM_004429.4(EFNB1):c.219T>G (p.Tyr73Ter)	EFNB1	Y73*	not provided	Pathogenic(Last reviewed: May 23, 2016)	criteria provided, single submitter	VCV000280631	X	68058550	X	68838707	280631	265119	rs886041800	NC_000023.11:68838706:T:G
NM_014927.5(CNKSR2):c.2340_2344del (p.His782fs)	CNKSR2	H733fs, H752fs, H703fs, H782fs	not provided	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000280628	X	21627383 - 21627387	X	21609265 - 21609269	280628	264832	rs886041798	NC_000023.11:21609264:CTTAC:
NM_000022.4(ADA):c.532dup (p.Val178fs)	ADA		not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000280626	20	43252916 - 43252917	20	44624275 - 44624276	280626	264870	rs886041796	NC_000020.11:44624275:CC:CCC
NM_000292.3(PHKA2):c.2672del (p.Thr891fs)	PHKA2	T891fs	not provided	Pathogenic(Last reviewed: May 21, 2016)	criteria provided, single submitter	VCV000280625	X	18924858	X	18906740	280625	265037	rs886041795	NC_000023.11:18906739:G:
NM_001282531.3(ADNP):c.2157C>A (p.Tyr719Ter)	ADNP	Y719*	not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000280623	20	49509094	20	50892557	280623	265101	rs587777526	NC_000020.11:50892556:G:T
NM_000284.4(PDHA1):c.954dup (p.Leu319fs)	PDHA1		not provided	Pathogenic(Last reviewed: May 18, 2016)	criteria provided, single submitter	VCV000280622	X	19377087 - 19377088	X	19358969 - 19358970	280622	264828	rs886041793	NC_000023.11:19358969:G:GG
NM_002501.4(NFIX):c.666G>A (p.Trp222Ter)	NFIX	W222*, W230*, W175*, W221*, W214*	not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000280621	19	13184279	19	13073465	280621	264831	rs886041792	NC_000019.10:13073464:G:A
NM_020461.4(TUBGCP6):c.1833+1G>A	TUBGCP6		not provided	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000280617	22	50664478	22	50226049	280617	264788	rs886041788	NC_000022.11:50226048:C:T
NM_172107.4(KCNQ2):c.629G>C (p.Arg210Pro)	KCNQ2	R210P	not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280614	20	62076073	20	63444720	280614	265110	rs886041262	NC_000020.11:63444719:C:G
NM_030632.3(ASXL3):c.5486del (p.Lys1829fs)	ASXL3	K1829fs	not provided	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000280612	18	31325294	18	33745330	280612	265047	rs886041785	NC_000018.10:33745329:AAAAA:AAAA
NM_001347721.2(DYRK1A):c.986_993del (p.Tyr329fs)	DYRK1A	Y329fs, Y338fs, Y300fs	not provided	Pathogenic(Last reviewed: May 11, 2016)	criteria provided, single submitter	VCV000280604	21	38865376 - 38865383	21	37493074 - 37493081	280604	264767	rs886041778	NC_000021.9:37493073:CCTTATGACCTT:CCTT
NM_014271.4(IL1RAPL1):c.703+1G>A	IL1RAPL1		not provided	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000280601	X	29417426	X	29399309	280601	264883	rs886041775	NC_000023.11:29399308:G:A
NM_001123383.1(BCOR):c.4834dup (p.Leu1612fs)	BCOR		not provided	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000280600	X	39913178 - 39913179	X	40053925 - 40053926	280600	264893	rs748074364	NC_000023.11:40053925:GGGGGG:GGGGGGG
NM_001008537.3(NEXMIF):c.1123del (p.Glu375fs)	NEXMIF	E375fs	not provided	Pathogenic(Last reviewed: Apr 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280599	X	73963269	X	74743434	280599	265173	rs886041774	NC_000023.11:74743433:CCCCCC:CCCCC
NM_015629.4(PRPF31):c.950del (p.Gly317fs)	PRPF31	G317fs	not provided	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000280597	19	54631450	19	54128075	280597	264956	rs886041773	NC_000019.10:54128074:GGG:GG
NM_001363819.1(DDX3X):c.-1824dup	DDX3X		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000280593	X	41196694 - 41196695	X	41337441 - 41337442	280593	265160	rs886041769	NC_000023.11:41337441:A:AA
NM_001111125.3(IQSEC2):c.2984G>A (p.Arg995Gln)	IQSEC2	R995Q, R790Q	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000280590	X	53270997	X	53241815	280590	264909	rs886041767	NC_000023.11:53241814:C:T
NM_001347721.2(DYRK1A):c.1071_1071+8del	DYRK1A		not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000280588	21	38865460 - 38865468	21	37493158 - 37493166	280588	264969	rs886041765	NC_000021.9:37493157:AATGAGGTAAATGA:AATGA
NM_001323289.2(CDKL5):c.693del (p.Ser232fs)	CDKL5	S232fs	not provided	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000280587	X	18606212	X	18588092	280587	264970	rs886041764	NC_000023.11:18588091:A:
NM_030632.3(ASXL3):c.1939dup (p.Thr647fs)	ASXL3		not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000280574	18	31319306 - 31319307	18	33739342 - 33739343	280574	264905	rs886041753	NC_000018.10:33739342:A:AA
NM_000074.2(CD40LG):c.638del (p.Ser213fs)	CD40LG	S213fs	not provided	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000280565	X	135741426	X	136659267	280565	265139	rs886041747	NC_000023.11:136659266:G:
NM_001942.4(DSG1):c.724C>T (p.Arg242Ter)	DSG1	R242*	not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000280563	18	28913591	18	31333628	280563	264724	rs568609861	NC_000018.10:31333627:C:T
NM_004975.4(KCNB1):c.1108T>C (p.Trp370Arg)	KCNB1	W370R	not provided	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000280560	20	47990989	20	49374452	280560	264751	rs886041743	NC_000020.11:49374451:A:G
NM_005676.5(RBM10):c.1693+2dup	RBM10		not provided	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000280558	X	47041266 - 47041267	X	47181867 - 47181868	280558	265104	rs886041742	NC_000023.11:47181867:T:TT
NM_001282531.3(ADNP):c.190dup (p.Thr64fs)	ADNP		Helsmoortel-Van der Aa Syndrome|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280557	20	49518564 - 49518565	20	50902027 - 50902028	280557	265107	rs886041741	NC_000020.11:50902027:T:TT
NM_001429.4(EP300):c.3472C>T (p.Gln1158Ter)	EP300	Q1158*, Q1132*	not provided	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000280554	22	41553383	22	41157379	280554	264931	rs886041739	NC_000022.11:41157378:C:T
NM_178152.3(DCX):c.467dup (p.Met156fs)	DCX		not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000280550	X	110644455 - 110644456	X	111401227 - 111401228	280550	264799	rs886041736	NC_000023.11:111401227:A:AA
NM_001123383.1(BCOR):c.3108dup (p.Ala1037fs)	BCOR		not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	VCV000280538	X	39930355 - 39930356	X	40071102 - 40071103	280538	264895	rs886041725	NC_000023.11:40071102:T:TT
NM_001282531.3(ADNP):c.790C>T (p.Arg264Ter)	ADNP	R264*	not provided	Pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, single submitter	VCV000280535	20	49510461	20	50893924	280535	264872	rs886041722	NC_000020.11:50893923:G:A
NM_020717.3(SHROOM4):c.3739C>T (p.Gln1247Ter)	SHROOM4	Q1247*	not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000280530	X	50350403	X	50607403	280530	265033	rs886041718	NC_000023.11:50607402:G:A
NM_014927.5(CNKSR2):c.114del (p.Ile39fs)	CNKSR2	I39fs	not provided	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000280521	X	21444664	X	21426546	280521	265046	rs886041712	NC_000023.11:21426545:G:
NM_001193416.3(DDX3X):c.1804C>T (p.Arg602Ter)	DDX3X	R603*, R602*, R587*, R416*	not provided|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280514	X	41206602	X	41347349	280514	265017	rs886041705	NC_000023.11:41347348:C:T
NM_001278116.2(L1CAM):c.1146C>G (p.Tyr382Ter)	L1CAM	Y382*, Y377*	not provided	Pathogenic(Last reviewed: Apr 14, 2016)	criteria provided, single submitter	VCV000280513	X	153135096	X	153869641	280513	265143	rs886041704	NC_000023.11:153869640:G:C
NM_001008537.3(NEXMIF):c.1441C>T (p.Arg481Ter)	NEXMIF	R481*	not provided|Mental retardation, X-linked 98|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280509	X	73962951	X	74743116	280509	265066	rs886041701	NC_000023.11:74743115:G:A
NM_000489.5(ATRX):c.599G>T (p.Cys200Phe)	ATRX	C200F, C162F	not provided	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000280508	X	76940494	X	77685002	280508	264924	rs886041700	NC_000023.11:77685001:C:A
NM_000444.6(PHEX):c.1080-1G>A	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280503	X	22129584	X	22111466	280503	264990	rs886041695	NC_000023.11:22111465:G:A
NM_000444.6(PHEX):c.617T>A (p.Leu206Ter)	PHEX	L206*	not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000280502	X	22095774	X	22077656	280502	265058	rs886041694	NC_000023.11:22077655:T:A
NM_001029896.2(WDR45):c.437-2A>G	WDR45		not provided	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000280501	X	48933606	X	49075947	280501	265108	rs886041693	NC_000023.11:49075946:T:C
NM_000444.6(PHEX):c.847_849+2del	PHEX		not provided	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	VCV000280487	X	22112214 - 22112218	X	22094096 - 22094100	280487	264984	rs886041681	NC_000023.11:22094095:TGAGGT:T
NM_000444.6(PHEX):c.508_529del (p.Leu170fs)	PHEX	L170fs	not provided	Pathogenic(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	VCV000280486	X	22095663 - 22095684	X	22077545 - 22077566	280486	264975	rs886041680	NC_000023.11:22077544:TGCTTGAATCTAATATTGGCCCTG:TG
NM_001323289.2(CDKL5):c.2095G>T (p.Glu699Ter)	CDKL5	E699*	not provided	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000280475	X	18627633	X	18609513	280475	265145	rs886041673	NC_000023.11:18609512:G:T
NM_001347721.2(DYRK1A):c.987T>G (p.Tyr329Ter)	DYRK1A	Y338*, Y300*, Y329*	not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000280454	21	38865381	21	37493079	280454	264967	rs886041658	NC_000021.9:37493078:T:G
NM_000252.2(MTM1):c.1611C>A (p.Tyr537Ter)	MTM1	Y537*	not provided	Pathogenic(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	VCV000280453	X	149832049	X	150663576	280453	264809	rs886041657	NC_000023.11:150663575:C:A
NM_001042631.2(SDHAF1):c.156C>A (p.Tyr52Ter)	SDHAF1	Y52*	not provided	Pathogenic(Last reviewed: Jul 3, 2017)	criteria provided, single submitter	VCV000280451	19	36486332	19	35995430	280451	265065	rs768768823	NC_000019.10:35995429:C:A
NM_001127221.1(CACNA1A):c.2130G>T (p.Leu710Phe)	CACNA1A	L710F, L709F	not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000280448	19	13414405	19	13303591	280448	264835	rs886041654	NC_000019.10:13303590:C:A
NM_000109.4(DMD):c.5250_5251AG[1] (p.Glu1751fs)	DMD		not provided	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000280447	X	32380953 - 32380954	X	32362836 - 32362837	280447	265090	rs886041653	NC_000023.11:32362835:CTCT:CT
NM_030632.3(ASXL3):c.1346del (p.Val449fs)	ASXL3	V449fs	not provided	Pathogenic(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	VCV000280445	18	31318714	18	33738750	280445	264726	rs886041652	NC_000018.10:33738749:T:
NM_002501.4(NFIX):c.1087dup (p.Arg363fs)	NFIX		not provided	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000280440	19	13192497 - 13192498	19	13081683 - 13081684	280440	264833	rs886041647	NC_000019.10:13081683:CCCCC:CCCCCC
NM_003688.3(CASK):c.2255dup (p.Asn752fs)	CASK		not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000280437	X	41394005 - 41394006	X	41534752 - 41534753	280437	265018	rs886041645	NC_000023.11:41534752:TTTTTT:TTTTTTT
NM_000109.4(DMD):c.10570_10571delinsTTTAAATGTAGGTGTAAGAAAACTTTAAAGAAACTTTAAAGTGGGG (p.Glu3524delinsPheLysCysArgCysLysLysThrLeuLysLysLeuTer)	DMD		not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	VCV000280418	X	31165594 - 31165595	X	31147477 - 31147478	280418	264885	rs886041629	NC_000023.11:31147476:TC:CCCCACTTTAAAGTTTCTTTAAAGTTTTCTTACACCTACATTTAAA
NM_000444.6(PHEX):c.154G>T (p.Glu52Ter)	PHEX	E52*	not provided	Pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, single submitter	VCV000280415	X	22056622	X	22038504	280415	265049	rs886041626	NC_000023.11:22038503:G:T
NM_004975.4(KCNB1):c.820dup (p.Tyr274fs)	KCNB1		not provided	Pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000280403	20	47991276 - 47991277	20	49374739 - 49374740	280403	264756	rs886041617	NC_000020.11:49374739:A:AA
NM_172107.2(KCNQ2):c.297delG (p.Phe100Serfs)	KCNQ2		not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000280397	20	62078190	20	63446837	280397	264763	rs886041611	NC_000020.11:63446836:CC:C
NM_172107.4(KCNQ2):c.1604dup (p.Leu536fs)	KCNQ2		not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, single submitter	VCV000280394	20	62045467 - 62045468	20	63414114 - 63414115	280394	264963	rs886041608	NC_000020.11:63414114:CCC:CCCC
NM_000095.3(COMP):c.875G>T (p.Cys292Phe)	COMP	C292F	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000280393	19	18899121	19	18788312	280393	265062	rs886041607	NC_000019.10:18788311:C:A
NM_001029896.2(WDR45):c.771_772del (p.Asp257fs)	WDR45	D257fs, D258fs	not provided	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000280391	X	48933078 - 48933079	X	49075419 - 49075420	280391	265025	rs886041605	NC_000023.11:49075418:TAT:T
NM_005027.4(PIK3R2):c.1690A>G (p.Lys564Glu)	PIK3R2	K564E	not provided	Pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, single submitter	VCV000280388	19	18278070	19	18167260	280388	265059	rs886041602	NC_000019.10:18167259:A:G
NM_014009.3(FOXP3):c.210+1G>C	FOXP3		not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000280381	X	49114752	X	49258295	280381	264904	rs886041596	NC_000023.11:49258294:C:G
NM_001039591.3(USP9X):c.1140G>A (p.Trp380Ter)	USP9X	W380*	not provided	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000280380	X	41000663	X	41141410	280380	265099	rs886041595	NC_000023.11:41141409:G:A
NM_000455.4(STK11):c.717G>A (p.Trp239Ter)	STK11	W239*	Peutz-Jeghers syndrome|not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280378	19	1220699	19	1220700	280378	264827	rs137853082	NC_000019.10:1220699:G:A
NM_005027.4(PIK3R2):c.1126A>G (p.Lys376Glu)	PIK3R2	K376E	not provided	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000280374	19	18273793	19	18162983	280374	264943	rs886041591	NC_000019.10:18162982:A:G
NM_001356.4(DDX3X):c.233C>G (p.Ser78Ter)	DDX3X	S78*, S62*	not provided	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000280371	X	41200818	X	41341565	280371	265161	rs886041589	NC_000023.11:41341564:C:G
NM_000444.6(PHEX):c.1309dup (p.Glu437fs)	PHEX		not provided	Pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000280370	X	22151644 - 22151645	X	22133527 - 22133528	280370	264843	rs886041588	NC_000023.11:22133527:GG:GGG
NM_000397.3(CYBB):c.1573del (p.Ser525fs)	CYBB	S525fs	not provided	Pathogenic(Last reviewed: Feb 17, 2016)	criteria provided, single submitter	VCV000280363	X	37668930	X	37809677	280363	265096	rs886041582	NC_000023.11:37809676:AA:A
NM_005120.3(MED12):c.5125C>T (p.Arg1709Ter)	MED12	R1709*	not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000280361	X	70356230	X	71136380	280361	265172	rs886041581	NC_000023.11:71136379:C:T
NM_001083962.2(TCF4):c.1471C>T (p.Gln491Ter)	TCF4	Q491*, Q330*, Q331*, Q449*, Q488*, Q466*, Q467*, Q490*, Q593*, Q361*, Q275*, Q420*, Q468*, Q497*	not provided	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000280357	18	52901794	18	55234563	280357	264910	rs886041578	NC_000018.10:55234562:G:A
NM_001008537.3(NEXMIF):c.2205_2212del (p.Ala736fs)	NEXMIF	A736fs	not provided	Pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, single submitter	VCV000280347	X	73962180 - 73962187	X	74742345 - 74742352	280347	265127	rs886041570	NC_000023.11:74742344:GCCCAGCAGC:GC
NM_000444.6(PHEX):c.779dup (p.Leu260fs)	PHEX		not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000280345	X	22112143 - 22112144	X	22094025 - 22094026	280345	264836	rs886041569	NC_000023.11:22094025:TTTT:TTTTT
NM_001127221.1(CACNA1A):c.4070T>G (p.Ile1357Ser)	CACNA1A	I1357S, I1360S, I1356S	not provided	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000280312	19	13373570	19	13262756	280312	265053	rs886041541	NC_000019.10:13262755:A:C
NM_020533.3(MCOLN1):c.615dup (p.Ser206fs)	MCOLN1		not provided	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000280304	19	7592443 - 7592444	19	7527557 - 7527558	280304	265094	rs886041533	NC_000019.10:7527557:CCCCCC:CCCCCCC
NM_212472.2(PRKAR1A):c.360del (p.Asp121fs)	PRKAR1A	D121fs	not provided	Pathogenic(Last reviewed: Feb 27, 2016)	criteria provided, single submitter	VCV000280301	17	66519874	17	68523733	280301	264700	rs886041530	NC_000017.11:68523732:AAAA:AAA
NM_000444.6(PHEX):c.664-1G>A	PHEX		not provided	Pathogenic(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000280300	X	22108546	X	22090428	280300	265147	rs886041529	NC_000023.11:22090427:G:A
NM_004006.2(DMD):c.6290+1G>C	DMD		not provided	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000280296	X	32305645	X	32287528	280296	265005	rs886041527	NC_000023.11:32287527:C:G
NM_000531.6(OTC):c.216+1del	OTC		not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000280295	X	38226682	X	38367429	280295	265011	rs886041526	NC_000023.11:38367428:GG:G
NM_001429.4(EP300):c.3502-1G>T	EP300		not provided	Pathogenic(Last reviewed: Feb 20, 2016)	criteria provided, single submitter	VCV000280286	22	41554415	22	41158411	280286	264993	rs886041520	NC_000022.11:41158410:G:T
NM_176787.5(PIGN):c.1434_1434+1delinsAA	PIGN		not provided	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000280280	18	59780366 - 59780367	18	62113133 - 62113134	280280	265050	rs886041514	NC_000018.10:62113132:CC:TT
NM_000495.5(COL4A5):c.2396-1G>T	COL4A5		not provided	Pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, single submitter	VCV000280273	X	107858140	X	108614910	280273	265136	rs886041509	NC_000023.11:108614909:G:T
NM_194277.2(FRMD7):c.905+1G>A	FRMD7		not provided	Pathogenic(Last reviewed: Feb 10, 2016)	criteria provided, single submitter	VCV000280271	X	131216390	X	132082362	280271	264944	rs886041507	NC_000023.11:132082361:C:T
NM_001282531.3(ADNP):c.819del (p.Lys274fs)	ADNP	K274fs	not provided	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000280262	20	49510432	20	50893895	280262	264958	rs886041498	NC_000020.11:50893894:GGG:GG
NM_000444.6(PHEX):c.733-2A>T	PHEX		not provided	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000280260	X	22112099	X	22093981	280260	264977	rs886041496	NC_000023.11:22093980:A:T
NM_178152.3(DCX):c.304C>G (p.Arg102Gly)	DCX	R102G, R183G	not provided	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000280251	X	110653323	X	111410095	280251	265003	rs587783541	NC_000023.11:111410094:G:C
NM_032620.4(GTPBP3):c.1049del (p.Leu350fs)	GTPBP3	L329fs, L350fs, L372fs, L382fs	not provided	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000280249	19	17451927	19	17341118	280249	264736	rs886041488	NC_000019.10:17341117:T:
NM_001111125.3(IQSEC2):c.804del (p.Tyr269fs)	IQSEC2	Y64fs, Y269fs	Severe intellectual deficiency|not provided|Mental retardation, X-linked 1	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280241	X	53285177	X	53255995	280241	264918	rs886041481	NC_000023.11:53255994:GGGGGG:GGGGG
NM_005183.2(CACNA1F):c.276delG (p.Lys92Asnfs)	CACNA1F		not provided	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000280239	X	49087769	X	49231307	280239	265031	rs886041479	NC_000023.11:49231306:CC:C
NM_001943.5(DSG2):c.495dup (p.Gly166fs)	DSG2		Arrhythmogenic right ventricular cardiomyopathy, type 10|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280230	18	29101176 - 29101177	18	31521213 - 31521214	280230	264903	rs781532110	NC_000018.10:31521213:TT:TTT
NM_000061.2(BTK):c.469C>T (p.Gln157Ter)	BTK	Q157*, Q191*	not provided	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000280229	X	100617600	X	101362612	280229	264795	rs886041473	NC_000023.11:101362611:G:A
NM_015338.5(ASXL1):c.1867C>T (p.Gln623Ter)	ASXL1	Q623*, Q562*	not provided	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000280228	20	31022382	20	32434579	280228	265097	rs111316898	NC_000020.11:32434578:C:T
NM_005629.4(SLC6A8):c.1072_1095del (p.Val358_Phe365del)	SLC6A8		not provided	Pathogenic(Last reviewed: Jan 15, 2016)	criteria provided, single submitter	VCV000280226	X	152958966 - 152958989	X	153693511 - 153693534	280226	265140	rs886041471	NC_000023.11:153693510:GGCTTCGTGGTCTTCTCCATCCTGGGCTTC:GGCTTC
NM_015559.3(SETBP1):c.1568del (p.His523fs)	SETBP1	H523fs	SETBP1-Related Disorder|not provided	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000280223	18	42530873	18	44950908	280223	264907	rs886041469	NC_000018.10:44950907:A:
NM_005676.5(RBM10):c.170_171del (p.Asp56_Tyr57insTer)	RBM10		not provided	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000280214	X	47028865 - 47028866	X	47169466 - 47169467	280214	265164	rs886041461	NC_000023.11:47169465:TAT:T
NM_173630.4(RTTN):c.3589_3590del (p.Thr1196_Asp1197insTer)	RTTN		not provided	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000280213	18	67781774 - 67781775	18	70114538 - 70114539	280213	264919	rs886041460	NC_000018.10:70114537:TCT:T
NM_212472.2(PRKAR1A):c.374dup (p.Met125fs)	PRKAR1A		not provided	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000280210	17	66519890 - 66519891	17	68523749 - 68523750	280210	264802	rs886041457	NC_000017.11:68523749:T:TT
NM_021140.3(KDM6A):c.2150dup (p.Ser718fs)	KDM6A		not provided	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000280203	X	44929049 - 44929050	X	45069804 - 45069805	280203	264897	rs886041452	NC_000023.11:45069804:A:AA
NM_001282531.3(ADNP):c.1235del (p.Leu412fs)	ADNP	L412fs	not provided	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000280199	20	49510016	20	50893479	280199	264957	rs886041449	NC_000020.11:50893478:A:
NM_000444.6(PHEX):c.1241del (p.Leu414fs)	PHEX	L414fs	not provided	Pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000280196	X	22132643	X	22114525	280196	265073	rs886041446	NC_000023.11:22114524:T:
NM_001111125.3(IQSEC2):c.2272C>T (p.Arg758Ter)	IQSEC2	R758*, R553*	not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000280180	X	53279486	X	53250304	280180	265167	rs886041433	NC_000023.11:53250303:G:A
NM_002501.4(NFIX):c.1116dup (p.Ser373fs)	NFIX		not provided	Pathogenic(Last reviewed: Dec 8, 2015)	criteria provided, single submitter	VCV000280179	19	13192527 - 13192528	19	13081713 - 13081714	280179	264730	rs886041432	NC_000019.10:13081713:CCCC:CCCCC
NM_152296.5(ATP1A3):c.2840G>A (p.Gly947Glu)	ATP1A3	G947E, G960E, G958E	not provided	Pathogenic(Last reviewed: Dec 11, 2015)	criteria provided, single submitter	VCV000280178	19	42471895	19	41967743	280178	264855	rs886041431	NC_000019.10:41967742:C:T
NM_001008537.3(NEXMIF):c.2138_2171dup (p.Ser724delinsArgGluGluSerAlaGlnTer)	NEXMIF		not provided	Pathogenic(Last reviewed: Dec 28, 2015)	criteria provided, single submitter	VCV000280172	X	73962220 - 73962221	X	74742385 - 74742386	280172	265063	rs886041427	NC_000023.11:74742385:CTTTTAAATTTGATTTTATTGAGCACTTTCCTCTCT:CTTTTAAATTTGATTTTATTGAGCACTTTCCTCTCTTTTAAATTTGATTTTATTGAGCACTTTCCTCTCT
NM_002501.4(NFIX):c.637C>T (p.Gln213Ter)	NFIX	Q221*, Q213*, Q205*, Q212*, Q166*	not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000280162	19	13184250	19	13073436	280162	264930	rs886041422	NC_000019.10:13073435:C:T
NM_000496.3(CRYBB2):c.563G>A (p.Arg188His)	CRYBB2	R188H	not provided|Cataract 3, multiple types	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280142	22	25627684	22	25231717	280142	264987	rs886041410	NC_000022.11:25231716:G:A
NM_001366385.1(CARD14):c.349+1G>A	CARD14		not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000280130	17	78156590	17	80182791	280130	264710	rs886041402	NC_000017.11:80182790:G:A
NM_000023.4(SGCA):c.530del (p.Ser177fs)	SGCA	S177fs	not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280105	17	48245879	17	50168518	280105	264772	rs886041387	NC_000017.11:50168517:C:
NM_001848.2(COL6A1):c.842G>A (p.Gly281Glu)	COL6A1	G281E	not provided	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000280099	21	47409035	21	45989121	280099	264917	rs886041383	NC_000021.9:45989120:G:A
NM_001029896.2(WDR45):c.19C>T (p.Arg7Ter)	WDR45	R7*	not provided|Neurodegeneration with brain iron accumulation 5|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280098	X	48935736	X	49078077	280098	265026	rs886041382	NC_000023.11:49078076:G:A
NM_001029896.2(WDR45):c.584_585del (p.Ile195fs)	WDR45	I195fs, I196fs	not provided|Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280097	X	48933344 - 48933345	X	49075685 - 49075686	280097	265165	rs886041381	NC_000023.11:49075684:TAT:T
NM_000377.2(WAS):c.1157dup (p.Gly387fs)	WAS		not provided	Pathogenic(Last reviewed: Dec 18, 2015)	criteria provided, single submitter	VCV000280093	X	48547269 - 48547270	X	48688880 - 48688881	280093	265023	rs886041379	NC_000023.11:48688880:CCCCC:CCCCCC
NM_000328.3(RPGR):c.1905+1406dup	RPGR		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Feb 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280089	X	38144934 - 38144935	X	38285681 - 38285682	280089	265159	rs886041376	NC_000023.11:38285681:TTTTTTT:TTTTTTTT
NM_000199.5(SGSH):c.629G>A (p.Trp210Ter)	SGSH	W210*	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280083	17	78188005	17	80214206	280083	265041	rs886041370	NC_000017.11:80214205:C:T
NM_000444.6(PHEX):c.1601C>T (p.Pro534Leu)	PHEX	P534L	not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280076	X	22208575	X	22190458	280076	264997	rs886041363	NC_000023.11:22190457:C:T
NM_000444.6(PHEX):c.1586_1586+1del	PHEX		not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000280075	X	22196491 - 22196492	X	22178374 - 22178375	280075	265076	rs886041362	NC_000023.11:22178373:AGAG:AG
NM_000444.6(PHEX):c.1543C>T (p.Gln515Ter)	PHEX	Q515*	not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280074	X	22196450	X	22178333	280074	264847	rs886041361	NC_000023.11:22178332:C:T
NM_000444.6(PHEX):c.1367G>A (p.Trp456Ter)	PHEX	W456*	not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280072	X	22151704	X	22133587	280072	265148	rs886041359	NC_000023.11:22133586:G:A
NM_000444.6(PHEX):c.1080-2A>G	PHEX		not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280071	X	22129583	X	22111465	280071	265071	rs886041358	NC_000023.11:22111464:A:G
NM_000444.6(PHEX):c.1158G>A (p.Trp386Ter)	PHEX	W386*	not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000280070	X	22129663	X	22111545	280070	264996	rs886041357	NC_000023.11:22111544:G:A
NM_000271.5(NPC1):c.3613dup (p.Thr1205fs)	NPC1		not provided	Pathogenic(Last reviewed: Jan 28, 2016)	criteria provided, single submitter	VCV000280069	18	21113459 - 21113460	18	23533495 - 23533496	280069	264712	rs886041356	NC_000018.10:23533495:T:TT
NM_000152.5(GAA):c.2237G>A (p.Trp746Ter)	GAA	W746*	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280063	17	78090814	17	80117015	280063	265034	rs752921215	NC_000017.11:80117014:G:A
NM_212472.2(PRKAR1A):c.738T>G (p.Tyr246Ter)	PRKAR1A	Y246*	not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000280060	17	66524010	17	68527869	280060	265024	rs886041351	NC_000017.11:68527868:T:G
NM_004006.2(DMD):c.1865C>G (p.Ser622Ter)	DMD	S622*, S499*, S614*, S618*	not provided	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000280051	X	32583946	X	32565829	280051	265157	rs886041344	NC_000023.11:32565828:G:C
NM_000252.2(MTM1):c.593dup (p.Tyr198Ter)	MTM1		not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000280049	X	149809805 - 149809806	X	150641332 - 150641333	280049	265028	rs886041343	NC_000023.11:150641332:A:AA
NM_172107.4(KCNQ2):c.1229del (p.Pro410fs)	KCNQ2	P410fs, P400fs	Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280043	20	62055548	20	63424195	280043	264761	rs886041339	NC_000020.11:63424194:GGGGGG:GGGGG
NM_000206.2(IL2RG):c.2T>C (p.Met1Thr)	IL2RG	M1T	not provided	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000280036	X	70331388	X	71111538	280036	265122	rs886041334	NC_000023.11:71111537:A:G
NM_000206.2(IL2RG):c.924+1G>A	IL2RG		not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000280035	X	70328126	X	71108276	280035	265121	rs886041333	NC_000023.11:71108275:C:T
NM_004586.3(RPS6KA3):c.205G>T (p.Glu69Ter)	RPS6KA3	E69*	not provided	Pathogenic(Last reviewed: Feb 23, 2016)	criteria provided, single submitter	VCV000280030	X	20227444	X	20209326	280030	264829	rs886041331	NC_000023.11:20209325:C:A
NM_004586.3(RPS6KA3):c.603_605TGA[1] (p.Asp202del)	RPS6KA3	D202del	not provided	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000280029	X	20206638 - 20206640	X	20188520 - 20188522	280029	265039	rs886041330	NC_000023.11:20188519:TCATCA:TCA
NM_016327.3(UPB1):c.873+1G>A	UPB1		not provided	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000280025	22	24916437	22	24520469	280025	264981	rs747539101	NC_000022.11:24520468:G:A
NM_004586.3(RPS6KA3):c.1934G>A (p.Trp645Ter)	RPS6KA3	W645*	not provided	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000280023	X	20179787	X	20161669	280023	265038	rs886041328	NC_000023.11:20161668:C:T
NM_000397.3(CYBB):c.565_568delATTA	CYBB		not provided	Pathogenic(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000280000	X	37655281 - 37655284	X	37796028 - 37796031	280000	265095	rs886041312	NC_000023.11:37796027:ATTAATTA:ATTA
NM_144773.3(PROKR2):c.458+1G>A	PROKR2		not provided	Pathogenic(Last reviewed: Nov 9, 2015)	criteria provided, single submitter	VCV000279994	20	5294557	20	5313911	279994	264879	rs886041307	NC_000020.11:5313910:C:T
NM_003688.3(CASK):c.2630T>G (p.Leu877Ter)	CASK	L877*, L853*, L854*, L882*	not provided	Pathogenic(Last reviewed: Oct 19, 2015)	criteria provided, single submitter	VCV000279991	X	41379809	X	41520556	279991	265102	rs886041306	NC_000023.11:41520555:A:C
NM_002501.4(NFIX):c.303del (p.Cys102fs)	NFIX	C94fs, C102fs, C55fs, C101fs, C110fs	not provided	Pathogenic(Last reviewed: Oct 16, 2015)	criteria provided, single submitter	VCV000279989	19	13136105	19	13025291	279989	264922	rs886041304	NC_000019.10:13025290:CCCCCC:CCCCC
NM_006031.6(PCNT):c.9535dup (p.Val3179fs)	PCNT		not provided	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000279984	21	47860904 - 47860905	21	46440991 - 46440992	279984	264920	rs747058622	NC_000021.9:46440991:GGGGG:GGGGGG
NM_000194.3(HPRT1):c.145C>T (p.Leu49Phe)	HPRT1	L49F	not provided	Pathogenic(Last reviewed: Sep 24, 2015)	criteria provided, single submitter	VCV000279979	X	133609221	X	134475191	279979	264805	rs886041298	NC_000023.11:134475190:C:T
NM_000529.2(MC2R):c.579_581del (p.Tyr193_Val194delinsTer)	MC2R		not provided	Pathogenic(Last reviewed: Sep 15, 2015)	criteria provided, single submitter	VCV000279974	18	13884937 - 13884939	18	13884938 - 13884940	279974	265044	rs886041294	NC_000018.10:13884937:ACA:
NM_000383.4(AIRE):c.132+1_132+3delinsCT	AIRE		Polyglandular autoimmune syndrome, type 1|not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279973	21	45706022 - 45706024	21	44286139 - 44286141	279973	264972	rs886041293	NC_000021.9:44286138:GTG:CT
NM_001347721.2(DYRK1A):c.760C>T (p.Arg254Ter)	DYRK1A	R263*, R225*, R254*	not provided	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000279970	21	38862599	21	37490297	279970	264914	rs886041291	NC_000021.9:37490296:C:T
NM_000194.3(HPRT1):c.266_269del (p.Ser89fs)	HPRT1	S89fs	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000279966	X	133609341 - 133609344	X	134475311 - 134475314	279966	265021	rs886041288	NC_000023.11:134475310:AGTGA:A
NM_003688.3(CASK):c.523dup (p.Val175fs)	CASK		not provided	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000279959	X	41530689 - 41530690	X	41671436 - 41671437	279959	265162	rs886041284	NC_000023.11:41671436:C:CC
NM_005993.5(TBCD):c.1423G>A (p.Ala475Thr)	TBCD	A475T	not provided	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000279953	17	80828204	17	82870328	279953	264891	rs775014444	NC_000017.11:82870327:G:A
NM_000068.4(CACNA1A):c.4506_4508CTT[2] (p.Phe1505del)	CACNA1A	F1502del	not provided	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000279951	19	13368252 - 13368254	19	13257438 - 13257440	279951	264732	rs886041279	NC_000019.10:13257437:AAGAAGAAG:AAGAAG
NM_172107.4(KCNQ2):c.629G>A (p.Arg210His)	KCNQ2	R210H	not provided|Early infantile epileptic encephalopathy 7|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279931	20	62076073	20	63444720	279931	264902	rs886041262	NC_000020.11:63444719:C:T
NM_021074.5(NDUFV2):c.120+5_120+8del	NDUFV2		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7|not provided	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000279920	18	9117902 - 9117905	18	9117904 - 9117907	279920	264825	rs752670374	NC_000018.10:9117903:GTAAGTAA:GTAA
NM_000377.2(WAS):c.466_469delAGAC	WAS		not provided	Pathogenic(Last reviewed: Apr 21, 2016)	criteria provided, single submitter	VCV000279917	X	48544331 - 48544334	X	48685942 - 48685945	279917	265105	rs886041254	NC_000023.11:48685941:ACAGACAGAC:ACAGAC
NM_003244.3(TGIF1):c.778del (p.Arg260fs)	TGIF1	R389fs, R260fs, R263fs, R240fs, R274fs	not provided	Pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	VCV000279908	18	3457897	18	3457899	279908	264727	rs886041249	NC_000018.10:3457898:C:
NM_001083962.2(TCF4):c.655G>A (p.Asp219Asn)	TCF4	D219N, D148N, D3N, D195N, D194N, D218N, D321N, D59N, D89N, D177N, D217N, D225N	not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000279907	18	52946782	18	55279551	279907	264822	rs886041248	NC_000018.10:55279550:C:T
NM_000346.4(SOX9):c.442G>T (p.Glu148Ter)	SOX9	E148*	not provided	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000279897	17	70118870	17	72122729	279897	264703	rs886041242	NC_000017.11:72122728:G:T
NM_004782.4(SNAP29):c.2T>C (p.Met1Thr)	SNAP29	M1T	Leukodystrophy, hypomyelinating, 2|not provided	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	VCV000279894	22	21213400	22	20859112	279894	264773	rs886041240	NC_000022.11:20859111:T:C
NM_000199.5(SGSH):c.1139A>G (p.Gln380Arg)	SGSH	Q380R	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279891	17	78184621	17	80210822	279891	264874	rs144143780	NC_000017.11:80210821:T:C
NM_212472.2(PRKAR1A):c.46C>T (p.Arg16Ter)	PRKAR1A	R16*	Carney complex, type 1|not provided	Pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279877	17	66511586	17	68515445	279877	264800	rs886041228	NC_000017.11:68515444:C:T
NM_003560.4(PLA2G6):c.1077G>A (p.Ser359=)	PLA2G6		not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000279875	22	38528838	22	38132831	279875	264928	rs368497893	NC_000022.11:38132830:C:T
NM_000444.6(PHEX):c.1645+1G>A	PHEX		not provided|Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279871	X	22208620	X	22190503	279871	264998	rs886041225	NC_000023.11:22190502:G:A
NM_000444.6(PHEX):c.1645C>T (p.Arg549Ter)	PHEX	R549*	not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279870	X	22208619	X	22190502	279870	265149	rs886041224	NC_000023.11:22190501:C:T
NM_000444.6(PHEX):c.733-1G>A	PHEX		not provided	Pathogenic(Last reviewed: Jul 16, 2016)	criteria provided, single submitter	VCV000279869	X	22112100	X	22093982	279869	264979	rs886041223	NC_000023.11:22093981:G:A
NM_000276.4(OCRL):c.940-11G>A	OCRL		Lowe syndrome||not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000279859	X	128696350	X	129562373	279859	265010	rs776743373	NC_000023.11:129562372:G:A
NM_000475.5(NR0B1):c.1301del (p.Phe434fs)	NR0B1	F434fs	not provided	Pathogenic(Last reviewed: May 20, 2016)	criteria provided, single submitter	VCV000279854	X	30322808	X	30304691	279854	265156	rs886041215	NC_000023.11:30304690:AAAA:AAA
NM_007059.4(KPTN):c.597_598dup (p.Ser200fs)	KPTN		not provided|Mental retardation, autosomal recessive 41	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279826	19	47984017 - 47984018	19	47480760 - 47480761	279826	264742	rs766372684	NC_000019.10:47480760:TA:TATA
NM_000213.5(ITGB4):c.600dup (p.Phe201fs)	ITGB4		not provided	Pathogenic(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	VCV000279814	17	73725372 - 73725373	17	75729291 - 75729292	279814	264865	rs752657203	NC_000017.11:75729291:CCCCCCC:CCCCCCCC
NM_000213.5(ITGB4):c.3793+2dup	ITGB4		not provided	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000279813	17	73747193 - 73747194	17	75751112 - 75751113	279813	264804	rs886041205	NC_000017.11:75751112:T:TT
NM_000152.5(GAA):c.1655T>C (p.Leu552Pro)	GAA	L552P	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279811	17	78085800	17	80112001	279811	265030	rs779556619	NC_000017.11:80112000:T:C
NM_001958.4(EEF1A2):c.271G>A (p.Asp91Asn)	EEF1A2	D91N	not provided|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279803	20	62127262	20	63495909	279803	264912	rs886041197	NC_000020.11:63495908:C:T
NM_173483.4(CYP4F22):c.59dup (p.Ile21fs)	CYP4F22		Autosomal recessive congenital ichthyosis 5|not provided	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000279799	19	15636205 - 15636206	19	15525394 - 15525395	279799	265057	rs531800013	NC_000019.10:15525394:G:GG
NM_000397.3(CYBB):c.1272G>A (p.Trp424Ter)	CYBB	W424*	not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000279797	X	37664379	X	37805126	279797	264889	rs886041195	NC_000023.11:37805125:G:A
NM_000397.3(CYBB):c.742dup (p.Ile248fs)	CYBB		not provided|Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279796	X	37658269 - 37658270	X	37799016 - 37799017	279796	265008	rs886041194	NC_000023.11:37799016:AAAAAA:AAAAAAA
NM_000397.3(CYBB):c.388del (p.Arg130fs)	CYBB	R130fs	not provided	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000279795	X	37652966	X	37793713	279795	265158	rs886041193	NC_000023.11:37793712:CCC:CC
NM_000397.3(CYBB):c.271C>T (p.Arg91Ter)	CYBB	R91*	not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000279794	X	37651246	X	37791993	279794	265093	rs886041192	NC_000023.11:37791992:C:T
NM_000397.3(CYBB):c.23_26dup (p.Leu10fs)	CYBB		not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000279793	X	37639351 - 37639352	X	37780098 - 37780099	279793	265091	rs886041191	NC_000023.11:37780098:GAGGG:GAGGGAGGG
NM_000390.4(CHM):c.1138C>T (p.Gln380Ter)	CHM	Q380*, Q232*	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279777	X	85211186	X	85956181	279777	265068	rs886041181	NC_000023.11:85956180:G:A
NM_000390.4(CHM):c.969T>A (p.Tyr323Ter)	CHM	Y323*, Y175*	not provided	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000279776	X	85211355	X	85956350	279776	265175	rs886041180	NC_000023.11:85956349:A:T
NM_000390.4(CHM):c.799C>T (p.Arg267Ter)	CHM	R267*, R119*	Choroideremia|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279775	X	85213886	X	85958881	279775	265129	rs886041179	NC_000023.11:85958880:G:A
NM_000390.4(CHM):c.757C>T (p.Arg253Ter)	CHM	R253*, R105*	not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000279774	X	85213928	X	85958923	279774	265176	rs886041178	NC_000023.11:85958922:G:A
NM_000390.4(CHM):c.525_526del (p.Glu177fs)	CHM	E29fs, E177fs	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279773	X	85218846 - 85218847	X	85963841 - 85963842	279773	265131	rs886041177	NC_000023.11:85963840:CT:
NM_000390.3(CHM):c.315_318delTCAG (p.Ser105Argfs)	CHM		not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, single submitter	VCV000279772	X	85219054 - 85219057	X	85964049 - 85964052	279772	265069	rs886041176	
NM_000390.4(CHM):c.130G>T (p.Gly44Ter)	CHM	G44*	not provided	Pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000279771	X	85236800	X	85981796	279771	265177	rs886041175	NC_000023.11:85981795:C:A
NM_000390.4(CHM):c.116+1G>T	CHM		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279770	X	85282494	X	86027490	279770	265072	rs786204761	NC_000023.11:86027489:C:A
NM_000390.4(CHM):c.49+1G>T	CHM		not provided	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000279769	X	85302487	X	86047483	279769	265133	rs886041174	NC_000023.11:86047482:C:A
NM_003688.3(CASK):c.429+1G>A	CASK		not provided	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000279730	X	41598636	X	41739383	279730	265103	rs886041153	NC_000023.11:41739382:C:T
NM_000061.2(BTK):c.1573C>T (p.Arg525Ter)	BTK	R525*, R349*, R559*	not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000279714	X	100609676	X	101354688	279714	264940	rs886041149	NC_000023.11:101354687:G:A
NM_000061.2(BTK):c.215dup (p.Asn72fs)	BTK		X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279713	X	100629548 - 100629549	X	101374560 - 101374561	279713	265134	rs886041148	NC_000023.11:101374560:TTTTTTT:TTTTTTTT
NM_000047.2(ARSL):c.1711C>T (p.Gln571Ter)	ARSL	Q571*, Q580*, Q596*, Q517*	not provided	Pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000279692	X	2852932	X	2934891	279692	265154	rs886041135	NC_000023.11:2934890:G:A
NM_000047.2(ARSL):c.1300G>A (p.Gly434Ser)	ARSL	G434S, G443S, G459S, G380S	not provided	Pathogenic(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	VCV000279691	X	2854894	X	2936853	279691	265155	rs886041134	NC_000023.11:2936852:C:T
NM_000383.4(AIRE):c.205_208dup (p.Asp70fs)	AIRE		not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000279674	21	45706511 - 45706512	21	44286628 - 44286629	279674	264768	rs886041124	NC_000021.9:44286628:CAGG:CAGGCAGG
NM_000383.4(AIRE):c.199_202delinsTGG (p.Leu67fs)	AIRE		not provided	Pathogenic(Last reviewed: Jul 5, 2016)	criteria provided, single submitter	VCV000279673	21	45706506 - 45706509	21	44286623 - 44286626	279673	264915	rs886041123	NC_000021.9:44286622:CTGA:TGG
NM_001282531.3(ADNP):c.2188C>T (p.Arg730Ter)	ADNP	R730*	Hypothyroidism|Abnormality of the dentition|Stereotypy|Aggressive behavior|Seizures|Growth hormone deficiency|Global developmental delay||Helsmoortel-Van der Aa Syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279598	20	49509063	20	50892526	279598	263863	rs886041116	NC_000020.11:50892525:G:A
NM_000271.5(NPC1):c.2728G>A (p.Gly910Ser)	NPC1	G910S	not provided|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000268187	18	21119842	18	23539878	268187	263804	rs768999208	NC_000018.10:23539877:C:T
NC_000023.10:g.(?_147030199)_(147046357_?)del	FMR1		Intellectual disability	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000268184	X	147030199 - 147046357			268184	263801		
NM_002024.5(FMR1):c.990+1G>A	FMR1		Intellectual disability	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000268183	X	147018133	X	147936614	268183	263803	rs886041089	NC_000023.11:147936613:G:A
NM_002024.5(FMR1):c.420-8A>G	FMR1		Intellectual disability	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000268182	X	147011459	X	147929940	268182	263802	rs886041088	NC_000023.11:147929939:A:G
NM_005993.5(TBCD):c.1130G>A (p.Arg377Gln)	TBCD	R377Q	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268175	17	80765526	17	82807650	268175	263793	rs764085684	NC_000017.11:82807649:G:A
NM_005993.5(TBCD):c.1876G>A (p.Ala626Thr)	TBCD	A626T	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268174	17	80863883	17	82906007	268174	263792	rs749225304	NC_000017.11:82906006:G:A
NM_005993.5(TBCD):c.686T>G (p.Leu229Arg)	TBCD	L229R	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268173	17	80739512	17	82781636	268173	263791	rs778417127	NC_000017.11:82781635:T:G
NM_005993.5(TBCD):c.2810C>G (p.Pro937Arg)	TBCD	P937R	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268172	17	80887105	17	82929229	268172	263790	rs886041087	NC_000017.11:82929228:C:G
NM_005993.5(TBCD):c.3365C>T (p.Pro1122Leu)	TBCD	P1122L	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268171	17	80896008	17	82938132	268171	263789	rs755177846	NC_000017.11:82938131:C:T
NM_005993.5(TBCD):c.2280C>A (p.Tyr760Ter)	TBCD	Y760*	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum|not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000268170	17	80882834	17	82924958	268170	263788	rs754750539	NC_000017.11:82924957:C:A
NM_005993.5(TBCD):c.1160T>G (p.Met387Arg)	TBCD	M387R	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268169	17	80767595	17	82809719	268169	263787	rs886041086	NC_000017.11:82809718:T:G
NM_005993.5(TBCD):c.2761G>A (p.Ala921Thr)	TBCD	A921T	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268168	17	80887056	17	82929180	268168	263786	rs886041085	NC_000017.11:82929179:G:A
NM_005993.5(TBCD):c.2314C>T (p.Arg772Cys)	TBCD	R772C	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268167	17	80882868	17	82924992	268167	263785	rs181969865	NC_000017.11:82924991:C:T
NM_005993.5(TBCD):c.1564-12C>G	TBCD		Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000268166	17	80851411	17	82893535	268166	263784	rs886041084	NC_000017.11:82893534:C:G
NM_024298.5(MBOAT7):c.820_826del (p.Gly274fs)	MBOAT7	G201fs, G274fs	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268115	19	54684518 - 54684524	19	54180801 - 54180807	268115	263641	rs886041061	NC_000019.10:54180800:GGCCGCC:
NM_024298.5(MBOAT7):c.854+1G>C	MBOAT7		Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000268114	19	54684489	19	54180772	268114	263640	rs886041060	NC_000019.10:54180771:C:G
NM_024298.5(MBOAT7):c.423del (p.Leu142fs)	MBOAT7	L69fs, L142fs	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268113	19	54687474	19	54183591	268113	263639	rs886041059	NC_000019.10:54183590:CCCC:CCC
NM_024298.5(MBOAT7):c.758_778del (p.Glu253_Ala259del)	MBOAT7		Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268112	19	54684566 - 54684586	19	54180849 - 54180869	268112	263638	rs750035706	NC_000019.10:54180848:CGGCGGCAATGCAGCCGCACTCGGCGGCAAT:CGGCGGCAAT
NM_024298.5(MBOAT7):c.126_145del (p.Leu43fs)	MBOAT7	L43fs, P12fs	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Nov 11, 2016)	no assertion criteria provided	VCV000268111	19	54692132 - 54692151	19	54188278 - 54188297	268111	263637	rs886041058	NC_000019.10:54188277:GGGGGCCACAGGTGAACAGGG:G
GRCh37/hg19 Xp22.12(chrX:20179739-20938979)x1	RPS6KA3		See cases	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000268067	X	20179739 - 20938979			268067	263508		
NM_080675.4(SUN5):c.851C>G (p.Ser284Ter)	SUN5	S284*	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268052	20	31573588	20	32985782	268052	263462	rs886041025	NC_000020.11:32985781:G:C
NM_080675.4(SUN5):c.781G>A (p.Val261Met)	SUN5	V261M	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268051	20	31573658	20	32985852	268051	263461	rs886041024	NC_000020.11:32985851:C:T
NM_080675.4(SUN5):c.381del (p.Val128fs)	SUN5	V128fs	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268050	20	31585453	20	32997647	268050	263460	rs781693813	NC_000020.11:32997646:TTT:TT
NM_080675.4(SUN5):c.485T>A (p.Met162Lys)	SUN5	M162K	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268049	20	31583474	20	32995668	268049	263459	rs886041023	NC_000020.11:32995667:A:T
NM_080675.4(SUN5):c.1066C>T (p.Arg356Cys)	SUN5	R356C	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268048	20	31571674	20	32983868	268048	263458	rs754130052	NC_000020.11:32983867:G:A
NM_080675.4(SUN5):c.824C>T (p.Thr275Met)	SUN5	T275M	Spermatogenic failure 16	Pathogenic(Last reviewed: Nov 7, 2016)	no assertion criteria provided	VCV000268047	20	31573615	20	32985809	268047	263457	rs756459525	NC_000020.11:32985808:G:A
NM_006087.4(TUBB4A):c.1181T>G (p.Phe394Cys)	TUBB4A	F445C, F394C, F439C, F322C	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267794	19	6495329	19	6495318	267794	263148	rs886041022	NC_000019.10:6495317:A:C
NM_006087.4(TUBB4A):c.1172G>A (p.Arg391His)	TUBB4A	R442H, R391H, R436H, R319H	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267793	19	6495338	19	6495327	267793	263149	rs886041021	NC_000019.10:6495326:C:T
NM_006087.4(TUBB4A):c.1164G>A (p.Met388Ile)	TUBB4A	M439I, M388I, M316I, M433I	Aplasia/Hypoplasia of the cerebellum|Abnormal basal ganglia MRI signal intensity|Microcephaly|Cerebral hypomyelination|Tetraplegia/tetraparesis|Global developmental delay|Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267792	19	6495346	19	6495335	267792	263150	rs797045074	NC_000019.10:6495334:C:T
NM_006087.4(TUBB4A):c.1163T>C (p.Met388Thr)	TUBB4A	M439T, M388T, M316T, M433T	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267791	19	6495347	19	6495336	267791	263151	rs886041020	NC_000019.10:6495335:A:G
NM_006087.4(TUBB4A):c.1099T>C (p.Phe367Leu)	TUBB4A	F418L, F367L, F295L, F412L	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267789	19	6495411	19	6495400	267789	263153	rs886041018	NC_000019.10:6495399:A:G
NM_006087.4(TUBB4A):c.1099T>A (p.Phe367Ile)	TUBB4A	F418I, F367I, F295I, F412I	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267788	19	6495411	19	6495400	267788	263154	rs886041018	NC_000019.10:6495399:A:T
NM_006087.4(TUBB4A):c.1091C>A (p.Ala364Asp)	TUBB4A	A415D, A364D, A292D, A409D	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267787	19	6495419	19	6495408	267787	263155	rs886041017	NC_000019.10:6495407:G:T
NM_006087.4(TUBB4A):c.1061G>A (p.Cys354Tyr)	TUBB4A	C405Y, C354Y, C399Y, C282Y	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267786	19	6495449	19	6495438	267786	263156	rs886041016	NC_000019.10:6495437:C:T
NM_006087.4(TUBB4A):c.1054G>A (p.Ala352Thr)	TUBB4A	A403T, A352T, A280T, A397T	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267785	19	6495456	19	6495445	267785	263157	rs886041015	NC_000019.10:6495444:C:T
NM_006087.4(TUBB4A):c.968T>G (p.Met323Arg)	TUBB4A	M374R, M323R, M251R, M368R	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267784	19	6495542	19	6495531	267784	263158	rs886041014	NC_000019.10:6495530:A:C
NM_006087.4(TUBB4A):c.900G>T (p.Met300Ile)	TUBB4A	M351I, M300I, M345I, M228I	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267782	19	6495610	19	6495599	267782	263160	rs886041012	NC_000019.10:6495598:C:A
NM_006087.3:c.900C>A	TUBB4A		Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267781					267781	263170		
NM_006087.4(TUBB4A):c.874C>A (p.Gln292Lys)	TUBB4A	Q343K, Q292K, Q220K, Q337K	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267780	19	6495636	19	6495625	267780	263161	rs886041011	NC_000019.10:6495624:G:T
NM_006087.4(TUBB4A):c.845G>C (p.Arg282Pro)	TUBB4A	R333P, R282P, R327P, R210P	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267779	19	6495665	19	6495654	267779	263162	rs756762431	NC_000019.10:6495653:C:G
NM_006087.4(TUBB4A):c.731G>A (p.Gly244Asp)	TUBB4A	G295D, G244D, G172D, G289D	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267778	19	6495779	19	6495768	267778	263164	rs886041010	NC_000019.10:6495767:C:T
NM_006087.4(TUBB4A):c.731G>T (p.Gly244Val)	TUBB4A	G295V, G244V, G172V, G289V	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267777	19	6495779	19	6495768	267777	263163	rs886041010	NC_000019.10:6495767:C:A
NM_006087.4(TUBB4A):c.716G>T (p.Cys239Phe)	TUBB4A	C290F, C239F, C284F, C167F	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267776	19	6495794	19	6495783	267776	263166	rs886041009	NC_000019.10:6495782:C:A
NM_006087.4(TUBB4A):c.544C>A (p.Pro182Thr)	TUBB4A	P233T, P182T, P227T, P110T	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267775	19	6495966	19	6495955	267775	263167	rs886041008	NC_000019.10:6495954:G:T
NM_006087.4(TUBB4A):c.533C>T (p.Thr178Met)	TUBB4A	T229M, T178M, T106M, T223M	Leukodystrophy, hypomyelinating, 6|not provided	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000267774	19	6495977	19	6495966	267774	263168	rs587777468	NC_000019.10:6495965:G:A
NM_006087.4(TUBB4A):c.4C>T (p.Arg2Trp)	TUBB4A	R53W, R2W, R47W	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267773	19	6502220	19	6502209	267773	263169	rs587776983	NC_000019.10:6502208:G:A
NM_006087.4(TUBB4A):c.730G>A (p.Gly244Ser)	TUBB4A	G244S, G295S, G289S, G172S	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000267772	19	6495780	19	6495769	267772	263165	rs886041007	NC_000019.10:6495768:C:T
Single allele	EPG5		Vici syndrome	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000267450					267450	262714		
NM_006494.4(ERF):c.266A>G (p.Tyr89Cys)	ERF	Y89C, Y14C	not provided|Chitayat syndrome	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000267443	19	42754086	19	42249934	267443	262701	rs886041001	NC_000019.10:42249933:T:C
NM_152296.5(ATP1A3):c.385G>A (p.Val129Met)	ATP1A3	V129M, V142M, V140M	Juvenile onset psychosis	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	VCV000267411	19	42490354	19	41986202	267411	262636	rs1555865401	NC_000019.10:41986201:C:T
NC_000023.10:g.(?_103031918)_(103045531_?)dup	PLP1		Hereditary spastic paraplegia 2	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	VCV000267338	X	103031918 - 103045531			267338	262412		
NM_000054.6(AVPR2):c.966del (p.Trp323fs)	AVPR2	W323fs	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Sep 16, 2016)	no assertion criteria provided	VCV000267269	X	153172029	X	153906575	267269	262272	rs886040961	NC_000023.11:153906574:CCCC:CCC
NM_000836.2(GRIN2D):c.1999G>A (p.Val667Ile)	GRIN2D	V667I	Epileptic encephalopathy, early infantile, 46	Pathogenic(Last reviewed: Oct 19, 2016)	no assertion criteria provided	VCV000267211	19	48922979	19	48419722	267211	262090	rs886040861	NC_000019.10:48419721:G:A
NM_001415.4(EIF2S3):c.777T>G (p.Ile259Met)	EIF2S3	I259M	MEHMO syndrome	Pathogenic(Last reviewed: Jan 18, 2018)	no assertion criteria provided	VCV000267206	X	24084119	X	24066002	267206	262085	rs886040856	NC_000023.11:24066001:T:G
NM_001415.4(EIF2S3):c.665T>C (p.Ile222Thr)	EIF2S3	I222T	MEHMO syndrome	Pathogenic(Last reviewed: Jan 18, 2018)	no assertion criteria provided	VCV000267205	X	24082345	X	24064228	267205	262084	rs886040855	NC_000023.11:24064227:T:C
NM_001165927.1(MKS1):c.231+2T>A	MKS1		Meckel-Gruber syndrome	Pathogenic	no assertion criteria provided	VCV000266091	17	56294025	17	58216664	266091	260925	rs886039803	NC_000017.11:58216663:A:T
NM_033380.3(COL4A5):c.2766del (p.Gly923fs)	COL4A5	G923fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000266009	X	107865119	X	108621889	266009	260806	rs886039890	NC_000023.11:108621888:AAA:AA
NM_033380.3(COL4A5):c.4900_4903del (p.Pro1634fs)	COL4A5	P1628fs, P1634fs	Alport syndrome 1, X-linked recessive	Pathogenic	no assertion criteria provided	VCV000266001	X	107938573 - 107938576	X	108695343 - 108695346	266001	260808	rs886039886	NC_000023.11:108695342:CTCCCT:CT
NM_000527.4(LDLR):c.2312-?_*2514del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265906	19	11234021 - 11244506			265906	260656		
NM_000527.4(LDLR):c.1061-?_1845+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000265901	19	11222190 - 11227674			265901	260654		
NM_000527.4(LDLR):c.618_638del (p.Gly207_Ser213del)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265899	19	11216198 - 11216218	19	11105522 - 11105542	265899	260658	rs886039830	NC_000019.10:11105521:AGTGGCGAGTGCATCCACTCCAG:AG
NM_000451.3(SHOX):c.528G>C (p.Glu176Asp)	SHOX	E176D	Short stature, idiopathic, X-linked	Pathogenic(Last reviewed: Mar 3, 2016)	no assertion criteria provided	VCV000265858	X	601597	X	640862	265858	260558	rs778921118	NC_000024.10:640861:G:C
NM_001711.6(BGN):c.238G>A (p.Gly80Ser)	BGN	G80S	Thoracic aortic aneurysm and aortic dissection|Meester-loeys syndrome	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000265798	X	152770327	X	153504869	265798	260502	rs886037825	NC_000023.11:153504868:G:A
NM_001711.6(BGN):c.908A>C (p.Gln303Pro)	BGN	Q303P	Thoracic aortic aneurysm and aortic dissection|Meester-loeys syndrome	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000265795	X	152772642	X	153507184	265795	260503	rs886037824	NC_000023.11:153507183:A:C
NM_001711.6(BGN):c.5G>A (p.Trp2Ter)	BGN	W2*	Thoracic aortic aneurysm and aortic dissection|Meester-loeys syndrome	Pathogenic(Last reviewed: May 10, 2017)	no assertion criteria provided	VCV000265794	X	152770094	X	153504636	265794	260501	rs886037823	NC_000023.11:153504635:G:A
NM_001415.4(EIF2S3):c.1394_1397del (p.Ile465fs)	EIF2S3	I465fs	MEHMO syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265789	X	24094874 - 24094877	X	24076757 - 24076760	265789	260479	rs886040857	NC_000023.11:24076756:CAATCAA:CAA
NM_001291412.2(SON):c.245-3285del	SON	H1547fs	ZTTK syndrome|not provided	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000265776	21	34926177	21	33553871	265776	260466	rs886039776	NC_000021.9:33553870:A:
NM_138927.3(SON):c.6002_6003insCC (p.Arg2002fs)	SON		ZTTK syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2016)	no assertion criteria provided	VCV000265775	21	34927538 - 34927539	21	33555232 - 33555233	265775	260465	rs886039775	NC_000021.9:33555232:C:CCC
NM_001291412.2(SON):c.245-2376_245-2375del	SON		ZTTK syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	VCV000265774	21	34927083 - 34927084	21	33554777 - 33554778	265774	260464	rs886039774	NC_000021.9:33554776:AGAGA:AGA
NM_000444.6(PHEX):c.1204C>T (p.Gln402Ter)	PHEX	Q402*	not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	VCV000265702	X	22132606	X	22114488	265702	260300	rs886039745	NC_000023.11:22114487:C:T
NM_001193466.2(KANSL1):c.1532del (p.Lys510_Leu511insTer)	KANSL1		not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000265688	17	44159808	17	46082442	265688	260180	rs886039733	NC_000017.11:46082441:AA:A
NM_003895.3(SYNJ1):c.858_862del (p.Gln287fs)	SYNJ1	Q248fs, Q287fs	not provided	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000265687	21	34066582 - 34066586	21	32694272 - 32694276	265687	260238	rs886039732	NC_000021.9:32694271:TTTGT:
NM_001184880.2(PCDH19):c.2849-2A>G	PCDH19		not provided	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000265682	X	99551875	X	100296877	265682	260268	rs886039728	NC_000023.11:100296876:T:C
NM_015338.5(ASXL1):c.2922C>A (p.Tyr974Ter)	ASXL1	Y974*, Y913*	not provided	Pathogenic(Last reviewed: Aug 18, 2016)	criteria provided, single submitter	VCV000265675	20	31023437	20	32435634	265675	260227	rs886039722	NC_000020.11:32435633:C:A
NM_001356.4(DDX3X):c.635C>A (p.Pro212His)	DDX3X	P212H, P196H, P26H	not provided	Pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000265672	X	41202560	X	41343307	265672	260321	rs886039719	NC_000023.11:41343306:C:A
NM_003588.3(CUL4B):c.2243_2244del (p.Phe748fs)	CUL4B	F735fs, F552fs, F730fs, F748fs	not provided	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000265671	X	119668412 - 119668413	X	120534557 - 120534558	265671	260277	rs886039718	NC_000023.11:120534556:AAAAA:AAA
NM_001184880.2(PCDH19):c.646_655del (p.Pro216fs)	PCDH19	P216fs	not provided	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000265659	X	99662941 - 99662950	X	100407943 - 100407952	265659	260269	rs886039707	NC_000023.11:100407942:GGCGCGGCGGG:G
NM_018486.3(HDAC8):c.907G>T (p.Gly303Ter)	HDAC8	G303*, G212*	not provided	Pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000265658	X	71684412	X	72464562	265658	260342	rs886039706	NC_000023.11:72464561:C:A
NM_001005360.2(DNM2):c.1879C>G (p.Pro627Ala)	DNM2	P627A, P623A	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000265656	19	10934561	19	10823885	265656	260206	rs886039704	NC_000019.10:10823884:C:G
NM_003688.3(CASK):c.2100G>A (p.Trp700Ter)	CASK	W700*, W677*, W671*	not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000265654	X	41401999	X	41542746	265654	260325	rs886039702	NC_000023.11:41542745:C:T
NM_000346.4(SOX9):c.555del (p.Gln186fs)	SOX9	Q186fs	not provided	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, single submitter	VCV000265652	17	70118981	17	72122840	265652	260189	rs886039700	NC_000017.11:72122839:GGG:GG
NM_002501.4(NFIX):c.950_954del (p.Asp317fs)	NFIX	D309fs, D316fs, D270fs, D317fs, D325fs	not provided	Pathogenic(Last reviewed: Jul 30, 2016)	criteria provided, single submitter	VCV000265650	19	13186480 - 13186484	19	13075666 - 13075670	265650	260208	rs886039698	NC_000019.10:13075665:ATGCA:
NM_000284.4(PDHA1):c.760-1G>T	PDHA1		not provided	Pathogenic(Last reviewed: Jul 24, 2016)	criteria provided, single submitter	VCV000265640	X	19373803	X	19355685	265640	260294	rs886039690	NC_000023.11:19355684:G:T
NM_000109.4(DMD):c.9479del (p.Leu3160fs)	DMD	L1827fs, L3045fs, L3168fs, L3164fs, L1824fs, L100fs, L3160fs, L439fs, L708fs	not provided	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000265630	X	31227675	X	31209558	265630	260305	rs886039681	NC_000023.11:31209557:AAA:AA
NM_001077488.4(GNAS):c.787C>T (p.Gln263Ter)	GNAS	Q262*, Q263*, Q905*, Q247*, Q203*, Q248*	not provided	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000265625	20	57484804	20	58909749	265625	260233	rs886039677	NC_000020.11:58909748:C:T
NM_152424.4(AMER1):c.1243_1259del (p.Met415fs)	AMER1	M415fs	not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000265617	X	63411908 - 63411924	X	64192028 - 64192044	265617	260336	rs886039672	NC_000023.11:64192027:TTGGGCCGTGGATACATTTGGGC:TTGGGC
NM_015338.5(ASXL1):c.3144_3145del (p.Asp1049fs)	ASXL1	D1049fs, D988fs	not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000265615	20	31023658 - 31023659	20	32435855 - 32435856	265615	260228	rs886039670	NC_000020.11:32435854:GTG:G
NM_001127221.1(CACNA1A):c.1363C>T (p.Arg455Ter)	CACNA1A	R455*, R454*	not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265613	19	13428121	19	13317307	265613	260212	rs886039668	NC_000019.10:13317306:G:A
NM_000109.4(DMD):c.10126del (p.Arg3376fs)	DMD	R2043fs, R316fs, R3261fs, R3380fs, R3384fs, R924fs, R2040fs, R3376fs, R655fs	not provided	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265606	X	31196859	X	31178742	265606	260304	rs886039663	NC_000023.11:31178741:TTTT:TTT
NM_000444.6(PHEX):c.134T>A (p.Leu45Ter)	PHEX	L45*	not provided	Pathogenic(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	VCV000265604	X	22056602	X	22038484	265604	260295	rs886039661	NC_000023.11:22038483:T:A
NM_001347721.2(DYRK1A):c.700_702delinsATAGAGGTTGT (p.Tyr234fs)	DYRK1A		not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000265603	21	38862539 - 38862541	21	37490237 - 37490239	265603	260241	rs886039660	NC_000021.9:37490236:TAC:ATAGAGGTTGT
NM_000061.2(BTK):c.307C>T (p.Gln103Ter)	BTK	Q103*, Q137*	not provided	Pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	VCV000265600	X	100626623	X	101371635	265600	260272	rs886039657	NC_000023.11:101371634:G:A
NM_001347721.2(DYRK1A):c.1098del (p.Val367fs)	DYRK1A	V367fs, V376fs, V338fs	not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000265595	21	38868445	21	37496143	265595	260242	rs886039652	NC_000021.9:37496142:AA:A
NM_003688.3(CASK):c.2512A>T (p.Lys838Ter)	CASK	K838*, K815*, K814*, K843*	not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000265594	X	41383281	X	41524028	265594	260322	rs886039651	NC_000023.11:41524027:T:A
NM_030632.3(ASXL3):c.1777G>T (p.Glu593Ter)	ASXL3	E593*	not provided	Pathogenic(Last reviewed: Jun 7, 2016)	criteria provided, single submitter	VCV000265593	18	31319145	18	33739181	265593	260203	rs886039650	NC_000018.10:33739180:G:T
NM_001347721.2(DYRK1A):c.630C>A (p.Tyr210Ter)	DYRK1A	Y219*, Y181*, Y210*	not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000265592	21	38858909	21	37486607	265592	260240	rs746177928	NC_000021.9:37486606:C:A
NM_001282531.3(ADNP):c.1106_1108delinsCTGT (p.Leu369fs)	ADNP		not provided	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000265590	20	49510143 - 49510145	20	50893606 - 50893608	265590	260232	rs886039649	NC_000020.11:50893605:GTA:ACAG
NM_001029896.2(WDR45):c.827+1G>A	WDR45		Neurodegeneration with brain iron accumulation 5|not provided|Neurodegeneration with brain iron accumulation	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265508	X	48933022	X	49075363	265508	260331	rs1557083958	NC_000023.11:49075362:C:T
NM_000444.6(PHEX):c.1363G>T (p.Glu455Ter)	PHEX	E455*	not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000265504	X	22151700	X	22133583	265504	260302	rs886039585	NC_000023.11:22133582:G:T
NM_000444.6(PHEX):c.1209G>A (p.Trp403Ter)	PHEX	W403*	not provided	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000265503	X	22132611	X	22114493	265503	260301	rs886039584	NC_000023.11:22114492:G:A
NM_000444.6(PHEX):c.1079+1G>A	PHEX		not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000265502	X	22117270	X	22099152	265502	260299	rs886039583	NC_000023.11:22099151:G:A
NM_000444.6(PHEX):c.850del (p.Glu283_Ile284insTer)	PHEX		not provided	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000265501	X	22115073	X	22096955	265501	260298	rs886039582	NC_000023.11:22096954:A:
NM_000444.6(PHEX):c.538del (p.Trp180fs)	PHEX	W180fs	not provided	Pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000265500	X	22095693	X	22077575	265500	260297	rs886039581	NC_000023.11:22077574:TTT:TT
NM_000444.6(PHEX):c.219_220TG[1] (p.Val74fs)	PHEX		not provided	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000265498	X	22065199 - 22065200	X	22047081 - 22047082	265498	260296	rs886039580	NC_000023.11:22047080:TGTG:TG
NM_000271.5(NPC1):c.1819C>T (p.Arg607Ter)	NPC1	R607*	not provided|Niemann-Pick disease, type C	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265495	18	21125052	18	23545088	265495	260201	rs377130051	NC_000018.10:23545087:G:A
NM_000397.3(CYBB):c.1498G>C (p.Asp500His)	CYBB	D500H	not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000265470	X	37668856	X	37809603	265470	260319	rs886039563	NC_000023.11:37809602:G:C
NM_005183.4(CACNA1F):c.148C>T (p.Arg50Ter)	CACNA1F	R50*	not provided	Pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000265465	X	49088267	X	49231805	265465	260334	rs886039560	NC_000023.11:49231804:G:A
NM_001256789.3(CACNA1F):c.1840C>T (p.Arg614Ter)	CACNA1F	R625*, R560*, R614*	Ocular albinism, type II|not provided	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000265464	X	49081260	X	49224798	265464	260333	rs886039559	NC_000023.11:49224797:G:A
NM_000487.6(ARSA):c.474C>A (p.Cys158Ter)	ARSA	C158*, C72*	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265461	22	51065472	22	50627044	265461	260266	rs768028181	NC_000022.11:50627043:G:T
NM_000383.4(AIRE):c.1265del (p.Pro422fs)	AIRE	P422fs	Polyglandular autoimmune syndrome, type 1|not provided	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265456	21	45713044	21	44293161	265456	260244	rs764878471	NC_000021.9:44293160:CC:C
NM_000061.2(BTK):c.1632-2A>G	BTK		not provided	Pathogenic(Last reviewed: Mar 31, 2016)	criteria provided, single submitter	VCV000265455	X	100608978	X	101353990	265455	260271	rs886039555	NC_000023.11:101353989:T:C
NM_000455.4(STK11):c.597+1G>T	STK11		Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265451	19	1220505	19	1220506	265451	260207	rs886039554	NC_000019.10:1220505:G:T
NM_003560.4(PLA2G6):c.208C>T (p.Arg70Ter)	PLA2G6	R70*	not provided	Pathogenic(Last reviewed: May 8, 2017)	criteria provided, single submitter	VCV000265449	22	38565226	22	38169219	265449	260265	rs886039552	NC_000022.11:38169218:G:A
NM_003560.4(PLA2G6):c.2221C>T (p.Arg741Trp)	PLA2G6	R741W, R509W, R515W, R687W, R563W	not provided|Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265448	22	38508566	22	38112559	265448	260264	rs530348521	NC_000022.11:38112558:G:A
NM_004006.2(DMD):c.3259C>T (p.Gln1087Ter)	DMD	Q1087*, Q1079*, Q1083*, Q964*	not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000265414	X	32482720	X	32464603	265414	260311	rs886039536	NC_000023.11:32464602:G:A
NM_004006.2(DMD):c.5314A>T (p.Lys1772Ter)	DMD	K1772*, K431*, K1649*, K428*, K1764*, K1768*	not provided	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, single submitter	VCV000265413	X	32380916	X	32362799	265413	260310	rs886039535	NC_000023.11:32362798:T:A
NM_004006.2(DMD):c.6762+1G>T	DMD		not provided	Pathogenic(Last reviewed: Jul 27, 2016)	criteria provided, single submitter	VCV000265412	X	31950196	X	31932079	265412	260309	rs886039534	NC_000023.11:31932078:C:A
NM_004006.2(DMD):c.9148C>T (p.Gln3050Ter)	DMD	Q3050*, Q3042*, Q590*, Q2927*, Q321*, Q1706*, Q1709*, Q3046*	not provided	Pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, single submitter	VCV000265411	X	31366688	X	31348571	265411	260307	rs886039533	NC_000023.11:31348570:G:A
NM_000109.4(DMD):c.9447_9450del (p.Ile3149fs)	DMD	I1813fs, I3149fs, I3157fs, I428fs, I697fs, I1816fs, I3034fs, I3153fs, I89fs	not provided	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000265410	X	31227704 - 31227707	X	31209587 - 31209590	265410	260306	rs886039532	NC_000023.11:31209586:ATAAATA:ATA
NM_005629.4(SLC6A8):c.1000_1002AAC[2] (p.Asn336del)	SLC6A8	N336del	Creatine transporter deficiency|not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265402	X	152958804 - 152958806	X	153693349 - 153693351	265402	260285	rs782433037	NC_000023.11:153693348:CAACAACAAC:CAACAAC
NM_000252.2(MTM1):c.49G>T (p.Glu17Ter)	MTM1	E17*	not provided	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000265397	X	149761125	X	150592663	265397	260284	rs886039522	NC_000023.11:150592662:G:T
NM_000276.4(OCRL):c.2358_2359TG[1] (p.Val787fs)	OCRL		not provided	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000265392	X	128722879 - 128722880	X	129588902 - 129588903	265392	260279	rs886039519	NC_000023.11:129588901:TGTG:TG
NM_000276.4(OCRL):c.1576C>T (p.Pro526Ser)	OCRL	P526S, P527S	not provided	Pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000265391	X	128703350	X	129569373	265391	260278	rs886039518	NC_000023.11:129569372:C:T
NM_172107.4(KCNQ2):c.1741C>G (p.Arg581Gly)	KCNQ2	R581G, R553G, R550G, R563G	not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000265380	20	62044825	20	63413472	265380	260235	rs118192236	NC_000020.11:63413471:G:C
NM_006031.6(PCNT):c.7819C>T (p.Arg2607Ter)	PCNT	R2607*, R2489*	not provided	Pathogenic(Last reviewed: Oct 13, 2015)	criteria provided, single submitter	VCV000265364	21	47850052	21	46430138	265364	260249	rs749426946	NC_000021.9:46430137:C:T
NM_004187.4(KDM5C):c.3880C>T (p.Gln1294Ter)	KDM5C	Q1294*, Q1293*, Q1227*	not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000265353	X	53223479	X	53194297	265353	260335	rs782663655	NC_000023.11:53194296:G:A
NM_000489.5(ATRX):c.1738del (p.Ala580fs)	ATRX	A542fs, A580fs	not provided	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000265348	X	76939010	X	77683518	265348	260343	rs886039493	NC_000023.11:77683517:C:
NM_004484.3(GPC3):c.175+1G>A	GPC3		not provided	Pathogenic(Last reviewed: Jul 31, 2015)	criteria provided, single submitter	VCV000265343	X	133119301	X	133985274	265343	260282	rs886039489	NC_000023.11:133985273:C:T
NM_172107.4(KCNQ2):c.624del (p.Met208fs)	KCNQ2	M208fs	not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000265338	20	62076078	20	63444725	265338	260236	rs886039485	NC_000020.11:63444724:C:
NM_006031.6(PCNT):c.1843C>T (p.Gln615Ter)	PCNT	Q615*, Q497*	not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000265331	21	47775448	21	46355533	265331	260248	rs777830265	NC_000021.9:46355532:C:T
NM_004006.2(DMD):c.8218-2A>G	DMD		not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000265325	X	31525572	X	31507455	265325	260308	rs886039478	NC_000023.11:31507454:T:C
NM_003688.3(CASK):c.2329G>T (p.Glu777Ter)	CASK	E777*, E753*, E754*, E782*	not provided	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000265323	X	41390436	X	41531183	265323	260324	rs746017736	NC_000023.11:41531182:C:A
NM_003688.3(CASK):c.609G>A (p.Trp203Ter)	CASK	W203*	not provided	Pathogenic(Last reviewed: Apr 4, 2015)	criteria provided, single submitter	VCV000265320	X	41524629	X	41665376	265320	260326	rs886039474	NC_000023.11:41665375:C:T
NM_004484.3(GPC3):c.1437del (p.Gly481fs)	GPC3	G504fs, G427fs, G465fs, G481fs	not provided	Pathogenic(Last reviewed: Apr 3, 2015)	criteria provided, single submitter	VCV000265319	X	132730604	X	133596576	265319	260280	rs886039473	NC_000023.11:133596575:GGG:GG
NM_003688.3(CASK):c.2506-2A>G	CASK		not provided|Nystagmus|Inability to walk|Dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265316	X	41383289	X	41524036	265316	260323	rs398122845	NC_000023.11:41524035:T:C
NM_006087.4(TUBB4A):c.785G>A (p.Arg262His)	TUBB4A	R262H, R313H, R190H, R307H	Leukodystrophy, hypomyelinating, 6|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265314	19	6495725	19	6495714	265314	260216	rs886039470	NC_000019.10:6495713:C:T
NM_004247.4(EFTUD2):c.1860+2del	EFTUD2		not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	VCV000265311	17	42937271	17	44859903	265311	260178	rs886039467	NC_000017.11:44859902:A:
NM_001399.5(EDA):c.707-1G>A	EDA		not provided	Pathogenic(Last reviewed: Mar 5, 2016)	criteria provided, single submitter	VCV000265310	X	69249353	X	70029503	265310	260339	rs886039466	NC_000023.11:70029502:G:A
NM_001029896.2(WDR45):c.46C>T (p.Gln16Ter)	WDR45	Q16*	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265291	X	48935709	X	49078050	265291	260332	rs1557084549	NC_000023.11:49078049:G:A
NM_000377.2(WAS):c.223G>A (p.Val75Met)	WAS	V75M	X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome||not provided|X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265289	X	48542762	X	48684373	265289	260329	rs782290433	NC_000023.11:48684372:G:A
NM_000199.5(SGSH):c.877C>T (p.Pro293Ser)	SGSH	P293S	Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265258	17	78185942	17	80212143	265258	260197	rs143947056	NC_000017.11:80212142:G:A
NM_198129.3(LAMA3):c.8436+1G>A	LAMA3		not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000265228	18	21508730	18	23928766	265228	260202	rs886039412	NC_000018.10:23928765:G:A
NM_001278116.2(L1CAM):c.2547+1G>A	L1CAM		not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000265227	X	153131158	X	153865703	265227	260286	rs886039411	NC_000023.11:153865702:C:T
NM_001278116.2(L1CAM):c.2544C>A (p.Tyr848Ter)	L1CAM	Y848*, Y843*	Spastic paraplegia|not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265226	X	153131162	X	153865707	265226	260287	rs886039410	NC_000023.11:153865706:G:T
NM_001278116.2(L1CAM):c.2092G>A (p.Gly698Arg)	L1CAM	G698R, G693R	not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000265225	X	153132856	X	153867401	265225	260288	rs886039409	NC_000023.11:153867400:C:T
NM_001278116.2(L1CAM):c.1417C>T (p.Arg473Cys)	L1CAM	R473C, R468C	Spastic paraplegia|not provided	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265224	X	153134145	X	153868690	265224	260290	rs886039408	NC_000023.11:153868689:G:A
NM_001278116.2(L1CAM):c.1453C>T (p.Arg485Ter)	L1CAM	R485*, R480*	not provided	Pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000265223	X	153134109	X	153868654	265223	260289	rs886039407	NC_000023.11:153868653:G:A
NM_001278116.2(L1CAM):c.523+12C>T	L1CAM		not provided	Pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000265222	X	153136500	X	153871045	265222	260292	rs886039406	NC_000023.11:153871044:G:A
NM_001278116.2(L1CAM):c.807-6G>A	L1CAM		Spastic paraplegia|not provided	Pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265221	X	153135701	X	153870246	265221	260291	rs886039405	NC_000023.11:153870245:C:T
NM_001278116.2(L1CAM):c.177del (p.Ser60fs)	L1CAM	S55fs, S60fs	not provided	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000265220	X	153138067	X	153872612	265220	260293	rs886039404	NC_000023.11:153872611:GG:G
NM_021140.3(KDM6A):c.2326_2329del (p.Asp776fs)	KDM6A	D480fs, D731fs, D828fs, D697fs, D776fs, D783fs	not provided	Pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, single submitter	VCV000265212	X	44929224 - 44929227	X	45069979 - 45069982	265212	260327	rs886039398	NC_000023.11:45069978:CAGACA:CA
NM_000219.6(KCNE1):c.262C>T (p.Gln88Ter)	KCNE1	Q88*	not provided	Pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	VCV000265208	21	35821671	21	34449373	265208	260239	rs750349088	NC_000021.9:34449372:G:A
NM_004975.4(KCNB1):c.934C>T (p.Arg312Cys)	KCNB1	R312C	Intellectual disability|not provided|Epileptic encephalopathy, early infantile, 26	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265207	20	47991163	20	49374626	265207	260231	rs886039396	NC_000020.11:49374625:G:A
NM_000216.4(ANOS1):c.1891C>T (p.Arg631Ter)	ANOS1	R631*	not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000265206	X	8502453	X	8534412	265206	260344	rs886039395	NC_000023.11:8534411:G:A
NM_000215.3(JAK3):c.1765G>A (p.Gly589Ser)	JAK3	G589S	Adenoid cystic carcinoma|not provided	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000265205	19	17947959	19	17837150	265205	260213	rs886039394	NC_000019.10:17837149:C:T
NM_000211.5(ITGB2):c.1602C>A (p.Cys534Ter)	ITGB2	C534*, C465*	not provided	Pathogenic(Last reviewed: Aug 28, 2015)	criteria provided, single submitter	VCV000265200	21	46309948	21	44890033	265200	260245	rs748574145	NC_000021.9:44890032:G:T
NM_000206.2(IL2RG):c.270-15A>G	IL2RG		X-linked severe combined immunodeficiency|not provided	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000265194	X	70330553	X	71110703	265194	260341	rs886039387	NC_000023.11:71110702:T:C
NM_001164619.2(GPC3):c.175+32101_175+32102del	GPC3	C72fs	not provided	Pathogenic(Last reviewed: Aug 26, 2015)	criteria provided, single submitter	VCV000265186	X	133087200 - 133087201	X	133953173 - 133953174	265186	260281	rs886039384	NC_000023.11:133953172:AT:
NM_001077488.4(GNAS):c.974-2A>G	GNAS		not provided	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000265185	20	57485387	20	58910332	265185	260234	rs886039383	NC_000020.11:58910331:A:G
NM_000152.5(GAA):c.2238G>C (p.Trp746Cys)	GAA	W746C	Glycogen storage disease|not specified|Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265160	17	78090815	17	80117016	265160	260196	rs1800312	NC_000017.11:80117015:G:C
NM_001972.4(ELANE):c.628G>A (p.Gly210Arg)	ELANE	G210R	not provided	Pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	VCV000265119	19	855988	19	855988	265119	260219	rs140880838	NC_000019.10:855987:G:A
NM_004247.4(EFTUD2):c.2694_2697GTCT[1] (p.Val900fs)	EFTUD2		not provided	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000265116	17	42929791 - 42929794	17	44852423 - 44852426	265116	260177	rs886039349	NC_000017.11:44852422:AGACAGACAGA:AGACAGA
NM_006579.3(EBP):c.439C>T (p.Arg147Cys)	EBP	R147C	not provided	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000265110	X	48385643	X	48527255	265110	260328	rs886039345	NC_000023.11:48527254:C:T
NM_001399.5(EDA):c.706+1G>A	EDA		Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265107	X	69247887	X	70028037	265107	260338	rs886039344	NC_000023.11:70028036:G:A
NM_017653.5(DYM):c.1504C>T (p.Gln502Ter)	DYM	Q502*, Q501*, Q557*, Q556*	not provided	Pathogenic(Last reviewed: Jul 4, 2017)	criteria provided, single submitter	VCV000265106	18	46690114	18	49163744	265106	260204	rs763380940	NC_000018.10:49163743:G:A
NM_178152.3(DCX):c.706-2A>G	DCX		not provided	Pathogenic(Last reviewed: May 27, 2015)	criteria provided, single submitter	VCV000265096	X	110576383	X	111333155	265096	260276	rs886039339	NC_000023.11:111333154:T:C
NM_000397.3(CYBB):c.1449G>A (p.Trp483Ter)	CYBB	W483*	not provided	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000265093	X	37665774	X	37806521	265093	260318	rs886039338	NC_000023.11:37806520:G:A
NM_000397.3(CYBB):c.907C>T (p.His303Tyr)	CYBB	H303Y	not provided	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, single submitter	VCV000265092	X	37663139	X	37803886	265092	260317	rs137854595	NC_000023.11:37803885:C:T
NM_000397.3(CYBB):c.868C>T (p.Arg290Ter)	CYBB	R290*	not provided|Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000265091	X	37660572	X	37801319	265091	260316	rs886039337	NC_000023.11:37801318:C:T
NM_000397.3(CYBB):c.484-2A>T	CYBB		not provided	Pathogenic(Last reviewed: Apr 7, 2016)	criteria provided, single submitter	VCV000265090	X	37655202	X	37795949	265090	260315	rs886039336	NC_000023.11:37795948:A:T
NM_000397.3(CYBB):c.469C>T (p.Arg157Ter)	CYBB	R157*	not provided	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000265089	X	37653049	X	37793796	265089	260314	rs886039335	NC_000023.11:37793795:C:T
NM_000397.3(CYBB):c.448G>T (p.Glu150Ter)	CYBB	E150*	not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000265088	X	37653028	X	37793775	265088	260313	rs886039334	NC_000023.11:37793774:G:T
NM_000397.3(CYBB):c.337+1G>T	CYBB		not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000265087	X	37651313	X	37792060	265087	260312	rs886039333	NC_000023.11:37792059:G:T
NM_000022.4(ADA):c.478+1G>A	ADA		not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000265025	20	43254209	20	44625568	265025	260230	rs761242509	NC_000020.11:44625567:C:T
NM_001242897.2(DEPDC5):c.4306C>T (p.Gln1436Ter)	DEPDC5	Q1436*, Q1536*, Q1458*, Q1505*, Q1514*, Q1527*, Q1508*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264747	22	32302277	22	31906291	264747	259379	rs886039274	NC_000022.11:31906290:C:T
NM_001242897.2(DEPDC5):c.4097G>A (p.Trp1366Ter)	DEPDC5	W1366*, W1466*, W1457*, W1388*, W1438*, W1435*, W1444*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264746	22	32297749	22	31901763	264746	259378	rs886039273	NC_000022.11:31901762:G:A
NM_001242897.2(DEPDC5):c.3961del (p.Glu1321fs)	DEPDC5	E1393fs, E1421fs, E1321fs, E1343fs, E1399fs, E1390fs, E1412fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264745	22	32293524	22	31897538	264745	259377	rs886039272	NC_000022.11:31897537:GG:G
NM_001242897.2(DEPDC5):c.3887del (p.Ala1296fs)	DEPDC5	A1387fs, A1368fs, A1374fs, A1396fs, A1296fs, A1318fs, A1365fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264744	22	32289721	22	31893735	264744	259376	rs886039271	NC_000022.11:31893734:C:
NM_001242897.2(DEPDC5):c.3733+5A>G	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264743	22	32275743	22	31879757	264743	259375	rs886039270	NC_000022.11:31879756:A:G
NM_001242897.2(DEPDC5):c.3694C>T (p.Arg1232Ter)	DEPDC5	R1232*, R1332*, R1254*, R1323*, R1301*, R1304*, R1310*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000264742	22	32275699	22	31879713	264742	259374	rs886039269	NC_000022.11:31879712:C:T
NM_001242897.2(DEPDC5):c.3502C>T (p.Arg1168Ter)	DEPDC5	R1168*, R1268*, R1237*, R1240*, R1259*, R1190*, R1246*	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000264741	22	32272248	22	31876262	264741	259372	rs886039268	NC_000022.11:31876261:C:T
NM_001242897.2(DEPDC5):c.3396+5G>A	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264740	22	32270396	22	31874410	264740	259371	rs886039267	NC_000022.11:31874409:G:A
NM_001242897.2(DEPDC5):c.3144del (p.Ile1048fs)	DEPDC5	I1120fs, I1048fs, I1117fs, I1148fs, I1070fs, I1126fs, I1139fs	Rolandic epilepsy|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jan 1, 2017)	no assertion criteria provided	VCV000264739	22	32266689	22	31870703	264739	259368	rs886039266	NC_000022.11:31870702:A:
NM_001242897.2(DEPDC5):c.2812C>T (p.Gln938Ter)	DEPDC5	Q1016*, Q938*, Q988*, Q1007*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264738	22	32242844	22	31846858	264738	259364	rs886039265	NC_000022.11:31846857:C:T
NM_001242897.2(DEPDC5):c.2386C>T (p.Arg796Ter)	DEPDC5	R796*, R874*, R846*, R865*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264737	22	32239185	22	31843199	264737	259363	rs578185749	NC_000022.11:31843198:C:T
NM_001242897.2(DEPDC5):c.2156del (p.Gln719fs)	DEPDC5	Q769fs, Q797fs, Q719fs, Q788fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264736	22	32234706	22	31838720	264736	259362	rs886039264	NC_000022.11:31838719:A:
NM_001242897.2(DEPDC5):c.1759C>T (p.Arg587Ter)	DEPDC5	R587*, R559*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264734	22	32215100	22	31819114	264734	259360	rs886039263	NC_000022.11:31819113:C:T
NM_001242897.2(DEPDC5):c.1750_1756del (p.Leu584fs)	DEPDC5	L556fs, L584fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264733	22	32215087 - 32215093	22	31819101 - 31819107	264733	259359	rs886039262	NC_000022.11:31819100:CATGCTGCATG:CATG
NM_001242897.2(DEPDC5):c.1555C>T (p.Gln519Ter)	DEPDC5	Q519*, Q491*	Seizures|not provided|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000264732	22	32211087	22	31815101	264732	259357	rs886039261	NC_000022.11:31815100:C:T
NM_001242897.2(DEPDC5):c.1393C>T (p.Gln465Ter)	DEPDC5	Q465*, Q437*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264731	22	32206575	22	31810589	264731	259355	rs886039260	NC_000022.11:31810588:C:T
NM_001242897.2(DEPDC5):c.1264C>T (p.Arg422Ter)	DEPDC5	R422*, R394*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000264730	22	32202154	22	31806168	264730	259352	rs757511744	NC_000022.11:31806167:C:T
NM_001242897.2(DEPDC5):c.1114C>T (p.Gln372Ter)	DEPDC5	Q372*, Q344*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264729	22	32200180	22	31804194	264729	259350	rs886039259	NC_000022.11:31804193:C:T
NM_001242897.2(DEPDC5):c.1093_1099dup (p.Val367fs)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264728	22	32200157 - 32200158	22	31804171 - 31804172	264728	259349	rs886039258	NC_000022.11:31804171:GGATTTGG:GGATTTGGGATTTGG
NM_001242897.2(DEPDC5):c.985del (p.Thr329fs)	DEPDC5	T329fs, T301fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264727	22	32198727	22	31802741	264727	259348	rs886039257	NC_000022.11:31802740:AA:A
NM_001242897.2(DEPDC5):c.918C>G (p.Tyr306Ter)	DEPDC5	Y306*, Y278*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264726	22	32194614	22	31798628	264726	259347	rs886039256	NC_000022.11:31798627:C:G
NM_001242897.2(DEPDC5):c.856C>T (p.Arg286Ter)	DEPDC5	R286*, R258*	Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000264725	22	32193674	22	31797688	264725	259346	rs886039255	NC_000022.11:31797687:C:T
NM_001242897.2(DEPDC5):c.783_786del (p.Asn261fs)	DEPDC5	N233fs, N261fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264724	22	32193601 - 32193604	22	31797615 - 31797618	264724	259343	rs886039254	NC_000022.11:31797614:TGAG:
NM_001242897.2(DEPDC5):c.727C>T (p.Arg243Ter)	DEPDC5	R243*, R215*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000264723	22	32188763	22	31792777	264723	259341	rs772872014	NC_000022.11:31792776:C:T
NM_001242897.2(DEPDC5):c.730C>T (p.Gln244Ter)	DEPDC5	Q244*, Q216*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264722	22	32188766	22	31792780	264722	259342	rs886039253	NC_000022.11:31792779:C:T
NM_001242897.2(DEPDC5):c.526C>T (p.Gln176Ter)	DEPDC5	Q176*, Q148*	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000264720	22	32179935	22	31783949	264720	259338	rs886039251	NC_000022.11:31783948:C:T
NM_001242897.2(DEPDC5):c.492_496del (p.Arg165fs)	DEPDC5	R137fs, R165fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264719	22	32179898 - 32179902	22	31783912 - 31783916	264719	259337	rs886039250	NC_000022.11:31783911:GTTTCGTT:GTT
NM_001242897.2(DEPDC5):c.484-1G>A	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264718	22	32179892	22	31783906	264718	259336	rs886039249	NC_000022.11:31783905:G:A
NM_001242897.2(DEPDC5):c.454_455del (p.Met152fs)	DEPDC5	M124fs, M152fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264717	22	32174125 - 32174126	22	31778139 - 31778140	264717	259335	rs886039248	NC_000022.11:31778138:AT:
NM_001242897.2(DEPDC5):c.435G>A (p.Trp145Ter)	DEPDC5	W145*, W117*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264716	22	32174106	22	31778120	264716	259334	rs886039247	NC_000022.11:31778119:G:A
NM_001242897.2(DEPDC5):c.279+1G>A	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264715	22	32161047	22	31765061	264715	259333	rs886039246	NC_000022.11:31765060:G:A
NM_001242897.2(DEPDC5):c.193+1G>A	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264714	22	32156689	22	31760703	264714	259331	rs886039245	NC_000022.11:31760702:G:A
NM_001242897.2(DEPDC5):c.132dup (p.Asn45fs)	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264713	22	32154601 - 32154602	22	31758615 - 31758616	264713	259329	rs886039244	NC_000022.11:31758615:CCCC:CCCCC
NM_001242897.2(DEPDC5):c.59-1G>C	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264712	22	32154531	22	31758545	264712	259328	rs886039243	NC_000022.11:31758544:G:C
NM_001983.4(ERCC1):c.676A>T (p.Lys226Ter)	ERCC1	K226*	Cockayne syndrome	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000264678	19	45918145	19	45414887	264678	259255	rs886039224	NC_000019.10:45414886:T:A
NM_001429.4(EP300):c.68_69TC[1] (p.Ser24fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000264649	22	41489075 - 41489076	22	41093071 - 41093072	264649	259242	rs1555902247	NC_000022.11:41093070:CTCTC:CTC
NM_176787.5(PIGN):c.694A>T (p.Lys232Ter)	PIGN	K232*	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 29, 2016)	no assertion criteria provided	VCV000264641	18	59814315	18	62147082	264641	259234	rs886039218	NC_000018.10:62147081:T:A
NM_176787.5(PIGN):c.1674+1G>C	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000264640	18	59774218	18	62106985	264640	259233	rs376355678	NC_000018.10:62106984:C:G
NM_176787.5(PIGN):c.1966C>T (p.Gln656Ter)	PIGN	E656*, Q656*	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 29, 2016)	no assertion criteria provided	VCV000264639	18	59770029	18	62102796	264639	259232	rs886039217	NC_000018.10:62102795:G:A
NM_176787.5(PIGN):c.324_549+196del	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 28, 2016)	no assertion criteria provided	VCV000264638	18	59821582 - 59824939	18	62154349 - 62157706	264638	259231		
NM_176787.5(PIGN):c.548_549+6del	PIGN		not provided|Multiple congenital anomalies-hypotonia-seizures syndrome 1|Multiple congenital anomalies-hypotonia-seizures syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264637	18	59821772 - 59821779	18	62154539 - 62154546	264637	259230	rs779636222	NC_000018.10:62154538:ACAAACCT:
NM_176787.5(PIGN):c.1434+5G>A	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 28, 2016)	no assertion criteria provided	VCV000264636	18	59780362	18	62113129	264636	259229	rs369486176	NC_000018.10:62113128:C:T
NM_176787.5(PIGN):c.2340T>A (p.Tyr780Ter)	PIGN	Y780*	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000264635	18	59756019	18	62088786	264635	259228	rs749334082	NC_000018.10:62088785:A:T
NM_176787.5(PIGN):c.755A>T (p.Asp252Val)	PIGN	D252V	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Sep 28, 2016)	no assertion criteria provided	VCV000264634	18	59814254	18	62147021	264634	259227	rs886039216	NC_000018.10:62147020:T:A
NM_001145073.3(USP27X):c.1141T>C (p.Tyr381His)	USP27X	Y381H	Mental retardation, X-linked 105	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000254685	X	49646051	X	49881448	254685	249261	rs886038211	NC_000023.11:49881447:T:C
NM_001145073.3(USP27X):c.1026_1030del (p.Ser342fs)	USP27X	S342fs	Mental retardation, X-linked 105	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000254684	X	49645933 - 49645937	X	49881330 - 49881334	254684	249260	rs886038210	NC_000023.11:49881329:AAGTAAAG:AAG
NM_014728.3(FRMPD4):c.1657T>C (p.Cys553Arg)	FRMPD4	C553R, C545R, C513R, C555R, C590R, C550R	Mental retardation, X-linked 104	Pathogenic(Last reviewed: Jan 7, 2019)	no assertion criteria provided	VCV000254683	X	12734235	X	12716116	254683	249259	rs886038209	NC_000023.11:12716115:T:C
NM_014728.3(FRMPD4):c.1851del (p.Cys618fs)	FRMPD4	C618fs, C578fs, C620fs, C655fs, C610fs, C615fs	Mental retardation, X-linked 104	Pathogenic(Last reviewed: Jan 7, 2019)	no assertion criteria provided	VCV000254682	X	12734425	X	12716306	254682	249258	rs886038208	NC_000023.11:12716305:CCCCC:CCCC
NM_001165927.1(MKS1):c.1558+1G>T	MKS1		Joubert syndrome 28	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000254677	17	56283643	17	58206282	254677	249228	rs886038204	NC_000017.11:58206281:C:A
NM_001165927.1(MKS1):c.1461-2A>G	MKS1		Joubert syndrome 28	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000254675	17	56283743	17	58206382	254675	249226	rs886038203	NC_000017.11:58206381:T:C
KLHL15, 1-BP DEL	KLHL15		Mental retardation, X-linked 103	Pathogenic(Last reviewed: Sep 22, 2016)	no assertion criteria provided	VCV000254658					254658	249206		
KLHL15, 22.5-KB DEL	KLHL15		Mental retardation, X-linked 103	Pathogenic(Last reviewed: Sep 22, 2016)	no assertion criteria provided	VCV000254657					254657	249205		
NM_001127221.1(CACNA1A):c.4522G>T (p.Ala1508Ser)	CACNA1A	A1511S, A1508S, A1507S	Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000254269	19	13368235	19	13257421	254269	248802	rs886037946	NC_000019.10:13257420:C:A
NM_001127221.1(CACNA1A):c.2137G>A (p.Ala713Thr)	CACNA1A	A713T, A712T	Familial hemiplegic migraine type 1||Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2|Inborn genetic diseases|not provided|Epileptic encephalopathy, early infantile, 42	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254268	19	13414398	19	13303584	254268	248801	rs886037945	NC_000019.10:13303583:C:T
NM_001127221.1(CACNA1A):c.301G>C (p.Glu101Gln)	CACNA1A	E101Q	Epileptic encephalopathy, early infantile, 42	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000254267	19	13566019	19	13455205	254267	248800	rs886037944	NC_000019.10:13455204:C:G
NM_001003787.4(STRADA):c.842dup (p.Asp281fs)	STRADA		Polyhydramnios, megalencephaly, and symptomatic epilepsy	Pathogenic(Last reviewed: Sep 15, 2016)	no assertion criteria provided	VCV000254243	17	61784010 - 61784011	17	63706650 - 63706651	254243	248751	rs886037929	NC_000017.11:63706650:T:TT
NM_001081563.2(DMPK):c.*224_*226CTG[28]CCG[2]CTG[2]CCG[1]CTG[88]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	VCV000254214					254214	248729		
NM_001081563.2(DMPK):c.*224_*226CTG[30]CCG[2]CTG[2]CCG[1]CTG[105]	DMPK		Steinert myotonic dystrophy syndrome	Pathogenic	no assertion criteria provided	VCV000254213					254213	248728		
NM_003688.3(CASK):c.1465C>T (p.Arg489Trp)	CASK	R489W, R483W	CASK-Related Disorder|Mental retardation and microcephaly with pontine and cerebellar hypoplasia|Smith-Magenis Syndrome-like	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254208	X	41437631	X	41578378	254208	248723	rs1114167352	NC_000023.11:41578377:G:A
NM_030662.3(MAP2K2):c.210_212del (p.Asp71del)	MAP2K2	D71del	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000254207	19	4117508 - 4117510	19	4117510 - 4117512	254207	248722	rs1114167351	NC_000019.10:4117509:TCATC:TC
NM_004187.4(KDM5C):c.3068A>G (p.Lys1023Arg)	KDM5C	K1023R, K1022R, K956R	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000254201	X	53225150	X	53195968	254201	248716	rs782367133	NC_000023.11:53195967:T:C
NM_002640.4(SERPINB8):c.850C>T (p.Arg284Ter)	SERPINB8	R284*, R102*, R104*	Peeling skin syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	no assertion criteria provided	VCV000254200	18	61654237	18	63987003	254200	248715	rs144666367	NC_000018.10:63987002:C:T
NM_002640.4(SERPINB8):c.2T>C (p.Met1Thr)	SERPINB8	M1T	Peeling skin syndrome 5	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254199	18	61645544	18	63978310	254199	248714	rs374612640	NC_000018.10:63978309:T:C
NM_002640.4(SERPINB8):c.947del (p.Lys316fs)	SERPINB8	K136fs, K316fs, K134fs	Peeling skin syndrome 5	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254198	18	61654333	18	63987099	254198	248713	rs762923677	NC_000018.10:63987098:AA:A
NM_133171.5(ELMO2):c.2080del (p.Leu694fs)	ELMO2	L606fs, L694fs	Vascular malformation, primary intraosseous	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254193	20	44996082	20	46367443	254193	248708	rs886037919	NC_000020.11:46367442:GG:G
NM_133171.5(ELMO2):c.1802-1G>C	ELMO2		Vascular malformation, primary intraosseous	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254192	20	44999165	20	46370526	254192	248707	rs886037918	NC_000020.11:46370525:C:G
NM_133171.5(ELMO2):c.1065+1G>A	ELMO2		Vascular malformation, primary intraosseous	Pathogenic(Last reviewed: Sep 13, 2016)	no assertion criteria provided	VCV000254191	20	45003874	20	46375235	254191	248706	rs768410753	NC_000020.11:46375234:C:T
NM_004187.4(KDM5C):c.156G>T (p.Trp52Cys)	KDM5C	W52C	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic	no assertion criteria provided	VCV000254174	X	53250093	X	53220911	254174	248653	rs886037836	NC_000023.11:53220910:C:A
NM_001305545.1(RNF43):c.-45C>T	RNF43	R113*	Sessile serrated polyposis cancer syndrome	Pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000254140	17	56448310	17	58370949	254140	248607	rs1567880628	NC_000017.11:58370948:G:A
NM_004006.2(DMD):c.32-?_93+?dup62	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 3, 2016)	criteria provided, single submitter	VCV000254069	X	33038256 - 33038317	X	33020139 - 33020200	254069	248539		
NM_004006.2(DMD):c.94-?_4233+?del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, single submitter	VCV000254062					254062	248543		
NM_000455.4(STK11):c.-1115-?_290+?del	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000254061					254061	248540		
NM_004006.2(DMD):c.7661-?_10921+?del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 26, 2015)	criteria provided, single submitter	VCV000254035					254035	248542		
GRCh37/hg19 Xp11.4(chrX:41485589-41486197)x1	CASK		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253662	X	41485589 - 41486197			253662	248110		
GRCh37/hg19 Xq28(chrX:153126942-153141190)x0	L1CAM		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253651	X	153126942 - 153141190			253651	248099		
GRCh37/hg19 22q12.3(chr22:34146948-34157735)x1	LARGE1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253645	22	34146948 - 34157735			253645	248093		
GRCh37/hg19 Xq28(chrX:153126942-153141972)x0	L1CAM		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253610	X	153126942 - 153141972			253610	248058		
GRCh37/hg19 Xq13.1(chrX:69250807-69256658)x1	EDA		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253607	X	69250807 - 69256658			253607	248055		
GRCh37/hg19 Xp21.1(chrX:31986184-31986956)x1	DMD		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253600	X	31986184 - 31986956			253600	248048		
GRCh37/hg19 Xp21.1(chrX:31836968-31945018)x1	DMD		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253594	X	31836968 - 31945018			253594	248042		
GRCh37/hg19 Xp21.1(chrX:31766614-31855217)x0	DMD		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253586	X	31766614 - 31855217			253586	248034		
GRCh37/hg19 Xp21.1(chrX:31766614-31896429)x0	DMD		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253476	X	31766614 - 31896429			253476	247924		
GRCh37/hg19 Xq22.2(chrX:103031174-103046823)x0	PLP1		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253460	X	103031174 - 103046823			253460	247908		
GRCh37/hg19 18q21.2(chr18:52921652-52926903)x1	TCF4		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253457	18	52921652 - 52926903			253457	247905		
GRCh37/hg19 Xq26.3(chrX:135067386-135068117)x0	SLC9A6		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253442	X	135067386 - 135068117			253442	247890		
GRCh37/hg19 20q13.33(chr20:62051174-62078598)x1	KCNQ2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253418	20	62051174 - 62078598			253418	247866		
GRCh37/hg19 Xq22.1(chrX:99551100-99606139)x1	PCDH19		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253396	X	99551100 - 99606139			253396	247844		
GRCh37/hg19 Xp22.13(chrX:18597661-18600349)x1	CDKL5		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253395	X	18597661 - 18600349			253395	247843		
GRCh37/hg19 Xp22.13(chrX:18442534-18529433)x0	CDKL5		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253393	X	18442534 - 18529433			253393	247841		
GRCh37/hg19 20q13.33(chr20:62045767-62055866)x1	KCNQ2		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253385	20	62045767 - 62055866			253385	247833		
NM_001429.4(EP300):c.4511T>G (p.Phe1504Cys)	EP300	F1504C, F1478C	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000253314	22	41568561	22	41172557	253314	247755	rs1114167306	NC_000022.11:41172556:T:G
NM_001429.4(EP300):c.3163C>T (p.Arg1055Ter)	EP300	R1055*, R1029*	not provided|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000253312	22	41551019	22	41155015	253312	247753	rs886041830	NC_000022.11:41155014:C:T
NM_001429.4(EP300):c.3728+5G>C	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000253311	22	41558788	22	41162784	253311	247754	rs1114167305	NC_000022.11:41162783:G:C
NM_001429.4(EP300):c.4954_4957dup (p.Cys1653fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	VCV000253310	22	41572424 - 41572425	22	41176420 - 41176421	253310	247756	rs1555912040	NC_000022.11:41176420:ATGT:ATGTATGT
NM_016004.5(IFT52):c.878del (p.Leu293fs)	IFT52	L293fs, L76fs, L117fs	Short-rib thoracic dysplasia 16 with or without polydactyly|Short Rib Polydactyly Syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000253308	20	42252640	20	43624000	253308	247751	rs886037870	NC_000020.11:43623999:T:
NM_016004.5(IFT52):c.595G>A (p.Ala199Thr)	IFT52	A199T, A23T	Short-rib thoracic dysplasia 16 with or without polydactyly|Short Rib Polydactyly Syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000253307	20	42242599	20	43613959	253307	247750	rs886037869	NC_000020.11:43613958:G:A
NM_016004.5(IFT52):c.424C>T (p.Arg142Ter)	IFT52	R142*	Short-rib thoracic dysplasia 16 with or without polydactyly	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000253306	20	42233652	20	43605012	253306	247749	rs748090019	NC_000020.11:43605011:C:T
NM_006701.2:c.Exon 3 deletion	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253189					253189	247602		
NM_006701.5(TXNL4A):c.154-959_257+638del	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253188	18	77736960 - 77738660	18	79976960 - 79978660	253188	247600		
NM_006701.5(TXNL4A):c.153+3A>G	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000253187	18	77748237	18	79988237	253187	247601	rs879255559	NC_000018.10:79988236:T:C
NM_017947.4(MOCOS):c.1037dup (p.Gln347fs)	MOCOS			Pathogenic(Last reviewed: Jul 27, 2016)	no assertion criteria provided	VCV000253163	18	33785055 - 33785056	18	36205092 - 36205093	253163	247575	rs886037855	NC_000018.10:36205092:AAA:AAAA
NM_017947.4(MOCOS):c.2326C>T (p.Arg776Cys)	MOCOS	R776C		Pathogenic(Last reviewed: Jul 27, 2016)	no assertion criteria provided	VCV000253162	18	33840055	18	36260092	253162	247574	rs750896617	NC_000018.10:36260091:C:T
NM_017947.4(MOCOS):c.169G>C (p.Ala57Pro)	MOCOS	A57P		Pathogenic(Last reviewed: Jul 27, 2016)	no assertion criteria provided	VCV000253161	18	33775246	18	36195283	253161	247573	rs886037854	NC_000018.10:36195282:G:C
NM_001830.4(CLCN4):c.1606G>A (p.Val536Met)	CLCN4	V536M, V442M	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253116	X	10181750	X	10213710	253116	247528	rs1569231897	NC_000023.11:10213709:G:A
NM_001830.4(CLCN4):c.661C>G (p.Leu221Val)	CLCN4	L221V, L127V	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253115	X	10174503	X	10206463	253115	247527	rs1569230006	NC_000023.11:10206462:C:G
NM_001830.4(CLCN4):c.232G>A (p.Gly78Ser)	CLCN4	G78S	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253114	X	10155642	X	10187602	253114	247526	rs1569226551	NC_000023.11:10187601:G:A
NM_001830.4(CLCN4):c.2191G>C (p.Gly731Arg)	CLCN4	G731R, G637R	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253113	X	10188916	X	10220876	253113	247525	rs1569233549	NC_000023.11:10220875:G:C
CLCN4, 13-BP DEL	CLCN4		Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253112					253112	247524		
LAS1L, ARG415TRP	LAS1L	R415W	Wilson-Turner X-linked mental retardation syndrome	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000253107					253107	247518		
LAS1L, ALA269GLY	LAS1L	A269G	Wilson-Turner X-linked mental retardation syndrome	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000253106					253106	247517		
NM_003504.4(CDC45):c.(342+1_343-1)_(486+1_487-1)del	CDC45		Meier-gorlin syndrome 7	Pathogenic(Last reviewed: Oct 20, 2016)	no assertion criteria provided	VCV000253105			22	19482828 - 19494326	253105	247516		
NM_001178010.2(CDC45):c.333C>T (p.Asn111=)	CDC45	N111N	Meier-gorlin syndrome 7	Pathogenic(Last reviewed: Oct 20, 2016)	no assertion criteria provided	VCV000253103	22	19470341	22	19482818	253103	247514	rs748749078	NC_000022.11:19482817:C:T
NM_001178010.2(CDC45):c.318C>T (p.Val106=)	CDC45	V106V	Meier-gorlin syndrome 7	Pathogenic(Last reviewed: Oct 20, 2016)	no assertion criteria provided	VCV000253098	22	19470326	22	19482803	253098	247509	rs745800041	NC_000022.11:19482802:C:T
NM_000475.5(NR0B1):c.116G>A (p.Trp39Ter)	NR0B1	W39*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Aug 10, 2016)	no assertion criteria provided	VCV000253090	X	30327365	X	30309248	253090	247501	rs1569269179	NC_000023.11:30309247:C:T
NM_016120.4(RLIM):c.1795C>T (p.Arg599Cys)	RLIM	R599C	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000253089	X	73811355	X	74591520	253089	247500	rs1569309459	NC_000023.11:74591519:G:A
NM_016120.4(RLIM):c.1159C>T (p.Arg387Cys)	RLIM	R387C	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000253088	X	73811991	X	74592156	253088	247499	rs1569309776	NC_000023.11:74592155:G:A
NM_016120.4(RLIM):c.1760C>G (p.Pro587Arg)	RLIM	P587R	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000253087	X	73811390	X	74591555	253087	247498	rs1569309474	NC_000023.11:74591554:G:C
NM_001399.5(EDA):c.755A>T (p.His252Leu)	EDA	H252L	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000253056	X	69250332	X	70030482	253056	247467	rs879255552	NC_000023.11:70030481:A:T
NM_001399.5(EDA):c.776C>A (p.Ala259Glu)	EDA	A259E	Tooth agenesis, selective, X-linked, 1	Pathogenic(Last reviewed: Aug 22, 2016)	no assertion criteria provided	VCV000253053	X	69250353	X	70030503	253053	247464	rs879255611	NC_000023.11:70030502:C:A
NM_020812.4(DOCK6):c.3154G>A (p.Glu1052Lys)	DOCK6	E1052K, E1087K	Adams-Oliver syndrome 2	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000253048	19	11333497	19	11222821	253048	247459	rs774877657	NC_000019.10:11222820:C:T
NM_020812.4(DOCK6):c.5939+2T>C	DOCK6		Adams-Oliver syndrome 2	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000253047	19	11311390	19	11200714	253047	247458	rs201387914	NC_000019.10:11200713:A:G
NM_020812.4(DOCK6):c.788T>A (p.Val263Asp)	DOCK6	V263D	Adams-Oliver syndrome 2	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000253046	19	11358760	19	11248084	253046	247457	rs879255610	NC_000019.10:11248083:A:T
NM_001079858.3(ADGRG2):c.1545dup (p.Glu516Ter)	ADGRG2		Congenital bilateral aplasia of vas deferens from CFTR mutation|Vas deferens, congenital bilateral aplasia of, X-linked	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000253015	X	19026118 - 19026119	X	19008000 - 19008001	253015	247422	rs774488954	NC_000023.11:19008000:AAAAAAA:AAAAAAAA
NM_001079858.3(ADGRG2):c.2002_2006delinsAGA (p.Leu668fs)	ADGRG2		Congenital bilateral aplasia of vas deferens from CFTR mutation|Vas deferens, congenital bilateral aplasia of, X-linked	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000253014	X	19021188 - 19021192	X	19003070 - 19003074	253014	247421	rs879255539	NC_000023.11:19003069:CACAG:TCT
NM_001079858.3(ADGRG2):c.2845del (p.Cys949fs)	ADGRG2	C919fs, C925fs, C911fs, C949fs, C946fs, C927fs, C933fs, C935fs	Congenital bilateral aplasia of vas deferens from CFTR mutation|Vas deferens, congenital bilateral aplasia of, X-linked	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, single submitter	VCV000253013	X	19013038	X	18994920	253013	247420	rs879255538	NC_000023.11:18994919:AA:A
NM_005120.3(MED12):c.3067A>G (p.Ile1023Val)	MED12	I1023V	FG syndrome 1	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000252963	X	70347828	X	71127978	252963	247365	rs879255526	NC_000023.11:71127977:A:G
NM_005120.3(MED12):c.2444G>A (p.Arg815Gln)	MED12	R815Q	FG syndrome 1	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000252962	X	70345907	X	71126057	252962	247364	rs762905361	NC_000023.11:71126056:G:A
NM_000496.3(CRYBB2):c.563G>T (p.Arg188Leu)	CRYBB2	R188L	Congenital cataract	Pathogenic(Last reviewed: Jul 29, 2016)	no assertion criteria provided	VCV000252952	22	25627684	22	25231717	252952	247358	rs886041410	NC_000022.11:25231716:G:T
NM_138927.3(SON):c.5753_5756del (p.Val1918fs)	SON	V1918fs	Failure to thrive|Global developmental delay|ZTTK syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252929	21	34927288 - 34927291	21	33554982 - 33554985	252929	247331	rs886039773	NC_000021.9:33554981:AGTTAG:AG
NM_005183.4(CACNA1F):c.4723G>T (p.Glu1575Ter)	CACNA1F	E1575*, E1564*, E1510*	not provided	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000252649	X	49066401	X	49209941	252649	247199	rs879255389	NC_000023.11:49209940:C:A
NM_002250.3(KCNN4):c.1055G>A (p.Arg352His)	KCNN4	R352H	not provided|Dehydrated hereditary stomatocytosis 2	Pathogenic(Last reviewed: Oct 30, 2015)	criteria provided, single submitter	VCV000252601	19	44273179	19	43769027	252601	247170	rs774455945	NC_000019.10:43769026:C:T
NM_001195798.2(LDLR):c.2548-2del	LDLR	Q673fs, Q683fs, Q810fs, Q851fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252359	19	11241961	19	11131285	252359	246644	rs879255229	NC_000019.10:11131284:A:
NM_000527.5(LDLR):c.2547+1G>A	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252352	19	11240347	19	11129671	252352	246637	rs879255224	NC_000019.10:11129670:G:A
NM_000527.4(LDLR):c.2546del (p.Pro848_Ser849insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252351	19	11240345	19	11129669	252351	246636	rs879255223	NC_000019.10:11129668:C:
NM_000527.5(LDLR):c.2546C>A (p.Ser849Ter)	LDLR	S849*, S671*, S808*, S681*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252350	19	11240345	19	11129669	252350	246635	rs377437226	NC_000019.10:11129668:C:A
NM_000527.4(LDLR):c.2544dup (p.Ser849fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252349	19	11240343	19	11129663 - 11129664	252349	246634	rs879255222	NC_000019.10:11129663:CCCC:CCCCC
NM_000527.4(LDLR):c.2509del (p.His837fs)	LDLR	H669fs, H796fs, H837fs, H659fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252348	19	11240307	19	11129631	252348	246633	rs879255221	NC_000019.10:11129630:CC:C
NM_000527.5(LDLR):c.2500_2502delinsC (p.Asp834fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252346	19	11240299 - 11240301	19	11129623 - 11129625	252346	246631	rs879255219	NC_000019.10:11129622:GAT:C
NM_000527.4(LDLR):c.2478dup (p.Val827fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252344	19	11240277	19	11129597 - 11129598	252344	246629	rs747344293	NC_000019.10:11129597:CCCC:CCCCC
NM_001195798.2(LDLR):c.2478del (p.Val827fs)	LDLR	V827fs, V649fs, V659fs, V786fs	Familial hypercholesterolemia 1|Familial hypercholesterolemia|not provided	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252342	19	11240274	19	11129598	252342	246628	rs747344293	NC_000019.10:11129597:CCCC:CCC
NM_000527.5(LDLR):c.2475C>A (p.Asn825Lys)	LDLR	N825K, N657K, N784K, N647K	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252341	19	11240274	19	11129598	252341	246626	rs374045590	NC_000019.10:11129597:C:A
NM_000527.5(LDLR):c.2446A>T (p.Lys816Ter)	LDLR	K816*, K775*, K638*, K648*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252338	19	11240245	19	11129569	252338	246623	rs879255213	NC_000019.10:11129568:A:T
NM_000527.5(LDLR):c.2438G>A (p.Trp813Ter)	LDLR	W813*, W645*, W635*, W772*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252337	19	11240237	19	11129561	252337	246622	rs879255212	NC_000019.10:11129560:G:A
NM_000527.5(LDLR):c.2431A>T (p.Lys811Ter)	LDLR	K811*, K633*, K643*, K770*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252336	19	11240230	19	11129554	252336	246621	rs879255211	NC_000019.10:11129553:A:T
NM_000527.5(LDLR):c.2430G>A (p.Trp810Ter)	LDLR	W810*, W632*, W642*, W769*	Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252335	19	11240229	19	11129553	252335	246620	rs879255210	NC_000019.10:11129552:G:A
NM_000527.4(LDLR):c.2420_2426del (p.Phe807fs)	LDLR	F629fs, F639fs, F766fs, F807fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252334	19	11240219 - 11240225	19	11129540 - 11129546	252334	246619	rs879255209	NC_000019.10:11129539:TCTTCCTTCT:TCT
NM_000527.5(LDLR):c.2417_2418insGG (p.Phe807fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252332	19	11240216 - 11240217	19	11129540 - 11129541	252332	246618	rs879255207	NC_000019.10:11129540::GG
NM_000527.5(LDLR):c.2417_2418insG (p.Phe807fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252331	19	11240216 - 11240217	19	11129540 - 11129541	252331	246617	rs879255207	NC_000019.10:11129540::G
NM_000527.4(LDLR):c.2416del (p.Val806fs)	LDLR	V628fs, V638fs, V765fs, V806fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252329	19	11240211	19	11129535	252329	246614	rs773618064	NC_000019.10:11129534:GGGGG:GGGG
NM_000527.4(LDLR):c.2408_2409dup (p.Leu804fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252326	19	11240207 - 11240208	19	11129530 - 11129531	252326	246611	rs879255202	NC_000019.10:11129530:GC:GCGC
NM_000527.4(LDLR):c.2403_2406del (p.Leu802fs)	LDLR	L761fs, L802fs, L634fs, L624fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252324	19	11240202 - 11240205	19	11129523 - 11129526	252324	246609	rs879255200	NC_000019.10:11129522:CTTCCTT:CTT
NM_000527.5(LDLR):c.2399_2403delinsGGGT (p.Val800fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252322	19	11240198 - 11240202	19	11129522 - 11129526	252322	246608	rs879255198	NC_000019.10:11129521:TCTTC:GGGT
NM_000527.5(LDLR):c.2390-1G>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252317	19	11240188	19	11129512	252317	246602	rs879255193	NC_000019.10:11129511:G:C
NM_000527.5(LDLR):c.2390-1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252316	19	11240188	19	11129512	252316	246601	rs879255193	NC_000019.10:11129511:G:A
c.(2389+1_2390-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252315	19	11238762 - 11244506			252315	246741		
c.(2389+1_2390-1)_(2547+1_2548-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252314	19	11238762 - 11241956			252314	246740		
NM_000527.5(LDLR):c.2390-2A>G	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252313	19	11240187	19	11129511	252313	246600	rs767790696	NC_000019.10:11129510:A:G
NM_000527.5(LDLR):c.2389+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252300	19	11238762	19	11128086	252300	246587	rs879255186	NC_000019.10:11128085:G:T
NM_000527.5(LDLR):c.2389+1G>A	LDLR		Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252299	19	11238762	19	11128086	252299	246586	rs879255186	NC_000019.10:11128085:G:A
NM_000527.4(LDLR):c.2385del (p.Ile796fs)	LDLR	I628fs, I618fs, I755fs, I796fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252297	19	11238754	19	11128078	252297	246584	rs879255185	NC_000019.10:11128077:CCCC:CCC
NM_000527.4(LDLR):c.2343_2347del (p.Lys782fs)	LDLR	K614fs, K782fs, K604fs, K741fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252289	19	11238715 - 11238719	19	11128037 - 11128041	252289	246577	rs879255181	NC_000019.10:11128036:GAGAAGA:GA
NM_000527.5(LDLR):c.2333_2334insC (p.Arg778fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252288	19	11238705 - 11238706	19	11128029 - 11128030	252288	246575	rs879255180	NC_000019.10:11128029::C
NM_000527.4(LDLR):c.2318del (p.Gly773fs)	LDLR	G732fs, G595fs, G605fs, G773fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252286	19	11238688	19	11128012	252286	246573	rs879255178	NC_000019.10:11128011:GGG:GG
NM_000527.5(LDLR):c.2317_2318insTA (p.Gly773fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252285	19	11238689 - 11238690	19	11128013 - 11128014	252285	246572	rs879255177	NC_000019.10:11128013::TA
c.(2311+1_2312-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252284	19	11234021 - 11244506			252284	246739		
c.(2311+1_2312-1)_*807del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252283	19	11234021 - 11242799			252283	246738		
c.(2311+1_2312-1)_(*220_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252282	19	11234021 - 11242212			252282	246737		
c.(2311+1_2312-1)_(2547+1_2548-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252281	19	11234021 - 11241956			252281	246736		
c.(2311+1_2312-1)_(2547+1_2548-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252279	19	11234021 - 11241956			252279	246734		
NM_000527.5(LDLR):c.2311+2T>G	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252275	19	11234022	19	11123346	252275	246568	rs879255176	NC_000019.10:11123345:T:G
NM_000527.5(LDLR):c.2311+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252274	19	11234021	19	11123345	252274	246567	rs879255175	NC_000019.10:11123344:G:T
NM_000527.5(LDLR):c.2311+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252272	19	11234021	19	11123345	252272	246565	rs879255175	NC_000019.10:11123344:G:A
NM_000527.5(LDLR):c.2308C>T (p.Gln770Ter)	LDLR	Q770*, Q729*, Q592*, Q602*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252271	19	11234017	19	11123341	252271	246564	rs763625913	NC_000019.10:11123340:C:T
NM_000527.4(LDLR):c.2299del (p.Met767fs)	LDLR	M726fs, M767fs, M589fs, M599fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252270	19	11234007	19	11123331	252270	246563	rs879255174	NC_000019.10:11123330:AA:A
NM_000527.4(LDLR):c.2297_2298del (p.Thr766fs)	LDLR	T598fs, T725fs, T588fs, T766fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252268	19	11234006 - 11234007	19	11123329 - 11123330	252268	246562	rs879255172	NC_000019.10:11123328:ACA:A
NM_000527.4(LDLR):c.2266del (p.Thr756fs)	LDLR	T578fs, T588fs, T715fs, T756fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252264	19	11233975	19	11123299	252264	246557	rs879255169	NC_000019.10:11123298:A:
NM_000527.4(LDLR):c.2264_2273del (p.Ala755fs)	LDLR	A577fs, A714fs, A755fs, A587fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252263	19	11233973 - 11233982	19	11123295 - 11123304	252263	246556	rs879255168	NC_000019.10:11123294:GGCCACCCCTGG:GG
NM_000527.4(LDLR):c.2230del (p.Arg744fs)	LDLR	R703fs, R576fs, R566fs, R744fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252261	19	11233937	19	11123261	252261	246554	rs879255167	NC_000019.10:11123260:CCC:CC
NM_000527.4(LDLR):c.2226del (p.Thr743fs)	LDLR	T575fs, T565fs, T702fs, T743fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252260	19	11233934	19	11123258	252260	246553	rs879255166	NC_000019.10:11123257:CC:C
NM_000527.4(LDLR):c.2207dup (p.Arg737fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252256	19	11233916	19	11123239 - 11123240	252256	246549	rs879255164	NC_000019.10:11123239:T:TT
NM_001195798.2(LDLR):c.2199_2200CA[1] (p.Thr734fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252255	19	11233908 - 11233909	19	11123232 - 11123233	252255	246548	rs879255163	NC_000019.10:11123231:CACA:CA
NM_000527.4(LDLR):c.2191del (p.Val731fs)	LDLR	V553fs, V563fs, V731fs, V690fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252253	19	11233899	19	11123223	252253	246546	rs879255161	NC_000019.10:11123222:GG:G
NM_000527.4(LDLR):c.2191_2203dup (p.Ala735fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252252	19	11233900 - 11233912	19	11123221 - 11123222	252252	246545	rs879255160	NC_000019.10:11123221:AGGTCAGCTCCACAG:AGGTCAGCTCCACAGGTCAGCTCCACAG
NM_001195798.2(LDLR):c.2187_2197del (p.Lys730fs)	LDLR	K552fs, K562fs, K689fs, K730fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252251	19	11233896 - 11233906	19	11123217 - 11123227	252251	246544	rs879255159	NC_000019.10:11123216:GCTAAAGGTCAGCT:GCT
NM_000527.4(LDLR):c.2186dup (p.Val731fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252250	19	11233895	19	11123218 - 11123219	252250	246543	rs879255158	NC_000019.10:11123218:T:TT
NM_000527.4(LDLR):c.2184del (p.Arg728fs)	LDLR	R560fs, R550fs, R728fs, R687fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252249	19	11233892	19	11123216	252249	246542	rs879255157	NC_000019.10:11123215:GG:G
NM_000527.4(LDLR):c.2178del (p.Val727fs)	LDLR	V549fs, V686fs, V727fs, V559fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252248	19	11233886	19	11123210	252248	246541	rs879255156	NC_000019.10:11123209:CC:C
NM_000527.4(LDLR):c.2175del (p.Thr726fs)	LDLR	T685fs, T548fs, T558fs, T726fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252247	19	11233883	19	11123207	252247	246540	rs879255155	NC_000019.10:11123206:CC:C
NM_000527.4(LDLR):c.2167del (p.Glu723fs)	LDLR	E545fs, E723fs, E555fs, E682fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252245	19	11233875	19	11123199	252245	246538	rs879255153	NC_000019.10:11123198:GG:G
NM_000527.5(LDLR):c.2164C>T (p.Gln722Ter)	LDLR	Q722*, Q681*, Q544*, Q554*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252244	19	11233873	19	11123197	252244	246537	rs879255152	NC_000019.10:11123196:C:T
c.(2140+1_2141-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252240	19	11231199 - 11244506			252240	246733		
FH Tonami 1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252239	19	11231199 - 11238683			252239	246732		
NM_000527.5(LDLR):c.2140+2T>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252237	19	11231200	19	11120524	252237	246532	rs879255147	NC_000019.10:11120523:T:C
NM_000527.5(LDLR):c.2140+1G>T	LDLR		Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252235	19	11231199	19	11120523	252235	246530	rs145787161	NC_000019.10:11120522:G:T
NM_000527.5(LDLR):c.2133C>A (p.Cys711Ter)	LDLR	C711*, C670*, C543*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252232	19	11231191	19	11120515	252232	246527	rs879255146	NC_000019.10:11120514:C:A
NM_000527.4(LDLR):c.2108_2114dup (p.Arg706fs)	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252223	19	11231166 - 11231172	19	11120487 - 11120488	252223	246518	rs879255141	NC_000019.10:11120487:GCTGCTGGC:GCTGCTGGCTGCTGGC
NM_001195803.2(LDLR):c.1606+257_1606+260dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252222	19	11231166 - 11231169	19	11120489 - 11120490	252222	246517	rs879255140	NC_000019.10:11120489:TGCT:TGCTTGCT
NM_001195803.2(LDLR):c.1606+245del	LDLR	P531fs, P699fs, P658fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252218	19	11231152	19	11120476	252218	246514	rs879255138	NC_000019.10:11120475:CCC:CC
NM_000527.5(LDLR):c.2093G>T (p.Cys698Phe)	LDLR	C698F, C657F, C530F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252216	19	11231151	19	11120475	252216	246511	rs879255136	NC_000019.10:11120474:G:T
NM_001195803.2(LDLR):c.1606+241del	LDLR	C657fs, C530fs, C698fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252214	19	11231150	19	11120474	252214	246509	rs879255135	NC_000019.10:11120473:T:
NM_000527.5(LDLR):c.2088C>A (p.Cys696Ter)	LDLR	C696*, C528*, C655*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252211	19	11231146	19	11120470	252211	246506	rs112954220	NC_000019.10:11120469:C:A
NM_000527.5(LDLR):c.2087G>A (p.Cys696Tyr)	LDLR	C696Y, C528Y, C655Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252210	19	11231145	19	11120469	252210	246505	rs879255134	NC_000019.10:11120468:G:A
NM_000527.4(LDLR):c.2085_2103del (p.Ala697fs)	LDLR	A529fs, A656fs, A697fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252209	19	11231143 - 11231161	19	11120466 - 11120484	252209	246504	rs879255133	NC_000019.10:11120465:CCTGCGCCTGCCCGGACGGC:C
NM_000527.4(LDLR):c.2077_2078del (p.Lys693fs)	LDLR	K693fs, K652fs, K525fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252207	19	11231135 - 11231136	19	11120459 - 11120460	252207	246502	rs879255131	NC_000019.10:11120458:AA:
NM_000527.5(LDLR):c.2072C>A (p.Ser691Ter)	LDLR	S691*, S650*, S523*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252206	19	11231130	19	11120454	252206	246501	rs369943481	NC_000019.10:11120453:C:A
NM_000527.4(LDLR):c.2068del (p.His690fs)	LDLR	H522fs, H649fs, H690fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252205	19	11231122	19	11120446	252205	246500	rs879255130	NC_000019.10:11120445:CCCCC:CCCC
NM_001195803.2(LDLR):c.1606+212dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252203	19	11231121	19	11120443 - 11120444	252203	246498	rs879255128	NC_000019.10:11120443:AA:AAA
NM_000527.4(LDLR):c.2063del (p.Asn688fs)	LDLR	N647fs, N520fs, N688fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252202	19	11231120	19	11120444	252202	246497	rs879255128	NC_000019.10:11120443:AA:A
NM_001195803.2(LDLR):c.1606+209dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252201	19	11231118	19	11120441 - 11120442	252201	246496	rs751228587	NC_000019.10:11120441:T:TT
NM_000527.4(LDLR):c.2060del (p.Ile687fs)	LDLR	I646fs, I687fs, I519fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252200	19	11231118	19	11120442	252200	246495	rs879255127	NC_000019.10:11120441:T:
NM_000527.5(LDLR):c.2056C>T (p.Gln686Ter)	LDLR	Q686*, Q645*, Q518*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252199	19	11231114	19	11120438	252199	246493	rs879255126	NC_000019.10:11120437:C:T
NM_001195803.2(LDLR):c.1606+205_1606+217del	LDLR	Q518fs, Q645fs, Q686fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252198	19	11231114 - 11231126	19	11120438 - 11120450	252198	246494	rs879255125	NC_000019.10:11120437:CAGATCAACCCCC:
NM_001195803.2(LDLR):c.1606+204del	LDLR	Q518fs, Q645fs, Q686fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252197	19	11231113	19	11120437	252197	246492	rs879255124	NC_000019.10:11120436:G:
NM_001195803.2(LDLR):c.1606+204_1606+216del	LDLR	Q518fs, Q645fs, Q686fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252196	19	11231113 - 11231125	19	11120433 - 11120445	252196	246491	rs879255123	NC_000019.10:11120432:CCCCGCAGATCAACCCC:CCCC
NM_001195803.2(LDLR):c.1606+203del	LDLR	P685fs, P517fs, P644fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252195	19	11231109	19	11120433	252195	246490	rs879255122	NC_000019.10:11120432:CCCC:CCC
NM_000527.5(LDLR):c.2053C>T (p.Pro685Ser)	LDLR	P685S, P644S, P517S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252194	19	11231111	19	11120435	252194	246489	rs2569548	NC_000019.10:11120434:C:T
NM_000527.4(LDLR):c.2050_2063del (p.Ala684fs)	LDLR	A643fs, A516fs, A684fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252191	19	11231108 - 11231121	19	11120432 - 11120445	252191	246487	rs879255121	NC_000019.10:11120431:GCCCCGCAGATCAA:
NM_001195803.2(LDLR):c.1606+195_1606+198del	LDLR	A643fs, A516fs, A684fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252190	19	11231104 - 11231107	19	11120425 - 11120428	252190	246485	rs879255120	NC_000019.10:11120424:CCTCCCT:CCT
NM_000527.5(LDLR):c.2042G>A (p.Cys681Tyr)	LDLR	C681Y, C513Y, C640Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252186	19	11231100	19	11120424	252186	246481	rs201637900	NC_000019.10:11120423:G:A
NM_000527.5(LDLR):c.2037T>A (p.Tyr679Ter)	LDLR	Y679*, Y638*, Y511*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252183	19	11231095	19	11120419	252183	246478	rs760436036	NC_000019.10:11120418:T:A
NM_001195803.2(LDLR):c.1606+185dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252182	19	11231094	19	11120417 - 11120418	252182	246477	rs879255117	NC_000019.10:11120417:A:AA
NM_001195803.2(LDLR):c.1606+184dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252181	19	11231093	19	11120416 - 11120417	252181	246476	rs879255116	NC_000019.10:11120416:T:TT
NM_000527.5(LDLR):c.2032C>T (p.Gln678Ter)	LDLR	Q678*, Q510*, Q637*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252179	19	11231090	19	11120414	252179	246474	rs879255114	NC_000019.10:11120413:C:T
NM_000527.4(LDLR):c.2030_2042del (p.Cys677fs)	LDLR	C509fs, C636fs, C677fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252177	19	11231088 - 11231100	19	11120412 - 11120424	252177	246473	rs879255113	NC_000019.10:11120411:GCCAGTATCTGTG:
NM_001195803.2(LDLR):c.1606+164del	LDLR	L504fs, L631fs, L672fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252171	19	11231073	19	11120397	252171	246466	rs879255112	NC_000019.10:11120396:T:
NM_001195803.2(LDLR):c.1606+163del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252170	19	11231070	19	11120394	252170	246465	rs879255110	NC_000019.10:11120393:CCC:CC
NM_001195803.2(LDLR):c.1606+162_1606+163del	LDLR	L504fs, L631fs, L672fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252169	19	11231071 - 11231072	19	11120394 - 11120395	252169	246464	rs879255110	NC_000019.10:11120393:CCC:C
NM_000527.5(LDLR):c.2001T>G (p.Cys667Trp)	LDLR	C667W, C499W, C626W	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252168	19	11231059	19	11120383	252168	246462	rs879255109	NC_000019.10:11120382:T:G
NM_000527.5(LDLR):c.2001T>A (p.Cys667Ter)	LDLR	C667*, C499*, C626*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252167	19	11231059	19	11120383	252167	246461	rs879255109	NC_000019.10:11120382:T:A
NM_001195803.2(LDLR):c.1606+150_1606+156del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252166	19	11231059 - 11231065	19	11120382 - 11120388	252166	246463	rs879255108	NC_000019.10:11120381:GTGAGAGG:G
NM_001195803.2(LDLR):c.1606+149del	LDLR	C626fs, C499fs, C667fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252164	19	11231058	19	11120382	252164	246460	rs879255107	NC_000019.10:11120381:G:
NM_000527.5(LDLR):c.1999T>C (p.Cys667Arg)	LDLR	C667R, C499R, C626R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252163	19	11231057	19	11120381	252163	246458	rs150021927	NC_000019.10:11120380:T:C
NM_000527.5(LDLR):c.1998G>A (p.Trp666Ter)	LDLR	W666*, W625*, W498*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252161	19	11231056	19	11120380	252161	246455	rs752935814	NC_000019.10:11120379:G:A
NM_001195803.2(LDLR):c.1606+147del	LDLR	W498fs, W625fs, W666fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252160	19	11231055	19	11120379	252160	246456	rs879255106	NC_000019.10:11120378:GG:G
NM_000527.5(LDLR):c.1997G>A (p.Trp666Ter)	LDLR	W666*, W625*, W498*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252158	19	11231055	19	11120379	252158	246453	rs879255105	NC_000019.10:11120378:G:A
NM_000527.4(LDLR):c.1996_2012del (p.Trp666fs)	LDLR	W625fs, W666fs, W498fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252157	19	11231054 - 11231070	19	11120376 - 11120392	252157	246452	rs879255104	NC_000019.10:11120375:ACTGGTGTGAGAGGACCAC:AC
c.(1987+1_1988-1)_(2311+1_2312-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252154	19	11230910 - 11238683			252154	246731		
NM_000527.5(LDLR):c.1988-2A>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252153	19	11231044	19	11120368	252153	246449	rs879255101	NC_000019.10:11120367:A:T
NM_000527.4(LDLR):c.1988-52_2006del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252150	19	11230994 - 11231064	19	11120318 - 11120388	252150	246446	rs1555807306	
NM_000527.4(LDLR):c.1987+1del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252146	19	11230909	19	11120233	252146	246442	rs879255097	NC_000019.10:11120232:GG:G
NM_000527.5(LDLR):c.1986_1987delinsC (p.Arg662fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252145	19	11230908 - 11230909	19	11120232 - 11120233	252145	246441	rs879255096	NC_000019.10:11120231:AG:C
NM_000527.4(LDLR):c.1975_1987+16del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252139	19	11230897 - 11230925	19	11120220 - 11120248	252139	246436	rs879255093	NC_000019.10:11120219:CACCCAGCCAAGAGGTAAGGGTGGGTCAGC:C
NM_000527.4(LDLR):c.1964del (p.Phe655fs)	LDLR	F528fs, F614fs, F487fs, F655fs	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252134	19	11230885	19	11120209	252134	246430	rs879255089	NC_000019.10:11120208:TT:T
NM_000527.4(LDLR):c.1961_1965dup (p.His656fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252133	19	11230883 - 11230887	19	11120203 - 11120204	252133	246429	rs879255088	NC_000019.10:11120203:TTCTCTTC:TTCTCTTCTCTTC
NM_000527.4(LDLR):c.1948_1952dup (p.Asp651fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252125	19	11230870 - 11230874	19	11120192 - 11120193	252125	246422	rs1555807275	NC_000019.10:11120192:AGAGGA:AGAGGAGAGGA
NM_000527.4(LDLR):c.1946dup (p.Glu650fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252124	19	11230868	19	11120188 - 11120189	252124	246420	rs879255082	NC_000019.10:11120188:CCCC:CCCCC
NM_000527.4(LDLR):c.1946del (p.Pro649fs)	LDLR	P608fs, P481fs, P522fs, P649fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252123	19	11230865	19	11120189	252123	246419	rs879255082	NC_000019.10:11120188:CCCC:CCC
NM_000527.4(LDLR):c.1936del (p.Leu646fs)	LDLR	L605fs, L519fs, L478fs, L646fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252119	19	11230857	19	11120181	252119	246415	rs879255078	NC_000019.10:11120180:CC:C
NM_000527.5(LDLR):c.1935_1936insA (p.Leu646fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252117	19	11230857 - 11230858	19	11120181 - 11120182	252117	246413	rs879255077	NC_000019.10:11120181::A
NM_000527.4(LDLR):c.1934dup (p.Asn645fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252116	19	11230856	19	11120176 - 11120177	252116	246412	rs879255076	NC_000019.10:11120176:AAAA:AAAAA
NM_001195798.2(LDLR):c.1886del (p.Phe629fs)	LDLR	F502fs, F588fs, F629fs, F461fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252104	19	11230805	19	11120129	252104	246401	rs879255068	NC_000019.10:11120128:TTTT:TTT
NM_000527.5(LDLR):c.1879G>A (p.Ala627Thr)	LDLR	A627T, A500T, A459T, A586T	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252101	19	11230801	19	11120125	252101	246397	rs879255066	NC_000019.10:11120124:G:A
NM_000527.4(LDLR):c.1876del (p.Glu626fs)	LDLR	E626fs, E499fs, E585fs, E458fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252100	19	11230798	19	11120122	252100	246396	rs879255065	NC_000019.10:11120121:G:
NM_000527.4(LDLR):c.1872del (p.Asn625fs)	LDLR	N457fs, N584fs, N625fs, N498fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252098	19	11230794	19	11120118	252098	246394	rs879255063	NC_000019.10:11120117:C:
NM_001195798.2(LDLR):c.1868_1870TCA[1] (p.Ile624del)	LDLR	I624del	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252097	19	11230789 - 11230791	19	11120113 - 11120115	252097	246393	rs879255062	NC_000019.10:11120112:ATCATCA:ATCA
NM_001195798.2(LDLR):c.1865_1866AT[1] (p.Ile623fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252095	19	11230787 - 11230788	19	11120111 - 11120112	252095	246392	rs879255061	NC_000019.10:11120110:ATAT:AT
NM_000527.5(LDLR):c.1864G>A (p.Asp622Asn)	LDLR	D622N, D581N, D454N, D495N	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252092	19	11230786	19	11120110	252092	246388	rs879255059	NC_000019.10:11120109:G:A
NM_000527.5(LDLR):c.1862C>G (p.Thr621Arg)	LDLR	T621R, T453R, T494R, T580R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252091	19	11230784	19	11120108	252091	246387	rs879255058	NC_000019.10:11120107:C:G
NM_000527.5(LDLR):c.1860G>A (p.Trp620Ter)	LDLR	W620*, W493*, W452*, W579*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252089	19	11230782	19	11120106	252089	246384	rs875989933	NC_000019.10:11120105:G:A
NM_000527.4(LDLR):c.1860dup (p.Thr621fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252088	19	11230782	19	11120104 - 11120105	252088	246386	rs879255057	NC_000019.10:11120104:GG:GGG
NM_000527.5(LDLR):c.1859G>A (p.Trp620Ter)	LDLR	W620*, W493*, W579*, W452*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252087	19	11230781	19	11120105	252087	246383	rs879255056	NC_000019.10:11120104:G:A
NM_000527.5(LDLR):c.1856T>G (p.Phe619Cys)	LDLR	F619C, F451C, F492C, F578C	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252085	19	11230778	19	11120102	252085	246381	rs879255054	NC_000019.10:11120101:T:G
NM_000527.5(LDLR):c.1856T>C (p.Phe619Ser)	LDLR	F619S, F492S, F451S, F578S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252084	19	11230778	19	11120102	252084	246380	rs879255054	NC_000019.10:11120101:T:C
NM_000527.5(LDLR):c.1855_1856insA (p.Phe619fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252082	19	11230777 - 11230778	19	11120101 - 11120102	252082	246379	rs879255053	NC_000019.10:11120101::A
NM_000527.5(LDLR):c.1846-1G>A	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252079	19	11230767	19	11120091	252079	246375	rs879255051	NC_000019.10:11120090:G:A
c.(1845+1_1846-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252078	19	11227675 - 11244506			252078	246730		
c.(1845+1_1846-1)_(2311+1_2312-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252076	19	11227675 - 11238683			252076	246728		
c.(1845+1_1846-1)_(2140+1_2141-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252075	19	11227675 - 11233849			252075	246727		
FH London 1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252074	19	11227675 - 11233849			252074	246726		
NM_000527.5(LDLR):c.1845+2T>C	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252070	19	11227676	19	11117000	252070	246371	rs778408161	NC_000019.10:11116999:T:C
NM_000527.5(LDLR):c.1845+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252069	19	11227675	19	11116999	252069	246369	rs879255049	NC_000019.10:11116998:G:T
NM_000527.5(LDLR):c.1845+1G>C	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252068	19	11227675	19	11116999	252068	246368	rs879255049	NC_000019.10:11116998:G:C
NM_000527.5(LDLR):c.1845+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252067	19	11227675	19	11116999	252067	246367	rs879255049	NC_000019.10:11116998:G:A
NM_000527.4(LDLR):c.1845+1del	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252066	19	11227674	19	11116998	252066	246370	rs879255048	NC_000019.10:11116997:GG:G
NM_000527.4(LDLR):c.1841_1842del (p.Val613_Phe614insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252062	19	11227670 - 11227671	19	11116993 - 11116994	252062	246363	rs879255044	NC_000019.10:11116992:TTT:T
NM_000527.4(LDLR):c.1832dup (p.Leu611fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252056	19	11227661	19	11116983 - 11116984	252056	246357	rs879255039	NC_000019.10:11116983:TT:TTT
NM_000527.5(LDLR):c.1829C>T (p.Ser610Phe)	LDLR	S610F, S442F, S483F, S569F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252055	19	11227658	19	11116982	252055	246355	rs879255038	NC_000019.10:11116981:C:T
NM_000527.4(LDLR):c.1829_1831del (p.Ser610del)	LDLR	S610del, S442del, S483del, S569del	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000252053	19	11227658 - 11227660	19	11116980 - 11116982	252053	246356	rs879255037	NC_000019.10:11116979:CTCCT:CT
NM_000527.4(LDLR):c.1815_1825del (p.Ala606fs)	LDLR	A438fs, A479fs, A606fs, A565fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252045	19	11227644 - 11227654	19	11116966 - 11116976	252045	246346	rs879255032	NC_000019.10:11116965:CTGGCCCACCCCT:CT
NM_000527.5(LDLR):c.1813C>T (p.Leu605=)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252044	19	11227642	19	11116966	252044	246345	rs879255031	NC_000019.10:11116965:C:T
NM_000527.5(LDLR):c.1807A>T (p.Lys603Ter)	LDLR	K603*, K562*, K435*, K476*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252042	19	11227636	19	11116960	252042	246343	rs879255029	NC_000019.10:11116959:A:T
NM_000527.4(LDLR):c.1802dup (p.Asp601fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252041	19	11227631	19	11116954 - 11116955	252041	246342	rs879255028	NC_000019.10:11116954:A:AA
NM_000527.5(LDLR):c.1798G>T (p.Glu600Ter)	LDLR	E600*, E432*, E473*, E559*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252037	19	11227627	19	11116951	252037	246338	rs879255026	NC_000019.10:11116950:G:T
NM_000527.4(LDLR):c.1789del (p.Thr597fs)	LDLR	T429fs, T470fs, T556fs, T597fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252031	19	11227618	19	11116942	252031	246332	rs879255022	NC_000019.10:11116941:A:
NM_000527.5(LDLR):c.1786A>T (p.Lys596Ter)	LDLR	K596*, K428*, K469*, K555*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252030	19	11227615	19	11116939	252030	246331	rs879255021	NC_000019.10:11116938:A:T
NM_000527.4(LDLR):c.1784_1790del (p.Arg595fs)	LDLR	R468fs, R427fs, R595fs, R554fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252028	19	11227613 - 11227619	19	11116936 - 11116942	252028	246330	rs879255020	NC_000019.10:11116935:CGGAAGAC:C
NM_000527.4(LDLR):c.1779del (p.Asn594fs)	LDLR	N553fs, N594fs, N426fs, N467fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252027	19	11227608	19	11116932	252027	246328	rs879255019	NC_000019.10:11116931:C:
NM_000527.4(LDLR):c.1778dup (p.Asn594fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252026	19	11227607	19	11116926 - 11116927	252026	246327	rs875989931	NC_000019.10:11116926:GGGGG:GGGGGG
NM_000527.4(LDLR):c.1778del (p.Gly593fs)	LDLR	G425fs, G466fs, G593fs, G552fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252025	19	11227603	19	11116927	252025	246326	rs875989931	NC_000019.10:11116926:GGGGG:GGGG
NM_000527.4(LDLR):c.1766del (p.Asp589fs)	LDLR	D421fs, D462fs, D589fs, D548fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252024	19	11227595	19	11116919	252024	246325	rs879255016	NC_000019.10:11116918:A:
NM_000527.4(LDLR):c.1766_1767del (p.Asp589fs)	LDLR	D421fs, D589fs, D462fs, D548fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252023	19	11227595 - 11227596	19	11116919 - 11116920	252023	246324	rs879255015	NC_000019.10:11116918:AT:
NM_000527.4(LDLR):c.1759del (p.Ser587fs)	LDLR	S460fs, S546fs, S419fs, S587fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252020	19	11227587	19	11116911	252020	246321	rs879255014	NC_000019.10:11116910:AA:A
NM_000527.4(LDLR):c.1756del (p.Ser586fs)	LDLR	S545fs, S586fs, S418fs, S459fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252019	19	11227585	19	11116909	252019	246320	rs879255013	NC_000019.10:11116908:T:
NM_000527.4(LDLR):c.1752del (p.Ile585fs)	LDLR	I458fs, I585fs, I417fs, I544fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252016	19	11227580	19	11116904	252016	246317	rs879255011	NC_000019.10:11116903:CC:C
NM_000527.4(LDLR):c.1749_1753del (p.Ser584fs)	LDLR	S416fs, S543fs, S584fs, S457fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000252013	19	11227578 - 11227582	19	11116900 - 11116904	252013	246315	rs879255008	NC_000019.10:11116899:CACTCCA:CA
NM_000527.4(LDLR):c.1745_1746del (p.Leu582fs)	LDLR	L455fs, L541fs, L414fs, L582fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000252011	19	11227574 - 11227575	19	11116898 - 11116899	252011	246312	rs879255006	NC_000019.10:11116897:TT:
NM_000527.4(LDLR):c.1737del (p.Ser580fs)	LDLR	S412fs, S539fs, S453fs, S580fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252010	19	11227566	19	11116890	252010	246311	rs879255005	NC_000019.10:11116889:C:
NM_000527.5(LDLR):c.1735G>A (p.Asp579Asn)	LDLR	D579N, D452N, D538N, D411N	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252006	19	11227564	19	11116888	252006	246306	rs875989929	NC_000019.10:11116887:G:A
NM_000527.5(LDLR):c.1730G>C (p.Trp577Ser)	LDLR	W577S, W409S, W536S, W450S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252003	19	11227559	19	11116883	252003	246303	rs138947766	NC_000019.10:11116882:G:C
NM_000527.5(LDLR):c.1729T>C (p.Trp577Arg)	LDLR	W577R, W409R, W536R, W450R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000252001	19	11227558	19	11116882	252001	246301	rs879255000	NC_000019.10:11116881:T:C
NM_000527.5(LDLR):c.1729T>G (p.Trp577Gly)	LDLR	W577G, W409G, W536G, W450G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000252000	19	11227558	19	11116882	252000	246302	rs879255000	NC_000019.10:11116881:T:G
NM_000527.4(LDLR):c.1718del (p.Gly573fs)	LDLR	G573fs, G405fs, G532fs, G446fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251995	19	11227546	19	11116870	251995	246296	rs879254998	NC_000019.10:11116869:GG:G
NM_000527.5(LDLR):c.1706-1G>T	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251993	19	11227534	19	11116858	251993	246294	rs879254996	NC_000019.10:11116857:G:T
c.(1705+1_1706-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251991	19	11226889 - 11244506			251991	246725		
c.(1705+1_1706-1)_(2389+1_2390-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251990	19	11226889 - 11240188			251990	246724		
c.(1705+1_1706-1)_(1845+1_1846-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251989	19	11226889 - 11230767			251989	246723		
c.(1705+1_1706-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251988	19	11226889 - 11230767			251988	246722		
NM_000527.5(LDLR):c.1706-2A>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251987	19	11227533	19	11116857	251987	246292	rs878854027	NC_000019.10:11116856:A:C
NM_000527.5(LDLR):c.1705+2_1705+3insC	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251982	19	11226890 - 11226891	19	11116214 - 11116215	251982	246287	rs879254994	NC_000019.10:11116214::C
NM_000527.5(LDLR):c.1705+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251981	19	11226889	19	11116213	251981	246286	rs875989926	NC_000019.10:11116212:G:T
NM_000527.5(LDLR):c.1705+1G>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251980	19	11226889	19	11116213	251980	246285	rs875989926	NC_000019.10:11116212:G:C
NM_000527.5(LDLR):c.1703T>C (p.Leu568Pro)	LDLR	L568P, L441P, L400P, L527P	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251977	19	11226886	19	11116210	251977	246282	rs879254991	NC_000019.10:11116209:T:C
NM_000527.5(LDLR):c.1702C>G (p.Leu568Val)	LDLR	L568V, L441V, L527V, L400V	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251976	19	11226885	19	11116209	251976	246280	rs746959386	NC_000019.10:11116208:C:G
NM_000527.4(LDLR):c.1702_1705dup (p.Asp569fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251975	19	11226885 - 11226888	19	11116208 - 11116209	251975	246281	rs879254990	NC_000019.10:11116208:CTAG:CTAGCTAG
NM_000527.5(LDLR):c.1698_1704delinsGCCCAAT (p.Ile566_Leu568delinsMetProAsn)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251974	19	11226881 - 11226887	19	11116205 - 11116211	251974	246279	rs879254989	NC_000019.10:11116204:CACCCTA:GCCCAAT
NM_000527.5(LDLR):c.1690A>G (p.Asn564Asp)	LDLR	N564D, N396D, N437D, N523D	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251973	19	11226873	19	11116197	251973	246278	rs397509365	NC_000019.10:11116196:A:G
NM_000527.4(LDLR):c.1689dup (p.Asn564fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251972	19	11226872	19	11116193 - 11116194	251972	246277	rs879254988	NC_000019.10:11116193:CCC:CCCC
NM_000527.5(LDLR):c.1686G>A (p.Trp562Ter)	LDLR	W562*, W394*, W521*, W435*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251969	19	11226869	19	11116193	251969	246273	rs879254985	NC_000019.10:11116192:G:A
NM_000527.5(LDLR):c.1686_1693delinsT (p.Trp562fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251968	19	11226869 - 11226876	19	11116193 - 11116200	251968	246274	rs879254984	NC_000019.10:11116192:GCCCAATG:T
NM_000527.4(LDLR):c.1683del (p.Gln561fs)	LDLR	Q520fs, Q393fs, Q561fs, Q434fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251966	19	11226866	19	11116190	251966	246271	rs879254982	NC_000019.10:11116189:G:
NM_000527.5(LDLR):c.1681C>T (p.Gln561Ter)	LDLR	Q561*, Q520*, Q393*, Q434*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251965	19	11226864	19	11116188	251965	246270	rs879254981	NC_000019.10:11116187:C:T
NM_000527.5(LDLR):c.1672G>T (p.Glu558Ter)	LDLR	E558*, E431*, E390*, E517*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251964	19	11226855	19	11116179	251964	246269	rs879254980	NC_000019.10:11116178:G:T
NM_000527.4(LDLR):c.1671_1672del (p.Glu558fs)	LDLR	E390fs, E517fs, E431fs, E558fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251963	19	11226854 - 11226855	19	11116178 - 11116179	251963	246268	rs879254979	NC_000019.10:11116177:TG:
NM_000527.4(LDLR):c.1662_1669dup (p.Thr557delinsSerTrpTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251961	19	11226845 - 11226852	19	11116168 - 11116169	251961	246266	rs879254977	NC_000019.10:11116168:GCTGGTGA:GCTGGTGAGCTGGTGA
NM_000527.5(LDLR):c.1661C>A (p.Ser554Ter)	LDLR	S554*, S427*, S386*, S513*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251959	19	11226844	19	11116168	251959	246264	rs879254976	NC_000019.10:11116167:C:A
NM_000527.5(LDLR):c.1659_1661delinsATACTTTCA (p.Tyr553_Ser554delinsTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251958	19	11226842 - 11226844	19	11116166 - 11116168	251958	246263	rs879254975	NC_000019.10:11116165:CTC:ATACTTTCA
NM_000527.4(LDLR):c.1651del (p.Asp551fs)	LDLR	D510fs, D424fs, D551fs, D383fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251956	19	11226833	19	11116157	251956	246260	rs879254973	NC_000019.10:11116156:GG:G
NM_000527.4(LDLR):c.1655del (p.Ile552fs)	LDLR	I425fs, I511fs, I552fs, I384fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251954	19	11226838	19	11116162	251954	246261	rs879254972	NC_000019.10:11116161:T:
NM_000527.5(LDLR):c.1645_1646insC (p.Gly549fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251953	19	11226828 - 11226829	19	11116152 - 11116153	251953	246258	rs879254971	NC_000019.10:11116152::C
NM_000527.5(LDLR):c.1644_1645insC (p.Gly549fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251950	19	11226827 - 11226828	19	11116151 - 11116152	251950	246257	rs879254969	NC_000019.10:11116151::C
NM_000527.5(LDLR):c.1640_1652delinsAGCGTCATCTTCCTGAC (p.Leu547fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251948	19	11226823 - 11226835	19	11116147 - 11116159	251948	246254	rs879254967	NC_000019.10:11116146:TGAATGGTGTGGA:AGCGTCATCTTCCTGAC
NM_000527.5(LDLR):c.1633G>A (p.Gly545Arg)	LDLR	G545R, G377R, G504R, G418R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251942	19	11226816	19	11116140	251942	246247	rs879254965	NC_000019.10:11116139:G:A
NM_000527.4(LDLR):c.1632del (p.Gly546fs)	LDLR	G546fs, G378fs, G419fs, G505fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251941	19	11226813	19	11116137	251941	246246	rs879254964	NC_000019.10:11116136:AAA:AA
NM_000527.4(LDLR):c.1629_1652del (p.Lys543_Asp551delinsAsn)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251940	19	11226812 - 11226835	19	11116135 - 11116158	251940	246245	rs879254963	NC_000019.10:11116134:AGAAAGGGGGCCTGAATGGTGTGGA:A
NM_000527.5(LDLR):c.1625T>G (p.Ile542Ser)	LDLR	I542S, I501S, I374S, I415S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251939	19	11226808	19	11116132	251939	246244	rs879254962	NC_000019.10:11116131:T:G
NM_000527.4(LDLR):c.1610del (p.Gly537fs)	LDLR	G369fs, G410fs, G496fs, G537fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251934	19	11226790	19	11116114	251934	246239	rs879254959	NC_000019.10:11116113:GGGG:GGG
NM_000527.5(LDLR):c.1609G>T (p.Gly537Ter)	LDLR	G537*, G369*, G410*, G496*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251933	19	11226792	19	11116116	251933	246238	rs879254958	NC_000019.10:11116115:G:T
NM_000527.5(LDLR):c.1607G>A (p.Trp536Ter)	LDLR	W536*, W368*, W409*, W495*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251932	19	11226790	19	11116114	251932	246237	rs879254957	NC_000019.10:11116113:G:A
NM_000527.5(LDLR):c.1599G>A (p.Trp533Ter)	LDLR	W533*, W406*, W492*, W365*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251927	19	11226782	19	11116106	251927	246232	rs879254952	NC_000019.10:11116105:G:A
NM_000527.4(LDLR):c.1587_1591del (p.Phe530fs)	LDLR	F530fs, F403fs, F362fs, F489fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251923	19	11226770 - 11226774	19	11116094 - 11116098	251923	246228	rs879254949	NC_000019.10:11116093:CTTCA:
c.(1586+1_1587-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251921	19	11224439 - 11244506			251921	246721		
c.(1586+1_1587-1)_(2547+1_2548-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251920	19	11224439 - 11241956			251920	246720		
c.(1586+1_1587-1)_(2389+1_2390-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251919	19	11224439 - 11240188			251919	246719		
c.(1586+1_1587-1)_(2311+1_2312-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251918	19	11224439 - 11238683			251918	246718		
c.(1586+1_1587-1)_(2140+1_2141-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251917	19	11224439 - 11233849			251917	246717		
c.(1586+1_1587-1)_(2140+1_2141-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251916	19	11224439 - 11233849			251916	246716		
c.(1586+1_1587-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251914	19	11224439 - 11230767			251914	246714		
c.(1586+1_1587-1)_(1705+1_1706-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251913	19	11224439 - 11227534			251913	246713		
NM_000527.5(LDLR):c.1587-2A>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251912	19	11226768	19	11116092	251912	246226	rs879254947	NC_000019.10:11116091:A:T
NM_000527.5(LDLR):c.1586+2T>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251908	19	11224440	19	11113764	251908	246222	rs879254945	NC_000019.10:11113763:T:C
NM_000527.5(LDLR):c.1586+2T>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251907	19	11224440	19	11113764	251907	246221	rs879254945	NC_000019.10:11113763:T:A
NM_000527.5(LDLR):c.1586+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251905	19	11224439	19	11113763	251905	246219	rs755389753	NC_000019.10:11113762:G:A
NM_000527.5(LDLR):c.1558A>G (p.Arg520Gly)	LDLR	R520G, R352G, R479G, R393G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251897	19	11224410	19	11113734	251897	246211	rs879254939	NC_000019.10:11113733:A:G
NM_000527.4(LDLR):c.1549_1555del (p.Ser517fs)	LDLR	S476fs, S390fs, S517fs, S349fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251892	19	11224401 - 11224407	19	11113723 - 11113729	251892	246207	rs879254935	NC_000019.10:11113722:GCTCCAAGC:GC
NM_000527.4(LDLR):c.1533dup (p.Phe512fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251889	19	11224385	19	11113708 - 11113709	251889	246203	rs879254933	NC_000019.10:11113708:A:AA
NM_000527.5(LDLR):c.1532T>G (p.Leu511Ter)	LDLR	L511*, L384*, L343*, L470*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251888	19	11224384	19	11113708	251888	246202	rs879254932	NC_000019.10:11113707:T:G
NM_000527.5(LDLR):c.1522delinsCTGAAT (p.Arg508fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251884	19	11224374	19	11113698	251884	246198	rs879254930	NC_000019.10:11113697:A:CTGAAT
NM_000527.4(LDLR):c.1516_1562del (p.Val506fs)	LDLR	V379fs, V465fs, V506fs, V338fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251880	19	11224368 - 11224414	19	11113684 - 11113730	251880	246195	rs879254927	NC_000019.10:11113683:CCAAGGGCGTGAAGAGGAAAACGTTATTCAGGGAGAACGGCTCCAAGCCAAGGGC:CCAAGGGC
NM_000527.5(LDLR):c.1510A>T (p.Lys504Ter)	LDLR	K504*, K463*, K336*, K377*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251878	19	11224362	19	11113686	251878	246192	rs730882103	NC_000019.10:11113685:A:T
NM_000527.4(LDLR):c.1502dup (p.Asp502fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251875	19	11224354	19	11113677 - 11113678	251875	246189	rs879254924	NC_000019.10:11113677:C:CC
NM_000527.5(LDLR):c.1502C>T (p.Ala501Val)	LDLR	A501V, A460V, A374V, A333V	Familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251874	19	11224354	19	11113678	251874	246188	rs755667663	NC_000019.10:11113677:C:T
NM_000527.4(LDLR):c.1498_1499del (p.Val500fs)	LDLR	V459fs, V500fs, V332fs, V373fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251872	19	11224350 - 11224351	19	11113673 - 11113674	251872	246186	rs879254923	NC_000019.10:11113672:TGT:T
NM_001195798.2(LDLR):c.1494_1495CT[1] (p.Ser499fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251871	19	11224345 - 11224346	19	11113669 - 11113670	251871	246185	rs879254922	NC_000019.10:11113668:TCTCT:TCT
NM_000527.5(LDLR):c.1477_1479delinsAGAGACA (p.Ser493fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251866	19	11224329 - 11224331	19	11113653 - 11113655	251866	246180	rs879254919	NC_000019.10:11113652:TCT:AGAGACA
NM_000527.4(LDLR):c.1471dup (p.Thr491fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251862	19	11224323	19	11113646 - 11113647	251862	246176	rs879254916	NC_000019.10:11113646:A:AA
NM_000527.5(LDLR):c.1470G>A (p.Trp490Ter)	LDLR	W490*, W363*, W322*, W449*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251861	19	11224322	19	11113646	251861	246175	rs879254915	NC_000019.10:11113645:G:A
NM_000527.5(LDLR):c.1463T>A (p.Ile488Asn)	LDLR	I488N, I447N, I320N, I361N	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251856	19	11224315	19	11113639	251856	246170	rs879254913	NC_000019.10:11113638:T:A
NM_000527.5(LDLR):c.1449G>A (p.Trp483Ter)	LDLR	W483*, W442*, W315*, W356*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251849	19	11224301	19	11113625	251849	246162	rs879254907	NC_000019.10:11113624:G:A
NM_000527.4(LDLR):c.1439_1449del (p.Ala480fs)	LDLR	A353fs, A312fs, A439fs, A480fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251842	19	11224291 - 11224301	19	11113611 - 11113621	251842	246156	rs879254902	NC_000019.10:11113610:CTGGCTGTGGACTGG:CTGG
NM_000527.4(LDLR):c.1434del (p.Leu479fs)	LDLR	L311fs, L438fs, L352fs, L479fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251839	19	11224284	19	11113608	251839	246153	rs879254899	NC_000019.10:11113607:GGG:GG
NM_000527.5(LDLR):c.1423_1424delinsA (p.Ala475fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251835	19	11224275 - 11224276	19	11113599 - 11113600	251835	246149	rs879254896	NC_000019.10:11113598:GC:A
NM_000527.5(LDLR):c.1420C>T (p.Gln474Ter)	LDLR	Q474*, Q433*, Q347*, Q306*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251834	19	11224272	19	11113596	251834	246148	rs201967266	NC_000019.10:11113595:C:T
NM_001195798.2(LDLR):c.1415_1418dup (p.Gln474fs)	LDLR		Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251830	19	11224267 - 11224270	19	11113590 - 11113591	251830	246144	rs879254892	NC_000019.10:11113590:ACAT:ACATACAT
NM_001195798.2(LDLR):c.1392del (p.Tyr465fs)	LDLR	Y297fs, Y338fs, Y424fs, Y465fs	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251825	19	11224243	19	11113567	251825	246139	rs879254888	NC_000019.10:11113566:CC:C
NM_000527.5(LDLR):c.1379_1402delinsCAGCTTGACCCGC (p.His460_Val468delinsProAlaTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251822	19	11224231 - 11224254	19	11113555 - 11113578	251822	246136	rs879254887	NC_000019.10:11113554:ACGGCGTCTCTTCCTATGACACCG:CAGCTTGACCCGC
NM_000527.5(LDLR):c.1379_1396delinsCAGCTTA (p.His460_Asp466delinsProAlaTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251821	19	11224231 - 11224248	19	11113555 - 11113572	251821	246135	rs879254886	NC_000019.10:11113554:ACGGCGTCTCTTCCTATG:CAGCTTA
NM_000527.4(LDLR):c.1377_1380del (p.His460fs)	LDLR	H292fs, H419fs, H333fs, H460fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251820	19	11224229 - 11224232	19	11113552 - 11113555	251820	246134	rs879254885	NC_000019.10:11113551:CCCAC:C
NM_001195798.2(LDLR):c.1372_1373AG[1] (p.Arg458fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251818	19	11224224 - 11224225	19	11113548 - 11113549	251818	246132	rs879254884	NC_000019.10:11113547:AGAG:AG
NM_000527.4(LDLR):c.1367_1376del (p.Leu456fs)	LDLR	L288fs, L415fs, L329fs, L456fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251816	19	11224219 - 11224228	19	11113540 - 11113549	251816	246131	rs879254883	NC_000019.10:11113539:AGCTTGACAGAGC:AGC
NM_000527.4(LDLR):c.1365del (p.Gln455fs)	LDLR	Q287fs, Q328fs, Q414fs, Q455fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251815	19	11224217	19	11113541	251815	246129	rs879254882	NC_000019.10:11113540:G:
NM_000527.4(LDLR):c.1363del (p.Gln455fs)	LDLR	Q287fs, Q328fs, Q414fs, Q455fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251814	19	11224213	19	11113537	251814	246128	rs879254881	NC_000019.10:11113536:CCC:CC
NM_000527.5(LDLR):c.1363C>T (p.Gln455Ter)	LDLR	Q455*, Q328*, Q287*, Q414*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251813	19	11224215	19	11113539	251813	246127	rs879254880	NC_000019.10:11113538:C:T
NM_000527.5(LDLR):c.1358+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251802	19	11224126	19	11113450	251802	246116	rs775924858	NC_000019.10:11113449:G:A
NM_000527.4(LDLR):c.1343del (p.Gln448fs)	LDLR	Q407fs, Q448fs, Q280fs, Q321fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251799	19	11224110	19	11113434	251799	246113	rs879254872	NC_000019.10:11113433:A:
NM_000527.5(LDLR):c.1342C>T (p.Gln448Ter)	LDLR	Q448*, Q280*, Q321*, Q407*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251798	19	11224109	19	11113433	251798	246112	rs879254871	NC_000019.10:11113432:C:T
NM_000527.4(LDLR):c.1336del (p.Leu446fs)	LDLR	L278fs, L405fs, L446fs, L319fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251795	19	11224102	19	11113426	251795	246109	rs879254868	NC_000019.10:11113425:CC:C
NM_000527.5(LDLR):c.1329G>C (p.Trp443Cys)	LDLR	W443C, W316C, W402C, W275C	Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251792	19	11224096	19	11113420	251792	246106	rs879254867	NC_000019.10:11113419:G:C
NM_000527.5(LDLR):c.1329G>A (p.Trp443Ter)	LDLR	W443*, W402*, W275*, W316*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251791	19	11224096	19	11113420	251791	246105	rs879254867	NC_000019.10:11113419:G:A
NM_000527.5(LDLR):c.1328G>A (p.Trp443Ter)	LDLR	W443*, W275*, W316*, W402*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251789	19	11224095	19	11113419	251789	246103	rs879254866	NC_000019.10:11113418:G:A
NM_000527.5(LDLR):c.1326C>G (p.Tyr442Ter)	LDLR	Y442*, Y274*, Y315*, Y401*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251788	19	11224093	19	11113417	251788	246102	rs879254865	NC_000019.10:11113416:C:G
NM_000527.5(LDLR):c.1323C>G (p.Ile441Met)	LDLR	I441M, I400M, I273M, I314M	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251784	19	11224090	19	11113414	251784	246098	rs5933	NC_000019.10:11113413:C:G
NM_000527.5(LDLR):c.1322T>C (p.Ile441Thr)	LDLR	I441T, I273T, I314T, I400T	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251783	19	11224089	19	11113413	251783	246097	rs879254862	NC_000019.10:11113412:T:C
NM_000527.4(LDLR):c.1309dup (p.Ala437fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251779	19	11224076	19	11113398 - 11113399	251779	246093	rs879254859	NC_000019.10:11113398:GG:GGG
NM_000527.4(LDLR):c.1306del (p.Val436fs)	LDLR	V395fs, V309fs, V268fs, V436fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251777	19	11224072	19	11113396	251777	246091	rs879254858	NC_000019.10:11113395:GG:G
NM_000527.4(LDLR):c.1303del (p.Glu435fs)	LDLR	E267fs, E308fs, E394fs, E435fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251776	19	11224069	19	11113393	251776	246090	rs879254857	NC_000019.10:11113392:GG:G
NM_000527.4(LDLR):c.1291_1331del (p.Val430_Ala431insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251769	19	11224058 - 11224098	19	11113377 - 11113417	251769	246083	rs879254854	NC_000019.10:11113376:TGGTCGCTCTGGACACGGAGGTGGCCAGCAATAGAATCTACTGGTC:TGGTC
NM_000527.5(LDLR):c.1268T>C (p.Ile423Thr)	LDLR	I423T, I255T, I296T, I382T	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251760	19	11224035	19	11113359	251760	246074	rs879254849	NC_000019.10:11113358:T:C
NM_000527.5(LDLR):c.1257C>G (p.Tyr419Ter)	LDLR	Y419*, Y292*, Y378*, Y251*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251758	19	11224024	19	11113348	251758	246072	rs774439908	NC_000019.10:11113347:C:G
NM_000527.5(LDLR):c.1257C>A (p.Tyr419Ter)	LDLR	Y419*, Y292*, Y378*, Y251*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251757	19	11224024	19	11113348	251757	246071	rs774439908	NC_000019.10:11113347:C:A
NM_000527.5(LDLR):c.1252G>T (p.Glu418Ter)	LDLR	E418*, E250*, E291*, E377*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251755	19	11224019	19	11113343	251755	246069	rs869320651	NC_000019.10:11113342:G:T
NM_000527.5(LDLR):c.1247G>A (p.Arg416Gln)	LDLR	R416Q, R248Q, R375Q, R289Q	Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251752	19	11224014	19	11113338	251752	246066	rs773658037	NC_000019.10:11113337:G:A
NM_000527.4(LDLR):c.1245_1249dup (p.Ser417fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251751	19	11224012 - 11224016	19	11113332 - 11113333	251751	246065	rs879254846	NC_000019.10:11113332:GGACCGGA:GGACCGGACCGGA
NM_000527.5(LDLR):c.1243G>C (p.Asp415His)	LDLR	D415H, D288H, D247H, D374H	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251748	19	11224010	19	11113334	251748	246062	rs879254844	NC_000019.10:11113333:G:C
NM_000527.5(LDLR):c.1235T>C (p.Met412Thr)	LDLR	M412T, M371T, M244T, M285T	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251745	19	11224002	19	11113326	251745	246059	rs879254842	NC_000019.10:11113325:T:C
NM_000527.4(LDLR):c.1233del (p.Lys411_Met412insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251744	19	11224000	19	11113324	251744	246058	rs879254841	NC_000019.10:11113323:G:
NM_000527.5(LDLR):c.1215C>G (p.Asn405Lys)	LDLR	N405K, N364K, N237K, N278K	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251738	19	11223982	19	11113306	251738	246052	rs879254837	NC_000019.10:11113305:C:G
NM_000527.5(LDLR):c.1211C>T (p.Thr404Ile)	LDLR	T404I, T236I, T363I, T277I	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251736	19	11223978	19	11113302	251736	246050	rs879254835	NC_000019.10:11113301:C:T
NM_000527.4(LDLR):c.1209del (p.Phe403fs)	LDLR	F276fs, F362fs, F403fs, F235fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251734	19	11223976	19	11113300	251734	246048	rs879254833	NC_000019.10:11113299:C:
NM_000527.4(LDLR):c.1208del (p.Phe403fs)	LDLR	F276fs, F362fs, F235fs, F403fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251733	19	11223974	19	11113298	251733	246047	rs879254832	NC_000019.10:11113297:TT:T
NM_001195798.2(LDLR):c.1206_1207del (p.Phe403fs)	LDLR	F235fs, F403fs, F276fs, F362fs	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251730	19	11223973 - 11223974	19	11113296 - 11113297	251730	246044	rs879254829	NC_000019.10:11113295:TCT:T
NM_000527.4(LDLR):c.1205dup (p.Phe403fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251729	19	11223972	19	11113294 - 11113295	251729	246043	rs879254828	NC_000019.10:11113294:TT:TTT
NM_000527.5(LDLR):c.1200C>A (p.Tyr400Ter)	LDLR	Y400*, Y273*, Y232*, Y359*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251728	19	11223967	19	11113291	251728	246042	rs879254827	NC_000019.10:11113290:C:A
NM_000527.5(LDLR):c.1187-1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251723	19	11223953	19	11113277	251723	246037	rs879254824	NC_000019.10:11113276:G:A
c.(1186+1_1187-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251722	19	11222316 - 11244506			251722	246712		
c.(1186+1_1187-1)_(2140+1_2141-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251720	19	11222316 - 11233849			251720	246710		
c.(1186+1_1187-1)_(1845+1_1846-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251719	19	11222316 - 11230767			251719	246709		
c.(1186+1_1187-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251718	19	11222316 - 11230767			251718	246708		
c.(1186+1_1187-1)_(1586+1_1587-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251717	19	11222316 - 11226769			251717	246707		
c.(1186+1_1187-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251716	19	11222316 - 11226769			251716	246706		
c.(1186+1_1187-1)_(1358+1_1359-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251715	19	11222316 - 11224210			251715	246705		
c.(1186+1_1187-1)_(1358+1_1359-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251714	19	11222316 - 11224210			251714	246704		
NM_000527.5(LDLR):c.1187-2A>G	LDLR		not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251713	19	11223952	19	11113276	251713	246036	rs879254823	NC_000019.10:11113275:A:G
NM_000527.5(LDLR):c.1186+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251705	19	11222316	19	11111640	251705	246028	rs730880131	NC_000019.10:11111639:G:A
NM_000527.4(LDLR):c.1186+1del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251703	19	11222314	19	11111638	251703	246027	rs879254819	NC_000019.10:11111637:GGG:GG
NM_000527.4(LDLR):c.1182del (p.Val395fs)	LDLR	V395fs, V227fs, V268fs, V354fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251701	19	11222311	19	11111635	251701	246024	rs879254817	NC_000019.10:11111634:T:
NM_000527.5(LDLR):c.1176C>A (p.Cys392Ter)	LDLR	C392*, C265*, C351*, C224*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251699	19	11222305	19	11111629	251699	246021	rs750649426	NC_000019.10:11111628:C:A
NM_000527.4(LDLR):c.1178del (p.Lys393fs)	LDLR	K266fs, K352fs, K393fs, K225fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251698	19	11222306	19	11111630	251698	246022	rs879254815	NC_000019.10:11111629:AA:A
NM_000527.5(LDLR):c.1174T>C (p.Cys392Arg)	LDLR	C392R, C265R, C351R, C224R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251697	19	11222303	19	11111627	251697	246019	rs879254814	NC_000019.10:11111626:T:C
NM_000527.4(LDLR):c.1174dup (p.Cys392fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251696	19	11222303	19	11111626 - 11111627	251696	246020	rs879254813	NC_000019.10:11111626:T:TT
NM_000527.4(LDLR):c.1173del (p.Cys392fs)	LDLR	C351fs, C224fs, C392fs, C265fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251695	19	11222301	19	11111625	251695	246018	rs879254812	NC_000019.10:11111624:CC:C
NM_000527.5(LDLR):c.1168A>T (p.Lys390Ter)	LDLR	K390*, K222*, K263*, K349*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251694	19	11222297	19	11111621	251694	246017	rs879254811	NC_000019.10:11111620:A:T
NM_000527.5(LDLR):c.1150C>T (p.Gln384Ter)	LDLR	Q384*, Q216*, Q257*, Q343*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251688	19	11222279	19	11111603	251688	246011	rs879254805	NC_000019.10:11111602:C:T
NM_000527.5(LDLR):c.1136G>A (p.Cys379Tyr)	LDLR	C379Y, C211Y, C252Y, C338Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251686	19	11222265	19	11111589	251686	246009	rs879254804	NC_000019.10:11111588:G:A
NM_000527.5(LDLR):c.1135T>C (p.Cys379Arg)	LDLR	C379R, C211R, C252R, C338R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251685	19	11222264	19	11111588	251685	246008	rs879254803	NC_000019.10:11111587:T:C
NM_000527.4(LDLR):c.1135_1186+14del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251684	19	11222262 - 11222327	19	11111586 - 11111651	251684	246007	rs1555804793	
NM_000527.5(LDLR):c.1132C>T (p.Gln378Ter)	LDLR	Q378*, Q210*, Q251*, Q337*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251683	19	11222261	19	11111585	251683	246006	rs879254802	NC_000019.10:11111584:C:T
NM_000527.5(LDLR):c.1124A>G (p.Tyr375Cys)	LDLR	Y375C, Y207C, Y248C, Y334C	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251679	19	11222253	19	11111577	251679	246002	rs879254800	NC_000019.10:11111576:A:G
NM_000527.5(LDLR):c.1123_1124insC (p.Tyr375fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251677	19	11222252 - 11222253	19	11111576 - 11111577	251677	246000	rs1555804777	NC_000019.10:11111576::C
NM_000527.4(LDLR):c.1120_1123dup (p.Tyr375fs)	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251676	19	11222249 - 11222252	19	11111571 - 11111572	251676	245999	rs879254799	NC_000019.10:11111571:TGGCT:TGGCTGGCT
NM_000527.5(LDLR):c.1118G>A (p.Gly373Asp)	LDLR	G373D, G246D, G205D, G332D	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251673	19	11222247	19	11111571	251673	245996	rs879254797	NC_000019.10:11111570:G:A
NM_000527.5(LDLR):c.1113_1114insTGGG (p.Glu372fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251670	19	11222242 - 11222243	19	11111565 - 11111566	251670	245993	rs879254794	NC_000019.10:11111565:G:GTGGG
NM_000527.5(LDLR):c.1109A>C (p.Asn370Thr)	LDLR	N370T, N243T, N329T, N202T	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251668	19	11222238	19	11111562	251668	245991	rs879254792	NC_000019.10:11111561:A:C
NM_000527.5(LDLR):c.1104C>A (p.Cys368Ter)	LDLR	C368*, C200*, C327*, C241*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251667	19	11222233	19	11111557	251667	245990	rs113669610	NC_000019.10:11111556:C:A
NM_000527.5(LDLR):c.1099_1104delinsGT (p.Leu367fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251663	19	11222228 - 11222233	19	11111552 - 11111557	251663	245986	rs879254790	NC_000019.10:11111551:CTCTGC:GT
NM_000527.5(LDLR):c.1096C>T (p.Gln366Ter)	LDLR	Q366*, Q325*, Q198*, Q239*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251660	19	11222225	19	11111549	251660	245983	rs879254789	NC_000019.10:11111548:C:T
NM_001195798.2(LDLR):c.1085del (p.Asp362fs)	LDLR	D194fs, D235fs, D321fs, D362fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251655	19	11222214	19	11111538	251655	245978	rs879254786	NC_000019.10:11111537:A:
NM_000527.5(LDLR):c.1075C>T (p.Gln359Ter)	LDLR	Q359*, Q191*, Q232*, Q318*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251653	19	11222204	19	11111528	251653	245976	rs879254784	NC_000019.10:11111527:C:T
NM_000527.4(LDLR):c.1070_1073dup (p.Cys358Ter)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251650	19	11222199 - 11222202	19	11111520 - 11111521	251650	245974	rs879254782	NC_000019.10:11111520:TGAGTG:TGAGTGAGTG
NM_000527.4(LDLR):c.1067del (p.Asp356fs)	LDLR	D188fs, D315fs, D356fs, D229fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251646	19	11222196	19	11111520	251646	245969	rs879254778	NC_000019.10:11111519:A:
NM_000527.4(LDLR):c.1062dup (p.Ile355fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251641	19	11222191	19	11111514 - 11111515	251641	245964	rs879254775	NC_000019.10:11111514:T:TT
NM_000527.5(LDLR):c.1061A>T (p.Asp354Val)	LDLR	D354V, D313V, D186V, D227V	Familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251640	19	11222190	19	11111514	251640	245961	rs755449669	NC_000019.10:11111513:A:T
NM_000527.5(LDLR):c.1061-1G>C	LDLR		Familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251637	19	11222189	19	11111513	251637	245958	rs879254774	NC_000019.10:11111512:G:C
NM_000527.5(LDLR):c.1061-1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251636	19	11222189	19	11111513	251636	245957	rs879254774	NC_000019.10:11111512:G:A
c.(1060+1_1061-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251635	19	11221448 - 11230767			251635	246703		
c.(1060+1_1061-1)_(1586+1_1587-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251634	19	11221448 - 11226769			251634	246702		
c.(1060+1_1061-1)_(1186+1_1187-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251633	19	11221448 - 11223953			251633	246701		
NM_000527.5(LDLR):c.1060+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251623	19	11221448	19	11110772	251623	245947	rs879254771	NC_000019.10:11110771:G:A
NM_000527.5(LDLR):c.1056C>G (p.Cys352Trp)	LDLR	C352W, C184W, C225W, C311W	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251622	19	11221443	19	11110767	251622	245945	rs13306515	NC_000019.10:11110766:C:G
NM_000527.5(LDLR):c.1056C>A (p.Cys352Ter)	LDLR	C352*, C184*, C225*, C311*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251621	19	11221443	19	11110767	251621	245944	rs13306515	NC_000019.10:11110766:C:A
NM_000527.5(LDLR):c.1056_1060+3del	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251620	19	11221443 - 11221450	19	11110765 - 11110772	251620	245946	rs879254770	NC_000019.10:11110764:TGCGAAGGTG:TG
NM_000527.4(LDLR):c.1054_1064del (p.Cys352fs)	LDLR	C184fs, C352fs, C225fs, C311fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251616	19	11221441 - 11222193	19	11110765 - 11111517	251616	245942	rs1555804565	
NM_001195798.2(LDLR):c.1047_1054GCGAAGAT[3] (p.Ile355fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251615	19	11221440 - 11221447	19	11110757 - 11110758	251615	245939	rs879254768	NC_000019.10:11110757:GCGAAGATGCGAAG:GCGAAGATGCGAAGATGCGAAG
NM_000527.4(LDLR):c.1046del (p.Gln349fs)	LDLR	Q308fs, Q181fs, Q222fs, Q349fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251614	19	11221433	19	11110757	251614	245938	rs879254767	NC_000019.10:11110756:A:
NM_000527.4(LDLR):c.1045dup (p.Gln349fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251613	19	11221432	19	11110753 - 11110754	251613	245937	rs879254765	NC_000019.10:11110753:CCC:CCCC
NM_000527.4(LDLR):c.1045del (p.Gln349fs)	LDLR	Q308fs, Q181fs, Q222fs, Q349fs	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251612	19	11221430	19	11110754	251612	245936	rs879254765	NC_000019.10:11110753:CCC:CC
NM_000527.4(LDLR):c.1042del (p.Ala348fs)	LDLR	A348fs, A180fs, A307fs, A221fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251610	19	11221428	19	11110752	251610	245934	rs879254764	NC_000019.10:11110751:GG:G
NM_000527.5(LDLR):c.1042_1043insA (p.Ala348fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251609	19	11221429 - 11221430	19	11110753 - 11110754	251609	245933	rs879254763	NC_000019.10:11110753::A
NM_000527.4(LDLR):c.1034dup (p.Leu346fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251608	19	11221421	19	11110744 - 11110745	251608	245932	rs879254762	NC_000019.10:11110744:A:AA
NM_000527.4(LDLR):c.1031del (p.Phe344fs)	LDLR	F176fs, F303fs, F344fs, F217fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251607	19	11221417	19	11110741	251607	245931	rs879254761	NC_000019.10:11110740:TT:T
NM_000527.5(LDLR):c.1028G>A (p.Gly343Asp)	LDLR	G343D, G175D, G302D, G216D	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251606	19	11221415	19	11110739	251606	245930	rs879254760	NC_000019.10:11110738:G:A
NM_000527.5(LDLR):c.1019_1020delinsTG (p.Cys340Leu)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251599	19	11221406 - 11221407	19	11110730 - 11110731	251599	245924	rs879254758	NC_000019.10:11110729:GC:TG
NM_000527.4(LDLR):c.1017dup (p.Cys340fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251598	19	11221404	19	11110727 - 11110728	251598	245922	rs879254757	NC_000019.10:11110727:G:GG
NM_000527.5(LDLR):c.1014C>A (p.Cys338Ter)	LDLR	C338*, C170*, C211*, C297*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251596	19	11221401	19	11110725	251596	245920	rs879254755	NC_000019.10:11110724:C:A
NM_000527.5(LDLR):c.1013G>A (p.Cys338Tyr)	LDLR	C338Y, C211Y, C297Y, C170Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251595	19	11221400	19	11110724	251595	245919	rs879254754	NC_000019.10:11110723:G:A
NM_000527.5(LDLR):c.1012T>A (p.Cys338Ser)	LDLR	C338S, C170S, C211S, C297S	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251592	19	11221399	19	11110723	251592	245916	rs879254753	NC_000019.10:11110722:T:A
NM_001195798.2(LDLR):c.1008del (p.Gly335_Tyr336insTer)	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251590	19	11221395	19	11110719	251590	245914	rs879254751	NC_000019.10:11110718:C:
NM_000527.5(LDLR):c.1008C>A (p.Tyr336Ter)	LDLR	Y336*, Y168*, Y209*, Y295*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251589	19	11221395	19	11110719	251589	245913	rs767024374	NC_000019.10:11110718:C:A
NM_000527.5(LDLR):c.1007A>G (p.Tyr336Cys)	LDLR	Y336C, Y168C, Y209C, Y295C	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251588	19	11221394	19	11110718	251588	245912	rs879254750	NC_000019.10:11110717:A:G
NM_000527.5(LDLR):c.985T>G (p.Cys329Gly)	LDLR	C329G, C161G, C202G, C288G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251585	19	11221372	19	11110696	251585	245909	rs879254749	NC_000019.10:11110695:T:G
NM_000527.4(LDLR):c.980dup (p.His327fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251584	19	11221367	19	11110690 - 11110691	251584	245908	rs879254748	NC_000019.10:11110690:A:AA
NM_000527.4(LDLR):c.971del (p.Gly324fs)	LDLR	G156fs, G197fs, G324fs, G283fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251579	19	11221357	19	11110681	251579	245903	rs879254745	NC_000019.10:11110680:GG:G
NM_000527.4(LDLR):c.969del (p.Gly324fs)	LDLR	G197fs, G324fs, G156fs, G283fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251578	19	11221356	19	11110680	251578	245902	rs879254744	NC_000019.10:11110679:C:
NM_000527.4(LDLR):c.968del (p.Gly323fs)	LDLR	G155fs, G196fs, G282fs, G323fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251576	19	11221354	19	11110678	251576	245900	rs879254743	NC_000019.10:11110677:GG:G
NM_000527.5(LDLR):c.965A>T (p.Asn322Ile)	LDLR	N322I, N154I, N195I, N281I	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251575	19	11221352	19	11110676	251575	245899	rs879254742	NC_000019.10:11110675:A:T
NM_001195798.2(LDLR):c.961_963AAC[1] (p.Asn322del)	LDLR	N322del	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251574	19	11221346 - 11221348	19	11110670 - 11110672	251574	245898	rs879254741	NC_000019.10:11110669:ACAACAAC:ACAAC
NM_000527.4(LDLR):c.961_962del (p.Asn321fs)	LDLR	N280fs, N153fs, N194fs, N321fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251573	19	11221348 - 11221349	19	11110672 - 11110673	251573	245897	rs879254740	NC_000019.10:11110671:AA:
NM_000527.5(LDLR):c.952T>C (p.Cys318Arg)	LDLR	C318R, C150R, C277R, C191R	not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251570	19	11221339	19	11110663	251570	245894	rs879254738	NC_000019.10:11110662:T:C
NM_000527.4(LDLR):c.951del (p.Glu317fs)	LDLR	E317fs, E149fs, E276fs, E190fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251569	19	11221337	19	11110661	251569	245893	rs879254737	NC_000019.10:11110660:AA:A
NM_000527.5(LDLR):c.949G>T (p.Glu317Ter)	LDLR	E317*, E149*, E190*, E276*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251568	19	11221336	19	11110660	251568	245892	rs746834464	NC_000019.10:11110659:G:T
NM_000527.5(LDLR):c.949G>A (p.Glu317Lys)	LDLR	E317K, E190K, E276K, E149K	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251567	19	11221336	19	11110660	251567	245891	rs746834464	NC_000019.10:11110659:G:A
NM_000527.4(LDLR):c.946_994del (p.Asn316fs)	LDLR	N148fs, N189fs, N316fs, N275fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251565	19	11221333 - 11221381	19	11110653 - 11110701	251565	245889	rs879254736	NC_000019.10:11110652:GACCAACGAATGCTTGGACAACAACGGCGGCTGTTCCCACGTCTGCAATGACC:GACC
NM_000527.5(LDLR):c.941-1G>A	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251564	19	11221327	19	11110651	251564	245888	rs879254735	NC_000019.10:11110650:G:A
c.(940+1_941-1)_(*2514_?)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251563	19	11218191 - 11244506			251563	246700		
c.(940+1_941-1)_(2311+1_2312-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251562	19	11218191 - 11238683			251562	246699		
c.(940+1_941-1)_(2140+1_2141-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251561	19	11218191 - 11233849			251561	246698		
c.(940+1_941-1)_(1845+1_1846-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251560	19	11218191 - 11230767			251560	246697		
c.(940+1_941-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251559	19	11218191 - 11230767			251559	246696		
c.(940+1_941-1)_(1586+1_1587-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251558	19	11218191 - 11226769			251558	246695		
c.(940+1_941-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251557	19	11218191 - 11226769			251557	246694		
NM_000527.5(LDLR):c.941-2A>G	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251554	19	11221326	19	11110650	251554	245887	rs112366278	NC_000019.10:11110649:A:G
NM_000527.5(LDLR):c.940+2T>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251543	19	11218192	19	11107516	251543	245876	rs875989912	NC_000019.10:11107515:T:A
NM_000527.5(LDLR):c.940+1G>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251542	19	11218191	19	11107515	251542	245875	rs879254729	NC_000019.10:11107514:G:C
NM_000527.5(LDLR):c.939C>A (p.Cys313Ter)	LDLR	C313*, C272*, C186*, C145*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251539	19	11218189	19	11107513	251539	245872	rs13306512	NC_000019.10:11107512:C:A
NM_000527.4(LDLR):c.939_940+3del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251536	19	11218186 - 11218190	19	11107510 - 11107514	251536	245869	rs879254727	NC_000019.10:11107509:GTGCGGTG:GTG
NM_001195798.2(LDLR):c.933_934AG[1] (p.Glu312fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251535	19	11218183 - 11218184	19	11107507 - 11107508	251535	245868	rs879254726	NC_000019.10:11107506:AGAG:AG
NM_000527.5(LDLR):c.934G>T (p.Glu312Ter)	LDLR	E312*, E144*, E271*, E185*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251534	19	11218184	19	11107508	251534	245867	rs879254725	NC_000019.10:11107507:G:T
NM_000527.4(LDLR):c.933del (p.Glu312fs)	LDLR	E144fs, E185fs, E312fs, E271fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251533	19	11218181	19	11107505	251533	245866	rs879254723	NC_000019.10:11107504:AAA:AA
NM_001195798.2(LDLR):c.932_933del (p.Lys311fs)	LDLR	K143fs, K311fs, K184fs, K270fs	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251530	19	11218182 - 11218183	19	11107505 - 11107506	251530	245865	rs879254723	NC_000019.10:11107504:AAA:A
NM_000527.5(LDLR):c.921T>G (p.Asp307Glu)	LDLR	D307E, D180E, D139E, D266E	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251527	19	11218171	19	11107495	251527	245860	rs879254720	NC_000019.10:11107494:T:G
NM_000527.5(LDLR):c.917C>G (p.Ser306Ter)	LDLR	S306*, S179*, S138*, S265*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251524	19	11218167	19	11107491	251524	245857	rs11547917	NC_000019.10:11107490:C:G
NM_000527.5(LDLR):c.917C>A (p.Ser306Ter)	LDLR	S306*, S179*, S138*, S265*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251523	19	11218167	19	11107491	251523	245856	rs11547917	NC_000019.10:11107490:C:A
NM_000527.4(LDLR):c.916_919dup (p.Asp307fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251522	19	11218166 - 11218169	19	11107488 - 11107489	251522	245855	rs879254718	NC_000019.10:11107488:GTCAG:GTCAGTCAG
NM_000527.5(LDLR):c.915G>A (p.Trp305Ter)	LDLR	W305*, W178*, W264*, W137*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251520	19	11218165	19	11107489	251520	245853	rs757252110	NC_000019.10:11107488:G:A
NM_000527.5(LDLR):c.914G>A (p.Trp305Ter)	LDLR	W305*, W264*, W137*, W178*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251518	19	11218164	19	11107488	251518	245851	rs879254717	NC_000019.10:11107487:G:A
NM_000527.5(LDLR):c.910G>T (p.Asp304Tyr)	LDLR	D304Y, D177Y, D263Y, D136Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251517	19	11218160	19	11107484	251517	245850	rs121908030	NC_000019.10:11107483:G:T
NM_000527.5(LDLR):c.902A>G (p.Asp301Gly)	LDLR	D301G, D260G, D133G, D174G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251514	19	11218152	19	11107476	251514	245847	rs879254714	NC_000019.10:11107475:A:G
NM_000527.5(LDLR):c.898A>T (p.Arg300Ter)	LDLR	R300*, R132*, R259*, R173*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251511	19	11218148	19	11107472	251511	245844	rs767618089	NC_000019.10:11107471:A:T
NM_000527.4(LDLR):c.896del (p.Ala299fs)	LDLR	A131fs, A258fs, A299fs, A172fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251509	19	11218146	19	11107470	251509	245842	rs879254712	NC_000019.10:11107469:C:
NM_000527.4(LDLR):c.890del (p.Asn297fs)	LDLR	N297fs, N129fs, N256fs, N170fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251506	19	11218139	19	11107463	251506	245839	rs879254710	NC_000019.10:11107462:AA:A
NM_000527.5(LDLR):c.888C>A (p.Cys296Ter)	LDLR	C296*, C128*, C255*, C169*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251504	19	11218138	19	11107462	251504	245837	rs879254708	NC_000019.10:11107461:C:A
NM_000527.5(LDLR):c.887_889delinsAGC (p.Cys296_Asn297delinsTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251501	19	11218137 - 11218139	19	11107461 - 11107463	251501	245836	rs879254706	NC_000019.10:11107460:GCA:AGC
NM_000527.4(LDLR):c.884del (p.Val295fs)	LDLR	V127fs, V254fs, V295fs, V168fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251500	19	11218134	19	11107458	251500	245833	rs879254705	NC_000019.10:11107457:T:
NM_000527.5(LDLR):c.881_882del (p.Lys294fs)	LDLR	K253fs, K294fs, K126fs, K167fs	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251499	19	11218131 - 11218132	19	11107454 - 11107455	251499	245832	rs879254704	NC_000019.10:11107453:AAA:A
NM_000527.4(LDLR):c.877del (p.Asp293fs)	LDLR	D125fs, D166fs, D252fs, D293fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251497	19	11218126	19	11107450	251497	245830	rs879254702	NC_000019.10:11107449:GG:G
NM_000527.4(LDLR):c.875dup (p.Asp293fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251496	19	11218125	19	11107448 - 11107449	251496	245829	rs879254701	NC_000019.10:11107448:T:TT
NM_000527.4(LDLR):c.874del (p.Leu292fs)	LDLR	L124fs, L165fs, L251fs, L292fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251495	19	11218122	19	11107446	251495	245828	rs879254700	NC_000019.10:11107445:CCC:CC
NM_000527.4(LDLR):c.865del (p.Cys289fs)	LDLR	C121fs, C248fs, C289fs, C162fs	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251491	19	11218115	19	11107439	251491	245825	rs879254696	NC_000019.10:11107438:T:
NM_000527.5(LDLR):c.862G>T (p.Glu288Ter)	LDLR	E288*, E120*, E161*, E247*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251490	19	11218112	19	11107436	251490	245823	rs368657165	NC_000019.10:11107435:G:T
NM_000527.5(LDLR):c.859G>T (p.Gly287Cys)	LDLR	G287C, G119C, G160C, G246C	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251489	19	11218109	19	11107433	251489	245822	rs375495026	NC_000019.10:11107432:G:T
NM_000527.5(LDLR):c.858C>A (p.Ser286Arg)	LDLR	S286R, S159R, S245R, S118R	Familial hypercholesterolemia 1|not provided|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251488	19	11218108	19	11107432	251488	245821	rs140241383	NC_000019.10:11107431:C:A
NM_000527.5(LDLR):c.828C>G (p.Cys276Trp)	LDLR	C276W, C108W, C149W, C235W	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251482	19	11218078	19	11107402	251482	245815	rs146651743	NC_000019.10:11107401:C:G
NM_000527.4(LDLR):c.823_824CT[1] (p.Cys276fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251478	19	11218073 - 11218074	19	11107397 - 11107398	251478	245811	rs879254691	NC_000019.10:11107396:CTCT:CT
NM_000527.4(LDLR):c.820_827del (p.Thr274fs)	LDLR	T147fs, T106fs, T233fs, T274fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251476	19	11218070 - 11218077	19	11107392 - 11107399	251476	245810	rs879254689	NC_000019.10:11107391:TGACACTCTG:TG
NM_000527.5(LDLR):c.818-1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251475	19	11218067	19	11107391	251475	245808	rs879254688	NC_000019.10:11107390:G:A
c.(817+1_818-1)_(*2514_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251474	19	11217364 - 11244506			251474	246691		
c.(817+1_818-1)_(1186+1_1187-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251473	19	11217364 - 11223953			251473	246690		
c.(817+1_818-1)_(940+1_941-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251472	19	11217364 - 11221327			251472	246689		
NM_000527.5(LDLR):c.818-2A>G	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251471	19	11218066	19	11107390	251471	245807	rs879254687	NC_000019.10:11107389:A:G
NM_000527.5(LDLR):c.817+1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251469	19	11217364	19	11106688	251469	245805	rs879254685	NC_000019.10:11106687:G:A
NM_001195800.2(LDLR):c.314-708_314-705del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251467	19	11217360 - 11217363	19	11106684 - 11106687	251467	245803	rs879254684	NC_000019.10:11106683:AATG:
NM_000527.5(LDLR):c.810C>A (p.Cys270Ter)	LDLR	C270*, C229*, C143*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251465	19	11217356	19	11106680	251465	245801	rs773328511	NC_000019.10:11106679:C:A
NM_001195800.2(LDLR):c.314-726_314-723del	LDLR	D139fs, D225fs, D266fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251455	19	11217342 - 11217345	19	11106666 - 11106669	251455	245792	rs879254677	NC_000019.10:11106665:GATG:
NM_001195800.2(LDLR):c.314-732_314-729del	LDLR	M137fs, M223fs, M264fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251452	19	11217336 - 11217339	19	11106660 - 11106663	251452	245789	rs879254675	NC_000019.10:11106659:ATGA:
NM_000527.4(LDLR):c.781del (p.Cys261fs)	LDLR	C134fs, C220fs, C261fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251451	19	11217327	19	11106651	251451	245787	rs879254674	NC_000019.10:11106650:T:
NM_001195800.2(LDLR):c.314-746_314-745del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251450	19	11217320 - 11217321	19	11106644 - 11106645	251450	245786	rs879254673	NC_000019.10:11106643:ATAT:AT
NM_000527.5(LDLR):c.772G>T (p.Glu258Ter)	LDLR	E258*, E131*, E217*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251449	19	11217318	19	11106642	251449	245785	rs879254672	NC_000019.10:11106641:G:T
NM_000527.5(LDLR):c.767A>G (p.Asp256Gly)	LDLR	D256G, D129G, D215G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251444	19	11217313	19	11106637	251444	245780	rs879254670	NC_000019.10:11106636:A:G
NM_000527.5(LDLR):c.761A>C (p.Gln254Pro)	LDLR	Q254P, Q213P, Q127P	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251437	19	11217307	19	11106631	251437	245773	rs879254667	NC_000019.10:11106630:A:C
NM_000527.5(LDLR):c.760C>T (p.Gln254Ter)	LDLR	Q254*, Q213*, Q127*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251436	19	11217306	19	11106630	251436	245772	rs759109699	NC_000019.10:11106629:C:T
NM_000527.4(LDLR):c.752dup (p.Ser252fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251434	19	11217298	19	11106620 - 11106621	251434	245770	rs879254666	NC_000019.10:11106620:GG:GGG
NM_000527.5(LDLR):c.744C>A (p.Cys248Ter)	LDLR	C248*, C121*, C207*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251431	19	11217290	19	11106614	251431	245767	rs879254664	NC_000019.10:11106613:C:A
NM_000527.5(LDLR):c.743G>T (p.Cys248Phe)	LDLR	C248F, C207F, C121F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251430	19	11217289	19	11106613	251430	245766	rs879254663	NC_000019.10:11106612:G:T
NM_001195800.2(LDLR):c.314-785del	LDLR	G205fs, G119fs, G246fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251426	19	11217282	19	11106606	251426	245763	rs879254660	NC_000019.10:11106605:GG:G
NM_000527.5(LDLR):c.724C>T (p.Gln242Ter)	LDLR	Q242*, Q201*, Q115*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251424	19	11217270	19	11106594	251424	245760	rs879254658	NC_000019.10:11106593:C:T
NM_000527.5(LDLR):c.718G>T (p.Glu240Ter)	LDLR	E240*, E113*, E199*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251422	19	11217264	19	11106588	251422	245758	rs768563000	NC_000019.10:11106587:G:T
NM_001195800.2(LDLR):c.314-814dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251420	19	11217254	19	11106577 - 11106578	251420	245756	rs879254656	NC_000019.10:11106577:T:TT
NM_001195800.2(LDLR):c.314-817dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251418	19	11217251	19	11106573 - 11106574	251418	245754	rs879254653	NC_000019.10:11106573:CC:CCC
NM_001195800.2(LDLR):c.314-819dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251416	19	11217249	19	11106572 - 11106573	251416	245752	rs1555803643	NC_000019.10:11106572:A:AA
NM_000527.5(LDLR):c.695-1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251415	19	11217240	19	11106564	251415	245751	rs879254652	NC_000019.10:11106563:G:T
c.(694+1_695-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251414	19	11216277 - 11226769			251414	246688		
c.(694+1_695-1)_(940+1_941-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251413	19	11216277 - 11221327			251413	246687		
c.(694+1_695-1)_(817+1_818-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251412	19	11216277 - 11218067			251412	246686		
NM_000527.4(LDLR):c.695-6_698del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251411	19	11217235 - 11217244	19	11106558 - 11106567	251411	245750	rs879254651	NC_000019.10:11106557:TTTCCAGCTGT:T
NM_000527.4(LDLR):c.695-356_940+1059del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251407	19	11216885 - 11219249	19	11106187 - 11108551	251407	245746		
NM_000527.5(LDLR):c.694+1G>A	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251402	19	11216277	19	11105601	251402	245741	rs879254646	NC_000019.10:11105600:G:A
NM_001195800.2(LDLR):c.314-1792_314-827del	LDLR	A232fs, A191fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251401	19	11216276 - 11217241	19	11105598 - 11106563	251401	245740	rs1555803491	
NM_000527.4(LDLR):c.693_694+20del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251399	19	11216275 - 11216296	19	11105597 - 11105618	251399	245739	rs879254645	NC_000019.10:11105596:TGCGGTATGGGCGGGGCCAGGGTG:TG
NM_000527.5(LDLR):c.691T>C (p.Cys231Arg)	LDLR	C231R, C190R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251396	19	11216273	19	11105597	251396	245735	rs746091400	NC_000019.10:11105596:T:C
NM_000527.5(LDLR):c.683A>C (p.Glu228Ala)	LDLR	E228A, E187A	Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251394	19	11216265	19	11105589	251394	245733	rs879254642	NC_000019.10:11105588:A:C
NM_000527.5(LDLR):c.682G>C (p.Glu228Gln)	LDLR	E228Q, E187Q	Familial hypercholesterolemia 1|not provided|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251393	19	11216264	19	11105588	251393	245730	rs121908029	NC_000019.10:11105587:G:C
NM_000527.4(LDLR):c.682del (p.Glu228fs)	LDLR	E228fs, E187fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251391	19	11216264	19	11105588	251391	245731	rs879254640	NC_000019.10:11105587:G:
NM_000527.5(LDLR):c.681_682insTGAG (p.Glu228Ter)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251389	19	11216263 - 11216264	19	11105587 - 11105588	251389	245728	rs1555803427	NC_000019.10:11105587::TGAG
NM_000527.5(LDLR):c.680A>T (p.Asp227Val)	LDLR	D227V, D186V	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251388	19	11216262	19	11105586	251388	245725	rs879254638	NC_000019.10:11105585:A:T
NM_000527.4(LDLR):c.680_682delACGins14 (p.?)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251387	19	11216262 - 11216264	19	11105586 - 11105588	251387	245727		
NM_000527.5(LDLR):c.676T>C (p.Ser226Pro)	LDLR	S226P, S185P	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251384	19	11216258	19	11105582	251384	245722	rs879254635	NC_000019.10:11105581:T:C
NM_001195800.2(LDLR):c.314-1811del	LDLR	K184fs, K225fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251382	19	11216255	19	11105579	251382	245721	rs879254633	NC_000019.10:11105578:AAA:AA
NM_000527.4(LDLR):c.675_681dup (p.Glu228delinsIleTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251380	19	11216257 - 11216263	19	11105580 - 11105581	251380	245719	rs1555803426|rs387906306	NC_000019.10:11105580:ATCTGAC:ATCTGACATCTGAC
NM_001195800.2(LDLR):c.314-1812_314-1805dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251379	19	11216256 - 11216263	19	11105579 - 11105580	251379	245718	rs1555803423	NC_000019.10:11105579:AATCTGAC:AATCTGACAATCTGAC
NM_000527.5(LDLR):c.673_682delinsTGCAA (p.Lys225fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251378	19	11216255 - 11216264	19	11105579 - 11105588	251378	245717	rs879254631	NC_000019.10:11105578:AAATCTGACG:TGCAA
NM_001195800.2(LDLR):c.314-1816dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251372	19	11216252	19	11105574 - 11105575	251372	245711	rs879254629	NC_000019.10:11105574:GG:GGG
NM_001195800.2(LDLR):c.314-1817_314-1807dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251368	19	11216251 - 11216261	19	11105574 - 11105575	251368	245708	rs879254625	NC_000019.10:11105574:GGACAAATCTG:GGACAAATCTGGGACAAATCTG
NM_001195800.2(LDLR):c.314-1818_314-1805dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251367	19	11216250 - 11216263	19	11105573 - 11105574	251367	245706	rs1555803424	NC_000019.10:11105573:AGGACAAATCTGAC:AGGACAAATCTGACAGGACAAATCTGAC
NM_000527.5(LDLR):c.666C>A (p.Cys222Ter)	LDLR	C222*, C181*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251364	19	11216248	19	11105572	251364	245702	rs756613387	NC_000019.10:11105571:C:A
NM_000527.4(LDLR):c.666_687del (p.Asp221_Cys222insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251363	19	11216248 - 11216269	19	11105572 - 11105593	251363	245704	rs879254623	NC_000019.10:11105571:CAAGGACAAATCTGACGAGGAA:
NM_000527.5(LDLR):c.665G>T (p.Cys222Phe)	LDLR	C222F, C181F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251362	19	11216247	19	11105571	251362	245701	rs730882086	NC_000019.10:11105570:G:T
NM_000527.5(LDLR):c.664_681delinsCCGACTG (p.Cys222fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251360	19	11216246 - 11216263	19	11105570 - 11105587	251360	245700	rs879254622	NC_000019.10:11105569:TGCAAGGACAAATCTGAC:CCGACTG
NM_001195800.2(LDLR):c.314-1829_314-1825dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251359	19	11216239 - 11216243	19	11105561 - 11105562	251359	245693	rs879254358	NC_000019.10:11105561:GCCCCG:GCCCCGCCCCG
NM_001195800.2(LDLR):c.314-1823_314-1803dup	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251358	19	11216245 - 11216265	19	11105565 - 11105566	251358	245698	rs879254620	NC_000019.10:11105565:CGACTGCAAGGACAAATCTGACGA:CGACTGCAAGGACAAATCTGACGACTGCAAGGACAAATCTGACGA
NM_000527.5(LDLR):c.661G>T (p.Asp221Tyr)	LDLR	D221Y, D180Y	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251356	19	11216243	19	11105567	251356	245694	rs875989906	NC_000019.10:11105566:G:T
NM_001195800.2(LDLR):c.314-1825_314-1809del	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251355	19	11216243 - 11216259	19	11105566 - 11105582	251355	245696	rs879254619	NC_000019.10:11105565:CGACTGCAAGGACAAATC:C
NM_001195800.2(LDLR):c.314-1825_314-1813dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251354	19	11216243 - 11216255	19	11105566 - 11105567	251354	245695	rs1555803428	NC_000019.10:11105566:GACTGCAAGGACA:GACTGCAAGGACAGACTGCAAGGACA
NM_001195800.2(LDLR):c.314-1835_314-1799del	LDLR	D176fs, D217fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251351	19	11216233 - 11216269	19	11105556 - 11105592	251351	245689	rs879254615	NC_000019.10:11105555:ATGGTGGCCCCGACTGCAAGGACAAATCTGACGAGGAA:A
NM_000527.5(LDLR):c.649_650insT (p.Asp217fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251350	19	11216231 - 11216232	19	11105555 - 11105556	251350	245687	rs879254614	NC_000019.10:11105555::T
NM_001195800.2(LDLR):c.314-1838_314-1837del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251348	19	11216228 - 11216229	19	11105552 - 11105553	251348	245685	rs879254612	NC_000019.10:11105551:TGTG:TG
NM_000527.4(LDLR):c.646del (p.Cys216fs)	LDLR	C216fs, C175fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251344	19	11216228	19	11105552	251344	245682	rs879254609	NC_000019.10:11105551:T:
NM_000527.4(LDLR):c.645_646del (p.Arg215_Cys216insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251343	19	11216227 - 11216228	19	11105551 - 11105552	251343	245680	rs879254608	NC_000019.10:11105550:CT:
NM_000527.5(LDLR):c.642G>A (p.Trp214Ter)	LDLR	W214*, W173*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251340	19	11216224	19	11105548	251340	245677	rs879254606	NC_000019.10:11105547:G:A
NM_000527.5(LDLR):c.626G>A (p.Cys209Tyr)	LDLR	C209Y, C168Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251332	19	11216208	19	11105532	251332	245669	rs879254600	NC_000019.10:11105531:G:A
NM_001195800.2(LDLR):c.314-1861_314-1860dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251331	19	11216207 - 11216208	19	11105529 - 11105530	251331	245668	rs879254599	NC_000019.10:11105529:GTG:GTGTG
NM_001195800.2(LDLR):c.314-1863_314-1842del	LDLR	E167fs, E208fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251330	19	11216205 - 11216226	19	11105524 - 11105545	251330	245667	rs879254598	NC_000019.10:11105523:TGGCGAGTGCATCCACTCCAGCTGGCG:TGGCG
NM_000527.5(LDLR):c.622G>T (p.Glu208Ter)	LDLR	E208*, E167*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251329	19	11216204	19	11105528	251329	245666	rs879254597	NC_000019.10:11105527:G:T
NM_000527.5(LDLR):c.622G>A (p.Glu208Lys)	LDLR	E208K, E167K	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251328	19	11216204	19	11105528	251328	245665	rs879254597	NC_000019.10:11105527:G:A
NM_000527.4(LDLR):c.617del (p.Ser206fs)	LDLR	S165fs, S206fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251324	19	11216199	19	11105523	251324	245661	rs879254594	NC_000019.10:11105522:G:
NM_000527.4(LDLR):c.616dup (p.Ser206fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251323	19	11216198	19	11105520 - 11105521	251323	245660	rs879254593	NC_000019.10:11105520:AA:AAA
NM_000527.4(LDLR):c.609del (p.Cys204fs)	LDLR	C204fs, C163fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251319	19	11216191	19	11105515	251319	245656	rs879254591	NC_000019.10:11105514:C:
NM_001195800.2(LDLR):c.314-1886del	LDLR	F200fs, F159fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251316	19	11216182	19	11105506	251316	245653	rs879254588	NC_000019.10:11105505:C:
NM_000527.5(LDLR):c.593C>A (p.Ser198Ter)	LDLR	S198*, S157*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251312	19	11216175	19	11105499	251312	245649	rs748672083	NC_000019.10:11105498:C:A
NM_000527.5(LDLR):c.591C>A (p.Cys197Ter)	LDLR	C197*, C156*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251310	19	11216173	19	11105497	251310	245647	rs879254584	NC_000019.10:11105496:C:A
NM_000527.5(LDLR):c.590G>T (p.Cys197Phe)	LDLR	C197F, C156F	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251309	19	11216172	19	11105496	251309	245646	rs376459828	NC_000019.10:11105495:G:T
NM_000527.5(LDLR):c.589T>G (p.Cys197Gly)	LDLR	C197G, C156G	Homozygous familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251308	19	11216171	19	11105495	251308	245645	rs730882085	NC_000019.10:11105494:T:G
NM_001195800.2(LDLR):c.314-1903_314-1897del	LDLR	S154fs, S195fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251306	19	11216165 - 11216171	19	11105488 - 11105494	251306	245643	rs879254582	NC_000019.10:11105487:TAGCCCCT:T
NM_000527.5(LDLR):c.581_582insA (p.Ser194fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251305	19	11216163 - 11216164	19	11105487 - 11105488	251305	245642	rs879254581	NC_000019.10:11105487::A
NM_001195800.2(LDLR):c.314-1908del	LDLR	D152fs, D193fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251304	19	11216160	19	11105484	251304	245641	rs879254580	NC_000019.10:11105483:A:
NM_001195800.2(LDLR):c.314-1908_314-1902del	LDLR	D152fs, D193fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251303	19	11216160 - 11216166	19	11105483 - 11105489	251303	245640	rs879254579	NC_000019.10:11105482:GACAGTAG:G
NM_000527.5(LDLR):c.571C>T (p.Gln191Ter)	LDLR	Q191*, Q150*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251302	19	11216153	19	11105477	251302	245639	rs879254578	NC_000019.10:11105476:C:T
NM_001195800.2(LDLR):c.314-1918_314-1896del	LDLR	F149fs, F190fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251301	19	11216150 - 11216172	19	11105472 - 11105494	251301	245638	rs879254577	NC_000019.10:11105471:TGTTCCAAGGGGACAGTAGCCCCTG:TG
NM_000527.5(LDLR):c.564C>A (p.Tyr188Ter)	LDLR	Y188*, Y147*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251299	19	11216146	19	11105470	251299	245636	rs121908034	NC_000019.10:11105469:C:A
NM_001195800.2(LDLR):c.314-1924del	LDLR	Y147fs, Y188fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251298	19	11216142	19	11105466	251298	245635	rs879254575	NC_000019.10:11105465:TTT:TT
NM_001195800.2(LDLR):c.314-1925_314-1924del	LDLR	Y188fs, Y147fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251297	19	11216143 - 11216144	19	11105466 - 11105467	251297	245634	rs879254575	NC_000019.10:11105465:TTT:T
NM_000527.5(LDLR):c.558_559insG (p.Leu187fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251296	19	11216140 - 11216141	19	11105464 - 11105465	251296	245633	rs879254574	NC_000019.10:11105464::G
NM_001195800.2(LDLR):c.314-1929del	LDLR	G186fs, G145fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251295	19	11216136	19	11105460	251295	245632	rs879254573	NC_000019.10:11105459:GGGG:GGG
NM_000527.5(LDLR):c.544C>T (p.Gln182Ter)	LDLR	Q182*, Q141*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251292	19	11216126	19	11105450	251292	245629	rs879254570	NC_000019.10:11105449:C:T
NM_000527.5(LDLR):c.539G>A (p.Trp180Ter)	LDLR	W180*, W139*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251291	19	11216121	19	11105445	251291	245628	rs879254569	NC_000019.10:11105444:G:A
NM_000527.5(LDLR):c.535G>T (p.Glu179Ter)	LDLR	E179*, E138*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251289	19	11216117	19	11105441	251289	245626	rs879254567	NC_000019.10:11105440:G:T
NM_000527.5(LDLR):c.534T>G (p.Asp178Glu)	LDLR	D178E, D137E	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251287	19	11216116	19	11105440	251287	245624	rs879254566	NC_000019.10:11105439:T:G
NM_000527.5(LDLR):c.533A>G (p.Asp178Gly)	LDLR	D178G, D137G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251286	19	11216115	19	11105439	251286	245623	rs875989902	NC_000019.10:11105438:A:G
NM_000527.5(LDLR):c.532G>C (p.Asp178His)	LDLR	D178H, D137H	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251284	19	11216114	19	11105438	251284	245620	rs879254565	NC_000019.10:11105437:G:C
NM_000527.5(LDLR):c.532_533insT (p.Asp178fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251282	19	11216114 - 11216115	19	11105438 - 11105439	251282	245622	rs879254564	NC_000019.10:11105438::T
NM_001195800.2(LDLR):c.314-1960_314-1953dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251280	19	11216108 - 11216115	19	11105431 - 11105432	251280	245617	rs879254562	NC_000019.10:11105431:GGCTCGGA:GGCTCGGAGGCTCGGA
NM_000527.5(LDLR):c.519C>G (p.Cys173Trp)	LDLR	C173W, C132W	Familial hypercholesterolemia 1|Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251277	19	11216101	19	11105425	251277	245614	rs769318035	NC_000019.10:11105424:C:G
NM_000527.5(LDLR):c.519C>A (p.Cys173Ter)	LDLR	C173*, C132*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251276	19	11216101	19	11105425	251276	245613	rs769318035	NC_000019.10:11105424:C:A
NM_000527.4(LDLR):c.518del (p.Cys173fs)	LDLR	C132fs, C173fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251274	19	11216100	19	11105424	251274	245612	rs879254559	NC_000019.10:11105423:G:
NM_000527.5(LDLR):c.517T>C (p.Cys173Arg)	LDLR	C173R, C132R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251272	19	11216099	19	11105423	251272	245609	rs879254558	NC_000019.10:11105422:T:C
NM_000527.5(LDLR):c.514G>T (p.Asp172Tyr)	LDLR	D172Y, D131Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251268	19	11216096	19	11105420	251268	245605	rs879254554	NC_000019.10:11105419:G:T
NM_000527.5(LDLR):c.514G>A (p.Asp172Asn)	LDLR	D172N, D131N	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251266	19	11216096	19	11105420	251266	245603	rs879254554	NC_000019.10:11105419:G:A
NM_001195800.2(LDLR):c.314-1973dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251265	19	11216095	19	11105415 - 11105416	251265	245602	rs879254552	NC_000019.10:11105415:CCCC:CCCCC
NM_001195800.2(LDLR):c.314-1973del	LDLR	D131fs, D172fs	Familial hypercholesterolemia|Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251264	19	11216092	19	11105416	251264	245601	rs879254552	NC_000019.10:11105415:CCCC:CCC
NM_000527.5(LDLR):c.508_509insC (p.Asp170fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251263	19	11216090 - 11216091	19	11105414 - 11105415	251263	245600	rs879254551	NC_000019.10:11105414::C
NM_000527.5(LDLR):c.502G>C (p.Asp168His)	LDLR	D168H, D127H	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251258	19	11216084	19	11105408	251258	245595	rs200727689	NC_000019.10:11105407:G:C
NM_000527.5(LDLR):c.501C>G (p.Cys167Trp)	LDLR	C167W, C126W	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251257	19	11216083	19	11105407	251257	245594	rs752596535	NC_000019.10:11105406:C:G
NM_000527.5(LDLR):c.495G>A (p.Trp165Ter)	LDLR	W165*, W124*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251254	19	11216077	19	11105401	251254	245591	rs879254546	NC_000019.10:11105400:G:A
NM_000527.4(LDLR):c.482_488del (p.Ile161fs)	LDLR	I120fs, I161fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251250	19	11216064 - 11216070	19	11105386 - 11105392	251250	245587	rs879254542	NC_000019.10:11105385:CATCCCCCA:CA
NM_000527.5(LDLR):c.478T>C (p.Cys160Arg)	LDLR	C160R, C119R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251247	19	11216060	19	11105384	251247	245584	rs879254540	NC_000019.10:11105383:T:C
NM_001195800.2(LDLR):c.314-2014del	LDLR	S158fs, S117fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251244	19	11216054	19	11105378	251244	245581	rs879254538	NC_000019.10:11105377:T:
NM_001195800.2(LDLR):c.314-2020_314-2002dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251243	19	11216048 - 11216066	19	11105370 - 11105371	251243	245580	rs879254537	NC_000019.10:11105370:CAACAGCTCCACCTGCATCC:CAACAGCTCCACCTGCATCCAACAGCTCCACCTGCATCC
NM_000527.5(LDLR):c.465C>A (p.Cys155Ter)	LDLR	C155*, C114*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251242	19	11216047	19	11105371	251242	245579	rs766094434	NC_000019.10:11105370:C:A
NM_000527.5(LDLR):c.464G>A (p.Cys155Tyr)	LDLR	C155Y, C114Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251240	19	11216046	19	11105370	251240	245577	rs879254536	NC_000019.10:11105369:G:A
NM_000527.5(LDLR):c.463T>G (p.Cys155Gly)	LDLR	C155G, C114G	Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251239	19	11216045	19	11105369	251239	245576	rs879254535	NC_000019.10:11105368:T:G
NM_000527.5(LDLR):c.460C>T (p.Gln154Ter)	LDLR	Q154*, Q113*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251237	19	11216042	19	11105366	251237	245574	rs879254534	NC_000019.10:11105365:C:T
NM_000527.4(LDLR):c.450dup (p.Ala151fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251231	19	11216032	19	11105353 - 11105354	251231	245568	rs879254530	NC_000019.10:11105353:CCC:CCCC
NM_000527.5(LDLR):c.443G>C (p.Cys148Ser)	LDLR	C148S, C107S	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251227	19	11216025	19	11105349	251227	245564	rs879254526	NC_000019.10:11105348:G:C
NM_000527.5(LDLR):c.443G>A (p.Cys148Tyr)	LDLR	C148Y, C107Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251225	19	11216025	19	11105349	251225	245563	rs879254526	NC_000019.10:11105348:G:A
NM_000527.5(LDLR):c.442T>C (p.Cys148Arg)	LDLR	C148R, C107R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251224	19	11216024	19	11105348	251224	245562	rs879254525	NC_000019.10:11105347:T:C
NM_001195800.2(LDLR):c.314-2055_314-2052dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251221	19	11216013 - 11216016	19	11105336 - 11105337	251221	245559	rs879254523	NC_000019.10:11105336:CGGT:CGGTCGGT
NM_000527.5(LDLR):c.428G>A (p.Cys143Tyr)	LDLR	C143Y, C102Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251220	19	11216010	19	11105334	251220	245558	rs879254522	NC_000019.10:11105333:G:A
NM_000527.5(LDLR):c.427T>C (p.Cys143Arg)	LDLR	C143R, C102R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251219	19	11216009	19	11105333	251219	245557	rs875989901	NC_000019.10:11105332:T:C
NM_001195800.2(LDLR):c.314-2062_314-2056del	LDLR	S101fs, S142fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251218	19	11216006 - 11216012	19	11105327 - 11105333	251218	245556	rs879254521	NC_000019.10:11105326:GCCTCCTGCC:GCC
NM_000527.5(LDLR):c.420G>C (p.Glu140Asp)	LDLR	E140D, E99D	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251216	19	11216002	19	11105326	251216	245554	rs879254520	NC_000019.10:11105325:G:C
NM_000527.5(LDLR):c.418G>T (p.Glu140Ter)	LDLR	E140*, E99*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251214	19	11216000	19	11105324	251214	245552	rs748944640	NC_000019.10:11105323:G:T
NM_000527.5(LDLR):c.418G>A (p.Glu140Lys)	LDLR	E140K, E99K	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251213	19	11216000	19	11105324	251213	245551	rs748944640	NC_000019.10:11105323:G:A
NM_000527.5(LDLR):c.416A>T (p.Asp139Val)	LDLR	D139V, D98V	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251212	19	11215998	19	11105322	251212	245550	rs879254518	NC_000019.10:11105321:A:T
NM_000527.5(LDLR):c.416A>G (p.Asp139Gly)	LDLR	D139G, D98G	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251211	19	11215998	19	11105322	251211	245549	rs879254518	NC_000019.10:11105321:A:G
NM_000527.5(LDLR):c.413C>G (p.Ser138Ter)	LDLR	S138*, S97*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251208	19	11215995	19	11105319	251208	245546	rs755799528	NC_000019.10:11105318:C:G
NM_000527.5(LDLR):c.401G>T (p.Cys134Phe)	LDLR	C134F, C93F	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251204	19	11215983	19	11105307	251204	245542	rs879254514	NC_000019.10:11105306:G:T
NM_001195800.2(LDLR):c.314-2089dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251201	19	11215979	19	11105300 - 11105301	251201	245540	rs879254512	NC_000019.10:11105300:GGG:GGGG
NM_001195800.2(LDLR):c.314-2097dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251199	19	11215971	19	11105294 - 11105295	251199	245537	rs879254510	NC_000019.10:11105294:C:CC
NM_000527.5(LDLR):c.389C>G (p.Ser130Ter)	LDLR	S130*, S89*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251198	19	11215971	19	11105295	251198	245536	rs879254509	NC_000019.10:11105294:C:G
NM_000527.5(LDLR):c.382T>C (p.Cys128Arg)	LDLR	C128R, C87R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251193	19	11215964	19	11105288	251193	245530	rs879254505	NC_000019.10:11105287:T:C
NM_001195800.2(LDLR):c.314-2104_314-2101del	LDLR	C128fs, C87fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251192	19	11215964 - 11215967	19	11105288 - 11105291	251192	245531	rs879254504	NC_000019.10:11105287:TGTG:
NM_000527.5(LDLR):c.374_375insCTGA (p.Gln125delinsHisTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251188	19	11215956 - 11215957	19	11105279 - 11105280	251188	245526	rs879254500	NC_000019.10:11105279:A:ACTGA
NM_000527.5(LDLR):c.373C>T (p.Gln125Ter)	LDLR	Q125*, Q84*	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251187	19	11215955	19	11105279	251187	245525	rs875989899	NC_000019.10:11105278:C:T
NM_000527.5(LDLR):c.371_372insC (p.Gln125fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251186	19	11215953 - 11215954	19	11105277 - 11105278	251186	245524	rs879254499	NC_000019.10:11105277::C
NM_001195800.2(LDLR):c.314-2117_314-2093del	LDLR	R124fs, R83fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251183	19	11215951 - 11215975	19	11105274 - 11105298	251183	245521	rs879254497	NC_000019.10:11105273:CTCGGCAGTTCGTCTGTGACTCAGAC:C
NM_001195800.2(LDLR):c.314-2121TC[2]	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251182	19	11215947 - 11215948	19	11105271 - 11105272	251182	245520	rs879254496	NC_000019.10:11105270:TCTCTC:TCTC
NM_001195800.2(LDLR):c.314-2120dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251179	19	11215948	19	11105271 - 11105272	251179	245517	rs879254494	NC_000019.10:11105271:C:CC
NM_000527.5(LDLR):c.361T>C (p.Cys121Arg)	LDLR	C121R, C80R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251174	19	11215943	19	11105267	251174	245512	rs879254492	NC_000019.10:11105266:T:C
NM_001195800.2(LDLR):c.314-2129del	LDLR	K79fs, K120fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251172	19	11215937	19	11105261	251172	245510	rs879254491	NC_000019.10:11105260:GGG:GG
NM_001195800.2(LDLR):c.314-2130_314-2124del	LDLR	G119fs, G78fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251171	19	11215938 - 11215944	19	11105260 - 11105266	251171	245509	rs879254490	NC_000019.10:11105259:TGGGAAGTG:TG
NM_001195800.2(LDLR):c.314-2133del	LDLR	D77fs, D118fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251169	19	11215935	19	11105259	251169	245507	rs879254488	NC_000019.10:11105258:A:
NM_000527.4(LDLR):c.350_372dup (p.Gln125fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251168	19	11215932 - 11215954	19	11105255 - 11105256	251168	245506	rs879254487	NC_000019.10:11105255:ACGATGGGAAGTGCATCTCTCGG:ACGATGGGAAGTGCATCTCTCGGACGATGGGAAGTGCATCTCTCGG
NM_000527.5(LDLR):c.346T>C (p.Cys116Arg)	LDLR	C116R, C75R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251163	19	11215928	19	11105252	251163	245501	rs879254482	NC_000019.10:11105251:T:C
NM_001195800.2(LDLR):c.314-2147dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251161	19	11215921	19	11105244 - 11105245	251161	245499	rs879254481	NC_000019.10:11105244:G:GG
NM_001195800.2(LDLR):c.314-2148_314-2133del	LDLR	E72fs, E113fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251160	19	11215920 - 11215935	19	11105244 - 11105259	251160	245498	rs879254480	NC_000019.10:11105243:AGTTTCGCTGCCACGA:
NM_001195800.2(LDLR):c.314-2151_314-2142del	LDLR	D112fs, D71fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251159	19	11215917 - 11215926	19	11105240 - 11105249	251159	245497	rs879254479	NC_000019.10:11105239:GACGAGTTTCG:G
NM_001195800.2(LDLR):c.314-2159dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251158	19	11215909	19	11105232 - 11105233	251158	245496	rs879254478	NC_000019.10:11105232:C:CC
NM_000527.5(LDLR):c.326G>T (p.Cys109Phe)	LDLR	C109F, C68F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251157	19	11215908	19	11105232	251157	245495	rs121908042	NC_000019.10:11105231:G:T
NM_000527.5(LDLR):c.325T>C (p.Cys109Arg)	LDLR	C109R, C68R	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251156	19	11215907	19	11105231	251156	245493	rs140807148	NC_000019.10:11105230:T:C
NM_001195800.2(LDLR):c.314-2161_314-2149del	LDLR	C109fs, C68fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251155	19	11215907 - 11215919	19	11105227 - 11105239	251155	245494	rs879254477	NC_000019.10:11105226:GACGTGCTCCCAGGACG:GACG
NM_000527.5(LDLR):c.324_325delinsTC (p.Cys109Arg)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251154	19	11215906 - 11215907	19	11105230 - 11105231	251154	245492	rs879254476	NC_000019.10:11105229:GT:TC
NM_001195800.2(LDLR):c.314-2166dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251152	19	11215902	19	11105224 - 11105225	251152	245490	rs879254475	NC_000019.10:11105224:AA:AAA
NM_000527.4(LDLR):c.320_332del (p.Lys107fs)	LDLR	K107fs, K66fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251151	19	11215902 - 11215914	19	11105222 - 11105234	251151	245489	rs879254474	NC_000019.10:11105221:CCCAAGACGTGCTCCCA:CCCA
NM_001195800.2(LDLR):c.314-2168dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251150	19	11215900	19	11105219 - 11105220	251150	245488	rs875989898	NC_000019.10:11105219:CCCCC:CCCCCC
NM_000527.5(LDLR):c.314-1G>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251148	19	11215895	19	11105219	251148	245486	rs879254471	NC_000019.10:11105218:G:A
FH Vancouver 6	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251146	19	11213463 - 11221327			251146	246684		
c.(313+1_314-1)_(694+1_695-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251143	19	11213463 - 11217240			251143	246681		
NM_000527.5(LDLR):c.314-2A>C	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251142	19	11215894	19	11105218	251142	245485	rs879254470	NC_000019.10:11105217:A:C
NM_000527.4(LDLR):c.314-446_1187-386dup	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251140	19	11215450 - 11223568	19	11104774 - 11112892	251140	245483		
NM_000527.5(LDLR):c.313+2T>A	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251135	19	11213464	19	11102788	251135	245478	rs793888517	NC_000019.10:11102787:T:A
NM_000527.5(LDLR):c.313+1G>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251134	19	11213463	19	11102787	251134	245476	rs112029328	NC_000019.10:11102786:G:T
NM_001195798.2(LDLR):c.313+1dup	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251133	19	11213462 - 11213463	19	11102786 - 11102787	251133	245477	rs879254466	NC_000019.10:11102786:G:GG
NM_001195799.2(LDLR):c.191-2437_191-2434del	LDLR	C104fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251128	19	11213459 - 11213462	19	11102782 - 11102785	251128	245472	rs879254463	NC_000019.10:11102781:CTGTC:C
NM_001195799.2(LDLR):c.190+2431del	LDLR	E101fs	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251126	19	11213452	19	11102776	251126	245469	rs764797225	NC_000019.10:11102775:G:
NM_000527.5(LDLR):c.301G>T (p.Glu101Ter)	LDLR	E101*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251125	19	11213450	19	11102774	251125	245467	rs144172724	NC_000019.10:11102773:G:T
NM_001195799.2(LDLR):c.190+2429del	LDLR	E101fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251124	19	11213450	19	11102774	251124	245468	rs879254461	NC_000019.10:11102773:G:
NM_001195799.2(LDLR):c.190+2424_190+2425del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251120	19	11213445 - 11213446	19	11102769 - 11102770	251120	245463	rs879254458	NC_000019.10:11102768:CA:
NM_000527.5(LDLR):c.285C>A (p.Cys95Ter)	LDLR	C95*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251115	19	11213434	19	11102758	251115	245458	rs139400379	NC_000019.10:11102757:C:A
NM_000527.5(LDLR):c.284G>T (p.Cys95Phe)	LDLR	C95F	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251114	19	11213433	19	11102757	251114	245457	rs879254457	NC_000019.10:11102756:G:T
NM_000527.5(LDLR):c.270T>A (p.Asp90Glu)	LDLR	D90E	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251107	19	11213419	19	11102743	251107	245450	rs372828849	NC_000019.10:11102742:T:A
NM_000527.5(LDLR):c.261G>A (p.Trp87Ter)	LDLR	W87*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251100	19	11213410	19	11102734	251100	245442	rs199570811	NC_000019.10:11102733:G:A
NM_000527.5(LDLR):c.261_262delinsAG (p.Trp87_Arg88delinsTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251099	19	11213410 - 11213411	19	11102734 - 11102735	251099	245443	rs879254453	NC_000019.10:11102733:GA:AG
NM_000527.5(LDLR):c.260G>A (p.Trp87Ter)	LDLR	W87*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251098	19	11213409	19	11102733	251098	245441	rs879254452	NC_000019.10:11102732:G:A
NM_000527.5(LDLR):c.245G>T (p.Cys82Phe)	LDLR	C82F	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251093	19	11213394	19	11102718	251093	245436	rs879254448	NC_000019.10:11102717:G:T
NM_000527.5(LDLR):c.245G>A (p.Cys82Tyr)	LDLR	C82Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251092	19	11213394	19	11102718	251092	245435	rs879254448	NC_000019.10:11102717:G:A
NM_001195799.2(LDLR):c.190+2372del	LDLR	C82fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251090	19	11213393	19	11102717	251090	245434	rs879254446	NC_000019.10:11102716:T:
NM_001195799.2(LDLR):c.190+2370dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251089	19	11213391	19	11102714 - 11102715	251089	245432	rs879254445	NC_000019.10:11102714:G:GG
NM_001195799.2(LDLR):c.190+2364dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251086	19	11213385	19	11102708 - 11102709	251086	245429	rs879254443	NC_000019.10:11102708:T:TT
NM_000527.4(LDLR):c.232del (p.Arg78fs)	LDLR	R78fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251084	19	11213380	19	11102704	251084	245427	rs879254442	NC_000019.10:11102703:CC:C
NM_001195799.2(LDLR):c.190+2358dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251083	19	11213379	19	11102698 - 11102699	251083	245426	rs879254440	NC_000019.10:11102698:GGGGG:GGGGGG
NM_001195799.2(LDLR):c.190+2358del	LDLR	G77fs	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251082	19	11213375	19	11102699	251082	245425	rs879254440	NC_000019.10:11102698:GGGGG:GGGG
NM_000527.5(LDLR):c.223T>A (p.Cys75Ser)	LDLR	C75S	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251079	19	11213372	19	11102696	251079	245422	rs879254439	NC_000019.10:11102695:T:A
NM_001195799.2(LDLR):c.190+2342del	LDLR	D72fs	Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251078	19	11213360	19	11102684	251078	245421	rs879254438	NC_000019.10:11102683:GGGG:GGG
NM_000527.5(LDLR):c.204C>A (p.Cys68Ter)	LDLR	C68*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251077	19	11213353	19	11102677	251077	245420	rs879254437	NC_000019.10:11102676:C:A
NM_001195799.2(LDLR):c.190+2327dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251076	19	11213348	19	11102671 - 11102672	251076	245419	rs879254436	NC_000019.10:11102671:A:AA
NM_001195799.2(LDLR):c.190+2323dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251075	19	11213344	19	11102667 - 11102668	251075	245418	rs879254435	NC_000019.10:11102667:T:TT
NM_000527.5(LDLR):c.195_196insAT (p.Val66fs)	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251074	19	11213344 - 11213345	19	11102667 - 11102668	251074	245417	rs879254435	NC_000019.10:11102667:T:TAT
NM_000527.5(LDLR):c.195_196insA (p.Val66fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251073	19	11213344 - 11213345	19	11102668 - 11102669	251073	245416	rs1555802710	NC_000019.10:11102668::A
NM_000527.5(LDLR):c.193_201delinsGACTTCA (p.Ser65fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251072	19	11213342 - 11213350	19	11102666 - 11102674	251072	245415	rs879254434	NC_000019.10:11102665:TCTGTCACC:GACTTCA
NM_000527.5(LDLR):c.191-1G>A	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251071	19	11213339	19	11102663	251071	245413	rs879254433	NC_000019.10:11102662:G:A
c.(190+1_191-1)_(1845+1_1846-1)dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251069	19	11211022 - 11230767			251069	246679		
c.(190+1_191-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251068	19	11211022 - 11230767			251068	246678		
c.(190+1_191-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251067	19	11211022 - 11226769			251067	246677		
c.(190+1_191-1)_(1060+1_1061-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251065	19	11211022 - 11222189			251065	246675		
c.(190+1_191-1)_(940+1_941-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251063	19	11211022 - 11221327			251063	246673		
c.(190+1_191-1)_(817+1_818-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251061	19	11211022 - 11218067			251061	246671		
c.(190+1_191-1)_(694+1_695-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251059	19	11211022 - 11217240			251059	246669		
c.(190+1_191-1)_(313+1_314-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251058	19	11211022 - 11215895			251058	246668		
NM_000527.5(LDLR):c.191-2delinsCT	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251057	19	11213338	19	11102662	251057	245412	rs879254432	NC_000019.10:11102661:A:CT
c.191-512_940+631del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251055	19	11212828 - 11218821	19	11102152 - 11108145	251055	245410		
NM_000527.4(LDLR):c.190+2_190+3dup	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251050	19	11211020 - 11211021	19	11100344 - 11100345	251050	245406	rs879254429	NC_000019.10:11100344:TGTG:TGTGTG
NM_000527.5(LDLR):c.185_186insT (p.Cys63fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251045	19	11211016 - 11211017	19	11100340 - 11100341	251045	245400	rs879254425	NC_000019.10:11100340::T
NM_000527.4(LDLR):c.172del (p.Glu58fs)	LDLR	E58fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251042	19	11211003	19	11100327	251042	245398	rs879254422	NC_000019.10:11100326:G:
NM_000527.5(LDLR):c.157C>T (p.Gln53Ter)	LDLR	Q53*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251039	19	11210988	19	11100312	251039	245394	rs879254419	NC_000019.10:11100311:C:T
NM_000527.5(LDLR):c.155G>A (p.Cys52Tyr)	LDLR	C52Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251038	19	11210986	19	11100310	251038	245393	rs879254418	NC_000019.10:11100309:G:A
NM_000527.4(LDLR):c.148del (p.Ala50fs)	LDLR	A50fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251036	19	11210979	19	11100303	251036	245392	rs879254417	NC_000019.10:11100302:G:
NM_000527.5(LDLR):c.138C>A (p.Cys46Ter)	LDLR	C46*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251032	19	11210969	19	11100293	251032	245387	rs754676104	NC_000019.10:11100292:C:A
NM_000527.5(LDLR):c.136T>G (p.Cys46Gly)	LDLR	C46G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251030	19	11210967	19	11100291	251030	245385	rs879254415	NC_000019.10:11100290:T:G
NM_000527.4(LDLR):c.132_133dup (p.Val45fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251029	19	11210961 - 11210962	19	11100285 - 11100286	251029	245384	rs879254414	NC_000019.10:11100285:GGG:GGGGG
NM_000527.5(LDLR):c.126C>A (p.Tyr42Ter)	LDLR	Y42*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251028	19	11210957	19	11100281	251028	245383	rs751317621	NC_000019.10:11100280:C:A
NM_000527.4(LDLR):c.118del (p.Ile40fs)	LDLR	I40fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251027	19	11210949	19	11100273	251027	245382	rs879254413	NC_000019.10:11100272:A:
NM_000527.4(LDLR):c.117del (p.Lys38_Cys39insTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251026	19	11210948	19	11100272	251026	245381	rs879254412	NC_000019.10:11100271:C:
NM_000527.5(LDLR):c.116_117delinsAA (p.Cys39Ter)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251025	19	11210947 - 11210948	19	11100271 - 11100272	251025	245380	rs879254411	NC_000019.10:11100270:GC:AA
NM_000527.4(LDLR):c.114dup (p.Cys39fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251024	19	11210945	19	11100266 - 11100267	251024	245379	rs879254410	NC_000019.10:11100266:AAA:AAAA
NM_000527.4(LDLR):c.108del (p.Asp36fs)	LDLR	D36fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251023	19	11210939	19	11100263	251023	245378	rs879254409	NC_000019.10:11100262:C:
NM_000527.5(LDLR):c.103C>T (p.Gln35Ter)	LDLR	Q35*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000251021	19	11210934	19	11100258	251021	245376	rs879254408	NC_000019.10:11100257:C:T
NM_000527.5(LDLR):c.102C>A (p.Cys34Ter)	LDLR	C34*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251020	19	11210933	19	11100257	251020	245375	rs879254407	NC_000019.10:11100256:C:A
NM_000527.5(LDLR):c.100T>G (p.Cys34Gly)	LDLR	C34G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251018	19	11210931	19	11100255	251018	245373	rs879254405	NC_000019.10:11100254:T:G
NM_000527.4(LDLR):c.99del (p.Gln33fs)	LDLR	Q33fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251017	19	11210930	19	11100254	251017	245372	rs879254404	NC_000019.10:11100253:G:
NM_000527.4(LDLR):c.93_99del (p.Glu31fs)	LDLR	E31fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251015	19	11210924 - 11210930	19	11100248 - 11100254	251015	245370	rs879254402	NC_000019.10:11100247:GTTCCAG:
NM_000527.5(LDLR):c.91G>T (p.Glu31Ter)	LDLR	E31*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251014	19	11210922	19	11100246	251014	245369	rs776421777	NC_000019.10:11100245:G:T
NM_000527.5(LDLR):c.85A>T (p.Arg29Ter)	LDLR	R29*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251011	19	11210916	19	11100240	251011	245366	rs879254401	NC_000019.10:11100239:A:T
NM_000527.5(LDLR):c.81C>A (p.Cys27Ter)	LDLR	C27*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251009	19	11210912	19	11100236	251009	245364	rs2228671	NC_000019.10:11100235:C:A
NM_000527.4(LDLR):c.77_78del (p.Arg26fs)	LDLR	R26fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000251008	19	11210908 - 11210909	19	11100231 - 11100232	251008	245363	rs879254400	NC_000019.10:11100230:AGA:A
NM_000527.4(LDLR):c.76del (p.Arg26fs)	LDLR	R26fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251007	19	11210907	19	11100231	251007	245362	rs879254399	NC_000019.10:11100230:A:
NM_000527.5(LDLR):c.76A>T (p.Arg26Ter)	LDLR	R26*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251006	19	11210907	19	11100231	251006	245361	rs879254398	NC_000019.10:11100230:A:T
NM_000527.5(LDLR):c.68-1G>C	LDLR		Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000251005	19	11210898	19	11100222	251005	245360	rs879254397	NC_000019.10:11100221:G:C
c.(67+1_68-1)_(2547+1_2548-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251004	19	11200292 - 11241956			251004	246667		
c.(67+1_68-1)_(2140+1_2141-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251002	19	11200292 - 11233849			251002	246665		
c.(67+1_68-1)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251001	19	11200292 - 11230767			251001	246664		
c.(67+1_68-1)_(1705+1_1706-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000251000	19	11200292 - 11227534			251000	246663		
c.(67+1_68-1)_(1586+1_1587-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250999	19	11200292 - 11226769			250999	246662		
c.(67+1_68-1)_(817+1_818-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250996	19	11200292 - 11218067			250996	246659		
c.(67+1_68-1)_(694+1_695-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250995	19	11200292 - 11217240			250995	246658		
c.(67+1_68-1)_(190+1_191-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250994	19	11200292 - 11213339			250994	246657		
NM_000527.5(LDLR):c.68-2A>T	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000250993	19	11210897	19	11100221	250993	245359	rs879254396	NC_000019.10:11100220:A:T
NM_000527.5(LDLR):c.68-2A>G	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000250992	19	11210897	19	11100221	250992	245358	rs879254396	NC_000019.10:11100220:A:G
c.67+4761_818-332del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250990	19	11205052 - 11217736	19	11094376 - 11107060	250990	245356		
NM_000527.4(LDLR):c.67+3968_940+296dup	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000250989	19	11204259 - 11218486	19	11093583 - 11107810	250989	245355		
c.(?_-187)_*2584del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000250940	19	11200038 - 11244576			250940	246656		
c.(?_-187)_(2311+1_2312-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250939	19	11200038 - 11238683			250939	246655		
c.(?_-187)_(2140+1_2141-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250938	19	11200038 - 11233849			250938	246654		
c.(?_-187)_(1845+1_1846-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250937	19	11200038 - 11230767			250937	246653		
c.(?_-187)_(1186+1_1187-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250936	19	11200038 - 11223953			250936	246652		
c.(?_-187)_(1060+1_1061-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000250935	19	11200038 - 11222189			250935	246651		
c.(?_-187)_(940+1_941-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000250934	19	11200038 - 11221327			250934	246650		
c.(?_-187)_(67+1_68-1)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000250932	19	11200038 - 11210898			250932	246648		
NM_001042537:c.916delC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000246605					246605	245213		
NM_001429.4(EP300):c.2164dup (p.Gln722fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000246604	22	41543870 - 41543871	22	41147866 - 41147867	246604	245212	rs879253873	NC_000022.11:41147866:CCC:CCCC
NM_001005360.2(DNM2):c.1609G>A (p.Gly537Ser)	DNM2	G537S, G533S	not provided|Charcot-Marie-Tooth disease, dominant intermediate B|Sensorimotor neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000246295	19	10922991	19	10812315	246295	245116	rs121909093	NC_000019.10:10812314:G:A
NM_000166.6(GJB1):c.643C>T (p.Arg215Trp)	GJB1	R215W	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246098	X	70444200	X	71224350	246098	245189	rs879254099	NC_000023.11:71224349:C:T
NM_000166.6(GJB1):c.462T>G (p.Tyr154Ter)	GJB1	Y154*	Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000246097	X	70444019	X	71224169	246097	245187	rs879254098	NC_000023.11:71224168:T:G
NM_000166.6(GJB1):c.239A>G (p.Gln80Arg)	GJB1	Q80R	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000246096	X	70443796	X	71223946	246096	245182	rs879254097	NC_000023.11:71223945:A:G
NM_000166.6(GJB1):c.231G>A (p.Trp77Ter)	GJB1	W77*	not provided|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Mar 28, 2016)	criteria provided, single submitter	VCV000246095	X	70443788	X	71223938	246095	245181	rs879254096	NC_000023.11:71223937:G:A
NM_001005360.2(DNM2):c.1678G>A (p.Glu560Lys)	DNM2	E560K, E556K	not provided	Pathogenic(Last reviewed: Nov 18, 2015)	criteria provided, single submitter	VCV000246082	19	10930662	19	10819986	246082	245117	rs879254086	NC_000019.10:10819985:G:A
NM_000166.6(GJB1):c.112G>A (p.Val38Met)	GJB1	V38M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245946	X	70443669	X	71223819	245946	245179	rs879254012	NC_000023.11:71223818:G:A
NM_020956.2(PRX):c.*1379C>T	PRX	R392*	Charcot-Marie-Tooth disease type 4|Dejerine-Sottas disease|not provided	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245870	19	40903085	19	40397178	245870	245137	rs773009397	NC_000019.10:40397177:G:A
NM_000166.6(GJB1):c.396del (p.Trp132fs)	GJB1	W132fs	not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000245787	X	70443952	X	71224102	245787	245185	rs879253946	NC_000023.11:71224101:GG:G
NM_000052.7(ATP7A):c.1707+6_1707+9del	ATP7A		not provided	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000245767	X	77258734 - 77258737	X	78003237 - 78003240	245767	245191	rs879253938	NC_000023.11:78003236:GTAAGTAAG:GTAAG
NM_000166.6(GJB1):c.282C>A (p.His94Gln)	GJB1	H94Q	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, single submitter	VCV000245724	X	70443839	X	71223989	245724	245183	rs756000896	NC_000023.11:71223988:C:A
NM_000166.6(GJB1):c.541G>A (p.Val181Met)	GJB1	V181M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245705	X	70444098	X	71224248	245705	245188	rs879253909	NC_000023.11:71224247:G:A
NM_004977.2(KCNC3):c.1283C>T (p.Thr428Ile)	KCNC3	T428I		Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000245604	19	50826927	19	50323670	245604	245205	rs879253883	NC_000019.10:50323669:G:A
NM_001972.4(ELANE):c.597+1G>C	ELANE		not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000245599	19	855795	19	855795	245599	245162	rs1555710005	NC_000019.10:855794:G:C
NM_001972.4(ELANE):c.597+5G>A	ELANE		Cyclical neutropenia|not provided|Cyclical neutropenia|Neutropenia, severe congenital 1, autosomal dominant|Neutropenia	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000245598	19	855799	19	855799	245598	245163	rs879253882	NC_000019.10:855798:G:A
NM_001711.6(BGN):c.776G>T (p.Gly259Val)	BGN	G259V		Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000243091	X	152772510	X	153507052	243091	244174	rs879255605	NC_000023.11:153507051:G:T
NM_001711.6(BGN):c.439A>G (p.Lys147Glu)	BGN	K147E		Pathogenic(Last reviewed: Dec 15, 2016)	no assertion criteria provided	VCV000243090	X	152771408	X	153505950	243090	244173	rs879255604	NC_000023.11:153505949:A:G
Single allele	ABHD12		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	VCV000243081	20	25364310 - 25378180	20	25383675 - 25397545	243081	244168		
MAFB, 600-KB DEL	MAFB		Duane syndrome type 3	Pathogenic(Last reviewed: Jul 18, 2016)	no assertion criteria provided	VCV000243047					243047	244128		
NM_001243036.1(SLC7A9):c.1225-4678_1324del	SLC7A9		Cystinuria	Pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000242913	19	33324130 - 33328907	19	32833224 - 32838001	242913	244022		
NM_001015877.2(PHF6):c.255C>A (p.Cys85Ter)	PHF6	C85*	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242879	X	133527545	X	134393515	242879	244000	rs1114167289	NC_000023.11:134393514:C:A
NM_015166.3(MLC1):c.617G>T (p.Gly206Val)	MLC1	G206V	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242875	22	50512742	22	50074313	242875	243999	rs1114167286	NC_000022.11:50074312:C:A
NM_001145901.2(SARS2):c.1048T>C (p.Phe350Leu)	SARS2	F350L, F348L	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242874	19	39408569	19	38917929	242874	243995	rs1114167285	NC_000019.10:38917928:A:G
NM_203473.3(PORCN):c.268C>T (p.Arg90Ter)	PORCN	R90*, R19*	Focal dermal hypoplasia	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242872	X	48369814	X	48511426	242872	244003	rs1114167283	NC_000023.11:48511425:C:T
NM_024105.4(ALG12):c.117del (p.Gln40fs)	ALG12	Q40fs	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000242855	22	50307297	22	49913649	242855	243959	rs761221480	NC_000022.11:49913648:C:
NM_024105.4(ALG12):c.1001del (p.Asn334fs)	ALG12	N334fs	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000242854	22	50298146	22	49904498	242854	243958	rs759244819	NC_000022.11:49904497:TT:T
NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	RPS19	V15F	not provided	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000242804	19	42364887	19	41860817	242804	21358	rs104894717	NC_000019.10:41860816:G:T
NM_001083961.1(WDR62):c.3304C>T	WDR62	Q1102*, Q1097*	not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000242539	19	36593722	19	36102820	242539	205492	rs376633424	NC_000019.10:36102819:C:T
NM_000271.4(NPC1):c.3234_3237dupATTT	NPC1		Niemann-Pick disease type C1	Pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000242483	18	21116644 - 21116645	18	23536680 - 23536681	242483	213648	rs863224902	NC_000018.10:23536680:AAATA:AAATAAATA
NM_000271.4(NPC1):c.2213C>A	NPC1	S738*	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000242482	18	21123451	18	23543487	242482	213649	rs777286835	NC_000018.10:23543486:G:T
NM_000496.3(CRYBB2):c.355G>A (p.Gly119Arg)	CRYBB2	G119R	Cataract 3, multiple types	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000242473	22	25625451	22	25229484	242473	214002	rs864309698	NC_000022.11:25229483:G:A
NM_001029896.2(WDR45):c.611G>A (p.Gly204Asp)	WDR45	G205D, G204D	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000242347	X	48933318	X	49075659	242347	243898	rs878855326	NC_000023.11:49075658:C:T
NM_001008537.3(NEXMIF):c.937C>T (p.Arg313Ter)	NEXMIF	R313*	not provided|Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000242327	X	73963455	X	74743620	242327	243875	rs878854425	NC_000023.11:74743619:G:A
NM_001008537.3(NEXMIF):c.625dup (p.Leu209fs)	NEXMIF		not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000242325	X	73963766 - 73963767	X	74743931 - 74743932	242325	243881	rs878854423	NC_000023.11:74743931:GGGGG:GGGGGG
NM_001008537.3(NEXMIF):c.652C>T (p.Arg218Ter)	NEXMIF	R218*	Continuous spike and waves during slow-wave sleep syndrome|not provided	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000242323	X	73963740	X	74743905	242323	243873	rs758719615	NC_000023.11:74743904:G:A
NM_001008537.3(NEXMIF):c.3053_3066del (p.Gly1018fs)	NEXMIF	G1018fs	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000242320	X	73961326 - 73961339	X	74741491 - 74741504	242320	243877	rs878854419	NC_000023.11:74741490:GATATCATCATCGC:
NM_001008537.3(NEXMIF):c.422del (p.Gln141fs)	NEXMIF	Q141fs	not provided	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	VCV000242319	X	73963970	X	74744135	242319	243878	rs878854418	NC_000023.11:74744134:T:
NM_001972.4(ELANE):c.336_359del (p.Asn113_Ile120del)	ELANE		not provided	Pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000242297	19	853372 - 853395	19	853372 - 853395	242297	243870	rs879255272	NC_000019.10:853371:TAAACTTGCTCAACGACATCGTGAT:T
NM_001972.4(ELANE):c.140T>C (p.Leu47Pro)	ELANE	L47P	not provided	Pathogenic(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	VCV000242289	19	852948	19	852948	242289	243857	rs878855319	NC_000019.10:852947:T:C
NM_001972.4(ELANE):c.597+1G>A	ELANE		not provided|Cyclical neutropenia|Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242287	19	855795	19	855795	242287	243869	rs1555710005	NC_000019.10:855794:G:A
NM_001972.4(ELANE):c.452G>T (p.Cys151Phe)	ELANE	C151F	not provided	Pathogenic(Last reviewed: Jan 19, 2013)	criteria provided, single submitter	VCV000242284	19	855649	19	855649	242284	243861	rs57246956	NC_000019.10:855648:G:T
NM_001972.4(ELANE):c.212G>T (p.Cys71Phe)	ELANE	C71F	not provided	Pathogenic(Last reviewed: Mar 7, 2015)	criteria provided, single submitter	VCV000242278	19	853020	19	853020	242278	243851	rs878855315	NC_000019.10:853019:G:T
NM_172107.4(KCNQ2):c.1386_1387TG[1] (p.Val463fs)	KCNQ2		Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000242008	20	62046392 - 62046393	20	63415039 - 63415040	242008	243589	rs878855236	NC_000020.11:63415038:CACA:CA
NM_023036.6(DNAI2):c.1420G>A (p.Gly474Arg)	DNAI2	G474R, G462R	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000241448	17	72306228	17	74310089	241448	242970	rs878855078	NC_000017.11:74310088:G:A
NM_017950.4(CCDC40):c.2852dup (p.Lys952fs)	CCDC40		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000241240	17	78069080 - 78069081	17	80095281 - 80095282	241240	243013	rs878855042	NC_000017.11:80095281:T:TT
NM_017950.4(CCDC40):c.1620del (p.Ile541fs)	CCDC40	I541fs	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	VCV000241235	17	78055401	17	80081602	241235	243008	rs878855041	NC_000017.11:80081601:CC:C
NM_005359.5(SMAD4):c.906G>A (p.Trp302Ter)	SMAD4	W302*	Hereditary cancer-predisposing syndrome|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000240156	18	48586237	18	51059867	240156	243071	rs878854769	NC_000018.10:51059866:G:A
NM_005359.5(SMAD4):c.1206dupT (p.Ser403Terfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 11, 2016)	criteria provided, single submitter	VCV000240143	18	48593453 - 48593454	18	51067083 - 51067084	240143	243074	rs878854765	NC_000018.10:51067083:TT:TTT
NM_004484.3(GPC3):c.1574-?_*379+?del	GPC3		Wilms tumor 1	Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	VCV000239938					239938	243719		
NM_000109.4(DMD):c.7757del (p.Gln2586fs)	DMD	Q2471fs, Q2594fs, Q1253fs, Q1250fs, Q2586fs, Q2590fs, Q134fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000239612	X	31697583	X	31679466	239612	243793	rs878854621	NC_000023.11:31679465:T:
NM_004006.2(DMD):c.5506C>T (p.Gln1836Ter)	DMD	Q1836*, Q1832*, Q1828*, Q495*, Q492*, Q1713*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000239608	X	32364140	X	32346023	239608	243797	rs770845480	NC_000023.11:32346022:G:A
NM_004006.2(DMD):c.4870C>T (p.Gln1624Ter)	DMD	Q1624*, Q280*, Q1616*, Q283*, Q1620*, Q1501*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000239606	X	32383292	X	32365175	239606	243799	rs762250680	NC_000023.11:32365174:G:A
NM_004006.2(DMD):c.1705-1G>T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000239601	X	32591755	X	32573638	239601	243804	rs878854619	NC_000023.11:32573637:C:A
NM_004006.2(DMD):c.1504C>T (p.Gln502Ter)	DMD	Q502*, Q379*, Q494*, Q498*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000239599	X	32613972	X	32595855	239599	243806	rs878854618	NC_000023.11:32595854:G:A
NM_001195800.2(LDLR):c.314-2107del	LDLR	V127fs, V86fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 10, 2016)	criteria provided, single submitter	VCV000237870	19	11215961	19	11105285	237870	243270	rs878854028	NC_000019.10:11105284:G:
NM_000527.5(LDLR):c.1706-2A>T	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000237865	19	11227533	19	11116857	237865	243274	rs878854027	NC_000019.10:11116856:A:T
NM_000527.5(LDLR):c.166T>C (p.Ser56Pro)	LDLR	S56P	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000237864	19	11210997	19	11100321	237864	243267	rs878854026	NC_000019.10:11100320:T:C
NM_016418.5(NF2):c.1627A>T (p.Lys543Ter)	NF2	K543*, K501*, K460*, K502*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000237621	22	30077480	22	29681491	237621	243701	rs878853925	NC_000022.11:29681490:A:T
NM_000268.3(NF2):c.-443-?_*3798+?del	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000237611					237611	243642		
NM_000166.6(GJB1):c.208C>G (p.Pro70Ala)	GJB1	P70A	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000237122	X	70443765	X	71223915	237122	243822	rs878853697	NC_000023.11:71223914:C:G
NM_001183.6(ATP6AP1):c.938A>G (p.Tyr313Cys)	ATP6AP1	Y313C	Immunodeficiency 47	Pathogenic(Last reviewed: Feb 13, 2017)	no assertion criteria provided	VCV000236242	X	153663499	X	154435153	236242	237805	rs878853278	NC_000023.11:154435152:A:G
NM_001183.6(ATP6AP1):c.1036G>A (p.Glu346Lys)	ATP6AP1	E346K	Immunodeficiency 47	Pathogenic(Last reviewed: Feb 13, 2017)	no assertion criteria provided	VCV000236241	X	153663684	X	154435338	236241	237804	rs878853277	NC_000023.11:154435337:G:A
NM_001183.6(ATP6AP1):c.431T>C (p.Leu144Pro)	ATP6AP1	L144P	Immunodeficiency 47	Pathogenic(Last reviewed: Feb 13, 2017)	no assertion criteria provided	VCV000236240	X	153660679	X	154432333	236240	237803	rs878853276	NC_000023.11:154432332:T:C
NM_001183.6(ATP6AP1):c.1284G>A (p.Met428Ile)	ATP6AP1	M428I	Immunodeficiency 47	Pathogenic(Last reviewed: Feb 13, 2017)	no assertion criteria provided	VCV000236239	X	153664108	X	154435762	236239	237802	rs878853275	NC_000023.11:154435761:G:A
NM_000159.4(GCDH):c.731del (p.Gly244fs)	GCDH	G244fs	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000236190	19	13007111	19	12896297	236190	237752	rs878853244	NC_000019.10:12896296:GGGG:GGG
NM_000307.5(POU3F4):c.235C>T (p.Gln79Ter)	POU3F4	Q79*	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000236062	X	82763567	X	83508559	236062	237626	rs878853242	NC_000023.11:83508558:C:T
NM_001039213.4(CEACAM16):c.703C>T (p.Arg235Cys)	CEACAM16	R235C	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236048	19	45208901	19	44705631	236048	237625	rs746164064	NC_000019.10:44705630:C:T
NM_144612.6(LOXHD1):c.5894dup (p.Gly1966fs)	LOXHD1		Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236044	18	44065083 - 44065084	18	46485120 - 46485121	236044	237624	rs878853231	NC_000018.10:46485120:CC:CCC
NM_024422.6(DSC2):c.1660C>T (p.Gln554Ter)	DSC2	Q554*	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11, WITH OR WITHOUT MILD PALMOPLANTAR KERATODERMA|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000235909	18	28659816	18	31079850	235909	237539	rs878853170	NC_000018.10:31079849:G:A
NM_005121.3(MED13):c.4198C>T (p.Arg1400Ter)	MED13	R1400*	not specified	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000235901	17	60044006	17	61966645	235901	237536	rs773685207	NC_000017.11:61966644:G:A
NM_004924.6(ACTN4):c.584G>A (p.Gly195Asp)	ACTN4	G195D	Focal segmental glomerulosclerosis 1	Pathogenic(Last reviewed: Feb 8, 2017)	no assertion criteria provided	VCV000235864	19	39198768	19	38708128	235864	237519	rs878853159	NC_000019.10:38708127:G:A
NM_000159.4(GCDH):c.431A>C (p.Gln144Pro)	GCDH	Q144P	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000235858	19	13004393	19	12893579	235858	237514	rs878853154	NC_000019.10:12893578:A:C
NM_000159.4(GCDH):c.456C>G (p.Ile152Met)	GCDH	I152M	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000235857	19	13004418	19	12893604	235857	237515	rs878853153	NC_000019.10:12893603:C:G
NM_001079872.1(CUL4B):c.755_756CA[1] (p.Gln253fs)	CUL4B		Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235856	X	119681009 - 119681010	X	120547154 - 120547155	235856	237505	rs878853152	NC_000023.11:120547153:TGTG:TG
NM_004187.4(KDM5C):c.1296dup (p.Glu433Ter)	KDM5C		Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235855	X	53240783 - 53240784	X	53211601 - 53211602	235855	237509	rs878853151	NC_000023.11:53211601:AA:AAA
NM_001083962.2(TCF4):c.520C>T (p.Arg174Ter)	TCF4	R174*, R103*, R172*, R173*, R150*, R149*, R132*, R276*, R44*	not provided|Intellectual disability|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235853	18	53017619	18	55350388	235853	237503	rs878853149	NC_000018.10:55350387:G:A
NM_015107.3(PHF8):c.1141+5G>C	PHF8		Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235852	X	54028583	X	54002150	235852	237511	rs878853148	NC_000023.11:54002149:C:G
NM_014271.4(IL1RAPL1):c.894_903del (p.Trp299fs)	IL1RAPL1	W299fs	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235849	X	29935693 - 29935702	X	29917576 - 29917585	235849	237506	rs878853146	NC_000023.11:29917575:AGTTTGGGAAAGT:AGT
NM_001111125.3(IQSEC2):c.3097C>T (p.Gln1033Ter)	IQSEC2	Q1033*, Q828*	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235847	X	53268395	X	53239213	235847	237510	rs878853144	NC_000023.11:53239212:G:A
NM_004187.4(KDM5C):c.2152G>C (p.Ala718Pro)	KDM5C	A718P, A651P, A717P	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235844	X	53228250	X	53199068	235844	237508	rs878853141	NC_000023.11:53199067:C:G
NM_001142730.3(KCTD1):c.1882C>T (p.Pro628Ser)	KCTD1	P20S, P28S, P628S		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000235828	18	24081142	18	26501178	235828	237499	rs878853125	NC_000018.10:26501177:G:A
NM_001142730.3(KCTD1):c.2031C>A (p.Asp677Glu)	KCTD1	D69E, D677E, D77E		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000235827	18	24056581	18	26476617	235827	237498	rs878853124	NC_000018.10:26476616:G:T
NM_000495.5(COL4A5):c.1339+1G>A	COL4A5		not provided	Pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000235810	X	107834462	X	108591232	235810	237469	rs878853114	NC_000023.11:108591231:G:A
NM_000252.2(MTM1):c.564_566TAA[1] (p.Asn189del)	MTM1	N189del	not provided	Pathogenic(Last reviewed: Jan 6, 2016)	criteria provided, single submitter	VCV000235767	X	149809777 - 149809779	X	150641304 - 150641306	235767	237446	rs878853108	NC_000023.11:150641303:TAATAA:TAA
NM_001278116.2(L1CAM):c.992-2A>G	L1CAM		not provided	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000235709	X	153135391	X	153869936	235709	237389	rs878853099	NC_000023.11:153869935:T:C
NM_000687.4(AHCY):c.293C>T (p.Pro98Leu)	AHCY	P70L, P100L, P98L	not provided	Pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	VCV000235681	20	32881889	20	34294083	235681	237361	rs757966746	NC_000020.11:34294082:G:A
NM_000159.4(GCDH):c.1156C>T (p.Arg386Ter)	GCDH	R386*	Glutaric aciduria, type 1|not provided	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235616	19	13008590	19	12897776	235616	237297	rs752127949	NC_000019.10:12897775:C:T
NM_000054.6(AVPR2):c.392T>C (p.Leu131Pro)	AVPR2	L131P	not provided	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000235612	X	153171352	X	153905898	235612	237293	rs878853079	NC_000023.11:153905897:T:C
NM_001363.5(DKC1):c.1345C>G (p.Arg449Gly)	DKC1	R449G, R444G	not provided	Pathogenic(Last reviewed: Dec 17, 2015)	criteria provided, single submitter	VCV000235576	X	154004468	X	154776193	235576	237257	rs878853071	NC_000023.11:154776192:C:G
NM_004429.4(EFNB1):c.101_114dup (p.Ser39fs)	EFNB1		not provided	Pathogenic(Last reviewed: Jan 30, 2015)	criteria provided, single submitter	VCV000235545	X	68049711 - 68049712	X	68829868 - 68829869	235545	237226	rs879255545	NC_000023.11:68829868:CCTGGAGCCCGTATCCTGGAGC:CCTGGAGCCCGTATCCTGGAGCCCGTATCCTGGAGC
NM_020473.3(PIGA):c.13+3637dup	PIGA		not provided	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000235496	X	15349984 - 15349985	X	15331862 - 15331863	235496	237178	rs879255543	NC_000023.11:15331862:CC:CCC
NM_000495.5(COL4A5):c.4531del (p.Arg1511fs)	COL4A5	R1517fs, R1511fs	not provided	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000235408	X	107935998	X	108692768	235408	237093	rs878853030	NC_000023.11:108692767:C:
NM_001165927.1(MKS1):c.478C>T (p.Arg160Ter)	MKS1	R160*, R170*	Meckel syndrome type 1|Joubert syndrome 28|Bardet-Biedl syndrome 13|Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235405	17	56292109	17	58214748	235405	237090	rs756853299	NC_000017.11:58214747:G:A
NM_000495.5(COL4A5):c.2031_2038del (p.Gly678fs)	COL4A5	G678fs	not provided	Pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	VCV000235352	X	107844705 - 107844712	X	108601475 - 108601482	235352	237039	rs878853017	NC_000023.11:108601474:AGGTCTTC:
NM_000411.8(HLCS):c.2005C>T (p.His669Tyr)	HLCS	H669Y, H816Y	not provided	Pathogenic(Last reviewed: Jan 5, 2016)	criteria provided, single submitter	VCV000235250	21	38128847	21	36756546	235250	236937	rs878852989	NC_000021.9:36756545:G:A
NM_001039213.4(CEACAM16):c.505G>A (p.Gly169Arg)	CEACAM16	G169R	Deafness, autosomal dominant 4b	Pathogenic(Last reviewed: Apr 30, 2019)	no assertion criteria provided	VCV000235136	19	45207410	19	44704140	235136	236870	rs876661405	NC_000019.10:44704139:G:A
NM_007363.5(NONO):c.1171+1G>T	NONO		Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000235099	X	70518359	X	71298509	235099	236862	rs876661316	NC_000023.11:71298508:G:T
NM_000271.5(NPC1):c.3127A>G (p.Thr1043Ala)	NPC1	T1043A	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000235096	18	21116755	18	23536791	235096	236859	rs876661319	NC_000018.10:23536790:T:C
NM_001429.4(EP300):c.769_786del (p.Tyr257_Gly262del)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Mar 20, 2016)	no assertion criteria provided	VCV000235095	22	41521906 - 41521923	22	41125902 - 41125919	235095	236858	rs876661318	NC_000022.11:41125901:ATATACTCAGAATCCTGGA:A
NM_000117.2(EMD):c.153dup (p.Ser52fs)	EMD		Cardiovascular phenotype|Emery-Dreifuss muscular dystrophy 1, X-linked|not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234991	X	153608114 - 153608115	X	154379754 - 154379755	234991	236822	rs876661345	NC_000023.11:154379754:CCCCCC:CCCCCCC
NM_000166.6(GJB1):c.151T>C (p.Phe51Leu)	GJB1	F51L	not provided|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234871	X	70443708	X	71223858	234871	232161	rs876661269	NC_000023.11:71223857:T:C
NM_000891.2(KCNJ2):c.902T>G (p.Met301Arg)	KCNJ2	M301R	not provided	Pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000234729	17	68172082	17	70175941	234729	232033	rs876661184	NC_000017.11:70175940:T:G
NM_000166.6(GJB1):c.556G>T (p.Glu186Ter)	GJB1	E186*	Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000234612	X	70444113	X	71224263	234612	232162	rs116840821	NC_000023.11:71224262:G:T
NM_000116.5(TAZ):c.461-2A>G	TAZ		not provided	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000234475	X	153647880	X	154419541	234475	232141	rs876661038	NC_000023.11:154419540:A:G
NM_000455.4(STK11):c.179dup (p.Tyr60Ter)	STK11		not provided	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234416	19	1207090 - 1207091	19	1207091 - 1207092	234416	232073	rs876661012	NC_000019.10:1207091:A:AA
NM_014646.2(LPIN2):c.132_133GT[4] (p.Ser46fs)	LPIN2		not provided	Pathogenic(Last reviewed: Jan 12, 2015)	criteria provided, single submitter	VCV000234327	18	2960703 - 2960704	18	2960705 - 2960706	234327	232064	rs876660982	NC_000018.10:2960705:ACAC:ACACACAC
NM_005359.5(SMAD4):c.153delA (p.Asp52Metfs)	SMAD4	D52fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 13, 2015)	criteria provided, single submitter	VCV000233889	18	48573564	18	51047194	233889	236526	rs786203560	NC_000018.10:51047193:AAAAAA:AAAAA
NM_005359.5(SMAD4):c.1585_1586dupTT (p.Leu529Phefs)	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 18, 2015)	criteria provided, single submitter	VCV000233042	18	48604762 - 48604763	18	51078392 - 51078393	233042	236547	rs876660150	NC_000018.10:51078392:TT:TTTT
NM_005359.5(SMAD4):c.297G>A (p.Trp99Ter)	SMAD4	W99*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2015)	criteria provided, single submitter	VCV000232929	18	48575103	18	51048733	232929	236527	rs876660079	NC_000018.10:51048732:G:A
NM_005359.5(SMAD4):c.931C>T (p.Gln311Ter)	SMAD4	Q311*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000230663	18	48586262	18	51059892	230663	236538	rs876658694	NC_000018.10:51059891:C:T
NM_000455.4(STK11):c.291-2A>G	STK11		Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230469	19	1218414	19	1218415	230469	236560	rs876658584	NC_000019.10:1218414:A:G
NM_000307.5(POU3F4):c.603_606CAAA[1] (p.Gln203fs)	POU3F4		Rare genetic deafness	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	VCV000228391	X	82763935 - 82763938	X	83508927 - 83508930	228391	231297	rs876657719	NC_000023.11:83508926:CAAACAAA:CAAA
NM_000527.5(LDLR):c.313+1G>C	LDLR		Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000228358	19	11213463	19	11102787	228358	230978	rs112029328	NC_000019.10:11102786:G:C
NM_000527.4(LDLR):c.1428dup (p.Asp477fs)	LDLR		Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228357	19	11224280	19	11113599 - 11113600	228357	230982	rs876657697	NC_000019.10:11113599:CCCCC:CCCCCC
NM_002294.3(LAMP2):c.294G>A (p.Trp98Ter)	LAMP2	W98*	not provided|Danon disease	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228356	X	119589315	X	120455460	228356	231248	rs876657696	NC_000023.11:120455459:C:T
NM_133261.3(GIPC3):c.411+1G>A	GIPC3		Rare genetic deafness	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000228349	19	3586679	19	3586681	228349	230991	rs876657692	NC_000019.10:3586680:G:A
NM_001399.4(EDA):c.(?_707)_(741_?)del (p.(?))	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 7, 2012)	criteria provided, single submitter	VCV000228340	X	69249354 - 69249388	X	70029504 - 70029538	228340	176312		
NM_001399.5(EDA):c.960T>G (p.Tyr320Ter)	EDA	Y320*, Y318*, Y315*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	VCV000228339	X	69255243	X	70035393	228339	231294	rs876657687	NC_000023.11:70035392:T:G
NM_001399.5(EDA):c.659_676del (p.217_219PGP[1])	EDA		Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228338	X	69247839 - 69247856	X	70027979 - 70027996	228338	231291	rs876657686	NC_000023.11:70027978:CCTGGTCCTCCAGGTCCTCCTGGTCCTC:CCTGGTCCTC
NM_001399.5(EDA):c.648_683del (p.Pro219_Gly230del)	EDA		Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000228337	X	69247828 - 69247863	X	70027973 - 70028008	228337	231287	rs876657685	NC_000023.11:70027972:GGACCACCTGGTCCTCCAGGTCCTCCTGGTCCTCAAGGACC:GGACC
NM_001399.5(EDA):c.319_322dup (p.Gln108fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000228336	X	68836470 - 68836471	X	69616626 - 69616627	228336	231289	rs876657684	NC_000023.11:69616626:GGGC:GGGCGGGC
NM_023036.6(DNAI2):c.1304G>A (p.Trp435Ter)	DNAI2	W435*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 9	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228335	17	72305484	17	74309345	228335	230781	rs752924362	NC_000017.11:74309344:G:A
NM_004006.2(DMD):c.(?_6439)-24498_(7873_?)-5329del	DMD		Muscular dystrophy	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000228331	X	31681590 - 32011129	X	31663473 - 31993012	228331	231238		
NM_017950.4(CCDC40):c.940-2A>G	CCDC40		Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228326	17	78023861	17	80050062	228326	230795	rs750708201	NC_000017.11:80050061:A:G
NM_017721.5(CC2D1A):c.748+1G>T	CC2D1A		Mental retardation, autosomal recessive 3|Mental Retardation, Psychosocial|not provided	Pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000228325	19	14024452	19	13913639	228325	230984	rs876657679	NC_000019.10:13913638:G:T
NM_001399.5(EDA):c.866G>A (p.Arg289His)	EDA	R289H, R286H	Partial congenital absence of teeth|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228257	X	69253320	X	70033470	228257	231292	rs876657641	NC_000023.11:70033469:G:A
NM_001399.5(EDA):c.1067C>T (p.Ala356Val)	EDA	A356V, A351V, A354V	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000228255	X	69255350	X	70035500	228255	231296	rs876657639	NC_000023.11:70035499:C:T
NM_000022.4(ADA):c.704G>A (p.Arg235Gln)	ADA	R235Q, R211Q, R100Q	Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228244	20	43251546	20	44622905	228244	231104	rs79281338	NC_000020.11:44622904:C:T
NM_001323289.2(CDKL5):c.173T>A (p.Leu58Ter)	CDKL5	L58*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 9, 2016)	no assertion criteria provided	VCV000226417	X	18593501	X	18575381	226417	228220	rs875989950	NC_000023.11:18575380:T:A
NM_000527.4(LDLR):c.314-?_1060+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Feb 12, 2009)	no assertion criteria provided	VCV000226407	19	11215895 - 11221447			226407	228103		
NM_000527.4(LDLR):c.2141-?_(2583_?)del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Feb 12, 2009)	no assertion criteria provided	VCV000226406	19	11233849 - 11244506			226406	228110		
NM_000527.4(LDLR):c.314-?_694+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jun 14, 2011)	no assertion criteria provided	VCV000226405	19	11215895 - 11216277			226405	228102		
NM_000527.4(LDLR):c.191-?_1186+?dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 13, 2010)	no assertion criteria provided	VCV000226404	19	11213339 - 11222316			226404	228101		
NM_000527.4(LDLR):c.1846-?_2140+?dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 18, 2010)	no assertion criteria provided	VCV000226403	19	11230767 - 11231199			226403	228108		
NM_000527.4(LDLR):c.1187-?_1586+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226401	19	11223953 - 11224439			226401	228105		
NM_000527.4(LDLR):c.941-?_1186+?dup	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 7, 2008)	no assertion criteria provided	VCV000226400	19	11221327 - 11222316			226400	228104		
NM_000527.4(LDLR):c.2141-?_2311+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000226399	19	11233849 - 11234021			226399	228109		
NM_000527.4(LDLR):c.818-?_1186+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 4, 2013)	no assertion criteria provided	VCV000226398	19	11218067 - 11222316			226398	228208		
NM_000527.4(LDLR):c.1587-?_1845+?del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226397	19	11226769 - 11227675			226397	228106		
NM_000527.4(LDLR):c.2344A>T (p.Lys782Ter)	LDLR	K782*, K604*, K614*, K741*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Oct 4, 2013)	no assertion criteria provided	VCV000226392	19	11238716	19	11128040	226392	228205	rs875989943	NC_000019.10:11128039:A:T
NM_000527.5(LDLR):c.2312-3C>A	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226391	19	11238681	19	11128005	226391	228204	rs875989942	NC_000019.10:11128004:C:A
NM_001195798.2(LDLR):c.2292del (p.Ile764fs)	LDLR	I723fs, I764fs, I586fs, I596fs	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226390	19	11234001	19	11123325	226390	228203	rs875989941	NC_000019.10:11123324:A:
NM_001195798.2(LDLR):c.2271del (p.Leu759fs)	LDLR	L591fs, L718fs, L759fs, L581fs	Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226388	19	11233980	19	11123304	226388	228201	rs875989940	NC_000019.10:11123303:T:
NM_000527.5(LDLR):c.2029T>C (p.Cys677Arg)	LDLR	C677R, C636R, C509R	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226384	19	11231087	19	11120411	226384	228197	rs775092314	NC_000019.10:11120410:T:C
NM_000527.4(LDLR):c.2027del (p.Gly676fs)	LDLR	G508fs, G635fs, G676fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000226383	19	11231084	19	11120408	226383	228196	rs875989937	NC_000019.10:11120407:GG:G
NM_001195798.2(LDLR):c.1952_1953AT[1] (p.Met652fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226381	19	11230874 - 11230875	19	11120198 - 11120199	226381	228194	rs875989935	NC_000019.10:11120197:ATAT:AT
NM_000527.5(LDLR):c.1897C>T (p.Arg633Cys)	LDLR	R633C, R465C, R592C, R506C	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226379	19	11230819	19	11120143	226379	228192	rs746118995	NC_000019.10:11120142:C:T
NM_000527.5(LDLR):c.1880C>A (p.Ala627Asp)	LDLR	A627D, A586D, A459D, A500D	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226377	19	11230802	19	11120126	226377	228190	rs875989934	NC_000019.10:11120125:C:A
NM_000527.5(LDLR):c.1731G>A (p.Trp577Ter)	LDLR	W577*, W450*, W409*, W536*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226370	19	11227560	19	11116884	226370	228182	rs875989928	NC_000019.10:11116883:G:A
NM_001195798.2(LDLR):c.1715_1719delinsA (p.Ser572fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226369	19	11227544 - 11227548	19	11116868 - 11116872	226369	228181	rs875989927	NC_000019.10:11116867:GTGGC:A
NM_000527.5(LDLR):c.1705+1G>A	LDLR		Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226367	19	11226889	19	11116213	226367	228179	rs875989926	NC_000019.10:11116212:G:A
NM_000527.5(LDLR):c.1694G>C (p.Gly565Ala)	LDLR	G565A, G438A, G524A, G397A	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226366	19	11226877	19	11116201	226366	228178	rs28942082	NC_000019.10:11116200:G:C
NM_000527.5(LDLR):c.1685G>A (p.Trp562Ter)	LDLR	W562*, W435*, W394*, W521*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000226364	19	11226868	19	11116192	226364	228177	rs875989925	NC_000019.10:11116191:G:A
NM_000527.5(LDLR):c.1618G>A (p.Ala540Thr)	LDLR	A540T, A499T, A372T, A413T	Familial hypercholesterolemia|Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226363	19	11226801	19	11116125	226363	228176	rs769370816	NC_000019.10:11116124:G:A
NM_000527.4(LDLR):c.1555C>A (p.Pro519Thr)	LDLR	P519T, P392T, P478T, P351T	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 18, 2014)	no assertion criteria provided	VCV000226360	19	11224407	19	11113731	226360	228173	rs875989923	NC_000019.10:11113730:C:A
NM_000527.4(LDLR):c.1469G>T (p.Trp490Leu)	LDLR	W490L, W322L, W449L, W363L	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000226358	19	11224321	19	11113645	226358	228171	rs875989922	NC_000019.10:11113644:G:T
NM_000527.5(LDLR):c.1469G>A (p.Trp490Ter)	LDLR	W490*, W449*, W322*, W363*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000226357	19	11224321	19	11113645	226357	228170	rs875989922	NC_000019.10:11113644:G:A
NM_000527.5(LDLR):c.1448G>A (p.Trp483Ter)	LDLR	W483*, W315*, W356*, W442*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226356	19	11224300	19	11113624	226356	228169	rs875989921	NC_000019.10:11113623:G:A
NM_001195798.2(LDLR):c.1371_1374dup (p.Ala459fs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226355	19	11224223 - 11224226	19	11113544 - 11113545	226355	228168	rs875989920	NC_000019.10:11113544:GACAGA:GACAGACAGA
NM_000527.5(LDLR):c.1285G>C (p.Val429Leu)	LDLR	V429L, V388L, V302L, V261L	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226353	19	11224052	19	11113376	226353	228166	rs28942078	NC_000019.10:11113375:G:C
NM_000527.5(LDLR):c.1216C>T (p.Arg406Trp)	LDLR	R406W, R238W, R365W, R279W	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226351	19	11223983	19	11113307	226351	228164	rs121908043	NC_000019.10:11113306:C:T
NM_000527.5(LDLR):c.1187-10G>A	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226349	19	11223944	19	11113268	226349	228162	rs765696008	NC_000019.10:11113267:G:A
NM_000527.4(LDLR):c.1162del (p.His388fs)	LDLR	H220fs, H347fs, H261fs, H388fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000226348	19	11222287	19	11111611	226348	228161	rs875989917	NC_000019.10:11111610:CCCCC:CCCC
NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs)	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000226347	19	11222247 - 11222250	19	11111568 - 11111569	226347	228160	rs875989916	NC_000019.10:11111568:GGGTGG:GGGTGGGTGG
NM_000527.5(LDLR):c.1048C>T (p.Arg350Ter)	LDLR	R350*, R182*, R223*, R309*	Familial hypercholesterolemia|Familial hypercholesterolemia 1|not provided	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226342	19	11221435	19	11110759	226342	228156	rs769737896	NC_000019.10:11110758:C:T
NM_000527.5(LDLR):c.1033C>T (p.Gln345Ter)	LDLR	Q345*, Q218*, Q304*, Q177*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226341	19	11221420	19	11110744	226341	228155	rs875989913	NC_000019.10:11110743:C:T
NM_000527.5(LDLR):c.940+2T>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226340	19	11218192	19	11107516	226340	228153	rs875989912	NC_000019.10:11107515:T:C
NM_000527.5(LDLR):c.938G>A (p.Cys313Tyr)	LDLR	C313Y, C272Y, C145Y, C186Y	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226339	19	11218188	19	11107512	226339	228151	rs875989911	NC_000019.10:11107511:G:A
NM_001195798.2(LDLR):c.938_939delinsAT (p.Cys313Tyr)	LDLR		not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226338	19	11218188 - 11218189	19	11107512 - 11107513	226338	228152	rs875989910	NC_000019.10:11107511:GC:AT
NM_000527.5(LDLR):c.912C>G (p.Asp304Glu)	LDLR	D304E, D136E, D177E, D263E	Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226336	19	11218162	19	11107486	226336	228149	rs875989909	NC_000019.10:11107485:C:G
NM_000527.4(LDLR):c.908_926dup (p.Ile310_Lys311insGlyLeuValArgTer)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 23, 2013)	no assertion criteria provided	VCV000226335	19	11218155 - 11218156	19	11107479 - 11107480	226335	228148	rs875989908	NC_000019.10:11107479:CCGGGACTGGTCAGATGAACC:CCGGGACTGGTCAGATGAACCGGGACTGGTCAGATGAACC
NM_000527.5(LDLR):c.796G>A (p.Asp266Asn)	LDLR	D266N, D225N, D139N	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226334	19	11217342	19	11106666	226334	228147	rs875989907	NC_000019.10:11106665:G:A
NM_000527.5(LDLR):c.682G>T (p.Glu228Ter)	LDLR	E228*, E187*	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226333	19	11216264	19	11105588	226333	228146	rs121908029	NC_000019.10:11105587:G:T
NM_000527.5(LDLR):c.661G>A (p.Asp221Asn)	LDLR	D221N, D180N	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226331	19	11216243	19	11105567	226331	228144	rs875989906	NC_000019.10:11105566:G:A
NM_001195800.2(LDLR):c.314-1826del	LDLR	D180fs, D221fs	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226330	19	11216239	19	11105563	226330	228143	rs875989905	NC_000019.10:11105562:CCCC:CCC
NM_001195800.2(LDLR):c.314-1832_314-1830del	LDLR	G219del, G197del, G218del	Familial hypercholesterolemia 1|Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000226329	19	11216233 - 11216235	19	11105557 - 11105559	226329	228142	rs121908027	NC_000019.10:11105556:TGGTGG:TGG
NM_001195800.2(LDLR):c.314-1838dup	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226328	19	11216230	19	11105553 - 11105554	226328	228141	rs875989903	NC_000019.10:11105553:T:TT
NM_000527.5(LDLR):c.429C>A (p.Cys143Ter)	LDLR	C143*, C102*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226325	19	11216011	19	11105335	226325	228138	rs199774121	NC_000019.10:11105334:C:A
NM_000527.5(LDLR):c.400T>C (p.Cys134Arg)	LDLR	C134R, C93R	Homozygous familial hypercholesterolemia|not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226322	19	11215982	19	11105306	226322	228135	rs875989900	NC_000019.10:11105305:T:C
NM_000527.5(LDLR):c.337G>T (p.Glu113Ter)	LDLR	E113*, E72*	not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226320	19	11215919	19	11105243	226320	228133	rs769383881	NC_000019.10:11105242:G:T
NM_000527.5(LDLR):c.326G>A (p.Cys109Tyr)	LDLR	C109Y, C68Y	not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226319	19	11215908	19	11105232	226319	228132	rs121908042	NC_000019.10:11105231:G:A
NM_001195800.2(LDLR):c.314-2168del	LDLR	K107fs, K66fs	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jun 14, 2012)	no assertion criteria provided	VCV000226318	19	11215896	19	11105220	226318	228131	rs875989898	NC_000019.10:11105219:CCCCC:CCCC
NM_000527.4(LDLR):c.313+2dup	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226317	19	11213464	19	11102787 - 11102788	226317	228130	rs875989897	NC_000019.10:11102787:T:TT
NM_000527.4(LDLR):c.313_313+1del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000226316	19	11213462 - 11213463	19	11102786 - 11102787	226316	228129	rs875989896	NC_000019.10:11102785:CG:
NM_000527.5(LDLR):c.311G>A (p.Cys104Tyr)	LDLR	C104Y	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226315	19	11213460	19	11102784	226315	228128	rs875989895	NC_000019.10:11102783:G:A
NM_000527.5(LDLR):c.304C>T (p.Gln102Ter)	LDLR	Q102*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000226314	19	11213453	19	11102777	226314	228127	rs563390335	NC_000019.10:11102776:C:T
NM_000527.5(LDLR):c.269A>G (p.Asp90Gly)	LDLR	D90G	Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226313	19	11213418	19	11102742	226313	228126	rs771019366	NC_000019.10:11102741:A:G
NM_000527.5(LDLR):c.266G>A (p.Cys89Tyr)	LDLR	C89Y	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226312	19	11213415	19	11102739	226312	228125	rs875989894	NC_000019.10:11102738:G:A
NM_000527.5(LDLR):c.253C>T (p.Gln85Ter)	LDLR	Q85*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226311	19	11213402	19	11102726	226311	228124	rs875989893	NC_000019.10:11102725:C:T
NM_000527.5(LDLR):c.246C>A (p.Cys82Ter)	LDLR	C82*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000226309	19	11213395	19	11102719	226309	228122	rs875989891	NC_000019.10:11102718:C:A
NM_001195799.2(LDLR):c.190+2324_190+2325del	LDLR	V66fs	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226307	19	11213345 - 11213346	19	11102668 - 11102669	226307	228120	rs875989889	NC_000019.10:11102667:TGT:T
NM_000527.5(LDLR):c.191-2A>G	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000226306	19	11213338	19	11102662	226306	228119	rs544203837	NC_000019.10:11102661:A:G
NM_000527.5(LDLR):c.82G>T (p.Glu28Ter)	LDLR	E28*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000226305	19	11210913	19	11100237	226305	228118	rs551747280	NC_000019.10:11100236:G:T
NM_000527.4(LDLR):c.1846-2179_2140+2154del	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jun 5, 2008)	no assertion criteria provided	VCV000226298	19	11228589 - 11233352	19	11117913 - 11122676	226298	228188		
GRCh37/hg19 Xp22.2(chrX:10299643-10638042)	MID1		Abnormality of esophagus morphology	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000226291	X	10299643 - 10638042			226291	228094		
NM_001278116.2(L1CAM):c.2380C>T (p.Gln794Ter)	L1CAM	Q794*, Q789*	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000226120	X	153132155	X	153866700	226120	227923	rs875989884	NC_000023.11:153866699:G:A
NM_001323289.2(CDKL5):c.747dup (p.Pro250fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000226116	X	18613467 - 18613468	X	18595347 - 18595348	226116	227924	rs875989880	NC_000023.11:18595347:TTT:TTTT
NM_177433.3(MAGED2):c.397A>T (p.Lys133Ter)	MAGED2	K133*	Bartter syndrome, type 5, antenatal, transient	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000226035	X	54836506	X	54810073	226035	227840	rs875989852	NC_000023.11:54810072:A:T
NM_177433.3(MAGED2):c.1336C>T (p.Arg446Cys)	MAGED2	R446C	Bartter syndrome, type 5, antenatal, transient	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000226034	X	54841158	X	54814725	226034	227839	rs878854407	NC_000023.11:54814724:C:T
NM_177433.3(MAGED2):c.384_385TG[1] (p.Val129fs)	MAGED2		Bartter syndrome, type 5, antenatal, transient	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000226033	X	54836493 - 54836494	X	54810060 - 54810061	226033	227838	rs878854406	NC_000023.11:54810059:TGTG:TG
NM_177433.3(MAGED2):c.991-2A>G	MAGED2		Bartter syndrome, type 5, antenatal, transient	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000226032	X	54838588	X	54812155	226032	227837	rs878854405	NC_000023.11:54812154:A:G
NM_177433.3(MAGED2):c.1038C>G (p.Tyr346Ter)	MAGED2	Y346*	Bartter syndrome, type 5, antenatal, transient	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000226031	X	54838637	X	54812204	226031	227836	rs878854404	NC_000023.11:54812203:C:G
NM_001356.4(DDX3X):c.577G>T (p.Gly193Ter)	DDX3X	G177*, G193*, G7*	Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000225894	X	41202502	X	41343249	225894	227709	rs875989803	NC_000023.11:41343248:G:T
NM_000308.3(CTSA):c.887_888del (p.Tyr296fs)	CTSA	Y278fs, Y279fs, Y296fs	Combined deficiency of sialidase AND beta galactosidase	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000225877	20	44523343 - 44523344	20	45894704 - 45894705	225877	227690	rs875989777	NC_000020.11:45894703:TAT:T
NM_003200.5(TCF3):c.1823-508G>A	TCF3	E555K	Agammaglobulinemia 8, autosomal dominant	Pathogenic(Last reviewed: Aug 21, 2017)	no assertion criteria provided	VCV000225870	19	1612356	19	1612357	225870	227683	rs879255271	NC_000019.10:1612356:C:T
NM_001111125.3(IQSEC2):c.2366C>T (p.Ala789Val)	IQSEC2	A789V, A584V	Mental retardation, X-linked 1	Pathogenic(Last reviewed: May 10, 2016)	no assertion criteria provided	VCV000225865	X	53277996	X	53248814	225865	227679	rs875989799	NC_000023.11:53248813:G:A
NM_001611.5(ACP5):c.772_790del (p.Ser258fs)	ACP5	S258fs	Spondyloenchondrodysplasia with immune dysregulation	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000225659	19	11686013 - 11686031	19	11575198 - 11575216	225659	227495	rs878853218	NC_000019.10:11575197:TGAAATTCCCAGCCCCACT:
NM_001611.5(ACP5):c.816dup (p.Lys273fs)	ACP5		Spondyloenchondrodysplasia with immune dysregulation	Pathogenic(Last reviewed: Aug 25, 2017)	no assertion criteria provided	VCV000225658	19	11685986 - 11685987	19	11575171 - 11575172	225658	227494	rs879255600	NC_000019.10:11575171:G:GG
NM_004006.2(DMD):c.6502G>T (p.Glu2168Ter)	DMD	E2168*, E827*, E2160*, E824*, E2164*, E2045*	Duchenne muscular dystrophy|Becker muscular dystrophy	Pathogenic(Last reviewed: Oct 3, 2016)	no assertion criteria provided	VCV000225615	X	31986568	X	31968451	225615	227452	rs779739455	NC_000023.11:31968450:C:A
NM_004586.3(RPS6KA3):c.913C>T (p.Arg305Ter)	RPS6KA3	R305*	Mental retardation, X-linked 19|Coffin-Lowry syndrome|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225519	X	20195135	X	20177017	225519	227426	rs869320705	NC_000023.11:20177016:G:A
NM_003331.5(TYK2):c.209_212del (p.Cys70fs)	TYK2	C70fs	not provided|Tyrosine kinase 2 deficiency	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000225508	19	10479076 - 10479079	19	10368400 - 10368403	225508	227400	rs770927552	NC_000019.10:10368399:AAGCAAG:AAG
NM_152296.5(ATP1A3):c.946G>A (p.Gly316Ser)	ATP1A3	G316S, G327S, G329S	Dystonia 12	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000225200	19	42489117	19	41984965	225200	227128	rs869320661	NC_000019.10:41984964:C:T
NM_000206.2(IL2RG):c.677G>A (p.Arg226His)	IL2RG	R226H	X-linked severe combined immunodeficiency|not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000225196	X	70329158	X	71109308	225196	227109	rs869320660	NC_000023.11:71109307:C:T
NM_000206.2(IL2RG):c.676C>T (p.Arg226Cys)	IL2RG	R226C	X-linked severe combined immunodeficiency|Combined immunodeficiency, X-linked|not provided|Combined immunodeficiency, X-linked|X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000225195	X	70329159	X	71109309	225195	227110	rs869320659	NC_000023.11:71109308:G:A
NM_000206.2(IL2RG):c.670C>T (p.Arg224Trp)	IL2RG	R224W	X-linked severe combined immunodeficiency|Combined immunodeficiency, X-linked|not provided	Pathogenic(Last reviewed: Jan 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225194	X	70329165	X	71109315	225194	227111	rs869320658	NC_000023.11:71109314:G:A
NM_001144967.3(NEDD4L):c.2036A>G (p.Tyr679Cys)	NEDD4L	Y679C, Y558C, Y671C, Y659C, Y538C, Y615C, Y651C	Periventricular nodular heterotopia 7|Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000225193	18	56033433	18	58366201	225193	227105	rs879255599	NC_000018.10:58366200:A:G
NM_001144967.3(NEDD4L):c.2082G>T (p.Gln694His)	NEDD4L	Q694H, Q573H, Q553H, Q630H, Q666H, Q686H, Q674H	Periventricular nodular heterotopia 7|Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay	Pathogenic(Last reviewed: Nov 16, 2016)	no assertion criteria provided	VCV000225192	18	56034996	18	58367764	225192	227106	rs879255598	NC_000018.10:58367763:G:T
NM_001144967.3(NEDD4L):c.2690G>A (p.Arg897Gln)	NEDD4L	R897Q, R756Q, R776Q, R877Q, R889Q, R833Q, R869Q	Periventricular nodular heterotopia 7|Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay	Pathogenic(Last reviewed: Apr 26, 2018)	no assertion criteria provided	VCV000225190	18	56057912	18	58390680	225190	227108	rs879255596	NC_000018.10:58390679:G:A
NM_000527.5(LDLR):c.2140G>T (p.Glu714Ter)	LDLR	E714*, E546*, E673*	not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000225183	19	11231198	19	11120522	225183	227098	rs869320652	NC_000019.10:11120521:G:T
NM_006031.6(PCNT):c.3594_3598dup (p.Leu1200fs)	PCNT		Inborn genetic diseases	Pathogenic(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	VCV000225019	21	47808785 - 47808786	21	46388870 - 46388871	225019	226983	rs869312929	NC_000021.9:46388870:GGCCC:GGCCCGGCCC
NM_022095.4(ZNF335):c.3332G>T (p.Arg1111Leu)	ZNF335	R1111L	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	VCV000225017	20	44579092	20	45950453	225017	226980	rs397514642	NC_000020.11:45950452:C:A
NM_018255.4(ELP2):c.617A>G (p.His206Arg)	ELP2	H271R, H206R, H57R, H245R, H180R	ELP2-Related Disorders|Mental retardation, autosomal recessive 58|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000225008	18	33722272	18	36142309	225008	226967	rs773432002	NC_000018.10:36142308:A:G
NM_006031.6(PCNT):c.2728C>T (p.Gln910Ter)	PCNT	Q910*, Q792*	Inborn genetic diseases	Pathogenic(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	VCV000224992	21	47786617	21	46366702	224992	226982	rs869312917	NC_000021.9:46366701:C:T
NM_003721.4(RFXANK):c.438+1G>T	RFXANK		Inborn genetic diseases	Pathogenic(Last reviewed: May 24, 2013)	criteria provided, single submitter	VCV000224982	19	19308431	19	19197622	224982	226973	rs869312922	NC_000019.10:19197621:G:T
NM_016937.4(POLA1):c.1375-354A>G	POLA1		Pigmentary disorder, reticulate, with systemic manifestations, X-linked	Pathogenic	criteria provided, single submitter	VCV000224980	X	24744696	X	24726579	224980	226861	rs869312979	NC_000023.11:24726578:A:G
NM_001830.4(CLCN4):c.1630G>C (p.Gly544Arg)	CLCN4	G544R, G450R	CLCN4-related disorder	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000224917	X	10181774	X	10213734	224917	226786	rs587777161	NC_000023.11:10213733:G:C
NM_003331.5(TYK2):c.1912C>T (p.Arg638Ter)	TYK2	R638*	Tyrosine kinase 2 deficiency	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000224888	19	10472493	19	10361817	224888	226733	rs201025290	NC_000019.10:10361816:G:A
NM_003331.5(TYK2):c.149del (p.Ser50fs)	TYK2	S50fs	Tyrosine kinase 2 deficiency	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000224887	19	10488934	19	10378258	224887	226732	rs879253732	NC_000019.10:10378257:G:
NM_003331.5(TYK2):c.460G>T (p.Glu154Ter)	TYK2	E154*	Tyrosine kinase 2 deficiency	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000224886	19	10478736	19	10368060	224886	226731	rs879253731	NC_000019.10:10368059:C:A
NM_003331.4(TYK2):c.3318_3319insC	TYK2		Tyrosine kinase 2 deficiency	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000224885					224885	226730	rs1555715518	
NM_004782.4(SNAP29):c.223del (p.Val75fs)	SNAP29	V75fs		Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224877	22	21213618	22	20859330	224877	226728	rs869312906	NC_000022.11:20859329:GGGG:GGG
NM_021220.4(OVOL2):c.-274T>G	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 30, 2016)	no assertion criteria provided	VCV000224840	20	18038552	20	18057908	224840	226680	rs869320630	NC_000020.11:18057907:A:C
NM_001303461.1(OVOL2):c.-297+949T>C	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 30, 2016)	no assertion criteria provided	VCV000224839	20	18038585	20	18057941	224839	226679	rs869320629	NC_000020.11:18057940:A:G
NM_001303461.1(OVOL2):c.-297+886T>C	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 30, 2016)	no assertion criteria provided	VCV000224838	20	18038648	20	18058004	224838	226678	rs869320628	NC_000020.11:18058003:A:G
NM_001303461.1(OVOL2):c.-297+895_-297+916dup	OVOL2		Posterior polymorphous corneal dystrophy 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000224837	20	18038617 - 18038618	20	18057973 - 18057974	224837	226677	rs869320627	NC_000020.11:18057973:CCGGTTCCGGCGGCCGGGGCTGCC:CCGGTTCCGGCGGCCGGGGCTGCCGGTTCCGGCGGCCGGGGCTGCC
NM_177559.3(CSNK2A1):c.149A>C (p.Tyr50Ser)	CSNK2A1	Y50S	Okur-chung neurodevelopmental syndrome	Pathogenic(Last reviewed: Aug 5, 2016)	no assertion criteria provided	VCV000224800	20	485826	20	505182	224800	226618	rs869312849	NC_000020.11:505181:T:G
NM_177559.3(CSNK2A1):c.524A>G (p.Asp175Gly)	CSNK2A1	D175G, D39G	Okur-chung neurodevelopmental syndrome	Pathogenic(Last reviewed: Aug 5, 2016)	no assertion criteria provided	VCV000224799	20	472995	20	492351	224799	226617	rs869312848	NC_000020.11:492350:T:C
NM_177559.3(CSNK2A1):c.824+2T>C	CSNK2A1		Okur-chung neurodevelopmental syndrome	Pathogenic(Last reviewed: Aug 5, 2016)	no assertion criteria provided	VCV000224797	20	469320	20	488676	224797	226615	rs869312846	NC_000020.11:488675:A:G
NM_177559.3(CSNK2A1):c.140G>A (p.Arg47Gln)	CSNK2A1	R47Q	Okur-chung neurodevelopmental syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224796	20	485835	20	505191	224796	226619	rs869312845	NC_000020.11:505190:C:T
NM_177559.3(CSNK2A1):c.593A>G (p.Lys198Arg)	CSNK2A1	K198R, K62R	Okur-chung neurodevelopmental syndrome|not provided	Pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224790	20	472926	20	492282	224790	226616	rs869312840	NC_000020.11:492281:T:C
NM_001429.4(EP300):c.7220_7221CA[1] (p.Gln2408fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000224785	22	41574935 - 41574936	22	41178931 - 41178932	224785	226604	rs1057519375	NC_000022.11:41178930:CACA:CA
NM_152906.7(TANGO2):c.418C>T (p.Arg140Ter)	TANGO2	R140*, R181*, R42*, R106*	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	Pathogenic(Last reviewed: May 9, 2019)	no assertion criteria provided	VCV000224774	22	20043503	22	20055980	224774	226593	rs764883927	NC_000022.11:20055979:C:T
NM_152906.7(TANGO2):c.4del (p.Cys2fs)	TANGO2	C2fs	METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	Pathogenic(Last reviewed: May 9, 2019)	no assertion criteria provided	VCV000224773	22	20024325	22	20036802	224773	226592	rs869320693	NC_000022.11:20036801:T:
NM_152906.5(TANGO2):c.146-3605_451+2245del	TANGO2		METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION|Cardiac arrhythmia|Intellectual functioning disability|Acute rhabdomyolysis|Seizures|Episodic flaccid weakness	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000224772			22	20048857 - 20058261	224772	226591		
NM_152906.5(TANGO2):c.57-1743_*10769del	TANGO2		Cardiac arrhythmia|Intellectual functioning disability|Acute rhabdomyolysis|Seizures|Episodic flaccid weakness|METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000224770	22	20029135 - 20062954	22	20041612 - 20075431	224770	226589		
NM_015629.4(PRPF31):c.1120C>T (p.Gln374Ter)	PRPF31	Q374*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000224758	19	54631726	19	54128351	224758	226535	rs869312187	NC_000019.10:54128350:C:T
NM_000328.3(RPGR):c.1905+23C>G	RPGR	S643*	Retinal dystrophy	Pathogenic(Last reviewed: Jan 30, 2015)	no assertion criteria provided	VCV000224756	X	38146324	X	38287071	224756	226536	rs869312185	NC_000023.11:38287070:G:C
NM_005461.4(MAFB):c.(?_391)_*(390_?)del	MAFB		Duane syndrome type 1|Duane retraction syndrome 2	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000224629	20	39316129 - 39317100	20	40687489 - 40688460	224629	226408		
NM_005461.5(MAFB):c.803del (p.Asn268fs)	MAFB	N268fs	Duane retraction syndrome 3 with or without deafness|Duane syndrome type 1|Duane retraction syndrome 2	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000224628	20	39316688	20	40688048	224628	226409	rs879255275	NC_000020.11:40688047:TT:T
NM_005461.5(MAFB):c.644del (p.Gln215fs)	MAFB	Q215fs	Duane syndrome type 3|Duane syndrome type 1|Duane retraction syndrome 2	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000224627	20	39316847	20	40688207	224627	226410	rs879255277	NC_000020.11:40688206:T:
NM_005461.5(MAFB):c.440del (p.Gly147fs)	MAFB	G147fs	Duane syndrome type 3|Duane syndrome type 1|Duane retraction syndrome 2	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000224626	20	39317051	20	40688411	224626	226411	rs879255276	NC_000020.11:40688410:CCC:CC
GRCh37/hg19 Xq26.2(chrX:132834006-132986815)	GPC3		Simpson-Golabi-Behmel syndrome	Pathogenic	no assertion criteria provided	VCV000224615	X	132834006 - 132986815			224615	226397		
NM_005359.5(SMAD4):c.(?_-538)_1139+?del	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224549	18	48556583 - 48591976	18	51030213 - 51065606	224549	226369		
NM_005359.5(SMAD4):c.886_895delCCCCATCCCG (p.Pro296Aspfs)	SMAD4	P296fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	VCV000224548	18	48584805 - 48584814	18	51058435 - 51058444	224548	226370	rs869312781	NC_000018.10:51058434:CCGCCCCATCCCG:CCG
NM_032608.7(MYO18B):c.6496G>T (p.Glu2166Ter)	MYO18B	E2166*, E2167*	Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000224413	22	26422436	22	26026470	224413	226149	rs869312740	NC_000022.11:26026469:G:T
NM_001161748.2(LIM2):c.461G>A (p.Gly154Glu)	LIM2	G154E, G196E	Cataract 19, multiple types	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000224327	19	51883516	19	51380262	224327	226063	rs869312732	NC_000019.10:51380261:C:T
g.6109607_6112272del	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224186					224186	225914		
g.6116239_6120157del	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224185					224185	225913		
NM_017671.4(FERMT1):c.850-272_1139+53del	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224184	20	6075533 - 6078550	20	6094886 - 6097903	224184	225912		
NM_017671.4(FERMT1):c.0_-19+470del	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224183	20	6102951 - 6104903	20	6122304 - 6124256	224183	225911		
NM_017671.4(FERMT1):c.1848G>A (p.Trp616Ter)	FERMT1	W616*	Kindler's syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000224182	20	6060095	20	6079448	224182	225893	rs869312731	NC_000020.11:6079447:C:T
NM_017671.4(FERMT1):c.1383C>A (p.Tyr461Ter)	FERMT1	Y461*	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224181	20	6065923	20	6085276	224181	225895	rs142328166	NC_000020.11:6085275:G:T
NM_017671.4(FERMT1):c.1176T>G (p.Tyr392Ter)	FERMT1	Y392*	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224180	20	6069700	20	6089053	224180	225897	rs869312730	NC_000020.11:6089052:A:C
NM_017671.4(FERMT1):c.1161del (p.Ala388fs)	FERMT1	A388fs	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224179	20	6069715	20	6089068	224179	225898	rs869312729	NC_000020.11:6089067:TTTT:TTT
NM_017671.4(FERMT1):c.1139+740G>A	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224178	20	6074846	20	6094199	224178	225899	rs869312728	NC_000020.11:6094198:C:T
NM_017671.4(FERMT1):c.1139+2T>C	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224177	20	6075584	20	6094937	224177	225900	rs869312727	NC_000020.11:6094936:A:G
NM_017671.4(FERMT1):c.992_993CA[1] (p.Gln332fs)	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224176	20	6077643 - 6077644	20	6096996 - 6096997	224176	225901	rs866141540	NC_000020.11:6096995:TGTGT:TGT
NM_017671.4(FERMT1):c.958-1G>A	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224175	20	6077681	20	6097034	224175	225902	rs869312726	NC_000020.11:6097033:C:T
NM_017671.4(FERMT1):c.957+1G>A	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224174	20	6078170	20	6097523	224174	225903	rs869312725	NC_000020.11:6097522:C:T
NM_017671.4(FERMT1):c.910G>T (p.Glu304Ter)	FERMT1	E304*	Kindler's syndrome	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000224173	20	6078218	20	6097571	224173	225904	rs146180696	NC_000020.11:6097570:C:A
NM_017671.4:c.676insC	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224172					224172	225910		
NM_017671.4(FERMT1):c.550dup (p.Ser184fs)	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224171	20	6091140 - 6091141	20	6110493 - 6110494	224171	225906	rs869312724	NC_000020.11:6110493:T:TT
NM_017671.4(FERMT1):c.373del (p.Cys125fs)	FERMT1	C125fs	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224170	20	6096470	20	6115823	224170	225907	rs869312723	NC_000020.11:6115822:A:
NM_017671.4(FERMT1):c.-20A>G	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224169	20	6103422	20	6122775	224169	225909	rs869312722	NC_000020.11:6122774:T:C
NM_017671.4(FERMT1):c.1867_1869del (p.Ile623del)	FERMT1	I623del	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224168	20	6057985 - 6057987	20	6077338 - 6077340	224168	225892	rs869312721	NC_000020.11:6077337:GATGA:GA
NM_017671.4(FERMT1):c.299_301del (p.Arg100del)	FERMT1	R100del	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224167	20	6096542 - 6096544	20	6115895 - 6115897	224167	225908	rs869312720	NC_000020.11:6115894:GACGA:GA
NM_017671.4(FERMT1):c.1675T>C (p.Trp559Arg)	FERMT1	W559R	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224166	20	6064730	20	6084083	224166	225894	rs869312719	NC_000020.11:6084082:A:G
NM_017671.4(FERMT1):c.1198T>C (p.Ser400Pro)	FERMT1	S400P	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224165	20	6069678	20	6089031	224165	225896	rs869312718	NC_000020.11:6089030:A:G
NM_017671.4(FERMT1):c.889A>G (p.Arg297Gly)	FERMT1	R297G	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000224164	20	6078239	20	6097592	224164	225905	rs779612399	NC_000020.11:6097591:T:C
NM_001347721.2(DYRK1A):c.1612C>T (p.Gln538Ter)	DYRK1A	Q547*, Q538*, Q509*	not provided|Mental retardation, autosomal dominant 7	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000224154	21	38878494	21	37506191	224154	225882	rs869312708	NC_000021.9:37506190:C:T
NM_030632.3(ASXL3):c.1682C>A (p.Ser561Ter)	ASXL3	S561*	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000224134	18	31319050	18	33739086	224134	225864	rs869312696	NC_000018.10:33739085:C:A
NM_001356.4(DDX3X):c.619C>T (p.Gln207Ter)	DDX3X	Q207*, Q21*, Q191*	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000224129	X	41202544	X	41343291	224129	225859	rs869312692	NC_000023.11:41343290:C:T
NM_005334.3(HCFC1):c.5048C>G (p.Pro1683Arg)	HCFC1	P1683R	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000224121	X	153217504	X	153952053	224121	225851	rs869312686	NC_000023.11:153952052:G:C
NM_001008537.3(NEXMIF):c.2995_2996CT[2] (p.Ser1000fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000224106	X	73961392 - 73961393	X	74741557 - 74741558	224106	225836	rs875989829	NC_000023.11:74741556:AGAGAG:AGAG
NM_005650.3(TCF20):c.5383_5384TG[1] (p.Cys1795fs)	TCF20		not provided	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000224102	22	42605926 - 42605927	22	42209920 - 42209921	224102	225832	rs869312678	NC_000022.11:42209919:CACA:CA
NM_001356.4(DDX3X):c.745G>T (p.Glu249Ter)	DDX3X	E249*, E233*, E63*	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000224100	X	41203055	X	41343802	224100	225830	rs752738546	NC_000023.11:41343801:G:T
NM_139058.3(ARX):c.1002_1007delinsTGTACCA (p.Phe335fs)	ARX		Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	VCV000224076	X	25031105 - 25031110	X	25012988 - 25012993	224076	225804	rs869312662	NC_000023.11:25012987:GTGAAC:TGGTACA
NM_000709.4(BCKDHA):c.940C>T (p.Arg314Ter)	BCKDHA	R314*, R313*	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224072	19	41928620	19	41422715	224072	225801	rs753698250	NC_000019.10:41422714:C:T
NM_018129.4(PNPO):c.674G>A (p.Arg225His)	PNPO	R225H	Growth delay|Intrauterine growth retardation|Seizures|Pyridoxal phosphate-responsive seizures|Distal hereditary motor neuronopathy type 5	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000223153	17	46024036	17	47946670	223153	224877	rs550423482	NC_000017.11:47946669:G:A
NM_001204402.1(PRPS1):c.-159T>C	PRPS1	S16P	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Sep 23, 2016)	no assertion criteria provided	VCV000223101	X	106871904	X	107628674	223101	224828	rs869025594	NC_000023.11:107628673:T:C
NM_002764.3(PRPS1):c.830A>C (p.Gln277Pro)	PRPS1	Q277P, Q73P	Arts syndrome|Deafness, X-linked 1	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223100	X	106890961	X	107647731	223100	224827	rs869025593	NC_000023.11:107647730:A:C
NM_001039591.3(USP9X):c.1111C>T (p.Arg371Ter)	USP9X	R371*	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223098	X	41000634	X	41141381	223098	224825	rs869025592	NC_000023.11:41141380:C:T
NM_001039591.3(USP9X):c.3763C>T (p.Gln1255Ter)	USP9X	Q1255*	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223097	X	41047323	X	41188070	223097	224824	rs869025591	NC_000023.11:41188069:C:T
NM_001039591.3(USP9X):c.2644_2645insA (p.Arg882fs)	USP9X		Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223096	X	41029255 - 41029256	X	41170002 - 41170003	223096	224823	rs869025590	NC_000023.11:41170002::A
NM_001039591.3(USP9X):c.3028-2A>G	USP9X		Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223095	X	41031089	X	41171836	223095	224822	rs869025589	NC_000023.11:41171835:A:G
NM_001039591.3(USP9X):c.2554C>T (p.Arg852Ter)	USP9X	R852*	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223094	X	41027389	X	41168136	223094	224821	rs869025588	NC_000023.11:41168135:C:T
NM_001257988.1(TYMP):c.784del (p.Ser261_Leu262insTer)	TYMP		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223081	22	50965149	22	50526720	223081	224806	rs1064792888	NC_000022.11:50526719:GG:G
NM_001257988.1(TYMP):c.720del (p.Val241fs)	TYMP	V241fs	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223080	22	50965639	22	50527210	223080	224805	rs1064792887	NC_000022.11:50527209:GG:G
NM_001257988.1(TYMP):c.263_264del (p.Thr88fs)	TYMP	T88fs	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223079	22	50967718 - 50967719	22	50529289 - 50529290	223079	224804	rs1064792886	NC_000022.11:50529288:GG:
c.52_53delCT	TYMP		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223078					223078	224803		
NM_001257988.1(TYMP):c.99dup (p.Lys34fs)	TYMP		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223072	22	50968039 - 50968040	22	50529610 - 50529611	223072	224797	rs1064792880	NC_000022.11:50529610:GGG:GGGG
NM_001953.4(TYMP):c.929-3G>A	TYMP		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223063					223063	224788		
NM_001257988.1(TYMP):c.928+1G>A	TYMP		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223062	22	50965004	22	50526575	223062	224787	rs1064792876	NC_000022.11:50526574:C:T
NM_001257988.1(TYMP):c.938T>C (p.Leu313Pro)	TYMP	L313P	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223050	22	50964896	22	50526467	223050	224775	rs892141220	NC_000022.11:50526466:A:G
NM_001257988.1(TYMP):c.931G>T (p.Gly311Cys)	TYMP	G311C	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223049	22	50964903	22	50526474	223049	224774	rs121913040	NC_000022.11:50526473:C:A
NM_001257988.1(TYMP):c.931G>A (p.Gly311Ser)	TYMP	G311S	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223048	22	50964903	22	50526474	223048	224773	rs121913040	NC_000022.11:50526473:C:T
NM_001257988.1(TYMP):c.893G>A (p.Gly298Asp)	TYMP	G298D	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223046	22	50965040	22	50526611	223046	224771	rs1064792872	NC_000022.11:50526610:C:T
NM_001257988.1(TYMP):c.865G>A (p.Glu289Lys)	TYMP	E289K	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223044	22	50965068	22	50526639	223044	224769	rs946234163	NC_000022.11:50526638:C:T
NM_001257988.1(TYMP):c.856G>A (p.Glu286Lys)	TYMP	E286K	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223043	22	50965077	22	50526648	223043	224768	rs866001342	NC_000022.11:50526647:C:T
NM_001257988.1(TYMP):c.847C>G (p.His283Asp)	TYMP	H283D	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223041	22	50965086	22	50526657	223041	224766	rs1064792871	NC_000022.11:50526656:G:C
NM_001257988.1(TYMP):c.760A>C (p.Thr254Pro)	TYMP	T254P	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223040	22	50965599	22	50527170	223040	224765	rs1064792870	NC_000022.11:50527169:T:G
NM_001257988.1(TYMP):c.715G>A (p.Ala239Thr)	TYMP	A239T	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223039	22	50965644	22	50527215	223039	224764	rs1064792869	NC_000022.11:50527214:C:T
NM_001257988.1(TYMP):c.707T>C (p.Phe236Ser)	TYMP	F236S	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223038	22	50965652	22	50527223	223038	224763	rs1064792868	NC_000022.11:50527222:A:G
NM_001257988.1(TYMP):c.623T>G (p.Val208Gly)	TYMP	V208G	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223036	22	50966040	22	50527611	223036	224761	rs1064792867	NC_000022.11:50527610:A:C
NM_001257988.1(TYMP):c.605G>A (p.Arg202Lys)	TYMP	R202K	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223033	22	50966058	22	50527629	223033	224758	rs121913041	NC_000022.11:50527628:C:T
NM_001257988.1(TYMP):c.530T>C (p.Leu177Pro)	TYMP	L177P	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223032	22	50966133	22	50527704	223032	224757	rs1064792866	NC_000022.11:50527703:A:G
NM_001257988.1(TYMP):c.518T>G (p.Met173Arg)	TYMP	M173R	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223031	22	50966145	22	50527716	223031	224756	rs1064792865	NC_000022.11:50527715:A:C
NM_001257988.1(TYMP):c.478T>C (p.Ser160Pro)	TYMP	S160P	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223030	22	50966979	22	50528550	223030	224755	rs1064792864	NC_000022.11:50528549:A:G
NM_001257988.1(TYMP):c.467A>G (p.Asp156Gly)	TYMP	D156G	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223029	22	50966990	22	50528561	223029	224754	rs1064792863	NC_000022.11:50528560:T:C
NM_001257988.1(TYMP):c.401C>A (p.Ala134Glu)	TYMP	A134E	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223026	22	50967581	22	50529152	223026	224751	rs199901350	NC_000022.11:50529151:G:T
NM_001257988.1(TYMP):c.398T>C (p.Leu133Pro)	TYMP	L133P	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223025	22	50967584	22	50529155	223025	224750	rs1064792862	NC_000022.11:50529154:A:G
NM_001257988.1(TYMP):c.340G>A (p.Asp114Asn)	TYMP	D114N	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223024	22	50967642	22	50529213	223024	224749	rs1064792861	NC_000022.11:50529212:C:T
NM_001257988.1(TYMP):c.328C>T (p.Gln110Ter)	TYMP	Q110*	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223023	22	50967654	22	50529225	223023	224748	rs1064792860	NC_000022.11:50529224:G:A
NM_001257988.1(TYMP):c.275C>A (p.Thr92Asn)	TYMP	T92N	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223022	22	50967707	22	50529278	223022	224747	rs891107196	NC_000022.11:50529277:G:T
NM_001257988.1(TYMP):c.261G>T (p.Glu87Asp)	TYMP	E87D	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223021	22	50967721	22	50529292	223021	224746	rs749827433	NC_000022.11:50529291:C:A
NM_001257988.1(TYMP):c.261G>C (p.Glu87Asp)	TYMP	E87D	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223020	22	50967721	22	50529292	223020	224745	rs749827433	NC_000022.11:50529291:C:G
NM_001257988.1(TYMP):c.228G>A (p.Met76Ile)	TYMP	M76I	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223019	22	50967754	22	50529325	223019	224744	rs1064792859	NC_000022.11:50529324:C:T
NM_001257988.1(TYMP):c.162C>G (p.Ile54Met)	TYMP	I54M	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223018	22	50967977	22	50529548	223018	224743	rs1064792858	NC_000022.11:50529547:G:C
NM_001257988.1(TYMP):c.146T>G (p.Leu49Arg)	TYMP	L49R	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223017	22	50967993	22	50529564	223017	224742	rs1064792857	NC_000022.11:50529563:A:C
NM_001257988.1(TYMP):c.128A>C (p.Lys43Thr)	TYMP	K43T	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223015	22	50968011	22	50529582	223015	224740	rs752137335	NC_000022.11:50529581:T:G
NM_001257988.1(TYMP):c.112G>T (p.Glu38Ter)	TYMP	E38*	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000223014	22	50968027	22	50529598	223014	224739	rs1054084896	NC_000022.11:50529597:C:A
NM_001195798.2(LDLR):c.1486_1487del (p.Gly496fs)	LDLR	G328fs, G455fs, G369fs, G496fs	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000222689	19	11224338 - 11224339	19	11113661 - 11113662	222689	224549	rs869025454	NC_000019.10:11113660:GGG:G
NM_001195798.2(LDLR):c.1476_1477CT[1] (p.Ser493fs)	LDLR		Familial hypercholesterolemia|not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222688	19	11224328 - 11224329	19	11113652 - 11113653	222688	224548	rs869025453	NC_000019.10:11113651:CTCT:CT
NM_007363.5(NONO):c.1093C>T (p.Arg365Ter)	NONO	R365*, R276*	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000222083	X	70517750	X	71297900	222083	223782	rs869025345	NC_000023.11:71297899:C:T
NM_007363.5(NONO):c.1394dup (p.Asn466fs)	NONO		Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Jun 8, 2017)	no assertion criteria provided	VCV000222082	X	70519900 - 70519901	X	71300050 - 71300051	222082	223781	rs869025344	NC_000023.11:71300050:CCCC:CCCCC
NM_007363.5(NONO):c.1131G>A (p.Ala377=)	NONO		Mental retardation, X-linked, syndromic 34|not provided	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000222081	X	70517788	X	71297938	222081	223780	rs869025343	NC_000023.11:71297937:G:A
NM_033380.3(COL4A5):c.1010G>T (p.Gly337Val)	COL4A5	G337V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000222062	X	107827733	X	108584503	222062	223756	rs869025334	NC_000023.11:108584502:G:T
NM_033380.3(COL4A5):c.82G>T (p.Ala28Ser)	COL4A5	A28S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000222061	X	107782976	X	108539746	222061	223755	rs869025333	NC_000023.11:108539745:G:T
NM_033380.3(COL4A5):c.2741G>A (p.Gly914Asp)	COL4A5	G914D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000222060	X	107865096	X	108621866	222060	223760	rs869025332	NC_000023.11:108621865:G:A
NM_033380.3(COL4A5):c.2395+1G>A	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000222059	X	107850123	X	108606893	222059	223759	rs869025331	NC_000023.11:108606892:G:A
NM_033380.3(COL4A5):c.1780-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000222057	X	107841931	X	108598701	222057	223758	rs104886338	NC_000023.11:108598700:G:T
NM_001143986.2(TLE6):c.1529C>A (p.Ser510Tyr)	TLE6	S510Y, S387Y	Preimplantation embryonic lethality 1	Pathogenic(Last reviewed: Dec 2, 2016)	no assertion criteria provided	VCV000222026	19	2993572	19	2993574	222026	223717	rs767222404	NC_000019.10:2993573:C:A
NM_013447.4(ADGRE2):c.1475G>A (p.Cys492Tyr)	ADGRE2	C492Y	Vibratory urticaria	Pathogenic(Last reviewed: Jun 24, 2016)	no assertion criteria provided	VCV000222005	19	14865881	19	14755069	222005	223695	rs199718602	NC_000019.10:14755068:C:T
NM_018896.5(CACNA1G):c.5144G>A (p.Arg1715His)	CACNA1G	R1715H, R1670H, R1681H, R1704H, R1677H, R1688H, R1697H, R1663H, R1658H, R1674H, R1679H, R1692H, R1722H	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS|Spinocerebellar ataxia 42|Spinocerebellar ataxia 42|CACNA1G-related disorders	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000221981	17	48694921	17	50617560	221981	223669	rs755221106	NC_000017.11:50617559:G:A
NM_000202.7(IDS):c.-217_103del320	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000221979	X	148586565 - 148586884	X	149505035 - 149505354	221979	223667	rs1557340558	
NM_000202.8(IDS):c.1463del (p.Met488fs)	IDS	M398fs, M488fs	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000221976	X	148564467	X	149482936	221976	223658	rs869025307	NC_000023.11:149482935:A:
NM_000159.4(GCDH):c.795_796insCTATGATCATC (p.Met266delinsLeuTer)	GCDH		Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 15, 2015)	no assertion criteria provided	VCV000221909	19	13007169 - 13007170	19	12896355 - 12896356	221909	223592	rs869025300	NC_000019.10:12896355:ATGATCATC:ATGATCATCCTATGATCATC
NM_000334.4(SCN4A):c.1320T>G (p.Asn440Lys)	SCN4A	N440K	Hyperkalemic Periodic Paralysis Type 1	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000221261	17	62041960	17	63964600	221261	222958	rs864622785	NC_000017.11:63964599:A:C
NM_002340.6(LSS):c.1741T>C (p.Trp581Arg)	LSS	W581R, W570R, W501R	Cataract 44	Pathogenic(Last reviewed: Jan 17, 2017)	no assertion criteria provided	VCV000221227	21	47615666	21	46195752	221227	222925	rs864622780	NC_000021.9:46195751:A:G
NM_002340.6(LSS):c.1762G>A (p.Gly588Ser)	LSS	G588S, G577S, G508S	Cataract 44	Pathogenic(Last reviewed: Jan 17, 2017)	no assertion criteria provided	VCV000221226	21	47615645	21	46195731	221226	222924	rs561449819	NC_000021.9:46195730:C:T
NM_000202.8(IDS):c.191T>A (p.Ile64Asn)	IDS	I64N	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000221222	X	148585736	X	149504206	221222	222919	rs781997631	NC_000023.11:149504205:A:T
NM_000202.8(IDS):c.241-5A>T	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Mar 25, 2008)	criteria provided, single submitter	VCV000221219	X	148585024	X	149503494	221219	222918	rs113993952	NC_000023.11:149503493:T:A
NM_000202.8(IDS):c.1181-1G>A	IDS		Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Dec 5, 2011)	criteria provided, single submitter	VCV000221218	X	148564750	X	149483219	221218	222901	rs864622777	NC_000023.11:149483218:C:T
NM_000202.8(IDS):c.411del (p.His138fs)	IDS	H138fs, H48fs	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Dec 11, 2007)	criteria provided, single submitter	VCV000221216	X	148584849	X	149503319	221216	222915	rs864622776	NC_000023.11:149503318:AAA:AA
NM_000202.8(IDS):c.22_37del (p.Arg8fs)	IDS	R8fs	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: May 16, 2012)	criteria provided, single submitter	VCV000221215	X	148586631 - 148586646	X	149505101 - 149505116	221215	222921	rs864622775	NC_000023.11:149505100:GCCAGAGAAGGCCTCGGCC:GCC
NM_000202.8(IDS):c.401G>A (p.Gly134Glu)	IDS	G134E, G44E	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Feb 26, 2008)	criteria provided, single submitter	VCV000221207	X	148584859	X	149503329	221207	222916	rs193302910	NC_000023.11:149503328:C:T
NM_000202.8(IDS):c.359C>A (p.Pro120His)	IDS	P120H, P30H	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Dec 3, 2010)	criteria provided, single submitter	VCV000221206	X	148584901	X	149503371	221206	222917	rs193302911	NC_000023.11:149503370:G:T
NM_000202.8(IDS):c.181T>C (p.Ser61Pro)	IDS	S61P	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Jan 27, 2010)	criteria provided, single submitter	VCV000221205	X	148585746	X	149504216	221205	222920	rs113993955	NC_000023.11:149504215:A:G
NM_000202.8(IDS):c.1433A>G (p.Asp478Gly)	IDS	D478G, D388G	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: May 22, 2013)	criteria provided, single submitter	VCV000221204	X	148564497	X	149482966	221204	222898	rs864622773	NC_000023.11:149482965:T:C
NM_000202.8(IDS):c.1393C>T (p.Gln465Ter)	IDS	Q465*, Q375*	not provided|Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000221202	X	148564537	X	149483006	221202	222900	rs864622772	NC_000023.11:149483005:G:A
NM_000455.4(STK11):c.394del (p.Cys132fs)	STK11	C132fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 31, 2015)	criteria provided, single submitter	VCV000220968	19	1219342	19	1219343	220968	222789	rs864622707	NC_000019.10:1219342:T:
NM_000166.6(GJB1):c.644G>C (p.Arg215Pro)	GJB1	R215P	Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000219704	X	70444201	X	71224351	219704	222887	rs864622215	NC_000023.11:71224350:G:C
NM_004230.4(S1PR2):c.323G>C (p.Arg108Pro)	S1PR2	R108P	Deafness, autosomal recessive 68	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000219259	19	10335259	19	10224583	219259	217338	rs869312749	NC_000019.10:10224582:C:G
NM_004230.4(S1PR2):c.419A>G (p.Tyr140Cys)	S1PR2	Y140C	Deafness, autosomal recessive 68	Pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	VCV000219249	19	10335163	19	10224487	219249	217271	rs869312750	NC_000019.10:10224486:T:C
NM_172107.3(KCNQ2):c.319C>T (p.Leu107Phe)	KCNQ2	L107F	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000219241	20	62078168	20	63446815	219241	217263	rs864321712	NC_000020.11:63446814:G:A
NM_172107.4(KCNQ2):c.775G>T (p.Asp259Tyr)	KCNQ2	D259Y	Benign familial neonatal seizures 1	Pathogenic	no assertion criteria provided	VCV000219240	20	62073800	20	63442447	219240	217261	rs777257591	NC_000020.11:63442446:C:A
NM_172107.4(KCNQ2):c.2147C>T (p.Thr716Ile)	KCNQ2	T716I, T685I, T688I, T698I	Early infantile epileptic encephalopathy 7	Pathogenic	no assertion criteria provided	VCV000219239	20	62038469	20	63407116	219239	217256	rs864321711	NC_000020.11:63407115:G:A
NM_172107.4(KCNQ2):c.388G>A (p.Glu130Lys)	KCNQ2	E130K	Early infantile epileptic encephalopathy 7	Pathogenic	no assertion criteria provided	VCV000219238	20	62076717	20	63445364	219238	217262	rs864321710	NC_000020.11:63445363:C:T
NM_172107.4(KCNQ2):c.943G>C (p.Gly315Arg)	KCNQ2	G315R	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000219237	20	62070058	20	63438705	219237	217257	rs864321709	NC_000020.11:63438704:C:G
NM_172107.4(KCNQ2):c.803T>C (p.Leu268Pro)	KCNQ2	L268P	Early infantile epileptic encephalopathy 7	Pathogenic	no assertion criteria provided	VCV000219236	20	62073772	20	63442419	219236	217260	rs864321708	NC_000020.11:63442418:A:G
NM_172107.3(KCNQ2):c.917C>T (p.Ala306Val)	KCNQ2	A306V	Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219235	20	62070961	20	63439608	219235	217258	rs864321707	NC_000020.11:63439607:G:A
NM_172107.4(KCNQ2):c.850T>G (p.Tyr284Asp)	KCNQ2	Y284D	Early infantile epileptic encephalopathy 7	Pathogenic	no assertion criteria provided	VCV000219234	20	62071028	20	63439675	219234	217259	rs864321706	NC_000020.11:63439674:A:C
NM_178526.5(SLC25A42):c.871A>G (p.Asn291Asp)	SLC25A42	N291D	Mitochondrial myopathy|SLC25A42-related mitochondrial disorder|METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000219191	19	19221599	19	19110790	219191	217217	rs864321624	NC_000019.10:19110789:A:G
NM_173630.4(RTTN):c.5750A>G (p.Asp1917Gly)	RTTN	D1917G, D1005G	Microcephaly, short stature, and polymicrogyria with or without seizures|Congenital microcephaly	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219187	18	67696033	18	70028797	219187	217210	rs780270096	NC_000018.10:70028796:T:C
NM_004606.4(TAF1):c.2926G>C (p.Asp976His)	TAF1	D976H, D955H	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219118	X	70612503	X	71392653	219118	216920	rs864321631	NC_000023.11:71392652:G:C
NM_004606.4(TAF1):c.3736C>T (p.Arg1246Trp)	TAF1	R1246W, R1225W	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219116	X	70618477	X	71398627	219116	216918	rs864321629	NC_000023.11:71398626:C:T
NM_004606.4(TAF1):c.2419T>C (p.Cys807Arg)	TAF1	C807R, C786R	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219115	X	70607243	X	71387393	219115	216917	rs864321628	NC_000023.11:71387392:T:C
NM_004606.4(TAF1):c.4010T>C (p.Ile1337Thr)	TAF1	I1337T, I1316T	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219114	X	70621541	X	71401691	219114	216916	rs864321627	NC_000023.11:71401690:T:C
NM_006494.4(ERF):c.1A>G (p.Met1Val)	ERF	M1V	Craniosynostosis 4	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000218957	19	42759151	19	42254999	218957	215791	rs864321681	NC_000019.10:42254998:T:C
NM_006494.4(ERF):c.23-2A>G	ERF		Craniosynostosis 4	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000218956	19	42754719	19	42250567	218956	215790	rs864321680	NC_000019.10:42250566:T:C
NM_020436.5(SALL4):c.410dup (p.Gly138fs)	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000218947	20	50408611 - 50408612	20	51792072 - 51792073	218947	215781	rs879255537	NC_000020.11:51792072:CC:CCC
NM_014268.4(MAPRE2):c.427C>T (p.Arg143Cys)	MAPRE2	R143C, R100C, R131C, R90C	Skin creases, congenital symmetric circumferential, 2	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218930	18	32681940	18	35101976	218930	215756	rs864309720	NC_000018.10:35101975:C:T
NM_014268.4(MAPRE2):c.203A>G (p.Asn68Ser)	MAPRE2	N68S, N25S, N56S	Skin creases, congenital symmetric circumferential, 2	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218929	18	32650239	18	35070275	218929	215755	rs864309719	NC_000018.10:35070274:A:G
NM_014268.4(MAPRE2):c.454C>T (p.Gln152Ter)	MAPRE2	Q152*, Q109*, Q140*, Q99*	Skin creases, congenital symmetric circumferential, 2	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218928	18	32681967	18	35102003	218928	215754	rs864309718	NC_000018.10:35102002:C:T
NM_014268.4(MAPRE2):c.260A>G (p.Tyr87Cys)	MAPRE2	Y87C, Y44C, Y75C, Y34C	Skin creases, congenital symmetric circumferential, 2	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000218927	18	32677419	18	35097455	218927	215753	rs864309717	NC_000018.10:35097454:A:G
NM_000554.6(CRX):c.661del (p.Tyr221fs)	CRX	Y221fs	Bull's eye maculopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000218923	19	48342985	19	47839728	218923	215732	rs864309708	NC_000019.10:47839727:T:
NM_000554.6(CRX):c.660del (p.Tyr221fs)	CRX	Y221fs	Bull's eye maculopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000218922	19	48342981	19	47839724	218922	215731	rs864309707	NC_000019.10:47839723:CCCC:CCC
NM_000554.6(CRX):c.449C>G (p.Ser150Ter)	CRX	S150*	Bull's eye maculopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	VCV000218921	19	48342773	19	47839516	218921	215730	rs864309706	NC_000019.10:47839515:C:G
NM_152296.5(ATP1A3):c.967C>T (p.Pro323Ser)	ATP1A3	P323S, P336S, P334S	not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000218558	19	42489096	19	41984944	218558	215572	rs864309572	NC_000019.10:41984943:G:A
NM_001015877.2(PHF6):c.418G>A (p.Ala140Thr)	PHF6	A140T	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000218375	X	133527982	X	134393952	218375	215102	rs864309532	NC_000023.11:134393951:G:A
NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg)	RAB39B	G192R	Early-onset parkinsonism-intellectual disability syndrome|X-linked dominant Parkinson's disease	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218362	X	154490156	X	155260871	218362	215090	rs864309527	NC_000023.11:155260870:C:T
NM_001303256.3(MORC2):c.260C>T (p.Ser87Leu)	MORC2	S25L, S87L	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, axonal, type 2z	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218308	22	31345795	22	30949809	218308	215004	rs864309504	NC_000022.11:30949808:G:A
NM_001303256.3(MORC2):c.754C>T (p.Arg252Trp)	MORC2	R252W	Charcot-Marie-Tooth disease|Inborn genetic diseases|Distal spinal muscular atrophy|Charcot-Marie-Tooth disease, axonal, type 2z	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218307	22	31337490	22	30941503	218307	215003	rs864309503	NC_000022.11:30941502:G:A
NM_002361.4(MAG):c.399C>G (p.Ser133Arg)	MAG	S133R, S108R	Spastic paraplegia 75, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2015)	no assertion criteria provided	VCV000218187	19	35786868	19	35295965	218187	214840	rs2301600	NC_000019.10:35295964:C:G
NM_001143981.2(CHRDL1):c.805_806TC[1] (p.His270fs)	CHRDL1		Megalocornea	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000218164	X	109932002 - 109932003	X	110688774 - 110688775	218164	214810	rs863225435	NC_000023.11:110688773:GAGA:GA
NM_014008.5(CCDC22):c.1670A>G (p.Tyr557Cys)	CCDC22	Y557C	Ritscher-Schinzel syndrome 1|Ritscher-schinzel syndrome 2	Pathogenic(Last reviewed: Jan 21, 2020)	no assertion criteria provided	VCV000218106	X	49106004	X	49249543	218106	214761	rs863225429	NC_000023.11:49249542:A:G
NM_014008.5(CCDC22):c.49A>G (p.Thr17Ala)	CCDC22	T17A	Ritscher-Schinzel syndrome 1|Ritscher-schinzel syndrome 2	Pathogenic(Last reviewed: Jan 21, 2020)	no assertion criteria provided	VCV000218105	X	49092145	X	49235685	218105	214760	rs863225428	NC_000023.11:49235684:A:G
NM_001323289.2(CDKL5):c.353A>G (p.Gln118Arg)	CDKL5	Q118R	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000217875	X	18598038	X	18579918	217875	214546	rs863225290	NC_000023.11:18579917:A:G
NM_001323289.2(CDKL5):c.2716C>T (p.Gln906Ter)	CDKL5	Q906*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Aug 10, 2015)	no assertion criteria provided	VCV000217874	X	18646710	X	18628590	217874	214547	rs863225289	NC_000023.11:18628589:C:T
NM_001863.5(COX6B1):c.58C>T (p.Arg20Cys)	COX6B1	R20C	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000217745	19	36142203	19	35651301	217745	214391	rs778740017	NC_000019.10:35651300:C:T
NM_001165927.1(MKS1):c.1231C>T (p.Pro411Ser)	MKS1	P411S, P421S, P218S	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217681	17	56285267	17	58207906	217681	214362	rs863225210	NC_000017.11:58207905:G:A
NM_001165927.1(MKS1):c.737_738insC (p.Glu246fs)	MKS1		Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217680	17	56290433 - 56290434	17	58213072 - 58213073	217680	214366	rs863225209	NC_000017.11:58213072::G
NM_001165927.1(MKS1):c.920G>A (p.Gly307Glu)	MKS1	G307E, G317E, G114E	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217679	17	56288349	17	58210988	217679	214365	rs863225208	NC_000017.11:58210987:C:T
NM_001165927.1(MKS1):c.1559-2A>T	MKS1		Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217678	17	56283533	17	58206172	217678	214359	rs863225207	NC_000017.11:58206171:T:A
NM_001165927.1(MKS1):c.1085_1087del (p.Ser362del)	MKS1	S362del, S372del, S169del	Meckel syndrome type 1|Bardet-Biedl syndrome 13|Joubert syndrome 28|Joubert syndrome 28|Limb undergrowth|Rotary nystagmus|Global developmental delay|Chronic kidney disease|Polydactyly|Joubert syndrome|Meckel-Gruber syndrome|Joubert syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217677	17	56285514 - 56285516	17	58208153 - 58208155	217677	214364	rs754279998	NC_000017.11:58208152:AGGAG:AG
NM_001165927.1(MKS1):c.351del (p.Tyr118fs)	MKS1	Y128fs, Y118fs	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217676	17	56293485	17	58216124	217676	214368	rs863225206	NC_000017.11:58216123:GG:G
NM_001165927.1(MKS1):c.50+286G>T	MKS1	D19Y	Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217675	17	56296537	17	58219176	217675	214370	rs863225205	NC_000017.11:58219175:C:A
NM_001165927.1(MKS1):c.232-179_232-37del	MKS1		Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217674	17	56293641 - 56293783	17	58216280 - 58216422	217674	214369	rs1555600644	
NM_001165927.1(MKS1):c.1498dup (p.Arg500fs)	MKS1		Joubert syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000217673	17	56283703 - 56283704	17	58206342 - 58206343	217673	214360	rs863225204	NC_000017.11:58206342:G:GG
NM_001165927.1(MKS1):c.1178C>T (p.Ser393Leu)	MKS1	S393L, S403L, S200L	Joubert syndrome|Joubert syndrome 28|not provided|Meckel syndrome type 1|Bardet-Biedl syndrome 13	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217672	17	56285320	17	58207959	217672	214363	rs773684291	NC_000017.11:58207958:G:A
NM_014225.6(PPP2R1A):c.773G>A (p.Arg258His)	PPP2R1A	R258H, R79H	not provided|Impaired use of nonverbal behaviors|Generalized hypotonia|Microcephaly|Abnormal facial shape|Profound global developmental delay|Stereotypy|Brachydactyly|Autistic behavior|Synophrys|Mental retardation, autosomal dominant 36	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217458	19	52716329	19	52213076	217458	214099	rs863225094	NC_000019.10:52213075:G:A
NG_009095.2:g.(16929_16947)_(21383_21401)del	CACNA1F			Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000217444			X	49216966 - 49221438	217444	214084		
NM_001256789.3(CACNA1F):c.2509G>A (p.Gly837Ser)	CACNA1F	G848S, G783S, G837S		Pathogenic(Last reviewed: Jun 11, 2013)	no assertion criteria provided	VCV000217443	X	49076127	X	49219668	217443	214083	rs863225090	NC_000023.11:49219667:C:T
NM_004655.4(AXIN2):c.314T>G (p.Val105Gly)	AXIN2	V105G	Non-syndromic oligodontia	Pathogenic	no assertion criteria provided	VCV000217441	17	63554425	17	65558307	217441	214080	rs752881223	NC_000017.11:65558306:A:C
NC_000023.10:g.(?_18643248)_(18646707_?)del	CDKL5		not provided	Pathogenic(Last reviewed: Feb 13, 2015)	no assertion criteria provided	VCV000217358	X	18643248 - 18646707	X	18625128 - 18628587	217358	196440		
NM_001323289.2(CDKL5):c.1897C>T (p.Gln633Ter)	CDKL5	Q633*	not provided	Pathogenic(Last reviewed: Feb 13, 2015)	no assertion criteria provided	VCV000217357	X	18622941	X	18604821	217357	196443	rs863225065	NC_000023.11:18604820:C:T
NM_001123383.1(BCOR):c.1136_1139del (p.Val379fs)	BCOR	V379fs	Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217354	X	39933460 - 39933463	X	40074207 - 40074210	217354	214010	rs864309702	NC_000023.11:40074206:CTAACT:CT
NM_198270.4(NHS):c.3624C>A (p.Cys1208Ter)	NHS	C1208*, C1031*, C1052*, C1229*	Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217352	X	17745913	X	17727793	217352	214008	rs111534978	NC_000023.11:17727792:C:A
NM_001123383.1(BCOR):c.4288_4291del (p.Glu1430fs)	BCOR	E1412fs, E1464fs, E1430fs	Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217327	X	39921427 - 39921430	X	40062174 - 40062177	217327	214009	rs864309680	NC_000023.11:40062173:TCTC:
NM_198270.4(NHS):c.2707del (p.Glu903fs)	NHS	E903fs, E726fs, E747fs, E924fs	Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000217326	X	17744995	X	17726875	217326	214007	rs864309679	NC_000023.11:17726874:GG:G
NM_020964.3(EPG5):c.7447C>T (p.Arg2483Ter)	EPG5	R2483*	Vici syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217320	18	43435648	18	45855683	217320	213972	rs863225064	NC_000018.10:45855682:G:A
NM_000531.6(OTC):c.72_77+18del	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Jul 6, 2015)	no assertion criteria provided	VCV000217299	X	38212020 - 38212043	X	38352767 - 38352790	217299	213950	rs863225061	NC_000023.11:38352766:ATTTTCGGTAAGTGATGGTCAGAGA:A
NM_000023.4(SGCA):c.100C>T (p.Arg34Cys)	SGCA	R34C	Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217250	17	48244791	17	50167430	217250	213838	rs758647756	NC_000017.11:50167429:C:T
NM_181882.3(PRX):c.2787del (p.Lys930fs)	PRX	K930fs	Charcot-Marie-Tooth disease, demyelinating, type 4F|Charcot-Marie-Tooth disease type 4|not provided	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217239	19	40901472	19	40395565	217239	213839	rs754521978	NC_000019.10:40395564:GG:G
NM_004006.2(DMD):c.9938_9941dup (p.Asn3314delinsLysTer)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000217220	X	31200887 - 31200888	X	31182770 - 31182771	217220	213844	rs863225018	NC_000023.11:31182770:TTAC:TTACTTAC
NM_004006.2(DMD):c.9551dup (p.Asn3184fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 16, 2015)	criteria provided, single submitter	VCV000217219	X	31227626 - 31227627	X	31209509 - 31209510	217219	213845	rs863225017	NC_000023.11:31209509:TT:TTT
NM_004006.2(DMD):c.94-1G>A	DMD		not provided	Pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000217218	X	32867938	X	32849821	217218	213889	rs863225016	NC_000023.11:32849820:C:T
NM_000109.4(DMD):c.9176_9179CAAA[1] (p.Asn3060fs)	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217217	X	31341732 - 31341735	X	31323615 - 31323618	217217	213846	rs863225015	NC_000023.11:31323614:TTTGTTTG:TTTG
NM_000109.4(DMD):c.8944_8945GA[1] (p.Asn2983fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217216	X	31462711 - 31462712	X	31444594 - 31444595	217216	213847	rs863225014	NC_000023.11:31444593:TCTCT:TCT
NM_004006.2(DMD):c.8390+2T>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	VCV000217215	X	31525396	X	31507279	217215	213848	rs863225013	NC_000023.11:31507278:A:G
NM_004006.2(DMD):c.8357G>A (p.Trp2786Ter)	DMD	W2786*, W1442*, W1445*, W2778*, W2782*, W57*, W2663*, W326*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 29, 2013)	criteria provided, single submitter	VCV000217214	X	31525431	X	31507314	217214	213849	rs863225012	NC_000023.11:31507313:C:T
NM_004006.2(DMD):c.8038C>T (p.Arg2680Ter)	DMD	R2680*, R1336*, R2557*, R2676*, R220*, R2672*, R1339*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217213	X	31645969	X	31627852	217213	213850	rs863225011	NC_000023.11:31627851:G:A
NM_004006.2(DMD):c.8027+2T>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 8, 2012)	criteria provided, single submitter	VCV000217212	X	31676105	X	31657988	217212	213851	rs863225010	NC_000023.11:31657987:A:T
NM_004006.2(DMD):c.7817G>A (p.Trp2606Ter)	DMD	W2606*, W2598*, W1262*, W1265*, W2483*, W2602*, W146*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217211	X	31697547	X	31679430	217211	213852	rs863225009	NC_000023.11:31679429:C:T
NM_004006.2(DMD):c.7755G>A (p.Trp2585Ter)	DMD	W2585*, W1241*, W2581*, W1244*, W125*, W2462*, W2577*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	VCV000217210	X	31697609	X	31679492	217210	213853	rs762394978	NC_000023.11:31679491:C:T
NM_004006.2(DMD):c.7105G>T (p.Glu2369Ter)	DMD	E2369*, E2246*, E2361*, E2365*, E1025*, E1028*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217209	X	31854930	X	31836813	217209	213854	rs863225008	NC_000023.11:31836812:C:A
NM_004013.2(DMD):c.-770dup	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217208	X	31986458 - 31986459	X	31968341 - 31968342	217208	213855	rs863225007	NC_000023.11:31968341:TTTTTT:TTTTTTT
NM_004006.2(DMD):c.6128_6131del (p.Asp2043fs)	DMD	D1920fs, D2039fs, D2043fs, D699fs, D2035fs, D702fs	Duchenne muscular dystrophy|not specified	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217207	X	32305805 - 32305808	X	32287688 - 32287691	217207	213856	rs863225006	NC_000023.11:32287687:CTATCT:CT
NM_004006.2(DMD):c.5917C>T (p.Gln1973Ter)	DMD	Q1973*, Q1850*, Q1965*, Q1969*, Q629*, Q632*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217206	X	32360222	X	32342105	217206	213857	rs863225005	NC_000023.11:32342104:G:A
NM_004006.2(DMD):c.5641C>T (p.Gln1881Ter)	DMD	Q1881*, Q1758*, Q1877*, Q1873*, Q537*, Q540*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	VCV000217205	X	32361349	X	32343232	217205	213858	rs863225004	NC_000023.11:32343231:G:A
NM_004006.2(DMD):c.5602_5605del (p.Arg1868fs)	DMD	R527fs, R1860fs, R1864fs, R1745fs, R1868fs, R524fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217204	X	32361385 - 32361388	X	32343268 - 32343271	217204	213859	rs863225003	NC_000023.11:32343267:TTCTTT:TT
NM_004006.2(DMD):c.5461G>T (p.Glu1821Ter)	DMD	E1821*, E1698*, E480*, E1813*, E1817*, E477*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 20, 2013)	criteria provided, single submitter	VCV000217203	X	32364185	X	32346068	217203	213860	rs863225002	NC_000023.11:32346067:C:A
NM_000109.4(DMD):c.5326G>T (p.Glu1776Ter)	DMD	E1784*, E1776*, E1661*, E1780*, E440*, E443*	not specified|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217202	X	32366621	X	32348504	217202	213861	rs777864641	NC_000023.11:32348503:C:A
NM_004006.2(DMD):c.5131C>T (p.Gln1711Ter)	DMD	Q1711*, Q1703*, Q370*, Q1707*, Q367*, Q1588*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217201	X	32382722	X	32364605	217201	213862	rs863225001	NC_000023.11:32364604:G:A
NM_004006.2(DMD):c.4918del (p.Thr1640fs)	DMD	T1636fs, T296fs, T1517fs, T1640fs, T1632fs, T299fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 29, 2013)	criteria provided, single submitter	VCV000217200	X	32383244	X	32365127	217200	213863	rs863225000	NC_000023.11:32365126:TTTT:TTT
NM_004006.2(DMD):c.4729C>T (p.Arg1577Ter)	DMD	R1577*, R1454*, R233*, R1569*, R1573*, R236*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217199	X	32398743	X	32380626	217199	213864	rs863224999	NC_000023.11:32380625:G:A
NM_004006.2(DMD):c.4606G>T (p.Glu1536Ter)	DMD	E1536*, E1413*, E1532*, E195*, E1528*, E192*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000217198	X	32404495	X	32386378	217198	213865	rs863224998	NC_000023.11:32386377:C:A
NM_004006.2(DMD):c.4240C>T (p.Gln1414Ter)	DMD	Q1414*, Q1406*, Q1291*, Q1410*, Q70*, Q73*	Duchenne muscular dystrophy|not specified	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217197	X	32408292	X	32390175	217197	213866	rs863224997	NC_000023.11:32390174:G:A
NM_004006.2(DMD):c.358-2A>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217196	X	32834759	X	32816642	217196	213884	rs863224996	NC_000023.11:32816641:T:C
NM_004006.2(DMD):c.355C>T (p.Gln119Ter)	DMD	Q119*, Q111*, Q115*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217195	X	32841414	X	32823297	217195	213885	rs863224995	NC_000023.11:32823296:G:A
NM_004006.2(DMD):c.3433-5_3434del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000217194	X	32472948 - 32472954	X	32454831 - 32454837	217194	213867	rs863224994	NC_000023.11:32454830:ACCTTCCAC:AC
NM_004006.2(DMD):c.3427C>T (p.Gln1143Ter)	DMD	Q1143*, Q1135*, Q1139*, Q1020*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 30, 2012)	criteria provided, single submitter	VCV000217193	X	32481561	X	32463444	217193	213868	rs863224993	NC_000023.11:32463443:G:A
NM_004006.2(DMD):c.2991C>G (p.Tyr997Ter)	DMD	Y997*, Y989*, Y874*, Y993*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 27, 2014)	criteria provided, single submitter	VCV000217192	X	32486786	X	32468669	217192	213869	rs863224992	NC_000023.11:32468668:G:C
NM_004006.2(DMD):c.282dup (p.Gly95fs)	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000217191	X	32841486 - 32841487	X	32823369 - 32823370	217191	213886	rs863224991	NC_000023.11:32823369:AA:AAA
NM_004006.2(DMD):c.2804-2A>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217190	X	32490428	X	32472311	217190	213870	rs794727357	NC_000023.11:32472310:T:G
NM_004006.2(DMD):c.280del (p.Ile94fs)	DMD	I86fs, I90fs, I94fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	VCV000217189	X	32841489	X	32823372	217189	213887	rs863224990	NC_000023.11:32823371:T:
NM_004006.2(DMD):c.2797C>T (p.Gln933Ter)	DMD	Q933*, Q810*, Q925*, Q929*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217188	X	32503042	X	32484925	217188	213871	rs756949497	NC_000023.11:32484924:G:A
NM_004006.2(DMD):c.265-2A>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 3, 2015)	criteria provided, single submitter	VCV000217187	X	32841506	X	32823389	217187	213888	rs863224989	NC_000023.11:32823388:T:C
NM_004006.2(DMD):c.2623-3C>G	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217186	X	32503219	X	32485102	217186	213872	rs863224988	NC_000023.11:32485101:G:C
NM_004006.2(DMD):c.2611A>T (p.Lys871Ter)	DMD	K871*, K748*, K863*, K867*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 15, 2013)	criteria provided, single submitter	VCV000217185	X	32509405	X	32491288	217185	213873	rs863224987	NC_000023.11:32491287:T:A
NM_004006.2(DMD):c.2407C>T (p.Gln803Ter)	DMD	Q803*, Q795*, Q799*, Q680*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217184	X	32509609	X	32491492	217184	213874	rs863224986	NC_000023.11:32491491:G:A
NM_004006.2(DMD):c.2368C>T (p.Gln790Ter)	DMD	Q790*, Q667*, Q782*, Q786*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000217183	X	32519884	X	32501767	217183	213875	rs762860653	NC_000023.11:32501766:G:A
NM_004006.2(DMD):c.2215G>T (p.Glu739Ter)	DMD	E739*, E731*, E735*, E616*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217182	X	32536202	X	32518085	217182	213876	rs863224985	NC_000023.11:32518084:C:A
NM_004006.2(DMD):c.1683G>A (p.Trp561Ter)	DMD	W561*, W438*, W553*, W557*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	VCV000217181	X	32591883	X	32573766	217181	213877	rs863224984	NC_000023.11:32573765:C:T
NM_004006.2(DMD):c.1663C>T (p.Gln555Ter)	DMD	Q555*, Q432*, Q547*, Q551*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000217180	X	32591903	X	32573786	217180	213878	rs863224983	NC_000023.11:32573785:G:A
NM_004006.2(DMD):c.1483-1G>C	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000217179	X	32613994	X	32595877	217179	213879	rs863224982	NC_000023.11:32595876:C:G
NM_004006.2(DMD):c.1388G>A (p.Trp463Ter)	DMD	W463*, W455*, W459*, W340*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 30, 2012)	criteria provided, single submitter	VCV000217178	X	32632514	X	32614397	217178	213880	rs863224981	NC_000023.11:32614396:C:T
NM_004006.2(DMD):c.1331+1G>A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000217177	X	32662248	X	32644131	217177	213881	rs863224980	NC_000023.11:32644130:C:T
NM_004006.2(DMD):c.1324C>T (p.Gln442Ter)	DMD	Q442*, Q434*, Q438*, Q319*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217176	X	32662256	X	32644139	217176	213882	rs863224979	NC_000023.11:32644138:G:A
NM_004006.2(DMD):c.1150-2del	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000217175	X	32662432	X	32644315	217175	213883	rs863224978	NC_000023.11:32644314:T:
NM_004006.2(DMD):c.10504G>T (p.Glu3502Ter)	DMD	E3502*, E1042*, E2161*, E3379*, E3498*, E434*, E1029*, E773*, E2158*, E3494*, E421*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 18, 2013)	criteria provided, single submitter	VCV000217174	X	31187609	X	31169492	217174	213840	rs863224977	NC_000023.11:31169491:C:A
NM_004006.2(DMD):c.10412T>G (p.Leu3471Ter)	DMD	L3471*, L2127*, L403*, L3463*, L1011*, L3348*, L998*, L2130*, L3467*, L390*, L742*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	VCV000217173	X	31187701	X	31169584	217173	213841	rs863224976	NC_000023.11:31169583:A:C
NM_004006.2(DMD):c.10223+1G>C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 24, 2012)	criteria provided, single submitter	VCV000217172	X	31196785	X	31178668	217172	213842	rs398123834	NC_000023.11:31178667:C:G
NM_004006.2(DMD):c.10133del (p.Asn3378fs)	DMD	N2034fs, N310fs, N3370fs, N649fs, N3374fs, N3378fs, N2037fs, N3255fs, N918fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 29, 2012)	criteria provided, single submitter	VCV000217171	X	31196876	X	31178759	217171	213843	rs863224975	NC_000023.11:31178758:TTTTTT:TTTTT
NM_000166.6(GJB1):c.490C>T (p.Arg164Trp)	GJB1	R164W	Charcot-Marie-Tooth Neuropathy X|not provided|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217170	X	70444047	X	71224197	217170	213894	rs139643362	NC_000023.11:71224196:C:T
NM_000166.6(GJB1):c.44G>A (p.Arg15Gln)	GJB1	R15Q	Charcot-Marie-Tooth Neuropathy X|not provided|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217169	X	70443601	X	71223751	217169	213891	rs863224974	NC_000023.11:71223750:G:A
NM_000166.6(GJB1):c.319C>T (p.Arg107Trp)	GJB1	R107W	X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217168	X	70443876	X	71224026	217168	213893	rs863224973	NC_000023.11:71224025:C:T
NM_000166.6(GJB1):c.224G>A (p.Arg75Gln)	GJB1	R75Q	Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217167	X	70443781	X	71223931	217167	213892	rs863224972	NC_000023.11:71223930:G:A
NM_000166.6(GJB1):c.-103C>T	GJB1		X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217166	X	70443099	X	71223249	217166	213890	rs863224971	NC_000023.11:71223248:C:T
NM_006087.4(TUBB4A):c.763G>A (p.Val255Ile)	TUBB4A	V255I, V306I, V300I, V183I	Cerebral palsy|Leukodystrophy, hypomyelinating, 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217025	19	6495747	19	6495736	217025	213656	rs767399782	NC_000019.10:6495735:C:T
NM_000328.3(RPGR):c.1905+1273_1905+1274del	RPGR		Cone-rod dystrophy, X-linked 1|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216990	X	38145073 - 38145074	X	38285820 - 38285821	216990	213666	rs771214648	NC_000023.11:38285819:TCTCT:TCT
NM_172107.4(KCNQ2):c.841G>T (p.Gly281Trp)	KCNQ2	G281W	Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000216949	20	62071037	20	63439684	216949	213659	rs794727813	NC_000020.11:63439683:C:A
NM_004006.2(DMD):c.4000G>T (p.Gly1334Ter)	DMD	G1334*, G1326*, G1330*, G1211*	Duchenne muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000216919	X	32456429	X	32438312	216919	213665	rs146880270	NC_000023.11:32438311:C:A
NM_004750.5(CRLF1):c.713dup (p.Pro239fs)	CRLF1		Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	VCV000216913	19	18707843 - 18707844	19	18597033 - 18597034	216913	213653	rs768727082	NC_000019.10:18597033:GGGGGG:GGGGGGG
NM_003688.3(CASK):c.2303-2A>G	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	VCV000216899	X	41390464	X	41531211	216899	213668	rs863224854	NC_000023.11:41531210:T:C
NM_017950.4(CCDC40):c.961C>T (p.Arg321Ter)	CCDC40	R321*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 15	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216118	17	78023884	17	80050085	216118	213410	rs754867753	NC_000017.11:80050084:C:T
NM_017950.4(CCDC40):c.3097A>T (p.Lys1033Ter)	CCDC40	K1033*	Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000216117	17	78071119	17	80097320	216117	213417	rs863224519	NC_000017.11:80097319:A:T
NM_005359.5(SMAD4):c.1142T>A (p.Leu381Ter)	SMAD4	L381*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000216093	18	48593391	18	51067021	216093	213425	rs863224507	NC_000018.10:51067020:T:A
NM_005359.5(SMAD4):c.(?_-1)_(*1_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Apr 10, 2015)	criteria provided, single submitter	VCV000216092					216092	213508		
NM_003413.3(ZIC3):c.(?_-1)_(*1_?)del	ZIC3			Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000216089					216089	213507		
NM_000455.4(STK11):c.719C>A (p.Ser240Ter)	STK11	S240*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 17, 2015)	criteria provided, single submitter	VCV000216070	19	1220701	19	1220702	216070	213437	rs730881976	NC_000019.10:1220701:C:A
NM_001278116.2(L1CAM):c.1939A>T (p.Lys647Ter)	L1CAM	K647*, K642*	Spastic paraplegia	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000216069	X	153133255	X	153867800	216069	213496	rs863224494	NC_000023.11:153867799:T:A
NM_000166.6(GJB1):c.9G>A (p.Trp3Ter)	GJB1	W3*	Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000216040	X	70443566	X	71223716	216040	213497	rs863224472	NC_000023.11:71223715:G:A
NM_000166.6(GJB1):c.547C>T (p.Arg183Cys)	GJB1	R183C	Charcot-Marie-Tooth disease|not provided|X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216039	X	70444104	X	71224254	216039	213502	rs863224471	NC_000023.11:71224253:C:T
NM_000166.6(GJB1):c.305A>G (p.Glu102Gly)	GJB1	E102G	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000216038	X	70443862	X	71224012	216038	213501	rs779696968	NC_000023.11:71224011:A:G
NM_000166.6(GJB1):c.83T>A (p.Ile28Asn)	GJB1	I28N	Charcot-Marie-Tooth disease|X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000215983	X	70443640	X	71223790	215983	213498	rs768834663	NC_000023.11:71223789:T:A
NM_001257988.1(TYMP):c.516+2T>A	TYMP		not provided	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000215334	22	50966939	22	50528510	215334	211987	rs797044454	NC_000022.11:50528509:A:T
NM_001145901.2(SARS2):c.30G>A (p.Trp10Ter)	SARS2	W10*	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis|not provided	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000215114	19	39421347	19	38930707	215114	211885	rs145754412	NC_000019.10:38930706:C:T
NM_001145901.2(SARS2):c.595+1G>A	SARS2		not provided	Pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	VCV000215111	19	39412031	19	38921391	215111	211876	rs863224195	NC_000019.10:38921390:C:T
NM_000284.4(PDHA1):c.985_998dup (p.Glu333fs)	PDHA1		not provided	Pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000214949	X	19377118 - 19377119	X	19359000 - 19359001	214949	212017	rs863224157	NC_000023.11:19359000:CTTGCCAGTGTGGA:CTTGCCAGTGTGGACTTGCCAGTGTGGA
NM_000284.4(PDHA1):c.1159_1162dup (p.Ser388Ter)	PDHA1		not provided	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000214947	X	19377755 - 19377756	X	19359637 - 19359638	214947	212021	rs863224156	NC_000023.11:19359637:TAAGT:TAAGTAAGT
NM_000284.4(PDHA1):c.1008+1_1008+27del	PDHA1		not provided	Pathogenic(Last reviewed: Jan 7, 2013)	criteria provided, single submitter	VCV000214946	X	19377142 - 19377168	X	19359024 - 19359050	214946	212018	rs863224155	NC_000023.11:19359023:GGTACAGTCACTTGTTCATGGTGGTTTG:G
NM_000284.4(PDHA1):c.937_940dup (p.Ser314fs)	PDHA1		not provided	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000214945	X	19377070 - 19377071	X	19358952 - 19358953	214945	212016	rs137853251	NC_000023.11:19358952:AAGA:AAGAAAGA
NM_000284.4(PDHA1):c.936_939del (p.Ser312fs)	PDHA1	S312fs, S319fs, S350fs, S281fs	not provided	Pathogenic(Last reviewed: Sep 9, 2013)	criteria provided, single submitter	VCV000214944	X	19377067 - 19377070	X	19358949 - 19358952	214944	212015	rs863224153	NC_000023.11:19358948:AAGTAAG:AAG
NM_000284.4(PDHA1):c.506C>T (p.Ala169Val)	PDHA1	A169V, A207V, A176V	Pyruvate dehydrogenase E1-alpha deficiency|not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214941	X	19371287	X	19353169	214941	212009	rs863224150	NC_000023.11:19353168:C:T
NM_000284.4(PDHA1):c.292-1G>A	PDHA1		not provided	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000214939	X	19369398	X	19351280	214939	212005	rs863224149	NC_000023.11:19351279:G:A
NM_000284.4(PDHA1):c.214C>T (p.Arg72Cys)	PDHA1	R72C, R110C	Pyruvate dehydrogenase E1-alpha deficiency|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000214938	X	19368151	X	19350033	214938	212004	rs863224148	NC_000023.11:19350032:C:T
NM_000284.4(PDHA1):c.1132C>T (p.Arg378Cys)	PDHA1	R378C, R347C, R385C, R416C	Pyruvate dehydrogenase E1-alpha deficiency|not provided	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000214936	X	19377730	X	19359612	214936	212019	rs863224147	NC_000023.11:19359611:C:T
NM_000284.4(PDHA1):c.910C>T (p.Arg304Ter)	PDHA1	R304*, R342*, R311*, R273*	Pyruvate dehydrogenase E1-alpha deficiency|not provided	Pathogenic(Last reviewed: Oct 22, 2015)	criteria provided, multiple submitters, no conflicts	VCV000214935	X	19377044	X	19358926	214935	212014	rs863224146	NC_000023.11:19358925:C:T
NM_025136.4(OPA3):c.540G>C (p.Ter180Tyr)	OPA3		not provided	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000214928	19	46056772	19	45553514	214928	211897	rs774281852	NC_000019.10:45553513:C:G
NM_024407.5(NDUFS7):c.2T>C (p.Met1Thr)	NDUFS7	M1T	not provided	Pathogenic(Last reviewed: Sep 30, 2013)	criteria provided, single submitter	VCV000214831	19	1383927	19	1383928	214831	211857	rs863224113	NC_000019.10:1383927:T:C
NM_001193375.2(NDUFA11):c.314-1566A>G	NDUFA11		not provided	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000214694	19	5894867	19	5894856	214694	211905	rs863224079	NC_000019.10:5894855:T:C
NM_014297.5(ETHE1):c.221dup (p.Tyr74Ter)	ETHE1		not provided	Pathogenic(Last reviewed: May 20, 2013)	criteria provided, single submitter	VCV000214323	19	44030671 - 44030672	19	43526519 - 43526520	214323	211894	rs863223955	NC_000019.10:43526519:T:TT
NM_014297.5(ETHE1):c.488G>A (p.Arg163Gln)	ETHE1	R163Q, R65Q, R152Q, R40Q	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000214322	19	44015606	19	43511454	214322	211889	rs745656120	NC_000019.10:43511453:C:T
NM_000032.5(ALAS2):c.1699A>G (p.Met567Val)	ALAS2	M567V, M554V, M530V	not provided	Pathogenic(Last reviewed: Oct 3, 2014)	criteria provided, single submitter	VCV000214104	X	55035678	X	55009245	214104	212023	rs863223906	NC_000023.11:55009244:T:C
NM_000032.5(ALAS2):c.1355G>A (p.Arg452His)	ALAS2	R452H, R439H, R415H	not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000214099	X	55041262	X	55014829	214099	212029	rs863223904	NC_000023.11:55014828:C:T
NM_000032.5(ALAS2):c.606G>A (p.Met202Ile)	ALAS2	M202I, M189I, M165I	not provided	Pathogenic(Last reviewed: Jun 23, 2014)	criteria provided, single submitter	VCV000214095	X	55047517	X	55021084	214095	212034	rs863223901	NC_000023.11:55021083:C:T
NM_006796.2(AFG3L2):c.2067_2068del (p.Tyr689_Ser690delinsTer)	AFG3L2		not provided	Pathogenic(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	VCV000214059	18	12337447 - 12337448	18	12337448 - 12337449	214059	211844	rs765987297	NC_000018.10:12337447:TGT:T
NM_000071.2(CBS):c.1135C>T (p.Arg379Trp)	CBS	R379W, R274W	not provided|Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212881	21	44480561	21	43060451	212881	210409	rs769080151	NC_000021.9:43060450:G:A
NM_000071.2(CBS):c.325T>C (p.Cys109Arg)	CBS	C109R, C4R	Classic homocystinuria|not provided|Cardiovascular phenotype|Homocystinuria	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212878	21	44486479	21	43066369	212878	210444	rs778220779	NC_000021.9:43066368:A:G
NM_000071.2(CBS):c.253G>A (p.Gly85Arg)	CBS	G85R	Classic homocystinuria|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212874	21	44488682	21	43068572	212874	210446	rs863223435	NC_000021.9:43068571:C:T
NM_000071.2(CBS):c.146C>T (p.Pro49Leu)	CBS	P49L	Classic homocystinuria|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212872	21	44492158	21	43072048	212872	210450	rs148865119	NC_000021.9:43072047:G:A
NM_000071.2(CBS):c.1280C>T (p.Pro427Leu)	CBS	P427L, P322L	not specified|not provided	Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000212867	21	44479022	21	43058912	212867	210403	rs863223434	NC_000021.9:43058911:G:A
NM_000071.2(CBS):c.1111G>A (p.Val371Met)	CBS	V371M, V266M	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212862	21	44480585	21	43060475	212862	210411	rs372010465	NC_000021.9:43060474:C:T
NM_000071.2(CBS):c.992C>A (p.Ala331Glu)	CBS	A331E, A226E	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212857	21	44482468	21	43062358	212857	210420	rs777919630	NC_000021.9:43062357:G:T
NM_000071.2(CBS):c.969G>A (p.Trp323Ter)	CBS	W323*, W218*	not provided|Classic homocystinuria	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212856	21	44482491	21	43062381	212856	210421	rs863223432	NC_000021.9:43062380:C:T
NM_000071.2(CBS):c.736+2T>G	CBS		not provided	Pathogenic(Last reviewed: Feb 27, 2013)	criteria provided, single submitter	VCV000212853	21	44485311	21	43065201	212853	210428	rs863223430	NC_000021.9:43065200:A:C
NM_000071.2(CBS):c.700G>A (p.Asp234Asn)	CBS	D234N, D129N	not provided|Homocystinuria	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212852	21	44485349	21	43065239	212852	210429	rs773734233	NC_000021.9:43065238:C:T
NM_000071.2(CBS):c.361C>T (p.Arg121Cys)	CBS	R121C, R16C	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212842	21	44486443	21	43066333	212842	210443	rs775992753	NC_000021.9:43066332:G:A
NM_001083962.2(TCF4):c.978delinsGG (p.Ala327fs)	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000212724	18	52928709	18	55261478	212724	209339	rs863223404	NC_000018.10:55261477:T:CC
NM_001029896.2(WDR45):c.827+2_827+3del	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000212594	X	48933020 - 48933021	X	49075361 - 49075362	212594	209075	rs797046103	NC_000023.11:49075360:CAC:C
NM_001029896.2(WDR45):c.516+1G>T	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000212593	X	48933524	X	49075865	212593	209076	rs797046102	NC_000023.11:49075864:C:A
NM_001029896.2(WDR45):c.397C>T (p.Arg133Ter)	WDR45	R134*, R133*	not provided|Neurodegeneration with brain iron accumulation 5|Cerebral-cerebellar-coloboma syndrome, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212592	X	48934128	X	49076469	212592	209077	rs797046101	NC_000023.11:49076468:G:A
NM_020461.4(TUBGCP6):c.895C>T (p.Arg299Ter)	TUBGCP6	R299*	Microcephaly and chorioretinopathy with or without mental retardation	Pathogenic(Last reviewed: Dec 12, 2014)	criteria provided, single submitter	VCV000212517	22	50678643	22	50240214	212517	208816	rs192919234	NC_000022.11:50240213:G:A
NM_020461.4(TUBGCP6):c.2356C>T (p.Arg786Ter)	TUBGCP6	R786*	Microcephaly and chorioretinopathy with or without mental retardation	Pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000212509	22	50660936	22	50222507	212509	208809	rs772174079	NC_000022.11:50222506:G:A
NM_001083962.2(TCF4):c.655+1_655+2dup	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212381	18	52946779 - 52946780	18	55279548 - 55279549	212381	208460	rs797046036	NC_000018.10:55279548:AC:ACAC
NM_001083962.2(TCF4):c.1965dup (p.Gly656fs)	TCF4		Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, multiple submitters, no conflicts	VCV000212379	18	52895506 - 52895507	18	55228275 - 55228276	212379	208455	rs797046035	NC_000018.10:55228275:GG:GGG
NM_001083962.2(TCF4):c.1411C>T (p.Gln471Ter)	TCF4	Q471*, Q400*, Q446*, Q470*, Q310*, Q311*, Q429*, Q448*, Q477*, Q341*, Q468*, Q255*, Q447*, Q573*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000212377	18	52901854	18	55234623	212377	208457	rs797046033	NC_000018.10:55234622:G:A
NM_001281463.1(SMC1A):c.2303G>A (p.Arg768Gln)	SMC1A	R768Q, R790Q	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212267	X	53430549	X	53403617	212267	209112	rs797045993	NC_000023.11:53403616:C:T
NM_006517.5(SLC16A2):c.374del (p.Tyr125fs)	SLC16A2	Y125fs	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Aug 28, 2013)	criteria provided, single submitter	VCV000212192	X	73641846	X	74422011	212192	209178	rs797045966	NC_000023.11:74422010:A:
NM_006517.5(SLC16A2):c.256del (p.Arg86fs)	SLC16A2	R86fs	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212191	X	73641726	X	74421891	212191	209177	rs797045965	NC_000023.11:74421890:CCC:CC
NM_006517.5(SLC16A2):c.1474_1481del (p.Val492fs)	SLC16A2	V492fs	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212189	X	73751240 - 73751247	X	74531405 - 74531412	212189	209182	rs797045963	NC_000023.11:74531404:CTGTAATCCT:CT
NM_006517.5(SLC16A2):c.1392dup (p.Ile465fs)	SLC16A2		Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212188	X	73749263 - 73749264	X	74529428 - 74529429	212188	209181	rs797045962	NC_000023.11:74529428:CCCCCC:CCCCCCC
NM_006517.5(SLC16A2):c.940C>T (p.Arg314Ter)	SLC16A2	R314*	not provided|Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212186	X	73744558	X	74524723	212186	209179	rs766773277	NC_000023.11:74524722:C:T
NM_015559.3(SETBP1):c.1821del (p.Ser608fs)	SETBP1	S608fs	Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000212152	18	42531125	18	44951160	212152	208453	rs797045952	NC_000018.10:44951159:CC:C
NM_004586.3(RPS6KA3):c.1304_1307del (p.Val435fs)	RPS6KA3	V435fs	Mental retardation, X-linked 19	Pathogenic(Last reviewed: Mar 24, 2015)	criteria provided, single submitter	VCV000212067	X	20190910 - 20190913	X	20172792 - 20172795	212067	208997	rs797045920	NC_000023.11:20172791:CAAACA:CA
NM_007254.4(PNKP):c.1386+49_1387-33del	PNKP		Early infantile epileptic encephalopathy 10|Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211919	19	50364800 - 50364816	19	49861543 - 49861559	211919	208613	rs752902474	NC_000019.10:49861542:GGGGTCAGGGGAGGAGGGGGGTCAGGGG:GGGGTCAGGGG
NM_003560.4(PLA2G6):c.1349-2A>G	PLA2G6		Neurodegeneration with brain iron accumulation 2b	Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	VCV000211909	22	38522458	22	38126451	211909	208794	rs797045888	NC_000022.11:38126450:T:C
NM_006031.6(PCNT):c.4934_4935AG[2] (p.Arg1646fs)	PCNT			Pathogenic(Last reviewed: Dec 29, 2014)	criteria provided, single submitter	VCV000211864	21	47821607 - 47821608	21	46401693 - 46401694	211864	208751	rs797045879	NC_000021.9:46401692:AGAGAG:AGAG
NM_006031.6(PCNT):c.1714_1717del (p.Lys572fs)	PCNT	K572fs, K454fs		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000211844	21	47773933 - 47773936	21	46354019 - 46354022	211844	208735	rs797045875	NC_000021.9:46354018:AGAAAG:AG
NM_001184880.2(PCDH19):c.490C>T (p.Gln164Ter)	PCDH19	Q164*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	VCV000211839	X	99663106	X	100408108	211839	208822	rs797045873	NC_000023.11:100408107:G:A
NM_015922.3(NSDHL):c.1038_1041dup (p.Gly348fs)	NSDHL		Child syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211748	X	152037575 - 152037576	X	152869031 - 152869032	211748	208917	rs797045835	NC_000023.11:152869031:CATG:CATGCATG
NM_002501.4(NFIX):c.970_971del (p.Lys324fs)	NFIX	K332fs, K277fs, K323fs, K316fs, K324fs	Marshall-Smith syndrome	Pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	VCV000211593	19	13189440 - 13189441	19	13078626 - 13078627	211593	208537	rs797045738	NC_000019.10:13078625:AAA:A
NM_002501.4(NFIX):c.1080_1096del (p.Ser361fs)	NFIX	S361fs, S320fs, S314fs, S353fs, S360fs, S369fs	Marshall-Smith syndrome	Pathogenic(Last reviewed: May 12, 2014)	criteria provided, single submitter	VCV000211591	19	13192494 - 13192510	19	13081680 - 13081696	211591	208538	rs797045737	NC_000019.10:13081679:GGAGCCCCCGGGCCACAG:G
NM_000252.2(MTM1):c.96dup (p.Glu33Ter)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211540	X	149764993 - 149764994	X	150596529 - 150596530	211540	208896	rs797045724	NC_000023.11:150596529:T:TT
NM_000252.2(MTM1):c.969dup (p.Val324fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000211539	X	149818283 - 149818284	X	150649810 - 150649811	211539	208906	rs587783865	NC_000023.11:150649810:AAAAAAA:AAAAAAAA
NM_000252.2(MTM1):c.949dup (p.Met317fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Apr 29, 2013)	criteria provided, single submitter	VCV000211538	X	149818269 - 149818270	X	150649796 - 150649797	211538	208905	rs797045722	NC_000023.11:150649796:A:AA
NM_000252.2(MTM1):c.867_867+1dup	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211537	X	149814343 - 149814344	X	150645870 - 150645871	211537	208904	rs797045721	NC_000023.11:150645870:GG:GGGG
NM_000252.2(MTM1):c.808_811del (p.Gln270fs)	MTM1	Q270fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211536	X	149814282 - 149814285	X	150645809 - 150645812	211536	208903	rs797045720	NC_000023.11:150645808:AAACAAA:AAA
NM_000252.2(MTM1):c.549dup (p.Arg184fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211535	X	149809760 - 149809761	X	150641287 - 150641288	211535	208902	rs797045719	NC_000023.11:150641287:GG:GGG
NM_000252.2(MTM1):c.419dup (p.Tyr140Ter)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211533	X	149787586 - 149787587	X	150619113 - 150619114	211533	208900	rs797045718	NC_000023.11:150619113:A:AA
NM_000252.2(MTM1):c.342_342+4del	MTM1		Severe X-linked myotubular myopathy|not provided	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000211532	X	149783168 - 149783172	X	150614695 - 150614699	211532	208899	rs797045717	NC_000023.11:150614694:GTAAAGTAA:GTAA
NM_000252.2(MTM1):c.1349_1353+4del	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000211530	X	149828223 - 149828231	X	150659750 - 150659758	211530	208912	rs797045715	NC_000023.11:150659749:AAAACAGGTAA:AA
NM_000252.2(MTM1):c.130dup (p.Ile44fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211529	X	149765026 - 149765027	X	150596562 - 150596563	211529	208897	rs797045714	NC_000023.11:150596562:AA:AAA
NM_000252.2(MTM1):c.1306_1308del (p.Pro436del)	MTM1	P436del	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211528	X	149828180 - 149828182	X	150659707 - 150659709	211528	208911	rs797045713	NC_000023.11:150659706:CTCCT:CT
NM_000252.2(MTM1):c.1283del (p.Asn428fs)	MTM1	N428fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211527	X	149828155	X	150659682	211527	208910	rs797045712	NC_000023.11:150659681:AAAAA:AAAA
NM_000252.2(MTM1):c.1227_1228delinsT (p.Lys409fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000211526	X	149826467 - 149826468	X	150657994 - 150657995	211526	208909	rs797045711	NC_000023.11:150657993:AG:T
NM_000252.2(MTM1):c.1089dup (p.Val364fs)	MTM1		Severe X-linked myotubular myopathy|Myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211525	X	149826326 - 149826327	X	150657853 - 150657854	211525	208908	rs587783752	NC_000023.11:150657853:AAA:AAAA
NM_000252.2(MTM1):c.1015dup (p.Ser339fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000211524	X	149818335 - 149818336	X	150649862 - 150649863	211524	208907	rs797045709	NC_000023.11:150649862:T:TT
NM_001165927.1(MKS1):c.814C>T (p.Arg272Ter)	MKS1	R272*, R282*, R79*	Joubert syndrome 28|Meckel syndrome type 1|Bardet-Biedl syndrome 13|Meckel syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211503	17	56290357	17	58212996	211503	208405	rs797045706	NC_000017.11:58212995:G:A
NM_001278116.2(L1CAM):c.2351A>G (p.Tyr784Cys)	L1CAM	Y784C, Y779C	Hydrocephalus due to aqueductal stenosis	Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	VCV000211340	X	153132184	X	153866729	211340	208928	rs797045674	NC_000023.11:153866728:T:C
NM_001278116.2(L1CAM):c.2278C>T (p.Arg760Ter)	L1CAM	R760*, R755*	Corpus callosum, partial agenesis of, X-linked|X-linked hydrocephalus syndrome|not provided|Hydrocephalus due to aqueductal stenosis	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211339	X	153132257	X	153866802	211339	208929	rs797045673	NC_000023.11:153866801:G:A
NM_001008537.3(NEXMIF):c.2772_2773insTTTC (p.Glu925fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000211263	X	73961619 - 73961620	X	74741784 - 74741785	211263	209190	rs797045646	NC_000023.11:74741784::GAAA
NM_021140.3(KDM6A):c.1543del (p.Val515fs)	KDM6A	V515fs, V522fs, V567fs, V219fs, V436fs, V470fs	Kabuki syndrome 2	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000211254	X	44922682	X	45063437	211254	209050	rs797045642	NC_000023.11:45063436:G:
NM_004187.4(KDM5C):c.3118C>T (p.Gln1040Ter)	KDM5C	Q1040*, Q1039*, Q973*	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000211249	X	53225100	X	53195918	211249	209093	rs782246658	NC_000023.11:53195917:G:A
NM_172107.4(KCNQ2):c.693G>T (p.Glu231Asp)	KCNQ2	E231D	Seizures	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000211234	20	62073882	20	63442529	211234	208706	rs797044938	NC_000020.11:63442528:C:A
NM_000208.4(INSR):c.1610+2T>C	INSR		Hyperinsulinemic hypoglycemia familial 5	Pathogenic(Last reviewed: Jan 7, 2015)	criteria provided, single submitter	VCV000211189	19	7167977	19	7167966	211189	208635	rs797045624	NC_000019.10:7167965:A:G
NM_018486.3(HDAC8):c.229C>T (p.Gln77Ter)	HDAC8	Q77*	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Oct 24, 2014)	criteria provided, single submitter	VCV000211141	X	71788670	X	72568820	211141	209173	rs797045611	NC_000023.11:72568819:G:A
NM_018486.3(HDAC8):c.130_133TTGA[1] (p.Ile45fs)	HDAC8		Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	VCV000211139	X	71791934 - 71791937	X	72572084 - 72572087	211139	209174	rs797045610	NC_000023.11:72572083:TCAATCAA:TCAA
NM_005257.5(GATA6):c.1087C>T (p.Gln363Ter)	GATA6	Q363*	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Oct 29, 2014)	criteria provided, single submitter	VCV000211063	18	19752192	18	22172231	211063	208434	rs797045593	NC_000018.10:22172230:C:T
NM_014009.3(FOXP3):c.727del (p.Glu243fs)	FOXP3	E208fs, E243fs	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000211046	X	49112184	X	49255723	211046	209083	rs797045588	NC_000023.11:49255722:CC:C
NM_001429.4(EP300):c.6915_6918del (p.Asn2305fs)	EP300	N2279fs, N2305fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000210941	22	41574627 - 41574630	22	41178623 - 41178626	210941	208801	rs797045560	NC_000022.11:41178622:CAATCAA:CAA
NM_001429.4(EP300):c.4836dup (p.Val1613fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000210940	22	41572305 - 41572306	22	41176301 - 41176302	210940	208800	rs797045559	NC_000022.11:41176301:TT:TTT
NM_004247.4(EFTUD2):c.1297_1298del (p.Met433fs)	EFTUD2	M433fs, M398fs, M423fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, single submitter	VCV000210915	17	42941138 - 42941139	17	44863770 - 44863771	210915	208399	rs797045551	NC_000017.11:44863769:AT:
NM_004247.4(EFTUD2):c.1149+1G>C	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000210914	17	42945174	17	44867806	210914	208400	rs797045550	NC_000017.11:44867805:C:G
NM_006579.3(EBP):c.484dup (p.Asp162fs)	EBP			Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210906	X	48386632 - 48386633	X	48528244 - 48528245	210906	209069	rs797045547	NC_000023.11:48528244:GGGG:GGGGG
NM_006579.3(EBP):c.423_427delinsT (p.Arg142fs)	EBP			Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210905	X	48385627 - 48385631	X	48527239 - 48527243	210905	209068	rs797045546	NC_000023.11:48527238:CCGCC:T
NM_006579.3(EBP):c.329_332dup (p.Tyr111Ter)	EBP			Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210903	X	48385403 - 48385404	X	48527015 - 48527016	210903	209066	rs797045544	NC_000023.11:48527015:GATA:GATAGATA
NM_006579.3(EBP):c.225dup (p.His76fs)	EBP			Pathogenic(Last reviewed: Jun 18, 2015)	criteria provided, single submitter	VCV000210902	X	48382382 - 48382383	X	48523994 - 48523995	210902	209065	rs797045543	NC_000023.11:48523994:TT:TTT
NM_001347721.2(DYRK1A):c.1271_1272insT (p.Pro425fs)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 25, 2015)	criteria provided, single submitter	VCV000210890	21	38877644 - 38877645	21	37505341 - 37505342	210890	208718	rs797045539	NC_000021.9:37505341::T
NM_178152.3(DCX):c.875dup (p.Thr293fs)	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210837	X	110574202 - 110574203	X	111330974 - 111330975	210837	208841	rs797045520	NC_000023.11:111330974:TT:TTT
NM_178152.3(DCX):c.81_85dup (p.Pro29fs)	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210835	X	110653541 - 110653542	X	111410313 - 111410314	210835	208851	rs797045519	NC_000023.11:111410313:GGCTAGGC:GGCTAGGCTAGGC
NM_178152.3(DCX):c.685_699dup (p.Tyr229_Gly233dup)	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210834	X	110644223 - 110644224	X	111400995 - 111400996	210834	208843	rs797045518	NC_000023.11:111400995:TCCATCCAGAGTGTA:TCCATCCAGAGTGTATCCATCCAGAGTGTA
NM_178152.3(DCX):c.681dup (p.Leu228fs)	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210833	X	110644241 - 110644242	X	111401013 - 111401014	210833	208844	rs587783579	NC_000023.11:111401013:TTTTTT:TTTTTTT
NM_178152.3(DCX):c.528del (p.Phe176fs)	DCX	F176fs, F257fs	Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210831	X	110644395	X	111401167	210831	208846	rs797045515	NC_000023.11:111401166:AAA:AA
NM_178152.3(DCX):c.339dup (p.Gly114fs)	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210830	X	110653287 - 110653288	X	111410059 - 111410060	210830	208847	rs797045514	NC_000023.11:111410059:G:GG
NM_178152.3(DCX):c.280A>G (p.Asn94Asp)	DCX	N94D, N175D	Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210828	X	110653347	X	111410119	210828	208849	rs797045512	NC_000023.11:111410118:T:C
NM_178151.2(DCX):c.226_234delCGTTTTCGCins2	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210827	X	110653393 - 110653401	X	111410165 - 111410173	210827	208850		
NM_178152.3(DCX):c.23_24del (p.His7_Phe8insTer)	DCX		Abnormal cortical gyration	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210826	X	110653603 - 110653604	X	111410375 - 111410376	210826	208852	rs797045510	NC_000023.11:111410374:AAA:A
NM_001848.2(COL6A1):c.1003-2A>G	COL6A1		Bethlem myopathy 1|Muscular Diseases	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210745	21	47410685	21	45990771	210745	208723	rs797045477	NC_000021.9:45990770:A:G
NM_001126054.2(CASK):c.2460_2461AG[1] (p.Glu821fs)	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	VCV000210586	X	41383261 - 41383262	X	41524008 - 41524009	210586	209041	rs797045433	NC_000023.11:41524007:CTCT:CT
NM_003688.3(CASK):c.2377C>T (p.Gln793Ter)	CASK	Q793*, Q798*, Q769*, Q770*	Deficiency of butyrylcholine esterase|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000210585	X	41390388	X	41531135	210585	209042	rs749742837	NC_000023.11:41531134:G:A
NM_003688.3(CASK):c.1981del (p.Leu661fs)	CASK	L638fs, L661fs, L632fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: May 8, 2015)	criteria provided, single submitter	VCV000210581	X	41413030	X	41553777	210581	209046	rs797045431	NC_000023.11:41553776:G:
NM_000052.7(ATP7A):c.876del (p.Ser293fs)	ATP7A	S293fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210479	X	77244994	X	77989498	210479	209210	rs797045400	NC_000023.11:77989497:G:
NM_000052.7(ATP7A):c.598C>T (p.Gln200Ter)	ATP7A	Q200*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210478	X	77244215	X	77988719	210478	209209	rs797045399	NC_000023.11:77988718:C:T
NM_000052.7(ATP7A):c.4226+5G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210476	X	77301074	X	78045577	210476	209299	rs797045398	NC_000023.11:78045576:G:A
NM_000052.7(ATP7A):c.420_421AG[1] (p.Glu141fs)	ATP7A		Menkes kinky-hair syndrome|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome|Cutis laxa, X-linked	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210474	X	77244037 - 77244038	X	77988541 - 77988542	210474	209207	rs797045397	NC_000023.11:77988540:AGAG:AG
NM_000052.7(ATP7A):c.4132dup (p.Met1378fs)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210472	X	77300974 - 77300975	X	78045477 - 78045478	210472	209297	rs797045395	NC_000023.11:78045477:A:AA
NM_000052.7(ATP7A):c.4123+1G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210470	X	77298933	X	78043435	210470	209296	rs797045393	NC_000023.11:78043434:G:A
NM_000052.7(ATP7A):c.4011_4013TCT[1] (p.Leu1339del)	ATP7A	L1339del	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210469	X	77298820 - 77298822	X	78043322 - 78043324	210469	209294	rs797045392	NC_000023.11:78043321:TCTTCT:TCT
NM_000052.7(ATP7A):c.4005+1G>T	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210468	X	77298287	X	78042789	210468	209293	rs797045391	NC_000023.11:78042788:G:T
NM_000052.7(ATP7A):c.3943G>A (p.Gly1315Arg)	ATP7A	G1315R, G1237R	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210467	X	77298224	X	78042726	210467	209292	rs797045390	NC_000023.11:78042725:G:A
NM_000052.7(ATP7A):c.3920del (p.Pro1307fs)	ATP7A	P1229fs, P1307fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210465	X	77298198	X	78042700	210465	209290	rs797045389	NC_000023.11:78042699:CCCC:CCC
NM_000052.7(ATP7A):c.3920C>G (p.Pro1307Arg)	ATP7A	P1307R, P1229R	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210464	X	77298201	X	78042703	210464	209289	rs797045388	NC_000023.11:78042702:C:G
NM_000052.7(ATP7A):c.3801+1G>T	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210462	X	77296232	X	78040734	210462	209287	rs797045386	NC_000023.11:78040733:G:T
NM_000052.7(ATP7A):c.3775_3776delinsTTAC (p.Lys1259fs)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210460	X	77296205 - 77296206	X	78040707 - 78040708	210460	209285	rs797045384	NC_000023.11:78040706:AA:TTAC
NM_000052.7(ATP7A):c.3774delinsATGACTGG (p.Ser1258delinsArgTer)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210459	X	77296204	X	78040706	210459	209284	rs797045383	NC_000023.11:78040705:T:ATGACTGG
NM_000052.7(ATP7A):c.3764G>A (p.Gly1255Glu)	ATP7A	G1255E, G1177E	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210458	X	77296194	X	78040696	210458	209283	rs797045382	NC_000023.11:78040695:G:A
NM_000052.7(ATP7A):c.3537del (p.Val1180fs)	ATP7A	V1102fs, V1180fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210456	X	77294357	X	78038859	210456	209281	rs797045380	NC_000023.11:78038858:AAA:AA
NM_000052.7(ATP7A):c.3502C>T (p.Gln1168Ter)	ATP7A	Q1168*, Q1090*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210454	X	77289310	X	78033812	210454	209279	rs797045379	NC_000023.11:78033811:C:T
NM_000052.7(ATP7A):c.3466C>T (p.Gln1156Ter)	ATP7A	Q1156*, Q1078*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210453	X	77289274	X	78033776	210453	209278	rs797045378	NC_000023.11:78033775:C:T
NM_000052.7(ATP7A):c.3379G>T (p.Glu1127Ter)	ATP7A	E1127*, E1049*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210451	X	77289187	X	78033689	210451	209276	rs797045377	NC_000023.11:78033688:G:T
NM_000052.7(ATP7A):c.3340del (p.Val1114fs)	ATP7A	V1114fs, V1036fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210449	X	77289148	X	78033650	210449	209274	rs797045375	NC_000023.11:78033649:G:
NM_000052.7(ATP7A):c.3288C>A (p.Cys1096Ter)	ATP7A	C1096*, C1018*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210447	X	77287074	X	78031576	210447	209272	rs797045373	NC_000023.11:78031575:C:A
NM_000052.7(ATP7A):c.3285T>G (p.Tyr1095Ter)	ATP7A	Y1095*, Y1017*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210446	X	77287071	X	78031573	210446	209271	rs797045372	NC_000023.11:78031572:T:G
NM_000052.6(ATP7A):c.3152_3156delACGGAins4	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210445	X	77286938 - 77286942	X	78031440 - 78031444	210445	209270		
NM_000052.7(ATP7A):c.3132T>G (p.Asp1044Glu)	ATP7A	D1044E, D966E	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210444	X	77286918	X	78031420	210444	209269	rs797045370	NC_000023.11:78031419:T:G
NM_000052.7(ATP7A):c.3127_3131delinsAGTACAGG (p.Phe1043_Asp1044delinsSerThrGly)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210443	X	77286913 - 77286917	X	78031415 - 78031419	210443	209268	rs797045369	NC_000023.11:78031414:TTTGA:AGTACAGG
NM_000052.7(ATP7A):c.3124del (p.Val1042fs)	ATP7A	V964fs, V1042fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210442	X	77286909	X	78031411	210442	209267	rs797045368	NC_000023.11:78031410:GG:G
NM_000052.7(ATP7A):c.3112-1G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210441	X	77286897	X	78031399	210441	209266	rs797045367	NC_000023.11:78031398:G:A
NM_000052.7(ATP7A):c.3069_3083del (p.Ile1024_Gly1028del)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210440	X	77284897 - 77284911	X	78029400 - 78029414	210440	209265	rs797045366	NC_000023.11:78029399:GGCATACTAATAAAAGG:GG
NM_000052.7(ATP7A):c.2956C>T (p.Arg986Ter)	ATP7A	R986*, R908*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210438	X	77284786	X	78029289	210438	209263	rs72554650	NC_000023.11:78029288:C:T
NM_000052.7(ATP7A):c.2916+3_2916+6del	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210437	X	77276577 - 77276580	X	78021080 - 78021083	210437	209262	rs797045364	NC_000023.11:78021079:GTAAGT:GT
NM_000052.7(ATP7A):c.2645dup (p.Ala882_Lys883insTer)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210433	X	77275758 - 77275759	X	78020261 - 78020262	210433	209258	rs797045361	NC_000023.11:78020261:C:CC
NM_000052.7(ATP7A):c.2555C>T (p.Pro852Leu)	ATP7A	P852L, P774L	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210432	X	77271307	X	78015810	210432	209257	rs797045360	NC_000023.11:78015809:C:T
NM_000052.7(ATP7A):c.2499-1G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210431	X	77271250	X	78015753	210431	209255	rs797045359	NC_000023.11:78015752:G:A
NM_000052.7(ATP7A):c.2499-1_2504dup	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210430	X	77271248 - 77271249	X	78015751 - 78015752	210430	209256	rs797045358	NC_000023.11:78015751:AGTGAAGA:AGTGAAGAGTGAAGA
NM_000052.7(ATP7A):c.2498+2T>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210429	X	77270252	X	78014755	210429	209254	rs797045357	NC_000023.11:78014754:T:A
NM_000052.7(ATP7A):c.2405_2406+1delinsT	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210427	X	77268608 - 77268610	X	78013111 - 78013113	210427	209252	rs797045356	NC_000023.11:78013110:AGG:T
NM_000052.7(ATP7A):c.2395_2405delinsAGCATC (p.His799fs)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210426	X	77268598 - 77268608	X	78013101 - 78013111	210426	209251	rs797045355	NC_000023.11:78013100:CATATAGCAAA:AGCATC
NM_000052.7(ATP7A):c.2383C>T (p.Arg795Ter)	ATP7A	R795*	not provided|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210425	X	77268586	X	78013089	210425	209250	rs72554645	NC_000023.11:78013088:C:T
NM_000052.7(ATP7A):c.2357T>G (p.Met786Arg)	ATP7A	M786R	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210424	X	77268560	X	78013063	210424	209249	rs797045354	NC_000023.11:78013062:T:G
NM_000052.7(ATP7A):c.2302del (p.Ala768fs)	ATP7A	A768fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210423	X	77268505	X	78013008	210423	209248	rs797045353	NC_000023.11:78013007:G:
NM_000052.7(ATP7A):c.2248_2251dup (p.Val751fs)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210422	X	77268448 - 77268449	X	78012951 - 78012952	210422	209247	rs797045352	NC_000023.11:78012951:TGATTG:TGATTGATTG
NM_000052.7(ATP7A):c.2187G>A (p.Trp729Ter)	ATP7A	W729*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210421	X	77268390	X	78012893	210421	209246	rs797045351	NC_000023.11:78012892:G:A
NM_000052.7(ATP7A):c.2179G>T (p.Gly727Ter)	ATP7A	G727*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210419	X	77268382	X	78012885	210419	209244	rs72554644	NC_000023.11:78012884:G:T
NM_000052.7(ATP7A):c.2179G>A (p.Gly727Arg)	ATP7A	G727R	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210418	X	77268382	X	78012885	210418	209243	rs72554644	NC_000023.11:78012884:G:A
NM_000052.7(ATP7A):c.2173-2A>G	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210417	X	77268374	X	78012877	210417	209242	rs797045349	NC_000023.11:78012876:A:G
NM_000052.7(ATP7A):c.2172+5G>C	ATP7A		Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome|Cutis laxa, X-linked|Menkes kinky-hair syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210415	X	77267176	X	78011679	210415	209241	rs797045347	NC_000023.11:78011678:G:C
NM_000052.7(ATP7A):c.2160T>A (p.Cys720Ter)	ATP7A	C720*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210414	X	77267159	X	78011662	210414	209239	rs797045346	NC_000023.11:78011661:T:A
NM_000052.7(ATP7A):c.1996G>C (p.Gly666Arg)	ATP7A	G666R	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210411	X	77266995	X	78011498	210411	209236	rs797045344	NC_000023.11:78011497:G:C
NM_000052.7(ATP7A):c.1978_2008dup (p.Tyr670fs)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210409	X	77266975 - 77266976	X	78011478 - 78011479	210409	209234	rs797045343	NC_000023.11:78011478:TTTCTGTATTCCTGTAATGGGGCTGATGATAT:TTTCTGTATTCCTGTAATGGGGCTGATGATATTTCTGTATTCCTGTAATGGGGCTGATGATAT
NM_000052.7(ATP7A):c.1950G>A (p.Trp650Ter)	ATP7A	W650*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210408	X	77266949	X	78011452	210408	209233	rs797045342	NC_000023.11:78011451:G:A
NM_000052.7(ATP7A):c.1947-1G>C	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210407	X	77266945	X	78011448	210407	209232	rs794729231	NC_000023.11:78011447:G:C
NM_000052.7(ATP7A):c.1946+5G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210406	X	77266754	X	78011257	210406	209231	rs797045341	NC_000023.11:78011256:G:A
NM_000052.7(ATP7A):c.1946+1G>C	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210405	X	77266750	X	78011253	210405	209230	rs797045340	NC_000023.11:78011252:G:C
NM_000052.7(ATP7A):c.1933C>T (p.Arg645Ter)	ATP7A	R645*	not provided|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210404	X	77266736	X	78011239	210404	209229	rs72554640	NC_000023.11:78011238:C:T
NM_000052.7(ATP7A):c.1874T>G (p.Leu625Ter)	ATP7A	L625*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210402	X	77266677	X	78011180	210402	209227	rs797045339	NC_000023.11:78011179:T:G
NM_000052.7(ATP7A):c.1870-1G>C	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210401	X	77266672	X	78011175	210401	209226	rs797045338	NC_000023.11:78011174:G:C
NM_000052.7(ATP7A):c.1831G>T (p.Glu611Ter)	ATP7A	E611*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210400	X	77264722	X	78009225	210400	209225	rs797045337	NC_000023.11:78009224:G:T
NM_000052.7(ATP7A):c.1782C>G (p.Tyr594Ter)	ATP7A	Y594*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210399	X	77264673	X	78009176	210399	209224	rs797045336	NC_000023.11:78009175:C:G
NM_000052.7(ATP7A):c.1667_1668del (p.Ile556fs)	ATP7A	I556fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	VCV000210396	X	77258692 - 77258693	X	78003195 - 78003196	210396	209221	rs797045333	NC_000023.11:78003194:ATA:A
NM_000052.7(ATP7A):c.1639C>T (p.Arg547Ter)	ATP7A	R547*	Menkes kinky-hair syndrome|Distal spinal muscular atrophy, X-linked 3|Menkes kinky-hair syndrome|Cutis laxa, X-linked	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210395	X	77258665	X	78003168	210395	209220	rs797045332	NC_000023.11:78003167:C:T
NM_000052.7(ATP7A):c.1544-1G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210394	X	77258569	X	78003072	210394	209219	rs797045331	NC_000023.11:78003071:G:A
NM_000052.7(ATP7A):c.1460C>A (p.Ser487Ter)	ATP7A	S487*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210392	X	77254098	X	77998601	210392	209217	rs797045330	NC_000023.11:77998600:C:A
NM_000052.7(ATP7A):c.1355del (p.Val452fs)	ATP7A	V452fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210391	X	77253993	X	77998496	210391	209216	rs797045329	NC_000023.11:77998495:T:
NM_000052.7(ATP7A):c.1225C>T (p.Arg409Ter)	ATP7A	R409*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210389	X	77245343	X	77989847	210389	209214	rs72554636	NC_000023.11:77989846:C:T
NM_000052.7(ATP7A):c.1020_1024dup (p.Leu342fs)	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210388	X	77245136 - 77245137	X	77989640 - 77989641	210388	209213	rs797045327	NC_000023.11:77989640:CGGGGC:CGGGGCGGGGC
NM_000052.7(ATP7A):c.1006G>T (p.Glu336Ter)	ATP7A	E336*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210386	X	77245124	X	77989628	210386	209211	rs797045325	NC_000023.11:77989627:G:T
NM_030632.3(ASXL3):c.1188_1191ACAG[1] (p.Thr398fs)	ASXL3		not provided|Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000210364	18	31318556 - 31318559	18	33738592 - 33738595	210364	208445	rs797045317	NC_000018.10:33738591:ACAGACAG:ACAG
NM_139058.3(ARX):c.562_563delinsTA (p.Ala188Ter)	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210335	X	25031549 - 25031550	X	25013432 - 25013433	210335	209017	rs797045303	NC_000023.11:25013431:GC:TA
NM_139058.3(ARX):c.1471dup (p.Leu491fs)	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000210321	X	25023004 - 25023005	X	25004887 - 25004888	210321	209010	rs797045292	NC_000023.11:25004887:GGGGGG:GGGGGGG
NM_139058.3(ARX):c.1449-82_1469dup	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210320	X	25023006 - 25023007	X	25004889 - 25004890	210320	209011	rs1556046904	
NM_139058.3(ARX):c.1337dup (p.Pro447fs)	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210319	X	25025338 - 25025339	X	25007221 - 25007222	210319	209012	rs797045291	NC_000023.11:25007221:GG:GGG
NM_139058.3(ARX):c.1164_1165insCAAAG (p.Ala389fs)	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210318	X	25025511 - 25025512	X	25007394 - 25007395	210318	209013	rs797045290	NC_000023.11:25007394:CTT:CTTTGCTT
NM_139058.2(ARX):c.1120-82_1469dup	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000210317					210317	209312		
NM_139058.3(ARX):c.1096del (p.Asp366fs)	ARX	D366fs	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Apr 16, 2015)	criteria provided, single submitter	VCV000210316	X	25028400	X	25010283	210316	209014	rs797045289	NC_000023.11:25010282:CC:C
NM_001077488.4(GNAS):c.684G>T (p.Gln228His)	GNAS	Q227H, Q228H, Q213H, Q168H, Q212H, Q870H	McCune-Albright syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	VCV000210048	20	57484597	20	58909542	210048	206653	rs137854533	NC_000020.11:58909541:G:T
NM_001077488.4(GNAS):c.683A>T (p.Gln228Leu)	GNAS	Q227L, Q228L, Q212L, Q168L, Q870L, Q213L	McCune-Albright syndrome|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000210047	20	57484596	20	58909541	210047	206652	rs121913494	NC_000020.11:58909540:A:T
NM_001077488.4(GNAS):c.682C>A (p.Gln228Lys)	GNAS	Q227K, Q228K, Q168K, Q213K, Q870K, Q212K	McCune-Albright syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	VCV000210046	20	57484595	20	58909540	210046	206651	rs797045203	NC_000020.11:58909539:C:A
NM_001077488.4(GNAS):c.605G>T (p.Arg202Leu)	GNAS	R201L, R202L, R844L, R142L, R186L, R187L	McCune-Albright syndrome|Squamous cell carcinoma of the head and neck|Malignant melanoma of skin|Lung adenocarcinoma|Pancreatic adenocarcinoma|Hepatocellular carcinoma|Neoplasm of the breast|Adrenocortical carcinoma|Adenocarcinoma of stomach|Uterine cervical neoplasms|Neoplasm of the large intestine|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000210045	20	57484421	20	58909366	210045	206650	rs121913495	NC_000020.11:58909365:G:T
NM_000285.4(PEPD):c.1103T>G (p.Leu368Arg)	PEPD	L368R, L327R, L304R	Prolidase deficiency	Pathogenic(Last reviewed: Apr 6, 2015)	no assertion criteria provided	VCV000209998	19	33882250	19	33391344	209998	206589	rs797045185	NC_000019.10:33391343:A:C
NM_000285.4(PEPD):c.634G>C (p.Ala212Pro)	PEPD	A212P, A148P	Prolidase deficiency	Pathogenic(Last reviewed: Apr 6, 2015)	no assertion criteria provided	VCV000209997	19	33953938	19	33463032	209997	206590	rs747700126	NC_000019.10:33463031:C:G
Single allele	LAMA1		Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000209992	18	7038809 - 7050936	18	7038809 - 7050936	209992	206578		
NM_005559.4(LAMA1):c.6345+3G>C	LAMA1		Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000209991	18	6977723	18	6977724	209991	206577	rs797045184	NC_000018.10:6977723:C:G
NM_005559.3:c.2988_2989delA	LAMA1		Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000209990					209990	206580		
NM_005559.4(LAMA1):c.6701del (p.Pro2234fs)	LAMA1	P2234fs	Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000209987	18	6973129	18	6973130	209987	206576	rs797045182	NC_000018.10:6973129:GGGG:GGG
NM_001083962.2(TCF4):c.1069+1G>T	TCF4	G333V	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	VCV000209195	18	52927179	18	55259948	209195	205790	rs797045072	NC_000018.10:55259947:C:A
NM_001281463.1(SMC1A):c.2481del (p.Ile827fs)	SMC1A	I849fs, I827fs	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000209192	X	53426526	X	53399604	209192	205800	rs797045069	NC_000023.11:53399603:T:
NM_002501.4(NFIX):c.338_342dup (p.Arg116fs)	NFIX		Sotos syndrome 2	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000209174	19	13136144 - 13136145	19	13025330 - 13025331	209174	205791	rs797045056	NC_000019.10:13025330:AGATC:AGATCAGATC
NM_002204.4(ITGA3):c.2070+1G>A	ITGA3		Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	Pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000209163	17	48154486	17	50077122	209163	205786	rs797045048	NC_000017.11:50077121:G:A
NM_001077488.4(GNAS):c.34C>T (p.Gln12Ter)	GNAS	Q12*	Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000209158	20	57466815	20	58891760	209158	205793	rs797045046	NC_000020.11:58891759:C:T
NM_001347721.2(DYRK1A):c.1135dup (p.Ala379fs)	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Nov 7, 2013)	criteria provided, single submitter	VCV000209151	21	38868482 - 38868483	21	37496180 - 37496181	209151	205794	rs797045042	NC_000021.9:37496180:G:GG
NM_001347721.2(DYRK1A):c.1373G>A (p.Arg458Gln)	DYRK1A	R467Q, R458Q, R429Q	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000209150	21	38877746	21	37505443	209150	205795	rs797045041	NC_000021.9:37505442:G:A
NM_033380.3(COL4A5):c.4016-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 30, 2012)	criteria provided, single submitter	VCV000209142	X	107924114	X	108680884	209142	205798	rs797045035	NC_000023.11:108680883:G:A
NM_001172646.1(PLCB4):c.986A>C (p.Asn329Thr)	PLCB4	N329T	Auriculocondylar syndrome 1	Pathogenic(Last reviewed: Sep 17, 2012)	criteria provided, single submitter	VCV000209128	20	9364980	20	9384333	209128	205719	rs387907179	NC_000020.11:9384332:A:C
NM_001830.4(CLCN4):c.1876dup (p.Ile626fs)	CLCN4		CLCN4-related disorder	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000209118	X	10182019 - 10182020	X	10213979 - 10213980	209118	205715	rs879255586	NC_000023.11:10213979:A:AA
NM_001830.4(CLCN4):c.823G>A (p.Val275Met)	CLCN4	V275M, V181M	CLCN4-related disorder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000209117	X	10174796	X	10206756	209117	205714	rs879255585	NC_000023.11:10206755:G:A
NM_001830.4(CLCN4):c.2152C>T (p.Arg718Trp)	CLCN4	R718W, R624W	CLCN4-related disorder|not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209116	X	10188877	X	10220837	209116	205713	rs879255584	NC_000023.11:10220836:C:T
GRCh37/hg19 Xp22.2(chrX:10187807-10189796)	CLCN4		CLCN4-related disorder	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000209114	X	10182428 - 10201480			209114	205711		
NM_001830.4(CLCN4):c.1601C>T (p.Ser534Leu)	CLCN4	S534L, S440L	CLCN4-related disorder	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000209113	X	10181745	X	10213705	209113	205710	rs879255582	NC_000023.11:10213704:C:T
NM_001830.4(CLCN4):c.662T>C (p.Leu221Pro)	CLCN4	L221P, L127P	CLCN4-related disorder	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000209112	X	10174504	X	10206464	209112	205709	rs879255581	NC_000023.11:10206463:T:C
NM_001830.4(CLCN4):c.635T>G (p.Val212Gly)	CLCN4	V212G, V118G	CLCN4-related disorder	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000209111	X	10174477	X	10206437	209111	205708	rs879255580	NC_000023.11:10206436:T:G
NM_006280.3(SSR4):c.317del (p.Phe106fs)	SSR4	F117fs, F106fs, F114fs	Congenital disorder of glycosylation type 1y	Pathogenic(Last reviewed: Mar 15, 2014)	no assertion criteria provided	VCV000209110	X	153063234	X	153797779	209110	205707	rs606231298	NC_000023.11:153797778:TT:T
NM_006579.3(EBP):c.139T>C (p.Trp47Arg)	EBP	W47R	MEND syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000209040	X	48382298	X	48523910	209040	205600	rs878854359	NC_000023.11:48523909:T:C
NM_006579.3(EBP):c.224T>A (p.Ile75Asn)	EBP	I75N	MEND syndrome	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000209039	X	48382383	X	48523995	209039	205599	rs797045153	NC_000023.11:48523994:T:A
NM_006579.3(EBP):c.33C>A (p.Tyr11Ter)	EBP	Y11*	Chondrodysplasia punctata 2, X-linked dominant, atypical	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000209038	X	48382192	X	48523804	209038	205598	rs878854358	NC_000023.11:48523803:C:A
NM_080860.4(RSPH1):c.366G>A (p.Arg122=)	RSPH1		Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000208998	21	43905914	21	42485804	208998	205565	rs797045148	NC_000021.9:42485803:C:T
NM_001083961.1(WDR62):c.2030T>C	WDR62	L677P	Abnormality of neuronal migration	Pathogenic(Last reviewed: Oct 31, 2014)	no assertion criteria provided	VCV000208910	19	36581418	19	36090516	208910	205490	rs863223377	NC_000019.10:36090515:T:C
NM_001111125.3(IQSEC2):c.3116-3_3116-2del	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: May 1, 2014)	criteria provided, single submitter	VCV000208858	X	53267490 - 53267491	X	53238308 - 53238309	208858	205419	rs797045140	NC_000023.11:53238307:TGTG:TG
NM_000208.4(INSR):c.394G>A (p.Gly132Ser)	INSR	G132S	Pineal hyperplasia AND diabetes mellitus syndrome	Pathogenic	no assertion criteria provided	VCV000208852	19	7267614	19	7267603	208852	205413	rs886037750	NC_000019.10:7267602:C:T
NM_032608.7(MYO18B):c.6905C>A (p.Ser2302Ter)	MYO18B	S2302*, S2303*	Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000208842	22	26422845	22	26026879	208842	205404	rs556752387	NC_000022.11:26026878:C:A
NM_152906.7(TANGO2):c.605+1G>A	TANGO2		Cardiac arrhythmia|Intellectual functioning disability|Acute rhabdomyolysis|Seizures|Episodic flaccid weakness|METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION|Neurodegeneration	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208824	22	20049207	22	20061684	208824	205386	rs372949028	NC_000022.11:20061683:G:A
NM_152906.7(TANGO2):c.460G>A (p.Gly154Arg)	TANGO2	G154R, G120R, G56R, G92R, G133R, G195R	Cardiac arrhythmia|Intellectual functioning disability|Acute rhabdomyolysis|Seizures|Episodic flaccid weakness|METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000208823	22	20049061	22	20061538	208823	205385	rs752298579	NC_000022.11:20061537:G:A
NM_001017980.3(VMA21):c.54-16_54-8del	VMA21			Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000208806	X	150572083 - 150572091	X	151403611 - 151403619	208806	205367	rs878854357	NC_000023.11:151403610:CTTTGTTTACTTT:CTTT
NM_001017980.3(VMA21):c.*13_*104del	VMA21			Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000208805	X	150573543 - 150573634	X	151405071 - 151405162	208805	205366	rs1556035617	
NM_001017980.3(VMA21):c.164-6T>G	VMA21			Pathogenic(Last reviewed: Apr 21, 2015)	no assertion criteria provided	VCV000208804	X	150573382	X	151404910	208804	205365	rs878854356	NC_000023.11:151404909:T:G
NM_001017980.3(VMA21):c.272G>C (p.Gly91Ala)	VMA21	G91A, G146A		Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000208802	X	150573496	X	151405024	208802	205363	rs878854354	NC_000023.11:151405023:G:C
NM_001017980.3(VMA21):c.164-7T>G	VMA21			Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000208801	X	150573381	X	151404909	208801	205362	rs878854353	NC_000023.11:151404908:T:G
NM_001017980.3(VMA21):c.54-27A>T	VMA21			Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000208799	X	150572076	X	151403604	208799	205360	rs878854352	NC_000023.11:151403603:A:T
NM_001017980.3(VMA21):c.54-27A>C	VMA21			Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000208798	X	150572076	X	151403604	208798	205359	rs878854352	NC_000023.11:151403603:A:C
NM_003588.3(CUL4B):c.149C>T (p.Pro50Leu)	CUL4B	P50L, P32L, P37L	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000208797	X	119694399	X	120560544	208797	205358	rs869320682	NC_000023.11:120560543:G:A
NM_003588.3(CUL4B):c.1906+1G>T	CUL4B		Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000208796	X	119672514	X	120538659	208796	205357	rs797044862	NC_000023.11:120538658:C:A
NM_172107.4(KCNQ2):c.710A>G (p.Tyr237Cys)	KCNQ2	Y237C	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	VCV000208758	20	62073865	20	63442512	208758	205321	rs797044935	NC_000020.11:63442511:T:C
NM_001111125.3(IQSEC2):c.2582G>C (p.Ser861Thr)	IQSEC2	S861T, S656T	Inborn genetic diseases	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000208753	X	53277296	X	53248114	208753	205346	rs797044932	NC_000023.11:53248113:C:G
NM_002501.4(NFIX):c.361C>T (p.Arg121Cys)	NFIX	R121C, R120C, R113C, R74C, R129C	Inborn genetic diseases	Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000208724	19	13136168	19	13025354	208724	205311	rs797044911	NC_000019.10:13025353:C:T
NM_001017980.3(VMA21):c.163+4A>G	VMA21		Inborn genetic diseases|	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208720	X	150572216	X	151403744	208720	205332	rs797044909	NC_000023.11:151403743:A:G
NM_001015877.2(PHF6):c.915_916delinsAA (p.Cys305_Gly306delinsTer)	PHF6		Inborn genetic diseases	Pathogenic(Last reviewed: Dec 17, 2013)	criteria provided, single submitter	VCV000208718	X	133551279 - 133551280	X	134417249 - 134417250	208718	205329	rs797044908	NC_000023.11:134417248:TG:AA
NM_003560.4(PLA2G6):c.1019_1025del (p.Gly340fs)	PLA2G6	G114fs, G162fs, G340fs	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 8, 2014)	criteria provided, single submitter	VCV000208712	22	38528890 - 38528896	22	38132883 - 38132889	208712	205324	rs797044903	NC_000022.11:38132882:TTGGCCC:
NM_001281463.1(SMC1A):c.3130C>T (p.Arg1044Cys)	SMC1A	R1044C, R1066C	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	VCV000208703	X	53409516	X	53382595	208703	205348	rs797044896	NC_000023.11:53382594:G:A
NM_001001563.5(TIMM50):c.805G>A (p.Gly269Ser)	TIMM50	G372S, G269S, G156S	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000208697	19	39978809	19	39488169	208697	205312	rs797044891	NC_000019.10:39488168:G:A
NM_001111125.3(IQSEC2):c.2052_2053del (p.Cys684_Glu685delinsTer)	IQSEC2		Inborn genetic diseases	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000208694	X	53279705 - 53279706	X	53250523 - 53250524	208694	205347	rs797044889	NC_000023.11:53250522:CGC:C
NM_005334.3(HCFC1):c.5860G>A (p.Gly1954Arg)	HCFC1	G1954R	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 18, 2013)	criteria provided, single submitter	VCV000208691	X	153215838	X	153950387	208691	205335	rs797044886	NC_000023.11:153950386:C:T
NM_004859.4(CLTC):c.2733_2734GA[4] (p.Asp913fs)	CLTC		Intellectual disability, autosomal dominant 56|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000208688	17	57754484 - 57754485	17	59677123 - 59677124	208688	205306	rs797044884	NC_000017.11:59677123:AGAGAGA:AGAGAGAGA
NM_000292.3(PHKA2):c.884G>A (p.Arg295His)	PHKA2	R295H	Glycogen storage disease type IXa1|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208676	X	18958147	X	18940029	208676	205340	rs797044877	NC_000023.11:18940028:C:T
NM_004977.2(KCNC3):c.1268G>A (p.Arg423His)	KCNC3	R423H	|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208671	19	50826942	19	50323685	208671	205316	rs797044872	NC_000019.10:50323684:C:T
NM_012280.4(FTSJ1):c.34T>A (p.Tyr12Asn)	FTSJ1	Y12N	Inborn genetic diseases	Pathogenic(Last reviewed: Jul 27, 2013)	criteria provided, single submitter	VCV000208659	X	48336469	X	48478081	208659	205344	rs797044864	NC_000023.11:48478080:T:A
NM_018684.4(ZC4H2):c.148C>T (p.Gln50Ter)	ZC4H2	Q50*, Q27*	Inborn genetic diseases	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000208658	X	64141774	X	64921894	208658	205350	rs797044863	NC_000023.11:64921893:G:A
NM_001323289.2(CDKL5):c.514G>A (p.Val172Ile)	CDKL5	V172I	Inborn genetic diseases	Pathogenic(Last reviewed: Sep 30, 2013)	criteria provided, single submitter	VCV000208653	X	18602433	X	18584313	208653	205338	rs797044858	NC_000023.11:18584312:G:A
NM_006306.4(SMC1A):c.3549_3552dup (p.Ile1185fs)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 85, WITH OR WITHOUT MIDLINE BRAIN DEFECTS	Pathogenic(Last reviewed: Sep 8, 2015)	criteria provided, single submitter	VCV000208627	X	53407606 - 53407607	X	53380685 - 53380686	208627	205197	rs863225459	NC_000023.11:53380685:GGCC:GGCCGGCC
NM_006306.4(SMC1A):c.2853_2856del (p.Ser951fs)	SMC1A	S951fs, S929fs	Congenital muscular hypertrophy-cerebral syndrome|EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 85, WITH OR WITHOUT MIDLINE BRAIN DEFECTS|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208626	X	53423153 - 53423156	X	53396233 - 53396236	208626	205198	rs863225458	NC_000023.11:53396232:CTGACT:CT
NM_001174089.2(SLC4A11):c.425_433delinsC (p.Arg142fs)	SLC4A11		Corneal endothelial dystrophy	Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	VCV000208613	20	3214819 - 3214827	20	3234173 - 3234181	208613	205190	rs797045107	NC_000020.11:3234172:TGGCGAAGC:G
NM_000782.5(CYP24A1):c.1039C>T (p.Gln347Ter)	CYP24A1	Q347*	Hypercalcemia, infantile, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000208571	20	52775614	20	54159075	208571	205191	rs777947329	NC_000020.11:54159074:G:A
NM_145020.5(CFAP53):c.121C>T (p.Arg41Ter)	CFAP53	R41*	Heterotaxy, visceral, 6, autosomal	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000208550	18	47788538	18	50262168	208550	205070	rs375801610	NC_000018.10:50262167:G:A
NM_001356.4(DDX3X):c.1084C>T (p.Arg362Cys)	DDX3X	R362C, R346C, R176C	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208549	X	41204491	X	41345238	208549	205066	rs797045026	NC_000023.11:41345237:C:T
NM_001356.4(DDX3X):c.873C>A (p.Tyr291Ter)	DDX3X	Y291*, Y105*, Y275*	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208548	X	41203500	X	41344247	208548	205065	rs869320681	NC_000023.11:41344246:C:A
NM_001356.4(DDX3X):c.977G>A (p.Arg326His)	DDX3X	R326H, R310H, R140H	Inborn genetic diseases|Mental retardation, X-linked 102|not provided	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208547	X	41203604	X	41344351	208547	205064	rs797045025	NC_000023.11:41344350:G:A
NM_001356.4(DDX3X):c.1520T>C (p.Ile507Thr)	DDX3X	I507T, I321T, I491T	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208546	X	41205780	X	41346527	208546	205063	rs797045024	NC_000023.11:41346526:T:C
NM_001081550.2(THOC2):c.2399T>C (p.Ile800Thr)	THOC2	I800T	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208526	X	122765621	X	123631770	208526	205044	rs797045021	NC_000023.11:123631769:A:G
NM_001081550.2(THOC2):c.3034T>C (p.Ser1012Pro)	THOC2	S1012P	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208525	X	122759786	X	123625935	208525	205043	rs797045020	NC_000023.11:123625934:A:G
NM_001081550.2(THOC2):c.937C>T (p.Leu313Phe)	THOC2	L313F	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208524	X	122802090	X	123668239	208524	205042	rs797045019	NC_000023.11:123668238:G:A
NM_001081550.2(THOC2):c.1313T>C (p.Leu438Pro)	THOC2	L438P	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208523	X	122799566	X	123665715	208523	205041	rs797045018	NC_000023.11:123665714:A:G
NM_001972.4(ELANE):c.561C>A (p.Cys187Ter)	ELANE	C187*	Neutropenia, severe congenital 1, autosomal dominant	Pathogenic(Last reviewed: Mar 5, 2014)	no assertion criteria provided	VCV000208494	19	855758	19	855758	208494	205024	rs797045009	NC_000019.10:855757:C:A
NM_001083962.2(TCF4):c.968C>T (p.Ala323Val)	TCF4	A323V, A107V, A163V, A252V, A298V, A425V, A193V, A281V, A299V, A322V, A321V, A329V	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 19, 2014)	no assertion criteria provided	VCV000208487	18	52928719	18	55261488	208487	205021	rs797045003	NC_000018.10:55261487:G:A
NM_016097.5(IER3IP1):c.80del (p.Phe27fs)	IER3IP1	F27fs	Microcephaly, epilepsy, and diabetes syndrome	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000208459	18	44702569	18	47176198	208459	204984	rs863223399	NC_000018.10:47176197:AA:A
NM_002204.4(ITGA3):c.1387C>T (p.Arg463Trp)	ITGA3	R463W	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208455	17	48151816	17	50074452	208455	204980	rs797044989	NC_000017.11:50074451:C:T
NM_058004.4(PI4KA):c.5560G>A (p.Asp1854Asn)	PI4KA	D1854N, D1832N, D1823N	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208451	22	21067580	22	20713292	208451	204976	rs747119727	NC_000022.11:20713291:C:T
NM_058004.4(PI4KA):c.2386C>T (p.Arg796Ter)	PI4KA	R796*, R774*	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000208450	22	21119924	22	20765636	208450	204975	rs777006911	NC_000022.11:20765635:G:A
NM_000528.4(MAN2B1):c.685C>T (p.Arg229Trp)	MAN2B1	R229W	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208258	19	12774595	19	12663781	208258	204512	rs763257568	NC_000019.10:12663780:G:A
NM_000891.2(KCNJ2):c.966G>C (p.Trp322Cys)	KCNJ2	W322C	Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208081	17	68172146	17	70176005	208081	204360	rs797044842	NC_000017.11:70176004:G:C
NM_000891.2(KCNJ2):c.271_282del (p.Ala91_Leu94del)	KCNJ2		Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208080	17	68171447 - 68171458	17	70175306 - 70175317	208080	204359	rs797044841	NC_000017.11:70175305:CCTGGCTTTCGTCCTG:CCTG
NM_020533.3(MCOLN1):c.235C>T (p.Gln79Ter)	MCOLN1	Q79*	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208042	19	7590050	19	7525164	208042	204284	rs797044832	NC_000019.10:7525163:C:T
NM_020533.3(MCOLN1):c.920del (p.Leu307fs)	MCOLN1	L307fs	Mucolipidosis type IV	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208039	19	7593525	19	7528639	208039	204292	rs755042147	NC_000019.10:7528638:T:
NM_020533.3(MCOLN1):c.302_303del (p.Phe101fs)	MCOLN1	F101fs	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208038	19	7591389 - 7591390	19	7526503 - 7526504	208038	204286	rs797044830	NC_000019.10:7526502:TC:
NM_020533.2(MCOLN1):c.236_237insNC_012920.1:m.12435_12527 (p.Gln79delinsHisHisTyrValLysSerIleValAlaSerThrPheIleIleSerLeuPheProThrThrIlePheMetCysLeuAspGlnGluValIleIleSer)	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208037	19	7590051 - 7590052	19	7525165 - 7525166	208037	204285		
NM_020533.3(MCOLN1):c.1388G>A (p.Cys463Tyr)	MCOLN1	C463Y	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208036	19	7595200	19	7530314	208036	204297	rs797044829	NC_000019.10:7530313:G:A
NM_020533.3(MCOLN1):c.1395C>G (p.Phe465Leu)	MCOLN1	F465L	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208035	19	7595207	19	7530321	208035	204298	rs797044828	NC_000019.10:7530320:C:G
NM_020533.3(MCOLN1):c.1340T>C (p.Leu447Pro)	MCOLN1	L447P	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208034	19	7594579	19	7529693	208034	204296	rs797044827	NC_000019.10:7529692:T:C
NM_020533.3(MCOLN1):c.1336G>T (p.Val446Leu)	MCOLN1	V446L	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208033	19	7594575	19	7529689	208033	204295	rs754097561	NC_000019.10:7529688:G:T
NM_020533.3(MCOLN1):c.497G>T (p.Cys166Phe)	MCOLN1	C166F	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208032	19	7591738	19	7526852	208032	204289	rs797044826	NC_000019.10:7526851:G:T
NM_020533.3(MCOLN1):c.317T>C (p.Leu106Pro)	MCOLN1	L106P	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208031	19	7591404	19	7526518	208031	204287	rs797044825	NC_000019.10:7526517:T:C
NM_020533.3(MCOLN1):c.1453_1463dup (p.Ser488fs)	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000208029	19	7595256 - 7595257	19	7530370 - 7530371	208029	204300	rs797044823	NC_000019.10:7530370:CGCAGCAGGGCCGCAGCAG:CGCAGCAGGGCCGCAGCAGGGCCGCAGCAG
NM_020533.3(MCOLN1):c.1210dup (p.Tyr404fs)	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208028	19	7594061 - 7594062	19	7529175 - 7529176	208028	204293	rs797044822	NC_000019.10:7529175:T:TT
NM_020533.3(MCOLN1):c.473_474del (p.Thr158fs)	MCOLN1	T158fs	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208027	19	7591714 - 7591715	19	7526828 - 7526829	208027	204288	rs797044821	NC_000019.10:7526827:CC:
NM_020533.3(MCOLN1):c.163_197delinsTCA (p.Lys55fs)	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208026	19	7589978 - 7590012	19	7525092 - 7525126	208026	204283	rs797044820	NC_000019.10:7525091:AAGTTTCGAGCCAAGGGCCGCAAGCCCTGCAAGCT:TCA
NM_020533.3(MCOLN1):c.1615del (p.Ala539fs)	MCOLN1	A539fs	Mucolipidosis type IV	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000208025	19	7598447	19	7533561	208025	204302	rs1555742780	NC_000019.10:7533560:GG:G
NM_020533.3(MCOLN1):c.1704A>T (p.Gly568=)	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208024	19	7598537	19	7533651	208024	204303	rs751298168	NC_000019.10:7533650:A:T
NM_020533.3(MCOLN1):c.1406A>G (p.Asn469Ser)	MCOLN1	N469S	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208023	19	7595218	19	7530332	208023	204299	rs797044818	NC_000019.10:7530331:A:G
NM_020533.3(MCOLN1):c.1219_1221TTC[1] (p.Phe408del)	MCOLN1	F408del	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208022	19	7594070 - 7594072	19	7529184 - 7529186	208022	204294	rs797044817	NC_000019.10:7529183:CTTCTTC:CTTC
AF287270:g.511_6943del	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000208020					208020	204304		
NM_000276.3(OCRL):c.-165-?_238+?del	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208016					208016	204261		
NM_000276.3(OCRL):c.-165-?_199+?del	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208015					208015	204260		
OCRL:exon 6-12 del	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208014					208014	204281		
NG_008638.1:g.(5550_9683)_(13328_22050)del	OCRL			Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208013					208013	204280		
NM_000276.3:c.2140_*2286del	OCRL			Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208012					208012	204279		
NM_000276.3(OCRL):c.-165-?_*2286+?del	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208011					208011	204262		
Single allele	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208010	X	128692865 - 128697110	X	129558888 - 129563133	208010	204264		
NC_000023.11:g.(129551601)_129559858del	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208009					208009	204258		
Single allele	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208008					208008	204278		
Single allele	CLCN5		Hypophosphatemic rickets, X-linked recessive	Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208007					208007	204277		
Single allele	CLCN5			Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208006					208006	204276		
NM_001127898.4(CLCN5):c.2393_2415del (p.Val798fs)	CLCN5	V728fs, V798fs, V748fs		Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208002	X	49856814 - 49856836	X	50092157 - 50092179	208002	204272	rs797044815	NC_000023.11:50092156:GATGTGTTAAAGCATATAGCACAGATG:GATG
NG_007159.3:g.(?_162979)_(164232_?)del	CLCN5			Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208001	X	49845251 - 49846504	X	50080594 - 50081847	208001	204263		
NM_001127898.4(CLCN5):c.2362C>T (p.Arg788Ter)	CLCN5	R718*, R788*, R738*		Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000208000	X	49856787	X	50092130	208000	204271	rs797044814	NC_000023.11:50092129:C:T
NM_001127898.4(CLCN5):c.2119C>T (p.Arg707Ter)	CLCN5	R637*, R707*, R657*	not provided|	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000207999	X	49855147	X	50090490	207999	204270	rs797044813	NC_000023.11:50090489:C:T
NM_001127898.4(CLCN5):c.1609C>T (p.Arg537Ter)	CLCN5	R467*, R537*, R487*	not provided|	Pathogenic(Last reviewed: Sep 16, 2018)	no assertion criteria provided	VCV000207997	X	49853406	X	50088749	207997	204268	rs797044811	NC_000023.11:50088748:C:T
NM_001127898.4(CLCN5):c.1249C>T (p.Arg417Ter)	CLCN5	R347*, R417*, R367*	not provided|	Pathogenic(Last reviewed: Mar 29, 2016)	criteria provided, single submitter	VCV000207996	X	49851219	X	50086562	207996	204267	rs797044810	NC_000023.11:50086561:C:T
NM_001127898.4(CLCN5):c.1046G>A (p.Trp349Ter)	CLCN5	W279*, W349*, W299*		Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000207995	X	49851016	X	50086359	207995	204266	rs797044809	NC_000023.11:50086358:G:A
NM_001127898.4(CLCN5):c.310C>T (p.Arg104Ter)	CLCN5	R104*, R34*, R54*		Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000207994	X	49834680	X	50070025	207994	204265	rs797044808	NC_000023.11:50070024:C:T
NM_001356.4(DDX3X):c.1210del (p.Ala404fs)	DDX3X	A218fs, A404fs, A388fs	not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, single submitter	VCV000207820	X	41204695	X	41345442	207820	204052	rs796052238	NC_000023.11:41345441:GG:G
NM_001193416.3(DDX3X):c.1463G>A (p.Arg488His)	DDX3X	R488H, R472H, R302H	Mental retardation, X-linked 102|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207817	X	41205629	X	41346376	207817	204058	rs796052235	NC_000023.11:41346375:G:A
NM_001356.4(DDX3X):c.1462C>T (p.Arg488Cys)	DDX3X	R488C, R472C, R302C	not provided	Pathogenic(Last reviewed: Feb 22, 2017)	criteria provided, single submitter	VCV000207816	X	41205628	X	41346375	207816	204057	rs796052234	NC_000023.11:41346374:C:T
NM_001356.4(DDX3X):c.1126C>T (p.Arg376Cys)	DDX3X	R376C, R360C, R190C	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000207813	X	41204533	X	41345280	207813	204050	rs796052231	NC_000023.11:41345279:C:T
NM_001356.4(DDX3X):c.1535_1536del (p.His512fs)	DDX3X	H326fs, H496fs, H512fs	History of neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207812	X	41205795 - 41205796	X	41346542 - 41346543	207812	204060	rs796052230	NC_000023.11:41346541:AT:
NM_001356.4(DDX3X):c.1321del (p.Asp441fs)	DDX3X	D425fs, D441fs, D255fs	not provided	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000207809	X	41205486	X	41346233	207809	204054	rs796052227	NC_000023.11:41346232:GG:G
NM_001356.4(DDX3X):c.1541T>C (p.Ile514Thr)	DDX3X	I514T, I498T, I328T	not provided	Pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000207808	X	41205801	X	41346548	207808	204061	rs796052226	NC_000023.11:41346547:T:C
NM_001083962.2(TCF4):c.1962_1965GGCC[3] (p.Pro657fs)	TCF4		not provided	Pathogenic(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	VCV000207544	18	52895502 - 52895503	18	55228271 - 55228272	207544	203499	rs796053428	NC_000018.10:55228271:GGCCGGCC:GGCCGGCCGGCC
NM_001083962.2(TCF4):c.1505_1518del (p.Gln502fs)	TCF4	Q431fs, Q478fs, Q501fs, Q502fs, Q508fs, Q499fs, Q460fs, Q604fs, Q286fs, Q341fs, Q342fs, Q372fs, Q477fs, Q479fs	not provided	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000207543	18	52899871 - 52899884	18	55232640 - 55232653	207543	203506	rs796053427	NC_000018.10:55232639:GACACTCTGCCCCTG:G
NM_001083962.2(TCF4):c.680_682delinsT (p.Trp227fs)	TCF4		not provided	Pathogenic(Last reviewed: Jan 10, 2013)	criteria provided, single submitter	VCV000207541	18	52942957 - 52942959	18	55275726 - 55275728	207541	203510	rs796053425	NC_000018.10:55275725:TCC:A
NM_001083962.2(TCF4):c.516_517dup (p.Val173fs)	TCF4		not provided	Pathogenic(Last reviewed: Jul 31, 2013)	criteria provided, single submitter	VCV000207540	18	53017621 - 53017622	18	55350390 - 55350391	207540	203512	rs796053424	NC_000018.10:55350390:CT:CTCT
NM_001083962.2(TCF4):c.1570C>T (p.Gln524Ter)	TCF4	Q524*, Q363*, Q482*, Q523*, Q364*, Q453*, Q499*, Q500*, Q501*, Q521*, Q626*, Q308*, Q394*, Q530*	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207534	18	52899819	18	55232588	207534	203505	rs796053418	NC_000018.10:55232587:G:A
NM_006950.3(SYN1):c.1264C>T (p.Arg422Ter)	SYN1	R422*	not provided	Pathogenic(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	VCV000207469	X	47434568	X	47575169	207469	204021	rs757027813	NC_000023.11:47575168:G:A
NM_001042537.1(SLC9A6):c.951_952CA[1] (p.Thr318fs)	SLC9A6		not provided	Pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000207255	X	135092652 - 135092653	X	136010493 - 136010494	207255	203993	rs796053297	NC_000023.11:136010492:CACA:CA
NM_001042537.1(SLC9A6):c.346dup (p.Leu116fs)	SLC9A6		not provided	Pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000207251	X	135076964 - 135076965	X	135994805 - 135994806	207251	203983	rs796053293	NC_000023.11:135994805:C:CC
NM_006359.2(SLC9A6):c.585dupG (p.Ser196Valfs)	SLC9A6		not provided	Pathogenic(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	VCV000207249	X	135081013 - 135081014	X	135998854 - 135998855	207249	203991	rs796053291	NC_000023.11:135998854:GG:GGG
NM_001042537.1(SLC9A6):c.1727+1G>A	SLC9A6		not provided	Pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, single submitter	VCV000207241	X	135115653	X	136033494	207241	203998	rs796053283	NC_000023.11:136033493:G:A
NM_018129.4(PNPO):c.448_451del (p.Pro150fs)	PNPO	P150fs	not provided|Pyridoxal phosphate-responsive seizures	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2015)	criteria provided, multiple submitters, no conflicts	VCV000206460	17	46023254 - 46023257	17	47945888 - 47945891	206460	203481	rs796052872	NC_000017.11:47945887:CTGCCTG:CTG
NM_018129.4(PNPO):c.98A>T (p.Asp33Val)	PNPO	D33V	Pyridoxal phosphate-responsive seizures|not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206458	17	46019139	17	47941773	206458	203474	rs370243877	NC_000017.11:47941772:A:T
NM_018129.4(PNPO):c.2T>C (p.Met1Thr)	PNPO	M1T	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000206456	17	46019043	17	47941677	206456	203471	rs796052870	NC_000017.11:47941676:T:C
NM_018129.4(PNPO):c.686G>A (p.Arg229Gln)	PNPO	R229Q	Pyridoxal phosphate-responsive seizures|not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206452	17	46024048	17	47946682	206452	203490	rs773450573	NC_000017.11:47946681:G:A
NM_018129.4(PNPO):c.674G>T (p.Arg225Leu)	PNPO	R225L	not provided	Pathogenic(Last reviewed: Jan 18, 2016)	criteria provided, single submitter	VCV000206451	17	46024036	17	47946670	206451	203489	rs550423482	NC_000017.11:47946669:G:T
NM_018129.4(PNPO):c.673C>T (p.Arg225Cys)	PNPO	R225C	Pyridoxal phosphate-responsive seizures|not provided	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206450	17	46024035	17	47946669	206450	203488	rs769266169	NC_000017.11:47946668:C:T
NM_018129.4(PNPO):c.471C>A (p.Tyr157Ter)	PNPO	Y157*	not provided	Pathogenic(Last reviewed: Feb 15, 2013)	criteria provided, single submitter	VCV000206442	17	46023280	17	47945914	206442	203482	rs148597698	NC_000017.11:47945913:C:A
NM_007254.4(PNKP):c.1317_1321dup (p.Ala441fs)	PNKP		not provided	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000206429	19	50364929 - 50364930	19	49861672 - 49861673	206429	203579	rs796052862	NC_000019.10:49861672:CGGCTCGG:CGGCTCGGCTCGG
NM_007254.4(PNKP):c.1293_1298+2dup	PNKP		not provided	Pathogenic(Last reviewed: Feb 1, 2013)	criteria provided, single submitter	VCV000206427	19	50365026 - 50365027	19	49861769 - 49861770	206427	203582	rs796052861	NC_000019.10:49861769:ACCTGGCG:ACCTGGCGACCTGGCG
NM_007254.4(PNKP):c.1288_1294dup (p.Ala432fs)	PNKP		not provided	Pathogenic(Last reviewed: Oct 14, 2013)	criteria provided, single submitter	VCV000206426	19	50365032 - 50365033	19	49861775 - 49861776	206426	203583	rs796052860	NC_000019.10:49861775:CGCGGCTCGCGGC:CGCGGCTCGCGGCTCGCGGC
NM_007254.4(PNKP):c.603dup (p.Lys202Ter)	PNKP		History of neurodevelopmental disorder|not provided|Early infantile epileptic encephalopathy 12	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206424	19	50367468 - 50367469	19	49864211 - 49864212	206424	203608	rs796052859	NC_000019.10:49864211:A:AA
NM_007254.4(PNKP):c.1189-2A>C	PNKP		not provided	Pathogenic(Last reviewed: Oct 25, 2013)	criteria provided, single submitter	VCV000206406	19	50365140	19	49861883	206406	203588	rs767645983	NC_000019.10:49861882:T:G
NM_007254.4(PNKP):c.992G>A (p.Trp331Ter)	PNKP	W331*	not provided	Pathogenic(Last reviewed: May 9, 2013)	criteria provided, single submitter	VCV000206398	19	50365665	19	49862408	206398	203596	rs772727116	NC_000019.10:49862407:C:T
NM_007254.4(PNKP):c.610C>T (p.Arg204Ter)	PNKP	R204*	not provided	Pathogenic(Last reviewed: Feb 12, 2014)	criteria provided, single submitter	VCV000206388	19	50367462	19	49864205	206388	203607	rs796052850	NC_000019.10:49864204:G:A
NM_007254.4(PNKP):c.490C>T (p.Gln164Ter)	PNKP	Q164*	not provided	Pathogenic(Last reviewed: Aug 1, 2013)	criteria provided, single submitter	VCV000206387	19	50368392	19	49865135	206387	203609	rs375781731	NC_000019.10:49865134:G:A
NM_001184880.2(PCDH19):c.2384del (p.Glu795fs)	PCDH19	E795fs, E748fs	not provided	Pathogenic(Last reviewed: Jan 15, 2015)	criteria provided, single submitter	VCV000206370	X	99657754	X	100402756	206370	203888	rs796052844	NC_000023.11:100402755:T:
NM_001184880.2(PCDH19):c.1952_1953CT[2] (p.Ser653fs)	PCDH19		not provided	Pathogenic(Last reviewed: Jan 19, 2015)	criteria provided, single submitter	VCV000206369	X	99661637 - 99661640	X	100406639 - 100406642	206369	203894	rs796052835	NC_000023.11:100406638:AGAGAGAGA:AGAGA
NM_001184880.2(PCDH19):c.966dup (p.Pro323fs)	PCDH19		not provided	Pathogenic(Last reviewed: Oct 1, 2014)	criteria provided, single submitter	VCV000206368	X	99662629 - 99662630	X	100407631 - 100407632	206368	203927	rs796052842	NC_000023.11:100407631:CCCC:CCCCC
NM_001184880.2(PCDH19):c.218_219insG (p.Asp73fs)	PCDH19		not provided	Pathogenic(Last reviewed: Aug 12, 2014)	criteria provided, single submitter	VCV000206367	X	99663377 - 99663378	X	100408379 - 100408380	206367	203951	rs796052841	NC_000023.11:100408379::C
NM_001184880.2(PCDH19):c.1019A>G (p.Asn340Ser)	PCDH19	N340S	not provided|Early infantile epileptic encephalopathy 9|History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206364	X	99662577	X	100407579	206364	203925	rs796052839	NC_000023.11:100407578:T:C
NM_001184880.2(PCDH19):c.498C>G (p.Tyr166Ter)	PCDH19	Y166*	not provided	Pathogenic(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000206361	X	99663098	X	100408100	206361	203940	rs796052837	NC_000023.11:100408099:G:C
NM_001184880.2(PCDH19):c.2399del (p.Asn800fs)	PCDH19	N753fs, N800fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000206360	X	99657739	X	100402741	206360	203887	rs796052836	NC_000023.11:100402740:TT:T
NM_001184880.2(PCDH19):c.1952_1953CT[5] (p.Ala654fs)	PCDH19		not provided	Pathogenic(Last reviewed: Feb 26, 2013)	criteria provided, single submitter	VCV000206359	X	99661636 - 99661637	X	100406638 - 100406639	206359	203893	rs796052835	NC_000023.11:100406638:AGAGAGAGA:AGAGAGAGAGA
NM_001184880.2(PCDH19):c.1952dup (p.Leu652fs)	PCDH19		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000206358	X	99661643 - 99661644	X	100406645 - 100406646	206358	203895	rs796052834	NC_000023.11:100406645:G:GG
NM_001184880.2(PCDH19):c.1752_1759del (p.Tyr585fs)	PCDH19	Y585fs	not provided	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000206357	X	99661837 - 99661844	X	100406839 - 100406846	206357	203901	rs796052833	NC_000023.11:100406838:CCAGGTAGCC:CC
NM_001184880.2(PCDH19):c.1683_1696del (p.Val562fs)	PCDH19	V562fs	not provided	Pathogenic(Last reviewed: Apr 30, 2014)	criteria provided, single submitter	VCV000206356	X	99661900 - 99661913	X	100406902 - 100406915	206356	203903	rs796052832	NC_000023.11:100406901:GGGCTGTGATGACCGGG:GGG
NM_001184880.2(PCDH19):c.1308del (p.Lys437fs)	PCDH19	K437SfsX132, K437fs	not provided	Pathogenic(Last reviewed: Apr 23, 2012)	criteria provided, single submitter	VCV000206355	X	99662288	X	100407290	206355	203914	rs796052831	NC_000023.11:100407289:GG:G
NM_001184880.2(PCDH19):c.1134del (p.Gly379fs)	PCDH19	G379fs	not provided	Pathogenic(Last reviewed: Oct 31, 2012)	criteria provided, single submitter	VCV000206354	X	99662462	X	100407464	206354	203920	rs796052830	NC_000023.11:100407463:T:
NM_001184880.2(PCDH19):c.1091dup (p.Tyr366fs)	PCDH19		not provided|Early infantile epileptic encephalopathy 9|Global developmental delay|Generalized seizures|Temporal cortical atrophy|Delayed speech and language development|Generalized tonic-clonic seizures|Prominent fingertip pads|Absence seizures|Strabismus|Frontal cortical atrophy|Long palpebral fissure|Hand tremor	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206353	X	99662504 - 99662505	X	100407506 - 100407507	206353	203922	rs758946412	NC_000023.11:100407506:GGGGGGG:GGGGGGGG
NM_001184880.2(PCDH19):c.1376del (p.Gln459fs)	PCDH19	Q459fs	not provided	Pathogenic(Last reviewed: Oct 18, 2012)	criteria provided, single submitter	VCV000206352	X	99662220	X	100407222	206352	203909	rs796052829	NC_000023.11:100407221:T:
NM_001184880.2(PCDH19):c.1059_1062del (p.Glu354fs)	PCDH19	E354fs	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206351	X	99662534 - 99662537	X	100407536 - 100407539	206351	203923	rs796052828	NC_000023.11:100407535:CTCACT:CT
NM_001184880.2(PCDH19):c.805del (p.Thr269fs)	PCDH19	T269fs	not provided	Pathogenic(Last reviewed: Jul 23, 2014)	criteria provided, single submitter	VCV000206350	X	99662791	X	100407793	206350	203928	rs796052827	NC_000023.11:100407792:T:
NM_001184880.2(PCDH19):c.524del (p.Gly175fs)	PCDH19	G175fs	not provided	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	VCV000206349	X	99663072	X	100408074	206349	203938	rs796052826	NC_000023.11:100408073:CC:C
NM_001184880.2(PCDH19):c.2656C>T (p.Arg886Ter)	PCDH19	R839*, R886*	not provided	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000206341	X	99605663	X	100350665	206341	203882	rs756414485	NC_000023.11:100350664:G:A
NM_001184880.2(PCDH19):c.1855C>T (p.Gln619Ter)	PCDH19	Q619*	not provided	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000206338	X	99661741	X	100406743	206338	203899	rs796052820	NC_000023.11:100406742:G:A
NM_001184880.2(PCDH19):c.1625C>G (p.Ser542Ter)	PCDH19	S542*	not provided	Pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	VCV000206335	X	99661971	X	100406973	206335	203906	rs796052817	NC_000023.11:100406972:G:C
NM_001184880.2(PCDH19):c.1240G>T (p.Glu414Ter)	PCDH19	E414*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000206329	X	99662356	X	100407358	206329	203917	rs796052813	NC_000023.11:100407357:C:A
NM_001184880.2(PCDH19):c.1114C>T (p.Arg372Trp)	PCDH19	R372W	not provided|Early infantile epileptic encephalopathy 9	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206327	X	99662482	X	100407484	206327	203921	rs796052812	NC_000023.11:100407483:G:A
NM_001184880.2(PCDH19):c.1031C>T (p.Pro344Leu)	PCDH19	P344L	not provided	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000206326	X	99662565	X	100407567	206326	203924	rs796052811	NC_000023.11:100407566:G:A
NM_001184880.2(PCDH19):c.696T>A (p.Asn232Lys)	PCDH19	N232K	not provided	Pathogenic(Last reviewed: Oct 11, 2012)	criteria provided, single submitter	VCV000206322	X	99662900	X	100407902	206322	203931	rs796052807	NC_000023.11:100407901:A:T
NM_001184880.2(PCDH19):c.695A>G (p.Asn232Ser)	PCDH19	N232S	not provided|Early infantile epileptic encephalopathy 9|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000206321	X	99662901	X	100407903	206321	203932	rs587784299	NC_000023.11:100407902:T:C
NM_001184880.2(PCDH19):c.619C>T (p.Arg207Ter)	PCDH19	R207*	not provided	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000206316	X	99662977	X	100407979	206316	203936	rs796052802	NC_000023.11:100407978:G:A
NM_001184880.2(PCDH19):c.473C>G (p.Ser158Ter)	PCDH19	S158*	not provided	Pathogenic(Last reviewed: Oct 8, 2013)	criteria provided, single submitter	VCV000206315	X	99663123	X	100408125	206315	203941	rs796052801	NC_000023.11:100408124:G:C
NM_001184880.2(PCDH19):c.91G>T (p.Glu31Ter)	PCDH19	E31*	not provided	Pathogenic(Last reviewed: May 28, 2013)	criteria provided, single submitter	VCV000206307	X	99663505	X	100408507	206307	203953	rs796052794	NC_000023.11:100408506:C:A
NM_172107.4(KCNQ2):c.1887+1G>T	KCNQ2		not provided	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000205950	20	62039765	20	63408412	205950	203713	rs796052670	NC_000020.11:63408411:C:A
NM_172107.3(KCNQ2):c.1888del (p.Val630Serfs)	KCNQ2		not provided	Pathogenic(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	VCV000205946	20	62038728	20	63407375	205946	203712	rs796052668	
NM_172107.4(KCNQ2):c.2126_2127del (p.Pro709fs)	KCNQ2	P678fs, P691fs, P709fs, P681fs	Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, multiple submitters, no conflicts	VCV000205945	20	62038489 - 62038490	20	63407136 - 63407137	205945	203702	rs796052667	NC_000020.11:63407135:AG:
NM_172107.4(KCNQ2):c.1930dup (p.Tyr644fs)	KCNQ2		not provided	Pathogenic(Last reviewed: Jan 24, 2013)	criteria provided, single submitter	VCV000205943	20	62038685 - 62038686	20	63407332 - 63407333	205943	203711	rs796052666	NC_000020.11:63407332:A:AA
NM_172107.4(KCNQ2):c.1734_1735delinsAA (p.Met578_Leu579delinsIleMet)	KCNQ2		not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000205942	20	62044831 - 62044832	20	63413478 - 63413479	205942	203721	rs796052665	NC_000020.11:63413477:GC:TT
NM_172107.4(KCNQ2):c.331_332GT[1] (p.Ser113fs)	KCNQ2		not provided|Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	VCV000205940	20	62078153 - 62078154	20	63446800 - 63446801	205940	203801	rs796052663	NC_000020.11:63446799:ACACA:ACA
NM_172107.3(KCNQ2):c.2245G>T (p.Glu749Ter)	KCNQ2	E749*	Early infantile epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205931	20	62038371	20	63407018	205931	203701	rs796052658	NC_000020.11:63407017:C:A
NM_172107.4(KCNQ2):c.1160del (p.Pro387fs)	KCNQ2	P387fs, P377fs	not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000205929	20	62059777	20	63428424	205929	203754	rs796052657	NC_000020.11:63428423:GGGGGG:GGGGG
NM_172107.4(KCNQ2):c.1734G>C (p.Met578Ile)	KCNQ2	M578I, M550I, M560I, M547I	not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000205919	20	62044832	20	63413479	205919	203722	rs796052655	NC_000020.11:63413478:C:G
NM_172107.3(KCNQ2):c.1687G>A (p.Asp563Asn)	KCNQ2	D563N	not provided|Early infantile epileptic encephalopathy|Seizures|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205917	20	62044879	20	63413526	205917	203724	rs796052653	NC_000020.11:63413525:C:T
NM_172107.4(KCNQ2):c.1682C>T (p.Pro561Leu)	KCNQ2	P561L, P533L, P530L, P543L	not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000205916	20	62044884	20	63413531	205916	203725	rs796052652	NC_000020.11:63413530:G:A
NM_172107.3(KCNQ2):c.1678C>T (p.Arg560Trp)	KCNQ2	R560W	Early infantile epileptic encephalopathy 7|Global developmental delay|Absent speech|Limb dystonia|Early infantile epileptic encephalopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205915	20	62044888	20	63413535	205915	203726	rs773171451	NC_000020.11:63413534:G:A
NM_172107.4(KCNQ2):c.1666A>G (p.Lys556Glu)	KCNQ2	K556E, K525E, K528E, K538E	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000205914	20	62044900	20	63413547	205914	203727	rs1555853593	NC_000020.11:63413546:T:C
NM_172107.4(KCNQ2):c.1764-1G>C	KCNQ2		not provided	Pathogenic(Last reviewed: Feb 25, 2014)	criteria provided, single submitter	VCV000205910	20	62039890	20	63408537	205910	203718	rs796052649	NC_000020.11:63408536:C:G
NM_172107.4(KCNQ2):c.1632-1G>A	KCNQ2		not provided	Pathogenic(Last reviewed: Jul 26, 2013)	criteria provided, single submitter	VCV000205909	20	62044935	20	63413582	205909	203731	rs118192233	NC_000020.11:63413581:C:T
NM_172107.4(KCNQ2):c.1010C>G (p.Ala337Gly)	KCNQ2	A337G	not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	VCV000205894	20	62069991	20	63438638	205894	203764	rs796052643	NC_000020.11:63438637:G:C
NM_172107.4(KCNQ2):c.1009G>A (p.Ala337Thr)	KCNQ2	A337T	not provided	Pathogenic(Last reviewed: Aug 30, 2012)	criteria provided, single submitter	VCV000205893	20	62069992	20	63438639	205893	203765	rs796052642	NC_000020.11:63438638:C:T
NM_172107.4(KCNQ2):c.1004C>T (p.Pro335Leu)	KCNQ2	P335L	not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205892	20	62069997	20	63438644	205892	203766	rs796052641	NC_000020.11:63438643:G:A
NM_172107.4(KCNQ2):c.916G>C (p.Ala306Pro)	KCNQ2	A306P	not provided	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000205888	20	62070962	20	63439609	205888	203770	rs74315390	NC_000020.11:63439608:C:G
NM_172107.4(KCNQ2):c.915C>A (p.Phe305Leu)	KCNQ2	F305L	Early infantile epileptic encephalopathy 7|not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205887	20	62070963	20	63439610	205887	203771	rs775918190	NC_000020.11:63439609:G:T
NM_172107.4(KCNQ2):c.881C>T (p.Ala294Val)	KCNQ2	A294V	Epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 7|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205886	20	62070997	20	63439644	205886	203772	rs118192211	NC_000020.11:63439643:G:A
NM_172107.4(KCNQ2):c.848A>G (p.Lys283Arg)	KCNQ2	K283R	not provided	Pathogenic(Last reviewed: Jul 17, 2014)	criteria provided, single submitter	VCV000205885	20	62071030	20	63439677	205885	203774	rs796052637	NC_000020.11:63439676:T:C
NM_172107.4(KCNQ2):c.844G>A (p.Asp282Asn)	KCNQ2	D282N	not provided	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000205884	20	62071034	20	63439681	205884	203775	rs796052636	NC_000020.11:63439680:C:T
NM_172107.4(KCNQ2):c.809G>A (p.Trp270Ter)	KCNQ2	W270*	not provided	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	VCV000205882	20	62073766	20	63442413	205882	203777	rs796052634	NC_000020.11:63442412:C:T
NM_172107.4(KCNQ2):c.740C>T (p.Ser247Leu)	KCNQ2	S247L	Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2016)	criteria provided, multiple submitters, no conflicts	VCV000205878	20	62073835	20	63442482	205878	203782	rs74315392	NC_000020.11:63442481:G:A
NM_172107.4(KCNQ2):c.692A>G (p.Glu231Gly)	KCNQ2	E231G	not provided	Pathogenic(Last reviewed: May 9, 2013)	criteria provided, single submitter	VCV000205876	20	62073883	20	63442530	205876	203784	rs796052629	NC_000020.11:63442529:T:C
NM_172107.4(KCNQ2):c.636C>A (p.Asp212Glu)	KCNQ2	D212E	not provided	Pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	VCV000205874	20	62076066	20	63444713	205874	203787	rs796052627	NC_000020.11:63444712:G:T
NM_172107.4(KCNQ2):c.628C>T (p.Arg210Cys)	KCNQ2	R210C	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000205873	20	62076074	20	63444721	205873	203788	rs796052626	NC_000020.11:63444720:G:A
NM_172107.4(KCNQ2):c.612G>C (p.Gln204His)	KCNQ2	Q204H	not provided	Pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000205871	20	62076090	20	63444737	205871	203790	rs796052625	NC_000020.11:63444736:C:G
NM_172107.4(KCNQ2):c.611A>G (p.Gln204Arg)	KCNQ2	Q204R	not provided	Pathogenic(Last reviewed: Sep 11, 2012)	criteria provided, single submitter	VCV000205870	20	62076091	20	63444738	205870	203791	rs796052624	NC_000020.11:63444737:T:C
NM_172107.3(KCNQ2):c.583T>C (p.Ser195Pro)	KCNQ2	S195P	not provided|Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000205866	20	62076119	20	63444766	205866	203795	rs796052620	NC_000020.11:63444765:A:G
NM_172107.4(KCNQ2):c.578C>A (p.Ala193Asp)	KCNQ2	A193D	not provided	Pathogenic(Last reviewed: May 3, 2012)	criteria provided, single submitter	VCV000205865	20	62076124	20	63444771	205865	203796	rs796052619	NC_000020.11:63444770:G:T
NM_172107.4(KCNQ2):c.431G>A (p.Arg144Gln)	KCNQ2	R144Q	Early infantile epileptic encephalopathy 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000205864	20	62076674	20	63445321	205864	203798	rs796052618	NC_000020.11:63445320:C:T
NM_172107.4(KCNQ2):c.297-2A>G	KCNQ2		Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000205861	20	62078192	20	63446839	205861	203802	rs796052615	NC_000020.11:63446838:T:C
NM_172107.4(KCNQ2):c.294C>G (p.Tyr98Ter)	KCNQ2	Y98*	not provided	Pathogenic(Last reviewed: May 28, 2013)	criteria provided, single submitter	VCV000205860	20	62103523	20	63472170	205860	203803	rs796052614	NC_000020.11:63472169:G:C
NM_172107.4(KCNQ2):c.222C>G (p.Tyr74Ter)	KCNQ2	Y74*	not provided	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000205859	20	62103595	20	63472242	205859	203804	rs796052613	NC_000020.11:63472241:G:C
NM_001193466.2(KANSL1):c.2203+1G>A	KANSL1		not provided	Pathogenic(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	VCV000205795	17	44117067	17	46039701	205795	203395	rs796052595	NC_000017.11:46039700:C:T
NM_000156.6(GAMT):c.522G>A (p.Trp174Ter)	GAMT	W174*	Deficiency of guanidinoacetate methyltransferase|Cerebral creatine deficiency syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205584	19	1398963	19	1398964	205584	203537	rs370421531	NC_000019.10:1398963:C:T
NM_000156.6(GAMT):c.491G>A (p.Gly164Asp)	GAMT	G164D	not provided	Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000205581	19	1398994	19	1398995	205581	203539	rs760101382	NC_000019.10:1398994:C:T
NM_000026.4(ADSL):c.1349C>G (p.Thr450Ser)	ADSL	T450S, T386S	not provided	Pathogenic(Last reviewed: Jan 14, 2015)	criteria provided, single submitter	VCV000204816	22	40761041	22	40365037	204816	203865	rs372895468	NC_000022.11:40365036:C:G
NM_000026.4(ADSL):c.568C>T (p.Arg190Ter)	ADSL	R190*, R126*	Adenylosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204814	22	40754953	22	40358949	204814	203845	rs750614500	NC_000022.11:40358948:C:T
NM_000026.4(ADSL):c.5C>T (p.Ala2Val)	ADSL	A2V	not provided	Pathogenic(Last reviewed: Apr 9, 2012)	criteria provided, single submitter	VCV000204808	22	40742567	22	40346563	204808	203835	rs143083947	NC_000022.11:40346562:C:T
NM_000026.4(ADSL):c.340T>C (p.Tyr114His)	ADSL	Y114H, Y50H	Adenylosuccinate lyase deficiency|Difficulty standing|Generalized myoclonic seizures|Progressive neurologic deterioration|Severe global developmental delay|Inability to walk|not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204807	22	40746022	22	40350018	204807	203840	rs374259530	NC_000022.11:40350017:T:C
NM_000026.4(ADSL):c.1339T>C (p.Ser447Pro)	ADSL	S447P, S383P	Adenylosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000204801	22	40761031	22	40365027	204801	203863	rs777821034	NC_000022.11:40365026:T:C
NM_000026.4(ADSL):c.1276C>T (p.Arg426Cys)	ADSL	R426C, R362C	not provided	Pathogenic(Last reviewed: Jul 19, 2012)	criteria provided, single submitter	VCV000204798	22	40760968	22	40364964	204798	203860	rs796052248	NC_000022.11:40364963:C:T
NM_000026.4(ADSL):c.1187G>A (p.Arg396His)	ADSL	R396H, R332H	Adenylosuccinate lyase deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000204796	22	40760365	22	40364361	204796	203858	rs763542069	NC_000022.11:40364360:G:A
NM_000026.4(ADSL):c.1128G>C (p.Glu376Asp)	ADSL	E376D, E312D	not provided	Pathogenic(Last reviewed: Dec 6, 2016)	criteria provided, single submitter	VCV000204795	22	40760306	22	40364302	204795	203857	rs796052247	NC_000022.11:40364301:G:C
NM_000026.4(ADSL):c.1009C>T (p.Arg337Ter)	ADSL	R337*, R273*	not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000204789	22	40757638	22	40361634	204789	203854	rs761493155	NC_000022.11:40361633:C:T
NM_000026.4(ADSL):c.853C>T (p.Gln285Ter)	ADSL	Q285*, Q221*	not provided	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000204788	22	40757337	22	40361333	204788	203850	rs796052246	NC_000022.11:40361332:C:T
NM_000709.4(BCKDHA):c.470A>C (p.Gln157Pro)	BCKDHA	Q157P	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000204380	19	41920048	19	41414143	204380	200771	rs869312125	NC_000019.10:41414142:A:C
NM_000709.4(BCKDHA):c.1198A>T (p.Lys400Ter)	BCKDHA	K400*, K399*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000204379	19	41930373	19	41424468	204379	200774	rs863225262	NC_000019.10:41424467:A:T
NM_000709.4(BCKDHA):c.476G>A (p.Arg159Gln)	BCKDHA	R159Q	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	VCV000204378	19	41920054	19	41414149	204378	200772	rs773048903	NC_000019.10:41414148:G:A
NM_000709.4(BCKDHA):c.844G>C (p.Asp282His)	BCKDHA	D282H	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2011)	criteria provided, single submitter	VCV000204377	19	41928266	19	41422361	204377	200773	rs869312124	NC_000019.10:41422360:G:C
TCF4, (CTG)n REPEAT EXPANSION, IVS3	TCF4		Corneal dystrophy, Fuchs endothelial, 3	Pathogenic(Last reviewed: Mar 6, 2015)	no assertion criteria provided	VCV000204360					204360	200754		
NM_000054.6(AVPR2):c.388A>T (p.Ile130Phe)	AVPR2	I130F	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000204318	X	153171348	X	153905894	204318	200712	rs796052096	NC_000023.11:153905893:A:T
NM_001347721.2(DYRK1A):c.856C>T (p.Leu286Phe)	DYRK1A	L295F, L257F, L286F	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204011	21	38862695	21	37490393	204011	200405	rs797044526	NC_000021.9:37490392:C:T
NM_001347721.2(DYRK1A):c.425dup (p.Asn142fs)	DYRK1A		Mental retardation, autosomal dominant 7|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204008	21	38853058 - 38853059	21	37480756 - 37480757	204008	200401	rs797044523	NC_000021.9:37480756:AAAAAA:AAAAAAA
NM_001347721.2(DYRK1A):c.1074_1077del (p.Asp359fs)	DYRK1A	D368fs, D359fs, D330fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204007	21	38868421 - 38868424	21	37496119 - 37496122	204007	200406	rs797044522	NC_000021.9:37496118:TAGAT:T
NM_001347721.2(DYRK1A):c.434del (p.Lys145fs)	DYRK1A	K145fs, K154fs, K116fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204006	21	38853070	21	37480768	204006	200402	rs797044521	NC_000021.9:37480767:AAAA:AAA
NM_001347721.2(DYRK1A):c.1372C>T (p.Arg458Ter)	DYRK1A	R467*, R458*, R429*	not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000204005	21	38877745	21	37505442	204005	200407	rs797044520	NC_000021.9:37505441:C:T
NM_001347721.2(DYRK1A):c.285C>G (p.Tyr95Ter)	DYRK1A	Y104*, Y95*, Y66*	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204004	21	38850587	21	37478285	204004	200400	rs797044519	NC_000021.9:37478284:C:G
NM_000531.6(OTC):c.562_563del (p.Gly188fs)	OTC	G188fs	not provided	Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	VCV000203870	X	38262892 - 38262893	X	38403639 - 38403640	203870	200387	rs796052016	NC_000023.11:38403638:GG:
NM_000531.6(OTC):c.217-2dup	OTC		not provided	Pathogenic(Last reviewed: Nov 13, 2013)	criteria provided, single submitter	VCV000203869	X	38229046 - 38229047	X	38369793 - 38369794	203869	200386	rs796052015	NC_000023.11:38369793:A:AA
NM_000531.6(OTC):c.919A>G (p.Lys307Glu)	OTC	K307E	not provided	Pathogenic(Last reviewed: Jul 6, 2015)	criteria provided, single submitter	VCV000203867	X	38271166	X	38411913	203867	200389	rs796052013	NC_000023.11:38411912:A:G
NM_000531.6(OTC):c.615G>C (p.Met205Ile)	OTC	M205I	not provided	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000203866	X	38262945	X	38403692	203866	200388	rs796052012	NC_000023.11:38403691:G:C
NM_000411.8(HLCS):c.782del (p.Gly261fs)	HLCS	G261fs, G408fs	not provided|Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Nov 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203777	21	38308963	21	36936663	203777	200375	rs771944310	NC_000021.9:36936662:CCC:CC
NM_000411.8(HLCS):c.1892del (p.Pro630_Leu631insTer)	HLCS		not provided	Pathogenic(Last reviewed: May 27, 2014)	criteria provided, single submitter	VCV000203775	21	38128960	21	36756659	203775	200365	rs796051978	NC_000021.9:36756658:AA:A
NM_000709.4(BCKDHA):c.661_664del (p.Tyr221fs)	BCKDHA	Y221fs	Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000203638	19	41928081 - 41928084	19	41422176 - 41422179	203638	200344	rs796051938	NC_000019.10:41422175:CGTACG:CG
NM_004247.4(EFTUD2):c.764dup (p.Cys256fs)	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 18, 2015)	no assertion criteria provided	VCV000203386	17	42953406 - 42953407	17	44876038 - 44876039	203386	199808	rs794729651	NC_000017.11:44876038:A:AA
NM_002772.3(TMPRSS15):c.1428+2T>G	TMPRSS15		Enterokinase deficiency	Pathogenic(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000202209	21	19715821	21	18343504	202209	198643	rs138221037	NC_000021.9:18343503:A:C
NM_015166.3(MLC1):c.223del (p.Val75fs)	MLC1	V75fs	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 3, 2014)	no assertion criteria provided	VCV000202208	22	50521557	22	50083128	202208	198646	rs794729233	NC_000022.11:50083127:C:
NM_000052.7(ATP7A):c.1947-1G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Mar 26, 2014)	no assertion criteria provided	VCV000202206	X	77266945	X	78011448	202206	198649	rs794729231	NC_000023.11:78011447:G:A
NM_000284.4(PDHA1):c.422G>A (p.Arg141Gln)	PDHA1	R141Q, R148Q, R179Q	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Sep 23, 2013)	no assertion criteria provided	VCV000202188	X	19371203	X	19353085	202188	198647	rs794729213	NC_000023.11:19353084:G:A
NM_172107.4(KCNQ2):c.698_699insACC (p.Thr234_Ala235insPro)	KCNQ2		Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000202170	20	62073876 - 62073877	20	63442523 - 63442524	202170	198642	rs794729197	NC_000020.11:63442523::GGT
NM_000116.5(TAZ):c.526C>T (p.His176Tyr)	TAZ	H176Y, H146Y, H194Y	not provided	Pathogenic(Last reviewed: Feb 22, 2012)	criteria provided, single submitter	VCV000202100	X	153647947	X	154419608	202100	198555	rs794729174	NC_000023.11:154419607:C:T
NM_000116.5(TAZ):c.582G>A (p.Trp194Ter)	TAZ	W194*, W164*	not provided	Pathogenic(Last reviewed: May 31, 2012)	criteria provided, single submitter	VCV000202093	X	153648084	X	154419745	202093	198556	rs794729167	NC_000023.11:154419744:G:A
NM_000116.5(TAZ):c.280C>T (p.Arg94Cys)	TAZ	R94C, R112C	not provided	Pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	VCV000202092	X	153641585	X	154413248	202092	198554	rs104894942	NC_000023.11:154413247:C:T
NM_000116.5(TAZ):c.154G>T (p.Glu52Ter)	TAZ	E52*, E70*	not provided	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	VCV000202091	X	153640467	X	154412130	202091	198552	rs794729166	NC_000023.11:154412129:G:T
NM_000117.2(EMD):c.187+1G>T	EMD		Emery-Dreifuss muscular dystrophy 1, X-linked|not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201772	X	153608155	X	154379795	201772	198543	rs794729010	NC_000023.11:154379794:G:T
NM_004006.2(DMD):c.2623-1G>T	DMD		not provided	Pathogenic(Last reviewed: Nov 6, 2014)	criteria provided, single submitter	VCV000201759	X	32503217	X	32485100	201759	198588	rs794729005	NC_000023.11:32485099:C:A
NM_000268.3(NF2):c.810+1G>A	NF2		not provided	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000201123	22	30057329	22	29661340	201123	198036	rs794728682	NC_000022.11:29661339:G:A
NM_000527.4(LDLR):c.178C>T (p.Gln60Ter)	LDLR	Q60*	Familial hypercholesterolemia 1	Pathogenic	no assertion criteria provided	VCV000200924	19	11211009	19	11100333	200924	198010	rs794728585	NC_000019.10:11100332:C:T
NM_000527.5(LDLR):c.590G>A (p.Cys197Tyr)	LDLR	C197Y, C156Y	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200919	19	11216172	19	11105496	200919	198012	rs376459828	NC_000019.10:11105495:G:A
NM_000527.5(LDLR):c.501C>A (p.Cys167Ter)	LDLR	C167*, C126*	not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200918	19	11216083	19	11105407	200918	198011	rs752596535	NC_000019.10:11105406:C:A
NM_001943.5(DSG2):c.601_605del (p.Val201fs)	DSG2	V201fs	not provided	Pathogenic(Last reviewed: May 17, 2013)	criteria provided, single submitter	VCV000199823	18	29102120 - 29102124	18	31522157 - 31522161	199823	197970	rs794728092	NC_000018.10:31522156:ATCGTATC:ATC
NM_001943.5(DSG2):c.464_465insT (p.Glu156fs)	DSG2		not provided|Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000199822	18	29101147 - 29101148	18	31521184 - 31521185	199822	197968	rs794728091	NC_000018.10:31521184::T
NM_001943.5(DSG2):c.1750C>T (p.Gln584Ter)	DSG2	Q584*	Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000199810	18	29118812	18	31538849	199810	197986	rs794728086	NC_000018.10:31538848:C:T
NM_001943.5(DSG2):c.769C>T (p.Gln257Ter)	DSG2	Q257*	not provided	Pathogenic(Last reviewed: May 28, 2014)	criteria provided, single submitter	VCV000199800	18	29104489	18	31524526	199800	197972	rs794728083	NC_000018.10:31524525:C:T
NM_024422.6(DSC2):c.2487del (p.Phe829fs)	DSC2	F829fs	not provided	Pathogenic(Last reviewed: Jul 6, 2012)	criteria provided, single submitter	VCV000199779	18	28648881	18	31068915	199779	197933	rs794728073	NC_000018.10:31068914:AAAA:AAA
NM_000411.8(HLCS):c.1624C>T (p.Gln542Ter)	HLCS	Q542*, Q689*	not provided	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000199017	21	38137369	21	36765068	199017	196177	rs794727957	NC_000021.9:36765067:G:A
NM_000071.2(CBS):c.785C>T (p.Thr262Met)	CBS	T262M, T157M	not provided|Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000198988	21	44484053	21	43063943	198988	196148	rs149119723	NC_000021.9:43063942:G:A
NM_017653.5(DYM):c.621-2A>G	DYM		Dyggve-Melchior-Clausen syndrome|Smith-McCort dysplasia 1|not provided	Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	VCV000198883	18	46858378	18	49332008	198883	196043	rs775414124	NC_000018.10:49332007:T:C
NM_000487.6(ARSA):c.1408_1418del (p.Ala470fs)	ARSA	A384fs, A470fs	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	VCV000198735	22	51063685 - 51063695	22	50625257 - 50625267	198735	190193	rs80338823	NC_000022.11:50625256:GTCACAGCTGCGTC:GTC
NM_033290.4(MID1):c.1444_1447dup (p.Ser483fs)	MID1		not provided	Pathogenic(Last reviewed: Jul 14, 2014)	criteria provided, single submitter	VCV000198721	X	10427685 - 10427686	X	10459645 - 10459646	198721	195882	rs797044786	NC_000023.11:10459645:TGTTTGT:TGTTTGTTTGT
NM_000271.5(NPC1):c.1142G>A (p.Trp381Ter)	NPC1	W381*	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000198702	18	21136391	18	23556427	198702	195863	rs794727897	NC_000018.10:23556426:C:T
NM_000199.5(SGSH):c.1027dup (p.Leu343fs)	SGSH		Mucopolysaccharidosis, MPS-III-A|Sanfilippo syndrome|not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198694	17	78184732 - 78184733	17	80210933 - 80210934	198694	195855	rs778700037	NC_000017.11:80210933:GG:GGG
NM_000033.4(ABCD1):c.1781-1G>A	ABCD1		not provided	Pathogenic(Last reviewed: May 14, 2014)	criteria provided, single submitter	VCV000198687	X	153008440	X	153742986	198687	195848	rs797044781	NC_000023.11:153742985:G:A
NM_004006.2(DMD):c.10554-2A>G	DMD		not provided	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	VCV000198665	X	31165637	X	31147520	198665	195826	rs794727890	NC_000023.11:31147519:T:C
NM_023010.3(UPF3B):c.670_673GAAA[1] (p.Arg225fs)	UPF3B		Mental retardation, syndromic 14, X-linked|not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000198608	X	118975169 - 118975172	X	119841206 - 119841209	198608	195769	rs794727881	NC_000023.11:119841205:TTTCTTTCT:TTTCT
NM_000109.4(DMD):c.548C>G (p.Ser183Ter)	DMD	S191*, S187*, S183*, S68*	not provided	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000198504	X	32827687	X	32809570	198504	195665	rs794727863	NC_000023.11:32809569:G:C
NM_000109.4(DMD):c.603del (p.Ile201fs)	DMD	I209fs, I201fs, I205fs, I86fs	not provided	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000198503	X	32827632	X	32809515	198503	195664	rs794727862	NC_000023.11:32809514:T:
NM_000109.4(DMD):c.523dup (p.Trp175fs)	DMD		not provided	Pathogenic(Last reviewed: Mar 31, 2015)	criteria provided, single submitter	VCV000198502	X	32827711 - 32827712	X	32809594 - 32809595	198502	195663	rs796065333	NC_000023.11:32809594:A:AA
NM_000109.4(DMD):c.541C>T (p.Gln181Ter)	DMD	Q189*, Q181*, Q185*, Q66*	not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000198501	X	32827694	X	32809577	198501	195662	rs794727861	NC_000023.11:32809576:G:A
NM_000709.4(BCKDHA):c.861_868del (p.Gly288fs)	BCKDHA	G288fs, G287fs	not provided|Maple syrup urine disease|Maple syrup urine disease type 1A	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198433	19	41928539 - 41928546	19	41422634 - 41422641	198433	195594	rs794727847	NC_000019.10:41422633:CGAGGCCCCG:CG
NM_000328.3(RPGR):c.642_656delinsC (p.Gly215fs)	RPGR		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000198414	X	38169990 - 38170004	X	38310737 - 38310751	198414	195575	rs796065331	NC_000023.11:38310736:TTCTCAGGTTCTCCA:G
NM_000159.4(GCDH):c.572T>C (p.Met191Thr)	GCDH	M191T	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000198396	19	13006872	19	12896058	198396	195557	rs149120354	NC_000019.10:12896057:T:C
NM_000109.4(DMD):c.9954C>G (p.Tyr3318Ter)	DMD	Y3326*, Y1985*, Y3318*, Y597*, Y866*, Y1982*, Y258*, Y3203*, Y3322*	not provided	Pathogenic(Last reviewed: Apr 7, 2015)	criteria provided, single submitter	VCV000198374	X	31198595	X	31180478	198374	195535	rs794727832	NC_000023.11:31180477:G:C
NM_000109.4(DMD):c.9192C>G (p.Tyr3064Ter)	DMD	Y3072*, Y2949*, Y3064*, Y3068*, Y343*, Y1728*, Y1731*, Y612*	not provided	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000198320	X	31341723	X	31323606	198320	195481	rs794727820	NC_000023.11:31323605:G:C
NM_000109.4(DMD):c.391_404del (p.Ile131fs)	DMD	I135fs, I139fs, I16fs, I131fs	not provided	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000198163	X	32834687 - 32834700	X	32816570 - 32816583	198163	195324	rs794727795	NC_000023.11:32816569:CAGCTCAGGAGAATC:C
NM_004006.2(DMD):c.8669-2A>C	DMD		not provided	Pathogenic(Last reviewed: Aug 15, 2014)	criteria provided, single submitter	VCV000198020	X	31496493	X	31478376	198020	195181	rs794727770	NC_000023.11:31478375:T:G
NM_004006.2(DMD):c.8656C>T (p.Gln2886Ter)	DMD	Q2886*, Q2763*, Q1545*, Q157*, Q1542*, Q2878*, Q2882*, Q426*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000198011	X	31497112	X	31478995	198011	195172	rs201361100	NC_000023.11:31478994:G:A
NM_000109.4(DMD):c.8160del (p.Lys2721fs)	DMD	K1388fs, K269fs, K2721fs, K2725fs, K1385fs, K2606fs, K2729fs	not provided	Pathogenic(Last reviewed: Jul 21, 2014)	criteria provided, single submitter	VCV000197980	X	31645823	X	31627706	197980	195141	rs794727763	NC_000023.11:31627705:GG:G
NM_000109.4(DMD):c.7420del (p.Thr2475fs)	DMD	T1142fs, T2360fs, T23fs, T2475fs, T2479fs, T2483fs, T1139fs	not provided	Pathogenic(Last reviewed: May 11, 2015)	criteria provided, single submitter	VCV000197925	X	31792175	X	31774058	197925	195086	rs794727749	NC_000023.11:31774057:G:
NM_004013.2(DMD):c.-86_-85del	DMD	T1091fs, T2309fs, T2424fs, T2428fs, T2432fs, T1088fs	not provided	Pathogenic(Last reviewed: May 26, 2015)	criteria provided, single submitter	VCV000197913	X	31838105 - 31838106	X	31819988 - 31819989	197913	195074	rs794727746	NC_000023.11:31819987:GG:
NM_004013.2(DMD):c.-134dup	DMD		not provided	Pathogenic(Last reviewed: Aug 6, 2014)	criteria provided, single submitter	VCV000197912	X	31838153 - 31838154	X	31820036 - 31820037	197912	195073	rs797044764	NC_000023.11:31820036:AAA:AAAA
NM_172107.3(KCNQ2):c.793G>A (p.Ala265Thr)	KCNQ2	A265T	not provided|Early infantile epileptic encephalopathy|Seizures|Early infantile epileptic encephalopathy 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000197891	20	62073782	20	63442429	197891	195052	rs794727740	NC_000020.11:63442428:C:T
NM_004010.3(DMD):c.-79dup	DMD		not provided	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000197758	X	32841477 - 32841478	X	32823360 - 32823361	197758	194919	rs797044756	NC_000023.11:32823360:A:AA
NM_000071.2(CBS):c.374G>A (p.Arg125Gln)	CBS	R125Q, R20Q	Classic homocystinuria|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197625	21	44486430	21	43066320	197625	194786	rs781444670	NC_000021.9:43066319:C:T
NM_004013.2(DMD):c.-399A>T	DMD	K2328*, K2320*, K984*, K2205*, K2324*, K987*	not provided	Pathogenic(Last reviewed: Jun 12, 2014)	criteria provided, single submitter	VCV000197593	X	31893421	X	31875304	197593	194754	rs754896795	NC_000023.11:31875303:T:A
NM_004013.2(DMD):c.-711_-708dup	DMD		not provided	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000197544	X	31950285 - 31950286	X	31932168 - 31932169	197544	194705	rs797044743	NC_000023.11:31932168:AAACAAA:AAACAAACAAA
NM_000109.4(DMD):c.6214del (p.Gln2072fs)	DMD	Q2080fs, Q736fs, Q1957fs, Q2072fs, Q2076fs, Q739fs	not provided	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000197482	X	32305698	X	32287581	197482	194643	rs794727672	NC_000023.11:32287580:GGG:GG
NM_000109.4(DMD):c.5844G>A (p.Trp1948Ter)	DMD	W1956*, W1948*, W1952*, W615*, W612*, W1833*	not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000197434	X	32360271	X	32342154	197434	194595	rs794727666	NC_000023.11:32342153:C:T
NM_000109.4(DMD):c.5673del (p.Lys1891fs)	DMD	K1891fs, K1895fs, K1776fs, K555fs, K1899fs, K558fs	not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197412	X	32361293	X	32343176	197412	194573	rs794727661	NC_000023.11:32343175:TTTTTTTT:TTTTTTT
NM_024301.5(FKRP):c.947C>G (p.Pro316Arg)	FKRP	P316R	not provided|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197347	19	47259654	19	46756397	197347	194508	rs752582904	NC_000019.10:46756396:C:G
NM_004187.4(KDM5C):c.486T>A (p.Tyr162Ter)	KDM5C	Y162*, Y95*	not provided	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000197228	X	53247014	X	53217832	197228	194389	rs797044731	NC_000023.11:53217831:A:T
NM_000454.4(SOD1):c.341T>C (p.Ile114Thr)	SOD1	I114T	Motor neuron disease|Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197145	21	33039672	21	31667359	197145	194306	rs121912441	NC_000021.9:31667358:T:C
NM_000033.4(ABCD1):c.1288C>T (p.Gln430Ter)	ABCD1	Q430*	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000197096	X	153001862	X	153736408	197096	194257	rs797044726	NC_000023.11:153736407:C:T
NM_000489.5(ATRX):c.7364_7365AT[1] (p.Met2456fs)	ATRX		not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000196938	X	76763941 - 76763942	X	77508463 - 77508464	196938	194099	rs797044723	NC_000023.11:77508462:ATAT:AT
NM_004006.2(DMD):c.4675-2A>G	DMD		not provided	Pathogenic(Last reviewed: Aug 8, 2014)	criteria provided, single submitter	VCV000196897	X	32398799	X	32380682	196897	194058	rs794727575	NC_000023.11:32380681:T:C
NM_000109.4(DMD):c.4499del (p.Leu1500fs)	DMD	L1504fs, L1385fs, L1500fs, L1508fs, L164fs, L167fs	not provided	Pathogenic(Last reviewed: Jun 25, 2014)	criteria provided, single submitter	VCV000196864	X	32404578	X	32386461	196864	194025	rs794727567	NC_000023.11:32386460:AA:A
NM_000109.4(DMD):c.4291A>T (p.Arg1431Ter)	DMD	R1439*, R1431*, R98*, R1316*, R1435*, R95*	not provided	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000196695	X	32408217	X	32390100	196695	193856	rs794727550	NC_000023.11:32390099:T:A
NM_004463.3(FGD1):c.527dup (p.Leu177fs)	FGD1		not provided|Aarskog syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000196389	X	54497147 - 54497148	X	54470714 - 54470715	196389	193550	rs756586058	NC_000023.11:54470714:GGGGGGGG:GGGGGGGGG
NM_004187.4(KDM5C):c.351+1G>T	KDM5C		not provided	Pathogenic(Last reviewed: Jul 9, 2014)	criteria provided, single submitter	VCV000196375	X	53247457	X	53218275	196375	193536	rs797044706	NC_000023.11:53218274:C:A
NM_004010.3(DMD):c.-237C>T	DMD	Q45*, Q37*, Q41*	not provided	Pathogenic(Last reviewed: Jul 30, 2014)	criteria provided, single submitter	VCV000196372	X	32867898	X	32849781	196372	193533	rs794727499	NC_000023.11:32849780:G:A
NM_001037.5(SCN1B):c.347del (p.Ser116fs)	SCN1B	S116fs, S83fs	not provided	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000196303	19	35524542	19	35033638	196303	193464	rs794727487	NC_000019.10:35033637:C:
NM_000202.8(IDS):c.314_317dup (p.Ser107fs)	IDS		not provided	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	VCV000196234	X	148584942 - 148584943	X	149503412 - 149503413	196234	193395	rs797044703	NC_000023.11:149503412:TTGA:TTGATTGA
NM_000109.4(DMD):c.3814A>T (p.Lys1272Ter)	DMD	K1280*, K1157*, K1276*, K1272*	not provided	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000196126	X	32459380	X	32441263	196126	193287	rs794727463	NC_000023.11:32441262:T:A
NM_000109.4(DMD):c.3511G>T (p.Glu1171Ter)	DMD	E1179*, E1056*, E1175*, E1171*	not provided	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000195967	X	32472847	X	32454730	195967	193128	rs794727422	NC_000023.11:32454729:C:A
NM_000109.4(DMD):c.3473_3476del (p.Leu1158fs)	DMD	L1043fs, L1158fs, L1162fs, L1166fs	not provided	Pathogenic(Last reviewed: Aug 29, 2014)	criteria provided, single submitter	VCV000195966	X	32472882 - 32472885	X	32454765 - 32454768	195966	193127	rs794727421	NC_000023.11:32454764:GATAGAT:GAT
NM_033380.3(COL4A5):c.1844G>A (p.Gly615Glu)	COL4A5	G615E	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000195859	X	107841996	X	108598766	195859	193020	rs794727397	NC_000023.11:108598765:G:A
NM_000109.4(DMD):c.2907_2908GA[1] (p.Arg970fs)	DMD		not provided	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, single submitter	VCV000195680	X	32490296 - 32490297	X	32472179 - 32472180	195680	192841	rs794727359	NC_000023.11:32472178:TCTCT:TCT
NM_000109.4(DMD):c.2791_2792del (p.Leu931fs)	DMD	L931fs, L935fs, L816fs, L939fs	not provided	Pathogenic(Last reviewed: Sep 17, 2014)	criteria provided, single submitter	VCV000195679	X	32490414 - 32490415	X	32472297 - 32472298	195679	192840	rs794727358	NC_000023.11:32472296:AAA:A
NM_004006.2(DMD):c.2804-2A>T	DMD		not provided	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000195678	X	32490428	X	32472311	195678	192839	rs794727357	NC_000023.11:32472310:T:A
NM_001127221.1(CACNA1A):c.3825+1G>A	CACNA1A		not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000195663	19	13394080	19	13283266	195663	192824	rs794727355	NC_000019.10:13283265:C:T
NM_004187.4(KDM5C):c.3126_3128delinsCAGG (p.Asp1043fs)	KDM5C		not provided	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000195601	X	53224585 - 53224587	X	53195403 - 53195405	195601	192762	rs797044682	NC_000023.11:53195402:TCA:CCTG
NM_004006.2(DMD):c.2803+1G>C	DMD		not provided	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, single submitter	VCV000195600	X	32503035	X	32484918	195600	192761	rs398123908	NC_000023.11:32484917:C:G
NM_000276.4(OCRL):c.2299C>T (p.Gln767Ter)	OCRL	Q767*, Q759*, Q768*	not provided	Pathogenic(Last reviewed: May 28, 2014)	criteria provided, single submitter	VCV000195559	X	128722198	X	129588221	195559	192720	rs794727333	NC_000023.11:129588220:C:T
NM_017950.4(CCDC40):c.3354C>A (p.Tyr1118Ter)	CCDC40	Y1118*	not provided|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195522	17	78073499	17	80099700	195522	192683	rs374909386	NC_000017.11:80099699:C:A
NM_000109.4(DMD):c.2455G>T (p.Glu819Ter)	DMD	E827*, E819*, E823*, E704*	not provided	Pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	VCV000195495	X	32509537	X	32491420	195495	192656	rs794727323	NC_000023.11:32491419:C:A
NM_000109.4(DMD):c.2577_2578del (p.Gln861fs)	DMD	Q746fs, Q861fs, Q865fs, Q869fs	not provided	Pathogenic(Last reviewed: Jul 9, 2014)	criteria provided, single submitter	VCV000195491	X	32509414 - 32509415	X	32491297 - 32491298	195491	192652	rs794727322	NC_000023.11:32491296:TTTT:TT
NM_000528.4(MAN2B1):c.2402dup (p.Ser802fs)	MAN2B1		not provided|Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195465	19	12759983 - 12759984	19	12649169 - 12649170	195465	192626	rs797044680	NC_000019.10:12649169:CCCCCC:CCCCCCC
NM_001159773.2(CANT1):c.278del (p.Leu93fs)	CANT1	L93fs	not provided	Pathogenic(Last reviewed: Mar 17, 2015)	criteria provided, single submitter	VCV000195399	17	76993427	17	78997345	195399	192560	rs767601069	NC_000017.11:78997344:A:
NM_017653.5(DYM):c.122del (p.Phe41fs)	DYM	F41fs	not provided	Pathogenic(Last reviewed: Jan 6, 2015)	criteria provided, single submitter	VCV000195317	18	46956643	18	49430273	195317	192478	rs794727290	NC_000018.10:49430272:AAA:AA
NM_001256789.3(CACNA1F):c.244C>T (p.Arg82Ter)	CACNA1F	R82*	Ocular albinism, type II|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195237	X	49088171	X	49231709	195237	192398	rs797044676	NC_000023.11:49231708:G:A
NM_003688.3(CASK):c.79C>T (p.Arg27Ter)	CASK	R27*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195200	X	41712461	X	41853208	195200	192361	rs794727270	NC_000023.11:41853207:G:A
NM_000202.8(IDS):c.208dup (p.His70fs)	IDS		not provided	Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	VCV000195037	X	148585718 - 148585719	X	149504188 - 149504189	195037	192199	rs797044671	NC_000023.11:149504188:GGG:GGGG
NM_000166.6(GJB1):c.271G>A (p.Val91Met)	GJB1	V91M	Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195025	X	70443828	X	71223978	195025	192187	rs756928158	NC_000023.11:71223977:G:A
NM_000271.5(NPC1):c.2621A>T (p.Asp874Val)	NPC1	D874V	Niemann-Pick disease, type C|Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194810	18	21119949	18	23539985	194810	191973	rs372030650	NC_000018.10:23539984:T:A
NM_017950.4(CCDC40):c.2824_2825insCTGT (p.Arg942fs)	CCDC40		Primary ciliary dyskinesia|not provided|Kartagener syndrome	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194774	17	78063675 - 78063676	17	80089876 - 80089877	194774	191937	rs587778819	NC_000017.11:80089876::CTGT
NM_002743.3(PRKCSH):c.1460_1463del (p.Lys487fs)	PRKCSH	K484fs, K494fs, K487fs	not provided	Pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000194734	19	11560098 - 11560101	19	11449283 - 11449286	194734	191897	rs794727187	NC_000019.10:11449282:GAAAGA:GA
NM_000276.4(OCRL):c.1714-1G>A	OCRL		not provided	Pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000194704	X	128709873	X	129575896	194704	191867	rs794727182	NC_000023.11:129575895:G:A
NM_000109.4(DMD):c.1888C>T (p.Gln630Ter)	DMD	Q638*, Q634*, Q515*, Q630*	not provided	Pathogenic(Last reviewed: Feb 24, 2015)	criteria provided, single submitter	VCV000194636	X	32583899	X	32565782	194636	191799	rs794727170	NC_000023.11:32565781:G:A
NM_001123383.1(BCOR):c.4760dup (p.Gly1588fs)	BCOR		not provided	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000194417	X	39913252 - 39913253	X	40053999 - 40054000	194417	191580	rs797044647	NC_000023.11:40053999:GGGGGG:GGGGGGG
NM_206965.2(FTCD):c.1607T>A (p.Leu536Ter)	FTCD	L536*	not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000194395	21	47556920	21	46137006	194395	191558	rs149266909	NC_000021.9:46137005:A:T
NM_004006.2(DMD):c.1704+1G>A	DMD		not provided|not specified	Pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000194384	X	32591861	X	32573744	194384	191547	rs794727123	NC_000023.11:32573743:C:T
NM_004463.3(FGD1):c.2016-2A>G	FGD1		not provided	Pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000194218	X	54476736	X	54450303	194218	191381	rs794727099	NC_000023.11:54450302:T:C
NM_000109.4(DMD):c.1505_1508TCAC[1] (p.His504fs)	DMD		not provided	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000194215	X	32613940 - 32613943	X	32595823 - 32595826	194215	191378	rs794727097	NC_000023.11:32595822:GTGAGTGAG:GTGAG
NM_000152.5(GAA):c.1802C>T (p.Ser601Leu)	GAA	S601L	not provided	Pathogenic(Last reviewed: Nov 19, 2014)	criteria provided, single submitter	VCV000194154	17	78086424	17	80112625	194154	191317	rs374470794	NC_000017.11:80112624:C:T
NM_000071.2(CBS):c.1218del (p.Lys406fs)	CBS	K406fs, K301fs	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194150	21	44479341	21	43059231	194150	191313	rs794727083	NC_000021.9:43059230:C:
NM_001165927.1(MKS1):c.995-2A>C	MKS1		not provided|Joubert syndrome 28|Meckel syndrome type 1|Bardet-Biedl syndrome 13	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000194102	17	56285946	17	58208585	194102	191265	rs794727070	NC_000017.11:58208584:T:G
NM_001323289.2(CDKL5):c.1152C>G (p.Tyr384Ter)	CDKL5	Y384*	not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000194049	X	18622196	X	18604076	194049	191212	rs794727064	NC_000023.11:18604075:C:G
NM_001323289.2(CDKL5):c.1891_1916del (p.Ile631fs)	CDKL5	I631fs	not provided	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	VCV000194048	X	18622931 - 18622956	X	18604811 - 18604836	194048	191211	rs794727063	NC_000023.11:18604810:GAGCATAGGGCAAGGGATGGCAGCTAGAGC:GAGC
NM_001848.2(COL6A1):c.957+2T>C	COL6A1		not provided	Pathogenic(Last reviewed: Aug 6, 2014)	criteria provided, single submitter	VCV000194040	21	47410200	21	45990286	194040	191203	rs794727060	NC_000021.9:45990285:T:C
NM_004006.2(DMD):c.1150-2A>G	DMD		not provided	Pathogenic(Last reviewed: Dec 5, 2014)	criteria provided, single submitter	VCV000193870	X	32662432	X	32644315	193870	191033	rs794727030	NC_000023.11:32644314:T:C
NM_000109.4(DMD):c.1262C>G (p.Ser421Ter)	DMD	S429*, S306*, S421*, S425*	not provided	Pathogenic(Last reviewed: Apr 9, 2015)	criteria provided, single submitter	VCV000193869	X	32662294	X	32644177	193869	191032	rs398123853	NC_000023.11:32644176:G:C
NM_001848.2(COL6A1):c.904G>C (p.Gly302Arg)	COL6A1	G302R	not provided	Pathogenic(Last reviewed: Oct 23, 2014)	criteria provided, single submitter	VCV000193851	21	47409666	21	45989752	193851	191014	rs794727028	NC_000021.9:45989751:G:C
NM_000159.4(GCDH):c.1168G>C (p.Gly390Arg)	GCDH	G390R	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193799	19	13008602	19	12897788	193799	190962	rs372983141	NC_000019.10:12897787:G:C
NM_000159.4(GCDH):c.1213A>G (p.Met405Val)	GCDH	M405V	Glutaric aciduria, type 1|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193798	19	13008647	19	12897833	193798	190961	rs141437721	NC_000019.10:12897832:A:G
NM_015629.4(PRPF31):c.1073+1G>A	PRPF31		Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193720	19	54631576	19	54128201	193720	190883	rs794727001	NC_000019.10:54128200:G:A
NM_000109.4(DMD):c.1046del (p.Ser349fs)	DMD	S353fs, S349fs, S234fs, S357fs	not provided	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	VCV000193664	X	32663160	X	32645043	193664	190827	rs794726994	NC_000023.11:32645042:G:
NM_000109.4(DMD):c.1069C>T (p.Gln357Ter)	DMD	Q365*, Q242*, Q357*, Q361*	Dilated cardiomyopathy 3B|Becker muscular dystrophy|Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000193663	X	32663137	X	32645020	193663	190826	rs794726993	NC_000023.11:32645019:G:A
NM_000033.4(ABCD1):c.1992-2A>G	ABCD1		not provided	Pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000193547	X	153008941	X	153743487	193547	190711	rs797044626	NC_000023.11:153743486:A:G
NM_000033.4(ABCD1):c.2000_2001AC[3] (p.His669fs)	ABCD1		not provided	Pathogenic(Last reviewed: Sep 17, 2014)	criteria provided, single submitter	VCV000193546	X	153008950 - 153008951	X	153743496 - 153743497	193546	190710	rs797044625	NC_000023.11:153743495:CACACACAC:CACACAC
NM_000022.4(ADA):c.956_960del (p.Glu319fs)	ADA	E184fs, E295fs, E319fs	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193544	20	43249674 - 43249678	20	44621033 - 44621037	193544	190708	rs771266745	NC_000020.11:44621032:CTCTTC:C
NM_139058.3(ARX):c.30C>A (p.Cys10Ter)	ARX	C10*	not provided	Pathogenic(Last reviewed: Jan 22, 2015)	criteria provided, single submitter	VCV000193494	X	25033825	X	25015708	193494	190658	rs794726959	NC_000023.11:25015707:G:T
NM_006517.5(SLC16A2):c.326G>A (p.Trp109Ter)	SLC16A2	W109*	not provided	Pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000193349	X	73641798	X	74421963	193349	190513	rs794726932	NC_000023.11:74421962:G:A
NM_000109.4(DMD):c.7+127960_7+127961delinsT	DMD		not provided	Pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	VCV000193266	X	33229415 - 33229416	X	33211298 - 33211299	193266	190430	rs796065325	NC_000023.11:33211297:TT:A
NM_001399.5(EDA):c.396+2T>C	EDA		not provided	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000193204	X	68836550	X	69616706	193204	190369	rs727504814	NC_000023.11:69616705:T:C
NM_001184880.2(PCDH19):c.814C>T (p.Gln272Ter)	PCDH19	Q272*	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193191	X	99662782	X	100407784	193191	190356	rs794726897	NC_000023.11:100407783:G:A
NM_000033.4(ABCD1):c.887A>G (p.Tyr296Cys)	ABCD1	Y296C	Adrenoleukodystrophy|not provided	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193033	X	152991608	X	153726153	193033	190198	rs797044610	NC_000023.11:153726152:A:G
SOX9, 136-KB DEL, UPSTREAM REGULATORY REGION	SOX9		46,XY sex reversal 10	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000192390					192390	190177		
SOX9, 577-KB DEL, UPSTREAM REGULATORY REGION	SOX9		46,XY sex reversal 10	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000192389					192389	190176		
SOX9, 240-KB DEL, UPSTREAM REGULATORY REGION	SOX9		46,XY sex reversal 10	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000192388					192388	190175		
SOX9, 148-KB DUP, UPSTREAM REGULATORY REGION	SOX9		46,XX sex reversal 2	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000192387					192387	190174		
SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION	SOX9		46,XX sex reversal 2	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000192386					192386	190173		
NM_006087.4(TUBB4A):c.568C>T (p.His190Tyr)	TUBB4A	H190Y, H241Y, H235Y, H118Y	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000192383	19	6495942	19	6495931	192383	190170	rs761635539	NC_000019.10:6495930:G:A
NM_001003811.2(TEX11):c.2092G>A (p.Ala698Thr)	TEX11	A698T, A683T	Spermatogenic failure, X-linked, 2	Pathogenic(Last reviewed: May 28, 2015)	no assertion criteria provided	VCV000192380	X	69825271	X	70605421	192380	190167	rs140984555	NC_000023.11:70605420:C:T
NM_001003811.2(TEX11):c.511A>G (p.Met171Val)	TEX11	M171V, M156V	Spermatogenic failure, X-linked, 2	Pathogenic(Last reviewed: May 28, 2015)	no assertion criteria provided	VCV000192379	X	70072943	X	70853093	192379	190166	rs143246552	NC_000023.11:70853092:T:C
TEX11, 90-KB DEL, EX10-12	TEX11		Spermatogenic failure, X-linked, 2	Pathogenic(Last reviewed: May 28, 2015)	no assertion criteria provided	VCV000192378					192378	190165		
NM_194277.2(FRMD7):c.556A>G (p.Met186Val)	FRMD7	M186V, M171V	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000192295	X	131219698	X	132085670	192295	190088	rs786205896	NC_000023.11:132085669:T:C
NM_001958.4(EEF1A2):c.364G>A (p.Glu122Lys)	EEF1A2	E122K	Epileptic encephalopathy, early infantile, 33|Mental retardation, autosomal dominant 38|Inborn genetic diseases|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000192252	20	62126415	20	63495062	192252	190049	rs786205866	NC_000020.11:63495061:C:T
NM_001958.4(EEF1A2):c.754G>C (p.Asp252His)	EEF1A2	D252H	Epileptic encephalopathy, early infantile, 33|Mental retardation, autosomal dominant 38	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000192251	20	62124508	20	63493155	192251	190048	rs786205865	NC_000020.11:63493154:C:G
NG_009304.1:g.2160_7401del	TYROBP		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000192243	19	36396786 - 36402027	19	35905884 - 35911125	192243	190042		
NM_000455.4(STK11):c.842del (p.Pro281fs)	STK11	P281fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000192227	19	1221314	19	1221315	192227	190029	rs121913321	NC_000019.10:1221314:CCCCCC:CCCCC
NM_000455.4(STK11):c.844dup (p.Leu282fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	VCV000192226	19	1221320 - 1221321	19	1221321 - 1221322	192226	190030	rs786205864	NC_000019.10:1221321:C:CC
NM_001282684.1(KCTD17):c.434G>A (p.Arg145His)	KCTD17	R145H	Dystonia 26, myoclonic	Pathogenic(Last reviewed: May 12, 2015)	no assertion criteria provided	VCV000191372	22	37453460	22	37057420	191372	189177	rs786205860	NC_000022.11:37057419:G:A
NM_000451.3(SHOX):c.-646_-645insTGT	SHOX		Short stature, idiopathic, X-linked	Pathogenic	no assertion criteria provided	VCV000191363	X	585123 - 585124	X	624388 - 624389	191363	189166	rs1556450972	NC_000024.10:624388:TT:TTGTT
NM_153638.3(PANK2):c.1292T>C (p.Phe431Ser)	PANK2	F140S, F431S	Retinitis pigmentosa	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000191359	20	3893161	20	3912514	191359	189162	rs863223343	NC_000020.11:3912513:T:C
NM_000390.4(CHM):c.1144G>T (p.Glu382Ter)	CHM	E382*, E234*	not provided	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000191251	X	85211180	X	85956175	191251	189054	rs786205604	NC_000023.11:85956174:C:A
NM_006915.3(RP2):c.2T>C (p.Met1Thr)	RP2	M1T	Retinitis pigmentosa|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000191246	X	46696537	X	46837102	191246	189049	rs797044561	NC_000023.11:46837101:T:C
NM_002501.4(NFIX):c.520G>T (p.Glu174Ter)	NFIX	E174*, E182*, E173*, E127*, E166*	not provided	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000191097	19	13136327	19	13025513	191097	188902	rs786205515	NC_000019.10:13025512:G:T
NM_019613.4(WDR45B):c.673C>T (p.Arg225Ter)	WDR45B	R225*	NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	no assertion criteria provided	VCV000191088	17	80576950	17	82619074	191088	188893	rs786205510	NC_000017.11:82619073:G:A
NM_001165927.1(MKS1):c.1036C>T (p.Gln346Ter)	MKS1	Q346*, Q356*, Q153*	Meckel-Gruber syndrome|not provided	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000191083	17	56285903	17	58208542	191083	188889	rs786205508	NC_000017.11:58208541:G:A
NM_001037.5(SCN1B):c.73G>A (p.Asp25Asn)	SCN1B	D25N	not provided	Pathogenic(Last reviewed: Feb 17, 2012)	criteria provided, single submitter	VCV000190879	19	35523464	19	35032560	190879	188678	rs786205837	NC_000019.10:35032559:G:A
NM_001037.5(SCN1B):c.449-1G>A	SCN1B		not provided	Pathogenic(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	VCV000190871	19	35530020	19	35039116	190871	188700	rs786205835	NC_000019.10:35039115:G:A
NM_001242897.2(DEPDC5):c.418C>T (p.Gln140Ter)	DEPDC5	Q140*, Q112*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000190476	22	32174089	22	31778103	190476	188295	rs786205703	NC_000022.11:31778102:C:T
NC_000018.9(TXNL4A):g.77748604_77748637del34	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000190413	18	77748604 - 77748637	18	79988604 - 79988637	190413	188238	rs786205699	NC_000018.10:79988603:GCGCGCGCTAGCGCCGTGCGTGCTGACGGCATGTGCG:GCG
NP_002046.1:p.Phe261_Thr302del	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190369					190369	188194		
NM_002055.5(GFAP):c.619-3C>G	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190368	17	42990801	17	44913433	190368	188179	rs112611995	NC_000017.11:44913432:G:C
NM_002055.5(GFAP):c.1171+475_1171+482delinsATC	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190366	17	42987501 - 42987508	17	44910133 - 44910140	190366	188161	rs797044592	NC_000017.11:44910132:CAGCTAAC:GAT
NM_002055.5(GFAP):c.1249del (p.Asp417fs)	GFAP	D457fs, D417fs	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190365	17	42985440	17	44908072	190365	188159	rs797044591	NC_000017.11:44908071:CCC:CC
NP_002046.1(GFAP):p.Met415Ile	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190364					190364	188193		
NM_002055.5(GFAP):c.1193C>T (p.Ser398Phe)	GFAP	S398F, S438F	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190363	17	42985496	17	44908128	190363	188160	rs267607508	NC_000017.11:44908127:G:A
NM_002055.5(GFAP):c.1154C>G (p.Ser385Cys)	GFAP	S385C	Alexander Disease|not provided	Pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	VCV000190362	17	42988000	17	44910632	190362	188164	rs797044590	NC_000017.11:44910631:G:C
NM_002055.5(GFAP):c.1154C>T (p.Ser385Phe)	GFAP	S385F	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190361	17	42988000	17	44910632	190361	188163	rs797044590	NC_000017.11:44910631:G:A
NM_002055.5(GFAP):c.1118A>C (p.Glu373Ala)	GFAP	E373A	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190360	17	42988613	17	44911245	190360	188165	rs797044589	NC_000017.11:44911244:T:G
NP_002046.1(GFAP):p.Glu373Asp	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190359					190359	188192		
NM_002055.5(GFAP):c.1090G>A (p.Ala364Thr)	GFAP	A364T	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190358	17	42988641	17	44911273	190358	188166	rs58645997	NC_000017.11:44911272:C:T
NM_002055.5(GFAP):c.1085A>G (p.Glu362Gly)	GFAP	E362G	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190357	17	42988646	17	44911278	190357	188167	rs797044588	NC_000017.11:44911277:T:C
NM_002055.5(GFAP):c.1074C>G (p.Ala358=)	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190356	17	42988657	17	44911289	190356	188191	rs797044587	NC_000017.11:44911288:G:C
NM_002055.5(GFAP):c.1073C>T (p.Ala358Val)	GFAP	A358V	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190355	17	42988658	17	44911290	190355	188168	rs797044586	NC_000017.11:44911289:G:A
NM_002055.5(GFAP):c.1051G>C (p.Asp351His)	GFAP	D351H	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190354	17	42988680	17	44911312	190354	188169	rs797044585	NC_000017.11:44911311:C:G
NM_002055.5(GFAP):c.1049_1050insCTTGCA (p.Gln350_Asp351insHisLeu)	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190353	17	42988681 - 42988682	17	44911313 - 44911314	190353	188170	rs797044584	NC_000017.11:44911313:TG:TGCAAGTG
NM_002055.5(GFAP):c.868C>G (p.Gln290Glu)	GFAP	Q290E	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190350	17	42989078	17	44911710	190350	188172	rs797044583	NC_000017.11:44911709:G:C
NM_002055.5(GFAP):c.803C>A (p.Ala268Asp)	GFAP	A268D	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190349	17	42989143	17	44911775	190349	188173	rs797044582	NC_000017.11:44911774:G:T
NM_002055.5(GFAP):c.799G>C (p.Ala267Pro)	GFAP	A267P	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190348	17	42989147	17	44911779	190348	188174	rs797044581	NC_000017.11:44911778:C:G
NM_002055.5(GFAP):c.791_792delinsCT (p.Leu264Pro)	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190347	17	42989154 - 42989155	17	44911786 - 44911787	190347	188190	rs797044580	NC_000017.11:44911785:CA:AG
NM_002055.5(GFAP):c.791T>C (p.Leu264Pro)	GFAP	L264P	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190346	17	42989155	17	44911787	190346	188175	rs797044579	NC_000017.11:44911786:A:G
NM_002055.5(GFAP):c.772C>T (p.Arg258Cys)	GFAP	R258C	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190345	17	42990645	17	44913277	190345	188176	rs797044578	NC_000017.11:44913276:G:A
NM_002055.5(GFAP):c.692T>A (p.Leu231His)	GFAP	L231H	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190343	17	42990725	17	44913357	190343	188178	rs797044577	NC_000017.11:44913356:A:T
NM_002055.5(GFAP):c.369_374GCGGCT[3] (p.124_125RL[3])	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190342	17	42992474 - 42992475	17	44915106 - 44915107	190342	188180	rs797044576	NC_000017.11:44915106:AGCCGCAGCCGCAGC:AGCCGCAGCCGCAGCCGCAGC
NM_002055.5(GFAP):c.365_373dup (p.Leu125_Arg126insGlnLeuArg)	GFAP		Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190341	17	42992481 - 42992482	17	44915113 - 44915114	190341	188181	rs797044575	NC_000017.11:44915113:GCCGCAGCT:GCCGCAGCTGCCGCAGCT
NM_002055.5(GFAP):c.278A>C (p.Gln93Pro)	GFAP	Q93P	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190340	17	42992577	17	44915209	190340	188182	rs797044574	NC_000017.11:44915208:T:G
NM_002055.5(GFAP):c.259G>A (p.Val87Ile)	GFAP	V87I	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190339	17	42992596	17	44915228	190339	188183	rs267607518	NC_000017.11:44915227:C:T
NM_002055.5(GFAP):c.256A>G (p.Lys86Glu)	GFAP	K86E	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190338	17	42992599	17	44915231	190338	188184	rs797044573	NC_000017.11:44915230:T:C
NM_002055.5(GFAP):c.239T>C (p.Phe80Ser)	GFAP	F80S	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190337	17	42992616	17	44915248	190337	188185	rs797044572	NC_000017.11:44915247:A:G
NM_002055.5(GFAP):c.232G>A (p.Asp78Asn)	GFAP	D78N	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190335	17	42992623	17	44915255	190335	188186	rs797044571	NC_000017.11:44915254:C:T
NM_002055.5(GFAP):c.218T>C (p.Met73Thr)	GFAP	M73T	Alexander Disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000190334	17	42992637	17	44915269	190334	188187	rs61060395	NC_000017.11:44915268:A:G
NM_002055.5(GFAP):c.205G>A (p.Glu69Lys)	GFAP	E69K	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190333	17	42992650	17	44915282	190333	188188	rs797044570	NC_000017.11:44915281:C:T
NM_002055.5(GFAP):c.197G>A (p.Arg66Gln)	GFAP	R66Q	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000190332	17	42992658	17	44915290	190332	188189	rs797044569	NC_000017.11:44915289:C:T
NM_014225.6(PPP2R1A):c.536C>T (p.Pro179Leu)	PPP2R1A	P179L	Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Mental retardation, autosomal dominant 36|not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000190313	19	52715971	19	52212718	190313	188142	rs786205228	NC_000019.10:52212717:C:T
NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp)	PPP2R1A	R182W, R3W	Mental retardation, autosomal dominant 36|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190312	19	52715979	19	52212726	190312	188141	rs786205227	NC_000019.10:52212725:C:T
RPS6KA3, 7.2-KB DEL	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000190301					190301	188130		
NM_001282531.3(ADNP):c.1222_1223del (p.Lys408fs)	ADNP	K408fs	Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190279	20	49510028 - 49510029	20	50893491 - 50893492	190279	188113	rs1555810376	NC_000020.11:50893490:TTT:T
NM_001282531.3(ADNP):c.2156dup (p.Tyr719Ter)	ADNP		Helsmoortel-Van der Aa Syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190278	20	49509094 - 49509095	20	50892557 - 50892558	190278	188112	rs1135401808	NC_000020.11:50892557:T:TT
NM_198994.3(TGM6):c.1719_1721AGA[1] (p.Glu574del)	TGM6	E574del	Spinocerebellar ataxia 35	Pathogenic(Last reviewed: Oct 21, 2014)	no assertion criteria provided	VCV000190254	20	2411131 - 2411133	20	2430485 - 2430487	190254	188078	rs793888526	NC_000020.11:2430484:AAGAAGA:AAGA
NM_198994.3(TGM6):c.331C>T (p.Arg111Cys)	TGM6	R111C	Spinocerebellar ataxia 35	Pathogenic(Last reviewed: Oct 21, 2014)	no assertion criteria provided	VCV000190253	20	2375989	20	2395343	190253	188077	rs372250159	NC_000020.11:2395342:C:T
NM_198270.4(NHS):c.852+1del	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000190248	X	17710588	X	17692468	190248	188072	rs786205677	NC_000023.11:17692467:GG:G
NM_021140.3(KDM6A):c.2515_2518del (p.Asn839fs)	KDM6A	N543fs, N760fs, N846fs, N891fs, N794fs, N839fs	Kabuki syndrome 2	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000190247	X	44929412 - 44929415	X	45070167 - 45070170	190247	188071	rs786205676	NC_000023.11:45070166:ACAAACA:ACA
NM_182895.5(SCARF2):c.441_457del (p.Trp148fs)	SCARF2	W148fs		Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000190239	22	20785702 - 20785718	22	20431415 - 20431431	190239	188068	rs786205883	NC_000022.11:20431414:CGCAGCGCGCGCCCCAGCGC:CGC
NM_017763.5(RNF43):c.394C>T (p.Arg132Ter)	RNF43	R132*, R5*	Colon Serrated Polyposis|Sessile serrated polyposis cancer syndrome	Pathogenic	criteria provided, single submitter	VCV000190226	17	56440943	17	58363582	190226	188056	rs786205215	NC_000017.11:58363581:G:A
NM_001008537.3(NEXMIF):c.1882C>T (p.Arg628Ter)	NEXMIF	R628*	Mental retardation, X-linked 98|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190220	X	73962510	X	74742675	190220	188055	rs786205208	NC_000023.11:74742674:G:A
NM_001278649.2(OSBPL2):c.-184-3532_-184-3531del	OSBPL2	R50fs, R38fs	Deafness, autosomal dominant 67	Pathogenic(Last reviewed: Feb 10, 2015)	no assertion criteria provided	VCV000190111	20	60835140 - 60835141	20	62260084 - 62260085	190111	187946	rs786205881	NC_000020.11:62260083:TG:
NM_001278649.2(OSBPL2):c.-184-3517_-184-3516del	OSBPL2		Deafness, autosomal dominant 67	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000190110	20	60835152 - 60835153	20	62260096 - 62260097	190110	187945	rs786205880	NC_000020.11:62260095:CTCTC:CTC
NM_173354.5(SIK1):c.1906G>A (p.Gly636Ser)	SIK1	G636S	Epileptic encephalopathy, early infantile, 30	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190109	21	44837493	21	43417613	190109	187944	rs786205163	NC_000021.9:43417612:C:T
NM_173354.5(SIK1):c.1897C>T (p.Gln633Ter)	SIK1	Q633*	Epileptic encephalopathy, early infantile, 30	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190108	21	44837502	21	43417622	190108	187943	rs786205162	NC_000021.9:43417621:G:A
NM_173354.5(SIK1):c.1840C>T (p.Gln614Ter)	SIK1	Q614*	Epileptic encephalopathy, early infantile, 30	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190107	21	44837559	21	43417679	190107	187942	rs786205161	NC_000021.9:43417678:G:A
NM_173354.5(SIK1):c.1039G>T (p.Glu347Ter)	SIK1	E347*	Epileptic encephalopathy, early infantile, 30	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190106	21	44839819	21	43419939	190106	187941	rs786205160	NC_000021.9:43419938:C:A
NM_173354.5(SIK1):c.859C>A (p.Pro287Thr)	SIK1	P287T	Epileptic encephalopathy, early infantile, 30	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190105	21	44840227	21	43420347	190105	187940	rs786205159	NC_000021.9:43420346:G:T
NC_000017.11:g.(?_68515394)_(68515576_?)del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	VCV000189814			17	68515394 - 68515576	189814	187682		
NC_000017.11:g.(?_68512379)_(68512548_?)del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	VCV000189813			17	68512379 - 68512548	189813	187680		
NM_212472.2(PRKAR1A):c.177+3A>G	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	VCV000189811	17	66511720	17	68515579	189811	187684	rs797044568	NC_000017.11:68515578:A:G
NM_001323289.2(CDKL5):c.942del (p.Lys314fs)	CDKL5	K314fs	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189600	X	18616695	X	18598575	189600	187606	rs786204992	NC_000023.11:18598574:AAAA:AAA
NM_001323289.2(CDKL5):c.91A>G (p.Arg31Gly)	CDKL5	R31G	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189599	X	18528966	X	18510846	189599	187580	rs786204991	NC_000023.11:18510845:A:G
NM_003159.2(CDKL5):c.745-?_825+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189598					189598	187451		
NM_001323289.2(CDKL5):c.660_664dup (p.Thr222fs)	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189597	X	18606178 - 18606179	X	18588058 - 18588059	189597	187604	rs786204990	NC_000023.11:18588058:TTTTA:TTTTATTTTA
NM_003159.2(CDKL5):c.65-?_99+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189596					189596	187447		
NM_001323289.2(CDKL5):c.528G>T (p.Trp176Cys)	CDKL5	W176C	Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189595	X	18602447	X	18584327	189595	187601	rs786204989	NC_000023.11:18584326:G:T
NM_001323289.2(CDKL5):c.526T>G (p.Trp176Gly)	CDKL5	W176G	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189594	X	18602445	X	18584325	189594	187600	rs587783084	NC_000023.11:18584324:T:G
NM_001323289.2(CDKL5):c.510_511dup (p.Tyr171fs)	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189593	X	18602428 - 18602429	X	18584308 - 18584309	189593	187599	rs786204988	NC_000023.11:18584308:GT:GTGT
NM_001323289.2(CDKL5):c.504_505CA[1] (p.Thr169fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189592	X	18602422 - 18602423	X	18584302 - 18584303	189592	187598	rs786204987	NC_000023.11:18584301:ACACA:ACA
NM_001323289.2(CDKL5):c.464-1G>A	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189591	X	18602382	X	18584262	189591	187596	rs786204986	NC_000023.11:18584261:G:A
NM_001323289.2(CDKL5):c.458A>G (p.Asp153Gly)	CDKL5	D153G	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189590	X	18600065	X	18581945	189590	187595	rs786204985	NC_000023.11:18581944:A:G
NM_001323289.2(CDKL5):c.404-1G>A	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189589	X	18600010	X	18581890	189589	187593	rs267608474	NC_000023.11:18581889:G:A
NM_001323289.2(CDKL5):c.403+540_554+61del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189588	X	18598625 - 18602531	X	18580505 - 18584411	189588	187591		
NM_003159.2(CDKL5):c.404-?_554+?del	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189587					189587	187450		
NM_001323289.2(CDKL5):c.403+1G>A	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189586	X	18598089	X	18579969	189586	187589	rs786204984	NC_000023.11:18579968:G:A
NM_001323289.2(CDKL5):c.283-3_290del	CDKL5		Atypical Rett syndrome|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189585	X	18597964 - 18597974	X	18579844 - 18579854	189585	187587	rs786204983	NC_000023.11:18579843:TTAGAATATGCT:T
NM_001323289.2(CDKL5):c.275_276insAA (p.Glu93fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189584	X	18593603 - 18593604	X	18575483 - 18575484	189584	187586	rs786204982	NC_000023.11:18575483::AA
NM_001323289.2(CDKL5):c.2704C>T (p.Gln902Ter)	CDKL5	Q902*	Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189583	X	18646698	X	18628578	189583	187628	rs786204981	NC_000023.11:18628577:C:T
NM_001323289.2(CDKL5):c.2531dup (p.His844fs)	CDKL5		not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189582	X	18646524 - 18646525	X	18628404 - 18628405	189582	187626	rs786204980	NC_000023.11:18628404:A:AA
NM_003159.2(CDKL5):c.-253_99+?del	CDKL5		Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189581	X	18443725 - 18528974	X	18425605 - 18510854	189581	187438		
NM_003159.2(CDKL5):c.-253_977+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189580	X	18443725 - 18616733	X	18425605 - 18598613	189580	187440		
NM_003159.2(CDKL5):c.-253_825+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189579	X	18443725 - 18613548	X	18425605 - 18595428	189579	187439		
NM_003159.2(CDKL5):c.-253_64+?del	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189578	X	18443725 - 18525280	X	18425605 - 18507160	189578	187437		
NM_003159.2(CDKL5):c.-253_2276+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189577	X	18443725 - 18631395	X	18425605 - 18613275	189577	187441		
NM_003159.2(CDKL5):c.(?_-253)_-162-27968del	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189576	X	18443725 - 18497087	X	18425605 - 18478967	189576	187442		
NM_003159.2(CDKL5):c.(?_-253)_(*85_?)del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189575					189575	187632		
NM_001323289.2(CDKL5):c.2494C>T (p.Gln832Ter)	CDKL5	Q832*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189573	X	18643365	X	18625245	189573	187625	rs17857094	NC_000023.11:18625244:C:T
NM_001323289.2(CDKL5):c.2277-2A>G	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189571	X	18637985	X	18619865	189571	187622	rs786204979	NC_000023.11:18619864:A:G
NM_001323289.2(CDKL5):c.2103_2104AC[1] (p.His702fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189570	X	18627641 - 18627642	X	18609521 - 18609522	189570	187621	rs786204978	NC_000023.11:18609520:ACAC:AC
NM_001323289.2(CDKL5):c.207_213del (p.Glu70fs)	CDKL5	E70fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189569	X	18593535 - 18593541	X	18575415 - 18575421	189569	187584	rs786204977	NC_000023.11:18575414:GGAAAAC:
NM_001323289.2(CDKL5):c.1854del (p.Asp618fs)	CDKL5	D618fs	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189567	X	18622898	X	18604778	189567	187619	rs786204975	NC_000023.11:18604777:C:
NM_001323289.2(CDKL5):c.1784dup (p.Leu596fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189566	X	18622826 - 18622827	X	18604706 - 18604707	189566	187618	rs786204974	NC_000023.11:18604706:GG:GGG
NM_001323289.2(CDKL5):c.-162-2A>G	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189565	X	18525053	X	18506933	189565	187577	rs786204973	NC_000023.11:18506932:A:G
NM_003159.2(CDKL5):c.-162-?_99+?del	CDKL5		Atypical Rett syndrome|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189564					189564	187444		
NM_003159.2(CDKL5):c.-162-?_64+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189563					189563	187443		
NM_003159.2(CDKL5):c.-162-?_145+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189562					189562	187445		
NM_001323289.2(CDKL5):c.1550del (p.Phe517fs)	CDKL5	F517fs	Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189560	X	18622593	X	18604473	189560	187617	rs786204972	NC_000023.11:18604472:TT:T
NM_001323289.2(CDKL5):c.1432_1433insT (p.Arg478fs)	CDKL5		not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189558	X	18622476 - 18622477	X	18604356 - 18604357	189558	187616	rs786204971	NC_000023.11:18604356::T
NM_001323289.2(CDKL5):c.1417dup (p.Ile473fs)	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189557	X	18622459 - 18622460	X	18604339 - 18604340	189557	187615	rs786204970	NC_000023.11:18604339:AA:AAA
NM_001323289.2(CDKL5):c.1375C>T (p.Gln459Ter)	CDKL5	Q459*	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189556	X	18622419	X	18604299	189556	187614	rs786204969	NC_000023.11:18604298:C:T
NM_001323289.2(CDKL5):c.1341del (p.Phe447fs)	CDKL5	F447fs	Atypical Rett syndrome	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000189555	X	18622385	X	18604265	189555	187613	rs786204968	NC_000023.11:18604264:C:
NM_001323289.2(CDKL5):c.1245_1246AG[1] (p.Glu416fs)	CDKL5		not provided|Epileptic encephalopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189554	X	18622289 - 18622290	X	18604169 - 18604170	189554	187611	rs786204967	NC_000023.11:18604168:AGAG:AG
NM_001323289.2(CDKL5):c.1090G>T (p.Glu364Ter)	CDKL5	E364*	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189553	X	18622134	X	18604014	189553	187610	rs786204966	NC_000023.11:18604013:G:T
NM_001323289.2(CDKL5):c.1071del (p.Asp357fs)	CDKL5	D357fs	not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189552	X	18622115	X	18603995	189552	187609	rs786204965	NC_000023.11:18603994:C:
NM_001323289.2(CDKL5):c.1008_1029del (p.Ser337fs)	CDKL5	S337fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189551	X	18622052 - 18622073	X	18603932 - 18603953	189551	187608	rs786204964	NC_000023.11:18603931:GTCTCACCACAGATCTAACAGC:
NM_003159.2(CDKL5):c.100-?_145+?del	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000189550					189550	187448		
NM_000918.4(P4HB):c.1178A>G (p.Tyr393Cys)	P4HB	Y393C	Cole-Carpenter syndrome 1	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000189337	17	79803618	17	81845742	189337	187226	rs786204843	NC_000017.11:81845741:T:C
NM_001146079.2(CLDN14):c.694G>A (p.Gly232Arg)	CLDN14	G232R	Deafness, autosomal recessive 29	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2019)	no assertion criteria provided	VCV000189333	21	37833300	21	36461002	189333	187221	rs786204841	NC_000021.9:36461001:C:T
NM_001146079.2(CLDN14):c.167G>A (p.Trp56Ter)	CLDN14	W56*	Deafness, autosomal recessive 29	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000189332	21	37833827	21	36461529	189332	187220	rs371100799	NC_000021.9:36461528:C:T
NM_001146079.2(CLDN14):c.242G>A (p.Arg81His)	CLDN14	R81H	Deafness, autosomal recessive 29	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000189331	21	37833752	21	36461454	189331	187219	rs368027306	NC_000021.9:36461453:C:T
NM_004917.4(KLK4):c.245del (p.Gly82fs)	KLK4	G82fs	Amelogenesis imperfecta, hypomaturation type, IIA1	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000189294	19	51412065	19	50908809	189294	187180	rs786204825	NC_000019.10:50908808:CCC:CC
NM_000894.2(LHB):c.183+1G>T	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000189293	19	49519803	19	49016546	189293	187179	rs786204822	NC_000019.10:49016545:C:A
NM_000894.2(LHB):c.28_39del (p.Leu10_Leu13del)	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000189292	19	49519948 - 49519959	19	49016691 - 49016702	189292	187178	rs769066903	NC_000019.10:49016690:CAGCAGCAGCAACAGCAGCAGC:CAGCAGCAGC
NM_000894.2(LHB):c.88_96del (p.His30_Ile32del)	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Nov 5, 2009)	no assertion criteria provided	VCV000189291	19	49519891 - 49519899	19	49016634 - 49016642	189291	187177	rs786204823	NC_000019.10:49016633:GATGGGGTGG:G
NM_000894.2(LHB):c.183+1G>C	LHB		Isolated lutropin deficiency	Pathogenic(Last reviewed: Aug 30, 2007)	no assertion criteria provided	VCV000189290	19	49519803	19	49016546	189290	187176	rs786204822	NC_000019.10:49016545:C:G
NM_002240.5(KCNJ6):c.460G>A (p.Gly154Ser)	KCNJ6	G154S	Keppen-Lubinsky syndrome	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000189255	21	39087000	21	37714697	189255	187137	rs786204795	NC_000021.9:37714696:C:T
NM_002240.5(KCNJ6):c.452_454CCA[1] (p.Thr152del)	KCNJ6	T152del	Keppen-Lubinsky syndrome	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000189254	21	39087003 - 39087005	21	37714700 - 37714702	189254	187136	rs786204794	NC_000021.9:37714699:TGGTGGT:TGGT
NM_003573.2(LTBP4):c.254del (p.Leu85fs)	LTBP4	L122fs, L85fs	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	VCV000189236	19	41105997	19	40600091	189236	187130	rs747013505	NC_000019.10:40600090:T:
NM_000390.4(CHM):c.116+1G>A	CHM		Retinal dystrophy|Choroideremia	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000189189	X	85282494	X	86027490	189189	187074	rs786204761	NC_000023.11:86027489:C:T
NM_000071.2(CBS):c.302T>C (p.Leu101Pro)	CBS	L101P	Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189185	21	44488633	21	43068523	189185	187062	rs786204757	NC_000021.9:43068522:A:G
NM_000152.5(GAA):c.1438-1G>C	GAA		Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189184	17	78084525	17	80110726	189184	187003	rs147804176	NC_000017.11:80110725:G:C
NM_000271.5(NPC1):c.3557G>A (p.Arg1186His)	NPC1	R1186H	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189174	18	21114444	18	23534480	189174	187022	rs200444084	NC_000018.10:23534479:C:T
NM_000152.5(GAA):c.1979G>A (p.Arg660His)	GAA	R660H	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189172	17	78086765	17	80112966	189172	187013	rs374143224	NC_000017.11:80112965:G:A
NM_000159.4(GCDH):c.262C>T (p.Arg88Cys)	GCDH	R88C	Glutaric aciduria, type 1|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189150	19	13002779	19	12891965	189150	187035	rs142967670	NC_000019.10:12891964:C:T
NM_000152.5(GAA):c.1826dup (p.Tyr609Ter)	GAA		Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189144	17	78086447 - 78086448	17	80112648 - 80112649	189144	187007	rs786204727	NC_000017.11:80112648:A:AA
NM_000152.5(GAA):c.1309C>T (p.Arg437Cys)	GAA	R437C	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189082	17	78082610	17	80108811	189082	187001	rs770610356	NC_000017.11:80108810:C:T
NM_004646.3(NPHS1):c.3442C>T (p.Gln1148Ter)	NPHS1	Q1148*	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189074	19	36321994	19	35831092	189074	187046	rs150855173	NC_000019.10:35831091:G:A
NM_000487.6(ARSA):c.304del (p.Leu102fs)	ARSA	L16fs, L102fs	Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000189073	22	51065755	22	50627327	189073	187072	rs786204673	NC_000022.11:50627326:GG:G
NM_000528.4(MAN2B1):c.1383C>G (p.Tyr461Ter)	MAN2B1	Y461*, Y460*	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189068	19	12768296	19	12657482	189068	187033	rs775200333	NC_000019.10:12657481:G:C
NM_000152.5(GAA):c.655G>A (p.Gly219Arg)	GAA	G219R	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189065	17	78079656	17	80105857	189065	186993	rs370950728	NC_000017.11:80105856:G:A
NM_000159.4(GCDH):c.383G>A (p.Arg128Gln)	GCDH	R128Q	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189063	19	13004345	19	12893531	189063	187037	rs755586631	NC_000019.10:12893530:G:A
NM_000383.4(AIRE):c.232T>C (p.Trp78Arg)	AIRE	W78R	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Jul 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189060	21	45706539	21	44286656	189060	187064	rs179363880	NC_000021.9:44286655:T:C
NM_000152.5(GAA):c.1128_1129delinsC (p.Trp376fs)	GAA		not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189041	17	78082340 - 78082341	17	80108541 - 80108542	189041	186999	rs786204646	NC_000017.11:80108540:GG:C
NM_000152.5(GAA):c.2104C>T (p.Arg702Cys)	GAA	R702C	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189040	17	78087080	17	80113281	189040	187016	rs786204645	NC_000017.11:80113280:C:T
NM_000159.4(GCDH):c.271+1G>A	GCDH		Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189030	19	13002789	19	12891975	189030	187036	rs786204639	NC_000019.10:12891974:G:A
NM_000152.5(GAA):c.1548G>A (p.Trp516Ter)	GAA	W516*	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189025	17	78084636	17	80110837	189025	187005	rs140826989	NC_000017.11:80110836:G:A
NM_000152.5(GAA):c.1933G>C (p.Asp645His)	GAA	D645H	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189013	17	78086719	17	80112920	189013	187011	rs368438393	NC_000017.11:80112919:G:C
NM_000159.4(GCDH):c.533G>A (p.Gly178Glu)	GCDH	G178E	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189012	19	13006833	19	12896019	189012	187040	rs786204627	NC_000019.10:12896018:G:A
NM_000159.4(GCDH):c.1205G>A (p.Arg402Gln)	GCDH	R402Q	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000189011	19	13008639	19	12897825	189011	187044	rs786204626	NC_000019.10:12897824:G:A
NM_000152.5(GAA):c.2608C>T (p.Arg870Ter)	GAA	R870*	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189009	17	78092118	17	80118319	189009	187018	rs780321415	NC_000017.11:80118318:C:T
NM_000152.5(GAA):c.1441T>C (p.Trp481Arg)	GAA	W481R	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189007	17	78084529	17	80110730	189007	187004	rs772883420	NC_000017.11:80110729:T:C
NM_000487.6(ARSA):c.240dup (p.Gly81fs)	ARSA		Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188976	22	51065818 - 51065819	22	50627390 - 50627391	188976	187073	rs786204599	NC_000022.11:50627390:GG:GGG
NM_000071.2(CBS):c.362G>A (p.Arg121His)	CBS	R121H, R16H	Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188948	21	44486442	21	43066332	188948	187059	rs770095972	NC_000021.9:43066331:C:T
NM_000159.4(GCDH):c.1060G>A (p.Gly354Ser)	GCDH	G354S	Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188946	19	13008220	19	12897406	188946	187042	rs768925619	NC_000019.10:12897405:G:A
NM_000152.5(GAA):c.1827del (p.Arg608_Tyr609insTer)	GAA		not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188936	17	78086449	17	80112650	188936	187008	rs781088002	NC_000017.11:80112649:C:
NM_000383.4(AIRE):c.1249dup (p.Leu417fs)	AIRE		not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188935	21	45713024 - 45713025	21	44293141 - 44293142	188935	187066	rs786204567	NC_000021.9:44293141:CCCCC:CCCCCC
NM_000071.2(CBS):c.667-14_667-7del	CBS		not provided|Homocystinuria|Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188911	21	44485389 - 44485396	21	43065279 - 43065286	188911	187058	rs764160782	NC_000021.9:43065278:AGAAAGAGAG:AG
NM_000152.5(GAA):c.2140del (p.His714fs)	GAA	H714fs	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188904	17	78087115	17	80113316	188904	187017	rs786204549	NC_000017.11:80113315:CC:C
NM_000152.5(GAA):c.1942G>A (p.Gly648Ser)	GAA	G648S	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188902	17	78086728	17	80112929	188902	187012	rs536906561	NC_000017.11:80112928:G:A
NM_000152.5(GAA):c.766_785delinsC (p.Tyr256fs)	GAA		not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188880	17	78081429 - 78081448	17	80107630 - 80107649	188880	186995	rs786204532	NC_000017.11:80107629:TATATCACAGGCCTCGCCGA:C
NM_000152.5(GAA):c.1411_1414del (p.Glu471fs)	GAA	E471fs	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188874	17	78083828 - 78083831	17	80110029 - 80110032	188874	187002	rs770276275	NC_000017.11:80110028:GAGA:
NM_000159.4(GCDH):c.769C>T (p.Arg257Trp)	GCDH	R257W	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188872	19	13007152	19	12896338	188872	187041	rs766518430	NC_000019.10:12896337:C:T
NM_000271.5(NPC1):c.2761C>T (p.Gln921Ter)	NPC1	Q921*	Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, multiple submitters, no conflicts	VCV000188849	18	21119809	18	23539845	188849	187029	rs786204512	NC_000018.10:23539844:G:A
NM_000487.6(ARSA):c.1489_1492dup (p.Arg498fs)	ARSA		not provided|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188843	22	51063610 - 51063611	22	50625182 - 50625183	188843	187069	rs774153480	NC_000022.11:50625182:GGGGGG:GGGGGGGGGG
NM_000152.5(GAA):c.1051del (p.Val351fs)	GAA	V351fs	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000188841	17	78082183	17	80108384	188841	186998	rs786204507	NC_000017.11:80108383:GG:G
NM_000071.2(CBS):c.689del (p.Leu230fs)	CBS	L230fs, L125fs	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188829	21	44485360	21	43065250	188829	187057	rs775351239	NC_000021.9:43065249:A:
NM_000071.2(CBS):c.1136G>A (p.Arg379Gln)	CBS	R379Q, R274Q	Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188825	21	44480560	21	43060450	188825	187054	rs763036586	NC_000021.9:43060449:C:T
NM_004646.3(NPHS1):c.565G>T (p.Glu189Ter)	NPHS1	E189*	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000188816	19	36341309	19	35850407	188816	187050	rs139598219	NC_000019.10:35850406:C:A
NM_000152.5(GAA):c.569G>A (p.Arg190His)	GAA	R190H	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188809	17	78079570	17	80105771	188809	186992	rs528367092	NC_000017.11:80105770:G:A
NM_000152.5(GAA):c.784G>A (p.Glu262Lys)	GAA	E262K	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188806	17	78081447	17	80107648	188806	186996	rs201896815	NC_000017.11:80107647:G:A
NM_000071.2(CBS):c.1039G>A (p.Gly347Ser)	CBS	G347S, G242S	not provided|Homocystinuria|Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188801	21	44482421	21	43062311	188801	187055	rs771298943	NC_000021.9:43062310:C:T
NM_000383.4(AIRE):c.463+2T>C	AIRE		not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000188800	21	45707018	21	44287135	188800	187065	rs786204478	NC_000021.9:44287134:T:C
NM_000152.5(GAA):c.925G>A (p.Gly309Arg)	GAA	G309R	not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188797	17	78081665	17	80107866	188797	186997	rs543300039	NC_000017.11:80107865:G:A
NM_000271.5(NPC1):c.1211G>A (p.Arg404Gln)	NPC1	R404Q	Niemann-Pick disease, type C|Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188794	18	21136322	18	23556358	188794	187031	rs139751448	NC_000018.10:23556357:C:T
NM_000159.4(GCDH):c.482G>A (p.Arg161Gln)	GCDH	R161Q	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188789	19	13004444	19	12893630	188789	187039	rs777201305	NC_000019.10:12893629:G:A
NM_000152.5(GAA):c.1843G>A (p.Gly615Arg)	GAA	G615R	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188786	17	78086465	17	80112666	188786	187009	rs549029029	NC_000017.11:80112665:G:A
NM_000152.5(GAA):c.1A>G (p.Met1Val)	GAA	M1V	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188785	17	78078386	17	80104587	188785	186987	rs786204467	NC_000017.11:80104586:A:G
NM_000071.2(CBS):c.1566del (p.Lys523fs)	CBS	K523fs, K418fs	Classic homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188784	21	44474080	21	43053970	188784	187051	rs786204466	NC_000021.9:43053969:CCC:CC
NM_000152.5(GAA):c.2014C>T (p.Arg672Trp)	GAA	R672W	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188773	17	78086800	17	80113001	188773	187014	rs757111744	NC_000017.11:80113000:C:T
NM_004646.3(NPHS1):c.2928G>T (p.Arg976Ser)	NPHS1	R976S	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188761	19	36330320	19	35839418	188761	187048	rs138656762	NC_000019.10:35839417:C:A
NM_000271.5(NPC1):c.3614C>A (p.Thr1205Lys)	NPC1	T1205K	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188747	18	21113459	18	23533495	188747	187020	rs758902805	NC_000018.10:23533494:G:T
NM_000023.4(SGCA):c.371T>C (p.Ile124Thr)	SGCA	I124T	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188733	17	48245366	17	50168005	188733	186982	rs768814872	NC_000017.11:50168004:T:C
NM_000152.5(GAA):c.1933G>A (p.Asp645Asn)	GAA	D645N	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188728	17	78086719	17	80112920	188728	187010	rs368438393	NC_000017.11:80112919:G:A
NM_000271.5(NPC1):c.2819C>T (p.Ser940Leu)	NPC1	S940L	not provided|Niemann-Pick disease, type C|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000188716	18	21119411	18	23539447	188716	187026	rs143124972	NC_000018.10:23539446:G:A
NM_000152.5(GAA):c.2237G>C (p.Trp746Ser)	GAA	W746S	Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188484	17	78090814	17	80117015	188484	186561	rs752921215	NC_000017.11:80117014:G:C
NM_001943.5(DSG2):c.523+1G>C	DSG2		Arrhythmogenic right ventricular cardiomyopathy, type 10|Dilated cardiomyopathy 1BB	Pathogenic(Last reviewed: Sep 17, 2014)	no assertion criteria provided	VCV000188450	18	29101207	18	31521244	188450	186568	rs553299589	NC_000018.10:31521243:G:C
NM_000455.4(STK11):c.580G>A (p.Asp194Asn)	STK11	D194N	Lung adenocarcinoma|Neoplasm|not provided|Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188348	19	1220487	19	1220488	188348	186283	rs121913315	NC_000019.10:1220487:G:A
NM_005359.5(SMAD4):c.1353_1354insGCTACTGCACAAGCTGCAGCAGCTGCCC (p.Gln461Argfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 25, 2014)	criteria provided, single submitter	VCV000188177	18	48603052 - 48603053	18	51076682 - 51076683	188177	186281	rs786204125	NC_000018.10:51076682:GCTACTGCACAAGCTGCAGCAGCTGCCC:GCTACTGCACAAGCTGCAGCAGCTGCCCGCTACTGCACAAGCTGCAGCAGCTGCCC
NM_000166.6(GJB1):c.116C>T (p.Ala39Val)	GJB1	A39V	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Oct 7, 2014)	criteria provided, single submitter	VCV000188136	X	70443673	X	71223823	188136	186290	rs786204095	NC_000023.11:71223822:C:T
NM_021175.4(HAMP):c.216C>A (p.Cys72Ter)	HAMP	C72*	Hemochromatosis type 1	Pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	VCV000188077	19	35775906	19	35285003	188077	186284	rs763369315	NC_000019.10:35285002:C:A
NM_000152.5(GAA):c.1437G>A (p.Lys479=)	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Dec 21, 2014)	no assertion criteria provided	VCV000188044	17	78083854	17	80110055	188044	185936	rs796051877	NC_000017.11:80110054:G:A
NM_001031.5(RPS28):c.1A>G (p.Met1Val)	RPS28	M1V	Diamond-Blackfan anemia 15 with mandibulofacial dysostosis	Pathogenic(Last reviewed: May 19, 2015)	criteria provided, single submitter	VCV000187848	19	8386415	19	8321531	187848	185739	rs786203997	NC_000019.10:8321530:A:G
NM_001127221.1(CACNA1A):c.2868del (p.Arg957fs)	CACNA1A	R960fs, R956fs, R957fs	Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000187828	19	13409582	19	13298768	187828	185732	rs786200962	NC_000019.10:13298767:A:
NM_005215.3(DCC):c.698-?_985+?del (p.Asp233_Leu328del)	DCC		Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187801					187801	185701		
NM_005215.4(DCC):c.3834_3835TC[1] (p.Leu1279fs)	DCC		Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187800	18	51013263 - 51013264	18	53486893 - 53486894	187800	185700	rs797044556	NC_000018.10:53486892:CTCTC:CTC
NM_005215.4(DCC):c.2868_2872GGAAG[3] (p.Pro960fs)	DCC		Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187799	18	50929193 - 50929194	18	53402823 - 53402824	187799	185699	rs797044555	NC_000018.10:53402823:AGGGAAGGGAAG:AGGGAAGGGAAGGGAAG
NM_005215.4(DCC):c.1336_1337insAGCC (p.Arg446fs)	DCC		Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187798	18	50683798 - 50683799	18	53157428 - 53157429	187798	185694	rs797044554	NC_000018.10:53157428:CC:CCAGCC
NM_005215.4(DCC):c.1140+1G>A	DCC		Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187797	18	50589830	18	53063460	187797	185693	rs797044553	NC_000018.10:53063459:G:A
NM_005215.4(DCC):c.823C>T (p.Arg275Ter)	DCC	R275*	|Mirror movements 1	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000187796	18	50450202	18	52923832	187796	185692	rs754914260	NC_000018.10:52923831:C:T
NM_005215.4(DCC):c.571dup (p.Val191fs)	DCC		Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187795	18	50432570 - 50432571	18	52906200 - 52906201	187795	185691	rs797044552	NC_000018.10:52906200:GG:GGG
NM_005215.4(DCC):c.377C>A (p.Ser126Ter)	DCC	S126*	Mirror movements 1	Pathogenic(Last reviewed: Jan 6, 2015)	no assertion criteria provided	VCV000187794	18	50278709	18	52752339	187794	185689	rs797044551	NC_000018.10:52752338:C:A
NM_007254.4(PNKP):c.1549_1550insTGTACTGC (p.Gln517fs)	PNKP		Ataxia-oculomotor apraxia 4	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000187768	19	50364521 - 50364522	19	49861264 - 49861265	187768	185666	rs1555810613	NC_000019.10:49861264:G:GCAGTACAG
NM_007254.4(PNKP):c.1322_1323insAGCCG (p.Gly442fs)	PNKP		Ataxia-oculomotor apraxia 4	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000187767	19	50364928 - 50364929	19	49861671 - 49861672	187767	185665	rs886037744	NC_000019.10:49861671::CGGCT
NM_000455.4(STK11):c.899del (p.Ile300fs)	STK11	I300fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	VCV000187299	19	1221984	19	1221985	187299	185519	rs786203624	NC_000019.10:1221984:T:
NM_005359.5(SMAD4):c.153dupA (p.Asp52Argfs)	SMAD4		not provided|Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000187217	18	48573563 - 48573564	18	51047193 - 51047194	187217	185431	rs786203560	NC_000018.10:51047193:AAAAAA:AAAAAAA
NM_005359.5(SMAD4):c.898_904+1dupCATTACTG	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 3, 2014)	criteria provided, single submitter	VCV000185371	18	48584819 - 48584820	18	51058449 - 51058450	185371	185445	rs1555685974	NC_000018.10:51058449:CATTACTG:CATTACTGCATTACTG
NM_005359.5(SMAD4):c.1242dupA (p.Asp415Argfs)	SMAD4		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	VCV000183978	18	48593490 - 48593491	18	51067120 - 51067121	183978	185449	rs786201200	NC_000018.10:51067120:A:AA
NM_000455.4(STK11):c.910C>T (p.Arg304Trp)	STK11	R304W	Inborn genetic diseases|Peutz-Jeghers syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183802	19	1221995	19	1221996	183802	185520	rs786201090	NC_000019.10:1221995:C:T
NM_001429.4(EP300):c.4933C>T (p.Arg1645Ter)	EP300	R1645*, R1619*	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Mar 9, 2015)	criteria provided, single submitter	VCV000183678	22	41572404	22	41176400	183678	181577	rs139310551	NC_000022.11:41176399:C:T
NM_003091.4(SNRPB):c.-72C>A	SNRPB		Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000183435	20	2451408	20	2470762	183435	181541	rs786201022	NC_000020.11:2470761:G:T
NM_003091.4(SNRPB):c.155+406C>A	SNRPB		Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183434	20	2447847	20	2467201	183434	181540	rs786201021	NC_000020.11:2467200:G:T
NM_003091.4(SNRPB):c.155+302G>T	SNRPB	G56W	Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Jul 22, 2014)	no assertion criteria provided	VCV000183433	20	2447951	20	2467305	183433	181539	rs786201020	NC_000020.11:2467304:C:A
NM_003091.4(SNRPB):c.155+302G>C	SNRPB	G56R	Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183432	20	2447951	20	2467305	183432	181538	rs786201020	NC_000020.11:2467304:C:G
NM_003091.4(SNRPB):c.155+301G>C	SNRPB	R55S	Cerebro-costo-mandibular syndrome	Pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183431	20	2447952	20	2467306	183431	181537	rs786201019	NC_000020.11:2467305:C:G
NM_001015509.2(PTRH2):c.272_273del (p.Ala91fs)	PTRH2	A90fs, A91fs	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183428	17	57775070 - 57775071	17	59697709 - 59697710	183428	181534	rs786201017	NC_000017.11:59697708:AG:
NM_017831.4(RNF125):c.520C>T (p.Arg174Cys)	RNF125	R174C	Tenorio syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183422	18	29645880	18	32065917	183422	181525	rs370242930	NC_000018.10:32065916:C:T
NM_017831.4(RNF125):c.336G>A (p.Met112Ile)	RNF125	M112I	Tenorio syndrome	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183420	18	29622159	18	32042196	183420	181523	rs786201014	NC_000018.10:32042195:G:A
NC_000023.9:g.146703942_146820448del	FMR1		Fragile X syndrome	Pathogenic(Last reviewed: Jun 5, 2014)	no assertion criteria provided	VCV000183388					183388	181492		
NM_020812.4(DOCK6):c.1362_1365del (p.Thr455fs)	DOCK6	T455fs	Adams-Oliver syndrome|Adams-Oliver syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183335	19	11353955 - 11353958	19	11243279 - 11243282	183335	181457	rs730882238	NC_000019.10:11243278:AGTTAG:AG
NM_001015509.2(PTRH2):c.257A>C (p.Gln86Pro)	PTRH2	Q85P, Q86P	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset|Global developmental delay|Cerebellar ataxia|Hearing impairment	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000183332	17	57775086	17	59697725	183332	181454	rs730882234	NC_000017.11:59697724:T:G
NM_006420.3(ARFGEF2):c.656dup (p.Val220fs)	ARFGEF2		not provided|Global developmental delay|Hydrocephalus|Seizures	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000183282	20	47570141 - 47570142	20	48953604 - 48953605	183282	181464	rs730882200	NC_000020.11:48953604:CCCC:CCCCC
NM_000328.3(RPGR):c.1905+521_1905+522del	RPGR		Retinal dystrophy|Retinitis pigmentosa	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000183262	X	38145825 - 38145826	X	38286572 - 38286573	183262	181395	rs730882261	NC_000023.11:38286571:CTCT:CT
NM_000527.5(LDLR):c.502G>A (p.Asp168Asn)	LDLR	D168N, D127N	Familial hypercholesterolemia 1|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183136	19	11216084	19	11105408	183136	181228	rs200727689	NC_000019.10:11105407:G:A
NM_000527.5(LDLR):c.1246C>T (p.Arg416Trp)	LDLR	R416W, R289W, R375W, R248W	Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183110	19	11224013	19	11113337	183110	181252	rs570942190	NC_000019.10:11113336:C:T
NM_000527.5(LDLR):c.662A>G (p.Asp221Gly)	LDLR	D221G, D180G	Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183092	19	11216244	19	11105568	183092	181233	rs373822756	NC_000019.10:11105567:A:G
NM_001242897.2(DEPDC5):c.4267C>T (p.Gln1423Ter)	DEPDC5	Q1423*, Q1523*, Q1492*, Q1495*, Q1445*, Q1501*, Q1514*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000183030	22	32302238	22	31906252	183030	181178	rs797044546	NC_000022.11:31906251:C:T
NM_001242897.2(DEPDC5):c.2121-2A>G	DEPDC5		Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000183029	22	32234669	22	31838683	183029	181177	rs797044545	NC_000022.11:31838682:A:G
NM_000455.4(STK11):c.398_399TG[2] (p.Cys134fs)	STK11		Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000182913	19	1219345 - 1219346	19	1219346 - 1219347	182913	181052	rs587782424	NC_000019.10:1219345:GTGTGTG:GTGTG
NM_000455.4(STK11):c.891G>T (p.Arg297Ser)	STK11	R297S	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000182912	19	1221976	19	1221977	182912	181075	rs730881984	NC_000019.10:1221976:G:T
NM_000455.4(STK11):c.526G>A (p.Asp176Asn)	STK11	D176N	Peutz-Jeghers syndrome|not provided	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182907	19	1220433	19	1220434	182907	181057	rs730881979	NC_000019.10:1220433:G:A
NM_000455.4(STK11):c.409C>T (p.Gln137Ter)	STK11	Q137*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000182896	19	1219357	19	1219358	182896	181053	rs730881970	NC_000019.10:1219357:C:T
NM_000455.4(STK11):c.396C>A (p.Cys132Ter)	STK11	C132*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 8, 2015)	criteria provided, single submitter	VCV000182895	19	1219344	19	1219345	182895	181050	rs730881969	NC_000019.10:1219344:C:A
NM_000455.4(STK11):c.218_230del (p.Cys73fs)	STK11	C73fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	VCV000182876	19	1207128 - 1207140	19	1207129 - 1207141	182876	181045	rs730881959	NC_000019.10:1207128:GTGCAGGAGGGCCGT:GT
NM_000455.4(STK11):c.134_145del (p.Leu45_Tyr49delinsHis)	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	VCV000182875	19	1207046 - 1207057	19	1207047 - 1207058	182875	181043	rs730881958	NC_000019.10:1207046:TCATCGGCAAGT:
NM_005359.5(SMAD4):c.1338_1339delGA (p.Gln446Hisfs)	SMAD4	Q446fs	not provided	Pathogenic(Last reviewed: Oct 2, 2014)	criteria provided, single submitter	VCV000182874	18	48603036 - 48603037	18	51076666 - 51076667	182874	181041	rs730881957	NC_000018.10:51076665:AGA:A
NM_005359.5(SMAD4):c.1259_1260insCG (p.Ala421Valfs)	SMAD4		Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182873	18	48593505 - 48593506	18	51067135 - 51067136	182873	181040	rs730881956	NC_000018.10:51067135:GCG:GCGCG
NM_005359.5(SMAD4):c.1239C>A (p.Tyr413Ter)	SMAD4	Y413*	not provided	Pathogenic(Last reviewed: Sep 17, 2014)	criteria provided, single submitter	VCV000182871	18	48593488	18	51067118	182871	181039	rs730881954	NC_000018.10:51067117:C:A
NM_005359.5(SMAD4):c.1231_1232delAG (p.Ser411Leufs)	SMAD4		not provided|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000182867	18	48593478 - 48593479	18	51067108 - 51067109	182867	181038	rs730881952	NC_000018.10:51067107:AGAG:AG
NM_000271.5(NPC1):c.2861C>T (p.Ser954Leu)	NPC1	S954L	not provided|Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181457	18	21119369	18	23539405	181457	179794	rs543206298	NC_000018.10:23539404:G:A
NM_000271.5(NPC1):c.1628C>T (p.Pro543Leu)	NPC1	P543L	Niemann-Pick disease, type C|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000181455	18	21131617	18	23551653	181455	179798	rs369368181	NC_000018.10:23551652:G:A
NM_030662.3(MAP2K2):c.169T>C (p.Phe57Leu)	MAP2K2	F57L	not provided	Pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000180911	19	4117551	19	4117553	180911	179828	rs121434498	NC_000019.10:4117552:A:G
NM_013995.2(LAMP2):c.974del (p.Leu325fs)	LAMP2	L325RfsX21, L325fs	not provided	Pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000180893	X	119575704	X	120441849	180893	179887	rs730880498	NC_000023.11:120441848:A:
NM_013995.2(LAMP2):c.65-1G>C	LAMP2		not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000180891	X	119590625	X	120456770	180891	179907	rs730880496	NC_000023.11:120456769:C:G
NM_013995.2(LAMP2):c.651dup (p.Pro218fs)	LAMP2		not provided	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000180888	X	119581785 - 119581786	X	120447930 - 120447931	180888	179897	rs730880493	NC_000023.11:120447930:TTTTT:TTTTTT
NM_013995.2(LAMP2):c.584_588dup (p.Val197fs)	LAMP2		Cardiomyopathy|Danon disease	Pathogenic(Last reviewed: May 8, 2014)	criteria provided, single submitter	VCV000180887	X	119581848 - 119581849	X	120447993 - 120447994	180887	179899	rs730880492	NC_000023.11:120447993:TGTTG:TGTTGTGTTG
NM_013995.2(LAMP2):c.64+2T>A	LAMP2		not provided	Pathogenic(Last reviewed: Aug 31, 2012)	criteria provided, single submitter	VCV000180884	X	119602959	X	120469104	180884	179909	rs730880490	NC_000023.11:120469103:A:T
NM_013995.2(LAMP2):c.864+2T>C	LAMP2		not provided	Pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000180877	X	119580158	X	120446303	180877	179889	rs730880485	NC_000023.11:120446302:A:G
NM_013995.2(LAMP2):c.864+1G>A	LAMP2		not provided	Pathogenic(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	VCV000180876	X	119580159	X	120446304	180876	179890	rs727503119	NC_000023.11:120446303:C:T
NM_013995.2(LAMP2):c.795C>A (p.Cys265Ter)	LAMP2	C265*	Danon disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000180874	X	119580229	X	120446374	180874	179893	rs730880483	NC_000023.11:120446373:G:T
NM_004793.4(LONP1):c.2171C>T (p.Ala724Val)	LONP1	A724V, A660V, A528V	CODAS syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180660	19	5694547	19	5694536	180660	178826	rs879255249	NC_000019.10:5694535:G:A
NM_004793.4(LONP1):c.1892C>A (p.Ser631Tyr)	LONP1	S631Y, S435Y, S567Y	CODAS syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180659	19	5696264	19	5696253	180659	178825	rs879255248	NC_000019.10:5696252:G:T
NM_004793.4(LONP1):c.2026C>T (p.Pro676Ser)	LONP1	P676S, P612S, P480S	CODAS syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180658	19	5694900	19	5694889	180658	178824	rs879255247	NC_000019.10:5694888:G:A
NM_004793.4(LONP1):c.2353A>G (p.Arg785Gly)	LONP1	R721G, R785G, R589G	CODAS syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000180657	19	5693748	19	5693737	180657	178823	rs730880293	NC_000019.10:5693736:T:C
LIPE, 2-BP INS, CG	LIPE		Familial partial lipodystrophy 6	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000180647					180647	178808		
NM_001242897.2(DEPDC5):c.2293C>T (p.Arg765Ter)	DEPDC5	R843*, R765*, R834*, R815*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000180644	22	32239092	22	31843106	180644	178806	rs541024038	NC_000022.11:31843105:C:T
NM_032620.4(GTPBP3):c.32_33delinsGTG (p.Gln11fs)	GTPBP3		Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180619	19	17448452 - 17448453	19	17337643 - 17337644	180619	178785	rs886037736	NC_000019.10:17337642:AA:GTG
NM_032620.4(GTPBP3):c.1009G>C (p.Asp337His)	GTPBP3	D337H, D359H, D369H	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180618	19	17451887	19	17341078	180618	178784	rs886037735	NC_000019.10:17341077:G:C
NM_032620.4(GTPBP3):c.964G>C (p.Ala322Pro)	GTPBP3	A322P, A344P, A354P	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180617	19	17450398	19	17339589	180617	178783	rs372174278	NC_000019.10:17339588:G:C
NM_032620.4(GTPBP3):c.476A>T (p.Glu159Val)	GTPBP3	E159V, E181V	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180616	19	17449435	19	17338626	180616	178782	rs730880255	NC_000019.10:17338625:A:T
NM_032620.4(GTPBP3):c.1375G>A (p.Glu459Lys)	GTPBP3	E459K, E481K, E438K, E491K	Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180615	19	17452408	19	17341599	180615	178781	rs886037734	NC_000019.10:17341598:G:A
NM_032620.4(GTPBP3):c.1291dup (p.Arg431fs)	GTPBP3		Combined oxidative phosphorylation deficiency 23	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000180614	19	17452321 - 17452322	19	17341512 - 17341513	180614	178780	rs869320746	NC_000019.10:17341512:CCC:CCCC
NM_004646.3(NPHS1):c.1756A>G (p.Arg586Gly)	NPHS1	R586G	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: May 16, 2014)	no assertion criteria provided	VCV000180463	19	36336572	19	35845670	180463	178743	rs730880174	NC_000019.10:35845669:T:C
NM_000527.5(LDLR):c.1468T>C (p.Trp490Arg)	LDLR	W490R, W363R, W449R, W322R	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180402	19	11224320	19	11113644	180402	178734	rs730880130	NC_000019.10:11113643:T:C
NM_001123383.1(BCOR):c.4202_4206del (p.Pro1401fs)	BCOR	P1435fs, P1383fs, P1401fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000180245	X	39921512 - 39921516	X	40062259 - 40062263	180245	178424	rs730880034	NC_000023.11:40062258:GCATGGCA:GCA
NM_001123383.1(BCOR):c.4640-141_4875-665del	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000180244	X	39912318 - 39913727	X	40053065 - 40054474	180244	178423		
NC_000023.11:g.(?_40051246)_(40075180_?)del	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000180243			X	40051246 - 40075180	180243	178422		
NM_003688.3(CASK):c.1976G>A (p.Gly659Asp)	CASK	G659D, G630D, G636D	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jan 21, 2014)	no assertion criteria provided	VCV000180215	X	41413035	X	41553782	180215	178395	rs727505397	NC_000023.11:41553781:C:T
NM_001083962.2(TCF4):c.1438C>T (p.Gln480Ter)	TCF4	Q480*, Q409*, Q457*, Q479*, Q264*, Q455*, Q477*, Q319*, Q350*, Q456*, Q582*, Q320*, Q438*, Q486*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000180214	18	52901827	18	55234596	180214	178394	rs727505396	NC_000018.10:55234595:G:A
NM_001080467.3(MYO5B):c.2003+2T>A	MYO5B		Congenital microvillous atrophy	Pathogenic(Last reviewed: Sep 18, 2014)	no assertion criteria provided	VCV000180212	18	47462620	18	49936250	180212	178393	rs727505394	NC_000018.10:49936249:A:T
NM_001281463.1(SMC1A):c.55C>T (p.Leu19Phe)	SMC1A	L41F, L19F	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180200	X	53442107	X	53415158	180200	178386	rs727503776	NC_000023.11:53415157:G:A
NM_001281463.1(SMC1A):c.2908-2A>G	SMC1A		Congenital muscular hypertrophy-cerebral syndrome|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180198	X	53410176	X	53383255	180198	178384	rs727503774	NC_000023.11:53383254:T:C
NM_001281463.1(SMC1A):c.730_732AAG[2] (p.Lys246del)	SMC1A	K268del, K246del	Congenital muscular hypertrophy-cerebral syndrome|Hirsutism|Progressive sensorineural hearing impairment|Abnormality of the heart valves|Hypertonia|Global developmental delay|Microcephaly	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000180197	X	53439900 - 53439902	X	53412950 - 53412952	180197	178385	rs727503773	NC_000023.11:53412949:CTTCTTCTTCT:CTTCTTCT
NM_000152.5(GAA):c.896T>C (p.Leu299Pro)	GAA	L299P	Glycogen storage disease, type II	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000180144	17	78081636	17	80107837	180144	178325	rs121907940	NC_000017.11:80107836:T:C
NM_000152.5(GAA):c.2078dup (p.Ala694fs)	GAA		not provided|Glycogen storage disease, type II	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000180143	17	78087053 - 78087054	17	80113254 - 80113255	180143	178324	rs730880372	NC_000017.11:80113254:A:AA
NM_000152.5(GAA):c.1004G>A (p.Gly335Glu)	GAA	G335E	Glycogen storage disease, type II	Pathogenic	no assertion criteria provided	VCV000180142	17	78082137	17	80108338	180142	178323	rs730880022	NC_000017.11:80108337:G:A
NM_001399.4(EDA):c.(?_-115)_(174_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000180114	X	68836038 - 68836326	X	69616194 - 69616482	180114	176432		
NM_144612.6(LOXHD1):c.3169C>T (p.Arg1057Ter)	LOXHD1	R1057*	Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179755	18	44139458	18	46559495	179755	176706	rs727505104	NC_000018.10:46559494:G:A
NM_001399.5(EDA):c.132_135dup (p.Phe46fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	VCV000179733	X	68836282 - 68836283	X	69616438 - 69616439	179733	176445	rs727505089	NC_000023.11:69616438:TGGGT:TGGGTGGGT
NM_001399.5(EDA):c.502+1G>A	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 28, 2014)	criteria provided, single submitter	VCV000179641	X	69176983	X	69957133	179641	176325	rs727505013	NC_000023.11:69957132:G:A
NM_001399.5(EDA):c.396+2T>G	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	VCV000179360	X	68836550	X	69616706	179360	176324	rs727504814	NC_000023.11:69616705:T:G
NM_001399.4(EDA):c.(?_925)_(1176_?)del (p.(?))	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 5, 2013)	criteria provided, single submitter	VCV000179326	X	69255208 - 69255459	X	70035358 - 70035609	179326	176435		
NM_001399.4(EDA):c.(?_397)_(502_?)del (p.(?))	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 5, 2013)	criteria provided, single submitter	VCV000179325	X	69176877 - 69176982	X	69957027 - 69957132	179325	176311		
NM_133261.3(GIPC3):c.279_295del (p.Gln95fs)	GIPC3	Q95fs	Rare genetic deafness	Pathogenic(Last reviewed: Oct 29, 2013)	criteria provided, single submitter	VCV000179296	19	3586546 - 3586562	19	3586546 - 3586562	179296	176587	rs727504771	NC_000019.10:3586545:GGGGGTCAGATAGGCCTGG:GG
NM_002294.3(LAMP2):c.1093+1G>A	LAMP2		Danon disease|not provided	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, multiple submitters, no conflicts	VCV000179254	X	119575584	X	120441729	179254	176316	rs727504742	NC_000023.11:120441728:C:T
NM_000117.2(EMD):c.650_654dupTGGGC	EMD		Neuromuscular disease	Pathogenic(Last reviewed: Jul 19, 2013)	criteria provided, single submitter	VCV000179133	X	153609432 - 153609433	X	154381072 - 154381073	179133	178263	rs730880352	NC_000023.11:154381072:GGGCTGGGCTGGGC:GGGCTGGGCTGGGCTGGGC
NM_001399.5(EDA):c.474A>C (p.Lys158Asn)	EDA	K158N	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jul 11, 2013)	criteria provided, single submitter	VCV000179127	X	69176954	X	69957104	179127	176447	rs727504649	NC_000023.11:69957103:A:C
NM_013995.2(LAMP2):c.851_852del (p.Phe284fs)	LAMP2	F284fs	Danon disease	Pathogenic(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	VCV000179126	X	119580172 - 119580173	X	120446317 - 120446318	179126	176319	rs727504648	NC_000023.11:120446316:AAA:A
NM_013995.2(LAMP2):c.121del (p.Cys41fs)	LAMP2	C41fs	Danon disease	Pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	VCV000179062	X	119590568	X	120456713	179062	176443	rs727504600	NC_000023.11:120456712:AA:A
NM_013995.2(LAMP2):c.1020del (p.Gly341fs)	LAMP2	G341fs	Primary dilated cardiomyopathy|Danon disease	Pathogenic(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	VCV000178999	X	119575658	X	120441803	178999	176439	rs727504597	NC_000023.11:120441802:A:
NM_001399.5(EDA):c.396+1G>A	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Apr 11, 2013)	criteria provided, single submitter	VCV000178916	X	68836549	X	69616705	178916	176446	rs727504537	NC_000023.11:69616704:G:A
NM_144612.6(LOXHD1):c.4480C>T	LOXHD1	R1494*, R383*, R287*	Rare genetic deafness|Deafness, autosomal recessive 77|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000178396	18	44109190	18	46529227	178396	176561	rs201587138	NC_000018.10:46529226:G:A
NM_001399.5(EDA):c.766C>T (p.Gln256Ter)	EDA	Q256*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177947	X	69250343	X	70030493	177947	176327	rs727504417	NC_000023.11:70030492:C:T
NM_000116.5(TAZ):c.708_709TG[1] (p.Val237fs)	TAZ		3-Methylglutaconic aciduria type 2|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Jun 21, 2011)	criteria provided, single submitter	VCV000177908	X	153649005 - 153649006	X	154420666 - 154420667	177908	178197	rs727504394	NC_000023.11:154420665:TGTG:TG
NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys)	MAP2K2	Y134C	not provided|Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000177868	19	4110556	19	4110558	177868	176031	rs727504370	NC_000019.10:4110557:T:C
NM_024022.3(TMPRSS3):c.1192C>T (p.Gln398Ter)	TMPRSS3	Q398*, Q397*, Q271*	Rare genetic deafness	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	VCV000177740	21	43796652	21	42376543	177740	176240	rs727504304	NC_000021.9:42376542:G:A
NM_020436.5(SALL4):c.496dup (p.Gln166fs)	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000177616	20	50408525 - 50408526	20	51791986 - 51791987	177616	178178	rs797044509	NC_000020.11:51791986:GGGGGG:GGGGGGG
NM_003283.6(TNNT1):c.323C>G (p.Ser108Ter)	TNNT1	S108*, S97*	not provided	Pathogenic(Last reviewed: Dec 19, 2013)	criteria provided, single submitter	VCV000167737	19	55652315	19	55140947	167737	178101	rs727504177	NC_000019.10:55140946:G:C
NM_001083962.2(TCF4):c.655+1G>T	TCF4		Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167729	18	52946781	18	55279550	167729	178096	rs587784465	NC_000018.10:55279549:C:A
NM_001083962.2(TCF4):c.748C>T (p.Gln250Ter)	TCF4	Q250*, Q226*, Q34*, Q120*, Q208*, Q249*, Q256*, Q179*, Q352*, Q90*, Q225*, Q248*	not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000167728	18	52942891	18	55275660	167728	177295	rs727504175	NC_000018.10:55275659:G:A
NM_001083962.2(TCF4):c.1357dup (p.Thr453fs)	TCF4		not provided	Pathogenic(Last reviewed: Feb 16, 2014)	no assertion criteria provided	VCV000167727	18	52901907 - 52901908	18	55234676 - 55234677	167727	178095	rs786200992	NC_000018.10:55234676:T:TT
NM_001083962.2(TCF4):c.1414del (p.Val472fs)	TCF4	V342fs, V430fs, V256fs, V311fs, V447fs, V469fs, V472fs, V574fs, V312fs, V471fs, V478fs, V401fs, V448fs, V449fs	not provided	Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	VCV000167726	18	52901851	18	55234620	167726	178094	rs727504174	NC_000018.10:55234619:CC:C
NM_000455.4(STK11):c.988dup (p.Asp330fs)	STK11		not provided	Pathogenic(Last reviewed: Feb 16, 2014)	criteria provided, single submitter	VCV000167723	19	1223049 - 1223050	19	1223050 - 1223051	167723	178091	rs786200991	NC_000019.10:1223050:GG:GGG
NM_000455.4(STK11):c.921-2A>T	STK11		not provided	Pathogenic(Last reviewed: Apr 28, 2014)	criteria provided, single submitter	VCV000167722	19	1222982	19	1222983	167722	178090	rs727504172	NC_000019.10:1222982:A:T
NM_001042537.1(SLC9A6):c.604-1G>A	SLC9A6		not provided	Pathogenic(Last reviewed: Mar 7, 2014)	criteria provided, single submitter	VCV000167702	X	135080640	X	135998481	167702	178080	rs797044508	NC_000023.11:135998480:G:A
NM_005359.5(SMAD4):c.326delTinsAAATATGAAC (p.Leu109_Cys443delinsGlnIleTer)	SMAD4		not provided	Pathogenic(Last reviewed: Apr 3, 2014)	criteria provided, single submitter	VCV000167685	18	48575132	18	51048762	167685	178070	rs727504151	NC_000018.10:51048761:T:AAATATGAAC
NM_000023.4(SGCA):c.739G>A (p.Val247Met)	SGCA	V247M	Autosomal recessive limb-girdle muscular dystrophy type 2D|Sarcoglycanopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167677	17	48246607	17	50169246	167677	177421	rs143570936	NC_000017.11:50169245:G:A
NM_006915.3(RP2):c.352del (p.Arg118fs)	RP2	R118fs	not provided	Pathogenic(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	VCV000167608	X	46713160	X	46853725	167608	178022	rs797044507	NC_000023.11:46853724:C:
NM_015629.4(PRPF31):c.1273C>T (p.Gln425Ter)	PRPF31	Q425*	not provided	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000167538	19	54632558	19	54129183	167538	177036	rs727504107	NC_000019.10:54129182:C:T
NM_198270.4(NHS):c.2570del (p.Gly857fs)	NHS	G878fs, G701fs, G857fs, G680fs	not provided	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000167357	X	17744858	X	17726738	167357	177872	rs727504044	NC_000023.11:17726737:GG:G
NM_198270.4(NHS):c.565+1G>T	NHS		not provided	Pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	VCV000167352	X	17394446	X	17376323	167352	177867	rs727504040	NC_000023.11:17376322:G:T
NM_000252.2(MTM1):c.1644+3_1644+6del	MTM1		not provided	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, single submitter	VCV000167309	X	149832081 - 149832084	X	150663608 - 150663611	167309	177844	rs797044504	NC_000023.11:150663607:AAGTAAGT:AAGT
NM_000252.2(MTM1):c.1415_1416del (p.Ser472fs)	MTM1	S472fs	not provided	Pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	VCV000167308	X	149828905 - 149828906	X	150660432 - 150660433	167308	177843	rs797044503	NC_000023.11:150660431:GT:
NM_033290.4(MID1):c.1302_1305dup (p.Ser436Ter)	MID1		not provided	Pathogenic(Last reviewed: Jan 2, 2014)	criteria provided, single submitter	VCV000167301	X	10427827 - 10427828	X	10459787 - 10459788	167301	177839	rs786200982	NC_000023.11:10459787:ATCA:ATCAATCA
NM_001008537.3(NEXMIF):c.1582del (p.Arg528fs)	NEXMIF	R528fs	Mental retardation, X-linked 98|not provided	Pathogenic(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	VCV000167215	X	73962810	X	74742975	167215	177793	rs727503977	NC_000023.11:74742974:T:
NM_172107.3(KCNQ2):c.821C>T (p.Thr274Met)	KCNQ2	T274M	Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167208	20	62071057	20	63439704	167208	177432	rs727503974	NC_000020.11:63439703:G:A
NM_000194.3(HPRT1):c.532+2T>G	HPRT1		not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000167182	X	133632468	X	134498438	167182	177771	rs727503964	NC_000023.11:134498437:T:G
NM_000194.3(HPRT1):c.212dup (p.Tyr72fs)	HPRT1		not provided	Pathogenic(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	VCV000167181	X	133609282 - 133609283	X	134475252 - 134475253	167181	177770	rs786200980	NC_000023.11:134475252:GGGGGG:GGGGGGG
NM_000159.4(GCDH):c.1240G>A (p.Glu414Lys)	GCDH	E414K	Glutaric aciduria, type 1|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167133	19	13008674	19	12897860	167133	177296	rs147611168	NC_000019.10:12897859:G:A
NM_000152.5(GAA):c.1841C>A (p.Thr614Lys)	GAA	T614K	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167113	17	78086463	17	80112664	167113	177162	rs369531647	NC_000017.11:80112663:C:A
NM_021120.4(DLG3):c.2280T>G (p.Tyr760Ter)	DLG3	Y760*, Y309*, Y455*	not provided	Pathogenic(Last reviewed: Feb 7, 2014)	criteria provided, single submitter	VCV000166996	X	69720772	X	70500922	166996	177675	rs727503900	NC_000023.11:70500921:T:G
NM_178152.3(DCX):c.763G>T (p.Glu255Ter)	DCX	E255*, E336*	not provided	Pathogenic(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	VCV000166991	X	110576324	X	111333096	166991	177305	rs727503898	NC_000023.11:111333095:C:A
NM_004006.2(DMD):c.883C>T (p.Arg295Ter)	DMD	R295*, R287*, R291*, R172*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000166864	X	32716064	X	32697947	166864	177442	rs727503864	NC_000023.11:32697946:G:A
NM_000109.4(DMD):c.2460T>G (p.Tyr820Ter)	DMD	Y828*, Y824*, Y705*, Y820*	not provided	Pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	VCV000166854	X	32509532	X	32491415	166854	177584	rs727503858	NC_000023.11:32491414:A:C
NM_000109.4(DMD):c.2731A>T (p.Lys911Ter)	DMD	K919*, K911*, K915*, K796*	not provided	Pathogenic(Last reviewed: Apr 7, 2014)	criteria provided, single submitter	VCV000166824	X	32503084	X	32484967	166824	177048	rs727503850	NC_000023.11:32484966:T:A
NM_004006.2(DMD):c.2956C>T (p.Gln986Ter)	DMD	Q986*, Q863*, Q982*, Q978*	not provided	Pathogenic(Last reviewed: Nov 10, 2015)	criteria provided, multiple submitters, no conflicts	VCV000166817	X	32486821	X	32468704	166817	177178	rs727503844	NC_000023.11:32468703:G:A
NM_000109.4(DMD):c.3508G>T (p.Glu1170Ter)	DMD	E1178*, E1170*, E1174*, E1055*	not provided	Pathogenic(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	VCV000166784	X	32472850	X	32454733	166784	177441	rs727503836	NC_000023.11:32454732:C:A
NM_000109.4(DMD):c.4782A>T (p.Gly1594=)	DMD		not provided	Pathogenic(Last reviewed: Aug 11, 2014)	criteria provided, single submitter	VCV000166763	X	32398666	X	32380549	166763	177531	rs727503830	NC_000023.11:32380548:T:A
NM_000109.4(DMD):c.5339C>G (p.Ser1780Ter)	DMD	S1788*, S447*, S1665*, S1780*, S1784*, S444*	not provided	Pathogenic(Last reviewed: Dec 20, 2013)	criteria provided, single submitter	VCV000166756	X	32366608	X	32348491	166756	177526	rs199774535	NC_000023.11:32348490:G:C
NM_001123383.1(BCOR):c.776C>A (p.Ser259Ter)	BCOR	S259*	not provided	Pathogenic(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	VCV000166750	X	39933823	X	40074570	166750	177049	rs727503826	NC_000023.11:40074569:G:T
NM_000709.4(BCKDHA):c.117dup (p.Arg40fs)	BCKDHA		Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000166741	19	41916543 - 41916544	19	41410638 - 41410639	166741	177515	rs398123489	NC_000019.10:41410638:CCCCCCC:CCCCCCCC
NM_000109.4(DMD):c.8656G>T (p.Glu2886Ter)	DMD	E2894*, E1553*, E165*, E2890*, E2886*, E1550*, E434*, E2771*	not provided	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000166668	X	31496480	X	31478363	166668	177309	rs727503802	NC_000023.11:31478362:C:A
NM_004006.2(DMD):c.9164-1G>C	DMD		not provided	Pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000166661	X	31341776	X	31323659	166661	177475	rs398124082	NC_000023.11:31323658:C:G
NM_000033.4(ABCD1):c.1825G>A (p.Glu609Lys)	ABCD1	E609K	Adrenoleukodystrophy|not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000166626	X	153008485	X	153743031	166626	177307	rs150346282	NC_000023.11:153743030:G:A
NM_000033.4(ABCD1):c.1661G>A (p.Arg554His)	ABCD1	R554H	not provided	Pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	VCV000166625	X	153006054	X	153740600	166625	177044	rs201568579	NC_000023.11:153740599:G:A
NM_001039141.3(TRIOBP):c.6598C>T (p.Arg2200Ter)	TRIOBP	R2200*, R487*	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000165613	22	38165057	22	37769050	165613	176305	rs727503528	NC_000022.11:37769049:C:T
NM_024022.3(TMPRSS3):c.208del (p.His70fs)	TMPRSS3	H70fs	Inborn genetic diseases|Deafness, autosomal recessive 8|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000165492	21	43809152	21	42389043	165492	176368	rs727503493	NC_000021.9:42389042:GG:G
NM_212472.2(PRKAR1A):c.623del (p.Gly208fs)	PRKAR1A	G208fs	Carney complex|not provided	Pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000164995	17	66521967	17	68525826	164995	176495	rs727503379	NC_000017.11:68525825:GG:G
NM_002473.6(MYH9):c.4546G>T (p.Val1516Leu)	MYH9	V1516L	Rare genetic deafness	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000164432	22	36685142	22	36289096	164432	176262	rs727503284	NC_000022.11:36289095:C:A
NM_144612.6(LOXHD1):c.2303del (p.Gly768fs)	LOXHD1	G768fs	Rare genetic deafness	Pathogenic(Last reviewed: May 15, 2014)	criteria provided, single submitter	VCV000163919	18	44146354	18	46566391	163919	176571	rs727503146	NC_000018.10:46566390:CCC:CC
NM_144612.6(LOXHD1):c.4099G>T (p.Glu1367Ter)	LOXHD1	E1367*, E160*, E256*	Rare genetic deafness|Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163910	18	44114411	18	46534448	163910	176564	rs373937326	NC_000018.10:46534447:C:A
NM_002294.3(LAMP2):c.183+1G>A	LAMP2		Danon disease|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000163816	X	119590505	X	120456650	163816	176320	rs727503120	NC_000023.11:120456649:C:T
NM_002294.3(LAMP2):c.864+1G>T	LAMP2		Danon disease|not provided	Pathogenic(Last reviewed: Oct 8, 2013)	criteria provided, multiple submitters, no conflicts	VCV000163813	X	119580159	X	120446304	163813	176441	rs727503119	NC_000023.11:120446303:C:A
NM_002294.3(LAMP2):c.877C>T (p.Arg293Ter)	LAMP2	R293*	Danon disease|Danon disease|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163812	X	119576505	X	120442650	163812	176318	rs727503118	NC_000023.11:120442649:G:A
NM_000117.3(EMD):c.266-2A>G	EMD		Neuromuscular disease|not provided	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000163403	X	153608592	X	154380232	163403	176795	rs727503036	NC_000023.11:154380231:A:G
NM_001399.5(EDA):c.991C>T (p.Gln331Ter)	EDA	Q331*, Q326*, Q329*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: May 5, 2014)	criteria provided, single submitter	VCV000163324	X	69255274	X	70035424	163324	176330	rs727503011	NC_000023.11:70035423:C:T
NM_001399.5(EDA):c.948del (p.Phe317fs)	EDA	F312fs, F315fs, F317fs	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 3, 2014)	criteria provided, single submitter	VCV000163323	X	69255231	X	70035381	163323	176452	rs727503010	NC_000023.11:70035380:C:
NM_001399.5(EDA):c.822G>A (p.Trp274Ter)	EDA	W274*, W271*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	VCV000163321	X	69253276	X	70033426	163321	176451	rs397516675	NC_000023.11:70033425:G:A
NM_001399.5(EDA):c.809del (p.Val270fs)	EDA	V267fs, V270fs	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 20, 2013)	criteria provided, single submitter	VCV000163320	X	69253263	X	70033413	163320	176328	rs727503008	NC_000023.11:70033412:T:
NM_001399.5(EDA):c.676C>T (p.Gln226Ter)	EDA	Q226*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Aug 21, 2014)	criteria provided, single submitter	VCV000163315	X	69247856	X	70028006	163315	176448	rs727503007	NC_000023.11:70028005:C:T
NM_001399.4(EDA):c.(?_503)-88_(1176_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jun 25, 2013)	criteria provided, single submitter	VCV000163308	X	69242980 - 69255459	X	70023130 - 70035609	163308	176434		
NM_001399.4(EDA):c.(?_397-304)_(460_?)del	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 6, 2012)	criteria provided, single submitter	VCV000163306	X	69176573 - 69176940	X	69956723 - 69957090	163306	176433		
NM_006796.2(AFG3L2):c.1875G>A (p.Met625Ile)	AFG3L2	M625I	Spastic ataxia 5, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162524	18	12340305	18	12340306	162524	172197	rs727502823	NC_000018.10:12340305:C:T
NM_024422.6(DSC2):c.663T>A (p.Tyr221Ter)	DSC2	Y221*	not provided|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162504	18	28667744	18	31087781	162504	172182	rs145476705	NC_000018.10:31087780:A:T
NM_004006.3(DMD):c.1812+1G>A	DMD		not provided|Duchenne muscular dystrophy|Becker muscular dystrophy|Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162497	X	32591646	X	32573529	162497	172184	rs373286166	NC_000023.11:32573528:C:T
NM_002730.4(PRKACA):c.597_599dup (p.Cys200_Gly201insTrp)	PRKACA		Pigmented nodular adrenocortical disease, primary, 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000162471	19	14208434 - 14208436	19	14097621 - 14097622	162471	172145	rs724160013	NC_000019.10:14097621:CAC:CACCAC
NM_020461.4(TUBGCP6):c.3163C>T (p.His1055Tyr)	TUBGCP6	H1055Y	Microcephaly and chorioretinopathy, autosomal recessive, 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162406	22	50659625	22	50221196	162406	172109	rs724159997	NC_000022.11:50221195:G:A
NM_020461.4(TUBGCP6):c.3565G>T (p.Gly1189Ter)	TUBGCP6	G1189*	Microcephaly and chorioretinopathy, autosomal recessive, 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162405	22	50659223	22	50220794	162405	172108	rs724159976	NC_000022.11:50220793:C:A
NM_020461.4(TUBGCP6):c.2546A>G (p.Glu849Gly)	TUBGCP6	E849G	Microcephaly and chorioretinopathy, autosomal recessive, 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162404	22	50660242	22	50221813	162404	172107	rs368449236	NC_000022.11:50221812:T:C
NM_020461.4(TUBGCP6):c.2215C>T (p.Arg739Ter)	TUBGCP6	R739*	Microcephaly and chorioretinopathy, autosomal recessive, 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162403	22	50662625	22	50224196	162403	172106	rs724159975	NC_000022.11:50224195:G:A
NM_020461.4(TUBGCP6):c.4333_4334insT (p.His1445fs)	TUBGCP6		Microcephaly and chorioretinopathy, autosomal recessive, 1	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000162402	22	50657867 - 50657868	22	50219438 - 50219439	162402	172105	rs727502807	NC_000022.11:50219438::A
NM_001305563.1(TXNL4A):c.-60-10914_-60-10880del	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162208	18	77748581 - 77748636	18	79988581 - 79988636	162208	171916		
NM_006701.4(TXNL4A):c.258_429del172 (p.Asn87Alafs)	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162207	18	77733685 - 77737597	18	79973685 - 79977597	162207	171915		
NC_000018.9:g.77748262delA	TXNL4A	V44fs	Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162206	18	77748262	18	79988262	162206	171914	rs727502795	NC_000018.10:79988261:A:
NC_000018.9:g.77748356G>A	TXNL4A	Q13*	Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162205	18	77748356	18	79988356	162205	171913	rs727502794	NC_000018.10:79988355:G:A
NC_000018.9:g.77733765C>A	TXNL4A	E117*, E46*, E109*, E78*	Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162204	18	77733765	18	79973765	162204	171912	rs727502793	NC_000018.10:79973764:C:A
NC_000018.9:g.77748581_77748614del34	TXNL4A		Burn-McKeown syndrome	Pathogenic(Last reviewed: Mar 28, 2016)	no assertion criteria provided	VCV000162203	18	77748581 - 77748614	18	79988581 - 79988614	162203	171911	rs535089924	NC_000018.10:79988580:CGCCGTGCGTGCTGACGGCATGCGCGCGCGCTAGCGCCGTGCGTGCTGACGGCATG:CGCCGTGCGTGCTGACGGCATG
NM_001130823.3(DNMT1):c.1531T>C (p.Tyr511His)	DNMT1	Y495H, Y511H, Y390H	Hereditary sensory neuropathy type IE|not provided	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000162188	19	10265694	19	10155018	162188	171896	rs199473692	NC_000019.10:10155017:A:G
NM_001347721.2(DYRK1A):c.1205dup (p.Arg404fs)	DYRK1A		Absent or delayed speech development|Deeply set eye|Seizures|Microcephaly|Feeding difficulties|Intellectual disability	Pathogenic(Last reviewed: Sep 9, 2014)	no assertion criteria provided	VCV000162161	21	38868551 - 38868552	21	37496249 - 37496250	162161	171872	rs724159956	NC_000021.9:37496249:GG:GGG
NM_001347721.2(DYRK1A):c.817dup (p.Ser273fs)	DYRK1A		Absent or delayed speech development|Deeply set eye|Seizures|Microcephaly|Feeding difficulties|Intellectual disability	Pathogenic(Last reviewed: Sep 9, 2014)	no assertion criteria provided	VCV000162159	21	38862655 - 38862656	21	37490353 - 37490354	162159	171869	rs724159954	NC_000021.9:37490353:A:AA
NM_001347721.2(DYRK1A):c.1282C>T (p.Arg428Ter)	DYRK1A	R437*, R428*, R399*	Mental retardation, autosomal dominant 7|Absent or delayed speech development|Deeply set eye|Seizures|Microcephaly|Feeding difficulties|Intellectual disability|not provided	Pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162158	21	38877655	21	37505352	162158	171873	rs724159953	NC_000021.9:37505351:C:T
NM_001347721.2(DYRK1A):c.918dup (p.Gln307fs)	DYRK1A		Absent or delayed speech development|Deeply set eye|Seizures|Microcephaly|Feeding difficulties|Intellectual disability	Pathogenic(Last reviewed: Sep 9, 2014)	no assertion criteria provided	VCV000162156	21	38862753 - 38862754	21	37490451 - 37490452	162156	171870	rs724159952	NC_000021.9:37490451:GGGG:GGGGG
NM_001347721.2(DYRK1A):c.594_597delinsGAA (p.Glu199fs)	DYRK1A		Absent or delayed speech development|Deeply set eye|Microcephaly|Feeding difficulties|Intellectual disability|Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000162154	21	38858873 - 38858876	21	37486571 - 37486574	162154	171867	rs724159950	NC_000021.9:37486570:TGAG:GAA
NM_001347721.2(DYRK1A):c.586C>T (p.Arg196Ter)	DYRK1A	R205*, R196*, R167*	Mental retardation, autosomal dominant 7|Microphthalmia|Microcephaly|Generalized seizures|Global developmental delay|Absent or delayed speech development|Deeply set eye|Microcephaly|Feeding difficulties|Intellectual disability|not provided|Intellectual disability	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162153	21	38858865	21	37486563	162153	171866	rs724159949	NC_000021.9:37486562:C:T
NM_001347721.2(DYRK1A):c.736C>T (p.Arg246Ter)	DYRK1A	R255*, R217*, R246*	Mental retardation, autosomal dominant 7|Absent or delayed speech development|Deeply set eye|Seizures|Microcephaly|Feeding difficulties|Intellectual disability|not provided	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162152	21	38862575	21	37490273	162152	171868	rs724159948	NC_000021.9:37490272:C:T
NM_000033.4(ABCD1):c.253dup (p.Arg85fs)	ABCD1		not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000162148	X	152990969 - 152990970	X	153725514 - 153725515	162148	171860	rs713993050	NC_000023.11:153725514:CCCCC:CCCCCC
NM_000395.3(CSF2RB):c.812C>T (p.Ser271Leu)	CSF2RB	S271L	Surfactant metabolism dysfunction, pulmonary, 5	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000161978	22	37326510	22	36930468	161978	171700	rs672601313	NC_000022.11:36930467:C:T
NM_000100.4(CSTB):c.168+2_168+21delinsAA	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000161421	21	45194518 - 45194537	21	43774637 - 43774656	161421	171260	rs864309482	NC_000021.9:43774636:CTCCTGAGGCCCACACTCTA:TT
NM_000100.3(CSTB):c.168+2_168+19del	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000161420	21	45194520 - 45194537	21	43774639 - 43774656	161420	171261	rs312262707	NC_000021.9:43774638:CCTGAGGCCCACACTCTACCT:CCT
NM_000100.3(CSTB):c.149G>A (p.Gly50Glu)	CSTB	G50E	Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000161419	21	45194558	21	43774677	161419	171262	rs312262708	NC_000021.9:43774676:C:T
NM_000100.3(CSTB):c.136C>T (p.Gln46Ter)	CSTB	Q46*	Unverricht-Lundborg syndrome|Progressive myoclonic epilepsy|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000161418	21	45194571	21	43774690	161418	171263	rs545986367	NC_000021.9:43774689:G:A
NM_000527.5(LDLR):c.1444G>A (p.Asp482Asn)	LDLR	D482N, D355N, D441N, D314N	not provided|Familial hypercholesterolemia 1|Hypercholesterolaemia|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000161284	19	11224296	19	11113620	161284	171214	rs139624145	NC_000019.10:11113619:G:A
NM_000527.5(LDLR):c.1775G>A (p.Gly592Glu)	LDLR	G592E, G424E, G465E, G551E	Familial hypercholesterolemia 1|not provided|Homozygous familial hypercholesterolemia|Hypercholesterolaemia|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000161271	19	11227604	19	11116928	161271	171217	rs137929307	NC_000019.10:11116927:G:A
NM_000527.5(LDLR):c.1467C>G (p.Tyr489Ter)	LDLR	Y489*, Y448*, Y321*, Y362*	Familial hypercholesterolemia 1|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000161270	19	11224319	19	11113643	161270	171215	rs370777955	NC_000019.10:11113642:C:G
NM_000527.5(LDLR):c.296C>G (p.Ser99Ter)	LDLR	S99*	Familial hypercholesterolemia 1|Hypercholesterolaemia|Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000161269	19	11213445	19	11102769	161269	171198	rs377271627	NC_000019.10:11102768:C:G
NM_000527.5(LDLR):c.301G>A (p.Glu101Lys)	LDLR	E101K	Familial hypercholesterolemia 1|not provided|Homozygous familial hypercholesterolemia|Hypercholesterolaemia|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000161266	19	11213450	19	11102774	161266	171199	rs144172724	NC_000019.10:11102773:G:A
NM_000527.5(LDLR):c.2475C>G (p.Asn825Lys)	LDLR	N825K, N647K, N657K, N784K	Familial hypercholesterolemia 1|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000161265	19	11240274	19	11129598	161265	171224	rs374045590	NC_000019.10:11129597:C:G
NM_152296.5(ATP1A3):c.1250T>C (p.Leu417Pro)	ATP1A3	L417P, L428P, L430P	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161157	19	42485926	19	41981774	161157	170989	rs606231449	NC_000019.10:41981773:A:G
NM_152296.5(ATP1A3):c.1144T>C (p.Trp382Arg)	ATP1A3	W382R, W393R, W395R	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161156	19	42486108	19	41981956	161156	170990	rs606231448	NC_000019.10:41981955:A:G
NM_152296.5(ATP1A3):c.1109C>A (p.Thr370Asn)	ATP1A3	T370N, T383N, T381N	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161155	19	42486143	19	41981991	161155	170992	rs573535377	NC_000019.10:41981990:G:T
NM_152296.5(ATP1A3):c.3035_3037ACT[3] (p.Tyr1013dup)	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161154	19	42471090 - 42471091	19	41966938 - 41966939	161154	170965	rs397515382	NC_000019.10:41966938:AGTAGTAG:AGTAGTAGTAG
NM_152296.5(ATP1A3):c.2974G>T (p.Asp992Tyr)	ATP1A3	D992Y, D1003Y, D1005Y	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161153	19	42471440	19	41967288	161153	170966	rs606231447	NC_000019.10:41967287:C:A
NM_152296.5(ATP1A3):c.2864C>A (p.Ala955Asp)	ATP1A3	A955D, A966D, A968D	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161152	19	42471871	19	41967719	161152	170967	rs606231446	NC_000019.10:41967718:G:T
NM_152296.5(ATP1A3):c.2781C>G (p.Cys927Trp)	ATP1A3	C927W, C938W, C940W	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161151	19	42472975	19	41968823	161151	170968	rs606231445	NC_000019.10:41968822:G:C
NM_152296.5(ATP1A3):c.2780G>T (p.Cys927Phe)	ATP1A3	C927F, C940F, C938F	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161150	19	42472976	19	41968824	161150	170969	rs606231444	NC_000019.10:41968823:C:A
NM_152296.5(ATP1A3):c.2780G>A (p.Cys927Tyr)	ATP1A3	C927Y, C938Y, C940Y	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161149	19	42472976	19	41968824	161149	170970	rs606231444	NC_000019.10:41968823:C:T
NM_152296.5(ATP1A3):c.2767G>T (p.Asp923Tyr)	ATP1A3	D923Y, D936Y, D934Y	Dystonia 12|Alternating hemiplegia of childhood 2|not provided	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000161148	19	42472989	19	41968837	161148	170971	rs267606670	NC_000019.10:41968836:C:A
NM_152296.5(ATP1A3):c.2752_2754GTC[1] (p.Val919del)	ATP1A3	V919del	Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000161147	19	42472999 - 42473001	19	41968847 - 41968849	161147	170972	rs606231443	NC_000019.10:41968846:GACGAC:GAC
NM_152296.5(ATP1A3):c.2600G>A (p.Gly867Asp)	ATP1A3	G867D, G867N, G878D, G880D	Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161146	19	42473675	19	41969523	161146	170973	rs606231442	NC_000019.10:41969522:C:T
NM_152296.5(ATP1A3):c.2542+1G>A	ATP1A3		Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161145	19	42474336	19	41970184	161145	170974	rs606231441	NC_000019.10:41970183:C:T
NM_152296.5(ATP1A3):c.2429T>G (p.Ile810Ser)	ATP1A3	I810S, I821S, I823S	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161144	19	42474450	19	41970298	161144	170975	rs536681257	NC_000019.10:41970297:A:C
NM_152296.5(ATP1A3):c.2428A>T (p.Ile810Phe)	ATP1A3	I810F, I821F, I823F	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161143	19	42474451	19	41970299	161143	170976	rs606231440	NC_000019.10:41970298:T:A
NM_152296.5(ATP1A3):c.2415C>G (p.Asp805Glu)	ATP1A3	D805E, D816E, D818E	Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000161141	19	42474543	19	41970391	161141	170978	rs606231439	NC_000019.10:41970390:G:C
NM_152296.5(ATP1A3):c.2411C>T (p.Thr804Ile)	ATP1A3	T804I, T815I, T817I	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161140	19	42474547	19	41970395	161140	170979	rs606231438	NC_000019.10:41970394:G:A
NM_152296.5(ATP1A3):c.2318A>T (p.Asn773Ile)	ATP1A3	N773I, N786I, N784I	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161139	19	42474640	19	41970488	161139	170980	rs606231437	NC_000019.10:41970487:T:A
NM_152296.5(ATP1A3):c.2318A>G (p.Asn773Ser)	ATP1A3	N773S, N786S, N784S	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161138	19	42474640	19	41970488	161138	170981	rs606231437	NC_000019.10:41970487:T:C
NM_152296.5(ATP1A3):c.2316C>A (p.Ser772Arg)	ATP1A3	S772R, S785R, S783R	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161137	19	42474642	19	41970490	161137	170982	rs534926223	NC_000019.10:41970489:G:T
NM_152296.5(ATP1A3):c.2312C>A (p.Thr771Asn)	ATP1A3	T771N, T782N, T784N	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161136	19	42474646	19	41970494	161136	170983	rs557939077	NC_000019.10:41970493:G:T
NM_152296.5(ATP1A3):c.2270T>C (p.Leu757Pro)	ATP1A3	L757P, L768P, L770P	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161135	19	42474688	19	41970536	161135	170984	rs606231436	NC_000019.10:41970535:A:G
NM_152296.5(ATP1A3):c.2267G>A (p.Arg756His)	ATP1A3	R756H, R769H, R767H	not provided|Alternating hemiplegia of childhood 2|Dystonia 12|Inborn genetic diseases|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000161134	19	42474691	19	41970539	161134	170985	rs606231435	NC_000019.10:41970538:C:T
NM_152296.5(ATP1A3):c.2263G>T (p.Gly755Cys)	ATP1A3	G755C, G766C, G768C	Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000161133	19	42479781	19	41975629	161133	170987	rs557052809	NC_000019.10:41975628:C:A
NM_152296.5(ATP1A3):c.2263G>A (p.Gly755Ser)	ATP1A3	G755S, G766S, G768S	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161132	19	42479781	19	41975629	161132	170988	rs557052809	NC_000019.10:41975628:C:T
NM_152296.5(ATP1A3):c.2264G>C (p.Gly755Ala)	ATP1A3	G755A, G768A, G766A	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161131	19	42474694	19	41970542	161131	170986	rs606231434	NC_000019.10:41970541:C:G
NM_152296.5(ATP1A3):c.1112T>C (p.Leu371Pro)	ATP1A3	L371P, L382P, L384P	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161130	19	42486140	19	41981988	161130	170991	rs606231433	NC_000019.10:41981987:A:G
NM_152296.5(ATP1A3):c.1072G>T (p.Gly358Cys)	ATP1A3	G358C, G369C, G371C	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161129	19	42486180	19	41982028	161129	170993	rs606231432	NC_000019.10:41982027:C:A
NM_152296.5(ATP1A3):c.1003A>C (p.Thr335Pro)	ATP1A3	T335P, T348P, T346P	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161128	19	42486249	19	41982097	161128	170994	rs606231431	NC_000019.10:41982096:T:G
NM_152296.5(ATP1A3):c.998G>T (p.Cys333Phe)	ATP1A3	C333F, C344F, C346F	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161127	19	42486254	19	41982102	161127	170995	rs606231430	NC_000019.10:41982101:C:A
NM_152296.5(ATP1A3):c.976_978CTG[1] (p.Leu327del)	ATP1A3	L327del	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161126	19	42489082 - 42489084	19	41984930 - 41984932	161126	170996	rs397515578	NC_000019.10:41984929:CAGCAG:CAG
NM_152296.5(ATP1A3):c.965T>A (p.Val322Asp)	ATP1A3	V322D, V333D, V335D	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161125	19	42489098	19	41984946	161125	170997	rs606231428	NC_000019.10:41984945:A:T
NM_152296.5(ATP1A3):c.821T>A (p.Ile274Asn)	ATP1A3	I274N, I287N, I285N	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161124	19	42489242	19	41985090	161124	170998	rs80356532	NC_000019.10:41985089:A:T
NM_152296.5(ATP1A3):c.419A>T (p.Gln140Leu)	ATP1A3	Q140L, Q151L, Q153L	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161123	19	42490320	19	41986168	161123	170999	rs606231427	NC_000019.10:41986167:T:A
NM_152296.5(ATP1A3):c.410C>T (p.Ser137Phe)	ATP1A3	S137F, S150F, S148F	Alternating hemiplegia of childhood 2|Epicanthus|Depressed nasal bridge|Abnormality of earlobe|Seizures|Ventriculomegaly	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000161122	19	42490329	19	41986177	161122	171000	rs542652468	NC_000019.10:41986176:G:A
NM_152296.5(ATP1A3):c.410C>A (p.Ser137Tyr)	ATP1A3	S137Y, S150Y, S148Y	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000161121	19	42490329	19	41986177	161121	171001	rs542652468	NC_000019.10:41986176:G:T
NM_030777.4(SLC2A10):c.737G>A (p.Gly246Glu)	SLC2A10	G246E	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161108	20	45354412	20	46725773	161108	170946	rs564317065	NC_000020.11:46725772:G:A
NM_030777.4(SLC2A10):c.731_734del (p.Leu244fs)	SLC2A10	L244fs	Arterial tortuosity syndrome|not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000161107	20	45354403 - 45354406	20	46725764 - 46725767	161107	170945	rs864309481	NC_000020.11:46725763:AACTAAC:AAC
NM_030777.4(SLC2A10):c.425G>T (p.Gly142Val)	SLC2A10	G142V	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161105	20	45354100	20	46725461	161105	170941	rs864309480	NC_000020.11:46725460:G:T
NM_030777.4(SLC2A10):c.1411+1G>A	SLC2A10		Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161103	20	45355626	20	46726987	161103	170951	rs864309479	NC_000020.11:46726986:G:A
NM_030777.4(SLC2A10):c.1334G>A (p.Gly445Glu)	SLC2A10	G445E	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161102	20	45355548	20	46726909	161102	170950	rs753723351	NC_000020.11:46726908:G:A
NM_030777.4(SLC2A10):c.1330C>T (p.Arg444Ter)	SLC2A10	R444*	Arterial tortuosity syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000161101	20	45355544	20	46726905	161101	170949	rs370547023	NC_000020.11:46726904:C:T
NM_030777.4(SLC2A10):c.1411+480_1547+299del	SLC2A10		Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161099	20	45356083 - 45358404	20	46727444 - 46729765	161099	170952		
NM_030777.4(SLC2A10):c.756C>A (p.Cys252Ter)	SLC2A10	C252*	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161098	20	45354431	20	46725792	161098	170947	rs864309478	NC_000020.11:46725791:C:A
NM_030777.4(SLC2A10):c.685C>T (p.Arg229Ter)	SLC2A10	R229*	Arterial tortuosity syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000161096	20	45354360	20	46725721	161096	170942	rs756457861	NC_000020.11:46725720:C:T
NM_030777.4(SLC2A10):c.417T>A (p.Tyr139Ter)	SLC2A10	Y139*	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000161095	20	45354092	20	46725453	161095	170940	rs572620317	NC_000020.11:46725452:T:A
NM_001083961.2(WDR62):c.332+1G>A	WDR62		Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Dec 18, 2012)	criteria provided, single submitter	VCV000160282	19	36550933	19	36060031	160282	169477	rs587784553	NC_000019.10:36060030:G:A
NM_001083961.2(WDR62):c.2655C>G (p.Tyr885Ter)	WDR62	Y885*	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	VCV000160272	19	36590435	19	36099533	160272	169511	rs587784549	NC_000019.10:36099532:C:G
NM_001083961.2(WDR62):c.2084_2090dup (p.Ser698fs)	WDR62		Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	VCV000160260	19	36582150 - 36582151	19	36091248 - 36091249	160260	169499	rs587784546	NC_000019.10:36091248:AAAGCAT:AAAGCATAAAGCAT
NM_001083962.2(TCF4):c.991-2A>G	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	VCV000160093	18	52927260	18	55260029	160093	169444	rs587784470	NC_000018.10:55260028:T:C
NM_001083962.2(TCF4):c.990G>A (p.Ser330=)	TCF4		not provided|Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160092	18	52928697	18	55261466	160092	169445	rs587784469	NC_000018.10:55261465:C:T
NM_001083962.2(TCF4):c.791del (p.Ser264fs)	TCF4	S222fs, S240fs, S263fs, S366fs, S104fs, S270fs, S48fs, S134fs, S239fs, S262fs, S264fs, S193fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160090	18	52937193	18	55269962	160090	169447	rs587784468	NC_000018.10:55269961:C:
NM_001083962.2(TCF4):c.656-1G>C	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160087	18	52942984	18	55275753	160087	169449	rs587784466	NC_000018.10:55275752:C:G
NM_001083962.2(TCF4):c.655+1G>A	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160086	18	52946781	18	55279550	160086	169451	rs587784465	NC_000018.10:55279549:C:T
NM_001083962.2(TCF4):c.469C>T (p.Arg157Ter)	TCF4	R157*, R115*, R132*, R259*, R27*, R133*, R156*, R86*, R155*	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160085	18	53018135	18	55350904	160085	169452	rs587784464	NC_000018.10:55350903:G:A
NM_001083962.2(TCF4):c.415del (p.Leu139fs)	TCF4	L139fs, L241fs, L9fs, L137fs, L138fs, L68fs, L115fs, L97fs, L114fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160084	18	53018189	18	55350958	160084	169453	rs587784463	NC_000018.10:55350957:GGG:GG
NM_001083962.2(TCF4):c.1498G>T (p.Gly500Ter)	TCF4	G500*, G506*, G284*, G370*, G458*, G475*, G497*, G602*, G339*, G340*, G429*, G476*, G477*, G499*	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160078	18	52899891	18	55232660	160078	169441	rs587784459	NC_000018.10:55232659:C:A
NM_001083962.2(TCF4):c.1146+1G>A	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160076	18	52924545	18	55257314	160076	169443	rs587784458	NC_000018.10:55257313:C:T
NM_001281463.1(SMC1A):c.550-2A>G	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159962	X	53440090	X	53413140	159962	170159	rs587784423	NC_000023.11:53413139:T:C
NM_001281463.1(SMC1A):c.520C>T (p.Arg174Cys)	SMC1A	R196C, R174C	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000159961	X	53440211	X	53413261	159961	170161	rs587784422	NC_000023.11:53413260:G:A
NM_001281463.1(SMC1A):c.481C>T (p.Gln161Ter)	SMC1A	Q183*, Q161*	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159960	X	53440250	X	53413300	159960	170162	rs587784421	NC_000023.11:53413299:G:A
NM_001281463.1(SMC1A):c.3188A>G (p.Tyr1063Cys)	SMC1A	Y1085C, Y1063C	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159956	X	53409458	X	53382537	159956	170140	rs587784418	NC_000023.11:53382536:T:C
NM_001281463.1(SMC1A):c.2302C>T (p.Arg768Trp)	SMC1A	R790W, R768W	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000159950	X	53430550	X	53403618	159950	170145	rs587784412	NC_000023.11:53403617:G:A
NM_001281463.1(SMC1A):c.2065C>T (p.Arg689Trp)	SMC1A	R711W, R689W	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159947	X	53432009	X	53405077	159947	170148	rs587784409	NC_000023.11:53405076:G:A
NM_001281463.1(SMC1A):c.1127G>A (p.Arg376Gln)	SMC1A	R398Q, R376Q	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Aug 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159938	X	53438772	X	53411822	159938	170157	rs587784403	NC_000023.11:53411821:C:T
NM_001042537.1(SLC9A6):c.2078T>G (p.Leu693Ter)	SLC9A6	L693*, L641*, L609*, L661*	Christianson syndrome	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000159932	X	135126855	X	136044696	159932	169942	rs587784399	NC_000023.11:136044695:T:G
NM_001042537.1(SLC9A6):c.183del (p.Lys61fs)	SLC9A6	K9fs, K61fs	Christianson syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159931	X	135067844	X	135985685	159931	169938	rs587784398	NC_000023.11:135985684:G:
NM_006517.5(SLC16A2):c.277C>T (p.Gln93Ter)	SLC16A2	Q93*	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159906	X	73641749	X	74421914	159906	170180	rs587784386	NC_000023.11:74421913:C:T
NM_006517.5(SLC16A2):c.1111C>T (p.Arg371Cys)	SLC16A2	R371C	Allan-Herndon-Dudley syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159902	X	73745669	X	74525834	159902	170184	rs587784384	NC_000023.11:74525833:C:T
NM_006517.5(SLC16A2):c.916C>T (p.Gln306Ter)	SLC16A2	Q306*	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159900	X	73744534	X	74524699	159900	170182	rs587784382	NC_000023.11:74524698:C:T
NM_007254.4(PNKP):c.1295_1298+6del	PNKP		Early infantile epileptic encephalopathy 12|not provided|Early infantile epileptic encephalopathy 10|Ataxia-oculomotor apraxia type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159788	19	50365023 - 50365032	19	49861766 - 49861775	159788	169587	rs587784366	NC_000019.10:49861765:CGCTACCTGGCGC:CGC
NM_003560.4(PLA2G6):c.986G>A (p.Arg329His)	PLA2G6	R329H, R103H, R151H	not provided|Infantile neuroaxonal dystrophy|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159784	22	38528929	22	38132922	159784	169804	rs587784363	NC_000022.11:38132921:C:T
NM_003560.4(PLA2G6):c.821T>G (p.Met274Arg)	PLA2G6	M274R, M48R, M96R	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159780	22	38531068	22	38135061	159780	169807	rs587784362	NC_000022.11:38135060:A:C
NM_003560.4(PLA2G6):c.755del (p.Asn252fs)	PLA2G6	N74fs, N252fs	Iron accumulation in brain	Pathogenic(Last reviewed: Apr 1, 2014)	criteria provided, single submitter	VCV000159778	22	38536031	22	38140024	159778	169809	rs587784361	NC_000022.11:38140023:TT:T
NM_003560.4(PLA2G6):c.673C>T (p.His225Tyr)	PLA2G6	H225Y, H47Y	not provided|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2015)	criteria provided, multiple submitters, no conflicts	VCV000159775	22	38536113	22	38140106	159775	169811	rs587784359	NC_000022.11:38140105:G:A
NM_003560.4(PLA2G6):c.517C>T (p.Gln173Ter)	PLA2G6	Q173*	Iron accumulation in brain	Pathogenic(Last reviewed: Jul 9, 2013)	criteria provided, single submitter	VCV000159773	22	38539204	22	38143197	159773	169813	rs587784357	NC_000022.11:38143196:G:A
NM_003560.4(PLA2G6):c.2325_2326CA[1] (p.Thr776fs)	PLA2G6		Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159764	22	38508261 - 38508262	22	38112254 - 38112255	159764	169764	rs587784352	NC_000022.11:38112253:TGTGT:TGT
NM_003560.4(PLA2G6):c.2233C>T (p.Arg745Trp)	PLA2G6	R745W, R691W, R519W, R567W, R513W	Neurodegeneration with brain iron accumulation 2b|Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159762	22	38508554	22	38112547	159762	169766	rs587784350	NC_000022.11:38112546:G:A
NM_003560.4(PLA2G6):c.2098C>T (p.Gln700Ter)	PLA2G6	Q700*, Q468*, Q474*, Q646*, Q522*	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159758	22	38509598	22	38113591	159758	169770	rs587784346	NC_000022.11:38113590:G:A
NM_003560.4(PLA2G6):c.1903C>T (p.Arg635Ter)	PLA2G6	R635*, R403*, R581*, R409*, R457*	PLA2G6-associated neurodegeneration|not provided|Infantile neuroaxonal dystrophy|Iron accumulation in brain	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159749	22	38511665	22	38115658	159749	169779	rs587784339	NC_000022.11:38115657:G:A
NM_003560.4(PLA2G6):c.1799G>A (p.Arg600Gln)	PLA2G6	R600Q, R374Q, R546Q, R368Q, R422Q	not provided|Neurodegeneration with brain iron accumulation 2b|Iron accumulation in brain|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159748	22	38512162	22	38116155	159748	169780	rs149712244	NC_000022.11:38116154:C:T
NM_003560.4(PLA2G6):c.1754C>T (p.Thr585Ile)	PLA2G6	T585I, T407I, T531I, T359I, T353I	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159747	22	38512207	22	38116200	159747	169781	rs587784338	NC_000022.11:38116199:G:A
NM_003560.4(PLA2G6):c.1699G>A (p.Glu567Lys)	PLA2G6	E567K, E513K, E335K, E341K, E389K	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159743	22	38516809	22	38120802	159743	169784	rs587784337	NC_000022.11:38120801:C:T
NM_003560.4(PLA2G6):c.1674del (p.Leu560fs)	PLA2G6	L334fs, L382fs, L328fs, L506fs, L560fs	Iron accumulation in brain	Pathogenic(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	VCV000159742	22	38516834	22	38120827	159742	169785	rs587784336	NC_000022.11:38120826:CCCC:CCC
NM_003560.4(PLA2G6):c.1613G>A (p.Arg538His)	PLA2G6	R538H, R306H, R312H, R484H, R360H	not provided|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159739	22	38516895	22	38120888	159739	169788	rs535486098	NC_000022.11:38120887:C:T
NM_003560.4(PLA2G6):c.1612C>T (p.Arg538Cys)	PLA2G6	R538C, R360C, R306C, R312C, R484C	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159738	22	38516896	22	38120889	159738	169789	rs370691849	NC_000022.11:38120888:G:A
NM_003560.4(PLA2G6):c.1509del (p.Ser504fs)	PLA2G6	S450fs, S504fs, S272fs, S278fs, S326fs	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159734	22	38519184	22	38123177	159734	169793	rs587784333	NC_000022.11:38123176:GG:G
NM_003560.4(PLA2G6):c.1442T>A (p.Leu481Gln)	PLA2G6	L481Q, L249Q, L427Q, L303Q, L255Q	Iron accumulation in brain|Neurodegeneration with brain iron accumulation 2b	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000159731	22	38519251	22	38123244	159731	169796	rs587784330	NC_000022.11:38123243:A:T
NC_000022.10:g.38522454delG	PLA2G6	L273fs, L219fs, L225fs, L397fs, L451fs	Iron accumulation in brain	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159730	22	38522454	22	38126447	159730	169797	rs587784329	NC_000022.11:38126446:G:
NM_003560.4(PLA2G6):c.1117G>A (p.Gly373Arg)	PLA2G6	G373R, G195R, G147R	Infantile neuroaxonal dystrophy|Iron accumulation in brain	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159728	22	38525530	22	38129523	159728	169799	rs587784327	NC_000022.11:38129522:C:T
NM_006031.6(PCNT):c.8917C>T (p.Arg2973Ter)	PCNT	R2973*, R2776*		Pathogenic(Last reviewed: Sep 9, 2013)	criteria provided, single submitter	VCV000159681	21	47855982	21	46436069	159681	169727	rs587784321	NC_000021.9:46436068:C:T
NM_006031.6(PCNT):c.8868dup (p.Ala2957fs)	PCNT			Pathogenic(Last reviewed: Apr 28, 2014)	criteria provided, single submitter	VCV000159677	21	47855932 - 47855933	21	46436019 - 46436020	159677	169723	rs587784320	NC_000021.9:46436019:T:TT
NM_006031.6(PCNT):c.7796del (p.Leu2599fs)	PCNT	L2599fs, L2481fs		Pathogenic(Last reviewed: Jan 27, 2014)	criteria provided, single submitter	VCV000159663	21	47850029	21	46430115	159663	169709	rs587784319	NC_000021.9:46430114:T:
NM_006031.6(PCNT):c.5727_5736del (p.Leu1910fs)	PCNT	L1792fs, L1910fs		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000159623	21	47831708 - 47831717	21	46411794 - 46411803	159623	169673	rs587784312	NC_000021.9:46411793:GCAGCCCCTGGCAGCC:GCAGCC
NM_006031.6(PCNT):c.5578G>T (p.Glu1860Ter)	PCNT	E1860*, E1742*		Pathogenic(Last reviewed: Sep 9, 2013)	criteria provided, single submitter	VCV000159621	21	47831565	21	46411651	159621	169671	rs369195346	NC_000021.9:46411650:G:T
NM_006031.6(PCNT):c.5020G>T (p.Glu1674Ter)	PCNT	E1674*, E1556*		Pathogenic(Last reviewed: Aug 22, 2013)	criteria provided, single submitter	VCV000159615	21	47822302	21	46402388	159615	169667	rs587784308	NC_000021.9:46402387:G:T
NM_006031.6(PCNT):c.2984_2994del (p.Ala995fs)	PCNT	A995fs, A877fs	not provided|	Pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000159580	21	47786870 - 47786880	21	46366955 - 46366965	159580	169639	rs587784302	NC_000021.9:46366954:GAGCAGACTTTGAG:GAG
NM_006031.6(PCNT):c.1468C>T (p.Gln490Ter)	PCNT	Q490*, Q372*		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159565	21	47773029	21	46353115	159565	169625	rs181690344	NC_000021.9:46353114:C:T
NM_002547.3(OPHN1):c.496C>T (p.Gln166Ter)	OPHN1	Q166*	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159477	X	67433805	X	68213963	159477	170172	rs587784234	NC_000023.11:68213962:G:A
NM_015922.3(NSDHL):c.906C>A (p.Tyr302Ter)	NSDHL	Y302*	Child syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159457	X	152037444	X	152868900	159457	170082	rs587784226	NC_000023.11:152868899:C:A
NM_015922.3(NSDHL):c.904del (p.Tyr302fs)	NSDHL	Y302fs	Child syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159456	X	152037442	X	152868898	159456	170081	rs587784225	NC_000023.11:152868897:T:
NM_015922.3(NSDHL):c.757C>T (p.Gln253Ter)	NSDHL	Q253*	Child syndrome	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000159454	X	152036185	X	152867641	159454	170079	rs141571609	NC_000023.11:152867640:C:T
NM_000252.2(MTM1):c.969del (p.Lys323_Val324insTer)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159012	X	149818284	X	150649811	159012	170021	rs587783865	NC_000023.11:150649810:AAAAAAA:AAAAAA
NM_000252.2(MTM1):c.961_962del (p.Leu321fs)	MTM1	L321fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159011	X	149818281 - 149818282	X	150649808 - 150649809	159011	170020	rs587783864	NC_000023.11:150649807:TTT:T
NM_000252.2(MTM1):c.958T>C (p.Ser320Pro)	MTM1	S320P	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159010	X	149818279	X	150649806	159010	170019	rs587783863	NC_000023.11:150649805:T:C
NM_000252.2(MTM1):c.912del (p.Glu305fs)	MTM1	E305fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Mar 15, 2013)	criteria provided, single submitter	VCV000159007	X	149818232	X	150649759	159007	170016	rs587783860	NC_000023.11:150649758:CC:C
NM_000252.2(MTM1):c.888_889del (p.Glu296_Ser297insTer)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159006	X	149818208 - 149818209	X	150649735 - 150649736	159006	170015	rs587783859	NC_000023.11:150649734:AAA:A
NM_000252.2(MTM1):c.867+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000159005	X	149814345	X	150645872	159005	170014	rs587783858	NC_000023.11:150645871:G:A
NM_000252.2(MTM1):c.85C>T (p.Arg29Ter)	MTM1	R29*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159004	X	149764983	X	150596519	159004	169960	rs587783857	NC_000023.11:150596518:C:T
NM_000252.2(MTM1):c.791T>G (p.Ile264Ser)	MTM1	I264S	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159003	X	149814268	X	150645795	159003	170013	rs587783856	NC_000023.11:150645794:T:G
NM_000252.2(MTM1):c.779A>C (p.Tyr260Ser)	MTM1	Y260S	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159002	X	149814256	X	150645783	159002	170012	rs587783855	NC_000023.11:150645782:A:C
NM_000252.2(MTM1):c.757C>T (p.Arg253Ter)	MTM1	R253*	Severe X-linked myotubular myopathy|not provided	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000159001	X	149814234	X	150645761	159001	170011	rs587783854	NC_000023.11:150645760:C:T
NM_000252.2(MTM1):c.683T>C (p.Leu228Pro)	MTM1	L228P	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158998	X	149814160	X	150645687	158998	170008	rs587783851	NC_000023.11:150645686:T:C
NM_000252.2(MTM1):c.679G>A (p.Val227Met)	MTM1	V227M	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158997	X	149814156	X	150645683	158997	170007	rs587783850	NC_000023.11:150645682:G:A
NM_000252.2(MTM1):c.678+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158996	X	149809892	X	150641419	158996	170006	rs587783849	NC_000023.11:150641418:G:A
NM_000252.2(MTM1):c.664C>T (p.Arg222Ter)	MTM1	R222*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158994	X	149809877	X	150641404	158994	170004	rs587783847	NC_000023.11:150641403:C:T
NM_000252.2(MTM1):c.64-1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158993	X	149764961	X	150596497	158993	169959	rs587783846	NC_000023.11:150596496:G:A
NM_000252.2(MTM1):c.637C>T (p.Leu213Phe)	MTM1	L213F	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158991	X	149809850	X	150641377	158991	170003	rs587783845	NC_000023.11:150641376:C:T
NM_000252.2(MTM1):c.63+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158989	X	149761140	X	150592678	158989	169956	rs587783843	NC_000023.11:150592677:G:A
NM_000252.2(MTM1):c.629A>G (p.Asp210Gly)	MTM1	D210G	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158988	X	149809842	X	150641369	158988	170002	rs587783842	NC_000023.11:150641368:A:G
NM_000252.2(MTM1):c.614C>T (p.Pro205Leu)	MTM1	P205L	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158987	X	149809827	X	150641354	158987	170001	rs587783841	NC_000023.11:150641353:C:T
NM_000252.2(MTM1):c.611T>G (p.Val204Gly)	MTM1	V204G	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158986	X	149809824	X	150641351	158986	170000	rs587783840	NC_000023.11:150641350:T:G
NM_000252.2(MTM1):c.591_594del (p.Tyr198fs)	MTM1	Y198fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158985	X	149809802 - 149809805	X	150641329 - 150641332	158985	169999	rs587783839	NC_000023.11:150641328:ACTTAC:AC
NM_000252.2(MTM1):c.557C>T (p.Thr186Ile)	MTM1	T186I	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158982	X	149809770	X	150641297	158982	169996	rs587783836	NC_000023.11:150641296:C:T
NM_000252.2(MTM1):c.550A>G (p.Arg184Gly)	MTM1	R184G	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158981	X	149809763	X	150641290	158981	169995	rs587783835	NC_000023.11:150641289:A:G
NM_000252.2(MTM1):c.549G>A (p.Trp183Ter)	MTM1	W183*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Apr 26, 2013)	criteria provided, single submitter	VCV000158980	X	149809762	X	150641289	158980	169994	rs587783834	NC_000023.11:150641288:G:A
NM_000252.2(MTM1):c.539_545del (p.Asn180fs)	MTM1	N180fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158979	X	149809749 - 149809755	X	150641276 - 150641282	158979	169993	rs587783833	NC_000023.11:150641275:CCAATCACCA:CCA
NM_000252.2(MTM1):c.535C>T (p.Pro179Ser)	MTM1	P179S	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158978	X	149809748	X	150641275	158978	169992	rs587783832	NC_000023.11:150641274:C:T
NM_000252.2(MTM1):c.529-2A>G	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158977	X	149809740	X	150641267	158977	169991	rs587783831	NC_000023.11:150641266:A:G
NM_000252.2(MTM1):c.528+1G>T	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158976	X	149807500	X	150639027	158976	169990	rs587783830	NC_000023.11:150639026:G:T
NM_000252.2(MTM1):c.514G>T (p.Glu172Ter)	MTM1	E172*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158974	X	149807485	X	150639012	158974	169988	rs587783828	NC_000023.11:150639011:G:T
NM_000252.2(MTM1):c.469del (p.Glu157fs)	MTM1	E157fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158973	X	149807440	X	150638967	158973	169987	rs587783827	NC_000023.11:150638966:G:
NM_000252.2(MTM1):c.431del (p.Leu144fs)	MTM1	L144fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Sep 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158972	X	149787599	X	150619126	158972	169986	rs587783826	NC_000023.11:150619125:T:
NM_000252.2(MTM1):c.420C>G (p.Tyr140Ter)	MTM1	Y140*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158971	X	149787588	X	150619115	158971	169985	rs587783825	NC_000023.11:150619114:C:G
NM_000252.2(MTM1):c.402del (p.Phe134fs)	MTM1	F134fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158970	X	149787568	X	150619095	158970	169984	rs587783824	NC_000023.11:150619094:TTT:TT
NM_000252.2(MTM1):c.3G>A (p.Met1Ile)	MTM1	M1I	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158969	X	149761079	X	150592617	158969	169955	rs587783823	NC_000023.11:150592616:G:A
NM_000252.2(MTM1):c.395_396AT[1] (p.Met133fs)	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158968	X	149787563 - 149787564	X	150619090 - 150619091	158968	169983	rs587783822	NC_000023.11:150619089:ATAT:AT
NM_000252.2(MTM1):c.343-2A>G	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158967	X	149787509	X	150619036	158967	169982	rs587783821	NC_000023.11:150619035:A:G
NM_000252.2(MTM1):c.340A>T (p.Lys114Ter)	MTM1	K114*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158965	X	149783170	X	150614697	158965	169980	rs587783819	NC_000023.11:150614696:A:T
NM_000252.2(MTM1):c.301A>G (p.Ser101Gly)	MTM1	S101G	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158964	X	149783131	X	150614658	158964	169979	rs587783818	NC_000023.11:150614657:A:G
NM_000252.2(MTM1):c.2T>G (p.Met1Arg)	MTM1	M1R	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158963	X	149761078	X	150592616	158963	169954	rs587783817	NC_000023.11:150592615:T:G
NM_000252.2(MTM1):c.260T>C (p.Leu87Pro)	MTM1	L87P	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158962	X	149783090	X	150614617	158962	169978	rs587783816	NC_000023.11:150614616:T:C
NM_000252.2(MTM1):c.252del (p.Asp84fs)	MTM1	D84fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158961	X	149783082	X	150614609	158961	169977	rs587783815	NC_000023.11:150614608:T:
NM_000252.2(MTM1):c.232-3C>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158960	X	149783059	X	150614586	158960	169974	rs587783814	NC_000023.11:150614585:C:A
NM_000252.2(MTM1):c.232-2A>C	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158959	X	149783060	X	150614587	158959	169975	rs587783813	NC_000023.11:150614586:A:C
NM_000252.2(MTM1):c.232-1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158958	X	149783061	X	150614588	158958	169976	rs587783812	NC_000023.11:150614587:G:A
NM_000252.2(MTM1):c.231+2T>G	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158957	X	149767152	X	150598688	158957	169973	rs587783811	NC_000023.11:150598687:T:G
NM_000252.2(MTM1):c.231+1G>A	MTM1		Severe X-linked myotubular myopathy|not provided	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158956	X	149767151	X	150598687	158956	169972	rs587783810	NC_000023.11:150598686:G:A
NM_000252.2(MTM1):c.208C>T (p.Leu70Phe)	MTM1	L70F	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158955	X	149767127	X	150598663	158955	169971	rs587783809	NC_000023.11:150598662:C:T
NM_000252.2(MTM1):c.205C>G (p.Arg69Gly)	MTM1	R69G	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158954	X	149767124	X	150598660	158954	169970	rs132630304	NC_000023.11:150598659:C:G
NM_000252.2(MTM1):c.1792del (p.His598fs)	MTM1	H598fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000158953	X	149840045	X	150671572	158953	170074	rs34119065	NC_000023.11:150671571:CCCC:CCC
NM_000252.2(MTM1):c.1558C>T (p.Arg520Ter)	MTM1	R520*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158950	X	149831996	X	150663523	158950	170071	rs587783805	NC_000023.11:150663522:C:T
NM_000252.2(MTM1):c.154del (p.Ile52fs)	MTM1	I52fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158949	X	149767073	X	150598609	158949	169969	rs587783804	NC_000023.11:150598608:A:
NM_000252.2(MTM1):c.153_156del (p.Ile52fs)	MTM1	I52fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158948	X	149767070 - 149767073	X	150598606 - 150598609	158948	169968	rs587783803	NC_000023.11:150598605:TACATA:TA
NM_000252.2(MTM1):c.1509del (p.Asn503fs)	MTM1	N503fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158947	X	149831947	X	150663474	158947	170070	rs587783802	NC_000023.11:150663473:C:
NM_000252.2(MTM1):c.1495T>C (p.Trp499Arg)	MTM1	W499R	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158946	X	149831933	X	150663460	158946	170069	rs587783801	NC_000023.11:150663459:T:C
NM_000252.2(MTM1):c.1467+2T>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158944	X	149828959	X	150660486	158944	170067	rs587783799	NC_000023.11:150660485:T:A
NM_000252.2(MTM1):c.1467+1G>T	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158943	X	149828958	X	150660485	158943	170066	rs587783798	NC_000023.11:150660484:G:T
NM_000252.2(MTM1):c.1467+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Jun 6, 2013)	criteria provided, single submitter	VCV000158942	X	149828958	X	150660485	158942	170065	rs587783798	NC_000023.11:150660484:G:A
NM_000252.2(MTM1):c.1465_1468del (p.Gln489fs)	MTM1	Q489fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158941	X	149828952 - 149828955	X	150660479 - 150660482	158941	170064	rs587783797	NC_000023.11:150660478:AGACAG:AG
NM_000252.2(MTM1):c.145G>T (p.Val49Phe)	MTM1	V49F	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158940	X	149767064	X	150598600	158940	169967	rs587783796	NC_000023.11:150598599:G:T
NM_000252.2(MTM1):c.145G>A (p.Val49Ile)	MTM1	V49I	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158939	X	149767064	X	150598600	158939	169966	rs587783796	NC_000023.11:150598599:G:A
NM_000252.2(MTM1):c.1456C>T (p.Arg486Ter)	MTM1	R486*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158938	X	149828946	X	150660473	158938	170063	rs587783795	NC_000023.11:150660472:C:T
NM_000252.2(MTM1):c.1433T>C (p.Phe478Ser)	MTM1	F478S	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158937	X	149828923	X	150660450	158937	170062	rs587783794	NC_000023.11:150660449:T:C
NM_000252.2(MTM1):c.1427G>T (p.Gly476Val)	MTM1	G476V	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158936	X	149828917	X	150660444	158936	170061	rs587783793	NC_000023.11:150660443:G:T
NM_000252.2(MTM1):c.1420C>T (p.Arg474Ter)	MTM1	R474*	not provided|Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158935	X	149828910	X	150660437	158935	170060	rs587783792	NC_000023.11:150660436:C:T
NM_000252.2(MTM1):c.139_141del (p.Lys47del)	MTM1	K47del	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158931	X	149767058 - 149767060	X	150598594 - 150598596	158931	169963	rs587783788	NC_000023.11:150598593:AAA:
NM_000252.2(MTM1):c.1378G>T (p.Glu460Ter)	MTM1	E460*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158928	X	149828868	X	150660395	158928	170056	rs587783786	NC_000023.11:150660394:G:T
NM_000252.2(MTM1):c.1376A>T (p.Asn459Ile)	MTM1	N459I	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158927	X	149828866	X	150660393	158927	170055	rs587783785	NC_000023.11:150660392:A:T
NM_000252.2(MTM1):c.1354-1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158924	X	149828843	X	150660370	158924	170053	rs587783782	NC_000023.11:150660369:G:A
NM_000252.2(MTM1):c.1353+2T>C	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158922	X	149828231	X	150659758	158922	170052	rs587783780	NC_000023.11:150659757:T:C
NM_000252.2(MTM1):c.1353+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158921	X	149828230	X	150659757	158921	170051	rs587783779	NC_000023.11:150659756:G:A
NM_000252.2(MTM1):c.1337G>A (p.Trp446Ter)	MTM1	W446*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158920	X	149828213	X	150659740	158920	170049	rs587783778	NC_000023.11:150659739:G:A
NM_000252.2(MTM1):c.1307del (p.Pro436fs)	MTM1	P436fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158917	X	149828182	X	150659709	158917	170046	rs587783775	NC_000023.11:150659708:CC:C
NM_000252.2(MTM1):c.1283_1286del (p.Asn428fs)	MTM1	N428fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158915	X	149828158 - 149828161	X	150659685 - 150659688	158915	170044	rs587783773	NC_000023.11:150659684:AACCA:A
NM_000252.2(MTM1):c.1262G>A (p.Arg421Gln)	MTM1	R421Q	Severe X-linked myotubular myopathy|not provided	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158914	X	149828138	X	150659665	158914	170043	rs587783772	NC_000023.11:150659664:G:A
NM_000252.2(MTM1):c.1261C>T (p.Arg421Ter)	MTM1	R421*	Severe X-linked myotubular myopathy|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158913	X	149828137	X	150659664	158913	170042	rs587783771	NC_000023.11:150659663:C:T
NM_000252.2(MTM1):c.1261-1G>C	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158912	X	149828136	X	150659663	158912	170041	rs587783770	NC_000023.11:150659662:G:C
NM_000252.2(MTM1):c.1260+1G>A	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158910	X	149826501	X	150658028	158910	170039	rs587783768	NC_000023.11:150658027:G:A
NM_000252.2(MTM1):c.1244G>A (p.Gly415Glu)	MTM1	G415E	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158908	X	149826484	X	150658011	158908	170037	rs587783766	NC_000023.11:150658010:G:A
NM_000252.2(MTM1):c.1232G>A (p.Trp411Ter)	MTM1	W411*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158905	X	149826472	X	150657999	158905	170034	rs587783763	NC_000023.11:150657998:G:A
NM_000252.2(MTM1):c.1205G>C (p.Gly402Ala)	MTM1	G402A	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158904	X	149826445	X	150657972	158904	170033	rs587783762	NC_000023.11:150657971:G:C
NM_000252.2(MTM1):c.1191T>G (p.Tyr397Ter)	MTM1	Y397*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158903	X	149826431	X	150657958	158903	170032	rs587783761	NC_000023.11:150657957:T:G
NM_000252.2(MTM1):c.1160C>A (p.Ser387Tyr)	MTM1	S387Y	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158901	X	149826400	X	150657927	158901	170030	rs587783759	NC_000023.11:150657926:C:A
NM_000252.2(MTM1):c.1139A>T (p.Asp380Val)	MTM1	D380V	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158900	X	149826379	X	150657906	158900	170029	rs587783758	NC_000023.11:150657905:A:T
NM_000252.2(MTM1):c.1137G>A (p.Trp379Ter)	MTM1	W379*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158899	X	149826377	X	150657904	158899	170028	rs587783757	NC_000023.11:150657903:G:A
NM_000252.2(MTM1):c.1136G>A (p.Trp379Ter)	MTM1	W379*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158898	X	149826376	X	150657903	158898	170027	rs587783756	NC_000023.11:150657902:G:A
NM_000252.2(MTM1):c.1132G>A (p.Gly378Arg)	MTM1	G378R	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158897	X	149826372	X	150657899	158897	170026	rs587783755	NC_000023.11:150657898:G:A
NM_000252.2(MTM1):c.1120C>G (p.His374Asp)	MTM1	H374D	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158896	X	149826360	X	150657887	158896	170025	rs587783754	NC_000023.11:150657886:C:G
NM_000252.2(MTM1):c.109C>T (p.Arg37Ter)	MTM1	R37*	not provided|Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158895	X	149765007	X	150596543	158895	169961	rs587783753	NC_000023.11:150596542:C:T
NM_000252.2(MTM1):c.1088_1089del (p.Lys363fs)	MTM1	K363fs	not provided|Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, multiple submitters, no conflicts	VCV000158894	X	149826327 - 149826328	X	150657854 - 150657855	158894	170024	rs587783752	NC_000023.11:150657853:AAA:A
NM_000252.2(MTM1):c.1053+1G>C	MTM1		Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158893	X	149818375	X	150649902	158893	170023	rs587783751	NC_000023.11:150649901:G:C
NM_018486.3(HDAC8):c.131del (p.Ser43_Leu44insTer)	HDAC8		Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Dec 2, 2013)	criteria provided, single submitter	VCV000158658	X	71791940	X	72572090	158658	170176	rs587783663	NC_000023.11:72572089:AAA:AA
NM_006579.3(EBP):c.480T>G (p.Tyr160Ter)	EBP	Y160*		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158549	X	48386632	X	48528244	158549	170131	rs587783616	NC_000023.11:48528243:T:G
NM_006579.3(EBP):c.462_463CT[1] (p.Ser155fs)	EBP			Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158548	X	48385665 - 48385666	X	48527277 - 48527278	158548	170130	rs587783615	NC_000023.11:48527276:TCTCT:TCT
NM_006579.3(EBP):c.328C>T (p.Arg110Ter)	EBP	R110*		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158545	X	48385403	X	48527015	158545	170127	rs587783613	NC_000023.11:48527014:C:T
NM_006579.3(EBP):c.310T>C (p.Tyr104His)	EBP	Y104H		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158541	X	48385385	X	48526997	158541	170123	rs587783609	NC_000023.11:48526996:T:C
NM_006579.3(EBP):c.304A>T (p.Lys102Ter)	EBP	K102*		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158540	X	48385379	X	48526991	158540	170122	rs587783608	NC_000023.11:48526990:A:T
NM_006579.3(EBP):c.301+2T>A	EBP			Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158538	X	48382462	X	48524074	158538	170120	rs587783606	NC_000023.11:48524073:T:A
NM_006579.3(EBP):c.292_296del (p.Ser98fs)	EBP	S98fs		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158536	X	48382450 - 48382454	X	48524062 - 48524066	158536	170118	rs587783604	NC_000023.11:48524061:ATCTCA:A
NM_006579.3(EBP):c.182G>A (p.Trp61Ter)	EBP	W61*		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158532	X	48382341	X	48523953	158532	170114	rs587783600	NC_000023.11:48523952:G:A
NM_006579.3(EBP):c.141G>T (p.Trp47Cys)	EBP	W47C	|MEND syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158530	X	48382300	X	48523912	158530	170113	rs587783599	NC_000023.11:48523911:G:T
NM_001005360.2(DNM2):c.1880C>G (p.Pro627Arg)	DNM2	P627R, P623R	Myopathy, centronuclear|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158520	19	10934562	19	10823886	158520	169467	rs587783598	NC_000019.10:10823885:C:G
NM_001005360.2(DNM2):c.1862T>C (p.Leu621Pro)	DNM2	L621P, L617P	Myopathy, centronuclear	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158519	19	10934544	19	10823868	158519	169466	rs587783597	NC_000019.10:10823867:T:C
NM_001005360.2(DNM2):c.1565G>A (p.Arg522His)	DNM2	R522H, R518H	Myopathy, centronuclear|Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|not provided	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158514	19	10922947	19	10812271	158514	169461	rs587783595	NC_000019.10:10812270:G:A
NM_001195553.2(DCX):c.95G>A (p.Ser32Asn)	DCX	S32N, S113N	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158512	X	110653532	X	111410304	158512	169934	rs587783593	NC_000023.11:111410303:C:T
NM_001195553.2(DCX):c.907C>T (p.Arg303Ter)	DCX	R303*, R384*	not provided|Heterotopia	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158511	X	110574171	X	111330943	158511	169849	rs587783592	NC_000023.11:111330942:G:A
NM_001195553.2(DCX):c.853A>T (p.Lys285Ter)	DCX	K285*, K366*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158510	X	110574225	X	111330997	158510	169850	rs587783591	NC_000023.11:111330996:T:A
NM_001195553.2(DCX):c.814C>T (p.Arg272Ter)	DCX	R272*, R353*	not provided|Heterotopia	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158509	X	110574264	X	111331036	158509	169851	rs587783590	NC_000023.11:111331035:G:A
NM_001195553.2(DCX):c.809-1G>A	DCX		Heterotopia|Lissencephaly, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158508	X	110574270	X	111331042	158508	169852	rs587783589	NC_000023.11:111331041:C:T
NM_001195553.2(DCX):c.781C>T (p.Gln261Ter)	DCX	Q261*, Q342*	not provided|Heterotopia	Pathogenic(Last reviewed: Sep 2, 2014)	criteria provided, multiple submitters, no conflicts	VCV000158507	X	110576306	X	111333078	158507	169853	rs587783588	NC_000023.11:111333077:G:A
NM_001195553.2(DCX):c.766A>T (p.Lys256Ter)	DCX	K256*, K337*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158505	X	110576321	X	111333093	158505	169855	rs587783586	NC_000023.11:111333092:T:A
NM_001195553.2(DCX):c.751G>T (p.Ala251Ser)	DCX	A251S, A332S	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158504	X	110576336	X	111333108	158504	169856	rs587783585	NC_000023.11:111333107:C:A
NM_001195553.2(DCX):c.734_736ATG[2] (p.Asp247del)	DCX	D247del	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158502	X	110576345 - 110576347	X	111333117 - 111333119	158502	169858	rs587783583	NC_000023.11:111333116:CATCATCATCA:CATCATCA
NM_001195553.2(DCX):c.683T>C (p.Leu228Pro)	DCX	L228P, L309P	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158499	X	110644240	X	111401012	158499	169861	rs587783580	NC_000023.11:111401011:A:G
NM_001195553.2(DCX):c.681del (p.Lys227fs)	DCX	K227fs, K308fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158498	X	110644242	X	111401014	158498	169862	rs587783579	NC_000023.11:111401013:TTTTTT:TTTTT
NM_001195553.2(DCX):c.670del (p.Val224fs)	DCX	V224fs, V305fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158497	X	110644253	X	111401025	158497	169863	rs587783578	NC_000023.11:111401024:CCCC:CCC
NM_001195553.2(DCX):c.666del (p.Val224fs)	DCX	V224fs, V305fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158495	X	110644257	X	111401029	158495	169865	rs587783576	NC_000023.11:111401028:GG:G
NM_001195553.2(DCX):c.651del (p.Ile218fs)	DCX	I218fs, I299fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158494	X	110644272	X	111401044	158494	169866	rs587783575	NC_000023.11:111401043:GG:G
NM_001195553.2(DCX):c.641T>C (p.Ile214Thr)	DCX	I214T, I295T	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158493	X	110644282	X	111401054	158493	169867	rs587783574	NC_000023.11:111401053:A:G
NM_001195553.2(DCX):c.628G>T (p.Val210Phe)	DCX	V210F, V291F	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158492	X	110644295	X	111401067	158492	169868	rs587783573	NC_000023.11:111401066:C:A
NM_001195553.2(DCX):c.611C>A (p.Ala204Asp)	DCX	A204D, A285D	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158490	X	110644312	X	111401084	158490	169870	rs587783571	NC_000023.11:111401083:G:T
NM_001195553.2(DCX):c.608C>A (p.Thr203Lys)	DCX	T203K, T284K	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158489	X	110644315	X	111401087	158489	169871	rs104894782	NC_000023.11:111401086:G:T
NM_001195553.2(DCX):c.607A>G (p.Thr203Ala)	DCX	T203A, T284A	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158488	X	110644316	X	111401088	158488	169872	rs587783570	NC_000023.11:111401087:T:C
NM_001195553.2(DCX):c.586C>T (p.Arg196Cys)	DCX	R196C, R277C	not provided|Heterotopia	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158485	X	110644337	X	111401109	158485	169875	rs587783568	NC_000023.11:111401108:G:A
NM_001195553.2(DCX):c.586C>G (p.Arg196Gly)	DCX	R196G, R277G	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158484	X	110644337	X	111401109	158484	169876	rs587783568	NC_000023.11:111401108:G:C
NM_001195553.2(DCX):c.586C>A (p.Arg196Ser)	DCX	R196S, R277S	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158483	X	110644337	X	111401109	158483	169877	rs587783568	NC_000023.11:111401108:G:T
NM_001195553.2(DCX):c.578_585del (p.Lys193fs)	DCX	K274fs, K193fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158482	X	110644338 - 110644345	X	111401110 - 111401117	158482	169878	rs587783567	NC_000023.11:111401109:CACAGCCT:
NM_001195553.2(DCX):c.572C>G (p.Pro191Arg)	DCX	P191R, P272R	not provided|Heterotopia	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158481	X	110644351	X	111401123	158481	169879	rs587783566	NC_000023.11:111401122:G:C
NM_001195553.2(DCX):c.55C>T (p.Arg19Ter)	DCX	R19*, R100*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158479	X	110653572	X	111410344	158479	169935	rs587783564	NC_000023.11:111410343:G:A
NM_001195553.2(DCX):c.557G>T (p.Arg186Leu)	DCX	R186L, R267L	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158478	X	110644366	X	111401138	158478	169881	rs587783563	NC_000023.11:111401137:C:A
NM_001195553.2(DCX):c.556C>T (p.Arg186Cys)	DCX	R186C, R267C	not provided|Heterotopia	Pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158476	X	110644367	X	111401139	158476	169883	rs587783562	NC_000023.11:111401138:G:A
NM_001195553.2(DCX):c.538A>G (p.Lys180Glu)	DCX	K180E, K261E	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158474	X	110644385	X	111401157	158474	169885	rs587783560	NC_000023.11:111401156:T:C
NM_001195553.2(DCX):c.533G>T (p.Arg178Leu)	DCX	R178L, R259L	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158473	X	110644390	X	111401162	158473	169886	rs587783559	NC_000023.11:111401161:C:A
NM_001195553.2(DCX):c.532C>T (p.Arg178Cys)	DCX	R178C, R259C	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158472	X	110644391	X	111401163	158472	169887	rs587783558	NC_000023.11:111401162:G:A
NM_001195553.2(DCX):c.532C>G (p.Arg178Gly)	DCX	R178G, R259G	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158471	X	110644391	X	111401163	158471	169888	rs587783558	NC_000023.11:111401162:G:C
NM_001195553.2(DCX):c.520A>G (p.Lys174Glu)	DCX	K174E, K255E	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158470	X	110644403	X	111401175	158470	169889	rs587783557	NC_000023.11:111401174:T:C
NM_001195553.2(DCX):c.494_504del (p.Ser165fs)	DCX	S246fs, S165fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158469	X	110644419 - 110644429	X	111401191 - 111401201	158469	169890	rs587783556	NC_000023.11:111401190:TGCACTGTTGCTGC:TGC
NM_001195553.2(DCX):c.478_479del (p.Gln160fs)	DCX	Q241fs, Q160fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158468	X	110644444 - 110644445	X	111401216 - 111401217	158468	169891	rs587783555	NC_000023.11:111401215:TG:
NM_001195553.2(DCX):c.478C>T (p.Gln160Ter)	DCX	Q160*, Q241*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158467	X	110644445	X	111401217	158467	169892	rs587783554	NC_000023.11:111401216:G:A
NM_001195553.2(DCX):c.451A>T (p.Lys151Ter)	DCX	K151*, K232*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158466	X	110644472	X	111401244	158466	169893	rs587783553	NC_000023.11:111401243:T:A
NM_001195553.2(DCX):c.451A>G (p.Lys151Glu)	DCX	K151E, K232E	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158465	X	110644472	X	111401244	158465	169894	rs587783553	NC_000023.11:111401243:T:C
NM_001195553.2(DCX):c.413A>G (p.Tyr138Cys)	DCX	Y138C, Y219C	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158464	X	110644510	X	111401282	158464	169895	rs587783552	NC_000023.11:111401281:T:C
NM_001195553.2(DCX):c.412T>C (p.Tyr138His)	DCX	Y138H, Y219H	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158463	X	110644511	X	111401283	158463	169896	rs587783551	NC_000023.11:111401282:A:G
NM_001195553.2(DCX):c.409G>T (p.Glu137Ter)	DCX	E137*, E218*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158462	X	110644514	X	111401286	158462	169897	rs587783550	NC_000023.11:111401285:C:A
NM_001195553.2(DCX):c.391_393del (p.Asn131del)	DCX	N131del, N212del	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158461	X	110644530 - 110644532	X	111401302 - 111401304	158461	169898	rs587783549	NC_000023.11:111401301:GTTGT:GT
NM_001195553.2(DCX):c.386C>T (p.Ser129Leu)	DCX	S129L, S210L	Heterotopia	Pathogenic(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	VCV000158460	X	110644537	X	111401309	158460	169899	rs587783548	NC_000023.11:111401308:G:A
NM_178151.2(DCX):c.367del	DCX		Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158457	X	110644556	X	111401328	158457	169902	rs587783545	NC_000023.11:111401327:CCCC:CCC
NM_001195553.2(DCX):c.364G>A (p.Gly122Arg)	DCX	G122R, G203R	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158456	X	110653263	X	111410035	158456	169903	rs587783544	NC_000023.11:111410034:C:T
NM_001195553.2(DCX):c.310A>T (p.Ile104Phe)	DCX	I104F, I185F	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158453	X	110653317	X	111410089	158453	169906	rs201870761	NC_000023.11:111410088:T:A
NM_001195553.2(DCX):c.304C>T (p.Arg102Cys)	DCX	R102C, R183C	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158452	X	110653323	X	111410095	158452	169907	rs587783541	NC_000023.11:111410094:G:A
NM_001195553.2(DCX):c.301G>A (p.Val101Met)	DCX	V101M, V182M	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158451	X	110653326	X	111410098	158451	169908	rs587783540	NC_000023.11:111410097:C:T
NM_001195553.2(DCX):c.2T>C (p.Met1Thr)	DCX	M1T, M82T	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158450	X	110653625	X	111410397	158450	169936	rs587783539	NC_000023.11:111410396:A:G
NM_001195553.2(DCX):c.299G>T (p.Gly100Val)	DCX	G100V, G181V	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158449	X	110653328	X	111410100	158449	169909	rs587783538	NC_000023.11:111410099:C:A
NM_001195553.2(DCX):c.290T>G (p.Leu97Arg)	DCX	L97R, L178R	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158447	X	110653337	X	111410109	158447	169911	rs587783537	NC_000023.11:111410108:A:C
NM_001195553.2(DCX):c.272T>C (p.Leu91Pro)	DCX	L91P, L172P	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158446	X	110653355	X	111410127	158446	169912	rs587783536	NC_000023.11:111410126:A:G
NM_001195553.2(DCX):c.266G>C (p.Arg89Pro)	DCX	R89P, R170P	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158445	X	110653361	X	111410133	158445	169913	rs61729440	NC_000023.11:111410132:C:G
NM_001195553.2(DCX):c.265C>T (p.Arg89Ter)	DCX	R89*, R170*	Heterotopia	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000158444	X	110653362	X	111410134	158444	169914	rs104894785	NC_000023.11:111410133:G:A
NM_001195553.2(DCX):c.233G>T (p.Arg78Leu)	DCX	R78L, R159L	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158443	X	110653394	X	111410166	158443	169915	rs104894784	NC_000023.11:111410165:C:A
NM_001195553.2(DCX):c.232C>T (p.Arg78Cys)	DCX	R78C, R159C	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158442	X	110653395	X	111410167	158442	169916	rs587783535	NC_000023.11:111410166:G:A
NM_001195553.2(DCX):c.218C>T (p.Ser73Phe)	DCX	S73F, S154F	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158440	X	110653409	X	111410181	158440	169918	rs587783533	NC_000023.11:111410180:G:A
NM_001195553.2(DCX):c.210C>A (p.Tyr70Ter)	DCX	Y70*, Y151*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158439	X	110653417	X	111410189	158439	169919	rs587783532	NC_000023.11:111410188:G:T
NM_001195553.2(DCX):c.182G>A (p.Gly61Glu)	DCX	G61E, G142E	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158434	X	110653445	X	111410217	158434	169924	rs587783527	NC_000023.11:111410216:C:T
NM_001195553.2(DCX):c.176G>A (p.Arg59His)	DCX	R59H, R140H	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158433	X	110653451	X	111410223	158433	169925	rs122457137	NC_000023.11:111410222:C:T
NM_001195553.2(DCX):c.151_154del (p.Lys51fs)	DCX	K51fs, K132fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158430	X	110653473 - 110653476	X	111410245 - 111410248	158430	169928	rs587783524	NC_000023.11:111410244:CTTTCTT:CTT
NM_001195553.2(DCX):c.150G>T (p.Lys50Asn)	DCX	K50N, K131N	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158429	X	110653477	X	111410249	158429	169929	rs587783523	NC_000023.11:111410248:C:A
NM_001195553.2(DCX):c.130C>T (p.Gln44Ter)	DCX	Q44*, Q125*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158428	X	110653497	X	111410269	158428	169930	rs587783522	NC_000023.11:111410268:G:A
NM_001195553.2(DCX):c.128T>C (p.Leu43Ser)	DCX	L43S, L124S	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158427	X	110653499	X	111410271	158427	169931	rs587783521	NC_000023.11:111410270:A:G
NM_001195553.2(DCX):c.124del (p.Thr42fs)	DCX	T42fs, T123fs	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158426	X	110653503	X	111410275	158426	169932	rs587783520	NC_000023.11:111410274:TT:T
NM_001195553.2(DCX):c.115C>T (p.Arg39Ter)	DCX	R39*, R120*	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158425	X	110653512	X	111410284	158425	169933	rs587783519	NC_000023.11:111410283:G:A
NM_001195553.2(DCX):c.1045-2A>G	DCX		Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158424	X	110544973	X	111301745	158424	169848	rs587783518	NC_000023.11:111301744:T:C
NM_001323289.2(CDKL5):c.622C>T (p.Gln208Ter)	CDKL5	Q208*	Stereotypical body rocking|Global developmental delay|Seizures|Stereotypical hand wringing|Generalized hypotonia|Stereotypy|Delayed speech and language development|Bruxism|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158186	X	18606141	X	18588021	158186	170101	rs587783405	NC_000023.11:18588020:C:T
NM_001323289.2(CDKL5):c.1797dup (p.Ser600fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 22, 2013)	criteria provided, single submitter	VCV000158181	X	18622839 - 18622840	X	18604719 - 18604720	158181	170107	rs587783401	NC_000023.11:18604719:CC:CCC
NM_001323289.2(CDKL5):c.146-1G>A	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158179	X	18593473	X	18575353	158179	170097	rs587783399	NC_000023.11:18575352:G:A
NM_001323289.2(CDKL5):c.1345_1346del (p.Glu449fs)	CDKL5	E449fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158177	X	18622389 - 18622390	X	18604269 - 18604270	158177	170104	rs587783398	NC_000023.11:18604268:GA:
NM_001136191.3(KANK2):c.2009C>T (p.Ala670Val)	KANK2	A670V, A678V	Palmoplantar keratoderma and woolly hair	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000158088	19	11285208	19	11174532	158088	167939	rs606231303	NC_000019.10:11174531:G:A
NM_003688.3(CASK):c.880C>T (p.Gln294Ter)	CASK	Q294*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158087	X	41495866	X	41636613	158087	167938	rs587783371	NC_000023.11:41636612:G:A
NM_003688.3(CASK):c.708+1G>A	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158082	X	41524529	X	41665276	158082	167932	rs587783368	NC_000023.11:41665275:C:T
NM_003688.3(CASK):c.430-2A>T	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158077	X	41530785	X	41671532	158077	167924	rs587783366	NC_000023.11:41671531:T:A
NM_003688.3(CASK):c.2470C>T (p.Gln824Ter)	CASK	Q824*, Q800*, Q829*, Q801*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158074	X	41390295	X	41531042	158074	167921	rs587783364	NC_000023.11:41531041:G:A
NM_003688.3(CASK):c.20_27del (p.Leu7fs)	CASK	L7fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Apr 3, 2014)	criteria provided, single submitter	VCV000158071	X	41782215 - 41782222	X	41922962 - 41922969	158071	167918	rs587783362	NC_000023.11:41922961:CTCGAACA:
NM_003688.3(CASK):c.2074C>T (p.Gln692Ter)	CASK	Q692*, Q663*, Q669*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158070	X	41402025	X	41542772	158070	167917	rs587783361	NC_000023.11:41542771:G:A
NM_003688.3(CASK):c.2041C>T (p.Arg681Ter)	CASK	R681*, R658*, R652*	not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158069	X	41402058	X	41542805	158069	167916	rs587783360	NC_000023.11:41542804:G:A
NM_003688.3(CASK):c.1644_1645del (p.Val549fs)	CASK	V543fs, V549fs	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158066	X	41420835 - 41420836	X	41561582 - 41561583	158066	167913	rs587783357	NC_000023.11:41561581:CT:
NM_139058.3(ARX):c.998C>G (p.Thr333Ser)	ARX	T333S	epileptic encephalopathy, early infanitle, 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157766	X	25031114	X	25012997	157766	167614	rs104894745	NC_000023.11:25012996:G:C
NM_139058.3(ARX):c.995G>T (p.Arg332Leu)	ARX	R332L	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157765	X	25031117	X	25013000	157765	167613	rs111033612	NC_000023.11:25012999:C:A
NM_139058.3(ARX):c.617del (p.Gly206fs)	ARX	G206fs	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157759	X	25031495	X	25013378	157759	167607	rs587783202	NC_000023.11:25013377:CC:C
NM_139058.3(ARX):c.34G>T (p.Glu12Ter)	ARX	E12*	epileptic encephalopathy, early infanitle, 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157757	X	25033821	X	25015704	157757	167605	rs587783200	NC_000023.11:25015703:C:A
NM_139058.3(ARX):c.172del (p.Ala58fs)	ARX	A58fs	not provided	Pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	VCV000157750	X	25033683	X	25015566	157750	167598	rs587783193	NC_000023.11:25015565:C:
NM_139058.3(ARX):c.1544del (p.Gly515fs)	ARX	G515fs	epileptic encephalopathy, early infanitle, 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157749	X	25022932	X	25004815	157749	167597	rs587783192	NC_000023.11:25004814:CCC:CC
NM_139058.3(ARX):c.1465del (p.Ala489fs)	ARX	A489fs	Epileptic encephalopathy, early infantile, 1|Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157748	X	25023011	X	25004894	157748	167596	rs587783191	NC_000023.11:25004893:CC:C
NM_139058.3(ARX):c.1414C>T (p.Arg472Ter)	ARX	R472*	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157746	X	25025262	X	25007145	157746	167594	rs587783189	NC_000023.11:25007144:G:A
NM_139058.3(ARX):c.1372del (p.Ala458fs)	ARX	A458fs	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000157744	X	25025304	X	25007187	157744	167592	rs587783187	NC_000023.11:25007186:CCCC:CCC
NM_139058.3(ARX):c.1111C>T (p.Arg371Ter)	ARX	R371*	not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000157739	X	25028385	X	25010268	157739	167587	rs587783182	NC_000023.11:25010267:G:A
NM_021102.4(SPINT2):c.502G>A (p.Gly168Ser)	SPINT2	G168S, G111S	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000157607	19	38780869	19	38290229	157607	167467	rs606231284	NC_000019.10:38290228:G:A
NM_014927.5(CNKSR2):c.453dup (p.Asp152fs)	CNKSR2		Intellectual disability, X-linked, syndromic, Houge type	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000157605	X	21458832 - 21458833	X	21440714 - 21440715	157605	167465	rs606231282	NC_000023.11:21440714:A:AA
NM_013444.3(UBQLN2):c.1490C>T (p.Pro497Leu)	UBQLN2	P497L	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000157594	X	56591796	X	56565363	157594	167455	rs387906709	NC_000023.11:56565362:C:T
NM_003784.4(SERPINB7):c.522dup (p.Val175fs)	SERPINB7		Palmoplantar keratoderma, nagashima type|not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000157566	18	61465904 - 61465905	18	63798670 - 63798671	157566	167428	rs672601344	NC_000018.10:63798670:T:TT
NM_015559.3(SETBP1):c.1876C>T (p.Arg626Ter)	SETBP1	R626*	not provided|Mental retardation, autosomal dominant 29|Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157560	18	42531181	18	44951216	157560	167423	rs606231273	NC_000018.10:44951215:C:T
NM_015559.3(SETBP1):c.1873C>T (p.Arg625Ter)	SETBP1	R625*	Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29|not provided|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157559	18	42531178	18	44951213	157559	167422	rs606231272	NC_000018.10:44951212:C:T
NM_015559.3(SETBP1):c.427del (p.Arg143fs)	SETBP1	R143fs	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157558	18	42281738	18	44701771	157558	167421	rs606231271	NC_000018.10:44701770:CCC:CC
NM_015559.3(SETBP1):c.3032C>G (p.Ser1011Ter)	SETBP1	S1011*	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157557	18	42532337	18	44952372	157557	167420	rs606231270	NC_000018.10:44952371:C:G
NM_015559.3(SETBP1):c.1596G>A (p.Trp532Ter)	SETBP1	W532*	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157556	18	42530901	18	44950936	157556	167419	rs672601342	NC_000018.10:44950935:G:A
NM_015559.3(SETBP1):c.2464del (p.Ile822fs)	SETBP1	I822fs	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157555	18	42531769	18	44951803	157555	167418	rs606231269	NC_000018.10:44951802:AA:A
NM_001323289.2(CDKL5):c.2671C>T (p.Gln891Ter)	CDKL5	Q891*	not provided	Pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	VCV000156692	X	18646665	X	18628545	156692	166546	rs587783159	NC_000023.11:18628544:C:T
NM_001323289.2(CDKL5):c.2596C>T (p.Gln866Ter)	CDKL5	Q866*	not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 16, 2012)	criteria provided, multiple submitters, no conflicts	VCV000156691	X	18646590	X	18628470	156691	166545	rs587783158	NC_000023.11:18628469:C:T
NM_001323289.2(CDKL5):c.1944+2T>G	CDKL5		not provided	Pathogenic(Last reviewed: Mar 12, 2012)	criteria provided, single submitter	VCV000156687	X	18622990	X	18604870	156687	166541	rs587783155	NC_000023.11:18604869:T:G
NM_001323289.2(CDKL5):c.1324C>T (p.Gln442Ter)	CDKL5	Q442*	not provided	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000156682	X	18622368	X	18604248	156682	166536	rs587783151	NC_000023.11:18604247:C:T
NM_001323289.2(CDKL5):c.826-1G>C	CDKL5		not provided	Pathogenic(Last reviewed: Nov 9, 2012)	criteria provided, single submitter	VCV000156680	X	18616581	X	18598461	156680	166534	rs587783149	NC_000023.11:18598460:G:C
NM_001323289.2(CDKL5):c.1670C>G (p.Ser557Ter)	CDKL5	S557*	not provided	Pathogenic(Last reviewed: Feb 21, 2013)	criteria provided, single submitter	VCV000156676	X	18622714	X	18604594	156676	166530	rs587783145	NC_000023.11:18604593:C:G
NM_001323289.2(CDKL5):c.99+5G>A	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 29, 2012)	criteria provided, single submitter	VCV000156660	X	18528979	X	18510859	156660	166514	rs587783131	NC_000023.11:18510858:G:A
NM_001323289.2(CDKL5):c.73G>A (p.Gly25Arg)	CDKL5	G25R	not provided	Pathogenic(Last reviewed: Oct 15, 2012)	criteria provided, single submitter	VCV000156659	X	18528948	X	18510828	156659	166513	rs587783130	NC_000023.11:18510827:G:A
NM_001323289.2(CDKL5):c.2608dup (p.Ser870fs)	CDKL5		not provided	Pathogenic(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	VCV000156654	X	18646600 - 18646601	X	18628480 - 18628481	156654	166508	rs587783126	NC_000023.11:18628480:TT:TTT
NM_001323289.2(CDKL5):c.2549del (p.Asn850fs)	CDKL5	N850fs	not provided	Pathogenic(Last reviewed: May 7, 2013)	criteria provided, single submitter	VCV000156653	X	18646541	X	18628421	156653	166507	rs587783125	NC_000023.11:18628420:AAA:AA
NM_001323289.2(CDKL5):c.2469del (p.Glu824fs)	CDKL5	E824fs	not provided	Pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	VCV000156652	X	18643337	X	18625217	156652	166506	rs587783124	NC_000023.11:18625216:CCCC:CCC
NM_001323289.2(CDKL5):c.2360_2363del (p.Lys787fs)	CDKL5	K787fs	not provided	Pathogenic(Last reviewed: Feb 26, 2013)	criteria provided, single submitter	VCV000156651	X	18638068 - 18638071	X	18619948 - 18619951	156651	166505	rs587783123	NC_000023.11:18619947:AAAGAA:AA
NM_001323289.2(CDKL5):c.2323_2326del (p.Glu775fs)	CDKL5	E775fs	not provided	Pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	VCV000156650	X	18638032 - 18638035	X	18619912 - 18619915	156650	166504	rs267608654	NC_000023.11:18619911:AGAGA:A
NM_001323289.2(CDKL5):c.2254dup (p.Arg752fs)	CDKL5		not provided	Pathogenic(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	VCV000156649	X	18631368 - 18631369	X	18613248 - 18613249	156649	166503	rs587783121	NC_000023.11:18613248:AAAAA:AAAAAA
NM_001323289.2(CDKL5):c.2203_2204AG[1] (p.Arg735fs)	CDKL5		not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	VCV000156648	X	18631322 - 18631323	X	18613202 - 18613203	156648	166502	rs587783120	NC_000023.11:18613201:AGAG:AG
NM_001323289.2(CDKL5):c.2148_2149del (p.Tyr716_Arg717delinsTer)	CDKL5		not provided	Pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000156647	X	18627685 - 18627686	X	18609565 - 18609566	156647	166501	rs587783119	NC_000023.11:18609564:ACA:A
NM_001323289.2(CDKL5):c.1909del (p.Ala637fs)	CDKL5	A637fs	not provided	Pathogenic(Last reviewed: Jul 18, 2013)	criteria provided, single submitter	VCV000156646	X	18622953	X	18604833	156646	166500	rs587783118	NC_000023.11:18604832:G:
NM_001323289.2(CDKL5):c.1885_1886dup (p.Leu629fs)	CDKL5		not provided	Pathogenic(Last reviewed: Nov 14, 2012)	criteria provided, single submitter	VCV000156645	X	18622928 - 18622929	X	18604808 - 18604809	156645	166499	rs587783117	NC_000023.11:18604808:TT:TTTT
NM_001323289.2(CDKL5):c.1795dup (p.Thr599fs)	CDKL5		not provided	Pathogenic(Last reviewed: Dec 19, 2012)	criteria provided, single submitter	VCV000156644	X	18622838 - 18622839	X	18604718 - 18604719	156644	166498	rs587783116	NC_000023.11:18604718:A:AA
NM_001323289.2(CDKL5):c.1671dup (p.Arg558fs)	CDKL5		not provided	Pathogenic(Last reviewed: Mar 28, 2014)	criteria provided, single submitter	VCV000156643	X	18622714 - 18622715	X	18604594 - 18604595	156643	166497	rs587783115	NC_000023.11:18604594:A:AA
NM_001323289.2(CDKL5):c.1345_1363del (p.Glu449fs)	CDKL5	E449fs	not provided	Pathogenic(Last reviewed: Dec 7, 2012)	criteria provided, single submitter	VCV000156641	X	18622388 - 18622406	X	18604268 - 18604286	156641	166495	rs587783113	NC_000023.11:18604267:GGAAAGCTCTCAAAGCAAAG:G
NM_001323289.2(CDKL5):c.808dup (p.Leu270fs)	CDKL5		not provided	Pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000156640	X	18613530 - 18613531	X	18595410 - 18595411	156640	166494	rs587783112	NC_000023.11:18595410:C:CC
NM_001323289.2(CDKL5):c.549_552del (p.Leu184fs)	CDKL5	L184fs	not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000156639	X	18602465 - 18602468	X	18584345 - 18584348	156639	166493	rs587783111	NC_000023.11:18584344:CTTACTT:CTT
NM_001323289.2(CDKL5):c.282+4del	CDKL5		not provided	Pathogenic(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	VCV000156638	X	18593613	X	18575493	156638	166492	rs587783110	NC_000023.11:18575492:AA:A
NM_001323289.2(CDKL5):c.248del (p.Gly83fs)	CDKL5	G83fs	not provided	Pathogenic(Last reviewed: Aug 2, 2013)	criteria provided, single submitter	VCV000156637	X	18593573	X	18575453	156637	166491	rs587783109	NC_000023.11:18575452:GGGG:GGG
NM_139058.3(ARX):c.1141G>A (p.Ala381Thr)	ARX	A381T	not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000156619	X	25025535	X	25007418	156619	166473	rs587783096	NC_000023.11:25007417:C:T
NM_001323289.2(CDKL5):c.700C>T (p.Gln234Ter)	CDKL5	Q234*	not provided	Pathogenic(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	VCV000156608	X	18606219	X	18588099	156608	166462	rs587783089	NC_000023.11:18588098:C:T
NM_001323289.2(CDKL5):c.577G>A (p.Asp193Asn)	CDKL5	D193N	not provided	Pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	VCV000156605	X	18606096	X	18587976	156605	166459	rs587783086	NC_000023.11:18587975:G:A
NM_001323289.2(CDKL5):c.542A>C (p.Glu181Ala)	CDKL5	E181A	not provided	Pathogenic(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	VCV000156604	X	18602461	X	18584341	156604	166458	rs587783085	NC_000023.11:18584340:A:C
NM_001323289.2(CDKL5):c.449A>G (p.Lys150Arg)	CDKL5	K150R	not provided	Pathogenic(Last reviewed: Jun 6, 2013)	criteria provided, single submitter	VCV000156602	X	18600056	X	18581936	156602	166456	rs587783083	NC_000023.11:18581935:A:G
NM_001323289.2(CDKL5):c.413C>T (p.Pro138Leu)	CDKL5	P138L	not provided	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	VCV000156600	X	18600020	X	18581900	156600	166454	rs587783081	NC_000023.11:18581899:C:T
NM_001323289.2(CDKL5):c.404-2A>G	CDKL5		not provided	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000156599	X	18600009	X	18581889	156599	166453	rs587783080	NC_000023.11:18581888:A:G
NM_001323289.2(CDKL5):c.356T>G (p.Leu119Arg)	CDKL5	L119R	not provided	Pathogenic(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	VCV000156597	X	18598041	X	18579921	156597	166451	rs587783078	NC_000023.11:18579920:T:G
NM_001323289.2(CDKL5):c.351T>A (p.Tyr117Ter)	CDKL5	Y117*	not provided	Pathogenic(Last reviewed: Jul 19, 2013)	criteria provided, single submitter	VCV000156596	X	18598036	X	18579916	156596	166450	rs587783077	NC_000023.11:18579915:T:A
NM_001323289.2(CDKL5):c.282+2T>G	CDKL5		not provided	Pathogenic(Last reviewed: Sep 17, 2014)	criteria provided, single submitter	VCV000156594	X	18593612	X	18575492	156594	166448	rs587783075	NC_000023.11:18575491:T:G
NM_001323289.2(CDKL5):c.250A>T (p.Lys84Ter)	CDKL5	K84*	not provided	Pathogenic(Last reviewed: Jan 31, 2013)	criteria provided, single submitter	VCV000156593	X	18593578	X	18575458	156593	166447	rs587783074	NC_000023.11:18575457:A:T
NM_001323289.2(CDKL5):c.220G>T (p.Glu74Ter)	CDKL5	E74*	not provided	Pathogenic(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	VCV000156592	X	18593548	X	18575428	156592	166446	rs587783073	NC_000023.11:18575427:G:T
NM_001323289.2(CDKL5):c.211A>G (p.Asn71Asp)	CDKL5	N71D	not provided|Atypical Rett syndrome	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	VCV000156591	X	18593539	X	18575419	156591	166445	rs587783072	NC_000023.11:18575418:A:G
NM_022082.4(SLC17A9):c.25C>T (p.Arg9Cys)	SLC17A9	R9C	Porokeratosis 8, disseminated superficial actinic type	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000156579	20	61584207	20	62952855	156579	166403	rs548728088	NC_000020.11:62952854:C:T
NM_022082.4(SLC17A9):c.932G>A (p.Arg311Gln)	SLC17A9	R311Q, R305Q	Porokeratosis 8, disseminated superficial actinic type	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000156578	20	61596505	20	62965153	156578	166402	rs606231251	NC_000020.11:62965152:G:A
NM_144773.3(PROKR2):c.743G>A (p.Arg248Gln)	PROKR2	R248Q	Hypogonadotropic hypogonadism 3 without anosmia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000156565	20	5283098	20	5302452	156565	166369	rs376142095	NC_000020.11:5302451:C:T
NM_144773.3(PROKR2):c.343G>A (p.Val115Met)	PROKR2	V115M	Kallmann syndrome 3	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000156563	20	5294673	20	5314027	156563	166367	rs138672528	NC_000020.11:5314026:C:T
NM_004975.4(KCNB1):c.1135G>A (p.Gly379Arg)	KCNB1	G379R	Epileptic encephalopathy, early infantile, 26	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000156535	20	47990962	20	49374425	156535	166306	rs587777850	NC_000020.11:49374424:C:T
NM_004975.4(KCNB1):c.1121C>T (p.Thr374Ile)	KCNB1	T374I	not provided|Epileptic encephalopathy, early infantile, 26	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000156534	20	47990976	20	49374439	156534	166305	rs587777849	NC_000020.11:49374438:G:A
NM_004975.4(KCNB1):c.1041C>A (p.Ser347Arg)	KCNB1	S347R	Epileptic encephalopathy, early infantile, 26	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000156533	20	47991056	20	49374519	156533	166304	rs587777848	NC_000020.11:49374518:G:T
NM_171998.4(RAB39B):c.503C>A (p.Thr168Lys)	RAB39B	T168K	not provided|Early-onset parkinsonism-intellectual disability syndrome	Pathogenic	criteria provided, single submitter	VCV000156532	X	154490227	X	155260942	156532	166303	rs587777874	NC_000023.11:155260941:G:T
NM_005359.5(SMAD4):c.1547dupA (p.Ser517Glufs)	SMAD4		not provided|Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000156513	18	48604724 - 48604725	18	51078354 - 51078355	156513	166278	rs587783060	NC_000018.10:51078354:A:AA
NM_145045.5(CCDC151):c.1256C>A (p.Ser419Ter)	CCDC151	S419*, S365*, S359*	Ciliary dyskinesia, primary, 30|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000156366	19	11533390	19	11422722	156366	166146	rs587777780	NC_000019.10:11422721:G:T
NM_145045.5(CCDC151):c.925G>T (p.Glu309Ter)	CCDC151	E309*, E255*, E249*	Ciliary dyskinesia, primary, 30|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000156365	19	11537002	19	11426182	156365	166145	rs587777779	NC_000019.10:11426181:C:A
NM_000307.4(POU3F4):c.896delA (p.Lys299Serfs)	POU3F4	L298*, K299fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000156303	X	82764227	X	83509219	156303	166083	rs267606974	NC_000023.11:83509218:AA:A
NM_002049.3(GATA1):c.1240T>C (p.Ter414Arg)	GATA1	*414R	GATA-1-related thrombocytopenia with dyserythropoiesis|Thrombocytopenia	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000156270	X	48652569	X	48794162	156270	166055	rs587776456	NC_000023.11:48794161:T:C
NM_002049.3(GATA1):c.994G>T (p.Gly332Cys)	GATA1	G332C	GATA-1-related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000156269	X	48652323	X	48793916	156269	166054	rs587776455	NC_000023.11:48793915:G:T
NM_002049.3(GATA1):c.622G>C (p.Gly208Arg)	GATA1	G208R	GATA-1-related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000156268	X	48650753	X	48792346	156268	166053	rs587776454	NC_000023.11:48792345:G:C
NM_002049.3(GATA1):c.220G>C (p.Val74Leu)	GATA1	V74L	GATA-1-related thrombocytopenia with dyserythropoiesis|Anemia without thromobocytopenia, X-linked	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000156266	X	48649736	X	48791329	156266	166051	rs587776452	NC_000023.11:48791328:G:C
NM_002049.3(GATA1):c.2T>C (p.Met1Thr)	GATA1	M1T	GATA-1-related thrombocytopenia with dyserythropoiesis|Anemia without thromobocytopenia, X-linked	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000156265	X	48649518	X	48791111	156265	166050	rs587776451	NC_000023.11:48791110:T:C
NM_016120.4(RLIM):c.1067A>G (p.Tyr356Cys)	RLIM	Y356C	Mental retardation, X-linked 61|Non-syndromic X-linked intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2015)	no assertion criteria provided	VCV000156224	X	73812083	X	74592248	156224	166020	rs786205133	NC_000023.11:74592247:T:C
NM_001323289.2(CDKL5):c.978-2A>G	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156095	X	18622020	X	18603900	156095	165891	rs267608553	NC_000023.11:18603899:A:G
NM_001323289.2(CDKL5):c.64+2del	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156093	X	18525282	X	18507162	156093	165889	rs267608419	NC_000023.11:18507161:T:
NM_001323289.2(CDKL5):c.464-2A>G	CDKL5		Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156090	X	18602381	X	18584261	156090	165886	rs267608480	NC_000023.11:18584260:A:G
NM_001323289.2(CDKL5):c.463+1G>A	CDKL5		Atypical Rett syndrome|not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156088	X	18600071	X	18581951	156088	165884	rs267608479	NC_000023.11:18581950:G:A
NM_001323289.2(CDKL5):c.404-1G>T	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156087	X	18600010	X	18581890	156087	165883	rs267608474	NC_000023.11:18581889:G:T
NM_001323289.2(CDKL5):c.2376+1G>C	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156081	X	18638087	X	18619967	156081	165877	rs267608656	NC_000023.11:18619966:G:C
NM_001323289.2(CDKL5):c.2376+1G>A	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156080	X	18638087	X	18619967	156080	165876	rs267608656	NC_000023.11:18619966:G:A
NM_001323289.2(CDKL5):c.2047-1G>A	CDKL5		Atypical Rett syndrome|not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156077	X	18627584	X	18609464	156077	165873	rs267608650	NC_000023.11:18609463:G:A
NM_001323289.2(CDKL5):c.145+2T>C	CDKL5		Atypical Rett syndrome|not provided	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000156074	X	18582644	X	18564524	156074	165870	rs267608430	NC_000023.11:18564523:T:C
NM_001323289.2(CDKL5):c.100-2A>G	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000156073	X	18582595	X	18564475	156073	165869	rs267608423	NC_000023.11:18564474:A:G
NM_005257.5(GATA6):c.1072del (p.Val358fs)	GATA6	V358fs	Abnormality of cardiovascular system morphology|Congenital diaphragmatic hernia|Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	VCV000156011	18	19752176	18	22172215	156011	165815	rs1555628863	NC_000018.10:22172214:GG:G
NM_005257.5(GATA6):c.712G>T (p.Gly238Ter)	GATA6	G238*	Abnormality of cardiovascular system morphology|Congenital diaphragmatic hernia|Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	VCV000156010	18	19751817	18	22171856	156010	165814	rs587777710	NC_000018.10:22171855:G:T
NM_003331.5(TYK2):c.2303_2311del (p.Ser768_Glu771delinsTer)	TYK2		Tyrosine kinase 2 deficiency	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000155930	19	10468679 - 10468687	19	10358003 - 10358011	155930	165726	rs869320745	NC_000019.10:10358002:CCTCCCTGG:
NM_002067.5(GNA11):c.179G>T (p.Arg60Leu)	GNA11	R60L	Hypocalcemia, autosomal dominant 2	Pathogenic(Last reviewed: Sep 1, 2014)	no assertion criteria provided	VCV000155926	19	3110189	19	3110191	155926	165722	rs587777707	NC_000019.10:3110190:G:T
IL12RB1, 3-BP DEL, EX10	IL12RB1		Immunodeficiency 30	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000155909					155909	165691		
NM_000166.6(GJB1):c.790C>T (p.Arg264Cys)	GJB1	R264C	X-linked hereditary motor and sensory neuropathy	Pathogenic	no assertion criteria provided	VCV000155727	X	70444347	X	71224497	155727	165481	rs587777879	NC_000023.11:71224496:C:T
NM_000166.6(GJB1):c.77C>T (p.Ser26Leu)	GJB1	S26L	X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth Neuropathy X|not provided	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000155726	X	70443634	X	71223784	155726	165480	rs587777876	NC_000023.11:71223783:C:T
NM_000166.6(GJB1):c.580A>G (p.Met194Val)	GJB1	M194V	X-linked hereditary motor and sensory neuropathy	Pathogenic	no assertion criteria provided	VCV000155725	X	70444137	X	71224287	155725	165479	rs587777878	NC_000023.11:71224286:A:G
NM_000166.6(GJB1):c.259C>G (p.Pro87Ala)	GJB1	P87A	Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000155724	X	70443816	X	71223966	155724	165478	rs587777877	NC_000023.11:71223965:C:G
GRCh38/hg38 Xp22.12(chrX:20154969-20217590)x0	RPS6KA3		See cases	Pathogenic(Last reviewed: Jul 18, 2014)	no assertion criteria provided	VCV000155652	X	20173087 - 20235708	X	20154969 - 20217590	155652	165406		
GRCh38/hg38 Xp21.1(chrX:32275729-32353585)x1	DMD		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000154764	X	32293846 - 32371702	X	32275729 - 32353585	154764	164518		
GRCh38/hg38 Xp21.1(chrX:31695292-31840818)x0	DMD		See cases	Pathogenic(Last reviewed: Jun 22, 2015)	no assertion criteria provided	VCV000153319	X	31713409 - 31858935	X	31695292 - 31840818	153319	163070		
GRCh38/hg38 Xq23(chrX:111318320-111348178)x3	DCX		See cases	Pathogenic(Last reviewed: Mar 24, 2014)	no assertion criteria provided	VCV000153209	X	110561548 - 110591406	X	111318320 - 111348178	153209	162960		
GRCh38/hg38 Xp21.1(chrX:31645986-31773985)x1	DMD		See cases	Pathogenic(Last reviewed: Feb 4, 2013)	no assertion criteria provided	VCV000152962	X	31664103 - 31792102	X	31645986 - 31773985	152962	162713		
GRCh38/hg38 Xp21.1(chrX:31640772-31665565)x0	DMD		See cases	Pathogenic(Last reviewed: Jan 21, 2013)	no assertion criteria provided	VCV000152751	X	31658889 - 31683682	X	31640772 - 31665565	152751	162502		
GRCh38/hg38 Xp21.1(chrX:31744885-32562211)x0	DMD		See cases	Pathogenic(Last reviewed: Feb 4, 2013)	no assertion criteria provided	VCV000152267	X	31763002 - 32580328	X	31744885 - 32562211	152267	162018		
GRCh38/hg38 Xp21.1(chrX:32267823-32372572)x0	DMD		See cases	Pathogenic(Last reviewed: Dec 3, 2012)	no assertion criteria provided	VCV000151961	X	32285940 - 32390689	X	32267823 - 32372572	151961	161712		
GRCh38/hg38 Xq21.1(chrX:77995123-78039221)x0	ATP7A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000150780	X	77250619 - 77294719	X	77995123 - 78039221	150780	160531		
GRCh38/hg38 Xq21.33-22.1(chrX:98369057-100524621)x1	PCDH19		See cases	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000150630	X	97624055 - 99779618	X	98369057 - 100524621	150630	160381		
GRCh38/hg38 Xp22.12(chrX:21356600-21624363)x0	CNKSR2		See cases	Pathogenic(Last reviewed: Feb 16, 2018)	no assertion criteria provided	VCV000149741	X	21374718 - 21642481	X	21356600 - 21624363	149741	159492		
GRCh38/hg38 Xp21.1(chrX:31870708-32353592)x0	DMD		See cases	Pathogenic(Last reviewed: Jun 20, 2011)	no assertion criteria provided	VCV000149580	X	31888825 - 32371709	X	31870708 - 32353592	149580	159331		
GRCh38/hg38 Xp21.2-21.1(chrX:31189847-31945183)x2	DMD		See cases	Pathogenic(Last reviewed: Feb 20, 2012)	no assertion criteria provided	VCV000149130	X	31207964 - 31963300	X	31189847 - 31945183	149130	158881		
GRCh38/hg38 Xp22.13(chrX:18564194-18595430)x1	CDKL5		See cases	Pathogenic(Last reviewed: Sep 30, 2011)	no assertion criteria provided	VCV000148738	X	18582314 - 18613550	X	18564194 - 18595430	148738	158489		
GRCh38/hg38 22q12.2(chr22:29602475-29639153)x1	NF2		See cases	Pathogenic(Last reviewed: May 6, 2011)	no assertion criteria provided	VCV000148402	22	29998464 - 30035142	22	29602475 - 29639153	148402	158153		
GRCh38/hg38 Xp21.1(chrX:31898812-32022323)x0	DMD		See cases	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000148275	X	31916929 - 32040440	X	31898812 - 32022323	148275	158026		
GRCh38/hg38 Xp21.1(chrX:31724913-31806626)x0	DMD		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000147812	X	31743030 - 31824743	X	31724913 - 31806626	147812	157563		
GRCh38/hg38 Xp22.12(chrX:20240043-20795704)x1	RPS6KA3		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000147408	X	20258161 - 20813822	X	20240043 - 20795704	147408	157159		
GRCh38/hg38 Xq12(chrX:68060610-68353960)x2	OPHN1		See cases	Pathogenic(Last reviewed: Oct 20, 2010)	no assertion criteria provided	VCV000146620	X	67280452 - 67573802	X	68060610 - 68353960	146620	156371		
GRCh38/hg38 Xq21.33-22.1(chrX:99011557-100309964)x1	PCDH19		See cases	Pathogenic(Last reviewed: Jan 24, 2011)	no assertion criteria provided	VCV000146264	X	98266555 - 99564962	X	99011557 - 100309964	146264	156015		
GRCh38/hg38 Xp21.1(chrX:32203741-32353533)x1	DMD		See cases	Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	VCV000146011	X	32221858 - 32371650	X	32203741 - 32353533	146011	155762		
GRCh38/hg38 Xp22.13(chrX:18560628-18588106)x2	CDKL5		See cases	Pathogenic(Last reviewed: Sep 30, 2010)	no assertion criteria provided	VCV000145441	X	18578748 - 18606226	X	18560628 - 18588106	145441	155192		
GRCh38/hg38 Xp21.1(chrX:31518960-31601824)x2	DMD		See cases	Pathogenic(Last reviewed: Aug 30, 2010)	no assertion criteria provided	VCV000145412	X	31537077 - 31619941	X	31518960 - 31601824	145412	155163		
GRCh38/hg38 Xp21.1(chrX:31744863-31846787)x1	DMD		See cases	Pathogenic(Last reviewed: Jul 30, 2010)	no assertion criteria provided	VCV000145359	X	31762980 - 31864904	X	31744863 - 31846787	145359	155110		
GRCh38/hg38 Xp21.1(chrX:31744863-31846787)x0	DMD		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000145357	X	31762980 - 31864904	X	31744863 - 31846787	145357	155108		
GRCh38/hg38 Xp21.1(chrX:31856886-32482971)x1	DMD		See cases	Pathogenic(Last reviewed: Jul 30, 2010)	no assertion criteria provided	VCV000145344	X	31875003 - 32501088	X	31856886 - 32482971	145344	155095		
GRCh38/hg38 Xp21.1(chrX:31540244-32059446)x0	DMD		See cases	Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	VCV000145146	X	31558361 - 32077563	X	31540244 - 32059446	145146	154897		
GRCh38/hg38 Xq21.1(chrX:77798947-77887557)x2	MAGT1		See cases	Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	VCV000145142	X	77054444 - 77143054	X	77798947 - 77887557	145142	154893		
GRCh38/hg38 Xq25(chrX:123473778-123593934)x2	GRIA3		See cases	Pathogenic(Last reviewed: Nov 30, 2010)	no assertion criteria provided	VCV000145141	X	122607629 - 122727785	X	123473778 - 123593934	145141	154892		
GRCh38/hg38 Xp21.2-21.1(chrX:31431098-31525874)x0	DMD		See cases	Pathogenic(Last reviewed: Dec 30, 2009)	no assertion criteria provided	VCV000144366	X	31449215 - 31543991	X	31431098 - 31525874	144366	154117		
NM_005559.4(LAMA1):c.555T>G (p.Tyr185Ter)	LAMA1	Y185*	Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000144111	18	7050726	18	7050727	144111	153863	rs587777681	NC_000018.10:7050726:A:C
NM_005559.4(LAMA1):c.2816_2817del (p.Tyr939fs)	LAMA1	Y939fs	Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000144110	18	7016662 - 7016663	18	7016663 - 7016664	144110	153862	rs587777680	NC_000018.10:7016662:ATA:A
NM_005559.4(LAMA1):c.2986del (p.Thr996fs)	LAMA1	T996fs	Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Aug 7, 2014)	no assertion criteria provided	VCV000144109	18	7016493	18	7016494	144109	153861	rs587777679	NC_000018.10:7016493:T:
NM_005559.4(LAMA1):c.588+2T>G	LAMA1		Poretti-Boltshauser syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	VCV000144107	18	7050691	18	7050692	144107	153859	rs587777677	NC_000018.10:7050691:A:C
NM_182895.5(SCARF2):c.2531del (p.Gln844fs)	SCARF2	Q844fs, Q849fs		Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000144051	22	20779735	22	20425445	144051	153786	rs587777658	NC_000022.11:20425444:T:
NM_182895.5(SCARF2):c.190T>C (p.Cys64Arg)	SCARF2	C64R		Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000144050	22	20786259	22	20431972	144050	153785	rs587777657	NC_000022.11:20431971:A:G
NM_001037811.2(HSD17B10):c.257A>G (p.Asp86Gly)	HSD17B10	D86G	HSD10 disease	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000144033	X	53459295	X	53432347	144033	153772	rs587777651	NC_000023.11:53432346:T:C
NM_001080510.4(METTL23):c.397C>T (p.Gln133Ter)	METTL23	Q133*, Q129*, Q66*	Mental retardation, autosomal recessive 44	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000144025	17	74729449	17	76733367	144025	153756	rs587777646	NC_000017.11:76733366:C:T
NM_001080510.4(METTL23):c.282_286del (p.Gln94fs)	METTL23	Q27fs, Q90fs, Q94fs	Mental retardation, autosomal recessive 44	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000144024	17	74729256 - 74729260	17	76733174 - 76733178	144024	153755	rs587777645	NC_000017.11:76733173:AAGATA:A
NM_001206985.2(METTL23):c.-33_-30del	METTL23	H53fs, H57fs	Inborn genetic diseases|not provided|Mental retardation, autosomal recessive 44	Pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000144023	17	74729142 - 74729145	17	76733060 - 76733063	144023	153754	rs587777644	NC_000017.11:76733059:CTCACT:CT
NM_080860.4(RSPH1):c.281G>A (p.Trp94Ter)	RSPH1	W94*, W56*	Primary ciliary dyskinesia 24|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000144011	21	43906565	21	42486455	144011	153742	rs587777635	NC_000021.9:42486454:C:T
NM_005027.4(PIK3R2):c.1202T>C (p.Leu401Pro)	PIK3R2	L401P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000143990	19	18273869	19	18163059	143990	153720	rs587777624	NC_000019.10:18163058:T:C
NM_001323289.2(CDKL5):c.964dup (p.Thr322fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143840	X	18616719 - 18616720	X	18598599 - 18598600	143840	153572	rs267608552	NC_000023.11:18598599:A:AA
NM_001323289.2(CDKL5):c.900_901GA[3] (p.Leu302fs)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143838	X	18616654 - 18616655	X	18598534 - 18598535	143838	153570	rs267608546	NC_000023.11:18598534:AGAGA:AGAGAGA
NM_001323289.2(CDKL5):c.884del (p.Pro295fs)	CDKL5	P295fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143837	X	18616638	X	18598518	143837	153569	rs267608542	NC_000023.11:18598517:CCC:CC
NM_001323289.2(CDKL5):c.867dup (p.Gln290fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143836	X	18616621 - 18616622	X	18598501 - 18598502	143836	153568	rs267608537	NC_000023.11:18598501:AA:AAA
NM_001323289.2(CDKL5):c.838_847del (p.Asp281fs)	CDKL5	D281fs	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143834	X	18616592 - 18616601	X	18598472 - 18598481	143834	153566	rs61750250	NC_000023.11:18598471:AGTTGGACCCAG:AG
NM_001323289.2(CDKL5):c.801_802del (p.Asn267fs)	CDKL5	N267fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143833	X	18613523 - 18613524	X	18595403 - 18595404	143833	153565	rs267608528	NC_000023.11:18595402:ATA:A
NM_003159.2(CDKL5):c.65dupG	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143831	X	18528938 - 18528939	X	18510818 - 18510819	143831	153563	rs267608420	NC_000023.11:18510818:GG:GGG
NM_001323289.2(CDKL5):c.659T>C (p.Leu220Pro)	CDKL5	L220P	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000143830	X	18606178	X	18588058	143830	153562	rs267608511	NC_000023.11:18588057:T:C
NM_001323289.2(CDKL5):c.607G>T (p.Glu203Ter)	CDKL5	E203*	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143829	X	18606126	X	18588006	143829	153561	rs267608505	NC_000023.11:18588005:G:T
NM_001323289.2(CDKL5):c.587C>T (p.Ser196Leu)	CDKL5	S196L	Epileptic encephalopathy|not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143827	X	18606106	X	18587986	143827	153559	rs267608501	NC_000023.11:18587985:C:T
NM_001323289.2(CDKL5):c.578A>G (p.Asp193Gly)	CDKL5	D193G	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143826	X	18606097	X	18587977	143826	153558	rs267608500	NC_000023.11:18587976:A:G
NM_001323289.2(CDKL5):c.549dup (p.Leu184fs)	CDKL5		not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143825	X	18602467 - 18602468	X	18584347 - 18584348	143825	153557	rs267608497	NC_000023.11:18584347:A:AA
NM_001323289.2(CDKL5):c.539C>T (p.Pro180Leu)	CDKL5	P180L	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143824	X	18602458	X	18584338	143824	153556	rs61749704	NC_000023.11:18584337:C:T
NM_001323289.2(CDKL5):c.532C>T (p.Arg178Trp)	CDKL5	R178W	not provided|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000143823	X	18602451	X	18584331	143823	153555	rs267608493	NC_000023.11:18584330:C:T
NM_001323289.2(CDKL5):c.513C>A (p.Tyr171Ter)	CDKL5	Y171*	not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000143822	X	18602432	X	18584312	143822	153554	rs267608490	NC_000023.11:18584311:C:A
NM_001323289.2(CDKL5):c.425T>A (p.Leu142Ter)	CDKL5	L142*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143821	X	18600032	X	18581912	143821	153553	rs267608477	NC_000023.11:18581911:T:A
NM_001323289.2(CDKL5):c.400C>T (p.Arg134Ter)	CDKL5	R134*	not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000143820	X	18598085	X	18579965	143820	153552	rs267608472	NC_000023.11:18579964:C:T
NM_001323289.2(CDKL5):c.39del (p.Phe13fs)	CDKL5	F13fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143819	X	18525253	X	18507133	143819	153551	rs267608415	NC_000023.11:18507132:TTT:TT
NM_001323289.2(CDKL5):c.352C>T (p.Gln118Ter)	CDKL5	Q118*	Atypical Rett syndrome|not provided	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000143817	X	18598037	X	18579917	143817	153549	rs267608453	NC_000023.11:18579916:C:T
NM_001323289.2(CDKL5):c.2635_2636del (p.Leu879fs)	CDKL5	L879fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|Atypical Rett syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143809	X	18646629 - 18646630	X	18628509 - 18628510	143809	153541	rs61753251	NC_000023.11:18628508:CT:
NM_001323289.2(CDKL5):c.2593C>T (p.Gln865Ter)	CDKL5	Q865*	Early infantile epileptic encephalopathy 2|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000143808	X	18646587	X	18628467	143808	153540	rs267608663	NC_000023.11:18628466:C:T
NM_001323289.2(CDKL5):c.2572del (p.Arg858fs)	CDKL5	R858fs	Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143807	X	18646563	X	18628443	143807	153539	rs267608662	NC_000023.11:18628442:CCCC:CCC
NM_001323289.2(CDKL5):c.2529del (p.Leu843fs)	CDKL5	L843fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143806	X	18646523	X	18628403	143806	153538	rs267608661	NC_000023.11:18628402:A:
NM_001323289.2(CDKL5):c.2504del (p.Pro835fs)	CDKL5	P835fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143805	X	18646497	X	18628377	143805	153537	rs267608660	NC_000023.11:18628376:CC:C
NM_001323289.2(CDKL5):c.2413C>T (p.Gln805Ter)	CDKL5	Q805*	Early infantile epileptic encephalopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143804	X	18643284	X	18625164	143804	153536	rs267608659	NC_000023.11:18625163:C:T
NM_001323289.2(CDKL5):c.2363_2367del (p.Lys788fs)	CDKL5	K788fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143802	X	18638072 - 18638076	X	18619952 - 18619956	143802	153534	rs267608655	NC_000023.11:18619951:AAGAAA:A
NM_001323289.2(CDKL5):c.2343del (p.Arg781fs)	CDKL5	R781fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000143801	X	18638052	X	18619932	143801	153533	rs62643614	NC_000023.11:18619931:GG:G
NM_001323289.2(CDKL5):c.2323_2324GA[1] (p.Lys776fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143800	X	18638032 - 18638033	X	18619912 - 18619913	143800	153532	rs267608654	NC_000023.11:18619911:AGAGA:AGA
NM_001323289.2(CDKL5):c.225_228GAAG[1] (p.Glu77fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143799	X	18593553 - 18593556	X	18575433 - 18575436	143799	153531	rs267608441	NC_000023.11:18575432:GAAGGAAG:GAAG
NM_001323289.2(CDKL5):c.215T>A (p.Ile72Asn)	CDKL5	I72N	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143797	X	18593543	X	18575423	143797	153529	rs62641235	NC_000023.11:18575422:T:A
NM_001323289.2(CDKL5):c.2152G>A (p.Val718Met)	CDKL5	V718M	Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Mar 19, 2014)	criteria provided, single submitter	VCV000143796	X	18627690	X	18609570	143796	153528	rs267608653	NC_000023.11:18609569:G:A
NM_001323289.2(CDKL5):c.2066del (p.Pro689fs)	CDKL5	P689fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143795	X	18627602	X	18609482	143795	153527	rs267608651	NC_000023.11:18609481:CCC:CC
NM_003159.2(CDKL5):c.2045_2046delAGins18 (p.?)	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143794	X	18627031 - 18627032	X	18608911 - 18608912	143794	153526		
NM_001323289.2(CDKL5):c.2016dup (p.Ser673fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143793	X	18627000 - 18627001	X	18608880 - 18608881	143793	153525	rs267608648	NC_000023.11:18608880:CC:CCC
NM_001323289.2(CDKL5):c.2016del (p.Ser673fs)	CDKL5	S673fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143792	X	18627001	X	18608881	143792	153524	rs267608648	NC_000023.11:18608880:CC:C
NM_001323289.2(CDKL5):c.199C>T (p.Leu67Phe)	CDKL5	L67F	Early infantile epileptic encephalopathy 2|Rett syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143791	X	18593527	X	18575407	143791	153523	rs267608437	NC_000023.11:18575406:C:T
NM_001323289.2(CDKL5):c.1954C>T (p.Gln652Ter)	CDKL5	Q652*	Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143790	X	18626940	X	18608820	143790	153522	rs267608647	NC_000023.11:18608819:C:T
NM_001323289.2(CDKL5):c.1892_1893dup (p.Gly632Ter)	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143787	X	18622934 - 18622935	X	18604814 - 18604815	143787	153519	rs267608646	NC_000023.11:18604814:ATA:ATATA
NM_001323289.2(CDKL5):c.183del (p.Met63fs)	CDKL5	M63fs	Early infantile epileptic encephalopathy 2|Autistic disorder of childhood onset|Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143785	X	18593510	X	18575390	143785	153517	rs62643608	NC_000023.11:18575389:TT:T
NM_001323289.2(CDKL5):c.175C>T (p.Arg59Ter)	CDKL5	R59*	Early infantile epileptic encephalopathy 2|not provided|Atypical Rett syndrome	Pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143783	X	18593503	X	18575383	143783	153515	rs62653623	NC_000023.11:18575382:C:T
NM_001323289.2(CDKL5):c.1708G>T (p.Glu570Ter)	CDKL5	E570*	Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143782	X	18622752	X	18604632	143782	153514	rs267608644	NC_000023.11:18604631:G:T
NM_001323289.2(CDKL5):c.1675C>T (p.Arg559Ter)	CDKL5	R559*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143781	X	18622719	X	18604599	143781	153513	rs267608395	NC_000023.11:18604598:C:T
NM_001323289.2(CDKL5):c.1648C>T (p.Arg550Ter)	CDKL5	R550*	Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000143780	X	18622692	X	18604572	143780	153512	rs267608643	NC_000023.11:18604571:C:T
NM_001323289.2(CDKL5):c.163_166del (p.Glu55fs)	CDKL5	E55fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143779	X	18593488 - 18593491	X	18575368 - 18575371	143779	153511	rs267608433	NC_000023.11:18575367:AAAGAAA:AAA
NM_001323289.2(CDKL5):c.1311dup (p.Ser438fs)	CDKL5		Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143774	X	18622354 - 18622355	X	18604234 - 18604235	143774	153506	rs267608623	NC_000023.11:18604234:C:CC
NM_001323289.2(CDKL5):c.125A>G (p.Lys42Arg)	CDKL5	K42R	Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143772	X	18582622	X	18564502	143772	153504	rs267608429	NC_000023.11:18564501:A:G
NM_001323289.2(CDKL5):c.1238C>G (p.Ser413Ter)	CDKL5	S413*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143771	X	18622282	X	18604162	143771	153503	rs267608618	NC_000023.11:18604161:C:G
NM_001323289.2(CDKL5):c.1082dup (p.Ala362fs)	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143769	X	18622123 - 18622124	X	18604003 - 18604004	143769	153501	rs267608566	NC_000023.11:18604003:CCC:CCCC
NM_001323289.2(CDKL5):c.1079del (p.Leu360fs)	CDKL5	L360fs	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143768	X	18622123	X	18604003	143768	153500	rs267608565	NC_000023.11:18604002:T:
NM_001323289.2(CDKL5):c.1039C>T (p.Gln347Ter)	CDKL5	Q347*	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143767	X	18622083	X	18603963	143767	153499	rs267608561	NC_000023.11:18603962:C:T
NM_001042472.3(ABHD12):c.477G>A (p.Trp159Ter)	ABHD12	W159*	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000143236	20	25300900	20	25320264	143236	152959	rs587777603	NC_000020.11:25320263:C:T
NM_001042472.3(ABHD12):c.1116C>G (p.His372Gln)	ABHD12	H372Q	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000143235	20	25282896	20	25302260	143235	152958	rs587777602	NC_000020.11:25302259:G:C
NM_004076.5(CRYBB3):c.581T>A (p.Val194Glu)	CRYBB3	V194E	Cataract, congenital nuclear, autosomal recessive 2	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000143233	22	25603124	22	25207157	143233	152956	rs587777601	NC_000022.11:25207156:T:A
NM_000334.4(SCN4A):c.664C>T (p.Arg222Trp)	SCN4A	R222W	Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1|Hypokalemic periodic paralysis 1|Potassium aggravated myotonia|Paramyotonia congenita of von Eulenburg|Congenital myasthenic syndrome, acetazolamide-responsive|Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143199	17	62048561	17	63971201	143199	152917	rs527236148	NC_000017.11:63971200:G:A
NM_000554.6(CRX):c.193G>C (p.Asp65His)	CRX	D65H	Retinitis pigmentosa	Pathogenic	no assertion criteria provided	VCV000143085	19	48339592	19	47836335	143085	152803	rs527236062	NC_000019.10:47836334:G:C
NM_000390.4(CHM):c.808C>T (p.Arg270Ter)	CHM	R270*, R122*	Choroideremia|not provided	Pathogenic(Last reviewed: Nov 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143078	X	85213877	X	85958872	143078	152796	rs527236048	NC_000023.11:85958871:G:A
NM_005359.5(SMAD4):c.1245_1248delCAGA (p.Asp415Glufs)	SMAD4	D415fs	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of pancreas|Myhre syndrome|Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142253	18	48593491 - 48593494	18	51067121 - 51067124	142253	151967	rs80338965	NC_000018.10:51067120:AGACAGA:AGA
NM_000455.4(STK11):c.734+1G>T	STK11		Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000141795	19	1220717	19	1220718	141795	151509	rs587782018	NC_000019.10:1220717:G:T
NM_000455.4(STK11):c.574del (p.Ile192fs)	STK11	I192fs	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 29, 2014)	criteria provided, single submitter	VCV000141581	19	1220478	19	1220479	141581	151295	rs587781856	NC_000019.10:1220478:AAAA:AAA
NM_005359.5(SMAD4):c.1345C>T (p.Gln449Ter)	SMAD4	Q449*	Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000140903	18	48603044	18	51076674	140903	150617	rs587781359	NC_000018.10:51076673:C:T
NM_031229.4(RBCK1):c.697_703dup (p.Glu235fs)	RBCK1		Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000140630	20	400315 - 400316	20	419671 - 419672	140630	150333	rs730880330	NC_000020.11:419671:GACGAGG:GACGAGGGACGAGG
NM_031229.4(RBCK1):c.790C>T (p.Gln264Ter)	RBCK1	Q222*, Q264*	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000140629	20	401548	20	420904	140629	150332	rs587777561	NC_000020.11:420903:C:T
NM_031229.4(RBCK1):c.720_723GGCG[3] (p.Glu243fs)	RBCK1		Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000140628	20	400338 - 400339	20	419694 - 419695	140628	150331	rs730880329	NC_000020.11:419694:GGCGGGCG:GGCGGGCGGGCG
NM_031229.4(RBCK1):c.727G>T (p.Glu243Ter)	RBCK1	E243*, E201*	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000140627	20	400346	20	419702	140627	150330	rs727503765	NC_000020.11:419701:G:T
NM_031229.4(RBCK1):c.1160A>G (p.Asn387Ser)	RBCK1	N387S, N345S, N217S	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000140626	20	408087	20	427443	140626	150329	rs566912235	NC_000020.11:427442:A:G
NM_031229.4(RBCK1):c.896_899del (p.Glu299fs)	RBCK1	E257fs, E299fs	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000140625	20	401651 - 401654	20	421007 - 421010	140625	150328	rs727503764	NC_000020.11:421006:GTGAGTG:GTG
NM_031229.4(RBCK1):c.121_122del (p.Leu41fs)	RBCK1	L41fs	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000140624	20	390623 - 390624	20	409979 - 409980	140624	150327	rs727503763	NC_000020.11:409978:CT:
NM_031229.4(RBCK1):c.553C>T (p.Gln185Ter)	RBCK1	Q185*, Q143*	Polyglucosan body myopathy 1 with or without immunodeficiency	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000140623	20	400083	20	419439	140623	150326	rs727503762	NC_000020.11:419438:C:T
NM_002085.5(GPX4):c.270C>A (p.Tyr90Ter)	GPX4	Y127*, Y90*, Y63*		Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000140617	19	1105455	19	1105456	140617	150322	rs769967246	NC_000019.10:1105455:C:A
NM_002085.5(GPX4):c.477-8_477-4del	GPX4			Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000140616	19	1106230 - 1106234	19	1106231 - 1106235	140616	150321		NC_000019.10:1106230:TTCTTTTC:TTC
NM_002085.5(GPX4):c.476+5G>A	GPX4			Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000140615	19	1105813	19	1105814	140615	150320	rs775146234	NC_000019.10:1105813:G:A
NM_000216.4(ANOS1):c.1A>G (p.Met1Val)	ANOS1	M1V		Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000140614	X	8700077	X	8732036	140614	150305	rs606231409	NC_000023.11:8732035:T:C
NM_004309.6(ARHGDIA):c.358C>T (p.Arg120Ter)	ARHGDIA	R120*, R165*	Nephrotic syndrome, type 8	Pathogenic(Last reviewed: Mar 10, 2015)	no assertion criteria provided	VCV000140594	17	79827106	17	81869230	140594	150286	rs587777553	NC_000017.11:81869229:G:A
NM_004309.6(ARHGDIA):c.518G>T (p.Gly173Val)	ARHGDIA	G173V, G218V	Nephrotic syndrome, type 8	Pathogenic(Last reviewed: Aug 1, 2013)	no assertion criteria provided	VCV000140593	17	79826849	17	81868973	140593	150285	rs587777552	NC_000017.11:81868972:C:A
NM_002764.3(PRPS1):c.925G>T (p.Val309Phe)	PRPS1	V309F, V105F	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140573	X	106893230	X	107650000	140573	150247	rs587781263	NC_000023.11:107649999:G:T
NM_002764.3(PRPS1):c.343A>G (p.Met115Val)	PRPS1	M115V	Charcot-Marie-Tooth disease, X-linked recessive, type 5|Deafness, X-linked 1	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140572	X	106884168	X	107640938	140572	150246	rs587781262	NC_000023.11:107640937:A:G
NM_002764.3(PRPS1):c.337G>T (p.Ala113Ser)	PRPS1	A113S	Deafness, X-linked 1	Pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000140571	X	106884162	X	107640932	140571	150245	rs587781261	NC_000023.11:107640931:G:T
NM_001272071.2(AP1S2):c.426+1G>T	AP1S2		Pettigrew syndrome	Pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	VCV000140457	X	15863501	X	15845378	140457	150141	rs587777542	NC_000023.11:15845377:C:A
NM_017565.4(FAM20A):c.612del (p.Leu205fs)	FAM20A	L205fs, L67fs	Enamel-renal syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000139650	17	66550946	17	68554805	139650	143269	rs587777531	NC_000017.11:68554804:GG:G
NM_001282531.3(ADNP):c.2157C>G (p.Tyr719Ter)	ADNP	Y719*	Inborn genetic diseases|Helsmoortel-Van der Aa Syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000139635	20	49509094	20	50892557	139635	143258	rs587777526	NC_000020.11:50892556:G:C
NM_001282531.3(ADNP):c.2808del (p.Lys935_Tyr936insTer)	ADNP		Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139634	20	49508443	20	50891906	139634	143257	rs587777525	NC_000020.11:50891905:G:
NM_001282531.3(ADNP):c.1211C>A (p.Ser404Ter)	ADNP	S404*	Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139633	20	49510040	20	50893503	139633	143256	rs587777524	NC_000020.11:50893502:G:T
NM_001282531.3(ADNP):c.2492_2495TAAA[1] (p.Asn832fs)	ADNP		History of neurodevelopmental disorder|not provided|Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000139632	20	49508752 - 49508755	20	50892215 - 50892218	139632	143255	rs587777523	NC_000020.11:50892214:TTTATTTA:TTTA
NM_001282531.3(ADNP):c.2491_2494del (p.Leu831fs)	ADNP	L831fs	not provided|Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000139631	20	49508757 - 49508760	20	50892220 - 50892223	139631	143254	rs587777522	NC_000020.11:50892219:TTAATT:TT
NM_152296.5(ATP1A3):c.2839G>C (p.Gly947Arg)	ATP1A3	G947R, G958R, G960R	Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000139579	19	42471896	19	41967744	139579	143209	rs398122887	NC_000019.10:41967743:C:G
NM_001015877.2(PHF6):c.914G>T (p.Cys305Phe)	PHF6	C305F	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000139557	X	133551278	X	134417248	139557	143192	rs587777489	NC_000023.11:134417247:G:T
NM_006087.4(TUBB4A):c.533C>G (p.Thr178Arg)	TUBB4A	T178R, T229R, T223R, T106R	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000139453	19	6495977	19	6495966	139453	143145	rs587777468	NC_000019.10:6495965:G:C
NM_006087.4(TUBB4A):c.5G>A (p.Arg2Gln)	TUBB4A	R2Q, R53Q, R47Q	not provided|Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000139452	19	6502219	19	6502208	139452	143144	rs587777467	NC_000019.10:6502207:C:T
NM_001242897.2(DEPDC5):c.1459C>T (p.Arg487Ter)	DEPDC5	R487*, R459*	Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000139434	22	32210991	22	31815005	139434	143126	rs587777459	NC_000022.11:31815004:C:T
NM_001242897.2(DEPDC5):c.3025C>T (p.Arg1009Ter)	DEPDC5	R1087*, R1009*, R1059*, R1078*	Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000139433	22	32253534	22	31857548	139433	143125	rs587777458	NC_000022.11:31857547:C:T
NM_018993.3(RIN2):c.1731dup (p.Ile578fs)	RIN2		Macrocephaly, alopecia, cutis laxa, and scoliosis	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000137627	20	19956393 - 19956394	20	19975749 - 19975750	137627	141330	rs759390822	NC_000020.11:19975749:CCCCCCC:CCCCCCCC
NM_001429.4(EP300):c.102_103CT[1] (p.Ser35fs)	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000137620	22	41513198 - 41513201	22	41117194 - 41117197	137620	141323	rs886037664	NC_000022.11:41117193:CTCTCT:CT
NM_005676.5(RBM10):c.448C>T (p.Gln150Ter)	RBM10	Q150*, Q215*, Q73*	TARP syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000137613	X	47032542	X	47173143	137613	141316	rs886044718	NC_000023.11:47173142:C:T
NM_005660.3(SLC35A2):c.638C>T (p.Ser213Phe)	SLC35A2	S213F, S241F, S226F, S152F	SLC35A2-CDG	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000135676	X	48762548	X	48905271	135676	139388	rs587777436	NC_000023.11:48905270:G:A
NM_005660.3(SLC35A2):c.972del (p.Phe324fs)	SLC35A2	F337fs, F324fs, F263fs, F352fs	SLC35A2-CDG	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000135675	X	48762214	X	48904937	135675	139387	rs587777435	NC_000023.11:48904936:AAA:AA
NM_005660.3(SLC35A2):c.433_434del (p.Tyr145fs)	SLC35A2	Y173fs, Y84fs, Y145fs, Y158fs	SLC35A2-CDG	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000135674	X	48762752 - 48762753	X	48905475 - 48905476	135674	139386	rs587777434	NC_000023.11:48905474:TAT:T
NM_006087.4(TUBB4A):c.467G>T (p.Arg156Leu)	TUBB4A	R156L, R207L, R201L, R84L	Leukodystrophy, hypomyelinating, 6|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000135659	19	6496043	19	6496032	135659	139377	rs587777429	NC_000019.10:6496031:C:A
NM_006087.4(TUBB4A):c.1228G>A (p.Glu410Lys)	TUBB4A	E410K, E461K, E338K, E455K	Leukodystrophy, hypomyelinating, 6|Leukodystrophy, hypomyelinating, 6|Autosomal dominant torsion dystonia 4	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000135658	19	6495282	19	6495271	135658	139376	rs587777428	NC_000019.10:6495270:C:T
NM_000271.5(NPC1):c.416dup (p.Asn140fs)	NPC1		Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132901	18	21148833 - 21148834	18	23568869 - 23568870	132901	136650	rs483352880	NC_000018.10:23568869:G:GG
NM_000271.5(NPC1):c.2912-3C>G	NPC1		Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132900	18	21118638	18	23538674	132900	136649	rs483352892	NC_000018.10:23538673:G:C
NM_000271.5(NPC1):c.2795dup (p.Tyr932Ter)	NPC1		Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132899	18	21119774 - 21119775	18	23539810 - 23539811	132899	136648	rs483352884	NC_000018.10:23539810:T:TT
NM_000271.5(NPC1):c.2366G>A (p.Arg789His)	NPC1	R789H	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132898	18	21121277	18	23541313	132898	136647	rs483352891	NC_000018.10:23541312:C:T
NM_000271.5(NPC1):c.2302dup (p.Val768fs)	NPC1		Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132897	18	21121340 - 21121341	18	23541376 - 23541377	132897	136646	rs483352881	NC_000018.10:23541376:C:CC
NM_000271.5(NPC1):c.2177G>C (p.Arg726Thr)	NPC1	R726T	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132895	18	21123487	18	23543523	132895	136644	rs483352890	NC_000018.10:23543522:C:G
NM_000271.5(NPC1):c.2128C>T (p.Gln710Ter)	NPC1	Q710*	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132894	18	21124310	18	23544346	132894	136643	rs483352889	NC_000018.10:23544345:G:A
NM_000271.5(NPC1):c.2054T>C (p.Ile685Thr)	NPC1	I685T	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132893	18	21124384	18	23544420	132893	136642	rs483352888	NC_000018.10:23544419:A:G
NM_000271.5(NPC1):c.1832A>G (p.Asp611Gly)	NPC1	D611G	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132892	18	21125039	18	23545075	132892	136641	rs483352887	NC_000018.10:23545074:T:C
NM_000271.5(NPC1):c.1553G>A (p.Arg518Gln)	NPC1	R518Q	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000132890	18	21134722	18	23554758	132890	136639	rs483352886	NC_000018.10:23554757:C:T
NM_000271.5(NPC1):c.1502A>T (p.Asp501Val)	NPC1	D501V	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132889	18	21134773	18	23554809	132889	136638	rs483352885	NC_000018.10:23554808:T:A
NM_000271.5(NPC1):c.1030del (p.Ser344fs)	NPC1	S344fs	Niemann-Pick disease type C1	Pathogenic	no assertion criteria provided	VCV000132888	18	21136503	18	23556539	132888	136637	rs483352883	NC_000018.10:23556538:A:
NM_020473.3(PIGA):c.13+3848C>T	PIGA	P93L	Multiple congenital anomalies-hypotonia-seizures syndrome 2	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000132819	X	15349775	X	15331653	132819	136568	rs587777400	NC_000023.11:15331652:G:A
NM_002641.3(PIGA):c.1030_1032del (p.Leu344del)	PIGA	L344del, L110del	not provided|Multiple congenital anomalies-hypotonia-seizures syndrome 2	Pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000132818	X	15342943 - 15342945	X	15324821 - 15324823	132818	136567	rs587777399	NC_000023.11:15324820:AAG:
NM_020473.3(PIGA):c.13+4186A>T	PIGA	I206F	Multiple congenital anomalies-hypotonia-seizures syndrome 2	Pathogenic(Last reviewed: May 6, 2014)	no assertion criteria provided	VCV000132817	X	15349437	X	15331315	132817	136566	rs201119959	NC_000023.11:15331314:T:A
NM_020473.3(PIGA):c.13+3800G>T	PIGA	R77L	Multiple congenital anomalies-hypotonia-seizures syndrome 2	Pathogenic(Last reviewed: May 6, 2014)	no assertion criteria provided	VCV000132816	X	15349823	X	15331701	132816	136565	rs587777398	NC_000023.11:15331700:C:A
NM_020473.3(PIGA):c.13+3644dup	PIGA		Multiple congenital anomalies-hypotonia-seizures syndrome 2	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000132815	X	15349976 - 15349977	X	15331854 - 15331855	132815	136564	rs587777397	NC_000023.11:15331854:AAA:AAAA
NM_002641.3(PIGA):c.355C>T (p.Arg119Trp)	PIGA	R119W	not provided|Multiple congenital anomalies-hypotonia-seizures syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000132814	X	15349698	X	15331576	132814	136563	rs587777396	NC_000023.11:15331575:G:A
NM_004714.3(DYRK1B):c.269A>C (p.His90Pro)	DYRK1B	H90P	Abdominal obesity-metabolic syndrome 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000132793	19	40321118	19	39830478	132793	136542	rs587777380	NC_000019.10:39830477:T:G
NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys)	DYRK1B	R102C	Abdominal obesity-metabolic syndrome 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000132792	19	40321083	19	39830443	132792	136541	rs367643250	NC_000019.10:39830442:G:A
NM_002894.3(RBBP8):c.604+1G>T	RBBP8		Seckel syndrome 2	Pathogenic(Last reviewed: Apr 23, 2013)	criteria provided, single submitter	VCV000130101	18	20562357	18	22982394	130101	135547	rs587780432	NC_000018.10:22982393:G:T
NM_172107.4(KCNQ2):c.1197del (p.Ser399fs)	KCNQ2	S389fs, S399fs	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000129331	20	62059740	20	63428387	129331	134777	rs587780365	NC_000020.11:63428386:A:
NM_001171155.2(PET100):c.142C>T (p.Gln48Ter)	PET100	Q48*	Congenital lactic acidosis|Mitochondrial complex IV deficiency|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Sep 12, 2016)	no assertion criteria provided	VCV000128250	19	7696362	19	7631476	128250	133699	rs587779779	NC_000019.10:7631475:C:T
NM_018474.6(KIZ):c.119_122del (p.Lys40fs)	KIZ	K40fs	Retinitis pigmentosa 69|Retinal dystrophy	Pathogenic(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV000128243	20	21112767 - 21112770	20	21132126 - 21132129	128243	133698	rs587777377	NC_000020.11:21132125:AACT:
NM_018474.6(KIZ):c.52G>T (p.Glu18Ter)	KIZ	E18*, R44L	Retinitis pigmentosa 69	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000128242	20	21106808	20	21126167	128242	133697	rs587777376	NC_000020.11:21126166:G:T
NM_005359.5(SMAD4):c.1351_1375del25 (p.Ala451Leufs)	SMAD4	A451fs	not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, multiple submitters, no conflicts	VCV000127949	18	48603043 - 48603067	18	51076673 - 51076697	127949	133406	rs587780124	NC_000018.10:51076672:GCAGCAGGCGGCTACTGCACAAGCTGCAGCAG:GCAGCAG
NM_006031.6(PCNT):c.196G>T (p.Gly66Ter)	PCNT	G66*	not provided|	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000127247	21	47746432	21	46326518	127247	132704	rs587779355	NC_000021.9:46326517:G:T
NM_002894.3(RBBP8):c.298C>T (p.Arg100Trp)	RBBP8	R100W	Seckel syndrome 2	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000127245	18	20548818	18	22968855	127245	132702	rs373804633	NC_000018.10:22968854:C:T
NM_007325.5(GRIA3):c.1888G>C (p.Gly630Arg)	GRIA3	G630R	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000127195	X	122561802	X	123427951	127195	132679	rs587777361	NC_000023.11:123427950:G:C
NM_021120.4(DLG3):c.985+1G>C	DLG3		X-Linked mental retardation 90	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000127194	X	69670634	X	70450784	127194	132678	rs587777360	NC_000023.11:70450783:G:C
NM_021120.4(DLG3):c.357+1G>C	DLG3		X-Linked mental retardation 90	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000127193	X	69665409	X	70445559	127193	132677	rs587777359	NC_000023.11:70445558:G:C
NM_006785.4(MALT1):c.1739G>C (p.Trp580Ser)	MALT1	W580S, W569S	Immunodeficiency 12	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000127139	18	56409232	18	58742000	127139	132637	rs587777337	NC_000018.10:58741999:G:C
NM_001011658.4(TRAPPC2):c.239-11_239-9del	TRAPPC2		Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000127114	X	13734217 - 13734219	X	13716098 - 13716100	127114	132622	rs587777330	NC_000023.11:13716097:ATTA:A
NM_001039591.3(USP9X):c.7526del (p.Gln2509fs)	USP9X	Q2525fs, Q2509fs	Mental retardation, X-linked 99	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000127091	X	41089848	X	41230595	127091	132601	rs587777318	NC_000023.11:41230594:A:
NM_001039591.3(USP9X):c.6278T>A (p.Leu2093His)	USP9X	L2093H	Mental retardation, X-linked 99	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000127090	X	41077693	X	41218440	127090	132600	rs587777317	NC_000023.11:41218439:T:A
NM_000343.4(SLC5A1):c.1673G>A (p.Arg558His)	SLC5A1	R558H, R431H	not provided|Congenital glucose-galactose malabsorption	Pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000127077	22	32500780	22	32104793	127077	132588	rs201799893	NC_000022.11:32104792:G:A
NM_001271696.3(ABCB7):c.624A>T (p.Glu208Asp)	ABCB7	E209D, E208D, E168D, E169D, E182D	X-linked sideroblastic anemia with ataxia	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000126455	X	74295428	X	75075593	126455	131981	rs515726147	NC_000023.11:75075592:T:A
NM_001111125.3(IQSEC2):c.2563C>T (p.Arg855Ter)	IQSEC2	R855*, R650*	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000126417	X	53277315	X	53248133	126417	131949	rs587777261	NC_000023.11:53248132:G:A
NM_001243197.1(IQSEC2):c.123-2226_*20117dup	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000126416	X	53276030 - 53298472	X	53246848 - 53269290	126416	131948		
nsv1067908	IQSEC2		Mental retardation, X-linked 1	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000126415	X	53283513 - 53325284	X	53254331 - 53296102	126415	131947		
NM_006397.2(RNASEH2A):c.872G>A (p.Arg291His)	RNASEH2A	R291H, R292H	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000126401	19	12924252	19	12813438	126401	131934	rs75037667	NC_000019.10:12813437:G:A
NM_006397.2(RNASEH2A):c.719C>T (p.Thr240Met)	RNASEH2A	T240M, T241M	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000126400	19	12923978	19	12813164	126400	131933	rs79843600	NC_000019.10:12813163:C:T
NM_006397.2(RNASEH2A):c.714_715GC[3] (p.Thr240fs)	RNASEH2A		Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000126399	19	12923972 - 12923973	19	12813158 - 12813159	126399	131932	rs78705193	NC_000019.10:12813158:GCGC:GCGCGC
NM_006397.2(RNASEH2A):c.690C>A (p.Phe230Leu)	RNASEH2A	F230L, F231L	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000126398	19	12923949	19	12813135	126398	131931	rs79767407	NC_000019.10:12813134:C:A
NM_006397.2(RNASEH2A):c.322C>T (p.Arg108Trp)	RNASEH2A	R108W	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000126397	19	12918142	19	12807328	126397	131930	rs76436818	NC_000019.10:12807327:C:T
NM_006397.2(RNASEH2A):c.207dup (p.Thr70fs)	RNASEH2A		Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000126396	19	12918026 - 12918027	19	12807212 - 12807213	126396	131929	rs77672568	NC_000019.10:12807212:G:GG
NM_005603.6(ATP8B1):c.625C>A (p.Pro209Thr)	ATP8B1	P209T	Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Mar 20, 2014)	no assertion criteria provided	VCV000126383	18	55365029	18	57697797	126383	131916	rs515726138	NC_000018.10:57697796:G:T
NM_005603.6(ATP8B1):c.1993G>T (p.Glu665Ter)	ATP8B1	E665*	Inborn genetic diseases|not provided|Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000126382	18	55336654	18	57669422	126382	131915	rs515726137	NC_000018.10:57669421:C:A
NM_001171155.2(PET100):c.3G>C (p.Met1Ile)	PET100	M1I	Mitochondrial complex IV deficiency|not provided	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000125441	19	7694722	19	7629836	125441	130979	rs587777839	NC_000019.10:7629835:G:C
NM_002361.4(MAG):c.1288T>G (p.Cys430Gly)	MAG	C430G, C405G	Spastic paraplegia 75, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000120188	19	35800833	19	35309930	120188	125797	rs587777229	NC_000019.10:35309929:T:G
NM_024301.5(FKRP):c.1A>G (p.Met1Val)	FKRP	M1V	not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000120180	19	47258708	19	46755451	120180	125788	rs587777223	NC_000019.10:46755450:A:G
NM_172107.4(KCNQ2):c.794C>T (p.Ala265Val)	KCNQ2	A265V	Early infantile epileptic encephalopathy|Seizures|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|KCNQ2-Related Disorders|not provided|Early infantile epileptic encephalopathy 7	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000120176	20	62073781	20	63442428	120176	125784	rs587777219	NC_000020.11:63442427:G:A
NM_003784.4(SERPINB7):c.455-1G>A	SERPINB7		Palmoplantar keratoderma, nagashima type	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000102448	18	61465837	18	63798603	102448	108190	rs577442939	NC_000018.10:63798602:G:A
NM_003784.4(SERPINB7):c.218_219delinsTAAACTTTACCT (p.Gln73fs)	SERPINB7		Palmoplantar keratoderma, nagashima type	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000102447	18	61459676 - 61459677	18	63792442 - 63792443	102447	108189	rs797044479	NC_000018.10:63792441:AG:TAAACTTTACCT
NM_003784.4(SERPINB7):c.796C>T (p.Arg266Ter)	SERPINB7	R266*, R249*	Palmoplantar keratoderma, nagashima type|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000102446	18	61471522	18	63804288	102446	108188	rs142859678	NC_000018.10:63804287:C:T
NM_014740.4(EIF4A3):c.809A>G (p.Asp270Gly)	EIF4A3	D270G		Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101503	17	78111999	17	80138200	101503	107249	rs587777204	NC_000017.11:80138199:T:C
NM_014740.4(EIF4A3):c.-98_-81del18insTCGGCAGCGGCACAGCGAGG[10]	EIF4A3			Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101502	17	78120841 - 78120858	17	80147042 - 80147059	101502	107248		
EIF4A3, 15-REPEAT EXPANSION	EIF4A3			Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101501					101501	107247		
NM_014740.4(EIF4A3):c.-98_-81del18insTCGGCAGCGGCACAGCGAGG[13]	EIF4A3			Pathogenic(Last reviewed: Jan 2, 2014)	no assertion criteria provided	VCV000101500	17	78120841 - 78120858	17	80147042 - 80147059	101500	107246		
NM_176787.5(PIGN):c.963G>A (p.Gln321=)	PIGN		Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Nov 20, 2013)	no assertion criteria provided	VCV000101048	18	59810539	18	62143306	101048	106813	rs587777187	NC_000018.10:62143305:C:T
NM_176787.5(PIGN):c.808T>C (p.Ser270Pro)	PIGN	S270P	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000101047	18	59813256	18	62146023	101047	106812	rs587777186	NC_000018.10:62146022:A:G
NM_001958.4(EEF1A2):c.208G>A (p.Gly70Ser)	EEF1A2	G70S	Inborn genetic diseases|Epileptic encephalopathy, early infantile, 33|Intellectual disability|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy|not provided	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100782	20	62127325	20	63495972	100782	106647	rs587777162	NC_000020.11:63495971:C:T
NM_001830.4(CLCN4):c.1630G>A (p.Gly544Arg)	CLCN4	G544R, G450R	not provided|Mental retardation 49, X-linked	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000100781	X	10181774	X	10213734	100781	106646	rs587777161	NC_000023.11:10213733:G:A
NM_144628.2(TBC1D20):c.71-?_*1+?del	TBC1D20		Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100778			20	435480 - 448074	100778	106644		
NM_144628.4(TBC1D20):c.672G>A (p.Trp224Ter)	TBC1D20	W224*	Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100777	20	420988	20	440344	100777	106643	rs587777160	NC_000020.11:440343:C:T
NM_144628.4(TBC1D20):c.352_353del (p.Gln118fs)	TBC1D20	Q118fs	Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100776	20	422672 - 422673	20	442028 - 442029	100776	106642	rs587777159	NC_000020.11:442027:TGT:T
NM_144628.4(TBC1D20):c.292C>T (p.Gln98Ter)	TBC1D20	Q98*	Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100775	20	425739	20	445095	100775	106641	rs587777158	NC_000020.11:445094:G:A
NM_144628.4(TBC1D20):c.199C>T (p.Arg67Ter)	TBC1D20	R67*	Warburg micro syndrome 4	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000100774	20	428590	20	447946	100774	106640	rs587777157	NC_000020.11:447945:G:A
NM_001204402.1(PRPS1):c.-82-4220C>G	PRPS1	A121G	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000100767	X	106884187	X	107640957	100767	106633	rs587777150	NC_000023.11:107640956:C:G
NM_000211.5(ITGB2):c.897+1G>T	ITGB2			Pathogenic	no assertion criteria provided	VCV000100764	21	46320234	21	44900319	100764	106629	rs201752283	NC_000021.9:44900318:C:A
NM_000211.5(ITGB2):c.897+1G>A	ITGB2		|Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000100763	21	46320234	21	44900319	100763	106628	rs201752283	NC_000021.9:44900318:C:T
NM_000211.5(ITGB2):c.843del (p.Asn282fs)	ITGB2	N282fs, N213fs		Pathogenic	no assertion criteria provided	VCV000100762	21	46320289	21	44900374	100762	106627	rs483352815	NC_000021.9:44900373:GGGGG:GGGG
NM_000211.5(ITGB2):c.576dup (p.Asn193fs)	ITGB2	N193QfsX72		Pathogenic	no assertion criteria provided	VCV000100757	21	46321571 - 46321572	21	44901656 - 44901657	100757	106622	rs483352813	NC_000021.9:44901656:GGGG:GGGGG
NM_000211.5(ITGB2):c.1907del (p.Lys636fs)	ITGB2	K567fs, K636fs		Pathogenic	no assertion criteria provided	VCV000100750	21	46308781	21	44888866	100750	106615	rs483352819	NC_000021.9:44888865:TTTT:TTT
NM_000211.5(ITGB2):c.1877+2T>C	ITGB2			Pathogenic	no assertion criteria provided	VCV000100748	21	46309189	21	44889274	100748	106613	rs483352818	NC_000021.9:44889273:A:G
NM_000211.5(ITGB2):c.1143del (p.Tyr382fs)	ITGB2	Y382fs, Y313fs		Pathogenic	no assertion criteria provided	VCV000100747	21	46313400	21	44893485	100747	106612	rs483352817	NC_000021.9:44893484:GG:G
NM_000211.5(ITGB2):c.1030G>T (p.Glu344Ter)	ITGB2	E344*, E275*		Pathogenic	no assertion criteria provided	VCV000100744	21	46314939	21	44895024	100744	106609	rs483352816	NC_000021.9:44895023:C:A
NM_000308.3(CTSA):c.284del (p.Pro95fs)	CTSA	P77fs, P95fs	Combined deficiency of sialidase AND beta galactosidase	Pathogenic	no assertion criteria provided	VCV000100724	20	44520588	20	45891949	100724	106589	rs587779402	NC_000020.11:45891948:CCC:CC
NM_007059.4(KPTN):c.714_731dup (p.Met241_Gln246dup)	KPTN		Mental retardation, autosomal recessive 41|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100680	19	47983175 - 47983176	19	47479918 - 47479919	100680	106552	rs587777148	NC_000019.10:47479918:ACCGACCACATCTGCAGAACC:ACCGACCACATCTGCAGAACCGACCACATCTGCAGAACC
NM_007059.4(KPTN):c.776C>A (p.Ser259Ter)	KPTN	S259*, S203*	Mental retardation, autosomal recessive 41|not provided	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100679	19	47983131	19	47479874	100679	106551	rs374298314	NC_000019.10:47479873:G:T
NM_003859.2(DPM1):c.373-5T>A	DPM1		Congenital disorder of glycosylation type 1E	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000100635	20	49562304	20	50945767	100635	106507	rs587777115	NC_000020.11:50945766:A:T
NC_000023.10:g.(68059108_68059111)_(68067499_68067502)del	EFNB1			Pathogenic(Last reviewed: Apr 15, 2013)	no assertion criteria provided	VCV000100628	X	68059108 - 68067502	X	68839265 - 68847659	100628	106500		
NM_004429.4(EFNB1):c.496C>T (p.Gln166Ter)	EFNB1	Q166*		Pathogenic(Last reviewed: Apr 15, 2013)	no assertion criteria provided	VCV000100627	X	68059596	X	68839753	100627	106499	rs587777109	NC_000023.11:68839752:C:T
NM_000709.4(BCKDHA):c.1312T>A (p.Tyr438Asn)	BCKDHA	Y393N, Y438N, Y437N	Maple syrup urine disease|not provided|Maple syrup urine disease type 1A	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100009	19	41930487	19	41424582	100009	17414	rs137852870	NC_000019.10:41424581:T:A
NM_022567.2(NYX):c.85_108del (p.Arg29_Ala36del)	NYX		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000099841	X	41332782 - 41332805	X	41473529 - 41473552	99841	105730	rs281865194	NC_000023.11:41473528:GCCTGCGCCCGCGCTTGTCCCGCCGCCTGCGCC:GCCTGCGCC
NM_000554.6(CRX):c.615del (p.Ser206fs)	CRX	S206fs	not provided|Cone-rod dystrophy 2	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000099618	19	48342935	19	47839678	99618	105507	rs281865516	NC_000019.10:47839677:CCCCC:CCCC
NM_000554.6(CRX):c.520del (p.Ala174fs)	CRX	A174fs	Leber congenital amaurosis 7|not provided	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000099611	19	48342843	19	47839586	99611	105500	rs281865515	NC_000019.10:47839585:GG:G
NM_000328.3(RPGR):c.101del (p.Asn34fs)	RPGR	N34fs, N44fs	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000098815	X	38182705	X	38323452	98815	104705	rs281865295	NC_000023.11:38323451:TTTTT:TTTT
NM_000328.3(RPGR):c.934+1G>A	RPGR		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000098812	X	38163887	X	38304634	98812	104702	rs62640592	NC_000023.11:38304633:C:T
NM_000328.3(RPGR):c.581G>A (p.Trp194Ter)	RPGR	W194*, W204*, W193*	not provided|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000098790	X	38176607	X	38317354	98790	104680	rs62650216	NC_000023.11:38317353:C:T
NM_000328.3(RPGR):c.492G>A (p.Trp164Ter)	RPGR	W164*, W163*, W174*	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000098789	X	38176696	X	38317443	98789	104679	rs62638648	NC_000023.11:38317442:C:T
NM_000328.3(RPGR):c.486del (p.Phe162fs)	RPGR	F162fs, F161fs, F172fs	not provided	Pathogenic(Last reviewed: Nov 29, 2016)	criteria provided, single submitter	VCV000098788	X	38176702	X	38317449	98788	104678	rs281865297	NC_000023.11:38317448:AAAAA:AAAA
NM_000328.3(RPGR):c.485_486del (p.Phe162fs)	RPGR	F162fs, F161fs, F172fs	Cone-rod dystrophy, X-linked 1|Retinal dystrophy|not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000098787	X	38176702 - 38176703	X	38317449 - 38317450	98787	104677	rs281865297	NC_000023.11:38317448:AAAAA:AAA
NM_000328.3(RPGR):c.372del (p.Glu125fs)	RPGR	E125fs, E135fs, E124fs	not provided|Retinal dystrophy	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000098783	X	38178179	X	38318926	98783	104673	rs62638642	NC_000023.11:38318925:GG:G
NM_000328.3(RPGR):c.28+1G>A	RPGR		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000098771	X	38186592	X	38327339	98771	104661	rs62638627	NC_000023.11:38327338:C:T
NM_000328.3(RPGR):c.248-2A>G	RPGR		not provided|Retinitis pigmentosa	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000098765	X	38180344	X	38321091	98765	104655	rs62638633	NC_000023.11:38321090:T:C
NM_000328.3(RPGR):c.1377_1378del (p.Leu460fs)	RPGR	L398fs, L459fs, L460fs, L470fs	Retinal dystrophy|not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000098739	X	38156573 - 38156574	X	38297320 - 38297321	98739	104629	rs62653029	NC_000023.11:38297319:AGA:A
NM_000328.3(RPGR):c.1092dup (p.Ala365fs)	RPGR		not provided|Retinal dystrophy	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000098727	X	38158361 - 38158362	X	38299108 - 38299109	98727	104617	rs281865301	NC_000023.11:38299108:AAAAA:AAAAAA
NM_001127255.1(NLRP7):c.337dup (p.Glu113fs)	NLRP7		Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Dec 9, 2013)	criteria provided, single submitter	VCV000097796	19	55452313 - 55452314	19	54940945 - 54940946	97796	103688	rs104895553	NC_000019.10:54940945:CC:CCC
NM_000531.6(OTC):c.996G>A (p.Trp332Ter)	OTC	W332*	not provided	Pathogenic	no assertion criteria provided	VCV000097380	X	38271243	X	38411990	97380	103272	rs72558482	NC_000023.11:38411989:G:A
NM_000531.6(OTC):c.995G>A (p.Trp332Ter)	OTC	W332*	not provided	Pathogenic	no assertion criteria provided	VCV000097379	X	38271242	X	38411989	97379	103271	rs72558481	NC_000023.11:38411988:G:A
NM_000531.6(OTC):c.994T>A (p.Trp332Arg)	OTC	W332R	not provided	Pathogenic	no assertion criteria provided	VCV000097378	X	38271241	X	38411988	97378	103270	rs72558480	NC_000023.11:38411987:T:A
NM_000531.6(OTC):c.991A>T (p.Lys331Ter)	OTC	K331*	not provided	Pathogenic	no assertion criteria provided	VCV000097377	X	38271238	X	38411985	97377	103269	rs72558479	NC_000023.11:38411984:A:T
NM_000531.6(OTC):c.982G>T (p.Glu328Ter)	OTC	E328*	not provided	Pathogenic	no assertion criteria provided	VCV000097375	X	38271229	X	38411976	97375	103267	rs72558477	NC_000023.11:38411975:G:T
NM_000531.6(OTC):c.976G>A (p.Glu326Lys)	OTC	E326K	not provided	Pathogenic	no assertion criteria provided	VCV000097374	X	38271223	X	38411970	97374	103266	rs72558476	NC_000023.11:38411969:G:A
NM_000531.6(OTC):c.962C>A (p.Ser321Ter)	OTC	S321*	not provided	Pathogenic	no assertion criteria provided	VCV000097373	X	38271209	X	38411956	97373	103265	rs72558475	NC_000023.11:38411955:C:A
NM_000531.6(OTC):c.958C>T (p.Arg320Ter)	OTC	R320*	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000097371	X	38271205	X	38411952	97371	103263	rs72558473	NC_000023.11:38411951:C:T
NM_000531.6(OTC):c.953C>T (p.Ser318Phe)	OTC	S318F	not provided	Pathogenic	no assertion criteria provided	VCV000097370	X	38271200	X	38411947	97370	103262	rs72558472	NC_000023.11:38411946:C:T
NM_000531.6(OTC):c.94C>T (p.Gln32Ter)	OTC	Q32*	not provided	Pathogenic	no assertion criteria provided	VCV000097369	X	38226560	X	38367307	97369	103261	rs72554304	NC_000023.11:38367306:C:T
NM_000531.6(OTC):c.947T>C (p.Phe316Ser)	OTC	F316S	not provided	Pathogenic	no assertion criteria provided	VCV000097368	X	38271194	X	38411941	97368	103260	rs72558471	NC_000023.11:38411940:T:C
NM_000531.6(OTC):c.944T>G (p.Val315Gly)	OTC	V315G	not provided	Pathogenic	no assertion criteria provided	VCV000097367	X	38271191	X	38411938	97367	103259	rs67414444	NC_000023.11:38411937:T:G
NM_000531.6(OTC):c.944T>A (p.Val315Asp)	OTC	V315D	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000097366	X	38271191	X	38411938	97366	103258	rs67414444	NC_000023.11:38411937:T:A
NM_000531.6(OTC):c.941_943del (p.Glu314del)	OTC	E314del	not provided	Pathogenic	no assertion criteria provided	VCV000097364	X	38271187 - 38271189	X	38411934 - 38411936	97364	103256	rs72558469	NC_000023.11:38411933:GAAG:G
NM_000531.6(OTC):c.931G>A (p.Val311Met)	OTC	V311M	not provided	Pathogenic	no assertion criteria provided	VCV000097363	X	38271178	X	38411925	97363	103255	rs72558468	NC_000023.11:38411924:G:A
NM_000531.6(OTC):c.929A>G (p.Glu310Gly)	OTC	E310G	not provided	Pathogenic	no assertion criteria provided	VCV000097362	X	38271176	X	38411923	97362	103254	rs72558467	NC_000023.11:38411922:A:G
NM_000531.6(OTC):c.928G>T (p.Glu310Ter)	OTC	E310*	not provided	Pathogenic	no assertion criteria provided	VCV000097361	X	38271175	X	38411922	97361	103253	rs72558466	NC_000023.11:38411921:G:T
NM_000531.6(OTC):c.914C>G (p.Pro305Arg)	OTC	P305R	not provided	Pathogenic	no assertion criteria provided	VCV000097360	X	38271161	X	38411908	97360	103252	rs67501347	NC_000023.11:38411907:C:G
NM_000531.6(OTC):c.914C>A (p.Pro305His)	OTC	P305H	not provided	Pathogenic	no assertion criteria provided	VCV000097359	X	38271161	X	38411908	97359	103251	rs67501347	NC_000023.11:38411907:C:A
NM_000531.6(OTC):c.908G>A (p.Cys303Tyr)	OTC	C303Y	not provided	Pathogenic	no assertion criteria provided	VCV000097358	X	38271155	X	38411902	97358	103250	rs72558464	NC_000023.11:38411901:G:A
NM_000531.6(OTC):c.907T>G (p.Cys303Gly)	OTC	C303G	not provided	Pathogenic	no assertion criteria provided	VCV000097357	X	38271154	X	38411901	97357	103249	rs67468335	NC_000023.11:38411900:T:G
NM_000531.6(OTC):c.907T>C (p.Cys303Arg)	OTC	C303R	not provided	Pathogenic	no assertion criteria provided	VCV000097356	X	38271154	X	38411901	97356	103248	rs67468335	NC_000023.11:38411900:T:C
NM_000531.6(OTC):c.906del (p.Cys303fs)	OTC	C303fs	not provided	Pathogenic	no assertion criteria provided	VCV000097355	X	38271153	X	38411900	97355	103247	rs67870245	NC_000023.11:38411899:C:
NM_000531.6(OTC):c.906C>G (p.His302Gln)	OTC	H302Q	not provided	Pathogenic	no assertion criteria provided	VCV000097354	X	38271153	X	38411900	97354	103246	rs67870244	NC_000023.11:38411899:C:G
NM_000531.6(OTC):c.905A>T (p.His302Leu)	OTC	H302L	not provided	Pathogenic	no assertion criteria provided	VCV000097353	X	38271152	X	38411899	97353	103245	rs67993095	NC_000023.11:38411898:A:T
NM_000531.6(OTC):c.905A>G (p.His302Arg)	OTC	H302R	not provided	Pathogenic	no assertion criteria provided	VCV000097352	X	38271152	X	38411899	97352	103244	rs67993095	NC_000023.11:38411898:A:G
NM_000531.6(OTC):c.904C>T (p.His302Tyr)	OTC	H302Y	not provided	Pathogenic	no assertion criteria provided	VCV000097351	X	38271151	X	38411898	97351	103243	rs72558463	NC_000023.11:38411897:C:T
NM_000531.6(OTC):c.903A>T (p.Leu301Phe)	OTC	L301F	not provided	Pathogenic	no assertion criteria provided	VCV000097350	X	38271150	X	38411897	97350	103242	rs72558462	NC_000023.11:38411896:A:T
NM_000531.6(OTC):c.893G>C (p.Trp298Ser)	OTC	W298S	not provided	Pathogenic	no assertion criteria provided	VCV000097349	X	38271140	X	38411887	97349	103241	rs72558461	NC_000023.11:38411886:G:C
NM_000531.6(OTC):c.892_893del (p.Trp298fs)	OTC	W298fs	not provided	Pathogenic	no assertion criteria provided	VCV000097348	X	38271139 - 38271140	X	38411886 - 38411887	97348	103240	rs72558460	NC_000023.11:38411885:TG:
NM_000531.6(OTC):c.890_893del (p.Asp297fs)	OTC	D297fs	not provided	Pathogenic	no assertion criteria provided	VCV000097347	X	38271134 - 38271137	X	38411881 - 38411884	97347	103239	rs72558459	NC_000023.11:38411880:CTGACTG:CTG
NM_000531.6(OTC):c.882del (p.Ala295fs)	OTC	A295fs	not provided	Pathogenic	no assertion criteria provided	VCV000097346	X	38271129	X	38411876	97346	103238	rs72558458	NC_000023.11:38411875:T:
NM_000531.6(OTC):c.876del (p.Val293fs)	OTC	V293fs	not provided	Pathogenic	no assertion criteria provided	VCV000097345	X	38271121	X	38411868	97345	103237	rs72558457	NC_000023.11:38411867:AAA:AA
NM_000531.6(OTC):c.867G>T (p.Lys289Asn)	OTC	K289N	not provided	Pathogenic	no assertion criteria provided	VCV000097344	X	38268278	X	38409025	97344	103236	rs72558456	NC_000023.11:38409024:G:T
NM_000531.6(OTC):c.867+1G>T	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097343	X	38268279	X	38409026	97343	103235	rs66512766	NC_000023.11:38409025:G:T
NM_000531.6(OTC):c.867+1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097342	X	38268279	X	38409026	97342	103234	rs66512766	NC_000023.11:38409025:G:A
NM_000531.6(OTC):c.835C>T (p.Gln279Ter)	OTC	Q279*	not provided	Pathogenic	no assertion criteria provided	VCV000097341	X	38268246	X	38408993	97341	103233	rs72558455	NC_000023.11:38408992:C:T
NM_000531.6(OTC):c.830G>T (p.Arg277Leu)	OTC	R277L	not provided	Pathogenic	no assertion criteria provided	VCV000097340	X	38268241	X	38408988	97340	103232	rs66724222	NC_000023.11:38408987:G:T
NM_000531.6(OTC):c.830G>A (p.Arg277Gln)	OTC	R277Q	not specified|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000097339	X	38268241	X	38408988	97339	103231	rs66724222	NC_000023.11:38408987:G:A
NM_000531.6(OTC):c.818del (p.Glu273fs)	OTC	E273fs	not provided	Pathogenic	no assertion criteria provided	VCV000097338	X	38268229	X	38408976	97338	103230	rs72558453	NC_000023.11:38408975:A:
NM_000531.6(OTC):c.809A>C (p.Gln270Pro)	OTC	Q270P	not provided	Pathogenic	no assertion criteria provided	VCV000097336	X	38268220	X	38408967	97336	103228	rs1800328	NC_000023.11:38408966:A:C
NM_000531.6(OTC):c.808C>T (p.Gln270Ter)	OTC	Q270*	not provided	Pathogenic	no assertion criteria provided	VCV000097335	X	38268219	X	38408966	97335	103227	rs72558451	NC_000023.11:38408965:C:T
NM_000531.6(OTC):c.806G>A (p.Gly269Glu)	OTC	G269E	not provided	Pathogenic	no assertion criteria provided	VCV000097334	X	38268217	X	38408964	97334	103226	rs72558450	NC_000023.11:38408963:G:A
NM_000531.6(OTC):c.803T>C (p.Met268Thr)	OTC	M268T	not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000097333	X	38268214	X	38408961	97333	103225	rs72558449	NC_000023.11:38408960:T:C
NM_000531.6(OTC):c.799A>C (p.Ser267Arg)	OTC	S267R	not provided	Pathogenic	no assertion criteria provided	VCV000097332	X	38268210	X	38408957	97332	103224	rs72558448	NC_000023.11:38408956:A:C
NM_000531.6(OTC):c.795G>A (p.Trp265Ter)	OTC	W265*	not provided	Pathogenic	no assertion criteria provided	VCV000097331	X	38268206	X	38408953	97331	103223	rs72558447	NC_000023.11:38408952:G:A
NM_000531.6(OTC):c.794G>T (p.Trp265Leu)	OTC	W265L	not provided	Pathogenic	no assertion criteria provided	VCV000097330	X	38268205	X	38408952	97330	103222	rs72558446	NC_000023.11:38408951:G:T
NM_000531.6(OTC):c.793T>C (p.Trp265Arg)	OTC	W265R	not provided	Pathogenic	no assertion criteria provided	VCV000097329	X	38268204	X	38408951	97329	103221	rs72558445	NC_000023.11:38408950:T:C
NM_000531.6(OTC):c.791C>T (p.Thr264Ile)	OTC	T264I	not provided	Pathogenic	no assertion criteria provided	VCV000097328	X	38268202	X	38408949	97328	103220	rs67156896	NC_000023.11:38408948:C:T
NM_000531.6(OTC):c.791C>A (p.Thr264Asn)	OTC	T264N	not provided	Pathogenic	no assertion criteria provided	VCV000097327	X	38268202	X	38408949	97327	103219	rs67156896	NC_000023.11:38408948:C:A
NM_000531.6(OTC):c.790A>G (p.Thr264Ala)	OTC	T264A	not provided	Pathogenic	no assertion criteria provided	VCV000097326	X	38268201	X	38408948	97326	103218	rs72558444	NC_000023.11:38408947:A:G
NM_000531.6(OTC):c.788A>G (p.Asp263Gly)	OTC	D263G	not provided	Pathogenic	no assertion criteria provided	VCV000097325	X	38268199	X	38408946	97325	103217	rs72558443	NC_000023.11:38408945:A:G
NM_000531.6(OTC):c.787G>A (p.Asp263Asn)	OTC	D263N	not provided	Pathogenic	no assertion criteria provided	VCV000097324	X	38268198	X	38408945	97324	103216	rs72558442	NC_000023.11:38408944:G:A
NM_000531.6(OTC):c.785C>T (p.Thr262Ile)	OTC	T262I	not provided	Pathogenic	no assertion criteria provided	VCV000097323	X	38268196	X	38408943	97323	103215	rs67333670	NC_000023.11:38408942:C:T
NM_000531.6(OTC):c.785C>A (p.Thr262Lys)	OTC	T262K	not provided	Pathogenic	no assertion criteria provided	VCV000097322	X	38268196	X	38408943	97322	103214	rs67333670	NC_000023.11:38408942:C:A
NM_000531.6(OTC):c.78-3C>G	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097321	X	38226541	X	38367288	97321	103213	rs72554303	NC_000023.11:38367287:C:G
NM_000531.6(OTC):c.78-1G>C	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097320	X	38226543	X	38367290	97320	103212	rs281865554	NC_000023.11:38367289:G:C
NM_000531.6(OTC):c.77G>C (p.Arg26Pro)	OTC	R26P	not provided	Pathogenic	no assertion criteria provided	VCV000097319	X	38212026	X	38352773	97319	103211	rs68031618	NC_000023.11:38352772:G:C
NM_000531.6(OTC):c.779T>C (p.Leu260Ser)	OTC	L260S	not provided	Pathogenic	no assertion criteria provided	VCV000097318	X	38268190	X	38408937	97318	103210	rs72558441	NC_000023.11:38408936:T:C
NM_000531.6(OTC):c.77+5G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097317	X	38212031	X	38352778	97317	103209	rs72552302	NC_000023.11:38352777:G:A
NM_000531.6(OTC):c.77+4A>C	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097316	X	38212030	X	38352777	97316	103208	rs72552301	NC_000023.11:38352776:A:C
NM_000531.6(OTC):c.77+3_77+6del	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097315	X	38212027 - 38212030	X	38352774 - 38352777	97315	103207	rs72558496	NC_000023.11:38352773:GTAAGT:GT
NM_000531.6(OTC):c.77+1G>T	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097314	X	38212027	X	38352774	97314	103206	rs67077695	NC_000023.11:38352773:G:T
NM_000531.6(OTC):c.77+1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097313	X	38212027	X	38352774	97313	103205	rs67077695	NC_000023.11:38352773:G:A
NM_000531.6(OTC):c.764A>C (p.His255Pro)	OTC	H255P	not provided	Pathogenic	no assertion criteria provided	VCV000097312	X	38268175	X	38408922	97312	103204	rs72558440	NC_000023.11:38408921:A:C
NM_000531.6(OTC):c.759del (p.Ala254fs)	OTC	A254fs	not provided	Pathogenic	no assertion criteria provided	VCV000097311	X	38268170	X	38408917	97311	103203	rs72558439	NC_000023.11:38408916:A:
NM_000531.6(OTC):c.757G>C (p.Ala253Pro)	OTC	A253P	not provided	Pathogenic	no assertion criteria provided	VCV000097310	X	38268168	X	38408915	97310	103202	rs67330615	NC_000023.11:38408914:G:C
NM_000531.6(OTC):c.757G>A (p.Ala253Thr)	OTC	A253T	not provided	Pathogenic	no assertion criteria provided	VCV000097309	X	38268168	X	38408915	97309	103201	rs67330615	NC_000023.11:38408914:G:A
NM_000531.6(OTC):c.740C>A (p.Thr247Lys)	OTC	T247K	not provided	Pathogenic	no assertion criteria provided	VCV000097308	X	38268151	X	38408898	97308	103200	rs72558437	NC_000023.11:38408897:C:A
NM_000531.6(OTC):c.731_739del (p.Leu244_Thr247delinsPro)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097307	X	38268142 - 38268150	X	38408889 - 38408897	97307	103199	rs72558438	NC_000023.11:38408888:TGTTGCTGA:
NM_000531.6(OTC):c.731T>A (p.Leu244Gln)	OTC	L244Q	not provided	Pathogenic	no assertion criteria provided	VCV000097306	X	38268142	X	38408889	97306	103198	rs72558436	NC_000023.11:38408888:T:A
NM_000531.6(OTC):c.725C>T (p.Thr242Ile)	OTC	T242I	not provided	Pathogenic	no assertion criteria provided	VCV000097305	X	38268136	X	38408883	97305	103197	rs72558435	NC_000023.11:38408882:C:T
NM_000531.6(OTC):c.718-2_731del	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097304	X	38268124 - 38268139	X	38408871 - 38408886	97304	103196	rs72558434	NC_000023.11:38408870:GCTAGAATGGTACCAAGCT:GCT
NM_000531.6(OTC):c.718-2A>G	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097303	X	38268127	X	38408874	97303	103195	rs72558433	NC_000023.11:38408873:A:G
NM_000531.6(OTC):c.717G>A (p.Glu239=)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097301	X	38268048	X	38408795	97301	103193	rs66851495	NC_000023.11:38408794:G:A
NM_000531.6(OTC):c.717+8_717+23del	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097300	X	38268053 - 38268068	X	38408800 - 38408815	97300	103192	rs111060774	NC_000023.11:38408799:GCTCTTTACATGTAAAGCT:GCT
NM_000531.6(OTC):c.717+3A>G	OTC		not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000097299	X	38268051	X	38408798	97299	103191	rs72558432	NC_000023.11:38408797:A:G
NM_000531.6(OTC):c.717+1G>T	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097298	X	38268049	X	38408796	97298	103190	rs66500027	NC_000023.11:38408795:G:T
NM_000531.6(OTC):c.717+1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097297	X	38268049	X	38408796	97297	103189	rs66500027	NC_000023.11:38408795:G:A
NM_000531.6(OTC):c.716A>T (p.Glu239Val)	OTC	E239V	not provided	Pathogenic	no assertion criteria provided	VCV000097296	X	38268047	X	38408794	97296	103188	rs67283833	NC_000023.11:38408793:A:T
NM_000531.6(OTC):c.716A>G (p.Glu239Gly)	OTC	E239G	not provided	Pathogenic	no assertion criteria provided	VCV000097295	X	38268047	X	38408794	97295	103187	rs67283833	NC_000023.11:38408793:A:G
NM_000531.6(OTC):c.700G>T (p.Glu234Ter)	OTC	E234*	not provided	Pathogenic	no assertion criteria provided	VCV000097294	X	38268031	X	38408778	97294	103186	rs72558430	NC_000023.11:38408777:G:T
NM_000531.6(OTC):c.698C>T (p.Ala233Val)	OTC	A233V	not provided	Pathogenic	no assertion criteria provided	VCV000097293	X	38268029	X	38408776	97293	103185	rs72558429	NC_000023.11:38408775:C:T
NM_000531.6(OTC):c.67C>T (p.Arg23Ter)	OTC	R23*	not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000097292	X	38212016	X	38352763	97292	103184	rs72552300	NC_000023.11:38352762:C:T
NM_000531.6(OTC):c.674C>G (p.Pro225Arg)	OTC	P225R	not provided	Pathogenic	no assertion criteria provided	VCV000097291	X	38268005	X	38408752	97291	103183	rs67120076	NC_000023.11:38408751:C:G
NM_000531.6(OTC):c.673C>A (p.Pro225Thr)	OTC	P225T	not provided	Pathogenic	no assertion criteria provided	VCV000097290	X	38268004	X	38408751	97290	103182	rs72558428	NC_000023.11:38408750:C:A
NM_000531.5(OTC):c.664-1delG	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097289	X	38267994	X	38408741	97289	103181	rs67839039	NC_000023.11:38408740:GGG:GG
NM_000531.6(OTC):c.664-1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097288	X	38267994	X	38408741	97288	103180	rs67839036	NC_000023.11:38408740:G:A
NM_000531.6(OTC):c.663G>C (p.Lys221Asn)	OTC	K221N	not provided	Pathogenic	no assertion criteria provided	VCV000097287	X	38262993	X	38403740	97287	103179	rs281865552	NC_000023.11:38403739:G:C
NM_000531.6(OTC):c.663G>A (p.Lys221=)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097286	X	38262993	X	38403740	97286	103178	rs281865552	NC_000023.11:38403739:G:A
NM_000531.6(OTC):c.663+2T>C	OTC		not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000097285	X	38262995	X	38403742	97285	103177	rs72558427	NC_000023.11:38403741:T:C
NM_000531.6(OTC):c.663+1G>T	OTC		not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000097284	X	38262994	X	38403741	97284	103176	rs68170503	NC_000023.11:38403740:G:T
NM_000531.6(OTC):c.663+1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097283	X	38262994	X	38403741	97283	103175	rs68170503	NC_000023.11:38403740:G:A
NM_000531.6(OTC):c.659C>T (p.Pro220Leu)	OTC	P220L	not provided	Pathogenic	no assertion criteria provided	VCV000097282	X	38262989	X	38403736	97282	103174	rs72558426	NC_000023.11:38403735:C:T
NM_000531.6(OTC):c.658C>G (p.Pro220Ala)	OTC	P220A	not provided	Pathogenic	no assertion criteria provided	VCV000097281	X	38262988	X	38403735	97281	103173	rs72558425	NC_000023.11:38403734:C:G
NM_000531.6(OTC):c.650C>A (p.Ala217Glu)	OTC	A217E	not provided	Pathogenic	no assertion criteria provided	VCV000097280	X	38262980	X	38403727	97280	103172	rs72558424	NC_000023.11:38403726:C:A
NM_000531.6(OTC):c.645dup (p.Gln216fs)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097279	X	38262973 - 38262974	X	38403720 - 38403721	97279	103171	rs72558422	NC_000023.11:38403720:TT:TTT
NM_000531.6(OTC):c.643C>T (p.Leu215Phe)	OTC	L215F	not provided	Pathogenic	no assertion criteria provided	VCV000097278	X	38262973	X	38403720	97278	103170	rs72558421	NC_000023.11:38403719:C:T
NM_000531.6(OTC):c.640C>T (p.His214Tyr)	OTC	H214Y	not provided	Pathogenic	no assertion criteria provided	VCV000097277	X	38262970	X	38403717	97277	103169	rs72558420	NC_000023.11:38403716:C:T
NM_000531.6(OTC):c.628A>C (p.Lys210Gln)	OTC	K210Q	not provided	Pathogenic	no assertion criteria provided	VCV000097276	X	38262958	X	38403705	97276	103168	rs72558418	NC_000023.11:38403704:A:C
NM_000531.6(OTC):c.626C>T (p.Ala209Val)	OTC	A209V	not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	VCV000097275	X	38262956	X	38403703	97275	103167	rs72558417	NC_000023.11:38403702:C:T
NM_000531.6(OTC):c.622G>A (p.Ala208Thr)	OTC	A208T	not provided	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000097274	X	38262952	X	38403699	97274	103166	rs72558416	NC_000023.11:38403698:G:A
NM_000531.6(OTC):c.621C>A (p.Ser207Arg)	OTC	S207R	not provided	Pathogenic	no assertion criteria provided	VCV000097273	X	38262951	X	38403698	97273	103165	rs72558415	NC_000023.11:38403697:C:A
NM_000531.6(OTC):c.620G>A (p.Ser207Asn)	OTC	S207N	not provided	Pathogenic	no assertion criteria provided	VCV000097272	X	38262950	X	38403697	97272	103164	rs72558414	NC_000023.11:38403696:G:A
NM_000531.6(OTC):c.618G>C (p.Met206Ile)	OTC	M206I	not provided	Pathogenic	no assertion criteria provided	VCV000097271	X	38262948	X	38403695	97271	103163	rs72558413	NC_000023.11:38403694:G:C
NM_000531.6(OTC):c.608C>G (p.Ser203Cys)	OTC	S203C	not provided	Pathogenic	no assertion criteria provided	VCV000097269	X	38262938	X	38403685	97269	103161	rs72558410	NC_000023.11:38403684:C:G
NM_000531.6(OTC):c.605A>C (p.His202Pro)	OTC	H202P	not provided	Pathogenic	no assertion criteria provided	VCV000097268	X	38262935	X	38403682	97268	103160	rs72558409	NC_000023.11:38403681:A:C
NM_000531.6(OTC):c.604C>T (p.His202Tyr)	OTC	H202Y	not provided	Pathogenic	no assertion criteria provided	VCV000097267	X	38262934	X	38403681	97267	103159	rs72558408	NC_000023.11:38403680:C:T
NM_000531.6(OTC):c.602T>C (p.Leu201Pro)	OTC	L201P	not provided	Pathogenic	no assertion criteria provided	VCV000097266	X	38262932	X	38403679	97266	103158	rs72558407	NC_000023.11:38403678:T:C
NM_000531.6(OTC):c.595A>G (p.Asn199Asp)	OTC	N199D	not provided	Pathogenic	no assertion criteria provided	VCV000097264	X	38262925	X	38403672	97264	103156	rs72558405	NC_000023.11:38403671:A:G
NM_000531.6(OTC):c.594C>A (p.Asn198Lys)	OTC	N198K	not provided	Pathogenic	no assertion criteria provided	VCV000097263	X	38262924	X	38403671	97263	103155	rs72558404	NC_000023.11:38403670:C:A
NM_000531.6(OTC):c.593A>T (p.Asn198Ile)	OTC	N198I	not provided	Pathogenic	no assertion criteria provided	VCV000097262	X	38262923	X	38403670	97262	103154	rs72558403	NC_000023.11:38403669:A:T
NM_000531.6(OTC):c.590G>A (p.Gly197Glu)	OTC	G197E	not provided	Pathogenic	no assertion criteria provided	VCV000097261	X	38262920	X	38403667	97261	103153	rs72556302	NC_000023.11:38403666:G:A
NM_000531.6(OTC):c.589G>A (p.Gly197Arg)	OTC	G197R	not provided	Pathogenic	no assertion criteria provided	VCV000097260	X	38262919	X	38403666	97260	103152	rs72556301	NC_000023.11:38403665:G:A
NM_000531.6(OTC):c.587A>T (p.Asp196Val)	OTC	D196V	not provided	Pathogenic	no assertion criteria provided	VCV000097259	X	38262917	X	38403664	97259	103151	rs72556300	NC_000023.11:38403663:A:T
NM_000531.6(OTC):c.586G>T (p.Asp196Tyr)	OTC	D196Y	not provided	Pathogenic	no assertion criteria provided	VCV000097258	X	38262916	X	38403663	97258	103150	rs66642398	NC_000023.11:38403662:G:T
NM_000531.6(OTC):c.586G>A (p.Asp196Asn)	OTC	D196N	not provided	Pathogenic	no assertion criteria provided	VCV000097257	X	38262916	X	38403663	97257	103149	rs66642398	NC_000023.11:38403662:G:A
NM_000531.6(OTC):c.586del (p.Asp196fs)	OTC	D196fs	not provided	Pathogenic	no assertion criteria provided	VCV000097256	X	38262913	X	38403660	97256	103148	rs67294956	NC_000023.11:38403659:GGGG:GGG
NM_000531.6(OTC):c.583G>A (p.Gly195Arg)	OTC	G195R	not provided	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000097255	X	38262913	X	38403660	97255	103147	rs67294955	NC_000023.11:38403659:G:A
NM_000531.6(OTC):c.578G>A (p.Trp193Ter)	OTC	W193*	not provided	Pathogenic	no assertion criteria provided	VCV000097254	X	38262908	X	38403655	97254	103146	rs72556299	NC_000023.11:38403654:G:A
NM_000531.6(OTC):c.577T>G (p.Trp193Gly)	OTC	W193G	not provided	Pathogenic	no assertion criteria provided	VCV000097253	X	38262907	X	38403654	97253	103145	rs67284661	NC_000023.11:38403653:T:G
NM_000531.6(OTC):c.577T>C (p.Trp193Arg)	OTC	W193R	not provided	Pathogenic	no assertion criteria provided	VCV000097252	X	38262907	X	38403654	97252	103144	rs67284661	NC_000023.11:38403653:T:C
NM_000531.6(OTC):c.576C>G (p.Ser192Arg)	OTC	S192R	not provided	Pathogenic	no assertion criteria provided	VCV000097251	X	38262906	X	38403653	97251	103143	rs72556298	NC_000023.11:38403652:C:G
NM_000531.6(OTC):c.571C>T (p.Leu191Phe)	OTC	L191F	not provided	Pathogenic	no assertion criteria provided	VCV000097250	X	38262901	X	38403648	97250	103142	rs72556296	NC_000023.11:38403647:C:T
NM_000531.6(OTC):c.563G>T (p.Gly188Val)	OTC	G188V	not provided	Pathogenic	no assertion criteria provided	VCV000097249	X	38262893	X	38403640	97249	103141	rs72556295	NC_000023.11:38403639:G:T
NM_000531.6(OTC):c.562G>C (p.Gly188Arg)	OTC	G188R	not provided	Pathogenic	no assertion criteria provided	VCV000097248	X	38262892	X	38403639	97248	103140	rs72556294	NC_000023.11:38403638:G:C
NM_000531.6(OTC):c.548A>G (p.Tyr183Cys)	OTC	Y183C	not provided	Pathogenic	no assertion criteria provided	VCV000097247	X	38262878	X	38403625	97247	103139	rs72556293	NC_000023.11:38403624:A:G
NM_000531.6(OTC):c.547T>G (p.Tyr183Asp)	OTC	Y183D	not provided	Pathogenic	no assertion criteria provided	VCV000097246	X	38262877	X	38403624	97246	103138	rs72556292	NC_000023.11:38403623:T:G
NM_000531.6(OTC):c.545A>T (p.His182Leu)	OTC	H182L	not provided	Pathogenic	no assertion criteria provided	VCV000097245	X	38262875	X	38403622	97245	103137	rs72556291	NC_000023.11:38403621:A:T
NM_000531.6(OTC):c.542A>G (p.Glu181Gly)	OTC	E181G	not provided	Pathogenic	no assertion criteria provided	VCV000097244	X	38262872	X	38403619	97244	103136	rs72556290	NC_000023.11:38403618:A:G
NM_000531.6(OTC):c.541-2A>G	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097243	X	38262869	X	38403616	97243	103135	rs72556289	NC_000023.11:38403615:A:G
NM_000531.6(OTC):c.540G>C (p.Gln180His)	OTC	Q180H	not provided	Pathogenic	no assertion criteria provided	VCV000097242	X	38260681	X	38401428	97242	103134	rs72556287	NC_000023.11:38401427:G:C
NM_000531.6(OTC):c.540+2T>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097241	X	38260683	X	38401430	97241	103133	rs67367843	NC_000023.11:38401429:T:A
NM_000531.6(OTC):c.540+1G>C	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097240	X	38260682	X	38401429	97240	103132	rs72556288	NC_000023.11:38401428:G:C
NM_000531.6(OTC):c.53del (p.His18fs)	OTC	H18fs	not provided	Pathogenic	no assertion criteria provided	VCV000097239	X	38212002	X	38352749	97239	103131	rs72552299	NC_000023.11:38352748:A:
NM_000531.6(OTC):c.536T>C (p.Leu179Pro)	OTC	L179P	not provided	Pathogenic	no assertion criteria provided	VCV000097238	X	38260677	X	38401424	97238	103130	rs72556286	NC_000023.11:38401423:T:C
NM_000531.6(OTC):c.533C>T (p.Thr178Met)	OTC	T178M	not provided	Pathogenic(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	VCV000097237	X	38260674	X	38401421	97237	103129	rs72556284	NC_000023.11:38401420:C:T
NM_000531.6(OTC):c.532_537del (p.Thr178_Leu179del)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097236	X	38260670 - 38260675	X	38401417 - 38401422	97236	103128	rs72556285	NC_000023.11:38401416:CTCACGCTC:CTC
NM_000531.6(OTC):c.527A>G (p.Tyr176Cys)	OTC	Y176C	not provided	Pathogenic	no assertion criteria provided	VCV000097235	X	38260668	X	38401415	97235	103127	rs72556283	NC_000023.11:38401414:A:G
NM_000531.6(OTC):c.526T>C (p.Tyr176His)	OTC	Y176H	not provided	Pathogenic	no assertion criteria provided	VCV000097234	X	38260667	X	38401414	97234	103126	rs72556282	NC_000023.11:38401413:T:C
NM_000531.6(OTC):c.524A>T (p.Asp175Val)	OTC	D175V	not provided	Pathogenic	no assertion criteria provided	VCV000097233	X	38260665	X	38401412	97233	103125	rs68033093	NC_000023.11:38401411:A:T
NM_000531.6(OTC):c.524A>G (p.Asp175Gly)	OTC	D175G	not provided	Pathogenic	no assertion criteria provided	VCV000097232	X	38260665	X	38401412	97232	103124	rs68033093	NC_000023.11:38401411:A:G
NM_000531.6(OTC):c.520G>C (p.Ala174Pro)	OTC	A174P	not provided	Pathogenic	no assertion criteria provided	VCV000097231	X	38260661	X	38401408	97231	103123	rs72556281	NC_000023.11:38401407:G:C
NM_000531.6(OTC):c.516C>G (p.Ile172Met)	OTC	I172M	not provided	Pathogenic	no assertion criteria provided	VCV000097230	X	38260657	X	38401404	97230	103122	rs72556280	NC_000023.11:38401403:C:G
NM_000531.6(OTC):c.514A>T (p.Ile172Phe)	OTC	I172F	not provided	Pathogenic	no assertion criteria provided	VCV000097229	X	38260655	X	38401402	97229	103121	rs72556279	NC_000023.11:38401401:A:T
NM_000531.6(OTC):c.506C>T (p.Pro169Leu)	OTC	P169L	not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000097228	X	38260647	X	38401394	97228	103120	rs72556278	NC_000023.11:38401393:C:T
NM_000531.6(OTC):c.504T>A (p.His168Gln)	OTC	H168Q	not provided	Pathogenic	no assertion criteria provided	VCV000097226	X	38260645	X	38401392	97226	103118	rs72556276	NC_000023.11:38401391:T:A
NM_000531.6(OTC):c.503A>G (p.His168Arg)	OTC	H168R	not provided	Pathogenic	no assertion criteria provided	VCV000097225	X	38260644	X	38401391	97225	103117	rs66867430	NC_000023.11:38401390:A:G
NM_000531.6(OTC):c.503A>C (p.His168Pro)	OTC	H168P	not provided	Pathogenic	no assertion criteria provided	VCV000097224	X	38260644	X	38401391	97224	103116	rs66867430	NC_000023.11:38401390:A:C
NM_000531.6(OTC):c.501C>G (p.Tyr167Ter)	OTC	Y167*	not provided	Pathogenic	no assertion criteria provided	VCV000097223	X	38260642	X	38401389	97223	103115	rs66564822	NC_000023.11:38401388:C:G
NM_000531.6(OTC):c.501C>A (p.Tyr167Ter)	OTC	Y167*	not provided	Pathogenic	no assertion criteria provided	VCV000097222	X	38260642	X	38401389	97222	103114	rs66564822	NC_000023.11:38401388:C:A
NM_000531.6(OTC):c.493G>T (p.Asp165Tyr)	OTC	D165Y	not provided	Pathogenic	no assertion criteria provided	VCV000097221	X	38260634	X	38401381	97221	103113	rs72556275	NC_000023.11:38401380:G:T
NM_000531.6(OTC):c.491C>G (p.Ser164Ter)	OTC	S164*	not provided	Pathogenic	no assertion criteria provided	VCV000097220	X	38260632	X	38401379	97220	103112	rs72556274	NC_000023.11:38401378:C:G
NM_000531.6(OTC):c.490T>C (p.Ser164Pro)	OTC	S164P	not provided	Pathogenic	no assertion criteria provided	VCV000097219	X	38260631	X	38401378	97219	103111	rs72556273	NC_000023.11:38401377:T:C
NM_000531.6(OTC):c.485G>A (p.Gly162Glu)	OTC	G162E	not provided	Pathogenic	no assertion criteria provided	VCV000097218	X	38260626	X	38401373	97218	103110	rs72556272	NC_000023.11:38401372:G:A
NM_000531.6(OTC):c.484G>C (p.Gly162Arg)	OTC	G162R	not provided	Pathogenic	no assertion criteria provided	VCV000097217	X	38260625	X	38401372	97217	103109	rs66626662	NC_000023.11:38401371:G:C
NM_000531.6(OTC):c.482A>G (p.Asn161Ser)	OTC	N161S	not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000097216	X	38260623	X	38401370	97216	103108	rs72556271	NC_000023.11:38401369:A:G
NM_000531.6(OTC):c.481A>G (p.Asn161Asp)	OTC	N161D	not provided	Pathogenic	no assertion criteria provided	VCV000097215	X	38260622	X	38401369	97215	103107	rs72556270	NC_000023.11:38401368:A:G
NM_000531.6(OTC):c.479T>G (p.Ile160Ser)	OTC	I160S	not provided	Pathogenic	no assertion criteria provided	VCV000097214	X	38260620	X	38401367	97214	103106	rs67954347	NC_000023.11:38401366:T:G
NM_000531.6(OTC):c.479T>C (p.Ile160Thr)	OTC	I160T	not provided	Pathogenic	no assertion criteria provided	VCV000097213	X	38260620	X	38401367	97213	103105	rs67954347	NC_000023.11:38401366:T:C
NM_000531.6(OTC):c.479T>A (p.Ile160Asn)	OTC	I160N	not provided	Pathogenic	no assertion criteria provided	VCV000097212	X	38260620	X	38401367	97212	103104	rs67954347	NC_000023.11:38401366:T:A
NM_000531.6(OTC):c.476T>C (p.Ile159Thr)	OTC	I159T	not provided	Pathogenic	no assertion criteria provided	VCV000097211	X	38260617	X	38401364	97211	103103	rs72556269	NC_000023.11:38401363:T:C
NM_000531.6(OTC):c.464C>A (p.Ala155Glu)	OTC	A155E	not provided	Pathogenic	no assertion criteria provided	VCV000097210	X	38260605	X	38401352	97210	103102	rs72556268	NC_000023.11:38401351:C:A
NM_000531.6(OTC):c.463G>T (p.Ala155Ser)	OTC	A155S	not provided	Pathogenic	no assertion criteria provided	VCV000097209	X	38260604	X	38401351	97209	103101	rs67890094	NC_000023.11:38401350:G:T
NM_000531.6(OTC):c.463G>C (p.Ala155Pro)	OTC	A155P	not provided	Pathogenic	no assertion criteria provided	VCV000097208	X	38260604	X	38401351	97208	103100	rs67890094	NC_000023.11:38401350:G:C
NM_000531.6(OTC):c.455C>T (p.Ala152Val)	OTC	A152V	not provided	Pathogenic	no assertion criteria provided	VCV000097207	X	38260596	X	38401343	97207	103099	rs72556266	NC_000023.11:38401342:C:T
NM_000531.6(OTC):c.452T>G (p.Leu151Arg)	OTC	L151R	not provided	Pathogenic	no assertion criteria provided	VCV000097206	X	38260593	X	38401340	97206	103098	rs72556265	NC_000023.11:38401339:T:G
NM_000531.6(OTC):c.451del (p.Leu151fs)	OTC	L151fs	not provided	Pathogenic	no assertion criteria provided	VCV000097205	X	38260590	X	38401337	97205	103097	rs72556264	NC_000023.11:38401336:CCC:CC
NM_000531.6(OTC):c.444G>T (p.Leu148Phe)	OTC	L148F	not provided	Pathogenic	no assertion criteria provided	VCV000097204	X	38260585	X	38401332	97204	103096	rs66741318	NC_000023.11:38401331:G:T
NM_000531.6(OTC):c.443T>G (p.Leu148Trp)	OTC	L148W	not provided	Pathogenic	no assertion criteria provided	VCV000097203	X	38260584	X	38401331	97203	103095	rs67016166	NC_000023.11:38401330:T:G
NM_000531.6(OTC):c.443T>C (p.Leu148Ser)	OTC	L148S	not provided	Pathogenic	no assertion criteria provided	VCV000097202	X	38260584	X	38401331	97202	103094	rs67016166	NC_000023.11:38401330:T:C
NM_000531.6(OTC):c.437C>G (p.Ser146Ter)	OTC	S146*	not provided	Pathogenic	no assertion criteria provided	VCV000097201	X	38260578	X	38401325	97201	103093	rs72556263	NC_000023.11:38401324:C:G
NM_000531.6(OTC):c.430A>T (p.Lys144Ter)	OTC	K144*	not provided	Pathogenic	no assertion criteria provided	VCV000097200	X	38260571	X	38401318	97200	103092	rs72556262	NC_000023.11:38401317:A:T
NM_000531.6(OTC):c.425T>A (p.Val142Glu)	OTC	V142E	not provided	Pathogenic	no assertion criteria provided	VCV000097199	X	38260566	X	38401313	97199	103091	rs72556261	NC_000023.11:38401312:T:A
NM_000531.6(OTC):c.421C>G (p.Arg141Gly)	OTC	R141G	not provided	Pathogenic	no assertion criteria provided	VCV000097197	X	38260562	X	38401309	97197	103089	rs67960011	NC_000023.11:38401308:C:G
NM_000531.6(OTC):c.416T>C (p.Leu139Ser)	OTC	L139S	not provided	Pathogenic	no assertion criteria provided	VCV000097195	X	38260557	X	38401304	97195	103087	rs72556259	NC_000023.11:38401303:T:C
NM_000531.6(OTC):c.42del (p.Phe14fs)	OTC	F14fs	not provided	Pathogenic	no assertion criteria provided	VCV000097194	X	38211988	X	38352735	97194	103086	rs72552298	NC_000023.11:38352734:TTTT:TTT
NM_000531.6(OTC):c.409G>A (p.Ala137Thr)	OTC	A137T	not provided	Pathogenic	no assertion criteria provided	VCV000097193	X	38260550	X	38401297	97193	103085	rs72556258	NC_000023.11:38401296:G:A
NM_000531.6(OTC):c.407A>T (p.Asp136Val)	OTC	D136V	not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000097192	X	38260548	X	38401295	97192	103084	rs72556257	NC_000023.11:38401294:A:T
NM_000531.6(OTC):c.404C>A (p.Ala135Glu)	OTC	A135E	not provided	Pathogenic	no assertion criteria provided	VCV000097191	X	38260545	X	38401292	97191	103083	rs72556256	NC_000023.11:38401291:C:A
NM_000531.6(OTC):c.403del (p.Ala135fs)	OTC	A135fs	not provided|Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000097190	X	38260543	X	38401290	97190	103082	rs72556255	NC_000023.11:38401289:GG:G
NM_000531.6(OTC):c.3G>A (p.Met1Ile)	OTC	M1I	not provided	Pathogenic	no assertion criteria provided	VCV000097189	X	38211952	X	38352699	97189	103081	rs72552296	NC_000023.11:38352698:G:A
NM_000531.6(OTC):c.395C>T (p.Ser132Phe)	OTC	S132F	not provided	Pathogenic	no assertion criteria provided	VCV000097188	X	38260536	X	38401283	97188	103080	rs72556254	NC_000023.11:38401282:C:T
NM_000531.6(OTC):c.394T>C (p.Ser132Pro)	OTC	S132P	not provided	Pathogenic	no assertion criteria provided	VCV000097187	X	38260535	X	38401282	97187	103079	rs72556253	NC_000023.11:38401281:T:C
NM_000531.6(OTC):c.392T>C (p.Leu131Ser)	OTC	L131S	not provided	Pathogenic	no assertion criteria provided	VCV000097186	X	38260533	X	38401280	97186	103078	rs72556252	NC_000023.11:38401279:T:C
NM_000531.6(OTC):c.390_392dup (p.Leu131dup)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097185	X	38260529 - 38260530	X	38401276 - 38401277	97185	103077	rs72556251	NC_000023.11:38401276:TATT:TATTATT
NM_000531.6(OTC):c.387-2A>G	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097184	X	38260526	X	38401273	97184	103076	rs66556380	NC_000023.11:38401272:A:G
NM_000531.6(OTC):c.387-2A>C	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097183	X	38260526	X	38401273	97183	103075	rs66556380	NC_000023.11:38401272:A:C
NM_000531.6(OTC):c.386G>T (p.Arg129Leu)	OTC	R129L	not provided	Pathogenic	no assertion criteria provided	VCV000097182	X	38240682	X	38381429	97182	103074	rs66656800	NC_000023.11:38381428:G:T
NM_000531.6(OTC):c.386G>C (p.Arg129Pro)	OTC	R129P	not provided	Pathogenic	no assertion criteria provided	VCV000097181	X	38240682	X	38381429	97181	103073	rs66656800	NC_000023.11:38381428:G:C
NM_000531.6(OTC):c.386+2T>C	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097180	X	38240684	X	38381431	97180	103072	rs72554359	NC_000023.11:38381430:T:C
NM_000531.6(OTC):c.386+1G>T	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097179	X	38240683	X	38381430	97179	103071	rs66737144	NC_000023.11:38381429:G:T
NM_000531.6(OTC):c.386+1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097178	X	38240683	X	38381430	97178	103070	rs66737144	NC_000023.11:38381429:G:A
NM_000531.6(OTC):c.377A>G (p.Asp126Gly)	OTC	D126G	not provided	Pathogenic	no assertion criteria provided	VCV000097177	X	38240673	X	38381420	97177	103069	rs72554358	NC_000023.11:38381419:A:G
NM_000531.6(OTC):c.376del (p.Asp126fs)	OTC	D126fs	not provided	Pathogenic	no assertion criteria provided	VCV000097176	X	38240671	X	38381418	97176	103068	rs72554357	NC_000023.11:38381417:GG:G
NM_000531.6(OTC):c.364_365insTT (p.Glu122fs)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097174	X	38240660 - 38240661	X	38381407 - 38381408	97174	103066	rs72554355	NC_000023.11:38381407::TT
NM_000531.6(OTC):c.357_358TG[1] (p.Val120fs)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097173	X	38240652 - 38240653	X	38381399 - 38381400	97173	103065	rs72554354	NC_000023.11:38381398:GTGTG:GTG
NM_000531.6(OTC):c.350A>T (p.His117Leu)	OTC	H117L	not provided	Pathogenic	no assertion criteria provided	VCV000097172	X	38240646	X	38381393	97172	103064	rs66539573	NC_000023.11:38381392:A:T
NM_000531.6(OTC):c.350A>G (p.His117Arg)	OTC	H117R	not provided	Pathogenic	no assertion criteria provided	VCV000097171	X	38240646	X	38381393	97171	103063	rs66539573	NC_000023.11:38381392:A:G
NM_000531.6(OTC):c.330del (p.Thr112fs)	OTC	T112fs	not provided	Pathogenic	no assertion criteria provided	VCV000097170	X	38240623	X	38381370	97170	103062	rs72554353	NC_000023.11:38381369:TTTT:TTT
NM_000531.6(OTC):c.317G>T (p.Gly106Val)	OTC	G106V	not provided	Pathogenic	no assertion criteria provided	VCV000097169	X	38240613	X	38381360	97169	103061	rs67651903	NC_000023.11:38381359:G:T
NM_000531.6(OTC):c.317G>A (p.Gly106Glu)	OTC	G106E	not provided	Pathogenic	no assertion criteria provided	VCV000097168	X	38240613	X	38381360	97168	103060	rs67651903	NC_000023.11:38381359:G:A
NM_000531.6(OTC):c.316G>A (p.Gly106Arg)	OTC	G106R	not provided	Pathogenic	no assertion criteria provided	VCV000097167	X	38240612	X	38381359	97167	103059	rs72554352	NC_000023.11:38381358:G:A
NM_000531.6(OTC):c.314G>T (p.Gly105Val)	OTC	G105V	not provided	Pathogenic	no assertion criteria provided	VCV000097166	X	38240610	X	38381357	97166	103058	rs72554351	NC_000023.11:38381356:G:T
NM_000531.6(OTC):c.305C>A (p.Ala102Glu)	OTC	A102E	not provided	Pathogenic	no assertion criteria provided	VCV000097165	X	38240601	X	38381348	97165	103057	rs72554350	NC_000023.11:38381347:C:A
NM_000531.6(OTC):c.2T>C (p.Met1Thr)	OTC	M1T	not provided	Pathogenic	no assertion criteria provided	VCV000097164	X	38211951	X	38352698	97164	103056	rs72552295	NC_000023.11:38352697:T:C
NM_000531.6(OTC):c.299G>A (p.Gly100Asp)	OTC	G100D	not provided	Pathogenic	no assertion criteria provided	VCV000097163	X	38240595	X	38381342	97163	103055	rs72554349	NC_000023.11:38381341:G:A
NM_000531.6(OTC):c.298+1_298+5del	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097161	X	38229129 - 38229133	X	38369876 - 38369880	97161	103053	rs111060773	NC_000023.11:38369875:AGGTAAG:AG
NM_000531.6(OTC):c.298+1G>T	OTC		not provided	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000097160	X	38229131	X	38369878	97160	103052	rs68058881	NC_000023.11:38369877:G:T
NM_000531.6(OTC):c.298+1G>A	OTC		Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000097159	X	38229131	X	38369878	97159	103051	rs68058881	NC_000023.11:38369877:G:A
NM_000531.6(OTC):c.29_32del (p.Asn10fs)	OTC	N10fs	not provided	Pathogenic	no assertion criteria provided	VCV000097157	X	38211976 - 38211979	X	38352723 - 38352726	97157	103049	rs72552297	NC_000023.11:38352722:AAACAA:AA
NM_000531.6(OTC):c.284T>C (p.Leu95Ser)	OTC	L95S	not provided	Pathogenic	no assertion criteria provided	VCV000097156	X	38229116	X	38369863	97156	103048	rs72554346	NC_000023.11:38369862:T:C
NM_000531.6(OTC):c.277A>G (p.Thr93Ala)	OTC	T93A	not provided	Pathogenic	no assertion criteria provided	VCV000097155	X	38229109	X	38369856	97155	103047	rs72554344	NC_000023.11:38369855:A:G
NM_000531.6(OTC):c.275G>T (p.Arg92Leu)	OTC	R92L	not provided	Pathogenic	no assertion criteria provided	VCV000097154	X	38229107	X	38369854	97154	103046	rs66550389	NC_000023.11:38369853:G:T
NM_000531.6(OTC):c.275G>C (p.Arg92Pro)	OTC	R92P	not provided	Pathogenic	no assertion criteria provided	VCV000097153	X	38229107	X	38369854	97153	103045	rs66550389	NC_000023.11:38369853:G:C
NM_000531.6(OTC):c.275G>A (p.Arg92Gln)	OTC	R92Q	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Dec 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000097152	X	38229107	X	38369854	97152	103044	rs66550389	NC_000023.11:38369853:G:A
NM_000531.6(OTC):c.274C>T (p.Arg92Ter)	OTC	R92*	not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000097151	X	38229106	X	38369853	97151	103043	rs67418243	NC_000023.11:38369852:C:T
NM_000531.6(OTC):c.274C>G (p.Arg92Gly)	OTC	R92G	not provided	Pathogenic	no assertion criteria provided	VCV000097150	X	38229106	X	38369853	97150	103042	rs67418243	NC_000023.11:38369852:C:G
NM_000531.6(OTC):c.271del (p.Thr91fs)	OTC	T91fs	not provided	Pathogenic	no assertion criteria provided	VCV000097149	X	38229103	X	38369850	97149	103041	rs72554343	NC_000023.11:38369849:A:
NM_000531.6(OTC):c.270T>G (p.Ser90Arg)	OTC	S90R	not provided	Pathogenic	no assertion criteria provided	VCV000097148	X	38229102	X	38369849	97148	103040	rs72554342	NC_000023.11:38369848:T:G
NM_000531.6(OTC):c.269G>A (p.Ser90Asn)	OTC	S90N	not provided	Pathogenic	no assertion criteria provided	VCV000097147	X	38229101	X	38369848	97147	103039	rs72554341	NC_000023.11:38369847:G:A
NM_000531.6(OTC):c.268A>G (p.Ser90Gly)	OTC	S90G	not provided	Pathogenic	no assertion criteria provided	VCV000097146	X	38229100	X	38369847	97146	103038	rs72554340	NC_000023.11:38369846:A:G
NM_000531.6(OTC):c.264A>T (p.Lys88Asn)	OTC	K88N	not provided	Pathogenic	no assertion criteria provided	VCV000097145	X	38229096	X	38369843	97145	103037	rs72554339	NC_000023.11:38369842:A:T
NM_000531.6(OTC):c.248G>A (p.Gly83Asp)	OTC	G83D	not provided	Pathogenic	no assertion criteria provided	VCV000097144	X	38229080	X	38369827	97144	103036	rs72554337	NC_000023.11:38369826:G:A
NM_000531.6(OTC):c.247G>C (p.Gly83Arg)	OTC	G83R	not provided	Pathogenic	no assertion criteria provided	VCV000097143	X	38229079	X	38369826	97143	103035	rs72554336	NC_000023.11:38369825:G:C
NM_000531.6(OTC):c.245T>G (p.Leu82Ter)	OTC	L82*	not provided	Pathogenic	no assertion criteria provided	VCV000097142	X	38229077	X	38369824	97142	103034	rs72554335	NC_000023.11:38369823:T:G
NM_000531.6(OTC):c.243_245del (p.Leu82del)	OTC	L82del	not provided	Pathogenic	no assertion criteria provided	VCV000097141	X	38229075 - 38229077	X	38369822 - 38369824	97141	103033	rs72554334	NC_000023.11:38369821:CTT:
NM_000531.6(OTC):c.240G>T (p.Lys80Asn)	OTC	K80N	not provided	Pathogenic	no assertion criteria provided	VCV000097140	X	38229072	X	38369819	97140	103032	rs72554333	NC_000023.11:38369818:G:T
NM_000531.6(OTC):c.232C>T (p.Gln78Ter)	OTC	Q78*	not provided	Pathogenic	no assertion criteria provided	VCV000097139	X	38229064	X	38369811	97139	103031	rs72554330	NC_000023.11:38369810:C:T
NM_000531.6(OTC):c.231G>T (p.Leu77Phe)	OTC	L77F	not provided	Pathogenic	no assertion criteria provided	VCV000097138	X	38229063	X	38369810	97138	103030	rs72554329	NC_000023.11:38369809:G:T
NM_000531.6(OTC):c.227T>C (p.Leu76Ser)	OTC	L76S	not provided	Pathogenic	no assertion criteria provided	VCV000097137	X	38229059	X	38369806	97137	103029	rs72554328	NC_000023.11:38369805:T:C
NM_000531.6(OTC):c.217-1G>A	OTC		Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000097136	X	38229048	X	38369795	97136	103028	rs72554327	NC_000023.11:38369794:G:A
NM_000531.6(OTC):c.216+1G>T	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097135	X	38226683	X	38367430	97135	103027	rs66693137	NC_000023.11:38367429:G:T
NM_000531.6(OTC):c.216+1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097134	X	38226683	X	38367430	97134	103026	rs66693137	NC_000023.11:38367429:G:A
NM_000531.6(OTC):c.205C>T (p.Gln69Ter)	OTC	Q69*	not provided	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000097133	X	38226671	X	38367418	97133	103025	rs72554326	NC_000023.11:38367417:C:T
NM_000531.6(OTC):c.200T>G (p.Ile67Arg)	OTC	I67R	not provided	Pathogenic	no assertion criteria provided	VCV000097132	X	38226666	X	38367413	97132	103024	rs72554325	NC_000023.11:38367412:T:G
NM_000531.6(OTC):c.1A>T (p.Met1Leu)	OTC	M1L	not provided	Pathogenic	no assertion criteria provided	VCV000097131	X	38211950	X	38352697	97131	103023	rs67752076	NC_000023.11:38352696:A:T
NM_000531.6(OTC):c.1A>G (p.Met1Val)	OTC	M1V	not provided	Pathogenic	no assertion criteria provided	VCV000097130	X	38211950	X	38352697	97130	103022	rs67752076	NC_000023.11:38352696:A:G
NM_000531.6(OTC):c.188T>C (p.Leu63Pro)	OTC	L63P	not provided	Pathogenic	no assertion criteria provided	VCV000097129	X	38226654	X	38367401	97129	103021	rs72554324	NC_000023.11:38367400:T:C
NM_000531.6(OTC):c.179C>T (p.Ser60Leu)	OTC	S60L	not provided	Pathogenic	no assertion criteria provided	VCV000097128	X	38226645	X	38367392	97128	103020	rs72554323	NC_000023.11:38367391:C:T
NM_000531.6(OTC):c.174G>A (p.Trp58Ter)	OTC	W58*	not provided	Pathogenic	no assertion criteria provided	VCV000097127	X	38226640	X	38367387	97127	103019	rs72554322	NC_000023.11:38367386:G:A
NM_000531.6(OTC):c.170T>A (p.Leu57Gln)	OTC	L57Q	not provided	Pathogenic	no assertion criteria provided	VCV000097126	X	38226636	X	38367383	97126	103018	rs72554321	NC_000023.11:38367382:T:A
NM_000531.6(OTC):c.163T>G (p.Tyr55Asp)	OTC	Y55D	not provided	Pathogenic	no assertion criteria provided	VCV000097124	X	38226629	X	38367376	97124	103016	rs72554319	NC_000023.11:38367375:T:G
NM_000531.6(OTC):c.158T>G (p.Ile53Ser)	OTC	I53S	not provided	Pathogenic	no assertion criteria provided	VCV000097123	X	38226624	X	38367371	97123	103015	rs66677059	NC_000023.11:38367370:T:G
NM_000531.6(OTC):c.156A>T (p.Glu52Asp)	OTC	E52D	not provided	Pathogenic	no assertion criteria provided	VCV000097121	X	38226622	X	38367369	97121	103013	rs72554318	NC_000023.11:38367368:A:T
NM_000531.6(OTC):c.155A>G (p.Glu52Gly)	OTC	E52G	not provided	Pathogenic	no assertion criteria provided	VCV000097120	X	38226621	X	38367368	97120	103012	rs72554317	NC_000023.11:38367367:A:G
NM_000531.6(OTC):c.154G>T (p.Glu52Ter)	OTC	E52*	not provided	Pathogenic	no assertion criteria provided	VCV000097119	X	38226620	X	38367367	97119	103011	rs66521141	NC_000023.11:38367366:G:T
NM_000531.6(OTC):c.154G>A (p.Glu52Lys)	OTC	E52K	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000097118	X	38226620	X	38367367	97118	103010	rs66521141	NC_000023.11:38367366:G:A
NM_000531.6(OTC):c.148G>A (p.Gly50Arg)	OTC	G50R	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000097117	X	38226614	X	38367361	97117	103009	rs67486158	NC_000023.11:38367360:G:A
NM_000531.6(OTC):c.145A>C (p.Thr49Pro)	OTC	T49P	not provided	Pathogenic	no assertion criteria provided	VCV000097116	X	38226611	X	38367358	97116	103008	rs72554316	NC_000023.11:38367357:A:C
NM_000531.6(OTC):c.143T>C (p.Phe48Ser)	OTC	F48S	not provided	Pathogenic	no assertion criteria provided	VCV000097115	X	38226609	X	38367356	97115	103007	rs72554315	NC_000023.11:38367355:T:C
NM_000531.6(OTC):c.140_141insG (p.Asn47fs)	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097114	X	38226606 - 38226607	X	38367353 - 38367354	97114	103006	rs72554314	NC_000023.11:38367353::G
NM_000531.6(OTC):c.140A>T (p.Asn47Ile)	OTC	N47I	not provided	Pathogenic	no assertion criteria provided	VCV000097113	X	38226606	X	38367353	97113	103005	rs67939655	NC_000023.11:38367352:A:T
NM_000531.6(OTC):c.140del (p.Asn47fs)	OTC	N47fs	not provided	Pathogenic	no assertion criteria provided	VCV000097111	X	38226601	X	38367348	97111	103003	rs72554313	NC_000023.11:38367347:AAAAAA:AAAAA
NM_000531.6(OTC):c.133C>G (p.Leu45Val)	OTC	L45V	not provided	Pathogenic	no assertion criteria provided	VCV000097110	X	38226599	X	38367346	97110	103002	rs72554311	NC_000023.11:38367345:C:G
NM_000531.6(OTC):c.131C>T (p.Thr44Ile)	OTC	T44I	not provided	Pathogenic	no assertion criteria provided	VCV000097109	X	38226597	X	38367344	97109	103001	rs72554310	NC_000023.11:38367343:C:T
NM_000531.6(OTC):c.127C>T (p.Leu43Phe)	OTC	L43F	not provided	Pathogenic	no assertion criteria provided	VCV000097108	X	38226593	X	38367340	97108	103000	rs72554309	NC_000023.11:38367339:C:T
NM_000531.6(OTC):c.115G>T (p.Gly39Cys)	OTC	G39C	not provided	Pathogenic	no assertion criteria provided	VCV000097106	X	38226581	X	38367328	97106	102998	rs72554306	NC_000023.11:38367327:G:T
NM_000531.6(OTC):c.106C>T (p.Gln36Ter)	OTC	Q36*	not provided	Pathogenic	no assertion criteria provided	VCV000097105	X	38226572	X	38367319	97105	102997	rs72554305	NC_000023.11:38367318:C:T
NM_000531.6(OTC):c.1061T>G (p.Phe354Cys)	OTC	F354C	not provided	Pathogenic	no assertion criteria provided	VCV000097104	X	38280331	X	38421078	97104	102996	rs72558495	NC_000023.11:38421077:T:G
NM_000531.6(OTC):c.1042C>T (p.Gln348Ter)	OTC	Q348*	not provided	Pathogenic	no assertion criteria provided	VCV000097103	X	38280312	X	38421059	97103	102995	rs72558494	NC_000023.11:38421058:C:T
NM_000531.6(OTC):c.1039C>A (p.Pro347Thr)	OTC	P347T	not provided	Pathogenic	no assertion criteria provided	VCV000097102	X	38280309	X	38421056	97102	102994	rs72558493	NC_000023.11:38421055:C:A
NM_000531.6(OTC):c.1034A>G (p.Tyr345Cys)	OTC	Y345C	not provided	Pathogenic	no assertion criteria provided	VCV000097101	X	38280304	X	38421051	97101	102993	rs72558492	NC_000023.11:38421050:A:G
NM_000531.6(OTC):c.1028C>A (p.Thr343Lys)	OTC	T343K	not provided	Pathogenic	no assertion criteria provided	VCV000097099	X	38280298	X	38421045	97099	102991	rs72558491	NC_000023.11:38421044:C:A
NM_000531.6(OTC):c.1022T>C (p.Leu341Pro)	OTC	L341P	not provided	Pathogenic	no assertion criteria provided	VCV000097098	X	38280292	X	38421039	97098	102990	rs72558490	NC_000023.11:38421038:T:C
NM_000531.6(OTC):c.1018T>C (p.Ser340Pro)	OTC	S340P	not provided	Pathogenic	no assertion criteria provided	VCV000097097	X	38280288	X	38421035	97097	102989	rs72558489	NC_000023.11:38421034:T:C
NM_000531.6(OTC):c.1015G>C (p.Val339Leu)	OTC	V339L	not provided	Pathogenic	no assertion criteria provided	VCV000097096	X	38280285	X	38421032	97096	102988	rs72558488	NC_000023.11:38421031:G:C
NM_000531.6(OTC):c.1009G>C (p.Val337Leu)	OTC	V337L	not provided	Pathogenic	no assertion criteria provided	VCV000097095	X	38280279	X	38421026	97095	102987	rs72558487	NC_000023.11:38421025:G:C
NM_000531.6(OTC):c.1006G>T (p.Ala336Ser)	OTC	A336S	not provided	Pathogenic	no assertion criteria provided	VCV000097094	X	38280276	X	38421023	97094	102986	rs72558486	NC_000023.11:38421022:G:T
NM_000531.6(OTC):c.1006-3C>G	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097093	X	38280273	X	38421020	97093	102985	rs72558485	NC_000023.11:38421019:C:G
NM_000531.6(OTC):c.1006-1G>A	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097092	X	38280275	X	38421022	97092	102984	rs67916658	NC_000023.11:38421021:G:A
NM_000531.6(OTC):c.1005G>A (p.Met335Ile)	OTC	M335I	not provided	Pathogenic	no assertion criteria provided	VCV000097091	X	38271252	X	38411999	97091	102983	rs281865553	NC_000023.11:38411998:G:A
NM_000531.6(OTC):c.1005+2T>C	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097090	X	38271254	X	38412001	97090	102982	rs72558484	NC_000023.11:38412000:T:C
NM_000531.6(OTC):c.1005+1G>T	OTC		not provided	Pathogenic	no assertion criteria provided	VCV000097089	X	38271253	X	38412000	97089	102981	rs72558483	NC_000023.11:38411999:G:T
NM_000166.6(GJB1):c.172C>T (p.Pro58Ser)	GJB1	P58S	X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000097063	X	70443729	X	71223879	97063	102962	rs483352926	NC_000023.11:71223878:C:T
NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs)	CALR	L367fs	Myelofibrosis|Thrombocythemia 1	Pathogenic(Last reviewed: Dec 19, 2013)	no assertion criteria provided	VCV000097006	19	13054565 - 13054616	19	12943751 - 12943802	97006	102915	rs1555760738	
NM_000146.4(FTL):c.-164C>T	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000096691	19	49468601	19	48965344	96691	102584	rs398124637	NC_000019.10:48965343:C:T
NM_000146.4(FTL):c.310G>T (p.Glu104Ter)	FTL	E104*	L-ferritin deficiency, autosomal recessive	Pathogenic(Last reviewed: Aug 26, 2013)	no assertion criteria provided	VCV000096690	19	49469598	19	48966341	96690	102583	rs199869995	NC_000019.10:48966340:G:T
NM_000146.4(FTL):c.1A>G (p.Met1Val)	FTL	M1V	L-ferritin deficiency	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000096689	19	49468765	19	48965508	96689	102582	rs139732572	NC_000019.10:48965507:A:G
NM_203473.3(PORCN):c.250del (p.Leu84fs)	PORCN	L84fs, L13fs	not provided	Pathogenic(Last reviewed: Aug 7, 2012)	criteria provided, single submitter	VCV000096664	X	48369795	X	48511407	96664	102557	rs398124617	NC_000023.11:48511406:CC:C
NM_198270.4(NHS):c.953G>A (p.Trp318Ter)	NHS	W318*, W141*, W162*, W339*	not provided	Pathogenic(Last reviewed: Jul 12, 2013)	criteria provided, single submitter	VCV000096646	X	17739661	X	17721541	96646	102539	rs398124611	NC_000023.11:17721540:G:A
NM_198270.4(NHS):c.400del (p.Arg134fs)	NHS	R134fs	not provided	Pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	VCV000096641	X	17394278	X	17376155	96641	102534	rs398124608	NC_000023.11:17376154:CCC:CC
NM_139058.3(ARX):c.980_983del (p.Lys327fs)	ARX	K327fs	not provided	Pathogenic(Last reviewed: May 8, 2015)	criteria provided, single submitter	VCV000096464	X	25031129 - 25031132	X	25013012 - 25013015	96464	102358	rs398124520	NC_000023.11:25013011:TGTTTG:TG
NM_139058.3(ARX):c.1149_1150GC[1] (p.Arg384fs)	ARX		not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000096448	X	25025524 - 25025525	X	25007407 - 25007408	96448	102342	rs398124506	NC_000023.11:25007406:GCGC:GC
NM_001015877.2(PHF6):c.3G>T (p.Met1Ile)	PHF6	M1I	not provided	Pathogenic(Last reviewed: Jul 2, 2012)	criteria provided, single submitter	VCV000096222	X	133511650	X	134377620	96222	102116	rs398124428	NC_000023.11:134377619:G:T
NM_024301.5(FKRP):c.941C>T (p.Thr314Met)	FKRP	T314M	not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096115	19	47259648	19	46756391	96115	102009	rs398124395	NC_000019.10:46756390:C:T
NM_001123383.1(BCOR):c.3468del (p.Leu1157fs)	BCOR	L1139fs, L1157fs	not provided	Pathogenic(Last reviewed: Nov 20, 2012)	criteria provided, single submitter	VCV000095770	X	39923623	X	40064370	95770	101667	rs398124313	NC_000023.11:40064369:A:
NM_015629.4(PRPF31):c.615C>A (p.Tyr205Ter)	PRPF31	Y205*	not provided	Pathogenic(Last reviewed: Jul 30, 2013)	criteria provided, single submitter	VCV000095735	19	54627215	19	54123836	95735	101632	rs144738703	NC_000019.10:54123835:C:A
NM_006915.3(RP2):c.631del (p.Arg211fs)	RP2	R211fs	not provided	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095443	X	46713439	X	46854004	95443	101342	rs398124239	NC_000023.11:46854003:C:
NM_001042537.1(SLC9A6):c.1072C>T (p.Gln358Ter)	SLC9A6	Q326*, Q358*, Q274*, Q306*	not provided	Pathogenic(Last reviewed: Aug 6, 2012)	criteria provided, single submitter	VCV000095378	X	135095138	X	136012979	95378	101277	rs398124224	NC_000023.11:136012978:C:T
NM_004737.6(LARGE1):c.1102C>T (p.Gln368Ter)	LARGE1	Q368*	not provided	Pathogenic(Last reviewed: Nov 15, 2012)	criteria provided, single submitter	VCV000095160	22	33777934	22	33381948	95160	101060	rs398124181	NC_000022.11:33381947:G:A
NM_004586.3(RPS6KA3):c.718_721del (p.Val240fs)	RPS6KA3	V240fs	not provided	Pathogenic(Last reviewed: Mar 6, 2013)	criteria provided, single submitter	VCV000095151	X	20205999 - 20206002	X	20187881 - 20187884	95151	101051	rs398124178	NC_000023.11:20187880:TAACTA:TA
NM_004586.3(RPS6KA3):c.632-1G>C	RPS6KA3		not provided|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000095150	X	20206089	X	20187971	95150	101050	rs398124177	NC_000023.11:20187970:C:G
NM_004586.3(RPS6KA3):c.185del (p.Lys62fs)	RPS6KA3	K62fs	not provided	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000095148	X	20227464	X	20209346	95148	101048	rs398124175	NC_000023.11:20209345:TTTT:TTT
NM_004463.3(FGD1):c.2135dup (p.Pro713fs)	FGD1		not provided	Pathogenic(Last reviewed: Jan 9, 2013)	criteria provided, single submitter	VCV000095088	X	54476104 - 54476105	X	54449671 - 54449672	95088	100988	rs398124162	NC_000023.11:54449671:GGGG:GGGGG
NM_004463.3(FGD1):c.2112_2113insTT (p.Asn705fs)	FGD1		not provided	Pathogenic(Last reviewed: Sep 27, 2012)	criteria provided, single submitter	VCV000095087	X	54476127 - 54476128	X	54449694 - 54449695	95087	100987	rs398124161	NC_000023.11:54449694::AA
NM_004463.3(FGD1):c.175C>T (p.Gln59Ter)	FGD1	Q59*	not provided	Pathogenic(Last reviewed: Oct 9, 2012)	criteria provided, single submitter	VCV000095085	X	54521691	X	54495258	95085	100985	rs398124160	NC_000023.11:54495257:G:A
NM_004463.3(FGD1):c.1468C>T (p.Gln490Ter)	FGD1	Q490*	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000095080	X	54492158	X	54465725	95080	100980	rs398124156	NC_000023.11:54465724:G:A
NM_004463.3(FGD1):c.1287T>G (p.Tyr429Ter)	FGD1	Y429*	not provided	Pathogenic(Last reviewed: Aug 9, 2012)	criteria provided, single submitter	VCV000095079	X	54494270	X	54467837	95079	100979	rs398124155	NC_000023.11:54467836:A:C
NM_004006.2(DMD):c.9862G>T (p.Glu3288Ter)	DMD	E3288*, E828*, E220*, E3280*, E559*, E1947*, E3284*, E1944*, E3165*	not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094864	X	31200967	X	31182850	94864	100764	rs398124106	NC_000023.11:31182849:C:A
NM_000109.4(DMD):c.9830_9839del (p.Met3277fs)	DMD	M217fs, M3162fs, M3285fs, M3277fs, M556fs, M1941fs, M1944fs, M3281fs, M825fs	Becker muscular dystrophy|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 14, 2015)	no assertion criteria provided	VCV000094863	X	31200966 - 31200975	X	31182849 - 31182858	94863	100763	rs398124105	NC_000023.11:31182848:TCCAGTCTCATCCAGTCT:TCCAGTCT
NM_004006.2(DMD):c.9650-2A>G	DMD		not provided	Pathogenic(Last reviewed: Jul 31, 2012)	criteria provided, single submitter	VCV000094855	X	31222237	X	31204120	94855	100755	rs398124100	NC_000023.11:31204119:T:C
NM_004006.2(DMD):c.961-5831C>T	DMD		not provided|Duchenne muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094849	X	32669100	X	32650983	94849	100749	rs398124099	NC_000023.11:32650982:G:A
NM_004006.2(DMD):c.9564-1G>A	DMD		not provided	Pathogenic(Last reviewed: Jun 19, 2013)	criteria provided, single submitter	VCV000094845	X	31224785	X	31206668	94845	100745	rs398124096	NC_000023.11:31206667:C:T
NM_004006.2(DMD):c.9361+1G>C	DMD		not provided	Pathogenic(Last reviewed: Oct 21, 2013)	criteria provided, single submitter	VCV000094842	X	31241163	X	31223046	94842	100742	rs398124094	NC_000023.11:31223045:C:G
NM_004006.2(DMD):c.9361+1G>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094841	X	31241163	X	31223046	94841	100741	rs398124094	NC_000023.11:31223045:C:T
NM_004006.2(DMD):c.9337C>T (p.Arg3113Ter)	DMD	R3113*, R2990*, R3105*, R653*, R3109*, R45*, R1769*, R1772*, R384*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094839	X	31241188	X	31223071	94839	100739	rs398124092	NC_000023.11:31223070:G:A
NM_004006.2(DMD):c.9225-647A>G	DMD		not provided|Duchenne muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094837	X	31279780	X	31261663	94837	100737	rs398124091	NC_000023.11:31261662:T:C
NM_000109.4(DMD):c.9130_9133TTTC[1] (p.Leu3045fs)	DMD		not provided	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000094824	X	31366675 - 31366678	X	31348558 - 31348561	94824	100724	rs398124081	NC_000023.11:31348557:GAAAGAAAG:GAAAG
NM_000109.4(DMD):c.9101del (p.His3034fs)	DMD	H1701fs, H2919fs, H3038fs, H3042fs, H313fs, H1698fs, H3034fs, H582fs	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000094823	X	31366711	X	31348594	94823	100723	rs398124080	NC_000023.11:31348593:T:
NM_000109.4(DMD):c.8884_8885TC[2] (p.Leu2963fs)	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094819	X	31496247 - 31496248	X	31478130 - 31478131	94819	100719	rs398124078	NC_000023.11:31478129:GAGAGAG:GAGAG
NM_000109.4(DMD):c.8626_8627CT[1] (p.Tyr2877fs)	DMD		not provided	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000094811	X	31497115 - 31497116	X	31478998 - 31478999	94811	100711	rs398124075	NC_000023.11:31478997:AGAG:AG
NM_004006.2(DMD):c.8608C>T (p.Arg2870Ter)	DMD	R2870*, R1526*, R1529*, R410*, R2747*, R2862*, R2866*, R141*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094810	X	31497160	X	31479043	94810	100710	rs398124074	NC_000023.11:31479042:G:A
NM_004006.2(DMD):c.8443C>T (p.Gln2815Ter)	DMD	Q2815*, Q1471*, Q1474*, Q2692*, Q355*, Q2807*, Q2811*, Q86*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	VCV000094807	X	31515009	X	31496892	94807	100707	rs398124072	NC_000023.11:31496891:G:A
NM_000109.4(DMD):c.8350_8351del (p.Lys2784fs)	DMD	K2792fs, K2788fs, K1448fs, K2669fs, K63fs, K1451fs, K2784fs, K332fs	not provided	Pathogenic(Last reviewed: Apr 25, 2014)	criteria provided, single submitter	VCV000094804	X	31525413 - 31525414	X	31507296 - 31507297	94804	100704	rs398124070	NC_000023.11:31507295:TTTTT:TTT
NM_004006.2(DMD):c.8069T>G (p.Leu2690Ter)	DMD	L2690*, L1346*, L2682*, L230*, L1349*, L2567*, L2686*	not provided	Pathogenic(Last reviewed: Feb 3, 2016)	criteria provided, single submitter	VCV000094786	X	31645938	X	31627821	94786	100686	rs398124061	NC_000023.11:31627820:A:C
NM_000109.4(DMD):c.8040_8041del (p.His2680fs)	DMD	H1344fs, H2688fs, H1347fs, H2680fs, H228fs, H2565fs, H2684fs	not provided	Pathogenic(Last reviewed: Mar 7, 2013)	criteria provided, single submitter	VCV000094785	X	31645942 - 31645943	X	31627825 - 31627826	94785	100685	rs398124060	NC_000023.11:31627824:TAT:T
NM_000109.4(DMD):c.7898del (p.Asn2633fs)	DMD	N1297fs, N2518fs, N2633fs, N2641fs, N1300fs, N181fs, N2637fs	not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000094782	X	31676212	X	31658095	94782	100682	rs398124059	NC_000023.11:31658094:TTT:TT
NM_004006.2(DMD):c.7894C>T (p.Gln2632Ter)	DMD	Q2632*, Q1288*, Q1291*, Q172*, Q2509*, Q2624*, Q2628*	not provided	Pathogenic(Last reviewed: Oct 24, 2012)	criteria provided, single submitter	VCV000094781	X	31676240	X	31658123	94781	100681	rs398124058	NC_000023.11:31658122:G:A
NM_000109.4(DMD):c.7747G>T (p.Glu2583Ter)	DMD	E2591*, E1247*, E2468*, E2587*, E1250*, E131*, E2583*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094778	X	31697593	X	31679476	94778	100678	rs398124055	NC_000023.11:31679475:C:A
NM_004006.2(DMD):c.7683G>A (p.Trp2561Ter)	DMD	W2561*, W2553*, W1220*, W101*, W1217*, W2438*, W2557*	not provided	Pathogenic(Last reviewed: Jul 8, 2014)	criteria provided, single submitter	VCV000094775	X	31697681	X	31679564	94775	100675	rs398124053	NC_000023.11:31679563:C:T
NM_004006.2(DMD):c.7682G>A (p.Trp2561Ter)	DMD	W2561*, W2557*, W101*, W1217*, W2438*, W1220*, W2553*	not provided	Pathogenic(Last reviewed: May 13, 2013)	criteria provided, single submitter	VCV000094774	X	31697682	X	31679565	94774	100674	rs398124052	NC_000023.11:31679564:C:T
NM_004006.2(DMD):c.7672C>T (p.Gln2558Ter)	DMD	Q2558*, Q1214*, Q1217*, Q2554*, Q2435*, Q2550*, Q98*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2018)	criteria provided, single submitter	VCV000094773	X	31697692	X	31679575	94773	100673	rs398124051	NC_000023.11:31679574:G:A
NM_004006.2(DMD):c.7657C>T (p.Arg2553Ter)	DMD	R2553*, R1212*, R2430*, R93*, R2549*, R1209*, R2545*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094772	X	31747751	X	31729634	94772	100672	rs398124050	NC_000023.11:31729633:G:A
NM_004006.2(DMD):c.7309+1G>A	DMD		not provided	Pathogenic(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	VCV000094760	X	31838091	X	31819974	94760	100660	rs398124044	NC_000023.11:31819973:C:T
NM_004006.2(DMD):c.7189C>T (p.Gln2397Ter)	DMD	Q2397*, Q1053*, Q2393*, Q1056*, Q2389*, Q2274*	not provided	Pathogenic(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	VCV000094758	X	31854846	X	31836729	94758	100658	rs398124042	NC_000023.11:31836728:G:A
NM_004013.2(DMD):c.-395dup	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 23, 2014)	criteria provided, single submitter	VCV000094754	X	31893416 - 31893417	X	31875299 - 31875300	94754	100654	rs398124040	NC_000023.11:31875299:TTTTTTT:TTTTTTTT
NM_004006.2(DMD):c.6906G>A (p.Trp2302Ter)	DMD	W2302*, W2179*, W2294*, W2298*, W958*, W961*	not provided	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000094750	X	31947719	X	31929602	94750	100650	rs398124036	NC_000023.11:31929601:C:T
NM_000109.4(DMD):c.649_651AAG[1] (p.Lys218del)	DMD	K226del	not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094746	X	32717382 - 32717384	X	32699265 - 32699267	94746	100646	rs398124034	NC_000023.11:32699264:CTTCTT:CTT
NM_004006.2(DMD):c.649+1G>A	DMD		not provided	Pathogenic(Last reviewed: Apr 22, 2013)	criteria provided, single submitter	VCV000094743	X	32827609	X	32809492	94743	100643	rs398124032	NC_000023.11:32809491:C:T
NM_000109.4(DMD):c.6365_6366CA[3] (p.Gln2123fs)	DMD		not provided	Pathogenic(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000094706	X	32235078 - 32235079	X	32216961 - 32216962	94706	100606	rs398124012	NC_000023.11:32216961:TGTGT:TGTGTGT
NM_000109.4(DMD):c.6365_6366CA[1] (p.Gln2123fs)	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 16, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094705	X	32235079 - 32235080	X	32216962 - 32216963	94705	100605	rs398124012	NC_000023.11:32216961:TGTGT:TGT
NM_004006.2(DMD):c.6283C>T (p.Arg2095Ter)	DMD	R2095*, R2087*, R754*, R1972*, R751*, R2091*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094697	X	32305653	X	32287536	94697	100597		NC_000023.11:32287535:G:A
NM_000109.4(DMD):c.6158del (p.Ala2053fs)	DMD	A2053fs, A717fs, A720fs, A1938fs, A2057fs, A2061fs	not provided	Pathogenic(Last reviewed: Feb 13, 2013)	criteria provided, single submitter	VCV000094694	X	32305754	X	32287637	94694	100594	rs398124005	NC_000023.11:32287636:G:
NM_004006.2(DMD):c.615T>A (p.Tyr205Ter)	DMD	Y205*, Y82*, Y201*, Y197*	not provided	Pathogenic(Last reviewed: Jul 25, 2013)	criteria provided, single submitter	VCV000094693	X	32827644	X	32809527	94693	100593	rs398124004	NC_000023.11:32809526:A:T
NM_004006.2(DMD):c.6072T>A (p.Cys2024Ter)	DMD	C2024*, C1901*, C2016*, C2020*, C680*, C683*	not provided	Pathogenic(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	VCV000094691	X	32328244	X	32310127	94691	100591	rs373804251	NC_000023.11:32310126:A:T
NM_004006.2(DMD):c.6000T>A (p.Tyr2000Ter)	DMD	Y2000*, Y1992*, Y1996*, Y656*, Y659*, Y1877*	not provided	Pathogenic(Last reviewed: Dec 21, 2012)	criteria provided, single submitter	VCV000094688	X	32328316	X	32310199	94688	100588	rs398124002	NC_000023.11:32310198:A:T
NM_004006.2(DMD):c.5938G>T (p.Glu1980Ter)	DMD	E1980*, E1972*, E639*, E1857*, E1976*, E636*	not provided	Pathogenic(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	VCV000094686	X	32328378	X	32310261	94686	100586	rs398124001	NC_000023.11:32310260:C:A
NM_004006.2(DMD):c.583C>T (p.Arg195Ter)	DMD	R195*, R191*, R72*, R187*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094684	X	32827676	X	32809559	94684	100584	rs398123999	NC_000023.11:32809558:G:A
NM_004006.2(DMD):c.5773G>T (p.Glu1925Ter)	DMD	E1925*, E1802*, E1917*, E1921*, E581*, E584*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	VCV000094681	X	32360366	X	32342249	94681	100581	rs398123997	NC_000023.11:32342248:C:A
NM_004006.2(DMD):c.5640T>A (p.Tyr1880Ter)	DMD	Y1880*, Y1757*, Y1876*, Y539*, Y1872*, Y536*	not provided	Pathogenic(Last reviewed: Sep 27, 2012)	criteria provided, single submitter	VCV000094676	X	32361350	X	32343233	94676	100576	rs398123993	NC_000023.11:32343232:A:T
NM_004006.2(DMD):c.5554C>T (p.Gln1852Ter)	DMD	Q1852*, Q1848*, Q1729*, Q508*, Q1844*, Q511*	not provided	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000094670	X	32364092	X	32345975	94670	100570	rs398123991	NC_000023.11:32345974:G:A
NM_004006.2(DMD):c.5530C>T (p.Arg1844Ter)	DMD	R1844*, R1721*, R1840*, R503*, R1836*, R500*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094669	X	32364116	X	32345999	94669	100569	rs1064325	NC_000023.11:32345998:G:A
NM_004006.2(DMD):c.5353C>T (p.Gln1785Ter)	DMD	Q1785*, Q1781*, Q441*, Q1777*, Q444*, Q1662*	not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094668	X	32366618	X	32348501	94668	100568	rs398123990	NC_000023.11:32348500:G:A
NM_004006.2(DMD):c.5287C>T (p.Arg1763Ter)	DMD	R1763*, R1640*, R419*, R1755*, R1759*, R422*	Duchenne muscular dystrophy|not specified|not provided	Pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094658	X	32380943	X	32362826	94658	100558	rs398123981	NC_000023.11:32362825:G:A
NM_000109.4(DMD):c.5100_5103del (p.Lys1700fs)	DMD	K364fs, K1585fs, K1700fs, K1704fs, K1708fs, K367fs	not provided	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000094653	X	32382726 - 32382729	X	32364609 - 32364612	94653	100553	rs398123979	NC_000023.11:32364608:TTTCTTT:TTT
NM_000109.4(DMD):c.5073_5074delinsATGAATGAATTCATT (p.Asp1691_Thr1692delinsGluTer)	DMD		not provided	Pathogenic(Last reviewed: Jul 11, 2013)	criteria provided, single submitter	VCV000094652	X	32382755 - 32382756	X	32364638 - 32364639	94652	100552	rs398123978	NC_000023.11:32364637:TG:AATGAATTCATTCAT
NM_004006.2(DMD):c.4996C>T (p.Arg1666Ter)	DMD	R1666*, R1658*, R1662*, R325*, R1543*, R322*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094646	X	32383166	X	32365049	94646	100546	rs398123973	NC_000023.11:32365048:G:A
NM_004006.2(DMD):c.4902_4908del (p.Gly1635fs)	DMD	G1631fs, G1635fs, G294fs, G1627fs, G291fs, G1512fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000094644	X	32383254 - 32383260	X	32365137 - 32365143	94644	100544	rs398123971	NC_000023.11:32365136:CTCTCCT:
NM_004006.2(DMD):c.4843A>T (p.Lys1615Ter)	DMD	K1615*, K271*, K274*, K1607*, K1492*, K1611*	not provided	Pathogenic(Last reviewed: Nov 17, 2015)	criteria provided, single submitter	VCV000094641	X	32398629	X	32380512	94641	100541	rs398123969	NC_000023.11:32380511:T:A
NM_000109.4(DMD):c.4516_4520GAAGT[1] (p.Val1507_Lys1508insTer)	DMD		not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094634	X	32404552 - 32404556	X	32386435 - 32386439	94634	100534	rs398123962	NC_000023.11:32386434:ACTTCACTTCACT:ACTTCACT
NM_000109.4(DMD):c.4510_4511del (p.Leu1504fs)	DMD	L1512fs, L1389fs, L1504fs, L1508fs, L168fs, L171fs	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000094633	X	32404566 - 32404567	X	32386449 - 32386450	94633	100533	rs398123961	NC_000023.11:32386448:AGA:A
NM_004006.2(DMD):c.4518+5G>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094630	X	32407613	X	32389496	94630	100530	rs398123960	NC_000023.11:32389495:C:T
NM_004006.2(DMD):c.4471_4472del (p.Lys1491fs)	DMD	K1368fs, K1491fs, K147fs, K1483fs, K1487fs, K150fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094627	X	32407664 - 32407665	X	32389547 - 32389548	94627	100527	rs398123957	NC_000023.11:32389546:TTT:T
NM_000109.4(DMD):c.4381C>T (p.Gln1461Ter)	DMD	Q1469*, Q125*, Q1465*, Q1461*, Q128*, Q1346*	not provided	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000094624	X	32407731	X	32389614	94624	100524	rs398123954	NC_000023.11:32389613:G:A
NM_004006.2(DMD):c.4375C>T (p.Arg1459Ter)	DMD	R1459*, R1336*, R115*, R118*, R1451*, R1455*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094623	X	32407761	X	32389644	94623	100523	rs398123953	NC_000023.11:32389643:G:A
NM_004006.2(DMD):c.434G>C (p.Arg145Pro)	DMD	R145P, R22P, R137P, R141P	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, multiple submitters, no conflicts	VCV000094622	X	32834681	X	32816564	94622	100522	rs398123952	NC_000023.11:32816563:C:G
NM_000109.4(DMD):c.4290_4291del (p.Arg1431fs)	DMD	R1316fs, R1431fs, R95fs, R1435fs, R1439fs, R98fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000094619	X	32408217 - 32408218	X	32390100 - 32390101	94619	100519	rs398123950	NC_000023.11:32390099:TTT:T
NM_000109.4(DMD):c.388_389del (p.Lys130fs)	DMD	K138fs, K15fs, K130fs, K134fs	not provided	Pathogenic(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	VCV000094614	X	32834702 - 32834703	X	32816585 - 32816586	94614	100514	rs398123949	NC_000023.11:32816584:TTTT:TT
NM_000109.4(DMD):c.4093C>T (p.Gln1365Ter)	DMD	Q1373*, Q1365*, Q1250*, Q1369*, Q29*, Q32*	not specified|not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094612	X	32429985	X	32411868	94612	100512	rs398123948	NC_000023.11:32411867:G:A
NM_000109.4(DMD):c.3755_3761delinsGG (p.Thr1252fs)	DMD		not provided	Pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	VCV000094606	X	32466574 - 32466580	X	32448457 - 32448463	94606	100506	rs398123946	NC_000023.11:32448456:TCCAAAG:CC
NM_000109.4(DMD):c.3723del (p.Trp1241fs)	DMD	W1241fs, W1245fs, W1249fs, W1126fs	not provided	Pathogenic(Last reviewed: Nov 13, 2012)	criteria provided, single submitter	VCV000094605	X	32466612	X	32448495	94605	100505	rs398123945	NC_000023.11:32448494:CC:C
NM_000109.4(DMD):c.3615dup (p.Val1206fs)	DMD		not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000094601	X	32466719 - 32466720	X	32448602 - 32448603	94601	100501	rs398123943	NC_000023.11:32448602:TTT:TTTT
NM_000109.4(DMD):c.3579+2T>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094598	X	32472777	X	32454660	94598	100498	rs146071084	NC_000023.11:32454659:A:T
NM_004006.2(DMD):c.3580C>T (p.Gln1194Ter)	DMD	Q1194*, Q1186*, Q1190*, Q1071*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094597	X	32472802	X	32454685	94597	100497	rs398123942	NC_000023.11:32454684:G:A
NM_004006.2(DMD):c.3432+3A>G	DMD		not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000094592	X	32481553	X	32463436	94592	100492	rs398123938	NC_000023.11:32463435:T:C
NM_004006.2(DMD):c.3432+1G>A	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094589	X	32481555	X	32463438	94589	100489	rs398123937	NC_000023.11:32463437:C:T
NM_004006.2(DMD):c.336G>A (p.Trp112Ter)	DMD	W112*, W108*, W104*	not provided	Pathogenic(Last reviewed: Nov 22, 2013)	criteria provided, single submitter	VCV000094585	X	32841433	X	32823316	94585	100485	rs398123936	NC_000023.11:32823315:C:T
NM_004006.2(DMD):c.3295C>T (p.Gln1099Ter)	DMD	Q1099*, Q1095*, Q976*, Q1091*	Becker muscular dystrophy|Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094584	X	32481693	X	32463576	94584	100484	rs398123935	NC_000023.11:32463575:G:A
NM_004006.2(DMD):c.3276+1G>A	DMD		not provided	Pathogenic(Last reviewed: Oct 13, 2013)	criteria provided, single submitter	VCV000094583	X	32482702	X	32464585	94583	100483	rs398123934	NC_000023.11:32464584:C:T
NM_004006.2(DMD):c.3151C>T (p.Arg1051Ter)	DMD	R1051*, R928*, R1043*, R1047*	Becker muscular dystrophy|Duchenne muscular dystrophy|Dilated cardiomyopathy 3B|Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094576	X	32486626	X	32468509	94576	100476	rs398123929	NC_000023.11:32468508:G:A
NM_004006.2(DMD):c.31+1G>T	DMD		not provided|Dilated cardiomyopathy 3B|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094554	X	33229398	X	33211281	94554	100454	rs398123923	NC_000023.11:33211280:C:A
NM_000109.4(DMD):c.3052G>T (p.Glu1018Ter)	DMD	E1026*, E1022*, E1018*, E903*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000094551	X	32486701	X	32468584	94551	100451	rs398123920	NC_000023.11:32468583:C:A
NM_000109.4(DMD):c.3035C>G (p.Ser1012Ter)	DMD	S1020*, S897*, S1012*, S1016*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000094550	X	32486718	X	32468601	94550	100450	rs398123919	NC_000023.11:32468600:G:C
NM_000109.4(DMD):c.2926-2A>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000094545	X	32486829	X	32468712	94545	100445	rs398123915	NC_000023.11:32468711:T:C
NM_000109.4(DMD):c.7+127974del	DMD	C10fs	not provided	Pathogenic(Last reviewed: Aug 28, 2012)	criteria provided, single submitter	VCV000094543	X	33229402	X	33211285	94543	100443	rs398123913	NC_000023.11:33211284:A:
NM_004006.2(DMD):c.2816T>A (p.Leu939Ter)	DMD	L939*, L935*, L816*, L931*	not provided	Pathogenic(Last reviewed: Feb 10, 2014)	criteria provided, single submitter	VCV000094538	X	32490414	X	32472297	94538	100438	rs398123910	NC_000023.11:32472296:A:T
NM_004006.2(DMD):c.2804-1G>A	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094537	X	32490427	X	32472310	94537	100437	rs398123909	NC_000023.11:32472309:C:T
NM_004006.2(DMD):c.2803+1G>T	DMD		not provided	Pathogenic(Last reviewed: Nov 20, 2015)	no assertion criteria provided	VCV000094536	X	32503035	X	32484918	94536	100436	rs398123908	NC_000023.11:32484917:C:A
NM_004006.2(DMD):c.2758C>T (p.Gln920Ter)	DMD	Q920*, Q912*, Q916*, Q797*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, single submitter	VCV000094532	X	32503081	X	32484964	94532	100432	rs398123905	NC_000023.11:32484963:G:A
NM_004006.2(DMD):c.2650C>T (p.Gln884Ter)	DMD	Q884*, Q880*, Q876*, Q761*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094530	X	32503189	X	32485072	94530	100430	rs398123903	NC_000023.11:32485071:G:A
NM_004006.2(DMD):c.2622+1G>A	DMD		not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094526	X	32509393	X	32491276	94526	100426	rs398123901	NC_000023.11:32491275:C:T
NM_000109.4(DMD):c.2523del (p.Glu842fs)	DMD	E727fs, E842fs, E846fs, E850fs	not provided	Pathogenic(Last reviewed: May 6, 2013)	criteria provided, single submitter	VCV000094520	X	32509469	X	32491352	94520	100420	rs398123895	NC_000023.11:32491351:A:
NM_004006.2(DMD):c.251del (p.Leu84fs)	DMD	L80fs, L76fs, L84fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000094518	X	32862913	X	32844796	94518	100418	rs398123893	NC_000023.11:32844795:AAAA:AAA
NM_000109.4(DMD):c.2412G>A (p.Trp804Ter)	DMD	W812*, W689*, W804*, W808*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000094512	X	32509580	X	32491463	94512	100412	rs398123889	NC_000023.11:32491462:C:T
NM_004006.2(DMD):c.2419C>T (p.Gln807Ter)	DMD	Q807*, Q684*, Q803*, Q799*	not provided	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000094511	X	32509597	X	32491480	94511	100411	rs398123888	NC_000023.11:32491479:G:A
NM_004006.2(DMD):c.2381-1G>T	DMD		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000094508	X	32509636	X	32491519	94508	100408	rs398123887	NC_000023.11:32491518:C:A
NM_004006.2(DMD):c.2380+1G>C	DMD		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000094505	X	32519871	X	32501754	94505	100405	rs398123884	NC_000023.11:32501753:C:G
NM_004006.2(DMD):c.2332C>T (p.Gln778Ter)	DMD	Q778*, Q655*, Q774*, Q770*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094504	X	32519920	X	32501803	94504	100404	rs398123883	NC_000023.11:32501802:G:A
NM_000109.4(DMD):c.2270_2273del (p.Ala757fs)	DMD	A642fs, A765fs, A757fs, A761fs	not provided	Pathogenic(Last reviewed: May 30, 2013)	criteria provided, single submitter	VCV000094502	X	32519955 - 32519958	X	32501838 - 32501841	94502	100402	rs398123882	NC_000023.11:32501837:ATGG:
NM_000109.4(DMD):c.2257_2261del (p.Glu753fs)	DMD	E638fs, E757fs, E753fs, E761fs	not provided	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094500	X	32536132 - 32536136	X	32518015 - 32518019	94500	100400	rs398123881	NC_000023.11:32518014:TTTTCTTTT:TTTT
NM_000109.4(DMD):c.2101del (p.Gln701fs)	DMD	Q586fs, Q705fs, Q709fs, Q701fs	not provided	Pathogenic(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	VCV000094492	X	32563319	X	32545202	94492	100392	rs398123875	NC_000023.11:32545201:GGGG:GGG
NM_004006.2(DMD):c.2032C>T (p.Gln678Ter)	DMD	Q678*, Q555*, Q670*, Q674*	not provided	Pathogenic(Last reviewed: Oct 5, 2012)	criteria provided, single submitter	VCV000094489	X	32563412	X	32545295	94489	100389	rs398123872	NC_000023.11:32545294:G:A
NM_000109.4(DMD):c.1966C>T (p.Gln656Ter)	DMD	Q664*, Q541*, Q660*, Q656*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094486	X	32583821	X	32565704	94486	100386	rs398123870	NC_000023.11:32565703:G:A
NM_004006.2(DMD):c.1886C>A (p.Ser629Ter)	DMD	S629*, S625*, S621*, S506*	not provided	Pathogenic(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	VCV000094483	X	32583925	X	32565808	94483	100383	rs398123867	NC_000023.11:32565807:G:T
NM_004006.2(DMD):c.1615C>T (p.Arg539Ter)	DMD	R539*, R535*, R531*, R416*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 11, 2013)	criteria provided, multiple submitters, no conflicts	VCV000094475	X	32591951	X	32573834	94475	100375	rs398123865	NC_000023.11:32573833:G:A
NM_000109.4(DMD):c.1501_1502TC[2] (p.Leu502fs)	DMD		not provided	Pathogenic(Last reviewed: Oct 9, 2013)	criteria provided, single submitter	VCV000094472	X	32613946 - 32613947	X	32595829 - 32595830	94472	100372	rs398123863	NC_000023.11:32595828:GAGAGA:GAGA
NM_004006.2(DMD):c.1482+1G>T	DMD		Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094469	X	32632419	X	32614302	94469	100369	rs398123862	NC_000023.11:32614301:C:A
NM_004006.2(DMD):c.1465C>T (p.Gln489Ter)	DMD	Q489*, Q485*, Q366*, Q481*	not provided	Pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	VCV000094468	X	32632437	X	32614320	94468	100368	rs398123861	NC_000023.11:32614319:G:A
NM_004010.3(DMD):c.-233_-232dup	DMD		not provided	Pathogenic	no assertion criteria provided	VCV000094465	X	32867892 - 32867893	X	32849775 - 32849776	94465	100365	rs398123859	NC_000023.11:32849775:AT:ATAT
NM_000109.4(DMD):c.1347del (p.Glu451fs)	DMD	E455fs, E336fs, E459fs, E451fs	not provided	Pathogenic(Last reviewed: Aug 1, 2012)	criteria provided, single submitter	VCV000094463	X	32632531	X	32614414	94463	100363	rs398123857	NC_000023.11:32614413:C:
NM_000109.4(DMD):c.1315_1316AG[3] (p.Val440fs)	DMD		not provided	Pathogenic(Last reviewed: Dec 10, 2012)	criteria provided, single submitter	VCV000094462	X	32632559 - 32632560	X	32614442 - 32614443	94462	100362	rs398123856	NC_000023.11:32614442:CTCT:CTCTCT
NM_004006.2(DMD):c.1332-9A>G	DMD		not provided	Pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000094460	X	32632579	X	32614462	94460	100360	rs72468700	NC_000023.11:32614461:T:C
NM_000109.4(DMD):c.1282dup (p.Val428fs)	DMD		not provided	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000094456	X	32662273 - 32662274	X	32644156 - 32644157	94456	100356	rs398123854	NC_000023.11:32644156:CCC:CCCC
NM_004006.2(DMD):c.1286C>A (p.Ser429Ter)	DMD	S429*, S306*, S421*, S425*	not provided	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000094455	X	32662294	X	32644177	94455	100355	rs398123853	NC_000023.11:32644176:G:T
NM_004006.2(DMD):c.1261C>T (p.Gln421Ter)	DMD	Q421*, Q298*, Q417*, Q413*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094454	X	32662319	X	32644202	94454	100354	rs398123852	NC_000023.11:32644201:G:A
NM_004006.2(DMD):c.10797+5G>A	DMD		Duchenne muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000094447	X	31165387	X	31147270	94447	100347	rs398123846	NC_000023.11:31147269:C:T
NM_000109.4(DMD):c.10601del (p.Pro3534fs)	DMD	P3419fs, P474fs, P813fs, P972fs, P1069fs, P1082fs, P2201fs, P2198fs, P3538fs, P3534fs, P3542fs, P461fs	not provided	Pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000094443	X	31165564	X	31147447	94443	100343	rs398123844	NC_000023.11:31147446:GGGG:GGG
NM_004006.2(DMD):c.1048G>T (p.Glu350Ter)	DMD	E350*, E227*, E346*, E342*	not provided	Pathogenic(Last reviewed: Jul 5, 2012)	criteria provided, single submitter	VCV000094437	X	32663182	X	32645065	94437	100337	rs398123840	NC_000023.11:32645064:C:A
NM_004020.3(DMD):c.2843+9127del	DMD	L1012fs, L3477fs, L3485fs, L3362fs, L404fs, L1025fs, L3481fs, L417fs, L756fs, L2141fs, L2144fs	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 2, 2015)	criteria provided, multiple submitters, no conflicts	VCV000094436	X	31187659	X	31169542	94436	100336	rs398123839	NC_000023.11:31169541:A:
NM_004020.3(DMD):c.2843+9120_2843+9121del	DMD	S2139fs, S3360fs, S3479fs, S402fs, S2142fs, S1010fs, S1023fs, S3475fs, S3483fs, S415fs, S754fs	not provided	Pathogenic(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	VCV000094434	X	31187665 - 31187666	X	31169548 - 31169549	94434	100334	rs398123837	NC_000023.11:31169547:GAG:G
NM_004017.3(DMD):c.1019+732dup	DMD		not provided|not specified	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094431	X	31196052 - 31196053	X	31177935 - 31177936	94431	100331	rs398123835	NC_000023.11:31177935:AA:AAA
NM_004006.2(DMD):c.10223+1G>A	DMD		not provided	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000094430	X	31196785	X	31178668	94430	100330	rs398123834	NC_000023.11:31178667:C:T
NM_004006.2(DMD):c.10171C>T (p.Arg3391Ter)	DMD	R3391*, R2047*, R2050*, R662*, R3387*, R323*, R3268*, R3383*, R931*	Becker muscular dystrophy|Duchenne muscular dystrophy|Dilated cardiomyopathy 3B|Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000094428	X	31196838	X	31178721	94428	100328	rs398123832	NC_000023.11:31178720:G:A
NM_004006.2(DMD):c.1012G>T (p.Glu338Ter)	DMD	E338*, E215*, E330*, E334*	not provided	Pathogenic(Last reviewed: Dec 14, 2012)	criteria provided, single submitter	VCV000094426	X	32663218	X	32645101	94426	100326	rs398123830	NC_000023.11:32645100:C:A
NM_004006.2(DMD):c.10086+1G>A	DMD		not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	VCV000094422	X	31198486	X	31180369	94422	100322	rs398123828	NC_000023.11:31180368:C:T
NM_004006.2(DMD):c.10033C>T (p.Arg3345Ter)	DMD	R3345*, R277*, R3222*, R2001*, R2004*, R3337*, R3341*, R616*, R885*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094421	X	31198540	X	31180423	94421	100321	rs398123827	NC_000023.11:31180422:G:A
NM_001323289.2(CDKL5):c.533G>A (p.Arg178Gln)	CDKL5	R178Q	not provided|Early infantile epileptic encephalopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094113	X	18602452	X	18584332	94113	100013	rs267606715	NC_000023.11:18584331:G:A
NM_002743.3(PRKCSH):c.1513G>T (p.Glu505Ter)	PRKCSH	E505*, E502*, E512*	not provided	Pathogenic(Last reviewed: Dec 6, 2012)	criteria provided, single submitter	VCV000094076	19	11560153	19	11449338	94076	99978	rs398123688	NC_000019.10:11449337:G:T
NM_013995.2(LAMP2):c.579_586del (p.Lys193fs)	LAMP2	K193fs	not provided	Pathogenic(Last reviewed: Aug 2, 2012)	criteria provided, single submitter	VCV000094059	X	119581851 - 119581858	X	120447996 - 120448003	94059	99961	rs398123685	NC_000023.11:120447995:TTGAAGTTTTG:TTG
NM_001848.2(COL6A1):c.877G>A (p.Gly293Arg)	COL6A1	G293R	not provided|Bethlem myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093895	21	47409540	21	45989626	93895	99797	rs398123643	NC_000021.9:45989625:G:A
NM_001848.2(COL6A1):c.868G>A (p.Gly290Arg)	COL6A1	G290R	not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093894	21	47409531	21	45989617	93894	99796	rs121912939	NC_000021.9:45989616:G:A
NM_001848.2(COL6A1):c.805-2A>G	COL6A1		not provided	Pathogenic(Last reviewed: Aug 28, 2012)	criteria provided, single submitter	VCV000093888	21	47408996	21	45989082	93888	99790	rs398123639	NC_000021.9:45989081:A:G
NM_001083962.2(TCF4):c.510_513AAAG[1] (p.Lys172fs)	TCF4		Intellectual disability|not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093545	18	53017622 - 53017625	18	55350391 - 55350394	93545	99450	rs398123561	NC_000018.10:55350390:CTTTCTTT:CTTT
NM_001083962.2(TCF4):c.1733G>A (p.Arg578His)	TCF4	R578H, R680H, R413H, R448H, R503H, R536H, R574H, R554H, R555H, R571H, R573H, R418H, R532H, R549H, R550H, R553H, R362H, R414H, R444H, R507H, R577H, R584H	Microcephaly|not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093542	18	52896224	18	55228993	93542	99447	rs121909123	NC_000018.10:55228992:C:T
NM_001083962.2(TCF4):c.1086G>A (p.Trp362Ter)	TCF4	W362*, W146*, W232*, W320*, W337*, W361*, W464*, W201*, W202*, W291*, W338*, W359*, W339*, W368*	not provided	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093540	18	52924606	18	55257375	93540	99445	rs398123560	NC_000018.10:55257374:C:T
NM_000709.4(BCKDHA):c.979G>A (p.Glu327Lys)	BCKDHA	E327K, E326K	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093385	19	41928659	19	41422754	93385	99292	rs398123515	NC_000019.10:41422753:G:A
NM_000709.4(BCKDHA):c.964C>T (p.Gln322Ter)	BCKDHA	Q322*, Q321*	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000093381	19	41928644	19	41422739	93381	99288	rs398123513	NC_000019.10:41422738:C:T
NM_000709.4(BCKDHA):c.917del (p.Val306fs)	BCKDHA	V305fs, V306fs	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093380	19	41928597	19	41422692	93380	99287	rs398123512	NC_000019.10:41422691:T:
NM_000709.4(BCKDHA):c.907_908GT[1] (p.Phe304fs)	BCKDHA		not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093378	19	41928586 - 41928587	19	41422681 - 41422682	93378	99285	rs398123510	NC_000019.10:41422680:TGTGT:TGT
NM_000709.4(BCKDHA):c.905A>C (p.Asp302Ala)	BCKDHA	D302A, D301A	not provided	Pathogenic(Last reviewed: Aug 25, 2013)	criteria provided, single submitter	VCV000093377	19	41928585	19	41422680	93377	99284	rs398123509	NC_000019.10:41422679:A:C
NM_000709.4(BCKDHA):c.853G>C (p.Ala285Pro)	BCKDHA	A285P	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093375	19	41928275	19	41422370	93375	99282	rs398123508	NC_000019.10:41422369:G:C
NM_000709.4(BCKDHA):c.741dup (p.Ala248fs)	BCKDHA		not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093370	19	41928162 - 41928163	19	41422257 - 41422258	93370	99277	rs398123504	NC_000019.10:41422257:T:TT
NM_000709.4(BCKDHA):c.659C>T (p.Ala220Val)	BCKDHA	A220V	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093367	19	41928081	19	41422176	93367	99274	rs375785084	NC_000019.10:41422175:C:T
NM_000709.4(BCKDHA):c.632C>T (p.Thr211Met)	BCKDHA	T211M	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093365	19	41925187	19	41419282	93365	99272	rs398123503	NC_000019.10:41419281:C:T
NM_000709.4(BCKDHA):c.288+1G>A	BCKDHA		Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093351	19	41916722	19	41410817	93351	99258	rs398123496	NC_000019.10:41410816:G:A
NM_000709.4(BCKDHA):c.14del (p.Ile5fs)	BCKDHA	I5fs	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093349	19	41903746	19	41397841	93349	99256	rs398123494	NC_000019.10:41397840:T:
NM_000709.4(BCKDHA):c.1314C>A (p.Tyr438Ter)	BCKDHA	Y238*, Y438*, Y437*	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093348	19	41930489	19	41424584	93348	99255	rs398123493	NC_000019.10:41424583:C:A
NM_000709.4(BCKDHA):c.1310_1311del (p.His437fs)	BCKDHA	H437fs, H436fs	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093347	19	41930484 - 41930485	19	41424579 - 41424580	93347	99254	rs398123492	NC_000019.10:41424578:CAC:C
NM_000709.4(BCKDHA):c.1302C>A (p.Tyr434Ter)	BCKDHA	Y434*, Y433*	not provided	Pathogenic(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000093346	19	41930477	19	41424572	93346	99253	rs398123491	NC_000019.10:41424571:C:A
NM_000709.4(BCKDHA):c.1234G>A (p.Val412Met)	BCKDHA	V412M, V411M	not provided|Maple syrup urine disease|Maple syrup urine disease type 1A	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093344	19	41930409	19	41424504	93344	99251	rs398123490	NC_000019.10:41424503:G:A
NM_000709.4(BCKDHA):c.117del (p.Arg40fs)	BCKDHA	R40fs	Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Jun 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093342	19	41916544	19	41410639	93342	99249	rs398123489	NC_000019.10:41410638:CCCCCCC:CCCCCC
NM_000709.4(BCKDHA):c.1036C>T (p.Arg346Cys)	BCKDHA	R346C, R345C	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093335	19	41928943	19	41423038	93335	99242	rs182923857	NC_000019.10:41423037:C:T
NM_000531.6(OTC):c.540+2T>C	OTC		not provided	Pathogenic(Last reviewed: Nov 13, 2012)	criteria provided, single submitter	VCV000093221	X	38260683	X	38401430	93221	99128	rs67367843	NC_000023.11:38401429:T:C
NM_000531.6(OTC):c.238A>G (p.Lys80Glu)	OTC	K80E	not provided	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000093219	X	38229070	X	38369817	93219	99126	rs72554332	NC_000023.11:38369816:A:G
NM_000528.4(MAN2B1):c.2436+2T>C	MAN2B1		Deficiency of alpha-mannosidase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, multiple submitters, no conflicts	VCV000093214	19	12759948	19	12649134	93214	99121	rs398123457	NC_000019.10:12649133:A:G
NM_000528.4(MAN2B1):c.2398G>A (p.Gly800Arg)	MAN2B1	G800R, G799R	not provided	Pathogenic(Last reviewed: Nov 5, 2012)	criteria provided, single submitter	VCV000093213	19	12759988	19	12649174	93213	99120	rs398123456	NC_000019.10:12649173:C:T
NM_000528.4(MAN2B1):c.1929G>A (p.Trp643Ter)	MAN2B1	W643*, W642*	not provided	Pathogenic(Last reviewed: Mar 13, 2013)	criteria provided, single submitter	VCV000093212	19	12763084	19	12652270	93212	99119	rs398123455	NC_000019.10:12652269:C:T
NM_000489.5(ATRX):c.7394del (p.Gly2465fs)	ATRX	G2427fs, G2465fs	not provided	Pathogenic(Last reviewed: Aug 7, 2012)	criteria provided, single submitter	VCV000093147	X	76763914	X	77508436	93147	99054	rs398123428	NC_000023.11:77508435:CC:C
NM_000489.5(ATRX):c.536A>G (p.Asn179Ser)	ATRX	N179S, N141S	Mental retardation-hypotonic facies syndrome X-linked, 1|not provided	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093141	X	76944369	X	77688876	93141	99048	rs398123425	NC_000023.11:77688875:T:C
NM_138270.4(ATRX):c.370+2732_370+2743delinsT	ATRX		not provided	Pathogenic(Last reviewed: Aug 6, 2012)	criteria provided, single submitter	VCV000093139	X	76949323 - 76949334	X	77693834 - 77693845	93139	99046	rs398123424	NC_000023.11:77693833:TTTGAGATTTTC:A
NM_000489.5(ATRX):c.189+1G>A	ATRX		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000093133	X	76954061	X	77698573	93133	99040	rs398123422	NC_000023.11:77698572:C:T
NM_000489.5(ATRX):c.134-2A>G	ATRX		not provided	Pathogenic(Last reviewed: Jul 17, 2013)	criteria provided, single submitter	VCV000093130	X	76954119	X	77698631	93130	99037	rs398123420	NC_000023.11:77698630:T:C
NM_000487.6(ARSA):c.991G>T (p.Glu331Ter)	ARSA	E331*, E245*	Metachromatic leukodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093129	22	51064480	22	50626052	93129	99036	rs398123419	NC_000022.11:50626051:C:A
NM_000487.6(ARSA):c.986C>T (p.Thr329Ile)	ARSA	T329I, T243I	not provided|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093128	22	51064485	22	50626057	93128	99035	rs398123418	NC_000022.11:50626056:G:A
NM_000487.6(ARSA):c.583del (p.Trp195fs)	ARSA	W109fs, W195fs	not provided	Pathogenic(Last reviewed: Mar 27, 2013)	criteria provided, single submitter	VCV000093124	22	51065363	22	50626935	93124	99031	rs398123416	NC_000022.11:50626934:A:
NM_000487.6(ARSA):c.34del (p.Ala12fs)	ARSA	A12fs	not provided	Pathogenic(Last reviewed: May 29, 2013)	criteria provided, single submitter	VCV000093122	22	51066174	22	50627746	93122	99029	rs398123415	NC_000022.11:50627745:CC:C
NM_000487.6(ARSA):c.195del (p.Phe64_Tyr65insTer)	ARSA		Metachromatic leukodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093121	22	51066013	22	50627585	93121	99028	rs398123414	NC_000022.11:50627584:G:
NM_000487.6(ARSA):c.1121_1122CT[2] (p.Phe376fs)	ARSA		not provided	Pathogenic(Last reviewed: Aug 15, 2012)	criteria provided, single submitter	VCV000093116	22	51064091 - 51064092	22	50625663 - 50625664	93116	99023	rs398123412	NC_000022.11:50625662:AGAGAGA:AGAGA
NM_000487.6(ARSA):c.1108-2A>G	ARSA		Metachromatic leukodystrophy|not provided	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093115	22	51064111	22	50625683	93115	99022	rs398123411	NC_000022.11:50625682:T:C
NM_000455.4(STK11):c.921-1G>T	STK11		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000093100	19	1222983	19	1222984	93100	99007	rs398123406	NC_000019.10:1222983:G:T
NM_000455.4(STK11):c.877G>T (p.Glu293Ter)	STK11	E293*	not provided	Pathogenic(Last reviewed: Jun 24, 2013)	criteria provided, single submitter	VCV000093098	19	1221962	19	1221963	93098	99005	rs398123405	NC_000019.10:1221962:G:T
NM_000455.4(STK11):c.169dup (p.Glu57fs)	STK11		Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	criteria provided, multiple submitters, no conflicts	VCV000093096	19	1207076 - 1207077	19	1207077 - 1207078	93096	99003	rs121913319	NC_000019.10:1207077:GGGGG:GGGGGG
NM_001278116.2(L1CAM):c.2879del (p.Glu960fs)	L1CAM	E955fs, E960fs	not provided	Pathogenic(Last reviewed: Feb 21, 2013)	criteria provided, single submitter	VCV000092929	X	153130443	X	153864988	92929	98836	rs398123364	NC_000023.11:153864987:T:
NM_001278116.2(L1CAM):c.23del (p.Val8fs)	L1CAM	V8fs	not provided	Pathogenic(Last reviewed: Jan 21, 2013)	criteria provided, single submitter	VCV000092926	X	153141269	X	153875814	92926	98833	rs398123362	NC_000023.11:153875813:A:
NM_033290.4(MID1):c.783del (p.Lys261fs)	MID1	K312fs, K223fs, K261fs	not provided	Pathogenic(Last reviewed: Nov 2, 2012)	criteria provided, single submitter	VCV000092880	X	10463705	X	10495665	92880	98787	rs398123343	NC_000023.11:10495664:TTT:TT
NM_033290.4(MID1):c.1798dup (p.His600fs)	MID1		not provided|Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000092876	X	10417613 - 10417614	X	10449573 - 10449574	92876	98783	rs398123342	NC_000023.11:10449573:GGGGGG:GGGGGGG
NM_000328.3(RPGR):c.505G>T (p.Glu169Ter)	RPGR	E169*, E179*, E168*	Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092857	X	38176683	X	38317430	92857	98764	rs369037463	NC_000023.11:38317429:C:A
NM_000328.3(RPGR):c.155-2A>G	RPGR		not provided	Pathogenic(Last reviewed: Jul 1, 2013)	criteria provided, single submitter	VCV000092851	X	38182200	X	38322947	92851	98758	rs62638632	NC_000023.11:38322946:T:C
NM_000284.4(PDHA1):c.483C>T (p.Tyr161=)	PDHA1		not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092770	X	19371264	X	19353146	92770	98677	rs398123300	NC_000023.11:19353145:C:T
NM_000276.4(OCRL):c.903_904AG[3] (p.Gly304fs)	OCRL		not provided	Pathogenic(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	VCV000092726	X	128695234 - 128695235	X	129561257 - 129561258	92726	98633	rs398123290	NC_000023.11:129561256:AGAGAGAG:AGAGAG
NM_000276.4(OCRL):c.2582-1G>A	OCRL		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092724	X	128724122	X	129590145	92724	98631	rs398123289	NC_000023.11:129590144:G:A
NM_000276.4(OCRL):c.2563del (p.Val855fs)	OCRL	V856fs, V847fs, V855fs	not provided	Pathogenic(Last reviewed: Jul 15, 2013)	criteria provided, single submitter	VCV000092723	X	128723915	X	129589938	92723	98630	rs398123288	NC_000023.11:129589937:G:
NM_000271.5(NPC1):c.2196dup (p.Pro733fs)	NPC1		Niemann-Pick disease type C1|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092706	18	21123467 - 21123468	18	23543503 - 23543504	92706	98613	rs398123284	NC_000018.10:23543503:A:AA
NM_000252.2(MTM1):c.70C>T (p.Arg24Ter)	MTM1	R24*	not provided|Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092678	X	149764968	X	150596504	92678	98585	rs398123275	NC_000023.11:150596503:C:T
NM_000252.2(MTM1):c.595_599del (p.Pro199fs)	MTM1	P199fs	not provided	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000092676	X	149809807 - 149809811	X	150641334 - 150641338	92676	98583	rs398123273	NC_000023.11:150641333:CCCTGC:C
NM_000252.2(MTM1):c.1644+1G>T	MTM1		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092675	X	149832083	X	150663610	92675	98582	rs398123272	NC_000023.11:150663609:G:T
NM_000252.2(MTM1):c.142_143del (p.Glu48fs)	MTM1	E48fs	not provided	Pathogenic(Last reviewed: May 24, 2013)	criteria provided, single submitter	VCV000092673	X	149767060 - 149767061	X	150598596 - 150598597	92673	98580	rs398123270	NC_000023.11:150598595:AGA:A
NM_000252.2(MTM1):c.1357_1358del (p.Pro453fs)	MTM1	P453fs	not provided	Pathogenic(Last reviewed: Jun 5, 2013)	criteria provided, single submitter	VCV000092671	X	149828846 - 149828847	X	150660373 - 150660374	92671	98578	rs398123268	NC_000023.11:150660372:CCC:C
NM_000252.2(MTM1):c.1306_1310dup (p.Phe438fs)	MTM1		not provided	Pathogenic(Last reviewed: Apr 23, 2014)	criteria provided, single submitter	VCV000092670	X	149828180 - 149828181	X	150659707 - 150659708	92670	98577	rs398123267	NC_000023.11:150659707:TCCTAT:TCCTATCCTAT
NM_000252.2(MTM1):c.1040T>G (p.Leu347Ter)	MTM1	L347*	not provided	Pathogenic(Last reviewed: Nov 8, 2012)	criteria provided, single submitter	VCV000092666	X	149818361	X	150649888	92666	98573	rs398123264	NC_000023.11:150649887:T:G
NM_000202.8(IDS):c.262C>T (p.Arg88Cys)	IDS	R88C	not provided|Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092618	X	148584998	X	149503468	92618	98526	rs398123249	NC_000023.11:149503467:G:A
NM_000202.8(IDS):c.253G>A (p.Ala85Thr)	IDS	A85T	not provided|Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092617	X	148585007	X	149503477	92617	98525	rs113993949	NC_000023.11:149503476:C:T
NM_000202.8(IDS):c.1403G>C (p.Arg468Pro)	IDS	R468P, R378P	not provided	Pathogenic(Last reviewed: Aug 11, 2015)	criteria provided, single submitter	VCV000092615	X	148564527	X	149482996	92615	98523	rs113993946	NC_000023.11:149482995:C:G
NM_000202.8(IDS):c.103+1G>C	IDS		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092614	X	148586564	X	149505034	92614	98522	rs398123247	NC_000023.11:149505033:C:G
NM_000194.3(HPRT1):c.486-1G>A	HPRT1		not provided	Pathogenic(Last reviewed: Oct 22, 2013)	criteria provided, single submitter	VCV000092604	X	133632419	X	134498389	92604	98512	rs398123241	NC_000023.11:134498388:G:A
NM_000194.3(HPRT1):c.384+1G>A	HPRT1		not provided	Pathogenic(Last reviewed: Jul 13, 2015)	criteria provided, single submitter	VCV000092603	X	133620561	X	134486531	92603	98511	rs398123240	NC_000023.11:134486530:G:A
NM_000159.4(GCDH):c.636-1G>A	GCDH		not provided|Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092534	19	13007018	19	12896204	92534	98443	rs398123195	NC_000019.10:12896203:G:A
NM_000159.4(GCDH):c.542A>G (p.Glu181Gly)	GCDH	E181G	not provided	Pathogenic(Last reviewed: Sep 7, 2012)	criteria provided, single submitter	VCV000092533	19	13006842	19	12896028	92533	98442	rs398123194	NC_000019.10:12896027:A:G
NM_000152.5(GAA):c.307T>G (p.Cys103Gly)	GAA	C103G	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092483	17	78078692	17	80104893	92483	98392	rs398123174	NC_000017.11:80104892:T:G
NM_000152.5(GAA):c.2544del (p.Lys849fs)	GAA	K849fs	not provided	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000092480	17	78092053	17	80118254	92480	98389	rs398123173	NC_000017.11:80118253:CC:C
NM_000152.5(GAA):c.2512C>T (p.Gln838Ter)	GAA	Q838*	not provided	Pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000092479	17	78092022	17	80118223	92479	98388	rs369532274	NC_000017.11:80118222:C:T
NM_000152.5(GAA):c.2105G>T (p.Arg702Leu)	GAA	R702L	not provided|Glycogen storage disease, type II	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092472	17	78087081	17	80113282	92472	98381	rs398123172	NC_000017.11:80113281:G:T
NM_000152.5(GAA):c.2066_2070dup (p.Ala691fs)	GAA		not provided	Pathogenic(Last reviewed: Oct 23, 2012)	criteria provided, single submitter	VCV000092471	17	78087039 - 78087040	17	80113240 - 80113241	92471	98380	rs398123171	NC_000017.11:80113240:CGAGCCG:CGAGCCGAGCCG
NM_000152.5(GAA):c.2012T>G (p.Met671Arg)	GAA	M671R	not provided	Pathogenic(Last reviewed: Sep 25, 2012)	criteria provided, single submitter	VCV000092469	17	78086798	17	80112999	92469	98378	rs398123170	NC_000017.11:80112998:T:G
NM_000152.5(GAA):c.1465G>A (p.Asp489Asn)	GAA	D489N	Glycogen storage disease, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092465	17	78084553	17	80110754	92465	98374	rs398123169	NC_000017.11:80110753:G:A
NM_000117.2(EMD):c.355C>T (p.Gln119Ter)	EMD	Q119*	not provided	Pathogenic(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	VCV000092440	X	153608683	X	154380323	92440	98349	rs398123157	NC_000023.11:154380322:C:T
NM_000117.2(EMD):c.239_240insT (p.Glu80fs)	EMD		not provided	Pathogenic(Last reviewed: Sep 11, 2013)	criteria provided, single submitter	VCV000092438	X	153608353 - 153608354	X	154379993 - 154379994	92438	98347	rs398123155	NC_000023.11:154379993::T
NM_000071.2(CBS):c.1006C>T (p.Arg336Cys)	CBS	R336C, R231C	not provided|Classic homocystinuria	Pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092423	21	44482454	21	43062344	92423	98334	rs398123151	NC_000021.9:43062343:G:A
NM_000052.7(ATP7A):c.3802-1G>T	ATP7A		not provided	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000092383	X	77298082	X	78042584	92383	98294	rs398123135	NC_000023.11:78042583:G:T
NM_000052.7(ATP7A):c.1205del (p.Lys402fs)	ATP7A	K402fs	not provided	Pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	VCV000092379	X	77245318	X	77989822	92379	98290	rs398123133	NC_000023.11:77989821:AAAAAA:AAAAA
NM_000033.4(ABCD1):c.498_520del (p.Val167fs)	ABCD1	V167fs	not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092327	X	152991216 - 152991238	X	153725761 - 153725783	92327	98238	rs398123112	NC_000023.11:153725760:TCTGGTGGCCCACGCCTACCGCCTCT:TCT
NM_000033.4(ABCD1):c.406C>T (p.Gln136Ter)	ABCD1	Q136*	not provided	Pathogenic(Last reviewed: Mar 18, 2013)	criteria provided, single submitter	VCV000092326	X	152991127	X	153725672	92326	98237	rs398123111	NC_000023.11:153725671:C:T
NM_000033.4(ABCD1):c.346G>A (p.Gly116Arg)	ABCD1	G116R	not provided	Pathogenic(Last reviewed: Apr 12, 2013)	criteria provided, single submitter	VCV000092325	X	152991067	X	153725612	92325	98236	rs398123110	NC_000023.11:153725611:G:A
NM_000033.4(ABCD1):c.31_46del (p.Arg11fs)	ABCD1	R11fs	not provided	Pathogenic(Last reviewed: Mar 4, 2014)	criteria provided, single submitter	VCV000092324	X	152990752 - 152990767	X	153725297 - 153725312	92324	98235	rs398123109	NC_000023.11:153725296:CGGGGGAACACGCTGA:
NM_000033.4(ABCD1):c.1866-10G>A	ABCD1		Adrenoleukodystrophy|not specified|not provided|Spastic paraplegia|Spastic gait	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092323	X	153008665	X	153743211	92323	98234	rs398123108	NC_000023.11:153743210:G:A
NM_000033.4(ABCD1):c.1802G>A (p.Trp601Ter)	ABCD1	W601*	not provided	Pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	VCV000092322	X	153008462	X	153743008	92322	98233	rs398123107	NC_000023.11:153743007:G:A
NM_000033.4(ABCD1):c.1771C>T (p.Arg591Trp)	ABCD1	R591W	not provided|Adrenoleukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092321	X	153006164	X	153740710	92321	98232	rs398123106	NC_000023.11:153740709:C:T
NM_000033.4(ABCD1):c.1679C>T (p.Pro560Leu)	ABCD1	P560L	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092320	X	153006072	X	153740618	92320	98231	rs398123105	NC_000023.11:153740617:C:T
NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	ABCD1	R518Q	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092317	X	153005610	X	153740156	92317	98228	rs398123102	NC_000023.11:153740155:G:A
NM_000033.4(ABCD1):c.1396C>T (p.Gln466Ter)	ABCD1	Q466*	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092314	X	153002613	X	153737159	92314	98225	rs398123100	NC_000023.11:153737158:C:T
NM_000023.4(SGCA):c.101G>A (p.Arg34His)	SGCA	R34H	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092301	17	48244792	17	50167431	92301	98212	rs371675217	NC_000017.11:50167430:G:A
NM_003906.5(MCM3AP):c.2743G>A (p.Glu915Lys)	MCM3AP	E915K	PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000092123	21	47686942	21	46267028	92123	97549	rs483352869	NC_000021.9:46267027:C:T
NM_021946.4(BCORL1):c.2459A>G (p.Asn820Ser)	BCORL1	N820S	SHUKLA-VERNON SYNDROME	Pathogenic(Last reviewed: Jul 25, 2019)	no assertion criteria provided	VCV000092122	X	129149207	X	130015231	92122	97548	rs398123004	NC_000023.11:130015230:A:G
NM_001042537.1(SLC9A6):c.1639G>T (p.Glu547Ter)	SLC9A6	E547*, E463*, E495*, E515*	Christianson syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000092121	X	135112313	X	136030154	92121	97547	rs398123003	NC_000023.11:136030153:G:T
NM_006087.4(TUBB4A):c.811G>A (p.Ala271Thr)	TUBB4A	A271T, A322T, A316T, A199T	Autosomal dominant torsion dystonia 4	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000092111	19	6495699	19	6495688	92111	97543	rs587777074	NC_000019.10:6495687:C:T
NM_002501.4(NFIX):c.716C>G (p.Ser239Ter)	NFIX	S239*, S192*, S247*, S231*, S238*	Sotos syndrome 2	Pathogenic(Last reviewed: Dec 18, 2013)	no assertion criteria provided	VCV000092044	19	13184738	19	13073924	92044	97522	rs587779381	NC_000019.10:13073923:C:G
NM_018486.3(HDAC8):c.356C>T (p.Thr119Met)	HDAC8	T119M	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000092043	X	71787820	X	72567970	92043	97521	rs587779380	NC_000023.11:72567969:G:A
NM_002730.3(PRKACA):c.617T>G (p.Leu206Arg)	PRKACA	L206R, L198R, L282R	not provided|Pigmented nodular adrenocortical disease, primary, 4	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	VCV000091945	19	14208416	19	14097604	91945	97423	rs386352352	NC_000019.10:14097603:A:C
NM_024876.4(COQ8B):c.1356_1362del (p.Gln452fs)	COQ8B	Q452fs, Q411fs	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000091851	19	41198213 - 41198219	19	40692308 - 40692314	91851	97328	rs398122983	NC_000019.10:40692307:AGGGCCC:
NM_024876.4(COQ8B):c.1199dup (p.His400fs)	COQ8B		Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000091850	19	41201903 - 41201904	19	40695998 - 40695999	91850	97327	rs398122982	NC_000019.10:40695998:T:TT
NM_024876.4(COQ8B):c.1027C>T (p.Arg343Trp)	COQ8B	R343W, R302W	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000091849	19	41206223	19	40700318	91849	97326	rs398122981	NC_000019.10:40700317:G:A
NM_024876.4(COQ8B):c.958C>T (p.Arg320Trp)	COQ8B	R320W, R279W	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000091848	19	41206292	19	40700387	91848	97325	rs369573693	NC_000019.10:40700386:G:A
NM_024876.4(COQ8B):c.1447G>T (p.Glu483Ter)	COQ8B	E483*, E442*	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000091847	19	41198128	19	40692223	91847	97324	rs398122980	NC_000019.10:40692222:C:A
NM_024876.4(COQ8B):c.857A>G (p.Asp286Gly)	COQ8B	D286G, D245G	Nephrotic syndrome, type 9	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000091846	19	41208541	19	40702636	91846	97323	rs398122979	NC_000019.10:40702635:T:C
NM_024876.4(COQ8B):c.532C>T (p.Arg178Trp)	COQ8B	R178W, R137W	Nephrotic syndrome, type 9	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000091845	19	41211045	19	40705140	91845	97322	rs398122978	NC_000019.10:40705139:G:A
NM_021140.3(KDM6A):c.1909_1912del (p.Ser637fs)	KDM6A	S592fs, S341fs, S558fs, S637fs, S689fs, S644fs	Kabuki syndrome 2	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000091403	X	44923045 - 44923048	X	45063800 - 45063803	91403	96880	rs398122969	NC_000023.11:45063799:CTATCTA:CTA
NM_000328.3(RPGR):c.1905+500_1905+501del	RPGR		Inborn genetic diseases|Retinal dystrophy|Retinitis pigmentosa 15|not provided|Retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000091389	X	38145846 - 38145847	X	38286593 - 38286594	91389	96865	rs398122960	NC_000023.11:38286592:CTCT:CT
NM_006420.3(ARFGEF2):c.1958+1G>A	ARFGEF2		Heterotopia, periventricular, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089028	20	47592737	20	48976200	89028	94574	rs398122523	NC_000020.11:48976199:G:A
NM_006192.5(PAX1):c.497G>T (p.Gly166Val)	PAX1	G166V	Otofaciocervical syndrome 2	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089026	20	21687286	20	21706648	89026	94572	rs540296842	NC_000020.11:21706647:G:T
nsv1197578	RPS19		Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088978	19	42364612 - 42369681			88978	94534		
NM_001039876.3(SYNE4):c.228_229del (p.Trp77fs)	SYNE4	W77fs	Deafness, autosomal recessive 76	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000088870	19	36499169 - 36499170	19	36008267 - 36008268	88870	94439	rs587777072	NC_000019.10:36008266:AT:
NM_203446.2(SYNJ1):c.773G>A (p.Arg258Gln)	SYNJ1	R258Q, R219Q	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000088844	21	34067416	21	32695106	88844	94413	rs398122403	NC_000021.9:32695105:C:T
NM_004595.5(SMS):c.983A>G (p.Tyr328Cys)	SMS	Y328C, Y275C	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Sep 15, 2013)	no assertion criteria provided	VCV000088767	X	22010752	X	21992634	88767	94346	rs397515553	NC_000023.11:21992633:A:G
NM_001008537.3(NEXMIF):c.183del (p.Arg62fs)	NEXMIF	R62fs	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 15, 2013)	no assertion criteria provided	VCV000088755	X	73964209	X	74744374	88755	94336	rs397518479	NC_000023.11:74744373:GGG:GG
NEXMIF, 70-KB DUP	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 15, 2013)	no assertion criteria provided	VCV000088754					88754	94335		
NM_001008537.3(NEXMIF):c.3597dup (p.Ser1200fs)	NEXMIF		Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 15, 2013)	no assertion criteria provided	VCV000088753	X	73960794 - 73960795	X	74740959 - 74740960	88753	94334	rs397518478	NC_000023.11:74740959:TTTTTT:TTTTTTT
NM_015295.2(SMCHD1):c.1580C>T (p.Thr527Met)	SMCHD1	T527M	Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088705	18	2700849	18	2700851	88705	94288	rs397518422	NC_000018.10:2700850:C:T
NM_005359.5(SMAD4):c.1486C>T (p.Arg496Cys)	SMAD4	R496C	Juvenile polyposis syndrome|not provided|Inborn genetic diseases|Hereditary cancer-predisposing syndrome|Myhre syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088673	18	48604664	18	51078294	88673	94253	rs397518413	NC_000018.10:51078293:C:T
NM_001942.4(DSG1):c.49-1G>A	DSG1		Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000088661	18	28906543	18	31326580	88661	94249	rs398122952	NC_000018.10:31326579:G:A
NM_001942.4(DSG1):c.430A>T (p.Arg144Ter)	DSG1	R144*		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000088660	18	28909912	18	31329949	88660	94248	rs397515641	NC_000018.10:31329948:A:T
NM_001942.4(DSG1):c.601C>T (p.Gln201Ter)	DSG1	Q201*		Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000088659	18	28911747	18	31331784	88659	94247	rs397515640	NC_000018.10:31331783:C:T
NM_001942.4(DSG1):c.121dup (p.Trp41fs)	DSG1			Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000088658	18	28906872 - 28906873	18	31326909 - 31326910	88658	94246	rs398122951	NC_000018.10:31326909:T:TT
NM_001942.4(DSG1):c.1628del (p.Asn543fs)	DSG1	N543fs		Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000088656	18	28919928	18	31339965	88656	94244	rs398122950	NC_000018.10:31339964:AA:A
NM_001942.4(DSG1):c.1079dup (p.Ile361fs)	DSG1			Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000088655	18	28916389 - 28916390	18	31336426 - 31336427	88655	94243	rs398122949	NC_000018.10:31336426:C:CC
NM_000216.4(ANOS1):c.1449+2del	ANOS1			Pathogenic(Last reviewed: Mar 26, 2013)	no assertion criteria provided	VCV000088647	X	8507703	X	8539662	88647	94235	rs397518425	NC_000023.11:8539661:A:
NM_001195553.2(DCX):c.305G>A (p.Arg102His)	DCX	R102H, R183H	Heterotopia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000082052	X	110653322	X	111410094	82052	92943	rs267606317	NC_000023.11:111410093:C:T
NM_002608.4(PDGFB):c.3G>A (p.Met1Ile)	PDGFB	M1I	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000075245	22	39639966	22	39243961	75245	86136	rs398122399	NC_000022.11:39243960:C:T
NM_002608.4(PDGFB):c.445C>T (p.Arg149Ter)	PDGFB	R149*, R134*	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000075243	22	39627638	22	39231633	75243	86134	rs397515633	NC_000022.11:39231632:G:A
NM_002608.4(PDGFB):c.726G>C (p.Ter242Tyr)	PDGFB	*242Y, *227Y	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Aug 14, 2017)	no assertion criteria provided	VCV000075241	22	39621728	22	39225723	75241	86132	rs398122398	NC_000022.11:39225722:C:G
NM_002608.4(PDGFB):c.356T>C (p.Leu119Pro)	PDGFB	L119P, L104P	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000075239	22	39627727	22	39231722	75239	86130	rs397515632	NC_000022.11:39231721:A:G
NM_002608.4(PDGFB):c.433C>T (p.Gln145Ter)	PDGFB	Q145*, Q130*	Idiopathic basal ganglia calcification 5	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000075237	22	39627650	22	39231645	75237	86128	rs397515631	NC_000022.11:39231644:G:A
NM_173630.4(RTTN):c.2796A>T (p.Leu932Phe)	RTTN	L932F, L20F	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH SEIZURES|not provided	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000068847	18	67802509	18	70135273	68847	79738	rs318240757	NC_000018.10:70135272:T:A
NM_006907.4(PYCR1):c.616G>A (p.Gly206Arg)	PYCR1	G206R, G233R	not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068789	17	79892546	17	81934670	68789	79681	rs121918375	NC_000017.11:81934669:C:T
NM_000394.4(CRYAA):c.62G>A (p.Arg21Gln)	CRYAA	R21Q	Cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000068461	21	44589271	21	43169161	68461	79353	rs397515626	NC_000021.9:43169160:G:A
NM_000394.4(CRYAA):c.61C>T (p.Arg21Trp)	CRYAA	R21W	Cataract, autosomal dominant, multiple types, with microcornea|Congenital cataract|Cataract, autosomal dominant	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000068460	21	44589270	21	43169160	68460	79352	rs397515625	NC_000021.9:43169159:C:T
NM_000394.4(CRYAA):c.34C>T (p.Arg12Cys)	CRYAA	R12C	Cataract, autosomal dominant|Cataract, autosomal dominant, multiple types, with microcornea	Pathogenic(Last reviewed: Dec 29, 2018)	criteria provided, single submitter	VCV000068459	21	44589243	21	43169133	68459	79351	rs397515624	NC_000021.9:43169132:C:T
NM_000394.4(CRYAA):c.160C>T (p.Arg54Cys)	CRYAA	R54C	Congenital cataract|Cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000068457	21	44589369	21	43169259	68457	79349	rs397515623	NC_000021.9:43169258:C:T
NM_000394.4(CRYAA):c.292G>A (p.Gly98Arg)	CRYAA	G98R, G61R	Cataract, autosomal dominant	Pathogenic(Last reviewed: Jul 12, 2006)	no assertion criteria provided	VCV000068456	21	44590729	21	43170619	68456	79348	rs398122947	NC_000021.9:43170618:G:A
NM_030632.3(ASXL3):c.1422dup (p.Glu475Ter)	ASXL3		Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000068454	18	31318789 - 31318790	18	33738825 - 33738826	68454	79345	rs1555742148	NC_000018.10:33738825:T:TT
NM_030632.3(ASXL3):c.1396C>T (p.Gln466Ter)	ASXL3	Q466*	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000068452	18	31318764	18	33738800	68452	79343	rs587777062	NC_000018.10:33738799:C:T
NM_030632.3(ASXL3):c.1210C>T (p.Gln404Ter)	ASXL3	Q404*	Bainbridge-Ropers syndrome	Pathogenic(Last reviewed: Feb 5, 2013)	no assertion criteria provided	VCV000068451	18	31318578	18	33738614	68451	79342	rs587777061	NC_000018.10:33738613:C:T
NM_001256447.2(BCAP31):c.97C>T (p.Gln33Ter)	BCAP31	Q33*, Q100*	Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068446	X	152986423	X	153720968	68446	79337	rs397515620	NC_000023.11:153720967:G:A
NM_001256447.2(BCAP31):c.194-2A>G	BCAP31		Chromosome Xq28 deletion syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068444	X	152981146	X	153715691	68444	79335	rs879255569	NC_000023.11:153715690:T:C
NM_001127221.1(CACNA1A):c.5035C>T (p.Arg1679Cys)	CACNA1A	R1679C, R1678C, R1684C, R1681C	Episodic ataxia type 2	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	VCV000068434	19	13346463	19	13235649	68434	79325	rs121908243	NC_000019.10:13235648:G:A
NM_001127221.1(CACNA1A):c.4999C>T (p.Arg1667Trp)	CACNA1A	R1667W, R1668W, R1669W, R1666W, R1672W	Familial hemiplegic migraine type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068433	19	13346499	19	13235685	68433	79324	rs121908220	NC_000019.10:13235684:G:A
NM_000397.3(CYBB):c.1609T>C (p.Cys537Arg)	CYBB	C537R	Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068386	X	37670066	X	37810813	68386	79277	rs151344454	NC_000023.11:37810812:T:C
NM_000397.3(CYBB):c.1223G>A (p.Gly408Glu)	CYBB	G408E	not provided	Pathogenic(Last reviewed: Feb 26, 2016)	criteria provided, single submitter	VCV000068377	X	37664330	X	37805077	68377	79268	rs151344474	NC_000023.11:37805076:G:A
NM_000022.4(ADA):c.529G>A (p.Val177Met)	ADA	V177M, V42M	Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068265	20	43252920	20	44624279	68265	79156	rs121908719	NC_000020.11:44624278:C:T
NM_000022.4(ADA):c.385G>A (p.Val129Met)	ADA	V129M	Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000068260	20	43254303	20	44625662	68260	79151	rs121908731	NC_000020.11:44625661:C:T
NM_000383.4(AIRE):c.977C>T (p.Pro326Leu)	AIRE	P326L	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000068232	21	45711075	21	44291192	68232	79123	rs179363885	NC_000021.9:44291191:C:T
NM_000383.4(AIRE):c.83T>C (p.Leu28Pro)	AIRE	L28P	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068229	21	45705972	21	44286089	68229	79120	rs179363878	NC_000021.9:44286088:T:C
NM_000383.4(AIRE):c.47C>T (p.Thr16Met)	AIRE	T16M	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000068227	21	45705936	21	44286053	68227	79118	rs179363877	NC_000021.9:44286052:C:T
NM_000383.4(AIRE):c.254A>G (p.Tyr85Cys)	AIRE	Y85C	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068222	21	45706561	21	44286678	68222	79113	rs179363882	NC_000021.9:44286677:A:G
NM_000383.4(AIRE):c.1616C>T (p.Pro539Leu)	AIRE	P539L	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068218	21	45717588	21	44297705	68218	79109	rs179363889	NC_000021.9:44297704:C:T
NM_000211.5(ITGB2):c.715G>A (p.Ala239Thr)	ITGB2	A239T, A170T	not provided|	Pathogenic	no assertion criteria provided	VCV000068216	21	46321433	21	44901518	68216	79107	rs179363873	NC_000021.9:44901517:C:T
NM_000211.5(ITGB2):c.382G>T (p.Asp128Tyr)	ITGB2	D128Y, D59Y	not provided|	Pathogenic	no assertion criteria provided	VCV000068215	21	46323397	21	44903482	68215	79106	rs137852615	NC_000021.9:44903481:C:A
NM_000487.6(ARSA):c.929G>T (p.Gly310Val)	ARSA	G310V, G224V	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000068164	22	51064632	22	50626204	68164	79055	rs199476356	NC_000022.11:50626203:C:A
NM_000487.6(ARSA):c.925G>A (p.Glu309Lys)	ARSA	E309K, E223K	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, single submitter	VCV000068162	22	51064636	22	50626208	68162	79053	rs199476360	NC_000022.11:50626207:C:T
NM_000487.6(ARSA):c.899T>C (p.Leu300Ser)	ARSA	L300S, L214S	not provided	Pathogenic(Last reviewed: Nov 14, 2012)	criteria provided, single submitter	VCV000068157	22	51064662	22	50626234	68157	79048	rs199476389	NC_000022.11:50626233:A:G
NM_000487.6(ARSA):c.883G>A (p.Gly295Ser)	ARSA	G295S, G209S	not provided|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000068154	22	51064678	22	50626250	68154	79045	rs199476349	NC_000022.11:50626249:C:T
NM_000487.6(ARSA):c.869G>A (p.Arg290His)	ARSA	R290H, R204H	Metachromatic leukodystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068153	22	51064692	22	50626264	68153	79044	rs199476355	NC_000022.11:50626263:C:T
NM_000487.6(ARSA):c.737G>A (p.Arg246His)	ARSA	R246H, R160H	not provided|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000068148	22	51065136	22	50626708	68148	79039	rs199476366	NC_000022.11:50626707:C:T
NM_000487.6(ARSA):c.449C>T (p.Pro150Leu)	ARSA	P150L, P64L	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000068134	22	51065610	22	50627182	68134	79025	rs199476375	NC_000022.11:50627181:G:A
NM_000487.6(ARSA):c.302G>T (p.Gly101Val)	ARSA	G101V, G15V	Metachromatic leukodystrophy|not provided	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000068129	22	51065757	22	50627329	68129	79020	rs74315455	NC_000022.11:50627328:C:A
NM_000487.6(ARSA):c.256C>T (p.Arg86Trp)	ARSA	R86W	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068126	22	51065803	22	50627375	68126	79017	rs199476352	NC_000022.11:50627374:G:A
NM_000527.4(LDLR):c.2061dup (p.Asn688fs)	LDLR	N688QfsX29	not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000068103	19	11231119	19	11120442 - 11120443	68103	78994	rs137853965	NC_000019.10:11120442:C:CC
NM_001195800.2(LDLR):c.314-1833del	LDLR	G218fs, G177fs	Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068100	19	11216234	19	11105558	68100	78991	rs137853966	NC_000019.10:11105557:GG:G
NM_000891.2(KCNJ2):c.899G>A (p.Gly300Asp)	KCNJ2	G300D	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000067588	17	68172079	17	70175938	67588	78484	rs104894579	NC_000017.11:70175937:G:A
NM_000891.2(KCNJ2):c.779G>C (p.Arg260Pro)	KCNJ2	R260P	Congenital long QT syndrome|not provided	Pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	VCV000067587	17	68171959	17	70175818	67587	78483	rs199473385	NC_000017.11:70175817:G:C
NM_000891.2(KCNJ2):c.653G>A (p.Arg218Gln)	KCNJ2	R218Q	Congenital long QT syndrome|Andersen Tawil syndrome|not provided|Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000067585	17	68171833	17	70175692	67585	78481	rs199473384	NC_000017.11:70175691:G:A
NM_000891.2(KCNJ2):c.644G>A (p.Gly215Asp)	KCNJ2	G215D	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Feb 18, 2017)	criteria provided, single submitter	VCV000067583	17	68171824	17	70175683	67583	78479	rs199473383	NC_000017.11:70175682:G:A
NM_000891.2(KCNJ2):c.431G>C (p.Gly144Ala)	KCNJ2	G144A	Congenital long QT syndrome|Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, single submitter	VCV000067575	17	68171611	17	70175470	67575	78471	rs199473377	NC_000017.11:70175469:G:C
NM_000891.2(KCNJ2):c.431G>A (p.Gly144Asp)	KCNJ2	G144D	Congenital long QT syndrome|Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000067574	17	68171611	17	70175470	67574	78470	rs199473377	NC_000017.11:70175469:G:A
NM_000891.2(KCNJ2):c.245G>A (p.Arg82Gln)	KCNJ2	R82Q	Congenital long QT syndrome|Andersen Tawil syndrome|Short QT syndrome 3|Andersen Tawil syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000067569	17	68171425	17	70175284	67569	78465	rs199473653	NC_000017.11:70175283:G:A
NM_000891.2(KCNJ2):c.244C>T (p.Arg82Trp)	KCNJ2	R82W	Ventricular tachycardia|Short QT syndrome 3|Andersen Tawil syndrome|Supraventricular tachycardia	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000067568	17	68171424	17	70175283	67568	78464	rs199473373	NC_000017.11:70175282:C:T
NM_000891.2(KCNJ2):c.233A>G (p.Asp78Gly)	KCNJ2	D78G	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000067567	17	68171413	17	70175272	67567	78463	rs199473371	NC_000017.11:70175271:A:G
NM_000891.2(KCNJ2):c.224C>T (p.Thr75Met)	KCNJ2	T75M	Congenital long QT syndrome|not provided|Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000067565	17	68171404	17	70175263	67565	78461	rs104894585	NC_000017.11:70175262:C:T
NM_000891.2(KCNJ2):c.200G>A (p.Arg67Gln)	KCNJ2	R67Q	Congenital long QT syndrome|not specified|not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000067560	17	68171380	17	70175239	67560	78456	rs199473368	NC_000017.11:70175238:G:A
NM_080860.4(RSPH1):c.308G>A (p.Gly103Asp)	RSPH1	G103D, G65D	Primary ciliary dyskinesia 24	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066991	21	43906538	21	42486428	66991	77876	rs587777060	NC_000021.9:42486427:C:T
NM_080860.4(RSPH1):c.275-2A>C	RSPH1		not provided|Primary ciliary dyskinesia|Primary ciliary dyskinesia 24|Kartagener syndrome	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066990	21	43906573	21	42486463	66990	77875	rs151107532	NC_000021.9:42486462:T:G
NM_080860.4(RSPH1):c.403_406AGTA[1] (p.Lys136fs)	RSPH1		Primary ciliary dyskinesia 24|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000066989	21	43905870 - 43905873	21	42485760 - 42485763	66989	77874	rs587777059	NC_000021.9:42485759:TACTTACT:TACT
NM_080860.4(RSPH1):c.366-3C>A	RSPH1		Primary ciliary dyskinesia 24|Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000066988	21	43905917	21	42485807	66988	77873	rs587777058	NC_000021.9:42485806:G:T
NM_080860.4(RSPH1):c.85G>T (p.Glu29Ter)	RSPH1	E29*	Primary ciliary dyskinesia|Primary ciliary dyskinesia 24|Kartagener syndrome	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066987	21	43913159	21	42493049	66987	77872	rs138320978	NC_000021.9:42493048:C:A
NM_005334.3(HCFC1):c.217G>A (p.Ala73Thr)	HCFC1	A73T	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066986	X	153230154	X	153964703	66986	77871	rs397515487	NC_000023.11:153964702:C:T
NM_005334.3(HCFC1):c.218C>T (p.Ala73Val)	HCFC1	A73V	not provided|Mental retardation 3, X-linked|Intellectual disability	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000066985	X	153230153	X	153964702	66985	77870	rs397515486	NC_000023.11:153964701:G:A
NM_005334.3(HCFC1):c.344C>T (p.Ala115Val)	HCFC1	A115V	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066984	X	153229734	X	153964283	66984	77869	rs397515485	NC_000023.11:153964282:G:A
NM_002055.5(GFAP):c.994G>A (p.Glu332Lys)	GFAP	E332K	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066515	17	42988737	17	44911369	66515	77412	rs267607514	NC_000017.11:44911368:C:T
NM_002055.5(GFAP):c.992T>C (p.Leu331Pro)	GFAP	L331P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066514	17	42988739	17	44911371	66514	77411	rs59985777	NC_000017.11:44911370:A:G
NM_002055.5(GFAP):c.835A>G (p.Lys279Glu)	GFAP	K279E	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066507	17	42989111	17	44911743	66507	77404	rs58536923	NC_000017.11:44911742:T:C
NM_002055.5(GFAP):c.773G>C (p.Arg258Pro)	GFAP	R258P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066505	17	42990644	17	44913276	66505	77402	rs61726468	NC_000017.11:44913275:C:G
NM_002055.5(GFAP):c.770A>G (p.Tyr257Cys)	GFAP	Y257C	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066504	17	42990647	17	44913279	66504	77401	rs267607505	NC_000017.11:44913278:T:C
NM_002055.5(GFAP):c.758C>G (p.Ala253Gly)	GFAP	A253G	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066502	17	42990659	17	44913291	66502	77399	rs61726470	NC_000017.11:44913290:G:C
NM_002055.5(GFAP):c.739T>C (p.Ser247Pro)	GFAP	S247P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066501	17	42990678	17	44913310	66501	77398	rs267607519	NC_000017.11:44913309:A:G
NM_002055.5(GFAP):c.731C>T (p.Ala244Val)	GFAP	A244V	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066500	17	42990686	17	44913318	66500	77397	rs61497286	NC_000017.11:44913317:G:A
NM_002055.5(GFAP):c.724T>G (p.Tyr242Asp)	GFAP	Y242D	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066499	17	42990693	17	44913325	66499	77396	rs60551555	NC_000017.11:44913324:A:C
NM_002055.5(GFAP):c.716G>T (p.Arg239Leu)	GFAP	R239L	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066498	17	42990701	17	44913333	66498	77395	rs59565950	NC_000017.11:44913332:C:A
NM_002055.5(GFAP):c.716G>C (p.Arg239Pro)	GFAP	R239P	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066497	17	42990701	17	44913333	66497	77394	rs59565950	NC_000017.11:44913332:C:G
NM_002055.5(GFAP):c.707A>C (p.Lys236Thr)	GFAP	K236T	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066496	17	42990710	17	44913342	66496	77393	rs267607525	NC_000017.11:44913341:T:G
NM_002055.5(GFAP):c.704T>C (p.Leu235Pro)	GFAP	L235P	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066495	17	42990713	17	44913345	66495	77392	rs60269890	NC_000017.11:44913344:A:G
NM_002055.5(GFAP):c.628G>A (p.Glu210Lys)	GFAP	E210K	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066493	17	42990789	17	44913421	66493	77390	rs57661783	NC_000017.11:44913420:C:T
NM_002055.5(GFAP):c.619G>C (p.Glu207Gln)	GFAP	E207Q	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066492	17	42990798	17	44913430	66492	77389	rs267607500	NC_000017.11:44913429:C:G
NM_002055.5(GFAP):c.619G>A (p.Glu207Lys)	GFAP	E207K	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066491	17	42990798	17	44913430	66491	77388	rs267607500	NC_000017.11:44913429:C:T
NM_002055.5(GFAP):c.613G>A (p.Glu205Lys)	GFAP	E205K	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066488	17	42991101	17	44913733	66488	77385	rs267607507	NC_000017.11:44913732:C:T
NM_002055.5(GFAP):c.382G>A (p.Asp128Asn)	GFAP	D128N	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066484	17	42992473	17	44915105	66484	77381	rs267607509	NC_000017.11:44915104:C:T
NM_002055.5(GFAP):c.302T>C (p.Leu101Pro)	GFAP	L101P	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066481	17	42992553	17	44915185	66481	77378	rs267607516	NC_000017.11:44915184:A:G
NM_002055.5(GFAP):c.290T>C (p.Leu97Pro)	GFAP	L97P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066480	17	42992565	17	44915197	66480	77377	rs59568967	NC_000017.11:44915196:A:G
NM_002055.5(GFAP):c.269T>C (p.Leu90Pro)	GFAP	L90P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066479	17	42992586	17	44915218	66479	77376	rs59661476	NC_000017.11:44915217:A:G
NM_002055.5(GFAP):c.260T>G (p.Val87Gly)	GFAP	V87G	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066478	17	42992595	17	44915227	66478	77375	rs60449251	NC_000017.11:44915226:A:C
NM_002055.5(GFAP):c.259G>C (p.Val87Leu)	GFAP	V87L	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066477	17	42992596	17	44915228	66477	77374	rs267607518	NC_000017.11:44915227:C:G
NM_002055.5(GFAP):c.256_259delinsGAGT (p.Lys86_Val87delinsGluPhe)	GFAP		Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066475	17	42992596 - 42992599	17	44915228 - 44915231	66475	77372	rs267607501	NC_000017.11:44915227:CCTT:ACTC
NM_002055.5(GFAP):c.247T>C (p.Tyr83His)	GFAP	Y83H	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066473	17	42992608	17	44915240	66473	77370	rs267607506	NC_000017.11:44915239:A:G
NM_002055.5(GFAP):c.236G>T (p.Arg79Leu)	GFAP	R79L	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066472	17	42992619	17	44915251	66472	77369	rs59285727	NC_000017.11:44915250:C:A
NM_002055.5(GFAP):c.236G>C (p.Arg79Pro)	GFAP	R79P	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066471	17	42992619	17	44915251	66471	77368	rs59285727	NC_000017.11:44915250:C:G
NM_002055.5(GFAP):c.235C>G (p.Arg79Gly)	GFAP	R79G	not provided|Alexander Disease	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000066470	17	42992620	17	44915252	66470	77367	rs59793293	NC_000017.11:44915251:G:C
NM_002055.5(GFAP):c.230A>G (p.Asn77Ser)	GFAP	N77S	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066468	17	42992625	17	44915257	66468	77365	rs57590980	NC_000017.11:44915256:T:C
NM_002055.5(GFAP):c.226C>G (p.Leu76Val)	GFAP	L76V	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066467	17	42992629	17	44915261	66467	77364	rs57120761	NC_000017.11:44915260:G:C
NM_002055.5(GFAP):c.221T>C (p.Met74Thr)	GFAP	M74T	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066466	17	42992634	17	44915266	66466	77363	rs267607504	NC_000017.11:44915265:A:G
NM_002055.5(GFAP):c.218T>G (p.Met73Arg)	GFAP	M73R	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066465	17	42992637	17	44915269	66465	77362	rs61060395	NC_000017.11:44915268:A:C
NM_002055.5(GFAP):c.218T>A (p.Met73Lys)	GFAP	M73K	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066464	17	42992637	17	44915269	66464	77361	rs61060395	NC_000017.11:44915268:A:T
NM_002055.5(GFAP):c.214G>A (p.Glu72Lys)	GFAP	E72K	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066463	17	42992641	17	44915273	66463	77360	rs267607523	NC_000017.11:44915272:C:T
NM_002055.5(GFAP):c.208C>T (p.Arg70Trp)	GFAP	R70W	not provided|Alexander Disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066460	17	42992647	17	44915279	66460	77357	rs60343255	NC_000017.11:44915278:G:A
NM_002055.5(GFAP):c.187A>C (p.Lys63Gln)	GFAP	K63Q	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066459	17	42992668	17	44915300	66459	77356	rs60095124	NC_000017.11:44915299:T:G
NM_002055.5(GFAP):c.1277A>T (p.Gln426Leu)	GFAP	Q426L, Q466L	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066456	17	42984737	17	44907369	66456	77353	rs267607521	NC_000017.11:44907368:T:A
NM_002055.5(GFAP):c.1250A>C (p.Asp417Ala)	GFAP	D417A, D457A	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066454	17	42985439	17	44908071	66454	77351	rs267607520	NC_000017.11:44908070:T:G
NM_002055.5(GFAP):c.1193C>A (p.Ser398Tyr)	GFAP	S398Y, S438Y	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066453	17	42985496	17	44908128	66453	77350	rs267607508	NC_000017.11:44908127:G:T
NM_002055.5(GFAP):c.1178G>T (p.Ser393Ile)	GFAP	S393I, S433I	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066452	17	42985511	17	44908143	66452	77349	rs62635764	NC_000017.11:44908142:C:A
NM_002055.5(GFAP):c.1157A>T (p.Asn386Ile)	GFAP	N386I	Alexander Disease|not provided	Pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000066448	17	42987997	17	44910629	66448	77345	rs61726471	NC_000017.11:44910628:T:A
NM_002055.5(GFAP):c.1148C>T (p.Thr383Ile)	GFAP	T383I	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066447	17	42988006	17	44910638	66447	77344	rs267607517	NC_000017.11:44910637:G:A
NM_002055.5(GFAP):c.1126C>T (p.Arg376Trp)	GFAP	R376W	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066443	17	42988605	17	44911237	66443	77340	rs267607512	NC_000017.11:44911236:G:A
NM_002055.5(GFAP):c.1121A>G (p.Glu374Gly)	GFAP	E374G	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066441	17	42988610	17	44911242	66441	77338	rs59628143	NC_000017.11:44911241:T:C
NM_002055.5(GFAP):c.1117G>C (p.Glu373Gln)	GFAP	E373Q	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066440	17	42988614	17	44911246	66440	77337	rs58075601	NC_000017.11:44911245:C:G
NM_002055.5(GFAP):c.1117G>A (p.Glu373Lys)	GFAP	E373K	Alexander Disease|not provided	Pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000066439	17	42988614	17	44911246	66439	77336	rs58075601	NC_000017.11:44911245:C:T
NM_002055.5(GFAP):c.1112A>T (p.Glu371Val)	GFAP	E371V	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066438	17	42988619	17	44911251	66438	77335	rs57815192	NC_000017.11:44911250:T:A
NM_002055.5(GFAP):c.1112A>G (p.Glu371Gly)	GFAP	E371G	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066437	17	42988619	17	44911251	66437	77334	rs57815192	NC_000017.11:44911250:T:C
NM_002055.5(GFAP):c.1111G>C (p.Glu371Gln)	GFAP	E371Q	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066436	17	42988620	17	44911252	66436	77333	rs267607526	NC_000017.11:44911251:C:G
NM_002055.5(GFAP):c.1097A>G (p.Tyr366Cys)	GFAP	Y366C	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066435	17	42988634	17	44911266	66435	77332	rs267607502	NC_000017.11:44911265:T:C
NM_002055.5(GFAP):c.1096T>C (p.Tyr366His)	GFAP	Y366H	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066434	17	42988635	17	44911267	66434	77331	rs58008462	NC_000017.11:44911266:A:G
NM_002055.5(GFAP):c.1091C>T (p.Ala364Val)	GFAP	A364V	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066433	17	42988640	17	44911272	66433	77330	rs267607503	NC_000017.11:44911271:G:A
NM_002055.5(GFAP):c.1090G>C (p.Ala364Pro)	GFAP	A364P	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066432	17	42988641	17	44911273	66432	77329	rs58645997	NC_000017.11:44911272:C:G
NM_002055.5(GFAP):c.1079A>T (p.Asp360Val)	GFAP	D360V	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066431	17	42988652	17	44911284	66431	77328	rs62636501	NC_000017.11:44911283:T:A
NM_002055.5(GFAP):c.1076T>C (p.Leu359Pro)	GFAP	L359P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066430	17	42988655	17	44911287	66430	77327	rs267607511	NC_000017.11:44911286:A:G
NM_002055.5(GFAP):c.1075C>G (p.Leu359Val)	GFAP	L359V	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066429	17	42988656	17	44911288	66429	77326	rs60825166	NC_000017.11:44911287:G:C
NM_002055.5(GFAP):c.1070T>C (p.Leu357Pro)	GFAP	L357P	Alexander Disease|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066428	17	42988661	17	44911293	66428	77325	rs267607515	NC_000017.11:44911292:A:G
NM_006785.4(MALT1):c.266G>T (p.Ser89Ile)	MALT1	S89I	Immunodeficiency 12	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000066089	18	56348458	18	58681226	66089	76991	rs398123058	NC_000018.10:58681225:G:T
NM_001015878.2(AURKC):c.436-2A>G	AURKC		Infertility associated with multi-tailed spermatozoa and excessive DNA	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000066088	19	57744826	19	57233458	66088	76990	rs397515484	NC_000019.10:57233457:A:G
SHOX, 47.5-KB DEL, DOWNSTREAM ENHANCER	SHOX		Short stature, idiopathic, X-linked|	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000066087					66087	76989		
NM_006397.2(RNASEH2A):c.69G>A (p.Val23=)	RNASEH2A	V23V	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Nov 22, 2016)	no assertion criteria provided	VCV000066067	19	12917556	19	12806742	66067	76971	rs397515480	NC_000019.10:12806741:G:A
NM_006397.2(RNASEH2A):c.704G>A (p.Arg235Gln)	RNASEH2A	R235Q, R236Q	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000066066	19	12923963	19	12813149	66066	76970	rs75718910	NC_000019.10:12813148:G:A
NM_006397.2(RNASEH2A):c.75C>T (p.Arg25=)	RNASEH2A	R25R	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Nov 22, 2016)	no assertion criteria provided	VCV000066065	19	12917562	19	12806748	66065	76969	rs397515479	NC_000019.10:12806747:C:T
NM_003868.3(FGF16):c.470C>A (p.Ser157Ter)	FGF16	S157*	Metacarpal 4-5 fusion	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066060	X	76711859	X	77456368	66060	76964	rs587777051	NC_000023.11:77456367:C:A
NM_003868.3(FGF16):c.535C>T (p.Arg179Ter)	FGF16	R179*	Metacarpal 4-5 fusion	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000066059	X	76711924	X	77456433	66059	76963	rs587777050	NC_000023.11:77456432:C:T
NM_017950.4(CCDC40):c.2824_2825insTGT (p.Arg942delinsMetTrp)	CCDC40		Ciliary dyskinesia, primary, 15	Pathogenic(Last reviewed: Sep 15, 2011)	no assertion criteria provided	VCV000065930	17	78063675 - 78063676	17	80089876 - 80089877	65930	76838	rs587778819	NC_000017.11:80089876::TGT
NM_152296.5(ATP1A3):c.2051C>T (p.Ser684Phe)	ATP1A3	S684F, S695F, S697F	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000065759	19	42480611	19	41976459	65759	76667	rs397515577	NC_000019.10:41976458:G:A
NM_023036.6(DNAI2):c.1494+1G>C	DNAI2		Kartagener syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000065721	17	72306303	17	74310164	65721	76629	rs397515565	NC_000017.11:74310163:G:C
NM_005629.4(SLC6A8):c.1661C>T (p.Pro554Leu)	SLC6A8	P554L, P544L, P439L	Creatine transporter deficiency	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000065693	X	152960238	X	153694783	65693	76601	rs397515559	NC_000023.11:153694782:C:T
NM_005629.4(SLC6A8):c.1631C>T (p.Pro544Leu)	SLC6A8	P544L, P429L, P534L	Creatine transporter deficiency	Pathogenic(Last reviewed: Aug 18, 2011)	no assertion criteria provided	VCV000065692	X	152960208	X	153694753	65692	76600	rs397515558	NC_000023.11:153694752:C:T
NM_005120.3(MED12):c.2873G>A (p.Gly958Glu)	MED12	G958E	FG syndrome 1	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000065683	X	70347209	X	71127359	65683	76591	rs397515554	NC_000023.11:71127358:G:A
NM_004595.5(SMS):c.443A>G (p.Gln148Arg)	SMS	Q148R, Q95R	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065679	X	21995292	X	21977174	65679	76587	rs397515551	NC_000023.11:21977173:A:G
NM_004595.5(SMS):c.200G>A (p.Gly67Glu)	SMS	G67E	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000065677	X	21990044	X	21971926	65677	76585	rs397515550	NC_000023.11:21971925:G:A
NM_004595.5(SMS):c.174T>A (p.Phe58Leu)	SMS	F58L	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jan 30, 2020)	no assertion criteria provided	VCV000065676	X	21990018	X	21971900	65676	76584	rs397515549	NC_000023.11:21971899:T:A
NM_000554.6(CRX):c.529del (p.Ala177fs)	CRX	A177fs	Leber congenital amaurosis 7|not provided	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000065614	19	48342851	19	47839594	65614	76522	rs61748449	NC_000019.10:47839593:GGG:GG
NM_000095.3(COMP):c.2153G>C (p.Arg718Pro)	COMP	R718P	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000065557	19	18893938	19	18783128	65557	76465	rs149551600	NC_000019.10:18783127:C:G
NM_000095.3(COMP):c.2042C>G (p.Ser681Cys)	COMP	S681C	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000065556	19	18895046	19	18784236	65556	76464	rs397515513	NC_000019.10:18784235:G:C
NM_000095.3(COMP):c.1813G>A (p.Asp605Asn)	COMP	D605N	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000065555	19	18895807	19	18784997	65555	76463	rs397515512	NC_000019.10:18784996:C:T
NM_000095.3(COMP):c.1665C>A (p.Asn555Lys)	COMP	N555K	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000065554	19	18896486	19	18785676	65554	76462	rs397515511	NC_000019.10:18785675:G:T
NM_000095.3(COMP):c.1156_1158del (p.Asn386del)	COMP	N386del	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000065553	19	18897438 - 18897440	19	18786628 - 18786630	65553	76461	rs397515510	NC_000019.10:18786627:GTTGT:GT
NM_130445.2(COL18A1):c.2118dupC (p.Gly707Argfs)	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Apr 5, 2015)	criteria provided, single submitter	VCV000065411	21	46911182 - 46911183	21	45491268 - 45491269	65411	76341	rs775168204	NC_000021.9:45491268:CCCCCCC:CCCCCCCC
NM_002351.4(SH2D1A):c.137+5G>C	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000065388	X	123480634	X	124346784	65388	76322	rs587777612	NC_000023.11:124346783:G:C
nsv1067900	PLCB4		Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064696	20	9388282 - 9393278	20	9407635 - 9412631	64696	75625		
NM_001172646.1(PLCB4):c.1079A>T (p.Asp360Val)	PLCB4	D360V	Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064695	20	9368124	20	9387477	64695	75624	rs397514771	NC_000020.11:9387476:A:T
NM_001172646.1(PLCB4):c.1078G>A (p.Asp360Asn)	PLCB4	D360N	Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064694	20	9368123	20	9387476	64694	75623	rs397514770	NC_000020.11:9387475:G:A
NM_001172646.1(PLCB4):c.1073A>T (p.Glu358Val)	PLCB4	E358V	Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064693	20	9368118	20	9387471	64693	75622	rs397514769	NC_000020.11:9387470:A:T
NM_001172646.1(PLCB4):c.1898G>T (p.Arg633Leu)	PLCB4	R621L, R633L	Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000064692	20	9389727	20	9409080	64692	75621	rs397514481	NC_000020.11:9409079:G:T
NM_001037.5(SCN1B):c.254G>A (p.Arg85His)	SCN1B	R85H, R52H	Brugada syndrome 5|Generalized epilepsy with febrile seizures plus, type 1|Atrial fibrillation, familial, 13|Brugada syndrome 5|Epileptic encephalopathy, early infantile, 52|not provided|Atrial fibrillation, familial, 13	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060767	19	35524449	19	35033545	60767	75309	rs16969925	NC_000019.10:35033544:G:A
NM_001005360.2(DNM2):c.1135T>G (p.Phe379Val)	DNM2	F379V	Lethal congenital contracture syndrome 5	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000060688	19	10906054	19	10795378	60688	75262	rs397514735	NC_000019.10:10795377:T:G
NM_000032.5(ALAS2):c.1651_1676del (p.Ser551fs)	ALAS2	S538fs, S514fs, S551fs	Protoporphyria, erythropoietic, X-linked	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060674	X	55035701 - 55035726	X	55009268 - 55009293	60674	75249	rs879255567	NC_000023.11:55009267:CGACAGAAATTGCAGGCAGCCACAGAC:C
NM_000032.5(ALAS2):c.1642C>T (p.Gln548Ter)	ALAS2	Q548*, Q535*, Q511*	Protoporphyria, erythropoietic, X-linked	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000060673	X	55035735	X	55009302	60673	75248	rs397514730	NC_000023.11:55009301:G:A
NM_002067.5(GNA11):c.632C>G (p.Ser211Trp)	GNA11	S211W	Hypocalcemia, autosomal dominant 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000060666	19	3118948	19	3118950	60666	75241	rs587777022	NC_000019.10:3118949:C:G
NM_002067.5(GNA11):c.178C>T (p.Arg60Cys)	GNA11	R60C	Hypocalcemia, autosomal dominant 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000060665	19	3110188	19	3110190	60665	75240	rs587777021	NC_000019.10:3110189:C:T
NM_002067.5(GNA11):c.1023C>G (p.Phe341Leu)	GNA11	F341L	Hypocalcemia, autosomal dominant 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000060664	19	3121120	19	3121122	60664	75239	rs140749796	NC_000019.10:3121121:C:G
NM_002067.5(GNA11):c.542G>A (p.Arg181Gln)	GNA11	R181Q	Hypocalcemia, autosomal dominant 2	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000060663	19	3115007	19	3115009	60663	75238	rs587777020	NC_000019.10:3115008:G:A
NM_002067.5(GNA11):c.404T>A (p.Leu135Gln)	GNA11	L135Q	Hypocalciuric hypercalcemia, familial, type II	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000060662	19	3113410	19	3113412	60662	75237	rs587777019	NC_000019.10:3113411:T:A
NM_002067.5(GNA11):c.595_597ATC[1] (p.Ile200del)	GNA11	I200del	Hypocalciuric hypercalcemia, familial, type II	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000060661	19	3115059 - 3115061	19	3115061 - 3115063	60661	75236	rs672601249	NC_000019.10:3115060:CATCATC:CATC
GRCh38/hg38 Xp21.1(chrX:31745624-31876916)x1	DMD		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059260	X	31763741 - 31895033	X	31745624 - 31876916	59260	73855		
GRCh38/hg38 Xp21.1(chrX:31632068-31954142)x0	DMD		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059256	X	31650185 - 31972259	X	31632068 - 31954142	59256	73851		
GRCh38/hg38 Xp21.3-21.2(chrX:29128906-29515069)x1	IL1RAPL1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059242	X	29147023 - 29533186	X	29128906 - 29515069	59242	73837		
GRCh38/hg38 Xp22.11(chrX:22099135-22109767)x0	PHEX		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059240	X	22117253 - 22127885	X	22099135 - 22109767	59240	73835		
GRCh38/hg38 Xq26.2(chrX:133474724-133869312)x2	GPC3		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058685	X	132608752 - 133003339	X	133474724 - 133869312	58685	73280		
GRCh38/hg38 Xp21.1(chrX:32662366-32758964)x2	DMD		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058614	X	32680483 - 32777081	X	32662366 - 32758964	58614	73209		
GRCh38/hg38 Xp21.2-21.1(chrX:31444405-31806767)x3	DMD		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058613	X	31462522 - 31824884	X	31444405 - 31806767	58613	73208		
GRCh38/hg38 Xp21.2(chrX:29713271-29740951)x3	IL1RAPL1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058612	X	29731388 - 29759068	X	29713271 - 29740951	58612	73207		
GRCh38/hg38 Xp21.3(chrX:28759823-29094411)x2	IL1RAPL1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058611	X	28777940 - 29112528	X	28759823 - 29094411	58611	73206		
GRCh38/hg38 Xp22.2(chrX:11104475-11121622)x3	HCCS		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058591	X	11122595 - 11139742	X	11104475 - 11121622	58591	73186		
GRCh38/hg38 Xp22.2(chrX:10759076-11065570)x2	MID1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058590	X	10727116 - 11083690	X	10759076 - 11065570	58590	73185		
GRCh38/hg38 Xq21.33-22.1(chrX:97610521-100562572)x1	PCDH19		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057970	X	96865520 - 99817569	X	97610521 - 100562572	57970	72565		
GRCh38/hg38 Xq21.1(chrX:77490616-77524711)x1	ATRX		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057925	X	76746094 - 76780189	X	77490616 - 77524711	57925	72520		
GRCh38/hg38 22q12.3(chr22:33757753-33862859)x1	LARGE1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057628	22	34153740 - 34258847	22	33757753 - 33862859	57628	72223		
GRCh38/hg38 22q12.3(chr22:33754145-33786313)x1	LARGE1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057627	22	34150132 - 34182300	22	33754145 - 33786313	57627	72222		
GRCh38/hg38 Xq27.3(chrX:147933767-147951004)x0	FMR1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057461	X	3458159 - 3475397	X	147933767 - 147951004	57461	72056		
NM_015352.2(POFUT1):c.482del (p.Lys161fs)	POFUT1	K161fs	Dowling-Degos disease 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000056809	20	30804463	20	32216660	56809	71436	rs886041033	NC_000020.11:32216659:AA:A
NM_015352.2(POFUT1):c.430G>T (p.Glu144Ter)	POFUT1	E144*	Dowling-Degos disease 2	Pathogenic(Last reviewed: Jun 6, 2013)	no assertion criteria provided	VCV000056808	20	30804412	20	32216609	56808	71435	rs398123038	NC_000020.11:32216608:G:T
NM_001165927.1(MKS1):c.485+1G>A	MKS1		Meckel syndrome type 1|Joubert syndrome 28|Bardet-Biedl syndrome 13|Meckel syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056624	17	56292101	17	58214740	56624	71263	rs201933838	NC_000017.11:58214739:C:T
NM_001165927.1(MKS1):c.442C>T (p.Arg148Ter)	MKS1	R148*, R158*	Meckel syndrome type 1|not provided	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000056623	17	56292145	17	58214784	56623	71262	rs386834050	NC_000017.11:58214783:G:A
NM_001165927.1(MKS1):c.1420_1423dup (p.Thr475fs)	MKS1		Meckel syndrome type 1|MKS1-Related Disorders|Joubert syndrome|Meckel-Gruber syndrome|Bardet-Biedl syndrome 13|Joubert syndrome|Joubert syndrome 28	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056617	17	56283862 - 56283863	17	58206501 - 58206502	56617	71256	rs386834044	NC_000017.11:58206501:TGCCTG:TGCCTGCCTG
NM_015294.6(TRIM37):c.2212del (p.Glu738fs)	TRIM37	E616fs, E721fs, E493fs, E584fs, E704fs, E738fs	Mulibrey nanism syndrome	Pathogenic	no assertion criteria provided	VCV000056568	17	57105821	17	59028460	56568	71207	rs386833416	NC_000017.11:59028459:CC:C
NM_015294.6(TRIM37):c.1411C>T (p.Arg471Ter)	TRIM37	R471*, R226*, R317*, R454*, R349*, R437*	Mulibrey nanism syndrome|not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000056565	17	57126658	17	59049297	56565	71204	rs386834001	NC_000017.11:59049296:G:A
NM_004646.3(NPHS1):c.808G>T (p.Gly270Cys)	NPHS1	G270C	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2017)	no assertion criteria provided	VCV000056523	19	36340170	19	35849268	56523	71162	rs386833961	NC_000019.10:35849267:C:A
NM_004646.3(NPHS1):c.736G>T (p.Glu246Ter)	NPHS1	E246*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000056521	19	36340242	19	35849340	56521	71160	rs386833959	NC_000019.10:35849339:C:A
NM_004646.3(NPHS1):c.614_621delinsTT (p.Thr205_Arg207delinsIle)	NPHS1		not provided|Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056518	19	36340543 - 36340550	19	35849641 - 35849648	56518	71157	rs1555763603	NC_000019.10:35849640:CCGGGGTG:AA
NM_004646.3(NPHS1):c.609-2A>C	NPHS1		not provided|Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056517	19	36340557	19	35849655	56517	71156	rs386833955	NC_000019.10:35849654:T:G
NM_004646.3(NPHS1):c.574C>T (p.Gln192Ter)	NPHS1	Q192*	Finnish congenital nephrotic syndrome|not provided	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000056515	19	36341300	19	35850398	56515	71154	rs386833953	NC_000019.10:35850397:G:A
NM_004646.3(NPHS1):c.534del (p.Thr179fs)	NPHS1	T179fs	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056514	19	36341340	19	35850438	56514	71153	rs386833952	NC_000019.10:35850437:C:
NM_004646.3(NPHS1):c.532C>T (p.Gln178Ter)	NPHS1	Q178*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000056513	19	36341342	19	35850440	56513	71152	rs386833951	NC_000019.10:35850439:G:A
NM_004646.3(NPHS1):c.515_517del (p.Thr172del)	NPHS1	T172del	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056509	19	36341872 - 36341874	19	35850970 - 35850972	56509	71148	rs386833947	NC_000019.10:35850969:TGGTG:TG
NM_004646.3(NPHS1):c.468C>G (p.Tyr156Ter)	NPHS1	Y156*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Nov 23, 2015)	criteria provided, single submitter	VCV000056505	19	36341921	19	35851019	56505	71144	rs386833943	NC_000019.10:35851018:G:C
NM_004646.3(NPHS1):c.3250dup (p.Val1084fs)	NPHS1		not provided|Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056497	19	36322580 - 36322581	19	35831678 - 35831679	56497	71136	rs386833935	NC_000019.10:35831678:CCCCCCC:CCCCCCCC
NM_004646.3(NPHS1):c.3250del (p.Val1084fs)	NPHS1	V1084fs	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000056496	19	36322581	19	35831679	56496	71135	rs386833935	NC_000019.10:35831678:CCCCCCC:CCCCCC
NM_004646.3(NPHS1):c.2606_2607dup (p.Asn870fs)	NPHS1		Finnish congenital nephrotic syndrome	Pathogenic	criteria provided, single submitter	VCV000056482	19	36333081 - 36333082	19	35842179 - 35842180	56482	71121	rs386833921	NC_000019.10:35842179:GGGG:GGGGGG
NM_004646.3(NPHS1):c.2515del (p.Gln839fs)	NPHS1	Q839fs	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000056479	19	36333174	19	35842272	56479	71118	rs386833918	NC_000019.10:35842271:GGGGGG:GGGGG
NM_004646.3(NPHS1):c.2417C>A (p.Ala806Asp)	NPHS1	A806D	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056473	19	36333370	19	35842468	56473	71112	rs386833912	NC_000019.10:35842467:G:T
NM_004646.3(NPHS1):c.1928T>C (p.Leu643Pro)	NPHS1	L643P	Finnish congenital nephrotic syndrome|Congenital nephrotic syndrome	Pathogenic/Likely pathogenic	no assertion criteria provided	VCV000056456	19	36336272	19	35845370	56456	71095	rs386833898	NC_000019.10:35845369:A:G
NM_004646.3(NPHS1):c.1868G>T (p.Cys623Phe)	NPHS1	C623F	not provided|Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000056453	19	36336332	19	35845430	56453	71092	rs386833895	NC_000019.10:35845429:C:A
NM_004646.3(NPHS1):c.1758-8_1785del	NPHS1		Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000056449	19	36336415 - 36336450	19	35845513 - 35845548	56449	71088	rs386833891	NC_000019.10:35845512:CCGGGGTGGGGCGGCCACGCCCTCCAGCCTGTGGAACCGGGGT:CCGGGGT
NM_004646.3(NPHS1):c.1715G>A (p.Ser572Asn)	NPHS1	S572N	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056447	19	36336613	19	35845711	56447	71086	rs386833889	NC_000019.10:35845710:C:T
NM_004646.3(NPHS1):c.1701C>A (p.Cys567Ter)	NPHS1	C567*	not provided|Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056445	19	36336627	19	35845725	56445	71084	rs386833887	NC_000019.10:35845724:G:T
NM_004646.3(NPHS1):c.1481del (p.Ser494fs)	NPHS1	S494fs	Finnish congenital nephrotic syndrome|not provided	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000056441	19	36337056	19	35846154	56441	71080	rs386833883	NC_000019.10:35846153:G:
NM_004646.3(NPHS1):c.139del (p.Ala47fs)	NPHS1	A47fs	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056440	19	36342494	19	35851592	56440	71079	rs386833882	NC_000019.10:35851591:CCCCC:CCCC
NM_004646.3(NPHS1):c.1379G>A (p.Arg460Gln)	NPHS1	R460Q	Finnish congenital nephrotic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000056438	19	36339004	19	35848102	56438	71077	rs386833880	NC_000019.10:35848101:C:T
NM_004646.3(NPHS1):c.121_122del (p.Leu41fs)	NPHS1	L41fs	not provided|Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056431	19	36342511 - 36342512	19	35851609 - 35851610	56431	71070	rs386833873	NC_000019.10:35851608:AG:
NM_004646.3(NPHS1):c.1099C>T (p.Arg367Cys)	NPHS1	R367C	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000056421	19	36339610	19	35848708	56421	71060	rs386833865	NC_000019.10:35848707:G:A
NM_004646.3(NPHS1):c.1096A>C (p.Ser366Arg)	NPHS1	S366R	not provided|Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000056420	19	36339613	19	35848711	56420	71059	rs386833864	NC_000019.10:35848710:T:G
NM_004646.3(NPHS1):c.1048T>C (p.Ser350Pro)	NPHS1	S350P	Finnish congenital nephrotic syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000056419	19	36339661	19	35848759	56419	71058	rs386833863	NC_000019.10:35848758:A:G
NM_003332.3(TYROBP):c.141del (p.Met48fs)	TYROBP	M37fs, M48fs	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000056395	19	36398436	19	35907534	56395	71034	rs386833840	NC_000019.10:35907533:C:
NM_000390.4(CHM):c.1609+2dup	CHM		Choroideremia	Pathogenic(Last reviewed: Feb 26, 2015)	no assertion criteria provided	VCV000056224	X	85133967 - 85133968	X	85878962 - 85878963	56224	70863	rs386833676	NC_000023.11:85878962:A:AA
NM_000383.4(AIRE):c.1163_1164insA (p.Met388fs)	AIRE		Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000056221	21	45712943 - 45712944	21	44293060 - 44293061	56221	70860	rs386833672	NC_000021.9:44293060::A
NM_000100.3(CSTB):c.66G>A (p.Gln22=)	CSTB		Unverricht-Lundborg syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000055961	21	45196085	21	43776204	55961	70600	rs386833443	NC_000021.9:43776203:C:T
NM_000100.3(CSTB):c.214_215TC[2] (p.Leu73fs)	CSTB		Unverricht-Lundborg syndrome|Inborn genetic diseases|Progressive myoclonic epilepsy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000055960	21	45194161 - 45194162	21	43774280 - 43774281	55960	70599	rs796943858	NC_000021.9:43774279:GAGAGA:GAGA
NM_000100.3(CSTB):c.169-2A>G	CSTB		Unverricht-Lundborg syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000055959	21	45194213	21	43774332	55959	70598	rs386833441	NC_000021.9:43774331:T:C
NM_000100.3(CSTB):c.168G>A (p.Lys56=)	CSTB		Unverricht-Lundborg syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000055958	21	45194539	21	43774658	55958	70597	rs386833440	NC_000021.9:43774657:C:T
NM_000100.3(CSTB):c.125C>A (p.Ser42Ter)	CSTB	S42*	Unverricht-Lundborg syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000055957	21	45194582	21	43774701	55957	70596	rs386833439	NC_000021.9:43774700:G:T
NM_006494.4(ERF):c.1270C>T (p.Gln424Ter)	ERF	Q424*, Q349*	Craniosynostosis 4	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055927	19	42752994	19	42248842	55927	70569	rs587777010	NC_000019.10:42248841:G:A
NM_006494.4(ERF):c.194G>A (p.Arg65Gln)	ERF	R65Q	Craniosynostosis 4	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055926	19	42754546	19	42250394	55926	70568	rs587777009	NC_000019.10:42250393:C:T
NM_006494.4(ERF):c.256C>T (p.Arg86Cys)	ERF	R86C, R11C	Craniosynostosis 1|not provided|Craniosynostosis 4	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000055925	19	42754484	19	42250332	55925	70567	rs587777008	NC_000019.10:42250331:G:A
NM_006494.4(ERF):c.547C>T (p.Arg183Ter)	ERF	R183*, R108*	Craniosynostosis 1|Craniosynostosis 4|Chitayat syndrome|Craniosynostosis 4	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000055923	19	42753717	19	42249565	55923	70565	rs587777006	NC_000019.10:42249564:G:A
NM_001142730.3(KCTD1):c.2009G>A (p.Gly670Asp)	KCTD1	G62D, G670D, G70D		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055888	18	24056603	18	26476639	55888	70536	rs587777003	NC_000018.10:26476638:C:T
NM_001142730.3(KCTD1):c.2045A>C (p.His682Pro)	KCTD1	H74P, H682P, H82P		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055887	18	24056567	18	26476603	55887	70535	rs587777002	NC_000018.10:26476602:T:G
NM_001142730.3(KCTD1):c.1922A>C (p.His641Pro)	KCTD1	H33P, H41P, H641P		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055886	18	24081102	18	26501138	55886	70534	rs587777001	NC_000018.10:26501137:T:G
NM_001142730.3(KCTD1):c.1923C>A (p.His641Gln)	KCTD1	H33Q, H41Q, H641Q		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055885	18	24081101	18	26501137	55885	70533	rs587777000	NC_000018.10:26501136:G:T
NM_001142730.3(KCTD1):c.1916C>A (p.Pro639His)	KCTD1	P31H, P39H, P639H		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055884	18	24081108	18	26501144	55884	70532	rs587776999	NC_000018.10:26501143:G:T
NM_001142730.3(KCTD1):c.1916C>T (p.Pro639Leu)	KCTD1	P31L, P639L, P39L		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055883	18	24081108	18	26501144	55883	70531	rs587776999	NC_000018.10:26501143:G:A
NM_001142730.3(KCTD1):c.1916C>G (p.Pro639Arg)	KCTD1	P31R, P639R, P39R		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055882	18	24081108	18	26501144	55882	70530	rs587776999	NC_000018.10:26501143:G:C
NM_001142730.3(KCTD1):c.1913C>A (p.Ala638Glu)	KCTD1	A30E, A638E, A38E		Pathogenic(Last reviewed: Jan 29, 2014)	no assertion criteria provided	VCV000055881	18	24081111	18	26501147	55881	70529	rs587776998	NC_000018.10:26501146:G:T
NM_000475.5(NR0B1):c.1274G>T (p.Arg425Ile)	NR0B1	R425I	Congenital adrenal hypoplasia, X-linked	Pathogenic	no assertion criteria provided	VCV000055874	X	30322835	X	30304718	55874	70525	rs387907373	NC_000023.11:30304717:C:A
NM_006012.4(CLPP):c.270+4A>G	CLPP		Autosomal recessive hearing impairment with normal menstrual cycles|Perrault syndrome 3	Pathogenic(Last reviewed: Jun 17, 2013)	no assertion criteria provided	VCV000055870	19	6361955	19	6361944	55870	70521	rs398123035	NC_000019.10:6361943:A:G
NM_006012.4(CLPP):c.440G>C (p.Cys147Ser)	CLPP	C147S	Perrault syndrome 3	Pathogenic(Last reviewed: Jun 17, 2013)	no assertion criteria provided	VCV000055869	19	6364535	19	6364524	55869	70520	rs398123034	NC_000019.10:6364523:G:C
NM_006012.4(CLPP):c.433A>C (p.Thr145Pro)	CLPP	T145P	Perrault syndrome 3	Pathogenic(Last reviewed: Jun 17, 2013)	no assertion criteria provided	VCV000055868	19	6364528	19	6364517	55868	70519	rs398123033	NC_000019.10:6364516:A:C
NM_020812.4(DOCK6):c.2520dup (p.Arg841fs)	DOCK6		Adams-Oliver syndrome 2	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000055814	19	11346307 - 11346308	19	11235631 - 11235632	55814	70470	rs397509398	NC_000019.10:11235631:AAA:AAAA
NM_002972.4(SBF1):c.1249A>G (p.Met417Val)	SBF1	M417V, M418V	Charcot-Marie-Tooth disease, type 4B3	Pathogenic(Last reviewed: Jul 9, 2013)	no assertion criteria provided	VCV000051005	22	50903513	22	50465084	51005	65676	rs587776986	NC_000022.11:50465083:T:C
NM_006087.4(TUBB4A):c.745G>A (p.Asp249Asn)	TUBB4A	D249N, D300N, D177N, D294N	not provided|Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000050985	19	6495765	19	6495754	50985	65656	rs483352809	NC_000019.10:6495753:C:T
NM_006087.4(TUBB4A):c.4C>G (p.Arg2Gly)	TUBB4A	R2G, R53G, R47G	Autosomal dominant torsion dystonia 4|Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000050984	19	6502220	19	6502209	50984	65655	rs587776983	NC_000019.10:6502208:G:C
NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	ZC4H2	R213W, R190W	Wieacker Wolff syndrome	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050983	X	64137701	X	64917821	50983	65654	rs879255236	NC_000023.11:64917820:G:A
NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	ZC4H2	P201S, P178S	Wieacker Wolff syndrome	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050982	X	64137737	X	64917857	50982	65653	rs398122939	NC_000023.11:64917856:G:A
NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	ZC4H2	R198Q, R175Q, G144R	not provided|Wieacker Wolff syndrome	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000050981	X	64137745	X	64917865	50981	65652	rs879255235	NC_000023.11:64917864:C:T
NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	ZC4H2	V63L, V40L	Wieacker Wolff syndrome	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050980	X	64141735	X	64921855	50980	65651	rs398122938	NC_000023.11:64921854:C:G
NM_001130823.3(DNMT1):c.1814G>C (p.Gly605Ala)	DNMT1	G605A, G484A, G589A	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	Pathogenic(Last reviewed: May 15, 2012)	no assertion criteria provided	VCV000050921	19	10265280	19	10154604	50921	65580	rs397509393	NC_000019.10:10154603:C:G
NM_001130823.3(DNMT1):c.1709C>T (p.Ala570Val)	DNMT1	A570V, A554V, A449V	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	Pathogenic(Last reviewed: May 15, 2012)	no assertion criteria provided	VCV000050920	19	10265385	19	10154709	50920	65579	rs397509392	NC_000019.10:10154708:G:A
NM_001130823.3(DNMT1):c.1816G>T (p.Val606Phe)	DNMT1	V606F, V485F, V590F	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	Pathogenic(Last reviewed: May 15, 2012)	no assertion criteria provided	VCV000050919	19	10265278	19	10154602	50919	65578	rs397509391	NC_000019.10:10154601:C:A
NM_001242897.2(DEPDC5):c.982C>T (p.Arg328Ter)	DEPDC5	R328*, R300*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000050825	22	32198725	22	31802739	50825	59815	rs587776977	NC_000022.11:31802738:C:T
NM_001242897.2(DEPDC5):c.715C>T (p.Arg239Ter)	DEPDC5	R239*, R211*	Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000050824	22	32188751	22	31792765	50824	59814	rs587776976	NC_000022.11:31792764:C:T
NM_001242897.2(DEPDC5):c.1122del (p.Leu374fs)	DEPDC5	L374fs, L346fs	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000050823	22	32200188	22	31804202	50823	59813	rs879255234	NC_000022.11:31804201:A:
NM_001242897.2(DEPDC5):c.3807G>A (p.Trp1269Ter)	DEPDC5	W1369*, W1269*, W1338*, W1341*, W1347*, W1360*, W1291*	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 19, 2015)	no assertion criteria provided	VCV000050822	22	32289641	22	31893655	50822	59812	rs587776975	NC_000022.11:31893654:G:A
NM_001242897.2(DEPDC5):c.489_491del (p.Phe164del)	DEPDC5	F164del, F136del	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000050821	22	32179897 - 32179899	22	31783911 - 31783913	50821	59811	rs587776974	NC_000022.11:31783910:TGTT:T
NM_001242897.2(DEPDC5):c.1663C>T (p.Arg555Ter)	DEPDC5	R555*, R527*	Seizures|Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000050820	22	32211195	22	31815209	50820	59810	rs587776973	NC_000022.11:31815208:C:T
NM_001242897.2(DEPDC5):c.21C>G (p.Tyr7Ter)	DEPDC5	Y7*	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000050819	22	32150928	22	31754942	50819	59809	rs768241563	NC_000022.11:31754941:C:G
NM_004309.6(ARHGDIA):c.547_549GAC[2] (p.Asp185del)	ARHGDIA	D185del	Nephrotic syndrome, type 8	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050501	17	79826812 - 79826814	17	81868936 - 81868938	50501	59540	rs587776969	NC_000017.11:81868935:GTCGTCGTC:GTCGTC
NM_005660.3(SLC35A2):c.3G>A (p.Met1Ile)	SLC35A2	M1I	SLC35A2-CDG	Pathogenic(Last reviewed: Nov 14, 2013)	no assertion criteria provided	VCV000050365	X	48768911	X	48911634	50365	59490	rs587776962	NC_000023.11:48911633:C:T
SLC35A2:c.15_91+48delinsA	SLC35A2		SLC35A2-CDG	Pathogenic(Last reviewed: Nov 14, 2013)	no assertion criteria provided	VCV000050363	X	48768775 - 48768899	X	48911498 - 48911622	50363	59488	rs1557044030	
NM_139062.4(CSNK1D):c.137A>G (p.His46Arg)	CSNK1D	H46R	Advanced sleep phase syndrome, familial, 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050319	17	80223612	17	82265736	50319	59460	rs397514693	NC_000017.11:82265735:T:C
NM_004782.4(SNAP29):c.487dup (p.Ser163fs)	SNAP29		not provided|	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000050295	22	21235388 - 21235389	22	20881100 - 20881101	50295	59436	rs387907363	NC_000022.11:20881100:A:AA
NM_005120.3(MED12):c.5185C>A (p.His1729Asn)	MED12	H1729N	Ohdo syndrome, X-linked	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000050281	X	70356290	X	71136440	50281	59422	rs387907362	NC_000023.11:71136439:C:A
NM_005120.3(MED12):c.3493T>C (p.Ser1165Pro)	MED12	S1165P	Ohdo syndrome, X-linked	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000050280	X	70348981	X	71129131	50280	59421	rs387907361	NC_000023.11:71129130:T:C
NM_005120.3(MED12):c.3443G>A (p.Arg1148His)	MED12	R1148H	Ohdo syndrome, X-linked	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000050279	X	70348536	X	71128686	50279	59420	rs387907360	NC_000023.11:71128685:G:A
NM_024422.6(DSC2):c.846C>G (p.Tyr282Ter)	DSC2	Y282*	Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000046199	18	28666635	18	31086672	46199	55364	rs397517406	NC_000018.10:31086671:G:C
NM_024022.3(TMPRSS3):c.916G>A (p.Ala306Thr)	TMPRSS3	A306T, A179T	not provided|Deafness, autosomal recessive 8|Rare genetic deafness	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000046131	21	43802210	21	42382101	46131	55296	rs181949335	NC_000021.9:42382100:C:T
NM_024022.3(TMPRSS3):c.413C>A (p.Ala138Glu)	TMPRSS3	A138E, A11E	not provided|Deafness, autosomal recessive 8|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000046119	21	43808545	21	42388436	46119	55284	rs147231991	NC_000021.9:42388435:G:T
NM_024022.3(TMPRSS3):c.323-6G>A	TMPRSS3		Rare genetic deafness	Pathogenic(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	VCV000046113	21	43808641	21	42388532	46113	55278	rs374793617	NC_000021.9:42388531:C:T
NM_024022.3(TMPRSS3):c.1276G>A (p.Ala426Thr)	TMPRSS3	A426T, A299T, A425T	not provided|Deafness, autosomal recessive 8|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000046102	21	43795896	21	42375787	46102	55267	rs56264519	NC_000021.9:42375786:C:T
NM_013995.2(LAMP2):c.864+3_864+6del	LAMP2		Danon disease|Hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044442	X	119580154 - 119580157	X	120446299 - 120446302	44442	53609	rs397516751	NC_000023.11:120446298:ACTCAC:AC
NM_002294.3(LAMP2):c.65-2A>G	LAMP2		Danon disease	Pathogenic(Last reviewed: May 21, 2010)	criteria provided, single submitter	VCV000044427	X	119590626	X	120456771	44427	53594	rs397516743	NC_000023.11:120456770:T:C
NM_002294.3(LAMP2):c.293G>A (p.Trp98Ter)	LAMP2	W98*	Danon disease|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044423	X	119589316	X	120455461	44423	53590	rs397516740	NC_000023.11:120455460:C:T
NM_001943.5(DSG2):c.523+2T>C	DSG2		Cardiovascular phenotype|Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044321	18	29101208	18	31521245	44321	53488	rs397516709	NC_000018.10:31521244:T:C
NM_001943.5(DSG2):c.1771_1772TG[1] (p.Cys591_Glu592delinsTer)	DSG2		not provided|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044286	18	29118833 - 29118834	18	31538870 - 31538871	44286	53453	rs397516703	NC_000018.10:31538869:TGTG:TG
NM_001399.5(EDA):c.961G>T (p.Glu321Ter)	EDA	E321*, E316*, E319*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 17, 2011)	no assertion criteria provided	VCV000044216	X	69255244	X	70035394	44216	53383	rs397516682	NC_000023.11:70035393:G:T
NM_001399.5(EDA):c.871G>A (p.Gly291Arg)	EDA	G291R, G288R	not provided|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000044211	X	69253325	X	70033475	44211	53378	rs397516677	NC_000023.11:70033474:G:A
NM_001399.5(EDA):c.822del (p.Trp274fs)	EDA	W274fs, W271fs	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jul 22, 2011)	criteria provided, single submitter	VCV000044210	X	69253275	X	70033425	44210	53377	rs397516676	NC_000023.11:70033424:GG:G
NM_001399.5(EDA):c.730C>T (p.Arg244Ter)	EDA	R244*	Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044205	X	69249377	X	70029527	44205	53372	rs397516672	NC_000023.11:70029526:C:T
NM_001399.5(EDA):c.663_697del (p.Pro222fs)	EDA	P222fs	Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044202	X	69247843 - 69247877	X	70027985 - 70028019	44202	53369	rs397516670	NC_000023.11:70027984:CCTCCAGGTCCTCCTGGTCCTCAAGGACCCCCTGGCCTCCAGG:CCTCCAGG
NM_001399.5(EDA):c.572_589del (p.188_190PGP[1])	EDA		not provided|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044200	X	69247752 - 69247769	X	70027889 - 70027906	44200	53367	rs397516668	NC_000023.11:70027888:CCTCCAGGACCCCCAGGACCTCCAGGACCCC:CCTCCAGGACCCC
NM_001399.5(EDA):c.562_589del (p.Pro188fs)	EDA	P188fs	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 22, 2012)	criteria provided, single submitter	VCV000044199	X	69247742 - 69247769	X	70027892 - 70027919	44199	53366	rs397516667	NC_000023.11:70027891:CCAGGACCCCCAGGACCTCCAGGACCCC:
NM_001399.5(EDA):c.553_588del (p.Asn185_Pro196del)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	VCV000044198	X	69247733 - 69247768	X	70027877 - 70027912	44198	53365	rs397516666	NC_000023.11:70027876:GGACCCAATGGCCCTCCAGGACCCCCAGGACCTCCAGGACCC:GGACCC
NM_001399.5(EDA):c.546_581del (p.Asn185_Pro196del)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044197	X	69247726 - 69247761	X	70027866 - 70027901	44197	53364	rs397516665	NC_000023.11:70027865:CAGGACCTCCTGGACCCAATGGCCCTCCAGGACCCCCAGGACCTCC:CAGGACCTCC
NM_001399.5(EDA):c.467G>T (p.Arg156Leu)	EDA	R156L	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000044194	X	69176947	X	69957097	44194	53361	rs132630314	NC_000023.11:69957096:G:T
NM_001399.5(EDA):c.457C>T (p.Arg153Cys)	EDA	R153C	Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044193	X	69176937	X	69957087	44193	53360	rs397516662	NC_000023.11:69957086:C:T
NM_001399.5(EDA):c.347T>A (p.Leu116Ter)	EDA	L116*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 4, 2011)	criteria provided, single submitter	VCV000044192	X	68836499	X	69616655	44192	53359	rs397516661	NC_000023.11:69616654:T:A
NM_001399.5(EDA):c.329C>A (p.Ser110Ter)	EDA	S110*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 20, 2011)	criteria provided, single submitter	VCV000044191	X	68836481	X	69616637	44191	53358	rs397516660	NC_000023.11:69616636:C:A
NM_001399.5(EDA):c.2T>C (p.Met1Thr)	EDA	M1T	not provided|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044190	X	68836154	X	69616310	44190	53357	rs397516659	NC_000023.11:69616309:T:C
NM_001399.5(EDA):c.272dup (p.Ser91fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 17, 2011)	criteria provided, single submitter	VCV000044187	X	68836423 - 68836424	X	69616579 - 69616580	44187	53354	rs397516656	NC_000023.11:69616579:G:GG
NM_001399.5(EDA):c.1094T>C (p.Val365Ala)	EDA	V365A, V360A, V363A	Partial congenital absence of teeth|Hypohidrotic X-linked ectodermal dysplasia|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044185	X	69255377	X	70035527	44185	53352	rs397516654	NC_000023.11:70035526:T:C
NM_000307.5(POU3F4):c.853_854del (p.Ile285fs)	POU3F4	I285fs	Rare genetic deafness|Deafness, X-linked 2	Pathogenic(Last reviewed: Jul 18, 2012)	criteria provided, single submitter	VCV000043352	X	82764185 - 82764186	X	83509177 - 83509178	43352	52522	rs397516336	NC_000023.11:83509176:AT:
NM_000307.5(POU3F4):c.499C>T (p.Arg167Ter)	POU3F4	R167*	Rare genetic deafness	Pathogenic(Last reviewed: Jun 10, 2008)	criteria provided, single submitter	VCV000043347	X	82763831	X	83508823	43347	52517	rs111033345	NC_000023.11:83508822:C:T
NM_000116.5(TAZ):c.718G>C (p.Gly240Arg)	TAZ	G240R, G210R, G244R, G196R, G226R	Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Mar 8, 2012)	criteria provided, single submitter	VCV000042266	X	153649015	X	154420676	42266	51436	rs387907218	NC_000023.11:154420675:G:C
NM_000116.5(TAZ):c.700-1G>A	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000042265	X	153648996	X	154420657	42265	51435	rs397515747	NC_000023.11:154420656:G:A
NM_000116.5(TAZ):c.310T>C (p.Phe104Leu)	TAZ	F104L, F122L	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Mar 15, 2012)	criteria provided, single submitter	VCV000042257	X	153641844	X	154413507	42257	51427	rs397515741	NC_000023.11:154413506:T:C
NM_005984.5(SLC25A1):c.821C>T (p.Ala274Val)	SLC25A1	A274V, A281V, A171V	Combined d-2- and l-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000042197	22	19163934	22	19176421	42197	51367	rs483352910	NC_000022.11:19176420:G:A
NM_005984.5(SLC25A1):c.389G>A (p.Gly130Asp)	SLC25A1	G130D, G27D, G137D	Combined d-2- and l-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000042196	22	19165292	22	19177779	42196	51366	rs368647424	NC_000022.11:19177778:C:T
NM_005984.5(SLC25A1):c.845G>A (p.Arg282His)	SLC25A1	R282H, R179H, R289H	Combined d-2- and l-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000042195	22	19163734	22	19176221	42195	51365	rs431905510	NC_000022.11:19176220:C:T
NM_005984.5(SLC25A1):c.844C>G (p.Arg282Gly)	SLC25A1	R282G, R179G, R289G	Combined d-2- and l-2-hydroxyglutaric aciduria	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000042193	22	19163735	22	19176222	42193	51363	rs431905509	NC_000022.11:19176221:G:C
NM_002739.5(PRKCG):c.76A>G (p.Arg26Gly)	PRKCG	R26G		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042174	19	54385824	19	53882570	42174	51340	rs386134157	NC_000019.10:53882569:A:G
NM_002739.5(PRKCG):c.417C>A (p.His139Gln)	PRKCG	H139Q		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042171	19	54393159	19	53889905	42171	51337	rs386134169	NC_000019.10:53889904:C:A
NM_002739.5(PRKCG):c.449_450delinsTT (p.Cys150Phe)	PRKCG			Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042170	19	54393191 - 54393192	19	53889937 - 53889938	42170	51336	rs386134170	NC_000019.10:53889936:GC:TT
NM_002739.5(PRKCG):c.413T>A (p.Val138Glu)	PRKCG	V138E	|not provided	Pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000042169	19	54393155	19	53889901	42169	51335	rs386134168	NC_000019.10:53889900:T:A
NM_002739.5(PRKCG):c.391T>C (p.Cys131Arg)	PRKCG	C131R		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042166	19	54392997	19	53889743	42166	51332	rs386134166	NC_000019.10:53889742:T:C
NM_002739.5(PRKCG):c.368G>A (p.Gly123Glu)	PRKCG	G123E		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042165	19	54392974	19	53889720	42165	51331	rs386134165	NC_000019.10:53889719:G:A
NM_002739.5(PRKCG):c.367G>A (p.Gly123Arg)	PRKCG	G123R		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042164	19	54392973	19	53889719	42164	51330	rs386134164	NC_000019.10:53889718:G:A
NM_002739.5(PRKCG):c.341G>A (p.Cys114Tyr)	PRKCG	C114Y		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042161	19	54392947	19	53889693	42161	51327	rs386134162	NC_000019.10:53889692:G:A
NM_002739.5(PRKCG):c.300_305del (p.His101_Lys102del)	PRKCG	H101del		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042157	19	54392902 - 54392907	19	53889648 - 53889653	42157	51323	rs386134161	NC_000019.10:53889647:ACAAACACAA:ACAA
NM_002739.5(PRKCG):c.229T>A (p.Cys77Ser)	PRKCG	C77S		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042148	19	54387441	19	53884187	42148	51314	rs386134160	NC_000019.10:53884186:T:A
NM_002739.5(PRKCG):c.188G>T (p.Gly63Val)	PRKCG	G63V		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042140	19	54386434	19	53883180	42140	51306	rs386134159	NC_000019.10:53883179:G:T
NM_002739.5(PRKCG):c.122G>C (p.Arg41Pro)	PRKCG	R41P		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042132	19	54385870	19	53882616	42132	51298	rs386134158	NC_000019.10:53882615:G:C
NM_002739.5(PRKCG):c.1078G>A (p.Gly360Ser)	PRKCG	G360S		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000042129	19	54401351	19	53898097	42129	51295	rs386134171	NC_000019.10:53898096:G:A
nsv1197577	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000042118	20	62015806 - 62064474	20	63384457 - 63433124	42118	51284		
NM_006517.5(SLC16A2):c.1253T>C (p.Leu418Pro)	SLC16A2	L418P	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042110	X	73749130	X	74529295	42110	51276	rs367543059	NC_000023.11:74529294:T:C
NM_198129.3(LAMA3):c.4998+1534dup	LAMA3		Junctional epidermolysis bullosa gravis of Herlitz|	Pathogenic(Last reviewed: Feb 22, 2008)	no assertion criteria provided	VCV000042049	18	21453158 - 21453159	18	23873194 - 23873195	42049	51215	rs80356678	NC_000018.10:23873194:G:GG
NM_198994.3(TGM6):c.1528G>C (p.Asp510His)	TGM6	D510H	Spinocerebellar ataxia 35	Pathogenic(Last reviewed: Oct 21, 2014)	no assertion criteria provided	VCV000042023	20	2398069	20	2417423	42023	51191	rs201964784	NC_000020.11:2417422:G:C
NM_001029896.2(WDR45):c.634C>T (p.Gln212Ter)	WDR45	Q213*, Q212*	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000041915	X	48933295	X	49075636	41915	51084	rs387907332	NC_000023.11:49075635:G:A
NM_001029896.2(WDR45):c.434dup (p.Leu147fs)	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000041914	X	48934090 - 48934091	X	49076431 - 49076432	41914	51083	rs387907331	NC_000023.11:49076431:TT:TTT
NM_001029896.2(WDR45):c.516G>C (p.Val172=)	WDR45		Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000041913	X	48933525	X	49075866	41913	51082	rs387907330	NC_000023.11:49075865:C:G
NM_001029896.2(WDR45):c.697C>T (p.Arg233Ter)	WDR45	R234*, R233*	Neurodegeneration with brain iron accumulation 5|Inborn genetic diseases|not provided|Delayed gross motor development|Global developmental delay|Absent speech|Hypoplasia of the corpus callosum|Seizures|Delayed speech and language development	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041912	X	48933232	X	49075573	41912	51081	rs387907329	NC_000023.11:49075572:G:A
NM_001029896.2(WDR45):c.1002_1003AT[1] (p.Tyr335fs)	WDR45		Neurodegeneration with brain iron accumulation 5|not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041911	X	48932540 - 48932541	X	49074881 - 49074882	41911	51080	rs387907328	NC_000023.11:49074880:ATAT:AT
NM_006950.3(SYN1):c.1648G>A (p.Ala550Thr)	SYN1	A550T	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Jun 15, 2011)	no assertion criteria provided	VCV000041889	X	47433735	X	47574336	41889	50326	rs397514680	NC_000023.11:47574335:C:T
NM_006950.3(SYN1):c.1663C>T (p.Gln555Ter)	SYN1	Q555*	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000041888	X	47433720	X	47574321	41888	50325	rs397514679	NC_000023.11:47574320:G:A
NM_000307.5(POU3F4):c.1060del (p.Thr354fs)	POU3F4	T354fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041458	X	82764389	X	83509381	41458	49894	rs398122517	NC_000023.11:83509380:AAAA:AAA
NM_000307.5(POU3F4):c.950dup (p.Leu317fs)	POU3F4		Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041457	X	82764280 - 82764281	X	83509272 - 83509273	41457	49893	rs398122516	NC_000023.11:83509272:TT:TTT
NM_001159773.2(CANT1):c.-147+1G>A	CANT1		Desbuquois dysplasia 1	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000041426	17	77005745	17	79009663	41426	49864	rs587776951	NC_000017.11:79009662:C:T
NLRP7, 14-BP DUP, NT939	NLRP7		Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041406					41406	49833		
NM_212472.2(PRKAR1A):c.85_95del (p.Ala29fs)	PRKAR1A	A29fs	Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041396	17	66511621 - 66511631	17	68515480 - 68515490	41396	49820	rs281864787	NC_000017.11:68515479:TCAAGCGCTGCTCAA:TCAA
NM_212472.2(PRKAR1A):c.846_847insA (p.Val283fs)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041395	17	66525087 - 66525088	17	68528946 - 68528947	41395	49819	rs281864795	NC_000017.11:68528946::A
NM_212472.2(PRKAR1A):c.82C>T (p.Gln28Ter)	PRKAR1A	Q28*	Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041394	17	66511622	17	68515481	41394	49818	rs281864780	NC_000017.11:68515480:C:T
NM_212472.2(PRKAR1A):c.711_712dup (p.Ser238fs)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041393	17	66523982 - 66523983	17	68527841 - 68527842	41393	49817	rs281864794	NC_000017.11:68527841:AA:AAAA
NM_212472.2(PRKAR1A):c.693dup (p.Arg232Ter)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041392	17	66522037 - 66522038	17	68525896 - 68525897	41392	49816	rs281864793	NC_000017.11:68525896:T:TT
NM_212472.2(PRKAR1A):c.682C>T (p.Arg228Ter)	PRKAR1A	R228*	Carney complex, type 1|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041391	17	66522027	17	68525886	41391	49815	rs281864784	NC_000017.11:68525885:C:T
NM_212472.2(PRKAR1A):c.638C>A (p.Ala213Asp)	PRKAR1A	A213D	Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041390	17	66521983	17	68525842	41390	49814	rs281864786	NC_000017.11:68525841:C:A
NM_212472.2(PRKAR1A):c.566_567delinsCAC (p.Glu189fs)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041389	17	66521911 - 66521912	17	68525770 - 68525771	41389	49813	rs281864792	NC_000017.11:68525769:AA:CAC
NM_212472.2(PRKAR1A):c.550-8_550-1del	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041388	17	66521886 - 66521893	17	68525745 - 68525752	41388	49812	rs281864800	NC_000017.11:68525744:GCACTTTAG:G
NM_212472.2(PRKAR1A):c.348+1G>C	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041387	17	66519068	17	68522927	41387	49811	rs281864797	NC_000017.11:68522926:G:C
NM_212472.2(PRKAR1A):c.286C>T (p.Arg96Ter)	PRKAR1A	R96*	Carney complex, type 1	Pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000041386	17	66519005	17	68522864	41386	49810	rs281864783	NC_000017.11:68522863:C:T
NM_212472.2(PRKAR1A):c.178_348del171 (p.Glu60_Lys116del)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041385	17	66518897 - 66519067	17	68522754 - 68522924	41385	49809	rs1555813158	
NM_212472.2(PRKAR1A):c.178-2A>G	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041384	17	66518895	17	68522754	41384	49808	rs281864796	NC_000017.11:68522753:A:G
NM_212472.2(PRKAR1A):c.139del (p.Met47fs)	PRKAR1A	M47fs	Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041383	17	66511679	17	68515538	41383	49807	rs281864789	NC_000017.11:68515537:A:
NM_212472.2(PRKAR1A):c.124C>T (p.Arg42Ter)	PRKAR1A	R42*	not provided|Carney complex, type 1	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000041382	17	66511664	17	68515523	41382	49806	rs281864782	NC_000017.11:68515522:C:T
NM_212472.2(PRKAR1A):c.109C>T (p.Gln37Ter)	PRKAR1A	Q37*	Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041381	17	66511649	17	68515508	41381	49805	rs281864781	NC_000017.11:68515507:C:T
NM_212472.2(PRKAR1A):c.101_105del (p.Ser34fs)	PRKAR1A	S34fs	Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000041380	17	66511638 - 66511642	17	68515497 - 68515501	41380	49804	rs281864788	NC_000017.11:68515496:ATTCTATT:ATT
NM_014646.2(LPIN2):c.1312_1313CT[2] (p.Ser439fs)	LPIN2		Majeed syndrome	Pathogenic(Last reviewed: Mar 14, 2013)	no assertion criteria provided	VCV000041250	18	2931393 - 2931394	18	2931395 - 2931396	41250	49674	rs318240736	NC_000018.10:2931394:AGAGAG:AGAG
NM_000095.3(COMP):c.2155G>A (p.Gly719Ser)	COMP	G719S	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	VCV000040997	19	18893936	19	18783126	40997	49419	rs312262904	NC_000019.10:18783125:C:T
NM_000095.3(COMP):c.1754C>T (p.Thr585Met)	COMP	T585M	Multiple epiphyseal dysplasia 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000040995	19	18895866	19	18785056	40995	49417	rs312262900	NC_000019.10:18785055:G:A
NM_000095.3(COMP):c.1754C>G (p.Thr585Arg)	COMP	T585R	Multiple epiphyseal dysplasia 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000040994	19	18895866	19	18785056	40994	49416	rs312262900	NC_000019.10:18785055:G:C
NM_000095.3(COMP):c.1754C>A (p.Thr585Lys)	COMP	T585K	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	VCV000040993	19	18895866	19	18785056	40993	49415	rs312262900	NC_000019.10:18785055:G:T
NM_000095.3(COMP):c.1747G>A (p.Glu583Lys)	COMP	E583K	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	VCV000040992	19	18895873	19	18785063	40992	49414	rs312262899	NC_000019.10:18785062:C:T
NM_000095.2:c.1679A>G	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	VCV000040991					40991	49413		
NM_000095.3(COMP):c.1405_1407GAC[4] (p.Asp473del)	COMP	D473del	not provided|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040988	19	18896845 - 18896847	19	18786035 - 18786037	40988	49410	rs193922900	NC_000019.10:18786034:GTCGTCGTCGTCGTCG:GTCGTCGTCGTCG
NM_001127898.4(CLCN5):c.1044G>C (p.Leu348Phe)	CLCN5	L278F, L348F, L298F		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040986	X	49851014	X	50086357	40986	49408	rs273585648	NC_000023.11:50086356:G:C
NM_001127898.4(CLCN5):c.1025A>G (p.Tyr342Cys)	CLCN5	Y272C, Y342C, Y292C		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040985	X	49850995	X	50086338	40985	49407	rs273585644	NC_000023.11:50086337:A:G
NM_001127898.4(CLCN5):c.884T>C (p.Leu295Pro)	CLCN5	L225P, L295P, L245P		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040984	X	49846455	X	50081798	40984	49406	rs273585645	NC_000023.11:50081797:T:C
NM_001127898.4(CLCN5):c.1849T>G (p.Trp617Gly)	CLCN5	W547G, W617G, W567G		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040983	X	49854877	X	50090220	40983	49405	rs273585650	NC_000023.11:50090219:T:G
NM_001127898.4(CLCN5):c.1847A>G (p.Lys616Arg)	CLCN5	K546R, K616R, K566R		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040982	X	49854875	X	50090218	40982	49404	rs273585649	NC_000023.11:50090217:A:G
NM_001127898.4(CLCN5):c.1747G>A (p.Gly583Arg)	CLCN5	G513R, G583R, G533R		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040981	X	49854775	X	50090118	40981	49403	rs273585647	NC_000023.11:50090117:G:A
NM_001127898.4(CLCN5):c.1230C>A (p.Asn410Lys)	CLCN5	N340K, N410K, N360K		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000040980	X	49851200	X	50086543	40980	49402	rs273585646	NC_000023.11:50086542:C:A
NG_012494.1:g.363924_416577delinsA	AMELX		Amelogenesis imperfecta, type 1E, with snow-capped teeth	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000040897					40897	49389		
NM_030662.3(MAP2K2):c.181A>G (p.Lys61Glu)	MAP2K2	K61E	Cardiofaciocutaneous syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040769	19	4117539	19	4117541	40769	49239	rs730880517	NC_000019.10:4117540:T:C
NM_004655.4(AXIN2):c.1989G>A (p.Trp663Ter)	AXIN2	W663*, W598*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000040260	17	63532590	17	65536472	40260	48744	rs730882193	NC_000017.11:65536471:C:T
NM_022095.4(ZNF335):c.3332G>A (p.Arg1111His)	ZNF335	R1111H	Primary autosomal recessive microcephaly 10	Pathogenic(Last reviewed: Nov 21, 2012)	no assertion criteria provided	VCV000040116	20	44579092	20	45950453	40116	48617	rs397514642	NC_000020.11:45950452:C:T
NM_006031.6(PCNT):c.1528dup (p.Thr510fs)	PCNT			Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000040076	21	47773083 - 47773084	21	46353169 - 46353170	40076	48589		NC_000021.9:46353169:AAAAAA:AAAAAAA
NM_014332.3(SMPX):c.99del (p.Arg34fs)	SMPX	R34fs	Deafness, X-linked 4	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040063	X	21761901	X	21743783	40063	48574	rs398122930	NC_000023.11:21743782:GGGGGG:GGGGG
NM_052865.4(MGME1):c.698A>G (p.Tyr233Cys)	MGME1	Y233C, Y248C, Y153C	Mitochondrial DNA depletion syndrome 11	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000040052	20	17956513	20	17975870	40052	48566	rs587776944	NC_000020.11:17975869:A:G
NM_052865.4(MGME1):c.456G>A (p.Trp152Ter)	MGME1	W152*	Mitochondrial DNA depletion syndrome 11	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000040051	20	17950958	20	17970315	40051	48565	rs587776943	NC_000020.11:17970314:G:A
NM_004247.4(EFTUD2):c.2823+1del	EFTUD2		Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000040048	17	42929077	17	44851709	40048	48562	rs879253728	NC_000017.11:44851708:CC:C
NM_004247.4(EFTUD2):c.623A>G (p.His208Arg)	EFTUD2	H208R, H198R, H173R	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000040047	17	42957003	17	44879635	40047	48561	rs397515431	NC_000017.11:44879634:T:C
NM_001042545.2(LTBP4):c.4039C>T (p.Arg1347Ter)	LTBP4	R1337*, R1347*, R1377*, R1414*	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040004	19	41132933	19	40627028	40004	48517	rs1382026467	NC_000019.10:40627027:C:T
NM_001042545.2(LTBP4):c.4025dup (p.Tyr1343fs)	LTBP4		Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040003	19	41132918 - 41132919	19	40627013 - 40627014	40003	48516	rs797044471	NC_000019.10:40627013:C:CC
NM_001042545.2(LTBP4):c.1252C>T (p.Arg418Ter)	LTBP4	R448*, R418*, R485*	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000040002	19	41114221	19	40608315	40002	48515	rs397515430	NC_000019.10:40608314:C:T
NM_021140.3(KDM6A):c.3351_3353TCT[1] (p.Leu1119del)	KDM6A	L1119del, L1171del	Kabuki syndrome 2	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039994	X	44942771 - 44942773	X	45083526 - 45083528	39994	48507	rs398122829	NC_000023.11:45083525:TCTTCT:TCT
NM_021140.3(KDM6A):c.1555C>T (p.Arg519Ter)	KDM6A	R519*, R571*, R440*, R223*, R474*, R526*	Kabuki syndrome 2	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039993	X	44922694	X	45063449	39993	48506	rs397514628	NC_000023.11:45063448:C:T
NM_021140.3(KDM6A):c.3717G>A (p.Trp1239Ter)	KDM6A	W1239*, W1291*, W1160*, W1194*, W1246*, W943*	Kabuki syndrome 2	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039992	X	44949156	X	45089911	39992	48505	rs398122929	NC_000023.11:45089910:G:A
NM_020964.3(EPG5):c.6232C>T (p.Arg2078Ter)	EPG5	R2078*	Vici syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039984	18	43447707	18	45867742	39984	48504	rs587776942	NC_000018.10:45867741:G:A
NM_020964.3(EPG5):c.2575G>T (p.Glu859Ter)	EPG5	E859*	Vici syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000039983	18	43505847	18	45925881	39983	48503	rs587776941	NC_000018.10:45925880:C:A
NM_020964.3(EPG5):c.3481C>T (p.Arg1161Ter)	EPG5	R1161*	Vici syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000039982	18	43496075	18	45916110	39982	48502	rs587776940	NC_000018.10:45916109:G:A
EPG5, 1-BP DUP, 5704T	EPG5		Vici syndrome	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039981					39981	48501		
NM_020964.3(EPG5):c.4588C>T (p.Gln1530Ter)	EPG5	Q1530*	Vici syndrome	Pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000039980	18	43481019	18	45901054	39980	48500	rs587776939	NC_000018.10:45901053:G:A
NM_182978.4(GNAL):c.377-359C>T	GNAL	R21*	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039972	18	11752493	18	11752494	39972	48492	rs398122928	NC_000018.10:11752493:C:T
NM_182978.4(GNAL):c.822dup (p.Arg275fs)	GNAL		Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039971	18	11864575 - 11864576	18	11864576 - 11864577	39971	48491	rs398122927	NC_000018.10:11864576:A:AA
NM_182978.4(GNAL):c.514dup (p.Ser172fs)	GNAL		Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039970	18	11753831 - 11753832	18	11753832 - 11753833	39970	48490	rs398122926	NC_000018.10:11753832:TTT:TTTT
NM_182978.4(GNAL):c.694G>A (p.Glu232Lys)	GNAL	E155K, E232K	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039969	18	11824986	18	11824987	39969	48489	rs398122925	NC_000018.10:11824986:G:A
NM_182978.4(GNAL):c.1109C>A (p.Ser370Ter)	GNAL	S293*, S370*, S86*	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039968	18	11872344	18	11872345	39968	48488	rs398122924	NC_000018.10:11872344:C:A
NM_182978.4(GNAL):c.640G>A (p.Val214Met)	GNAL	V137M, V214M	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039967	18	11824932	18	11824933	39967	48487	rs398122923	NC_000018.10:11824932:G:A
NM_015295.2(SMCHD1):c.4566G>A (p.Thr1522=)	SMCHD1	T1522T	Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039859	18	2762234	18	2762236	39859	48458		NC_000018.10:2762235:G:A
SMCHD1, IVS29DS, G-A, +1	SMCHD1		Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039858					39858	48457		
NM_015295.2(SMCHD1):c.1608del (p.Asp537fs)	SMCHD1	D537fs	Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039857	18	2700875	18	2700877	39857	48456	rs1057519614	NC_000018.10:2700876:AAA:AA
NM_015295.2(SMCHD1):c.2068C>T (p.Pro690Ser)	SMCHD1	P690S	Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039856	18	2707565	18	2707567	39856	48455	rs397514623	NC_000018.10:2707566:C:T
NM_015295.2(SMCHD1):c.1302_1306del (p.Tyr434_Arg436delinsTer)	SMCHD1		Facioscapulohumeral muscular dystrophy 2	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039855	18	2697996 - 2698000	18	2697998 - 2698002	39855	48454	rs387907319	NC_000018.10:2697997:ATATGATA:ATA
NM_001555.5(IGSF1):c.3581dup (p.Glu1195fs)	IGSF1		Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039853	X	130408742 - 130408743	X	131274768 - 131274769	39853	48452	rs398122921	NC_000023.11:131274768:A:AA
NM_001555.5(IGSF1):c.2573C>T (p.Ser858Phe)	IGSF1	S863F, S849F, S858F	Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039852	X	130410948	X	131276974	39852	48451	rs397514622	NC_000023.11:131276973:G:A
NM_001555.5(IGSF1):c.2233del (p.Glu745fs)	IGSF1	E745fs, E736fs, E750fs	Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039851	X	130411917	X	131277943	39851	48450	rs398122920	NC_000023.11:131277942:C:
NM_001555.5(IGSF1):c.2916G>A (p.Trp972Ter)	IGSF1	W977*, W972*, W963*	Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039850	X	130409720	X	131275746	39850	48449	rs398122919	NC_000023.11:131275745:C:T
NM_001555.5(IGSF1):c.2123_2149del (p.Ala708_Lys716del)	IGSF1		Hypothyroidism, central, and testicular enlargement	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000039849	X	130412001 - 130412027	X	131278027 - 131278053	39849	48448	rs1556181091	NC_000023.11:131278026:CCTTATACAGAGCAAACCCCATGCCTGCC:CC
MEGF8, GLY199ARG	MEGF8	G199R	Carpenter syndrome 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039848					39848	48447		
NM_001271938.2(MEGF8):c.1342C>T (p.Arg448Ter)	MEGF8	R448*	Carpenter syndrome 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039847	19	42841056	19	42336904	39847	48446	rs397514621	NC_000019.10:42336903:C:T
NM_001271938.2(MEGF8):c.7300A>G (p.Ser2434Gly)	MEGF8	S2367G, S2434G	Carpenter syndrome 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039846	19	42879689	19	42375537	39846	48445	rs397515428	NC_000019.10:42375536:A:G
NM_001271938.2(MEGF8):c.4697G>A (p.Arg1566His)	MEGF8	R1499H, R1566H	Carpenter syndrome 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039845	19	42861000	19	42356848	39845	48444	rs397515427	NC_000019.10:42356847:G:A
NM_005257.5(GATA6):c.1504_1505del (p.Lys502fs)	GATA6	K502fs	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000039844	18	19762792 - 19762793	18	22182831 - 22182832	39844	48443	rs587776936	NC_000018.10:22182830:AAA:A
NM_000390.4(CHM):c.1520A>G (p.His507Arg)	CHM	H507R, H359R	Choroideremia	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000039809	X	85134059	X	85879054	39809	48408	rs397514603	NC_000023.11:85879053:T:C
NM_005027.4(PIK3R2):c.1117G>A (p.Gly373Arg)	PIK3R2	G373R	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1|Inborn genetic diseases||not provided	Pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039808	19	18273784	19	18162974	39808	48407	rs587776934	NC_000019.10:18162973:G:A
NM_001866.2(COX7B):c.55C>T (p.Gln19Ter)	COX7B	Q19*	Linear skin defects with multiple congenital anomalies 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039769	X	77158154	X	77902657	39769	48368	rs397514585	NC_000023.11:77902656:C:T
NM_001866.3(COX7B):c.41-2A>G	COX7B		Linear skin defects with multiple congenital anomalies 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039768	X	77158138	X	77902641	39768	48367	rs397514584	NC_000023.11:77902640:A:G
NM_001866.3(COX7B):c.196del (p.Leu66fs)	COX7B	L66fs	Linear skin defects with multiple congenital anomalies 2	Pathogenic(Last reviewed: Nov 2, 2012)	no assertion criteria provided	VCV000039767	X	77160710	X	77905213	39767	48366	rs397514583	NC_000023.11:77905212:CC:C
NM_172107.4(KCNQ2):c.869G>A (p.Gly290Asp)	KCNQ2	G290D	Benign familial neonatal seizures 1|not provided|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000039762	20	62071009	20	63439656	39762	48361	rs397514582	NC_000020.11:63439655:C:T
NM_172107.4(KCNQ2):c.1636A>G (p.Met546Val)	KCNQ2	M546V, M515V, M518V, M528V	Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000039761	20	62044930	20	63413577	39761	48360	rs397515420	NC_000020.11:63413576:T:C
NM_172107.4(KCNQ2):c.638G>A (p.Arg213Gln)	KCNQ2	R213Q	Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|not provided|Early infantile epileptic encephalopathy 7|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039760	20	62076064	20	63444711	39760	48359	rs397514581	NC_000020.11:63444710:C:T
NM_018486.3(HDAC8):c.1001A>G (p.His334Arg)	HDAC8	H334R, H243R	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039714	X	71681858	X	72462008	39714	48313	rs397515418	NC_000023.11:72462007:T:C
NM_018486.3(HDAC8):c.932C>T (p.Thr311Met)	HDAC8	T311M, T220M	Inborn genetic diseases|Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039712	X	71681927	X	72462077	39712	48311	rs397515417	NC_000023.11:72462076:G:A
NM_018486.3(HDAC8):c.539A>G (p.His180Arg)	HDAC8	H180R, H89R	Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039711	X	71715017	X	72495167	39711	48310	rs397515416	NC_000023.11:72495166:T:C
NM_018486.3(HDAC8):c.490C>T (p.Arg164Ter)	HDAC8	R164*, R73*	Cornelia de Lange syndrome 5|not provided	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039710	X	71715066	X	72495216	39710	48309	rs397515415	NC_000023.11:72495215:G:A
NM_005334.3(HCFC1):c.674G>A (p.Ser225Asn)	HCFC1	S225N	not provided|Mental retardation 3, X-linked	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039695	X	153228714	X	153963263	39695	48294	rs318240758	NC_000023.11:153963262:C:T
NM_005334.3(HCFC1):c.-970T>C	HCFC1		Mental retardation 3, X-linked	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039694	X	153237261	X	153971810	39694	48293	rs398122908	NC_000023.11:153971809:A:G
DNAI2, TRP453TER	DNAI2	W453*	Ciliary dyskinesia, primary, 9	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039653					39653	48252		
NM_001364171.2(CCDC114):c.1050del (p.His350fs)	CCDC114	H313fs, H350fs	Ciliary dyskinesia, primary, 20	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039641	19	48806291	19	48303034	39641	48240	rs606231240	NC_000019.10:48303033:A:
NM_001364171.2(CCDC114):c.1502+5G>A	CCDC114		Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 20	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039640	19	48801252	19	48297995	39640	48239	rs201133219	NC_000019.10:48297994:C:T
NM_001364171.2(CCDC114):c.598-2A>G	CCDC114		Ciliary dyskinesia, primary, 20	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039639	19	48809582	19	48306325	39639	48238	rs606231239	NC_000019.10:48306324:T:C
NM_001364171.2(CCDC114):c.597+1G>A	CCDC114		Ciliary dyskinesia, primary, 20	Pathogenic(Last reviewed: Jan 10, 2013)	no assertion criteria provided	VCV000039638	19	48814809	19	48311552	39638	48237	rs606231238	NC_000019.10:48311551:C:T
NM_001364171.2(CCDC114):c.853G>A (p.Ala285Thr)	CCDC114	A248T, A285T	Primary ciliary dyskinesia|Kartagener syndrome|Ciliary dyskinesia, primary, 20	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039637	19	48807210	19	48303953	39637	48236	rs147718607	NC_000019.10:48303952:C:T
NM_001347721.2(DYRK1A):c.1071+1G>A	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039623	21	38865466	21	37493164	39623	48222	rs587776930	NC_000021.9:37493163:G:A
NM_001347721.2(DYRK1A):c.143_144del (p.Ile48fs)	DYRK1A	I48fs, I19fs	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039622	21	38845117 - 38845118	21	37472815 - 37472816	39622	48221	rs587776929	NC_000021.9:37472814:ATA:A
NM_000146.4(FTL):c.89C>T (p.Thr30Ile)	FTL	T30I		Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000039583	19	49468853	19	48965596	39583	48182	rs397514540	NC_000019.10:48965595:C:T
NM_001011551.3(C1GALT1C1):c.3G>C (p.Met1Ile)	C1GALT1C1	M1I	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000039574	X	119761019	X	120627164	39574	48173	rs587776928	NC_000023.11:120627163:C:G
NM_001011551.3(C1GALT1C1):c.577T>C (p.Ser193Pro)	C1GALT1C1	S193P	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000039573	X	119760445	X	120626590	39573	48172	rs397514537	NC_000023.11:120626589:A:G
CYP4F22, TRP521TER	CYP4F22	W521*	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000039560					39560	48159		
NM_015338.5(ASXL1):c.2893C>T (p.Arg965Ter)	ASXL1	R965*, R904*	Bohring-Opitz syndrome|not provided	Pathogenic(Last reviewed: May 25, 2016)	criteria provided, single submitter	VCV000039469	20	31023408	20	32435605	39469	48068	rs397515401	NC_000020.11:32435604:C:T
NM_001363734.1(ASXL1):c.2224_2228del (p.Gln742fs)	ASXL1	Q742fs, Q803fs	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000039468	20	31022921 - 31022925	20	32435118 - 32435122	39468	48067		NC_000020.11:32435117:GCAAGG:G
NM_004069.5(AP2S1):c.44G>A (p.Arg15His)	AP2S1	R15H, R31H, R17H	Hypocalciuric hypercalcemia, familial, type III|not provided	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000039426	19	47349359	19	46846102	39426	48025	rs397514499	NC_000019.10:46846101:C:T
NM_004069.5(AP2S1):c.44G>T (p.Arg15Leu)	AP2S1	R15L, R31L, R17L	Hypocalciuric hypercalcemia, familial, type III	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039425	19	47349359	19	46846102	39425	48024	rs397514499	NC_000019.10:46846101:C:A
NM_004069.5(AP2S1):c.43C>T (p.Arg15Cys)	AP2S1	R15C, R17C, R31C	Hypocalciuric hypercalcemia, familial, type III	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039424	19	47349360	19	46846103	39424	48023	rs397514498	NC_000019.10:46846102:G:A
NM_172107.2:c.(1228_1230)del12	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000039096					39096	47702		
NM_002473.5(MYH9):c.4270G>T (p.Asp1424Tyr)	MYH9	D1424Y	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000038966	22	36688106	22	36292060	38966	47569	rs80338831	NC_000022.11:36292059:C:A
NM_002473.5(MYH9):c.3494G>T (p.Arg1165Leu)	MYH9	R1165L	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Apr 5, 2011)	no assertion criteria provided	VCV000038965	22	36691114	22	36295068	38965	47568	rs80338830	NC_000022.11:36295067:C:A
NM_001363.5(DKC1):c.965G>A (p.Arg322Gln)	DKC1	R322Q		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038959	X	153999083	X	154770808	38959	47562	rs121912291	NC_000023.11:154770807:G:A
NM_001363.5(DKC1):c.961C>G (p.Leu321Val)	DKC1	L321V		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038958	X	153999079	X	154770804	38958	47561	rs2728726	NC_000023.11:154770803:C:G
NM_001363.5(DKC1):c.949C>T (p.Leu317Phe)	DKC1	L317F		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038957	X	153999067	X	154770792	38957	47560	rs121912290	NC_000023.11:154770791:C:T
NM_001363.5(DKC1):c.949C>G (p.Leu317Val)	DKC1	L317V		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038956	X	153999067	X	154770792	38956	47559	rs121912290	NC_000023.11:154770791:C:G
NM_001363.5(DKC1):c.941A>G (p.Lys314Arg)	DKC1	K314R		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038955	X	153999059	X	154770784	38955	47558	rs199422248	NC_000023.11:154770783:A:G
NM_001363.5(DKC1):c.91C>G (p.Gln31Glu)	DKC1	Q31E		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038954	X	153993725	X	154765450	38954	47557	rs137854491	NC_000023.11:154765449:C:G
NM_001363.5(DKC1):c.911G>A (p.Ser304Asn)	DKC1	S304N		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038953	X	153997581	X	154769306	38953	47556	rs199422247	NC_000023.11:154769305:G:A
NM_001363.5(DKC1):c.5C>T (p.Ala2Val)	DKC1	A2V		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038951	X	153991245	X	154762970	38951	47554	rs121912303	NC_000023.11:154762969:C:T
NM_001363.5(DKC1):c.29C>T (p.Pro10Leu)	DKC1	P10L		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038949	X	153993186	X	154764911	38949	47552	rs199422242	NC_000023.11:154764910:C:T
NM_001363.5(DKC1):c.204C>A (p.His68Gln)	DKC1	H68Q		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038948	X	153994214	X	154765939	38948	47551	rs199422245	NC_000023.11:154765938:C:A
NM_001363.5(DKC1):c.200C>T (p.Thr67Ile)	DKC1	T67I		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038947	X	153994210	X	154765935	38947	47550	rs199422244	NC_000023.11:154765934:C:T
NM_001363.5(DKC1):c.196A>G (p.Thr66Ala)	DKC1	T66A		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038946	X	153994206	X	154765931	38946	47549	rs121912297	NC_000023.11:154765930:A:G
NM_001363.5(DKC1):c.194G>C (p.Arg65Thr)	DKC1	R65T		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038945	X	153994204	X	154765929	38945	47548	rs121912301	NC_000023.11:154765928:G:C
NM_001363.5(DKC1):c.127A>G (p.Lys43Glu)	DKC1	K43E		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038943	X	153993761	X	154765486	38943	47546	rs199422243	NC_000023.11:154765485:A:G
NM_001363.5(DKC1):c.1226C>T (p.Pro409Leu)	DKC1	P409L		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038942	X	154002947	X	154774672	38942	47545	rs121912289	NC_000023.11:154774671:C:T
NM_001363.5(DKC1):c.121G>A (p.Glu41Lys)	DKC1	E41K		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038940	X	153993755	X	154765480	38940	47543	rs121912302	NC_000023.11:154765479:G:A
NM_001363.5(DKC1):c.1204G>A (p.Gly402Arg)	DKC1	G402R		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038939	X	154002925	X	154774650	38939	47542	rs121912299	NC_000023.11:154774649:G:A
NM_001363.5(DKC1):c.1193T>C (p.Leu398Pro)	DKC1	L398P		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038938	X	154002914	X	154774639	38938	47541	rs199422253	NC_000023.11:154774638:T:C
NM_001363.5(DKC1):c.115A>G (p.Lys39Glu)	DKC1	K39E		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038937	X	153993749	X	154765474	38937	47540	rs121912296	NC_000023.11:154765473:A:G
NM_001363.5(DKC1):c.1156G>A (p.Ala386Thr)	DKC1	A386T		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038936	X	154002877	X	154774602	38936	47539	rs199422252	NC_000023.11:154774601:G:A
NM_001363.5(DKC1):c.1151C>T (p.Pro384Leu)	DKC1	P384L		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038935	X	154001520	X	154773245	38935	47538	rs199422251	NC_000023.11:154773244:C:T
NM_001363.5(DKC1):c.1150C>T (p.Pro384Ser)	DKC1	P384S		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038934	X	154001519	X	154773244	38934	47537	rs199422250	NC_000023.11:154773243:C:T
NM_001363.5(DKC1):c.1075G>A (p.Asp359Asn)	DKC1	D359N		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038933	X	154001444	X	154773169	38933	47536	rs199422249	NC_000023.11:154773168:G:A
NM_001363.5(DKC1):c.1050G>A (p.Met350Ile)	DKC1	M350I		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038932	X	154001419	X	154773144	38932	47535	rs121912298	NC_000023.11:154773143:G:A
NM_001363.5(DKC1):c.1049T>C (p.Met350Thr)	DKC1	M350T		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038931	X	154001418	X	154773143	38931	47534	rs121912300	NC_000023.11:154773142:T:C
NM_001193466.2(KANSL1):c.1867_1870del (p.Ile623fs)	KANSL1	I623fs	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Nov 20, 2012)	no assertion criteria provided	VCV000038929	17	44128049 - 44128052	17	46050683 - 46050686	38929	47532	rs281865472	NC_000017.11:46050682:GGAT:
NM_033380.3(COL4A5):c.5048G>T (p.Arg1683Leu)	COL4A5	R1677L, R1683L	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038789	X	107939580	X	108696350	38789	47394	rs104886308	NC_000023.11:108696349:G:T
NM_033380.3(COL4A5):c.4960dup (p.Trp1654fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000038788	X	107938631 - 107938632	X	108695401 - 108695402	38788	47393	rs281874751	NC_000023.11:108695401:TTTT:TTTTT
ins10-15kb(intron47);del~40kb3'toCOL4A5	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038786					38786	47391		
NM_033380.3(COL4A5):c.4457C>G (p.Thr1486Arg)	COL4A5	T1480R, T1486R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038785	X	107930853	X	108687623	38785	47390	rs281874740	NC_000023.11:108687622:C:G
NM_033380.3(COL4A5):c.4316G>T (p.Gly1439Val)	COL4A5	G1433V, G1439V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038784	X	107930712	X	108687482	38784	47389	rs281874735	NC_000023.11:108687481:G:T
NM_033380.3(COL4A5):c.4298G>C (p.Gly1433Ala)	COL4A5	G1427A, G1433A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038783	X	107929342	X	108686112	38783	47388	rs104886274	NC_000023.11:108686111:G:C
NM_033380.3(COL4A5):c.4289G>A (p.Gly1430Glu)	COL4A5	G1424E, G1430E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038782	X	107929333	X	108686103	38782	47387	rs281874733	NC_000023.11:108686102:G:A
NM_000495.3:c.4253_4262del;4263_4280dup	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038781					38781	47386		
ins10-15kb(intron46);del25kb	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038779					38779	47384		
NM_000495.3(COL4A5):c.[3837_3845del;3857dupA]	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038778					38778	47383		
COL4A5 insertion	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038777					38777	47382		
c3247-?_4198+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038776					38776	47381		
NM_000495.4(COL4A5):c.3017-?_3246+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038774					38774	47379		
NM_033380.3(COL4A5):c.3107-4A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038773	X	107869436	X	108626206	38773	47378	rs397515497	NC_000023.11:108626205:A:G
NM_033380.3(COL4A5):c.2947del (p.Tyr983fs)	COL4A5	Y983fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000038772	X	107867494	X	108624264	38772	47377	rs281874708	NC_000023.11:108624263:TT:T
NM_000495.3(COL4A5):c.2918-?_5058+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038771					38771	47376		
NM_033380.3(COL4A5):c.2696G>T (p.Gly899Val)	COL4A5	G899V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038770	X	107865051	X	108621821	38770	47375	rs281874702	NC_000023.11:108621820:G:T
NM_033380.3(COL4A5):c.2696_2705del (p.Gly899fs)	COL4A5	G899fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000038769	X	107865049 - 107865058	X	108621819 - 108621828	38769	47374	rs281874701	NC_000023.11:108621818:GGGTATGATGGG:GG
NM_033380.3(COL4A5):c.2678G>T (p.Gly893Val)	COL4A5	G893V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038768	X	107865033	X	108621803	38768	47373	rs397515496	NC_000023.11:108621802:G:T
NM_033380.3(COL4A5):c.2623G>C (p.Gly875Arg)	COL4A5	G875R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038767	X	107863602	X	108620372	38767	47372	rs281874698	NC_000023.11:108620371:G:C
NM_033380.2(COL4A5):c.2587_2606del20ins75	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000038766	X	107863566 - 107863585	X	108620336 - 108620355	38766	47371		
c2510-?_3246+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038765					38765	47370		
NM_033380.3(COL4A5):c.2483G>A (p.Gly828Glu)	COL4A5	G828E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038764	X	107858228	X	108614998	38764	47369	rs281874695	NC_000023.11:108614997:G:A
NM_033380.3(COL4A5):c.2434_2441delinsAACCTGGACCAATGGGACCAATGGGAACAC (p.Pro812fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000038763	X	107858179 - 107858186	X	108614949 - 108614956	38763	47368	rs397515495	NC_000023.11:108614948:CCTCCTGG:AACCTGGACCAATGGGACCAATGGGAACAC
NM_033380.3(COL4A5):c.2164G>C (p.Gly722Arg)	COL4A5	G722R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038762	X	107846211	X	108602981	38762	47367	rs281874687	NC_000023.11:108602980:G:C
NM_033380.3(COL4A5):c.2014G>C (p.Gly672Arg)	COL4A5	G672R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038761	X	107844688	X	108601458	38761	47366	rs281874685	NC_000023.11:108601457:G:C
c1949-?_2395+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038760					38760	47365		
NM_033380.3(COL4A5):c.1883C>T (p.Pro628Leu)	COL4A5	P628L	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038759	X	107842035	X	108598805	38759	47364	rs281874682	NC_000023.11:108598804:C:T
NM_033380.3(COL4A5):c.1835G>A (p.Gly612Asp)	COL4A5	G612D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038758	X	107841987	X	108598757	38758	47363	rs281874680	NC_000023.11:108598756:G:A
NM_033380.3(COL4A5):c.1744G>A (p.Gly582Arg)	COL4A5	G582R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038757	X	107840763	X	108597533	38757	47362	rs281874677	NC_000023.11:108597532:G:A
NM_033380.3(COL4A5):c.1589G>A (p.Gly530Asp)	COL4A5	G530D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038756	X	107840608	X	108597378	38756	47361	rs281874671	NC_000023.11:108597377:G:A
NM_033380.3(COL4A5):c.1216G>A (p.Gly406Ser)	COL4A5	G406S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038755	X	107834338	X	108591108	38755	47360	rs281874660	NC_000023.11:108591107:G:A
NM_033380.3(COL4A5):c.1135C>T (p.Gln379Ter)	COL4A5	Q379*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038754	X	107829947	X	108586717	38754	47359	rs281874657	NC_000023.11:108586716:C:T
NM_033380.3(COL4A5):c.682G>T (p.Glu228Ter)	COL4A5	E228*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038752	X	107821344	X	108578114	38752	47357	rs281874762	NC_000023.11:108578113:G:T
NM_033380.3(COL4A5):c.665T>G (p.Phe222Cys)	COL4A5	F222C	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	VCV000038751	X	107821327	X	108578097	38751	47356	rs281874761	NC_000023.11:108578096:T:G
NM_033380.3(COL4A5):c.476del (p.Gly159fs)	COL4A5	G159fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000038749	X	107816813	X	108573583	38749	47354	rs281874748	NC_000023.11:108573582:GG:G
NM_033380.3(COL4A5):c.438+2T>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038748	X	107814698	X	108571468	38748	47353	rs281874738	NC_000023.11:108571467:T:C
NM_033380.3(COL4A5):c.430G>C (p.Gly144Arg)	COL4A5	G144R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038747	X	107814688	X	108571458	38747	47352	rs104886052	NC_000023.11:108571457:G:C
c82-?_5058+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038746					38746	47351		
NM_000495.3(COL4A5):c.1-?_3246+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038742					38742	47347		
NM_005359.5(SMAD4):c.1447+1G>A	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038740	18	48603147	18	51076777	38740	47345	rs377767387	NC_000018.10:51076776:G:A
NM_005359.5(SMAD4):c.189_197delAAATGGAGCins44 (p.?)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038739	18	48573605 - 48573613	18	51047235 - 51047243	38739	47344		
NM_005359.5(SMAD4):c.424+1G>A	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000038738	18	48575231	18	51048861	38738	47343	rs377767386	NC_000018.10:51048860:G:A
NM_006796.2(AFG3L2):c.2098G>A (p.Glu700Lys)	AFG3L2	E700K		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000038393	18	12337417	18	12337418	38393	46954	rs151344522	NC_000018.10:12337417:C:T
NM_006796.2(AFG3L2):c.2012G>A (p.Gly671Glu)	AFG3L2	G671E		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000038392	18	12337503	18	12337504	38392	46953	rs151344518	NC_000018.10:12337503:C:T
NM_006796.2(AFG3L2):c.1997T>C (p.Met666Thr)	AFG3L2	M666T		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000038389	18	12337518	18	12337519	38389	46950	rs151344515	NC_000018.10:12337518:A:G
NM_006796.2(AFG3L2):c.1961C>T (p.Thr654Ile)	AFG3L2	T654I		Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2019)	no assertion criteria provided	VCV000038387	18	12340219	18	12340220	38387	46948	rs151344513	NC_000018.10:12340219:G:A
NM_006282.5(STK4):c.749G>A (p.Trp250Ter)	STK4	W250*	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000037325	20	43625865	20	44997224	37325	45900		NC_000020.11:44997223:G:A
NM_006282.5(STK4):c.1103del (p.Met368fs)	STK4	M368fs	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations	Pathogenic(Last reviewed: Apr 12, 2012)	no assertion criteria provided	VCV000037324	20	43629950	20	45001309	37324	45899		NC_000020.11:45001308:T:
NM_006282.5(STK4):c.349C>T (p.Arg117Ter)	STK4	R117*	T-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations|Inherited Immunodeficiency Diseases	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000037323	20	43610573	20	44981932	37323	45898	rs387907316	NC_000020.11:44981931:C:T
NM_005534.3(IFNGR2):c.382_387dup (p.Thr128_Met129dup)	IFNGR2		Immunodeficiency 28	Pathogenic(Last reviewed: Aug 4, 2008)	no assertion criteria provided	VCV000037286	21	34793959 - 34793960	21	33421652 - 33421653	37286	45859	rs398122890	NC_000021.9:33421652:TGACAATG:TGACAATGACAATG
NM_018486.3(HDAC8):c.164+5G>A	HDAC8		Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000037252	X	71791902	X	72572052	37252	45845	rs398122888	NC_000023.11:72572051:C:T
NM_001167.3(XIAP):c.608G>A (p.Cys203Tyr)	XIAP	C203Y	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000037244	X	123020120	X	123886270	37244	45837	rs387907301	NC_000023.11:123886269:G:A
NM_000023.4(SGCA):c.574C>T (p.Arg192Ter)	SGCA	R192*	Muscular dystrophy|Autosomal recessive limb-girdle muscular dystrophy type 2D|not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000037202	17	48245923	17	50168562	37202	45812	rs387907298	NC_000017.11:50168561:C:T
NM_152296.5(ATP1A3):c.2839G>A (p.Gly947Arg)	ATP1A3	G947R, G958R, G960R	Alternating hemiplegia of childhood 2|not provided|Dystonia 12|Hemiplegia|Epilepsy|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000037110	19	42471896	19	41967744	37110	45780	rs398122887	NC_000019.10:41967743:C:T
NM_152296.5(ATP1A3):c.2431T>C (p.Ser811Pro)	ATP1A3	S811P, S824P, S822P	Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000037109	19	42474448	19	41970296	37109	45779	rs387907282	NC_000019.10:41970295:A:G
NM_152296.5(ATP1A3):c.2443G>A (p.Glu815Lys)	ATP1A3	E815K, E826K, E828K	Global developmental delay|Oculogyric crisis|Hemiplegia|not provided|Alternating hemiplegia of childhood 2|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037108	19	42474436	19	41970284	37108	45778	rs387907281	NC_000019.10:41970283:C:T
NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)	ATP1A3	D801N, D812N, D814N	Tetraparesis|Dystonia|Oculogyric crisis|Dystonia 12|Inborn genetic diseases|not provided|Alternating hemiplegia of childhood 2|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037107	19	42474557	19	41970405	37107	45777	rs80356537	NC_000019.10:41970404:C:T
NM_005543.4(INSL3):c.217C>T (p.Arg73Ter)	INSL3	R49*, R73*	Cryptorchidism	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000037092	19	17927842	19	17817033	37092	45767	rs398122886	NC_000019.10:17817032:G:A
NM_152424.4(AMER1):c.811C>T (p.Gln271Ter)	AMER1	Q271*	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000037046	X	63412356	X	64192476	37046	45732	rs387907269	NC_000023.11:64192475:G:A
NM_152424.4(AMER1):c.1267del (p.Leu423fs)	AMER1	L423fs	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000037045	X	63411900	X	64192020	37045	45731	rs398122877	NC_000023.11:64192019:GG:G
NM_001018113.3(FANCB):c.1855_1856AG[1] (p.Arg619fs)	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000037044	X	14863047 - 14863048	X	14844925 - 14844926	37044	45730	rs1569083464	NC_000023.11:14844924:CTCT:CT
NM_001018113.3(FANCB):c.2150T>G (p.Leu717Ter)	FANCB	L717*	Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Sep 27, 2019)	no assertion criteria provided	VCV000037043	X	14862640	X	14844518	37043	45729	rs1569083185	NC_000023.11:14844517:A:C
CCDC11, IVS6DS, G-A, +1	CFAP53		Heterotaxy, visceral, 6, autosomal	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037014					37014	45680		
NM_002501.4(NFIX):c.362G>C (p.Arg121Pro)	NFIX	R121P, R113P, R129P, R74P, R120P	Sotos syndrome 2	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000036967	19	13136169	19	13025355	36967	45624	rs387907255	NC_000019.10:13025354:G:C
NM_002501.4(NFIX):c.179T>C (p.Leu60Pro)	NFIX	L60P, L52P, L68P, L13P, L59P	Sotos syndrome 2	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000036966	19	13135986	19	13025172	36966	45623	rs387907254	NC_000019.10:13025171:T:C
NM_002501.4(NFIX):c.955+1G>T	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036965	19	13186486	19	13075672	36965	45622	rs398122876	NC_000019.10:13075671:G:T
NM_002501.4(NFIX):c.955+1G>A	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036964	19	13186486	19	13075672	36964	45621	rs398122876	NC_000019.10:13075671:G:A
NM_002501.4(NFIX):c.959dup (p.Ala321fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036963	19	13189427 - 13189428	19	13078613 - 13078614	36963	45620	rs398122875	NC_000019.10:13078613:CCC:CCCC
NM_002501.4(NFIX):c.994dup (p.Cys332fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036962	19	13189464 - 13189465	19	13078650 - 13078651	36962	45619	rs398122874	NC_000019.10:13078650:T:TT
NM_002501.4(NFIX):c.1243del (p.Ala415fs)	NFIX	A423fs, A414fs, A415fs, A368fs, A374fs, A407fs	Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036961	19	13192657	19	13081843	36961	45618	rs398122873	NC_000019.10:13081842:GG:G
NM_002501.4(NFIX):c.1049dup (p.Leu351fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036960	19	13189517 - 13189518	19	13078703 - 13078704	36960	45617	rs398122872	NC_000019.10:13078703:CCC:CCCC
NM_002501.4(NFIX):c.1003_1007CTCTC[1] (p.Ser337fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036959	19	13189473 - 13189477	19	13078659 - 13078663	36959	45616	rs398122871	NC_000019.10:13078658:CCTCTCCTCTC:CCTCTC
NM_002501.4(NFIX):c.1037dup (p.Thr347fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036958	19	13189505 - 13189506	19	13078691 - 13078692	36958	45615	rs398122870	NC_000019.10:13078691:TTT:TTTT
NM_002501.4(NFIX):c.1009_1010TC[1] (p.Gln338fs)	NFIX		Marshall-Smith syndrome	Pathogenic(Last reviewed: Aug 13, 2010)	no assertion criteria provided	VCV000036957	19	13189479 - 13189480	19	13078665 - 13078666	36957	45614	rs398122869	NC_000019.10:13078664:CTCTC:CTC
NM_002501.4(NFIX):c.568C>T (p.Gln190Ter)	NFIX	Q190*, Q143*, Q189*, Q198*, Q182*	Marshall-Smith syndrome|Sotos syndrome 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000036956	19	13183869	19	13073055	36956	45613	rs387907253	NC_000019.10:13073054:C:T
NM_018993.3(RIN2):c.1914_1915del (p.Glu638fs)	RIN2	E638fs, E687fs	Macrocephaly, alopecia, cutis laxa, and scoliosis	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000036923	20	19970801 - 19970802	20	19990157 - 19990158	36923	45584	rs587776915	NC_000020.11:19990156:GC:
NM_000377.2(WAS):c.37C>T (p.Arg13Ter)	WAS	R13*	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036911	X	48542279	X	48683890	36911	45572	rs193922415	NC_000023.11:48683889:C:T
NM_000475.5(NR0B1):c.1141C>T (p.Leu381Phe)	NR0B1	L381F	Congenital adrenal hypoplasia, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036665	X	30326340	X	30308223	36665	45326	rs386134263	NC_000023.11:30308222:G:A
NM_000527.4(LDLR):c.1978C>T (p.Gln660Ter)	LDLR	Q660*, Q492*, Q533*, Q619*	not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036458	19	11230900	19	11120224	36458	45121	rs193922569	NC_000019.10:11120223:C:T
NM_000527.5(LDLR):c.1358+2T>A	LDLR		Familial hypercholesterolemia|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036455	19	11224127	19	11113451	36455	45118	rs193922567	NC_000019.10:11113450:T:A
NM_000527.5(LDLR):c.1222G>A (p.Glu408Lys)	LDLR	E408K, E240K, E281K, E367K	Familial hypercholesterolemia|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036453	19	11223989	19	11113313	36453	45116	rs137943601	NC_000019.10:11113312:G:A
NM_000527.5(LDLR):c.1055G>A (p.Cys352Tyr)	LDLR	C352Y, C184Y, C311Y, C225Y	Familial hypercholesterolemia|Familial hypercholesterolemia 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036450	19	11221442	19	11110766	36450	45113	rs193922566	NC_000019.10:11110765:G:A
NM_000215.3(JAK3):c.678_679del (p.Cys227fs)	JAK3	C227fs	Severe combined immunodeficiency disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036423	19	17953307 - 17953308	19	17842498 - 17842499	36423	45086	rs193922364	NC_000019.10:17842497:AG:
NM_000215.3(JAK3):c.1767C>T (p.Gly589=)	JAK3		not provided|Severe combined immunodeficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036416	19	17947957	19	17837148	36416	45079	rs193922362	NC_000019.10:17837147:G:A
NM_000206.2(IL2RG):c.865C>T (p.Arg289Ter)	IL2RG	R289*	X-linked severe combined immunodeficiency|not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036389	X	70328186	X	71108336	36389	45052	rs137852508	NC_000023.11:71108335:G:A
NM_000206.2(IL2RG):c.455T>C (p.Val152Ala)	IL2RG	V152A	X-linked severe combined immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, multiple submitters, no conflicts	VCV000036386	X	70330145	X	71110295	36386	45049	rs193922348	NC_000023.11:71110294:A:G
NM_000206.2(IL2RG):c.270-1G>T	IL2RG		not provided|X-linked severe combined immunodeficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036384	X	70330539	X	71110689	36384	45047	rs193922346	NC_000023.11:71110688:C:A
NM_000397.3(CYBB):c.607G>T (p.Glu203Ter)	CYBB	E203*	Chronic granulomatous disease, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035974	X	37655327	X	37796074	35974	44638	rs193922449	NC_000023.11:37796073:G:T
NM_000074.2(CD40LG):c.761C>T (p.Thr254Met)	CD40LG	T254M	|Hyperimmunoglobulin M syndrome	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035814	X	135741549	X	136659390	35814	44478	rs193922136	NC_000023.11:136659389:C:T
NM_000074.2(CD40LG):c.31C>T (p.Arg11Ter)	CD40LG	R11*	|not specified	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035812	X	135730438	X	136648279	35812	44476	rs193922135	NC_000023.11:136648278:C:T
NM_000061.2(BTK):c.472_475del (p.Thr158fs)	BTK	T158fs, T192fs	X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035761	X	100617594 - 100617597	X	101362606 - 101362609	35761	44425	rs193922128	NC_000023.11:101362605:CTGTCTG:CTG
NM_000061.2(BTK):c.1455C>A (p.Tyr485Ter)	BTK	Y485*, Y519*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000035757	X	100611151	X	101356163	35757	44421	rs193922124	NC_000023.11:101356162:G:T
NM_000054.6(AVPR2):c.838dup (p.Tyr280fs)	AVPR2		Nephrogenic diabetes insipidus	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000035747	X	153171797 - 153171798	X	153906343 - 153906344	35747	44411	rs193922121	NC_000023.11:153906343:T:TT
NM_000054.6(AVPR2):c.554del (p.Gly185fs)	AVPR2	G185fs	Nephrogenic diabetes insipidus|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000035742	X	153171513	X	153906059	35742	44406	rs193922116	NC_000023.11:153906058:GG:G
NM_000033.4(ABCD1):c.838C>T (p.Arg280Cys)	ABCD1	R280C	Adrenoleukodystrophy|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035643	X	152991559	X	153726104	35643	44308	rs193922098	NC_000023.11:153726103:C:T
NM_000033.4(ABCD1):c.421G>A (p.Ala141Thr)	ABCD1	A141T	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Feb 3, 2014)	criteria provided, multiple submitters, no conflicts	VCV000035642	X	152991142	X	153725687	35642	44307	rs193922097	NC_000023.11:153725686:G:A
CARD14, IVS3DS, G-A, +1	CARD14		Pityriasis rubra pilaris	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035575					35575	44242		
CARD14, 3-BP DEL, 412GAG	CARD14		Pityriasis rubra pilaris	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035574					35574	44241		
NM_001366385.1(CARD14):c.467T>C (p.Leu156Pro)	CARD14	L156P	Pityriasis rubra pilaris|Papulosquamous eruptions	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000035573	17	78157829	17	80184030	35573	44240	rs387907240	NC_000017.11:80184029:T:C
NM_002204.4(ITGA3):c.1883G>C (p.Arg628Pro)	ITGA3	R628P	Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	Pathogenic(Last reviewed: Apr 19, 2012)	no assertion criteria provided	VCV000035572	17	48154006	17	50076642	35572	44239	rs140781106	NC_000017.11:50076641:G:C
NM_002204.4(ITGA3):c.1538-1G>A	ITGA3		Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	Pathogenic(Last reviewed: Apr 19, 2012)	no assertion criteria provided	VCV000035571	17	48152962	17	50075598	35571	44238	rs1567701091	NC_000017.11:50075597:G:A
ITGA3, 1-BP DEL, NT1173	ITGA3		Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	Pathogenic(Last reviewed: Apr 19, 2012)	no assertion criteria provided	VCV000035570					35570	44237		
NM_002144.4(HOXB1):c.619C>T (p.Arg207Cys)	HOXB1	R207C	Hereditary congenital facial paresis 3	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035567	17	46607196	17	48529834	35567	44236	rs387907239	NC_000017.11:48529833:G:A
NM_000116.5(TAZ):c.718G>A (p.Gly240Arg)	TAZ	G240R, G226R, G244R, G196R, G210R	3-Methylglutaconic aciduria type 2|not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000035505	X	153649015	X	154420676	35505	44181	rs387907218	NC_000023.11:154420675:G:A
NM_017636.4(TRPM4):c.2741A>G (p.Lys914Arg)	TRPM4	K914R, K560R, K799R, K378R, K740R, K769R		Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035490	19	49703652	19	49200395	35490	44163	rs172151858	NC_000019.10:49200394:A:G
NM_017636.4(TRPM4):c.490C>T (p.Arg164Trp)	TRPM4	R164W		Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000035488	19	49671558	19	49168301	35488	44161	rs387907216	NC_000019.10:49168300:C:T
NM_017565.4(FAM20A):c.590-2A>G	FAM20A		Enamel-renal syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035478	17	66550970	17	68554829	35478	44150	rs587776914	NC_000017.11:68554828:T:C
NM_017565.4(FAM20A):c.32_33CT[1] (p.Leu12fs)	FAM20A		Enamel-renal syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000035475	17	66596773 - 66596774	17	68600632 - 68600633	35475	44147	rs587776911	NC_000017.11:68600631:AGAG:AG
COMP, 3-BP DEL, 1139GAC	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000035474					35474	44146		
NM_002049.3(GATA1):c.646C>T (p.Arg216Trp)	GATA1	R216W	Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000031943	X	48650777	X	48792370	31943	40608	rs387907207	NC_000023.11:48792369:C:T
NM_002049.4(GATA1):c.220+1del	GATA1		GATA-1-related thrombocytopenia with dyserythropoiesis|Anemia without thromobocytopenia, X-linked	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000031942	X	48649736	X	48791329	31942	40607	rs587776453	NC_000023.11:48791328:GG:G
NM_001399.5(EDA):c.826C>T (p.Arg276Cys)	EDA	R276C, R273C	Hypohidrotic X-linked ectodermal dysplasia|Ectodermal dysplasia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000031908	X	69253280	X	70033430	31908	40564	rs387907197	NC_000023.11:70033429:C:T
NM_213607.3(CCDC103):c.383dup (p.Pro129fs)	CCDC103		Kartagener syndrome|Ciliary dyskinesia, primary, 17	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000031697	17	42979834 - 42979835	17	44902466 - 44902467	31697	40357	rs587776910	NC_000017.11:44902466:GGGGG:GGGGGG
NM_001193466.2(KANSL1):c.1652+1G>A	KANSL1		Koolen-de Vries syndrome|not provided	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000031696	17	44144914	17	46067548	31696	40356	rs281865470	NC_000017.11:46067547:C:T
NM_001193466.2(KANSL1):c.916C>T (p.Gln306Ter)	KANSL1	Q306*	Koolen-de Vries syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000031695	17	44248594	17	46171228	31695	40355	rs281865468	NC_000017.11:46171227:G:A
NM_001193466.2(KANSL1):c.2783_2784AG[1] (p.Arg929fs)	KANSL1		Koolen-de Vries syndrome	Pathogenic(Last reviewed: Nov 20, 2012)	no assertion criteria provided	VCV000031694	17	44110497 - 44110498	17	46033131 - 46033132	31694	40354	rs281865471	NC_000017.11:46033130:CTCTC:CTC
NM_001193466.2(KANSL1):c.1816C>T (p.Arg606Ter)	KANSL1	R606*	Koolen-de Vries syndrome|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031693	17	44143935	17	46066569	31693	40353	rs281865469	NC_000017.11:46066568:G:A
NM_004247.4(EFTUD2):c.2496C>G (p.Tyr832Ter)	EFTUD2	Y832*, Y797*, Y822*	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031642	17	42930729	17	44853361	31642	40319	rs879253727	NC_000017.11:44853360:G:C
NM_001172646.1(PLCB4):c.1984A>C (p.Asn662His)	PLCB4	N650H, N662H	Auriculocondylar syndrome 2|Auriculocondylar syndrome 1	Pathogenic(Last reviewed: Sep 17, 2012)	criteria provided, single submitter	VCV000031641	20	9389813	20	9409166	31641	40318	rs397514483	NC_000020.11:9409165:A:C
NM_001172646.1(PLCB4):c.1897C>T (p.Arg633Cys)	PLCB4	R621C, R633C	Auriculocondylar syndrome 1|Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Sep 17, 2012)	criteria provided, single submitter	VCV000031640	20	9389726	20	9409079	31640	40317	rs397514482	NC_000020.11:9409078:C:T
NM_001172646.1(PLCB4):c.1898G>A (p.Arg633His)	PLCB4	R621H, R633H	Auriculocondylar syndrome 2|Auriculocondylar syndrome 1|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000031639	20	9389727	20	9409080	31639	40316	rs397514481	NC_000020.11:9409079:G:A
NM_001172646.1(PLCB4):c.986A>G (p.Asn329Ser)	PLCB4	N329S	Auriculocondylar syndrome 2	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031638	20	9364980	20	9384333	31638	40315	rs387907179	NC_000020.11:9384332:A:G
NM_001172646.1(PLCB4):c.1904A>G (p.Tyr635Cys)	PLCB4	Y623C, Y635C	Auriculocondylar syndrome 1|Auriculocondylar syndrome 2	Pathogenic(Last reviewed: Sep 17, 2012)	criteria provided, single submitter	VCV000031637	20	9389733	20	9409086	31637	40314	rs397514480	NC_000020.11:9409085:A:G
NM_024422.6(DSC2):c.1841del (p.Ser614fs)	DSC2	S614fs	Arrhythmogenic right ventricular dysplasia, familial, 11, with mild palmoplantar keratoderma and woolly hair	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000031635	18	28654696	18	31074730	31635	40312	rs397514043	NC_000018.10:31074729:C:
NM_015166.3(MLC1):c.206C>T (p.Ser69Leu)	MLC1	S69L	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031622	22	50521574	22	50083145	31622	40300	rs281875309	NC_000022.11:50083144:G:A
NM_001366385.1(CARD14):c.424G>A (p.Glu142Lys)	CARD14	E142K	Psoriasis susceptibility 2|not provided	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031610	17	78157786	17	80183987	31610	40294	rs281875212	NC_000017.11:80183986:G:A
NM_001366385.1(CARD14):c.413A>C (p.Glu138Ala)	CARD14	E138A	Psoriasis 2, pustular|not provided	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031609	17	78157775	17	80183976	31609	40293	rs281875214	NC_000017.11:80183975:A:C
NM_001366385.1(CARD14):c.425A>G (p.Glu142Gly)	CARD14	E142G	Psoriasis susceptibility 2|not provided	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031608	17	78157787	17	80183988	31608	40292	rs281875213	NC_000017.11:80183987:A:G
NM_001366385.1(CARD14):c.349+5G>A	CARD14		Psoriasis susceptibility 2	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031607	17	78156594	17	80182795	31607	40291	rs587777763	NC_000017.11:80182794:G:A
NM_001366385.1(CARD14):c.349G>A (p.Gly117Ser)	CARD14	G117S	Psoriasis susceptibility 2|Papulosquamous eruptions|not provided	Pathogenic(Last reviewed: Mar 1, 2018)	no assertion criteria provided	VCV000031606	17	78156589	17	80182790	31606	40290	rs281875215	NC_000017.11:80182789:G:A
USH1G, 15-BP DEL, NT163	USH1G		Usher syndrome, type 1G	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031577					31577	40256		
NM_001256715.2(DNAAF3):c.621dup (p.Val208fs)	DNAAF3		Kartagener syndrome|Ciliary dyskinesia, primary, 2	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000031534	19	55673052 - 55673053	19	55161684 - 55161685	31534	40207	rs397515395	NC_000019.10:55161684:A:AA
NM_001256715.2(DNAAF3):c.265C>T (p.Arg89Ter)	DNAAF3	R136*, R157*, R89*, R35*	Kartagener syndrome|Ciliary dyskinesia, primary, 2|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000031533	19	55676795	19	55165427	31533	40206	rs387907152	NC_000019.10:55165426:G:A
NM_001256715.2(DNAAF3):c.182T>C (p.Leu61Pro)	DNAAF3	L108P, L129P, L61P	Kartagener syndrome|Ciliary dyskinesia, primary, 2	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000031532	19	55677272	19	55165904	31532	40205	rs387907151	NC_000019.10:55165903:A:G
NM_001039213.4(CEACAM16):c.418A>C (p.Thr140Pro)	CEACAM16	T140P	Deafness, autosomal dominant 4b	Pathogenic(Last reviewed: Mar 8, 2011)	no assertion criteria provided	VCV000031238	19	45207323	19	44704053	31238	40195	rs387907149	NC_000019.10:44704052:A:C
NM_005786.6(TSHZ1):c.723G>A (p.Trp241Ter)	TSHZ1	W241*, W286*	Aural atresia, congenital	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000031186	18	72998220	18	75286265	31186	40143	rs730882070	NC_000018.10:75286264:G:A
NM_005786.6(TSHZ1):c.946_947insA (p.Pro316fs)	TSHZ1		Aural atresia, congenital	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000031185	18	72998443 - 72998444	18	75286488 - 75286489	31185	40142	rs730882069	NC_000018.10:75286488::A
NM_024599.5(RHBDF2):c.566C>T (p.Pro189Leu)	RHBDF2	P189L, D188N, P160L	Palmoplantar keratoderma-esophageal carcinoma syndrome	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000031179	17	74475081	17	76478999	31179	40136	rs387907130	NC_000017.11:76478998:G:A
NM_024599.5(RHBDF2):c.557T>C (p.Ile186Thr)	RHBDF2	I186T, I157T	Palmoplantar keratoderma-esophageal carcinoma syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000031178	17	74475090	17	76479008	31178	40135	rs387907129	NC_000017.11:76479007:A:G
NM_020812.4(DOCK6):c.1245dup (p.Asp416Ter)	DOCK6		Adams-Oliver syndrome 2	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000031128	19	11354245 - 11354246	19	11243569 - 11243570	31128	40085		NC_000019.10:11243569:A:AA
NM_032040.5(CCDC8):c.84dup (p.Lys29Ter)	CCDC8		Three M syndrome 3	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000031105	19	46915983 - 46915984	19	46412726 - 46412727	31105	40062	rs1568590155	NC_000019.10:46412726:A:AA
NM_032040.5(CCDC8):c.612dup (p.Lys205fs)	CCDC8		Three M syndrome 3	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000031104	19	46915455 - 46915456	19	46412198 - 46412199	31104	40061	rs752254407	NC_000019.10:46412198:CCCCC:CCCCCC
NM_012469.4(PRPF6):c.2185C>T (p.Arg729Trp)	PRPF6	R729W	Retinitis pigmentosa 60	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000031089	20	62658491	20	64027138	31089	40046	rs387907100	NC_000020.11:64027137:C:T
NM_198994.3(TGM6):c.980A>G (p.Asp327Gly)	TGM6	D327G	Spinocerebellar ataxia 35	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031086	20	2381081	20	2400435	31086	40043	rs387907098	NC_000020.11:2400434:A:G
NM_017950.4(CCDC40):c.1345C>T (p.Arg449Ter)	CCDC40	R449*	Ciliary dyskinesia, primary, 15|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000031072	17	78032684	17	80058885	31072	40029	rs387907093	NC_000017.11:80058884:C:T
NM_017950.4(CCDC40):c.1951C>T (p.Gln651Ter)	CCDC40	Q651*	Primary ciliary dyskinesia|Ciliary dyskinesia, primary, 15	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000031071	17	78055819	17	80082020	31071	40028	rs387907092	NC_000017.11:80082019:C:T
NM_017950.4(CCDC40):c.1315C>T (p.Gln439Ter)	CCDC40	Q439*	Ciliary dyskinesia, primary, 15	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031070	17	78032448	17	80058649	31070	40027	rs387907091	NC_000017.11:80058648:C:T
NM_017950.4(CCDC40):c.248del (p.Ala83fs)	CCDC40	A83fs	not provided|Ciliary dyskinesia, primary, 15|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031069	17	78013765	17	80039966	31069	40026	rs397515393	NC_000017.11:80039965:C:
NM_182895.5(SCARF2):c.1328_1329del (p.Val443fs)	SCARF2	V443fs	not provided|	Pathogenic(Last reviewed: Jan 19, 2017)	criteria provided, single submitter	VCV000031047	22	20783918 - 20783919	22	20429631 - 20429632	31047	40004	rs587776902	NC_000022.11:20429630:CAC:C
NM_182895.5(SCARF2):c.773G>A (p.Cys258Tyr)	SCARF2	C258Y		Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031046	22	20785386	22	20431099	31046	40003	rs387907086	NC_000022.11:20431098:C:T
NM_001083961.2(WDR62):c.2742_2743AG[2] (p.Gln918fs)	WDR62		Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000031042	19	36591652 - 36591653	19	36100750 - 36100751	31042	39999	rs764201220	NC_000019.10:36100749:AGAGAG:AGAG
NM_001083961.2(WDR62):c.2086del (p.Ser696fs)	WDR62	S696fs	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000031041	19	36582150	19	36091248	31041	39998	rs863223322	NC_000019.10:36091247:AAAA:AAA
NM_001083961.2(WDR62):c.193G>A (p.Val65Met)	WDR62	V65M	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000031040	19	36549697	19	36058795	31040	39997	rs387907084	NC_000019.10:36058794:G:A
NM_001083961.2(WDR62):c.363del (p.Asp122fs)	WDR62	D122fs	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000031039	19	36556890	19	36065988	31039	39996	rs587776901	NC_000019.10:36065987:T:
NM_001083961.2(WDR62):c.3936dup (p.Val1313fs)	WDR62		Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000031038	19	36594660 - 36594661	19	36103758 - 36103759	31038	39995	rs587776900	NC_000019.10:36103758:CCCCCC:CCCCCCC
NM_001083961.2(WDR62):c.1531G>A (p.Asp511Asn)	WDR62	D511N	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000031037	19	36574124	19	36083222	31037	39994	rs387907083	NC_000019.10:36083221:G:A
NM_001083961.2(WDR62):c.4241dup (p.Ser1415fs)	WDR62		Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000031036	19	36595506 - 36595507	19	36104604 - 36104605	31036	39993	rs587776899	NC_000019.10:36104604:T:TT
NM_001083961.2(WDR62):c.1313G>A (p.Arg438His)	WDR62	R438H	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000031035	19	36572414	19	36081512	31035	39992	rs387907082	NC_000019.10:36081511:G:A
NM_001159773.2(CANT1):c.1079C>A (p.Ala360Asp)	CANT1	A360D	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031019	17	76989759	17	78993677	31019	39976	rs387907081	NC_000017.11:78993676:G:T
NM_001159773.2(CANT1):c.676G>A (p.Val226Met)	CANT1	V226M	Desbuquois dysplasia 1|EPIPHYSEAL DYSPLASIA, MULTIPLE, 7	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000031018	17	76991259	17	78995177	31018	39975	rs377546036	NC_000017.11:78995176:C:T
NM_001159773.2(CANT1):c.375G>C (p.Trp125Cys)	CANT1	W125C	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031017	17	76993330	17	78997248	31017	39974	rs587776898	NC_000017.11:78997247:C:G
NM_001159773.2(CANT1):c.671T>C (p.Leu224Pro)	CANT1	L224P	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000031016	17	76991264	17	78995182	31016	39973	rs150181226	NC_000017.11:78995181:A:G
NM_001159773.2(CANT1):c.277_278del (p.Leu93fs)	CANT1	L93fs	Desbuquois dysplasia 1|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000031015	17	76993427 - 76993428	17	78997345 - 78997346	31015	39972	rs587776897	NC_000017.11:78997344:AG:
NM_001159773.2(CANT1):c.897_901GCGCC[3] (p.Ser303fs)	CANT1		Desbuquois dysplasia 1|not provided	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000031013	17	76989931 - 76989932	17	78993849 - 78993850	31013	39970	rs587776895	NC_000017.11:78993849:GGCGCGGCGCGGC:GGCGCGGCGCGGCGCGGC
NM_144612.6(LOXHD1):c.4714C>T	LOXHD1	R1572*, R461*, R365*	not provided|Deafness, autosomal recessive 77|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030990	18	44104697	18	46524734	30990	39947	rs75949023	NC_000018.10:46524733:G:A
NM_015338.5(ASXL1):c.2197C>T (p.Gln733Ter)	ASXL1	Q733*, Q672*	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 26, 2011)	no assertion criteria provided	VCV000030989	20	31022712	20	32434909	30989	39946	rs387907078	NC_000020.11:32434908:C:T
NM_001363734.1(ASXL1):c.2352dup (p.Ser785fs)	ASXL1		Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 26, 2011)	no assertion criteria provided	VCV000030988	20	31023045 - 31023046	20	32435242 - 32435243	30988	39945		NC_000020.11:32435242:CCCCC:CCCCCC
NM_015338.5(ASXL1):c.3083C>A (p.Ser1028Ter)	ASXL1	S1028*, S967*	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 26, 2011)	no assertion criteria provided	VCV000030987	20	31023598	20	32435795	30987	39944	rs200702600	NC_000020.11:32435794:C:A
NM_015338.5(ASXL1):c.1210C>T (p.Arg404Ter)	ASXL1	R404*, R343*	not provided|Feeding difficulties|Small for gestational age|Delayed gross motor development|Global developmental delay|Hypertrichosis|Delayed speech and language development|Intellectual disability, severe|Abnormality of the corpus callosum|Glabellar hemangioma|Prominent metopic ridge|Bohring-Opitz syndrome|Developmental delay|dystrophia	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030986	20	31021211	20	32433408	30986	39943	rs373145711	NC_000020.11:32433407:C:T
NM_015338.5(ASXL1):c.2773C>T (p.Gln925Ter)	ASXL1	Q925*, Q864*	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Jun 26, 2011)	no assertion criteria provided	VCV000030985	20	31023288	20	32435485	30985	39942	rs387907077	NC_000020.11:32435484:C:T
NM_001145901.2(SARS2):c.1175A>G (p.Asp392Gly)	SARS2	D390G, D392G	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	Pathogenic(Last reviewed: Feb 11, 2011)	no assertion criteria provided	VCV000030982	19	39406946	19	38916306	30982	39939	rs727502784	NC_000019.10:38916305:T:C
NM_000140.4(FECH):c.553G>A (p.Ala185Thr)	FECH	A185T, A191T	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000030951	18	55233724	18	57566492	30951	39908	rs397514476	NC_000018.10:57566491:C:T
NM_025219.3(DNAJC5):c.344T>G (p.Leu115Arg)	DNAJC5	L115R	Neuronal ceroid lipofuscinosis 4B	Pathogenic	criteria provided, single submitter	VCV000030894	20	62562226	20	63930873	30894	39851	rs387907043	NC_000020.11:63930872:T:G
NM_025219.3(DNAJC5):c.343_345CTC[1] (p.Leu116del)	DNAJC5	L116del	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 4B	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030893	20	62562224 - 62562226	20	63930871 - 63930873	30893	39850	rs587776892	NC_000020.11:63930870:CCTCCTC:CCTC
NM_017565.4(FAM20A):c.406C>T (p.Arg136Ter)	FAM20A	R136*	Enamel-renal syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030879	17	66551883	17	68555742	30879	39836	rs144411158	NC_000017.11:68555741:G:A
NM_001029871.4(RSPO4):c.199G>C (p.Gly67Arg)	RSPO4	G67R	Anonychia	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000030847	20	948662	20	968019	30847	39804	rs387907028	NC_000020.11:968018:C:G
NM_001029871.4(RSPO4):c.190C>T (p.Arg64Cys)	RSPO4	R64C	Anonychia	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000030846	20	948671	20	968028	30846	39803	rs387907027	NC_000020.11:968027:G:A
NM_001029871.4(RSPO4):c.301C>T (p.Gln101Ter)	RSPO4	Q101*	Anonychia	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000030845	20	947925	20	967282	30845	39802	rs387907026	NC_000020.11:967281:G:A
NM_138501.6(TECR):c.545C>T (p.Pro182Leu)	TECR	P182L, P197L	Mental retardation, autosomal recessive 14	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000030810	19	14675653	19	14564841	30810	39767	rs199469705	NC_000019.10:14564840:C:T
NM_020461.4(TUBGCP6):c.5458T>G (p.Ter1820Gly)	TUBGCP6	*1820G	Microcephaly and chorioretinopathy, autosomal recessive, 1	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030809	22	50656167	22	50217738	30809	39766	rs387907019	NC_000022.11:50217737:A:C
NM_153609.3(TMPRSS6):c.1564G>A (p.Glu522Lys)	TMPRSS6	E522K, E513K	Microcytic anemia	Pathogenic(Last reviewed: May 28, 2009)	no assertion criteria provided	VCV000030802	22	37469590	22	37073550	30802	39759	rs387907018	NC_000022.11:37073549:C:T
NM_016097.5(IER3IP1):c.233T>C (p.Leu78Pro)	IER3IP1	L78P	Microcephaly, epilepsy, and diabetes syndrome	Pathogenic(Last reviewed: Nov 1, 2012)	no assertion criteria provided	VCV000030786	18	44682564	18	47156193	30786	39743	rs387907012	NC_000018.10:47156192:A:G
NM_005461.5(MAFB):c.161C>T (p.Ser54Leu)	MAFB	S54L	Multicentric carpo-tarsal osteolysis with or without nephropathy|not provided	Pathogenic(Last reviewed: Sep 19, 2014)	criteria provided, single submitter	VCV000030773	20	39317330	20	40688690	30773	39730	rs730880014	NC_000020.11:40688689:G:A
NM_005461.5(MAFB):c.212C>T (p.Pro71Leu)	MAFB	P71L	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030772	20	39317279	20	40688639	30772	39729	rs387907008	NC_000020.11:40688638:G:A
NM_005461.5(MAFB):c.211C>T (p.Pro71Ser)	MAFB	P71S	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030771	20	39317280	20	40688640	30771	39728	rs387907007	NC_000020.11:40688639:G:A
NM_005461.5(MAFB):c.209C>T (p.Ser70Leu)	MAFB	S70L	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030770	20	39317282	20	40688642	30770	39727	rs387907006	NC_000020.11:40688641:G:A
NM_005461.5(MAFB):c.208T>G (p.Ser70Ala)	MAFB	S70A	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030769	20	39317283	20	40688643	30769	39726	rs387907005	NC_000020.11:40688642:A:C
NM_005461.5(MAFB):c.184A>C (p.Thr62Pro)	MAFB	T62P	Multicentric carpo-tarsal osteolysis with or without nephropathy	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030768	20	39317307	20	40688667	30768	39725	rs387907004	NC_000020.11:40688666:T:G
NM_133261.3(GIPC3):c.565C>T (p.Arg189Cys)	GIPC3	R189C	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030758	19	3586965	19	3586967	30758	39715	rs387907002	NC_000019.10:3586966:C:T
NM_133261.3(GIPC3):c.136G>A (p.Gly46Arg)	GIPC3	G46R	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030757	19	3585731	19	3585733	30757	39714		NC_000019.10:3585732:G:A
NM_133261.3(GIPC3):c.767G>A (p.Gly256Asp)	GIPC3	G256D	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030756	19	3589890	19	3589892	30756	39713	rs387907001	NC_000019.10:3589891:G:A
NM_133261.3(GIPC3):c.685dup (p.Ala229fs)	GIPC3		Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030755	19	3589526 - 3589527	19	3589528 - 3589529	30755	39712		NC_000019.10:3589528:GGGGGGG:GGGGGGGG
NM_133261.3(GIPC3):c.903G>A (p.Trp301Ter)	GIPC3	W301*	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Feb 15, 2011)	no assertion criteria provided	VCV000030754	19	3590152	19	3590154	30754	39711	rs387907000	NC_000019.10:3590153:G:A
NM_133261.3(GIPC3):c.785T>G (p.Leu262Arg)	GIPC3	L262R	Deafness, autosomal recessive 15	Pathogenic(Last reviewed: Feb 15, 2011)	no assertion criteria provided	VCV000030753	19	3589908	19	3589910	30753	39710	rs387906999	NC_000019.10:3589909:T:G
NM_014297.5(ETHE1):c.554T>G (p.Leu185Arg)	ETHE1	L185R, L62R, L87R, L174R	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030725	19	44012968	19	43508816	30725	39682	rs387906987	NC_000019.10:43508815:A:C
SOX9, 178-KB DUP, UPSTREAM REGULATORY REGION	SOX9		46,XX sex reversal 2	Pathogenic(Last reviewed: Jan 6, 2011)	no assertion criteria provided	VCV000030708					30708	39665		
NM_172341.4(PSENEN):c.279del (p.Phe94fs)	PSENEN	F94fs	Acne inversa, familial, 2	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000030682	19	36237720	19	35746819	30682	39639	rs1555738943	NC_000019.10:35746818:CC:C
NM_172341.3(PSENEN):c.66del (p.Phe23Leufs)	PSENEN		Acne inversa, familial, 2	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000030681	19	36237319	19	35746418	30681	39638	rs1555738837	NC_000019.10:35746417:GGGGGG:GGGGG
PLCB1, 0.5-MB DEL	PLCB1		Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	VCV000030644					30644	39601		
NM_000527.5(LDLR):c.2140+86C>G	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000030627	19	11231284	19	11120608	30627	39584	rs587776886	NC_000019.10:11120607:C:G
NM_001126121.2(SLC25A19):c.373G>A (p.Gly125Ser)	SLC25A19	G125S	Striatal necrosis, bilateral, and progressive polyneuropathy	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000030590	17	73279590	17	75283509	30590	39547	rs387906944	NC_000017.11:75283508:C:T
NM_176787.5(PIGN):c.2126G>A (p.Arg709Gln)	PIGN	R709Q	Multiple congenital anomalies-hypotonia-seizures syndrome 1	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030549	18	59763135	18	62095902	30549	39506	rs397514475	NC_000018.10:62095901:C:T
NM_006031.6(PCNT):c.3460G>T (p.Glu1154Ter)	PCNT	E1154*, E1036*		Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030543	21	47805894	21	46385979	30543	39500	rs387906928	NC_000021.9:46385978:G:T
PCNT, 3-BP DEL, 9460AAG	PCNT			Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000030542					30542	39499		
NM_006031.6(PCNT):c.3840G>C (p.Gln1280His)	PCNT	Q1280H, Q1162H		Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030541	21	47809346	21	46389431	30541	39498	rs1569239749	NC_000021.9:46389430:G:C
RIPK4, 1-BP INS, 777A	RIPK4			Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030514					30514	39471		
NM_020639.3(RIPK4):c.362T>A (p.Ile121Asn)	RIPK4	I121N		Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030513	21	43176797	21	41756637	30513	39470	rs387906923	NC_000021.9:41756636:A:T
NM_020639.3(RIPK4):c.242T>A (p.Ile81Asn)	RIPK4	I81N		Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030512	21	43176917	21	41756757	30512	39469	rs387906922	NC_000021.9:41756756:A:T
NM_020639.3(RIPK4):c.1127C>A (p.Ser376Ter)	RIPK4	S376*		Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000030511	21	43164110	21	41743950	30511	39468	rs387906921	NC_000021.9:41743949:G:T
NM_004738.4(VAPB):c.137C>T (p.Thr46Ile)	VAPB	T46I	not provided|Amyotrophic lateral sclerosis type 8	Pathogenic(Last reviewed: Dec 17, 2010)	no assertion criteria provided	VCV000030510	20	56993345	20	58418289	30510	39467	rs281875284	NC_000020.11:58418288:C:T
GP6, 16-BP DEL	GP6		Platelet-type bleeding disorder 11	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000030506					30506	39463		
GP6, 5-BP DUP, 356AGCCC	GP6		Platelet-type bleeding disorder 11	Pathogenic(Last reviewed: Aug 27, 2009)	no assertion criteria provided	VCV000030504					30504	39461		
GP6, ARG38CYS	GP6	R38C	Platelet-type bleeding disorder 11	Pathogenic(Last reviewed: Aug 27, 2009)	no assertion criteria provided	VCV000030503					30503	39460		
NM_024022.3(TMPRSS3):c.308A>G (p.Asp103Gly)	TMPRSS3	D103G	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000030493	21	43809052	21	42388943	30493	39450	rs387906915	NC_000021.9:42388942:T:C
TMPRSS3, 1-BP DEL, 207C	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000030492					30492	39449		
NM_014339.6(IL17RA):c.850C>T (p.Gln284Ter)	IL17RA	Q284*	Immunodeficiency 51	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000030486	22	17585619	22	17104729	30486	39443	rs387906913	NC_000022.11:17104728:C:T
NM_000199.5(SGSH):c.892T>C (p.Ser298Pro)	SGSH	S298P	not provided|Mucopolysaccharidosis, MPS-III-A|Diarrhea|Developmental regression|Nystagmus|Retinal dystrophy|Severe visual impairment|Gastrointestinal dysmotility|Global developmental delay|Mucopolysaccharidosis|Sanfilippo syndrome	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030459	17	78185927	17	80212128	30459	39416	rs138504221	NC_000017.11:80212127:A:G
NM_020433.4(JPH2):c.494C>T (p.Ser165Phe)	JPH2	S165F	Familial hypertrophic cardiomyopathy 17	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000030457	20	42788933	20	44160293	30457	39414	rs387906898	NC_000020.11:44160292:G:A
NM_020433.4(JPH2):c.421T>C (p.Tyr141His)	JPH2	Y141H	Familial hypertrophic cardiomyopathy 17	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000030456	20	42789006	20	44160366	30456	39413	rs387906897	NC_000020.11:44160365:A:G
NM_020433.4(JPH2):c.301A>C (p.Ser101Arg)	JPH2	S101R	Familial hypertrophic cardiomyopathy 17	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000030455	20	42815045	20	44186405	30455	39412		NC_000020.11:44186404:T:G
NM_006796.2(AFG3L2):c.2011G>A (p.Gly671Arg)	AFG3L2	G671R		Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000030425	18	12337504	18	12337505	30425	39382	rs151344517	NC_000018.10:12337504:C:T
NM_006796.2(AFG3L2):c.1997T>G (p.Met666Arg)	AFG3L2	M666R		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000030424	18	12337518	18	12337519	30424	39381	rs151344515	NC_000018.10:12337518:A:C
NM_002894.2(RBBP8):c.1808_1809delTA (p.Ile603Lysfs)	RBBP8	I603fs	Microcephaly with mental retardation and digital anomalies	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000030409	18	20573597 - 20573598	18	22993634 - 22993635	30409	39366	rs587776884	NC_000018.10:22993633:ATA:A
NM_002894.3(RBBP8):c.2287+53T>G	RBBP8		Seckel syndrome 2	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000030408	18	20581745	18	23001782	30408	39365	rs587776883	NC_000018.10:23001781:T:G
NM_004247.4(EFTUD2):c.1910T>G (p.Leu637Arg)	EFTUD2	L637R, L602R, L627R	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030404	17	42936500	17	44859132	30404	39361	rs387906879	NC_000017.11:44859131:A:C
NM_004247.4(EFTUD2):c.2493C>A (p.Tyr831Ter)	EFTUD2	Y831*, Y821*, Y796*	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030403	17	42930732	17	44853364	30403	39360	rs879253726	NC_000017.11:44853363:G:T
NM_004247.4(EFTUD2):c.1759_1760del (p.Val587fs)	EFTUD2	V552fs, V587fs, V577fs	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030402	17	42937373 - 42937374	17	44860005 - 44860006	30402	39359	rs879253725	NC_000017.11:44860004:ACA:A
NM_004247.4(EFTUD2):c.2770C>T (p.Gln924Ter)	EFTUD2	Q924*, Q914*, Q889*	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030401	17	42929131	17	44851763	30401	39358	rs387906878	NC_000017.11:44851762:G:A
NM_004247.4(EFTUD2):c.784C>T (p.Arg262Trp)	EFTUD2	R262W, R227W, R252W	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000030400	17	42953387	17	44876019	30400	39357	rs387906877	NC_000017.11:44876018:G:A
NM_003560.4(PLA2G6):c.991G>T (p.Asp331Tyr)	PLA2G6	D331Y, D105Y, D153Y	not provided|Parkinson disease 14	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000030371	22	38528924	22	38132917	30371	39328	rs199935023	NC_000022.11:38132916:C:A
NM_003560.4(PLA2G6):c.109C>T (p.Arg37Ter)	PLA2G6	R37*	not provided|Infantile neuroaxonal dystrophy|Iron accumulation in brain	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030370	22	38565325	22	38169318	30370	39327	rs200075782	NC_000022.11:38169317:G:A
NC_000022.11:g.(38134406_38134454)_(38141038_38141086)del	PLA2G6		Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000030369	22	38530413 - 38537093	22	38134406 - 38141086	30369	39326		
NM_003560.4(PLA2G6):c.216C>A (p.Phe72Leu)	PLA2G6	F72L	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030368	22	38541654	22	38145647	30368	39325	rs774631197	NC_000022.11:38145646:G:T
NM_003560.4(PLA2G6):c.1354C>T (p.Gln452Ter)	PLA2G6	Q452*, Q220*, Q226*, Q274*, Q398*	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030367	22	38522451	22	38126444	30367	39324	rs387906864	NC_000022.11:38126443:G:A
LARGE1, 42.9-KB INS/4.1-KB DEL	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000030365					30365	39322		
NM_005619.5(RTN2):c.1100C>T (p.Ser367Phe)	RTN2	S367F, S27F, S294F	Hereditary spastic paraplegia 12	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000030326	19	45992745	19	45489487	30326	39282	rs140494585	NC_000019.10:45489486:G:A
RTN2, DEL	RTN2		Hereditary spastic paraplegia 12	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000030325					30325	39281		
NM_005619.5(RTN2):c.178dup (p.Arg60fs)	RTN2		Hereditary spastic paraplegia 12	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000030324	19	45998164 - 45998165	19	45494906 - 45494907	30324	39280		NC_000019.10:45494906:GGGGGG:GGGGGGG
NM_005450.5(NOG):c.696C>G (p.Cys232Trp)	NOG	C232W	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000030290	17	54672280	17	56594919	30290	39246	rs387906844	NC_000017.11:56594918:C:G
NM_001429.4(EP300):c.638del (p.Gly213fs)	EP300	G213fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030276	22	41513732	22	41117728	30276	39232	rs1569090642	NC_000022.11:41117727:GGG:GG
NM_006949.4(STXBP2):c.1621G>A (p.Gly541Ser)	STXBP2	G541S, G552S, G538S	not provided|Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030219	19	7712322	19	7647436	30219	39175	rs61736587	NC_000019.10:7647435:G:A
NM_005257.5(GATA6):c.1399G>A (p.Ala467Thr)	GATA6	A467T	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Dec 11, 2011)	no assertion criteria provided	VCV000030216	18	19761510	18	22181549	30216	39172	rs387906820	NC_000018.10:22181548:G:A
NM_005257.5(GATA6):c.1396A>G (p.Asn466Asp)	GATA6	N466D	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Dec 11, 2011)	no assertion criteria provided	VCV000030215	18	19761507	18	22181546	30215	39171	rs387906813	NC_000018.10:22181545:A:G
NM_005257.5(GATA6):c.1367G>A (p.Arg456His)	GATA6	R456H	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000030214	18	19761478	18	22181517	30214	39170	rs387906819	NC_000018.10:22181516:G:A
NM_005257.5(GATA6):c.1366C>T (p.Arg456Cys)	GATA6	R456C	Pancreatic agenesis and congenital heart disease|Abnormality of cardiovascular system morphology|Congenital diaphragmatic hernia	Pathogenic(Last reviewed: Jan 24, 2014)	criteria provided, single submitter	VCV000030213	18	19761477	18	22181516	30213	39169	rs387906818	NC_000018.10:22181515:C:T
NM_005257.5(GATA6):c.1448_1455del (p.Met483fs)	GATA6	M483fs	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Dec 11, 2011)	no assertion criteria provided	VCV000030212	18	19762736 - 19762743	18	22182775 - 22182782	30212	39168	rs587776872	NC_000018.10:22182774:ATGAAAAAA:A
NM_005257.5(GATA6):c.1354A>G (p.Thr452Ala)	GATA6	T452A	Pancreatic agenesis and congenital heart disease	Pathogenic(Last reviewed: Dec 11, 2011)	no assertion criteria provided	VCV000030211	18	19761465	18	22181504	30211	39167	rs387906817	NC_000018.10:22181503:A:G
NM_005257.5(GATA6):c.1396A>C (p.Asn466His)	GATA6	N466H	Persistent truncus arteriosus	Pathogenic(Last reviewed: Aug 18, 2009)	no assertion criteria provided	VCV000030207	18	19761507	18	22181546	30207	39163	rs387906813	NC_000018.10:22181545:A:C
NM_005257.5(GATA6):c.1455_1456AG[1] (p.Glu486fs)	GATA6		Persistent truncus arteriosus	Pathogenic(Last reviewed: Aug 18, 2009)	no assertion criteria provided	VCV000030206	18	19762744 - 19762745	18	22182783 - 22182784	30206	39162		NC_000018.10:22182782:AGAG:AG
NM_005359.5(SMAD4):c.1500A>G (p.Ile500Met)	SMAD4	I500M	Myhre syndrome|not provided	Pathogenic(Last reviewed: Jan 31, 2017)	no assertion criteria provided	VCV000030151	18	48604678	18	51078308	30151	39107	rs281875320	NC_000018.10:51078307:A:G
NM_005359.5(SMAD4):c.1498A>G (p.Ile500Val)	SMAD4	I500V	Juvenile polyposis syndrome|not provided|Myhre syndrome|Myhre syndrome|Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of pancreas|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030150	18	48604676	18	51078306	30150	39106	rs281875322	NC_000018.10:51078305:A:G
NM_005359.5(SMAD4):c.1499T>C (p.Ile500Thr)	SMAD4	I500T	not provided|Myhre syndrome	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000030149	18	48604677	18	51078307	30149	39105	rs281875321	NC_000018.10:51078306:T:C
NC_000021.7:g.37796500_37849000del	DYRK1A		Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030131	21	38874630 - 38927130			30131	39087		
NM_000891.2(KCNJ2):c.913A>C (p.Thr305Pro)	KCNJ2	T305P	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	VCV000030120	17	68172093	17	70175952	30120	39076	rs199473387	NC_000017.11:70175951:A:C
NM_000891.2(KCNJ2):c.161G>T (p.Cys54Phe)	KCNJ2	C54F	Familial periodic paralysis|Andersen Tawil syndrome	Pathogenic(Last reviewed: Apr 15, 2007)	no assertion criteria provided	VCV000030119	17	68171341	17	70175200	30119	39075	rs199473650	NC_000017.11:70175199:G:T
NM_004187.4(KDM5C):c.1660C>A (p.Pro554Thr)	KDM5C	P554T, P487T, P553T	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000029997	X	53239682	X	53210500	29997	38952	rs387906729	NC_000023.11:53210499:G:T
NM_004187.4(KDM5C):c.2172C>A (p.Cys724Ter)	KDM5C	C724*, C657*, C723*	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000029996	X	53228230	X	53199048	29996	38951	rs281860639	NC_000023.11:53199047:G:T
NM_000451.3(SHOX):c.509C>A (p.Ala170Asp)	SHOX	A170D		Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029995	X	601578	X	640843	29995	38950	rs397514462	NC_000024.10:640842:C:A
NM_000451.3(SHOX):c.508G>C (p.Ala170Pro)	SHOX	A170P	Langer mesomelic dysplasia syndrome|	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029994	X	601577	X	640842	29994	38949	rs397514461	NC_000024.10:640841:G:C
NM_003336.4(UBE2A):c.32G>A (p.Arg11Gln)	UBE2A	R11Q	Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000029993	X	118708706	X	119574743	29993	38948	rs387906728	NC_000023.11:119574742:G:A
UBE2A, GLY23ARG	UBE2A	G23R	Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000029992					29992	38947		
NM_001204402.1(PRPS1):c.-82-2793G>C	PRPS1	V142L	Arts syndrome	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000029989	X	106885614	X	107642384	29989	38944	rs398122855	NC_000023.11:107642383:G:C
NM_002641.3(PIGA):c.1234C>T (p.Arg412Ter)	PIGA	R412*, R178*	Multiple congenital anomalies-hypotonia-seizures syndrome 2|not provided	Pathogenic(Last reviewed: Apr 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029988	X	15339849	X	15321727	29988	38943	rs387906726	NC_000023.11:15321726:G:A
NM_002024.6(FMR1):c.80C>A (p.Ser27Ter)	FMR1	S27*	Fragile X syndrome	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000029987	X	147003479	X	147921961	29987	38942	rs1569545382	NC_000023.11:147921960:C:A
NM_001278116.2(L1CAM):c.3458-1G>C	L1CAM		X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000029986	X	153129005	X	153863550	29986	38941	rs879253724	NC_000023.11:153863549:C:G
NM_000194.3(HPRT1):c.143G>A (p.Arg48His)	HPRT1	R48H	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-nyhan syndrome, neurologic variant|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-Nyhan syndrome	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000029985	X	133609219	X	134475189	29985	38940	rs387906725	NC_000023.11:134475188:G:A
NC_000023.9:g.9688757-?_9693917+?del	GPR143		Ocular albinism, type I	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000029984					29984	38939		
AFF2, 121- to 145-KB DEL	AFF2		FRAXE	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000029983					29983	38938		
NM_032121.5(MAGT1):c.409C>T (p.Arg137Ter)	MAGT1	R137*, R105*	Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia|not provided	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000029982	X	77126382	X	77870885	29982	38937	rs387906724	NC_000023.11:77870884:G:A
NM_032121.5(MAGT1):c.922_922+9del	MAGT1		Immunodeficiency, X-Linked, with magnesium defect, Epstein-Barr virus infection, and neoplasia	Pathogenic(Last reviewed: Jul 27, 2011)	no assertion criteria provided	VCV000029981	X	77109389 - 77109398	X	77853892 - 77853901	29981	38936		NC_000023.11:77853891:AAAGGATACTAAA:AAA
NM_203473.3(PORCN):c.1094G>A (p.Arg365Gln)	PORCN	R365Q, R364Q, R288Q, R359Q, R370Q	Focal dermal hypoplasia	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000029980	X	48374470	X	48516082	29980	38935	rs387906723	NC_000023.11:48516081:G:A
NM_152424.4(AMER1):c.429T>A (p.Cys143Ter)	AMER1	C143*	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029979	X	63412738	X	64192858	29979	38934	rs387906722	NC_000023.11:64192857:A:T
NM_194277.2(FRMD7):c.1050+5G>A	FRMD7		Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000029978	X	131214029	X	132080001	29978	38933		NC_000023.11:132080000:C:T
NM_194277.2(FRMD7):c.812G>A (p.Cys271Tyr)	FRMD7	C271Y, C256Y	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029977	X	131216484	X	132082456	29977	38932	rs387906721	NC_000023.11:132082455:C:T
NM_194277.2(FRMD7):c.691T>G (p.Leu231Val)	FRMD7	L231V, L216V	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029976	X	131218568	X	132084540	29976	38931	rs387906720	NC_000023.11:132084539:A:C
NM_033290.4(MID1):c.712G>T (p.Glu238Ter)	MID1	E238*, E200*	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000029975	X	10491176	X	10523136	29975	38930	rs387906719	NC_000023.11:10523135:C:A
NM_004463.3(FGD1):c.1966C>T (p.Arg656Ter)	FGD1	R656*	Aarskog syndrome	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000029974	X	54481930	X	54455497	29974	38929	rs387906718	NC_000023.11:54455496:G:A
OCRL, 2-BP DEL, 166TT	OCRL			Pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000029973					29973	38928		
OCRL, ILE526THR	OCRL	I526T		Pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000029972					29972	38927		
OCRL, ARG476TRP	OCRL	R476W		Pathogenic(Last reviewed: Feb 27, 2020)	no assertion criteria provided	VCV000029971					29971	38926		
NM_000397.3(CYBB):c.532A>C (p.Thr178Pro)	CYBB	T178P	Chronic granulomatous disease|Atypical mycobacteriosis, familial, X-linked 2|not provided	Pathogenic(Last reviewed: Feb 11, 2016)	no assertion criteria provided	VCV000029970	X	37655252	X	37795999	29970	38925	rs151344497	NC_000023.11:37795998:A:C
NM_000397.3(CYBB):c.692A>C (p.Gln231Pro)	CYBB	E231P, Q231P	Chronic granulomatous disease|Atypical mycobacteriosis, familial, X-linked 2|not provided	Pathogenic(Last reviewed: Feb 11, 2016)	no assertion criteria provided	VCV000029969	X	37658225	X	37798972	29969	38924	rs151344498	NC_000023.11:37798971:A:C
NM_001353921.2(ARHGEF9):c.4C>T (p.Gln2Ter)	ARHGEF9	Q2*	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000029968	X	63005022	X	63785142	29968	38923	rs397514460	NC_000023.11:63785141:G:A
NM_000377.2(WAS):c.881T>C (p.Ile294Thr)	WAS	I294T	|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029967	X	48546792	X	48688403	29967	38922	rs387906717	NC_000023.11:48688402:T:C
NM_000377.2(WAS):c.814T>C (p.Ser272Pro)	WAS	S272P		Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000029966	X	48546725	X	48688336	29966	38921	rs387906716	NC_000023.11:48688335:T:C
NM_139058.3(ARX):c.1604T>A (p.Leu535Gln)	ARX	L535Q	Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000029965	X	25022872	X	25004755	29965	38920	rs387906715	NC_000023.11:25004754:A:T
NM_139058.3(ARX):c.81C>G (p.Tyr27Ter)	ARX	Y27*	Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000029964	X	25033774	X	25015657	29964	38919	rs398122854	NC_000023.11:25015656:G:C
NM_004006.2(DMD):c.9G>A (p.Trp3Ter)	DMD	W3*	Duchenne muscular dystrophy|Becker muscular dystrophy|not provided|Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029962	X	33229421	X	33211304	29962	38917	rs398122853	NC_000023.11:33211303:C:T
NM_001143981.2(CHRDL1):c.652C>T (p.Arg218Ter)	CHRDL1	R218*, R217*, R138*	Megalocornea	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029961	X	109937517	X	110694289	29961	38916	rs387906714	NC_000023.11:110694288:G:A
NM_001143981.2(CHRDL1):c.100_101GA[1] (p.Glu34fs)	CHRDL1		Megalocornea	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029960	X	110006027 - 110006028	X	110762799 - 110762800	29960	38915	rs398122852	NC_000023.11:110762798:TCTCT:TCT
NM_001143981.2(CHRDL1):c.301+2T>G	CHRDL1		Megalocornea	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029959	X	110002887	X	110759659	29959	38914	rs587776868	NC_000023.11:110759658:A:C
NM_001143981.2(CHRDL1):c.782G>T (p.Cys261Phe)	CHRDL1	C261F, C181F, C260F	Megalocornea	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029958	X	109932028	X	110688800	29958	38913	rs387906713	NC_000023.11:110688799:C:A
NM_001143981.2(CHRDL1):c.872del (p.Cys291fs)	CHRDL1	C290fs, C211fs, C291fs	Megalocornea	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029957	X	109931938	X	110688710	29957	38912	rs398122851	NC_000023.11:110688709:C:
NM_003413.4(ZIC3):c.163_165GCC[3] (p.Ala54_Ala55dup)	ZIC3		VACTERL association with hydrocephaly, X-linked	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000029955	X	136649012 - 136649013	X	137566853 - 137566854	29955	38910	rs398122850	NC_000023.11:137566853:GCC:GCCGCCGCC
NM_013444.3(UBQLN2):c.1516C>A (p.Pro506Thr)	UBQLN2	P506T	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029952	X	56591822	X	56565389	29952	38907	rs387906711	NC_000023.11:56565388:C:A
NM_013444.3(UBQLN2):c.1489C>T (p.Pro497Ser)	UBQLN2	P497S	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029951	X	56591795	X	56565362	29951	38906	rs387906710	NC_000023.11:56565361:C:T
NM_013444.3(UBQLN2):c.1490C>A (p.Pro497His)	UBQLN2	P497H	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029950	X	56591796	X	56565363	29950	38905	rs387906709	NC_000023.11:56565362:C:A
NM_001042537.1(SLC9A6):c.1012_1020del (p.Gly338_Ala340del)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000029949	X	135092713 - 135092721	X	136010554 - 136010562	29949	38904	rs398122849	NC_000023.11:136010553:GGTGCTGCT:
NM_014332.3(SMPX):c.130del (p.Glu44fs)	SMPX	E44fs	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029948	X	21761870	X	21743752	29948	38903	rs398122848	NC_000023.11:21743751:CC:C
NM_014332.3(SMPX):c.214G>T (p.Glu72Ter)	SMPX	E72*	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029947	X	21755734	X	21737616	29947	38902	rs387906708	NC_000023.11:21737615:C:A
NM_014332.3(SMPX):c.109G>T (p.Glu37Ter)	SMPX	E37*	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029946	X	21761891	X	21743773	29946	38901	rs387906707	NC_000023.11:21743772:C:A
NM_014332.3(SMPX):c.175G>T (p.Gly59Ter)	SMPX	G59*	Deafness, X-linked 4	Pathogenic(Last reviewed: May 13, 2011)	no assertion criteria provided	VCV000029945	X	21755773	X	21737655	29945	38900	rs387906706	NC_000023.11:21737654:C:A
NG_008292.1:g.700375-?_1335033+?del	IL1RAPL1		Mental retardation 21, X-linked	Pathogenic(Last reviewed: Dec 15, 2008)	no assertion criteria provided	VCV000029944					29944	38899		
NM_021120.4(DLG3):c.1092dup (p.Thr365fs)	DLG3		X-Linked mental retardation 90	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000029942	X	69671817 - 69671818	X	70451967 - 70451968	29942	38897	rs398122846	NC_000023.11:70451967:CCCCCC:CCCCCCC
NM_003688.3(CASK):c.1639C>T (p.Gln547Ter)	CASK	Q547*, Q541*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000029941	X	41420841	X	41561588	29941	38896	rs387906705	NC_000023.11:41561587:G:A
NG_016754.1:g.5000-?_5105+?del	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000029940					29940	38895		
NM_003688.3(CASK):c.316C>T (p.Arg106Ter)	CASK	R106*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029939	X	41604817	X	41745564	29939	38894	rs387906704	NC_000023.11:41745563:G:A
nsv1067838	KDM6A		Kabuki syndrome 2	Pathogenic(Last reviewed: Jan 13, 2012)	no assertion criteria provided	VCV000029935	X	44866302 - 44912718	X	45007057 - 45053473	29935	38890		
NG_008960.1:g.224486-?_245539+?del	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000029934					29934	38889		
NM_001493.3(GDI1):c.1184_1185AG[1] (p.Ser396fs)	GDI1		X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029933	X	153670767 - 153670768	X	154442420 - 154442421	29933	38888	rs398122814	NC_000023.11:154442419:GAGAG:GAG
NM_004586.3(RPS6KA3):c.343A>T (p.Thr115Ser)	RPS6KA3	T115S	Mental retardation, X-linked 19	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000029932	X	20213246	X	20195128	29932	38887	rs387906703	NC_000023.11:20195127:T:A
NM_004586.3(RPS6KA3):c.455_457GAG[1] (p.Gly153del)	RPS6KA3	G153del	Mental retardation, X-linked 19	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000029931	X	20212333 - 20212335	X	20194215 - 20194217	29931	38886	rs398122813	NC_000023.11:20194214:CTCCTCC:CTCC
SMC1A, 8.152-KB DEL	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000029930					29930	38885		
NM_001281463.1(SMC1A):c.2285T>C (p.Ile762Thr)	SMC1A	I784T, I762T	not provided|Congenital muscular hypertrophy-cerebral syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029929	X	53430567	X	53403635	29929	38884	rs387906702	NC_000023.11:53403634:A:G
NM_006907.4(PYCR1):c.743G>A (p.Gly248Glu)	PYCR1	G248E, G275E, G217E	Autosomal recessive cutis laxa type 3B|not provided	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029865	17	79892256	17	81934380	29865	38820	rs281875319	NC_000017.11:81934379:C:T
NM_006907.4(PYCR1):c.345del (p.Arg116fs)	PYCR1	R116fs, R143fs	Autosomal recessive cutis laxa type 3B	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000029864	17	79892997	17	81935121	29864	38819	rs758601634	NC_000017.11:81935120:GGGGG:GGGG
NM_006907.4(PYCR1):c.769G>A (p.Ala257Thr)	PYCR1	A257T, A284T, A226T	Autosomal recessive cutis laxa type 3B|not provided	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000029863	17	79892230	17	81934354	29863	38818	rs281875318	NC_000017.11:81934353:C:T
NM_002739.5(PRKCG):c.1438G>T (p.Asp480Tyr)	PRKCG	D480Y		Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000029858	19	54403866	19	53900612	29858	38813	rs387906679	NC_000019.10:53900611:G:T
NM_002739.3(PRKCG):c.530_919del	PRKCG			Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000029857					29857	38812		
NM_001611.5(ACP5):c.831_833del (p.Tyr278del)	ACP5	Y278del	Spondyloenchondrodysplasia with immune dysregulation	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000029834	19	11685970 - 11685972	19	11575155 - 11575157	29834	38789	rs387906671	NC_000019.10:11575154:TAG:
NM_001626.6(AKT2):c.49G>A (p.Glu17Lys)	AKT2	E17K	Hypoinsulinemic hypoglycemia and hemihypertrophy	Pathogenic(Last reviewed: Oct 28, 2011)	no assertion criteria provided	VCV000029804	19	40762959	19	40257052	29804	38759	rs387906659	NC_000019.10:40257051:C:T
NM_001077488.4(GNAS):c.1177G>A (p.Glu393Lys)	GNAS	E392K, E393K, E378K, E1035K, E333K, E377K	not provided|Pseudohypoparathyroidism type 1C	Pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	VCV000029747	20	57485873	20	58910818	29747	38702	rs397514456	NC_000020.11:58910817:G:A
NM_001077488.4(GNAS):c.1166T>G (p.Leu389Arg)	GNAS	L388R, L389R, L373R, L374R, L1031R, L329R	Pseudohypoparathyroidism type 1C	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029746	20	57485862	20	58910807	29746	38701	rs397514457	NC_000020.11:58910806:T:G
NM_001077488.4(GNAS):c.1177G>T (p.Glu393Ter)	GNAS	E392*, E393*, E378*, E1035*, E333*, E377*	Pseudohypoparathyroidism type 1C	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029745	20	57485873	20	58910818	29745	38700	rs397514456	NC_000020.11:58910817:G:T
CSF2RB, 1-BP DEL, 631C	CSF2RB		Surfactant metabolism dysfunction, pulmonary, 5	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000029744					29744	38699		
NM_001130823.3(DNMT1):c.1518_1520delinsATA (p.Asp506_Pro507delinsGluTyr)	DNMT1		Hereditary sensory neuropathy type IE	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029683	19	10265705 - 10265707	19	10155029 - 10155031	29683	38638	rs199473691	NC_000019.10:10155028:GGA:TAT
NM_001130823.3(DNMT1):c.1532A>G (p.Tyr511Cys)	DNMT1	Y495C, Y511C, Y390C	not provided|Hereditary sensory neuropathy type IE|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000029682	19	10265693	19	10155017	29682	38637	rs199473690	NC_000019.10:10155016:T:C
NM_000782.5(CYP24A1):c.964G>A (p.Glu322Lys)	CYP24A1	E322K	Hypercalcemia, infantile, 1	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000029681	20	52779282	20	54162743	29681	38636	rs387907324	NC_000020.11:54162742:C:T
NM_000782.5(CYP24A1):c.1226T>C (p.Leu409Ser)	CYP24A1	L409S	Hypercalcemia, infantile, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029680	20	52774635	20	54158096	29680	38635	rs6068812	NC_000020.11:54158095:A:G
NM_000782.5(CYP24A1):c.1186C>T (p.Arg396Trp)	CYP24A1	R396W	Hypercalcemia, infantile, 1|not provided|Muscle cramps	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000029679	20	52774675	20	54158136	29679	38634	rs114368325	NC_000020.11:54158135:G:A
NM_000782.5(CYP24A1):c.451G>T (p.Glu151Ter)	CYP24A1	E151*	Hypercalcemia, infantile, 1	Pathogenic(Last reviewed: Aug 4, 2011)	no assertion criteria provided	VCV000029678	20	52788208	20	54171669	29678	38633	rs387907323	NC_000020.11:54171668:C:A
NM_000782.5(CYP24A1):c.476G>A (p.Arg159Gln)	CYP24A1	R159Q	Hypercalcemia, infantile, 1	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000029676	20	52788183	20	54171644	29676	38631	rs387907322	NC_000020.11:54171643:C:T
NM_000782.5(CYP24A1):c.1424_1425CT[1] (p.Cys477fs)	CYP24A1		Hypercalcemia, infantile, 1	Pathogenic(Last reviewed: Aug 4, 2011)	no assertion criteria provided	VCV000029675	20	52773934 - 52773935	20	54157395 - 54157396	29675	38630	rs876657376	NC_000020.11:54157394:AGAG:AG
COL18A1, 2-BP DEL	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000029653					29653	38608		
COL18A1, 2-BP DEL, 3617CT	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000029652					29652	38607		
NM_001250.6(CD40):c.95_97TAA[1] (p.Ile33del)	CD40	I33del		Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000029611	20	44750502 - 44750504	20	46121863 - 46121865	29611	38565	rs1568905451	NC_000020.11:46121862:TAATAA:TAA
NM_001614.5(ACTG1):c.766C>T (p.Arg256Trp)	ACTG1	R256W	Baraitser-Winter Syndrome 2|not provided|Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	VCV000029590	17	79478250	17	81511224	29590	38544	rs281875329	NC_000017.11:81511223:G:A
NM_001614.5(ACTG1):c.760C>T (p.Arg254Trp)	ACTG1	R254W	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029589	17	79478256	17	81511230	29589	38543	rs281875328	NC_000017.11:81511229:G:A
NM_001614.5(ACTG1):c.608C>A (p.Thr203Lys)	ACTG1	T203K	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029588	17	79478408	17	81511382	29588	38542	rs281875327	NC_000017.11:81511381:G:T
NM_001614.5(ACTG1):c.404C>T (p.Ala135Val)	ACTG1	A135V	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029587	17	79478612	17	81511586	29587	38541	rs11549190	NC_000017.11:81511585:G:A
NM_001614.5(ACTG1):c.359C>T (p.Thr120Ile)	ACTG1	T120I	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029586	17	79478933	17	81511907	29586	38540	rs281875325	NC_000017.11:81511906:G:A
NM_001614.5(ACTG1):c.464C>T (p.Ser155Phe)	ACTG1	S155F	Baraitser-Winter Syndrome 2|not provided	Pathogenic(Last reviewed: Sep 25, 2013)	criteria provided, single submitter	VCV000029585	17	79478552	17	81511526	29585	38539	rs281875326	NC_000017.11:81511525:G:A
NM_005359.5:c.1228-1229delCA	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024879	18	48592247	18	51065877	24879	36220	rs483352871	NC_000018.10:51065876:AAAA:AAA
NM_005359.5(SMAD4):c.1612_1625del (p.Glu538Hisfs)	SMAD4	E538fs	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024878	18	48604788 - 48604801	18	51078418 - 51078431	24878	36219	rs377767385	NC_000018.10:51078417:ACGAAGTACTTCATAC:AC
NM_005359.5(SMAD4):c.1607dup (p.Asp537Argfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024877	18	48604784 - 48604785	18	51078414 - 51078415	24877	36218	rs377767384	NC_000018.10:51078414:T:TT
NM_005359.5(SMAD4):c.1598T>C (p.Leu533Pro)	SMAD4	L533P	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024876	18	48604776	18	51078406	24876	36217	rs377767382	NC_000018.10:51078405:T:C
NM_005359.5(SMAD4):c.1600C>T (p.Gln534Ter)	SMAD4	Q534*	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024875	18	48604778	18	51078408	24875	36216	rs377767383	NC_000018.10:51078407:C:T
NM_005359.5(SMAD4):c.1598T>G (p.Leu533Arg)	SMAD4	L533R	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024874	18	48604776	18	51078406	24874	36215	rs377767382	NC_000018.10:51078405:T:G
NM_005359.5(SMAD4):c.1597C>G (p.Leu533Val)	SMAD4	L533V	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024873	18	48604775	18	51078405	24873	36214	rs377767381	NC_000018.10:51078404:C:G
NM_005359.5(SMAD4):c.1596delC (p.Leu533Serfs)	SMAD4	L533fs	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024872	18	48604773	18	51078403	24872	36213	rs377767380	NC_000018.10:51078402:CCC:CC
NM_005359.5(SMAD4):c.1596_1597delCCinsT (p.Leu533Serfs)	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024871	18	48604774 - 48604775	18	51078404 - 51078405	24871	36212	rs377767379	NC_000018.10:51078403:CC:T
NM_005359.5(SMAD4):c.1594delG (p.Ala532Profs)	SMAD4	A532fs	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024870	18	48604770	18	51078400	24870	36211	rs377767378	NC_000018.10:51078399:GGG:GG
NM_005359.5(SMAD4):c.1586_1587dup (p.His530Tyrfs)	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024869	18	48604763 - 48604764	18	51078393 - 51078394	24869	36210	rs1555687599	NC_000018.10:51078393:TA:TATA
NM_005359.5(SMAD4):c.1588delC (p.His530Thrfs)	SMAD4	H530fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024868	18	48604766	18	51078396	24868	36209	rs377767377	NC_000018.10:51078395:C:
NM_005359.5(SMAD4):c.1587dup (p.His530Thrfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024867	18	48604764 - 48604765	18	51078394 - 51078395	24867	36208	rs377767376	NC_000018.10:51078394:A:AA
NM_005359.5(SMAD4):c.1571G>T (p.Trp524Leu)	SMAD4	W524L	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024866	18	48604749	18	51078379	24866	36207	rs377767375	NC_000018.10:51078378:G:T
NM_005359.5(SMAD4):c.1564_1565delCC (p.Pro522Leufs)	SMAD4	P522fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024865	18	48604742 - 48604743	18	51078372 - 51078373	24865	36206	rs377767374	NC_000018.10:51078371:CC:
NM_005359.5(SMAD4):c.1547_1550dupAGAG (p.Ser517Argfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024863	18	48604724 - 48604725	18	51078354 - 51078355	24863	36204	rs377767373	NC_000018.10:51078354:AGAG:AGAGAGAG
NM_005359.5(SMAD4):c.1544delG (p.Arg515Asnfs)	SMAD4	R515fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024862	18	48604722	18	51078352	24862	36203	rs377767372	NC_000018.10:51078351:G:
NM_005359.5(SMAD4):c.1529G>T (p.Gly510Val)	SMAD4	G510V	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024861	18	48604707	18	51078337	24861	36202	rs377767371	NC_000018.10:51078336:G:T
NM_005359.5(SMAD4):c.1527G>A (p.Trp509Ter)	SMAD4	W509*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024860	18	48604705	18	51078335	24860	36201	rs377767370	NC_000018.10:51078334:G:A
NM_005359.5(SMAD4):c.1525T>A (p.Trp509Arg)	SMAD4	W509R	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024859	18	48604703	18	51078333	24859	36200	rs377767369	NC_000018.10:51078332:T:A
NM_005359.5(SMAD4):c.1478A>C (p.Asp493Ala)	SMAD4	D493A	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024858	18	48604656	18	51078286	24858	36199	rs377767368	NC_000018.10:51078285:A:C
NM_005359.5(SMAD4):c.1472G>T (p.Gly491Val)	SMAD4	G491V	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024857	18	48604650	18	51078280	24857	36198	rs377767367	NC_000018.10:51078279:G:T
NM_005359.5(SMAD4):c.1421delC (p.Ser474Terfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024856	18	48603120	18	51076750	24856	36197	rs377767366	NC_000018.10:51076749:C:
NM_005359.5(SMAD4):c.1411_1435del (p.Gly471Leufs)	SMAD4	G471fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024855	18	48603110 - 48603134	18	51076740 - 51076764	24855	36196	rs377767365	NC_000018.10:51076739:GGCCCAGGATCAGTAGGTGGAATAG:
NM_005359.5(SMAD4):c.1409_1410insCCCT (p.Gly471Profs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024854	18	48603108 - 48603109	18	51076738 - 51076739	24854	36195	rs377767364	NC_000018.10:51076738::CCCT
NM_005359.5(SMAD4):c.1361_1364delCACA (p.Ala454Glufs)	SMAD4	A454fs	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000024853	18	48603060 - 48603063	18	51076690 - 51076693	24853	36194	rs377767363	NC_000018.10:51076689:CACA:
NM_005359.5(SMAD4):c.1343_1365del (p.Gln448Argfs)	SMAD4	Q448fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024852	18	48603042 - 48603064	18	51076672 - 51076694	24852	36193	rs377767362	NC_000018.10:51076671:AGCAGCAGGCGGCTACTGCACAA:
NM_005359.5(SMAD4):c.1342C>T (p.Gln448Ter)	SMAD4	Q448*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024851	18	48603041	18	51076671	24851	36192	rs377767361	NC_000018.10:51076670:C:T
NM_005359.5(SMAD4):c.1333C>T (p.Arg445Ter)	SMAD4	R445*	not provided|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024850	18	48603032	18	51076662	24850	36191	rs377767360	NC_000018.10:51076661:C:T
NM_005359.5(SMAD4):c.1268delG (p.Gly423Glufs)	SMAD4	G423fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024849	18	48593516	18	51067146	24849	36190	rs377767359	NC_000018.10:51067145:GG:G
NM_005359.5(SMAD4):c.1242delA (p.Asp415Thrfs)	SMAD4	D415fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000024847	18	48593491	18	51067121	24847	36188	rs377767358	NC_000018.10:51067120:A:
NM_005359.5(SMAD4):c.1236C>G (p.Tyr412Ter)	SMAD4	Y412*	Juvenile polyposis syndrome|Carcinoma of pancreas	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024845	18	48593485	18	51067115	24845	36186	rs121912577	NC_000018.10:51067114:C:G
NM_005359.5(SMAD4):c.1193G>A (p.Trp398Ter)	SMAD4	W398*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024844	18	48593442	18	51067072	24844	36185	rs377767357	NC_000018.10:51067071:G:A
NM_005359.5(SMAD4):c.1168G>A (p.Glu390Lys)	SMAD4	E390K	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024843	18	48593417	18	51067047	24843	36184	rs377767356	NC_000018.10:51067046:G:A
NM_005359.5(SMAD4):c.1162C>T (p.Gln388Ter)	SMAD4	Q388*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024842	18	48593411	18	51067041	24842	34298	rs80338964	NC_000018.10:51067040:C:T
NM_005359.5(SMAD4):c.1148T>A (p.Ile383Lys)	SMAD4	I383K	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024840	18	48593397	18	51067027	24840	36181	rs377767355	NC_000018.10:51067026:T:A
NM_005359.5(SMAD4):c.1139+1G>A	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024839	18	48591977	18	51065607	24839	36180	rs377767354	NC_000018.10:51065606:G:A
NM_005359.5(SMAD4):c.1113delC (p.His371Glnfs)	SMAD4	H371fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024838	18	48591950	18	51065580	24838	36179	rs377767352	NC_000018.10:51065579:C:
NM_005359.5(SMAD4):c.1102_1103delTC (p.Ser368Glnfs)	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024837	18	48591936 - 48591937	18	51065566 - 51065567	24837	36178	rs377767351	NC_000018.10:51065565:CTCTC:CTC
NM_005359.5(SMAD4):c.1091T>G (p.Leu364Trp)	SMAD4	L364W	JP and JP/HHT	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024836	18	48591928	18	51065558	24836	36177	rs377767350	NC_000018.10:51065557:T:G
NM_005359.5(SMAD4):c.1088_1090delGTT (p.Cys363del)	SMAD4	C363del	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024835	18	48591923 - 48591925	18	51065553 - 51065555	24835	36176	rs377767349	NC_000018.10:51065552:TTGTT:TT
NM_005359.5(SMAD4):c.1087T>C (p.Cys363Arg)	SMAD4	C363R	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024834	18	48591924	18	51065554	24834	36175	rs377767348	NC_000018.10:51065553:T:C
NM_005359.5(SMAD4):c.1082G>T (p.Arg361Leu)	SMAD4	R361L	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024833	18	48591919	18	51065549	24833	36174	rs377767347	NC_000018.10:51065548:G:T
NM_005359.5(SMAD4):c.1082G>A (p.Arg361His)	SMAD4	R361H	Neoplasm of the breast|JP and JP/HHT|Juvenile polyposis syndrome|Carcinoma of esophagus|Pancreatic adenocarcinoma|Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach|Uterine cervical neoplasms|Myhre syndrome|Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of pancreas|Lung adenocarcinoma|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024832	18	48591919	18	51065549	24832	36173	rs377767347	NC_000018.10:51065548:G:A
NM_005359.5(SMAD4):c.1058A>C (p.Tyr353Ser)	SMAD4	Y353S	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024829	18	48591895	18	51065525	24829	36170	rs377767346	NC_000018.10:51065524:A:C
NM_005359.5(SMAD4):c.1055G>A (p.Gly352Glu)	SMAD4	G352E	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024828	18	48591892	18	51065522	24828	36169	rs377767345	NC_000018.10:51065521:G:A
NM_005359.5(SMAD4):c.1054G>A (p.Gly352Arg)	SMAD4	G352R	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|JP and JP/HHT|not provided	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024827	18	48591891	18	51065521	24827	36168	rs121912581	NC_000018.10:51065520:G:A
NM_005359.5(SMAD4):c.1042_1043del (p.Val348Tyrfs)	SMAD4	V348fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024826	18	48591878 - 48591879	18	51065508 - 51065509	24826	36167	rs377767344	NC_000018.10:51065507:TGT:T
NM_005359.5(SMAD4):c.1037delC (p.Pro346Leufs)	SMAD4	P346fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000024825	18	48591872	18	51065502	24825	36166	rs377767343	NC_000018.10:51065501:CCC:CC
NM_005359.5(SMAD4):c.988G>A (p.Glu330Lys)	SMAD4	E330K	JP and JP/HHT	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024823	18	48591825	18	51065455	24823	36164	rs377767342	NC_000018.10:51065454:G:A
NM_005359.5(SMAD4):c.1081C>A (p.Arg361Ser)	SMAD4	R361S	Juvenile polyposis syndrome|Neoplasm of the large intestine	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000024822	18	48591918	18	51065548	24822	36163	rs80338963	NC_000018.10:51065547:C:A
NM_005359.5(SMAD4):c.982_983insT (p.Tyr328Leufs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024821	18	48591817 - 48591818	18	51065447 - 51065448	24821	36162	rs377767341	NC_000018.10:51065447:TT:TTT
NM_005359.5(SMAD4):c.971delG (p.Cys324Phefs)	SMAD4	C324fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024820	18	48591808	18	51065438	24820	36161	rs377767340	NC_000018.10:51065437:G:
NM_005359.5(SMAD4):c.925_928dupGCAT (p.Phe310Cysfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024818	18	48586254 - 48586255	18	51059884 - 51059885	24818	36159	rs377767338	NC_000018.10:51059884:TGCAT:TGCATGCAT
NM_005359.5(SMAD4):c.831_832delAC (p.Pro278Terfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024816	18	48584749 - 48584750	18	51058379 - 51058380	24816	36157	rs377767336	NC_000018.10:51058378:ACACAC:ACAC
NM_005359.5(SMAD4):c.788-?_1659+?del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024814	18	48584710 - 48604837			24814	36155		
NM_005359.5(SMAD4):c.731_732insGCCC(p.Gln245Profs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000024813	18	48584558 - 48584559	18	51058186 - 51058187	24813	36154	rs377767335	NC_000018.10:51058186:CC:CCGCCC
NM_005359.5(SMAD4):c.692dupG (p.Ser232Glnfs)	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000024811	18	48584513 - 48584514	18	51058143 - 51058144	24811	36152	rs377767334	NC_000018.10:51058143:GGGGGG:GGGGGGG
NM_005359.5(SMAD4):c.668-?_1659+?del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024810	18	48584495 - 48604837			24810	36151		
NM_005359.5(SMAD4):c.608delC (p.Pro203Hisfs)	SMAD4	P203fs	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024809	18	48581301	18	51054931	24809	36150	rs377767333	NC_000018.10:51054930:CCCC:CCC
NM_005359.5(SMAD4):c.538C>T (p.Gln180Ter)	SMAD4	Q180*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024808	18	48581234	18	51054864	24808	36149	rs377767332	NC_000018.10:51054863:C:T
NM_005359.5(SMAD4):c.533C>G (p.Ser178Ter)	SMAD4	S178*	Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 25, 2015)	criteria provided, single submitter	VCV000024807	18	48581229	18	51054859	24807	36148	rs377767331	NC_000018.10:51054858:C:G
NM_005359.5(SMAD4):c.516_527del (p.Ser173_Gly176del)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024806	18	48581212 - 48581223	18	51054842 - 51054853	24806	36147	rs377767330	NC_000018.10:51054841:GTCCACTGAAGG:
NM_005359.5(SMAD4):c.437T>A (p.Leu146Ter)	SMAD4	L146*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024805	18	48575677	18	51049307	24805	36146	rs377767329	NC_000018.10:51049306:T:A
NM_005359.5(SMAD4):c.430_431delTC (p.Ser144Argfs)	SMAD4		Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024804	18	48575666 - 48575667	18	51049296 - 51049297	24804	36145	rs377767328	NC_000018.10:51049295:TCTCTC:TCTC
NM_005359.5(SMAD4):c.403C>T (p.Arg135Ter)	SMAD4	R135*	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000024802	18	48575209	18	51048839	24802	36143	rs377767326	NC_000018.10:51048838:C:T
NM_005359.5(SMAD4):c.375_381dup (p.Val128Cysfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024801	18	48575180 - 48575181	18	51048810 - 51048811	24801	36142	rs377767325	NC_000018.10:51048810:TGTCTGT:TGTCTGTTGTCTGT
NM_005359.5(SMAD4):c.373_374insAT (p.Ser125Asnfs)	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024800	18	48575179 - 48575180	18	51048809 - 51048810	24800	36141	rs377767324	NC_000018.10:51048809::AT
NM_005359.5(SMAD4):c.302G>A (p.Trp101Ter)	SMAD4	W101*	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024798	18	48575108	18	51048738	24798	36139	rs377767323	NC_000018.10:51048737:G:A
NM_005359.5(SMAD4):c.(?_-17093)_(1659_?)del	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024795	18	48540028 - 48604837	18	51013658 - 51078467	24795	36136		
NM_033380.3(COL4A5):c.5060G>T (p.Cys1687Phe)	COL4A5	C1681F, C1687F	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024792	X	107939592	X	108696362	24792	36133	rs281874754	NC_000023.11:108696361:G:T
NM_033380.3(COL4A5):c.5052T>G (p.Cys1684Trp)	COL4A5	C1678W, C1684W	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024791	X	107939584	X	108696354	24791	36132	rs104886311	NC_000023.11:108696353:T:G
NM_033380.3(COL4A5):c.5050T>C (p.Cys1684Arg)	COL4A5	C1678R, C1684R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024789	X	107939582	X	108696352	24789	36130	rs104886310	NC_000023.11:108696351:T:C
NM_033380.3(COL4A5):c.5048G>C (p.Arg1683Pro)	COL4A5	R1677P, R1683P	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024788	X	107939580	X	108696350	24788	36129	rs104886308	NC_000023.11:108696349:G:C
NM_033380.3(COL4A5):c.5047C>T (p.Arg1683Ter)	COL4A5	R1677*, R1683*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024786	X	107939579	X	108696349	24786	36127	rs104886306	NC_000023.11:108696348:C:T
NM_033380.3(COL4A5):c.5038C>T (p.Arg1680Ter)	COL4A5	R1674*, R1680*	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000024785	X	107939570	X	108696340	24785	36126	rs281874753	NC_000023.11:108696339:C:T
NM_033380.3(COL4A5):c.4995-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024783	X	107939525	X	108696295	24783	36124	rs281874752	NC_000023.11:108696294:A:G
NM_033380.3(COL4A5):c.4994G>A (p.Ser1665Asn)	COL4A5	S1659N, S1665N	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024782	X	107938669	X	108695439	24782	36123	rs104886305	NC_000023.11:108695438:G:A
NM_033380.3(COL4A5):c.4931G>A (p.Cys1644Tyr)	COL4A5	C1638Y, C1644Y	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024780	X	107938606	X	108695376	24780	36121	rs104886302	NC_000023.11:108695375:G:A
NM_033380.3(COL4A5):c.4912T>G (p.Cys1638Gly)	COL4A5	C1632G, C1638G	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024779	X	107938587	X	108695357	24779	36120	rs281874750	NC_000023.11:108695356:T:G
NM_033380.3(COL4A5):c.4822-151_4822-150insT	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024777	X	107938346 - 107938347	X	108695116 - 108695117	24777	36118	rs397515494	NC_000023.11:108695116::T
NM_033380.3(COL4A5):c.4821+121T>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024776	X	107938272	X	108695042	24776	36117	rs104886423	NC_000023.11:108695041:T:C
NM_033380.3(COL4A5):c.4821+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024775	X	107938152	X	108694922	24775	36116	rs587776404	NC_000023.11:108694921:G:A
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024774					24774	36115		
NM_033380.3(COL4A5):c.4821G>A (p.Met1607Ile)	COL4A5	M1601I, M1607I	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024773	X	107938151	X	108694921	24773	36114	rs104886300	NC_000023.11:108694920:G:A
NM_033380.3(COL4A5):c.4809T>A (p.Tyr1603Ter)	COL4A5	Y1597*, Y1603*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024772	X	107938139	X	108694909	24772	36113	rs104886299	NC_000023.11:108694908:T:A
NM_033380.3(COL4A5):c.4808A>G (p.Tyr1603Cys)	COL4A5	Y1597C, Y1603C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024771	X	107938138	X	108694908	24771	36112	rs104886298	NC_000023.11:108694907:A:G
NM_033380.3(COL4A5):c.4805G>A (p.Gly1602Asp)	COL4A5	G1596D, G1602D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024770	X	107938135	X	108694905	24770	36111	rs104886297	NC_000023.11:108694904:G:A
NM_033380.3(COL4A5):c.4786T>G (p.Trp1596Gly)	COL4A5	W1590G, W1596G	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024769	X	107938116	X	108694886	24769	36110	rs104886296	NC_000023.11:108694885:T:G
NM_033380.3(COL4A5):c.4784G>T (p.Gly1595Val)	COL4A5	G1589V, G1595V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024768	X	107938114	X	108694884	24768	36109	rs104886291	NC_000023.11:108694883:G:T
NM_033380.3(COL4A5):c.4775G>T (p.Cys1592Phe)	COL4A5	C1586F, C1592F	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024767	X	107938105	X	108694875	24767	36108	rs104886290	NC_000023.11:108694874:G:T
NM_033380.3(COL4A5):c.4774T>C (p.Cys1592Arg)	COL4A5	C1586R, C1592R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024766	X	107938104	X	108694874	24766	36107	rs104886289	NC_000023.11:108694873:T:C
NM_033380.3(COL4A5):c.4769C>T (p.Pro1590Leu)	COL4A5	P1584L, P1590L	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024765	X	107938099	X	108694869	24765	36106	rs281874747	NC_000023.11:108694868:C:T
NM_033380.3(COL4A5):c.4720G>A (p.Glu1574Lys)	COL4A5	E1568K, E1568Q, E1574K	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024763	X	107938050	X	108694820	24763	36104	rs281874746	NC_000023.11:108694819:G:A
NM_033380.3(COL4A5):c.4717T>C (p.Cys1573Arg)	COL4A5	C1567R, C1573R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024762	X	107938047	X	108694817	24762	36103	rs104886288	NC_000023.11:108694816:T:C
NM_033380.3(COL4A5):c.4709G>C (p.Cys1570Ser)	COL4A5	C1564S, C1570S	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024761	X	107938039	X	108694809	24761	36102	rs104886287	NC_000023.11:108694808:G:C
NM_000495.3(COL4A5):c.4689-?_5058+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024760					24760	36101		
NM_033380.3(COL4A5):c.4707-30_4707-9delinsCA	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024758	X	107938007 - 107938028	X	108694777 - 108694798	24758	36099	rs281874744	NC_000023.11:108694776:ATTATGTTCCTTCTCCTTTTCC:CA
NM_033380.3(COL4A5):c.4706G>A (p.Arg1569Gln)	COL4A5	R1563Q, R1569Q	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000024757	X	107936155	X	108692925	24757	36098	rs281874743	NC_000023.11:108692924:G:A
NM_033380.3(COL4A5):c.4708T>C (p.Cys1570Arg)	COL4A5	C1564R, C1570R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024756	X	107938038	X	108694808	24756	36097	rs281874745	NC_000023.11:108694807:T:C
NM_033380.3(COL4A5):c.4705C>T (p.Arg1569Ter)	COL4A5	R1563*, R1569*	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000024755	X	107936154	X	108692924	24755	36096	rs104886286	NC_000023.11:108692923:C:T
NP_203699.1:p.Ser1562fs	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024754					24754	36095		
NM_033380.3(COL4A5):c.4632G>A (p.Trp1544Ter)	COL4A5	W1538*, W1544*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024752	X	107936081	X	108692851	24752	36093	rs104886294	NC_000023.11:108692850:G:A
NM_033380.3(COL4A5):c.4631G>C (p.Trp1544Ser)	COL4A5	W1538S, W1544S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000024751	X	107936080	X	108692850	24751	36092	rs104886293	NC_000023.11:108692849:G:C
NM_033380.3(COL4A5):c.4581C>A (p.Cys1527Ter)	COL4A5	C1521*, C1527*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024750	X	107936030	X	108692800	24750	36091	rs104886292	NC_000023.11:108692799:C:A
NM_033380.3(COL4A5):c.4528+1G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024745	X	107930925	X	108687695	24745	36086	rs104886413	NC_000023.11:108687694:G:C
NM_033380.3(COL4A5):c.4519C>T (p.Gln1507Ter)	COL4A5	Q1501*, Q1507*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024743	X	107930915	X	108687685	24743	36084	rs281874741	NC_000023.11:108687684:C:T
NM_033380.3(COL4A5):c.4511C>A (p.Ala1504Asp)	COL4A5	A1498D, A1504D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024742	X	107930907	X	108687677	24742	36083	rs104886284	NC_000023.11:108687676:C:A
NM_033380.3(COL4A5):c.4481C>T (p.Ser1494Phe)	COL4A5	S1488F, S1494F	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024740	X	107930877	X	108687647	24740	36081	rs104886283	NC_000023.11:108687646:C:T
NM_033380.3(COL4A5):c.4475G>C (p.Gly1492Ala)	COL4A5	G1486A, G1492A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024739	X	107930871	X	108687641	24739	36080	rs104886282	NC_000023.11:108687640:G:C
NM_033380.3(COL4A5):c.4360G>A (p.Gly1454Ser)	COL4A5	G1448S, G1454S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024734	X	107930756	X	108687526	24734	36075	rs104886279	NC_000023.11:108687525:G:A
NM_033380.3(COL4A5):c.4343G>A (p.Gly1448Asp)	COL4A5	G1442D, G1448D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024733	X	107930739	X	108687509	24733	36074	rs104886277	NC_000023.11:108687508:G:A
NM_033380.3(COL4A5):c.4343G>C (p.Gly1448Ala)	COL4A5	G1442A, G1448A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024732	X	107930739	X	108687509	24732	36073	rs104886277	NC_000023.11:108687508:G:C
NM_033380.3(COL4A5):c.4369G>A (p.Gly1457Ser)	COL4A5	G1451S, G1457S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024731	X	107930765	X	108687535	24731	36072	rs104886280	NC_000023.11:108687534:G:A
NM_033380.3(COL4A5):c.4342G>C (p.Gly1448Arg)	COL4A5	G1442R, G1448R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024729	X	107930738	X	108687508	24729	36070	rs104886276	NC_000023.11:108687507:G:C
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024727					24727	36068		
NM_033380.2(COL4A5):c.4316-1G>C (p.?)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024726	X	107930711	X	108687481	24726	36067	rs281874734	NC_000023.11:108687480:G:C
NM_033380.3(COL4A5):c.4315+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 21, 2016)	criteria provided, single submitter	VCV000024725	X	107929360	X	108686130	24725	36066	rs587776403	NC_000023.11:108686129:G:A
NM_033380.3(COL4A5):c.4298G>T (p.Gly1433Val)	COL4A5	G1427V, G1433V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024724	X	107929342	X	108686112	24724	36065	rs104886274	NC_000023.11:108686111:G:T
NM_033380.3(COL4A5):c.4297G>T (p.Gly1433Cys)	COL4A5	G1427W, G1427C, G1433C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024723	X	107929341	X	108686111	24723	36064	rs104886273	NC_000023.11:108686110:G:T
NM_033380.3(COL4A5):c.4279G>T (p.Gly1427Trp)	COL4A5	G1421W, G1427W	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024721	X	107929323	X	108686093	24721	36062	rs104886272	NC_000023.11:108686092:G:T
NM_033380.3(COL4A5):c.4232dup (p.Gly1412fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024717	X	107929274 - 107929275	X	108686044 - 108686045	24717	36058	rs281874731	NC_000023.11:108686044:CC:CCC
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024716					24716	36057		
NM_033380.3(COL4A5):c.4217-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000024714	X	107929260	X	108686030	24714	36055	rs587776402	NC_000023.11:108686029:G:A
NM_033380.3(COL4A5):c.4214dup (p.Gly1406fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024713	X	107925114 - 107925115	X	108681884 - 108681885	24713	36054	rs104886409	NC_000023.11:108681884:CC:CCC
NM_033380.3(COL4A5):c.4195del (p.Gln1399fs)	COL4A5	Q1399fs, Q1393fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024712	X	107925094	X	108681864	24712	36053	rs281874729	NC_000023.11:108681863:CCCC:CCC
NM_033380.3(COL4A5):c.4195C>T (p.Gln1399Ter)	COL4A5	Q1393*, Q1399*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024711	X	107925097	X	108681867	24711	36052	rs104886405	NC_000023.11:108681866:C:T
NM_033380.3(COL4A5):c.4189G>T (p.Gly1397Ter)	COL4A5	G1391*, G1397*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024709	X	107925091	X	108681861	24709	36050	rs281874728	NC_000023.11:108681860:G:T
NM_033380.3(COL4A5):c.4179_4180insTCCT (p.Gly1394fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024708	X	107925081 - 107925082	X	108681851 - 108681852	24708	36049	rs606231371	NC_000023.11:108681851::TCCT
NM_033380.3(COL4A5):c.4165C>T (p.Gln1389Ter)	COL4A5	Q1383*, Q1389*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024707	X	107925067	X	108681837	24707	36048	rs281874727	NC_000023.11:108681836:C:T
NM_033380.3(COL4A5):c.4154G>T (p.Gly1385Val)	COL4A5	G1379V, G1385V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024706	X	107925056	X	108681826	24706	36047	rs104886269	NC_000023.11:108681825:G:T
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024703					24703	36044		
NM_033380.3(COL4A5):c.4087+1G>A	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000024702	X	107924187	X	108680957	24702	36043	rs587776401	NC_000023.11:108680956:G:A
NM_033380.3(COL4A5):c.4087G>A (p.Gly1363Ser)	COL4A5	G1357S, G1363S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024701	X	107924186	X	108680956	24701	36042	rs104886267	NC_000023.11:108680955:G:A
4245del6, 4241G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024700					24700	36041		
NM_033380.3(COL4A5):c.4024G>T (p.Gly1342Ter)	COL4A5	G1336*, G1342*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024699	X	107924123	X	108680893	24699	36040	rs1556453243	NC_000023.11:108680892:G:T
NM_033380.3(COL4A5):c.4016-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024698	X	107924113	X	108680883	24698	36039	rs104886397	NC_000023.11:108680882:A:G
NM_033380.3(COL4A5):c.4016-2A>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024697	X	107924113	X	108680883	24697	36038	rs104886397	NC_000023.11:108680882:A:T
NM_033380.3(COL4A5):c.4015G>A (p.Gly1339Ser)	COL4A5	G1333S, G1339S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024696	X	107923981	X	108680751	24696	36037	rs104886266	NC_000023.11:108680750:G:A
NM_033380.3(COL4A5):c.3976A>T (p.Lys1326Ter)	COL4A5	K1320*, K1326*, K1360*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024694	X	107923942	X	108680712	24694	36035	rs104886260	NC_000023.11:108680711:A:T
NM_000495.4(COL4A5):c.3925-?_4069+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024693					24693	36034		
NM_033380.3(COL4A5):c.3943-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024692	X	107923908	X	108680678	24692	36033	rs281874725	NC_000023.11:108680677:G:A
NM_033380.3(COL4A5):c.3943-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024691	X	107923907	X	108680677	24691	36032	rs587776400	NC_000023.11:108680676:A:G
NM_033380.3(COL4A5):c.3942+1G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024690	X	107920864	X	108677634	24690	36031	rs483352870	NC_000023.11:108677633:G:C
NM_033380.3(COL4A5):c.3942G>C (p.Gln1314His)	COL4A5	Q1308H, Q1314H	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024689	X	107920863	X	108677633	24689	36030	rs281874724	NC_000023.11:108677632:G:C
NM_033380.3(COL4A5):c.3826G>A (p.Gly1276Ser)	COL4A5	G1270S, G1276S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024685	X	107920747	X	108677517	24685	36026	rs104886257	NC_000023.11:108677516:G:A
COL4A5:c.3791-?_3924+?del (p.?)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024684	X	107917984 - 107923908	X	108674754 - 108680678	24684	36025		
NM_033380.3(COL4A5):c.3790+1del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024683	X	107911734	X	108668504	24683	36024	rs104886256	NC_000023.11:108668503:GG:G
NM_033380.3(COL4A5):c.3782G>A (p.Gly1261Glu)	COL4A5	G1261E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024682	X	107911726	X	108668496	24682	36023	rs104886264	NC_000023.11:108668495:G:A
NM_033380.3(COL4A5):c.3763G>A (p.Gly1255Arg)	COL4A5	G1255R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024681	X	107911707	X	108668477	24681	36022	rs104886263	NC_000023.11:108668476:G:A
NM_033380.3(COL4A5):c.3754G>A (p.Gly1252Ser)	COL4A5	G1252S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024679	X	107911698	X	108668468	24679	36020	rs104886262	NC_000023.11:108668467:G:A
NM_033380.3(COL4A5):c.3731G>A (p.Gly1244Asp)	COL4A5	G1244D	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000024678	X	107911675	X	108668445	24678	36019	rs104886261	NC_000023.11:108668444:G:A
NM_033380.3(COL4A5):c.3722G>T (p.Gly1241Val)	COL4A5	G1241V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024677	X	107911666	X	108668436	24677	36018	rs281874721	NC_000023.11:108668435:G:T
NM_033380.3(COL4A5):c.3721G>T (p.Gly1241Cys)	COL4A5	G1241C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000024676	X	107911665	X	108668435	24676	36017	rs104886255	NC_000023.11:108668434:G:T
NM_033380.3(COL4A5):c.3706_3722delinsT (p.Pro1236fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024673	X	107911650 - 107911666	X	108668420 - 108668436	24673	36014	rs281874720	NC_000023.11:108668419:CCCCCAGGCCCTCCTGG:T
NM_033380.3(COL4A5):c.3700C>T (p.Gln1234Ter)	COL4A5	Q1234*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024672	X	107911644	X	108668414	24672	36013	rs281874719	NC_000023.11:108668413:C:T
NM_033380.3(COL4A5):c.3694G>A (p.Gly1232Ser)	COL4A5	G1232S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024671	X	107911638	X	108668408	24671	36012	rs104886250	NC_000023.11:108668407:G:A
NM_000495.5(COL4A5):c.3692dup (p.Gly1232fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024670	X	107911633 - 107911634	X	108668403 - 108668404	24670	36011	rs104886254	NC_000023.11:108668403:CCC:CCCC
NM_000495.5(COL4A5):c.3692del (p.Pro1231fs)	COL4A5	P1231fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024669	X	107911634	X	108668404	24669	36010	rs104886254	NC_000023.11:108668403:CCC:CC
NM_033380.3(COL4A5):c.3686G>A (p.Gly1229Asp)	COL4A5	G1229D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024668	X	107911630	X	108668400	24668	36009	rs104886253	NC_000023.11:108668399:G:A
NM_033380.3(COL4A5):c.3668G>T (p.Gly1223Val)	COL4A5	G1223V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024667	X	107911612	X	108668382	24667	36008	rs104886252	NC_000023.11:108668381:G:T
NM_033380.3(COL4A5):c.3659G>A (p.Gly1220Asp)	COL4A5	G1220D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024666	X	107911603	X	108668373	24666	36007	rs104886251	NC_000023.11:108668372:G:A
NM_033380.3(COL4A5):c.3657_3728del (p.Lys1222_Pro1245del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024665	X	107911598 - 107911669	X	108668368 - 108668439	24665	36006	rs104886391	
NM_033380.3(COL4A5):c.3641G>A (p.Gly1214Glu)	COL4A5	G1214E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024663	X	107911585	X	108668355	24663	36004	rs104886248	NC_000023.11:108668354:G:A
NM_033380.3(COL4A5):c.3632G>A (p.Gly1211Glu)	COL4A5	G1211E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024662	X	107911576	X	108668346	24662	36003	rs104886247	NC_000023.11:108668345:G:A
NM_033380.3(COL4A5):c.3631G>C (p.Gly1211Arg)	COL4A5	G1211R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024661	X	107911575	X	108668345	24661	36002	rs104886246	NC_000023.11:108668344:G:C
NM_033380.3(COL4A5):c.3613G>A (p.Gly1205Ser)	COL4A5	G1205S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024659	X	107911557	X	108668327	24659	36000	rs104886245	NC_000023.11:108668326:G:A
NM_033380.3(COL4A5):c.3613G>T (p.Gly1205Cys)	COL4A5	G1205C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024658	X	107911557	X	108668327	24658	35999	rs104886245	NC_000023.11:108668326:G:T
NM_000495.3(COL4A5):c.3605-?_5058+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024657					24657	35998		
NM_033380.3(COL4A5):c.3605-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024656	X	107911548	X	108668318	24656	35997	rs104886384	NC_000023.11:108668317:G:A
NM_033380.3(COL4A5):c.3605-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024655	X	107911547	X	108668317	24655	35996	rs104886385	NC_000023.11:108668316:A:G
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024654					24654	35995		
NM_033380.3(COL4A5):c.3587G>A (p.Gly1196Glu)	COL4A5	G1196E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024652	X	107910396	X	108667166	24652	35993	rs281874717	NC_000023.11:108667165:G:A
NM_033380.3(COL4A5):c.3586G>A (p.Gly1196Arg)	COL4A5	G1196R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000024651	X	107910395	X	108667165	24651	35992	rs104886244	NC_000023.11:108667164:G:A
COL4A5:c.3554-?_3604+?del (p.?)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024649	X	107909825 - 107911548	X	108666595 - 108668318	24649	35990		
NM_033380.3(COL4A5):c.3554-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024648	X	107910362	X	108667132	24648	35989	rs104886381	NC_000023.11:108667131:G:A
NM_033380.3(COL4A5):c.3554-3C>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024647	X	107910360	X	108667130	24647	35988	rs104886382	NC_000023.11:108667129:C:G
NM_033380.3(COL4A5):c.3554-9C>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024646	X	107910354	X	108667124	24646	35987	rs104886383	NC_000023.11:108667123:C:G
NM_033380.3(COL4A5):c.3544G>C (p.Gly1182Arg)	COL4A5	G1182R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024645	X	107909815	X	108666585	24645	35986	rs104886242	NC_000023.11:108666584:G:C
NM_033380.3(COL4A5):c.3538C>T (p.Gln1180Ter)	COL4A5	Q1180*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024643	X	107909809	X	108666579	24643	35984	rs104886241	NC_000023.11:108666578:C:T
NM_033380.3(COL4A5):c.3535G>A (p.Gly1179Arg)	COL4A5	G1179R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024642	X	107909806	X	108666576	24642	35983	rs104886240	NC_000023.11:108666575:G:A
NM_000495.5(COL4A5):c.3508G>A (p.Gly1170Ser)	COL4A5	G1170S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 9, 2018)	no assertion criteria provided	VCV000024638	X	107909779	X	108666549	24638	35979	rs104886237	NC_000023.11:108666548:G:A
NM_033380.3(COL4A5):c.3499G>A (p.Gly1167Ser)	COL4A5	G1167S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024637	X	107909770	X	108666540	24637	35978	rs104886236	NC_000023.11:108666539:G:A
NM_033380.3(COL4A5):c.3481G>A (p.Gly1161Arg)	COL4A5	G1161R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024636	X	107909752	X	108666522	24636	35977	rs104886235	NC_000023.11:108666521:G:A
NM_033380.3(COL4A5):c.3472G>T (p.Gly1158Trp)	COL4A5	G1158R, G1158W	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024634	X	107909743	X	108666513	24634	35975	rs104886389	NC_000023.11:108666512:G:T
NM_033380.3(COL4A5):c.3455-9A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024633	X	107909717	X	108666487	24633	35974	rs104886388	NC_000023.11:108666486:A:G
NM_033380.3(COL4A5):c.3454+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024632	X	107908818	X	108665588	24632	35973	rs281874715	NC_000023.11:108665587:G:T
NM_033380.3(COL4A5):c.3427G>A (p.Gly1143Ser)	COL4A5	G1143S	Alport syndrome 1, X-linked recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024630	X	107908790	X	108665560	24630	35971	rs104886228	NC_000023.11:108665559:G:A
NM_033380.2(COL4A5):c.3403_3418del16ins3 (p.Ile1135fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024628	X	107908766 - 107908781	X	108665536 - 108665551	24628	35969		
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024627					24627	35968		
NM_000495.3(COL4A5):c.3374-?_5058+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024626					24626	35967		
NM_000495.4(COL4A5):c.3374-?_3790+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024624	X	107898688 - 107913457	X	108665507 - 108668504	24624	35965		
NM_033380.3(COL4A5):c.3374-11C>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024623	X	107908726	X	108665496	24623	35964	rs104886387	NC_000023.11:108665495:C:A
NM_033380.3(COL4A5):c.3373+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024622	X	107898688	X	108655458	24622	35963	rs281874714	NC_000023.11:108655457:G:A
NM_000495.5(COL4A5):c.3326_3327insT (p.Gly1110fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024618	X	107898640 - 107898641	X	108655410 - 108655411	24618	35959	rs397515492	NC_000023.11:108655410::T
NM_033380.3(COL4A5):c.3319G>A (p.Gly1107Arg)	COL4A5	G1107R	Alport syndrome 1, X-linked recessive	Pathogenic	criteria provided, single submitter	VCV000024617	X	107898633	X	108655403	24617	35958	rs104886225	NC_000023.11:108655402:G:A
NM_033380.3(COL4A5):c.3311G>T (p.Gly1104Val)	COL4A5	G1104V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024616	X	107898625	X	108655395	24616	35957	rs104886224	NC_000023.11:108655394:G:T
NM_033380.3(COL4A5):c.3289A>T (p.Lys1097Ter)	COL4A5	K1097*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024615	X	107898603	X	108655373	24615	35956	rs104886233	NC_000023.11:108655372:A:T
NM_033380.3(COL4A5):c.3257G>A (p.Gly1086Asp)	COL4A5	G1086D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024614	X	107898571	X	108655341	24614	35955	rs104886232	NC_000023.11:108655340:G:A
NM_033380.3(COL4A5):c.3256G>C (p.Gly1086Arg)	COL4A5	G1086R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024613	X	107898570	X	108655340	24613	35954	rs104886231	NC_000023.11:108655339:G:C
NM_000495.4(COL4A5):c.3247-?_5058+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024610					24610	35951		
NM_000495.3(COL4A5):c.(?_3247)_(3373_?)del (p.(?))	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024608	X	107898561 - 107898687	X	108655331 - 108655457	24608	35949		
NM_033380.3(COL4A5):c.3247G>A (p.Gly1083Ser)	COL4A5	G1083S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024607	X	107898561	X	108655331	24607	35948	rs104886223	NC_000023.11:108655330:G:A
NM_033380.3(COL4A5):c.3212C>G (p.Ser1071Ter)	COL4A5	S1071*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024606	X	107869545	X	108626315	24606	35947	rs104886222	NC_000023.11:108626314:C:G
NM_033380.3(COL4A5):c.3197G>C (p.Gly1066Ala)	COL4A5	G1066A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024604	X	107869530	X	108626300	24604	35945	rs104886221	NC_000023.11:108626299:G:C
NM_033380.3(COL4A5):c.3196G>A (p.Gly1066Ser)	COL4A5	G1066S	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000024603	X	107869529	X	108626299	24603	35944	rs104886219	NC_000023.11:108626298:G:A
NM_033380.3(COL4A5):c.3196G>C (p.Gly1066Arg)	COL4A5	G1066R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024602	X	107869529	X	108626299	24602	35943	rs104886219	NC_000023.11:108626298:G:C
NM_033380.3(COL4A5):c.3188G>T (p.Gly1063Val)	COL4A5	G1063V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024601	X	107869521	X	108626291	24601	35942	rs104886218	NC_000023.11:108626290:G:T
NM_033380.3(COL4A5):c.3181C>T (p.Gln1061Ter)	COL4A5	Q1061*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024600	X	107869514	X	108626284	24600	35941	rs104886213	NC_000023.11:108626283:C:T
NM_033380.3(COL4A5):c.3178G>T (p.Gly1060Ter)	COL4A5	G1060*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000024599	X	107869511	X	108626281	24599	35940	rs104886217	NC_000023.11:108626280:G:T
NM_033380.3(COL4A5):c.3169G>T (p.Gly1057Ter)	COL4A5	G1057*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024598	X	107869502	X	108626272	24598	35939	rs104886216	NC_000023.11:108626271:G:T
NM_033380.3(COL4A5):c.3134G>A (p.Gly1045Glu)	COL4A5	G1045E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024596	X	107869467	X	108626237	24596	35937	rs104886215	NC_000023.11:108626236:G:A
NM_033380.3(COL4A5):c.3115G>A (p.Gly1039Ser)	COL4A5	G1039S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024595	X	107869448	X	108626218	24595	35936	rs104886214	NC_000023.11:108626217:G:A
NM_033380.3(COL4A5):c.3107G>T (p.Gly1036Val)	COL4A5	G1036V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024594	X	107869440	X	108626210	24594	35935	rs104886212	NC_000023.11:108626209:G:T
NM_033380.3(COL4A5):c.3107-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024593	X	107869438	X	108626208	24593	35934	rs104886379	NC_000023.11:108626207:A:G
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024592					24592	35933		
NM_033380.3(COL4A5):c.3088G>A (p.Gly1030Ser)	COL4A5	G1030S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024591	X	107869006	X	108625776	24591	35932	rs104886210	NC_000023.11:108625775:G:A
NM_033380.3(COL4A5):c.3080G>T (p.Gly1027Val)	COL4A5	G1027V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024590	X	107868998	X	108625768	24590	35931	rs104886209	NC_000023.11:108625767:G:T
NM_033380.3(COL4A5):c.3046C>T (p.Gln1016Ter)	COL4A5	Q1016*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024588	X	107868964	X	108625734	24588	35929	rs104886207	NC_000023.11:108625733:C:T
NM_033380.3(COL4A5):c.3044G>T (p.Gly1015Val)	COL4A5	G1015V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024587	X	107868962	X	108625732	24587	35928	rs104886211	NC_000023.11:108625731:G:T
NM_033380.3(COL4A5):c.3017G>T (p.Gly1006Val)	COL4A5	G1006V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024585	X	107868935	X	108625705	24585	35926	rs104886202	NC_000023.11:108625704:G:T
NM_033380.3(COL4A5):c.3017-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024584	X	107868934	X	108625704	24584	35925	rs104886378	NC_000023.11:108625703:G:A
NM_033380.3(COL4A5):c.3016+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024583	X	107867565	X	108624335	24583	35924	rs104886377	NC_000023.11:108624334:G:T
NM_033380.3(COL4A5):c.2943del (p.Gly982fs)	COL4A5	G982fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024579	X	107867488	X	108624258	24579	35920	rs104886204	NC_000023.11:108624257:AAAA:AAA
NM_033380.3(COL4A5):c.2918-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024576	X	107867465	X	108624235	24576	35917	rs104886372	NC_000023.11:108624234:G:T
NM_033380.3(COL4A5):c.2917+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024575	X	107866056	X	108622826	24575	35916	rs104886371	NC_000023.11:108622825:G:T
NM_033380.3(COL4A5):c.2917+1G>C	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024574	X	107866056	X	108622826	24574	35915	rs104886371	NC_000023.11:108622825:G:C
NM_033380.3(COL4A5):c.2840G>A (p.Gly947Asp)	COL4A5	G947D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024570	X	107865978	X	108622748	24570	35911	rs104886370	NC_000023.11:108622747:G:A
NM_033380.3(COL4A5):c.2821G>T (p.Gly941Cys)	COL4A5	G941C	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024568	X	107865959	X	108622729	24568	35909	rs104886196	NC_000023.11:108622728:G:T
NM_033380.3(COL4A5):c.2788C>T (p.Gln930Ter)	COL4A5	Q930*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024565	X	107865926	X	108622696	24565	35906	rs104886194	NC_000023.11:108622695:C:T
NM_033380.3(COL4A5):c.2782C>T (p.Gln928Ter)	COL4A5	Q928*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024564	X	107865920	X	108622690	24564	35905	rs281874705	NC_000023.11:108622689:C:T
NM_033380.3(COL4A5):c.2767+2del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024562	X	107865124	X	108621894	24562	35903	rs104886366	NC_000023.11:108621893:T:
NM_033380.3(COL4A5):c.2746A>G (p.Ser916Gly)	COL4A5	S916G	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024561	X	107865101	X	108621871	24561	35902	rs104886193	NC_000023.11:108621870:A:G
NM_033380.3(COL4A5):c.2732G>A (p.Gly911Glu)	COL4A5	G911E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024559	X	107865087	X	108621857	24559	35900	rs104886363	NC_000023.11:108621856:G:A
NM_033380.3(COL4A5):c.2731G>A (p.Gly911Arg)	COL4A5	G911R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024558	X	107865086	X	108621856	24558	35899	rs281874704	NC_000023.11:108621855:G:A
NM_000495.5(COL4A5):c.2708dup (p.Pro904fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024556	X	107865061 - 107865062	X	108621831 - 108621832	24556	35897	rs104886362	NC_000023.11:108621831:CC:CCC
NM_033380.3(COL4A5):c.2705G>A (p.Gly902Glu)	COL4A5	G902E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024555	X	107865060	X	108621830	24555	35896	rs104886361	NC_000023.11:108621829:G:A
NM_000495.4(COL4A5):c.2678-?_3246+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024552					24552	35893		
NM_033380.3(COL4A5):c.2678-10T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024550	X	107865023	X	108621793	24550	35891	rs104886360	NC_000023.11:108621792:T:G
NM_033380.3(COL4A5):c.2660G>T (p.Gly887Val)	COL4A5	G887V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024549	X	107863639	X	108620409	24549	35890	rs104886201	NC_000023.11:108620408:G:T
NM_033380.3(COL4A5):c.2659G>C (p.Gly887Arg)	COL4A5	G887R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024548	X	107863638	X	108620408	24548	35889	rs281874699	NC_000023.11:108620407:G:C
NM_033380.3(COL4A5):c.2633G>T (p.Gly878Val)	COL4A5	G878V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024547	X	107863612	X	108620382	24547	35888	rs104886199	NC_000023.11:108620381:G:T
NM_033380.3(COL4A5):c.2624G>A (p.Gly875Glu)	COL4A5	G875E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024545	X	107863603	X	108620373	24545	35886	rs104886191	NC_000023.11:108620372:G:A
NM_033380.3(COL4A5):c.2614G>C (p.Gly872Arg)	COL4A5	G872R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024544	X	107863593	X	108620363	24544	35885	rs104886190	NC_000023.11:108620362:G:C
NM_033380.3(COL4A5):c.2605G>A (p.Gly869Arg)	COL4A5	G869R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024543	X	107863584	X	108620354	24543	35884	rs104886189	NC_000023.11:108620353:G:A
NM_033380.3(COL4A5):c.2597G>A (p.Gly866Glu)	COL4A5	G866E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024541	X	107863576	X	108620346	24541	35882	rs104886188	NC_000023.11:108620345:G:A
NM_033380.3(COL4A5):c.2578G>C (p.Gly860Arg)	COL4A5	G860R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024538	X	107863557	X	108620327	24538	35879	rs281874697	NC_000023.11:108620326:G:C
NM_033380.3(COL4A5):c.2555G>A (p.Gly852Glu)	COL4A5	G852E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024537	X	107863534	X	108620304	24537	35878	rs104886187	NC_000023.11:108620303:G:A
NM_033380.3(COL4A5):c.2554G>A (p.Gly852Arg)	COL4A5	G852R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024536	X	107863533	X	108620303	24536	35877	rs104886186	NC_000023.11:108620302:G:A
NM_033380.3(COL4A5):c.2550_2573del (p.Leu853_Gly860del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024535	X	107863520 - 107863543	X	108620290 - 108620313	24535	35876	rs104886359	NC_000023.11:108620289:TCCAGGACCTCCTGGACTTGATGTTCCAGGACC:TCCAGGACC
COL4A5:c.2510-?_2677+?del (p.Gly837_Gly893delinsGly)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024534	X	107863489 - 107863656	X	108620259 - 108620426	24534	35875		
NM_033380.3(COL4A5):c.2509G>A (p.Gly837Ser)	COL4A5	G837S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024530	X	107858254	X	108615024	24530	35871	rs104886185	NC_000023.11:108615023:G:A
NM_033380.3(COL4A5):c.2500G>C (p.Gly834Arg)	COL4A5	G834R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000024529	X	107858245	X	108615015	24529	35870	rs281874696	NC_000023.11:108615014:G:C
NM_033380.3(COL4A5):c.2466_2474ACCACCAGG[1] (p.823_825PPG[1])	COL4A5		Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000024527	X	107858209 - 107858217	X	108614979 - 108614987	24527	35868	rs104886356	NC_000023.11:108614978:GGACCACCAGGACCACCAGG:GGACCACCAGG
NM_033380.3(COL4A5):c.2473G>T (p.Gly825Ter)	COL4A5	G825*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024526	X	107858218	X	108614988	24526	35867	rs281874692	NC_000023.11:108614987:G:T
NM_033380.3(COL4A5):c.2464G>C (p.Gly822Arg)	COL4A5	G822R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024525	X	107858209	X	108614979	24525	35866	rs104886184	NC_000023.11:108614978:G:C
NM_033380.3(COL4A5):c.2432G>T (p.Gly811Val)	COL4A5	G811V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024521	X	107858177	X	108614947	24521	35862	rs104886183	NC_000023.11:108614946:G:T
NM_033380.3(COL4A5):c.2431G>A (p.Gly811Arg)	COL4A5	G811R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000024520	X	107858176	X	108614946	24520	35861	rs104886182	NC_000023.11:108614945:G:A
NM_033380.3(COL4A5):c.2423G>A (p.Gly808Glu)	COL4A5	G808E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024519	X	107858168	X	108614938	24519	35860	rs104886180	NC_000023.11:108614937:G:A
NM_033380.3(COL4A5):c.2404G>A (p.Gly802Arg)	COL4A5	G802R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024518	X	107858149	X	108614919	24518	35859	rs104886179	NC_000023.11:108614918:G:A
2606-2623del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024517					24517	35858		
NM_033380.3(COL4A5):c.2395+2del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024515	X	107850124	X	108606894	24515	35856	rs104886178	NC_000023.11:108606893:T:
NM_033380.3(COL4A5):c.2394A>G (p.Lys798=)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024514	X	107850121	X	108606891	24514	35855	rs281874691	NC_000023.11:108606890:A:G
NM_033380.3(COL4A5):c.2386G>A (p.Gly796Arg)	COL4A5	G796R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024513	X	107850113	X	108606883	24513	35854	rs104886177	NC_000023.11:108606882:G:A
NM_033380.3(COL4A5):c.2360G>T (p.Gly787Val)	COL4A5	G787V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024512	X	107850087	X	108606857	24512	35853	rs104886176	NC_000023.11:108606856:G:T
NM_033380.3(COL4A5):c.2348del (p.Pro783fs)	COL4A5	P783fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024510	X	107850074	X	108606844	24510	35851	rs104886175	NC_000023.11:108606843:CC:C
NM_033380.3(COL4A5):c.2315G>C (p.Gly772Ala)	COL4A5	G772A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024507	X	107850042	X	108606812	24507	35848	rs104886173	NC_000023.11:108606811:G:C
NM_033380.3(COL4A5):c.2315G>A (p.Gly772Asp)	COL4A5	G772D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024506	X	107850042	X	108606812	24506	35847	rs104886173	NC_000023.11:108606811:G:A
NM_033380.3(COL4A5):c.2305G>A (p.Gly769Arg)	COL4A5	G769R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024505	X	107850032	X	108606802	24505	35846	rs281874690	NC_000023.11:108606801:G:A
NM_033380.3(COL4A5):c.2297G>A (p.Gly766Asp)	COL4A5	G766D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024504	X	107850024	X	108606794	24504	35845	rs104886172	NC_000023.11:108606793:G:A
NM_000495.5(COL4A5):c.2288G>A (p.Gly763Glu)	COL4A5	G763E	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024503	X	107850015	X	108606785	24503	35844	rs281874689	NC_000023.11:108606784:G:A
NM_033380.3(COL4A5):c.2287G>A (p.Gly763Arg)	COL4A5	G763R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024502	X	107850014	X	108606784	24502	35843	rs104886171	NC_000023.11:108606783:G:A
NM_033380.3(COL4A5):c.2245-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024501	X	107849971	X	108606741	24501	35842	rs104886348	NC_000023.11:108606740:G:A
NM_033380.3(COL4A5):c.2244+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024500	X	107846293	X	108603063	24500	35841	rs104886347	NC_000023.11:108603062:T:G
NM_033380.3(COL4A5):c.2244+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024499	X	107846292	X	108603062	24499	35840	rs281874688	NC_000023.11:108603061:G:T
NM_033380.3(COL4A5):c.2228G>A (p.Gly743Asp)	COL4A5	G743D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024498	X	107846275	X	108603045	24498	35839	rs104886166	NC_000023.11:108603044:G:A
NM_033380.3(COL4A5):c.2219G>A (p.Gly740Glu)	COL4A5	G740E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024497	X	107846266	X	108603036	24497	35838	rs104886165	NC_000023.11:108603035:G:A
NM_033380.3(COL4A5):c.2215C>T (p.Pro739Ser)	COL4A5	P739S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024496	X	107846262	X	108603032	24496	35837	rs104886164	NC_000023.11:108603031:C:T
NM_033380.3(COL4A5):c.2207_2227del (p.Glu736_Pro742del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024495	X	107846253 - 107846273	X	108603023 - 108603043	24495	35836	rs104886346	NC_000023.11:108603022:GAAGGCCCTCCTGGGCCACCCG:G
NM_000495.5(COL4A5):c.2165G>A (p.Gly722Glu)	COL4A5	G722E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000024494	X	107846212	X	108602982	24494	35835	rs104886163	NC_000023.11:108602981:G:A
NM_033380.3(COL4A5):c.2155G>C (p.Gly719Arg)	COL4A5	G719R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024493	X	107846202	X	108602972	24493	35834	rs281874686	NC_000023.11:108602971:G:C
NM_000495.4(COL4A5):c.2147-?_2767+?dup621	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024492	X	107845220 - 107865905	X	108601990 - 108622675	24492	35833		
NM_000495.4(COL4A5):c.2147delG (p.Gly716Alafs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024491	X	107846194	X	108602963	24491	35832	rs104886162	
NM_033380.3(COL4A5):c.2147-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024490	X	107846192	X	108602962	24490	35831	rs104886344	NC_000023.11:108602961:A:G
NM_033380.3(COL4A5):c.2147-3C>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024489	X	107846191	X	108602961	24489	35830	rs104886345	NC_000023.11:108602960:C:G
NM_033380.3(COL4A5):c.2146+3A>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024488	X	107845222	X	108601992	24488	35829	rs104886343	NC_000023.11:108601991:A:C
NM_033380.3(COL4A5):c.2146G>C (p.Gly716Arg)	COL4A5	G716R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024487	X	107845219	X	108601989	24487	35828	rs104886161	NC_000023.11:108601988:G:C
NM_033380.3(COL4A5):c.2098G>T (p.Glu700Ter)	COL4A5	E700*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024485	X	107845171	X	108601941	24485	35826	rs104886169	NC_000023.11:108601940:G:T
NM_033380.3(COL4A5):c.2062_2114dup (p.Ile706fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024484	X	107845132 - 107845133	X	108601902 - 108601903	24484	35825	rs104886342	
NM_033380.3(COL4A5):c.2060G>A (p.Gly687Glu)	COL4A5	G687E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024483	X	107845133	X	108601903	24483	35824	rs104886168	NC_000023.11:108601902:G:A
NM_033380.3(COL4A5):c.2057del (p.Pro686fs)	COL4A5	P686fs	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000024482	X	107845129	X	108601899	24482	35823	rs104886167	NC_000023.11:108601898:CC:C
NM_033380.3(COL4A5):c.2051G>T (p.Gly684Val)	COL4A5	G684V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024480	X	107845124	X	108601894	24480	35821	rs104886160	NC_000023.11:108601893:G:T
NM_033380.3(COL4A5):c.2050G>T (p.Gly684Ter)	COL4A5	G684*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024479	X	107845123	X	108601893	24479	35820	rs104886159	NC_000023.11:108601892:G:T
NM_033380.3(COL4A5):c.2042G>A (p.Gly681Asp)	COL4A5	G681D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024478	X	107845115	X	108601885	24478	35819	rs104886158	NC_000023.11:108601884:G:A
NM_033380.3(COL4A5):c.2042-18A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024477	X	107845097	X	108601867	24477	35818	rs104886341	NC_000023.11:108601866:A:G
NM_033380.3(COL4A5):c.2041+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024475	X	107844716	X	108601486	24475	35816	rs104886340	NC_000023.11:108601485:G:T
NM_033380.3(COL4A5):c.2023G>A (p.Gly675Ser)	COL4A5	G675S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024474	X	107844697	X	108601467	24474	35815	rs104886157	NC_000023.11:108601466:G:A
NM_033380.3(COL4A5):c.2018del (p.Arg673fs)	COL4A5	R673fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024473	X	107844692	X	108601462	24473	35814	rs104886156	NC_000023.11:108601461:G:
NM_033380.3(COL4A5):c.2006G>C (p.Gly669Ala)	COL4A5	G669A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024472	X	107844680	X	108601450	24472	35813	rs104886151	NC_000023.11:108601449:G:C
NM_033380.3(COL4A5):c.2005G>C (p.Gly669Arg)	COL4A5	G669R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024471	X	107844679	X	108601449	24471	35812	rs281874684	NC_000023.11:108601448:G:C
NM_033380.3(COL4A5):c.1997G>A (p.Gly666Asp)	COL4A5	G666D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024470	X	107844671	X	108601441	24470	35811	rs104886153	NC_000023.11:108601440:G:A
NM_033380.3(COL4A5):c.1960del (p.Asp654fs)	COL4A5	D654fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024468	X	107844631	X	108601401	24468	35809	rs104886152	NC_000023.11:108601400:GGGG:GGG
NM_033380.3(COL4A5):c.1957G>A (p.Gly653Arg)	COL4A5	G653R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024467	X	107844631	X	108601401	24467	35808	rs104886150	NC_000023.11:108601400:G:A
NM_000495.4(COL4A5):c.1949-?_3373+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024466	X	107842101 - 107908736	X	108598871 - 108665506	24466	35807		
NM_033380.3(COL4A5):c.1948+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024464	X	107842101	X	108598871	24464	35805	rs104886339	NC_000023.11:108598870:G:A
NM_033380.3(COL4A5):c.1913G>T (p.Gly638Val)	COL4A5	G638V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024463	X	107842065	X	108598835	24463	35804	rs104886134	NC_000023.11:108598834:G:T
NM_033380.3(COL4A5):c.1913G>C (p.Gly638Ala)	COL4A5	G638A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024462	X	107842065	X	108598835	24462	35803	rs104886134	NC_000023.11:108598834:G:C
NM_033380.3(COL4A5):c.1912G>A (p.Gly638Ser)	COL4A5	G638S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024461	X	107842064	X	108598834	24461	35802	rs104886147	NC_000023.11:108598833:G:A
NM_033380.3(COL4A5):c.1904G>A (p.Gly635Asp)	COL4A5	G635D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024460	X	107842056	X	108598826	24460	35801	rs281874683	NC_000023.11:108598825:G:A
NM_033380.3(COL4A5):c.1897G>A (p.Glu633Lys)	COL4A5	E633K	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024459	X	107842049	X	108598819	24459	35800	rs104886146	NC_000023.11:108598818:G:A
NM_033380.3(COL4A5):c.1895G>A (p.Gly632Asp)	COL4A5	G632D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024458	X	107842047	X	108598817	24458	35799	rs104886145	NC_000023.11:108598816:G:A
NM_033380.3(COL4A5):c.1886G>A (p.Gly629Asp)	COL4A5	G629D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024457	X	107842038	X	108598808	24457	35798	rs104886144	NC_000023.11:108598807:G:A
NM_033380.3(COL4A5):c.1877G>C (p.Gly626Ala)	COL4A5	G626A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024456	X	107842029	X	108598799	24456	35797	rs104886143	NC_000023.11:108598798:G:C
NM_033380.3(COL4A5):c.1871G>A (p.Gly624Asp)	COL4A5	G624D	Alport syndrome 1, X-linked recessive|Hypertensive disorder|Glomerulopathy|Mild proteinuria|not provided	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024455	X	107842023	X	108598793	24455	35796	rs104886142	NC_000023.11:108598792:G:A
NM_033380.3(COL4A5):c.1861G>T (p.Gly621Cys)	COL4A5	G621C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024454	X	107842013	X	108598783	24454	35795	rs104886141	NC_000023.11:108598782:G:T
NM_033380.3(COL4A5):c.1856C>T (p.Pro619Leu)	COL4A5	P619L	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024453	X	107842008	X	108598778	24453	35794	rs281874681	NC_000023.11:108598777:C:T
NM_033380.3(COL4A5):c.1826G>T (p.Gly609Val)	COL4A5	G609V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024452	X	107841978	X	108598748	24452	35793	rs104886140	NC_000023.11:108598747:G:T
NM_033380.3(COL4A5):c.1825G>C (p.Gly609Arg)	COL4A5	G609R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024451	X	107841977	X	108598747	24451	35792	rs104886135	NC_000023.11:108598746:G:C
NM_033380.3(COL4A5):c.1808G>T (p.Gly603Val)	COL4A5	G603V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024450	X	107841960	X	108598730	24450	35791	rs104886133	NC_000023.11:108598729:G:T
NM_033380.3(COL4A5):c.1783G>A (p.Gly595Arg)	COL4A5	G595R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024449	X	107841935	X	108598705	24449	35790	rs104886132	NC_000023.11:108598704:G:A
NM_033380.3(COL4A5):c.1780G>A (p.Gly594Ser)	COL4A5	G594S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024448	X	107841932	X	108598702	24448	35789	rs104886131	NC_000023.11:108598701:G:A
NM_033380.3(COL4A5):c.1780-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024447	X	107841931	X	108598701	24447	35788	rs104886338	NC_000023.11:108598700:G:A
NM_033380.3(COL4A5):c.1779+3G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024446	X	107840801	X	108597571	24446	35787	rs281874679	NC_000023.11:108597570:G:C
NM_033380.3(COL4A5):c.1779+1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024445	X	107840799	X	108597569	24445	35786	rs104886337	NC_000023.11:108597568:G:T
NM_000495.5(COL4A5):c.1757_1770del (p.Leu586fs)	COL4A5	L586fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024444	X	107840776 - 107840789	X	108597546 - 108597559	24444	35785	rs281874678	NC_000023.11:108597545:TTCCTGGCCCGAAA:
NM_033380.3(COL4A5):c.1739_1948+98del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024443	X	107840757 - 107842197	X	108597527 - 108598967	24443	35784		
NM_033380.3(COL4A5):c.1738C>T (p.Gln580Ter)	COL4A5	Q580*	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000024442	X	107840757	X	108597527	24442	35783	rs281874676	NC_000023.11:108597526:C:T
NM_033380.3(COL4A5):c.1736G>A (p.Gly579Glu)	COL4A5	G579E, G579Q	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024441	X	107840755	X	108597525	24441	35782	rs104886130	NC_000023.11:108597524:G:A
NM_033380.3(COL4A5):c.1735G>A (p.Gly579Arg)	COL4A5	G579R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024440	X	107840754	X	108597524	24440	35781	rs104886139	NC_000023.11:108597523:G:A
NM_033380.3(COL4A5):c.1726G>A (p.Gly576Ser)	COL4A5	G576S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024439	X	107840745	X	108597515	24439	35780	rs281874675	NC_000023.11:108597514:G:A
NM_033380.3(COL4A5):c.1718G>A (p.Gly573Asp)	COL4A5	G573D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024438	X	107840737	X	108597507	24438	35779	rs104886138	NC_000023.11:108597506:G:A
NM_033380.3(COL4A5):c.1700G>C (p.Gly567Ala)	COL4A5	G567A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024437	X	107840719	X	108597489	24437	35778	rs104886137	NC_000023.11:108597488:G:C
NM_033380.3(COL4A5):c.1690G>T (p.Gly564Cys)	COL4A5	G564C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024436	X	107840709	X	108597479	24436	35777	rs281874674	NC_000023.11:108597478:G:T
NM_033380.3(COL4A5):c.1681G>A (p.Gly561Arg)	COL4A5	G561R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024435	X	107840700	X	108597470	24435	35776	rs104886136	NC_000023.11:108597469:G:A
NM_033380.3(COL4A5):c.1672G>C (p.Gly558Arg)	COL4A5	G558R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024434	X	107840691	X	108597461	24434	35775	rs104886129	NC_000023.11:108597460:G:C
NM_033380.3(COL4A5):c.1653del (p.Thr552fs)	COL4A5	T552fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024433	X	107840672	X	108597442	24433	35774	rs104886128	NC_000023.11:108597441:C:
NM_033380.3(COL4A5):c.1643G>A (p.Gly548Asp)	COL4A5	G548D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024432	X	107840662	X	108597432	24432	35773	rs281874673	NC_000023.11:108597431:G:A
NM_033380.3(COL4A5):c.1634G>T (p.Gly545Val)	COL4A5	G545V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024431	X	107840653	X	108597423	24431	35772	rs104886127	NC_000023.11:108597422:G:T
NM_033380.3(COL4A5):c.1633G>C (p.Gly545Arg)	COL4A5	G545R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024430	X	107840652	X	108597422	24430	35771	rs104886126	NC_000023.11:108597421:G:C
NM_033380.3(COL4A5):c.1607G>A (p.Gly536Asp)	COL4A5	G536D	Alport syndrome 1, X-linked recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024429	X	107840626	X	108597396	24429	35770	rs104886125	NC_000023.11:108597395:G:A
NM_033380.3(COL4A5):c.1598G>A (p.Gly533Glu)	COL4A5	G533E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024428	X	107840617	X	108597387	24428	35769	rs281874672	NC_000023.11:108597386:G:A
NM_033380.3(COL4A5):c.1587+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024427	X	107840299	X	108597069	24427	35768	rs104886313	NC_000023.11:108597068:G:A
NM_033380.3(COL4A5):c.1587+1del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024426	X	107840299	X	108597069	24426	35767	rs104886124	NC_000023.11:108597068:G:
NM_033380.3(COL4A5):c.1581_1596del (p.Leu528fs)	COL4A5	L528fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024425	X	107840292 - 107840615	X	108597062 - 108597385	24425	35766	rs1556412101	
NM_033380.3(COL4A5):c.1571G>A (p.Gly524Asp)	COL4A5	G524D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024424	X	107840282	X	108597052	24424	35765	rs104886119	NC_000023.11:108597051:G:A
NM_033380.3(COL4A5):c.1562G>A (p.Gly521Asp)	COL4A5	G521D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024422	X	107840273	X	108597043	24422	35763	rs104886122	NC_000023.11:108597042:G:A
NM_033380.3(COL4A5):c.1517-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024421	X	107840227	X	108596997	24421	35762	rs104886332	NC_000023.11:108596996:G:T
NM_033380.3(COL4A5):c.1516+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024420	X	107838832	X	108595602	24420	35761	rs104886331	NC_000023.11:108595601:G:A
NM_033380.3(COL4A5):c.1498G>C (p.Gly500Arg)	COL4A5	G500R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024419	X	107838813	X	108595583	24419	35760	rs281874670	NC_000023.11:108595582:G:C
NM_033380.3(COL4A5):c.1489G>T (p.Gly497Cys)	COL4A5	G497C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024418	X	107838804	X	108595574	24418	35759	rs104886120	NC_000023.11:108595573:G:T
1685del36	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024417					24417	35758		
NM_033380.3(COL4A5):c.1481G>A (p.Gly494Asp)	COL4A5	G494D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024416	X	107838796	X	108595566	24416	35757	rs104886118	NC_000023.11:108595565:G:A
NM_033380.3(COL4A5):c.1472G>A (p.Gly491Glu)	COL4A5	G491E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024415	X	107838787	X	108595557	24415	35756	rs104886117	NC_000023.11:108595556:G:A
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024414					24414	35755		
NM_033380.3(COL4A5):c.1424-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024413	X	107838738	X	108595508	24413	35754	rs104886329	NC_000023.11:108595507:G:A
NM_033380.3(COL4A5):c.1424-20T>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024412	X	107838719	X	108595489	24412	35753	rs281874668	NC_000023.11:108595488:T:A
NM_033380.3(COL4A5):c.1423+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024410	X	107834875	X	108591645	24410	35751	rs104886312	NC_000023.11:108591644:G:A
NM_033380.3(COL4A5):c.1423G>A (p.Gly475Ser)	COL4A5	G475S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000024409	X	107834874	X	108591644	24409	35750	rs281874667	NC_000023.11:108591643:G:A
NM_033380.3(COL4A5):c.1414G>A (p.Gly472Arg)	COL4A5	G472R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024408	X	107834865	X	108591635	24408	35749	rs104886116	NC_000023.11:108591634:G:A
NM_033380.3(COL4A5):c.1406G>A (p.Gly469Glu)	COL4A5	G469E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024407	X	107834857	X	108591627	24407	35748	rs104886115	NC_000023.11:108591626:G:A
NM_033380.3(COL4A5):c.1397G>A (p.Gly466Glu)	COL4A5	G466E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024406	X	107834848	X	108591618	24406	35747	rs104886114	NC_000023.11:108591617:G:A
NM_000495.5(COL4A5):c.1376dup (p.Gly460fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024405	X	107834821 - 107834822	X	108591591 - 108591592	24405	35746	rs104886113	NC_000023.11:108591591:CCCCCC:CCCCCCC
NM_033380.3(COL4A5):c.1376del (p.Pro459fs)	COL4A5	P459fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024404	X	107834822	X	108591592	24404	35745	rs104886113	NC_000023.11:108591591:CCCCCC:CCCCC
NM_033380.3(COL4A5):c.1371_1379del (p.455_457PPG[1])	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024403	X	107834817 - 107834825	X	108591587 - 108591595	24403	35744	rs104886321	NC_000023.11:108591586:CCAGGCCCCCCAGG:CCAGG
1567del9	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024401					24401	35742		
NM_033380.3(COL4A5):c.1340-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024399	X	107834789	X	108591559	24399	35740	rs104886319	NC_000023.11:108591558:A:G
NM_033380.3(COL4A5):c.1294G>A (p.Gly432Arg)	COL4A5	G432R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000024397	X	107834416	X	108591186	24397	35738	rs281874664	NC_000023.11:108591185:G:A
NM_033380.3(COL4A5):c.1286G>A (p.Gly429Glu)	COL4A5	G429E	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000024395	X	107834408	X	108591178	24395	35736	rs104886112	NC_000023.11:108591177:G:A
NM_033380.3(COL4A5):c.1276G>A (p.Gly426Arg)	COL4A5	G426R	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000024393	X	107834398	X	108591168	24393	35734	rs104886111	NC_000023.11:108591167:G:A
NM_033380.3(COL4A5):c.1268G>A (p.Gly423Glu)	COL4A5	G423E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024392	X	107834390	X	108591160	24392	35733	rs104886110	NC_000023.11:108591159:G:A
NM_033380.3(COL4A5):c.1259G>A (p.Gly420Glu)	COL4A5	G420E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024390	X	107834381	X	108591151	24390	35731	rs281874663	NC_000023.11:108591150:G:A
NM_033380.3(COL4A5):c.1243G>A (p.Gly415Arg)	COL4A5	G415R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024388	X	107834365	X	108591135	24388	35729	rs104886103	NC_000023.11:108591134:G:A
NM_033380.3(COL4A5):c.1235G>T (p.Gly412Val)	COL4A5	G412V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024387	X	107834357	X	108591127	24387	35728	rs104886102	NC_000023.11:108591126:G:T
NM_033380.3(COL4A5):c.1226G>A (p.Gly409Asp)	COL4A5	G409D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024386	X	107834348	X	108591118	24386	35727	rs104886101	NC_000023.11:108591117:G:A
NM_033380.3(COL4A5):c.1222A>T (p.Lys408Ter)	COL4A5	K408*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024385	X	107834344	X	108591114	24385	35726	rs281874662	NC_000023.11:108591113:A:T
NM_033380.3(COL4A5):c.1219C>T (p.Gln407Ter)	COL4A5	Q407*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024384	X	107834341	X	108591111	24384	35725	rs281874661	NC_000023.11:108591110:C:T
NM_033380.3(COL4A5):c.1217G>T (p.Gly406Val)	COL4A5	G406V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024383	X	107834339	X	108591109	24383	35724	rs104886100	NC_000023.11:108591108:G:T
NM_033380.3(COL4A5):c.1214_1215insA (p.Gln407fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024381	X	107834336 - 107834337	X	108591106 - 108591107	24381	35722	rs104886325	NC_000023.11:108591106::A
NM_000495.5(COL4A5):c.1213dup (p.Arg405fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024380	X	107834332 - 107834333	X	108591102 - 108591103	24380	35721	rs281874659	NC_000023.11:108591102:AAA:AAAA
NM_033380.3(COL4A5):c.1208G>T (p.Gly403Val)	COL4A5	G403V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024379	X	107834330	X	108591100	24379	35720	rs104886099	NC_000023.11:108591099:G:T
NM_033380.3(COL4A5):c.1199G>A (p.Gly400Glu)	COL4A5	G400E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024378	X	107834321	X	108591091	24378	35719	rs104886107	NC_000023.11:108591090:G:A
NM_033380.3(COL4A5):c.1181del (p.Gly394fs)	COL4A5	G394fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024376	X	107834301	X	108591071	24376	35717	rs281874658	NC_000023.11:108591070:GGG:GG
NM_000495.4(COL4A5):c.1166-?_2041+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024375					24375	35716		
NM_000495.4(COL4A5):c.1166-?_1516+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024374					24374	35715		
NM_000495.4(COL4A5):c.1166-?_1423+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024373					24373	35714		
NM_033380.3(COL4A5):c.1165+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024372	X	107829979	X	108586749	24372	35713	rs104886324	NC_000023.11:108586748:T:G
NM_033380.3(COL4A5):c.1165+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024371	X	107829978	X	108586748	24371	35712	rs104886317	NC_000023.11:108586747:G:A
NM_033380.3(COL4A5):c.1148G>A (p.Gly383Asp)	COL4A5	G383D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024370	X	107829960	X	108586730	24370	35711	rs104886105	NC_000023.11:108586729:G:A
NM_033380.3(COL4A5):c.1139G>A (p.Gly380Asp)	COL4A5	G380D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024369	X	107829951	X	108586721	24369	35710	rs104886098	NC_000023.11:108586720:G:A
NM_033380.3(COL4A5):c.1121G>C (p.Gly374Ala)	COL4A5	G374A	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024368	X	107829933	X	108586703	24368	35709	rs104886108	NC_000023.11:108586702:G:C
NM_033380.3(COL4A5):c.1117C>T (p.Arg373Ter)	COL4A5	R373*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024367	X	107829929	X	108586699	24367	35708	rs104886094	NC_000023.11:108586698:C:T
NM_033380.3(COL4A5):c.1112G>A (p.Gly371Glu)	COL4A5	G371E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024366	X	107829924	X	108586694	24366	35707	rs104886097	NC_000023.11:108586693:G:A
NM_033380.3(COL4A5):c.1094G>A (p.Gly365Glu)	COL4A5	G365E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000024364	X	107829906	X	108586676	24364	35705	rs104886096	NC_000023.11:108586675:G:A
NM_033380.3(COL4A5):c.1084G>A (p.Gly362Arg)	COL4A5	G362R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024363	X	107829896	X	108586666	24363	35704	rs281874656	NC_000023.11:108586665:G:A
NM_000495.5(COL4A5):c.1062dup (p.Ile355fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024361	X	107829873 - 107829874	X	108586643 - 108586644	24361	35702	rs104886316	NC_000023.11:108586643:T:TT
NM_000495.5(COL4A5):c.1060dup (p.Thr354fs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024360	X	107829870 - 107829871	X	108586640 - 108586641	24360	35701	rs281874655	NC_000023.11:108586640:AA:AAA
NM_000495.4(COL4A5):c.1033-?_1516+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024359					24359	35700		
NM_033380.3(COL4A5):c.1032+3_1032+6del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024356	X	107827756 - 107827759	X	108584526 - 108584529	24356	35697	rs104886314	NC_000023.11:108584525:GTAAGT:GT
NM_033380.3(COL4A5):c.1001G>T (p.Gly334Val)	COL4A5	G334V	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000024355	X	107827724	X	108584494	24355	35696	rs104886093	NC_000023.11:108584493:G:T
NM_033380.3(COL4A5):c.992G>T (p.Gly331Val)	COL4A5	G331V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024354	X	107827715	X	108584485	24354	35695	rs104886092	NC_000023.11:108584484:G:T
NM_033380.3(COL4A5):c.973G>T (p.Gly325Ter)	COL4A5	G325*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024353	X	107826150	X	108582920	24353	35694	rs104886088	NC_000023.11:108582919:G:T
NM_033380.3(COL4A5):c.973G>A (p.Gly325Arg)	COL4A5	G325R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000024352	X	107826150	X	108582920	24352	35693	rs104886088	NC_000023.11:108582919:G:A
NM_033380.3(COL4A5):c.960C>A (p.Tyr320Ter)	COL4A5	Y320*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024350	X	107826137	X	108582907	24350	35691	rs281874769	NC_000023.11:108582906:C:A
NM_033380.3(COL4A5):c.956G>A (p.Gly319Asp)	COL4A5	G319D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024349	X	107826133	X	108582903	24349	35690	rs104886086	NC_000023.11:108582902:G:A
NM_033380.3(COL4A5):c.955G>C (p.Gly319Arg)	COL4A5	G319R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024348	X	107826132	X	108582902	24348	35689	rs104886085	NC_000023.11:108582901:G:C
NM_033380.3(COL4A5):c.937G>A (p.Gly313Ser)	COL4A5	G313S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024346	X	107826114	X	108582884	24346	35687	rs104886084	NC_000023.11:108582883:G:A
NM_000495.4(COL4A5):c.937-?_990+?del (p.Gly313_Lys330del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024345	X	107826114 - 107826167	X	108582884 - 108582937	24345	35686		
NM_033380.3(COL4A5):c.937-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024344	X	107826113	X	108582883	24344	35685	rs104886448	NC_000023.11:108582882:G:A
NM_033380.3(COL4A5):c.928G>A (p.Gly310Arg)	COL4A5	G310R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024343	X	107824249	X	108581019	24343	35684	rs104886083	NC_000023.11:108581018:G:A
NM_033380.3(COL4A5):c.913G>T (p.Glu305Ter)	COL4A5	E305*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024341	X	107824234	X	108581004	24341	35682	rs104886081	NC_000023.11:108581003:G:T
NM_033380.3(COL4A5):c.892G>A (p.Gly298Ser)	COL4A5	G298S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024340	X	107824213	X	108580983	24340	35681	rs104886080	NC_000023.11:108580982:G:A
NM_033380.3(COL4A5):c.892-1G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024339	X	107824212	X	108580982	24339	35680	rs104886452	NC_000023.11:108580981:G:C
NM_033380.3(COL4A5):c.892-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024338	X	107824211	X	108580981	24338	35679	rs104886453	NC_000023.11:108580980:A:G
NM_033380.3(COL4A5):c.891+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024337	X	107823969	X	108580739	24337	35678	rs104886451	NC_000023.11:108580738:G:A
NM_033380.3(COL4A5):c.884G>A (p.Gly295Asp)	COL4A5	G295D	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000024336	X	107823961	X	108580731	24336	35677	rs104886079	NC_000023.11:108580730:G:A
NM_000495.5(COL4A5):c.875del (p.Gly292fs)	COL4A5	G292fs	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024335	X	107823951	X	108580721	24335	35676	rs281874768	NC_000023.11:108580720:GG:G
NM_033380.3(COL4A5):c.875G>T (p.Gly292Val)	COL4A5	G292V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024334	X	107823952	X	108580722	24334	35675	rs104886078	NC_000023.11:108580721:G:T
NM_033380.3(COL4A5):c.874G>C (p.Gly292Arg)	COL4A5	G292R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024333	X	107823951	X	108580721	24333	35674	rs104886073	NC_000023.11:108580720:G:C
NM_033380.3(COL4A5):c.866G>T (p.Gly289Val)	COL4A5	G289V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024330	X	107823943	X	108580713	24330	35671	rs104886450	NC_000023.11:108580712:G:T
NM_033380.3(COL4A5):c.859G>T (p.Glu287Ter)	COL4A5	E287*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024329	X	107823936	X	108580706	24329	35670	rs104886447	NC_000023.11:108580705:G:T
NM_033380.3(COL4A5):c.834+5G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024328	X	107823821	X	108580591	24328	35669	rs104886442	NC_000023.11:108580590:G:T
NM_033380.3(COL4A5):c.834+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024327	X	107823817	X	108580587	24327	35668	rs104886446	NC_000023.11:108580586:G:A
NM_033380.3(COL4A5):c.796C>T (p.Arg266Ter)	COL4A5	R266*	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000024325	X	107823778	X	108580548	24325	35666	rs104886071	NC_000023.11:108580547:C:T
NM_033380.3(COL4A5):c.791G>A (p.Gly264Asp)	COL4A5	G264D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024324	X	107823773	X	108580543	24324	35665	rs104886070	NC_000023.11:108580542:G:A
NM_033380.3(COL4A5):c.790G>C (p.Gly264Arg)	COL4A5	G264R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024323	X	107823772	X	108580542	24323	35664	rs104886069	NC_000023.11:108580541:G:C
NM_000495.4(COL4A5):c.781-?_1423+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024322					24322	35663		
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024321					24321	35662		
NM_033380.3(COL4A5):c.781-1_786delGGGACTT (p.?)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024320	X	107823762 - 107823768	X	108580532 - 108580538	24320	35661	rs104886445	NC_000023.11:108580531:GGGACTT:
NM_033380.3(COL4A5):c.780+2T>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024319	X	107821615	X	108578385	24319	35660	rs104886444	NC_000023.11:108578384:T:G
NM_033380.3(COL4A5):c.716G>A (p.Gly239Glu)	COL4A5	G239E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024317	X	107821549	X	108578319	24317	35658	rs104886068	NC_000023.11:108578318:G:A
NM_033380.3(COL4A5):c.689G>A (p.Gly230Asp)	COL4A5	G230D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024316	X	107821522	X	108578292	24316	35657	rs281874763	NC_000023.11:108578291:G:A
NM_033380.3(COL4A5):c.688G>C (p.Gly230Arg)	COL4A5	G230R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024314	X	107821521	X	108578291	24314	35655	rs104886076	NC_000023.11:108578290:G:C
NM_033380.3(COL4A5):c.688-3C>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024313	X	107821518	X	108578288	24313	35654	rs104886441	NC_000023.11:108578287:C:G
NM_033380.3(COL4A5):c.687+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024312	X	107821350	X	108578120	24312	35653	rs104886440	NC_000023.11:108578119:G:A
NM_033380.3(COL4A5):c.655G>A (p.Gly219Ser)	COL4A5	G219S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024311	X	107821317	X	108578087	24311	35652	rs104886075	NC_000023.11:108578086:G:A
NM_000495.4(COL4A5):c.648dup (p.Asn217Glufs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024310	X	107821306 - 107821307	X	108578076 - 108578077	24310	35651	rs104886438	NC_000023.11:108578076:GGGG:GGGGG
NM_000495.4(COL4A5):c.647_648dup (p.Asn217Glyfs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 13, 2018)	no assertion criteria provided	VCV000024309	X	107821306 - 107821307	X	108578076 - 108578077	24309	35650	rs104886438	NC_000023.11:108578076:GGGG:GGGGGG
NM_033380.3(COL4A5):c.647G>T (p.Gly216Val)	COL4A5	G216V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024308	X	107821309	X	108578079	24308	35649	rs104886074	NC_000023.11:108578078:G:T
NM_033380.3(COL4A5):c.646G>A (p.Gly216Arg)	COL4A5	G216R	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024307	X	107821308	X	108578078	24307	35648	rs104886067	NC_000023.11:108578077:G:A
NM_033380.3(COL4A5):c.646-3C>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024306	X	107821305	X	108578075	24306	35647	rs104886437	NC_000023.11:108578074:C:A
NM_033380.3(COL4A5):c.638G>A (p.Gly213Glu)	COL4A5	G213E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024304	X	107821210	X	108577980	24304	35645	rs104886066	NC_000023.11:108577979:G:A
NM_033380.3(COL4A5):c.635del (p.Pro212fs)	COL4A5	P212fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024303	X	107821206	X	108577976	24303	35644	rs104886065	NC_000023.11:108577975:CC:C
NM_033380.3(COL4A5):c.611_612del (p.Gly204fs)	COL4A5	G204fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000024302	X	107821183 - 107821184	X	108577953 - 108577954	24302	35643	rs281874759	NC_000023.11:108577952:GC:
NM_033380.3(COL4A5):c.611G>T (p.Gly204Val)	COL4A5	G204V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024301	X	107821183	X	108577953	24301	35642	rs104886063	NC_000023.11:108577952:G:T
NM_033380.3(COL4A5):c.611G>A (p.Gly204Asp)	COL4A5	G204D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000024300	X	107821183	X	108577953	24300	35641	rs104886063	NC_000023.11:108577952:G:A
NM_033380.3(COL4A5):c.610-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024298	X	107821180	X	108577950	24298	35639	rs281874758	NC_000023.11:108577949:A:G
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024297					24297	35638		
NM_033380.3(COL4A5):c.609+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024295	X	107819203	X	108575973	24295	35636	rs104886434	NC_000023.11:108575972:G:A
NM_033380.3(COL4A5):c.602G>T (p.Gly201Val)	COL4A5	G201V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024294	X	107819195	X	108575965	24294	35635	rs104886062	NC_000023.11:108575964:G:T
NM_033380.3(COL4A5):c.593G>A (p.Gly198Glu)	COL4A5	G198E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024293	X	107819186	X	108575956	24293	35634	rs104886057	NC_000023.11:108575955:G:A
NM_033380.3(COL4A5):c.584G>A (p.Gly195Asp)	COL4A5	G195D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024292	X	107819177	X	108575947	24292	35633	rs104886061	NC_000023.11:108575946:G:A
NM_033380.3(COL4A5):c.574G>A (p.Gly192Arg)	COL4A5	G192R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024291	X	107819167	X	108575937	24291	35632	rs104886060	NC_000023.11:108575936:G:A
NM_033380.3(COL4A5):c.548G>T (p.Gly183Val)	COL4A5	G183V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024289	X	107819141	X	108575911	24289	35630	rs104886059	NC_000023.11:108575910:G:T
NM_000495.4(COL4A5):c.547dup (p.Leu184Profs)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024288	X	107819138 - 107819139	X	108575908 - 108575909	24288	35629	rs104886432	NC_000023.11:108575908:GGG:GGGG
NM_033380.3(COL4A5):c.547-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024287	X	107819139	X	108575909	24287	35628	rs104886431	NC_000023.11:108575908:G:A
NM_033380.3(COL4A5):c.547-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024286	X	107819138	X	108575908	24286	35627	rs281874756	NC_000023.11:108575907:A:G
NM_033380.3(COL4A5):c.546+3_546+4insT	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024285	X	107816887 - 107816888	X	108573657 - 108573658	24285	35626	rs104886430	NC_000023.11:108573657::T
NM_033380.3(COL4A5):c.546+1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024284	X	107816885	X	108573655	24284	35625	rs104886429	NC_000023.11:108573654:G:A
NM_033380.3(COL4A5):c.538G>A (p.Gly180Arg)	COL4A5	G180R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024282	X	107816876	X	108573646	24282	35623	rs281874755	NC_000023.11:108573645:G:A
NM_033380.3(COL4A5):c.529G>C (p.Gly177Arg)	COL4A5	G177R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024280	X	107816867	X	108573637	24280	35621	rs104886056	NC_000023.11:108573636:G:C
NM_033380.3(COL4A5):c.529G>T (p.Gly177Cys)	COL4A5	G177C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024279	X	107816867	X	108573637	24279	35620	rs104886056	NC_000023.11:108573636:G:T
NM_033380.3(COL4A5):c.520G>C (p.Gly174Arg)	COL4A5	G174R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024278	X	107816858	X	108573628	24278	35619	rs104886055	NC_000023.11:108573627:G:C
NM_033380.3(COL4A5):c.466-2A>G	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024277	X	107816802	X	108573572	24277	35618	rs104886416	NC_000023.11:108573571:A:G
NM_033380.3(COL4A5):c.466-12G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024276	X	107816792	X	108573562	24276	35617	rs104886414	NC_000023.11:108573561:G:A
NM_033380.3(COL4A5):c.438+5G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024271	X	107814701	X	108571471	24271	35612	rs281874739	NC_000023.11:108571470:G:A
NM_033380.3(COL4A5):c.431G>A (p.Gly144Asp)	COL4A5	G144D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024270	X	107814689	X	108571459	24270	35611	rs281874737	NC_000023.11:108571458:G:A
NM_033380.3(COL4A5):c.430G>A (p.Gly144Ser)	COL4A5	G144S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024269	X	107814688	X	108571458	24269	35610	rs104886052	NC_000023.11:108571457:G:A
NM_033380.3(COL4A5):c.388G>T (p.Glu130Ter)	COL4A5	E130*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024268	X	107814646	X	108571416	24268	35609	rs104886051	NC_000023.11:108571415:G:T
NM_033380.3(COL4A5):c.386G>T (p.Gly129Val)	COL4A5	G129V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024267	X	107814644	X	108571414	24267	35608	rs281874723	NC_000023.11:108571413:G:T
NM_033380.3(COL4A5):c.386G>A (p.Gly129Glu)	COL4A5	G129E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024266	X	107814644	X	108571414	24266	35607	rs281874723	NC_000023.11:108571413:G:A
NM_033380.3(COL4A5):c.385G>A (p.Gly129Arg)	COL4A5	G129R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024265	X	107814643	X	108571413	24265	35606	rs281874722	NC_000023.11:108571412:G:A
NM_033380.3(COL4A5):c.385-1G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024264	X	107814642	X	108571412	24264	35605	rs104886395	NC_000023.11:108571411:G:C
NM_033380.3(COL4A5):c.385-719G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024263	X	107813924	X	108570694	24263	35604	rs104886396	NC_000023.11:108570693:G:A
NM_033380.3(COL4A5):c.351_359del (p.Pro118_Gly120del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024261	X	107812015 - 107812023	X	108568785 - 108568793	24261	35602	rs104886390	NC_000023.11:108568784:AGGACCTCAAGG:AGG
NM_033380.3(COL4A5):c.322-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024260	X	107811988	X	108568758	24260	35601	rs104886375	NC_000023.11:108568757:G:A
NM_033380.3(COL4A5):c.286G>A (p.Gly96Arg)	COL4A5	G96R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024258	X	107811868	X	108568638	24258	35599	rs281874706	NC_000023.11:108568637:G:A
NM_000495.4(COL4A5):c.277-?_609+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024257					24257	35598		
NM_033380.3(COL4A5):c.277-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024256	X	107811858	X	108568628	24256	35597	rs104886367	NC_000023.11:108568627:G:T
NM_033380.3(COL4A5):c.276+5G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024255	X	107807161	X	108563931	24255	35596	rs104886365	NC_000023.11:108563930:G:A
NM_000495.4(COL4A5):c.232-?_4510+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024253	X	107802384 - 107935977	X	108563882 - 108687694	24253	35594		
NM_000495.4(COL4A5):c.232-?_780+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024252			X	108563881 - 108578384	24252	35593		
NM_000495.4(COL4A5):c.232-?_2041+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024251	X	107807112 - 107844715	X	108559154 - 108601884	24251	35592		
NM_033380.3(COL4A5):c.232-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024250	X	107807111	X	108563881	24250	35591	rs104886350	NC_000023.11:108563880:G:A
NM_033380.3(COL4A5):c.232-1G>T	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024249	X	107807111	X	108563881	24249	35590	rs104886350	NC_000023.11:108563880:G:T
NM_033380.3(COL4A5):c.231+1G>A	COL4A5		not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000024248	X	107802384	X	108559154	24248	35589	rs104886349	NC_000023.11:108559153:G:A
COL4A5:c.142-?_231+?del(p.Gly48_Lys77del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024246	X	107783036 - 107807111	X	108539806 - 108563881	24246	35587		
NP_203699.1:p.Gly51fs	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024245					24245	35586		
NM_033380.3(COL4A5):c.142G>A (p.Gly48Arg)	COL4A5	G48R	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024244	X	107802294	X	108559064	24244	35585	rs281874669	NC_000023.11:108559063:G:A
NM_000495.4(COL4A5):c.142-?_2677+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024243	X	107783036 - 107865032	X	108559064 - 108620426	24243	35584		
NM_000495.4(COL4A5):c.142-?_3373+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024242	X	107783036 - 107908736	X	108559064 - 108655457	24242	35583		
NM_033380.3(COL4A5):c.142-1G>A	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024241	X	107802293	X	108559063	24241	35582	rs104886323	NC_000023.11:108559062:G:A
NM_033380.3(COL4A5):c.90T>G (p.Tyr30Ter)	COL4A5	Y30*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024239	X	107782984	X	108539754	24239	35580	rs104886047	NC_000023.11:108539753:T:G
NM_033380.3(COL4A5):c.87C>A (p.Cys29Ter)	COL4A5	C29*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024238	X	107782981	X	108539751	24238	35579	rs104886048	NC_000023.11:108539750:C:A
COL4A5:c.82-?_141+?del (p.Ala28_Lys47del)	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024237	X	107683437 - 107802293	X	108539746 - 108539805	24237	35578		
NM_000495.4(COL4A5):c.82-?_3373+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024234	X	107683437 - 107908736	X	108539746 - 108655457	24234	35575		
NM_000495.4(COL4A5):c.82-?_3246+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024233	X	107782976 - 107869579	X	108539746 - 108626349	24233	35574		
NM_000495.4(COL4A5):c.82-?_1165+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024232	X	107782976 - 107829977	X	108539746 - 108586747	24232	35573		
NM_000495.4(COL4A5):c.82-?_465+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024231					24231	35572		
NP_203699.1:p.Ala28_Lys1082dup	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024230					24230	35571		
NM_000495.5(COL4A5):c.65_77del (p.Gln22fs)	COL4A5	Q22fs	not provided|Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000024229	X	107683417 - 107683429	X	108440187 - 108440199	24229	35570	rs281874760	NC_000023.11:108440186:GGCAGCCTGCAGAGGC:GGC
NM_033380.3(COL4A5):c.49_50del (p.Leu17fs)	COL4A5	L17fs	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, single submitter	VCV000024228	X	107683404 - 107683405	X	108440174 - 108440175	24228	35569	rs104886427	NC_000023.11:108440173:CT:
NM_033380.3(COL4A5):c.13G>T (p.Gly5Ter)	COL4A5	G5*	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024226	X	107683368	X	108440138	24226	35567	rs104886049	NC_000023.11:108440137:G:T
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024220					24220	35561		
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024218					24218	35559		
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024216					24216	35557		
NP_203699.1:p.?	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024215					24215	35556		
NM_033380.3(COL4A5):c.1A>G (p.Met1Val)	COL4A5	M1V	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024214	X	107683356	X	108440126	24214	35555	rs104886050	NC_000023.11:108440125:A:G
NM_000495.3(COL4A5):c.1-?_81+?del	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024210					24210	35551		
NM_033380.3(COL4A5):c.81+1G>C	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000024205	X	107683437	X	108440207	24205	35546	rs281874765	NC_000023.11:108440206:G:C
NM_172107.4(KCNQ2):c.1148+2T>G	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021816	20	62062691	20	63431338	21816	34668	rs118192221	NC_000020.11:63431337:A:C
NM_172107.4(KCNQ2):c.1764-6C>A	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021815	20	62039895	20	63408542	21815	34667	rs118192239	NC_000020.11:63408541:G:T
NM_172107.4(KCNQ2):c.1764-2A>G	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021814	20	62039891	20	63408538	21814	34666	rs118192238	NC_000020.11:63408537:T:C
NM_172107.4(KCNQ2):c.1302-1G>C	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021812	20	62046480	20	63415127	21812	34664	rs118192225	NC_000020.11:63415126:C:G
NM_172107.4(KCNQ2):c.296+1G>A	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021811	20	62103520	20	63472167	21811	34663	rs118192190	NC_000020.11:63472166:C:T
NM_172107.3(KCNQ2):c.998G>A (p.Arg333Gln)	KCNQ2	R333Q	Early infantile epileptic encephalopathy|Benign familial neonatal seizures 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021810	20	62070003	20	63438650	21810	34662	rs118192216	NC_000020.11:63438649:C:T
NM_172107.3(KCNQ2):c.997C>T (p.Arg333Trp)	KCNQ2	R333W	Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021809	20	62070004	20	63438651	21809	34661	rs118192215	NC_000020.11:63438650:G:A
NM_172107.4(KCNQ2):c.967C>T (p.Gln323Ter)	KCNQ2	Q323*	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021808	20	62070034	20	63438681	21808	34660	rs118192214	NC_000020.11:63438680:G:A
NM_172107.4(KCNQ2):c.939dup (p.Ser314fs)	KCNQ2		Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021807	20	62070061 - 62070062	20	63438708 - 63438709	21807	34659	rs118192213	NC_000020.11:63438708:CCCC:CCCCC
NM_172107.4(KCNQ2):c.881C>G (p.Ala294Gly)	KCNQ2	A294G	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021805	20	62070997	20	63439644	21805	34657	rs118192211	NC_000020.11:63439643:G:C
NM_172107.4(KCNQ2):c.847_848insGT (p.Lys283fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021804	20	62071030 - 62071031	20	63439677 - 63439678	21804	34656	rs118192210	NC_000020.11:63439677::AC
NM_172107.4(KCNQ2):c.812G>T (p.Gly271Val)	KCNQ2	G271V	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021803	20	62073763	20	63442410	21803	34655	rs118192209	NC_000020.11:63442409:C:A
NM_172107.4(KCNQ2):c.807G>A (p.Trp269Ter)	KCNQ2	W269*	Early infantile epileptic encephalopathy|Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021802	20	62073768	20	63442415	21802	34654	rs118192208	NC_000020.11:63442414:C:T
NM_172107.4(KCNQ2):c.773A>G (p.Asn258Ser)	KCNQ2	N258S	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021801	20	62073802	20	63442449	21801	34653	rs118192207	NC_000020.11:63442448:T:C
NM_172107.4(KCNQ2):c.740C>A (p.Ser247Ter)	KCNQ2	S247*	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021799	20	62073835	20	63442482	21799	34651	rs74315392	NC_000020.11:63442481:G:T
NM_172107.4(KCNQ2):c.727C>T (p.Leu243Phe)	KCNQ2	L243F	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021798	20	62073848	20	63442495	21798	34650	rs118192205	NC_000020.11:63442494:G:A
NM_172107.4(KCNQ2):c.684C>A (p.His228Gln)	KCNQ2	H228Q	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021797	20	62076018	20	63444665	21797	34649	rs118192204	NC_000020.11:63444664:G:T
NM_172107.4(KCNQ2):c.65_68del (p.Val22fs)	KCNQ2	V22fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021796	20	62103749 - 62103752	20	63472396 - 63472399	21796	34648	rs118192187	NC_000020.11:63472395:CCCACC:CC
NM_172107.4(KCNQ2):c.637C>T (p.Arg213Trp)	KCNQ2	R213W	Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021795	20	62076065	20	63444712	21795	34647	rs118192203	NC_000020.11:63444711:G:A
NM_172107.4(KCNQ2):c.635A>G (p.Asp212Gly)	KCNQ2	D212G	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021794	20	62076067	20	63444714	21794	34646	rs118192202	NC_000020.11:63444713:T:C
NM_172107.4(KCNQ2):c.622A>G (p.Met208Val)	KCNQ2	M208V	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021793	20	62076080	20	63444727	21793	34645	rs118192201	NC_000020.11:63444726:T:C
NM_172107.4(KCNQ2):c.587C>T (p.Ala196Val)	KCNQ2	A196V	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021792	20	62076115	20	63444762	21792	34644	rs118192199	NC_000020.11:63444761:G:A
NM_172107.4(KCNQ2):c.585dup (p.Ala196fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021791	20	62076116 - 62076117	20	63444763 - 63444764	21791	34643	rs118192198	NC_000020.11:63444763:A:AA
NM_172107.4(KCNQ2):c.584_593delinsA (p.Ser195_Arg198delinsTer)	KCNQ2		Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021790	20	62076109 - 62076118	20	63444756 - 63444765	21790	34642	rs118192197	NC_000020.11:63444755:CGGAGCGCAG:T
NM_172107.4(KCNQ2):c.388-1_389del	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021789	20	62076716 - 62076718	20	63445363 - 63445365	21789	34641	rs118192196	NC_000020.11:63445362:TCCT:T
NM_172107.4(KCNQ2):c.387+1G>T	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021788	20	62078099	20	63446746	21788	34640	rs118192195	NC_000020.11:63446745:C:A
NM_172107.4(KCNQ2):c.365C>T (p.Ser122Leu)	KCNQ2	S122L	Early infantile epileptic encephalopathy|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021787	20	62078122	20	63446769	21787	34639	rs118192194	NC_000020.11:63446768:G:A
NM_172107.4(KCNQ2):c.356A>G (p.Glu119Gly)	KCNQ2	E119G	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021786	20	62078131	20	63446778	21786	34638	rs118192193	NC_000020.11:63446777:T:C
NM_172107.4(KCNQ2):c.346_348del (p.Lys116del)	KCNQ2	K116del	Benign familial neonatal seizures	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021785	20	62078139 - 62078141	20	63446786 - 63446788	21785	34637	rs118192192	NC_000020.11:63446785:CTT:
NM_172107.2(KCNQ2):c.314_316delCCT (p.Ser105del)	KCNQ2	S105del	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021784	20	62078171 - 62078173	20	63446818 - 63446820	21784	34636	rs118192191	NC_000020.11:63446817:AGGAG:AG
NM_172107.4(KCNQ2):c.2T>C (p.Met1Thr)	KCNQ2	M1T	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000021783	20	62103815	20	63472462	21783	34635	rs118192186	NC_000020.11:63472461:A:G
NM_172107.4(KCNQ2):c.2600_2604GGGCC[3] (p.Arg871fs)	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021782	20	62038006 - 62038007	20	63406653 - 63406654	21782	34634	rs118192246	NC_000020.11:63406653:GGCCCGGCCC:GGCCCGGCCCGGCCC
NM_172107.4(KCNQ2):c.2597del (p.Gly866fs)	KCNQ2	G838fs, G835fs, G848fs, G866fs	Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000021781	20	62038019	20	63406666	21781	34633	rs118192245	NC_000020.11:63406665:CCC:CC
NM_172107.4(KCNQ2):c.232del (p.Gln78fs)	KCNQ2	Q78fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021778	20	62103585	20	63472232	21778	34630	rs118192189	NC_000020.11:63472231:G:
NM_172107.4(KCNQ2):c.204dup (p.Lys69fs)	KCNQ2		Benign familial neonatal seizures 1|not provided	Pathogenic(Last reviewed: Dec 24, 2014)	criteria provided, single submitter	VCV000021776	20	62103612 - 62103613	20	63472259 - 63472260	21776	34628	rs118192188	NC_000020.11:63472259:GGGGGG:GGGGGGG
NM_172107.4(KCNQ2):c.2015del (p.Ser672fs)	KCNQ2	S641fs, S654fs, S644fs, S672fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021775	20	62038601	20	63407248	21775	34627	rs118192243	NC_000020.11:63407247:C:
NM_172107.4(KCNQ2):c.1A>G (p.Met1Val)	KCNQ2	M1V	not provided|Early infantile epileptic encephalopathy|Benign familial neonatal seizures 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021774	20	62103816	20	63472463	21774	34626	rs118192185	NC_000020.11:63472462:T:C
NM_172107.4(KCNQ2):c.1956del (p.Thr653fs)	KCNQ2	T635fs, T653fs, T622fs, T625fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021773	20	62038660	20	63407307	21773	34625	rs118192242	NC_000020.11:63407306:C:
NM_172107.4(KCNQ2):c.1930del (p.Tyr644fs)	KCNQ2	Y644fs, Y613fs, Y626fs, Y616fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021772	20	62038686	20	63407333	21772	34624	rs118192241	NC_000020.11:63407332:A:
NM_172107.4(KCNQ2):c.1910T>G (p.Leu637Arg)	KCNQ2	L637R, L609R, L619R, L606R	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021771	20	62038706	20	63407353	21771	34623	rs118192240	NC_000020.11:63407352:A:C
NM_172107.4(KCNQ2):c.1764A>T (p.Arg588Ser)	KCNQ2	R588S, R560S, R557S, R570S	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021770	20	62039889	20	63408536	21770	34622	rs118192237	NC_000020.11:63408535:T:A
NM_172107.3(KCNQ2):c.1742G>A (p.Arg581Gln)	KCNQ2	R581Q	not provided|Benign familial neonatal seizures 1|Epileptic encephalopathy|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021769	20	62044824	20	63413471	21769	34621	rs118192235	NC_000020.11:63413470:C:T
NM_172107.4(KCNQ2):c.1741C>T (p.Arg581Ter)	KCNQ2	R581*, R550*, R553*, R563*	not provided|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021768	20	62044825	20	63413472	21768	34620	rs118192236	NC_000020.11:63413471:G:A
NM_172107.4(KCNQ2):c.1658G>A (p.Arg553Gln)	KCNQ2	R553Q, R522Q, R535Q, R525Q	not provided|Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000021767	20	62044908	20	63413555	21767	34619	rs118192234	NC_000020.11:63413554:C:T
NM_172107.4(KCNQ2):c.1525+1G>A	KCNQ2		Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000021763	20	62046255	20	63414902	21763	34615	rs118192228	NC_000020.11:63414901:C:T
NM_172107.4(KCNQ2):c.1342C>T (p.Arg448Ter)	KCNQ2	R448*, R420*, R430*, R418*	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy|Seizures|not provided	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021762	20	62046439	20	63415086	21762	34614	rs118192226	NC_000020.11:63415085:G:A
NM_172107.4(KCNQ2):c.1288C>T (p.Pro430Ser)	KCNQ2	P430S	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021761	20	62050985	20	63419632	21761	34613	rs118192224	NC_000020.11:63419631:G:A
NM_172107.4(KCNQ2):c.1217+2T>G	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021760	20	62059718	20	63428365	21760	34612	rs118192223	NC_000020.11:63428364:A:C
NM_172107.4(KCNQ2):c.1192_1193del (p.Lys398fs)	KCNQ2	K398fs, K388fs	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021759	20	62059744 - 62059745	20	63428391 - 63428392	21759	34611	rs118192222	NC_000020.11:63428390:TT:
NM_172107.3(KCNQ2):c.1076C>A (p.Thr359Lys)	KCNQ2	T359K	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000021757	20	62065204	20	63433851	21757	34609	rs118192219	NC_000020.11:63433850:G:T
NM_172107.4(KCNQ2):c.1057C>G (p.Arg353Gly)	KCNQ2	R353G	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021756	20	62065223	20	63433870	21756	34608	rs118192218	NC_000020.11:63433869:G:C
NM_172107.4(KCNQ2):c.1016T>G (p.Leu339Arg)	KCNQ2	L339R	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000021755	20	62069985	20	63438632	21755	34607	rs118192217	NC_000020.11:63438631:A:C
NM_152841.2(HPS4):c.42dup (p.Leu15fs)	HPS4		Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021679	22	26875305 - 26875306	22	26479339 - 26479340	21679	34531	rs281865097	NC_000022.11:26479339:AAAAAAA:AAAAAAAA
NM_152841.2(HPS4):c.446A>G (p.His149Arg)	HPS4	H154R, H149R	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021678	22	26868308	22	26472342	21678	34530	rs281865098	NC_000022.11:26472341:T:C
NM_152841.2(HPS4):c.1851del (p.Thr618fs)	HPS4	T618fs, T641fs, T623fs	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000021676	22	26853914	22	26457948	21676	34528	rs281865099	NC_000022.11:26457947:GG:G
NM_018848.3(MKKS):c.873_876dup (p.Cys293fs)	MKKS		Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 13, 2009)	no assertion criteria provided	VCV000021672	20	10393286 - 10393287	20	10412638 - 10412639	21672	34524	rs113994196	NC_000020.11:10412638:CAGG:CAGGCAGG
NM_018848.3(MKKS):c.431_441del (p.Phe144fs)	MKKS	F144fs	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 13, 2009)	no assertion criteria provided	VCV000021670	20	10393722 - 10393732	20	10413074 - 10413084	21670	34522	rs113994195	NC_000020.11:10413073:AGTACTACTAAAGT:AGT
NM_015166.3(MLC1):c.298_423+108del	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000021523	22	50518239 - 50518796	22	50079810 - 50080367	21523	34375	rs1555967644	
NM_014646.2(LPIN2):c.2327+1G>C	LPIN2		Majeed syndrome	Pathogenic(Last reviewed: Sep 23, 2008)	no assertion criteria provided	VCV000021519	18	2922044	18	2922046	21519	34371	rs80338808	NC_000018.10:2922045:C:G
NM_006517.5(SLC16A2):c.359C>T (p.Ser120Phe)	SLC16A2	S120F	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000021463	X	73641831	X	74421996	21463	34315	rs113994162	NC_000023.11:74421995:C:T
NM_006517.5(SLC16A2):c.1276_1278TTC[1] (p.Phe427del)	SLC16A2	F427del	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000021461	X	73749152 - 73749154	X	74529317 - 74529319	21461	34313	rs113994164	NC_000023.11:74529316:CTTCTTC:CTTC
NM_005629.4(SLC6A8):c.318_320CTT[1] (p.Phe107del)	SLC6A8	F107del	not provided|Inborn genetic diseases|Creatine transporter deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021448	X	152955883 - 152955885	X	153690428 - 153690430	21448	34300	rs80338739	NC_000023.11:153690427:TTCTTCTT:TTCTT
NM_005333.5(HCCS):c.475G>A (p.Glu159Lys)	HCCS	E159K	Linear skin defects with multiple congenital anomalies 1	Pathogenic(Last reviewed: Aug 18, 2011)	no assertion criteria provided	VCV000021444	X	11136694	X	11118574	21444	34296	rs193929392	NC_000023.11:11118573:G:A
NM_001256789.3(CACNA1F):c.3133dup (p.Leu1045fs)	CACNA1F		not provided|Congenital stationary night blindness, type 2A	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000021443	X	49072944 - 49072945	X	49216484 - 49216485	21443	34295	rs80359870	NC_000023.11:49216484:GGGG:GGGGG
NM_004750.5(CRLF1):c.935G>A (p.Arg312His)	CRLF1	R312H	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021437	19	18707521	19	18596711	21437	34289	rs137853933	NC_000019.10:18596710:C:T
NM_004750.5(CRLF1):c.538C>T (p.Gln180Ter)	CRLF1	Q180*	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021434	19	18709401	19	18598591	21434	34286	rs137853926	NC_000019.10:18598590:G:A
NM_004750.5(CRLF1):c.413C>T (p.Pro138Leu)	CRLF1	P138L	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021433	19	18709696	19	18598886	21433	34285	rs137853930	NC_000019.10:18598885:G:A
NM_004750.5(CRLF1):c.397+1G>A	CRLF1		Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021432	19	18710374	19	18599564	21432	34284	rs137853932	NC_000019.10:18599563:C:T
NM_004750.5(CRLF1):c.31_53del (p.Gln11fs)	CRLF1	Q11fs	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021431	19	18717414 - 18717436	19	18606604 - 18606626	21431	34283	rs137853929	NC_000019.10:18606603:GGCGGCGGCCGCCGCGCGGATTGGGCGGCGG:GGCGGCGG
NM_004750.5(CRLF1):c.303del (p.Asn102fs)	CRLF1	N102fs	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021430	19	18710469	19	18599659	21430	34282	rs137853931	NC_000019.10:18599658:GG:G
NM_004750.5(CRLF1):c.1121T>G (p.Leu374Arg)	CRLF1	L374R	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: Mar 3, 2011)	no assertion criteria provided	VCV000021428	19	18705148	19	18594338	21428	34280	rs104894668	NC_000019.10:18594337:A:C
NM_004085.4(TIMM8A):c.112C>T (p.Gln38Ter)	TIMM8A	Q38*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 6, 2003)	no assertion criteria provided	VCV000021393	X	100603541	X	101348553	21393	34245	rs80356559	NC_000023.11:101348552:G:A
NM_015922.3(NSDHL):c.693_695GAA[1] (p.Lys232del)	NSDHL	K232del		Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000021268	X	152036121 - 152036123	X	152867577 - 152867579	21268	34120	rs121909833	NC_000023.11:152867576:GAAGAA:GAA
NM_015922.3(NSDHL):c.370G>A (p.Gly124Ser)	NSDHL	G124S	Child syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000021267	X	152027416	X	152858872	21267	34119	rs137853862	NC_000023.11:152858871:G:A
NM_015922.3(NSDHL):c.1098dup (p.Arg367fs)	NSDHL			Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000021266	X	152037633 - 152037634	X	152869089 - 152869090	21266	34118	rs121909834	NC_000023.11:152869089:TTT:TTTT
NM_015922.3(NSDHL):c.1046A>G (p.Tyr349Cys)	NSDHL	Y349C	Child syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000021265	X	152037584	X	152869040	21265	34117	rs137853863	NC_000023.11:152869039:A:G
NM_000227.5(LAMA3):c.2116A>T (p.Arg706Ter)	LAMA3	R2315*, R650*, R706*, R2259*	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Feb 22, 2008)	no assertion criteria provided	VCV000021264	18	21487827	18	23907863	21264	34116	rs80356679	NC_000018.10:23907862:A:T
NM_000528.4(MAN2B1):c.2426T>C (p.Leu809Pro)	MAN2B1	L809P, L808P	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021210	19	12759960	19	12649146	21210	34062	rs80338681	NC_000019.10:12649145:A:G
NM_000528.4(MAN2B1):c.2165+1G>A	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000021209	19	12760917	19	12650103	21209	34061	rs80338679	NC_000019.10:12650102:C:T
NM_000528.4(MAN2B1):c.1831-2A>G	MAN2B1		Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000021208	19	12763276	19	12652462	21208	34060	rs80338678	NC_000019.10:12652461:T:C
NM_000528.4(MAN2B1):c.1830+1G>C	MAN2B1		Inborn genetic diseases|Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: May 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000021207	19	12766507	19	12655693	21207	34059	rs80338677	NC_000019.10:12655692:C:G
NM_000487.6(ARSA):c.769G>C (p.Asp257His)	ARSA	D257H, D171H	not provided|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021187	22	51065104	22	50626676	21187	34039	rs80338819	NC_000022.11:50626675:C:G
NM_000487.6(ARSA):c.257G>A (p.Arg86Gln)	ARSA	R84Q, R86Q	not provided|Metachromatic leukodystrophy|Metachromatic leukodystrophy, late-onset	Pathogenic(Last reviewed: Dec 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021186	22	51065802	22	50627374	21186	34038	rs74315458	NC_000022.11:50627373:C:T
NM_000346.4(SOX9):c.1320C>A (p.Tyr440Ter)	SOX9	Y440*	not provided|Camptomelic dysplasia	Pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	VCV000021163	17	70120318	17	72124177	21163	34015	rs80338688	NC_000017.11:72124176:C:A
NM_000334.4(SCN4A):c.2014C>T (p.Arg672Cys)	SCN4A	R672C	Hypokalemic periodic paralysis 1|Hyperkalemic Periodic Paralysis Type 1	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000021151	17	62036630	17	63959270	21151	34003	rs80338785	NC_000017.11:63959269:G:A
NM_000271.5(NPC1):c.3160G>A (p.Ala1054Thr)	NPC1	A1054T	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jul 22, 2008)	no assertion criteria provided	VCV000021138	18	21116722	18	23536758	21138	33990	rs80358258	NC_000018.10:23536757:C:T
NM_000271.5(NPC1):c.2974G>A (p.Gly992Arg)	NPC1	G992R	not provided|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000021137	18	21118573	18	23538609	21137	33989	rs80358254	NC_000018.10:23538608:C:T
NM_000271.5(NPC1):c.2324A>C (p.Gln775Pro)	NPC1	Q775P	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000021134	18	21121319	18	23541355	21134	33986	rs80358253	NC_000018.10:23541354:T:G
NM_000166.6(GJB1):c.556G>A (p.Glu186Lys)	GJB1	E186K	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000021086	X	70444113	X	71224263	21086	33938	rs116840821	NC_000023.11:71224262:G:A
NM_000166.6(GJB1):c.43C>T (p.Arg15Trp)	GJB1	R15W	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021084	X	70443600	X	71223750	21084	33936	rs116840815	NC_000023.11:71223749:C:T
NM_000166.6(GJB1):c.223C>T (p.Arg75Trp)	GJB1	R75W	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021082	X	70443780	X	71223930	21082	33934	rs116840819	NC_000023.11:71223929:C:T
NM_000166.6(GJB1):c.187G>A (p.Val63Ile)	GJB1	V63I	not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021081	X	70443744	X	71223894	21081	33933	rs116840818	NC_000023.11:71223893:G:A
NM_000156.6(GAMT):c.327G>A (p.Lys109=)	GAMT		not provided|Cerebral creatine deficiency syndrome|Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021065	19	1399792	19	1399793	21065	33917	rs80338735	NC_000019.10:1399792:C:T
NM_000047.2(ARSL):c.1442C>T (p.Thr481Met)	ARSL	T481M, T490M, T427M, T506M		Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000021032	X	2853201	X	2935160	21032	33884	rs80338713	NC_000023.11:2935159:G:A
NM_000047.2(ARSL):c.119T>G (p.Ile40Ser)	ARSL	I40S, I49S, I65S		Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000021031	X	2876381	X	2958340	21031	33883	rs80338710	NC_000023.11:2958339:A:C
NR_104387.1(TAF1):n.5894C>T	TAF1			Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000021011	X	70749635	X	71529785	21011	33863	rs397509359	NC_000023.11:71529784:C:T
NM_001127898.4(CLCN5):c.1557+1G>T	CLCN5			Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000018451	X	49851528	X	50086871	18451	33490	rs1569540382	NC_000023.11:50086870:G:T
NM_001323289.2(CDKL5):c.533G>C (p.Arg178Pro)	CDKL5	R178P	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000018450	X	18602452	X	18584332	18450	33489	rs267606715	NC_000023.11:18584331:G:C
NM_000529.2(MC2R):c.376G>T (p.Ala126Ser)	MC2R	A126S	ACTH resistance	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000018425	18	13885142	18	13885143	18425	33464	rs267607231	NC_000018.10:13885142:C:A
NM_001614.5(ACTG1):c.354G>C (p.Lys118Asn)	ACTG1	K118N	not provided|Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Aug 15, 2009)	no assertion criteria provided	VCV000018321	17	79478938	17	81511912	18321	33360	rs267606630	NC_000017.11:81511911:C:G
NM_001614.5(ACTG1):c.1109T>C (p.Val370Ala)	ACTG1	V370A	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000018320	17	79477735	17	81510709	18320	33359	rs104894547	NC_000017.11:81510708:A:G
NM_001614.5(ACTG1):c.833C>T (p.Thr278Ile)	ACTG1	T278I	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000018319	17	79478104	17	81511078	18319	33358	rs28999112	NC_000017.11:81511077:G:A
NM_001614.5(ACTG1):c.791C>T (p.Pro264Leu)	ACTG1	P264L	not provided|Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000018318	17	79478225	17	81511199	18318	33357	rs104894546	NC_000017.11:81511198:G:A
NM_001614.5(ACTG1):c.994C>G (p.Pro332Ala)	ACTG1	P332A	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000018317	17	79477850	17	81510824	18317	33356	rs104894545	NC_000017.11:81510823:G:C
NM_001614.5(ACTG1):c.266C>T (p.Thr89Ile)	ACTG1	T89I	Deafness, autosomal dominant 20	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000018315	17	79479026	17	81512000	18315	33354	rs28999111	NC_000017.11:81511999:G:A
NM_000262.3(NAGA):c.577G>T (p.Glu193Ter)	NAGA	E193*	Alpha-N-acetylgalactosaminidase deficiency type 2	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000018164	22	42462734	22	42066730	18164	33203	rs121434531	NC_000022.11:42066729:C:A
NM_000262.3(NAGA):c.985C>T (p.Arg329Trp)	NAGA	R329W	Alpha-N-acetylgalactosaminidase deficiency type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000018163	22	42457044	22	42061040	18163	33202	rs121434530	NC_000022.11:42061039:G:A
NM_000262.3(NAGA):c.973G>A (p.Glu325Lys)	NAGA	E325K	|not provided|Alpha-N-acetylgalactosaminidase deficiency type 2||Alpha-N-acetylgalactosaminidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018162	22	42457056	22	42061052	18162	33201	rs121434529	NC_000022.11:42061051:C:T
NM_000484.4(APP):c.2018C>T (p.Ala673Val)	APP	A673V, A654V, A542V, A598V, A580V, A617V, A655V, A563V, A636V, A649V	Alzheimer disease	Pathogenic(Last reviewed: Mar 13, 2009)	no assertion criteria provided	VCV000018106	21	27269931	21	25897619	18106	33145	rs193922916	NC_000021.9:25897618:G:A
NM_000484.4(APP):c.2149G>C (p.Val717Leu)	APP	V717L, V680L, V607L, V642L, V661L, V586L, V624L, V693L, V698L, V699L	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, single submitter	VCV000018105	21	27264096	21	25891784	18105	33144	rs63750264	NC_000021.9:25891783:C:G
APP, DUP	APP		Alzheimer disease, early-onset, with cerebral amyloid angiopathy	Pathogenic(Last reviewed: Dec 2, 2008)	no assertion criteria provided	VCV000018104					18104	33143		
NM_000484.4(APP):c.2113C>G (p.Leu705Val)	APP	L705V, L595V, L686V, L687V, L574V, L612V, L630V, L668V, L681V, L649V	not provided|CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, PIEDMONT VARIANT	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000018103	21	27264132	21	25891820	18103	33142	rs63750921	NC_000021.9:25891819:G:C
NM_000484.4(APP):c.2140A>G (p.Thr714Ala)	APP	T714A, T604A, T639A, T658A, T583A, T696A, T677A, T690A, T621A, T695A	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: May 28, 2002)	no assertion criteria provided	VCV000018102	21	27264105	21	25891793	18102	33141	rs63750643	NC_000021.9:25891792:T:C
NM_000484.4(APP):c.2080G>A (p.Asp694Asn)	APP	N694D, D563N, D584N, D601N, D619N, D638N, D657N, D670N, D675N, D676N, D694N	not provided|Alzheimer disease|Cerebral amyloid angiopathy, APP-related	Pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	VCV000018101	21	27264165	21	25891853	18101	33140	rs63749810	NC_000021.9:25891852:C:T
NM_000484.4(APP):c.2141C>T (p.Thr714Ile)	APP	T714I, T677I, T690I, T604I, T639I, T658I, T621I, T695I, T696I, T583I	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: Jan 25, 2005)	no assertion criteria provided	VCV000018100	21	27264104	21	25891792	18100	33139	rs63750973	NC_000021.9:25891791:G:A
NM_000484.4(APP):c.2077G>A (p.Glu693Lys)	APP	E693K, E583K, E600K, E656K, E637K, E669K, E674K, E675K, E562K, E618K	not provided|Cerebral amyloid angiopathy, APP-related	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000018099	21	27264168	21	25891856	18099	33138	rs63750579	NC_000021.9:25891855:C:T
NM_000484.4(APP):c.2078A>G (p.Glu693Gly)	APP	E693G, E562G, E669G, E618G, E583G, E637G, E656G, E600G, E674G, E675G	not provided|Alzheimer disease|Alzheimer disease, type 1|Cerebral amyloid angiopathy, APP-related	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000018098	21	27264167	21	25891855	18098	33137	rs63751039	NC_000021.9:25891854:T:C
NM_000484.4(APP):c.2146A>G (p.Ile716Val)	APP	I716V, I585V, I641V, I698V, I697V, I606V, I623V, I660V, I679V, I692V	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000018096	21	27264099	21	25891787	18096	33135	rs63750399	NC_000021.9:25891786:T:C
NM_000484.4(APP):c.2010_2011inv (p.Lys670_Met671delinsAsnLeu)	APP		not provided|Alzheimer disease|Alzheimer disease, type 1	Pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000018093	21	27269938 - 27269939	21	25897626 - 25897627	18093	33132	rs281865161	NC_000021.9:25897625:TC:GA
NM_000484.4(APP):c.2075C>G (p.Ala692Gly)	APP	A692G, A655G, A561G, A582G, A617G, A636G, A599G, A668G, A673G, A674G	not provided|Alzheimer disease|Cerebral amyloid angiopathy, APP-related|Alzheimer disease, type 1	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000018091	21	27264170	21	25891858	18091	33130	rs63750671	NC_000021.9:25891857:G:C
NM_000484.4(APP):c.2150T>G (p.Val717Gly)	APP	V717G, V607G, V699G, V586G, V624G, V642G, V661G, V680G, V693G, V698G	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: Oct 31, 1991)	no assertion criteria provided	VCV000018090	21	27264095	21	25891783	18090	33129	rs63749964	NC_000021.9:25891782:A:C
NM_000484.4(APP):c.2149G>T (p.Val717Phe)	APP	V717F, V624F, V661F, V693F, V586F, V607F, V642F, V680F, V698F, V699F	Alzheimer disease|Alzheimer disease, type 1	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000018089	21	27264096	21	25891784	18089	33128	rs63750264	NC_000021.9:25891783:C:A
NM_000484.4(APP):c.2149G>A (p.Val717Ile)	APP	V717I, V607I, V624I, V661I, V642I, V680I, V693I, V698I, V699I, V586I	Alzheimer disease|Alzheimer disease, type 1|not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000018088	21	27264096	21	25891784	18088	33127	rs63750264	NC_000021.9:25891783:C:T
NM_000484.4(APP):c.2077G>C (p.Glu693Gln)	APP	E693Q, E618Q, E637Q, E656Q, E562Q, E583Q, E669Q, E600Q, E674Q, E675Q	Cerebral amyloid angiopathy, APP-related	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000018087	21	27264168	21	25891856	18087	33126	rs63750579	NC_000021.9:25891855:C:G
NM_001250.6(CD40):c.257-2A>T	CD40			Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000017750	20	44751247	20	46122608	17750	32789	rs1568906348	NC_000020.11:46122607:A:T
NM_001250.6(CD40):c.247T>C (p.Cys83Arg)	CD40	C83R		Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000017749	20	44750988	20	46122349	17749	32788	rs28931586	NC_000020.11:46122348:T:C
CD40, 455A-T, +5, EX5	CD40			Pathogenic(Last reviewed: Oct 23, 2001)	no assertion criteria provided	VCV000017748					17748	32787		
NM_021601.4(CD79A):c.265+115G>A	CD79A		Agammaglobulinemia 3, autosomal recessive	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000017707	19	42383360	19	41879290	17707	32746		NC_000019.10:41879289:G:A
NM_021601.4(CD79A):c.266-2A>G	CD79A		Agammaglobulinemia 3, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000017706	19	42383603	19	41879533	17706	32745		NC_000019.10:41879532:A:G
NM_000717.5(CA4):c.206G>A (p.Arg69His)	CA4	R69H	Retinitis pigmentosa 17	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000017609	17	58234014	17	60156653	17609	32648	rs121434552	NC_000017.11:60156652:G:A
NM_000717.5(CA4):c.655C>A (p.Arg219Ser)	CA4	R219S	Retinitis pigmentosa 17	Pathogenic(Last reviewed: Jan 15, 2005)	no assertion criteria provided	VCV000017608	17	58235718	17	60158357	17608	32647	rs121434551	NC_000017.11:60158356:C:A
NM_000717.5(CA4):c.40C>T (p.Arg14Trp)	CA4	R14W	Retinitis pigmentosa 17|Retinitis pigmentosa	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000017607	17	58227435	17	60150074	17607	32646	rs104894559	NC_000017.11:60150073:C:T
NM_001848.2(COL6A1):c.841G>A (p.Gly281Arg)	COL6A1	G281R	not provided|Ullrich congenital muscular dystrophy 1	Pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000017182	21	47409034	21	45989120	17182	32221	rs267606746	NC_000021.9:45989119:G:A
NM_001848.2(COL6A1):c.868G>C (p.Gly290Arg)	COL6A1	G290R	Ullrich congenital muscular dystrophy 1, autosomal dominant	Pathogenic(Last reviewed: Jul 7, 2009)	no assertion criteria provided	VCV000017181	21	47409531	21	45989617	17181	32220	rs121912939	NC_000021.9:45989616:G:C
NM_001848.2(COL6A1):c.850G>A (p.Gly284Arg)	COL6A1	G284R	Ullrich congenital muscular dystrophy 1|Ullrich congenital muscular dystrophy 1, autosomal dominant|Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017180	21	47409043	21	45989129	17180	32219	rs121912938	NC_000021.9:45989128:G:A
NM_001848.2(COL6A1):c.1977C>G (p.Tyr659Ter)	COL6A1	Y659*	Ullrich congenital muscular dystrophy 1	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000017179	21	47421895	21	46001981	17179	32218	rs121912937	NC_000021.9:46001980:C:G
NM_001848.2(COL6A1):c.1465del (p.Ala489fs)	COL6A1	A489fs	Ullrich congenital muscular dystrophy 1	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000017178	21	47417617	21	45997703	17178	32217	rs797044458	NC_000021.9:45997702:G:
NM_001848.2(COL6A1):c.857del (p.Pro286fs)	COL6A1	P286fs	Ullrich congenital muscular dystrophy 1	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000017177	21	47409049	21	45989135	17177	32216	rs797044457	NC_000021.9:45989134:CC:C
NM_001848.2(COL6A1):c.428+1G>A	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000017176	21	47404384	21	45984470	17176	32215	rs1569517717	NC_000021.9:45984469:G:A
NM_001848.2(COL6A1):c.805-572_903+5delinsTCCCTCCCCATTTCC	COL6A1		Ullrich congenital muscular dystrophy 1, autosomal dominant	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000017175	21	47408426 - 47409571	21	45988512 - 45989657	17175	32214		
NM_001848.2(COL6A1):c.1003_1056del54	COL6A1		Sensorimotor neuropathy|Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017174	21	47410741	21	45990827	17174	32213	rs398123631	NC_000021.9:45990826:G:A
NM_001848.2(COL6A1):c.362A>G (p.Lys121Arg)	COL6A1	K121R	Bethlem myopathy 1|not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000017173	21	47404317	21	45984403	17173	32212	rs121912936	NC_000021.9:45984402:A:G
NM_001848.2(COL6A1):c.1022G>A (p.Gly341Asp)	COL6A1	G341D	Bethlem myopathy 1	Pathogenic(Last reviewed: Feb 26, 2002)	no assertion criteria provided	VCV000017172	21	47410706	21	45990792	17172	32211	rs121912935	NC_000021.9:45990791:G:A
NM_001848.2(COL6A1):c.1056+2T>C	COL6A1		Bethlem myopathy 1	Pathogenic(Last reviewed: May 19, 1999)	no assertion criteria provided	VCV000017171	21	47410742	21	45990828	17171	32210	rs797044456	NC_000021.9:45990827:T:C
NM_001848.2(COL6A1):c.931-1G>A	COL6A1		not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Aug 25, 2015)	criteria provided, single submitter	VCV000017170	21	47410171	21	45990257	17170	32209	rs886042354	NC_000021.9:45990256:G:A
NM_001848.2(COL6A1):c.1577G>T (p.Gly526Val)	COL6A1	G286V, G526V	Bethlem myopathy 1	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000017169	21	47418313	21	45998399	17169	32208	rs121912934	NC_000021.9:45998398:G:T
COL18A1, IVS36DS, A-C, +3	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000017119					17119	32158		
COL18A1, 2-BP DEL, 3514CT	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000017116					17116	32155		
COL18A1, IVS1AS, A-T, -2	COL18A1		Knobloch syndrome 1	Pathogenic(Last reviewed: Aug 12, 2000)	no assertion criteria provided	VCV000017115					17115	32154		
DCC, 1-BP INS, 571G	DCC		Mirror movements 1	Pathogenic(Last reviewed: Apr 30, 2010)	no assertion criteria provided	VCV000017077					17077	32116		
DCC, IVS6DS, G-A, +1	DCC		Mirror movements 1	Pathogenic(Last reviewed: Apr 30, 2010)	no assertion criteria provided	VCV000017076					17076	32115		
NM_005215.4(DCC):c.503T>C (p.Met168Thr)	DCC	M168T	Esophageal carcinoma, somatic	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000017075	18	50432504	18	52906134	17075	32114	rs121912967	NC_000018.10:52906133:T:C
NM_005215.4(DCC):c.4124C>A (p.Pro1375His)	DCC	P1375H	Carcinoma of colon	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000017074	18	51052999	18	53526629	17074	32113	rs387906555	NC_000018.10:53526628:C:A
NM_000394.4(CRYAA):c.347G>A (p.Arg116His)	CRYAA	R116H, R79H	Cataract, autosomal dominant, multiple types, with microcornea|not provided|Cataract, autosomal dominant	Pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016960	21	44592215	21	43172105	16960	31999	rs121912973	NC_000021.9:43172104:G:A
NM_000394.4(CRYAA):c.145C>T (p.Arg49Cys)	CRYAA	R49C	Cataract, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2003)	no assertion criteria provided	VCV000016959	21	44589354	21	43169244	16959	31998	rs74315441	NC_000021.9:43169243:C:T
NM_000394.4(CRYAA):c.27G>A (p.Trp9Ter)	CRYAA	W9*	Cataract 9, autosomal recessive	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000016958	21	44589236	21	43169126	16958	31997	rs74315440	NC_000021.9:43169125:G:A
NM_000394.4(CRYAA):c.346C>T (p.Arg116Cys)	CRYAA	R116C, R79C	Cataract, autosomal dominant	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000016957	21	44592214	21	43172104	16957	31996	rs74315439	NC_000021.9:43172103:C:T
CRYBB2, 483C-T	CRYBB2		Cataract 3, multiple types	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016950					16950	31989		
NM_000496.3(CRYBB2):c.463C>T (p.Gln155Ter)	CRYBB2	Q155*	not provided|Cataract 3, multiple types|Congenital cataract	Pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000016949	22	25627584	22	25231617	16949	31988	rs74315489	NC_000022.11:25231616:C:T
NM_004076.4(CRYBB3):c.[493G>C];[493G>C]	CRYBB3	G165R	Cataract, congenital nuclear, autosomal recessive 2|Congenital cataract	Pathogenic(Last reviewed: Jan 9, 2015)	no assertion criteria provided	VCV000016948	22	25603036	22	25207069	16948	31987	rs74315490	NC_000022.11:25207068:G:C
NM_001886.3(CRYBA4):c.206T>C (p.Leu69Pro)	CRYBA4	L69P	Cataract 23, multiple types	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016947	22	27021492	22	26625528	16947	31986	rs74315487	NC_000022.11:26625527:T:C
NM_001886.3(CRYBA4):c.281T>C (p.Phe94Ser)	CRYBA4	F94S	Cataract 23, multiple types	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000016946	22	27021567	22	26625603	16946	31985	rs74315486	NC_000022.11:26625602:T:C
NM_001863.5(COX6B1):c.59G>A (p.Arg20His)	COX6B1	R19H, R20H	Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000016875	19	36142204	19	35651302	16875	31914	rs121909602	NC_000019.10:35651301:G:A
NM_024422.6(DSC2):c.1430del (p.Thr477fs)	DSC2	T477fs	Arrhythmogenic right ventricular cardiomyopathy, type 11	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000016848	18	28660152	18	31080186	16848	31887	rs397514041	NC_000018.10:31080185:G:
NM_001942.4(DSG1):c.85-1G>A	DSG1			Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000016819	18	28906836	18	31326873	16819	31858	rs1568039793	NC_000018.10:31326872:G:A
NM_001943.5(DSG2):c.1880-2A>G	DSG2		not provided|Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016817	18	29121154	18	31541191	16817	31856	rs397514038	NC_000018.10:31541190:A:G
NM_001943.5(DSG2):c.797A>G (p.Asn266Ser)	DSG2	N266S	Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Mar 7, 2006)	no assertion criteria provided	VCV000016815	18	29104517	18	31524554	16815	31854	rs121913011	NC_000018.10:31524553:A:G
NM_001943.5(DSG2):c.1520G>A (p.Cys507Tyr)	DSG2	C506Y, C507Y	Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000016813	18	29116261	18	31536298	16813	31852	rs121913009	NC_000018.10:31536297:G:A
NM_001943.5(DSG2):c.137G>A (p.Arg46Gln)	DSG2	R46Q	Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 10	Pathogenic(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016812	18	29099821	18	31519858	16812	31851	rs121913008	NC_000018.10:31519857:G:A
NM_001943.5(DSG2):c.918G>A (p.Trp306Ter)	DSG2	W305*, W306*	Arrhythmogenic right ventricular cardiomyopathy, type 10|not provided	Pathogenic(Last reviewed: Oct 5, 2011)	criteria provided, single submitter	VCV000016811	18	29104755	18	31524792	16811	31850	rs121913007	NC_000018.10:31524791:G:A
NM_001943.5(DSG2):c.146G>A (p.Arg49His)	DSG2	R49H	Arrhythmogenic right ventricular cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 10|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016810	18	29099830	18	31519867	16810	31849	rs121913006	NC_000018.10:31519866:G:A
NM_001983.4(ERCC1):c.693C>G (p.Phe231Leu)	ERCC1	F231L	Cerebrooculofacioskeletal syndrome 4|Cockayne syndrome	Pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000016778	19	45918128	19	45414870	16778	31817	rs121913028	NC_000019.10:45414869:G:C
NM_001983.4(ERCC1):c.472C>T (p.Gln158Ter)	ERCC1	Q158*	Cerebrooculofacioskeletal syndrome 4	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000016777	19	45922409	19	45419151	16777	31816	rs121913027	NC_000019.10:45419150:G:A
NM_001972.4(ELANE):c.640G>A (p.Gly214Arg)	ELANE	G185R, G214R	not provided|Neutropenia, severe congenital 1, autosomal dominant	Pathogenic(Last reviewed: Jun 30, 2015)	criteria provided, single submitter	VCV000016748	19	856000	19	856000	16748	31787	rs137854451	NC_000019.10:855999:G:A
NM_001972.4(ELANE):c.211T>C (p.Cys71Arg)	ELANE	C42R, C71R	Neutropenia, severe congenital 1, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000016746	19	853019	19	853019	16746	31785	rs28931611	NC_000019.10:853018:T:C
NM_001972.4(ELANE):c.377C>T (p.Ser126Leu)	ELANE	S97L, S126L	not specified|Cyclical neutropenia|Neutropenia, severe congenital 1, autosomal dominant|Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016745	19	855574	19	855574	16745	31784	rs137854450	NC_000019.10:855573:C:T
NM_001972.4(ELANE):c.214G>A (p.Val72Met)	ELANE	V72M	Neutropenia, severe congenital 1, autosomal dominant	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000016744	19	853022	19	853022	16744	31783	rs387906553	NC_000019.10:853021:G:A
NM_001972.4(ELANE):c.416C>T (p.Pro139Leu)	ELANE	P110L, P139L	not provided|Neutropenia, severe congenital 1, autosomal dominant|Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016743	19	855613	19	855613	16743	31782	rs137854448	NC_000019.10:855612:C:T
NM_001972.4(ELANE):c.182C>T (p.Ala61Val)	ELANE	A32V, A61V	Cyclical neutropenia|Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000016740	19	852990	19	852990	16740	31779	rs137854447	NC_000019.10:852989:C:T
NM_001972.4(ELANE):c.618G>T (p.Leu206Phe)	ELANE	L177F, L206F	Cyclical neutropenia	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000016739	19	855978	19	855978	16739	31778	rs137854446	NC_000019.10:855977:G:T
NM_001972.4(ELANE):c.659G>A (p.Arg220Gln)	ELANE	R191Q, R220Q	not provided|Neutropenia, severe congenital 1, autosomal dominant|Cyclical neutropenia|Cyclical neutropenia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016738	19	856019	19	856019	16738	31777	rs137854445	NC_000019.10:856018:G:A
NM_001985.3(ETFB):c.382G>A (p.Asp128Asn)	ETFB	D128N, D219N	Glutaric acidemia IIB	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000016718	19	51853639	19	51350385	16718	31757	rs104894678	NC_000019.10:51350384:C:T
ETFB, 1-EX DEL, IVSDS, +1, G-C	ETFB		Glutaric acidemia IIB	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000016717					16717	31756		
NM_001985.3(ETFB):c.491G>A (p.Arg164Gln)	ETFB	R164Q, R255Q	Glutaric acidemia IIB	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000016716	19	51850260	19	51347006	16716	31755	rs104894677	NC_000019.10:51347005:C:T
NM_001257988.1(TYMP):c.854T>C (p.Leu285Pro)	TYMP	L285P	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000016666	22	50965079	22	50526650	16666	31705	rs121913042	NC_000022.11:50526649:A:G
NM_001257988.1(TYMP):c.605G>C (p.Arg202Thr)	TYMP	R202T	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000016665	22	50966058	22	50527629	16665	31704	rs121913041	NC_000022.11:50527628:C:G
NM_001257988.1(TYMP):c.931G>C (p.Gly311Arg)	TYMP	G311R	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000016664	22	50964903	22	50526474	16664	31703	rs121913040	NC_000022.11:50526473:C:G
NM_001257988.1(TYMP):c.215-1G>C	TYMP		not provided|Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016662	22	50967768	22	50529339	16662	31701	rs767245071	NC_000022.11:50529338:C:G
NM_001257988.1(TYMP):c.131G>A (p.Arg44Gln)	TYMP	R44Q	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000016661	22	50968008	22	50529579	16661	31700	rs28931613	NC_000022.11:50529578:C:T
NM_001257988.1(TYMP):c.516+2T>C	TYMP		Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 14, 2016)	no assertion criteria provided	VCV000016654	22	50966939	22	50528510	16654	31693	rs797044454	NC_000022.11:50528509:A:G
NM_001257988.1(TYMP):c.866A>C (p.Glu289Ala)	TYMP	E289A	not provided|Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016653	22	50965067	22	50526638	16653	31692	rs121913036	NC_000022.11:50526637:T:G
NM_001928.4(CFD):c.125C>A (p.Ser42Ter)	CFD	S42*, S49*	Complement factor d deficiency	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000016564	19	860686	19	860686	16564	31603	rs104894667	NC_000019.10:860685:C:A
NM_000146.4(FTL):c.458dup (p.His153fs)	FTL		Neuroferritinopathy	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000016489	19	49469921 - 49469922	19	48966664 - 48966665	16489	31528	rs587776840	NC_000019.10:48966664:A:AA
NM_000146.4(FTL):c.469_484dup (p.Leu162fs)	FTL		Neuroferritinopathy	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000016488	19	49469932 - 49469933	19	48966675 - 48966676	16488	31527	rs398124640	NC_000019.10:48966675:GGCCCGGAGGCTGGGC:GGCCCGGAGGCTGGGCGGCCCGGAGGCTGGGC
NM_000146.4(FTL):c.496_497CT[3] (p.Phe167fs)	FTL		Neuroferritinopathy	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000016487	19	49469958 - 49469959	19	48966701 - 48966702	16487	31526	rs1114167274	NC_000019.10:48966701:TCTCT:TCTCTCT
NM_000146.4(FTL):c.286G>A (p.Ala96Thr)	FTL	A96T	Neuroferritinopathy	Pathogenic(Last reviewed: Aug 23, 2005)	no assertion criteria provided	VCV000016486	19	49469574	19	48966317	16486	31525	rs104894685	NC_000019.10:48966316:G:A
NM_000146.4(FTL):c.-168G>C	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000016485	19	49468597	19	48965340	16485	31524	rs398124635	NC_000019.10:48965339:G:C
NM_000146.4(FTL):c.-175_-170del	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000016484	19	49468587 - 49468592	19	48965330 - 48965335	16484	31523	rs398124639	NC_000019.10:48965329:TCTGTCTCT:TCT
FTL, 1-BP INS, 460A	FTL		Neuroferritinopathy	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000016483					16483	31522		
NM_000146.4(FTL):c.-149G>C	FTL			Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000016482	19	49468616	19	48965359	16482	31521	rs398124638	NC_000019.10:48965358:G:C
NM_000146.4(FTL):c.-164C>A	FTL		||Neuroferritinopathy	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000016481	19	49468601	19	48965344	16481	31520	rs398124637	NC_000019.10:48965343:C:A
NM_000146.4(FTL):c.-161C>T	FTL		||Neuroferritinopathy	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000016480	19	49468604	19	48965347	16480	31519	rs398124636	NC_000019.10:48965346:C:T
NM_000146.4(FTL):c.-168G>T	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000016479	19	49468597	19	48965340	16479	31518	rs398124635	NC_000019.10:48965339:G:T
NM_000146.4(FTL):c.-189_-161del	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000016478	19	49468575 - 49468603	19	48965318 - 48965346	16478	31517	rs1555796939	NC_000019.10:48965317:CGGTCCCGCGGGTCTGTCTCTTGCTTCAAC:C
NM_000146.4(FTL):c.-168G>A	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000016476	19	49468597	19	48965340	16476	31515	rs398124635	NC_000019.10:48965339:G:A
NM_000146.4(FTL):c.-159G>C	FTL			Pathogenic(Last reviewed: Feb 19, 2013)	no assertion criteria provided	VCV000016475	19	49468606	19	48965349	16475	31514	rs398124634	NC_000019.10:48965348:G:C
NM_000146.4(FTL):c.-160A>G	FTL		||Neuroferritinopathy	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000016474	19	49468605	19	48965348	16474	31513	rs398124633	NC_000019.10:48965347:A:G
NM_002055.5(GFAP):c.234C>A (p.Asp78Glu)	GFAP	D78E	Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016179	17	42992621	17	44915253	16179	31218	rs121909720	NC_000017.11:44915252:G:T
NM_002055.5(GFAP):c.1055T>C (p.Leu352Pro)	GFAP	L352P	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016178	17	42988676	17	44911308	16178	31217	rs28932769	NC_000017.11:44911307:A:G
NM_002055.5(GFAP):c.827G>T (p.Arg276Leu)	GFAP	R276L	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016177	17	42989119	17	44911751	16177	31216	rs121909719	NC_000017.11:44911750:C:A
NM_001131019.3(GFAP):c.1086G>C (p.Glu362Asp)	GFAP	E362D	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016176	17	42988645	17	44911277	16176	31215	rs121909718	NC_000017.11:44911276:C:G
NM_002055.5(GFAP):c.229A>T (p.Asn77Tyr)	GFAP	N77Y	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016175	17	42992626	17	44915258	16175	31214	rs58732244	NC_000017.11:44915257:T:A
NM_002055.5(GFAP):c.226C>T (p.Leu76Phe)	GFAP	L76F	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016174	17	42992629	17	44915261	16174	31213	rs57120761	NC_000017.11:44915260:G:A
NM_002055.5(GFAP):c.262C>A (p.Arg88Ser)	GFAP	R88S	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000016173	17	42992593	17	44915225	16173	31212	rs61622935	NC_000017.11:44915224:G:T
NM_002055.5(GFAP):c.262C>T (p.Arg88Cys)	GFAP	R88C	not provided|Alexander Disease	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000016172	17	42992593	17	44915225	16172	31211	rs61622935	NC_000017.11:44915224:G:A
NM_002055.5(GFAP):c.235C>T (p.Arg79Cys)	GFAP	R79C	not provided|Alexander Disease	Pathogenic(Last reviewed: Jan 17, 2017)	criteria provided, single submitter	VCV000016171	17	42992620	17	44915252	16171	31210	rs59793293	NC_000017.11:44915251:G:A
NM_002055.5(GFAP):c.236G>A (p.Arg79His)	GFAP	R79H	not provided|Alexander Disease	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000016170	17	42992619	17	44915251	16170	31209	rs59285727	NC_000017.11:44915250:C:T
NM_002055.5(GFAP):c.1246C>T (p.Arg416Trp)	GFAP	R416W, R456W	not provided|Alexander Disease	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000016169	17	42985443	17	44908075	16169	31208	rs121909717	NC_000017.11:44908074:G:A
NM_002055.5(GFAP):c.716G>A (p.Arg239His)	GFAP	R239H	not provided|Alexander Disease	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016168	17	42990701	17	44913333	16168	31207	rs59565950	NC_000017.11:44913332:C:T
NM_002055.5(GFAP):c.715C>T (p.Arg239Cys)	GFAP	R239C	not provided|Alexander Disease	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000016167	17	42990702	17	44913334	16167	31206	rs58064122	NC_000017.11:44913333:G:A
NM_002103.5(GYS1):c.1384C>T (p.Arg462Ter)	GYS1	R462*, R398*	Glycogen storage disease 0, muscle	Pathogenic(Last reviewed: Oct 11, 2007)	no assertion criteria provided	VCV000016057	19	49477915	19	48974658	16057	31096	rs121434584	NC_000019.10:48974657:G:A
GH1, EX3, G-A, +1	GH1		Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000015985					15985	31024		
GH1, EX3, A-C, +2	GH1		Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000015984					15984	31023		
GH1, IVS3, 22-BP DEL	GH1		Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000015982					15982	31021		
GH1, EX3DEL	GH1		Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000015978					15978	31017		
GH1, EX3, A-G, +5	GH1		Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000015977					15977	31016		
GH1, IVS3DS, 18-BP DEL, +28-45	GH1		Autosomal dominant isolated somatotropin deficiency	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000015973					15973	31012		
GH1, 1-BP DEL, 371C	GH1		Ateleiotic dwarfism	Pathogenic(Last reviewed: Sep 15, 2015)	no assertion criteria provided	VCV000015965					15965	31004		
GH1, 6.7-KB DEL	GH1		Ateleiotic dwarfism	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000015964					15964	31003		
GH1, 2-BP DEL, FS132TER	GH1		Ateleiotic dwarfism	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000015962					15962	31001		
GNAS, METHYLATION CHANGES, PATERNAL EPIGENOTYPE	GNAS		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000015960					15960	30999		
GNAS, TYR391TER	GNAS	Y391*	Pseudohypoparathyroidism type 1C	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000015959					15959	30998		
GNAS, 12-BP INS, NT1107	GNAS		Pseudohypoparathyroidism	Pathogenic(Last reviewed: Oct 30, 2007)	no assertion criteria provided	VCV000015958					15958	30997		
GNAS, 1-BP INS, A, EXON 3	GNAS		Pseudohypoparathyroidism	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000015957					15957	30996		
GNAS, 3-BP DEL, CAT, EXON 13	GNAS		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: Jan 5, 2001)	no assertion criteria provided	VCV000015956					15956	30995		
GNAS, 4.7-KB DEL	GNAS		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: Aug 5, 2016)	no assertion criteria provided	VCV000015954					15954	30993		
GNAS, 2-BP DEL, 860TG	GNAS		Progressive osseous heteroplasia	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000015952					15952	30991		
GNAS, 2-BP DEL, TG, EXON 11	GNAS		Pseudohypoparathyroidism	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000015951					15951	30990		
GNAS, 1-BP DEL, C, EXON 1	GNAS		Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000015950					15950	30989		
GNAS, 1-BP DEL, 348C	GNAS		Pseudohypoparathyroidism|Progressive osseous heteroplasia	Pathogenic(Last reviewed: Jan 10, 2002)	no assertion criteria provided	VCV000015949					15949	30988		
GNAS, 2-BP DEL, CT, EXON 4	GNAS		Pseudohypoparathyroidism|Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000015948					15948	30987		
GNAS, 2-BP DEL, GA, EXON 8	GNAS		Pseudohypoparathyroidism|Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000015947					15947	30986		
NM_001077488.4(GNAS):c.695G>A (p.Arg232His)	GNAS	R231H, R216H, R217H, R232H, R874H, R172H	Pseudohypoparathyroidism	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000015946	20	57484608	20	58909553	15946	30985	rs137854538	NC_000020.11:58909552:G:A
NM_001077488.4(GNAS):c.604C>G (p.Arg202Gly)	GNAS	R201G, R202G, R844G, R186G, R142G, R187G	McCune-Albright syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	VCV000015945	20	57484420	20	58909365	15945	30984	rs11554273	NC_000020.11:58909364:C:G
NM_001077488.4(GNAS):c.1099G>T (p.Ala367Ser)	GNAS	A366S, A1009S, A351S, A352S, A367S, A307S	PSEUDOHYPOPARATHYROIDISM, TYPE IA, WITH TESTOTOXICOSIS	Pathogenic(Last reviewed: Sep 8, 1994)	no assertion criteria provided	VCV000015944	20	57485795	20	58910740	15944	30983	rs137854537	NC_000020.11:58910739:G:T
GNAS, GLN170ALA	GNAS	Q170A	Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Apr 13, 1999)	no assertion criteria provided	VCV000015943					15943	30982		
NM_001077488.4(GNAS):c.775_776delinsGC (p.Arg259Ala)	GNAS	R258A	Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Apr 13, 1999)	no assertion criteria provided	VCV000015942	20	57484792 - 57484793	20	58909737 - 58909738	15942	30981	rs137854536	NC_000020.11:58909736:CG:GC
GNAS, 38-BP DEL, EX1/IVS1 BOUNDARY	GNAS		Pseudohypoparathyroidism|Pseudopseudohypoparathyroidism	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000015940					15940	30979		
NM_001077488.4(GNAS):c.753C>G (p.Ser251Arg)	GNAS	S250R, S235R, S236R, S251R, S893R, S191R	Pseudohypoparathyroidism	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000015939	20	57484770	20	58909715	15939	30978	rs137854534	NC_000020.11:58909714:C:G
NM_001077488.4(GNAS):c.568_571del (p.Asp190fs)	GNAS	D130fs, D174fs, D175fs, D189fs, D190fs, D832fs	Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism|not specified|Progressive osseous heteroplasia	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000015938	20	57484249 - 57484252	20	58909194 - 58909197	15938	30977	rs587776829	NC_000020.11:58909193:CTGACT:CT
NM_001077488.4(GNAS):c.604C>A (p.Arg202Ser)	GNAS	R201S, R202S, R187S, R142S, R186S, R844S	PITUITARY TUMOR 3, GROWTH HORMONE-SECRETING, SOMATIC|Cushing's syndrome|McCune-Albright syndrome|Polyostotic fibrous dysplasia, somatic, mosaic	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	VCV000015937	20	57484420	20	58909365	15937	30976	rs11554273	NC_000020.11:58909364:C:A
NM_001077488.4(GNAS):c.684G>C (p.Gln228His)	GNAS	Q227H, Q212H, Q213H, Q228H, Q870H, Q168H	PITUITARY ADENOMA 3, MULTIPLE TYPES	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	VCV000015936	20	57484597	20	58909542	15936	30975	rs137854533	NC_000020.11:58909541:G:C
NM_001077488.4(GNAS):c.683A>G (p.Gln228Arg)	GNAS	Q227R, Q212R, Q213R, Q228R, Q870R, Q168R	PITUITARY ADENOMA 3, MULTIPLE TYPES|McCune-Albright syndrome	Pathogenic(Last reviewed: Jan 7, 2015)	no assertion criteria provided	VCV000015935	20	57484596	20	58909541	15935	30974	rs121913494	NC_000020.11:58909540:A:G
NM_001077488.4(GNAS):c.605G>A (p.Arg202His)	GNAS	R201H, R186H, R187H, R202H, R844H, R142H	Lung adenocarcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|PITUITARY ADENOMA 3, MULTIPLE TYPES|Uterine cervical neoplasms|Pancreatic adenocarcinoma|Cushing's syndrome|Adenocarcinoma of stomach|Adrenocortical carcinoma|Neoplasm of the large intestine|Neoplasm|Neoplasm of the breast|McCune-Albright syndrome|Sex cord-stromal tumor	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000015934	20	57484421	20	58909366	15934	30973	rs121913495	NC_000020.11:58909365:G:A
NM_001077488.4(GNAS):c.604C>T (p.Arg202Cys)	GNAS	R201C, R202C, R844C, R186C, R142C, R187C	Lung adenocarcinoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Hepatocellular carcinoma|PITUITARY ADENOMA 3, MULTIPLE TYPES|Uterine cervical neoplasms|Pancreatic adenocarcinoma|Cushing's syndrome|Adrenocortical carcinoma|Adenocarcinoma of stomach|Neoplasm of the large intestine|Neoplasm|Neoplasm of the breast|McCune-Albright syndrome|Sex cord-stromal tumor	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000015933	20	57484420	20	58909365	15933	30972	rs11554273	NC_000020.11:58909364:C:T
NM_001077488.4(GNAS):c.496C>T (p.Arg166Cys)	GNAS	C165R, R150C, R151C, R165C, R166C, R808C, R106C	Pseudohypoparathyroidism	Pathogenic(Last reviewed: Jan 25, 2017)	no assertion criteria provided	VCV000015932	20	57480498	20	58905443	15932	30971	rs137854532	NC_000020.11:58905442:C:T
NM_001077488.4(GNAS):c.299T>C (p.Leu100Pro)	GNAS	L99P, L100P, L742P, L84P, L85P, L40P	Pseudohypoparathyroidism	Pathogenic(Last reviewed: Sep 30, 2013)	no assertion criteria provided	VCV000015931	20	57478624	20	58903569	15931	30970	rs137854531	NC_000020.11:58903568:T:C
GNAS, IVS3AS, A-G, -12	GNAS		Pseudohypoparathyroidism	Pathogenic(Last reviewed: Sep 30, 2013)	no assertion criteria provided	VCV000015930					15930	30969		
NM_001077488.4(GNAS):c.728del (p.Thr243fs)	GNAS	T243fs, T183fs, T227fs, T242fs, T228fs, T885fs	Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism|Progressive osseous heteroplasia	Pathogenic(Last reviewed: Jul 15, 2008)	no assertion criteria provided	VCV000015929	20	57484745	20	58909690	15929	30968		NC_000020.11:58909689:C:
NM_001077488.4(GNAS):c.842+1G>C	GNAS		Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism	Pathogenic(Last reviewed: Nov 1, 1990)	no assertion criteria provided	VCV000015928	20	57484860	20	58909805	15928	30967		NC_000020.11:58909804:G:C
NM_001077488.4(GNAS):c.1A>G (p.Met1Val)	GNAS	M1V	not provided|Pseudohypoparathyroidism|Pseudohypoparathyroidism type 1C|Pseudohypoparathyroidism type 1B|Pseudopseudohypoparathyroidism|Cushing's syndrome|McCune-Albright syndrome|Pseudohypoparathyroidism|Progressive osseous heteroplasia|PITUITARY ADENOMA 3, MULTIPLE TYPES	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000015927	20	57466782	20	58891727	15927	30966	rs137854530	NC_000020.11:58891726:A:G
NM_005543.4(INSL3):c.305G>A (p.Arg102His)	INSL3	R102H, A134T	Cryptorchidism	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014832	19	17927754	19	17816945	14832	29871	rs121912556	NC_000019.10:17816944:C:T
NM_005543.4(INSL3):c.304C>T (p.Arg102Cys)	INSL3	R102C	Cryptorchidism	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014831	19	17927755	19	17816946	14831	29870	rs104894698	NC_000019.10:17816945:G:A
NM_005543.4(INSL3):c.278C>T (p.Pro93Leu)	INSL3	P93L, P125S	Cryptorchidism	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014830	19	17927781	19	17816972	14830	29869	rs104894697	NC_000019.10:17816971:G:A
NM_005543.4(INSL3):c.330C>G (p.Asn110Lys)	INSL3	N86K, N110K, T142S	Cryptorchidism	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000014829	19	17927729	19	17816920	14829	29868	rs121912555	NC_000019.10:17816919:G:C
NM_020070.4(IGLL1):c.64C>T (p.Gln22Ter)	IGLL1	Q22*	Agammaglobulinemia 2, autosomal recessive	Pathogenic(Last reviewed: Jan 5, 1998)	no assertion criteria provided	VCV000014824	22	23922314	22	23580127	14824	29863	rs74315491	NC_000022.11:23580126:G:A
SOD1, IVS4AS, C-G, -304	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000014786					14786	29825		
SOD1, 6-BP DEL, GGACCA	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	VCV000014785					14785	29824		
NM_000454.4(SOD1):c.280G>C (p.Gly94Arg)	SOD1	G93R, G94R	Amyotrophic lateral sclerosis type 1|Motor neuron disease	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000014784	21	33039611	21	31667298	14784	29823	rs121912437	NC_000021.9:31667297:G:C
NM_000454.4(SOD1):c.242A>G (p.His81Arg)	SOD1	H80R, H81R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000014782	21	33039573	21	31667260	14782	29821	rs121912458	NC_000021.9:31667259:A:G
NM_000454.4(SOD1):c.137T>G (p.Phe46Cys)	SOD1	F45C, F46C	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014781	21	33036167	21	31663854	14781	29820	rs121912457	NC_000021.9:31663853:T:G
NM_000454.4(SOD1):c.37G>C (p.Gly13Arg)	SOD1	G12R, G13R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014780	21	33032119	21	31659806	14780	29819	rs121912456	NC_000021.9:31659805:G:C
NM_000454.4(SOD1):c.217G>A (p.Gly73Ser)	SOD1	G72S, G73S	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 9, 1997)	no assertion criteria provided	VCV000014779	21	33038809	21	31666496	14779	29818	rs121912455	NC_000021.9:31666495:G:A
NM_000454.4(SOD1):c.358-11A>G	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000014778	21	33040773	21	31668460	14778	29817		NC_000021.9:31668459:A:G
NM_000454.4(SOD1):c.380T>A (p.Leu127Ter)	SOD1	L126*, L127*	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000014777	21	33040806	21	31668493	14777	29816	rs121912454	NC_000021.9:31668492:T:A
NM_000454.4(SOD1):c.49G>A (p.Gly17Ser)	SOD1	G16S, G17S	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014776	21	33032131	21	31659818	14776	29815	rs121912453	NC_000021.9:31659817:G:A
NM_000454.4(SOD1):c.253T>G (p.Leu85Val)	SOD1	L84V, L85V	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1995)	no assertion criteria provided	VCV000014775	21	33039584	21	31667271	14775	29814	rs121912452	NC_000021.9:31667270:T:G
NM_000454.4(SOD1):c.404G>A (p.Ser135Asn)	SOD1	S134N, S135N	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014774	21	33040830	21	31668517	14774	29813	rs121912451	NC_000021.9:31668516:G:A
NM_000454.4(SOD1):c.64G>A (p.Glu22Lys)	SOD1	E21K, E22K	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000014773	21	33032146	21	31659833	14773	29812	rs121912450	NC_000021.9:31659832:G:A
NM_000454.4(SOD1):c.455T>C (p.Ile152Thr)	SOD1	I151T, I152T	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000014772	21	33040881	21	31668568	14772	29811	rs121912449	NC_000021.9:31668567:T:C
NM_000454.4(SOD1):c.20G>T (p.Cys7Phe)	SOD1	C6F, C7F	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000014771	21	33032102	21	31659789	14771	29810	rs121912448	NC_000021.9:31659788:G:T
NM_000454.4(SOD1):c.358-10T>G	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000014770	21	33040774	21	31668461	14770	29809		NC_000021.9:31668460:T:G
NM_000454.4(SOD1):c.436G>A (p.Ala146Thr)	SOD1	A145T, A146T	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000014769	21	33040862	21	31668549	14769	29808	rs121912447	NC_000021.9:31668548:G:A
NM_000454.4(SOD1):c.434T>C (p.Leu145Ser)	SOD1	L144S, L145S	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014768	21	33040860	21	31668547	14768	29807	rs121912446	NC_000021.9:31668546:T:C
NM_000454.4(SOD1):c.313A>T (p.Ile105Phe)	SOD1	I104F, I105F	Amyotrophic lateral sclerosis 1, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000014767	21	33039644	21	31667331	14767	29806	rs121912445	NC_000021.9:31667330:A:T
NM_000454.4(SOD1):c.13G>A (p.Ala5Thr)	SOD1	A4T, A5T	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014765	21	33032095	21	31659782	14765	29804	rs121912444	NC_000021.9:31659781:G:A
NM_000454.4(SOD1):c.140A>G (p.His47Arg)	SOD1	H46R, H47R	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014764	21	33036170	21	31663857	14764	29803	rs121912443	NC_000021.9:31663856:A:G
NM_000454.4(SOD1):c.14C>T (p.Ala5Val)	SOD1	A4V, A5V	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014763	21	33032096	21	31659783	14763	29802	rs121912442	NC_000021.9:31659782:C:T
NM_000454.4(SOD1):c.338T>C (p.Ile113Thr)	SOD1	I113T	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000014762	21	33039669	21	31667356	14762	29801	rs74315452	NC_000021.9:31667355:T:C
NM_000454.4(SOD1):c.302A>G (p.Glu101Gly)	SOD1	E100G, E101G	Amyotrophic lateral sclerosis type 1|Motor neuron disease	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000014761	21	33039633	21	31667320	14761	29800	rs121912439	NC_000021.9:31667319:A:G
NM_000454.4(SOD1):c.281G>C (p.Gly94Ala)	SOD1	G93A, G94A	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jul 25, 1997)	no assertion criteria provided	VCV000014760	21	33039612	21	31667299	14760	29799	rs121912438	NC_000021.9:31667298:G:C
NM_000454.4(SOD1):c.280G>T (p.Gly94Cys)	SOD1	G93C, G94C	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000014759	21	33039611	21	31667298	14759	29798	rs121912437	NC_000021.9:31667297:G:T
NM_000454.4(SOD1):c.256G>C (p.Gly86Arg)	SOD1	G85R, G86R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 18, 1998)	no assertion criteria provided	VCV000014758	21	33039587	21	31667274	14758	29797	rs121912436	NC_000021.9:31667273:G:C
NM_000454.4(SOD1):c.319C>G (p.Leu107Val)	SOD1	L106V, L107V	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000014757	21	33039650	21	31667337	14757	29796	rs121912440	NC_000021.9:31667336:C:G
NM_000454.4(SOD1):c.131A>G (p.His44Arg)	SOD1	H43R, H44R	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014756	21	33036161	21	31663848	14756	29795	rs121912435	NC_000021.9:31663847:A:G
NM_000454.4(SOD1):c.125G>A (p.Gly42Asp)	SOD1	G41D, G42D	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000014755	21	33036155	21	31663842	14755	29794	rs121912434	NC_000021.9:31663841:G:A
NM_000454.4(SOD1):c.124G>A (p.Gly42Ser)	SOD1	G41S, G42S	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Mar 4, 1993)	no assertion criteria provided	VCV000014754	21	33036154	21	31663841	14754	29793	rs121912433	NC_000021.9:31663840:G:A
NM_000454.4(SOD1):c.112G>A (p.Gly38Arg)	SOD1	G37R, G38R	Motor neuron disease|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000014752	21	33036142	21	31663829	14752	29791	rs121912431	NC_000021.9:31663828:G:A
ITGB4, 2,279-BP DEL	ITGB4		Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000014744					14744	29783		
NM_000213.5(ITGB4):c.3674G>A (p.Arg1225His)	ITGB4	R1225H	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000014743	17	73747073	17	75750992	14743	29782	rs121912468	NC_000017.11:75750991:G:A
NM_000213.5(ITGB4):c.3841C>T (p.Arg1281Trp)	ITGB4	R1281W	Epidermolysis bullosa junctionalis with pyloric atresia|not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000014742	17	73748302	17	75752221	14742	29781	rs121912467	NC_000017.11:75752220:C:T
ITGB4, 2-BP DEL, 4733CT	ITGB4			Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000014741					14741	29780		
NM_000213.5(ITGB4):c.2792G>A (p.Gly931Asp)	ITGB4	G931D	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000014740	17	73738672	17	75742591	14740	29779	rs121912466	NC_000017.11:75742590:G:A
ITGB4, IVS31DS, T-A, -19	ITGB4		Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000014739					14739	29778		
NM_000213.5(ITGB4):c.112T>C (p.Cys38Arg)	ITGB4	C38R	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000014738	17	73723307	17	75727227	14738	29777	rs121912465	NC_000017.11:75727226:T:C
NM_000213.5(ITGB4):c.4643G>A (p.Trp1548Ter)	ITGB4	W1478*, W1531*, W1548*	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000014737	17	73751866	17	75755785	14737	29776	rs121912464	NC_000017.11:75755784:G:A
NM_000213.5(ITGB4):c.3793+1G>A	ITGB4		Epidermolysis bullosa junctionalis with pyloric atresia|not provided	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000014736	17	73747193	17	75751112	14736	29775	rs147222357	NC_000017.11:75751111:G:A
NM_000213.5(ITGB4):c.1684T>C (p.Cys562Arg)	ITGB4	C562R	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000014735	17	73732158	17	75736077	14735	29774	rs121912463	NC_000017.11:75736076:T:C
NM_000213.5(ITGB4):c.182G>A (p.Cys61Tyr)	ITGB4	C61Y	Epidermolysis bullosa junctionalis with pyloric atresia|not provided	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000014734	17	73723504	17	75727423	14734	29773	rs80338755	NC_000017.11:75727422:G:A
NM_000213.5(ITGB4):c.1660C>T (p.Arg554Ter)	ITGB4	R554*	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000014733	17	73732134	17	75736053	14733	29772	rs121912462	NC_000017.11:75736052:C:T
NM_000213.5(ITGB4):c.467T>C (p.Leu156Pro)	ITGB4	L156P	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000014732	17	73723934	17	75727853	14732	29771	rs121912461	NC_000017.11:75727852:T:C
NM_000213.5(ITGB4):c.4620del (p.Thr1542fs)	ITGB4	T1542fs, T1472fs, T1525fs	Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000014731	17	73751840	17	75755759	14731	29770	rs794726676	NC_000017.11:75755758:GGGG:GGG
ITGB4, 1-BP DEL, 1150G	ITGB4		Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Jun 1, 1995)	no assertion criteria provided	VCV000014730					14730	29769		
ITGB4, 1-BP INS, 3801T	ITGB4		Epidermolysis bullosa junctionalis with pyloric atresia	Pathogenic(Last reviewed: Jun 1, 1995)	no assertion criteria provided	VCV000014729					14729	29768		
NM_005534.3(IFNGR2):c.663_689del (p.Phe224_Ile232del)	IFNGR2		Immunodeficiency 28	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000014728	21	34804582 - 34804608	21	33432275 - 33432301	14728	29767	rs587776823	NC_000021.9:33432274:AAGTAACATCTTTAGAGTCGGGCATTTAAG:AAG
NM_005534.3(IFNGR2):c.503C>A (p.Thr168Asn)	IFNGR2	T168N, T187N	Immunodeficiency 28	Pathogenic(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000014727	21	34799281	21	33426974	14727	29766	rs74315444	NC_000021.9:33426973:C:A
NM_001329128.1(IFNGR2):c.333_334AG[1] (p.Glu112fs)	IFNGR2		Immunodeficiency 28	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000014726	21	34793856 - 34793857	21	33421549 - 33421550	14726	29765	rs587776822	NC_000021.9:33421548:AGAG:AG
NM_000208.4(INSR):c.1372A>G (p.Asn458Asp)	INSR	N458D	Leprechaunism syndrome	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000014714	19	7170659	19	7170648	14714	29753	rs121913160	NC_000019.10:7170647:T:C
NM_000208.4(INSR):c.2480_2487del (p.Gln827fs)	INSR	Q815fs, Q827fs	Pineal hyperplasia AND diabetes mellitus syndrome	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000014713	19	7142882 - 7142889	19	7142871 - 7142878	14713	29752	rs587776820	NC_000019.10:7142870:GGTGTCCTGGT:GGT
NM_000208.4(INSR):c.1124-2A>G	INSR		Pineal hyperplasia AND diabetes mellitus syndrome	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000014712	19	7172447	19	7172436	14712	29751	rs587776819	NC_000019.10:7172435:T:C
NM_000208.4(INSR):c.438C>G (p.Ile146Met)	INSR	I146M	Leprechaunism syndrome	Pathogenic(Last reviewed: Sep 1, 1994)	no assertion criteria provided	VCV000014711	19	7267570	19	7267559	14711	29750	rs121913159	NC_000019.10:7267558:G:C
NM_000208.4(INSR):c.1316G>C (p.Trp439Ser)	INSR	W439S	Leprechaunism syndrome	Pathogenic(Last reviewed: May 13, 1994)	no assertion criteria provided	VCV000014710	19	7170715	19	7170704	14710	29749	rs121913158	NC_000019.10:7170703:C:G
NM_000208.4(INSR):c.3540G>A (p.Met1180Ile)	INSR	M1168I, M1180I	Insulin resistance	Pathogenic(Last reviewed: Jun 7, 1994)	no assertion criteria provided	VCV000014709	19	7120750	19	7120739	14709	29748	rs121913157	NC_000019.10:7120738:C:T
NM_000208.4(INSR):c.3602G>A (p.Arg1201Gln)	INSR	R1174Q, R1189Q, R1201Q	Hyperinsulinemic hypoglycemia familial 5|Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000014708	19	7120688	19	7120677	14708	29747	rs121913156	NC_000019.10:7120676:C:T
NC_000019.10:g.(?_7112255)_(7249328_?)del	INSR		Leprechaunism syndrome	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000014706			19	7112255 - 7249328	14706	29745		
NM_000208.4(INSR):c.442A>T (p.Lys148Ter)	INSR	K148*	Leprechaunism syndrome	Pathogenic(Last reviewed: Jul 31, 1993)	no assertion criteria provided	VCV000014705	19	7267566	19	7267555	14705	29744	rs121913155	NC_000019.10:7267554:T:A
NM_000208.4(INSR):c.3485C>A (p.Ala1162Glu)	INSR	A1150E, A1162E	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Apr 15, 1993)	no assertion criteria provided	VCV000014704	19	7122669	19	7122658	14704	29743	rs121913154	NC_000019.10:7122657:G:T
NM_000208.4(INSR):c.338G>C (p.Arg113Pro)	INSR	R113P	Leprechaunism syndrome	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000014703	19	7267670	19	7267659	14703	29742	rs121913153	NC_000019.10:7267658:C:G
NM_000208.4(INSR):c.164T>C (p.Val55Ala)	INSR	V55A	Leprechaunism syndrome	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000014702	19	7267844	19	7267833	14702	29741	rs121913152	NC_000019.10:7267832:A:G
NM_000208.4(INSR):c.3572G>A (p.Arg1191Gln)	INSR	R1179Q, R1191Q	Diabetes mellitus type 2	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000014700	19	7120718	19	7120707	14700	29739	rs121913150	NC_000019.10:7120706:C:T
NM_000208.4(INSR):c.172G>A (p.Gly58Arg)	INSR	G58R	Leprechaunism syndrome	Pathogenic(Last reviewed: Jan 5, 1992)	no assertion criteria provided	VCV000014699	19	7267836	19	7267825	14699	29738	rs52836744	NC_000019.10:7267824:C:T
NM_000208.4(INSR):c.3059G>A (p.Arg1020Gln)	INSR	R1008Q, R1020Q	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000014697	19	7125493	19	7125482	14697	29736	rs121913148	NC_000019.10:7125481:C:T
NM_000208.3(INSR):c.2683-542_2842+544del	INSR		Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000014696			19	7131594 - 7132859	14696	29735		
NM_000208.4(INSR):c.1466A>G (p.Asn489Ser)	INSR	N489S	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000014695	19	7170565	19	7170554	14695	29734	rs121913147	NC_000019.10:7170553:T:C
NM_000208.4(INSR):c.479G>A (p.Trp160Ter)	INSR	W160*	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000014694	19	7267529	19	7267518	14694	29733	rs121913146	NC_000019.10:7267517:C:T
NM_000208.4(INSR):c.707A>G (p.His236Arg)	INSR	H236R	Leprechaunism syndrome	Pathogenic(Last reviewed: Sep 5, 2014)	criteria provided, single submitter	VCV000014693	19	7184594	19	7184583	14693	29732	rs121913145	NC_000019.10:7184582:T:C
NM_000208.4(INSR):c.3079C>T (p.Arg1027Ter)	INSR	R988*, R1027*, R1015*	Pineal hyperplasia AND diabetes mellitus syndrome|Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000014692	19	7125473	19	7125462	14692	29731	rs121913144	NC_000019.10:7125461:G:A
NM_000208.4(INSR):c.126C>A (p.Asn42Lys)	INSR	N42K	Pineal hyperplasia AND diabetes mellitus syndrome	Pathogenic(Last reviewed: Nov 5, 1990)	no assertion criteria provided	VCV000014691	19	7267882	19	7267871	14691	29730	rs121913143	NC_000019.10:7267870:G:T
NM_000208.4(INSR):c.1225T>G (p.Phe409Val)	INSR	F409V	Insulin-resistant diabetes mellitus	Pathogenic(Last reviewed: Jan 5, 1991)	no assertion criteria provided	VCV000014690	19	7172344	19	7172333	14690	29729	rs121913142	NC_000019.10:7172332:A:C
NM_000208.4(INSR):c.779T>C (p.Leu260Pro)	INSR	L260P	Leprechaunism syndrome	Pathogenic(Last reviewed: Sep 1, 1989)	no assertion criteria provided	VCV000014689	19	7184522	19	7184511	14689	29728	rs121913141	NC_000019.10:7184510:A:G
NM_000208.4(INSR):c.3481G>A (p.Ala1161Thr)	INSR	A1149T, A1161T	Insulin resistance|Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Aug 1, 1990)	no assertion criteria provided	VCV000014687	19	7122673	19	7122662	14687	29726	rs121913139	NC_000019.10:7122661:C:T
NM_000208.4(INSR):c.2770C>T (p.Arg924Ter)	INSR	R924*, R912*	Leprechaunism syndrome	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000014686	19	7132241	19	7132230	14686	29725	rs387906538	NC_000019.10:7132229:G:A
INSR, EX17, ALU	INSR		Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jul 7, 1989)	no assertion criteria provided	VCV000014685					14685	29724		
NM_000208.4(INSR):c.2286G>T (p.Arg762Ser)	INSR	R750S, R762S	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jun 1, 1988)	no assertion criteria provided	VCV000014684	19	7143083	19	7143072	14684	29723	rs121913138	NC_000019.10:7143071:C:A
NM_000208.4(INSR):c.3680G>C (p.Trp1227Ser)	INSR	W1227S, W1215S	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Aug 1, 1990)	no assertion criteria provided	VCV000014683	19	7119574	19	7119563	14683	29722	rs121913140	NC_000019.10:7119562:C:G
NM_000208.4(INSR):c.2095C>T (p.Gln699Ter)	INSR	Q699*	Leprechaunism syndrome	Pathogenic(Last reviewed: May 6, 1988)	no assertion criteria provided	VCV000014682	19	7152873	19	7152862	14682	29721	rs121913137	NC_000019.10:7152861:G:A
NM_000208.4(INSR):c.1177G>A (p.Gly393Arg)	INSR	G393R	Leprechaunism syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	no assertion criteria provided	VCV000014681	19	7172392	19	7172381	14681	29720	rs267607184	NC_000019.10:7172380:C:T
NM_000208.4(INSR):c.1459A>G (p.Lys487Glu)	INSR	K487E	Leprechaunism syndrome	Pathogenic(Last reviewed: May 6, 1988)	no assertion criteria provided	VCV000014680	19	7170572	19	7170561	14680	29719	rs121913136	NC_000019.10:7170560:T:C
NM_000208.4(INSR):c.3104G>T (p.Gly1035Val)	INSR	G1023V, G1035V	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Sep 5, 1990)	no assertion criteria provided	VCV000014679	19	7125448	19	7125437	14679	29718	rs121913135	NC_000019.10:7125436:C:A
NM_001754.4(RUNX1):c.442_449del (p.Thr148fs)	RUNX1	T121fs, T148fs	Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 1, 2019)	reviewed by expert panel	VCV000014470	21	36252913 - 36252920	21	34880616 - 34880623	14470	29509	rs587776811	NC_000021.9:34880615:GCTGCGGT:
NM_001754.4(RUNX1):c.400G>C (p.Ala134Pro)	RUNX1	A107P, A134P	Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 30, 2019)	reviewed by expert panel	VCV000014468	21	36252962	21	34880665	14468	29507	rs74315451	NC_000021.9:34880664:C:G
NM_001754.4(RUNX1):c.861C>A (p.Tyr287Ter)	RUNX1	Y260*, Y287*	Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 29, 2019)	reviewed by expert panel	VCV000014467	21	36171704	21	34799407	14467	29506	rs121912499	NC_000021.9:34799406:G:T
NM_001754.4(RUNX1):c.508+3del	RUNX1		Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 1, 2019)	reviewed by expert panel	VCV000014466	21	36252851	21	34880554	14466	29505	rs587776810	NC_000021.9:34880553:T:
NM_001754.4(RUNX1):c.328A>G (p.Lys110Glu)	RUNX1	K83E, K110E	not provided|Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 29, 2019)	reviewed by expert panel	VCV000014465	21	36259163	21	34886866	14465	29504	rs121912498	NC_000021.9:34886865:T:C
NM_001754.4(RUNX1):c.602G>A (p.Arg201Gln)	RUNX1	R201Q, R174Q	not provided|Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 30, 2019)	reviewed by expert panel	VCV000014464	21	36231782	21	34859485	14464	29503	rs74315450	NC_000021.9:34859484:C:T
NM_001754.4(RUNX1):c.352-1G>T	RUNX1		not provided|Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Aug 1, 2019)	reviewed by expert panel	VCV000014463	21	36253011	21	34880714	14463	29502	rs587776809	NC_000021.9:34880713:C:A
NM_000894.2(LHB):c.167G>A (p.Gly56Asp)	LHB	G36D, G56D	Isolated lutropin deficiency	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000014416	19	49519820	19	49016563	14416	29455	rs121912517	NC_000019.10:49016562:C:T
NM_000894.2(LHB):c.221A>G (p.Gln74Arg)	LHB	Q54R, Q74R	Isolated lutropin deficiency	Pathogenic(Last reviewed: Jan 16, 1992)	no assertion criteria provided	VCV000014413	19	49519530	19	49016273	14413	29452	rs5030773	NC_000019.10:49016272:T:C
NM_001161748.2(LIM2):c.313T>G (p.Phe105Val)	LIM2	F105V, F147V	Cataract 19, multiple types	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000014356	19	51885684	19	51382430	14356	29395	rs121913555	NC_000019.10:51382429:A:C
MYH9, 18-BP DEL, NT228	MYH9		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000014086					14086	29125		
NM_002473.5(MYH9):c.3195_3215dup (p.Gln1068_Leu1074dup)	MYH9		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014085	22	36692945 - 36692946	22	36296899 - 36296900	14085	29124	rs876661302	NC_000022.11:36296899:GCGATCTGGGCCTGGAGCTCGGCGATCTGG:GCGATCTGGGCCTGGAGCTCGGCGATCTGGGCCTGGAGCTCGGCGATCTGG
NM_002473.5(MYH9):c.3195_3215del (p.Gln1068_Leu1074del)	MYH9		Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000014084	22	36692946 - 36692966	22	36296900 - 36296920	14084	29123	rs876661302	NC_000022.11:36296899:GCGATCTGGGCCTGGAGCTCGGCGATCTGG:GCGATCTGG
NM_002473.5(MYH9):c.287C>T (p.Ser96Leu)	MYH9	S96L	Autosomal dominant nonsyndromic deafness 17|MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000014083	22	36744995	22	36348950	14083	29122	rs121913657	NC_000022.11:36348949:G:A
NM_002473.5(MYH9):c.4270G>A (p.Asp1424Asn)	MYH9	D1424N	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014082	22	36688106	22	36292060	14082	29121	rs80338831	NC_000022.11:36292059:C:T
NM_002473.5(MYH9):c.5821del (p.Asp1941fs)	MYH9	D1941fs	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Jul 16, 2015)	no assertion criteria provided	VCV000014080	22	36678776	22	36282730	14080	29119	rs587776808	NC_000022.11:36282729:CCCC:CCC
NM_002473.5(MYH9):c.2114G>A (p.Arg705His)	MYH9	R705H	Autosomal dominant nonsyndromic deafness 17|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Apr 5, 2011)	no assertion criteria provided	VCV000014079	22	36702021	22	36305975	14079	29118	rs80338828	NC_000022.11:36305974:C:T
NM_002473.5(MYH9):c.2104C>T (p.Arg702Cys)	MYH9	R702C	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014078	22	36702031	22	36305985	14078	29117	rs80338826	NC_000022.11:36305984:G:A
NM_002473.5(MYH9):c.3464C>T (p.Thr1155Ile)	MYH9	T1155I	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000014077	22	36691572	22	36295526	14077	29116	rs121913656	NC_000022.11:36295525:G:A
NM_002473.5(MYH9):c.4270G>C (p.Asp1424His)	MYH9	D1424H	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Apr 5, 2011)	no assertion criteria provided	VCV000014076	22	36688106	22	36292060	14076	29115	rs80338831	NC_000022.11:36292059:C:G
NM_002473.5(MYH9):c.279C>G (p.Asn93Lys)	MYH9	N93K	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000014075	22	36745003	22	36348958	14075	29114	rs121913655	NC_000022.11:36348957:G:C
NM_002473.5(MYH9):c.3493C>T (p.Arg1165Cys)	MYH9	R1165C	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000014074	22	36691115	22	36295069	14074	29113	rs80338829	NC_000022.11:36295068:G:A
NM_002473.5(MYH9):c.5521G>A (p.Glu1841Lys)	MYH9	E1841K	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss|MYH9-related disorder	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000014073	22	36680520	22	36284474	14073	29112	rs80338834	NC_000022.11:36284473:C:T
NM_002473.5(MYH9):c.5797C>T (p.Arg1933Ter)	MYH9	R1933*	MYH9-related disorder|Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	Pathogenic(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000014072	22	36678800	22	36282754	14072	29111	rs80338835	NC_000022.11:36282753:G:A
NM_006179.4(NTF4):c.617G>A (p.Arg206Gln)	NTF4	R206Q	Glaucoma 1, open angle, O	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000014019	19	49564638	19	49061381	14019	29058	rs121918428	NC_000019.10:49061380:C:T
NM_001626.6(AKT2):c.821G>A (p.Arg274His)	AKT2	R274H, R212H	Diabetes mellitus type 2	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000013982	19	40743886	19	40237979	13982	29021	rs121434593	NC_000019.10:40237978:C:T
NM_000175.5(GPI):c.1124C>G (p.Thr375Arg)	GPI	T375R, T386R, T414R, T347R	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Sep 15, 1996)	no assertion criteria provided	VCV000013648	19	34887267	19	34396362	13648	28687	rs267606853	NC_000019.10:34396361:C:G
NM_000175.5(GPI):c.14C>T (p.Thr5Ile)	GPI	T5I, T44I	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Sep 15, 1996)	no assertion criteria provided	VCV000013647	19	34856185	19	34365280	13647	28686	rs267606852	NC_000019.10:34365279:C:T
NM_000175.5(GPI):c.1028A>G (p.Gln343Arg)	GPI	Q343R, Q354R, Q315R, Q382R	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Sep 15, 1996)	no assertion criteria provided	VCV000013646	19	34884937	19	34394032	13646	28685	rs267606851	NC_000019.10:34394031:A:G
NM_000175.5(GPI):c.1016T>C (p.Leu339Pro)	GPI	L339P, L378P, L311P, L350P	Hemolytic anemia, nonspherocytic, and neurologic deficits, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000013645	19	34884925	19	34394020	13645	28684	rs137853587	NC_000019.10:34394019:T:C
NM_000175.5(GPI):c.59A>C (p.His20Pro)	GPI	H20P, H59P	Hemolytic anemia, nonspherocytic, and neurologic deficits, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000013644	19	34856230	19	34365325	13644	28683	rs137853586	NC_000019.10:34365324:A:C
NM_000175.5(GPI):c.671C>T (p.Thr224Met)	GPI	T224M, T235M, T196M, T263M	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Sep 15, 1996)	no assertion criteria provided	VCV000013643	19	34869876	19	34378971	13643	28682	rs61754634	NC_000019.10:34378970:C:T
NM_000175.5(GPI):c.1615G>A (p.Asp539Asn)	GPI	D539N, D550N, D511N, D578N, D530N	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Sep 15, 1996)	no assertion criteria provided	VCV000013642	19	34890879	19	34399974	13642	28681	rs137853585	NC_000019.10:34399973:G:A
NM_000175.5(GPI):c.1574T>C (p.Ile525Thr)	GPI	I524T, I525T, I536T, I516T, I497T, I564T	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000013641	19	34890838	19	34399933	13641	28680	rs137853584	NC_000019.10:34399932:T:C
NM_000175.5(GPI):c.1040G>A (p.Arg347His)	GPI	R346H, R347H, R358H, R319H, R386H	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Jul 28, 2018)	criteria provided, single submitter	VCV000013640	19	34884949	19	34394044	13640	28679	rs137853583	NC_000019.10:34394043:G:A
NM_000175.5(GPI):c.475G>A (p.Gly159Ser)	GPI	G158S, G159S, G198S	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000013639	19	34868480	19	34377575	13639	28678	rs137853582	NC_000019.10:34377574:G:A
NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)	KCNE1	T7I	Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000013476	21	35821913	21	34449615	13476	28515	rs28933384	NC_000021.9:34449614:G:A
NM_000219.4:c.[172A>C;176T>C]	KCNE1		Jervell and Lange-Nielsen syndrome 2	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000013475	21	35821756 - 35821761	21	34449458 - 34449463	13475	28514	rs281865421	NC_000021.9:34449457:CAGGGT:AGGGGG
NM_004977.2(KCNC3):c.1344C>A (p.Phe448Leu)	KCNC3	F448L		Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000013474	19	50826866	19	50323609	13474	28513	rs104894700	NC_000019.10:50323608:G:T
NM_004977.2(KCNC3):c.1259G>A (p.Arg420His)	KCNC3	R420H	|not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013473	19	50826951	19	50323694	13473	28512	rs104894699	NC_000019.10:50323693:C:T
NM_002739.5(PRKCG):c.2091_*98del (p.Met697_Ter698delinsXaa)	PRKCG			Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013252	19	54410146 - 54410247	19	53906892 - 53906993	13252	28291	rs1555808841	
NM_002739.5(PRKCG):c.303C>G (p.His101Gln)	PRKCG	H101Q		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013251	19	54392909	19	53889655	13251	28290	rs121918518	NC_000019.10:53889654:C:G
NM_002739.5(PRKCG):c.1081A>G (p.Ser361Gly)	PRKCG	S361G		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013250	19	54401354	19	53898100	13250	28289	rs121918517	NC_000019.10:53898099:A:G
NM_002739.5(PRKCG):c.1927T>C (p.Phe643Leu)	PRKCG	F643L		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013249	19	54409982	19	53906728	13249	28288	rs121918516	NC_000019.10:53906727:T:C
NM_002739.5(PRKCG):c.380A>G (p.Gln127Arg)	PRKCG	Q127R	|not provided	Pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000013248	19	54392986	19	53889732	13248	28287	rs121918515	NC_000019.10:53889731:A:G
NM_002739.5(PRKCG):c.353G>A (p.Gly118Asp)	PRKCG	G118D		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013247	19	54392959	19	53889705	13247	28286	rs121918514	NC_000019.10:53889704:G:A
NM_002739.5(PRKCG):c.383G>A (p.Gly128Asp)	PRKCG	G128D		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013246	19	54392989	19	53889735	13246	28285	rs121918513	NC_000019.10:53889734:G:A
NM_002739.5(PRKCG):c.355T>C (p.Ser119Pro)	PRKCG	S119P		Pathogenic(Last reviewed: Apr 18, 2013)	no assertion criteria provided	VCV000013245	19	54392961	19	53889707	13245	28284	rs121918512	NC_000019.10:53889706:T:C
NM_002739.5(PRKCG):c.301C>T (p.His101Tyr)	PRKCG	H101Y		Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000013244	19	54392907	19	53889653	13244	28283	rs121918511	NC_000019.10:53889652:C:T
NM_002743.3(PRKCSH):c.215dup (p.Asn72fs)	PRKCSH		Polycystic liver disease 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013243	19	11548713 - 11548714	19	11437892 - 11437893	13243	28282	rs1555725707	NC_000019.10:11437892:AA:AAA
NM_002743.3(PRKCSH):c.1269C>G (p.Tyr423Ter)	PRKCSH	Y422*, Y423*, Y430*, Y420*	Polycystic liver disease 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013242	19	11559732	19	11448917	13242	28281	rs121918520	NC_000019.10:11448916:C:G
NM_002743.3(PRKCSH):c.1240C>T (p.Gln414Ter)	PRKCSH	Q413*, Q414*, Q411*, Q421*	Polycystic liver disease 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013241	19	11559419	19	11448604	13241	28280	rs121918519	NC_000019.10:11448603:C:T
NM_002743.3(PRKCSH):c.1440+2_1440+3del	PRKCSH		Polycystic liver disease 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013240	19	11559991 - 11559992	19	11449176 - 11449177	13240	28279	rs757957327	NC_000019.10:11449175:GTG:G
NM_002743.3(PRKCSH):c.292+1G>C	PRKCSH		Polycystic liver disease 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013239	19	11548793	19	11437972	13239	28278	rs774233325	NC_000019.10:11437971:G:C
NM_002743.3(PRKCSH):c.1341-2A>G	PRKCSH		Polycystic liver disease 1	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000013238	19	11559889	19	11449074	13238	28277	rs1555728968	NC_000019.10:11449073:A:G
NM_006907.4(PYCR1):c.752G>A (p.Arg251His)	PYCR1	R251H, R220H, R278H	Autosomal recessive cutis laxa type 3B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013198	17	79892247	17	81934371	13198	28237	rs121918378	NC_000017.11:81934370:C:T
NM_006907.4(PYCR1):c.356G>A (p.Arg119His)	PYCR1	R119H, R146H	Autosomal recessive cutis laxa type 3B|Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000013197	17	79892986	17	81935110	13197	28236	rs121918377	NC_000017.11:81935109:C:T
NM_006907.4(PYCR1):c.355C>G (p.Arg119Gly)	PYCR1	R119G, R146G	Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013196	17	79892987	17	81935111	13196	28235	rs121918376	NC_000017.11:81935110:G:C
NM_006907.4(PYCR1):c.11del (p.Gly4fs)	PYCR1	G31fs, G4fs	Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013195	17	79894680	17	81936804	13195	28234		NC_000017.11:81936803:CCC:CC
PYCR1, 3-BP DEL, NT797+2	PYCR1		Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013194					13194	28233		
NM_006907.4(PYCR1):c.618_633+7del	PYCR1		Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013192	17	79892522 - 79892544	17	81934646 - 81934668	13192	28231		NC_000017.11:81934645:CACTGACCAGGAGGGCCTGGGCCC:C
NM_006907.4(PYCR1):c.616G>T (p.Gly206Trp)	PYCR1	G206W, G233W	Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013191	17	79892546	17	81934670	13191	28230	rs121918375	NC_000017.11:81934669:C:A
NM_006907.4(PYCR1):c.797G>A (p.Arg266Gln)	PYCR1	R266Q, R235Q, R293Q	not provided|Inborn genetic diseases|Cutis laxa|Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013190	17	79892202	17	81934326	13190	28229	rs121918374	NC_000017.11:81934325:C:T
NM_002602.4(PDE6G):c.187+1G>T	PDE6G		Retinitis pigmentosa|Retinitis pigmentosa 57	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000013102	17	79618674	17	81651644	13102	28141		NC_000017.11:81651643:C:A
NM_000687.4(AHCY):c.336G>A (p.Trp112Ter)	AHCY	W112*, W84*, W114*	Hypermethioninemia with s-adenosylhomocysteine hydrolase deficiency	Pathogenic(Last reviewed: Mar 23, 2004)	no assertion criteria provided	VCV000012952	20	32880273	20	34292467	12952	27991	rs121918607	NC_000020.11:34292466:C:T
NM_152296.5(ATP1A3):c.2767G>A (p.Asp923Asn)	ATP1A3	D923N, D936N, D934N	Dystonia 12|Alternating hemiplegia of childhood 2|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012915	19	42472989	19	41968837	12915	27954	rs267606670	NC_000019.10:41968836:C:T
NM_152296.5(ATP1A3):c.2401G>T (p.Asp801Tyr)	ATP1A3	D801Y, D812Y, D814Y	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000012914	19	42474557	19	41970405	12914	27953	rs80356537	NC_000019.10:41970404:C:A
NM_152296.5(ATP1A3):c.2338T>C (p.Phe780Leu)	ATP1A3	F780L, F793L, F791L	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000012913	19	42474620	19	41970468	12913	27952	rs80356536	NC_000019.10:41970467:A:G
NM_152296.5(ATP1A3):c.2273T>G (p.Ile758Ser)	ATP1A3	I758S, I769S, I771S	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000012912	19	42474685	19	41970533	12912	27951	rs80356535	NC_000019.10:41970532:A:C
NM_152296.5(ATP1A3):c.829G>A (p.Glu277Lys)	ATP1A3	E277K, E290K, E288K	Dystonia 12	Pathogenic(Last reviewed: Jul 15, 2016)	criteria provided, single submitter	VCV000012911	19	42489234	19	41985082	12911	27950	rs80356533	NC_000019.10:41985081:C:T
NM_152296.5(ATP1A3):c.821T>C (p.Ile274Thr)	ATP1A3	I274T, I287T, I285T	Dystonia 12	Pathogenic(Last reviewed: May 4, 2014)	no assertion criteria provided	VCV000012910	19	42489242	19	41985090	12910	27949	rs80356532	NC_000019.10:41985089:A:G
NM_152296.5(ATP1A3):c.1838C>T (p.Thr613Met)	ATP1A3	T613M, T626M, T624M	Dystonia 12|not provided|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012909	19	42482193	19	41978041	12909	27948	rs80356534	NC_000019.10:41978040:G:A
NM_000343.4(SLC5A1):c.83A>G (p.Asp28Gly)	SLC5A1	D28G	Congenital glucose-galactose malabsorption	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000012908	22	32439351	22	32043364	12908	27947	rs121912669	NC_000022.11:32043363:A:G
NM_000343.4(SLC5A1):c.82G>A (p.Asp28Asn)	SLC5A1	D28N	Congenital glucose-galactose malabsorption	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000012907	22	32439350	22	32043363	12907	27946	rs121912668	NC_000022.11:32043362:G:A
NM_212472.2(PRKAR1A):c.709-7_709-2del	PRKAR1A		Carney complex|Pigmented nodular adrenocortical disease, primary, 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000012675	17	66523965 - 66523970	17	68527824 - 68527829	12675	27714	rs281864801	NC_000017.11:68527823:TTATTTTTATTTTTA:TTATTTTTA
NM_002734.4(PRKAR1A):c.892-1G>A	PRKAR1A		Adrenocortical tumor, somatic	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000012673	17	66526060	17	68529919	12673	27712	rs587776774	NC_000017.11:68529918:G:A
NM_212472.2(PRKAR1A):c.708+1G>T	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000012672	17	66522054	17	68525913	12672	27711	rs281864798	NC_000017.11:68525912:G:T
PRKAR1A, 16-BP DEL	PRKAR1A		Pigmented nodular adrenocortical disease, primary, 1	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000012671					12671	27710		
NM_212472.2(PRKAR1A):c.-37G>A	PRKAR1A		Pigmented nodular adrenocortical disease, primary, 1	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000012670	17	66508690	17	68512549	12670	27709	rs587776773	NC_000017.11:68512548:G:A
NM_212472.2(PRKAR1A):c.1A>G (p.Met1Val)	PRKAR1A	M1V	Carney complex, type 1|not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000012669	17	66511541	17	68515400	12669	27708	rs281864779	NC_000017.11:68515399:A:G
PRKAR1A, 2-BP DEL, 576TG	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000012668					12668	27707		
PRKAR1A, 2-BP DEL, 845TC	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000012667					12667	27706		
PRKAR1A, 1-BP DEL, 710G	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000012666					12666	27705		
NM_212472.2(PRKAR1A):c.618_621del (p.Ile206fs)	PRKAR1A	I206fs		Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000012665	17	66521961 - 66521964	17	68525820 - 68525823	12665	27704	rs281864791	NC_000017.11:68525819:ATTTAT:AT
NM_212472.2(PRKAR1A):c.891+3A>G	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000012664	17	66525135	17	68528994	12664	27703	rs281864799	NC_000017.11:68528993:A:G
NM_212472.2(PRKAR1A):c.786_787delinsCT (p.Trp262_Glu263delinsCysTer)	PRKAR1A		Carney complex, type 1	Pathogenic(Last reviewed: Sep 20, 2012)	no assertion criteria provided	VCV000012663	17	66525027 - 66525028	17	68528886 - 68528887	12663	27702	rs281864785	NC_000017.11:68528885:GG:CT
NM_212472.2(PRKAR1A):c.489_490TG[1] (p.Val164fs)	PRKAR1A		Carney complex, type 1|not provided	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012662	17	66520205 - 66520206	17	68524064 - 68524065	12662	27701	rs281864790	NC_000017.11:68524063:TGTG:TG
PDGFB, PDGFB/COL1A1 FUSION	PDGFB		Dermatofibrosarcoma protuberans	Pathogenic(Last reviewed: May 24, 2001)	no assertion criteria provided	VCV000012599					12599	27638		
PDGFB, 135-BP DEL, IVS5	PDGFB		Meningioma	Pathogenic(Last reviewed: Oct 1, 1990)	no assertion criteria provided	VCV000012598					12598	27637		
NM_003283.6(TNNT1):c.538G>T (p.Glu180Ter)	TNNT1	E180*, E169*	not provided|Nemaline myopathy 5	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000012440	19	55648544	19	55137176	12440	27479	rs80358249	NC_000019.10:55137175:C:A
AVP, 3-BP DEL, PHE3DEL	AVP		Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000012222					12222	27261		
NM_000490.5(AVP):c.61T>C (p.Tyr21His)	AVP	Y2H, Y21H	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000012221	20	3065260	20	3084614	12221	27260	rs121964893	NC_000020.11:3084613:A:G
NM_000490.5(AVP):c.346T>G (p.Cys116Gly)	AVP	C116G	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000012220	20	3063425	20	3082779	12220	27259	rs74315383	NC_000020.11:3082778:A:C
NM_000490.5(AVP):c.20C>T (p.Pro7Leu)	AVP	P7L	Diabetes insipidus, neurohypophyseal, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000012219	20	3065301	20	3084655	12219	27258	rs121964892	NC_000020.11:3084654:G:A
NM_000490.5(AVP):c.200T>C (p.Val67Ala)	AVP	V67A	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000012218	20	3063745	20	3083099	12218	27257	rs28934878	NC_000020.11:3083098:A:G
NM_000490.5(AVP):c.275G>A (p.Cys92Tyr)	AVP	C61Y, C92Y	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000012217	20	3063670	20	3083024	12217	27256	rs121964891	NC_000020.11:3083023:C:T
NM_000490.5(AVP):c.260C>T (p.Ser87Phe)	AVP	S56F, S87F	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000012216	20	3063685	20	3083039	12216	27255	rs121964890	NC_000020.11:3083038:G:A
NM_000490.5(AVP):c.337G>T (p.Glu113Ter)	AVP	E82*, E113*	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000012215	20	3063434	20	3082788	12215	27254	rs121964889	NC_000020.11:3082787:C:A
NM_000490.5(AVP):c.160G>C (p.Gly54Arg)	AVP	G23R, G54R	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000012214	20	3063785	20	3083139	12214	27253	rs121964888	NC_000020.11:3083138:C:G
NM_000490.5(AVP):c.161G>T (p.Gly54Val)	AVP	G23V, G54V	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000012213	20	3063784	20	3083138	12213	27252	rs121964887	NC_000020.11:3083137:C:A
NM_000490.5(AVP):c.56C>T (p.Ala19Val)	AVP	A19V	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000012212	20	3065265	20	3084619	12212	27251	rs387906512	NC_000020.11:3084618:G:A
NM_000490.5(AVP):c.287G>T (p.Gly96Val)	AVP	G65V, G96V	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000012211	20	3063658	20	3083012	12211	27250	rs121964886	NC_000020.11:3083011:C:A
AVP, 1-BP DEL, 227G	AVP		Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000012210					12210	27249		
NM_000490.5(AVP):c.277G>T (p.Gly93Trp)	AVP	G62W, G93W	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000012209	20	3063668	20	3083022	12209	27248	rs121964885	NC_000020.11:3083021:C:A
NM_000490.5(AVP):c.294C>A (p.Cys98Ter)	AVP	C67*, C98*	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000012208	20	3063651	20	3083005	12208	27247	rs121964884	NC_000020.11:3083004:G:T
AVP, 3-BP DEL, NT1824	AVP		Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000012207					12207	27246		
NM_000490.5(AVP):c.55G>A (p.Ala19Thr)	AVP	A19T	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000012206	20	3065266	20	3084620	12206	27245	rs387906511	NC_000020.11:3084619:C:T
NM_000490.5(AVP):c.143G>T (p.Gly48Val)	AVP	G17V, G48V	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000012205	20	3063802	20	3083156	12205	27244	rs121964883	NC_000020.11:3083155:C:A
NM_000490.5(AVP):c.262G>A (p.Gly88Ser)	AVP	G57S, G88S	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Feb 1, 1991)	no assertion criteria provided	VCV000012204	20	3063683	20	3083037	12204	27243	rs121964882	NC_000020.11:3083036:C:T
NM_001127898.4(CLCN5):c.989G>T (p.Gly330Val)	CLCN5	G260V, G330V, G280V		Pathogenic(Last reviewed: Aug 9, 2012)	no assertion criteria provided	VCV000011808	X	49850692	X	50086035	11808	26847	rs151340630	NC_000023.11:50086034:G:T
CLCN5, ALU INS, EX11	CLCN5			Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000011807					11807	26846		
NM_001127898.4(CLCN5):c.380G>T (p.Gly127Val)	CLCN5	G57V, G127V, G77V	Nephrolithiasis, X-linked recessive	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000011806	X	49837208	X	50072553	11806	26845	rs151340629	NC_000023.11:50072552:G:T
NM_001127898.4(CLCN5):c.1049G>C (p.Arg350Pro)	CLCN5	R280P, R300P, R350P	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000011805	X	49851019	X	50086362	11805	26844	rs151340628	NC_000023.11:50086361:G:C
NM_001127898.4(CLCN5):c.2295del (p.Met766fs)	CLCN5	M696fs, M716fs, M766fs	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000011804	X	49855476	X	50090819	11804	26843	rs1569540520	NC_000023.11:50090818:CCC:CC
NM_001127898.4(CLCN5):c.1238G>A (p.Trp413Ter)	CLCN5	W343*, W363*, W413*	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000011803	X	49851208	X	50086551	11803	26842	rs151340627	NC_000023.11:50086550:G:A
NM_001127898.4(CLCN5):c.1727G>A (p.Gly576Glu)	CLCN5	G506E, G526E, G576E	Nephrolithiasis, X-linked recessive	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000011801	X	49853524	X	50088867	11801	26840	rs151340625	NC_000023.11:50088866:G:A
NM_001127898.4(CLCN5):c.1768T>C (p.Ser590Pro)	CLCN5	S520P, S540P, S590P		Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000011799	X	49854796	X	50090139	11799	26838	rs151340623	NC_000023.11:50090138:T:C
NM_001127898.4(CLCN5):c.809T>G (p.Leu270Arg)	CLCN5	L200R, L220R, L270R		Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000011798	X	49846380	X	50081723	11798	26837	rs151340622	NC_000023.11:50081722:T:G
NM_001127898.4(CLCN5):c.2152C>T (p.Arg718Ter)	CLCN5	R648*, R718*, R668*		Pathogenic(Last reviewed: Sep 25, 2014)	no assertion criteria provided	VCV000011797	X	49855335	X	50090678	11797	26836	rs151340621	NC_000023.11:50090677:C:T
NM_001127898.4(CLCN5):c.1047G>A (p.Trp349Ter)	CLCN5	W279*, W299*, W349*	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis|	Pathogenic(Last reviewed: Mar 1, 1997)	no assertion criteria provided	VCV000011796	X	49851017	X	50086360	11796	26835	rs151340620	NC_000023.11:50086359:G:A
NM_000052.7(ATP7A):c.601C>T (p.Arg201Ter)	ATP7A	R201*	Menkes kinky-hair syndrome|not provided	Pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000011793	X	77244218	X	77988722	11793	26832	rs151340633	NC_000023.11:77988721:C:T
NM_000052.7(ATP7A):c.3911A>G (p.Asn1304Ser)	ATP7A	N1304S, N1226S	Cutis laxa, X-linked|Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011792	X	77298192	X	78042694	11792	26831	rs151340632	NC_000023.11:78042693:A:G
ATP7A, EX3-4 DEL	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000011791					11791	26830		
NM_000052.7(ATP7A):c.408_415del (p.Asn137fs)	ATP7A	N137fs	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000011790	X	77244025 - 77244032	X	77988529 - 77988536	11790	26829	rs1569549587	NC_000023.11:77988528:CAATCAGA:
ATP7A, EX8 DEL	ATP7A		Menkes disease, copper-replacement responsive	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000011789					11789	26828		
NM_000052.7(ATP7A):c.3056G>A (p.Gly1019Asp)	ATP7A	G1019D, G941D	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011788	X	77284886	X	78029389	11788	26827	rs72554652	NC_000023.11:78029388:G:A
NM_000052.7(ATP7A):c.4352del (p.Gly1451fs)	ATP7A	G1373fs, G1451fs	Cutis laxa, X-linked	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000011787	X	77301914	X	78046417	11787	26826	rs1569550376	NC_000023.11:78046416:GGG:GG
NM_000052.7(ATP7A):c.1707+1G>A	ATP7A		Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000011786	X	77258734	X	78003237	11786	26825	rs1569549753	NC_000023.11:78003236:G:A
NM_000052.7(ATP7A):c.2938C>T (p.Arg980Ter)	ATP7A	R980*, R902*	Menkes kinky-hair syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011784	X	77284768	X	78029271	11784	26823	rs72554649	NC_000023.11:78029270:C:T
ATP7A, 8-BP DEL, NT1552	ATP7A		Cutis laxa, X-linked	Pathogenic(Last reviewed: Sep 11, 2013)	no assertion criteria provided	VCV000011783					11783	26822		
NM_000052.7(ATP7A):c.1910C>T (p.Ser637Leu)	ATP7A	S637L	Menkes kinky-hair syndrome|Cutis laxa, X-linked	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011782	X	77266713	X	78011216	11782	26821	rs151340631	NC_000023.11:78011215:C:T
ATP7A, IVSAS, 2642A-G, -2	ATP7A		Cutis laxa, X-linked	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011781					11781	26820		
ATP7A, IVSXDS, A-T, +3	ATP7A		Menkes disease, mild	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011780					11780	26819		
NM_000489.5(ATRX):c.6811A>G (p.Arg2271Gly)	ATRX	R2271G, R2233G	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000011746	X	76778768	X	77523290	11746	26785	rs122445112	NC_000023.11:77523289:T:C
NM_000489.5(ATRX):c.659G>A (p.Cys220Tyr)	ATRX	C220Y, C182Y	Inborn genetic diseases|Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000011745	X	76940434	X	77684942	11745	26784	rs122445111	NC_000023.11:77684941:C:T
NM_000489.5(ATRX):c.1226T>C (p.Leu409Ser)	ATRX	L409S, L371S	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011743	X	76939522	X	77684030	11743	26782	rs122445109	NC_000023.11:77684029:A:G
NM_000489.5(ATRX):c.109C>T (p.Arg37Ter)	ATRX	R37*	Intellectual disability|Mental retardation-hypotonic facies syndrome X-linked, 1||Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011742	X	76972632	X	77717155	11742	26781	rs122445108	NC_000023.11:77717154:G:A
NM_000489.5(ATRX):c.236C>G (p.Ser79Ter)	ATRX	S79*	Acquired hemoglobin H disease	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011741	X	76953077	X	77697589	11741	26780	rs122445107	NC_000023.11:77697588:G:C
NM_000489.5(ATRX):c.20+1G>A	ATRX		Acquired hemoglobin H disease	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011740	X	77041467	X	77785981	11740	26779	rs587776756	NC_000023.11:77785980:C:T
NM_000489.5(ATRX):c.4862C>T (p.Thr1621Met)	ATRX	T1621M, T1583M		Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000011739	X	76889148	X	77633660	11739	26778	rs122445106	NC_000023.11:77633659:G:A
NM_000489.5(ATRX):c.7201-2A>G	ATRX		Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Mar 6, 2000)	no assertion criteria provided	VCV000011737	X	76764109	X	77508631	11737	26776	rs1569513021	NC_000023.11:77508630:T:C
NM_000489.5(ATRX):c.5225G>A (p.Arg1742Lys)	ATRX	R1742K, R1704K		Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000011736	X	76875910	X	77620442	11736	26775	rs122445104	NC_000023.11:77620441:C:T
NM_000489.5(ATRX):c.736C>T (p.Arg246Cys)	ATRX	R129C, R246C, R208C	|Mental retardation-hypotonic facies syndrome X-linked, 1|Acquired hemoglobin H disease|not provided|Inborn genetic diseases|	Pathogenic(Last reviewed: Aug 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011735	X	76940012	X	77684520	11735	26774	rs122445105	NC_000023.11:77684519:G:A
NM_000489.5(ATRX):c.751A>G (p.Lys251Glu)	ATRX	K251E, K213E		Pathogenic(Last reviewed: Jul 15, 1997)	no assertion criteria provided	VCV000011733	X	76939997	X	77684505	11733	26772	rs1569539477	NC_000023.11:77684504:T:C
NM_000489.5(ATRX):c.5131C>T (p.Pro1711Ser)	ATRX	P852S, P1673S, P1711S	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000011732	X	76888698	X	77633210	11732	26771	rs122445102	NC_000023.11:77633209:G:A
NM_000489.5(ATRX):c.6392G>A (p.Arg2131Gln)	ATRX	R1272Q, R2093Q, R2131Q	|Mental retardation-hypotonic facies syndrome X-linked, 1|Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000011731	X	76814252	X	77558781	11731	26770	rs122445101	NC_000023.11:77558780:C:T
ATRX, IVSAS, T-A, -10	ATRX			Pathogenic(Last reviewed: Mar 1, 1996)	no assertion criteria provided	VCV000011730					11730	26769		
NM_000489.5(ATRX):c.7162G>T (p.Glu2388Ter)	ATRX	E1530*, E2350*, E2388*		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011729	X	76776304	X	77520826	11729	26768	rs122445100	NC_000023.11:77520825:C:A
NM_000489.5(ATRX):c.7156C>T (p.Arg2386Ter)	ATRX	R1528*, R2348*, R2386*	|Intellectual disability, severe|Microcephaly|Osteosarcoma|Ambiguous genitalia|Cryptorchidism|not provided	Pathogenic(Last reviewed: Apr 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000011728	X	76776310	X	77520832	11728	26767	rs122445099	NC_000023.11:77520831:G:A
NM_000489.5(ATRX):c.6488A>G (p.Tyr2163Cys)	ATRX	Y1305C, Y2125C, Y2163C		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011727	X	76814156	X	77558685	11727	26766	rs122445098	NC_000023.11:77558684:T:C
NM_000489.5(ATRX):c.6250T>C (p.Tyr2084His)	ATRX	Y1226H, Y2046H, Y2084H		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011726	X	76829791	X	77574326	11726	26765	rs122445097	NC_000023.11:77574325:A:G
NM_000489.5(ATRX):c.6104A>T (p.Asp2035Val)	ATRX	D1177V, D1997V, D2035V		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011725	X	76849172	X	77593702	11725	26764	rs122445096	NC_000023.11:77593701:T:A
NM_000489.5(ATRX):c.4950G>T (p.Lys1650Asn)	ATRX	K792N, K1612N, K1650N		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011723	X	76889060	X	77633572	11723	26762	rs122445095	NC_000023.11:77633571:C:A
NM_000489.5(ATRX):c.4840T>C (p.Cys1614Arg)	ATRX	C755R, C1576R, C1614R		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011722	X	76889170	X	77633682	11722	26761	rs122445094	NC_000023.11:77633681:A:G
NM_000489.5(ATRX):c.4826A>G (p.His1609Arg)	ATRX	H750R, H1571R, H1609R		Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011721	X	76889184	X	77633696	11721	26760	rs122445093	NC_000023.11:77633695:T:C
NM_004429.4(EFNB1):c.196C>T (p.Arg66Ter)	EFNB1	R66*	|not provided	Pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011715	X	68058527	X	68838684	11715	26754	rs104894804	NC_000023.11:68838683:C:T
NM_004429.4(EFNB1):c.110G>A (p.Trp37Ter)	EFNB1	W37*		Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000011714	X	68049729	X	68829886	11714	26753	rs104894803	NC_000023.11:68829885:G:A
NM_004429.4(EFNB1):c.109T>G (p.Trp37Gly)	EFNB1	W37G		Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000011713	X	68049728	X	68829885	11713	26752	rs104894802	NC_000023.11:68829884:T:G
NM_004429.4(EFNB1):c.474G>T (p.Met158Ile)	EFNB1	M158I		Pathogenic(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000011712	X	68059574	X	68839731	11712	26751	rs28935170	NC_000023.11:68839730:G:T
NM_004429.4(EFNB1):c.472A>G (p.Met158Val)	EFNB1	M158V		Pathogenic(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000011711	X	68059572	X	68839729	11711	26750	rs28936071	NC_000023.11:68839728:A:G
NM_004429.4(EFNB1):c.452G>T (p.Gly151Val)	EFNB1	G151V		Pathogenic(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000011710	X	68059552	X	68839709	11710	26749	rs28936070	NC_000023.11:68839708:G:T
NM_004429.4(EFNB1):c.451G>A (p.Gly151Ser)	EFNB1	G151S		Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000011709	X	68059551	X	68839708	11709	26748	rs28936069	NC_000023.11:68839707:G:A
NM_004429.4(EFNB1):c.161C>T (p.Pro54Leu)	EFNB1	P54L	not provided|	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000011708	X	68058492	X	68838649	11708	26747	rs104894801	NC_000023.11:68838648:C:T
NM_004429.4(EFNB1):c.332C>T (p.Thr111Ile)	EFNB1	T111I		Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000011707	X	68058663	X	68838820	11707	26746	rs104894796	NC_000023.11:68838819:C:T
EFNB1, EX2-5DEL	EFNB1			Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000011706					11706	26745		
NM_005629.4(SLC6A8):c.1473C>G (p.Cys491Trp)	SLC6A8	C491W, C481W, C376W	Creatine transporter deficiency	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000011704	X	152959879	X	153694424	11704	26743	rs122453118	NC_000023.11:153694423:C:G
NM_005629.4(SLC6A8):c.395G>T (p.Gly132Val)	SLC6A8	G132V, G17V	Creatine transporter deficiency	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000011703	X	152956759	X	153691304	11703	26742	rs122453117	NC_000023.11:153691303:G:T
NM_005629.4(SLC6A8):c.1011C>G (p.Cys337Trp)	SLC6A8	C337W, C222W	Creatine transporter deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011702	X	152958816	X	153693361	11702	26741	rs122453116	NC_000023.11:153693360:C:G
NM_005629.4(SLC6A8):c.263-2A>G	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000011701	X	152955828	X	153690373	11701	26740	rs1569539244	NC_000023.11:153690372:A:G
NM_005629.4(SLC6A8):c.259G>A (p.Gly87Arg)	SLC6A8	G87R	Creatine transporter deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011700	X	152954288	X	153688833	11700	26739	rs122453115	NC_000023.11:153688832:G:A
NM_005629.4(SLC6A8):c.950dup (p.Tyr317Ter)	SLC6A8		Creatine transporter deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011699	X	152958754 - 152958755	X	153693299 - 153693300	11699	26738	rs1569539359	NC_000023.11:153693299:A:AA
NM_005629.4(SLC6A8):c.1216_1218TTC[2] (p.Phe408del)	SLC6A8	F408del	not provided|Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011698	X	152959434 - 152959436	X	153693979 - 153693981	11698	26737	rs80338740	NC_000023.11:153693978:TTCTTCTTC:TTCTTC
NM_005629.4(SLC6A8):c.1141G>C (p.Gly381Arg)	SLC6A8	G381R, G266R, G371R	Creatine transporter deficiency	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000011697	X	152959041	X	153693586	11697	26736	rs122453114	NC_000023.11:153693585:G:C
NM_005629.4(SLC6A8):c.1540C>T (p.Arg514Ter)	SLC6A8	R514*, R399*, R504*	not provided|Inborn genetic diseases|Creatine transporter deficiency	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011696	X	152960032	X	153694577	11696	26735	rs122453113	NC_000023.11:153694576:C:T
NM_001164617.2(GPC3):c.1228C>T (p.Arg410Ter)	GPC3	R387*, R410*, R371*, R333*	not provided|Simpson-Golabi-Behmel syndrome|Wilms tumor 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011694	X	132833930	X	133699902	11694	26733	rs122453121	NC_000023.11:133699901:G:A
NM_004484.3(GPC3):c.337+1G>A	GPC3		Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: Oct 15, 2005)	no assertion criteria provided	VCV000011693	X	133087076	X	133953049	11693	26732	rs869025183	NC_000023.11:133953048:C:T
NM_004484.3(GPC3):c.(1293_1293)-76_(1413_1413)del	GPC3		Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: Oct 15, 2005)	no assertion criteria provided	VCV000011692	X	132795703 - 132795954	X	133661675 - 133661926	11692	26731		
NM_004484.3(GPC3):c.1705G>A (p.Ala569Thr)	GPC3	A515T, A553T, A569T, A592T	Wilms tumor 1	Pathogenic(Last reviewed: Jun 17, 2002)	no assertion criteria provided	VCV000011691	X	132670190	X	133536162	11691	26730	rs122453120	NC_000023.11:133536161:C:T
NM_004484.3(GPC3):c.361C>T (p.His121Tyr)	GPC3	H105Y, H121Y, H67Y	Wilms tumor 1	Pathogenic(Last reviewed: Jun 17, 2002)	no assertion criteria provided	VCV000011690	X	132888180	X	133754153	11690	26729	rs122453119	NC_000023.11:133754152:G:A
NM_004484.3(GPC3):c.595C>T (p.Arg199Ter)	GPC3	R199*, R145*, R183*	Wilms tumor 1|not provided|Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011689	X	132887946	X	133753919	11689	26728	rs104894855	NC_000023.11:133753918:G:A
NM_004484.3(GPC3):c.1292+1G>T	GPC3		Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000011688	X	132826396	X	133692368	11688	26727	rs869025182	NC_000023.11:133692367:C:A
NM_004484.3(GPC3):c.886T>A (p.Trp296Arg)	GPC3	W296R, W242R, W280R	Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000011687	X	132887655	X	133753628	11687	26726	rs104894854	NC_000023.11:133753627:A:T
NM_004484.3(GPC3):c.1414_1573del160 (p.Leu472Asnfs)	GPC3		Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: May 22, 2000)	no assertion criteria provided	VCV000011686					11686	26725		
NM_001164619.2(GPC3):c.175+32082_175+32094del	GPC3	C65fs	Simpson-Golabi-Behmel syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000011685	X	133087208 - 133087220	X	133953181 - 133953193	11685	26724	rs869025181	NC_000023.11:133953180:CCCTTAGGGAGAC:
NM_000307.5(POU3F4):c.967C>G (p.Arg323Gly)	POU3F4	R323G	Deafness, X-linked 2	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000011684	X	82764299	X	83509291	11684	26723	rs104894924	NC_000023.11:83509290:C:G
NM_000307.5(POU3F4):c.990A>T (p.Arg330Ser)	POU3F4	R330S	Deafness, X-linked 2	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000011683	X	82764322	X	83509314	11683	26722	rs104894923	NC_000023.11:83509313:A:T
NM_000307.5(POU3F4):c.935C>T (p.Ala312Val)	POU3F4	A312V	Deafness, X-linked 2	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000011682	X	82764267	X	83509259	11682	26721	rs387906502	NC_000023.11:83509258:C:T
NM_000307.5(POU3F4):c.862_865del (p.Val289fs)	POU3F4	V289fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000011681	X	82764191 - 82764194	X	83509183 - 83509186	11681	26720	rs730882189	NC_000023.11:83509182:GTGAGTG:GTG
NM_000307.5(POU3F4):c.1000A>G (p.Lys334Glu)	POU3F4	K334E	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011680	X	82764332	X	83509324	11680	26719	rs104894922	NC_000023.11:83509323:A:G
NM_000307.5(POU3F4):c.950T>G (p.Leu317Trp)	POU3F4	L317W	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011679	X	82764282	X	83509274	11679	26718	rs104894921	NC_000023.11:83509273:T:G
NM_000307.5(POU3F4):c.604A>T (p.Lys202Ter)	POU3F4	K202*	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011678	X	82763936	X	83508928	11678	26717	rs104894920	NC_000023.11:83508927:A:T
NM_000307.5(POU3F4):c.648del (p.Leu217fs)	POU3F4	D215*, L217fs	Deafness, X-linked 2	Pathogenic(Last reviewed: Feb 3, 1995)	no assertion criteria provided	VCV000011677	X	82763977	X	83508969	11677	26716	rs1555984570	NC_000023.11:83508968:GGGG:GGG
NM_001281463.1(SMC1A):c.1421G>A (p.Arg474His)	SMC1A	R496H, R474H	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000011675	X	53436051	X	53409120	11675	26714	rs122454123	NC_000023.11:53409119:C:T
SMC1A, 15-BP DEL, NT173	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000011674					11674	26713		
NM_001281463.1(SMC1A):c.1412A>C (p.Glu471Ala)	SMC1A	E493A, E471A	Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000011673	X	53436060	X	53409129	11673	26712	rs122454122	NC_000023.11:53409128:T:G
NM_001281463.1(SMC1A):c.2427_2429del (p.Asp809_Gln810delinsGlu)	SMC1A		Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000011672	X	53426578 - 53426580	X	53399656 - 53399658	11672	26711		NC_000023.11:53399655:TGGT:T
NM_005333.5(HCCS):c.649C>T (p.Arg217Cys)	HCCS	R217C	Linear skin defects with multiple congenital anomalies 1	Pathogenic(Last reviewed: Aug 18, 2011)	no assertion criteria provided	VCV000011671	X	11139772	X	11121652	11671	26710	rs121917889	NC_000023.11:11121651:C:T
NM_005333.5(HCCS):c.589C>T (p.Arg197Ter)	HCCS	R197*	Linear skin defects with multiple congenital anomalies 1	Pathogenic(Last reviewed: Aug 18, 2011)	no assertion criteria provided	VCV000011670	X	11139094	X	11120974	11670	26709	rs121917888	NC_000023.11:11120973:C:T
HCCS, 8.6-KB DEL	HCCS		Linear skin defects with multiple congenital anomalies 1	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000011669					11669	26708		
RPS6KA3, DUP EXONS 17-20, NT1959	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000011668					11668	26707		
NM_004586.3(RPS6KA3):c.1428_1430del (p.Ile477del)	RPS6KA3	I477del	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jul 15, 2004)	no assertion criteria provided	VCV000011667	X	20187533 - 20187535	X	20169415 - 20169417	11667	26706		NC_000023.11:20169414:ATAAT:AT
NM_004586.3(RPS6KA3):c.803T>C (p.Phe268Ser)	RPS6KA3	F268S	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000011666	X	20204456	X	20186338	11666	26705	rs122454131	NC_000023.11:20186337:A:G
RPS6KA3, IVS3, L1 INS, -8	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000011665					11665	26704		
RPS6KA3, IVS12, A-G, -2	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000011664					11664	26703		
NM_004586.3(RPS6KA3):c.2144del (p.Ser715fs)	RPS6KA3	S715fs	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011663	X	20173595	X	20155477	11663	26702		NC_000023.11:20155476:G:
RPS6KA3, IVS5, A-G, -11	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011662					11662	26701		
NM_004586.3(RPS6KA3):c.486+3A>G	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011661	X	20212304	X	20194186	11661	26700		NC_000023.11:20194185:T:C
NM_004586.3(RPS6KA3):c.566T>A (p.Ile189Lys)	RPS6KA3	I189K	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000011660	X	20211632	X	20193514	11660	26699	rs122454130	NC_000023.11:20193513:A:T
NM_004586.3(RPS6KA3):c.1147C>T (p.Arg383Trp)	RPS6KA3	R383W	Mental retardation, X-linked 19	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000011659	X	20193362	X	20175244	11659	26698	rs122454129	NC_000023.11:20175243:G:A
NM_004586.3(RPS6KA3):c.2065C>T (p.Gln689Ter)	RPS6KA3	Q689*	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000011657	X	20174262	X	20156144	11657	26696	rs122454128	NC_000023.11:20156143:G:A
NM_004586.3(RPS6KA3):c.451_452del (p.Arg151fs)	RPS6KA3	R151fs	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000011656	X	20212341 - 20212342	X	20194223 - 20194224	11656	26695		NC_000023.11:20194222:CT:
NM_004586.3(RPS6KA3):c.340C>T (p.Arg114Trp)	RPS6KA3	R114W	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000011655	X	20213249	X	20195131	11655	26694	rs122454127	NC_000023.11:20195130:G:A
NM_004586.3(RPS6KA3):c.326-1G>C	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000011654	X	20213264	X	20195146	11654	26693	rs587776755	NC_000023.11:20195145:C:G
NM_004586.3(RPS6KA3):c.244G>T (p.Val82Phe)	RPS6KA3	V82F	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000011653	X	20222221	X	20204103	11653	26692	rs122454126	NC_000023.11:20204102:C:A
NM_004586.3(RPS6KA3):c.679T>G (p.Ser227Ala)	RPS6KA3	S227A	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 12, 1996)	no assertion criteria provided	VCV000011652	X	20206041	X	20187923	11652	26691	rs122454125	NC_000023.11:20187922:A:C
NM_004586.3(RPS6KA3):c.224G>T (p.Gly75Val)	RPS6KA3	G75V	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 12, 1996)	no assertion criteria provided	VCV000011651	X	20227425	X	20209307	11651	26690	rs122454124	NC_000023.11:20209306:C:A
RPS6KA3, 187-BP DEL, NT406	RPS6KA3		Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 12, 1996)	no assertion criteria provided	VCV000011650					11650	26689		
NM_004541.4(NDUFA1):c.111G>C (p.Arg37Ser)	NDUFA1	R37S	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000011649	X	119007275	X	119873312	11649	26688	rs104894885	NC_000023.11:119873311:G:C
NM_004541.4(NDUFA1):c.22G>C (p.Gly8Arg)	NDUFA1	G8R	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000011648	X	119005896	X	119871933	11648	26687	rs104894884	NC_000023.11:119871932:G:C
XIAP, 2606-BP DEL	XIAP		Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Nov 2, 2006)	no assertion criteria provided	VCV000011647					11647	26686		
NM_001167.3(XIAP):c.352G>T (p.Glu118Ter)	XIAP	E118*	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Nov 2, 2006)	no assertion criteria provided	VCV000011646	X	123019864	X	123886014	11646	26685	rs104894764	NC_000023.11:123886013:G:T
NM_001167.3(XIAP):c.292del (p.Glu99fs)	XIAP	E99fs	Lymphoproliferative syndrome 2, X-linked	Pathogenic(Last reviewed: Nov 2, 2006)	no assertion criteria provided	VCV000011645	X	123019804	X	123885954	11645	26684	rs1556404534	NC_000023.11:123885953:C:
NM_005676.5(RBM10):c.1235G>A (p.Trp412Ter)	RBM10	W412*, W334*, W477*, W335*, W411*	TARP syndrome	Pathogenic(Last reviewed: May 14, 2010)	no assertion criteria provided	VCV000011644	X	47039892	X	47180493	11644	26683	rs267607000	NC_000023.11:47180492:G:A
NM_005676.5(RBM10):c.1893dup (p.Pro632fs)	RBM10		TARP syndrome	Pathogenic(Last reviewed: May 14, 2010)	no assertion criteria provided	VCV000011643	X	47041667 - 47041668	X	47182268 - 47182269	11643	26682	rs886044715	NC_000023.11:47182268:A:AA
NM_006517.5(SLC16A2):c.1613del (p.Pro538fs)	SLC16A2	P538fs	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000011642	X	73751380	X	74531545	11642	26681	rs113994166	NC_000023.11:74531544:CC:C
NM_006517.5(SLC16A2):c.1121C>A (p.Ser374Ter)	SLC16A2	S448*, S374*	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000011640	X	73745679	X	74525844	11640	26679	rs104894940	NC_000023.11:74525843:C:A
NM_006517.5(SLC16A2):c.1079T>G (p.Leu360Trp)	SLC16A2	L434W, L360W	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000011639	X	73745637	X	74525802	11639	26678	rs104894939	NC_000023.11:74525801:T:G
NM_006517.5(SLC16A2):c.1481T>C (p.Leu494Pro)	SLC16A2	L568P, L494P	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000011638	X	73751249	X	74531414	11638	26677	rs104894938	NC_000023.11:74531413:T:C
nsv513796	SLC16A2		Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jun 15, 2017)	no assertion criteria provided	VCV000011637					11637	26676		
NM_006517.5(SLC16A2):c.1190T>C (p.Leu397Pro)	SLC16A2	L397P	Allan-Herndon-Dudley syndrome|Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000011636	X	73749067	X	74529232	11636	26675	rs122455132	NC_000023.11:74529231:T:C
SLC16A2, EX1DEL	SLC16A2		Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jun 15, 2017)	no assertion criteria provided	VCV000011635					11635	26674		
NM_006517.5(SLC16A2):c.449C>T (p.Ala150Val)	SLC16A2	A224V, A150V	Allan-Herndon-Dudley syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011634	X	73740843	X	74521008	11634	26673	rs104894936	NC_000023.11:74521007:C:T
SLC16A2, 1-BP DEL, 1212T	SLC16A2		Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000011633					11633	26672		
NM_006517.5(SLC16A2):c.1313T>C (p.Leu438Pro)	SLC16A2	L512P, L438P	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000011632	X	73749190	X	74529355	11632	26671	rs104894931	NC_000023.11:74529354:T:C
TSPAN7, 2-BP DEL, 564GT	TSPAN7		Mental retardation 58, X-linked	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011631					11631	26670		
NM_004615.3(TSPAN7):c.652G>T (p.Gly218Ter)	TSPAN7	G218*	Mental retardation 58, X-linked	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000011629	X	38540512	X	38681258	11629	26668	rs104894950	NC_000023.11:38681257:G:T
NM_001493.3(GDI1):c.1268G>C (p.Arg423Pro)	GDI1	R423P	X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000011628	X	153670943	X	154442596	11628	26667	rs121434609	NC_000023.11:154442595:G:C
NM_001493.3(GDI1):c.208C>T (p.Arg70Ter)	GDI1	R70*	X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000011627	X	153667165	X	154438819	11627	26666	rs121434608	NC_000023.11:154438818:C:T
NM_001493.3(GDI1):c.275T>C (p.Leu92Pro)	GDI1	L92P	X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Jul 12, 1996)	no assertion criteria provided	VCV000011626	X	153667373	X	154439027	11626	26665	rs121434607	NC_000023.11:154439026:T:C
NM_004595.5(SMS):c.395T>G (p.Val132Gly)	SMS	V132G, V79G	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000011625	X	21995244	X	21977126	11625	26664	rs267607076	NC_000023.11:21977125:T:G
NM_004595.5(SMS):c.166G>A (p.Gly56Ser)	SMS	G56S	Syndromic X-linked intellectual disability Snyder type|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000011624	X	21985430	X	21967312	11624	26663	rs121434610	NC_000023.11:21967311:G:A
NM_004595.5(SMS):c.329+5G>A	SMS		Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000011623	X	21990694	X	21972576	11623	26662	rs397515381	NC_000023.11:21972575:G:A
CACNA1F, 425-BP DEL	CACNA1F		Ocular albinism, type II	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000011621					11621	26660		
NM_001256789.3(CACNA1F):c.3439-1_3442delinsTGG	CACNA1F			Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000011620	X	49071701 - 49071705	X	49215241 - 49215245	11620	26659	rs863223294	NC_000023.11:49215240:GACGC:CCA
NM_005183.4(CACNA1F):c.2267T>C (p.Ile756Thr)	CACNA1F	I745T, I691T, I756T	Congenital stationary night blindness, type 2A, severe	Pathogenic(Last reviewed: May 24, 2005)	no assertion criteria provided	VCV000011619	X	49079035	X	49222576	11619	26658	rs122456136	NC_000023.11:49222575:A:G
CACNA1F, 1-BP DEL, 4548C	CACNA1F		Congenital stationary night blindness, type 2A	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000011618					11618	26657		
NM_001256789.3(CACNA1F):c.2650C>T (p.Arg884Ter)	CACNA1F	R830*, R884*, R895*	Congenital stationary night blindness, type 2A|Congenital stationary night blindness	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000011617	X	49075803	X	49219344	11617	26656	rs122456135	NC_000023.11:49219343:G:A
CACNA1F, 1-BP INS, 991C	CACNA1F		Congenital stationary night blindness, type 2A	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000011616					11616	26655		
NM_001256789.3(CACNA1F):c.2872C>T (p.Arg958Ter)	CACNA1F	R958*, R904*, R969*	Congenital stationary night blindness, type 2A|Retinal dystrophy|Congenital stationary night blindness	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000011615	X	49074970	X	49218511	11615	26654	rs122456134	NC_000023.11:49218510:G:A
NM_001256789.3(CACNA1F):c.1106G>A (p.Gly369Asp)	CACNA1F	G369D, G304D	Congenital stationary night blindness, type 2A	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000011614	X	49084510	X	49228048	11614	26653	rs122456133	NC_000023.11:49228047:C:T
NM_001177465.3(MAMLD1):c.1843-6553C>T	MAMLD1	R653*, R726*, R701*	Hypospadias 2, X-linked	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000011613	X	149671679	X	150503409	11613	26652	rs121909495	NC_000023.11:150503408:C:T
NM_001177465.3(MAMLD1):c.733C>T (p.Gln245Ter)	MAMLD1	Q197*, Q270*, Q245*	Hypospadias 2, X-linked	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000011612	X	149638653	X	150470381	11612	26651	rs121909494	NC_000023.11:150470380:C:T
NM_001177465.3(MAMLD1):c.514G>T (p.Glu172Ter)	MAMLD1	E124*, E197*, E172*	Hypospadias 2, X-linked	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000011611	X	149638434	X	150470162	11611	26650	rs121909493	NC_000023.11:150470161:G:T
NM_001195553.2(DCX):c.211G>T (p.Ala71Ser)	DCX	A71S, A152S	Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked	Pathogenic(Last reviewed: Jan 28, 2003)	no assertion criteria provided	VCV000011610	X	110653416	X	111410188	11610	26649	rs104894786	NC_000023.11:111410187:C:A
NM_001195553.2(DCX):c.587G>A (p.Arg196His)	DCX	R196H, R277H	Lissencephaly, X-linked|Subcortical laminar heterotopia, X-linked|Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011609	X	110644336	X	111401108	11609	26648	rs56030372	NC_000023.11:111401107:C:T
NM_178152.3(DCX):c.265C>G (p.Arg89Gly)	DCX	R89G, R170G	Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000011608	X	110653362	X	111410134	11608	26647	rs104894785	NC_000023.11:111410133:G:C
NM_178152.3(DCX):c.233G>A (p.Arg78His)	DCX	R78H, R159H	Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000011607	X	110653394	X	111410166	11607	26646	rs104894784	NC_000023.11:111410165:C:T
NM_178152.3(DCX):c.689_690CT[1] (p.Leu231fs)	DCX		Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011606	X	110644231 - 110644232	X	111401003 - 111401004	11606	26645	rs1569497266	NC_000023.11:111401002:AGAG:AG
NM_178152.3(DCX):c.32_33GA[3] (p.Asp12fs)	DCX		Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011604	X	110653591 - 110653592	X	111410363 - 111410364	11604	26643	rs1569498597	NC_000023.11:111410363:TCTCT:TCTCTCT
NM_001195553.2(DCX):c.139A>C (p.Ser47Arg)	DCX	S47R, S128R	Lissencephaly, X-linked|Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011603	X	110653488	X	111410260	11603	26642	rs104894783	NC_000023.11:111410259:T:G
NM_001195553.2(DCX):c.608C>G (p.Thr203Arg)	DCX	T203R, T284R	Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011602	X	110644315	X	111401087	11602	26641	rs104894782	NC_000023.11:111401086:G:C
NM_001195553.2(DCX):c.176G>T (p.Arg59Leu)	DCX	R59L, R140L	Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011601	X	110653451	X	111410223	11601	26640	rs122457137	NC_000023.11:111410222:C:A
DCX, IVS4, G-A, +1	DCX		Subcortical laminar heterotopia, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011600					11600	26639		
NM_001195553.2(DCX):c.373T>C (p.Tyr125His)	DCX	Y125H, Y206H	Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011599	X	110644550	X	111401322	11599	26638	rs104894781	NC_000023.11:111401321:A:G
NM_001195553.2(DCX):c.574C>T (p.Arg192Trp)	DCX	R192W, R273W	not provided|Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked|Heterotopia	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000011598	X	110644349	X	111401121	11598	26637	rs104894780	NC_000023.11:111401120:G:A
NM_001195553.2(DCX):c.184G>A (p.Asp62Asn)	DCX	D62N, D143N	Subcortical laminar heterotopia, X-linked|Lissencephaly, X-linked	Pathogenic(Last reviewed: Jan 9, 1998)	no assertion criteria provided	VCV000011597	X	110653443	X	111410215	11597	26636	rs104894779	NC_000023.11:111410214:C:T
NM_001363.5(DKC1):c.1259+1G>A	DKC1			Pathogenic(Last reviewed: Aug 15, 2008)	no assertion criteria provided	VCV000011596	X	154002981	X	154774706	11596	26635	rs1569558616	NC_000023.11:154774705:G:A
NM_001363.5(DKC1):c.1069A>G (p.Thr357Ala)	DKC1	T357A		Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000011595	X	154001438	X	154773163	11595	26634	rs137854492	NC_000023.11:154773162:A:G
NM_001363.5(DKC1):c.91C>A (p.Gln31Lys)	DKC1	Q31K		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000011594	X	153993725	X	154765450	11594	26633	rs137854491	NC_000023.11:154765449:C:A
NM_001363.5(DKC1):c.113T>C (p.Ile38Thr)	DKC1	I38T	|	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000011593	X	153993747	X	154765472	11593	26632	rs28936072	NC_000023.11:154765471:T:C
NM_001363.5(DKC1):c.146C>T (p.Thr49Met)	DKC1	T49M	not provided|Dyskeratosis congenita|	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011591	X	153993780	X	154765505	11591	26630	rs121912304	NC_000023.11:154765504:C:T
NM_001363.5(DKC1):c.16+592C>G	DKC1			Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000011590	X	153991848	X	154763573	11590	26629		NC_000023.11:154763572:C:G
NC_000023.11:g.(154776372_154776374)_(154778317_154778319)del	DKC1			Pathogenic(Last reviewed: Aug 15, 1999)	no assertion criteria provided	VCV000011588			X	154776372 - 154778319	11588	26627		
NM_001363.5(DKC1):c.1058C>T (p.Ala353Val)	DKC1	A353V	Dyskeratosis congenita|	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000011587	X	154001427	X	154773152	11587	26626	rs121912288	NC_000023.11:154773151:C:T
NM_001363.5(DKC1):c.1205G>A (p.Gly402Glu)	DKC1	G402E		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000011586	X	154002926	X	154774651	11586	26625	rs121912295	NC_000023.11:154774650:G:A
NM_001363.5(DKC1):c.214_215delinsTA (p.Leu72Tyr)	DKC1	L72Y		Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000011585	X	153994224 - 153994225	X	154765949 - 154765950	11585	26624	rs121912294	NC_000023.11:154765948:CT:TA
NM_001363.5(DKC1):c.119C>G (p.Pro40Arg)	DKC1	P40R		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000011584	X	153993753	X	154765478	11584	26623	rs121912292	NC_000023.11:154765477:C:G
NM_001363.5(DKC1):c.106T>G (p.Phe36Val)	DKC1	F36V		Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000011582	X	153993740	X	154765465	11582	26621	rs121912293	NC_000023.11:154765464:T:G
NM_002547.3(OPHN1):c.642_643TG[1] (p.Val215fs)	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000011581	X	67432007 - 67432008	X	68212165 - 68212166	11581	26620	rs1569244467	NC_000023.11:68212164:CACA:CA
OPHN1, 17.6-KB DEL	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000011580					11580	26619		
NM_002547.3(OPHN1):c.184C>T (p.Gln62Ter)	OPHN1	Q62*	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000011579	X	67518909	X	68299067	11579	26618	rs137854493	NC_000023.11:68299066:G:A
NM_002547.3(OPHN1):c.745_752dup (p.Lys251fs)	OPHN1		Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000011578	X	67430074 - 67430075	X	68210232 - 68210233	11578	26617	rs1569243931	NC_000023.11:68210232:TTCTTAAGTTCTT:TTCTTAAGTTCTTAAGTTCTT
NM_002547.3(OPHN1):c.1579del (p.Ile527fs)	OPHN1	I527fs	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Apr 30, 1998)	no assertion criteria provided	VCV000011577	X	67316819	X	68096977	11577	26616	rs1569211016	NC_000023.11:68096976:TT:T
NM_004299.6(ABCB7):c.1234G>C (p.Val412Leu)	ABCB7	V411L, V412L	X-linked sideroblastic anemia with ataxia	Pathogenic(Last reviewed: Apr 7, 2009)	no assertion criteria provided	VCV000011576	X	74290334	X	75070499	11576	26615	rs80356713	
NM_004299.6(ABCB7):c.1300G>A (p.Glu434Lys)	ABCB7	E433K, E434K	X-linked sideroblastic anemia with ataxia	Pathogenic(Last reviewed: Apr 7, 2009)	no assertion criteria provided	VCV000011575	X	74290268	X	75070433	11575	26614	rs80356714	
NM_001271696.3(ABCB7):c.1200T>G (p.Ile400Met)	ABCB7	I400M, I401M, I360M, I361M, I374M	not provided|X-linked sideroblastic anemia with ataxia	Pathogenic(Last reviewed: Nov 15, 2012)	criteria provided, single submitter	VCV000011574	X	74291351	X	75071516	11574	26613	rs72554634	NC_000023.11:75071515:A:C
IGBP1, -57delT and -55T-A, 5-PRIME UTR	IGBP1		Corpus callosum, agenesis of, with mental retardation, ocular coloboma, and micrognathia	Pathogenic(Last reviewed: Nov 15, 2003)	no assertion criteria provided	VCV000011573					11573	26612		
NM_002578.5(PAK3):c.276+4A>G	PAK3		Mental retardation 30, X-linked	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000011572	X	110385428	X	111142200	11572	26611	rs1569398769	NC_000023.11:111142199:A:G
NM_002578.5(PAK3):c.1337G>C (p.Trp446Ser)	PAK3	W446S, W467S, W461S, W482S	Mental retardation 30, X-linked	Pathogenic(Last reviewed: Oct 15, 2007)	no assertion criteria provided	VCV000011571	X	110439798	X	111196570	11571	26610	rs121434614	NC_000023.11:111196569:G:C
NM_002578.5(PAK3):c.1094C>A (p.Ala365Glu)	PAK3	A365E, A386E, A401E, A380E	Mental retardation 30, X-linked	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011570	X	110437630	X	111194402	11570	26609	rs121434613	NC_000023.11:111194401:C:A
NM_002578.5(PAK3):c.199C>T (p.Arg67Cys)	PAK3	R67C	Mental retardation 30, X-linked	Pathogenic(Last reviewed: Aug 14, 2000)	no assertion criteria provided	VCV000011569	X	110385347	X	111142119	11569	26608	rs121434612	NC_000023.11:111142118:C:T
NM_002578.5(PAK3):c.1255C>T (p.Arg419Ter)	PAK3	R419*, R455*, R440*, R434*	not provided|Mental retardation 30, X-linked	Pathogenic(Last reviewed: Jan 3, 2018)	no assertion criteria provided	VCV000011568	X	110439716	X	111196488	11568	26607	rs121434611	NC_000023.11:111196487:C:T
NM_001318510.2(ACSL4):c.1001C>T (p.Pro334Leu)	ACSL4	P375L, P334L	Mental retardation 63, X-linked	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000011566	X	108917632	X	109674403	11566	26605	rs122458139	NC_000023.11:109674402:G:A
NM_001318510.2(ACSL4):c.1003-2A>G	ACSL4		Mental retardation 63, X-linked	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011565	X	108912404	X	109669175	11565	26604	rs1569423317	NC_000023.11:109669174:T:C
NM_001318510.2(ACSL4):c.1585C>A (p.Arg529Ser)	ACSL4	R529S, R570S	Mental retardation 63, X-linked	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011564	X	108904872	X	109661643	11564	26603	rs122458138	NC_000023.11:109661642:G:T
NM_003688.3(CASK):c.2740T>C (p.Trp914Arg)	CASK	W914R, W890R, W891R, W919R	FG syndrome 4	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000011535	X	41379699	X	41520446	11535	26574	rs137852819	NC_000023.11:41520445:A:G
NM_003688.3(CASK):c.802T>C (p.Tyr268His)	CASK	Y268H	FG syndrome 4	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000011533	X	41519721	X	41660468	11533	26572	rs137852817	NC_000023.11:41660467:A:G
NM_003688.3(CASK):c.83G>T (p.Arg28Leu)	CASK	R28L	FG syndrome 4	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000011532	X	41712457	X	41853204	11532	26571	rs137852816	NC_000023.11:41853203:C:A
NM_003688.3(CASK):c.915G>A (p.Lys305=)	CASK		Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000011531	X	41495831	X	41636578	11531	26570	rs387906499	NC_000023.11:41636577:C:T
NM_003688.3(CASK):c.1915C>T (p.Arg639Ter)	CASK	R639*, R610*, R616*	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000011530	X	41413096	X	41553843	11530	26569	rs137852815	NC_000023.11:41553842:G:A
NM_000047.2(ARSL):c.1743G>A (p.Trp581Ter)	ARSL	W581*, W590*, W527*, W606*	|not provided	Pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000011529	X	2852900	X	2934859	11529	26568	rs80338714	NC_000023.11:2934858:C:T
NM_000047.2(ARSL):c.1732C>T (p.Pro578Ser)	ARSL	P578S, P524S, P603S, P587S		Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000011528	X	2852911	X	2934870	11528	26567	rs28935474	NC_000023.11:2934869:G:A
NM_000047.2(ARSL):c.1475G>A (p.Cys492Tyr)	ARSL	C492Y, C501Y, C517Y, C438Y		Pathogenic(Last reviewed: Dec 12, 1997)	no assertion criteria provided	VCV000011527	X	2853168	X	2935127	11527	26566	rs122460155	NC_000023.11:2935126:C:T
NM_000047.2(ARSL):c.733G>C (p.Gly245Arg)	ARSL	G245R, G191R, G254R, G270R		Pathogenic(Last reviewed: Apr 7, 1995)	no assertion criteria provided	VCV000011526	X	2867466	X	2949425	11526	26565	rs122460154	NC_000023.11:2949424:C:G
NM_000047.2(ARSL):c.410G>T (p.Gly137Val)	ARSL	G137V, G162V, G83V, G146V		Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000011525	X	2871204	X	2953163	11525	26564	rs80338711	NC_000023.11:2953162:C:A
NM_000047.2(ARSL):c.332G>C (p.Arg111Pro)	ARSL	R111P, R57P, R120P, R136P		Pathogenic(Last reviewed: Apr 7, 1995)	no assertion criteria provided	VCV000011524	X	2871282	X	2953241	11524	26563	rs122460153	NC_000023.11:2953240:C:G
NM_000047.2(ARSL):c.349G>A (p.Gly117Arg)	ARSL	G117R, G126R, G63R, G142R		Pathogenic(Last reviewed: Apr 7, 1995)	no assertion criteria provided	VCV000011523	X	2871265	X	2953224	11523	26562	rs122460152	NC_000023.11:2953223:C:T
NM_005120.3(MED12):c.3020A>G (p.Asn1007Ser)	MED12	N1007S	X-linked mental retardation with marfanoid habitus syndrome	Pathogenic(Last reviewed: Aug 8, 2008)	no assertion criteria provided	VCV000011521	X	70347781	X	71127931	11521	26560	rs80338759	NC_000023.11:71127930:A:G
NM_005120.3(MED12):c.2881C>T (p.Arg961Trp)	MED12	R961W	Ohdo syndrome, X-linked|X-linked mental retardation with marfanoid habitus syndrome|FG syndrome 1|FG syndrome 1|Broad thumb|Abnormal facial shape||Global developmental delay|Imperforate anus|Intellectual disability	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011520	X	70347217	X	71127367	11520	26559	rs80338758	NC_000023.11:71127366:C:T
DLG3, IVS8DS, G-A, +1	DLG3		X-Linked mental retardation 90	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000011519					11519	26558		
DLG3, IVS6DS, G-A, +5	DLG3		X-Linked mental retardation 90	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000011518					11518	26557		
NM_001011658.4(TRAPPC2):c.387del (p.Val130fs)	TRAPPC2	V164fs, V130fs	Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Feb 15, 2004)	no assertion criteria provided	VCV000011517	X	13732562	X	13714443	11517	26556	rs587776754	NC_000023.11:13714442:TTTT:TTT
NM_001011658.4(TRAPPC2):c.238+4T>C	TRAPPC2		Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000011516	X	13734649	X	13716530	11516	26555	rs587776753	NC_000023.11:13716529:A:G
NM_001011658.4(TRAPPC2):c.329C>A (p.Ser110Ter)	TRAPPC2	S110*, S144*	Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000011515	X	13732620	X	13714501	11515	26554	rs104894949	NC_000023.11:13714500:G:T
NM_001011658.4(TRAPPC2):c.391C>T (p.Gln131Ter)	TRAPPC2	Q131*, Q165*	Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011514	X	13732558	X	13714439	11514	26553	rs122460156	NC_000023.11:13714438:G:A
NM_001011658.4(TRAPPC2):c.248T>C (p.Phe83Ser)	TRAPPC2	F83S, F117S	Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011513	X	13734199	X	13716080	11513	26552	rs104894948	NC_000023.11:13716079:A:G
NM_001011658.4(TRAPPC2):c.93+5G>A	TRAPPC2		Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011512	X	13737985	X	13719866	11512	26551	rs587776752	NC_000023.11:13719865:C:T
NM_001011658.4(TRAPPC2):c.271_275del (p.Gln91fs)	TRAPPC2	Q125fs, Q91fs	Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000011510	X	13734172 - 13734176	X	13716053 - 13716057	11510	26549	rs587776751	NC_000023.11:13716052:TCTTGTCTT:TCTT
NM_001011658.4(TRAPPC2):c.157_158del (p.Met53fs)	TRAPPC2	M53fs, M87fs	Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000011509	X	13734733 - 13734734	X	13716614 - 13716615	11509	26548	rs587776750	NC_000023.11:13716613:AT:
NM_001011658.4(TRAPPC2):c.189_190TG[1] (p.Val64fs)	TRAPPC2		Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011508	X	13734699 - 13734700	X	13716580 - 13716581	11508	26547	rs587776749	NC_000023.11:13716579:CACA:CA
NM_001011658.4(TRAPPC2):c.53_54del (p.Val17_Phe18insTer)	TRAPPC2		Spondyloepiphyseal dysplasia tarda	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000011507	X	13738029 - 13738030	X	13719910 - 13719911	11507	26546	rs587776748	NC_000023.11:13719909:AAAAA:AAA
NM_001323289.2(CDKL5):c.863C>T (p.Thr288Ile)	CDKL5	T288I	Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000011504	X	18616619	X	18598499	11504	26543	rs267606713	NC_000023.11:18598498:C:T
NM_001323289.2(CDKL5):c.215T>C (p.Ile72Thr)	CDKL5	I72T	Rett syndrome|not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000011503	X	18593543	X	18575423	11503	26542	rs62641235	NC_000023.11:18575422:T:C
NM_001323289.2(CDKL5):c.119C>T (p.Ala40Val)	CDKL5	A40V	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011502	X	18582616	X	18564496	11502	26541	rs122460159	NC_000023.11:18564495:C:T
CDKL5, IVS6AS, G-T, -1	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000011501					11501	26540		
NM_001323289.2(CDKL5):c.2500C>T (p.Gln834Ter)	CDKL5	Q834*	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000011500	X	18646494	X	18628374	11500	26539	rs122460158	NC_000023.11:18628373:C:T
CDKL5, 2-BP DEL, 2636CT	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011499					11499	26538		
CDKL5, 4-BP DEL, 166GAAA	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011498					11498	26537		
NM_001323289.2(CDKL5):c.525A>T (p.Arg175Ser)	CDKL5	R175S	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000011497	X	18602444	X	18584324	11497	26536	rs61749700	NC_000023.11:18584323:A:T
NM_001323289.2(CDKL5):c.455G>T (p.Cys152Phe)	CDKL5	C152F	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000011496	X	18600062	X	18581942	11496	26535	rs122460157	NC_000023.11:18581941:G:T
CDKL5, IVSAS13, G-A, -1	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000011495					11495	26534		
CDKL5, 1-BP DEL, 183T	CDKL5		Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000011494					11494	26533		
NM_006579.3(EBP):c.53T>C (p.Leu18Pro)	EBP	L18P	MEND syndrome	Pathogenic(Last reviewed: Oct 15, 2003)	no assertion criteria provided	VCV000011493	X	48382212	X	48523824	11493	26532	rs104894795	NC_000023.11:48523823:T:C
NM_006579.3(EBP):c.440G>A (p.Arg147His)	EBP	R147H		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011492	X	48385644	X	48527256	11492	26531	rs28935174	NC_000023.11:48527255:G:A
NM_006579.3(EBP):c.587G>A (p.Trp196Ter)	EBP	W196*		Pathogenic(Last reviewed: Sep 15, 2004)	no assertion criteria provided	VCV000011491	X	48386739	X	48528351	11491	26530	rs104894794	NC_000023.11:48528350:G:A
NM_006579.3(EBP):c.523C>T (p.Gln175Ter)	EBP	Q175*		Pathogenic(Last reviewed: Sep 15, 2004)	no assertion criteria provided	VCV000011490	X	48386675	X	48528287	11490	26529	rs104894793	NC_000023.11:48528286:C:T
NM_006579.3(EBP):c.386G>A (p.Trp129Ter)	EBP	W129*		Pathogenic(Last reviewed: Sep 15, 2004)	no assertion criteria provided	VCV000011489	X	48385590	X	48527202	11489	26528	rs104894792	NC_000023.11:48527201:G:A
NM_006579.3(EBP):c.586_587insA (p.Trp196Ter)	EBP			Pathogenic(Last reviewed: Aug 12, 2000)	no assertion criteria provided	VCV000011488	X	48386738 - 48386739	X	48528350 - 48528351	11488	26527	rs1569480016	NC_000023.11:48528350::A
NM_006579.3(EBP):c.390del (p.Pro131fs)	EBP	P131fs		Pathogenic(Last reviewed: Aug 12, 2000)	no assertion criteria provided	VCV000011487	X	48385594	X	48527206	11487	26526	rs1569479901	NC_000023.11:48527205:A:
NM_006579.3(EBP):c.338+1G>T	EBP			Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000011486	X	48385414	X	48527026	11486	26525	rs1569479885	NC_000023.11:48527025:G:T
NM_006579.3(EBP):c.238G>A (p.Glu80Lys)	EBP	E80K		Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011485	X	48382397	X	48524009	11485	26524	rs104894800	NC_000023.11:48524008:G:A
NM_006579.3(EBP):c.187C>T (p.Arg63Ter)	EBP	R63*		Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000011484	X	48382346	X	48523958	11484	26523	rs104894799	NC_000023.11:48523957:C:T
NM_006579.3(EBP):c.87G>A (p.Trp29Ter)	EBP	W29*		Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000011483	X	48382246	X	48523858	11483	26522	rs104894798	NC_000023.11:48523857:G:A
IL1RAPL1, EX2-5DEL	IL1RAPL1		Mental retardation 21, X-linked	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000011482					11482	26521		
NM_014271.4(IL1RAPL1):c.1460G>A (p.Trp487Ter)	IL1RAPL1	W487*	Mental retardation 21, X-linked	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000011481	X	29973306	X	29955189	11481	26520	rs122461161	NC_000023.11:29955188:G:A
NM_014271.4(IL1RAPL1):c.1377C>A (p.Tyr459Ter)	IL1RAPL1	Y459*	Mental retardation 21, X-linked	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000011480	X	29973223	X	29955106	11480	26519	rs122461160	NC_000023.11:29955105:C:A
NM_001042537.1(SLC9A6):c.608_609del (p.His203fs)	SLC9A6	H119fs, H151fs, H203fs, H171fs	Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011479	X	135080645 - 135080646	X	135998486 - 135998487	11479	26518	rs730882188	NC_000023.11:135998485:AT:
NM_001042537.1(SLC9A6):c.603+3_603+4delinsCC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011478	X	135080347 - 135080348	X	135998188 - 135998189	11478	26517	rs730882187	NC_000023.11:135998187:AA:CC
NM_001042537.1(SLC9A6):c.1498C>T (p.Arg500Ter)	SLC9A6	R468*, R448*, R500*, R416*	not provided|Christianson syndrome	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000011477	X	135106524	X	136024365	11477	26516	rs122461162	NC_000023.11:136024364:C:T
NM_001042537.1(SLC9A6):c.860_865del (p.Glu287_Ser288del)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Oct 15, 2009)	no assertion criteria provided	VCV000011476	X	135084330 - 135084335	X	136002171 - 136002176	11476	26515	rs886037619	NC_000023.11:136002170:GTGAAAGTG:GTG
NM_005448.2(BMP15):c.631C>T (p.Gln211Ter)	BMP15	E211*, Q211*	Premature ovarian failure 4	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000011473	X	50659059	X	50916059	11473	26512	rs137853320	NC_000023.11:50916058:C:T
NM_005448.2(BMP15):c.226C>T (p.Arg76Cys)	BMP15	R76C	Premature ovarian failure 4	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000011471	X	50654009	X	50911009	11471	26510	rs104894766	NC_000023.11:50911008:C:T
NM_005448.2(BMP15):c.704A>G (p.Tyr235Cys)	BMP15	Y235C	Ovarian dysgenesis 2	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011470	X	50659132	X	50916132	11470	26509	rs104894765	NC_000023.11:50916131:A:G
NM_003639.4(IKBKG):c.517C>G (p.Arg173Gly)	IKBKG	R173G, R241G, R172G	not provided|Invasive pneumococcal disease, recurrent isolated, 2	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000011469	X	153786864	X	154558649	11469	26508	rs179363866	NC_000023.11:154558648:C:G
NM_003639.4(IKBKG):c.956G>A (p.Arg319Gln)	IKBKG	R319Q, R387Q, R318Q, R220Q	Familial atypical mycobacteriosis, type 1, X-linked	Pathogenic(Last reviewed: Jul 10, 2006)	no assertion criteria provided	VCV000011468	X	153791817	X	154563602	11468	26507	rs137853332	NC_000023.11:154563601:G:A
NM_003639.4(IKBKG):c.944A>C (p.Glu315Ala)	IKBKG	E315A, E216A, E314A, E383A	Familial atypical mycobacteriosis, type 1, X-linked	Pathogenic(Last reviewed: Jul 10, 2006)	no assertion criteria provided	VCV000011467	X	153791805	X	154563590	11467	26506	rs137853331	NC_000023.11:154563589:A:C
NM_003639.4(IKBKG):c.863C>G (p.Ala288Gly)	IKBKG	A288G, A356G, A287G	Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Mar 10, 2006)	no assertion criteria provided	VCV000011466	X	153791119	X	154562904	11466	26505	rs137853330	NC_000023.11:154562903:C:G
NM_003639.4(IKBKG):c.111dup (p.Met38fs)	IKBKG		Immunodeficiency without anhidrotic ectodermal dysplasia	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000011465	X	153780326 - 153780327	X	154552111 - 154552112	11465	26504	rs1569556522	NC_000023.11:154552111:CC:CCC
IKBKG, IVS8, -1, G-A	IKBKG		Immunodeficiency without anhidrotic ectodermal dysplasia	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000011464					11464	26503		
IKBKG, 1-BP INS, 1409A	IKBKG		Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000011463					11463	26502		
NM_003639.4(IKBKG):c.768+5G>A	IKBKG		Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000011462	X	153790004	X	154561789	11462	26501	rs1569556603	NC_000023.11:154561788:G:A
NM_003639.4(IKBKG):c.1207C>T (p.Gln403Ter)	IKBKG	Q403*, Q471*, Q304*, Q402*	Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011461	X	153792623	X	154564408	11461	26500	rs137853329	NC_000023.11:154564407:C:T
NM_003639.4(IKBKG):c.458T>G (p.Leu153Arg)	IKBKG	L153R, L152R, L221R	Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011460	X	153786805	X	154558590	11460	26499	rs137853328	NC_000023.11:154558589:T:G
IKBKG, 4.4-KB DUP	IKBKG		Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000011459					11459	26498		
IKBKG, 13-BP DUP, NT1166	IKBKG		Incontinentia pigmenti, atypical	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000011458					11458	26497		
NM_003639.4(IKBKG):c.1217A>T (p.Asp406Val)	IKBKG	D406V, D307V, D405V, D474V	Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000011457	X	153792633	X	154564418	11457	26496	rs137853327	NC_000023.11:154564417:A:T
NM_003639.4(IKBKG):c.1250G>T (p.Cys417Phe)	IKBKG	C417F, C485F, C416F, C318F	not provided|Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000011456	X	153792666	X	154564451	11456	26495	rs137853326	NC_000023.11:154564450:G:T
NM_003639.4(IKBKG):c.1249T>C (p.Cys417Arg)	IKBKG	C417R, C485R, C318R, C416R	Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011454	X	153792665	X	154564450	11454	26493	rs137853325	NC_000023.11:154564449:T:C
NM_003639.4(IKBKG):c.1171G>T (p.Glu391Ter)	IKBKG	E391*, E459*, E292*, E390*	not provided|Ectodermal dysplasia and immunodeficiency 1	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000011453	X	153792587	X	154564372	11453	26492	rs137853324	NC_000023.11:154564371:G:T
NM_003639.4(IKBKG):c.184C>T (p.Arg62Ter)	IKBKG	P62*, R130*, R62*	not provided|Incontinentia pigmenti syndrome	Pathogenic(Last reviewed: Feb 4, 2016)	criteria provided, single submitter	VCV000011452	X	153780401	X	154552186	11452	26491	rs137853323	NC_000023.11:154552185:C:T
IKBKG, 10-BP INS, NT127	IKBKG		Incontinentia pigmenti syndrome	Pathogenic(Last reviewed: May 25, 2000)	no assertion criteria provided	VCV000011451					11451	26490		
NM_003639.4(IKBKG):c.1259A>G (p.Ter420Trp)	IKBKG	*420W, *321W, *419W, *488W	Incontinentia pigmenti syndrome|Ectodermal dysplasia, anhidrotic, with immunodeficiency, osteopetrosis, and lymphedema	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000011450	X	153792675	X	154564460	11450	26489	rs137853321	NC_000023.11:154564459:A:G
NM_003639.4(IKBKG):c.1219A>G (p.Met407Val)	IKBKG	M407V, M406V, M475V, M308V	Incontinentia pigmenti syndrome	Pathogenic(Last reviewed: May 25, 2000)	no assertion criteria provided	VCV000011449	X	153792635	X	154564420	11449	26488	rs137853322	NC_000023.11:154564419:A:G
NM_003639.4(IKBKG):c.1110dup (p.Ala371fs)	IKBKG		Incontinentia pigmenti syndrome	Pathogenic(Last reviewed: May 25, 2000)	no assertion criteria provided	VCV000011448	X	153792222 - 153792223	X	154564007 - 154564008	11448	26487	rs1569556615	NC_000023.11:154564007:CCCCCC:CCCCCCC
IKBKG, EX4-10DEL	IKBKG		Incontinentia pigmenti syndrome	Pathogenic(Last reviewed: May 25, 2000)	no assertion criteria provided	VCV000011447					11447	26486		
NM_001037811.2(HSD17B10):c.718G>C (p.Glu240Gln)	HSD17B10	E249Q, E240Q	HSD10 disease	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000011446	X	53458393	X	53431445	11446	26485	rs62626305	NC_000023.11:53431444:C:G
NM_001037811.2(HSD17B10):c.568+6C>A	HSD17B10	R192R	HSD10 disease	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000011445	X	53458767	X	53431819	11445	26484	rs122462164	NC_000023.11:53431818:G:T
NM_001037811.2(HSD17B10):c.713A>G (p.Asn238Ser)	HSD17B10	N247S, N238S	HSD10 disease	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000011444	X	53458398	X	53431450	11444	26483	rs122461163	NC_000023.11:53431449:T:C
NM_001037811.2(HSD17B10):c.364C>G (p.Leu122Val)	HSD17B10	L122V	HSD10 disease	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000011443	X	53459058	X	53432110	11443	26482	rs28935476	NC_000023.11:53432109:G:C
NM_001037811.2(HSD17B10):c.388C>T (p.Arg130Cys)	HSD17B10	R130C	HSD10 disease	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000011442	X	53459034	X	53432086	11442	26481	rs28935475	NC_000023.11:53432085:G:A
NM_003413.4(ZIC3):c.763T>G (p.Trp255Gly)	ZIC3	W255G		Pathogenic(Last reviewed: Nov 15, 2008)	no assertion criteria provided	VCV000011441	X	136649613	X	137567454	11441	26480	rs122463168	NC_000023.11:137567453:T:G
ZIC3, 2-BP INS, 1507TT	ZIC3			Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011440					11440	26479		
NM_003413.4(ZIC3):c.1213A>G (p.Lys405Glu)	ZIC3	K405E		Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000011438	X	136651213	X	137569054	11438	26477	rs104894962	NC_000023.11:137569053:A:G
NM_003413.4(ZIC3):c.758G>C (p.Cys253Ser)	ZIC3	C253S		Pathogenic(Last reviewed: Nov 15, 2008)	no assertion criteria provided	VCV000011437	X	136649608	X	137567449	11437	26476	rs104894961	NC_000023.11:137567448:G:C
NM_003413.4(ZIC3):c.745C>T (p.Gln249Ter)	ZIC3	Q249*		Pathogenic(Last reviewed: May 28, 2018)	no assertion criteria provided	VCV000011436	X	136649595	X	137567436	11436	26475	rs104894960	NC_000023.11:137567435:C:T
NM_003413.4(ZIC3):c.1222A>T (p.Lys408Ter)	ZIC3	K408*	Congenital heart defects, multiple types, 1, X-linked	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000011435	X	136651222	X	137569063	11435	26474	rs387906498	NC_000023.11:137569062:A:T
NM_003413.4(ZIC3):c.804C>A (p.Cys268Ter)	ZIC3	C270*, C268*		Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011434	X	136649654	X	137567495	11434	26473	rs122462166	NC_000023.11:137567494:C:A
NM_003413.4(ZIC3):c.968C>T (p.Thr323Met)	ZIC3	T325M, T323M		Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011433	X	136649818	X	137567659	11433	26472	rs122462165	NC_000023.11:137567658:C:T
NM_015922.3(NSDHL):c.451G>T (p.Glu151Ter)	NSDHL	E151*	Child syndrome	Pathogenic(Last reviewed: Oct 15, 2003)	no assertion criteria provided	VCV000011431	X	152031176	X	152862632	11431	26470	rs104894905	NC_000023.11:152862631:G:T
NM_015922.3(NSDHL):c.544G>C (p.Ala182Pro)	NSDHL	A182P	Child syndrome	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011430	X	152034363	X	152865819	11430	26469	rs104894904	NC_000023.11:152865818:G:C
NM_015922.3(NSDHL):c.262C>T (p.Arg88Ter)	NSDHL	R88*	Child syndrome	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000011429	X	152018962	X	152850418	11429	26468	rs104894903	NC_000023.11:152850417:C:T
NM_015922.3(NSDHL):c.628C>T (p.Gln210Ter)	NSDHL	Q210*	Child syndrome	Pathogenic(Last reviewed: Feb 14, 2000)	no assertion criteria provided	VCV000011428	X	152034447	X	152865903	11428	26467	rs104894902	NC_000023.11:152865902:C:T
NM_015922.3(NSDHL):c.613G>A (p.Gly205Ser)	NSDHL	G205S	Child syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000011427	X	152034432	X	152865888	11427	26466	rs104894901	NC_000023.11:152865887:G:A
NM_015922.3(NSDHL):c.314C>T (p.Ala105Val)	NSDHL	A105V	Child syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000011426	X	152027360	X	152858816	11426	26465	rs104894909	NC_000023.11:152858815:C:T
NM_022567.2(NYX):c.302T>C (p.Ile101Thr)	NYX	I101T	Congenital stationary night blindness, type 1A	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000011425	X	41333008	X	41473755	11425	26464	rs104894911	NC_000023.11:41473754:T:C
NM_022567.2(NYX):c.281G>C (p.Arg94Pro)	NYX	R94P	Congenital stationary night blindness, type 1A	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000011424	X	41332987	X	41473734	11424	26463	rs104894910	NC_000023.11:41473733:G:C
NM_022567.2(NYX):c.559_560delinsAA (p.Ala187Lys)	NYX	A187K	not provided|Congenital stationary night blindness, type 1A	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000011423	X	41333265 - 41333266	X	41474012 - 41474013	11423	26462	rs62637027	NC_000023.11:41474011:GC:AA
NM_022567.2(NYX):c.105C>A (p.Cys35Ter)	NYX	C35*	not provided|Congenital stationary night blindness, type 1A	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000011422	X	41332811	X	41473558	11422	26461	rs62637021	NC_000023.11:41473557:C:A
NM_022567.2(NYX):c.1049G>A (p.Trp350Ter)	NYX	W350*	not provided|Congenital stationary night blindness, type 1A	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000011421	X	41333755	X	41474502	11421	26460	rs62637037	NC_000023.11:41474501:G:A
NYX, 24-BP DEL	NYX		Congenital stationary night blindness, type 1A	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000011420					11420	26459		
NM_014009.3(FOXP3):c.1099T>C (p.Phe367Leu)	FOXP3	P367L, F367L, F332L	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000011419	X	49108172	X	49251711	11419	26458	rs122467175	NC_000023.11:49251710:A:G
NM_014009.3(FOXP3):c.3G>A (p.Met1Ile)	FOXP3	M1I	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000011418	X	49114960	X	49258503	11418	26457	rs122467174	NC_000023.11:49258502:C:T
FOXP3, 543C-T	FOXP3		Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000011417					11417	26456		
NM_014009.3(FOXP3):c.970T>C (p.Phe324Leu)	FOXP3	F324K, F289L, F324L	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000011416	X	49109661	X	49253200	11416	26455	rs122467173	NC_000023.11:49253199:A:G
NM_014009.3(FOXP3):c.1117_1118delinsGC (p.Phe373Ala)	FOXP3	F373A	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000011415	X	49108153 - 49108154	X	49251692 - 49251693	11415	26454	rs122467172	NC_000023.11:49251691:AA:GC
FOXP3, 1-BP DEL	FOXP3		Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000011414					11414	26453		
NM_014009.3(FOXP3):c.751_753del (p.Glu251del)	FOXP3	E203del, E216del, E251del	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000011413	X	49111953 - 49111955	X	49255492 - 49255494	11413	26452	rs122467171	NC_000023.11:49255491:CTCCT:CT
NM_001114377.2(FOXP3):c.862+4A>G	FOXP3		Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000011412	X	49110374	X	49253913	11412	26451		NC_000023.11:49253912:T:C
NM_001114377.2(FOXP3):c.1188_1189del (p.Ter397ThrextTer?)	FOXP3	*397fs, *432fs	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000011411	X	49107797 - 49107798	X	49251336 - 49251337	11411	26450		NC_000023.11:49251335:AG:
NM_014009.3(FOXP3):c.1150G>A (p.Ala384Thr)	FOXP3	A384T, A349T	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000011410	X	49107941	X	49251480	11410	26449	rs122467170	NC_000023.11:49251479:C:T
NM_014009.3(FOXP3):c.1112T>G (p.Phe371Cys)	FOXP3	F371C, F336C	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000011409	X	49108159	X	49251698	11409	26448	rs122467169	NC_000023.11:49251697:A:C
FOXP3, 20-BP DEL, 3-BP INS, NT1290	FOXP3		Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000011408					11408	26447		
NM_014009.3(FOXP3):c.1189C>T (p.Arg397Trp)	FOXP3	R397W, R362W	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000011407	X	49107902	X	49251441	11407	26446	rs28935477	NC_000023.11:49251440:G:A
NM_023010.3(UPF3B):c.478T>G (p.Tyr160Asp)	UPF3B	Y160D	Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000011401	X	118977256	X	119843293	11401	26440	rs122468182	NC_000023.11:119843292:A:C
NM_023010.3(UPF3B):c.828_829del (p.Gly277fs)	UPF3B	G290fs, G277fs	Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000011399	X	118972469 - 118972470	X	119838506 - 119838507	11399	26438		NC_000023.11:119838505:CT:
BTK, 6.1-KB DEL	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000011397					11397	26436		
NM_000061.2(BTK):c.-31+5G>A	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000011396	X	100641045	X	101386057	11396	26435	rs1131691354	NC_000023.11:101386056:C:T
NM_000061.2(BTK):c.642_643del (p.Ser214fs)	BTK	S214fs, S248fs	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 4, 2001)	no assertion criteria provided	VCV000011395	X	100615689 - 100615690	X	101360701 - 101360702	11395	26434	rs1569292818	NC_000023.11:101360700:CAC:C
NM_000061.2(BTK):c.1685G>C (p.Arg562Pro)	BTK	R562P, R596P, R386P	not provided|X-linked agammaglobulinemia	Pathogenic(Last reviewed: Aug 20, 2015)	criteria provided, single submitter	VCV000011394	X	100608923	X	101353935	11394	26433	rs104894770	NC_000023.11:101353934:C:G
BTK, 26-BP INS, NT2019	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011393					11393	26432		
NM_000061.2(BTK):c.1955T>C (p.Leu652Pro)	BTK	L652P, L476P, L686P	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011392	X	100604898	X	101349910	11392	26431	rs128622212	NC_000023.11:101349909:A:G
BTK, 6-BP INS, NT2041	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 29, 2018)	no assertion criteria provided	VCV000011391					11391	26430		
NM_000061.2(BTK):c.1906G>T (p.Glu636Ter)	BTK	E636*, E460*, E670*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011390	X	100608184	X	101353196	11390	26429	rs128622211	NC_000023.11:101353195:C:A
NM_000061.2(BTK):c.1889T>A (p.Met630Lys)	BTK	M630K, M664K, M454K	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011389	X	100608201	X	101353213	11389	26428	rs128621210	NC_000023.11:101353212:A:T
NM_000061.2(BTK):c.1838G>A (p.Gly613Asp)	BTK	G613D, G437D, G647D	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011388	X	100608252	X	101353264	11388	26427	rs128621209	NC_000023.11:101353263:C:T
NM_000061.2(BTK):c.1820C>A (p.Ala607Asp)	BTK	A607D, A431D, A641D	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011387	X	100608270	X	101353282	11387	26426	rs128621208	NC_000023.11:101353281:G:T
NM_000061.2(BTK):c.1766A>G (p.Glu589Gly)	BTK	E589G, E413G, E623G	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011385	X	100608324	X	101353336	11385	26424	rs128621206	NC_000023.11:101353335:T:C
NM_000061.2(BTK):c.1741T>C (p.Trp581Arg)	BTK	Y581R, W581R, W615R, W405R	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011384	X	100608867	X	101353879	11384	26423	rs128621205	NC_000023.11:101353878:A:G
NM_000061.2(BTK):c.1684C>T (p.Arg562Trp)	BTK	R562W, R596W, R386W	Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000011383	X	100608924	X	101353936	11383	26422	rs128621204	NC_000023.11:101353935:G:A
NM_000061.2(BTK):c.1631+1G>T	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011382	X	100609617	X	101354629	11382	26421	rs1569291215	NC_000023.11:101354628:C:A
BTK, 4-BP DEL, CODON 527, GTTT	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011380					11380	26419		
BTK, 1-BP DEL, 1720A	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011379					11379	26418		
NM_000061.2(BTK):c.1559G>A (p.Arg520Gln)	BTK	R520Q, R554Q	X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000011378	X	100611047	X	101356059	11378	26417	rs128621202	NC_000023.11:101356058:C:T
NM_000061.2(BTK):c.1558C>T (p.Arg520Ter)	BTK	R520*, R554*	not provided|Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011377	X	100611048	X	101356060	11377	26416	rs128621201	NC_000023.11:101356059:G:A
NM_001287345.1(BTK):c.1039-1418C>A	BTK	C502*, C536*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011375	X	100611100	X	101356112	11375	26414	rs41310709	NC_000023.11:101356111:G:T
NM_001287345.1(BTK):c.1038+1516C>A	BTK	Y425*, Y459*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 30, 2018)	no assertion criteria provided	VCV000011374	X	100611846	X	101356858	11374	26413	rs128621199	NC_000023.11:101356857:G:T
NM_001287345.1(BTK):c.1038+1464T>C	BTK	L408P, L442P	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011373	X	100611898	X	101356910	11373	26412	rs128621198	NC_000023.11:101356909:A:G
BTK, 16-BP INS, NT1263	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011372					11372	26411		
NM_001287345.1(BTK):c.1038+813T>G	BTK	Y375*, Y409*	X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011371	X	100612549	X	101357561	11371	26410	rs128621197	NC_000023.11:101357560:A:C
BTK, IVS12AS, A-T, -2	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011370					11370	26409		
BTK, 1-BP DEL, IVS11DS, +1G	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011369					11369	26408		
NM_000061.2(BTK):c.1001A>C (p.Tyr334Ser)	BTK	Y334S, Y368S	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011368	X	100613399	X	101358411	11368	26407	rs128621196	NC_000023.11:101358410:T:G
NM_000061.2(BTK):c.919A>G (p.Arg307Gly)	BTK	R307G, R341G	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011367	X	100613660	X	101358672	11367	26406	rs128621195	NC_000023.11:101358671:T:C
BTK, 1-BP DEL/3-BP INS, CODON 261	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011365					11365	26404		
NM_000061.2(BTK):c.839+1G>A	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011364	X	100615075	X	101360087	11364	26403	rs1569292649	NC_000023.11:101360086:C:T
NM_000061.2(BTK):c.763C>T (p.Arg255Ter)	BTK	R255*, R289*	Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000011363	X	100615569	X	101360581	11363	26402	rs128621193	NC_000023.11:101360580:G:A
NM_000061.2(BTK):c.755G>A (p.Trp252Ter)	BTK	W252*, W286*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000011362	X	100615577	X	101360589	11362	26401	rs128621192	NC_000023.11:101360588:C:T
NM_000061.2(BTK):c.718G>T (p.Glu240Ter)	BTK	E240*, E274*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011361	X	100615614	X	101360626	11361	26400	rs128621191	NC_000023.11:101360625:C:A
NM_000061.2(BTK):c.653del (p.Lys218fs)	BTK	K218fs, K252fs	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011360	X	100615679	X	101360691	11360	26399	rs1569292813	NC_000023.11:101360690:TTTTT:TTTT
NM_000061.2(BTK):c.588_589insCTACATAG (p.Ile197fs)	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 29, 2018)	no assertion criteria provided	VCV000011359	X	100617160 - 100617161	X	101362172 - 101362173	11359	26398	rs1569293253	NC_000023.11:101362172:CT:CTATGTAGCT
NM_000061.2(BTK):c.557dup (p.Pro187fs)	BTK		X-linked agammaglobulinemia|X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000011358	X	100617191 - 100617192	X	101362203 - 101362204	11358	26397	rs864321665	NC_000023.11:101362203:TTTTTT:TTTTTTT
NM_000061.2(BTK):c.389del (p.Asn130fs)	BTK	N130fs, N164fs	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011357	X	100624988	X	101370000	11357	26396	rs864321664	NC_000023.11:101369999:TTTTT:TTTT
NM_000061.2(BTK):c.338T>A (p.Val113Asp)	BTK	V113D, V147D	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011356	X	100625039	X	101370051	11356	26395	rs128621190	NC_000023.11:101370050:A:T
NM_000061.2(BTK):c.310-2A>G	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011355	X	100625069	X	101370081	11355	26394	rs864321663	NC_000023.11:101370080:T:C
NM_000061.2(BTK):c.310-1G>C	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011354	X	100625068	X	101370080	11354	26393	rs864321662	NC_000023.11:101370079:C:G
NM_000061.2(BTK):c.141+3_141+4del	BTK		X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011353	X	100630128 - 100630129	X	101375140 - 101375141	11353	26392	rs864321661	NC_000023.11:101375139:TT:
NM_000061.2(BTK):c.228_231del (p.Glu76fs)	BTK	E76fs, E110fs	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011352	X	100629533 - 100629536	X	101374545 - 101374548	11352	26391	rs864321660	NC_000023.11:101374544:TCTTTCT:TCT
NM_000061.2(BTK):c.97A>C (p.Thr33Pro)	BTK	T33P, T67P	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011351	X	100630176	X	101375188	11351	26390	rs128620189	NC_000023.11:101375187:T:G
BTK, ALA-ASP, 1952C-A	BTK		Hypogammaglobulinemia, X-linked	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000011350					11350	26389		
NM_000061.2(BTK):c.2T>C (p.Met1Thr)	BTK	M1T, M35T	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Mar 1, 1996)	no assertion criteria provided	VCV000011349	X	100630271	X	101375283	11349	26388	rs128620186	NC_000023.11:101375282:A:G
NM_000061.2(BTK):c.83G>A (p.Arg28His)	BTK	R28H, R62H	not provided|Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia with growth hormone deficiency|X-linked agammaglobulinemia	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011348	X	100630190	X	101375202	11348	26387	rs128620185	NC_000023.11:101375201:C:T
NM_000061.2(BTK):c.1750+5G>A	BTK		X-linked agammaglobulinemia with growth hormone deficiency	Pathogenic(Last reviewed: Jun 13, 1994)	no assertion criteria provided	VCV000011347	X	100608853	X	101353865	11347	26386	rs864321659	NC_000023.11:101353864:C:T
NM_001287345.1(BTK):c.1038+44A>G	BTK	Y361C, Y395C	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011346	X	100613318	X	101358330	11346	26385	rs28935478	NC_000023.11:101358329:T:C
NM_000061.2(BTK):c.37C>T (p.Arg13Ter)	BTK	R13*, R47*	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000011344	X	100630236	X	101375248	11344	26383	rs128620187	NC_000023.11:101375247:G:A
NM_001287345.1(BTK):c.1038+1529A>G	BTK	K430E, K464E	X-linked agammaglobulinemia	Pathogenic(Last reviewed: Jan 21, 1993)	no assertion criteria provided	VCV000011343	X	100611833	X	101356845	11343	26382	rs128620184	NC_000023.11:101356844:T:C
NM_000061.2(BTK):c.1574G>A (p.Arg525Gln)	BTK	R525Q, R349Q, R559Q	Agammaglobulinemia, non-Bruton type|X-linked agammaglobulinemia	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000011342	X	100609675	X	101354687	11342	26381	rs128620183	NC_000023.11:101354686:C:T
NM_003588.3(CUL4B):c.901-2A>G	CUL4B		Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000011340	X	119679374	X	120545519	11340	26379	rs786200913	NC_000023.11:120545518:T:C
NM_003588.3(CUL4B):c.1162C>T (p.Arg388Ter)	CUL4B	R388*, R192*, R370*, R375*	Syndromic X-linked mental retardation, Cabezas type|Seizures|Short stature|Abnormal facial shape|Global developmental delay|Intellectual disability	Pathogenic(Last reviewed: Nov 29, 2014)	criteria provided, single submitter	VCV000011339	X	119678034	X	120544179	11339	26378	rs121434616	NC_000023.11:120544178:G:A
NM_003588.3(CUL4B):c.1714C>T (p.Arg572Cys)	CUL4B	R572C, R554C, R376C, R559C	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000011338	X	119673204	X	120539349	11338	26377	rs121434615	NC_000023.11:120539348:G:A
NM_004085.4(TIMM8A):c.127del (p.Cys43fs)	TIMM8A	C43fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 15, 2006)	no assertion criteria provided	VCV000011326	X	100603526	X	101348538	11326	26365	rs869320667	NC_000023.11:101348537:AAA:AA
NM_004085.4(TIMM8A):c.133-23A>C	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011325	X	100601671	X	101346683	11325	26364	rs869320666	NC_000023.11:101346682:T:G
NM_004085.4(TIMM8A):c.238C>T (p.Arg80Ter)	TIMM8A	R80*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011324	X	100601543	X	101346555	11324	26363	rs1054894	NC_000023.11:101346554:G:A
TIMM8A, DEL	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Mar 23, 2004)	no assertion criteria provided	VCV000011323					11323	26362		
NM_004085.4(TIMM8A):c.73del (p.Glu24_Val25insTer)	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000011322	X	100603580	X	101348592	11322	26361	rs869320665	NC_000023.11:101348591:CC:C
NM_004085.4(TIMM8A):c.198C>G (p.Cys66Trp)	TIMM8A	C66W	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 6, 2003)	no assertion criteria provided	VCV000011321	X	100601583	X	101346595	11321	26360	rs80356560	NC_000023.11:101346594:G:C
NM_004085.4(TIMM8A):c.70G>T (p.Glu24Ter)	TIMM8A	E24*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Apr 20, 2016)	no assertion criteria provided	VCV000011320	X	100603583	X	101348595	11320	26359	rs111033631	NC_000023.11:101348594:C:A
NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs)	TIMM8A	K50fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000011319	X	100601624 - 100601633	X	101346636 - 101346645	11319	26358	rs869320733	NC_000023.11:101346635:GCCCAGGCTTG:G
NM_004085.4(TIMM8A):c.116del (p.Met39fs)	TIMM8A	M39fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000011318	X	100603537	X	101348549	11318	26357	rs869320664	NC_000023.11:101348548:A:
NM_000033.4(ABCD1):c.-16_10del (p.Met1fs)	ABCD1	M1fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000011317	X	152990704 - 152990729	X	153725249 - 153725274	11317	26356	rs387906497	NC_000023.11:153725248:GCAGCCAGCCCAGGTGACATGCCGGTGC:GC
ABCD1, IVS1DS, G-A, -1	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000011316					11316	26355		
NM_000033.4(ABCD1):c.1865+1G>A	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000011315	X	153008526	X	153743072	11315	26354	rs1569541198	NC_000023.11:153743071:G:A
NM_000033.3(ABCD1):c.874_876delGAG (p.Glu292del)	ABCD1	E291del, E292del	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000011314	X	152991591 - 152991593	X	153726136 - 153726138	11314	26353	rs387906496	NC_000023.11:153726135:GGAGGAG:GGAG
NM_000033.4(ABCD1):c.1849C>T (p.Arg617Cys)	ABCD1	R617C	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011313	X	153008509	X	153743055	11313	26352	rs4010613	NC_000023.11:153743054:C:T
NM_000033.4(ABCD1):c.1850G>A (p.Arg617His)	ABCD1	R617H	Adrenoleukodystrophy|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011312	X	153008510	X	153743056	11312	26351	rs11146842	NC_000023.11:153743055:G:A
ABCD1, 1-BP DEL, 2204G	ABCD1		Addison's disease	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000011311					11311	26350		
NM_000033.4(ABCD1):c.1817C>T (p.Ser606Leu)	ABCD1	S606L	not provided|Adrenoleukodystrophy|Addison's disease	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011310	X	153008477	X	153743023	11310	26349	rs128624225	NC_000023.11:153743022:C:T
ABCD1, 2-BP DEL, 2177TA	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000011309					11309	26348		
NM_000033.4(ABCD1):c.1634+1G>A	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000011308	X	153005692	X	153740238	11308	26347	rs1569541096	NC_000023.11:153740237:G:A
NM_000033.4(ABCD1):c.1552C>T (p.Arg518Trp)	ABCD1	R518W	Adrenoleukodystrophy|not provided	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011307	X	153005609	X	153740155	11307	26346	rs128624224	NC_000023.11:153740154:C:T
NM_000033.4(ABCD1):c.1552del (p.Arg518fs)	ABCD1	R518fs	Adrenoleukodystrophy	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000011306	X	153005608	X	153740154	11306	26345	rs387906495	NC_000023.11:153740153:CC:C
NM_000033.4(ABCD1):c.1544C>T (p.Ser515Phe)	ABCD1	S515F	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011305	X	153005601	X	153740147	11305	26344	rs128624223	NC_000023.11:153740146:C:T
NM_000033.4(ABCD1):c.1429G>T (p.Glu477Ter)	ABCD1	E477*	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011304	X	153002646	X	153737192	11304	26343	rs128624222	NC_000023.11:153737191:G:T
NM_000033.4(ABCD1):c.1415_1416del (p.Gln472fs)	ABCD1	Q472fs	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011303	X	153002632 - 153002633	X	153737178 - 153737179	11303	26342	rs387906494	NC_000023.11:153737177:AG:
NM_000033.4(ABCD1):c.1252C>T (p.Arg418Trp)	ABCD1	R418W	not provided|Adrenoleukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011301	X	153001826	X	153736372	11301	26340	rs128624220	NC_000023.11:153736371:C:T
NM_000033.4(ABCD1):c.1202G>A (p.Arg401Gln)	ABCD1	R401Q	Adrenoleukodystrophy|not specified	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011300	X	153001686	X	153736232	11300	26339	rs128624219	NC_000023.11:153736231:G:A
NM_000033.4(ABCD1):c.796G>A (p.Gly266Arg)	ABCD1	G266R	not provided|Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011299	X	152991517	X	153726062	11299	26338	rs128624218	NC_000023.11:153726061:G:A
NM_000033.4(ABCD1):c.520T>G (p.Tyr174Asp)	ABCD1	Y174D	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011298	X	152991241	X	153725786	11298	26337	rs128624217	NC_000023.11:153725785:T:G
NM_000033.4(ABCD1):c.443A>G (p.Asn148Ser)	ABCD1	N148S	Adrenoleukodystrophy	Pathogenic(Last reviewed: Oct 1, 1994)	no assertion criteria provided	VCV000011297	X	152991164	X	153725709	11297	26336	rs128624216	NC_000023.11:153725708:A:G
NM_000033.4(ABCD1):c.1635-2A>G	ABCD1		Adrenoleukodystrophy	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000011294	X	153006026	X	153740572	11294	26333	rs1569541109	NC_000023.11:153740571:A:G
NM_000033.4(ABCD1):c.1451C>G (p.Pro484Arg)	ABCD1	P484R	Adrenoleukodystrophy	Pathogenic(Last reviewed: Dec 30, 1994)	no assertion criteria provided	VCV000011293	X	153002668	X	153737214	11293	26332	rs128624214	NC_000023.11:153737213:C:G
NM_000033.4(ABCD1):c.871G>A (p.Glu291Lys)	ABCD1	E291K	Adrenoleukodystrophy	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011292	X	152991592	X	153726137	11292	26331	rs128624213	NC_000023.11:153726136:G:A
DMD, EX45-47DEL	DMD		Becker muscular dystrophy, atypical	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000011291					11291	26330		
NM_000109.4(DMD):c.5961T>G (p.Tyr1987Ter)	DMD	Y1995*, Y1872*, Y654*, Y1987*, Y1991*, Y651*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000011290	X	32328331	X	32310214	11290	26329	rs128627257	NC_000023.11:32310213:A:C
NM_004006.2(DMD):c.8713C>T (p.Arg2905Ter)	DMD	R2905*, R1561*, R2897*, R445*, R1564*, R176*, R2782*, R2901*	Becker muscular dystrophy|Dilated cardiomyopathy 3B|Duchenne muscular dystrophy|Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011288	X	31496447	X	31478330	11288	26327	rs128627256	NC_000023.11:31478329:G:A
NM_004006.2(DMD):c.9225-285A>G	DMD		Duchenne muscular dystrophy|Becker muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011286	X	31279418	X	31261301	11286	26325	rs587776747	NC_000023.11:31261300:T:C
DMD, 16-BP DEL	DMD		Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000011285					11285	26324		
NM_000109.4(DMD):c.353del (p.Asn118fs)	DMD	N3fs, N122fs, N118fs, N126fs	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 30, 2003)	no assertion criteria provided	VCV000011284	X	32834738	X	32816621	11284	26323	rs1569528138	NC_000023.11:32816620:TTTTT:TTTT
NM_004006.2(DMD):c.3940C>T (p.Arg1314Ter)	DMD	R1314*, R1310*, R1191*, R1306*	Becker muscular dystrophy|not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011283	X	32456489	X	32438372	11283	26322	rs5030730	NC_000023.11:32438371:G:A
NM_004006.2(DMD):c.9568C>T (p.Arg3190Ter)	DMD	R3190*, R122*, R1849*, R3067*, R3186*, R1846*, R730*, R3182*, R461*	not provided|Duchenne muscular dystrophy|Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011282	X	31224780	X	31206663	11282	26321	rs104894797	NC_000023.11:31206662:G:A
DMD, ALU INS	DMD		Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000011281					11281	26320		
NM_000109.4(DMD):c.3607G>T (p.Glu1203Ter)	DMD	E1211*, E1207*, E1203*, E1088*	Becker muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011280	X	32466728	X	32448611	11280	26319	rs267606771	NC_000023.11:32448610:C:A
NM_000109.4(DMD):c.811A>G (p.Thr271Ala)	DMD	T279A, T156A, T271A, T275A	Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: May 20, 1997)	no assertion criteria provided	VCV000011279	X	32716112	X	32697995	11279	26318	rs128627255	NC_000023.11:32697994:T:C
DMD, 8-BP DEL, 1-BP INS, NT10692	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011278					11278	26317		
DMD, 1-BP DEL, 10683C	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011277					11277	26316		
DMD, IVS70, G-T, +5	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011275					11275	26314		
DMD, IVS70, G-A, +1	DMD		Intermediate muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011274					11274	26313		
NM_004006.2(DMD):c.10141C>T (p.Arg3381Ter)	DMD	R3381*, R3258*, R921*, R2040*, R313*, R2037*, R3373*, R3377*, R652*	X-linked DMD-related dystrophinopathy|not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011273	X	31196868	X	31178751	11273	26312	rs104894790	NC_000023.11:31178750:G:A
DMD, IVS65, G-A, +1	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011272					11272	26311		
DMD, 4-BP DEL, NT9679	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011271					11271	26310		
NM_004006.2(DMD):c.9197C>A (p.Ser3066Ter)	DMD	S3066*, S3058*, S3062*, S606*, S2943*, S337*, S1722*, S1725*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	VCV000011270	X	31341742	X	31323625	11270	26309	rs128626254	NC_000023.11:31323624:G:T
NM_000109.4(DMD):c.7378G>T (p.Glu2460Ter)	DMD	E2468*, E2345*, E2464*, E8*, E1127*, E2460*, E1124*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000011266	X	31792217	X	31774100	11266	26305	rs128626253	NC_000023.11:31774099:C:A
DMD, IVS47, G-A, +1, EX48DEL	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011265					11265	26304		
DMD, 1-BP INS, 7188A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011264					11264	26303		
NM_004013.2(DMD):c.-591C>T	DMD	Q2264*, Q2141*, Q2256*, Q920*, Q923*, Q2260*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011263	X	31947835	X	31929718	11263	26302	rs128626252	NC_000023.11:31929717:G:A
DMD, 17-BP DEL, NT6982	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011262					11262	26301		
NM_004006.2(DMD):c.6373C>T (p.Gln2125Ter)	DMD	Q2125*, Q2121*, Q784*, Q2002*, Q2117*, Q781*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000011261	X	32235098	X	32216981	11261	26300	rs128626251	NC_000023.11:32216980:G:A
NM_004006.2(DMD):c.6292C>T (p.Arg2098Ter)	DMD	R2098*, R2094*, R757*, R1975*, R2090*, R754*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011260	X	32235179	X	32217062	11260	26299	rs128626250	NC_000023.11:32217061:G:A
DMD, 1-BP DEL, 6408C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2012)	no assertion criteria provided	VCV000011259					11259	26298		
NM_004006.2(DMD):c.5899C>T (p.Arg1967Ter)	DMD	R1967*, R1844*, R626*, R1963*, R623*, R1959*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011258	X	32360240	X	32342123	11258	26297	rs128626249	NC_000023.11:32342122:G:A
NM_004006.2(DMD):c.4414C>T (p.Gln1472Ter)	DMD	Q1472*, Q131*, Q1468*, Q1349*, Q128*, Q1464*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011257	X	32407722	X	32389605	11257	26296	rs128626248	NC_000023.11:32389604:G:A
NM_000109.4(DMD):c.4189C>T (p.Gln1397Ter)	DMD	Q1405*, Q1401*, Q64*, Q1397*, Q1282*, Q61*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011256	X	32429889	X	32411772	11256	26295	rs128626247	NC_000023.11:32411771:G:A
NM_004006.2(DMD):c.3188G>A (p.Trp1063Ter)	DMD	W1063*, W1059*, W1055*, W940*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000011255	X	32482791	X	32464674	11255	26294	rs128626246	NC_000023.11:32464673:C:T
NM_004006.2(DMD):c.3121C>T (p.Gln1041Ter)	DMD	Q1041*, Q1033*, Q918*, Q1037*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011254	X	32486656	X	32468539	11254	26293	rs128626245	NC_000023.11:32468538:G:A
DMD, 1-BP INS, NT2928	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011253					11253	26292		
DMD, 52-BP DEL	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000011252					11252	26291		
NM_000109.4(DMD):c.2293A>G (p.Lys765Glu)	DMD	K773E, K650E, K765E, K769E	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000011251	X	32519935	X	32501818	11251	26290	rs128626244	NC_000023.11:32501817:T:C
NM_000109.4(DMD):c.2284A>T (p.Lys762Ter)	DMD	K770*, K766*, K762*, K647*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011250	X	32519944	X	32501827	11250	26289	rs128626243	NC_000023.11:32501826:T:A
NM_000109.4(DMD):c.1928G>A (p.Trp643Ter)	DMD	W651*, W528*, W647*, W643*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011249	X	32583859	X	32565742	11249	26288	rs128626242	NC_000023.11:32565741:C:T
BMD, IVS13, G-T, -1	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011248					11248	26287		
NM_000109.4(DMD):c.1465C>T (p.Gln489Ter)	DMD	Q497*, Q489*, Q493*, Q374*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000011247	X	32613987	X	32595870	11247	26286	rs128626241	NC_000023.11:32595869:G:A
NM_000109.4(DMD):c.1414G>T (p.Gly472Ter)	DMD	G480*, G357*, G476*, G472*	Intermediate muscular dystrophy	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000011246	X	32632464	X	32614347	11246	26285	rs128626240	NC_000023.11:32614346:C:A
DMD, 1-BP INS, NT1554	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000011245					11245	26284		
DMD, 11-BP DEL, NT989	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011244					11244	26283		
NM_000109.4(DMD):c.724G>T (p.Glu242Ter)	DMD	E250*, E242*, E127*, E246*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011243	X	32717312	X	32699195	11243	26282	rs128626239	NC_000023.11:32699194:C:A
NM_000109.4(DMD):c.700C>T (p.Gln234Ter)	DMD	Q242*, Q119*, Q234*, Q238*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 1, 1994)	no assertion criteria provided	VCV000011242	X	32717336	X	32699219	11242	26281	rs128626238	NC_000023.11:32699218:G:A
NM_000109.4(DMD):c.667T>A (p.Tyr223Asn)	DMD	Y231N, Y227N, Y223N, Y108N	Becker muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011241	X	32717369	X	32699252	11241	26280	rs128626237	NC_000023.11:32699251:A:T
DMD, 1-BP INS, 402A	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 28, 2012)	no assertion criteria provided	VCV000011240					11240	26279		
NM_004006.2(DMD):c.178C>T (p.Gln60Ter)	DMD	Q60*, Q52*, Q56*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011239	X	32867853	X	32849736	11239	26278	rs128626233	NC_000023.11:32849735:G:A
DMD, 2-BP DEL, 382AG	DMD		Intermediate muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011238					11238	26277		
NM_000109.4(DMD):c.9995G>A (p.Cys3332Tyr)	DMD	C3340Y, C1999Y, C3336Y, C611Y, C1996Y, C3217Y, C272Y, C3332Y, C880Y	Duchenne muscular dystrophy, mental retardation, and absence of erg b-wave	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000011236	X	31198554	X	31180437	11236	26275	rs104894788	NC_000023.11:31180436:C:T
DMD, 1-BP DEL, 10334C AND IVS69, G-T, +1	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000011234					11234	26273		
NM_000109.4(DMD):c.1993C>T (p.Gln665Ter)	DMD	Q673*, Q550*, Q669*, Q665*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000011233	X	32563427	X	32545310	11233	26272	rs128626232	NC_000023.11:32545309:G:A
DMD, 1-BP DEL, 724C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011232					11232	26271		
DMD, EX1DEL	DMD		Dilated cardiomyopathy 3B	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000011231					11231	26270		
NM_000109.4(DMD):c.479C>A (p.Ala160Asp)	DMD	A168D, A45D, A164D, A160D	Becker muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011230	X	32834612	X	32816495	11230	26269	rs128626236	NC_000023.11:32816494:G:T
NM_000109.4(DMD):c.3579+2T>G	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011229	X	32472777	X	32454660	11229	26268	rs146071084	NC_000023.11:32454659:A:C
NM_004010.3(DMD):c.-209T>G	DMD	L54R, L46R, L50R	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000011228	X	32867870	X	32849753	11228	26267	rs128626231	NC_000023.11:32849752:A:C
NM_000109.4(DMD):c.8524-1G>C	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000011227	X	31497221	X	31479104	11227	26266	rs1569546198	NC_000023.11:31479103:C:G
NM_000109.4(DMD):c.2356+3A>C	DMD		Becker muscular dystrophy	Pathogenic(Last reviewed: Jun 15, 1993)	no assertion criteria provided	VCV000011226	X	32519869	X	32501752	11226	26265	rs1569564916	NC_000023.11:32501751:T:G
NM_004006.2(DMD):c.433C>T (p.Arg145Ter)	DMD	R145*, R137*, R22*, R141*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011225	X	32834682	X	32816565	11225	26264	rs128626235	NC_000023.11:32816564:G:A
NM_000109.4(DMD):c.2290G>T (p.Glu764Ter)	DMD	E772*, E649*, E768*, E764*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000011224	X	32519938	X	32501821	11224	26263	rs267606770	NC_000023.11:32501820:C:A
DMD, 1-BP DEL, 2568C	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000011223					11223	26262		
NM_000109.4(DMD):c.2278C>T (p.Arg760Ter)	DMD	R768*, R760*, R764*, R645*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011222	X	32519950	X	32501833	11222	26261	rs201366610	NC_000023.11:32501832:G:A
NM_004010.3(DMD):c.-117C>T	DMD	Q85*, Q77*, Q81*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000011221	X	32862911	X	32844794	11221	26260	rs128626234	NC_000023.11:32844793:G:A
NM_004006.2(DMD):c.6955C>T (p.Gln2319Ter)	DMD	Q2319*, Q975*, Q2196*, Q978*, Q2315*, Q2311*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000011220	X	31893448	X	31875331	11220	26259	rs128625230	NC_000023.11:31875330:G:A
DMD, EX18DEL	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000011219					11219	26258		
DMD, EX21DEL	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000011218					11218	26257		
DMD, AG-T, EX48	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000011217					11217	26256		
DMD, 1-BP INS, EX12	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000011216					11216	26255		
DMD, 1-BP DEL, 10662T	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000011215					11215	26254		
DMD, EX73-76DEL	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 15, 1992)	no assertion criteria provided	VCV000011214					11214	26253		
NM_004006.2(DMD):c.10108C>T (p.Arg3370Ter)	DMD	R3370*, R3362*, R2026*, R910*, R641*, R2029*, R302*, R3247*, R3366*	not provided|Duchenne muscular dystrophy|Becker muscular dystrophy	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011213	X	31196901	X	31178784	11213	26252	rs104894787	NC_000023.11:31178783:G:A
DMD, IVS68, T-A, +2	DMD		Duchenne muscular dystrophy	Pathogenic(Last reviewed: Mar 15, 1992)	no assertion criteria provided	VCV000011212					11212	26251		
NM_004006.2(DMD):c.8944C>T (p.Arg2982Ter)	DMD	R2982*, R522*, R1641*, R2978*, R1638*, R2859*, R253*, R2974*	Duchenne muscular dystrophy|not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011211	X	31462738	X	31444621	11211	26250	rs128625229	NC_000023.11:31444620:G:A
NM_004006.2(DMD):c.5551C>T (p.Gln1851Ter)	DMD	Q1851*, Q1728*, Q507*, Q1843*, Q1847*, Q510*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Sep 16, 2015)	criteria provided, single submitter	VCV000011210	X	32364095	X	32345978	11210	26249	rs128625228	NC_000023.11:32345977:G:A
NM_004006.2(DMD):c.2791G>T (p.Glu931Ter)	DMD	E931*, E808*, E923*, E927*	not provided|Duchenne muscular dystrophy	Pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000011209	X	32503048	X	32484931	11209	26248	rs128625227	NC_000023.11:32484930:C:A
DMD, PROMOTER DEL	DMD		Becker muscular dystrophy, atypical	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000011208					11208	26247		
NM_000109.4(DMD):c.3445G>T (p.Glu1149Ter)	DMD	E1157*, E1149*, E1153*, E1034*	Duchenne muscular dystrophy	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000011207	X	32472913	X	32454796	11207	26246	rs128625226	NC_000023.11:32454795:C:A
NM_139058.3(ARX):c.232G>T (p.Glu78Ter)	ARX	E78*	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000011205	X	25031880	X	25013763	11205	26244	rs267606666	NC_000023.11:25013762:C:A
NM_139058.3(ARX):c.1105G>T (p.Glu369Ter)	ARX	E369*	Hydranencephaly with abnormal genitalia	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000011201	X	25028391	X	25010274	11201	26240	rs104894746	NC_000023.11:25010273:C:A
NM_139058.3(ARX):c.998C>A (p.Thr333Asn)	ARX	T333N	Corpus callosum agenesis-abnormal genitalia syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011200	X	25031114	X	25012997	11200	26239	rs104894745	NC_000023.11:25012996:G:T
NM_139058.3(ARX):c.98T>C (p.Leu33Pro)	ARX	L33P	Mental retardation, with or without seizures, ARX-related, X-linked	Pathogenic(Last reviewed: Apr 15, 2002)	no assertion criteria provided	VCV000011198	X	25033757	X	25015640	11198	26237	rs28936077	NC_000023.11:25015639:A:G
NM_139058.3(ARX):c.1028T>A (p.Leu343Gln)	ARX	L343Q	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000011197	X	25031084	X	25012967	11197	26236	rs104894741	NC_000023.11:25012966:A:T
ARX, EX1-2DEL	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000011195					11195	26234		
NM_139058.3(ARX):c.1187dup (p.Gly397fs)	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000011194	X	25025488 - 25025489	X	25007371 - 25007372	11194	26233	rs1328291159	NC_000023.11:25007371:GGGGGG:GGGGGGG
NM_139058.3(ARX):c.1117C>T (p.Gln373Ter)	ARX	Q373*	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000011193	X	25028379	X	25010262	11193	26232	rs104894740	NC_000023.11:25010261:G:A
NM_139058.3(ARX):c.995G>A (p.Arg332His)	ARX	R332H	Lissencephaly 2, X-linked|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011192	X	25031117	X	25013000	11192	26231	rs111033612	NC_000023.11:25012999:C:T
ARX, 32-BP DEL, NT420	ARX		Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000011190					11190	26229		
ARX, 1,517-BP DEL	ARX		Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011189					11189	26228		
NM_139058.3(ARX):c.1058C>T (p.Pro353Leu)	ARX	P353L	Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Aug 13, 2002)	no assertion criteria provided	VCV000011188	X	25031054	X	25012937	11188	26227	rs104894743	NC_000023.11:25012936:G:A
NM_002621.2(CFP):c.1240T>G (p.Tyr414Asp)	CFP	Y387D, Y414D	Properdin deficiency, type III	Pathogenic(Last reviewed: Oct 15, 1996)	no assertion criteria provided	VCV000011185	X	47485461	X	47626062	11185	26224	rs132630261	NC_000023.11:47626061:A:C
NM_002621.2(CFP):c.617C>G (p.Ser206Ter)	CFP	S179*, S206*	Properdin deficiency, X-linked	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000011184	X	47486689	X	47627290	11184	26223	rs132630260	NC_000023.11:47627289:G:C
NM_002621.2(CFP):c.893G>T (p.Gly298Val)	CFP	G271V, G298V	Properdin deficiency, X-linked	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000011183	X	47486219	X	47626820	11183	26222	rs28935480	NC_000023.11:47626819:C:A
NM_002621.2(CFP):c.298C>T (p.Arg100Trp)	CFP	R73W, R100W	Properdin deficiency, type II	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000011182	X	47487606	X	47628207	11182	26221	rs132630259	NC_000023.11:47628206:G:A
NM_002621.2(CFP):c.481C>T (p.Arg161Ter)	CFP	R134*, R161*	Properdin deficiency, X-linked	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000011181	X	47486963	X	47627564	11181	26220	rs132630258	NC_000023.11:47627563:G:A
EMD, 5-BP DEL, NT631	EMD		Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000011180					11180	26219		
NM_000117.2(EMD):c.547C>A (p.Pro183Thr)	EMD	P183T	Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000011179	X	153609339	X	154380979	11179	26218	rs104894806	NC_000023.11:154380978:C:A
NM_000117.2(EMD):c.548C>A (p.Pro183His)	EMD	P183H	Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000011178	X	153609340	X	154380980	11178	26217	rs104894805	NC_000023.11:154380979:C:A
EMD, 1-BP DEL, FS236TER	EMD		Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000011177					11177	26216		
NM_000117.2(EMD):c.130C>T (p.Gln44Ter)	EMD	Q43*, Q44*	not provided|Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Jul 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000011176	X	153608097	X	154379737	11176	26215	rs132630262	NC_000023.11:154379736:C:T
EMD, IVSAS, A-G, -3, 214-BP INS	EMD		Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000011175					11175	26214		
EMD, 2-BP INS, NT198	EMD		Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000011174					11174	26213		
EMD, 29-BP DEL, NT113	EMD		Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000011173					11173	26212		
NM_000117.2(EMD):c.1A>G (p.Met1Val)	EMD	M1V	not provided|Emery-Dreifuss muscular dystrophy 1, X-linked|Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011172	X	153607845	X	154379485	11172	26211	rs267606782	NC_000023.11:154379484:A:G
EMD, 2-BP DEL, NT564	EMD		Emery-Dreifuss muscular dystrophy, X-linked	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000011171					11171	26210		
CD40LG, ALU INS, EX1	CD40LG			Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000011170					11170	26209		
CD40LG, 1-BP INS, TTT-TTTT, FS84TER	CD40LG			Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000011169					11169	26208		
NM_000074.2(CD40LG):c.368C>A (p.Ala123Glu)	CD40LG	A123E		Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000011168	X	135738536	X	136656377	11168	26207	rs104894778	NC_000023.11:136656376:C:A
CD40LG, 10-BP DEL	CD40LG			Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000011167					11167	26206		
CD40LG, 8-BP DEL	CD40LG			Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000011166					11166	26205		
CD40LG, 63-BP DEL	CD40LG			Pathogenic(Last reviewed: Feb 11, 1993)	no assertion criteria provided	VCV000011165					11165	26204		
NM_000074.2(CD40LG):c.419G>A (p.Trp140Ter)	CD40LG	W140*		Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000011163	X	135741207	X	136659048	11163	26202	rs104894775	NC_000023.11:136659047:G:A
CD40LG, THR211ASP	CD40LG	T211D		Pathogenic(Last reviewed: Feb 12, 1993)	no assertion criteria provided	VCV000011161					11161	26200		
NM_000074.2(CD40LG):c.464T>C (p.Leu155Pro)	CD40LG	L155P		Pathogenic(Last reviewed: Feb 12, 1993)	no assertion criteria provided	VCV000011160	X	135741252	X	136659093	11160	26199	rs104894769	NC_000023.11:136659092:T:C
NM_000074.2(CD40LG):c.680G>T (p.Gly227Val)	CD40LG	G227V		Pathogenic(Last reviewed: Feb 12, 1993)	no assertion criteria provided	VCV000011159	X	135741468	X	136659309	11159	26198	rs104894768	NC_000023.11:136659308:G:T
NM_000074.2(CD40LG):c.703G>C (p.Ala235Pro)	CD40LG	A235P		Pathogenic(Last reviewed: Jan 29, 1993)	no assertion criteria provided	VCV000011157	X	135741491	X	136659332	11157	26196	rs104894771	NC_000023.11:136659331:G:C
CHM, L1 INS	CHM		Choroideremia	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011156					11156	26195		
NM_000390.4(CHM):c.877C>T (p.Arg293Ter)	CHM	R294*, R293*, R145*	not provided|Choroideremia	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000011154	X	85212923	X	85957918	11154	26193	rs132630266	NC_000023.11:85957917:G:A
NM_000390.4(CHM):c.1497C>A (p.Cys499Ter)	CHM	C499*, C351*	Choroideremia	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000011153	X	85149206	X	85894201	11153	26192	rs132630267	NC_000023.11:85894200:G:T
NM_000390.4(CHM):c.1580_1583TGTT[1] (p.Val529fs)	CHM		Retinal dystrophy|Choroideremia	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000011152	X	85133992 - 85133995	X	85878987 - 85878990	11152	26191	rs587776746	NC_000023.11:85878986:AACAAACAA:AACAA
CHM, 1-BP DEL, GGA146GA, FS159TER	CHM		Choroideremia	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000011151					11151	26190		
NM_000390.4(CHM):c.1471G>T (p.Glu491Ter)	CHM	E154*, E491*, E343*	Choroideremia	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000011150	X	85149232	X	85894227	11150	26189	rs132630265	NC_000023.11:85894226:C:A
NM_000390.4(CHM):c.1484C>A (p.Ser495Ter)	CHM	S158*, S495*, S347*	Choroideremia	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000011149	X	85149219	X	85894214	11149	26188	rs132630264	NC_000023.11:85894213:G:T
NM_000390.4(CHM):c.1358_1359delinsGA (p.Ser453Ter)	CHM	S116*	Choroideremia	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000011148	X	85155705 - 85155706	X	85900700 - 85900701	11148	26187	rs132630263	NC_000023.11:85900699:GG:TC
CHM, IVS13DS, INS T, +2	CHM		Choroideremia, Salla type	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000011147					11147	26186		
WAS, 1-BP DEL, CODON 241, C	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000011135					11135	26174		
WAS, 1-BP DEL, 758A	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000011134					11134	26173		
NM_000377.2:c.73_74delAC	WAS	T25fs	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Oct 26, 2006)	no assertion criteria provided	VCV000011133	X	48542314 - 48542315	X	48683925 - 48683926	11133	26172		NC_000023.11:48683924:CAC:C
NM_000377.2(WAS):c.11del (p.Gly4fs)	WAS	G4fs	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000011132	X	48542249	X	48683860	11132	26171	rs587776745	NC_000023.11:48683859:GGGGG:GGGG
NM_000377.2:c.559+2T>G	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000011131	X	48544525	X	48686136	11131	26170		NC_000023.11:48686135:T:G
NM_000377.2:c.560-1G>A	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Oct 15, 2002)	no assertion criteria provided	VCV000011130	X	48545169	X	48686780	11130	26169		NC_000023.11:48686779:G:A
WAS, IVS6DS, G-A, +5	WAS		Wiskott-Aldrich syndrome|X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000011129					11129	26168		
WAS, 15,800-BP DEL	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000011128					11128	26167		
NM_000377.2(WAS):c.1442T>A (p.Ile481Asn)	WAS	I481N	Thrombocytopenia, X-linked, intermittent	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000011127	X	48547812	X	48689423	11127	26166	rs132630276	NC_000023.11:48689422:T:A
NM_000377.2(WAS):c.173C>G (p.Pro58Arg)	WAS	P58R	Thrombocytopenia, X-linked, intermittent	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000011126	X	48542712	X	48684323	11126	26165	rs132630275	NC_000023.11:48684322:C:G
NM_000377.2(WAS):c.809T>C (p.Leu270Pro)	WAS	L270P		Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000011125	X	48546720	X	48688331	11125	26164	rs132630274	NC_000023.11:48688330:T:C
NM_000377.2(WAS):c.1097del (p.Gly366fs)	WAS	G366fs	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Jul 15, 1998)	no assertion criteria provided	VCV000011124	X	48547210	X	48688821	11124	26163	rs587776744	NC_000023.11:48688820:GGGGG:GGGG
NM_000377.2(WAS):c.134C>T (p.Thr45Met)	WAS	T45M	X-linked thrombocytopenia with normal platelets|Thrombocytopenia|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome|	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011123	X	48542673	X	48684284	11123	26162	rs132630273	NC_000023.11:48684283:C:T
NM_000377.2(WAS):c.244T>C (p.Ser82Pro)	WAS	S82P	Wiskott-Aldrich syndrome, attenuated	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000011122	X	48542783	X	48684394	11122	26161	rs132630272	NC_000023.11:48684393:T:C
NM_000377.2(WAS):c.395_400dup	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Jul 17, 2001)	no assertion criteria provided	VCV000011121	X	48544149 - 48544150	X	48685760 - 48685761	11121	26160	rs587776743	NC_000023.11:48685760:GACGAGGACGAGG:GACGAGGACGAGGACGAGG
NM_000377.2(WAS):c.1A>T (p.Met1Leu)	WAS	M1L	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000011120	X	48542243	X	48683854	11120	26159	rs587776742	NC_000023.11:48683853:A:T
NM_000377.2(WAS):c.100C>T (p.Arg34Ter)	WAS	R34*	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000011119	X	48542342	X	48683953	11119	26158	rs132630271	NC_000023.11:48683952:C:T
WAS, 1-BP INS, 512C	WAS		X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000011118					11118	26157		
NM_000377.2(WAS):c.707C>G (p.Ala236Gly)	WAS	A236E, A236G	X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000011117	X	48545317	X	48686928	11117	26156	rs132630270	NC_000023.11:48686927:C:G
NM_000377.2(WAS):c.167C>T (p.Ala56Val)	WAS	A56V	X-linked thrombocytopenia with normal platelets	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000011116	X	48542706	X	48684317	11116	26155	rs132630269	NC_000023.11:48684316:C:T
NM_000377.2(WAS):c.257G>A (p.Arg86His)	WAS	R86H	Wiskott-Aldrich syndrome|X-linked thrombocytopenia with normal platelets|Wiskott-Aldrich syndrome||not provided	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011115	X	48542796	X	48684407	11115	26154	rs132630268	NC_000023.11:48684406:G:A
NM_000377.2(WAS):c.257G>T (p.Arg86Leu)	WAS	R86L	Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Jan 16, 2018)	no assertion criteria provided	VCV000011114	X	48542796	X	48684407	11114	26153	rs132630268	NC_000023.11:48684406:G:T
WAS, 1-BP DEL, 211T	WAS		Wiskott-Aldrich syndrome	Pathogenic(Last reviewed: Jan 16, 2018)	no assertion criteria provided	VCV000011113					11113	26152		
NM_000116.5(TAZ):c.647-1G>C	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011112	X	153648550	X	154420211	11112	26151	rs587776741	NC_000023.11:154420210:G:C
NM_000116.5(TAZ):c.605_608del (p.Glu202fs)	TAZ	E158fs, E188fs, E202fs, E206fs, E172fs	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000011111	X	153648390 - 153648393	X	154420051 - 154420054	11111	26150		NC_000023.11:154420050:TGAGTG:TG
NM_000116.5(TAZ):c.280C>A (p.Arg94Ser)	TAZ	R94S, R112S	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000011110	X	153641585	X	154413248	11110	26149	rs104894942	NC_000023.11:154413247:C:A
NM_000116.5(TAZ):c.352T>C (p.Cys118Arg)	TAZ	C118R, C136R	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Mar 6, 2001)	no assertion criteria provided	VCV000011108	X	153641886	X	154413549	11108	26147	rs104894937	NC_000023.11:154413548:T:C
NM_000116.5(TAZ):c.284+110G>A	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000011107	X	153641699	X	154413362	11107	26146		NC_000023.11:154413361:G:A
TAZ, IVS1DS, G-C, +5	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000011106					11106	26145		
NM_000116.5(TAZ):c.589G>A (p.Gly197Arg)	TAZ	G197R, G153R, G201R, G183R, G167R	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000011105	X	153648376	X	154420037	11105	26144	rs132630277	NC_000023.11:154420036:G:A
TAZ, 1-BP DEL	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000011104					11104	26143		
TAZ, 1-BP INS, NT868	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000011103					11103	26142		
NM_000116.5(TAZ):c.239-1G>C	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000011102	X	153641543	X	154413206	11102	26141		NC_000023.11:154413205:G:C
NM_000116.5(TAZ):c.153C>G (p.Tyr51Ter)	TAZ	Y51*, Y69*	3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000011101	X	153640466	X	154412129	11101	26140	rs104894941	NC_000023.11:154412128:C:G
NM_000116.5(TAZ):c.239-1G>A	TAZ		3-Methylglutaconic aciduria type 2	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000011100	X	153641543	X	154413206	11100	26139		NC_000023.11:154413205:G:A
PLP1, IVS3, 19-BP DEL, +28	PLP1		Pelizaeus-Merzbacher disease, atypical	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000011097					11097	26136		
PLP1, DUP	PLP1		Pelizaeus-Merzbacher disease	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000011093					11093	26132		
PLP1, DEL	PLP1		Pelizaeus-Merzbacher disease	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000011078					11078	26117		
NM_001015877.2(PHF6):c.27dup (p.Gly10fs)	PHF6		Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000011072	X	133511668 - 133511669	X	134377638 - 134377639	11072	26111		NC_000023.11:134377638:AAAAAA:AAAAAAA
NM_001015877.2(PHF6):c.139-8A>G	PHF6		Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000011071	X	133512027	X	134377997	11071	26110		NC_000023.11:134377996:A:G
NM_001015877.2(PHF6):c.22A>T (p.Lys8Ter)	PHF6	K8*	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011070	X	133511669	X	134377639	11070	26109	rs132630301	NC_000023.11:134377638:A:T
NM_001015877.2(PHF6):c.769A>G (p.Arg257Gly)	PHF6	R257G, R258G	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000011069	X	133549085	X	134415055	11069	26108	rs104894919	NC_000023.11:134415054:A:G
NM_001015877.2(PHF6):c.2T>C (p.Met1Thr)	PHF6	M1Y, M1T	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000011068	X	133511649	X	134377619	11068	26107	rs132630300	NC_000023.11:134377618:T:C
NM_001015877.2(PHF6):c.686A>G (p.His229Arg)	PHF6	H229R, H230R	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011067	X	133547953	X	134413923	11067	26106	rs104894918	NC_000023.11:134413922:A:G
NM_001015877.2(PHF6):c.134G>A (p.Cys45Tyr)	PHF6	C45Y	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011066	X	133511781	X	134377751	11066	26105	rs132630299	NC_000023.11:134377750:G:A
NM_001015877.2(PHF6):c.700A>G (p.Lys234Glu)	PHF6	K234E, K235E	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011065	X	133547967	X	134413937	11065	26104	rs104894917	NC_000023.11:134413936:A:G
NM_001015877.2(PHF6):c.296G>T (p.Cys99Phe)	PHF6	C99F	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011064	X	133527586	X	134393556	11064	26103	rs132630298	NC_000023.11:134393555:G:T
NM_001015877.2(PHF6):c.1024C>T (p.Arg342Ter)	PHF6	R342*	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011063	X	133559286	X	134425256	11063	26102	rs132630297	NC_000023.11:134425255:C:T
NM_000252.2(MTM1):c.469G>A (p.Glu157Lys)	MTM1	E157K	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011062	X	149807440	X	150638967	11062	26101	rs132630307	NC_000023.11:150638966:G:A
NM_000252.2(MTM1):c.605del (p.Leu202fs)	MTM1	L202fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Apr 22, 2003)	no assertion criteria provided	VCV000011061	X	149809815	X	150641342	11061	26100	rs672601325	NC_000023.11:150641341:TTTT:TTT
NM_000252.2(MTM1):c.670C>T (p.Arg224Ter)	MTM1	R224*	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011060	X	149809883	X	150641410	11060	26099	rs132630306	NC_000023.11:150641409:C:T
NM_000252.2(MTM1):c.721C>T (p.Arg241Cys)	MTM1	R241C	Severe X-linked myotubular myopathy|not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011059	X	149814198	X	150645725	11059	26098	rs132630305	NC_000023.11:150645724:C:T
NM_000252.2(MTM1):c.1261-10A>G	MTM1		not provided|Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011058	X	149828127	X	150659654	11058	26097	rs397518445	NC_000023.11:150659653:A:G
NM_000252.2(MTM1):c.141_144del (p.Glu48fs)	MTM1	E48fs	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011057	X	149767058 - 149767061	X	150598594 - 150598597	11057	26096	rs587783791	NC_000023.11:150598593:AAAGAA:AA
NM_000252.2(MTM1):c.205C>T (p.Arg69Cys)	MTM1	R69C	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011055	X	149767124	X	150598660	11055	26094	rs132630304	NC_000023.11:150598659:C:T
NM_000252.2(MTM1):c.1190A>G (p.Tyr397Cys)	MTM1	Y415C, Y397C	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000011054	X	149826430	X	150657957	11054	26093	rs132630303	NC_000023.11:150657956:A:G
NM_000252.2(MTM1):c.566A>G (p.Asn189Ser)	MTM1	N207S, N189S	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011053	X	149809779	X	150641306	11053	26092	rs132630302	NC_000023.11:150641305:A:G
NM_001353921.2(ARHGEF9):c.185G>C (p.Gly62Ala)	ARHGEF9	G55A, G34A, G62A, G68A	Early infantile epileptic encephalopathy 8	Pathogenic(Last reviewed: Jun 23, 2004)	no assertion criteria provided	VCV000011049	X	62944437	X	63724557	11049	26088	rs121918361	NC_000023.11:63724556:C:G
NM_001399.5(EDA):c.1013C>T (p.Thr338Met)	EDA	T338M, T333M, T336M	Tooth agenesis, selective, X-linked, 1	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000011048	X	69255296	X	70035446	11048	26087	rs132630321	NC_000023.11:70035445:C:T
NM_001399.5(EDA):c.910_911TA[3] (p.Ser305fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000011047	X	69253363 - 69253364	X	70033513 - 70033514	11047	26086	rs1569406514	NC_000023.11:70033513:TATA:TATATA
NM_001399.5(EDA):c.573_574insT (p.Gly192fs)	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000011046	X	69247753 - 69247754	X	70027903 - 70027904	11046	26085	rs1569404873	NC_000023.11:70027903::T
NM_001399.5(EDA):c.1072C>G (p.Gln358Glu)	EDA	Q358E, Q353E, Q356E	Tooth agenesis, selective, X-linked, 1	Pathogenic(Last reviewed: Feb 15, 2007)	no assertion criteria provided	VCV000011045	X	69255355	X	70035505	11045	26084	rs132630320	NC_000023.11:70035504:C:G
NM_001399.5(EDA):c.193C>G (p.Arg65Gly)	EDA	R65G	Tooth agenesis, selective, X-linked, 1	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000011044	X	68836345	X	69616501	11044	26083	rs132630319	NC_000023.11:69616500:C:G
EDA, 1-BP DEL, EX6	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000011043					11043	26082		
EDA, 36-BP DEL, EX5	EDA		Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Sep 15, 2003)	no assertion criteria provided	VCV000011042					11042	26081		
NM_001399.5(EDA):c.183C>G (p.Tyr61Ter)	EDA	Y61*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000011041	X	68836335	X	69616491	11041	26080	rs132630318	NC_000023.11:69616490:C:G
NM_001399.5(EDA):c.1045G>A (p.Ala349Thr)	EDA	A349T, A344T, A347T	not provided|Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011040	X	69255328	X	70035478	11040	26079	rs132630317	NC_000023.11:70035477:G:A
NM_001399.5(EDA):c.671G>C (p.Gly224Ala)	EDA	G224A	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000011039	X	69247851	X	70028001	11039	26078	rs132630316	NC_000023.11:70028000:G:C
NM_001399.5(EDA):c.467G>A (p.Arg156His)	EDA	R156H	Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011037	X	69176947	X	69957097	11037	26076	rs132630314	NC_000023.11:69957096:G:A
NM_001399.5(EDA):c.466C>T (p.Arg156Cys)	EDA	R156C	Hypohidrotic X-linked ectodermal dysplasia|not provided	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011036	X	69176946	X	69957096	11036	26075	rs132630313	NC_000023.11:69957095:C:T
NM_001399.5(EDA):c.463C>T (p.Arg155Cys)	EDA	R155C	Hypohidrotic X-linked ectodermal dysplasia|Hypohidrotic X-linked ectodermal dysplasia|Tooth agenesis, selective, X-linked, 1|not provided	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011035	X	69176943	X	69957093	11035	26074	rs132630312	NC_000023.11:69957092:C:T
NM_001399.5(EDA):c.187G>A (p.Glu63Lys)	EDA	E63K	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000011034	X	68836339	X	69616495	11034	26073	rs132630311	NC_000023.11:69616494:G:A
NM_001399.5(EDA):c.67C>T (p.Gln23Ter)	EDA	Q23*	Hypohidrotic X-linked ectodermal dysplasia	Pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000011033	X	68836219	X	69616375	11033	26072	rs132630310	NC_000023.11:69616374:C:T
NHS, 4.8-KB DEL	NHS		Cataract 40	Pathogenic(Last reviewed: Jul 15, 2009)	no assertion criteria provided	VCV000011030					11030	26069		
NHS, 500-KB TRIPLICATION	NHS		Cataract 40	Pathogenic(Last reviewed: Jul 15, 2009)	no assertion criteria provided	VCV000011029					11029	26068		
NM_198270.4(NHS):c.853-2A>G	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000011028	X	17739559	X	17721439	11028	26067	rs786205257	NC_000023.11:17721438:A:G
NM_198270.4(NHS):c.115C>T (p.Gln39Ter)	NHS	Q39*	Nance-Horan syndrome	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000011027	X	17393995	X	17375872	11027	26066	rs104894881	NC_000023.11:17375871:C:T
NM_198270.4(NHS):c.718+1dup	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000011026	X	17706013 - 17706014	X	17687893 - 17687894	11026	26065	rs1556030707	NC_000023.11:17687893:GG:GGG
NM_198270.4(NHS):c.1117C>T (p.Arg373Ter)	NHS	R378*, R217*, R373*, R196*, R394*	Nance-Horan syndrome|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011025	X	17742490	X	17724370	11025	26064	rs132630322	NC_000023.11:17724369:C:T
NM_198270.4(NHS):c.3459del (p.Leu1154fs)	NHS	L977fs, L1154fs, L998fs, L1175fs	Nance-Horan syndrome	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000011024	X	17745747	X	17727627	11024	26063	rs786205256	NC_000023.11:17727626:CC:C
NM_198270.4(NHS):c.2387dup (p.Ser797fs)	NHS		Nance-Horan syndrome	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000011023	X	17744675 - 17744676	X	17726555 - 17726556	11023	26062	rs786205255	NC_000023.11:17726555:C:CC
NM_001184880.2(PCDH19):c.1671C>G (p.Asn557Lys)	PCDH19	N557K	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000011022	X	99661925	X	100406927	11022	26061	rs267606933	NC_000023.11:100406926:G:C
PCDH19, 5-BP DUP, NT1036	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000011021					11021	26060		
NM_001184880.2(PCDH19):c.142G>T (p.Glu48Ter)	PCDH19	E48*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000011020	X	99663454	X	100408456	11020	26059	rs132630326	NC_000023.11:100408455:C:A
NM_001184880.2(PCDH19):c.2030dup (p.Leu677fs)	PCDH19		Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011019	X	99661565 - 99661566	X	100406567 - 100406568	11019	26058	rs1569314152	NC_000023.11:100406567:AA:AAA
NM_001184880.2(PCDH19):c.2012C>G (p.Ser671Ter)	PCDH19	S671*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011018	X	99661584	X	100406586	11018	26057	rs132630325	NC_000023.11:100406585:G:C
NM_001184880.2(PCDH19):c.253C>T (p.Gln85Ter)	PCDH19	Q85*	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011017	X	99663343	X	100408345	11017	26056	rs132630324	NC_000023.11:100408344:G:A
NM_001184880.2(PCDH19):c.1322T>A (p.Val441Glu)	PCDH19	V441E	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011016	X	99662274	X	100407276	11016	26055	rs132630323	NC_000023.11:100407275:A:T
NM_000531.6(OTC):c.119G>A (p.Arg40His)	OTC	R40H	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011014	X	38226585	X	38367332	11014	26053	rs72554308	NC_000023.11:38367331:G:A
NM_000531.6(OTC):c.617T>G (p.Met206Arg)	OTC	M206R	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Aug 27, 1999)	no assertion criteria provided	VCV000011012	X	38262947	X	38403694	11012	26051	rs72558412	NC_000023.11:38403693:T:G
NM_000531.6(OTC):c.444G>C (p.Leu148Phe)	OTC	L148F	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Mar 17, 1997)	no assertion criteria provided	VCV000011011	X	38260585	X	38401332	11011	26050	rs66741318	NC_000023.11:38401331:G:C
NM_000531.6(OTC):c.386G>A (p.Arg129His)	OTC	R129H	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000011010	X	38240682	X	38381429	11010	26049	rs66656800	NC_000023.11:38381428:G:A
NM_000531.6(OTC):c.1033T>G (p.Tyr345Asp)	OTC	Y313D, Y345D	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000011009	X	38280303	X	38421050	11009	26048	rs66469337	NC_000023.11:38421049:T:G
NM_000531.6(OTC):c.281G>C (p.Arg94Thr)	OTC	R62T, R94T	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000011007	X	38229113	X	38369860	11007	26046	rs72554345	NC_000023.11:38369859:G:C
NM_000531.6(OTC):c.236G>A (p.Gly79Glu)	OTC	G47E, G79E	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000011006	X	38229068	X	38369815	11006	26045	rs72554331	NC_000023.11:38369814:G:A
NM_000531.6(OTC):c.484G>A (p.Gly162Arg)	OTC	G162R	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000011003	X	38260625	X	38401372	11003	26042	rs66626662	NC_000023.11:38401371:G:A
NM_000531.6(OTC):c.148G>T (p.Gly50Ter)	OTC	G50*	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000011002	X	38226614	X	38367361	11002	26041	rs67486158	NC_000023.11:38367360:G:T
NM_000531.6(OTC):c.259G>A (p.Glu87Lys)	OTC	E87K	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000011001	X	38229091	X	38369838	11001	26040	rs72554338	NC_000023.11:38369837:G:A
NM_000531.6(OTC):c.674C>T (p.Pro225Leu)	OTC	P225L	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Sep 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011000	X	38268005	X	38408752	11000	26039	rs67120076	NC_000023.11:38408751:C:T
NM_000531.6(OTC):c.829C>T (p.Arg277Trp)	OTC	R277W, R245W	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000010999	X	38268240	X	38408987	10999	26038	rs72558454	NC_000023.11:38408986:C:T
NM_000531.6(OTC):c.387-2A>T	OTC		Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010998	X	38260526	X	38401273	10998	26037	rs66556380	NC_000023.11:38401272:A:T
NM_000531.6(OTC):c.717+2T>C	OTC		Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010996	X	38268050	X	38408797	10996	26035	rs72558431	NC_000023.11:38408796:T:C
NM_000531.6(OTC):c.77G>A (p.Arg26Gln)	OTC	R26Q	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010993	X	38212026	X	38352773	10993	26032	rs68031618	NC_000023.11:38352772:G:A
NM_000531.6(OTC):c.134T>C (p.Leu45Pro)	OTC	L45P	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000010992	X	38226600	X	38367347	10992	26031	rs72554312	NC_000023.11:38367346:T:C
NM_000531.6(OTC):c.460G>T (p.Glu154Ter)	OTC	E154*	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000010991	X	38260601	X	38401348	10991	26030	rs72556267	NC_000023.11:38401347:G:T
NM_000531.6(OTC):c.646C>G (p.Gln216Glu)	OTC	Q216E	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000010990	X	38262976	X	38403723	10990	26029	rs72558423	NC_000023.11:38403722:C:G
NM_000531.6(OTC):c.332T>C (p.Leu111Pro)	OTC	L111P	Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Jan 26, 2017)	no assertion criteria provided	VCV000010989	X	38240628	X	38381375	10989	26028	rs1800324	NC_000023.11:38381374:T:C
NM_000531.6(OTC):c.421C>T (p.Arg141Ter)	OTC	R109*, R141*	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000010988	X	38260562	X	38401309	10988	26027	rs67960011	NC_000023.11:38401308:C:T
NM_000531.6(OTC):c.422G>A (p.Arg141Gln)	OTC	R109Q, R141Q	Ornithine carbamoyltransferase deficiency|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010987	X	38260563	X	38401310	10987	26026	rs68026851	NC_000023.11:38401309:G:A
OTC, DEL	OTC		Ornithine carbamoyltransferase deficiency	Pathogenic(Last reviewed: Aug 1, 1990)	no assertion criteria provided	VCV000010986					10986	26025		
NM_005710.2(PQBP1):c.194A>G (p.Tyr65Cys)	PQBP1	Y65C, Y57C	Renpenning syndrome 1	Pathogenic(Last reviewed: Jun 18, 2010)	no assertion criteria provided	VCV000010985	X	48759221	X	48901944	10985	26024	rs121917899	NC_000023.11:48901943:A:G
NM_005710.2(PQBP1):c.547_569del (p.Glu183fs)	PQBP1	E183fs, E175fs, E83fs	Renpenning syndrome 1	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000010983	X	48759761 - 48759783	X	48902484 - 48902506	10983	26022	rs606231197	NC_000023.11:48902483:GAGGAGCTGGCTCCCTATCCCAAGAG:GAG
NM_005710.2(PQBP1):c.640dup (p.Arg214fs)	PQBP1		Renpenning syndrome 1|not provided	Pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010982	X	48760065 - 48760066	X	48902788 - 48902789	10982	26021	rs606231196	NC_000023.11:48902788:CCCCCC:CCCCCCC
NM_005710.2(PQBP1):c.451_452AG[5] (p.Glu154fs)	PQBP1		Renpenning syndrome 1	Pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000010981	X	48759668 - 48759669	X	48902391 - 48902392	10981	26020	rs606231193	NC_000023.11:48902390:AGAGAGAGAGAG:AGAGAGAGAG
NM_144495.2(PQBP1):c.293-341AG[4]	PQBP1		Inborn genetic diseases|Intellectual disability|Renpenning syndrome 1|Microcephaly|Hyperactivity|Delayed speech and language development|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010980	X	48759668 - 48759671	X	48902391 - 48902394	10980	26019	rs606231193	NC_000023.11:48902390:AGAGAGAGAGAG:AGAGAGAG
NM_144495.2(PQBP1):c.293-341AG[7]	PQBP1		Renpenning syndrome 1|not provided	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000010979	X	48759667 - 48759668	X	48902390 - 48902391	10979	26018	rs606231193	NC_000023.11:48902390:AGAGAGAGAGAG:AGAGAGAGAGAGAG
NM_000475.5(NR0B1):c.109C>T (p.Gln37Ter)	NR0B1	Q37*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000010977	X	30327372	X	30309255	10977	26016	rs104894908	NC_000023.11:30309254:G:A
NM_000475.5(NR0B1):c.890T>C (p.Leu297Pro)	NR0B1	L297P	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Feb 27, 2010)	no assertion criteria provided	VCV000010976	X	30326591	X	30308474	10976	26015	rs104894907	NC_000023.11:30308473:A:G
NM_000475.5(NR0B1):c.1197C>A (p.Tyr399Ter)	NR0B1	Y399*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000010975	X	30322912	X	30304795	10975	26014	rs104894906	NC_000023.11:30304794:G:T
NR0B1, 2.2-KB DEL/27-BP INS	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000010974					10974	26013		
NM_000475.5(NR0B1):c.1138T>G (p.Tyr380Asp)	NR0B1	Y380D	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000010973	X	30326343	X	30308226	10973	26012	rs104894900	NC_000023.11:30308225:A:C
NR0B1, 1-BP INS, 430G	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000010972					10972	26011		
NM_000475.5(NR0B1):c.1142T>A (p.Leu381His)	NR0B1	L381H	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 1, 2000)	no assertion criteria provided	VCV000010971	X	30326339	X	30308222	10971	26010	rs104894899	NC_000023.11:30308221:A:T
NM_000475.5(NR0B1):c.501del (p.Gly169fs)	NR0B1	G169fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000010970	X	30326980	X	30308863	10970	26009	rs1569268976	NC_000023.11:30308862:T:
NM_000475.5(NR0B1):c.1316T>G (p.Ile439Ser)	NR0B1	I439S	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000010969	X	30322793	X	30304676	10969	26008	rs104894897	NC_000023.11:30304675:A:C
NM_000475.5(NR0B1):c.591C>A (p.Tyr197Ter)	NR0B1	Y197*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000010968	X	30326890	X	30308773	10968	26007	rs104894898	NC_000023.11:30308772:G:T
NM_000475.5(NR0B1):c.1231_1234del (p.Leu411fs)	NR0B1	L411fs	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000010967	X	30322875 - 30322878	X	30304758 - 30304761	10967	26006	rs1569268070	NC_000023.11:30304757:TGAGT:T
NR0B1, DEL	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010966					10966	26005		
NM_000475.5(NR0B1):c.873G>C (p.Trp291Cys)	NR0B1	W291C	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010965	X	30326608	X	30308491	10965	26004	rs28935482	NC_000023.11:30308490:C:G
NM_000475.5(NR0B1):c.1146G>T (p.Lys382Asn)	NR0B1	K382N	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010964	X	30326335	X	30308218	10964	26003	rs104894896	NC_000023.11:30308217:C:A
NR0B1, 2-BP DEL, 388AG	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010963					10963	26002		
NR0B1, DUP	NR0B1		46,XY sex reversal, type 2	Pathogenic(Last reviewed: Feb 19, 1998)	no assertion criteria provided	VCV000010962					10962	26001		
NR0B1, 1-BP DEL, 1169C	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000010961					10961	26000		
NR0B1, 2-BP DEL, 1610AG, AND 1-BP INS	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000010960					10960	25999		
NM_000475.5(NR0B1):c.813C>G (p.Tyr271Ter)	NR0B1	Y271*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000010959	X	30326668	X	30308551	10959	25998	rs104894895	NC_000023.11:30308550:G:C
NM_000475.5(NR0B1):c.1183C>T (p.Gln395Ter)	NR0B1	Q395*	Congenital adrenal hypoplasia, X-linked|not provided	Pathogenic(Last reviewed: Jul 20, 2016)	criteria provided, single submitter	VCV000010958	X	30322926	X	30304809	10958	25997	rs104894894	NC_000023.11:30304808:G:A
NM_000475.5(NR0B1):c.1319A>T (p.Asn440Ile)	NR0B1	N440I	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000010957	X	30322790	X	30304673	10957	25996	rs28935481	NC_000023.11:30304672:T:A
NM_000475.5(NR0B1):c.273C>A (p.Tyr91Ter)	NR0B1	Y91*	Congenital adrenal hypoplasia, X-linked|not provided	Pathogenic(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	VCV000010956	X	30327208	X	30309091	10956	25995	rs104894892	NC_000023.11:30309090:G:T
NR0B1, 1-BP DEL	NR0B1		Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000010955					10955	25994		
NM_000475.5(NR0B1):c.513G>A (p.Trp171Ter)	NR0B1	W171*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000010954	X	30326968	X	30308851	10954	25993	rs104894891	NC_000023.11:30308850:C:T
NM_000475.5(NR0B1):c.704G>A (p.Trp235Ter)	NR0B1	W235*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 15, 1994)	no assertion criteria provided	VCV000010953	X	30326777	X	30308660	10953	25992	rs104894889	NC_000023.11:30308659:C:T
NM_000475.5(NR0B1):c.800G>C (p.Arg267Pro)	NR0B1	R267P	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000010952	X	30326681	X	30308564	10952	25991	rs104894888	NC_000023.11:30308563:C:G
NM_000475.5(NR0B1):c.788T>A (p.Leu263Ter)	NR0B1	L263*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 15, 1994)	no assertion criteria provided	VCV000010951	X	30326693	X	30308576	10951	25990	rs104894887	NC_000023.11:30308575:A:T
NM_000475.5(NR0B1):c.1107G>A (p.Trp369Ter)	NR0B1	W369*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 15, 1994)	no assertion criteria provided	VCV000010950	X	30326374	X	30308257	10950	25989	rs104894886	NC_000023.11:30308256:C:T
NM_000475.5(NR0B1):c.847C>T (p.Gln283Ter)	NR0B1	Q283*	Congenital adrenal hypoplasia, X-linked	Pathogenic(Last reviewed: Dec 15, 1994)	no assertion criteria provided	VCV000010949	X	30326634	X	30308517	10949	25988	rs104894890	NC_000023.11:30308516:G:A
NM_000167.5(GK):c.862A>G (p.Asn288Asp)	GK	N288D, N294D	Deficiency of glycerol kinase	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000010948	X	30725701	X	30707584	10948	25987	rs132630331	NC_000023.11:30707583:A:G
NM_001128127.2(GK):c.42765-52ins316	GK		Deficiency of glycerol kinase	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000010947					10947	25986		
NM_000167.5(GK):c.1507T>C (p.Trp503Arg)	GK	W503R, W509R	Deficiency of glycerol kinase	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000010946	X	30742241	X	30724124	10946	25985	rs132630330	NC_000023.11:30724123:T:C
NM_000167.5(GK):c.1237C>T (p.Arg413Ter)	GK	R413*, R419*	Deficiency of glycerol kinase	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000010945	X	30738756	X	30720639	10945	25984	rs132630329	NC_000023.11:30720638:C:T
NC_000023.11:g.(30700906_30707555)_(30728743_?)del	GK		Deficiency of glycerol kinase	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000010944			X	30700906 - 30728743	10944	25983		
NM_000167.5(GK):c.1319A>T (p.Asp440Val)	GK	D440V, D446V	Deficiency of glycerol kinase	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000010943	X	30738838	X	30720721	10943	25982	rs132630328	NC_000023.11:30720720:A:T
NC_000023.11:g.(30720096_30720620)_(30720742_30720851)del	GK		Deficiency of glycerol kinase	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000010942	X	30738213 - 30738968	X	30720096 - 30720851	10942	25981		
NM_000167.5(GK):c.553-1G>C	GK		Deficiency of glycerol kinase	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000010941	X	30714158	X	30696041	10941	25980	rs587776740	NC_000023.11:30696040:G:C
NM_000397.3(CYBB):c.90_92delinsGGT (p.Tyr30_Arg31delinsTer)	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000010940	X	37641385 - 37641387	X	37782132 - 37782134	10940	25979	rs387906486	NC_000023.11:37782131:CCG:GGT
NM_000397.3(CYBB):c.45+6T>C	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000010939	X	37639381	X	37780128	10939	25978	rs1569478551	NC_000023.11:37780127:T:C
CYBB, EX4, L1 INS	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000010938					10938	25977		
CYBB, IVS5, G-T, +978	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Sep 28, 2001)	no assertion criteria provided	VCV000010937					10937	25976		
NM_000397.3(CYBB):c.907C>A (p.His303Asn)	CYBB	H303N	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000010936	X	37663139	X	37803886	10936	25975	rs137854595	NC_000023.11:37803885:C:A
CYBB, IN5, L1 INS	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000010934					10934	25973		
NM_000397.3(CYBB):c.252G>A (p.Ala84=)	CYBB		Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010933	X	37642853	X	37783600	10933	25972	rs387906485	NC_000023.11:37783599:G:A
NM_000397.3(CYBB):c.301C>T (p.His101Tyr)	CYBB	H101Y	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010932	X	37651276	X	37792023	10932	25971	rs137854594	NC_000023.11:37792022:C:T
NM_000397.3(CYBB):c.1499A>G (p.Asp500Gly)	CYBB	D500G	Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000010931	X	37668857	X	37809604	10931	25970	rs137854593	NC_000023.11:37809603:A:G
NM_000397.3:c.252+5G>A	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000010930	X	37642858	X	37783605	10930	25969		NC_000023.11:37783604:G:A
NM_000397.3(CYBB):c.676C>T (p.Arg226Ter)	CYBB	R226*	Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010929	X	37658209	X	37798956	10929	25968	rs137854592	NC_000023.11:37798955:C:T
CYBB, EX12DEL	CYBB		Chronic granulomatous disease, X-linked	Pathogenic(Last reviewed: Dec 19, 1991)	no assertion criteria provided	VCV000010928					10928	25967		
NM_000397.3(CYBB):c.911C>G (p.Pro304Arg)	CYBB	P304R	Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000010927	X	37663143	X	37803890	10927	25966	rs137854596	NC_000023.11:37803889:C:G
NM_000397.3(CYBB):c.302A>G (p.His101Arg)	CYBB	H101R	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010926	X	37651277	X	37792024	10926	25965	rs137854591	NC_000023.11:37792023:A:G
NM_000397.3(CYBB):c.466G>A (p.Ala156Thr)	CYBB	A156T	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010925	X	37653046	X	37793793	10925	25964	rs137854590	NC_000023.11:37793792:G:A
NM_000397.3(CYBB):c.731G>C (p.Cys244Ser)	CYBB	C244S	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010924	X	37658264	X	37799011	10924	25963	rs137854589	NC_000023.11:37799010:G:C
NM_000397.3(CYBB):c.217C>T (p.Arg73Ter)	CYBB	R73*	Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010923	X	37642818	X	37783565	10923	25962	rs137854588	NC_000023.11:37783564:C:T
NM_000397.3(CYBB):c.625C>T (p.His209Tyr)	CYBB	H209Y	Chronic granulomatous disease, X-linked|not provided	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010922	X	37655345	X	37796092	10922	25961	rs137854587	NC_000023.11:37796091:C:T
NM_000397.3(CYBB):c.1166G>C (p.Gly389Ala)	CYBB	G389A	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000010921	X	37664273	X	37805020	10921	25960	rs137854586	NC_000023.11:37805019:G:C
NM_000397.3(CYBB):c.1244C>A (p.Pro415His)	CYBB	P415H	not provided|Granulomatous disease, chronic, X-linked, variant	Pathogenic(Last reviewed: Feb 19, 2019)	no assertion criteria provided	VCV000010920	X	37664351	X	37805098	10920	25959	rs137854585	NC_000023.11:37805097:C:A
NM_001123383.1(BCOR):c.2613del (p.Phe871fs)	BCOR	F871fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Jul 30, 2005)	no assertion criteria provided	VCV000010919	X	39931986	X	40072733	10919	25958	rs730880013	NC_000023.11:40072732:G:
BCOR, 60-KB DEL	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000010918					10918	25957		
NM_001123383.1(BCOR):c.3286del (p.Glu1096fs)	BCOR	E1096fs, E1078fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000010917	X	39923805	X	40064552	10917	25956		NC_000023.11:40064551:C:
BCOR, EX9-15DEL	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000010915					10915	25954		
NM_001123383.1(BCOR):c.3881del (p.Gln1294fs)	BCOR	Q1276fs, Q1294fs, Q1328fs	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000010914	X	39922189	X	40062936	10914	25953		NC_000023.11:40062935:T:
NM_001123383.1(BCOR):c.2926C>T (p.Arg976Ter)	BCOR	R976*	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000010913	X	39931673	X	40072420	10913	25952	rs121434619	NC_000023.11:40072419:G:A
NM_001123383.1(BCOR):c.4072-1G>T	BCOR		Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000010912	X	39921647	X	40062394	10912	25951	rs1569146193	NC_000023.11:40062393:C:A
NM_001123383.1(BCOR):c.254C>T (p.Pro85Leu)	BCOR	P85L	Oculofaciocardiodental syndrome	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	VCV000010911	X	39934345	X	40075092	10911	25950	rs121434618	NC_000023.11:40075091:G:A
NM_002351.4(SH2D1A):c.164G>T (p.Arg55Leu)	SH2D1A	R55L	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000010910	X	123499637	X	124365787	10910	25949	rs111033630	NC_000023.11:124365786:G:T
SH2D1A, 163C-T	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Aug 7, 2000)	no assertion criteria provided	VCV000010909					10909	25948		
NM_002351.4(SH2D1A):c.3G>T (p.Met1Ile)	SH2D1A	M1I	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Aug 7, 2000)	no assertion criteria provided	VCV000010908	X	123480495	X	124346645	10908	25947	rs111033629	NC_000023.11:124346644:G:T
SH2D1A, EX1DEL	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000010907					10907	25946		
NM_002351.4(SH2D1A):c.-10C>T	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010906	X	123480483	X	124346633	10906	25945		NC_000023.11:124346632:C:T
NM_002351.4(SH2D1A):c.203C>T (p.Thr68Ile)	SH2D1A	T68I	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010905	X	123504027	X	124370177	10905	25944	rs111033627	NC_000023.11:124370176:C:T
NM_002351.4(SH2D1A):c.302C>T (p.Pro101Leu)	SH2D1A	P101L	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010904	X	123504126	X	124370276	10904	25943	rs111033626	NC_000023.11:124370275:C:T
NM_002351.4(SH2D1A):c.385T>A (p.Ter129Arg)	SH2D1A	*129R, *126R	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010903	X	123505239	X	124371389	10903	25942	rs111033625	NC_000023.11:124371388:T:A
NM_002351.4(SH2D1A):c.138-1G>T	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010902	X	123499610	X	124365760	10902	25941		NC_000023.11:124365759:G:T
NM_002351.4(SH2D1A):c.95G>C (p.Arg32Thr)	SH2D1A	R32T	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010901	X	123480587	X	124346737	10901	25940	rs111033624	NC_000023.11:124346736:G:C
SH2D1A, 159-BP DEL	SH2D1A		Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010900					10900	25939		
NM_002351.4(SH2D1A):c.172C>T (p.Gln58Ter)	SH2D1A	Q58*	Lymphoproliferative syndrome 1, X-linked	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010899	X	123499645	X	124365795	10899	25938	rs111033628	NC_000023.11:124365794:C:T
NM_002351.4(SH2D1A):c.163C>T (p.Arg55Ter)	SH2D1A	R55*	Lymphoproliferative syndrome 1, X-linked|X-Linked Lymphoproliferative Syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000010898	X	123499636	X	124365786	10898	25937	rs111033623	NC_000023.11:124365785:C:T
NM_012280.4(FTSJ1):c.192-2A>G	FTSJ1		Mental retardation 9, X-linked	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000010897	X	48337003	X	48478615	10897	25936		NC_000023.11:48478614:A:G
FTSJ1, IVS2, G DEL, +1	FTSJ1		Mental retardation 9, X-linked	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000010896					10896	25935		
NM_012280.4(FTSJ1):c.196C>T (p.Gln66Ter)	FTSJ1	Q66*	Mental retardation 9, X-linked	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000010895	X	48337009	X	48478621	10895	25934		NC_000023.11:48478620:C:T
FTSJ1, EX9DEL	FTSJ1		Mental retardation 9, X-linked	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000010894					10894	25933		
NM_000284.4(PDHA1):c.648A>C (p.Leu216Phe)	PDHA1	L216F, L185F, L223F, L254F	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Oct 9, 2002)	no assertion criteria provided	VCV000010893	X	19373511	X	19355393	10893	25932	rs121917898	NC_000023.11:19355392:A:C
NM_000284.4(PDHA1):c.*79_*90dup	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000010891	X	19377849 - 19377850	X	19359731 - 19359732	10891	25930	rs1555935690	NC_000023.11:19359731:AGTCAATGAAAT:AGTCAATGAAATAGTCAATGAAAT
NM_000284.4(PDHA1):c.863G>A (p.Arg288His)	PDHA1	R288H, R326H, R257H, R295H	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000010890	X	19375801	X	19357683	10890	25929	rs137853258	NC_000023.11:19357682:G:A
NM_000284.4(PDHA1):c.1074_1109dup (p.Pro359_Ser370dup)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000010889	X	19377671 - 19377672	X	19359553 - 19359554	10889	25928	rs606231191	NC_000023.11:19359553:GCCACCTTTGGAAGAGCTGGGCTACCACATCTACTC:GCCACCTTTGGAAGAGCTGGGCTACCACATCTACTCGCCACCTTTGGAAGAGCTGGGCTACCACATCTACTC
PDHA1, 13-BP INS, EX10	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000010888					10888	25927		
NM_000284.4(PDHA1):c.29G>C (p.Arg10Pro)	PDHA1	R10P	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010887	X	19362184	X	19344066	10887	25926	rs137853257	NC_000023.11:19344065:G:C
NM_000284.4(PDHA1):c.861_862insT (p.Arg288fs)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Aug 16, 2017)	no assertion criteria provided	VCV000010886	X	19375799 - 19375800	X	19357681 - 19357682	10886	25925	rs606231190	NC_000023.11:19357681::T
NM_000284.4(PDHA1):c.943G>A (p.Asp315Asn)	PDHA1	D315N, D284N, D322N, D353N	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000010884	X	19377077	X	19358959	10884	25923	rs137853256	NC_000023.11:19358958:G:A
NM_000284.4(PDHA1):c.727T>A (p.Tyr243Asn)	PDHA1	Y243N, Y281N, Y212N, Y250N	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Aug 15, 2017)	no assertion criteria provided	VCV000010883	X	19373590	X	19355472	10883	25922	rs137853255	NC_000023.11:19355471:T:A
NM_000284.4(PDHA1):c.615C>G (p.Phe205Leu)	PDHA1	F205L, F174L, F212L, F243L	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000010882	X	19373478	X	19355360	10882	25921	rs137853254	NC_000023.11:19355359:C:G
NM_000284.4(PDHA1):c.773A>C (p.Asp258Ala)	PDHA1	D258A, D265A, D227A, D296A	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Jun 1, 1994)	no assertion criteria provided	VCV000010881	X	19373817	X	19355699	10881	25920	rs137853253	NC_000023.11:19355698:A:C
NM_000284.4(PDHA1):c.1142_1145dup (p.Trp383fs)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000010880	X	19377737 - 19377738	X	19359619 - 19359620	10880	25919	rs606231189	NC_000023.11:19359619:CAATCA:CAATCAATCA
NM_000284.4(PDHA1):c.904C>T (p.Arg302Cys)	PDHA1	R302C, R309C, R271C, R340C	Pyruvate dehydrogenase E1-alpha deficiency|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010879	X	19377038	X	19358920	10879	25918	rs137853252	NC_000023.11:19358919:C:T
NM_000284.4(PDHA1):c.787C>G (p.Arg263Gly)	PDHA1	R263G, R270G, R301G, R232G	Pyruvate dehydrogenase E1-alpha deficiency|not provided	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010878	X	19373831	X	19355713	10878	25917	rs137853259	NC_000023.11:19355712:C:G
NM_000284.4(PDHA1):c.900-3_917dup	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000010877	X	19377029 - 19377030	X	19358911 - 19358912	10877	25916	rs606231188	NC_000023.11:19358911:ATAGTTACCGTACACGAGAAGA:ATAGTTACCGTACACGAGAAGATAGTTACCGTACACGAGAAGA
NM_000284.4(PDHA1):c.1073_1092del (p.Glu358fs)	PDHA1	E358fs, E365fs, E327fs, E396fs	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000010876	X	19377668 - 19377687	X	19359550 - 19359569	10876	25915	rs606231187	NC_000023.11:19359549:CTGAGCCACCTTTGGAAGAGCTG:CTG
NM_000284.4(PDHA1):c.1159_1160del (p.Lys387fs)	PDHA1	K356fs, K425fs, K394fs, K387fs	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000010875	X	19377757 - 19377758	X	19359639 - 19359640	10875	25914	rs606231186	NC_000023.11:19359638:AA:
NM_000284.4(PDHA1):c.938_940del (p.Lys313del)	PDHA1	K313del, K320del, K282del, K351del	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Jan 1, 1991)	no assertion criteria provided	VCV000010874	X	19377071 - 19377073	X	19358953 - 19358955	10874	25913	rs137853251	NC_000023.11:19358952:AAGA:A
NM_000284.4(PDHA1):c.1133G>A (p.Arg378His)	PDHA1	R378H, R416H, R347H, R385H	Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000010873	X	19377731	X	19359613	10873	25912	rs137853250	NC_000023.11:19359612:G:A
NM_000284.4(PDHA1):c.927_933AGTAAGA[1] (p.Ser312fs)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, single submitter	VCV000010872	X	19377059 - 19377065	X	19358941 - 19358947	10872	25911	rs606231185	NC_000023.11:19358940:GAAGTAAGAAGTAAGA:GAAGTAAGA
NM_000284.4(PDHA1):c.1163_1166CAGT[1] (p.Ser390fs)	PDHA1		Pyruvate dehydrogenase E1-alpha deficiency	Pathogenic(Last reviewed: Mar 1, 1989)	no assertion criteria provided	VCV000010871	X	19377758 - 19377761	X	19359640 - 19359643	10871	25910	rs606231184	NC_000023.11:19359639:AGTCAGTCAGT:AGTCAGT
NM_001018113.3(FANCB):c.1496+5G>A	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Feb 7, 2011)	no assertion criteria provided	VCV000010870	X	14868622	X	14850500	10870	25909	rs1569085810	NC_000023.11:14850499:C:T
FANCB, 1-BP INS, 811T	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000010869					10869	25908		
FANCB, 1-BP DEL, 1650T	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000010868					10868	25907		
FANCB, 3314-BP DEL	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000010867					10867	25906		
FANCB, 1-BP INS, 1838T	FANCB		Fanconi anemia, complementation group B	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000010866					10866	25905		
NM_001111125.3(IQSEC2):c.1075C>T (p.Arg359Cys)	IQSEC2	R359C, R154C	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000010865	X	53284038	X	53254856	10865	25904	rs267607188	NC_000023.11:53254855:G:A
NM_001111125.3(IQSEC2):c.2273G>A (p.Arg758Gln)	IQSEC2	R758Q, R553Q	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000010864	X	53279485	X	53250303	10864	25903	rs267607189	NC_000023.11:53250302:C:T
NM_001111125.3(IQSEC2):c.2402A>C (p.Gln801Pro)	IQSEC2	Q801P, Q596P	Mental retardation, X-linked 18	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000010863	X	53277960	X	53248778	10863	25902	rs267607187	NC_000023.11:53248777:T:G
NM_000276.4(OCRL):c.1436A>G (p.Tyr479Cys)	OCRL	Y462C, Y479C, Y480C		Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000010860	X	128701310	X	129567333	10860	25899	rs137853262	NC_000023.11:129567332:A:G
NM_000276.4(OCRL):c.1572C>G (p.His524Gln)	OCRL	H601Q, H524Q, H525Q	Lowe syndrome	Pathogenic(Last reviewed: Jun 5, 1998)	no assertion criteria provided	VCV000010859	X	128703346	X	129569369	10859	25898	rs137853261	NC_000023.11:129569368:C:G
NM_000276.4(OCRL):c.1499G>A (p.Arg500Gln)	OCRL	R577Q, R500Q, R501Q	not provided|Lowe syndrome	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010858	X	128703273	X	129569296	10858	25897	rs137853260	NC_000023.11:129569295:G:A
NM_000276.4(OCRL):c.2530C>T (p.Arg844Ter)	OCRL	R836*, R844*, R845*	Lowe syndrome	Pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000010857	X	128723882	X	129589905	10857	25896	rs387906484	NC_000023.11:129589904:C:T
OCRL, 112-BP DEL	OCRL		Lowe syndrome	Pathogenic(Last reviewed: Apr 1, 1993)	no assertion criteria provided	VCV000010856					10856	25895		
NM_000054.6(AVPR2):c.410G>T (p.Arg137Leu)	AVPR2	R137L	Nephrogenic syndrome of inappropriate antidiuresis	Pathogenic(Last reviewed: May 5, 2005)	no assertion criteria provided	VCV000010855	X	153171370	X	153905916	10855	25894	rs104894756	NC_000023.11:153905915:G:T
NM_000054.6(AVPR2):c.409C>T (p.Arg137Cys)	AVPR2	R137C	Nephrogenic syndrome of inappropriate antidiuresis	Pathogenic(Last reviewed: May 5, 2005)	no assertion criteria provided	VCV000010854	X	153171369	X	153905915	10854	25893	rs104894761	NC_000023.11:153905914:C:T
NM_000054.6(AVPR2):c.310C>T (p.Arg104Cys)	AVPR2	R104C	Nephrogenic diabetes insipidus|Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000010853	X	153171270	X	153905816	10853	25892	rs104894760	NC_000023.11:153905815:C:T
NM_000054.6(AVPR2):c.137T>A (p.Ile46Lys)	AVPR2	I46K	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000010852	X	153171097	X	153905643	10852	25891	rs104894759	NC_000023.11:153905642:T:A
NM_000054.6(AVPR2):c.313T>G (p.Phe105Val)	AVPR2	F105V	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000010851	X	153171273	X	153905819	10851	25890	rs104894758	NC_000023.11:153905818:T:G
NM_000054.6(AVPR2):c.541C>T (p.Arg181Cys)	AVPR2	R181C	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000010850	X	153171501	X	153906047	10850	25889	rs104894757	NC_000023.11:153906046:C:T
NM_000054.6(AVPR2):c.410G>A (p.Arg137His)	AVPR2	R137H	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 5, 2005)	no assertion criteria provided	VCV000010849	X	153171370	X	153905916	10849	25888	rs104894756	NC_000023.11:153905915:G:A
NM_000054.6(AVPR2):c.102del (p.Leu35fs)	AVPR2	L35fs	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000010848	X	153171062	X	153905608	10848	25887	rs1569545523	NC_000023.11:153905607:G:
AVPR2, 1-BP INS, 804G	AVPR2		Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000010847					10847	25886		
NM_000054.6(AVPR2):c.602G>A (p.Gly201Asp)	AVPR2	G201D	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010846	X	153171562	X	153906108	10846	25885	rs104894755	NC_000023.11:153906107:G:A
NM_000054.6(AVPR2):c.253G>A (p.Asp85Asn)	AVPR2	D85N	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010845	X	153171213	X	153905759	10845	25884	rs104894754	NC_000023.11:153905758:G:A
NM_000054.6(AVPR2):c.1009C>T (p.Arg337Ter)	AVPR2	R337*	not provided|Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000010844	X	153172075	X	153906621	10844	25883	rs104894753	NC_000023.11:153906620:C:T
NM_000054.6(AVPR2):c.839A>G (p.Tyr280Cys)	AVPR2	Y280C	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Aug 30, 1994)	no assertion criteria provided	VCV000010843	X	153171799	X	153906345	10843	25882	rs104894752	NC_000023.11:153906344:A:G
NM_000054.6(AVPR2):c.213G>A (p.Trp71Ter)	AVPR2	W71*	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000010842	X	153171173	X	153905719	10842	25881	rs104894751	NC_000023.11:153905718:G:A
AVPR2, 1-BP INS	AVPR2		Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 27, 1993)	no assertion criteria provided	VCV000010841					10841	25880		
NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)	AVPR2	R113W	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 27, 1993)	no assertion criteria provided	VCV000010840	X	153171297	X	153905843	10840	25879	rs28935496	NC_000023.11:153905842:C:T
NM_000054.6(AVPR2):c.607C>T (p.Arg203Cys)	AVPR2	R203C	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000010839	X	153171567	X	153906113	10839	25878	rs104894750	NC_000023.11:153906112:C:T
NM_000054.6(AVPR2):c.614A>G (p.Tyr205Cys)	AVPR2	Y205C	Nephrogenic diabetes insipidus|Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000010838	X	153171574	X	153906120	10838	25877	rs104894749	NC_000023.11:153906119:A:G
NM_000054.6(AVPR2):c.553G>T (p.Gly185Cys)	AVPR2	G185C	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000010837	X	153171513	X	153906059	10837	25876	rs104894748	NC_000023.11:153906058:G:T
NM_000054.6(AVPR2):c.395C>A (p.Ala132Asp)	AVPR2	A132D	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Sep 17, 1992)	no assertion criteria provided	VCV000010836	X	153171355	X	153905901	10836	25875	rs104894747	NC_000023.11:153905900:C:A
NM_000054.6(AVPR2):c.738del (p.Arg247fs)	AVPR2	R247fs	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Sep 17, 1992)	no assertion criteria provided	VCV000010835	X	153171693	X	153906239	10835	25874		NC_000023.11:153906238:GGGGGG:GGGGG
NM_004463.3(FGD1):c.1396A>G (p.Met466Val)	FGD1	M466V	Aarskog syndrome	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000010834	X	54492230	X	54465797	10834	25873	rs137853267	NC_000023.11:54465796:T:C
NM_004463.3(FGD1):c.944dup (p.Ala316fs)	FGD1		Aarskog syndrome	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000010833	X	54496605 - 54496606	X	54470172 - 54470173	10833	25872	rs1569541255	NC_000023.11:54470172:GGGGG:GGGGGG
NM_004463.3(FGD1):c.1328G>T (p.Arg443Leu)	FGD1	R433L, R443L	Aarskog syndrome	Pathogenic(Last reviewed: Jun 15, 2006)	no assertion criteria provided	VCV000010832	X	54494229	X	54467796	10832	25871	rs137853266	NC_000023.11:54467795:C:A
FGD1, 1-BP DEL, 2189A	FGD1		Aarskog syndrome	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000010831					10831	25870		
NM_004463.3(FGD1):c.1223G>A (p.Arg408Gln)	FGD1	R408Q	Aarskog syndrome	Pathogenic(Last reviewed: May 15, 2005)	no assertion criteria provided	VCV000010830	X	54494334	X	54467901	10830	25869	rs137853265	NC_000023.11:54467900:C:T
FGD1, EX9-12DEL	FGD1		Aarskog syndrome	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000010827					10827	25866		
NM_004463.3(FGD1):c.1565G>A (p.Arg522His)	FGD1	R522H	Aarskog syndrome	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000010826	X	54491955	X	54465522	10826	25865	rs137853264	NC_000023.11:54465521:C:T
NM_004463.3(FGD1):c.1829G>A (p.Arg610Gln)	FGD1	R610Q	Aarskog syndrome|not provided	Pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, single submitter	VCV000010825	X	54482666	X	54456233	10825	25864	rs28935497	NC_000023.11:54456232:C:T
FGD1, 1-BP INS, 2122G	FGD1		Aarskog syndrome	Pathogenic(Last reviewed: Nov 18, 1994)	no assertion criteria provided	VCV000010824					10824	25863		
PHEX, IVS4, T-C, +6	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000010823					10823	25862		
NM_000444.6(PHEX):c.849+1268G>T	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000010821	X	22113485	X	22095367	10821	25860		NC_000023.11:22095366:G:T
PHEX, A-G, NT-429	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000010820					10820	25859		
NM_000444.6(PHEX):c.254G>A (p.Cys85Tyr)	PHEX	C82Y, C85Y	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000010817	X	22065234	X	22047116	10817	25856	rs137853269	NC_000023.11:22047115:G:A
NM_000444.6(PHEX):c.830T>A (p.Leu277Ter)	PHEX	L274*, L277*	Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Apr 1, 1997)	no assertion criteria provided	VCV000010816	X	22112198	X	22094080	10816	25855	rs137853268	NC_000023.11:22094079:T:A
PHEX, IVS1AS, G-C, -1	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010815					10815	25854		
PHEX, IVS1AS, G-A, -1	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010814					10814	25853		
PHEX, 2-BP DEL, 675TC	PHEX		Familial X-linked hypophosphatemic vitamin D refractory rickets	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010813					10813	25852		
NM_033290.4(MID1):c.1544_1545AG[1] (p.Thr518_Pro519insTer)	MID1		Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000010812	X	10423018 - 10423019	X	10454978 - 10454979	10812	25851	rs1569268029	NC_000023.11:10454977:CTCT:CT
NM_033290.4(MID1):c.884T>C (p.Leu295Pro)	MID1	L295P, L257P, L346P	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000010811	X	10450649	X	10482609	10811	25850	rs104894866	NC_000023.11:10482608:A:G
MID1, EX1 DUP	MID1		Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000010810					10810	25849		
NM_033290.4(MID1):c.343G>T (p.Glu115Ter)	MID1	E115*	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Oct 12, 2000)	no assertion criteria provided	VCV000010809	X	10535245	X	10567205	10809	25848	rs104894865	NC_000023.11:10567204:C:A
NM_033290.4(MID1):c.1877T>C (p.Leu626Pro)	MID1	L626P, L588P	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Oct 12, 2000)	no assertion criteria provided	VCV000010808	X	10417535	X	10449495	10808	25847	rs28934611	NC_000023.11:10449494:A:G
NM_033290.4(MID1):c.1558dup (p.Glu520fs)	MID1		Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010807	X	10423006 - 10423007	X	10454966 - 10454967	10807	25846	rs1569268013	NC_000023.11:10454966:C:CC
MID1, 24-BP DUP	MID1		Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010806					10806	25845		
NM_033290.4(MID1):c.1311_1313GAT[1] (p.Met438del)	MID1	M438del	Opitz GBBB syndrome, type I	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000010805	X	10427817 - 10427819	X	10459777 - 10459779	10805	25844	rs1569270035	NC_000023.11:10459776:ATCATC:ATC
NM_153252.5(BRWD3):c.4786A>G (p.Lys1596Glu)	BRWD3	K1596E	Mental retardation, X-linked 93	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010804	X	79932731	X	80677232	10804	25843	rs137853272	NC_000023.11:80677231:T:C
NM_153252.5(BRWD3):c.946dup (p.Arg316fs)	BRWD3		Mental retardation, X-linked 93	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010803	X	79990664 - 79990665	X	80735165 - 80735166	10803	25842	rs730882186	NC_000023.11:80735165:T:TT
NM_153252.5(BRWD3):c.3325+1G>T	BRWD3		Mental retardation, X-linked 93	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010802	X	79947587	X	80692088	10802	25841	rs730882185	NC_000023.11:80692087:C:A
NM_015107.3(PHF8):c.836T>C (p.Phe279Ser)	PHF8	F279S, F315S	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010800	X	54037665	X	54011232	10800	25839	rs121918524	NC_000023.11:54011231:A:G
NM_015107.3(PHF8):c.529A>T (p.Lys177Ter)	PHF8	K177*, K213*	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000010799	X	54043095	X	54016662	10799	25838	rs121918523	NC_000023.11:54016661:T:A
NM_015107.3(PHF8):c.631C>T (p.Arg211Ter)	PHF8	R211*, R247*	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000010798	X	54040962	X	54014529	10798	25837	rs121918522	NC_000023.11:54014528:G:A
PHF8, 12-BP DEL	PHF8		Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000010797					10797	25836		
NM_020717.3(SHROOM4):c.3266C>T (p.Ser1089Leu)	SHROOM4	S1089L	X-linked intellectual disability, Stocco dos Santos type	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000010795	X	50350876	X	50607876	10795	25834	rs121434620	NC_000023.11:50607875:G:A
NM_001011551.3(C1GALT1C1):c.454G>A (p.Glu152Lys)	C1GALT1C1	E152K	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Oct 27, 2005)	no assertion criteria provided	VCV000010793	X	119760568	X	120626713	10793	25832	rs137853599	NC_000023.11:120626712:C:T
NM_001011551.3(C1GALT1C1):c.393T>A (p.Asp131Glu)	C1GALT1C1	D131E	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Oct 27, 2005)	no assertion criteria provided	VCV000010792	X	119760629	X	120626774	10792	25831	rs17261572	NC_000023.11:120626773:A:T
NM_001011551.3(C1GALT1C1):c.202C>T (p.Arg68Ter)	C1GALT1C1	R68*	Polyagglutinable erythrocyte syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000010791	X	119760820	X	120626965	10791	25830	rs137853598	NC_000023.11:120626964:G:A
FRMD7, 2-BP DEL, 1274TG	FRMD7		Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000010790					10790	25829		
NM_194277.2(FRMD7):c.685C>G (p.Arg229Gly)	FRMD7	R229G, R214G	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000010789	X	131218574	X	132084546	10789	25828	rs137852212	NC_000023.11:132084545:G:C
NM_194277.2(FRMD7):c.425T>G (p.Leu142Arg)	FRMD7	L142R, L127R	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Nov 29, 2007)	no assertion criteria provided	VCV000010788	X	131220020	X	132085992	10788	25827	rs137852211	NC_000023.11:132085991:A:C
FRMD7, 3-BP DEL, 41AGA	FRMD7		Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Aug 3, 2007)	no assertion criteria provided	VCV000010787					10787	25826		
NM_194277.2(FRMD7):c.70G>A (p.Gly24Arg)	FRMD7	G24R	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000010786	X	131234732	X	132100704	10786	25825	rs137852210	NC_000023.11:132100703:C:T
NM_194277.2(FRMD7):c.252G>A (p.Val84=)	FRMD7	V84V, M69I	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000010785	X	131231326	X	132097298	10785	25824	rs137852209	NC_000023.11:132097297:C:T
FRMD7, IVS3DS, T-G, +2	FRMD7		Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000010784					10784	25823		
NM_194277.2(FRMD7):c.1003C>T (p.Arg335Ter)	FRMD7	R335*, R320*	not provided|Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000010783	X	131214081	X	132080053	10783	25822	rs137852208	NC_000023.11:132080052:G:A
NM_194277.2(FRMD7):c.601C>T (p.Gln201Ter)	FRMD7	Q201*, Q186*	Infantile nystagmus, X-linked	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000010782	X	131219653	X	132085625	10782	25821	rs137852207	NC_000023.11:132085624:G:A
NM_001272071.2(AP1S2):c.226G>T (p.Glu76Ter)	AP1S2	Q66*, E76*	Pettigrew syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000010781	X	15864088	X	15845965	10781	25820	rs137852213	NC_000023.11:15845964:C:A
NM_001272071.2(AP1S2):c.288+5G>A	AP1S2		Pettigrew syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000010780	X	15864021	X	15845898	10780	25819	rs587776739	NC_000023.11:15845897:C:T
NM_001272071.2(AP1S2):c.180-5_180-2del	AP1S2		Pettigrew syndrome	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000010779	X	15864136 - 15864139	X	15846013 - 15846016	10779	25818	rs587776738	NC_000023.11:15846012:TGTA:
NM_001272071.2(AP1S2):c.154C>T (p.Arg52Ter)	AP1S2	R52*	not provided|Pettigrew syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000010778	X	15870494	X	15852371	10778	25817	rs104894735	NC_000023.11:15852370:G:A
NM_001272071.2(AP1S2):c.106C>T (p.Gln36Ter)	AP1S2	Q36*	Pettigrew syndrome	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000010777	X	15870542	X	15852419	10777	25816	rs104894739	NC_000023.11:15852418:G:A
GLA, EX2-6DUP	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 5, 1990)	no assertion criteria provided	VCV000010762					10762	25801		
GLA, EX6-7DEL	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 5, 1990)	no assertion criteria provided	VCV000010761					10761	25800		
GLA, EX3-7DEL	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 5, 1990)	no assertion criteria provided	VCV000010760					10760	25799		
GLA, EX3-4DEL	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 5, 1990)	no assertion criteria provided	VCV000010759					10759	25798		
GLA, EX1-2DEL	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 5, 1990)	no assertion criteria provided	VCV000010758					10758	25797		
GLA, 2-BP DEL, NT1176	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 16, 2017)	no assertion criteria provided	VCV000010756					10756	25795		
GLA, 1-BP INS, NT1040	GLA		Fabry disease	Pathogenic(Last reviewed: Jun 16, 2017)	no assertion criteria provided	VCV000010754					10754	25793		
GLA, 2-BP DEL, NT773	GLA		Fabry disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010751					10751	25790		
GLA, 1-BP DEL, NT716	GLA		Fabry disease	Pathogenic(Last reviewed: Jul 1, 1993)	no assertion criteria provided	VCV000010750					10750	25789		
GLA, IVS5AS, DEL -2,-3	GLA		Fabry disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010747					10747	25786		
GLA, EX4DEL	GLA		Fabry disease	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000010718					10718	25757		
GLA, EX3DEL	GLA		Fabry disease	Pathogenic(Last reviewed: Jul 16, 1990)	no assertion criteria provided	VCV000010714					10714	25753		
NM_016032.4(ZDHHC9):c.448C>T (p.Pro150Ser)	ZDHHC9	P150S	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010712	X	128957694	X	129823718	10712	25751	rs137852215	NC_000023.11:129823717:G:A
NM_016032.4(ZDHHC9):c.442C>T (p.Arg148Trp)	ZDHHC9	R148W	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010711	X	128957700	X	129823724	10711	25750	rs137852214	NC_000023.11:129823723:G:A
NM_016032.4(ZDHHC9):c.167+5G>C	ZDHHC9		Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010710	X	128975750	X	129841774	10710	25749	rs606231183	NC_000023.11:129841773:C:G
NM_016032.4(ZDHHC9):c.172_175del (p.Arg58fs)	ZDHHC9	R58fs	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010709	X	128963110 - 128963113	X	129829134 - 129829137	10709	25748	rs606231182	NC_000023.11:129829133:AGCG:
NM_152424.4(AMER1):c.1072C>T (p.Arg358Ter)	AMER1	R358*	Osteopathia striata with cranial sclerosis|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000010708	X	63412095	X	64192215	10708	25747	rs137852217	NC_000023.11:64192214:G:A
NM_152424.4(AMER1):c.1057C>T (p.Arg353Ter)	AMER1	R353*	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Apr 21, 2018)	criteria provided, single submitter	VCV000010707	X	63412110	X	64192230	10707	25746	rs137852216	NC_000023.11:64192229:G:A
AMER1, DEL	AMER1		Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000010706					10706	25745		
NM_152424.4(AMER1):c.780dup (p.Pro261fs)	AMER1		Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000010705	X	63412386 - 63412387	X	64192506 - 64192507	10705	25744	rs1569192251	NC_000023.11:64192506:TTTTT:TTTTTT
NM_152424.4(AMER1):c.671del (p.Pro224fs)	AMER1	P224fs	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000010704	X	63412496	X	64192616	10704	25743	rs1569192315	NC_000023.11:64192615:GGGG:GGG
NM_203473.3(PORCN):c.222G>A (p.Trp74Ter)	PORCN	W74*, W3*	Focal dermal hypoplasia	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000010703	X	48369768	X	48511380	10703	25742	rs137852219	NC_000023.11:48511379:G:A
NM_203473.3(PORCN):c.370C>T (p.Arg124Ter)	PORCN	R124*, R53*	not provided|Focal dermal hypoplasia	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	VCV000010702	X	48370320	X	48511932	10702	25741	rs137852218	NC_000023.11:48511931:C:T
NM_203473.3(PORCN):c.178G>A (p.Gly60Arg)	PORCN	G60R	Focal dermal hypoplasia	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000010701	X	48369724	X	48511336	10701	25740	rs267606973	NC_000023.11:48511335:G:A
NM_203473.3(PORCN):c.1044_1056dup (p.Thr353fs)	PORCN		Focal dermal hypoplasia	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000010700	X	48374310 - 48374311	X	48515922 - 48515923	10700	25739	rs587776737	NC_000023.11:48515922:TCCCTGGCTTTTATC:TCCCTGGCTTTTATCCCTGGCTTTTATC
NDP, 1-BP DEL	NDP		Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Sep 1, 1996)	no assertion criteria provided	VCV000010692					10692	25731		
NM_152274.5(CCNQ):c.658-1G>A	CCNQ		Syndactyly-telecanthus-anogenital and renal malformations syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000010675	X	152853913	X	153588455	10675	25714	rs63749972	NC_000023.11:153588454:C:T
NM_152274.5(CCNQ):c.303dup (p.Asn102Ter)	CCNQ		Syndactyly-telecanthus-anogenital and renal malformations syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000010674	X	152860130 - 152860131	X	153594672 - 153594673	10674	25713	rs1569536891	NC_000023.11:153594672:AAA:AAAA
NM_152274.5(CCNQ):c.657+1G>A	CCNQ		Syndactyly-telecanthus-anogenital and renal malformations syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000010673	X	152857963	X	153592505	10673	25712	rs1569536789	NC_000023.11:153592504:C:T
FAM58A, 4249-BP DEL	CCNQ		Syndactyly-telecanthus-anogenital and renal malformations syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000010672					10672	25711		
FAM58A, 40-KB DEL	CCNQ		Syndactyly-telecanthus-anogenital and renal malformations syndrome	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000010671					10671	25710		
NM_000351.6(STS):c.1256+1G>T	STS		X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Aug 15, 1997)	no assertion criteria provided	VCV000010557	X	7243540	X	7325499	10557	25596		NC_000023.11:7325498:G:T
NM_000351.6(STS):c.1331A>G (p.His444Arg)	STS	H444R, H451R, H439R	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Aug 15, 1997)	no assertion criteria provided	VCV000010556	X	7252101	X	7334060	10556	25595	rs137853169	NC_000023.11:7334059:A:G
NM_000351.6(STS):c.1115G>C (p.Trp372Ser)	STS	W372P, W372S, W379S, W367S	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Aug 15, 1997)	no assertion criteria provided	VCV000010555	X	7243398	X	7325357	10555	25594	rs137853168	NC_000023.11:7325356:G:C
NM_000351.6(STS):c.1022C>T (p.Ser341Leu)	STS	S341L, S336L, S348L	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Aug 15, 1997)	no assertion criteria provided	VCV000010554	X	7223150	X	7305109	10554	25593	rs137853167	NC_000023.11:7305108:C:T
NM_000351.6(STS):c.1337G>A (p.Cys446Tyr)	STS	C446Y, C453Y, C441Y	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Aug 15, 1997)	no assertion criteria provided	VCV000010553	X	7252107	X	7334066	10553	25592	rs137853166	NC_000023.11:7334065:G:A
NM_000351.6(STS):c.1114T>A (p.Trp372Arg)	STS	W372R, W367R, W379R	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Aug 15, 1997)	no assertion criteria provided	VCV000010552	X	7243397	X	7325356	10552	25591	rs137853165	NC_000023.11:7325355:T:A
NM_006915.3(RP2):c.358C>T (p.Arg120Ter)	RP2	R120*	Retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 2|not provided	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010551	X	46713166	X	46853731	10551	25590	rs104894927	NC_000023.11:46853730:C:T
RP2, 1-BP INS, 303T	RP2		Retinitis pigmentosa 2	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000010550					10550	25589		
NM_006915.3(RP2):c.353G>T (p.Arg118Leu)	RP2	R118L	Retinitis pigmentosa 2	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000010549	X	46713161	X	46853726	10549	25588	rs28933687	NC_000023.11:46853725:G:T
RP2, 1-BP DEL	RP2		Retinitis pigmentosa 2	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000010548					10548	25587		
NM_006915.3(RP2):c.453C>G (p.Tyr151Ter)	RP2	Y151*	Retinitis pigmentosa 2	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000010547	X	46713261	X	46853826	10547	25586	rs104894926	NC_000023.11:46853825:C:G
NM_006915.3(RP2):c.353G>A (p.Arg118His)	RP2	R118H	Retinal dystrophy|Retinitis pigmentosa 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000010546	X	46713161	X	46853726	10546	25585	rs28933687	NC_000023.11:46853725:G:A
NM_006915.3(RP2):c.76C>T (p.Gln26Ter)	RP2	Q26*	Retinitis pigmentosa 2|not provided	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000010545	X	46696611	X	46837176	10545	25584	rs104894925	NC_000023.11:46837175:C:T
NM_006915.3(RP2):c.16_18del (p.Ser6del)	RP2	S6del	Retinitis pigmentosa|Retinitis pigmentosa 2	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000010544	X	46696550 - 46696552	X	46837115 - 46837117	10544	25583	rs137852284	NC_000023.11:46837114:CTCC:C
NM_171998.4(RAB39B):c.21C>A (p.Tyr7Ter)	RAB39B	Y7*	Mental retardation, X-linked 72	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000010543	X	154493553	X	155264268	10543	25582	rs267606995	NC_000023.11:155264267:G:T
NM_171998.4(RAB39B):c.215+1G>A	RAB39B		Mental retardation, X-linked 72	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000010542	X	154493358	X	155264073	10542	25581	rs587776734	NC_000023.11:155264072:C:T
NM_000292.3(PHKA2):c.565A>G (p.Lys189Glu)	PHKA2	K189E	Glycogen storage disease IXa2	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000010541	X	18963249	X	18945131	10541	25580	rs137852295	NC_000023.11:18945130:T:C
PHKA2, 6-BP INS, NT3331	PHKA2		Glycogen storage disease IXa2	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000010540					10540	25579		
NM_000292.3(PHKA2):c.750_752del (p.Thr251del)	PHKA2	T251del	Glycogen storage disease IXa2	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000010539	X	18959759 - 18959761	X	18941641 - 18941643	10539	25578	rs587776733	NC_000023.11:18941640:GTCG:G
NM_000292.3(PHKA2):c.394C>T (p.His132Tyr)	PHKA2	H132Y	Glycogen storage disease IXa2	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000010537	X	18969282	X	18951164	10537	25576	rs137852292	NC_000023.11:18951163:G:A
NM_000292.3(PHKA2):c.395A>C (p.His132Pro)	PHKA2	H132P	Glycogen storage disease IXa2	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000010536	X	18969281	X	18951163	10536	25575	rs137852291	NC_000023.11:18951162:T:G
NM_000292.3(PHKA2):c.896A>G (p.Asp299Gly)	PHKA2	D299G	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000010534	X	18958135	X	18940017	10534	25573	rs137852289	NC_000023.11:18940016:T:C
NM_000292.3(PHKA2):c.421_423del (p.Phe141del)	PHKA2	F141del	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	VCV000010532	X	18969253 - 18969255	X	18951135 - 18951137	10532	25571	rs587776732	NC_000023.11:18951134:GAAGA:GA
NM_000292.3(PHKA2):c.3146C>A (p.Ser1049Ter)	PHKA2	S1049*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010530	X	18915417	X	18897299	10530	25569	rs137852287	NC_000023.11:18897298:G:T
NM_000292.3(PHKA2):c.717+1G>T	PHKA2		Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010529	X	18961827	X	18943709	10529	25568	rs587776731	NC_000023.11:18943708:C:A
NM_000292.3(PHKA2):c.2296C>T (p.Gln766Ter)	PHKA2	Q766*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010528	X	18926983	X	18908865	10528	25567	rs137852286	NC_000023.11:18908864:G:A
NM_000292.3(PHKA2):c.3025C>T (p.Gln1009Ter)	PHKA2	Q1009*	Glycogen storage disease type IXa1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010527	X	18919605	X	18901487	10527	25566	rs137852285	NC_000023.11:18901486:G:A
GPR143, 19-BP DUP	GPR143		Nystagmus 6, congenital, X-linked	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000010525					10525	25564		
GPR143, 37-BP DEL	GPR143		Nystagmus 6, congenital, X-linked	Pathogenic(Last reviewed: May 30, 2008)	no assertion criteria provided	VCV000010524					10524	25563		
GPR143, 14-BP DEL, NT816	GPR143		Ocular albinism, type I	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000010523					10523	25562		
NM_000273.3(GPR143):c.266C>T (p.Ser89Phe)	GPR143	S89F	Nystagmus 6, congenital, X-linked	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000010522	X	9728851	X	9760811	10522	25561	rs137852298	NC_000023.11:9760810:G:A
NM_000273.3(GPR143):c.104G>A (p.Gly35Asp)	GPR143	G35D	Ocular albinism, type I|not provided	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000010521	X	9733754	X	9765714	10521	25560	rs62635018	NC_000023.11:9765713:C:T
GPR143, 420G-A	GPR143		Ocular albinism, type I	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000010520					10520	25559		
NM_000273.3(GPR143):c.397T>A (p.Trp133Arg)	GPR143	W133R	Ocular albinism, type I|not provided	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000010519	X	9727430	X	9759390	10519	25558	rs137852296	NC_000023.11:9759389:A:T
NM_000273.3(GPR143):c.695C>A (p.Thr232Lys)	GPR143	T232K	Ocular albinism, type I|not provided	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000010518	X	9711677	X	9743637	10518	25557	rs137852297	NC_000023.11:9743636:G:T
NM_000273.3(GPR143):c.455G>A (p.Ser152Asn)	GPR143	S152N	not provided|Ocular albinism, type I	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000010517	X	9727372	X	9759332	10517	25556	rs58933950	NC_000023.11:9759331:C:T
NM_000273.3(GPR143):c.397T>C (p.Trp133Arg)	GPR143	W133R	not provided|Ocular albinism, type I	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000010516	X	9727430	X	9759390	10516	25555	rs137852296	NC_000023.11:9759389:A:G
GPR143, 17-BP DEL	GPR143		Ocular albinism, type I	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000010515					10515	25554		
GPR143, 2-BP INS, NT992	GPR143		Ocular albinism, type I	Pathogenic(Last reviewed: May 1, 1995)	no assertion criteria provided	VCV000010514					10514	25553		
NM_000513.2(OPN1MW):c.529T>C (p.Trp177Arg)	OPN1MW	W177R	Cone dystrophy 5, X-linked	Pathogenic(Last reviewed: Jul 9, 2010)	no assertion criteria provided	VCV000010513	X	153455662	X	154190173	10513	25552	rs267606927	NC_000023.11:154190172:T:C
NM_000513.2(OPN1MW):c.282C>A (p.Asn94Lys)	OPN1MW	N94K	Deuteranopia	Pathogenic(Last reviewed: Jun 7, 2002)	no assertion criteria provided	VCV000010512	X	153453428	X	154187939	10512	25551	rs104894915	NC_000023.11:154187938:C:A
NM_000513.2(OPN1MW):c.-112A>C	OPN1MW		Deuteranopia	Pathogenic(Last reviewed: Mar 18, 2003)	no assertion criteria provided	VCV000010510	X	153448055	X	154182566	10510	25549	rs724159983	NC_000023.11:154182565:A:C
NM_000513.2(OPN1MW):c.989G>A (p.Arg330Gln)	OPN1MW	R330Q	Deuteranopia	Pathogenic(Last reviewed: Jun 7, 2002)	no assertion criteria provided	VCV000010509	X	153461425	X	154195934	10509	25548	rs104894916	NC_000023.11:154195933:G:A
NM_000513.2(OPN1MW):c.607T>C (p.Cys203Arg)	OPN1MW	C203R	Deuteranopia|Cone monochromatism	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000010508	X	153457207	X	154191716	10508	25547	rs104894914	NC_000023.11:154191715:T:C
NC_000023.11:g.(154153459_154153462)_(154154925_154154928)del	OPN1LW		Cone monochromatism	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000010507			X	154153459 - 154154928	10507	25546		
NM_020061.6(OPN1LW):c.1013G>A (p.Gly338Glu)	OPN1LW	G338E	Protan defect	Pathogenic(Last reviewed: Jun 7, 2002)	no assertion criteria provided	VCV000010506	X	153424319	X	154158844	10506	25545	rs104894913	NC_000023.11:154158843:G:A
NM_020061.6(OPN1LW):c.607T>C (p.Cys203Arg)	OPN1LW	C203R	not provided|Cone monochromatism	Pathogenic(Last reviewed: Jul 2, 2015)	criteria provided, single submitter	VCV000010505	X	153420077	X	154154602	10505	25544	rs121434621	NC_000023.11:154154601:T:C
NM_020061.6(OPN1LW):c.739C>T (p.Arg247Ter)	OPN1LW	R247*	Cone monochromatism	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010503	X	153420209	X	154154734	10503	25542	rs104894912	NC_000023.11:154154733:C:T
NM_000202.8(IDS):c.349_351del (p.Ser117del)	IDS	S117del, S27del	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Nov 29, 2001)	no assertion criteria provided	VCV000010501	X	148584909 - 148584911	X	149503379 - 149503381	10501	25540	rs483352905	NC_000023.11:149503378:GGAG:G
NM_000202.8(IDS):c.1403G>T (p.Arg468Leu)	IDS	R468L, R378L	Mucopolysaccharidosis, type II, severe form	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000010500	X	148564527	X	149482996	10500	25539	rs113993946	NC_000023.11:149482995:C:A
IDS, 78-BP INS	IDS		Mucopolysaccharidosis, type II, mild form	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000010499					10499	25538		
NM_000202.8(IDS):c.1403G>A (p.Arg468Gln)	IDS	R468Q, R378Q	not provided|Mucopolysaccharidosis, type II, severe form|Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010498	X	148564527	X	149482996	10498	25537	rs113993946	NC_000023.11:149482995:C:T
NM_000202.8(IDS):c.1402C>T (p.Arg468Trp)	IDS	R468W, R378W	not provided|Mucopolysaccharidosis, MPS-II|Mucopolysaccharidosis, type II, mild form	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000010497	X	148564528	X	149482997	10497	25536	rs199422231	NC_000023.11:149482996:G:A
NM_000202.8(IDS):c.1425G>A (p.Trp475Ter)	IDS	W475*, W385*	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000010495	X	148564505	X	149482974	10495	25534	rs199422230	NC_000023.11:149482973:C:T
NM_000202.8(IDS):c.404A>G (p.Lys135Arg)	IDS	K135R, K45R	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000010494	X	148584856	X	149503326	10494	25533	rs104894861	NC_000023.11:149503325:T:C
NM_000202.8(IDS):c.1264T>G (p.Cys422Gly)	IDS	C422G, C332G	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Aug 1, 1992)	no assertion criteria provided	VCV000010493	X	148564666	X	149483135	10493	25532	rs199422229	NC_000023.11:149483134:A:C
NM_000202.8(IDS):c.1505G>C (p.Trp502Ser)	IDS	W502S, W412S	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010488	X	148564425	X	149482894	10488	25527	rs199422228	NC_000023.11:149482893:C:G
NM_000202.8(IDS):c.1327C>T (p.Arg443Ter)	IDS	R443*, R353*	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010486	X	148564603	X	149483072	10486	25525	rs199422227	NC_000023.11:149483071:G:A
NM_000032.5(ALAS2):c.1354C>T (p.Arg452Cys)	ALAS2	R452C, R439C, R415C	not provided|Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000010485	X	55041263	X	55014830	10485	25524	rs137852311	NC_000023.11:55014829:G:A
NM_000032.5(ALAS2):c.595T>C (p.Tyr199His)	ALAS2	Y199H, Y186H, Y162H	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000010484	X	55047528	X	55021095	10484	25523	rs137852310	NC_000023.11:55021094:A:G
NM_000032.5(ALAS2):c.1699_1700del (p.Met567fs)	ALAS2	M530fs, M554fs, M567fs	Protoporphyria, erythropoietic, X-linked	Pathogenic(Last reviewed: Feb 14, 2013)	no assertion criteria provided	VCV000010483	X	55035677 - 55035678	X	55009244 - 55009245	10483	25522	rs387906473	NC_000023.11:55009243:AT:
NM_000032.5(ALAS2):c.1702_1705AGTG[1] (p.Glu569fs)	ALAS2		Protoporphyria, erythropoietic, X-linked	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000010482	X	55035668 - 55035671	X	55009235 - 55009238	10482	25521	rs387906472	NC_000023.11:55009234:CACTCACTCA:CACTCA
NM_000032.5(ALAS2):c.1570C>G (p.His524Asp)	ALAS2	H524D, H511D, H487D	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000010481	X	55039949	X	55013516	10481	25520	rs137852309	NC_000023.11:55013515:G:C
NM_000032.5(ALAS2):c.475G>A (p.Asp159Asn)	ALAS2	D159N, D146N, D122N	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000010479	X	55047648	X	55021215	10479	25518	rs137852308	NC_000023.11:55021214:C:T
NM_000032.5(ALAS2):c.475G>T (p.Asp159Tyr)	ALAS2	D159Y, D146Y, D122Y	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000010478	X	55047648	X	55021215	10478	25517	rs137852308	NC_000023.11:55021214:C:A
NM_000032.5(ALAS2):c.1184G>A (p.Cys395Tyr)	ALAS2	C395Y, C382Y, C358Y	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Sep 21, 2005)	no assertion criteria provided	VCV000010477	X	55041433	X	55015000	10477	25516	rs137852307	NC_000023.11:55014999:C:T
NM_000032.5(ALAS2):c.1702A>G (p.Ser568Gly)	ALAS2	S568G, S555G, S531G	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000010476	X	55035675	X	55009242	10476	25515	rs137852306	NC_000023.11:55009241:T:C
NM_000032.5(ALAS2):c.1231C>T (p.Arg411Cys)	ALAS2	R411C, R398C, R374C	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000010475	X	55041386	X	55014953	10475	25514	rs137852305	NC_000023.11:55014952:G:A
NM_000032.5(ALAS2):c.569A>T (p.Asp190Val)	ALAS2	D190V, D177V, D153V	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Jul 15, 1997)	no assertion criteria provided	VCV000010474	X	55047554	X	55021121	10474	25513	rs28935484	NC_000023.11:55021120:T:A
NM_000032.5(ALAS2):c.514G>A (p.Ala172Thr)	ALAS2	A172T, A159T, A135T	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010473	X	55047609	X	55021176	10473	25512	rs137852304	NC_000023.11:55021175:C:T
NM_000032.5(ALAS2):c.895A>C (p.Lys299Gln)	ALAS2	K299Q, K286Q, K262Q	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Sep 21, 2005)	no assertion criteria provided	VCV000010472	X	55044027	X	55017594	10472	25511	rs137852303	NC_000023.11:55017593:T:G
NM_000032.5(ALAS2):c.871G>A (p.Gly291Ser)	ALAS2	G291S, G278S, G254S	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Sep 21, 2005)	no assertion criteria provided	VCV000010471	X	55044051	X	55017618	10471	25510	rs137852302	NC_000023.11:55017617:C:T
NM_000032.5(ALAS2):c.495C>A (p.Phe165Leu)	ALAS2	F165L, F152L, F128L	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Sep 21, 2005)	no assertion criteria provided	VCV000010470	X	55047628	X	55021195	10470	25509	rs137852301	NC_000023.11:55021194:G:T
NM_000032.5(ALAS2):c.1163C>G (p.Thr388Ser)	ALAS2	T388S, T375S, T351S	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: Sep 21, 2005)	no assertion criteria provided	VCV000010469	X	55042016	X	55015583	10469	25508	rs137852300	NC_000023.11:55015582:G:C
NM_000032.5(ALAS2):c.1427T>A (p.Ile476Asn)	ALAS2	I471N, I439N, I463N, I476N	Anemia, sideroblastic, 1	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000010468	X	55041190	X	55014757	10468	25507	rs137852299	NC_000023.11:55014756:A:T
NM_033380.3(COL4A5):c.5048G>A (p.Arg1683Gln)	COL4A5	R1677Q, R1683Q	not provided|Alport syndrome 1, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010467	X	107939580	X	108696350	10467	25506	rs104886308	NC_000023.11:108696349:G:A
NM_033380.3(COL4A5):c.4964T>G (p.Leu1655Arg)	COL4A5	L1649R, L1655R	Alport syndrome 1, X-linked recessive|not provided	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010466	X	107938639	X	108695409	10466	25505	rs104886303	NC_000023.11:108695408:T:G
NM_033380.3(COL4A5):c.161G>A (p.Gly54Asp)	COL4A5	G54D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000010465	X	107802313	X	108559083	10465	25504	rs104886043	NC_000023.11:108559082:G:A
NM_033380.3(COL4A5):c.974G>A (p.Gly325Glu)	COL4A5	G325E	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000010463	X	107826151	X	108582921	10463	25502	rs104886091	NC_000023.11:108582920:G:A
NM_033380.3(COL4A5):c.1561G>T (p.Gly521Cys)	COL4A5	G521C	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000010462	X	107840272	X	108597042	10462	25501	rs104886121	NC_000023.11:108597041:G:T
COL4A5, 3-PRIME AND PARTIAL 5-PRIME DELETION	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000010460					10460	25499		
NM_033380.3(COL4A5):c.3428G>A (p.Gly1143Asp)	COL4A5	G1143D	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	VCV000010458	X	107908791	X	108665561	10458	25497	rs104886229	NC_000023.11:108665560:G:A
COL4A5, 38-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000010457					10457	25496		
COL4A5, 450-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000010456					10456	25495		
COL4A5, 10-15-KB INS, 40-KB DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000010455					10455	25494		
COL4A5, CYS108SER	COL4A5	C108S	Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000010454					10454	25493		
COL4A5, EX5-10DEL	COL4A5		Alport syndrome 1, X-linked recessive	Pathogenic(Last reviewed: Jun 8, 1990)	no assertion criteria provided	VCV000010453					10453	25492		
NM_000166.6(GJB1):c.407T>C (p.Val136Ala)	GJB1	V136A	Dejerine-Sottas disease|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Apr 15, 2010)	no assertion criteria provided	VCV000010451	X	70443964	X	71224114	10451	25490	rs104894826	NC_000023.11:71224113:T:C
GJB1, -526G-C	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000010449					10449	25488		
GJB1, 3-BP DEL, 304GAG	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000010448					10448	25487		
GJB1, 21-BP DUP	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Sep 24, 2002)	no assertion criteria provided	VCV000010447					10447	25486		
NM_000166.6(GJB1):c.164C>T (p.Thr55Ile)	GJB1	T55I	Charcot-Marie-Tooth disease|not provided|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000010446	X	70443721	X	71223871	10446	25485	rs104894824	NC_000023.11:71223870:C:T
GJB1, -528T-G	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Nov 15, 2001)	no assertion criteria provided	VCV000010445					10445	25484		
GJB1, 367G-T	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000010443					10443	25482		
NM_000166.6(GJB1):c.614A>G (p.Asn205Ser)	GJB1	N205S	not provided|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010442	X	70444171	X	71224321	10442	25481	rs104894822	NC_000023.11:71224320:A:G
NM_000166.6(GJB1):c.283G>A (p.Val95Met)	GJB1	V95M	Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010441	X	70443840	X	71223990	10441	25480	rs104894821	NC_000023.11:71223989:G:A
GJB1, 1-BP DEL	GJB1		X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010440					10440	25479		
NM_000166.6(GJB1):c.37G>T (p.Val13Leu)	GJB1	V13L	X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010439	X	70443594	X	71223744	10439	25478	rs104894820	NC_000023.11:71223743:G:T
NM_000166.6(GJB1):c.194A>G (p.Tyr65Cys)	GJB1	Y65C	X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010438	X	70443751	X	71223901	10438	25477	rs104894819	NC_000023.11:71223900:A:G
NM_000166.6(GJB1):c.467T>G (p.Leu156Arg)	GJB1	L156R	not provided|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010437	X	70444024	X	71224174	10437	25476	rs104894818	NC_000023.11:71224173:T:G
NM_000166.6(GJB1):c.89T>A (p.Ile30Asn)	GJB1	I30N	X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010436	X	70443646	X	71223796	10436	25475	rs104894817	NC_000023.11:71223795:T:A
NM_000166.6(GJB1):c.658C>T (p.Arg220Ter)	GJB1	R220*	not provided|X-linked hereditary motor and sensory neuropathy|Charcot-Marie-Tooth Neuropathy X	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010435	X	70444215	X	71224365	10435	25474	rs104894814	NC_000023.11:71224364:C:T
NM_000166.6(GJB1):c.397T>C (p.Trp133Arg)	GJB1	W133R	X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000010434	X	70443954	X	71224104	10434	25473	rs104894813	NC_000023.11:71224103:T:C
NM_000166.6(GJB1):c.415G>A (p.Val139Met)	GJB1	V139M	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000010433	X	70443972	X	71224122	10433	25472	rs104894812	NC_000023.11:71224121:G:A
NM_000166.6(GJB1):c.514C>T (p.Pro172Ser)	GJB1	P172S	Charcot-Marie-Tooth Neuropathy X|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000010432	X	70444071	X	71224221	10432	25471	rs104894811	NC_000023.11:71224220:C:T
NM_000166.6(GJB1):c.424C>T (p.Arg142Trp)	GJB1	R142W	X-linked Charcot-Marie-Tooth disease type 1|Charcot-Marie-Tooth Neuropathy X|not provided|X-linked hereditary motor and sensory neuropathy	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010431	X	70443981	X	71224131	10431	25470	rs104894810	NC_000023.11:71224130:C:T
NM_002049.3(GATA1):c.154_173dup (p.Ala59fs)	GATA1		Acute megakaryoblastic leukemia	Pathogenic(Last reviewed: Apr 15, 2004)	no assertion criteria provided	VCV000010429	X	48649667 - 48649668	X	48791260 - 48791261	10429	25468	rs398124628	NC_000023.11:48791260:GCACAGCCACCGCTGCAGCTGC:GCACAGCCACCGCTGCAGCTGCACAGCCACCGCTGCAGCTGC
NM_002049.3(GATA1):c.647G>A (p.Arg216Gln)	GATA1	R216Q	Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000010428	X	48650778	X	48792371	10428	25467	rs104894809	NC_000023.11:48792370:G:A
NM_002049.3(GATA1):c.652G>T (p.Asp218Tyr)	GATA1	D218Y	GATA-1-related thrombocytopenia with dyserythropoiesis|Dyserythropoietic anemia with thrombocytopenia	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000010427	X	48650783	X	48792376	10427	25466	rs104894808	NC_000023.11:48792375:G:T
NM_002049.3(GATA1):c.184_187dup (p.Tyr63fs)	GATA1		Leukemia, megakaryoblastic, of Down syndrome	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000010426	X	48649699 - 48649700	X	48791292 - 48791293	10426	25465	rs398124627	NC_000023.11:48791292:TACT:TACTTACT
NM_002049.3(GATA1):c.622_623delinsTC (p.Gly208Ser)	GATA1	G208S	GATA-1-related thrombocytopenia with dyserythropoiesis|Thrombocytopenia, X-linked, without dyserythropoietic anemia	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000010425	X	48650753 - 48650754	X	48792346 - 48792347	10425	25464	rs137852312	NC_000023.11:48792345:GG:TC
NM_002049.3(GATA1):c.613G>A (p.Val205Met)	GATA1	V205M	Dyserythropoietic anemia with thrombocytopenia|GATA-1-related thrombocytopenia with dyserythropoiesis	Pathogenic(Last reviewed: Apr 17, 2014)	no assertion criteria provided	VCV000010423	X	48650744	X	48792337	10423	25462	rs104894815	NC_000023.11:48792336:G:A
GRIA3, 0.4-MB DEL	GRIA3		Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010359					10359	25398		
NM_007325.5(GRIA3):c.2117T>C (p.Met706Thr)	GRIA3	M706T	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010358	X	122598756	X	123464905	10358	25397	rs137852352	NC_000023.11:123464904:T:C
NM_007325.5(GRIA3):c.1891C>A (p.Arg631Ser)	GRIA3	R631S	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010357	X	122561805	X	123427954	10357	25396	rs137852351	NC_000023.11:123427953:C:A
NM_007325.5(GRIA3):c.2497G>A (p.Gly833Arg)	GRIA3	G833R	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010356	X	122616707	X	123482856	10356	25395	rs137852350	NC_000023.11:123482855:G:A
NM_006140.5(CSF2RA):c.586G>A (p.Gly196Arg)	CSF2RA	G174R, G196R, G63R	Surfactant metabolism dysfunction, pulmonary, 4	Pathogenic(Last reviewed: Nov 24, 2008)	no assertion criteria provided	VCV000010355	X	1409342	X	1290449	10355	25394	rs137852353	NC_000024.10:1290448:G:A
F8, ALU INS	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000010353					10353	25392		
NM_000132.3(F8):c.104A>G (p.Tyr35Cys)	F8	Y16C, Y35C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 15, 2002)	no assertion criteria provided	VCV000010352	X	154250724	X	155022449	10352	25391	rs137852476	NC_000023.11:155022448:T:C
NM_000132.3(F8):c.592T>G (p.Cys198Gly)	F8	C179G, C198G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000010351	X	154221220	X	154992945	10351	25390	rs137852475	NC_000023.11:154992944:A:C
F8, 1-BP DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 15, 2000)	no assertion criteria provided	VCV000010350					10350	25389		
F8, EX23-26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010349					10349	25388		
F8, EX23-24DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010348					10348	25387		
F8, EX19-21DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000010347					10347	25386		
F8, EX16DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 1, 1993)	no assertion criteria provided	VCV000010346					10346	25385		
F8, EX18-19DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 1, 1987)	no assertion criteria provided	VCV000010345					10345	25384		
F8, EX16-26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 1, 1992)	no assertion criteria provided	VCV000010344					10344	25383		
F8, EX15-22DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010343					10343	25382		
F8, EX14-22DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010342					10342	25381		
F8, EX14-21DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000010341					10341	25380		
F8, EX10DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000010340					10340	25379		
F8, EX5-13DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000010339					10339	25378		
F8, EX4-10DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010338					10338	25377		
F8, EX3-5DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000010337					10337	25376		
F8, EX2-4DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010336					10336	25375		
F8, EX1-6DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000010335					10335	25374		
NM_000132.3(F8):c.6968G>A (p.Arg2323His)	F8	R2304H, R2323H, R188H	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010334	X	154065960	X	154837685	10334	25373	rs137852474	NC_000023.11:154837684:C:T
NM_000132.3(F8):c.6967C>T (p.Arg2323Cys)	F8	R2304C, R2323C, R188C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, single submitter	VCV000010333	X	154065961	X	154837686	10333	25372	rs137852473	NC_000023.11:154837685:G:A
NM_000132.3(F8):c.6956C>T (p.Pro2319Leu)	F8	P2300L, P2319L, P184L	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000010332	X	154065972	X	154837697	10332	25371	rs137852472	NC_000023.11:154837696:G:A
NM_000132.3(F8):c.6914_6918del (p.Asn2305fs)	F8	N170fs, N2305fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010331	X	154066010 - 154066014	X	154837735 - 154837739	10331	25370	rs387906466	NC_000023.11:154837734:TTGATTT:TT
NM_000132.3(F8):c.6865C>T (p.Gln2289Ter)	F8	Q2270*, Q2289*, Q154*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010330	X	154088742	X	154860467	10330	25369	rs137852471	NC_000023.11:154860466:G:A
NM_000132.3(F8):c.6794_6795del (p.Gln2265fs)	F8	Q2265fs, Q130fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010329	X	154088812 - 154088813	X	154860537 - 154860538	10329	25368	rs387906465	NC_000023.11:154860536:CT:
NM_000132.3(F8):c.6794A>G (p.Gln2265Arg)	F8	Q2246R, Q2265R, Q130R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010328	X	154088813	X	154860538	10328	25367	rs137852470	NC_000023.11:154860537:T:C
NM_000132.3(F8):c.6744G>T (p.Trp2248Cys)	F8	W2248C, W113C	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000010327	X	154088863	X	154860588	10327	25366	rs137852469	NC_000023.11:154860587:C:A
NM_000132.3(F8):c.6699del (p.Arg2234fs)	F8	R2234fs, R99fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010326	X	154090017	X	154861742	10326	25365	rs387906464	NC_000023.11:154861741:CCC:CC
NM_000132.3(F8):c.6682C>G (p.Arg2228Gly)	F8	R2209G, R2228G, R93G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010325	X	154090034	X	154861759	10325	25364	rs137852355	NC_000023.11:154861758:G:C
NM_000132.3(F8):c.6683G>T (p.Arg2228Leu)	F8	R2209L, R2228L, R93L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 1, 1991)	no assertion criteria provided	VCV000010324	X	154090033	X	154861758	10324	25363	rs137852358	NC_000023.11:154861757:C:A
F8, 3-BP DEL, PRO220 DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010323					10323	25362		
NM_000132.3(F8):c.6631G>C (p.Ala2211Pro)	F8	A2192P, A2211P, A76P	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010322	X	154090085	X	154861810	10322	25361	rs137852468	NC_000023.11:154861809:C:G
NM_000132.3(F8):c.6544C>T (p.Arg2182Cys)	F8	R2163C, R2182C, R47C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000010321	X	154091388	X	154863113	10321	25360	rs137852467	NC_000023.11:154863112:G:A
NM_000132.3(F8):c.6545G>A (p.Arg2182His)	F8	R2163H, R2182H, R47H	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010320	X	154091387	X	154863112	10320	25359	rs137852466	NC_000023.11:154863111:C:T
NM_000132.3(F8):c.6532C>T (p.Arg2178Cys)	F8	R2159C, R2178C, R43C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010318	X	154091400	X	154863125	10318	25357	rs137852464	NC_000023.11:154863124:G:A
NM_000132.3(F8):c.6518C>T (p.Thr2173Ile)	F8	T2154I, T2173I, T38I	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010317	X	154091414	X	154863139	10317	25356	rs137852463	NC_000023.11:154863138:G:A
NM_000132.3(F8):c.6515C>A (p.Pro2172Gln)	F8	P2153Q, P2172Q, P37Q	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010316	X	154091417	X	154863142	10316	25355	rs137852462	NC_000023.11:154863141:G:T
NM_000132.3(F8):c.6506G>A (p.Arg2169His)	F8	R2169H, R34H	not provided|Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010315	X	154091426	X	154863151	10315	25354	rs137852461	NC_000023.11:154863150:C:T
NM_000132.3(F8):c.6533G>T (p.Arg2178Leu)	F8	R2159L, R2178L, R43L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010314	X	154091399	X	154863124	10314	25353	rs137852465	NC_000023.11:154863123:C:A
NM_000132.3(F8):c.6464_6465del (p.Lys2155fs)	F8	K20fs, K2155fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 25, 1991)	no assertion criteria provided	VCV000010313	X	154091467 - 154091468	X	154863192 - 154863193	10313	25352	rs387906463	NC_000023.11:154863191:TTTT:TT
NM_000132.3(F8):c.6412_6413del (p.Ser2138fs)	F8	S2138fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010312	X	154124368 - 154124369	X	154896093 - 154896094	10312	25351	rs387906462	NC_000023.11:154896092:GA:
NM_000132.3(F8):c.6413C>A (p.Ser2138Tyr)	F8	S2119Y, S2138Y	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010311	X	154124368	X	154896093	10311	25350	rs137852460	NC_000023.11:154896092:G:T
NM_000132.3(F8):c.6371A>G (p.Tyr2124Cys)	F8	Y2124C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010310	X	154124410	X	154896135	10310	25349	rs137852459	NC_000023.11:154896134:T:C
NM_000132.3(F8):c.6360T>G (p.Phe2120Leu)	F8	F2120L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010309	X	154124421	X	154896146	10309	25348	rs137852458	NC_000023.11:154896145:A:C
NM_000132.3(F8):c.6278A>G (p.Asp2093Gly)	F8	D2074G, D2093G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010308	X	154124503	X	154896228	10308	25347	rs137852457	NC_000023.11:154896227:T:C
NM_000132.3(F8):c.6263C>T (p.Ser2088Phe)	F8	S2069F, S2088F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010307	X	154128151	X	154899876	10307	25346	rs137852456	NC_000023.11:154899875:G:A
NM_000132.3(F8):c.6193T>C (p.Trp2065Arg)	F8	W2065R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010306	X	154128221	X	154899946	10306	25345	rs137852455	NC_000023.11:154899945:A:G
NM_000132.3(F8):c.6113A>G (p.Asn2038Ser)	F8	N2019S, N2038S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010305	X	154130328	X	154902053	10305	25344	rs137852454	NC_000023.11:154902052:T:C
NM_000132.3(F8):c.6046C>T (p.Arg2016Trp)	F8	R1997W, R2016W	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 22, 2018)	criteria provided, single submitter	VCV000010304	X	154130395	X	154902120	10304	25343	rs137852453	NC_000023.11:154902119:G:A
NM_000132.3(F8):c.6016G>T (p.Glu2006Ter)	F8	E2006*, E1987*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010303	X	154130425	X	154902150	10303	25342	rs267606791	NC_000023.11:154902149:C:A
NM_000132.3(F8):c.6049del (p.Val2017fs)	F8	V2017fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010302	X	154130392	X	154902117	10302	25341	rs387906461	NC_000023.11:154902116:CCC:CC
NM_000132.3(F8):c.5961del (p.Glu1988fs)	F8	E1988fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010301	X	154132218	X	154903943	10301	25340	rs387906460	NC_000023.11:154903942:TTTTTTT:TTTTTT
NM_000132.3(F8):c.5953C>T (p.Arg1985Ter)	F8	R1966*, R1985*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000010300	X	154132226	X	154903951	10300	25339	rs137852452	NC_000023.11:154903950:G:A
NM_000132.3(F8):c.5938C>T (p.His1980Tyr)	F8	H1961Y, H1980Y	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010299	X	154132241	X	154903966	10299	25338	rs137852451	NC_000023.11:154903965:G:A
NM_000132.3(F8):c.5936G>T (p.Gly1979Val)	F8	G1960V, G1979V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010298	X	154132243	X	154903968	10298	25337	rs137852450	NC_000023.11:154903967:C:A
NM_000132.3(F8):c.5900G>A (p.Gly1967Asp)	F8	G1948D, G1967D	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000010297	X	154132279	X	154904004	10297	25336	rs111033615	NC_000023.11:154904003:C:T
NM_000132.3(F8):c.5882G>A (p.Trp1961Ter)	F8	W1961*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010296	X	154132297	X	154904022	10296	25335	rs137852449	NC_000023.11:154904021:C:T
NM_000132.3(F8):c.5879G>T (p.Arg1960Leu)	F8	R1941L, R1960L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010295	X	154132300	X	154904025	10295	25334	rs28937294	NC_000023.11:154904024:C:A
NM_000132.3(F8):c.5822A>G (p.Asn1941Ser)	F8	N1922S, N1941S	not specified|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	VCV000010294	X	154132357	X	154904082	10294	25333	rs28933682	NC_000023.11:154904081:T:C
NM_000132.3(F8):c.5719dup (p.Ser1907fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010293	X	154132666 - 154132667	X	154904391 - 154904392	10293	25332	rs387906459	NC_000023.11:154904391:TTTT:TTTTT
NM_000132.3(F8):c.5710G>A (p.Glu1904Lys)	F8	E1885K, E1904K	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010292	X	154132676	X	154904401	10292	25331	rs28933681	NC_000023.11:154904400:C:T
NM_000132.3(F8):c.5677C>T (p.Gln1893Ter)	F8	Q1874*, Q1893*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010291	X	154132709	X	154904434	10291	25330	rs137852448	NC_000023.11:154904433:G:A
NM_000132.3(F8):c.5622dup (p.Leu1875fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010290	X	154132763 - 154132764	X	154904488 - 154904489	10290	25329	rs387906458	NC_000023.11:154904488:AA:AAA
NM_000132.3(F8):c.5618C>G (p.Pro1873Arg)	F8	P1854R, P1873R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010289	X	154132768	X	154904493	10289	25328	rs28933680	NC_000023.11:154904492:G:C
NM_000132.3(F8):c.5600A>G (p.His1867Arg)	F8	H1848R, H1867R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010288	X	154132786	X	154904511	10288	25327	rs28933679	NC_000023.11:154904510:T:C
NM_000132.3(F8):c.5593G>T (p.Asp1865Tyr)	F8	D1846Y, D1865Y	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010287	X	154132793	X	154904518	10287	25326	rs28933678	NC_000023.11:154904517:C:A
NM_000132.3(F8):c.5593G>A (p.Asp1865Asn)	F8	D1846N, D1865N	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010286	X	154132793	X	154904518	10286	25325	rs28933678	NC_000023.11:154904517:C:T
F8, IVS16DS, G-A, -1	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010285					10285	25324		
NM_000132.3(F8):c.5558C>T (p.Ala1853Val)	F8	A1834V, A1853V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010284	X	154133114	X	154904839	10284	25323	rs28933677	NC_000023.11:154904838:G:A
NM_000132.3(F8):c.5479A>T (p.Lys1827Ter)	F8	K1827*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010283	X	154133193	X	154904918	10283	25322	rs387906457	NC_000023.11:154904917:T:A
NM_000132.3(F8):c.5533A>C (p.Thr1845Pro)	F8	T1826P, T1845P	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010282	X	154133139	X	154904864	10282	25321	rs28933676	NC_000023.11:154904863:T:G
NM_000132.3(F8):c.5526G>A (p.Met1842Ile)	F8	M1823I, M1842I	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010280	X	154133146	X	154904871	10280	25319	rs28933674	NC_000023.11:154904870:C:T
NM_000132.3(F8):c.5443C>T (p.Gln1815Ter)	F8	Q1796*, Q1815*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010279	X	154133229	X	154904954	10279	25318	rs137852446	NC_000023.11:154904953:G:A
NM_000132.3(F8):c.5408C>A (p.Ser1803Tyr)	F8	S1784Y, S1803Y	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010277	X	154133264	X	154904989	10277	25316	rs137852444	NC_000023.11:154904988:G:T
NM_000132.3(F8):c.5398C>G (p.Arg1800Gly)	F8	R1781G, R1800G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010276	X	154133274	X	154904999	10276	25315	rs137852443	NC_000023.11:154904998:G:C
NM_000132.3(F8):c.5398C>T (p.Arg1800Cys)	F8	R1781C, R1800C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010275	X	154133274	X	154904999	10275	25314	rs137852443	NC_000023.11:154904998:G:A
NM_000132.3(F8):c.5399G>A (p.Arg1800His)	F8	R1781H, R1800H	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000010274	X	154133273	X	154904998	10274	25313	rs137852442	NC_000023.11:154904997:C:T
NM_000132.3(F8):c.5336G>A (p.Gly1779Glu)	F8	G1760E, G1779E	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010273	X	154134732	X	154906457	10273	25312	rs28937289	NC_000023.11:154906456:C:T
NM_000132.3(F8):c.5325G>C (p.Leu1775Phe)	F8	L1775F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010272	X	154134743	X	154906468	10272	25311	rs137852441	NC_000023.11:154906467:C:G
NM_000132.3(F8):c.5323T>G (p.Leu1775Val)	F8	L1756V, L1775V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010271	X	154134745	X	154906470	10271	25310	rs28937287	NC_000023.11:154906469:A:C
NM_000132.3(F8):c.5305G>A (p.Gly1769Arg)	F8	G1769R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010270	X	154134763	X	154906488	10270	25309	rs137852440	NC_000023.11:154906487:C:T
F8, IVS14AS, A-G, -2	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010269					10269	25308		
NM_000132.3(F8):c.5143C>G (p.Arg1715Gly)	F8	R1696G, R1715G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000010268	X	154156922	X	154928647	10268	25307	rs137852439	NC_000023.11:154928646:G:C
NM_000132.3(F8):c.5143C>T (p.Arg1715Ter)	F8	R1696*, R1715*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010267	X	154156922	X	154928647	10267	25306	rs137852439	NC_000023.11:154928646:G:A
NM_000132.3(F8):c.5123G>A (p.Arg1708His)	F8	R1689H, R1708H	Hereditary factor VIII deficiency disease|Abnormality of coagulation	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000010266	X	154156942	X	154928667	10266	25305	rs111033614	NC_000023.11:154928666:C:T
F8, GLU161TER	F8	E161*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010265					10265	25304		
NM_000132.3(F8):c.4858del (p.Ser1619_Leu1620insTer)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010264	X	154157207	X	154928932	10264	25303	rs387906456	NC_000023.11:154928931:GGG:GG
NM_000132.3(F8):c.4825dup (p.Thr1609fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010263	X	154157239 - 154157240	X	154928964 - 154928965	10263	25302	rs397514036	NC_000023.11:154928964:TTTTTT:TTTTTTT
F8, 2-BP DEL, GA	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010262					10262	25301		
NM_000132.3(F8):c.4379del (p.Asn1460fs)	F8	N1460fs	not provided|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010261	X	154157686	X	154929411	10261	25300	rs387906455	NC_000023.11:154929410:TTTTTTTT:TTTTTTT
F8, 1-BP INS, A	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010260					10260	25299		
NM_000132.3(F8):c.4324_4327AAGA[1] (p.Lys1443fs)	F8		Hereditary factor VIII deficiency disease|not provided	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000010259	X	154157734 - 154157737	X	154929459 - 154929462	10259	25298	rs387906454	NC_000023.11:154929458:TCTTTCTTTCT:TCTTTCT
NM_000132.3(F8):c.4296_4300del (p.His1434fs)	F8	H1434fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010258	X	154157765 - 154157769	X	154929490 - 154929494	10258	25297	rs387906453	NC_000023.11:154929489:GAGAAGAG:GAG
F8, 1-BP INS, A, CODON 1414	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010257					10257	25296		
NM_000132.3(F8):c.4121_4124del (p.Ile1374fs)	F8	I1374fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010256	X	154157941 - 154157944	X	154929666 - 154929669	10256	25295	rs387906452	NC_000023.11:154929665:TCTATCT:TCT
F8, 2-BP, INS, FS	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010255					10255	25294		
NM_000132.3(F8):c.3692del (p.Pro1231fs)	F8	P1231fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010254	X	154158373	X	154930098	10254	25293	rs387906451	NC_000023.11:154930097:GG:G
NM_000132.3(F8):c.3637del (p.Ile1213fs)	F8	I1213fs	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010253	X	154158428	X	154930153	10253	25292	rs387906450	NC_000023.11:154930152:TTTTTTTTT:TTTTTTTT
NM_000132.3(F8):c.3548_3549del (p.Lys1183fs)	F8	K1183fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010252	X	154158516 - 154158517	X	154930241 - 154930242	10252	25291	rs387906449	NC_000023.11:154930240:TTT:T
NM_000132.3(F8):c.2958_2959AG[2] (p.Ser988fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010250	X	154159102 - 154159103	X	154930827 - 154930828	10250	25289	rs387906448	NC_000023.11:154930826:CTCTCT:CTCT
NM_000132.3(F8):c.2945dup (p.Asn982fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000010249	X	154159119 - 154159120	X	154930844 - 154930845	10249	25288	rs387906447	NC_000023.11:154930844:TTTTTT:TTTTTTT
NM_000132.3(F8):c.2383A>T (p.Arg795Ter)	F8	R795*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1990)	no assertion criteria provided	VCV000010248	X	154159682	X	154931407	10248	25287	rs2228152	NC_000023.11:154931406:T:A
NM_000132.3(F8):c.2215G>A (p.Glu739Lys)	F8	E720K, E739K	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010247	X	154159850	X	154931575	10247	25286	rs28937285	NC_000023.11:154931574:C:T
NM_000132.3(F8):c.2167G>A (p.Ala723Thr)	F8	A704T, A723T	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010246	X	154159898	X	154931623	10246	25285	rs137852436	NC_000023.11:154931622:C:T
NM_000132.3(F8):c.2149C>T (p.Arg717Trp)	F8	R698W, R717W	Hereditary factor VIII deficiency disease|not provided|Abnormality of coagulation|Hereditary factor IX deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010245	X	154159916	X	154931641	10245	25284	rs137852435	NC_000023.11:154931640:G:A
NM_000132.3(F8):c.2029T>C (p.Phe677Leu)	F8	F677L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010244	X	154176057	X	154947782	10244	25283	rs137852434	NC_000023.11:154947781:A:G
F8, 3-BP DEL, PHE652DEL	F8	F652del	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000010243					10243	25282		
NM_000132.3(F8):c.1988C>T (p.Ala663Val)	F8	A644V, A663V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010242	X	154176098	X	154947823	10242	25281	rs137852433	NC_000023.11:154947822:G:A
NM_000132.3(F8):c.1965C>G (p.Tyr655Ter)	F8	Y655*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010241	X	154176121	X	154947846	10241	25280	rs137852432	NC_000023.11:154947845:G:C
NM_000132.3(F8):c.1957G>A (p.Val653Met)	F8	V634M, V653M	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000010240	X	154176129	X	154947854	10240	25279	rs137852431	NC_000023.11:154947853:C:T
NM_000132.3(F8):c.1958T>C (p.Val653Ala)	F8	V634A, V653A	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000010239	X	154176128	X	154947853	10239	25278	rs137852430	NC_000023.11:154947852:A:G
F8, IVS12DS, G-A, +5	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010238					10238	25277		
NM_000132.3(F8):c.1892A>G (p.Asn631Ser)	F8	N612S, N631S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010237	X	154182178	X	154953903	10237	25276	rs137852429	NC_000023.11:154953902:T:C
NM_000132.3(F8):c.1834C>T (p.Arg612Cys)	F8	R593C, R612C	Hereditary factor IX deficiency disease|not provided|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010236	X	154182236	X	154953961	10236	25275	rs137852428	NC_000023.11:154953960:G:A
NM_000132.3(F8):c.1814A>C (p.Tyr605Ser)	F8	Y586S, Y605S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010235	X	154182256	X	154953981	10235	25274	rs137852427	NC_000023.11:154953980:T:G
NM_000132.3(F8):c.1812G>C (p.Trp604Cys)	F8	W604C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010234	X	154182258	X	154953983	10234	25273	rs137852426	NC_000023.11:154953982:C:G
NM_000132.3(F8):c.1808G>T (p.Ser603Ile)	F8	S584I, S603I	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010233	X	154182262	X	154953987	10233	25272	rs137852425	NC_000023.11:154953986:C:A
NM_000132.3(F8):c.1804C>T (p.Arg602Ter)	F8	R583*, R602*	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010232	X	154182266	X	154953991	10232	25271	rs137852424	NC_000023.11:154953990:G:A
NM_000132.3(F8):c.1729T>C (p.Ser577Pro)	F8	S577P	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010231	X	154185255	X	154956980	10231	25270	rs387906446	NC_000023.11:154956979:A:G
NM_000132.3(F8):c.1750C>A (p.Gln584Lys)	F8	Q565K, Q584K	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010230	X	154185234	X	154956959	10230	25269	rs137852422	NC_000023.11:154956958:G:T
NM_000132.3(F8):c.1730C>T (p.Ser577Phe)	F8	S558F, S577F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000010229	X	154185254	X	154956979	10229	25268	rs28937282	NC_000023.11:154956978:G:A
NM_000132.3(F8):c.1726G>T (p.Glu576Ter)	F8	E557*, E576*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010228	X	154185258	X	154956983	10228	25267	rs137852421	NC_000023.11:154956982:C:A
NM_000132.3(F8):c.1682A>G (p.Asp561Gly)	F8	D542G, D561G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010227	X	154185302	X	154957027	10227	25266	rs137852420	NC_000023.11:154957026:T:C
NM_000132.3(F8):c.1660A>G (p.Ser554Gly)	F8	S535G, S554G	not provided|Hereditary factor VIII deficiency disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000010226	X	154185324	X	154957049	10226	25265	rs137852419	NC_000023.11:154957048:T:C
NM_000132.3(F8):c.1649G>A (p.Arg550His)	F8	R531H, R550H	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010225	X	154185335	X	154957060	10225	25264	rs137852418	NC_000023.11:154957059:C:T
NM_000132.3(F8):c.1648C>T (p.Arg550Cys)	F8	R531C, R550C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010223	X	154185336	X	154957061	10223	25262	rs137852417	NC_000023.11:154957060:G:A
NM_000132.3(F8):c.1636C>T (p.Arg546Trp)	F8	R527W, R546W	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010222	X	154185348	X	154957073	10222	25261	rs137852416	NC_000023.11:154957072:G:A
NM_000132.3(F8):c.1630G>A (p.Asp544Asn)	F8	D525N, D544N	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010221	X	154185354	X	154957079	10221	25260	rs137852415	NC_000023.11:154957078:C:T
NM_000132.3(F8):c.1596dup (p.Thr533fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010220	X	154185387 - 154185388	X	154957112 - 154957113	10220	25259	rs387906445	NC_000023.11:154957112:CC:CCC
F8, IVS10AS, G-T, +1	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010219					10219	25258		
F8, 11-BP DEL, FS	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010218					10218	25257		
NM_000132.3(F8):c.1492G>A (p.Gly498Arg)	F8	G498R	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010217	X	154189395	X	154961120	10217	25256	rs137852414	NC_000023.11:154961119:C:T
NM_000132.3(F8):c.1481T>C (p.Ile494Thr)	F8	I475T, I494T	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010216	X	154189406	X	154961131	10216	25255	rs137852413	NC_000023.11:154961130:A:G
NM_000132.3(F8):c.1418A>G (p.Tyr473Cys)	F8	Y473C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010215	X	154194270	X	154965995	10215	25254	rs387906444	NC_000023.11:154965994:T:C
NM_000132.3(F8):c.1417T>C (p.Tyr473His)	F8	Y473H	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010214	X	154194271	X	154965996	10214	25253	rs387906443	NC_000023.11:154965995:A:G
NM_000132.3(F8):c.1348T>A (p.Tyr450Asn)	F8	Y431N, Y450N	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 3, 1993)	no assertion criteria provided	VCV000010213	X	154194340	X	154966065	10213	25252	rs111033616	NC_000023.11:154966064:A:T
NM_000132.3(F8):c.1331A>G (p.Lys444Arg)	F8	K425R, K444R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010212	X	154194357	X	154966082	10212	25251	rs28937272	NC_000023.11:154966081:T:C
NM_000132.3(F8):c.1293del (p.Asn432fs)	F8	N432fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010211	X	154194395	X	154966120	10211	25250	rs387906442	NC_000023.11:154966119:C:
NM_000132.3(F8):c.1293G>T (p.Leu431Phe)	F8	L412F, L431F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010210	X	154194395	X	154966120	10210	25249	rs28933672	NC_000023.11:154966119:C:A
NM_000132.3(F8):c.1226A>G (p.Glu409Gly)	F8	E390G, E409G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010209	X	154194746	X	154966471	10209	25248	rs28933671	NC_000023.11:154966470:T:C
NM_000132.3(F8):c.1214T>G (p.Ile405Ser)	F8	I386S, I405S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010208	X	154194758	X	154966483	10208	25247	rs28933670	NC_000023.11:154966482:A:C
NM_000132.3(F8):c.1197_1198del (p.Lys399fs)	F8	K399fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010207	X	154194774 - 154194775	X	154966499 - 154966500	10207	25246	rs387906441	NC_000023.11:154966498:TTTT:TT
NM_000132.3(F8):c.1174T>C (p.Ser392Pro)	F8	S373P, S392P	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000010206	X	154194798	X	154966523	10206	25245	rs28933669	NC_000023.11:154966522:A:G
NM_000132.3(F8):c.1175C>T (p.Ser392Leu)	F8	S373L, S392L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1993)	no assertion criteria provided	VCV000010205	X	154194797	X	154966522	10205	25244	rs28933668	NC_000023.11:154966521:G:A
NM_000132.3(F8):c.1175C>A (p.Ser392Ter)	F8	S392*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1993)	no assertion criteria provided	VCV000010204	X	154194797	X	154966522	10204	25243	rs28933668	NC_000023.11:154966521:G:T
NM_000132.3(F8):c.1078_1079del (p.Glu360fs)	F8	E360fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010203	X	154194893 - 154194894	X	154966618 - 154966619	10203	25242	rs387906440	NC_000023.11:154966617:TC:
NM_000132.3(F8):c.1043G>C (p.Cys348Ser)	F8	C348S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010202	X	154194929	X	154966654	10202	25241	rs137852410	NC_000023.11:154966653:C:G
NM_000132.3(F8):c.986G>A (p.Cys329Tyr)	F8	C329Y	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010201	X	154197629	X	154969354	10201	25240	rs137852409	NC_000023.11:154969353:C:T
NM_000132.3(F8):c.1026T>A (p.Tyr342Ter)	F8	Y342*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010200	X	154194946	X	154966671	10200	25239	rs137852408	NC_000023.11:154966670:A:T
NM_000132.3(F8):c.980T>C (p.Leu327Pro)	F8	L308P, L327P	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010199	X	154197635	X	154969360	10199	25238	rs137852407	NC_000023.11:154969359:A:G
NM_000132.3(F8):c.943del (p.Ala315fs)	F8	A315fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010198	X	154197672	X	154969397	10198	25237	rs387906439	NC_000023.11:154969396:C:
NM_000132.3(F8):c.940A>G (p.Thr314Ala)	F8	T314A	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010197	X	154197675	X	154969400	10197	25236	rs137852406	NC_000023.11:154969399:T:C
NM_000132.3(F8):c.935T>C (p.Phe312Ser)	F8	F293S, F312S	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010196	X	154197680	X	154969405	10196	25235	rs137852405	NC_000023.11:154969404:A:G
NM_000132.3(F8):c.923C>T (p.Ser308Leu)	F8	S289L, S308L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1993)	no assertion criteria provided	VCV000010195	X	154197692	X	154969417	10195	25234	rs137852404	NC_000023.11:154969416:G:A
NM_000132.3(F8):c.907del (p.Ala303fs)	F8	A303fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010194	X	154197708	X	154969433	10194	25233	rs387906438	NC_000023.11:154969432:CC:C
NM_000132.3(F8):c.902G>T (p.Arg301Leu)	F8	R282L, R301L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010193	X	154197713	X	154969438	10193	25232	rs137852403	NC_000023.11:154969437:C:A
NM_000132.3(F8):c.902G>A (p.Arg301His)	F8	R282H, R301H	Hereditary factor VIII deficiency disease|not provided	Pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010192	X	154197713	X	154969438	10192	25231	rs137852403	NC_000023.11:154969437:C:T
NM_000132.3(F8):c.896A>T (p.Asn299Ile)	F8	N280I, N299I	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 3, 1993)	no assertion criteria provided	VCV000010191	X	154197719	X	154969444	10191	25230	rs137852402	NC_000023.11:154969443:T:A
NM_000132.3(F8):c.881C>T (p.Thr294Ile)	F8	T275I, T294I	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010190	X	154197734	X	154969459	10190	25229	rs137852401	NC_000023.11:154969458:G:A
NM_000132.3(F8):c.854T>G (p.Val285Gly)	F8	V266G, V285G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010189	X	154197761	X	154969486	10189	25228	rs137852400	NC_000023.11:154969485:A:C
NM_000132.3(F8):c.849del (p.Glu284fs)	F8	E284fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010188	X	154197766	X	154969491	10188	25227	rs387906437	NC_000023.11:154969490:A:
NM_000132.3(F8):c.832G>A (p.Gly278Arg)	F8	G278R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010187	X	154197783	X	154969508	10187	25226	rs137852399	NC_000023.11:154969507:C:T
NM_000132.3(F8):c.822G>A (p.Trp274Ter)	F8	W274*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010186	X	154197793	X	154969518	10186	25225	rs34371500	NC_000023.11:154969517:C:T
NM_000132.3(F8):c.797G>A (p.Gly266Glu)	F8	G266E	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 12, 2013)	no assertion criteria provided	VCV000010185	X	154197818	X	154969543	10185	25224	rs137852398	NC_000023.11:154969542:C:T
F8, IVS6AS, G-C, -1	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010184					10184	25223		
F8, IVS6DS, A-G, +3	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000010183					10183	25222		
F8, IVS5AS, A-G, -2	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 11, 2016)	no assertion criteria provided	VCV000010182					10182	25221		
NM_000132.3(F8):c.688_689del (p.Glu230fs)	F8	E230fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010181	X	154213060 - 154213061	X	154984785 - 154984786	10181	25220	rs387906436	NC_000023.11:154984784:TCT:T
NM_000132.3(F8):c.670G>T (p.Gly224Trp)	F8	G205W, G224W	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010180	X	154215512	X	154987237	10180	25219	rs137852397	NC_000023.11:154987236:C:A
NM_000132.3(F8):c.665A>T (p.Asp222Val)	F8	D203V, D222V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010179	X	154215517	X	154987242	10179	25218	rs137852396	NC_000023.11:154987241:T:A
NM_000132.3(F8):c.554A>C (p.Lys185Thr)	F8	K166T, K185T	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1991)	no assertion criteria provided	VCV000010178	X	154221258	X	154992983	10178	25217	rs137852395	NC_000023.11:154992982:T:G
NM_000132.3(F8):c.541G>A (p.Val181Met)	F8	V162M, V181M	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000010177	X	154221271	X	154992996	10177	25216	rs137852394	NC_000023.11:154992995:C:T
NM_000132.3(F8):c.493C>T (p.Pro165Ser)	F8	P146S, P165S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010176	X	154221319	X	154993044	10176	25215	rs137852393	NC_000023.11:154993043:G:A
NM_000132.3(F8):c.491G>T (p.Gly164Val)	F8	G145V, G164V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010175	X	154221321	X	154993046	10175	25214	rs137852392	NC_000023.11:154993045:C:A
NM_000132.3(F8):c.410C>T (p.Thr137Ile)	F8	T137I	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010174	X	154221402	X	154993127	10174	25213	rs137852391	NC_000023.11:154993126:G:A
NM_000132.3(F8):c.404A>G (p.Asp135Gly)	F8	D116G, D135G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010173	X	154221408	X	154993133	10173	25212	rs137852390	NC_000023.11:154993132:T:C
NM_000132.3(F8):c.398A>G (p.Tyr133Cys)	F8	Y114C, Y133C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010172	X	154221414	X	154993139	10172	25211	rs137852389	NC_000023.11:154993138:T:C
NM_000132.3(F8):c.396A>C (p.Glu132Asp)	F8	E132D	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010171	X	154221416	X	154993141	10171	25210	rs137852388	NC_000023.11:154993140:T:G
NM_000132.3(F8):c.388G>C (p.Gly130Arg)	F8	G130R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010170	X	154225248	X	154996973	10170	25209	rs137852387	NC_000023.11:154996972:C:G
NM_000132.3(F8):c.350T>G (p.Leu117Arg)	F8	L98R, L117R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010169	X	154225286	X	154997011	10169	25208	rs137852386	NC_000023.11:154997010:A:C
NM_000132.3(F8):c.328A>G (p.Met110Val)	F8	M91V, M110V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010168	X	154225308	X	154997033	10168	25207	rs137852385	NC_000023.11:154997032:T:C
NM_000132.3(F8):c.323A>C (p.Lys108Thr)	F8	K89T, K108T	Hereditary factor VIII deficiency disease|not specified	Pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000010167	X	154225313	X	154997038	10167	25206	rs137852384	NC_000023.11:154997037:T:G
NM_000132.3(F8):c.311T>A (p.Val104Asp)	F8	V85D, V104D	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010166	X	154225325	X	154997050	10166	25205	rs137852383	NC_000023.11:154997049:A:T
NM_000132.3(F8):c.296T>A (p.Val99Asp)	F8	V80D, V99D	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010165	X	154225340	X	154997065	10165	25204	rs137852382	NC_000023.11:154997064:A:T
NM_000132.3(F8):c.275G>T (p.Gly92Val)	F8	G73V, G92V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010164	X	154225361	X	154997086	10164	25203	rs137852381	NC_000023.11:154997085:C:A
NM_000132.3(F8):c.266G>A (p.Gly89Asp)	F8	G70D, G89D	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010163	X	154225370	X	154997095	10163	25202	rs137852380	NC_000023.11:154997094:C:T
F8, IVS4AS, A-G, -2	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010162					10162	25201		
F8, 23-BP DEL, FS	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1991)	no assertion criteria provided	VCV000010161					10161	25200		
NM_000132.3(F8):c.362_363GT[1] (p.Val122fs)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010160	X	154225271 - 154225272	X	154996996 - 154996997	10160	25199	rs387906435	NC_000023.11:154996995:ACAC:AC
NM_000132.3(F8):c.209_212del (p.Leu69_Phe70insTer)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010159	X	154227807 - 154227810	X	154999532 - 154999535	10159	25198	rs387906434	NC_000023.11:154999531:ACAAACA:ACA
NM_000132.3(F8):c.199_200del (p.Lys67fs)	F8	K67fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010158	X	154227819 - 154227820	X	154999544 - 154999545	10158	25197	rs387906433	NC_000023.11:154999543:TTTTT:TTT
F8, 10-BP INS, FS	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000010157					10157	25196		
NM_000132.3(F8):c.121G>T (p.Gly41Cys)	F8	G22C, G41C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010156	X	154250707	X	155022432	10156	25195	rs137852379	NC_000023.11:155022431:C:A
F8, 89-BP DEL, FS	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010155					10155	25194		
NM_000132.3(F8):c.89A>T (p.Glu30Val)	F8	E11V, E30V	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000010154	X	154250739	X	155022464	10154	25193	rs137852378	NC_000023.11:155022463:T:A
NM_000132.3(F8):c.77T>G (p.Leu26Arg)	F8	L7R, L26R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010153	X	154250751	X	155022476	10153	25192	rs137852377	NC_000023.11:155022475:A:C
NM_000132.3(F8):c.43C>T (p.Arg15Ter)	F8	R15*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000010152	X	154250785	X	155022510	10152	25191	rs387906432	NC_000023.11:155022509:G:A
F8, IVS6DS, A-G, +3, 186-BP DEL, EX5-6 DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000010151					10151	25190		
F8, IVS22 INV	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000010150					10150	25189		
NM_000132.3(F8):c.1754T>C (p.Ile585Thr)	F8	I566T, I585T	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	VCV000010149	X	154182316	X	154954041	10149	25188	rs137852376	NC_000023.11:154954040:A:G
NM_000132.3(F8):c.5372T>C (p.Met1791Thr)	F8	M1772T, M1791T	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000010148	X	154134696	X	154906421	10148	25187	rs137852375	NC_000023.11:154906420:A:G
NM_000132.3(F8):c.6955C>T (p.Pro2319Ser)	F8	P2300S, P2319S, P184S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000010147	X	154065973	X	154837698	10147	25186	rs137852374	NC_000023.11:154837697:G:A
NM_000132.3(F8):c.5167G>A (p.Glu1723Lys)	F8	E1704K, E1723K	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 1, 1991)	no assertion criteria provided	VCV000010146	X	154156898	X	154928623	10146	25185	rs137852373	NC_000023.11:154928622:C:T
NM_000132.3(F8):c.1336C>T (p.Arg446Ter)	F8	R427*, R446*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Oct 1, 1990)	no assertion criteria provided	VCV000010145	X	154194352	X	154966077	10145	25184	rs137852372	NC_000023.11:154966076:G:A
F8, EX13DUP	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1990)	no assertion criteria provided	VCV000010144					10144	25183		
NM_000132.3(F8):c.1077_1080del (p.Asn359fs)	F8	N359fs	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 1, 1990)	no assertion criteria provided	VCV000010143	X	154194892 - 154194895	X	154966617 - 154966620	10143	25182	rs387906431	NC_000023.11:154966616:TTCATT:TT
NM_000132.3(F8):c.1033G>T (p.Val345Leu)	F8	V326L, V345L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 1, 1990)	no assertion criteria provided	VCV000010142	X	154194939	X	154966664	10142	25181	rs137852371	NC_000023.11:154966663:C:A
NM_000132.3(F8):c.985T>C (p.Cys329Arg)	F8	C329R	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 1, 1990)	no assertion criteria provided	VCV000010141	X	154197630	X	154969355	10141	25180	rs387906430	NC_000023.11:154969354:A:G
NM_000132.3(F8):c.5821A>G (p.Asn1941Asp)	F8	N1922D, N1941D	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1990)	no assertion criteria provided	VCV000010140	X	154132358	X	154904083	10140	25179	rs137852369	NC_000023.11:154904082:T:C
NM_000132.3(F8):c.1063C>T (p.Arg355Ter)	F8	R336*, R355*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 30, 1985)	no assertion criteria provided	VCV000010139	X	154194909	X	154966634	10139	25178	rs137852368	NC_000023.11:154966633:G:A
F8, EX5-6 DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010138					10138	25177		
F8, EX5DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	VCV000010137					10137	25176		
F8, EX5DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010136					10136	25175		
F8, EX5DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010135					10135	25174		
F8, EX7-9DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1989)	no assertion criteria provided	VCV000010134					10134	25173		
F8, EX14DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1988)	no assertion criteria provided	VCV000010133					10133	25172		
F8, EX23-25DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 25, 1985)	no assertion criteria provided	VCV000010132					10132	25171		
NM_000132.3(F8):c.2114-?_5219+?del (p.?)	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1989)	no assertion criteria provided	VCV000010131	X	154134848 - 154175973	X	154906573 - 154947698	10131	25170		
F8, EX15-18DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010130					10130	25169		
NM_000132.3(F8):c.566C>T (p.Ser189Leu)	F8	S170L, S189L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 1, 1989)	no assertion criteria provided	VCV000010129	X	154221246	X	154992971	10129	25168	rs137852367	NC_000023.11:154992970:G:A
NM_000132.3(F8):c.6404G>C (p.Arg2135Pro)	F8	R2116P, R2135P	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 10, 1987)	no assertion criteria provided	VCV000010128	X	154124377	X	154896102	10128	25167	rs137852366	NC_000023.11:154896101:C:G
NM_000132.3(F8):c.6554T>C (p.Leu2185Ser)	F8	L2166S, L2185S, L50S	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010127	X	154091378	X	154863103	10127	25166	rs137852365	NC_000023.11:154863102:A:G
NM_000132.3(F8):c.6977G>A (p.Arg2326Gln)	F8	R2307Q, R2326Q, R191Q	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000010126	X	154065951	X	154837676	10126	25165	rs137852360	NC_000023.11:154837675:C:T
NM_000132.3(F8):c.1171C>T (p.Arg391Cys)	F8	R372C, R391C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 15, 1990)	no assertion criteria provided	VCV000010125	X	154194801	X	154966526	10125	25164	rs137852364	NC_000023.11:154966525:G:A
F8, EX1-26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1990)	no assertion criteria provided	VCV000010124					10124	25163		
F8, EX26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010123					10123	25162		
F8, EX1-22DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	VCV000010122					10122	25161		
F8, EX1-5DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1989)	no assertion criteria provided	VCV000010121					10121	25160		
F8, EX3DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1989)	no assertion criteria provided	VCV000010119					10119	25158		
NM_000132.3(F8):c.5878C>T (p.Arg1960Ter)	F8	R1941*, R1960*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 27, 1986)	no assertion criteria provided	VCV000010118	X	154132301	X	154904026	10118	25157	rs137852363	NC_000023.11:154904025:G:A
F8, EX11-18DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 22, 1985)	no assertion criteria provided	VCV000010117					10117	25156		
NM_000132.3(F8):c.5183A>G (p.Tyr1728Cys)	F8	Y1709C, Y1728C	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1990)	no assertion criteria provided	VCV000010116	X	154156882	X	154928607	10116	25155	rs137852362	NC_000023.11:154928606:T:C
NM_000132.3(F8):c.5096A>T (p.Tyr1699Phe)	F8	Y1680F, Y1699F	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000010115	X	154156969	X	154928694	10115	25154	rs28935203	NC_000023.11:154928693:T:A
NM_000132.3(F8):c.5122C>T (p.Arg1708Cys)	F8	R1689C, R1708C	FACTOR VIII (EAST HARTFORD)|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000010114	X	154156943	X	154928668	10114	25153	rs111033613	NC_000023.11:154928667:G:A
F8, EX14DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Aug 15, 1989)	no assertion criteria provided	VCV000010113					10113	25152		
NM_000132.3(F8):c.5113C>T (p.Gln1705Ter)	F8	E1686*, Q1705*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010112	X	154156952	X	154928677	10112	25151	rs137852361	NC_000023.11:154928676:G:A
NM_000132.3(F8):c.1172G>A (p.Arg391His)	F8	R372H, R391H	Hereditary factor IX deficiency disease|FACTOR VIII (OKAYAMA)|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010111	X	154194800	X	154966525	10111	25150	rs28935499	NC_000023.11:154966524:C:T
NM_000132.3(F8):c.5879G>A (p.Arg1960Gln)	F8	R1941Q, R1960Q	not provided|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000010110	X	154132300	X	154904025	10110	25149	rs28937294	NC_000023.11:154904024:C:T
NM_000132.3(F8):c.6977G>T (p.Arg2326Leu)	F8	R2307L, R2326L, R191L	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 1, 1989)	no assertion criteria provided	VCV000010109	X	154065951	X	154837676	10109	25148	rs137852360	NC_000023.11:154837675:C:A
F8, 2-BP DEL, EX8	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010108					10108	25147		
F8, EX15DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 15, 1995)	no assertion criteria provided	VCV000010107					10107	25146		
F8, LINE INS, EX14	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Mar 10, 1988)	no assertion criteria provided	VCV000010106					10106	25145		
F8, EX26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 1989)	no assertion criteria provided	VCV000010105					10105	25144		
F8, EX7-14DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010103					10103	25142		
F8, EX4-25DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010102					10102	25141		
F8, EX3-13DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010101					10101	25140		
F8, EX2-3DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010100					10100	25139		
NM_000132.3(F8):c.872A>G (p.Glu291Gly)	F8	E272G, E291G	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010099	X	154197743	X	154969468	10099	25138	rs137852359	NC_000023.11:154969467:T:C
NM_000132.3(F8):c.6683G>A (p.Arg2228Gln)	F8	R2209Q, R2228Q, R93Q	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000010098	X	154090033	X	154861758	10098	25137	rs137852358	NC_000023.11:154861757:C:T
NM_000132.3(F8):c.601+1632G>A	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010097	X	154219579	X	154991304	10097	25136	rs387906429	NC_000023.11:154991303:C:T
NM_000132.3(F8):c.6496C>T (p.Arg2166Ter)	F8	R2147*, R2166*, R31*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: May 1, 1988)	no assertion criteria provided	VCV000010096	X	154091436	X	154863161	10096	25135	rs137852357	NC_000023.11:154863160:G:A
F8, EX1DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010095					10095	25134		
F8, EX26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 15, 1995)	no assertion criteria provided	VCV000010094					10094	25133		
F8, EX22DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 1, 1987)	no assertion criteria provided	VCV000010093					10093	25132		
F8, EX23-25DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 1, 1987)	no assertion criteria provided	VCV000010092					10092	25131		
F8, EX24-25DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 1, 1987)	no assertion criteria provided	VCV000010091					10091	25130		
F8, EX14DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000010090					10090	25129		
F8, EX6DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000010089					10089	25128		
NM_000132.3(F8):c.6403C>T (p.Arg2135Ter)	F8	R2116*, R2135*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Nov 27, 1986)	no assertion criteria provided	VCV000010088	X	154124378	X	154896103	10088	25127	rs137852356	NC_000023.11:154896102:G:A
F8, EX26DEL	F8		Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 1, 1988)	no assertion criteria provided	VCV000010087					10087	25126		
NM_000132.3(F8):c.6682C>T (p.Arg2228Ter)	F8	R2209*, R2228*, R93*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 1, 1988)	no assertion criteria provided	VCV000010086	X	154090034	X	154861759	10086	25125	rs137852355	NC_000023.11:154861758:G:A
NM_000132.3(F8):c.6976C>T (p.Arg2326Ter)	F8	R2307*, R2326*, R191*	Hereditary factor VIII deficiency disease	Pathogenic(Last reviewed: Sep 1, 1988)	no assertion criteria provided	VCV000010085	X	154065952	X	154837677	10085	25124	rs137852354	NC_000023.11:154837676:G:A
NM_000194.3(HPRT1):c.193C>T (p.Leu65Phe)	HPRT1	L65F	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000010084	X	133609269	X	134475239	10084	25123	rs137852506	NC_000023.11:134475238:C:T
NM_000194.2(HPRT1):c.459T>G (p.Tyr153Ter)	HPRT1	Y153*	HPRT PARIS|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: Sep 27, 2017)	no assertion criteria provided	VCV000010082	X	133627594	X	134493564	10082	25121	rs137852505	NC_000023.11:134493563:T:G
NM_000194.2(HPRT1):c.582C>G (p.Asp194Glu)	HPRT1	D194E	HPRT MOOSE JAW|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010081	X	133632687	X	134498657	10081	25120	rs137852504	NC_000023.11:134498656:C:G
NM_000194.2(HPRT1):c.419G>A (p.Gly140Asp)	HPRT1	G140D	Lesch-Nyhan syndrome|HPRT TOKYO	Pathogenic, other(Last reviewed: Oct 24, 2013)	no assertion criteria provided	VCV000010080	X	133627554	X	134493524	10080	25119	rs137852503	NC_000023.11:134493523:G:A
NM_000194.2(HPRT1):c.155A>G (p.Asp52Gly)	HPRT1	D52G	HPRT EDINBURGH|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: Sep 27, 2017)	no assertion criteria provided	VCV000010079	X	133609231	X	134475201	10079	25118	rs137852502	NC_000023.11:134475200:A:G
HPRT COORPAROO	HPRT1		HPRT COORPAROO|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010078					10078	25117		
HPRT CHERMSIDE	HPRT1		HPRT CHERMSIDE|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010077					10077	25116		
NM_000194.2(HPRT1):c.232C>G (p.Leu78Val)	HPRT1	L78V	HPRT SWAN|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010076	X	133609308	X	134475278	10076	25115	rs137852501	NC_000023.11:134475277:C:G
NM_000194.2(HPRT1):c.172G>A (p.Gly58Arg)	HPRT1	G58R	HPRT TOOWONG|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010075	X	133609248	X	134475218	10075	25114	rs137852500	NC_000023.11:134475217:G:A
NM_000194.2(HPRT1):c.46G>A (p.Gly16Ser)	HPRT1	G16S	HPRT URANGAN|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010074	X	133607407	X	134473377	10074	25113	rs137852499	NC_000023.11:134473376:G:A
NM_000194.2(HPRT1):c.503C>T (p.Thr168Ile)	HPRT1	T168I	Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000010073	X	133632437	X	134498407	10073	25112	rs137852498	NC_000023.11:134498406:C:T
HPRT, EX2-3DUP, IVS1DEL	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010072					10072	25111		
HPRT, INV/DEL, EX6-9	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	VCV000010071					10071	25110		
HPRT,1-BP INS, 207G	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Mar 1, 1989)	no assertion criteria provided	VCV000010070					10070	25109		
HPRT, DEL	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010069					10069	25108		
HPRT, EX9DEL	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010068					10068	25107		
NC_000023.11:g.(134493178_134493182)_(134501172_134501176)del	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010067			X	134493178 - 134501176	10067	25106		
HPRT, EX4-9DEL	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Aug 2, 1984)	no assertion criteria provided	VCV000010066					10066	25105		
HPRT, EX2DEL	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010065					10065	25104		
HPRT, 13-BP DEL, 5-PRIME UTR	HPRT1		Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic(Last reviewed: Mar 1, 1989)	no assertion criteria provided	VCV000010064					10064	25103		
NM_000194.3(HPRT1):c.508C>T (p.Arg170Ter)	HPRT1	R170*	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000010063	X	133632442	X	134498412	10063	25102	rs137852497	NC_000023.11:134498411:C:T
NM_000194.3(HPRT1):c.428T>A (p.Met143Lys)	HPRT1	M143K	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Mar 1, 1989)	no assertion criteria provided	VCV000010062	X	133627563	X	134493533	10062	25101	rs137852496	NC_000023.11:134493532:T:A
NM_000194.2(HPRT1):c.170T>C (p.Met57Thr)	HPRT1	M56T, M57T	HPRT MONTREAL|Lesch-nyhan syndrome, neurologic variant	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010061	X	133609246	X	134475216	10061	25100	rs137852495	NC_000023.11:134475215:T:C
NM_000194.2(HPRT1):c.151C>T (p.Arg51Ter)	HPRT1	R51*	not provided|Lesch-Nyhan syndrome|HPRT FUJIMI	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010060	X	133609227	X	134475197	10060	25099	rs137852494	NC_000023.11:134475196:C:T
NM_000194.2(HPRT1):c.151C>G (p.Arg51Gly)	HPRT1	R51G	HPRT TORONTO|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: Sep 27, 2017)	no assertion criteria provided	VCV000010059	X	133609227	X	134475197	10059	25098	rs137852494	NC_000023.11:134475196:C:G
NM_000194.3(HPRT1):c.527C>T (p.Pro176Leu)	HPRT1	P176L	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jul 1, 1989)	no assertion criteria provided	VCV000010058	X	133632461	X	134498431	10058	25097	rs137852493	NC_000023.11:134498430:C:T
NM_000194.3(HPRT1):c.28-2A>T	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010057	X	133607387	X	134473357	10057	25096	rs1569354918	NC_000023.11:134473356:A:T
NM_000194.3(HPRT1):c.532+5G>A	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010056	X	133632471	X	134498441	10056	25095	rs1569360089	NC_000023.11:134498440:G:A
NM_000194.3(HPRT1):c.610-4_610-2delinsTTT	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010055	X	133634056 - 133634058	X	134500026 - 134500028	10055	25094	rs672601245	NC_000023.11:134500025:ATA:TTT
NM_000194.3(HPRT1):c.609+5G>A	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010054	X	133632719	X	134498689	10054	25093	rs1569360139	NC_000023.11:134498688:G:A
HPRT, 40-BP DEL	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010053					10053	25092		
HPRT, 1-BP DEL, TTG-TG	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010052					10052	25091		
HPRT, 1-BP DEL, TTA-TA	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010051					10051	25090		
HPRT, 2-BP DEL, GT	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010050					10050	25089		
NM_000194.3(HPRT1):c.529G>T (p.Asp177Tyr)	HPRT1	D176Y, D177Y	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010049	X	133632463	X	134498433	10049	25088	rs137852492	NC_000023.11:134498432:G:T
NM_000194.3(HPRT1):c.134G>A (p.Arg45Lys)	HPRT1	R44K, R45K	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010048	X	133607495	X	134473465	10048	25087	rs137852491	NC_000023.11:134473464:G:A
NM_000194.3(HPRT1):c.610C>G (p.His204Asp)	HPRT1	H203D, H204D	Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010047	X	133634060	X	134500030	10047	25086	rs137852490	NC_000023.11:134500029:C:G
NM_000194.3(HPRT1):c.325C>T (p.Gln109Ter)	HPRT1	Q108*, Q109*	Lesch-Nyhan syndrome|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency|Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000010046	X	133620501	X	134486471	10046	25085	rs137852489	NC_000023.11:134486470:C:T
NM_000194.2(HPRT1):c.209G>A (p.Gly70Glu)	HPRT1	G70E	Lesch-Nyhan syndrome|HPRT NEW HAVEN	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010044	X	133609285	X	134475255	10044	25083	rs137852487	NC_000023.11:134475254:G:A
NM_000194.2(HPRT1):c.595T>G (p.Phe199Val)	HPRT1	F199V	Lesch-Nyhan syndrome|HPRT NEW BRITON	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010043	X	133632700	X	134498670	10043	25082	rs137852486	NC_000023.11:134498669:T:G
NM_000194.2(HPRT1):c.312C>A (p.Ser104Arg)	HPRT1	S104R	HPRT MUNICH|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010042	X	133609388	X	134475358	10042	25081	rs137852485	NC_000023.11:134475357:C:A
NM_000194.2(HPRT1):c.481G>T (p.Ala161Ser)	HPRT1	A161S	HPRT MILWAUKEE|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010041	X	133627616	X	134493586	10041	25080	rs137852484	NC_000023.11:134493585:G:T
NM_000194.2(HPRT1):c.389T>A (p.Val130Asp)	HPRT1	V130D	Lesch-Nyhan syndrome|HPRT MIDLAND	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010040	X	133624222	X	134490192	10040	25079	rs137852483	NC_000023.11:134490191:T:A
HPRT MICHIGAN	HPRT1	V179del	HPRT MICHIGAN|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010039					10039	25078		
NM_000194.2(HPRT1):c.329C>T (p.Ser110Leu)	HPRT1	S110L	HPRT LONDON|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: Sep 27, 2017)	no assertion criteria provided	VCV000010038	X	133620505	X	134486475	10038	25077	rs137852482	NC_000023.11:134486474:C:T
NM_000194.2(HPRT1):c.580G>A (p.Asp194Asn)	HPRT1		Lesch-Nyhan syndrome	Pathogenic(Last reviewed: Jun 1, 1990)	no assertion criteria provided	VCV000010037	X	133632685	X	134498655	10037	25076	rs267606863	NC_000023.11:134498654:G:A
NM_000194.2(HPRT1):c.222C>A (p.Phe74Leu)	HPRT1	F74L	HPRT FLINT|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010036	X	133609298	X	134475268	10036	25075	rs137852481	NC_000023.11:134475267:C:A
NM_000194.2(HPRT1):c.643_*6del21 (p.Lys215fs)	HPRT1		Lesch-Nyhan syndrome|HPRT EVANSVILLE	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010035	X	133634093 - 133634113	X	134500063 - 134500083	10035	25074	rs387906428	NC_000023.11:134500062:AAATACAAAGCCTAAGATGAGA:A
NM_000194.2(HPRT1):c.122T>C (p.Leu41Pro)	HPRT1	L41P	HPRT DETROIT|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010034	X	133607483	X	134473453	10034	25073	rs137852480	NC_000023.11:134473452:T:C
HPRT CONNERSVILLE	HPRT1		HPRT CONNERSVILLE|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010033					10033	25072		
HPRT CHICAGO	HPRT1		HPRT CHICAGO|Lesch-Nyhan syndrome	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010032					10032	25071		
NM_000194.2(HPRT1):c.602A>G (p.Asp201Gly)	HPRT1	D201G	HPRT ASHVILLE|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010031	X	133632707	X	134498677	10031	25070	rs137852479	NC_000023.11:134498676:A:G
NM_000194.2(HPRT1):c.239A>T (p.Asp80Val)	HPRT1	D80V	HPRT ARLINGTON|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000010030	X	133609315	X	134475285	10030	25069	rs137852478	NC_000023.11:134475284:A:T
NM_000194.2(HPRT1):c.396T>G (p.Ile132Met)	HPRT1	I132M	HPRT ANN ARBOR|Partial hypoxanthine-guanine phosphoribosyltransferase deficiency	Pathogenic, other(Last reviewed: May 12, 2011)	no assertion criteria provided	VCV000010029	X	133624229	X	134490199	10029	25068	rs137852477	NC_000023.11:134490198:T:G
NM_000206.2(IL2RG):c.452T>C (p.Leu151Pro)	IL2RG	L151P	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Nov 15, 2008)	no assertion criteria provided	VCV000010028	X	70330356	X	71110506	10028	25067	rs137852511	NC_000023.11:71110505:A:G
NM_000206.2(IL2RG):c.664C>T (p.Arg222Cys)	IL2RG	R222C	Inborn genetic diseases|Combined immunodeficiency, X-linked	Pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, single submitter	VCV000010027	X	70329171	X	71109321	10027	25066	rs111033618	NC_000023.11:71109320:G:A
NM_000206.2(IL2RG):c.854G>A (p.Arg285Gln)	IL2RG	R285Q	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000010026	X	70328449	X	71108599	10026	25065	rs111033617	NC_000023.11:71108598:C:T
NM_000206.2(IL2RG):c.343T>C (p.Cys115Arg)	IL2RG	C115R	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Nov 21, 1996)	no assertion criteria provided	VCV000010025	X	70330465	X	71110615	10025	25064	rs111033622	NC_000023.11:71110614:A:G
NM_000206.2(IL2RG):c.703_711dup (p.Gln235_Trp237dup)	IL2RG		X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Feb 1, 1995)	no assertion criteria provided	VCV000010024	X	70329123 - 70329124	X	71109273 - 71109274	10024	25063	rs587776729	NC_000023.11:71109273:CCAATGCTG:CCAATGCTGCCAATGCTG
NM_000206.2(IL2RG):c.878T>A (p.Leu293Gln)	IL2RG	L271Q, L293Q	X-linked severe combined immunodeficiency|Combined immunodeficiency, X-linked	Pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000010023	X	70328173	X	71108323	10023	25062	rs137852510	NC_000023.11:71108322:A:T
NM_000206.2(IL2RG):c.458T>A (p.Ile153Asn)	IL2RG	I153N	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000010022	X	70330142	X	71110292	10022	25061	rs111033621	NC_000023.11:71110291:A:T
NM_000206.2(IL2RG):c.454+1G>A	IL2RG		X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000010021	X	70330353	X	71110503	10021	25060	rs1569480018	NC_000023.11:71110502:C:T
NM_000206.2(IL2RG):c.341G>A (p.Gly114Asp)	IL2RG	G114D	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000010020	X	70330467	X	71110617	10020	25059	rs111033620	NC_000023.11:71110616:C:T
NM_000206.2(IL2RG):c.186T>A (p.Cys62Ter)	IL2RG	C62*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000010019	X	70330830	X	71110980	10019	25058	rs111033619	NC_000023.11:71110979:A:T
NM_000206.2(IL2RG):c.923C>A (p.Ser308Ter)	IL2RG	S286*, S308*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000010018	X	70328128	X	71108278	10018	25057	rs137852509	NC_000023.11:71108277:G:T
IL2RG, ARG267TER	IL2RG	R267*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000010017					10017	25056		
NM_000206.2(IL2RG):c.355A>T (p.Lys119Ter)	IL2RG	K97*, K119*	X-linked severe combined immunodeficiency	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000010016	X	70330453	X	71110603	10016	25055	rs137852507	NC_000023.11:71110602:T:A
NM_000216.4(ANOS1):c.1062+1G>T	ANOS1			Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000010015	X	8538539	X	8570498	10015	25054	rs387906427	NC_000023.11:8570497:C:A
ANOS1, EX3-6 DEL	ANOS1			Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000010014					10014	25053		
NM_000216.4(ANOS1):c.1187C>T (p.Ser396Leu)	ANOS1	S396L		Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	VCV000010013	X	8536293	X	8568252	10013	25052	rs137852517	NC_000023.11:8568251:G:A
ANOS1, EX3-13 DEL	ANOS1			Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000010012					10012	25051		
NM_000216.4(ANOS1):c.784C>T (p.Arg262Ter)	ANOS1	R262*		Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000010011	X	8553380	X	8585339	10011	25050	rs137852516	NC_000023.11:8585338:G:A
ANOS1, 11-BP DUP, NT158	ANOS1			Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000010010					10010	25049		
ANOS1, EX5DEL	ANOS1			Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000010009					10009	25048		
NM_000216.4(ANOS1):c.1540G>A (p.Glu514Lys)	ANOS1	E514K		Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000010008	X	8504893	X	8536852	10008	25047	rs137852515	NC_000023.11:8536851:C:T
ANOS1, EX3-5DEL	ANOS1			Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000010007					10007	25046		
ANOS1, 1-BP DEL, PRO277FS	ANOS1			Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000010006					10006	25045		
NM_000216.4(ANOS1):c.774G>A (p.Trp258Ter)	ANOS1	W258*		Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000010005	X	8553390	X	8585349	10005	25044	rs137852514	NC_000023.11:8585348:C:T
NM_000216.4(ANOS1):c.769C>T (p.Arg257Ter)	ANOS1	R257*		Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000010004	X	8553395	X	8585354	10004	25043	rs137852513	NC_000023.11:8585353:G:A
NM_000216.4(ANOS1):c.711G>A (p.Trp237Ter)	ANOS1	W237*		Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000010003	X	8555850	X	8587809	10003	25042	rs137852512	NC_000023.11:8587808:C:T
ANOS1, 3,300-BP DEL	ANOS1			Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000010002					10002	25041		
NM_001278116.2(L1CAM):c.719C>T (p.Pro240Leu)	L1CAM	P240L, P235L	Corpus callosum, partial agenesis of, X-linked|X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000010001	X	153135930	X	153870475	10001	25040	rs137852526	NC_000023.11:153870474:G:A
NM_001278116.2(L1CAM):c.2974C>T (p.Gln992Ter)	L1CAM	Q974*, Q992*, Q987*	Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction|not provided	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000010000	X	153130348	X	153864893	10000	25039	rs879253717	NC_000023.11:153864892:G:A
NM_001278116.2(L1CAM):c.2254G>A (p.Val752Met)	L1CAM	V752M, V747M	Hydrocephalus, X-linked, with hirschsprung disease	Pathogenic(Last reviewed: Feb 15, 2002)	no assertion criteria provided	VCV000009998	X	153132281	X	153866826	9998	25037	rs137852525	NC_000023.11:153866825:C:T
NM_001278116.2(L1CAM):c.2421_2422del (p.Gly808fs)	L1CAM	G803fs, G808fs	Hydrocephalus, X-linked, with hirschsprung disease	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000009996	X	153132113 - 153132114	X	153866658 - 153866659	9996	25035	rs879253715	NC_000023.11:153866657:CA:
NM_001278116.2(L1CAM):c.1108G>A (p.Gly370Arg)	L1CAM	G370R, G365R	|not provided|Spastic paraplegia	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009995	X	153135273	X	153869818	9995	25034	rs137852524	NC_000023.11:153869817:C:T
NM_001278116.2(L1CAM):c.536T>G (p.Ile179Ser)	L1CAM	I179S, I174S		Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009994	X	153136403	X	153870948	9994	25033	rs137852523	NC_000023.11:153870947:A:C
NM_001278116.2(L1CAM):c.3581C>T (p.Ser1194Leu)	L1CAM	S1194L, S1185L, S1190L	not provided|X-linked hydrocephalus syndrome|	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000009993	X	153128311	X	153862856	9993	25032	rs137852522	NC_000023.11:153862855:G:A
NM_001278116.2(L1CAM):c.3489_3490del (p.Glu1164fs)	L1CAM	E1159fs, E1164fs		Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009992	X	153128972 - 153128973	X	153863517 - 153863518	9992	25031	rs879253714	NC_000023.11:153863516:CA:
NM_001278116.2(L1CAM):c.551G>A (p.Arg184Gln)	L1CAM	R184Q, R179Q	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009991	X	153136388	X	153870933	9991	25030	rs137852521	NC_000023.11:153870932:C:T
NM_001278116.2(L1CAM):c.1354G>A (p.Gly452Arg)	L1CAM	G452R, G447R	not provided|X-linked hydrocephalus syndrome|Spastic paraplegia|Hydrocephalus due to aqueductal stenosis	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009990	X	153134321	X	153868866	9990	25029	rs137852520	NC_000023.11:153868865:C:T
NM_001278116.2(L1CAM):c.1792G>A (p.Asp598Asn)	L1CAM	D598N, D593N		Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009989	X	153133489	X	153868034	9989	25028	rs137852519	NC_000023.11:153868033:C:T
NM_001278116.2(L1CAM):c.630C>A (p.His210Gln)	L1CAM	H210Q, H205Q		Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009988	X	153136309	X	153870854	9988	25027	rs28933683	NC_000023.11:153870853:G:T
L1CAM, 1.3-KB DUP	L1CAM		X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000009987					9987	25026		
NM_001278116.2(L1CAM):c.791G>A (p.Cys264Tyr)	L1CAM	C264Y, C259Y	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000009986	X	153135858	X	153870403	9986	25025	rs137852518	NC_000023.11:153870402:C:T
NM_001278116.2(L1CAM):c.2432-19A>C	L1CAM		X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000009985	X	153131293	X	153865838	9985	25024	rs879253713	NC_000023.11:153865837:T:G
LAMP2, 1-BP DEL, 1219A	LAMP2		Danon disease	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000009984					9984	25023		
NM_013995.2(LAMP2):c.961T>C (p.Trp321Arg)	LAMP2	W321R	Danon disease	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000009983	X	119575717	X	120441862	9983	25022	rs104894859	NC_000023.11:120441861:A:G
NM_002294.3(LAMP2):c.928G>A (p.Val310Ile)	LAMP2	V310I	not provided|Hypertrophic cardiomyopathy|Danon disease|Danon disease	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009982	X	119576454	X	120442599	9982	25021	rs104894858	NC_000023.11:120442598:C:T
NM_013995.2(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Q174*	Danon disease	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000009981	X	119582861	X	120449006	9981	25020	rs104894857	NC_000023.11:120449005:G:A
NM_013995.2(LAMP2):c.36_42del (p.Gly13fs)	LAMP2	G13fs	Danon disease	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000009980	X	119602983 - 119602989	X	120469128 - 120469134	9980	25019	rs1436181133	NC_000023.11:120469127:GAGCCCTGAGCCC:GAGCCC
NM_013995.2(LAMP2):c.883dup (p.Tyr295fs)	LAMP2		Danon disease	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000009979	X	119576498 - 119576499	X	120442643 - 120442644	9979	25018	rs1327363415	NC_000023.11:120442643:AAAA:AAAAA
NM_013995.2(LAMP2):c.14del (p.Arg5fs)	LAMP2	R5fs	Danon disease	Pathogenic(Last reviewed: Aug 24, 2000)	no assertion criteria provided	VCV000009978	X	119603011	X	120469156	9978	25017	rs1183994410	NC_000023.11:120469155:C:
NM_013995.2(LAMP2):c.741+1G>A	LAMP2		Danon disease	Pathogenic(Last reviewed: Aug 24, 2000)	no assertion criteria provided	VCV000009977	X	119581695	X	120447840	9977	25016	rs1251075016	NC_000023.11:120447839:C:T
LAMP2, 1-BP INS, 974A	LAMP2		Danon disease	Pathogenic(Last reviewed: Aug 24, 2000)	no assertion criteria provided	VCV000009976					9976	25015		
NM_013995.2(LAMP2):c.864+5G>C	LAMP2		Danon disease	Pathogenic(Last reviewed: Aug 24, 2000)	no assertion criteria provided	VCV000009975	X	119580155	X	120446300	9975	25014	rs1352584474	NC_000023.11:120446299:C:G
NM_013995.2(LAMP2):c.440T>A (p.Leu147Ter)	LAMP2	L113*, L147*	Danon disease	Pathogenic(Last reviewed: Aug 24, 2000)	no assertion criteria provided	VCV000009974	X	119582941	X	120449086	9974	25013	rs137852527	NC_000023.11:120449085:A:T
LAMP2, 2-BP DEL, 1097AA	LAMP2		Danon disease	Pathogenic(Last reviewed: Aug 24, 2000)	no assertion criteria provided	VCV000009973					9973	25012		
FMR1, (CGG)n REPEAT EXPANSION	FMR1		Fragile X syndrome|Fragile X tremor/ataxia syndrome|Premature ovarian failure 1	Pathogenic(Last reviewed: Jul 10, 2001)	no assertion criteria provided	VCV000009972					9972	25011		
NM_002024.5(FMR1):c.52-1_52delinsTA	FMR1		Fragile X syndrome	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000009971	X	147003450 - 147003451	X	147921932 - 147921933	9971	25010	rs1557176576	NC_000023.11:147921931:GG:TA
NM_002024.6(FMR1):c.373del (p.Thr125fs)	FMR1	T125fs	Fragile X syndrome	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000009970	X	147010279	X	147928761	9970	25009	rs1569545562	NC_000023.11:147928760:A:
NM_002024.5(FMR1):c.911T>A (p.Ile304Asn)	FMR1	I304N	Fragile X syndrome	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000009969	X	147018053	X	147936534	9969	25008	rs121434622	NC_000023.11:147936533:T:A
NM_002641.3(PIGA):c.1355_1356insAATTGAGATGGATGACTCCAGATTCTATCATTGA (p.Asp452delinsGluIleGluMetAspAspSerArgPheTyrHisTer)	PIGA		Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000009966	X	15339727 - 15339728	X	15321605 - 15321606	9966	25005	rs786200912	NC_000023.11:15321605:TCAATGATAGAATCTGGAGTCATCCATCTCAA:TCAATGATAGAATCTGGAGTCATCCATCTCAATTTCAATGATAGAATCTGGAGTCATCCATCTCAA
PIGA, IVS5DS, G-A, +1, SOMATIC	PIGA		Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000009965					9965	25004		
NM_002641.3(PIGA):c.1323_1324del (p.Leu442fs)	PIGA	L208fs, L442fs	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000009964	X	15339759 - 15339760	X	15321637 - 15321638	9964	25003	rs587776728	NC_000023.11:15321636:AGA:A
NM_020473.3(PIGA):c.13+4001del	PIGA	T144fs	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000009963	X	15349622	X	15331500	9963	25002	rs587776727	NC_000023.11:15331499:G:
NM_020473.3(PIGA):c.13+3819_13+3820insGT	PIGA		Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000009962	X	15349803 - 15349804	X	15331681 - 15331682	9962	25001	rs587776726	NC_000023.11:15331681::AC
NM_020473.3(PIGA):c.13+3733C>T	PIGA	Q55*	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Dec 15, 1995)	no assertion criteria provided	VCV000009961	X	15349890	X	15331768	9961	25000	rs199422233	NC_000023.11:15331767:G:A
NM_002641.3(PIGA):c.1115del (p.Pro372fs)	PIGA	P372fs, P138fs	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000009960	X	15342860	X	15324738	9960	24999	rs587776725	NC_000023.11:15324737:GG:G
NM_020473.3(PIGA):c.13+4029_13+4030insA	PIGA		Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000009959	X	15349593 - 15349594	X	15331471 - 15331472	9959	24998	rs587776724	NC_000023.11:15331471::T
NM_020473.3(PIGA):c.13+3864C>A	PIGA	Y98*	Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: Apr 27, 1999)	no assertion criteria provided	VCV000009958	X	15349759	X	15331637	9958	24997	rs199422232	NC_000023.11:15331636:G:T
NM_002641.3(PIGA):c.1188+2del	PIGA		Paroxysmal nocturnal hemoglobinuria 1	Pathogenic(Last reviewed: May 21, 1993)	no assertion criteria provided	VCV000009957	X	15342785	X	15324663	9957	24996	rs587776723	NC_000023.11:15324662:A:
NM_000291.4(PGK1):c.1132A>C (p.Thr378Pro)	PGK1	T378P	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000009956	X	77380841	X	78125344	9956	24995	rs137852539	NC_000023.11:78125343:A:C
NM_000291.4(PGK1):c.756+5G>A	PGK1		Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Mar 28, 2006)	no assertion criteria provided	VCV000009955	X	77378451	X	78122954	9955	24994	rs431905503	NC_000023.11:78122953:G:A
NM_000291.4(PGK1):c.491A>T (p.Asp164Val)	PGK1	D164V	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000009954	X	77372882	X	78117385	9954	24993	rs137852538	NC_000023.11:78117384:A:T
NM_000291.4(PGK1):c.959G>A (p.Ser320Asn)	PGK1	S319N, S320N	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000009953	X	77380393	X	78124896	9953	24992	rs137852537	NC_000023.11:78124895:G:A
NM_000291.4(PGK1):c.140T>A (p.Ile47Asn)	PGK1	I46N, I47N	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000009952	X	77369264	X	78113767	9952	24991	rs137852536	NC_000023.11:78113766:T:A
NM_000291.4(PGK1):c.854A>T (p.Asp285Val)	PGK1	D285V	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000009951	X	77378789	X	78123292	9951	24990	rs137852535	NC_000023.11:78123291:A:T
NM_000291.4(PGK1):c.758T>C (p.Ile253Thr)	PGK1	I252T, I253T	Phosphoglycerate kinase 1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000009950	X	77378693	X	78123196	9950	24989	rs137852534	NC_000023.11:78123195:T:C
NM_000291.4(PGK1):c.571_573AAG[1] (p.Lys192del)	PGK1	K192del, K191del	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000009949	X	77373596 - 77373598	X	78118099 - 78118101	9949	24988	rs431905502	NC_000023.11:78118098:GAAGAAG:GAAG
NM_000291.4(PGK1):c.946T>C (p.Cys316Arg)	PGK1	C315R, C316R	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: May 15, 1992)	no assertion criteria provided	VCV000009948	X	77380380	X	78124883	9948	24987	rs137852533	NC_000023.11:78124882:T:C
NM_000291.4(PGK1):c.473G>T (p.Gly158Val)	PGK1	G157V, G158V	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Mar 15, 1992)	no assertion criteria provided	VCV000009947	X	77372864	X	78117367	9947	24986	rs137852532	NC_000023.11:78117366:G:T
NM_000291.4(PGK1):c.263T>C (p.Leu88Pro)	PGK1	L88P	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000009946	X	77369387	X	78113890	9946	24985	rs137852531	NC_000023.11:78113889:T:C
NM_000291.4(PGK1):c.796_798delinsATG (p.Val266Met)	PGK1	V266M	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Apr 1, 1981)	no assertion criteria provided	VCV000009944	X	77378731 - 77378733	X	78123234 - 78123236	9944	24983	rs431905501	NC_000023.11:78123233:GTC:ATG
NM_000291.4(PGK1):c.617G>C (p.Arg206Pro)	PGK1	R206P	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Sep 1, 1980)	no assertion criteria provided	VCV000009943	X	77373643	X	78118146	9943	24982	rs137852529	NC_000023.11:78118145:G:C
NM_000291.4(PGK1):c.802G>A (p.Asp268Asn)	PGK1	D268N	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Jul 10, 1980)	no assertion criteria provided	VCV000009942	X	77378737	X	78123240	9942	24981	rs137852528	NC_000023.11:78123239:G:A
NM_002764.3(PRPS1):c.869T>C (p.Ile290Thr)	PRPS1	I290T, I86T	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009941	X	106893174	X	107649944	9941	24980	rs180177153	NC_000023.11:107649943:T:C
NM_002764.3(PRPS1):c.916G>A (p.Gly306Arg)	PRPS1	G306R, G102R	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009940	X	106893221	X	107649991	9940	24979	rs180177154	NC_000023.11:107649990:G:A
NM_001204402.1(PRPS1):c.-82-5746G>A	PRPS1	A87T	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009939	X	106882661	X	107639431	9939	24978	rs180177152	NC_000023.11:107639430:G:A
NM_001204402.1(PRPS1):c.-82-5812G>A	PRPS1	D65N	Deafness, X-linked 1	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000009938	X	106882595	X	107639365	9938	24977	rs180177151	NC_000023.11:107639364:G:A
NM_002764.3(PRPS1):c.398A>C (p.Gln133Pro)	PRPS1	Q133P	Arts syndrome	Pathogenic(Last reviewed: Nov 18, 2010)	no assertion criteria provided	VCV000009937	X	106884223	X	107640993	9937	24976	rs80338675	NC_000023.11:107640992:A:C
NM_002764.3(PRPS1):c.129A>C (p.Glu43Asp)	PRPS1	E43D	Charcot-Marie-Tooth disease, X-linked recessive, type 5	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000009934	X	106882531	X	107639301	9934	24973	rs80338731	NC_000023.11:107639300:A:C
NM_001204402.1(PRPS1):c.-34C>G	PRPS1	H193Q	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009933	X	106888455	X	107645225	9933	24972	rs137852545	NC_000023.11:107645224:C:G
NM_001204402.1(PRPS1):c.-44C>T	PRPS1	A190V	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009932	X	106888445	X	107645215	9932	24971	rs137852544	NC_000023.11:107645214:C:T
NM_001204402.1(PRPS1):c.-82-4197C>A	PRPS1	L129I	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009931	X	106884210	X	107640980	9931	24970	rs137852543	NC_000023.11:107640979:C:A
NM_001204402.1(PRPS1):c.-82-5851G>C	PRPS1	D52H	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Nov 1, 1975)	no assertion criteria provided	VCV000009930	X	106882556	X	107639326	9930	24969	rs137852542	NC_000023.11:107639325:G:C
NM_001204402.1(PRPS1):c.-66G>C	PRPS1	D183H	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000009929	X	106888423	X	107645193	9929	24968	rs137852541	NC_000023.11:107645192:G:C
NM_002637.4(PHKA1):c.667G>A (p.Gly223Arg)	PHKA1	G223R	Glycogen storage disease IXd	Pathogenic(Last reviewed: May 13, 2008)	no assertion criteria provided	VCV000009927	X	71887275	X	72667425	9927	24966	rs137852548	NC_000023.11:72667424:C:T
NM_002637.4(PHKA1):c.695del (p.Ala232fs)	PHKA1	A232fs	Glycogen storage disease IXd	Pathogenic(Last reviewed: Jan 24, 2012)	no assertion criteria provided	VCV000009926	X	71887247	X	72667397	9926	24965		NC_000023.11:72667396:G:
NM_002637.4(PHKA1):c.896A>T (p.Asp299Val)	PHKA1	D299V	Glycogen storage disease IXd	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000009925	X	71877460	X	72657610	9925	24964	rs137852547	NC_000023.11:72657609:T:A
PHKA1, IVSL, G-C, +1	PHKA1		Glycogen storage disease IXd	Pathogenic(Last reviewed: Aug 28, 1998)	no assertion criteria provided	VCV000009924					9924	24963		
NM_002637.4(PHKA1):c.3334G>T (p.Glu1112Ter)	PHKA1	E1112*, E1040*, E1099*	Glycogen storage disease IXd	Pathogenic(Last reviewed: Nov 1, 1994)	no assertion criteria provided	VCV000009923	X	71802412	X	72582562	9923	24962	rs137852546	NC_000023.11:72582561:C:A
NM_003336.4(UBE2A):c.382C>T (p.Gln128Ter)	UBE2A	Q128*, Q98*, Q95*	Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000009922	X	118717141	X	119583178	9922	24961	rs104894952	NC_000023.11:119583177:C:T
NM_000328.3(RPGR):c.1059+363G>A	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000009921	X	38160137	X	38300884	9921	24960	rs1410177435	NC_000023.11:38300883:C:T
RPGR, 912G-T	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000009920					9920	24959		
RPGR, 57-BP DEL, NT631	RPGR		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000009919					9919	24958		
NM_000328.3(RPGR):c.1905+1024G>T	RPGR	G392*, G977*	Cone-rod dystrophy, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000009918	X	38145323	X	38286070	9918	24957	rs137852551	NC_000023.11:38286069:C:A
NM_000328.3(RPGR):c.1905+942_1905+943inv	RPGR		Cone-rod dystrophy, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000009917	X	38145404 - 38145405	X	38286151 - 38286152	9917	24956	rs267607019	NC_000023.11:38286150:CT:AG
NM_000328.3(RPGR):c.517G>C (p.Gly173Arg)	RPGR	G173R, G172R, G183R	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000009916	X	38176671	X	38317418	9916	24955	rs137852550	NC_000023.11:38317417:C:G
RPGR, 2-BP DEL, 845TG	RPGR		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with deafness	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000009915					9915	24954		
RPGR, 15-BP DEL, NT694	RPGR		Cone-rod dystrophy, X-linked 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000009914					9914	24953		
RPGR, IVS15, G-T, +1164	RPGR		Macular degeneration, X-linked atrophic	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000009913					9913	24952		
NM_000328.3(RPGR):c.469+1G>T	RPGR		Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000009912	X	38178081	X	38318828	9912	24951	rs62638646	NC_000023.11:38318827:C:A
NM_000328.3(RPGR):c.1905+1187_1905+1188del	RPGR		Retinal dystrophy|Cone-rod dystrophy, X-linked 1	Pathogenic(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000009911	X	38145159 - 38145160	X	38285906 - 38285907	9911	24950	rs606231181	NC_000023.11:38285905:CTCTC:CTC
NM_000328.3(RPGR):c.1905+1191_1905+1192del	RPGR	E1033fs	Retinal dystrophy|Cone/cone-rod dystrophy|Cone-rod dystrophy, X-linked 1	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, single submitter	VCV000009910	X	38145155 - 38145156	X	38285902 - 38285903	9910	24949	rs606231180	NC_000023.11:38285901:CCCCC:CCC
RPGR, 1-BP INS, 173A	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000009909					9909	24948		
NM_000328.3(RPGR):c.1905+745G>T	RPGR	E299*, E884*	Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000009908	X	38145602	X	38286349	9908	24947	rs137852549	NC_000023.11:38286348:C:A
RPGR, 2-BP DEL, 673AG	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000009907					9907	24946		
NM_000328.3(RPGR):c.296C>A (p.Thr99Asn)	RPGR	T99N, T109N	not provided|Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000009906	X	38180294	X	38321041	9906	24945	rs62638637	NC_000023.11:38321040:G:T
RPGR, EX15ADEL	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000009905					9905	24944		
RPGR, 2-BP DEL, NT1571	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000009904					9904	24943		
RPGR, 2-BP DEL, 652AG	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000009903					9903	24942		
NM_000328.3(RPGR):c.179G>T (p.Gly60Val)	RPGR	G60V, G70V	Retinal dystrophy|not provided|Retinitis pigmentosa 15|Primary ciliary dyskinesia	Pathogenic(Last reviewed: May 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009902	X	38182174	X	38322921	9902	24941	rs62638634	NC_000023.11:38322920:C:A
RPGR, IVS10DS, A-G, +3	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000009901					9901	24940		
RPGR, 4-BP DEL, NT1433	RPGR		Retinitis pigmentosa 15	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000009900					9900	24939		
NM_000328.3(RPGR):c.823G>A (p.Gly275Ser)	RPGR	G275S, G274S, G285S	not provided|Retinitis pigmentosa|Retinitis pigmentosa 15	Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000009899	X	38163999	X	38304746	9899	24938	rs62642057	NC_000023.11:38304745:C:T
NM_000328.3(RPGR):c.703C>T (p.Pro235Ser)	RPGR	P235S, P234S, P245S	not provided|Retinitis pigmentosa 15	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000009898	X	38169943	X	38310690	9898	24937	rs62638651	NC_000023.11:38310689:G:A
NM_000328.3(RPGR):c.389T>G (p.Phe130Cys)	RPGR	F130C, F140C, F129C	not provided|Retinitis pigmentosa 15	Pathogenic(Last reviewed: Sep 15, 2010)	no assertion criteria provided	VCV000009897	X	38178162	X	38318909	9897	24936	rs62638644	NC_000023.11:38318908:A:C
RS1, 4-BP INS	RS1		Juvenile retinoschisis	Pathogenic(Last reviewed: Feb 16, 2000)	no assertion criteria provided	VCV000009894					9894	24933		
NM_000330.3(RS1):c.38T>C (p.Leu13Pro)	RS1	L13P	not provided|Juvenile retinoschisis	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000009892	X	18690151	X	18672031	9892	24931	rs104894935	NC_000023.11:18672030:A:G
SHOX, 1.1-MB DEL	SHOX		|Langer mesomelic dysplasia syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000009884					9884	24923		
NM_000451.3(SHOX):c.877T>C (p.Ter293Arg)	SHOX	*293R		Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000009883	X	605369	X	644634	9883	24922	rs137852559	NC_000024.10:644633:T:C
NM_000451.3(SHOX):c.728dup (p.Pro244fs)	SHOX		Langer mesomelic dysplasia syndrome	Pathogenic(Last reviewed: Jun 15, 2002)	no assertion criteria provided	VCV000009880	X	605214 - 605215	X	644479 - 644480	9880	24919		NC_000024.10:644479:CCCCCC:CCCCCCC
NM_000451.3(SHOX):c.502C>T (p.Arg168Trp)	SHOX	R168W	Langer mesomelic dysplasia syndrome|	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000009879	X	601571	X	640836	9879	24918	rs137852557	NC_000024.10:640835:C:T
NM_000451.3(SHOX):c.517C>T (p.Arg173Cys)	SHOX	R173C	|not provided	Pathogenic(Last reviewed: Jul 29, 2015)	criteria provided, single submitter	VCV000009878	X	601586	X	640851	9878	24917	rs137852556	NC_000024.10:640850:C:T
SHOX, 1-BP DEL, 1272G	SHOX			Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000009877					9877	24916		
SHOX, DEL	SHOX		Langer mesomelic dysplasia syndrome|	Pathogenic(Last reviewed: Jun 15, 2002)	no assertion criteria provided	VCV000009874					9874	24913		
NM_000451.3(SHOX):c.597C>G (p.Tyr199Ter)	SHOX	Y199*		Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000009873	X	601786	X	641051	9873	24912	rs137852553	NC_000024.10:641050:C:G
NM_000451.3(SHOX):c.583C>T (p.Arg195Ter)	SHOX	R195*	Short stature, idiopathic, X-linked|not provided	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000009872	X	601772	X	641037	9872	24911	rs137852552	NC_000024.10:641036:C:T
SOX3, 21-BP DUP, NT720, ALANINE TRACT EXPANSION	SOX3			Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000009870					9870	24909		
SOX3, DUP	SOX3			Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000009869					9869	24908		
SOX3, 33-BP DUP, NT711-743, ALANINE TRACT EXPANSION	SOX3		Mental retardation, X-linked, with isolated growth hormone deficiency	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000009868					9868	24907		
NM_006950.3(SYN1):c.1067G>A (p.Trp356Ter)	SYN1	W356*	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Mar 1, 2004)	no assertion criteria provided	VCV000009867	X	47435621	X	47576222	9867	24906	rs137852560	NC_000023.11:47576221:C:T
NM_003179.2(SYP):c.649G>C (p.Gly217Arg)	SYP	G217R	Mental retardation, X-linked 96	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009866	X	49048187	X	49191730	9866	24905	rs137852561	NC_000023.11:49191729:C:G
SYP, 4-BP DEL, 829GACT	SYP		Mental retardation, X-linked 96	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009865					9865	24904		
SYP, 2-BP DEL/INS	SYP		Mental retardation, X-linked 96	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009864					9864	24903		
SYP, 1-BP INS, 274A	SYP		Mental retardation, X-linked 96	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009863					9863	24902		
TAF1, SVA RETROTRANSPOSON INSERTION	TAF1			Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000009862					9862	24901		
NM_003334.4(UBA1):c.1731C>T (p.Asn577=)	UBA1	N577N	Spinal muscular atrophy, X-linked 2	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000009782	X	47065502	X	47206103	9782	24821	rs80356547	NC_000023.11:47206102:C:T
NM_003334.4(UBA1):c.1639A>G (p.Ser547Gly)	UBA1	S547G	Spinal muscular atrophy, X-linked 2	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000009781	X	47065410	X	47206011	9781	24820	rs80356546	NC_000023.11:47206010:A:G
NM_003334.4(UBA1):c.1617G>T (p.Met539Ile)	UBA1	M539I	Spinal muscular atrophy, X-linked 2	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000009780	X	47065388	X	47205989	9780	24819	rs80356545	NC_000023.11:47205988:G:T
XIST, C-G, -43	XIST		X inactivation, familial skewed, 1	Pathogenic(Last reviewed: Nov 1, 1997)	no assertion criteria provided	VCV000009779					9779	24818		
NM_001146702.1(KDM5C):c.151-432G>A	KDM5C	A77T	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000009778	X	53247580	X	53218398	9778	24817	rs199422239	NC_000023.11:53218397:C:T
NM_004187.4(KDM5C):c.2296C>T (p.Arg766Trp)	KDM5C	R766W, R699W, R765W	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000009777	X	53228018	X	53198836	9777	24816	rs199422238	NC_000023.11:53198835:G:A
NM_004187.4(KDM5C):c.1353C>G (p.Ser451Arg)	KDM5C	S451R, S384R, S450R	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000009776	X	53240727	X	53211545	9776	24815	rs199422237	NC_000023.11:53211544:G:C
NM_004187.4(KDM5C):c.2080C>T (p.Arg694Ter)	KDM5C	R694*, R693*, R627*	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000009775	X	53228322	X	53199140	9775	24814	rs199422236	NC_000023.11:53199139:G:A
NM_001146702.1(KDM5C):c.151-2904dup	KDM5C		Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000009773	X	53250046 - 53250047	X	53220864 - 53220865	9773	24812		NC_000023.11:53220864:GGGGGG:GGGGGGG
NM_004187.4(KDM5C):c.2191C>T (p.Leu731Phe)	KDM5C	L731F, L730F, L664F	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000009772	X	53228211	X	53199029	9772	24811	rs199422234	NC_000023.11:53199028:G:A
NM_021083.4(XK):c.895C>T (p.Gln299Ter)	XK	Q299*	McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000009771	X	37587275	X	37728022	9771	24810	rs104894954	NC_000023.11:37728021:C:T
NM_021083.4(XK):c.941G>A (p.Trp314Ter)	XK	W314*	McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000009770	X	37587321	X	37728068	9770	24809	rs104894953	NC_000023.11:37728067:G:A
XK, 13-BP DEL	XK		McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000009769					9769	24808		
NM_021083.4(XK):c.880T>C (p.Cys294Arg)	XK	C294R	McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000009768	X	37587260	X	37728007	9768	24807	rs28933690	NC_000023.11:37728006:T:C
NM_021083.4(XK):c.1013del (p.Phe338fs)	XK	F338fs	McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000009767	X	37587390	X	37728137	9767	24806		NC_000023.11:37728136:TTTT:TTT
XK, 1-BP DEL	XK		McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000009766					9766	24805		
NM_021083.4(XK):c.509-1G>A	XK		McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: Jun 17, 1994)	no assertion criteria provided	VCV000009765	X	37586888	X	37727635	9765	24804		NC_000023.11:37727634:G:A
NM_021083.4(XK):c.508+1G>A	XK		McLeod neuroacanthocytosis syndrome	Pathogenic(Last reviewed: Jun 17, 1994)	no assertion criteria provided	VCV000009764	X	37553802	X	37694549	9764	24803		NC_000023.11:37694548:G:A
NM_021998.5(ZNF711):c.1573A>T (p.Arg525Ter)	ZNF711	R525*, R571*	ZNF711-Related X-linked Mental Retardation	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009763	X	84526121	X	85271115	9763	24802	rs199422240	NC_000023.11:85271114:A:T
NM_021998.5(ZNF711):c.2125_2126TG[1] (p.Cys709_Glu710delinsTer)	ZNF711		ZNF711-Related X-linked Mental Retardation	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009762	X	84526673 - 84526674	X	85271667 - 85271668	9762	24801		NC_000023.11:85271666:TGTG:TG
USP9Y, DEL	USP9Y		Hypospermatogenesis, nonobstructive, Y-linked	Pathogenic(Last reviewed: Feb 26, 2009)	no assertion criteria provided	VCV000009758					9758	24797		
USP9Y, IVS7DS, 4-BP DEL	USP9Y		Spermatogenic failure, Y-linked 2	Pathogenic(Last reviewed: Dec 1, 1999)	no assertion criteria provided	VCV000009757					9757	24796		
NM_003140.3(SRY):c.380A>T (p.Tyr127Phe)	SRY	Y127F	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000009756	Y	2655265	Y	2787224	9756	24795	rs104894973	NC_000024.10:2787223:T:A
NM_003140.3(SRY):c.284G>A (p.Gly95Glu)	SRY	G95E	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000009755	Y	2655361	Y	2787320	9755	24794	rs104894972	NC_000024.10:2787319:C:T
NM_003140.3(SRY):c.53G>A (p.Ser18Asn)	SRY	S18N	46,XY sex reversal, type 1	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000009754	Y	2655592	Y	2787551	9754	24793	rs104894971	NC_000024.10:2787550:C:T
NM_003140.3(SRY):c.4C>T (p.Gln2Ter)	SRY	Q2*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000009753	Y	2655641	Y	2787600	9753	24792	rs104894977	NC_000024.10:2787599:G:A
NM_003140.3(SRY):c.397C>T (p.Arg133Trp)	SRY	R133W	46,XY sex reversal, type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000009752	Y	2655248	Y	2787207	9752	24791	rs104894976	NC_000024.10:2787206:G:A
NM_003140.3(SRY):c.12T>A (p.Tyr4Ter)	SRY	Y4*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000009751	Y	2655633	Y	2787592	9751	24790	rs104894975	NC_000024.10:2787591:A:T
NM_003140.3(SRY):c.283G>C (p.Gly95Arg)	SRY	G95R	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000009750	Y	2655362	Y	2787321	9750	24789	rs104894974	NC_000024.10:2787320:C:G
NM_003140.3(SRY):c.274A>T (p.Lys92Ter)	SRY	K92*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000009749	Y	2655371	Y	2787330	9749	24788	rs104894970	NC_000024.10:2787329:T:A
NM_003140.3(SRY):c.209G>A (p.Trp70Ter)	SRY	W70*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Nov 1, 1992)	no assertion criteria provided	VCV000009748	Y	2655436	Y	2787395	9748	24787	rs104894965	NC_000024.10:2787394:C:T
NM_003140.3(SRY):c.192G>A (p.Met64Ile)	SRY	M64I	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Nov 29, 1990)	no assertion criteria provided	VCV000009747	Y	2655453	Y	2787412	9747	24786	rs104894969	NC_000024.10:2787411:C:T
NM_003140.3(SRY):c.203T>C (p.Ile68Thr)	SRY	I68T	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000009746	Y	2655442	Y	2787401	9746	24785	rs104894968	NC_000024.10:2787400:A:G
NM_003140.3(SRY):c.320G>A (p.Trp107Ter)	SRY	W107*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000009745	Y	2655325	Y	2787284	9745	24784	rs104894967	NC_000024.10:2787283:C:T
NM_003140.3(SRY):c.337G>A (p.Ala113Thr)	SRY	A113T	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000009744	Y	2655308	Y	2787267	9744	24783	rs104894966	NC_000024.10:2787266:C:T
NM_003140.3(SRY):c.324del (p.Phe109fs)	SRY	F109fs	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000009743	Y	2655321	Y	2787280	9743	24782	rs606231179	NC_000024.10:2787279:T:
NM_003140.3(SRY):c.317A>T (p.Lys106Ile)	SRY	K106I	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jan 1, 1993)	no assertion criteria provided	VCV000009742	Y	2655328	Y	2787287	9742	24781	rs104894964	NC_000024.10:2787286:T:A
NM_003140.3(SRY):c.270C>G (p.Ile90Met)	SRY	I90M	46,XY sex reversal, type 1|46,XY true hermaphroditism, SRY-related	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000009741	Y	2655375	Y	2787334	9741	24780	rs104894959	NC_000024.10:2787333:G:C
NM_003140.3(SRY):c.277C>T (p.Gln93Ter)	SRY	Q93*	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000009740	Y	2655368	Y	2787327	9740	24779	rs104894958	NC_000024.10:2787326:G:A
NM_003140.3(SRY):c.178G>C (p.Val60Leu)	SRY	V60L	46,XY sex reversal, type 1	Pathogenic(Last reviewed: May 1, 1992)	no assertion criteria provided	VCV000009739	Y	2655467	Y	2787426	9739	24778	rs104894957	NC_000024.10:2787425:C:G
NM_003140.3(SRY):c.326T>C (p.Phe109Ser)	SRY	F109S	46,XY sex reversal, type 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000009738	Y	2655319	Y	2787278	9738	24777	rs104894956	NC_000024.10:2787277:A:G
NM_003140.3(SRY):c.362_363GA[1] (p.Glu122fs)	SRY		46,XY sex reversal, type 1	Pathogenic(Last reviewed: Feb 1, 1992)	no assertion criteria provided	VCV000009737	Y	2655278 - 2655281	Y	2787237 - 2787240	9737	24776	rs606231178	NC_000024.10:2787236:TCTCTCT:TCT
NM_138761.4(BAX):c.115_121del (p.Gly39fs)	BAX	G2fs, G39fs	T-cell acute lymphoblastic leukemia	Pathogenic(Last reviewed: Apr 15, 1998)	no assertion criteria provided	VCV000009514	19	49458971 - 49458977	19	48955714 - 48955720	9514	24553	rs398122840	NC_000019.10:48955713:GGGGGGGG:G
NM_138761.4(BAX):c.199G>A (p.Gly67Arg)	BAX	G67R, G30R	T-cell acute lymphoblastic leukemia	Pathogenic(Last reviewed: Apr 15, 1998)	no assertion criteria provided	VCV000009513	19	49459056	19	48955799	9513	24552	rs398122513	NC_000019.10:48955798:G:A
NM_138761.4(BAX):c.121del (p.Glu41fs)	BAX	E4fs, E41fs	Carcinoma of colon	Pathogenic(Last reviewed: Feb 14, 1997)	no assertion criteria provided	VCV000009512	19	49458971	19	48955714	9512	24551	rs398122840	NC_000019.10:48955713:GGGGGGGG:GGGGGGG
NM_138761.4(BAX):c.121dup (p.Glu41fs)	BAX		Carcinoma of colon	Pathogenic(Last reviewed: Feb 14, 1997)	no assertion criteria provided	VCV000009511	19	49458970 - 49458971	19	48955713 - 48955714	9511	24550	rs398122840	NC_000019.10:48955713:GGGGGGGG:GGGGGGGGG
ITGB2, IVS4AS, 169-BP DEL, -37	ITGB2		Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000009472					9472	24511		
NM_000211.5(ITGB2):c.817G>A (p.Gly273Arg)	ITGB2	G273R, G204R	Leukocyte adhesion deficiency|not provided|	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009471	21	46320315	21	44900400	9471	24510	rs137852618	NC_000021.9:44900399:C:T
NM_000211.5(ITGB2):c.412T>C (p.Ser138Pro)	ITGB2	S138P, S69P	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000009470	21	46323367	21	44903452	9470	24509	rs137852617	NC_000021.9:44903451:A:G
NM_000211.5(ITGB2):c.850G>A (p.Gly284Ser)	ITGB2	G284S, G215S	Leukocyte adhesion deficiency|	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009469	21	46320282	21	44900367	9469	24508	rs137852616	NC_000021.9:44900366:C:T
NM_000211.5(ITGB2):c.382G>A (p.Asp128Asn)	ITGB2	D128N, D59N	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: May 15, 1992)	no assertion criteria provided	VCV000009467	21	46323397	21	44903482	9467	24506	rs137852615	NC_000021.9:44903481:C:T
NM_000211.5(ITGB2):c.533C>T (p.Pro178Leu)	ITGB2	P178L, P109L	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Mar 15, 1992)	no assertion criteria provided	VCV000009466	21	46321615	21	44901700	9466	24505	rs137852614	NC_000021.9:44901699:G:A
NM_000211.5(ITGB2):c.1052A>G (p.Asn351Ser)	ITGB2	N351S, N282S	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000009465	21	46314917	21	44895002	9465	24504	rs137852613	NC_000021.9:44895001:T:C
ITGB2, IVS?AS, -12, 12-BP INS	ITGB2		Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Feb 15, 1992)	no assertion criteria provided	VCV000009464					9464	24503		
NM_000211.5(ITGB2):c.2T>A (p.Met1Lys)	ITGB2	M1K	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Apr 3, 2009)	no assertion criteria provided	VCV000009462	21	46330696	21	44910781	9462	24501	rs387906411	NC_000021.9:44910780:A:T
NM_000211.5(ITGB2):c.505G>A (p.Gly169Arg)	ITGB2	G169R, G100R	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000009461	21	46321643	21	44901728	9461	24500	rs137852612	NC_000021.9:44901727:C:T
NM_000211.5(ITGB2):c.446T>C (p.Leu149Pro)	ITGB2	L149P, L80P	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000009460	21	46323333	21	44903418	9460	24499	rs137852611	NC_000021.9:44903417:A:G
NM_000211.5(ITGB2):c.587A>C (p.Lys196Thr)	ITGB2	K196T, K127T	Leukocyte adhesion deficiency	Pathogenic(Last reviewed: Mar 1, 1990)	no assertion criteria provided	VCV000009459	21	46321561	21	44901646	9459	24498	rs137852610	NC_000021.9:44901645:T:G
NM_000211.5(ITGB2):c.1777C>T (p.Arg593Cys)	ITGB2	R593C, R524C	Leukocyte adhesion deficiency|	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000009458	21	46309291	21	44889376	9458	24497	rs137852609	NC_000021.9:44889375:G:A
SGCA, TYR134TER	SGCA	Y134*	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000009440					9440	24479		
NM_000023.4(SGCA):c.850C>T (p.Arg284Cys)	SGCA	R284C	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D|Sarcoglycanopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009439	17	48247606	17	50170245	9439	24478	rs137852623	NC_000017.11:50170244:C:T
NM_000023.4(SGCA):c.410A>G (p.Glu137Gly)	SGCA	E137G	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000009438	17	48245759	17	50168398	9438	24477	rs397514451	NC_000017.11:50168397:A:G
NM_000023.4(SGCA):c.229C>T (p.Arg77Cys)	SGCA	R77C	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D|Sarcoglycanopathy	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009437	17	48245014	17	50167653	9437	24476	rs28933693	NC_000017.11:50167652:C:T
NM_000023.4(SGCA):c.524T>C (p.Val175Ala)	SGCA	V175A	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Aug 26, 1994)	no assertion criteria provided	VCV000009436	17	48245873	17	50168512	9436	24475	rs137852622	NC_000017.11:50168511:T:C
NM_000023.4(SGCA):c.293G>A (p.Arg98His)	SGCA	R98H	not provided|Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009435	17	48245078	17	50167717	9435	24474	rs137852621	NC_000017.11:50167716:G:A
NM_000215.3(JAK3):c.172_174del (p.Ala58del)	JAK3	A58del	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000009366	19	17955053 - 17955055	19	17844244 - 17844246	9366	24405	rs137852627	NC_000019.10:17844243:GGC:
NM_000215.3(JAK3):c.507C>A (p.Asp169Glu)	JAK3	D169E	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000009365	19	17953895	19	17843086	9365	24404		NC_000019.10:17843085:G:T
NM_000215.3(JAK3):c.1333C>T (p.Arg445Ter)	JAK3	R445*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000009364	19	17950394	19	17839585	9364	24403	rs137852626	NC_000019.10:17839584:G:A
NM_000215.3(JAK3):c.1695C>A (p.Cys565Ter)	JAK3	C565*	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Nov 3, 1995)	no assertion criteria provided	VCV000009363	19	17948747	19	17837938	9363	24402	rs137852625	NC_000019.10:17837937:G:T
JAK3, 1-BP INS, 1172G	JAK3		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Nov 3, 1995)	no assertion criteria provided	VCV000009362					9362	24401		
JAK3, 151-BP DEL	JAK3		Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Sep 7, 1995)	no assertion criteria provided	VCV000009361					9361	24400		
NM_000215.3(JAK3):c.299A>G (p.Tyr100Cys)	JAK3	Y100C	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000009360	19	17954595	19	17843786	9360	24399	rs137852624	NC_000019.10:17843785:T:C
NM_001037.5(SCN1B):c.448+89G>A	SCN1B	W179*	Cardiac conduction defect, nonspecific	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000009256	19	35524732	19	35033828	9256	24295	rs267607029	NC_000019.10:35033827:G:A
NM_001037.5(SCN1B):c.259G>C (p.Glu87Gln)	SCN1B	E87Q, E54Q	Cardiac conduction defect, nonspecific	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000009255	19	35524454	19	35033550	9255	24294	rs121434627	NC_000019.10:35033549:G:C
NM_001037.5(SCN1B):c.208-2A>C	SCN1B		Generalized epilepsy with febrile seizures plus, type 1	Pathogenic(Last reviewed: Sep 23, 2003)	no assertion criteria provided	VCV000009253	19	35524401	19	35033497	9253	24292	rs724159982	NC_000019.10:35033496:A:C
NM_001037.5(SCN1B):c.363C>G (p.Cys121Trp)	SCN1B	C121W, C88W	Generalized epilepsy with febrile seizures plus|Brugada syndrome 5|Epileptic encephalopathy, early infantile, 52|Generalized epilepsy with febrile seizures plus, type 1|Atrial fibrillation, familial, 13|Atrial fibrillation, familial, 13|Brugada syndrome 5|Generalized epilepsy with febrile seizures plus, type 1|not provided|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009252	19	35524558	19	35033654	9252	24291	rs104894718	NC_000019.10:35033653:C:G
NM_000095.3(COMP):c.2152C>T (p.Arg718Trp)	COMP	R718W	Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jul 25, 2013)	no assertion criteria provided	VCV000009198	19	18893939	19	18783129	9198	24237	rs28936368	NC_000019.10:18783128:G:A
NM_000095.3(COMP):c.2223dup (p.Asn742fs)	COMP		Multiple epiphyseal dysplasia 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000009197	19	18893867 - 18893868	19	18783057 - 18783058	9197	24236	rs869320730	NC_000019.10:18783057:G:GG
COMP, 533-BP DEL, EX9	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000009196					9196	24235		
NM_000095.3(COMP):c.1042T>C (p.Cys348Arg)	COMP	C348R	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Nov 22, 2001)	no assertion criteria provided	VCV000009195	19	18898393	19	18787584	9195	24234	rs137852656	NC_000019.10:18787583:A:G
NM_000095.3(COMP):c.2156G>A (p.Gly719Asp)	COMP	G719D	Pseudoachondroplasia, severe|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	VCV000009194	19	18893935	19	18783125	9194	24233	rs137852655	NC_000019.10:18783124:C:T
NM_000095.2(COMP):c.1417_1419dupGAC (p.Asp473_Asn474insAsp)	COMP		Multiple epiphyseal dysplasia 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 16, 2015)	no assertion criteria provided	VCV000009193	19	18896844 - 18896845	19	18786034 - 18786035	9193	24232	rs193922900	NC_000019.10:18786034:GTCGTCGTCGTCGTCG:GTCGTCGTCGTCGTCGTCG
NM_000095.3(COMP):c.1405_1407GAC[7] (p.Asp472_Asp473dup)	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000009192	19	18896844 - 18896845	19	18786034 - 18786035	9192	24231		NC_000019.10:18786034:GTCGTCGTCGTCGTCG:GTCGTCGTCGTCGTCGTCGTCG
NM_000095.3(COMP):c.1418A>G (p.Asp473Gly)	COMP	D473G	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000009191	19	18896846	19	18786036	9191	24230	rs28936669	NC_000019.10:18786035:T:C
NM_000095.3(COMP):c.1358A>G (p.Asn453Ser)	COMP	N453S	Epiphyseal dysplasia, multiple, 1, severe	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000009190	19	18896906	19	18786096	9190	24229	rs28936668	NC_000019.10:18786095:T:C
NM_000095.3(COMP):c.982T>C (p.Cys328Arg)	COMP	C328R	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009188	19	18898453	19	18787644	9188	24227	rs137852653	NC_000019.10:18787643:A:G
NM_000095.3(COMP):c.1024G>T (p.Asp342Tyr)	COMP	D342Y	Epiphyseal dysplasia, multiple, 1, severe	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009187	19	18898411	19	18787602	9187	24226	rs137852652	NC_000019.10:18787601:C:A
COMP, 3-BP DEL, 1430GAC	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000009186					9186	24225		
COMP, 3-BP DEL, 459TCA	COMP		Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009185					9185	24224		
NM_000095.3(COMP):c.1403G>A (p.Cys468Tyr)	COMP	C468Y	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009184	19	18896861	19	18786051	9184	24223	rs137852651	NC_000019.10:18786050:C:T
NM_000095.3(COMP):c.1414G>T (p.Asp472Tyr)	COMP	D472Y	Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009183	19	18896850	19	18786040	9183	24222	rs137852650	NC_000019.10:18786039:C:A
NM_005220.3(DLX3):c.559_560CT[1] (p.Tyr188fs)	DLX3		Tricho-dento-osseous syndrome|Amelogenesis imperfecta, type IV	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000009073	17	48069183 - 48069184	17	49991819 - 49991820	9073	24112	rs387906406	NC_000017.11:49991818:AGAG:AG
NM_005220.3(DLX3):c.571_574del (p.Gly191fs)	DLX3	G191fs	Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000009072	17	48069171 - 48069174	17	49991807 - 49991810	9072	24111	rs387906405	NC_000017.11:49991806:CCCC:
NM_000891.2(KCNJ2):c.224C>G (p.Thr75Arg)	KCNJ2	T75R	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000008928	17	68171404	17	70175263	8928	23967	rs104894585	NC_000017.11:70175262:C:G
NM_000891.2(KCNJ2):c.514G>A (p.Asp172Asn)	KCNJ2	D172N	short QT syndrome|Short QT syndrome 3	Pathogenic(Last reviewed: Apr 15, 2005)	no assertion criteria provided	VCV000008927	17	68171694	17	70175553	8927	23966	rs104894584	NC_000017.11:70175552:G:A
NM_000891.2(KCNJ2):c.646A>C (p.Asn216His)	KCNJ2	N216H	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000008926	17	68171826	17	70175685	8926	23965	rs104894583	NC_000017.11:70175684:A:C
NM_000891.2(KCNJ2):c.904G>A (p.Val302Met)	KCNJ2	V302M	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000008925	17	68172084	17	70175943	8925	23964	rs104894582	NC_000017.11:70175942:G:A
NM_000891.2(KCNJ2):c.557C>T (p.Pro186Leu)	KCNJ2	P186L	Congenital long QT syndrome|Andersen Tawil syndrome	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000008924	17	68171737	17	70175596	8924	23963	rs104894581	NC_000017.11:70175595:C:T
NM_000891.2(KCNJ2):c.199C>T (p.Arg67Trp)	KCNJ2	R67W	Congenital long QT syndrome|not provided|Atrial fibrillation, familial, 9|Andersen Tawil syndrome|Short QT syndrome 3|not specified|Andersen Tawil syndrome|Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008923	17	68171379	17	70175238	8923	23962	rs104894580	NC_000017.11:70175237:C:T
KCNJ2, 6-BP DEL, NT1167	KCNJ2		Andersen Tawil syndrome	Pathogenic(Last reviewed: May 18, 2001)	no assertion criteria provided	VCV000008922					8922	23961		
KCNJ2, 12-BP DEL, NT513	KCNJ2		Andersen Tawil syndrome	Pathogenic(Last reviewed: May 18, 2001)	no assertion criteria provided	VCV000008921					8921	23960		
NM_000891.2(KCNJ2):c.899G>T (p.Gly300Val)	KCNJ2	G300V	Congenital long QT syndrome|not provided|Andersen Tawil syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000008920	17	68172079	17	70175938	8920	23959	rs104894579	NC_000017.11:70175937:G:T
NM_000891.2(KCNJ2):c.652C>T (p.Arg218Trp)	KCNJ2	R218W	Congenital long QT syndrome|not provided|Andersen Tawil syndrome|Short QT syndrome 3|Andersen Tawil syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008919	17	68171832	17	70175691	8919	23958	rs104894578	NC_000017.11:70175690:C:T
NM_000891.2(KCNJ2):c.212A>T (p.Asp71Val)	KCNJ2	D71V	Andersen Tawil syndrome|Congenital long QT syndrome	Pathogenic(Last reviewed: May 18, 2001)	no assertion criteria provided	VCV000008918	17	68171392	17	70175251	8918	23957	rs104894575	NC_000017.11:70175250:A:T
NM_198129.3(LAMA3):c.8962C>T (p.Gln2988Ter)	LAMA3	Q1368*, Q1323*, Q1379*, Q2932*, Q2988*	Adult junctional epidermolysis bullosa	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000008793	18	21519286	18	23939322	8793	23832	rs137852758	NC_000018.10:23939321:C:T
NM_000227.5(LAMA3):c.1981C>T (p.Arg661Ter)	LAMA3	R650*, R2214*, R2270*, R605*, R661*	Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008792	18	21487603	18	23907639	8792	23831	rs137852757	NC_000018.10:23907638:C:T
LAMA3, 1-BP DEL, 300G	LAMA3		Junctional epidermolysis bullosa gravis of Herlitz	Pathogenic(Last reviewed: Nov 20, 1995)	no assertion criteria provided	VCV000008791					8791	23830		
NM_139062.4(CSNK1D):c.130A>G (p.Thr44Ala)	CSNK1D	T44A	Advanced sleep phase syndrome, familial, 2	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000008741	17	80223619	17	82265743	8741	23780	rs104894561	NC_000017.11:82265742:T:C
NM_001887.4(CRYBB1):c.658G>T (p.Gly220Ter)	CRYBB1	G220*	Cataract, congenital nuclear, autosomal recessive 3	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000008687	22	26995555	22	26599591	8687	23726	rs74315488	NC_000022.11:26599590:C:A
NM_000479.5(AMH):c.1397_1419dup (p.Glu474delinsSerSerAlaTer)	AMH		Persistent mullerian duct syndrome, type I	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000008625	19	2251669 - 2251670	19	2251670 - 2251671	8625	23664	rs397518444	NC_000019.10:2251670:AGCTCAGCGTAGACCTCCGCGCC:AGCTCAGCGTAGACCTCCGCGCCAGCTCAGCGTAGACCTCCGCGCC
AMH, 14-BP DEL, EX2	AMH		Persistent mullerian duct syndrome, type I	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000008623					8623	23662		
NM_000479.5(AMH):c.1144G>T (p.Glu382Ter)	AMH	E358*, E382*	Persistent mullerian duct syndrome, type I	Pathogenic(Last reviewed: May 1, 1991)	no assertion criteria provided	VCV000008622	19	2251417	19	2251418	8622	23661	rs267606654	NC_000019.10:2251417:G:T
SMAD4, 2-BP DEL/1-BP INS, 1596CC/T	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000008548					8548	23587		
SMAD4, 14-BP DEL, NT1612	SMAD4		Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Pathogenic(Last reviewed: Mar 13, 2004)	no assertion criteria provided	VCV000008547					8547	23586		
NM_005359.5(SMAD4):c.1157G>A (p.Gly386Asp)	SMAD4	G386D	Pancreatic adenocarcinoma|Adenocarcinoma of prostate|Adenocarcinoma of stomach|JP and JP/HHT|Neoplasm of the large intestine|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of esophagus|Lung adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000008545	18	48593406	18	51067036	8545	23584	rs121912580	NC_000018.10:51067035:G:A
SMAD4, 2-BP DEL, 959AC	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000008544					8544	23583		
NM_005359.5(SMAD4):c.1081C>T (p.Arg361Cys)	SMAD4	R361C	Neoplasm of the breast|Juvenile polyposis syndrome|Uterine cervical neoplasms|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|JP, JP/HHT, and HHT|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|not provided|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma	Pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008543	18	48591918	18	51065548	8543	23582	rs80338963	NC_000018.10:51065547:C:T
SMAD4, 1-BP INS	SMAD4		Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Juvenile polyposis of stomach	Pathogenic(Last reviewed: Apr 30, 2005)	no assertion criteria provided	VCV000008542					8542	23581		
SMAD4, 2-BP DEL	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 15, 1998)	no assertion criteria provided	VCV000008541					8541	23580		
SMAD4, 4-BP DEL, NT1372	SMAD4		Juvenile polyposis syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000008540					8540	23579		
NM_005359.5(SMAD4):c.1543A>T (p.Arg515Ter)	SMAD4	R515*	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008539	18	48604721	18	51078351	8539	23578	rs121912579	NC_000018.10:51078350:A:T
NM_005359.5(SMAD4):c.1477G>C (p.Asp493His)	SMAD4	D493H	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008538	18	48604655	18	51078285	8538	23577	rs121912578	NC_000018.10:51078284:G:C
NM_005359.5(SMAD4):c.1072G>T (p.Gly358Ter)	SMAD4	G358*	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000008536	18	48591909	18	51065539	8536	23575	rs121912576	NC_000018.10:51065538:G:T
NM_000178.4(GSS):c.656A>G (p.Asp219Gly)	GSS	D219G	Gluthathione synthetase deficiency|Glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to	Pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000008531	20	33524779	20	34936976	8531	23570	rs28938472	NC_000020.11:34936975:T:C
NM_000178.4(GSS):c.373C>T (p.Arg125Cys)	GSS	R125C	Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008529	20	33530409	20	34942606	8529	23568	rs28936396	NC_000020.11:34942605:G:A
NM_000178.4(GSS):c.847C>T (p.Arg283Cys)	GSS	R283C	Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008528	20	33519924	20	34932121	8528	23567	rs121909309	NC_000020.11:34932120:G:A
NM_000178.4(GSS):c.799C>T (p.Arg267Trp)	GSS	R267W	Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008527	20	33523414	20	34935611	8527	23566	rs121909308	NC_000020.11:34935610:G:A
GSS, 1-BP DEL, NT3/4G	GSS		Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008526					8526	23565		
NM_000178.4(GSS):c.491G>A (p.Arg164Gln)	GSS	R164Q	Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008525	20	33530291	20	34942488	8525	23564	rs121909307	NC_000020.11:34942487:C:T
NC_000019.10:g.(13214609_13224667)_(13286966_13300549)del	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000008518			19	13214609 - 13300549	8518	23557		
NC_000019.10:g.(13255260_13259564)_(13259701_?)del	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000008517			19	13255260 - 13259701	8517	23556		
NC_000019.10:g.(13335910_13359606)_(13359799_13371687)dup	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000008516	19	13446724 - 13482501	19	13335910 - 13371687	8516	23555		
NC_000019.10:g.(13335910_13359606)_(13359799_13371687)del	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000008515	19	13446724 - 13482501	19	13335910 - 13371687	8515	23554		
NM_001127221.1(CACNA1A):c.4037G>A (p.Arg1346Gln)	CACNA1A	R1347Q, R1345Q, R1346Q, R1349Q	Familial hemiplegic migraine type 1|not provided	Pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000008513	19	13373603	19	13262789	8513	23552	rs121908230	NC_000019.10:13262788:C:T
NM_001127221.1(CACNA1A):c.860G>A (p.Cys287Tyr)	CACNA1A	C287Y	Episodic ataxia type 2	Pathogenic(Last reviewed: Jun 28, 2005)	no assertion criteria provided	VCV000008511	19	13470538	19	13359724	8511	23550	rs121908236	NC_000019.10:13359723:C:T
NM_001127221.1(CACNA1A):c.5126T>C (p.Ile1709Thr)	CACNA1A	I1710T, I1709T, I1714T, I1708T, I1711T	Familial hemiplegic migraine type 1||Episodic ataxia type 2|Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000008510	19	13346033	19	13235219	8510	23549	rs121909326	NC_000019.10:13235218:A:G
NM_001127221.1(CACNA1A):c.5455C>T (p.Arg1819Ter)	CACNA1A	R1820*, R1818*, R1819*, R1821*, R1824*	Episodic ataxia, type 2, and epilepsy	Pathogenic(Last reviewed: Jan 12, 2002)	no assertion criteria provided	VCV000008509	19	13340972	19	13230158	8509	23548	rs267606696	NC_000019.10:13230157:G:A
NM_001127221.1(CACNA1A):c.4208T>G (p.Phe1403Cys)	CACNA1A	F1406C, F1402C, F1403C, F1404C	Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 27, 2001)	no assertion criteria provided	VCV000008508	19	13372309	19	13261495	8508	23547	rs121908227	NC_000019.10:13261494:A:C
NM_001127221.1(CACNA1A):c.4636C>T (p.Arg1546Ter)	CACNA1A	R1549*, R1546*, R1545*	Familial hemiplegic migraine type 1|Epileptic encephalopathy, early infantile, 42||Episodic ataxia type 2|Episodic ataxia type 2|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008507	19	13366031	19	13255217	8507	23546	rs121909324	NC_000019.10:13255216:G:A
NM_001127221.1(CACNA1A):c.3832C>T (p.Arg1278Ter)	CACNA1A	R1281*, R1278*, R1277*	Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000008506	19	13387936	19	13277122	8506	23545	rs121909323	NC_000019.10:13277121:G:A
NM_001127221.1(CACNA1A):c.1748G>A (p.Arg583Gln)	CACNA1A	R583Q, R582Q	Familial hemiplegic migraine type 1||Migraine, sporadic hemiplegic|not provided	Pathogenic(Last reviewed: Sep 25, 2015)	criteria provided, single submitter	VCV000008505	19	13419266	19	13308452	8505	23544	rs121908217	NC_000019.10:13308451:C:T
NM_001127221.1(CACNA1A):c.653C>T (p.Ser218Leu)	CACNA1A	S218L	Episodic ataxia type 2|Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: May 12, 2016)	criteria provided, single submitter	VCV000008504	19	13476262	19	13365448	8504	23543	rs121908225	NC_000019.10:13365447:G:A
NM_001127221.1(CACNA1A):c.4366G>T (p.Val1456Leu)	CACNA1A	V1457L, V1455L, V1456L, V1459L	Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: Jul 13, 1999)	no assertion criteria provided	VCV000008503	19	13370403	19	13259589	8503	23542	rs121908237	NC_000019.10:13259588:C:A
NM_001127221.1(CACNA1A):c.4845del (p.Val1617fs)	CACNA1A	V1620fs, V1616fs, V1617fs	Episodic ataxia type 2	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000008502	19	13363829	19	13253015	8502	23541	rs587776695	NC_000019.10:13253014:C:
NM_001127221.1(CACNA1A):c.2816dup (p.Ser940fs)	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000008501	19	13409633 - 13409634	19	13298819 - 13298820	8501	23540	rs587776694	NC_000019.10:13298819:CCCCCC:CCCCCCC
NM_001127221.1(CACNA1A):c.5266G>A (p.Glu1756Lys)	CACNA1A	E1757K, E1755K, E1756K, E1758K, E1761K	Episodic ataxia type 2	Pathogenic(Last reviewed: Dec 4, 2007)	no assertion criteria provided	VCV000008500	19	13342661	19	13231847	8500	23539	rs121908226	NC_000019.10:13231846:C:T
NM_001127221.1(CACNA1A):c.4151A>G (p.Tyr1384Cys)	CACNA1A	Y1385C, Y1383C, Y1384C, Y1387C	Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: Oct 10, 2000)	no assertion criteria provided	VCV000008499	19	13372366	19	13261552	8499	23538	rs121908219	NC_000019.10:13261551:T:C
NM_001127221.1(CACNA1A):c.4469T>C (p.Phe1490Ser)	CACNA1A	F1491S, F1489S, F1490S, F1493S	Episodic ataxia type 2	Pathogenic(Last reviewed: Mar 1, 2001)	no assertion criteria provided	VCV000008498	19	13368288	19	13257474	8498	23537	rs121908233	NC_000019.10:13257473:A:G
NM_001127221.1(CACNA1A):c.2145C>A (p.Asp715Glu)	CACNA1A	D715E, D714E	Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: Sep 20, 2016)	no assertion criteria provided	VCV000008497	19	13414390	19	13303576	8497	23536	rs121908218	NC_000019.10:13303575:G:T
NM_001127221.1(CACNA1A):c.877G>A (p.Gly293Arg)	CACNA1A	G293R	Episodic ataxia type 2|	Pathogenic(Last reviewed: Jun 28, 2005)	no assertion criteria provided	VCV000008496	19	13470521	19	13359707	8496	23535	rs121908215	NC_000019.10:13359706:C:T
NM_001127221.1(CACNA1A):c.3992+1G>A	CACNA1A		Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008492	19	13386663	19	13275849	8492	23531	rs587776693	NC_000019.10:13275848:C:T
NM_001127221.1(CACNA1A):c.3797del (p.Pro1266fs)	CACNA1A	P1269fs, P1266fs, P1265fs	Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008491	19	13394109	19	13283295	8491	23530	rs587776692	NC_000019.10:13283294:GGG:GG
NM_001127221.1(CACNA1A):c.5428A>C (p.Ile1810Leu)	CACNA1A	I1811L, I1809L, I1810L, I1812L, I1815L	Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008490	19	13340999	19	13230185	8490	23529	rs121908214	NC_000019.10:13230184:T:G
NM_001127221.1(CACNA1A):c.2141T>C (p.Val714Ala)	CACNA1A	V714A, V713A	Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008489	19	13414394	19	13303580	8489	23528	rs121908213	NC_000019.10:13303579:A:G
NM_001127221.1(CACNA1A):c.1997C>T (p.Thr666Met)	CACNA1A	T666M, T665M	Epileptic encephalopathy, early infantile, 42|Episodic ataxia type 2|Migraine, sporadic hemiplegic, with progressive cerebellar ataxia|Episodic ataxia type 2|Familial hemiplegic migraine type 1||not provided	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008488	19	13414691	19	13303877	8488	23527	rs121908212	NC_000019.10:13303876:G:A
NM_001127221.1(CACNA1A):c.575G>A (p.Arg192Gln)	CACNA1A	R192Q	Familial hemiplegic migraine type 1	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000008487	19	13482558	19	13371744	8487	23526	rs121908211	NC_000019.10:13371743:C:T
NM_000100.3(CSTB):c.212A>C (p.Gln71Pro)	CSTB	Q71P	Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000008400	21	45194168	21	43774287	8400	23439	rs121909346	NC_000021.9:43774286:T:G
CSTB, 2-BP DEL, 2404TC	CSTB		Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000008399					8399	23438		
NM_000100.3(CSTB):c.10G>C (p.Gly4Arg)	CSTB	G4R	Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000008397	21	45196141	21	43776260	8397	23436	rs74315443	NC_000021.9:43776259:C:G
NM_000100.3(CSTB):c.202C>T (p.Arg68Ter)	CSTB	R68*	Rolandic epilepsy|Unverricht-Lundborg syndrome|Dystonia|Progressive microcephaly|Motor delay|Global brain atrophy|Aplasia/Hypoplasia of the corpus callosum|Intellectual disability, severe|Severe global developmental delay|Dyskinesia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000008396	21	45194178	21	43774297	8396	23435	rs74315442	NC_000021.9:43774296:G:A
NM_000100.3(CSTB):c.67-1G>C	CSTB		Inborn genetic diseases|not provided|Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)|Unverricht-Lundborg syndrome|Progressive myoclonic epilepsy|Chorea|Dyskinesia	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008395	21	45194641	21	43774760	8395	23434	rs147484110	NC_000021.9:43774759:C:G
NM_001390.4(DTNA):c.362C>T (p.Pro121Leu)	DTNA	P121L	Left ventricular noncompaction 1	Pathogenic(Last reviewed: Mar 6, 2001)	no assertion criteria provided	VCV000008306	18	32374214	18	34794250	8306	23345	rs104894654	NC_000018.10:34794249:C:T
NM_000156.6(GAMT):c.148A>C (p.Met50Leu)	GAMT	M50L	Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000008305	19	1401328	19	1401329	8305	23344	rs104894694	NC_000019.10:1401328:T:G
NM_000156.6(GAMT):c.506G>A (p.Cys169Tyr)	GAMT	C169Y	Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000008304	19	1398979	19	1398980	8304	23343	rs121909272	NC_000019.10:1398979:C:T
NM_000156.6(GAMT):c.59G>C (p.Trp20Ser)	GAMT	W20S	Cerebral creatine deficiency syndrome|not provided|Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008303	19	1401417	19	1401418	8303	23342	rs80338734	NC_000019.10:1401417:C:G
NM_000156.6(GAMT):c.299_311dup (p.Arg105fs)	GAMT		Cerebral creatine deficiency syndrome|Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008302	19	1399807 - 1399808	19	1399808 - 1399809	8302	23341	rs80338736	NC_000019.10:1399808:GGGGCCCAGTCCCGG:GGGGCCCAGTCCCGGGGCCCAGTCCCGG
GAMT, IVS2DS, G-A, -1	GAMT		Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000008301					8301	23340		
NM_030662.3(MAP2K2):c.383C>A (p.Pro128Gln)	MAP2K2	P128Q	Cardio-facio-cutaneous syndrome|not provided|Cardiofaciocutaneous syndrome 4	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008275	19	4110574	19	4110576	8275	23314	rs267607230	NC_000019.10:4110575:G:T
NM_030662.3(MAP2K2):c.169T>G (p.Phe57Val)	MAP2K2	F57V	Malignant melanoma of skin|Cardio-facio-cutaneous syndrome|Pancreatic adenocarcinoma|Adenocarcinoma of stomach|Cardiofaciocutaneous syndrome 4|Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008273	19	4117551	19	4117553	8273	23312	rs121434498	NC_000019.10:4117552:A:C
NM_030662.3(MAP2K2):c.170T>G (p.Phe57Cys)	MAP2K2	F57C	Cardio-facio-cutaneous syndrome|not provided|Cardiofaciocutaneous syndrome 4	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008272	19	4117550	19	4117552	8272	23311	rs121434497	NC_000019.10:4117551:A:C
NM_005570.4(LMAN1):c.2T>C (p.Met1Thr)	LMAN1	M1T	Combined deficiency of factor V and factor VIII, 1	Pathogenic(Last reviewed: Jun 15, 2008)	no assertion criteria provided	VCV000008066	18	57026475	18	59359243	8066	23105	rs121909253	NC_000018.10:59359242:A:G
NM_005570.4(LMAN1):c.1356del (p.Asn452_Leu453insTer)	LMAN1		Combined deficiency of factor V and factor VIII, 1	Pathogenic(Last reviewed: Jun 15, 2008)	no assertion criteria provided	VCV000008065	18	57000341	18	59333109	8065	23104	rs869312033	NC_000018.10:59333108:G:
NM_005570.4(LMAN1):c.796del (p.Gln266fs)	LMAN1	Q266fs	Combined deficiency of factor V and factor VIII, 1	Pathogenic(Last reviewed: Jun 15, 2008)	no assertion criteria provided	VCV000008064	18	57014771	18	59347539	8064	23103	rs869312032	NC_000018.10:59347538:GG:G
NM_005570.4(LMAN1):c.1149+2T>C	LMAN1		Combined deficiency of factor V and factor VIII, 1	Pathogenic(Last reviewed: Apr 3, 1998)	no assertion criteria provided	VCV000008063	18	57005990	18	59338758	8063	23102	rs869312031	NC_000018.10:59338757:A:G
NM_005570.4(LMAN1):c.89dup (p.Asp31fs)	LMAN1		Combined deficiency of factor V and factor VIII, 1	Pathogenic(Last reviewed: Apr 3, 1998)	no assertion criteria provided	VCV000008062	18	57026387 - 57026388	18	59359155 - 59359156	8062	23101	rs869312030	NC_000018.10:59359155:CCCC:CCCCC
NM_005535.3(IL12RB1):c.592T>C (p.Cys198Arg)	IL12RB1	C198R, C238R	Immunodeficiency 30	Pathogenic(Last reviewed: Dec 15, 2005)	no assertion criteria provided	VCV000008038	19	18186667	19	18075857	8038	23077	rs121434495	NC_000019.10:18075856:A:G
NM_005535.3(IL12RB1):c.1021+1G>C	IL12RB1		Immunodeficiency 30	Pathogenic(Last reviewed: Mar 15, 2005)	no assertion criteria provided	VCV000008037	19	18182921	19	18072111	8037	23076	rs587776680	NC_000019.10:18072110:C:G
NM_005535.3(IL12RB1):c.637C>T (p.Arg213Trp)	IL12RB1	R213W, R253W	Immunodeficiency 30	Pathogenic(Last reviewed: Jul 15, 2001)	no assertion criteria provided	VCV000008035	19	18186622	19	18075812	8035	23074	rs121434494	NC_000019.10:18075811:G:A
IL12RB1, 409-549DEL	IL12RB1		Immunodeficiency 30	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000008034					8034	23073		
NM_005535.3(IL12RB1):c.1126C>T (p.Gln376Ter)	IL12RB1	Q376*, Q416*	Immunodeficiency 30	Pathogenic(Last reviewed: May 29, 1998)	no assertion criteria provided	VCV000008033	19	18180419	19	18069609	8033	23072	rs121434493	NC_000019.10:18069608:G:A
NM_005535.3(IL12RB1):c.94C>T (p.Gln32Ter)	IL12RB1	Q32*, Q72*	Immunodeficiency 30|not provided	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008032	19	18194272	19	18083462	8032	23071	rs121434492	NC_000019.10:18083461:G:A
NM_000961.4(PTGIS):c.1358+2T>C	PTGIS		Essential hypertension	Pathogenic(Last reviewed: Oct 11, 2002)	no assertion criteria provided	VCV000007864	20	48127563	20	49511026	7864	22903	rs13306026	NC_000020.11:49511025:A:G
STXBP2, 1-BP DEL, 706G	STXBP2		Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000007863					7863	22902		
NM_006949.4(STXBP2):c.260del (p.Leu87fs)	STXBP2	L84fs, L98fs, L87fs	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000007862	19	7705630	19	7640744	7862	22901		NC_000019.10:7640743:T:
NM_006949.4(STXBP2):c.626T>C (p.Leu209Pro)	STXBP2	L209P, L206P, L220P	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000007861	19	7706967	19	7642081	7861	22900	rs121918541	NC_000019.10:7642080:T:C
STXBP2, IVS14AS, G-C, -1	STXBP2		Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000007860					7860	22899		
NM_006949.4(STXBP2):c.693_695del (p.Ile232del)	STXBP2	I232del, I229del, I243del	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000007859	19	7707117 - 7707119	19	7642231 - 7642233	7859	22898		NC_000019.10:7642230:TGAT:T
NM_006949.4(STXBP2):c.1430C>T (p.Pro477Leu)	STXBP2	P477L, P488L, P474L	Hemophagocytic lymphohistiocytosis, familial, 5	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, single submitter	VCV000007858	19	7711208	19	7646322	7858	22897	rs121918540	NC_000019.10:7646321:C:T
NM_001321120.2(TBX4):c.1595A>G (p.Gln532Arg)	TBX4	Q531R, Q532R		Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007857	17	59560831	17	61483470	7857	22896	rs28936696	NC_000017.11:61483469:A:G
NM_001321120.2(TBX4):c.184C>T (p.Gln62Ter)	TBX4	Q62*		Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007856	17	59534035	17	61456674	7856	22895	rs104894648	NC_000017.11:61456673:C:T
NM_001321120.2(TBX4):c.743G>T (p.Gly248Val)	TBX4	G248V		Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000007855	17	59557282	17	61479921	7855	22894	rs28938474	NC_000017.11:61479920:G:T
NM_024407.5(NDUFS7):c.17-1167C>G	NDUFS7		MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000007683	19	1386643	19	1386644	7683	22722	rs1568985256	NC_000019.10:1386643:C:G
NM_024407.5(NDUFS7):c.434G>A (p.Arg145His)	NDUFS7	R145H	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007682	19	1391143	19	1391144	7682	22721	rs121434479	NC_000019.10:1391143:G:A
NM_024407.5(NDUFS7):c.364G>A (p.Val122Met)	NDUFS7	V122M	not provided|MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3	Pathogenic(Last reviewed: Nov 23, 2018)	criteria provided, single submitter	VCV000007681	19	1391005	19	1391006	7681	22720	rs104894705	NC_000019.10:1391005:G:A
SLC5A5, EX3-7DEL	SLC5A5		Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000007671					7671	22710		
NM_000453.3(SLC5A5):c.1183G>A (p.Gly395Arg)	SLC5A5	G395R	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000007670	19	17992969	19	17882160	7670	22709	rs121909180	NC_000019.10:17882159:G:A
NM_000453.3(SLC5A5):c.1628G>A (p.Gly543Glu)	SLC5A5	G543E	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000007669	19	17999241	19	17888432	7669	22708	rs121909179	NC_000019.10:17888431:G:A
NM_000453.3(SLC5A5):c.277G>C (p.Gly93Arg)	SLC5A5	G93R	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Sep 1, 1998)	no assertion criteria provided	VCV000007668	19	17983405	19	17872596	7668	22707	rs121909178	NC_000019.10:17872595:G:C
NM_000453.3(SLC5A5):c.1593C>G (p.Tyr531Ter)	SLC5A5	Y531*	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007667	19	17999206	19	17888397	7667	22706	rs121909177	NC_000019.10:17888396:C:G
NM_000453.3(SLC5A5):c.799C>G (p.Gln267Glu)	SLC5A5	Q267E	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007666	19	17988632	19	17877823	7666	22705	rs121909176	NC_000019.10:17877822:C:G
NM_000453.3(SLC5A5):c.816C>A (p.Cys272Ter)	SLC5A5	C272*	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Nov 17, 1997)	no assertion criteria provided	VCV000007665	19	17988649	19	17877840	7665	22704	rs121909175	NC_000019.10:17877839:C:A
NM_000453.3(SLC5A5):c.1060A>C (p.Thr354Pro)	SLC5A5	T354P	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000007664	19	17992770	19	17881961	7664	22703	rs121909174	NC_000019.10:17881960:A:C
NM_013435.3(RAX):c.909C>G (p.Tyr303Ter)	RAX	Y303*	Microphthalmia, isolated 3	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000007638	18	56936368	18	59269136	7638	22677	rs121909128	NC_000018.10:59269135:G:C
NM_013435.3(RAX):c.664del (p.Ser222fs)	RAX	S222fs	Microphthalmia, isolated 3	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000007637	18	56936613	18	59269381	7637	22676		NC_000018.10:59269380:A:
NM_013435.3(RAX):c.575G>A (p.Arg192Gln)	RAX	R192Q	Microphthalmia, isolated 3	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000007636	18	56936702	18	59269470	7636	22675	rs121909127	NC_000018.10:59269469:C:T
NM_013435.3(RAX):c.439C>T (p.Gln147Ter)	RAX	Q147*	Microphthalmia, isolated 3	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000007635	18	56939697	18	59272465	7635	22674	rs104894663	NC_000018.10:59272464:G:A
NM_002872.5(RAC2):c.169G>A (p.Asp57Asn)	RAC2	D57N	Neutrophil immunodeficiency syndrome	Pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000007575	22	37628897	22	37232857	7575	22614	rs74315507	NC_000022.11:37232856:C:T
TBX1, 30-BP DUP, NT1399	TBX1		Tetralogy of Fallot	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000007568					7568	22607		
NM_080647.1(TBX1):c.582C>G (p.His194Gln)	TBX1	H194Q	Shprintzen syndrome	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000007567	22	19751747	22	19764224	7567	22606	rs74315522	NC_000022.11:19764223:C:G
TBX1, 23-BP DEL, NT1320	TBX1		Shprintzen syndrome	Pathogenic(Last reviewed: May 16, 2006)	no assertion criteria provided	VCV000007566					7566	22605		
NM_080647.1(TBX1):c.1223del (p.Ser408fs)	TBX1	S408fs	Conotruncal anomaly face syndrome/velocardiofacial syndrome	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000007565	22	19754125	22	19766602	7565	22604		NC_000022.11:19766601:C:
NM_080647.1(TBX1):c.443T>A (p.Phe148Tyr)	TBX1	F148Y	Conotruncal anomaly face syndrome/velocardiofacial syndrome	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000007563	22	19750796	22	19763273	7563	22602	rs28939675	NC_000022.11:19763272:T:A
NM_000455.4(STK11):c.738C>G (p.Tyr246Ter)	STK11	Y246*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000007460	19	1221215	19	1221216	7460	22499	rs137853083	NC_000019.10:1221215:C:G
NM_000455.4(STK11):c.891del (p.Arg297fs)	STK11	R297fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000007459	19	1221975	19	1221976	7459	22498	rs587776661	NC_000019.10:1221975:GG:G
NM_000455.4(STK11):c.717G>C (p.Trp239Cys)	STK11	W239C	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000007458	19	1220699	19	1220700	7458	22497	rs137853082	NC_000019.10:1220699:G:C
NM_000455.4(STK11):c.403G>C (p.Gly135Arg)	STK11	G135R	Cutaneous malignant melanoma 1	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000007457	19	1219351	19	1219352	7457	22496	rs137853081	NC_000019.10:1219351:G:C
NM_000455.4(STK11):c.145T>G (p.Tyr49Asp)	STK11	Y49D	Cutaneous malignant melanoma 1	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000007456	19	1207057	19	1207058	7456	22495	rs137853080	NC_000019.10:1207057:T:G
NM_000455.4(STK11):c.508C>T (p.Gln170Ter)	STK11	E170*, Q170*	Neoplasm|Cutaneous malignant melanoma 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000007455	19	1220415	19	1220416	7455	22494	rs121913323	NC_000019.10:1220415:C:T
NM_000455.4(STK11):c.936del (p.Lys312fs)	STK11	K312fs	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000007454	19	1222997	19	1222998	7454	22493	rs397518443	NC_000019.10:1222997:AAA:AA
NM_000455.4(STK11):c.650del (p.Pro217fs)	STK11	P217fs	Peutz-Jeghers syndrome|Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000007453	19	1220629	19	1220630	7453	22492	rs397518442	NC_000019.10:1220629:CCCC:CCC
NM_000455.4(STK11):c.108C>A (p.Tyr36Ter)	STK11	Y36*	Carcinoma of pancreas	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000007452	19	1207020	19	1207021	7452	22491	rs137853079	NC_000019.10:1207020:C:A
NM_000455.4(STK11):c.197dup (p.Leu67fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Apr 10, 1999)	no assertion criteria provided	VCV000007451	19	1207108 - 1207109	19	1207109 - 1207110	7451	22490	rs397518441	NC_000019.10:1207109:T:TT
NM_000455.4(STK11):c.580G>T (p.Asp194Tyr)	STK11	D194Y	Cutaneous melanoma|Cutaneous malignant melanoma 1	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)	no assertion criteria provided	VCV000007450	19	1220487	19	1220488	7450	22489	rs121913315	NC_000019.10:1220487:G:T
NM_000455.4(STK11):c.418del (p.Leu140fs)	STK11	L140fs	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 10, 2013)	criteria provided, single submitter	VCV000007449	19	1219366	19	1219367	7449	22488	rs397518440	NC_000019.10:1219366:C:
NM_000455.4(STK11):c.488G>A (p.Gly163Asp)	STK11	G163D	Malignant tumor of testis|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 1, 2012)	criteria provided, single submitter	VCV000007448	19	1220395	19	1220396	7448	22487	rs137853078	NC_000019.10:1220395:G:A
NM_000455.4(STK11):c.169G>T (p.Glu57Ter)	STK11	E57*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 8, 1998)	no assertion criteria provided	VCV000007447	19	1207081	19	1207082	7447	22486	rs137854584	NC_000019.10:1207081:G:T
NM_000455.4(STK11):c.908_916del (p.Ile303_His306delinsAsn)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 8, 1998)	no assertion criteria provided	VCV000007446	19	1221993 - 1222001	19	1221994 - 1222002	7446	22485	rs587776660	NC_000019.10:1221993:TCCGGCAGC:
NM_000455.4(STK11):c.200T>C (p.Leu67Pro)	STK11	L67P	not provided|Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007445	19	1207112	19	1207113	7445	22484	rs137853077	NC_000019.10:1207112:T:C
NM_000455.4(STK11):c.832_833TG[1] (p.Cys278fs)	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 8, 1998)	no assertion criteria provided	VCV000007444	19	1221309 - 1221310	19	1221310 - 1221311	7444	22483	rs587776659	NC_000019.10:1221309:TGTG:TG
NM_000455.4(STK11):c.250A>T (p.Lys84Ter)	STK11	K84*	not provided|Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007443	19	1207162	19	1207163	7443	22482	rs137853076	NC_000019.10:1207162:A:T
NM_000455.4(STK11):c.465-1G>A	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007442	19	1220371	19	1220372	7442	22481	rs587776658	NC_000019.10:1220371:G:A
NM_000455.4(STK11):c.718_721del (p.Ser240fs)	STK11	S240fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007441	19	1220698 - 1220701	19	1220699 - 1220702	7441	22480	rs587776657	NC_000019.10:1220698:GGTCGG:GG
NM_000455.4(STK11):c.843del (p.Leu282fs)	STK11	L282fs	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007440	19	1221320	19	1221321	7440	22479	rs587776656	NC_000019.10:1221320:G:
NM_000455.4(STK11):c.759C>A (p.Tyr253Ter)	STK11	Y253*	Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007439	19	1221236	19	1221237	7439	22478	rs137853075	NC_000019.10:1221236:C:A
STK11, EX4-5DEL/EX6-7INV	STK11		Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000007438					7438	22477		
CRX, 3-BP DEL/2-BP INS, NT816	CRX		Cone-rod dystrophy 2	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000007425					7425	22464		
NM_000554.6(CRX):c.122G>A (p.Arg41Gln)	CRX	R41Q	Cone-rod dystrophy 2|Leber congenital amaurosis 7|not provided|Retinal dystrophy|Cone-rod dystrophy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007421	19	48339521	19	47836264	7421	22460	rs61748436	NC_000019.10:47836263:G:A
CRX, 1-BP DEL, GLY217	CRX		Leber congenital amaurosis 7	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000007420					7420	22459		
CRX, 2-BP DEL, GLU168	CRX		Leber congenital amaurosis 7	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000007419					7419	22458		
NM_000554.6(CRX):c.121C>T (p.Arg41Trp)	CRX	R41W	not provided|Retinal dystrophy|Cone-rod dystrophy 2	Pathogenic(Last reviewed: Jan 13, 2019)	criteria provided, single submitter	VCV000007418	19	48339520	19	47836263	7418	22457	rs104894672	NC_000019.10:47836262:C:T
NM_000554.6(CRX):c.502del (p.Glu168fs)	CRX	E168fs	Cone-rod dystrophy 2	Pathogenic(Last reviewed: Nov 14, 1997)	no assertion criteria provided	VCV000007417	19	48342826	19	47839569	7417	22456	rs1568626209	NC_000019.10:47839568:G:
NM_000554.6(CRX):c.239A>C (p.Glu80Ala)	CRX	E80A	not provided|Cone-rod dystrophy 2	Pathogenic(Last reviewed: Nov 14, 1997)	no assertion criteria provided	VCV000007416	19	48339638	19	47836381	7416	22455	rs104894671	NC_000019.10:47836380:A:C
NM_172107.4(KCNQ2):c.620G>A (p.Arg207Gln)	KCNQ2	R207Q	not provided|Seizures, benign familial neonatal, 1, and/or myokymia|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007391	20	62076082	20	63444729	7391	22430	rs118192200	NC_000020.11:63444728:C:T
NM_172107.4(KCNQ2):c.2127del (p.Val710fs)	KCNQ2	V710fs, V679fs, V682fs, V692fs	not provided|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000007390	20	62038489	20	63407136	7390	22429	rs118192244	NC_000020.11:63407135:A:
NM_172107.4(KCNQ2):c.1662G>T (p.Lys554Asn)	KCNQ2	K526N, K523N, K536N, K554N	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000007388	20	62044904	20	63413551	7388	22427	rs267607198	NC_000020.11:63413550:C:A
KCNQ2, 10-BP DEL/1-BP INS, NT761	KCNQ2		Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000007387					7387	22426		
NM_172107.3(KCNQ2):c.619C>T (p.Arg207Trp)	KCNQ2	R207W	Seizures, benign familial neonatal, 1, and/or myokymia|Benign familial neonatal seizures 1|not provided|Inborn genetic diseases|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007386	20	62076083	20	63444730	7386	22425	rs74315391	NC_000020.11:63444729:G:A
KCNQ2, 1-BP DEL, 1846T	KCNQ2		Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000007384					7384	22423		
NM_172107.4(KCNQ2):c.916G>A (p.Ala306Thr)	KCNQ2	A306T	Benign familial neonatal seizures 1|Seizures	Pathogenic(Last reviewed: Nov 23, 2016)	criteria provided, single submitter	VCV000007382	20	62070962	20	63439609	7382	22421	rs74315390	NC_000020.11:63439608:C:T
NM_172107.4(KCNQ2):c.851A>G (p.Tyr284Cys)	KCNQ2	Y284C	Benign familial neonatal seizures 1	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000007381	20	62071027	20	63439674	7381	22420	rs28939683	NC_000020.11:63439673:T:C
NM_001083962.2(TCF4):c.908del (p.Thr303fs)	TCF4	T261fs, T303fs, T87fs, T143fs, T232fs, T279fs, T302fs, T309fs, T173fs, T278fs, T301fs, T405fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000007375	18	52937076	18	55269845	7375	22414		NC_000018.10:55269844:G:
NM_001083962.2(TCF4):c.1733G>C (p.Arg578Pro)	TCF4	R574P, R578P, R413P, R448P, R507P, R536P, R549P, R550P, R553P, R418P, R555P, R362P, R532P, R554P, R571P, R414P, R444P, R503P, R573P, R577P, R584P, R680P	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000007374	18	52896224	18	55228993	7374	22413	rs121909123	NC_000018.10:55228992:C:G
TCF4, IVS9AS, G-C, -1	TCF4		Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000007373					7373	22412		
NM_001083962.2(TCF4):c.1153C>T (p.Arg385Ter)	TCF4	R358*, R385*, R225*, R314*, R362*, R382*, R384*, R343*, R360*, R169*, R361*, R487*, R224*, R255*, R391*	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007372	18	52921925	18	55254694	7372	22411	rs121909122	NC_000018.10:55254693:G:A
NM_001083962.2(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	R576Q, R580Q, R446Q, R552Q, R364Q, R415Q, R450Q, R538Q, R586Q, R416Q, R420Q, R509Q, R534Q, R551Q, R556Q, R575Q, R682Q, R505Q, R555Q, R557Q, R573Q, R579Q	not provided|Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007371	18	52896218	18	55228987	7371	22410	rs121909121	NC_000018.10:55228986:C:T
NM_001083962.2(TCF4):c.1738C>T (p.Arg580Trp)	TCF4	R576W, R580W, R682W, R364W, R505W, R534W, R552W, R557W, R420W, R446W, R509W, R555W, R573W, R575W, R579W, R415W, R416W, R450W, R538W, R551W, R556W, R586W	Severe intellectual deficiency|not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000007370	18	52896219	18	55228988	7370	22409	rs121909120	NC_000018.10:55228987:G:A
NM_001005360.2(DNM2):c.1072G>A (p.Gly358Arg)	DNM2	G358R	not provided|Charcot-Marie-Tooth disease, type 2M|Charcot-Marie-Tooth disease, dominant intermediate B	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007287	19	10904475	19	10793799	7287	22326	rs267606772	NC_000019.10:10793798:G:A
NM_001005360.2(DNM2):c.1856C>G (p.Ser619Trp)	DNM2	S619W, S615W	Severe X-linked myotubular myopathy	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000007286	19	10934538	19	10823862	7286	22325	rs121909095	NC_000019.10:10823861:C:G
NM_001005360.2(DNM2):c.1856C>T (p.Ser619Leu)	DNM2	S619L, S615L	Myopathy, centronuclear|not provided|Severe X-linked myotubular myopathy|Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007285	19	10934538	19	10823862	7285	22324	rs121909095	NC_000019.10:10823861:C:T
NM_001005360.2(DNM2):c.1102G>A (p.Glu368Lys)	DNM2	E368K	Myopathy, centronuclear|Muscular Diseases|Charcot-Marie-Tooth disease, dominant intermediate B|not provided|Myopathy, centronuclear, 1	Pathogenic(Last reviewed: Sep 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007282	19	10904505	19	10793829	7282	22321	rs121909092	NC_000019.10:10793828:G:A
NM_001005360.2(DNM2):c.1393C>T (p.Arg465Trp)	DNM2	R465W	Myopathy, centronuclear|Charcot-Marie-Tooth disease, dominant intermediate B|not provided|Myopathy, centronuclear, 1	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007281	19	10909219	19	10798543	7281	22320	rs121909091	NC_000019.10:10798542:C:T
NM_001005360.2(DNM2):c.1105C>T (p.Arg369Trp)	DNM2	R369W	Myopathy, centronuclear|Charcot-Marie-Tooth disease|Myopathy, centronuclear, 1|Charcot-Marie-Tooth disease, dominant intermediate B	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007280	19	10904508	19	10793832	7280	22319	rs121909090	NC_000019.10:10793831:C:T
NM_001005360.2(DNM2):c.1106G>A (p.Arg369Gln)	DNM2	R369Q	Myopathy, centronuclear|Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007279	19	10904509	19	10793833	7279	22318	rs121909089	NC_000019.10:10793832:G:A
DNM2, LYS558 DEL	DNM2		Charcot-Marie-Tooth disease, dominant intermediate b, with neutropenia	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000007278					7278	22317		
DNM2, 9-BP DEL, NT1652	DNM2		Charcot-Marie-Tooth disease, dominant intermediate B	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000007276					7276	22315		
NM_005603.6(ATP8B1):c.1804C>T (p.Arg602Ter)	ATP8B1	R602*	Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Oct 15, 2004)	no assertion criteria provided	VCV000007274	18	55342081	18	57674849	7274	22313	rs121909105	NC_000018.10:57674848:G:A
NM_005603.6(ATP8B1):c.1367C>T (p.Thr456Met)	ATP8B1	T456M	Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Oct 15, 2004)	no assertion criteria provided	VCV000007273	18	55355593	18	57688361	7273	22312	rs121909104	NC_000018.10:57688360:G:A
NM_005603.6(ATP8B1):c.1660G>A (p.Asp554Asn)	ATP8B1	D554N	Cholestasis, progressive familial intrahepatic 1|not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000007269	18	55342225	18	57674993	7269	22308	rs121909101	NC_000018.10:57674992:C:T
ATP8B1, 9-BP DEL, NT2384	ATP8B1		Cholestasis, benign recurrent intrahepatic 1	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007268					7268	22307		
ATP8B1, 1.4-KB DEL	ATP8B1		Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007266					7266	22305		
NM_005603.6(ATP8B1):c.2097+2T>C	ATP8B1		Cholestasis, progressive familial intrahepatic 1|not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000007265	18	55336548	18	57669316	7265	22304	rs387906381	NC_000018.10:57669315:A:G
NM_005603.6(ATP8B1):c.863T>C (p.Leu288Ser)	ATP8B1	L288S	Cholestasis, progressive familial intrahepatic 1	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000007264	18	55362480	18	57695248	7264	22303	rs121909099	NC_000018.10:57695247:A:G
NM_005603.6(ATP8B1):c.923G>T (p.Gly308Val)	ATP8B1	G308V	Cholestasis, progressive familial intrahepatic 1|not provided	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000007262	18	55362420	18	57695188	7262	22301	rs111033609	NC_000018.10:57695187:C:A
NM_003244.3(TGIF1):c.16+1651C>G	TGIF1	Y59*	Holoprosencephaly 4	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000006983	18	3452154	18	3452156	6983	22022	rs121909070	NC_000018.10:3452155:C:G
NM_003244.3(TGIF1):c.485C>T (p.Ser162Phe)	TGIF1	S162F, S291F, S165F, S176F, S142F	Holoprosencephaly 4	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006982	18	3457604	18	3457606	6982	22021	rs121909069	NC_000018.10:3457605:C:T
NM_003244.3(TGIF1):c.451A>G (p.Thr151Ala)	TGIF1	T151A, T280A, T131A, T165A, T154A	Holoprosencephaly 4	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006981	18	3457570	18	3457572	6981	22020	rs121909068	NC_000018.10:3457571:A:G
NM_003244.3(TGIF1):c.188C>G (p.Pro63Arg)	TGIF1	P63R, P192R, P66R, P77R, P43R	Holoprosencephaly 4	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006980	18	3456523	18	3456525	6980	22019	rs121909067	NC_000018.10:3456524:C:G
NM_003244.3(TGIF1):c.83C>G (p.Ser28Cys)	TGIF1	S28C, S157C, S42C, S8C, S31C	Holoprosencephaly 4	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006979	18	3456418	18	3456420	6979	22018	rs121909066	NC_000018.10:3456419:C:G
NM_001429.4:c.730_1760del	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000006886					6886	21925		
NM_001429.4(EP300):c.7100del (p.Pro2367fs)	EP300	P2341fs, P2367fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006885	22	41574813	22	41178809	6885	21924	rs1569122847	NC_000022.11:41178808:CCC:CC
NC_000022.11:g.(?_41092585)_(41093099_41117186)del	EP300		Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006884			22	41092585 - 41117186	6884	21923		
NM_001429.4(EP300):c.2877_2884del (p.Thr960fs)	EP300	T960fs, T934fs	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006883	22	41547894 - 41547901	22	41151890 - 41151897	6883	21922	rs1569108381	NC_000022.11:41151889:AGCACAGAAG:AG
NM_001429.4(EP300):c.1942C>T (p.Arg648Ter)	EP300	R648*	Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006882	22	41537115	22	41141111	6882	21921	rs137853039	NC_000022.11:41141110:C:T
NM_001429.4(EP300):c.6662C>A (p.Pro2221Gln)	EP300	P2221Q, P2195Q	Carcinoma of colon	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000006881	22	41574377	22	41178373	6881	21920	rs28937578	NC_000022.11:41178372:C:A
NM_001429.4(EP300):c.1738C>T (p.Arg580Ter)	EP300	R580*	Carcinoma of colon	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000006880	22	41533772	22	41137768	6880	21919	rs137853038	NC_000022.11:41137767:C:T
NM_004646.3(NPHS1):c.793T>C (p.Cys265Arg)	NPHS1	C265R	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Aug 15, 2009)	no assertion criteria provided	VCV000006874	19	36340185	19	35849283	6874	21913	rs267606917	NC_000019.10:35849282:A:G
NM_004646.3(NPHS1):c.3478C>T (p.Arg1160Ter)	NPHS1	R1160*	not provided|Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006873	19	36321958	19	35831056	6873	21912	rs267606919	NC_000019.10:35831055:G:A
NPHS1, 1-BP INS, 3250G	NPHS1		Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000006869					6869	21908		
NM_004646.3(NPHS1):c.3325C>T (p.Arg1109Ter)	NPHS1	R1109*	Finnish congenital nephrotic syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006867	19	36322260	19	35831358	6867	21906	rs137853042	NC_000019.10:35831357:G:A
NM_203486.3(DLL3):c.1440del (p.Pro481fs)	DLL3	P481fs	Spondylocostal dysostosis 1, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000006834	19	39998025	19	39507385	6834	21873	rs786200903	NC_000019.10:39507384:G:
NM_203486.3(DLL3):c.712C>T (p.Arg238Ter)	DLL3	R238*	Spondylocostal dysostosis 1, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000006833	19	39994770	19	39504130	6833	21872	rs104894675	NC_000019.10:39504129:C:T
NM_203486.3(DLL3):c.1291_1307dup (p.Pro437fs)	DLL3		Spondylocostal dysostosis 1, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000006831	19	39997869 - 39997870	19	39507229 - 39507230	6831	21870	rs777791545	NC_000019.10:39507229:CGCGCGGACCCGTGCGCCGCGCG:CGCGCGGACCCGTGCGCCGCGCGGACCCGTGCGCCGCGCG
NM_203486.3(DLL3):c.1154G>A (p.Gly385Asp)	DLL3	G385D	Spondylocostal dysostosis 1, autosomal recessive	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000006830	19	39997739	19	39507099	6830	21869	rs104894674	NC_000019.10:39507098:G:A
NM_203486.3(DLL3):c.945_946del (p.Ala317fs)	DLL3	A317fs	Spondylocostal dysostosis 1, autosomal recessive	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000006829	19	39995943 - 39995944	19	39505303 - 39505304	6829	21868	rs786200900	NC_000019.10:39505302:AT:
NM_006892.4(DNMT3B):c.808T>C (p.Ser270Pro)	DNMT3B	S282P, S270P, S228P, S194P	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000006745	20	31376813	20	32789007	6745	21784	rs121908947	NC_000020.11:32789006:T:C
NM_006892.4(DNMT3B):c.2519G>A (p.Arg840Gln)	DNMT3B	R832Q, R840Q, R681Q, R757Q, R715Q, R820Q	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000006744	20	31395666	20	32807860	6744	21783	rs121908946	NC_000020.11:32807859:G:A
NM_006892.4(DNMT3B):c.88C>T (p.Gln30Ter)	DNMT3B	Q42*, Q30*	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000006743	20	31368217	20	32780411	6743	21782	rs121908945	NC_000020.11:32780410:C:T
NM_006892.4(DNMT3B):c.2237T>G (p.Val746Gly)	DNMT3B	V726G, V746G, V738G	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Nov 11, 1999)	no assertion criteria provided	VCV000006742	20	31393149	20	32805343	6742	21781	rs121908944	NC_000020.11:32805342:T:G
NM_006892.4(DNMT3B):c.2421-11G>A	DNMT3B		Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Oct 29, 1999)	no assertion criteria provided	VCV000006741	20	31395557	20	32807751	6741	21780	rs547940069	NC_000020.11:32807750:G:A
NM_006892.4(DNMT3B):c.1807G>A (p.Ala603Thr)	DNMT3B	A603T, A541T, A507T, A583T, A595T	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Oct 29, 1999)	no assertion criteria provided	VCV000006740	20	31388006	20	32800200	6740	21779	rs121908943	NC_000020.11:32800199:G:A
DNMT3B, 1-BP INS, CODON 53	DNMT3B		Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Nov 11, 1999)	no assertion criteria provided	VCV000006739					6739	21778		
DNMT3B, EX21-22DEL	DNMT3B		Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Nov 11, 1999)	no assertion criteria provided	VCV000006738					6738	21777		
DNMT3B, LEU656THR	DNMT3B	L656T	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Nov 11, 1999)	no assertion criteria provided	VCV000006737					6737	21776		
NM_006892.4(DNMT3B):c.1987G>A (p.Gly663Ser)	DNMT3B	G655S, G663S, G643S, G567S, G601S	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Nov 11, 1999)	no assertion criteria provided	VCV000006736	20	31388722	20	32800916	6736	21775	rs121908942	NC_000020.11:32800915:G:A
NM_006892.4(DNMT3B):c.2177T>G (p.Val726Gly)	DNMT3B	V718G, V726G, V664G, V706G, V630G	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000006735	20	31390222	20	32802416	6735	21774	rs121908941	NC_000020.11:32802415:T:G
NM_006892.4(DNMT3B):c.2452G>A (p.Val818Met)	DNMT3B	V659M, V798M, V735M, V810M, V818M, V693M	Immunodeficiency-centromeric instability-facial anomalies syndrome 1|Non-obstructive azoospermia	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000006734	20	31395599	20	32807793	6734	21773	rs121908940	NC_000020.11:32807792:G:A
NM_006892.4(DNMT3B):c.2450A>G (p.Asp817Gly)	DNMT3B	D809G, D817G, D692G, D797G, D658G, D734G	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	Pathogenic(Last reviewed: Nov 11, 1999)	no assertion criteria provided	VCV000006733	20	31395597	20	32807791	6733	21772	rs121908939	NC_000020.11:32807790:A:G
NM_005450.5(NOG):c.103C>G (p.Pro35Ala)	NOG	P35A	Brachydactyly type B2	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006708	17	54671687	17	56594326	6708	21747	rs28937580	NC_000017.11:56594325:C:G
NM_005450.5(NOG):c.615G>C (p.Trp205Cys)	NOG	W205C	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000006707	17	54672199	17	56594838	6707	21746	rs104894615	NC_000017.11:56594837:G:C
NM_005450.5(NOG):c.614G>A (p.Trp205Ter)	NOG	W205*	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000006706	17	54672198	17	56594837	6706	21745	rs1567745119	NC_000017.11:56594836:G:A
NOG, 1-BP INS, 252C	NOG		Stapes ankylosis with broad thumb and toes	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000006705					6705	21744		
NM_005450.5(NOG):c.328C>T (p.Gln110Ter)	NOG	Q110*	Stapes ankylosis with broad thumb and toes	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000006704	17	54671912	17	56594551	6704	21743	rs104894614	NC_000017.11:56594550:C:T
NM_005450.5(NOG):c.103C>T (p.Pro35Ser)	NOG	P35S	Stapes ankylosis with broad thumb and toes|Brachydactyly type B2|Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000006703	17	54671687	17	56594326	6703	21742	rs28937580	NC_000017.11:56594325:C:T
NM_005450.5(NOG):c.499C>G (p.Arg167Gly)	NOG	R167G	Brachydactyly type B2	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000006702	17	54672083	17	56594722	6702	21741	rs121908949	NC_000017.11:56594721:C:G
NOG, 1-BP DEL	NOG		Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006701					6701	21740		
NM_005450.5(NOG):c.386T>A (p.Leu129Ter)	NOG	L129*	Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006700	17	54671970	17	56594609	6700	21739	rs104894613	NC_000017.11:56594608:T:A
NM_005450.5(NOG):c.551G>A (p.Cys184Tyr)	NOG	C184Y	Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000006699	17	54672135	17	56594774	6699	21738	rs104894612	NC_000017.11:56594773:G:A
NM_005450.5(NOG):c.104C>G (p.Pro35Arg)	NOG	P35R	|Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006697	17	54671688	17	56594327	6697	21736	rs104894611	NC_000017.11:56594326:C:G
NM_005450.5(NOG):c.611G>T (p.Arg204Leu)	NOG	R204L		Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006696	17	54672195	17	56594834	6696	21735	rs104894610	NC_000017.11:56594833:G:T
NM_005450.5(NOG):c.565G>T (p.Gly189Cys)	NOG	G189C	Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006695	17	54672149	17	56594788	6695	21734	rs104894609	NC_000017.11:56594787:G:T
NM_005450.5(NOG):c.668C>T (p.Pro223Leu)	NOG	P223L	Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006694	17	54672252	17	56594891	6694	21733	rs104894608	NC_000017.11:56594890:C:T
NM_005450.5(NOG):c.649T>G (p.Trp217Gly)	NOG	W217G	Symphalangism-brachydactyly syndrome	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006693	17	54672233	17	56594872	6693	21732	rs104894603	NC_000017.11:56594871:T:G
NM_005450.5(NOG):c.664T>G (p.Tyr222Asp)	NOG	Y222D	Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Mar 1, 1999)	no assertion criteria provided	VCV000006692	17	54672248	17	56594887	6692	21731	rs121908948	NC_000017.11:56594886:T:G
NM_005450.5(NOG):c.665A>G (p.Tyr222Cys)	NOG	Y222C	|Symphalangism, proximal, 1A	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000006691	17	54672249	17	56594888	6691	21730	rs104894602	NC_000017.11:56594887:A:G
NM_003721.4(RFXANK):c.271+1G>C	RFXANK		Bare lymphocyte syndrome, type II, complementation group B	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000006599	19	19307856	19	19197047	6599	21638		NC_000019.10:19197046:G:C
RFXANK, 58-BP DEL	RFXANK		Bare lymphocyte syndrome, type II, complementation group B	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000006598					6598	21637		
RFXANK, 26-BP DEL, NT752	RFXANK		Bare lymphocyte syndrome, type II, complementation group B	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000006597					6597	21636		
NM_018129.4(PNPO):c.520C>T (p.Gln174Ter)	PNPO	A174*, Q174*	Pyridoxal phosphate-responsive seizures	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000006526	17	46023329	17	47945963	6526	21565	rs267606958	NC_000017.11:47945962:C:T
NM_018129.4(PNPO):c.784T>C (p.Ter262Gln)	PNPO	*262Q	Pyridoxal phosphate-responsive seizures	Pathogenic(Last reviewed: Apr 15, 2005)	no assertion criteria provided	VCV000006525	17	46024146	17	47946780	6525	21564	rs104894631	NC_000017.11:47946779:T:C
NM_018129.4(PNPO):c.364-1G>A	PNPO		Pyridoxal phosphate-responsive seizures	Pathogenic(Last reviewed: Apr 15, 2005)	no assertion criteria provided	VCV000006524	17	46022924	17	47945558	6524	21563	rs774710082	NC_000017.11:47945557:G:A
NM_018129.4(PNPO):c.685C>T (p.Arg229Trp)	PNPO	R229W	Pyridoxal phosphate-responsive seizures	Pathogenic(Last reviewed: Apr 15, 2005)	no assertion criteria provided	VCV000006523	17	46024047	17	47946681	6523	21562	rs104894629	NC_000017.11:47946680:C:T
NM_001195.5(BFSP1):c.736-1384_957-66del	BFSP1		Cataract 33, multiple types	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000006497	20	17477734 - 17481069	20	17497089 - 17500424	6497	21536		
NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	RPS19	G127E	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Jul 15, 2007)	no assertion criteria provided	VCV000006320	19	42373792	19	41869722	6320	21359	rs786200936	NC_000019.10:41869721:G:A
RPS19, LEU45GLN AND 2-BP INS, 160CT	RPS19	L45Q	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006318					6318	21357		
NM_001022.4(RPS19):c.307del (p.Val103fs)	RPS19	G107fs, V103fs	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006317	19	42373233	19	41869163	6317	21356	rs786200935	NC_000019.10:41869162:GGG:GG
NM_001022.4(RPS19):c.250A>T (p.Arg84Ter)	RPS19	R84*, E88V	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006316	19	42373178	19	41869108	6316	21355	rs121908649	NC_000019.10:41869107:A:T
NM_001022.4(RPS19):c.98G>A (p.Trp33Ter)	RPS19	W33*	Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006315	19	42365207	19	41861138	6315	21354	rs104894716	NC_000019.10:41861137:G:A
NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	RPS19	R62W, A66V	Diamond-Blackfan anemia|not provided|Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006314	19	42373112	19	41869042	6314	21353	rs104894711	NC_000019.10:41869041:C:T
NM_001022.4(RPS19):c.280C>T (p.Arg94Ter)	RPS19	R94*, P98L	not provided|Diamond-Blackfan anemia 1	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000006313	19	42373208	19	41869138	6313	21352	rs61762293	NC_000019.10:41869137:C:T
NM_001015878.2(AURKC):c.686G>A (p.Cys229Tyr)	AURKC	C229Y, C210Y, C195Y	Infertility associated with multi-tailed spermatozoa and excessive DNA	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000006307	19	57746353	19	57234985	6307	21346	rs121908654	NC_000019.10:57234984:G:A
NM_001015878.2(AURKC):c.145del (p.Leu49fs)	AURKC	L15fs, L30fs, L49fs	Infertility associated with multi-tailed spermatozoa and excessive DNA|not provided	Pathogenic(Last reviewed: Jan 11, 2016)	criteria provided, single submitter	VCV000006306	19	57743438	19	57232070	6306	21345	rs397515619	NC_000019.10:57232069:CCCC:CCC
DPM1, 13-BP DEL	DPM1		Congenital disorder of glycosylation type 1E	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000006297					6297	21336		
NM_003859.2(DPM1):c.274C>G (p.Arg92Gly)	DPM1	R92G	Congenital disorder of glycosylation type 1E	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000006296	20	49565187	20	50948650	6296	21335	rs121908583	NC_000020.11:50948649:G:C
LARGE1, 667FS	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000006222					6222	21261		
NM_004737.6(LARGE1):c.992C>T (p.Ser331Phe)	LARGE1	S331F	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000006221	22	33780191	22	33384205	6221	21260	rs267607210	NC_000022.11:33384204:G:A
LARGE1, GLN87FS	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000006220					6220	21259		
NM_004737.6(LARGE1):c.1483T>C (p.Trp495Arg)	LARGE1	W495R	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000006219	22	33700462	22	33304476	6219	21258	rs267607209	NC_000022.11:33304475:A:G
LARGE1, 63-KB DEL	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000006218					6218	21257		
LARGE1, 1-BP INS, 1999T	LARGE1		Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000006217					6217	21256		
NM_004737.6(LARGE1):c.1525G>A (p.Glu509Lys)	LARGE1	E509K	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000006216	22	33700420	22	33304434	6216	21255	rs121908675	NC_000022.11:33304433:C:T
NM_003560.4(PLA2G6):c.2239C>T (p.Arg747Trp)	PLA2G6	R747W, R521W, R515W, R569W, R693W	Parkinson disease 14|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006204	22	38508548	22	38112541	6204	21243	rs121908687	NC_000022.11:38112540:G:A
NM_003560.4(PLA2G6):c.2222G>A (p.Arg741Gln)	PLA2G6	R741Q, R515Q, R687Q, R509Q, R563Q	Infantile neuroaxonal dystrophy|Parkinson disease 14	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006203	22	38508565	22	38112558	6203	21242	rs121908686	NC_000022.11:38112557:C:T
NM_003560.4(PLA2G6):c.2370_2371del (p.Tyr790_Glu791delinsTer)	PLA2G6		Infantile neuroaxonal dystrophy|Iron accumulation in brain|Neurodegeneration with brain iron accumulation 2b|not provided	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000006201	22	38508218 - 38508219	22	38112211 - 38112212	6201	21240	rs587784353	NC_000022.11:38112210:CA:
NM_003560.4(PLA2G6):c.1894C>T (p.Arg632Trp)	PLA2G6	R632W, R400W, R406W, R454W, R578W	Karak syndrome	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000006199	22	38511674	22	38115667	6199	21238	rs121908683	NC_000022.11:38115666:G:A
NM_003560.4(PLA2G6):c.2070_2072del (p.Val691del)	PLA2G6	V691del, V465del, V513del, V459del, V637del	Infantile neuroaxonal dystrophy|Iron accumulation in brain|Neurodegeneration with brain iron accumulation 2b|not provided	Pathogenic(Last reviewed: Jul 18, 2015)	criteria provided, multiple submitters, no conflicts	VCV000006198	22	38509624 - 38509626	22	38113617 - 38113619	6198	21237	rs587784343	NC_000022.11:38113616:ACAAC:AC
NM_003560.4(PLA2G6):c.929T>A (p.Val310Glu)	PLA2G6	V310E, V132E, V84E	Infantile neuroaxonal dystrophy	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000006197	22	38528986	22	38132979	6197	21236	rs121908682	NC_000022.11:38132978:A:T
NM_003560.4(PLA2G6):c.1634A>C (p.Lys545Thr)	PLA2G6	K545T, K491T, K313T, K319T, K367T	Developmental regression|Microcephaly|Global developmental delay|Cerebellar ataxia|Congenital cerebellar hypoplasia|Neurodegeneration with brain iron accumulation 2b	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000006196	22	38516874	22	38120867	6196	21235	rs121908681	NC_000022.11:38120866:T:G
NM_003560.4(PLA2G6):c.2370T>G (p.Tyr790Ter)	PLA2G6	Y790*, Y558*, Y564*, Y612*, Y736*	PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy|Iron accumulation in brain|Inborn genetic diseases|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006195	22	38508219	22	38112212	6195	21234	rs121908680	NC_000022.11:38112211:A:C
STX16, 3-KB TO 4.4-KB MICRODELETION	STX16		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000006149					6149	21188		
NM_004917.4(KLK4):c.458G>A (p.Trp153Ter)	KLK4	W153*, W58*	Amelogenesis imperfecta, hypomaturation type, IIA1	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000006079	19	51411852	19	50908596	6079	21118	rs104894704	NC_000019.10:50908595:C:T
NM_172201.1(KCNE2):c.178T>C (p.Phe60Leu)	KCNE2	F60L	Congenital long QT syndrome|Long qt syndrome 3/6, digenic	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000006056	21	35742955	21	34370656	6056	21095	rs16991654	NC_000021.9:34370655:T:C
NM_000334.4(SCN4A):c.421A>G (p.Ile141Val)	SCN4A	I141V	Paramyotonia congenita of von Eulenburg	Pathogenic(Last reviewed: Nov 18, 2008)	no assertion criteria provided	VCV000005924	17	62049557	17	63972197	5924	20963	rs121908561	NC_000017.11:63972196:T:C
NM_000334.4(SCN4A):c.2014C>A (p.Arg672Ser)	SCN4A	R672S	Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1|Hypokalemic periodic paralysis 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000005916	17	62036630	17	63959270	5916	20955	rs80338785	NC_000017.11:63959269:G:T
NM_000334.4(SCN4A):c.2014C>G (p.Arg672Gly)	SCN4A	R672G	Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1|Hypokalemic periodic paralysis 1	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, single submitter	VCV000005913	17	62036630	17	63959270	5913	20952	rs80338785	NC_000017.11:63959269:G:C
NM_000334.4(SCN4A):c.2015G>A (p.Arg672His)	SCN4A	R672H	Hypokalemic periodic paralysis 1|Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000005912	17	62036629	17	63959269	5912	20951	rs80338788	NC_000017.11:63959268:C:T
NM_000334.4(SCN4A):c.2006G>A (p.Arg669His)	SCN4A	R669H	Hypokalemic periodic paralysis 1|Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000005911	17	62036638	17	63959278	5911	20950	rs80338784	NC_000017.11:63959277:C:T
NM_000334.4(SCN4A):c.1333G>A (p.Val445Met)	SCN4A	V445M	Hypokalemic periodic paralysis, type 2|Hyperkalemic Periodic Paralysis Type 1|Paramyotonia congenita of von Eulenburg|Hypokalemic periodic paralysis 1|Congenital myasthenic syndrome, acetazolamide-responsive|Potassium aggravated myotonia|not provided|Potassium aggravated myotonia|Hyperkalemic Periodic Paralysis Type 1	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005910	17	62041947	17	63964587	5910	20949	rs121908552	NC_000017.11:63964586:C:T
NM_004655.4(AXIN2):c.1966C>T (p.Arg656Ter)	AXIN2	R656*, R591*	Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000005881	17	63532613	17	65536495	5881	20920	rs121908568	NC_000017.11:65536494:G:A
NM_004655.4(AXIN2):c.1994del (p.Gly665fs)	AXIN2	L688*, G665fs, G600fs	Carcinoma of colon|Oligodontia-colorectal cancer syndrome	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000005880	17	63532585	17	65536467	5880	20919	rs267606674	NC_000017.11:65536466:CCCCCCC:CCCCCC
NM_004655.4(AXIN2):c.2116G>T (p.Glu706Ter)	AXIN2	E706*, E641*	Carcinoma of colon	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000005879	17	63532463	17	65536345	5879	20918	rs121908567	NC_000017.11:65536344:C:A
SEPT9, 38-KB DUP	SEPTIN9		Amyotrophy, hereditary neuralgic	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000005866					5866	20905		
NM_001113491.2(SEPTIN9):c.76+12996G>C	SEPTIN9		Amyotrophy, hereditary neuralgic	Pathogenic(Last reviewed: Dec 6, 2012)	no assertion criteria provided	VCV000005865	17	75316275	17	77320193	5865	20904	rs80338760	NC_000017.11:77320192:G:C
NM_001113491.2(SEPTIN9):c.332C>T (p.Ser111Phe)	SEPTIN9	S93F, S111F, S104F, S92F	Amyotrophy, hereditary neuralgic	Pathogenic(Last reviewed: Dec 6, 2012)	no assertion criteria provided	VCV000005864	17	75398396	17	77402314	5864	20903	rs80338762	NC_000017.11:77402313:C:T
NM_001113491.2(SEPTIN9):c.316C>T (p.Arg106Trp)	SEPTIN9	R88W, R106W, R99W, R87W	not provided|Amyotrophy, hereditary neuralgic	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005863	17	75398380	17	77402298	5863	20902	rs80338761	NC_000017.11:77402297:C:T
NM_003835.4(RGS9):c.895T>C (p.Trp299Arg)	RGS9	W299R, W296R	not provided|Leber congenital amaurosis|Bradyopsia	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000005862	17	63193278	17	65197160	5862	20901	rs121908449	NC_000017.11:65197159:T:C
NM_003332.3(TYROBP):c.2T>C (p.Met1Thr)	TYROBP	M1T	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000005797	19	36399129	19	35908227	5797	20836	rs104894732	NC_000019.10:35908226:A:G
TYROBP, 1-BP DEL, 141G	TYROBP		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005796					5796	20835		
TYROBP, EX1-4DEL	TYROBP		Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005795					5795	20834		
NM_014270.5(SLC7A9):c.368C>T (p.Thr123Met)	SLC7A9	T123M	Cystinuria	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000005793	19	33355112	19	32864206	5793	20832	rs79987078	NC_000019.10:32864205:G:A
SLC7A9, 789+2T-C	SLC7A9		Cystinuria	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000005792					5792	20831		
NM_014270.5(SLC7A9):c.695A>G (p.Tyr232Cys)	SLC7A9	Y232C	Cystinuria	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000005791	19	33353033	19	32862127	5791	20830	rs121908487	NC_000019.10:32862126:T:C
SLC7A9, 1-BP INS, 799A	SLC7A9		Cystinuria	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005790					5790	20829		
NM_014270.5(SLC7A9):c.782C>T (p.Pro261Leu)	SLC7A9	P261L	Cystinuria	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005789	19	33350838	19	32859932	5789	20828	rs121908486	NC_000019.10:32859931:G:A
NM_014270.5(SLC7A9):c.131T>C (p.Ile44Thr)	SLC7A9	I44T	Cystinuria	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005788	19	33355639	19	32864733	5788	20827	rs121908485	NC_000019.10:32864732:A:G
SLC7A9, 1-BP INS, 520T	SLC7A9		Cystinuria	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000005786					5786	20825		
SLC7A9, 2-BP DEL, 596TG	SLC7A9		Cystinuria	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000005785					5785	20824		
NM_014270.5(SLC7A9):c.583G>A (p.Gly195Arg)	SLC7A9	G195R	Cystinuria	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000005783	19	33353388	19	32862482	5783	20822	rs121908482	NC_000019.10:32862481:C:T
NM_014270.5(SLC7A9):c.544G>A (p.Ala182Thr)	SLC7A9	A182T	Cystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005782	19	33353427	19	32862521	5782	20821	rs79389353	NC_000019.10:32862520:C:T
NM_014270.5(SLC7A9):c.313G>A (p.Gly105Arg)	SLC7A9	G105R	Cystinuria|not provided	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005781	19	33355167	19	32864261	5781	20820	rs121908480	NC_000019.10:32864260:C:T
NM_014270.5(SLC7A9):c.508G>A (p.Val170Met)	SLC7A9	V170M	Cystinuria	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000005780	19	33353463	19	32862557	5780	20819	rs121908479	NC_000019.10:32862556:C:T
SNAP29, 1-BP DEL, 220G	SNAP29			Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000005741					5741	20780		
CRLF1, 2-BP DEL/1-BP INS, NT708	CRLF1		Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000005712					5712	20751		
NM_004750.5(CRLF1):c.1102A>T (p.Lys368Ter)	CRLF1	K368*	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000005711	19	18705167	19	18594357	5711	20750	rs137853144	NC_000019.10:18594356:T:A
NM_004750.5(CRLF1):c.527+5G>A	CRLF1		Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000005709	19	18709577	19	18598767	5709	20748	rs748847434	NC_000019.10:18598766:C:T
NM_004750.5(CRLF1):c.226T>G (p.Trp76Gly)	CRLF1	W76G	Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000005708	19	18710546	19	18599736	5708	20747	rs137853143	NC_000019.10:18599735:A:C
NM_004750.5(CRLF1):c.676dup (p.Thr226fs)	CRLF1		Cold-induced sweating syndrome 1	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000005707	19	18709262 - 18709263	19	18598452 - 18598453	5707	20746		NC_000019.10:18598452:T:TT
SCO2, 10-BP DUP, NT1302	SCO2		Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000005683					5683	20722		
NM_000154.2(GALK1):c.761del (p.Ser254fs)	GALK1	S254fs	Deficiency of galactokinase	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000005632	17	73758817	17	75762736	5632	20671		NC_000017.11:75762735:C:
NM_000154.2(GALK1):c.1144C>T (p.Gln382Ter)	GALK1	Q382*	Deficiency of galactokinase	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000005631	17	73754172	17	75758091	5631	20670	rs111033608	NC_000017.11:75758090:G:A
NM_000154.2(GALK1):c.82C>A (p.Pro28Thr)	GALK1	P28T	Deficiency of galactokinase	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005630	17	73761136	17	75765055	5630	20669	rs104894572	NC_000017.11:75765054:G:T
NM_000154.2(GALK1):c.238G>T (p.Glu80Ter)	GALK1	E80*	Deficiency of galactokinase	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000005629	17	73760095	17	75764014	5629	20668	rs104894577	NC_000017.11:75764013:C:A
NM_006899.5(IDH3B):c.395T>C (p.Leu132Pro)	IDH3B	L98P, L132P	Retinitis pigmentosa 46	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000005506	20	2641558	20	2660912	5506	20545	rs137853020	NC_000020.11:2660911:A:G
NM_006899.5(IDH3B):c.589del (p.Ile197fs)	IDH3B	I197fs	Retinitis pigmentosa 46	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000005505	20	2641179	20	2660533	5505	20544		NC_000020.11:2660532:T:
NM_006796.2(AFG3L2):c.1295A>C (p.Asn432Thr)	AFG3L2	N432T		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000005474	18	12353027	18	12353028	5474	20513	rs151344512	NC_000018.10:12353027:T:G
NM_006796.2(AFG3L2):c.2081C>A (p.Ala694Glu)	AFG3L2	A694E		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000005472	18	12337434	18	12337435	5472	20511	rs151344521	NC_000018.10:12337434:G:T
NM_006796.2(AFG3L2):c.2021_2022delinsTA (p.Ser674Leu)	AFG3L2			Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000005471	18	12337493 - 12337494	18	12337494 - 12337495	5471	20510	rs151344519	NC_000018.10:12337493:GG:TA
NM_006796.2(AFG3L2):c.2071G>A (p.Glu691Lys)	AFG3L2	E691K		Pathogenic(Last reviewed: May 17, 2011)	no assertion criteria provided	VCV000005470	18	12337444	18	12337445	5470	20509	rs151344520	NC_000018.10:12337444:C:T
NM_004924.6(ACTN4):c.784T>C (p.Ser262Pro)	ACTN4	S235P, S262P	Focal segmental glomerulosclerosis 1	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000005422	19	39200947	19	38710307	5422	20461	rs121908417	NC_000019.10:38710306:T:C
NM_004924.6(ACTN4):c.776C>T (p.Thr259Ile)	ACTN4	T232I, T259I	not provided|Focal segmental glomerulosclerosis 1	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000005421	19	39200939	19	38710299	5421	20460	rs121908416	NC_000019.10:38710298:C:T
NM_004924.6(ACTN4):c.763A>G (p.Lys255Glu)	ACTN4	K228E, K255E	Focal segmental glomerulosclerosis 1	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000005420	19	39200926	19	38710286	5420	20459	rs121908415	NC_000019.10:38710285:A:G
NM_001042545.2(LTBP4):c.4037dup (p.Arg1347fs)	LTBP4		Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000005399	19	41132925 - 41132926	19	40627020 - 40627021	5399	20438	rs606231161	NC_000019.10:40627020:CCCCCC:CCCCCCC
NM_001042545.2(LTBP4):c.730T>G (p.Cys244Gly)	LTBP4	C274G, C244G, C311G	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005398	19	41111674	19	40605768	5398	20437	rs267607229	NC_000019.10:40605767:T:G
NM_001042545.2(LTBP4):c.2481C>A (p.Cys827Ter)	LTBP4	C857*, C827*, C894*	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005397	19	41119359	19	40613453	5397	20436	rs267607228	NC_000019.10:40613452:C:A
NM_001042545.2(LTBP4):c.701del (p.Pro234fs)	LTBP4	P234fs, P301fs, P264fs	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005396	19	41111642	19	40605736	5396	20435	rs606231160	NC_000019.10:40605735:CCCC:CCC
NM_001042545.2(LTBP4):c.3464del (p.Gln1155fs)	LTBP4	Q1185fs, Q1155fs, Q1222fs	Cutis laxa with severe pulmonary, gastrointestinal, and urinary abnormalities	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005395	19	41128552	19	40622647	5395	20434	rs606231159	NC_000019.10:40622646:A:
NM_018848.3(MKKS):c.1496G>C (p.Cys499Ser)	MKKS	C499S	Bardet-biedl syndrome 2/6, digenic	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000005319	20	10386112	20	10405464	5319	20358	rs281797259	NC_000020.11:10405463:C:G
NM_018848.3(MKKS):c.442C>T (p.Gln148Ter)	MKKS	Q147*, Q148*	Bardet-biedl syndrome 2/6, digenic	Pathogenic(Last reviewed: Sep 21, 2001)	no assertion criteria provided	VCV000005318	20	10393721	20	10413073	5318	20357	rs137853154	NC_000020.11:10413072:G:A
NM_018848.3(MKKS):c.169A>G (p.Thr57Ala)	MKKS	T57A	Bardet-Biedl syndrome 6|	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000005316	20	10393994	20	10413346	5316	20355	rs74315399	NC_000020.11:10413345:T:C
MKKS, 2-BP DEL, 429CT AND 2-BP DEL, 433AG	MKKS		Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000005315					5315	20354		
NM_018848.3(MKKS):c.281del (p.Phe94fs)	MKKS	F94fs	Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000005313	20	10393882	20	10413234	5313	20352	rs587777827	NC_000020.11:10413233:AA:A
NM_018848.3(MKKS):c.792T>A (p.Tyr264Ter)	MKKS	Y264*	Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005312	20	10393371	20	10412723	5312	20351	rs74315397	NC_000020.11:10412722:A:T
NM_018848.3(MKKS):c.155G>A (p.Gly52Asp)	MKKS	G52D	Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000005311	20	10394008	20	10413360	5311	20350	rs28937875	NC_000020.11:10413359:C:T
NM_018848.3(MKKS):c.1225_1226del (p.Gly409fs)	MKKS	G409fs		Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000005310	20	10388310 - 10388311	20	10407662 - 10407663	5310	20349		NC_000020.11:10407661:CCC:C
NM_018848.3(MKKS):c.110A>G (p.Tyr37Cys)	MKKS	Y37C	Bardet-biedl syndrome 2/6, digenic||Bardet-Biedl syndrome||Bardet-Biedl syndrome 6|Retinal dystrophy|not provided|Bardet-Biedl syndrome 6|	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005309	20	10394053	20	10413405	5309	20348	rs74315396	NC_000020.11:10413404:T:C
NM_004715.4(CTDP1):c.863+389C>T	CTDP1		Charcot-Marie-Tooth disease|Congenital cataracts-facial dysmorphism-neuropathy syndrome	Pathogenic(Last reviewed: Aug 16, 2012)	no assertion criteria provided	VCV000005301	18	77470825	18	79710825	5301	20340	rs113994102	NC_000018.10:79710824:C:T
NM_015294.6(TRIM37):c.326G>C (p.Cys109Ser)	TRIM37	C109S, C75S	Mulibrey nanism syndrome	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000005245	17	57161406	17	59084045	5245	20284	rs121908391	NC_000017.11:59084044:C:G
TRIM37, 8-BP DEL, NT855	TRIM37		Mulibrey nanism syndrome	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000005244					5244	20283		
TRIM37, 1-BP INS, 1346A	TRIM37		Mulibrey nanism syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005243					5243	20282		
TRIM37, 5-BP DEL, NT838	TRIM37		Mulibrey nanism syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005242					5242	20281		
TRIM37, 1-BP DEL, 2212G	TRIM37		Mulibrey nanism syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005241					5241	20280		
TRIM37, 5-BP DEL, NT493	TRIM37		Mulibrey nanism syndrome	Pathogenic(Last reviewed: Jul 1, 2000)	no assertion criteria provided	VCV000005240					5240	20279		
NM_021102.4(SPINT2):c.1A>T (p.Met1Leu)	SPINT2	M1L	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005208	19	38755533	19	38264893	5208	20247	rs121908404	NC_000019.10:38264892:A:T
NM_021102.4(SPINT2):c.553+2T>A	SPINT2		Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005207	19	38780922	19	38290282	5207	20246	rs112576957	NC_000019.10:38290281:T:A
NM_021102.4(SPINT2):c.337+2T>C	SPINT2		Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005206	19	38778577	19	38287937	5206	20245	rs606231155	NC_000019.10:38287936:T:C
NM_021102.4(SPINT2):c.488A>G (p.Tyr163Cys)	SPINT2	Y163C, Y106C	Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000005205	19	38780855	19	38290215	5205	20244	rs121908403	NC_000019.10:38290214:A:G
NM_021102.4(SPINT2):c.593-1G>A	SPINT2		Diarrhea 3, secretory sodium, congenital, syndromic	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000005204	19	38782479	19	38291839	5204	20243	rs606231154	NC_000019.10:38291838:G:A
MCOLN1, 1704A-T	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000005139					5139	20178		
MCOLN1, 93-BP INS, NT236	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000005138					5138	20177		
NM_020533.3(MCOLN1):c.1207C>T (p.Arg403Cys)	MCOLN1	R403C	Mucolipidosis type IV	Pathogenic(Last reviewed: Jul 30, 2015)	no assertion criteria provided	VCV000005137	19	7594059	19	7529173	5137	20176	rs121908374	NC_000019.10:7529172:C:T
NM_020533.3(MCOLN1):c.304C>T (p.Arg102Ter)	MCOLN1	R102*	Mucolipidosis type IV|not provided	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005136	19	7591391	19	7526505	5136	20175	rs121908373	NC_000019.10:7526504:C:T
NM_020533.3(MCOLN1):c.1084G>T (p.Asp362Tyr)	MCOLN1	D362Y	not provided|Mucolipidosis type IV	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005135	19	7593806	19	7528920	5135	20174	rs121908372	NC_000019.10:7528919:G:T
MCOLN1, 3-BP DEL, 1346CTT	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Oct 12, 2000)	no assertion criteria provided	VCV000005134					5134	20173		
NM_020533.3(MCOLN1):c.964C>T (p.Arg322Ter)	MCOLN1	R321*, R322*	not provided|Mucolipidosis type IV	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005133	19	7593569	19	7528683	5133	20172	rs121908371	NC_000019.10:7528682:C:T
NG_015806.1:g.4127_10560del6434	MCOLN1		Mucolipidosis type IV	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005132	19	7586622 - 7593055	19	7521736 - 7528169	5132	20171		
NM_020533.3(MCOLN1):c.406-2A>G	MCOLN1		Mucolipidosis type IV|not provided|Mucolipidosis	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005131	19	7591645	19	7526759	5131	20170	rs104886461	NC_000019.10:7526758:A:G
NM_000199.5(SGSH):c.1105G>A (p.Glu369Lys)	SGSH	E369K	Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005117	17	78184655	17	80210856	5117	20156	rs104894640	NC_000017.11:80210855:C:T
SGSH, 11-BP DEL, NT1284	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000005116					5116	20155		
SGSH, 9-BP DEL, NT1307	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000005115					5115	20154		
NM_000199.5(SGSH):c.1339G>A (p.Glu447Lys)	SGSH	E447K	not provided|Mucopolysaccharidosis, MPS-III-A|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005114	17	78184421	17	80210622	5114	20153	rs104894639	NC_000017.11:80210621:C:T
NM_000199.5(SGSH):c.449G>A (p.Arg150Gln)	SGSH	R150Q	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005113	17	78188471	17	80214672	5113	20152	rs104894638	NC_000017.11:80214671:C:T
SGSH, 1-BP DEL, 1091C	SGSH		Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000005112					5112	20151		
NM_000199.5(SGSH):c.197C>G (p.Ser66Trp)	SGSH	S66W	Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-A|Sanfilippo syndrome	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005111	17	78190883	17	80217084	5111	20150	rs104894637	NC_000017.11:80217083:G:C
NM_000199.5(SGSH):c.383C>T (p.Pro128Leu)	SGSH	P128L	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005110	17	78188537	17	80214738	5110	20149	rs104894642	NC_000017.11:80214737:G:A
NM_000199.5(SGSH):c.1298G>A (p.Arg433Gln)	SGSH	R433Q	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005109	17	78184462	17	80210663	5109	20148	rs104894641	NC_000017.11:80210662:C:T
NM_000199.5(SGSH):c.220C>T (p.Arg74Cys)	SGSH	R74C	Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-A|Abnormality of carbohydrate metabolism/homeostasis	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005108	17	78190860	17	80217061	5108	20147	rs104894636	NC_000017.11:80217060:G:A
NM_000199.5(SGSH):c.734G>A (p.Arg245His)	SGSH	R245H	Sanfilippo syndrome|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-A|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005107	17	78187614	17	80213815	5107	20146	rs104894635	NC_000017.11:80213814:C:T
ARFGEF2, PRO81GLN, VAL83LEU, 249delA	ARFGEF2		Heterotopia, periventricular, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000005051					5051	20090		
NM_023036.6(DNAI2):c.787C>T (p.Arg263Ter)	DNAI2	R263*	Ciliary dyskinesia, primary, 9|Primary ciliary dyskinesia	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000004955	17	72295919	17	74299780	4955	19994	rs137852998	NC_000017.11:74299779:C:T
NM_023036.6(DNAI2):c.346-3T>G	DNAI2		Kartagener syndrome|Ciliary dyskinesia, primary, 9	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000004954	17	72283113	17	74286974	4954	19993	rs397515358	NC_000017.11:74286973:T:G
NM_023036.6(DNAI2):c.1494+1G>A	DNAI2		Ciliary dyskinesia, primary, 9	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000004953	17	72306303	17	74310164	4953	19992		NC_000017.11:74310163:G:A
NM_024022.3(TMPRSS3):c.647G>T (p.Arg216Leu)	TMPRSS3	R216L, R89L	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000004946	21	43803277	21	42383168	4946	19985	rs137853000	NC_000021.9:42383167:C:A
NM_024022.3(TMPRSS3):c.1211C>T (p.Pro404Leu)	TMPRSS3	P404L, P403L, P277L	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000004945	21	43795961	21	42375852	4945	19984	rs28939084	NC_000021.9:42375851:G:A
NM_024022.3(TMPRSS3):c.753G>C (p.Trp251Cys)	TMPRSS3	W251C, W124C	Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004944	21	43803171	21	42383062	4944	19983	rs137852999	NC_000021.9:42383061:C:G
TMPRSS3, IVS4AS, G-A, -6	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004943					4943	19982		
TMPRSS3, 8-BP DEL, SATELLITE REPEAT INS	TMPRSS3		Deafness, autosomal recessive 8	Pathogenic(Last reviewed: Jan 1, 2001)	no assertion criteria provided	VCV000004942					4942	19981		
NM_014646.2(LPIN2):c.540_541del (p.Thr180_Cys181insTer)	LPIN2		Majeed syndrome	Pathogenic(Last reviewed: Sep 23, 2008)	no assertion criteria provided	VCV000004909	18	2951102 - 2951103	18	2951104 - 2951105	4909	19948	rs80338806	NC_000018.10:2951103:AT:
NM_014646.2(LPIN2):c.2201C>T (p.Ser734Leu)	LPIN2	S734L	not provided|Majeed syndrome	Pathogenic(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	VCV000004908	18	2922171	18	2922173	4908	19947	rs80338807	NC_000018.10:2922172:G:A
NM_001146079.2(CLDN14):c.254T>A (p.Val85Asp)	CLDN14	V85D	Deafness, autosomal recessive 29|Hearing impairment	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000004851	21	37833740	21	36461442	4851	19890	rs74315437	NC_000021.9:36461441:A:T
NM_001146079.2(CLDN14):c.398del (p.Met133fs)	CLDN14	M133fs	Deafness, autosomal recessive 29	Pathogenic(Last reviewed: Jan 12, 2001)	no assertion criteria provided	VCV000004850	21	37833596	21	36461298	4850	19889	rs786200885	NC_000021.9:36461297:A:
NM_007254.4(PNKP):c.526C>T (p.Leu176Phe)	PNKP	L176F	Early infantile epileptic encephalopathy 10	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000004848	19	50367633	19	49864376	4848	19887	rs267606957	NC_000019.10:49864375:G:A
NM_007254.4(PNKP):c.1253_1269dup (p.Thr424fs)	PNKP		not provided|Early infantile epileptic encephalopathy 10|Ataxia-oculomotor apraxia 4|Early infantile epileptic encephalopathy 12	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004847	19	50365057 - 50365058	19	49861800 - 49861801	4847	19886	rs587784365	NC_000019.10:49861800:GTTGTCGATGGCGACCCGTT:GTTGTCGATGGCGACCCGTTGTCGATGGCGACCCGTT
NM_007254.4(PNKP):c.976G>A (p.Glu326Lys)	PNKP	E326K	not provided|Early infantile epileptic encephalopathy 10	Pathogenic(Last reviewed: Apr 2, 2015)	criteria provided, single submitter	VCV000004846	19	50365681	19	49862424	4846	19885	rs267606956	NC_000019.10:49862423:C:T
NM_012179.4(FBXO7):c.65C>T (p.Thr22Met)	FBXO7	T22M	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004811	22	32871054	22	32475067	4811	19850	rs121918305	NC_000022.11:32475066:C:T
NM_012179.4(FBXO7):c.1144+1G>T	FBXO7		Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000004810	22	32889269	22	32493282	4810	19849	rs730880272	NC_000022.11:32493281:G:T
NM_012179.4(FBXO7):c.1492C>T (p.Arg498Ter)	FBXO7	R498*, R419*, R384*	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004809	22	32894440	22	32498453	4809	19848	rs121918304	NC_000022.11:32498452:C:T
NM_012179.4(FBXO7):c.1132C>G (p.Arg378Gly)	FBXO7	R378G, R264G, R299G	Parkinson disease 15	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000004808	22	32889256	22	32493269	4808	19847	rs71799110	NC_000022.11:32493268:C:G
NM_004738.4(VAPB):c.166C>T (p.Pro56Ser)	VAPB	P56S	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis, typical|Amyotrophic lateral sclerosis type 8|Spinal muscular atrophy, late-onset, finkel type|not provided|Amyotrophic lateral sclerosis type 8	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004806	20	56993374	20	58418318	4806	19845	rs74315431	NC_000020.11:58418317:C:T
NM_020956.2(PRX):c.*3413C>T	PRX	R1070*	Charcot-Marie-Tooth disease, demyelinating, type 4F|Dejerine-Sottas disease|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004794	19	40901051	19	40395144	4794	19833	rs104894708	NC_000019.10:40395143:G:A
PRX, 1-BP DEL, 247C	PRX		Autosomal recessive Dejerine-Sottas syndrome	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000004793					4793	19832		
NM_020956.2(PRX):c.*2350T>A	PRX	C715*	Charcot-Marie-Tooth disease, demyelinating, type 4F|not provided|Charcot-Marie-Tooth disease type 4	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004792	19	40902114	19	40396207	4792	19831	rs104894707	NC_000019.10:40396206:A:T
PRX, 1-BP DEL, 2289T	PRX		Autosomal recessive Dejerine-Sottas syndrome	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000004790					4790	19829		
NM_020956.2(PRX):c.*1307C>T	PRX	R368*	not provided|Charcot-Marie-Tooth disease type 4|Autosomal recessive Dejerine-Sottas syndrome	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004789	19	40903157	19	40397250	4789	19828	rs104894715	NC_000019.10:40397249:G:A
PRX, 1-BP DEL, 2787C	PRX		Autosomal recessive Dejerine-Sottas syndrome	Pathogenic(Last reviewed: Feb 1, 2001)	no assertion criteria provided	VCV000004788					4788	19827		
NM_181882.3(PRX):c.2857C>T (p.Arg953Ter)	PRX	R953*	not provided|Charcot-Marie-Tooth disease, demyelinating, type 4F|Charcot-Marie-Tooth disease type 4|Autosomal recessive Dejerine-Sottas syndrome	Pathogenic(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004787	19	40901402	19	40395495	4787	19826	rs104894714	NC_000019.10:40395494:G:A
NM_018943.3(TUBA8):c.4-21_4-8del	TUBA8		Polymicrogyria with optic nerve hypoplasia	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000004782	22	18604222 - 18604235	22	18121455 - 18121468	4782	19821	rs878853254	NC_000022.11:18121454:CTCGTTGCTTCCCTCTC:CTC
MLC1, 17-BP DEL, G INS	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004723					4723	19762		
NM_015166.3(MLC1):c.135dup (p.Cys46fs)	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004722	22	50523196 - 50523197	22	50084767 - 50084768	4722	19761	rs80358241	NC_000022.11:50084767:GGGGGG:GGGGGGG
NM_015166.3(MLC1):c.176G>A (p.Gly59Glu)	MLC1	G59E	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004721	22	50523156	22	50084727	4721	19760	rs80358242	NC_000022.11:50084726:C:T
NM_015166.3(MLC1):c.594_597del (p.Ser197_Tyr198insTer)	MLC1	Y198*	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004720	22	50515270 - 50515273	22	50076841 - 50076844	4720	19759	rs267607236	NC_000022.11:50076840:TGAGT:T
NM_015166.3(MLC1):c.422A>G (p.Asn141Ser)	MLC1	N141S	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004718	22	50518348	22	50079919	4718	19757	rs121908344	NC_000022.11:50079918:T:C
NM_015166.3(MLC1):c.423C>A (p.Asn141Lys)	MLC1	N141K	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004717	22	50518347	22	50079918	4717	19756	rs121908343	NC_000022.11:50079917:G:T
NM_015166.3(MLC1):c.895-2A>G	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004716	22	50502629	22	50064200	4716	19755		NC_000022.11:50064199:T:C
MLC1, 7-BP DEL, NT564	MLC1		Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004715					4715	19754		
NM_006031.6(PCNT):c.8752C>T (p.Arg2918Ter)	PCNT	R2918*, R2721*		Pathogenic(Last reviewed: Feb 8, 2008)	no assertion criteria provided	VCV000004710	21	47855817	21	46435904	4710	19749	rs119479064	NC_000021.9:46435903:C:T
PCNT, 486-BP DEL, NT84	PCNT			Pathogenic(Last reviewed: Feb 8, 2008)	no assertion criteria provided	VCV000004709					4709	19748		
NM_006031.6(PCNT):c.3109G>T (p.Glu1037Ter)	PCNT	E1037*, E919*	|not provided	Pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000004708	21	47786998	21	46367083	4708	19747	rs119479063	NC_000021.9:46367082:G:T
NM_006031.6(PCNT):c.844dup (p.Glu282fs)	PCNT			Pathogenic(Last reviewed: Feb 8, 2008)	no assertion criteria provided	VCV000004707	21	47766777 - 47766778	21	46346863 - 46346864	4707	19746		NC_000021.9:46346863:GGG:GGGG
NM_006031.6(PCNT):c.5767C>T (p.Arg1923Ter)	PCNT	R1923*, R1805*		Pathogenic(Last reviewed: Mar 5, 2013)	criteria provided, single submitter	VCV000004706	21	47831754	21	46411840	4706	19745	rs119479062	NC_000021.9:46411839:C:T
NM_006031.6(PCNT):c.3568dup (p.Cys1190fs)	PCNT			Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000004705	21	47808759 - 47808760	21	46388844 - 46388845	4705	19744	rs397514033	NC_000021.9:46388844:T:TT
NM_006031.6(PCNT):c.1887del (p.Ala630fs)	PCNT	A512fs, A630fs		Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000004704	21	47775492	21	46355577	4704	19743	rs397509366	NC_000021.9:46355576:A:
NM_006031.6(PCNT):c.658G>T (p.Glu220Ter)	PCNT	E220*, E102*		Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000004703	21	47766060	21	46346146	4703	19742	rs119479061	NC_000021.9:46346145:G:T
NM_006397.2(RNASEH2A):c.109G>A (p.Gly37Ser)	RNASEH2A	G37S	Aicardi Goutieres syndrome 4	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000004641	19	12917596	19	12806782	4641	19680	rs76857106	NC_000019.10:12806781:G:A
NM_012398.3(PIP5K1C):c.757G>A (p.Asp253Asn)	PIP5K1C	D253N	Lethal congenital contractural syndrome 3	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000004615	19	3653452	19	3653454	4615	19654	rs121908315	NC_000019.10:3653453:C:T
NM_030777.4(SLC2A10):c.1276G>T (p.Gly426Trp)	SLC2A10	G426W	not provided|Arterial tortuosity syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000004589	20	45354951	20	46726312	4589	19628	rs121908172	NC_000020.11:46726311:G:T
NM_030777.4(SLC2A10):c.243C>G (p.Ser81Arg)	SLC2A10	S81R	not provided|Arterial tortuosity syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004588	20	45353918	20	46725279	4588	19627	rs80358230	NC_000020.11:46725278:C:G
NM_030777.4(SLC2A10):c.1334del (p.Gly445fs)	SLC2A10	G445fs	not provided|Arterial tortuosity syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004587	20	45355547	20	46726908	4587	19626	rs587776600	NC_000020.11:46726907:GG:G
NM_030777.4(SLC2A10):c.961del (p.Val321fs)	SLC2A10	V321fs	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000004586	20	45354636	20	46725997	4586	19625	rs587776599	NC_000020.11:46725996:G:
NM_030777.4(SLC2A10):c.510G>A (p.Trp170Ter)	SLC2A10	W170*	Arterial tortuosity syndrome	Pathogenic(Last reviewed: Sep 10, 2014)	no assertion criteria provided	VCV000004585	20	45354185	20	46725546	4585	19624	rs80358229	NC_000020.11:46725545:G:A
NM_153638.3(PANK2):c.533C>A (p.Ser178Ter)	PANK2	S68*, S178*	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000004561	20	3870280	20	3889633	4561	19600	rs137852969	NC_000020.11:3889632:C:A
NM_153638.3(PANK2):c.1442_1444del (p.Arg481_Glu482delinsGln)	PANK2		Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000004560	20	3897603 - 3897605	20	3916956 - 3916958	4560	19599	rs766251466	NC_000020.11:3916955:GAG:
NM_153638.3(PANK2):c.1413-1G>T	PANK2		Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Nov 25, 2003)	no assertion criteria provided	VCV000004559	20	3897573	20	3916926	4559	19598	rs148987163	NC_000020.11:3916925:G:T
NM_153638.3(PANK2):c.1310T>C (p.Met437Thr)	PANK2	M327T, M146T, M437T, M1T	Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration	Pathogenic(Last reviewed: Nov 25, 2003)	no assertion criteria provided	VCV000004558	20	3893179	20	3912532	4558	19597	rs28939088	NC_000020.11:3912531:T:C
NM_153638.3(PANK2):c.1441C>T (p.Arg481Ter)	PANK2	R371*, R190*, R481*, R45*	Dystonia|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000004557	20	3897602	20	3916955	4557	19596	rs137852968	NC_000020.11:3916954:C:T
NM_153638.3(PANK2):c.1583C>T (p.Thr528Met)	PANK2	T418M, T237M, T528M, T92M	Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Neurodegeneration with brain iron accumulation 1, atypical|Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000004556	20	3899364	20	3918717	4556	19595	rs137852967	NC_000020.11:3918716:C:T
NM_153638.3(PANK2):c.832C>T (p.Arg278Cys)	PANK2	R168C, R278C	Neurodegeneration with brain iron accumulation 1, atypical	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004555	20	3888776	20	3908129	4555	19594	rs137852966	NC_000020.11:3908128:C:T
NM_153638.3(PANK2):c.700A>G (p.Thr234Ala)	PANK2	T124A, T234A	Neurodegeneration with brain iron accumulation 1, atypical	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004554	20	3888644	20	3907997	4554	19593	rs137852965	NC_000020.11:3907996:A:G
NM_153638.3(PANK2):c.1051T>C (p.Ser351Pro)	PANK2	S240P, S351P, S60P	Neurodegeneration with brain iron accumulation 1, atypical	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004553	20	3891293	20	3910646	4553	19592	rs137852964	NC_000020.11:3910645:T:C
NM_153638.3(PANK2):c.1412G>A (p.Ser471Asn)	PANK2	S361N, S180N, S471N, S35N	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004552	20	3893281	20	3912634	4552	19591	rs137852963	NC_000020.11:3912633:G:A
NM_153638.3(PANK2):c.856C>T (p.Arg286Cys)	PANK2	R176C, R286C	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004551	20	3888800	20	3908153	4551	19590	rs137852962	NC_000020.11:3908152:C:T
NM_153638.3(PANK2):c.790C>T (p.Arg264Trp)	PANK2	R154W, R264W	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004550	20	3888734	20	3908087	4550	19589	rs137852961	NC_000020.11:3908086:C:T
NM_153638.3(PANK2):c.570C>G (p.Tyr190Ter)	PANK2	Y80*, Y190*	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000004549	20	3870317	20	3889670	4549	19588	rs137852960	NC_000020.11:3889669:C:G
NM_153638.3(PANK2):c.1561G>A (p.Gly521Arg)	PANK2	G411R, G230R, G521R, G85R	not provided|Inborn genetic diseases|Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration|Neurodegeneration with brain iron accumulation 1, atypical|Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004548	20	3899342	20	3918695	4548	19587	rs137852959	NC_000020.11:3918694:G:A
NM_153638.3(PANK2):c.930_936del (p.Phe311fs)	PANK2	F20fs, F311fs	Pigmentary pallidal degeneration	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004547	20	3888871 - 3888877	20	3908224 - 3908230	4547	19586	rs879253712	NC_000020.11:3908223:TGTCTTTTGT:TGT
TNFRSF13C, 24-BP DEL, NT89	TNFRSF13C		Common variable immunodeficiency 4	Pathogenic(Last reviewed: Aug 18, 2009)	no assertion criteria provided	VCV000004459					4459	19498		
NM_031483.7(ITCH):c.394dup (p.Ile132fs)	ITCH		Autoimmune disease, syndromic multisystem	Pathogenic(Last reviewed: Mar 12, 2010)	no assertion criteria provided	VCV000004391	20	33001602 - 33001603	20	34413796 - 34413797	4391	19430	rs587776592	NC_000020.11:34413796:AA:AAA
NM_015629.4(PRPF31):c.1374+654C>G	PRPF31		Retinitis pigmentosa 11	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004366	19	54633399	19	54130024	4366	19405	rs587776591	NC_000019.10:54130023:C:G
NM_015629.4(PRPF31):c.332_343del (p.His111_Ile114del)	PRPF31		Retinitis pigmentosa 11	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004365	19	54625879 - 54625890	19	54122500 - 54122511	4365	19404		NC_000019.10:54122499:TCATCCATAAGTTCATCC:TCATCC
NM_015629.4(PRPF31):c.770dup (p.Thr258fs)	PRPF31		Retinitis pigmentosa 11	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004364	19	54627948 - 54627949	19	54124569 - 54124570	4364	19403		NC_000019.10:54124569:AA:AAA
PRPF31, 33-BP INS, NT580	PRPF31		Retinitis pigmentosa 11	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004363					4363	19402		
NM_015629.4(PRPF31):c.581C>A (p.Ala194Glu)	PRPF31	A194E	Retinitis pigmentosa 11	Pathogenic(Last reviewed: Apr 6, 2007)	no assertion criteria provided	VCV000004362	19	54627181	19	54123802	4362	19401	rs119475043	NC_000019.10:54123801:C:A
PRPF31, IVS6AS, 42-BP DEL, -3	PRPF31		Retinitis pigmentosa 11	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004361					4361	19400		
NM_015629.4(PRPF31):c.527+3A>G	PRPF31		Retinitis pigmentosa 11|Retinal dystrophy	Pathogenic(Last reviewed: Jan 13, 2019)	criteria provided, single submitter	VCV000004360	19	54626942	19	54123563	4360	19399	rs587776590	NC_000019.10:54123562:A:G
NM_015629.4(PRPF31):c.646G>C (p.Ala216Pro)	PRPF31	A216P	Retinitis pigmentosa 11	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000004359	19	54627246	19	54123867	4359	19398	rs119475042	NC_000019.10:54123866:G:C
NM_015629.4(PRPF31):c.1115_1125del (p.Arg372fs)	PRPF31	R372fs	Retinitis pigmentosa 11	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000004358	19	54631719 - 54631729	19	54128344 - 54128354	4358	19397	rs587776589	NC_000019.10:54128343:CCGGAAGCAGGCC:CC
HAMP, +14G-A, 5-PRIME UTR	HAMP		Hemochromatosis type 2B	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000004287					4287	19326		
HAMP, 4-BP DEL, ATGG	HAMP		Hemochromatosis, juvenile, digenic	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000004285					4285	19324		
NM_021175.4(HAMP):c.166C>T (p.Arg56Ter)	HAMP	R56*	Hemochromatosis type 2B	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004284	19	35775856	19	35284953	4284	19323	rs104894695	NC_000019.10:35284952:C:T
NM_021175.4(HAMP):c.95del (p.Gly32fs)	HAMP	G32fs	Hemochromatosis type 2B	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000004283	19	35775694	19	35284791	4283	19322		NC_000019.10:35284790:GGG:GG
NM_001126121.2(SLC25A19):c.530G>C (p.Gly177Ala)	SLC25A19	G177A	Amish lethal microcephaly	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000004269	17	73274346	17	75278265	4269	19308	rs119473030	NC_000017.11:75278264:C:G
NM_001080467.3(MYO5B):c.1979C>T (p.Pro660Leu)	MYO5B	P660L	Congenital microvillous atrophy	Pathogenic(Last reviewed: Dec 15, 2008)	no assertion criteria provided	VCV000004252	18	47462646	18	49936276	4252	19291	rs121908106	NC_000018.10:49936275:G:A
NM_001080467.3(MYO5B):c.1966C>T (p.Arg656Cys)	MYO5B	R656C	Congenital microvillous atrophy	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004251	18	47462659	18	49936289	4251	19290	rs121908105	NC_000018.10:49936288:G:A
NM_001080467.3(MYO5B):c.1125G>A (p.Trp375Ter)	MYO5B	W375*	Congenital microvillous atrophy	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004250	18	47500917	18	49974547	4250	19289	rs121908104	NC_000018.10:49974546:C:T
NM_001080467.3(MYO5B):c.323T>G (p.Val108Gly)	MYO5B	V108G	Congenital microvillous atrophy	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004249	18	47563352	18	50036982	4249	19288	rs121908103	NC_000018.10:50036981:A:C
NM_001080467.3(MYO5B):c.1323-2A>G	MYO5B		Congenital microvillous atrophy	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004248	18	47489402	18	49963032	4248	19287	rs1568049625	NC_000018.10:49963031:T:C
MYO5B, 9-BP INS, NT1362	MYO5B		Congenital microvillous atrophy	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000004247					4247	19286		
NM_025136.4(OPA3):c.322_339del (p.Gln108_Glu113del)	OPA3		3-Methylglutaconic aciduria type 3	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	VCV000004242	19	46056973 - 46056990	19	45553715 - 45553732	4242	19281	rs80356526	NC_000019.10:45553714:CTCCTCCTTGTGGCGCTGCT:CT
NM_025136.4(OPA3):c.313C>G (p.Gln105Glu)	OPA3	Q105E	3-Methylglutaconic aciduria type 3|Optic atrophy and cataract, autosomal dominant|Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000004241	19	46056999	19	45553741	4241	19280	rs80356525	NC_000019.10:45553740:G:C
NM_025136.4(OPA3):c.277G>A (p.Gly93Ser)	OPA3	G93S	Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	VCV000004240	19	46057035	19	45553777	4240	19279	rs80356524	NC_000019.10:45553776:C:T
NM_025136.4(OPA3):c.143-1G>C	OPA3		3-Methylglutaconic aciduria type 3|Optic atrophy and cataract, autosomal dominant|3-Methylglutaconic aciduria type 3	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004239	19	46057170	19	45553912	4239	19278	rs80356523	NC_000019.10:45553911:C:G
NM_024301.5(FKRP):c.1387A>G (p.Asn463Asp)	FKRP	N463D	Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B5|Muscular dystrophy|not provided|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004235	19	47260094	19	46756837	4235	19274	rs121908110	NC_000019.10:46756836:A:G
NM_024301.5(FKRP):c.953G>A (p.Cys318Tyr)	FKRP	C318Y	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000004234	19	47259660	19	46756403	4234	19273	rs104894684	NC_000019.10:46756402:G:A
NM_024301.5(FKRP):c.919T>A (p.Tyr307Asn)	FKRP	Y307N	FKRP-Related Disorder|not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004233	19	47259626	19	46756369	4233	19272	rs104894692	NC_000019.10:46756368:T:A
NM_024301.5(FKRP):c.899T>C (p.Val300Ala)	FKRP	V300A	not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004232	19	47259606	19	46756349	4232	19271	rs104894691	NC_000019.10:46756348:T:C
NM_024301.5(FKRP):c.764G>A (p.Trp255Ter)	FKRP	W255*	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000004230	19	47259471	19	46756214	4230	19269	rs104894689	NC_000019.10:46756213:G:A
NM_024301.5(FKRP):c.1213G>T (p.Val405Leu)	FKRP	V405L	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B5	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000004227	19	47259920	19	46756663	4227	19266	rs28937904	NC_000019.10:46756662:G:T
NM_024301.5(FKRP):c.1364C>A (p.Ala455Asp)	FKRP	A455D	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B5|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004226	19	47260071	19	46756814	4226	19265	rs28937903	NC_000019.10:46756813:C:A
NM_024301.5(FKRP):c.663C>A (p.Ser221Arg)	FKRP	S221R	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B5	Pathogenic(Last reviewed: Mar 25, 2003)	no assertion criteria provided	VCV000004225	19	47259370	19	46756113	4225	19264	rs28937902	NC_000019.10:46756112:C:A
NM_024301.5(FKRP):c.1486T>A (p.Ter496Arg)	FKRP	*496R	Muscular dystrophy-dystroglycanopathy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000004223	19	47260193	19	46756936	4223	19262	rs104894682	NC_000019.10:46756935:T:A
NM_024301.5(FKRP):c.387_390dup (p.Asp131delinsThrTer)	FKRP		Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004222	19	47259092 - 47259093	19	46755835 - 46755836	4222	19261	rs587777823	NC_000019.10:46755835:TACCT:TACCTACCT
NM_024301.5(FKRP):c.826C>A (p.Leu276Ile)	FKRP	L276I	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Limb-girdle muscular dystrophy|Muscular dystrophy-dystroglycanopathy|Muscle weakness|Difficulty walking|Scapular winging|Paresthesia|Gait imbalance|Headache|Difficulty standing|Difficulty climbing stairs|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004221	19	47259533	19	46756276	4221	19260	rs28937900	NC_000019.10:46756275:C:A
NM_024301.5(FKRP):c.1343C>T (p.Pro448Leu)	FKRP	P448L	Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004220	19	47260050	19	46756793	4220	19259	rs104894681	NC_000019.10:46756792:C:T
NM_024301.5(FKRP):c.1154C>A (p.Ser385Ter)	FKRP	S385*	Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B5|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, single submitter	VCV000004219	19	47259861	19	46756604	4219	19258	rs104894680	NC_000019.10:46756603:C:A
NM_024301.5(FKRP):c.926A>G (p.Tyr309Cys)	FKRP	Y309C	Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B5	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004218	19	47259633	19	46756376	4218	19257	rs104894679	NC_000019.10:46756375:A:G
NM_002772.3(TMPRSS15):c.2707_2708del (p.Val903fs)	TMPRSS15	V903fs	Enterokinase deficiency	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004167	21	19651337 - 19651338	21	18279020 - 18279021	4167	19206		NC_000021.9:18279019:AC:
NM_002772.3(TMPRSS15):c.781C>T (p.Gln261Ter)	TMPRSS15	Q261*	Enterokinase deficiency	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004166	21	19732173	21	18359856	4166	19205	rs121908060	NC_000021.9:18359855:G:A
NM_002772.3(TMPRSS15):c.2569C>T (p.Arg857Ter)	TMPRSS15	R857*	Enterokinase deficiency	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000004165	21	19653456	21	18281139	4165	19204	rs121908059	NC_000021.9:18281138:G:A
NM_002772.3(TMPRSS15):c.2135C>G (p.Ser712Ter)	TMPRSS15	S712*	Enterokinase deficiency|not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000004164	21	19685292	21	18312975	4164	19203	rs77200626	NC_000021.9:18312974:G:C
NM_016327.3(UPB1):c.917-2A>G	UPB1		Deficiency of beta-ureidopropionase	Pathogenic(Last reviewed: Nov 15, 2004)	no assertion criteria provided	VCV000004148	22	24919585	22	24523617	4148	19187	rs876657373	NC_000022.11:24523616:A:G
NM_016327.3(UPB1):c.105-2A>G	UPB1		Deficiency of beta-ureidopropionase	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004147	22	24896073	22	24500105	4147	19186	rs138081800	NC_000022.11:24500104:A:G
HPS4, 1-BP DEL, C, CODON 685	HPS4		Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000004133					4133	19172		
NM_152841.2(HPS4):c.649G>T (p.Glu217Ter)	HPS4	E222*, E217*	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004132	22	26864522	22	26468556	4132	19171	rs119471025	NC_000022.11:26468555:C:A
NM_152841.2(HPS4):c.397G>T (p.Glu133Ter)	HPS4	E138*, E133*	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004131	22	26868357	22	26472391	4131	19170	rs119471024	NC_000022.11:26472390:C:A
NM_152841.2(HPS4):c.634C>T (p.Arg212Ter)	HPS4	R217*, R212*	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004130	22	26864537	22	26468571	4130	19169	rs119471023	NC_000022.11:26468570:G:A
NM_152841.2(HPS4):c.934_957dup (p.Ala312_Glu319dup)	HPS4		Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004129	22	26860623 - 26860624	22	26464657 - 26464658	4129	19168	rs281865164	NC_000022.11:26464657:CTCCTTCCTGCCATCTGGACAAGC:CTCCTTCCTGCCATCTGGACAAGCCTCCTTCCTGCCATCTGGACAAGC
NM_152841.2(HPS4):c.526C>T (p.Gln176Ter)	HPS4	Q181*, Q176*	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004128	22	26866740	22	26470774	4128	19167	rs119471022	NC_000022.11:26470773:G:A
NM_152841.2(HPS4):c.42del (p.Leu15fs)	HPS4	L15fs, L20fs	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004127	22	26875306	22	26479340	4127	19166	rs281865097	NC_000022.11:26479339:AAAAAAA:AAAAAA
NM_152841.2(HPS4):c.2069_2073AAGCA[3] (p.Lys694fs)	HPS4		Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004126	22	26849232 - 26849233	22	26453266 - 26453267	4126	19165	rs281865100	NC_000022.11:26453266:TGCTTTGCTTTGC:TGCTTTGCTTTGCTTTGC
NM_152841.2(HPS4):c.1876C>T (p.Gln626Ter)	HPS4	Q631*, Q626*, Q649*	Hermansky-Pudlak syndrome 4	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000004125	22	26853889	22	26457923	4125	19164	rs119471021	NC_000022.11:26457922:G:A
GAA, IVS1AS, G-C, -1	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000004037					4037	19076		
NM_000152.5(GAA):c.877G>A (p.Gly293Arg)	GAA	G293R	Glycogen storage disease, type II|Glycogen storage disease II, adult form|not provided	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004036	17	78081617	17	80107818	4036	19075	rs121907945	NC_000017.11:80107817:G:A
NM_000152.5(GAA):c.2560C>T (p.Arg854Ter)	GAA	R854*	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004034	17	78092070	17	80118271	4034	19073	rs121907943	NC_000017.11:80118270:C:T
NM_000152.5(GAA):c.525del (p.Glu176fs)	GAA	E176fs	Glycogen storage disease, type II|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004033	17	78078910	17	80105111	4033	19072	rs386834235	NC_000017.11:80105110:T:
NM_000152.5(GAA):c.1634C>T (p.Pro545Leu)	GAA	P545L	Glycogen storage disease II, adult form	Pathogenic(Last reviewed: Dec 1, 1994)	no assertion criteria provided	VCV000004032	17	78084822	17	80111023	4032	19071	rs121907942	NC_000017.11:80111022:C:T
NM_000152.5(GAA):c.2483_2646+1del	GAA		Glycogen storage disease, type II	Pathogenic(Last reviewed: May 9, 2013)	no assertion criteria provided	VCV000004031	17	78091992 - 78092156	17	80118193 - 80118357	4031	19070	rs1555603048	
NM_000152.5(GAA):c.1935C>A (p.Asp645Glu)	GAA	D645E	Glycogen storage disease, type II|Glycogen storage disease type II, infantile	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004029	17	78086721	17	80112922	4029	19068	rs28940868	NC_000017.11:80112921:C:A
NM_000152.5(GAA):c.2707_2709del (p.Lys903del)	GAA	K903del	Glycogen storage disease type II, infantile	Pathogenic(Last reviewed: Apr 1, 1995)	no assertion criteria provided	VCV000004028	17	78092510 - 78092512	17	80118711 - 80118713	4028	19067	rs121907939	NC_000017.11:80118710:AGAAG:AG
NM_000152.5(GAA):c.-32-13T>G	GAA		Inborn genetic diseases|Glycogen storage disease|Glycogen storage disease, type II|Glycogen storage disease II, adult form|Muscular Diseases|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004027	17	78078341	17	80104542	4027	19066	rs386834236	NC_000017.11:80104541:T:G
NM_000152.5(GAA):c.1585_1586delinsGT (p.Ser529Val)	GAA	S529V	Glycogen storage disease II, adult form	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000004026	17	78084773 - 78084774	17	80110974 - 80110975	4026	19065	rs121907941	NC_000017.11:80110973:TC:GT
NM_000152.5(GAA):c.2173C>T (p.Arg725Trp)	GAA	R725W	Glycogen storage disease, type II|Glycogen storage disease II, adult form	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004024	17	78087149	17	80113350	4024	19063	rs121907938	NC_000017.11:80113349:C:T
NM_000152.5(GAA):c.1927G>A (p.Gly643Arg)	GAA	G643R	Glycogen storage disease, type II|not provided|Glycogen storage disease II, adult form	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004023	17	78086713	17	80112914	4023	19062	rs28937909	NC_000017.11:80112913:G:A
NM_206965.2(FTCD):c.896G>C (p.Arg299Pro)	FTCD	R299P	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Pathogenic(Last reviewed: Sep 12, 2018)	no assertion criteria provided	VCV000004018	21	47570043	21	46150129	4018	19057	rs119469015	NC_000021.9:46150128:C:G
NM_017636.4(TRPM4):c.19G>A (p.Glu7Lys)	TRPM4	E7K		Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003770	19	49661142	19	49157885	3770	18809	rs267607142	NC_000019.10:49157884:G:A
NM_000527.5(LDLR):c.621C>T (p.Gly207=)	LDLR	G186G	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003747	19	11216203	19	11105527	3747	18786	rs121908044	NC_000019.10:11105526:C:T
NM_000527.5(LDLR):c.1216C>A (p.Arg406=)	LDLR	R385R	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003746	19	11223983	19	11113307	3746	18785	rs121908043	NC_000019.10:11113306:C:A
NM_000527.5(LDLR):c.2140+1G>A	LDLR		Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003744	19	11231199	19	11120523	3744	18783	rs145787161	NC_000019.10:11120522:G:A
NM_000527.5(LDLR):c.131G>A (p.Trp44Ter)	LDLR	W23*, W44*	not provided|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003741	19	11210962	19	11100286	3741	18780	rs267607213	NC_000019.10:11100285:G:A
NM_000527.5(LDLR):c.551G>A (p.Cys184Tyr)	LDLR	C163Y, C184Y, C143Y	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003739	19	11216133	19	11105457	3739	18778	rs121908039	NC_000019.10:11105456:G:A
NM_000527.4(LDLR):c.694+2T>C	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003738	19	11216278	19	11105602	3738	18777	rs200238879	NC_000019.10:11105601:T:C
NM_000527.4(LDLR):c.664_681dup18 (p.Asp227_Glu228insCysLysAspLysSerAsp)	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003733	19	11216246 - 11216263	19	11105566 - 11105567	3733	18772	rs387906306	NC_000019.10:11105566:GACTGCAAGGACAAATCTGAC:GACTGCAAGGACAAATCTGACTGCAAGGACAAATCTGAC
NM_000527.5(LDLR):c.1297G>C (p.Asp433His)	LDLR	D412H, D433H, D392H, D265H, D306H	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003732	19	11224064	19	11113388	3732	18771	rs121908036	NC_000019.10:11113387:G:C
NM_000527.4(LDLR):c.680_681delAC (p.Asp227Glyfs)	LDLR	D186fs, D227fs	not provided|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003731	19	11216262 - 11216263	19	11105586 - 11105587	3731	18770	rs387906305	NC_000019.10:11105585:AC:
NM_000527.5(LDLR):c.693C>A (p.Cys231Ter)	LDLR	C210*, C231*, C190*	Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003730	19	11216275	19	11105599	3730	18769	rs121908035	NC_000019.10:11105598:C:A
NM_000527.4(LDLR):c.925_931delCCCATCA (p.Pro309Lysfs)	LDLR	P309fs, P141fs, P182fs, P268fs	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003729	19	11218175 - 11218181	19	11107498 - 11107504	3729	18768	rs387906304	NC_000019.10:11107497:ACCCATCA:A
FH Pavia	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 1, 1992)	no assertion criteria provided	VCV000003728					3728	18767		
NM_000527.5(LDLR):c.564C>G (p.Tyr188Ter)	LDLR	Y167*, Y188*, Y147*	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003727	19	11216146	19	11105470	3727	18766	rs121908034	NC_000019.10:11105469:C:G
NM_000527.5(LDLR):c.523G>A (p.Asp175Asn)	LDLR	D154N, D175N, D134N	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003726	19	11216105	19	11105429	3726	18765	rs121908033	NC_000019.10:11105428:G:A
NM_000527.4(LDLR):c.1891_2311+1062del (p.(?))	LDLR		Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003724	19	11230813 - 11235082	19	11120137 - 11124406	3724	18763		
FH Leiden 3	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Aug 1, 1990)	no assertion criteria provided	VCV000003723					3723	18762		
LDLR, EX17-18DEL	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 1990)	no assertion criteria provided	VCV000003722					3722	18761		
FH Tsukuba 2	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 1, 1989)	no assertion criteria provided	VCV000003721					3721	18760		
FH Reykjavik	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Aug 1, 1989)	no assertion criteria provided	VCV000003719					3719	18758		
FH Vancouver 2	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jul 1, 1988)	no assertion criteria provided	VCV000003717					3717	18756		
FH London 2	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Apr 1, 1987)	no assertion criteria provided	VCV000003715					3715	18754		
FH Vancouver 3	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	VCV000003713	19	11211022 - 11223953	19	11100346 - 11113277	3713	18752		
nsv1067857	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 1, 1992)	no assertion criteria provided	VCV000003711	19	11234271 - 11242805	19	11123595 - 11132129	3711	18750		
NM_000527.5(LDLR):c.670G>A (p.Asp224Asn)	LDLR	D203N, D224N, D183N	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003706	19	11216252	19	11105576	3706	18745	rs387906303	NC_000019.10:11105575:G:A
NM_000527.4(LDLR):c.2447_2450dupAGAA (p.Asn817Lysfs)	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003705	19	11240246 - 11240249	19	11129568 - 11129569	3705	18744	rs387906302	NC_000019.10:11129568:AAGAA:AAGAAAGAA
NM_000527.5(LDLR):c.2483A>G (p.Tyr828Cys)	LDLR	Y807C, Y828C, Y660C, Y787C, Y650C	not provided|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003704	19	11240282	19	11129606	3704	18743	rs28942085	NC_000019.10:11129605:A:G
NM_000527.5(LDLR):c.2439G>A (p.Trp813Ter)	LDLR	W792*, W813*, W635*, W645*, W772*	Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003703	19	11240238	19	11129562	3703	18742	rs121908032	NC_000019.10:11129561:G:A
NM_000527.5(LDLR):c.2054C>T (p.Pro685Leu)	LDLR	P664L, P685L, P517L, P644L	not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003702	19	11231112	19	11120436	3702	18741	rs28942084	NC_000019.10:11120435:C:T
FH Cape Town 2	LDLR		FH LEIDEN 1|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003701	19	11218191 - 11223953	19	11107515 - 11113277	3701	18740		
FH Paris 1	LDLR		Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000003700	19	11217115 - 11217887	19	11106439 - 11107211	3700	18739	rs1555803632	
NM_000527.5(LDLR):c.2043C>A (p.Cys681Ter)	LDLR	C660*, C681*, C513*, C640*	not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003699	19	11231101	19	11120425	3699	18738	rs121908031	NC_000019.10:11120424:C:A
NM_000527.5(LDLR):c.1646G>A (p.Gly549Asp)	LDLR	G528D, G549D, G508D, G381D, G422D	not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003698	19	11226829	19	11116153	3698	18737	rs28941776	NC_000019.10:11116152:G:A
NM_000527.5(LDLR):c.1637G>A (p.Gly546Asp)	LDLR	G525D, G546D, G378D, G419D, G505D	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003697	19	11226820	19	11116144	3697	18736	rs28942081	NC_000019.10:11116143:G:A
NM_000527.5(LDLR):c.1567G>A (p.Val523Met)	LDLR	V502M, V523M, V396M, V355M, V482M	not provided|Familial hypercholesterolemia|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003696	19	11224419	19	11113743	3696	18735	rs28942080	NC_000019.10:11113742:G:A
NM_000527.5(LDLR):c.1291G>A (p.Ala431Thr)	LDLR	A410T, A431T, A263T, A304T, A390T	not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003695	19	11224058	19	11113382	3695	18734	rs28942079	NC_000019.10:11113381:G:A
NM_000527.5(LDLR):c.1285G>A (p.Val429Met)	LDLR	V408M, V429M, V302M, V388M, V261M	not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003694	19	11224052	19	11113376	3694	18733	rs28942078	NC_000019.10:11113375:G:A
NM_000527.5(LDLR):c.910G>A (p.Asp304Asn)	LDLR	D283N, D304N, D177N, D263N, D136N	not provided|Inborn genetic diseases|Homozygous familial hypercholesterolemia|Hypercholesterolaemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003692	19	11218160	19	11107484	3692	18731	rs121908030	NC_000019.10:11107483:G:A
NM_000527.5(LDLR):c.682G>A (p.Glu228Lys)	LDLR	E207K, E228K, E187K	not provided|Homozygous familial hypercholesterolemia|Carotid artery occlusion|Aortic dissection|Stroke|Carotid artery dissection|Internal carotid artery dissection|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003691	19	11216264	19	11105588	3691	18730	rs121908029	NC_000019.10:11105587:G:A
NM_000527.5(LDLR):c.681C>G (p.Asp227Glu)	LDLR	D206E, D227E, D186E	Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003690	19	11216263	19	11105587	3690	18729	rs121908028	NC_000019.10:11105586:C:G
NM_000527.5(LDLR):c.2000G>A (p.Cys667Tyr)	LDLR	C646Y, C667Y, C499Y, C626Y	not provided|Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003689	19	11231058	19	11120382	3689	18728	rs28942083	NC_000019.10:11120381:G:A
NM_000527.5(LDLR):c.1694G>T (p.Gly565Val)	LDLR	G544V, G565V, G524V, G438V, G397V	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003688	19	11226877	19	11116201	3688	18727	rs28942082	NC_000019.10:11116200:G:T
NM_000527.5(LDLR):c.530C>T (p.Ser177Leu)	LDLR	S156L, S177L, S136L	not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003686	19	11216112	19	11105436	3686	18725	rs121908026	NC_000019.10:11105435:C:T
NM_000527.5(LDLR):c.259T>G (p.Trp87Gly)	LDLR	W66G, W87G	not provided|Homozygous familial hypercholesterolemia|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003685	19	11213408	19	11102732	3685	18724	rs121908025	NC_000019.10:11102731:T:G
NM_000527.5(LDLR):c.97C>T (p.Gln33Ter)	LDLR	Q12*, Q33*	not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003683	19	11210928	19	11100252	3683	18722	rs121908024	NC_000019.10:11100251:C:T
NM_018714.3(COG1):c.1070+5G>A	COG1		COG1 congenital disorder of glycosylation	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000003655	17	71196165	17	73200026	3655	18694	rs1568296260	NC_000017.11:73200025:G:A
COG1, 1-BP INS, 2659C	COG1		COG1 congenital disorder of glycosylation	Pathogenic(Last reviewed: Mar 7, 2006)	no assertion criteria provided	VCV000003654					3654	18693		
NM_144773.3(PROKR2):c.969G>A (p.Met323Ile)	PROKR2	M323I	Kallmann syndrome 3	Pathogenic(Last reviewed: Oct 20, 2006)	no assertion criteria provided	VCV000003453	20	5282872	20	5302226	3453	18492	rs74315419	NC_000020.11:5302225:C:T
NM_144773.3(PROKR2):c.629A>G (p.Gln210Arg)	PROKR2	Q210R	Kallmann syndrome 3	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000003450	20	5283212	20	5302566	3450	18489	rs74315417	NC_000020.11:5302565:T:C
NM_024105.4(ALG12):c.1242C>G (p.Tyr414Ter)	ALG12	Y414*	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000003438	22	50297711	22	49904063	3438	18477	rs121907935	NC_000022.11:49904062:G:C
NM_024105.4(ALG12):c.473T>C (p.Leu158Pro)	ALG12	L158P	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000003437	22	50303733	22	49910085	3437	18476	rs121907934	NC_000022.11:49910084:A:G
NM_024105.4(ALG12):c.301G>A (p.Gly101Arg)	ALG12	G101R	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Jun 15, 2007)	no assertion criteria provided	VCV000003436	22	50304250	22	49910602	3436	18475	rs121907933	NC_000022.11:49910601:C:T
NM_024105.4(ALG12):c.437G>A (p.Arg146Gln)	ALG12	R146Q	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000003435	22	50304114	22	49910466	3435	18474	rs121907932	NC_000022.11:49910465:C:T
NM_024105.4(ALG12):c.200C>T (p.Thr67Met)	ALG12	T61M, T67M	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Sep 15, 2002)	no assertion criteria provided	VCV000003434	22	50307128	22	49913480	3434	18473	rs121907931	NC_000022.11:49913479:G:A
NM_024105.4(ALG12):c.424T>G (p.Phe142Val)	ALG12	F142V	ALG12-congenital disorder of glycosylation	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000003433	22	50304127	22	49910479	3433	18472	rs28942090	NC_000022.11:49910478:A:C
NM_020436.5(SALL4):c.2607del (p.Gln869fs)	SALL4	Q432fs, Q869fs	IVIC syndrome	Pathogenic(Last reviewed: Feb 15, 2007)	no assertion criteria provided	VCV000003330	20	50405535	20	51788996	3330	18369		NC_000020.11:51788995:TT:T
NM_020436.5(SALL4):c.2663A>G (p.His888Arg)	SALL4	H888R, H451R	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000003329	20	50405479	20	51788940	3329	18368	rs74315429	NC_000020.11:51788939:T:C
NM_020436.5(SALL4):c.2713C>T (p.Arg905Ter)	SALL4	R905*, R468*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	no assertion criteria provided	VCV000003328	20	50405429	20	51788890	3328	18367	rs74315428	NC_000020.11:51788889:G:A
SALL4, DEL	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000003327					3327	18366		
NM_020436.5(SALL4):c.1849C>T (p.Arg617Ter)	SALL4	R617*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000003326	20	50407173	20	51790634	3326	18365	rs74315427	NC_000020.11:51790633:G:A
NM_020436.5(SALL4):c.523A>T (p.Lys175Ter)	SALL4	K175*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Mar 26, 2020)	no assertion criteria provided	VCV000003325	20	50408499	20	51791960	3325	18364	rs74315426	NC_000020.11:51791959:T:A
NM_020436.5(SALL4):c.326del (p.Pro109fs)	SALL4	P109fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jun 18, 1994)	no assertion criteria provided	VCV000003324	20	50408696	20	51792157	3324	18363		NC_000020.11:51792156:GG:G
NM_020436.5(SALL4):c.2425del (p.Ala809fs)	SALL4	A809fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000003323	20	50406597	20	51790058	3323	18362		NC_000020.11:51790057:C:
NM_020436.5(SALL4):c.2593C>T (p.Arg865Ter)	SALL4	R865*, R428*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV000003322	20	50405549	20	51789010	3322	18361	rs74315425	NC_000020.11:51789009:G:A
NM_020436.5(SALL4):c.1904del (p.Phe635fs)	SALL4	F635fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000003321	20	50407118	20	51790579	3321	18360		NC_000020.11:51790578:AA:A
NM_020436.5(SALL4):c.941dup (p.Leu315fs)	SALL4		Duane-radial ray syndrome	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003320	20	50408080 - 50408081	20	51791541 - 51791542	3320	18359		NC_000020.11:51791541:G:GG
NM_020436.5(SALL4):c.1054del (p.Ala352fs)	SALL4	A352fs	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003319	20	50407968	20	51791429	3319	18358		NC_000020.11:51791428:CC:C
NM_020436.5(SALL4):c.1954C>T (p.Gln652Ter)	SALL4	Q652*	Duane-radial ray syndrome	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000003318	20	50407068	20	51790529	3318	18357	rs74315424	NC_000020.11:51790528:G:A
NM_000383.4(AIRE):c.239T>G (p.Val80Gly)	AIRE	V80G	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000003317	21	45706546	21	44286663	3317	18356	rs267606642	NC_000021.9:44286662:T:G
NM_000383.4(AIRE):c.789del (p.Ala264fs)	AIRE	A264fs	Polyglandular autoimmune syndrome, type 1|Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia	Pathogenic(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV000003315	21	45709676	21	44289793	3315	18354	rs387906295	NC_000021.9:44289792:C:
NM_000383.4(AIRE):c.1A>T (p.Met1Leu)	AIRE	M1L	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000003314	21	45705890	21	44286007	3314	18353	rs121434258	NC_000021.9:44286006:A:T
NM_000383.4(AIRE):c.682G>T (p.Gly228Trp)	AIRE	G228W	Autoimmune polyglandular syndrome type 1, autosomal dominant	Pathogenic(Last reviewed: Feb 28, 2017)	no assertion criteria provided	VCV000003313	21	45709569	21	44289686	3313	18352	rs121434257	NC_000021.9:44289685:G:T
NM_000383.4(AIRE):c.1513del (p.Ala505fs)	AIRE	A505fs	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000003312	21	45716275	21	44296392	3312	18351	rs387906294	NC_000021.9:44296391:G:
NM_000383.4(AIRE):c.1103dup (p.Leu370fs)	AIRE		Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000003311	21	45712877 - 45712878	21	44292994 - 44292995	3311	18350	rs387906293	NC_000021.9:44292994:CCCCCC:CCCCCCC
NM_000383.4(AIRE):c.415C>T (p.Arg139Ter)	AIRE	R139*	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000003310	21	45706968	21	44287085	3310	18349	rs121434256	NC_000021.9:44287084:C:T
NM_000383.4(AIRE):c.967_979del (p.Leu323fs)	AIRE	L323fs	not provided|Polyglandular autoimmune syndrome, type 1|Autoimmune polyglandular syndrome type 1, with reversible metaphyseal dysplasia	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003309	21	45711063 - 45711075	21	44291180 - 44291192	3309	18348	rs386833675	NC_000021.9:44291179:GCCTGTCCCCTCCGC:GC
NM_000383.4(AIRE):c.247A>G (p.Lys83Glu)	AIRE	K83E	Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000003308	21	45706554	21	44286671	3308	18347	rs121434255	NC_000021.9:44286670:A:G
NM_000383.4(AIRE):c.769C>T (p.Arg257Ter)	AIRE	R257*	not provided|Polyglandular autoimmune syndrome, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003307	21	45709656	21	44289773	3307	18346	rs121434254	NC_000021.9:44289772:C:T
NM_016418.5(NF2):c.205_211del (p.Lys69fs)	NF2	K69fs	Schwannomatosis 1	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000003300	22	30032830 - 30032836	22	29636841 - 29636847	3300	18339	rs587776565	NC_000022.11:29636840:AAGGACA:
NM_016418.5(NF2):c.125_126insG (p.Gly43fs)	NF2		Schwannomatosis 1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000003299	22	30032750 - 30032751	22	29636761 - 29636762	3299	18338	rs587776564	NC_000022.11:29636761::G
NC_000022.11:g.(29668447_29671826)_(29681601_?)del	NF2		Schwannomatosis 1	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000003298			22	29668447 - 29681601	3298	18337		
NM_016418.5(NF2):c.185T>C (p.Phe62Ser)	NF2	F62S	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000003297	22	30032810	22	29636821	3297	18336	rs121434261	NC_000022.11:29636820:T:C
NM_016418.5(NF2):c.1579G>T (p.Glu527Ter)	NF2	E527*, E485*, E486*, E444*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003296	22	30077432	22	29681443	3296	18335	rs74315505	NC_000022.11:29681442:G:T
NM_016418.5(NF2):c.1396C>T (p.Arg466Ter)	NF2	R466*, R383*, R425*, R424*	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003295	22	30070880	22	29674891	3295	18334	rs74315504	NC_000022.11:29674890:C:T
NM_016418.5(NF2):c.1387G>T (p.Glu463Ter)	NF2	E463*, E422*, E380*, E421*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003294	22	30070871	22	29674882	3294	18333	rs74315503	NC_000022.11:29674881:G:T
NM_016418.5(NF2):c.1219C>T (p.Gln407Ter)	NF2	Q407*, Q365*, Q366*, Q324*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003293	22	30069354	22	29673365	3293	18332	rs74315501	NC_000022.11:29673364:C:T
NM_016418.5(NF2):c.1021C>T (p.Arg341Ter)	NF2	R341*, R300*, R258*, R299*	Neurofibromatosis, type 2|not provided	Pathogenic(Last reviewed: Mar 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003292	22	30067836	22	29671847	3292	18331	rs74315499	NC_000022.11:29671846:C:T
NM_016418.5(NF2):c.958C>T (p.Gln320Ter)	NF2	Q320*, Q278*, Q241*, Q283*, Q324*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003291	22	30064394	22	29668405	3291	18330	rs74315497	NC_000022.11:29668404:C:T
NM_016418.5(NF2):c.784C>T (p.Arg262Ter)	NF2	R262*, R221*, R220*, R179*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000003290	22	30057302	22	29661313	3290	18329	rs74315496	NC_000022.11:29661312:C:T
NM_016418.5(NF2):c.544G>T (p.Glu182Ter)	NF2	E182*, E141*, E140*, E99*	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000003289	22	30051610	22	29655621	3289	18328	rs74315495	NC_000022.11:29655620:G:T
NM_016418.5(NF2):c.1613A>C (p.Gln538Pro)	NF2	Q538P, Q455P, Q496P, Q497P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Feb 1, 1996)	no assertion criteria provided	VCV000003287	22	30077466	22	29681477	3287	18326	rs74315494	NC_000022.11:29681476:A:C
NM_016418.5(NF2):c.1604T>C (p.Leu535Pro)	NF2	L535P, L494P, L452P, L493P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 1, 1995)	no assertion criteria provided	VCV000003286	22	30077457	22	29681468	3286	18325	rs74315493	NC_000022.11:29681467:T:C
NM_016418.5(NF2):c.169C>T (p.Arg57Ter)	NF2	R57*	Meningioma|not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003285	22	30032794	22	29636805	3285	18324	rs121434259	NC_000022.11:29636804:C:T
NM_016418.5(NF2):c.995del (p.Lys332fs)	NF2	K332fs, K291fs, K249fs, K290fs	Meningioma	Pathogenic(Last reviewed: Feb 1, 1994)	no assertion criteria provided	VCV000003284	22	30064429	22	29668440	3284	18323	rs587776563	NC_000022.11:29668439:AAA:AA
NM_016418.5(NF2):c.240+1G>T	NF2		Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 10, 1993)	no assertion criteria provided	VCV000003283	22	30032866	22	29636877	3283	18322	rs587776562	NC_000022.11:29636876:G:T
NM_016418.5(NF2):c.1079T>C (p.Leu360Pro)	NF2	L360P, L277P, L318P, L319P	Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jun 10, 1993)	no assertion criteria provided	VCV000003282	22	30067894	22	29671905	3282	18321	rs74315492	NC_000022.11:29671904:T:C
NM_000529.2(MC2R):c.761A>G (p.Tyr254Cys)	MC2R	Y254C	ACTH resistance	Pathogenic(Last reviewed: Sep 1, 2002)	no assertion criteria provided	VCV000003266	18	13884757	18	13884758	3266	18305	rs28940892	NC_000018.10:13884757:T:C
NM_000529.2(MC2R):c.409C>T (p.Arg137Trp)	MC2R	R137W	Glucocorticoid Deficiency|ACTH resistance	Pathogenic(Last reviewed: Apr 16, 2008)	no assertion criteria provided	VCV000003265	18	13885109	18	13885110	3265	18304	rs104894660	NC_000018.10:13885109:G:A
NM_000529.2(MC2R):c.752G>T (p.Cys251Phe)	MC2R	C251F	ACTH resistance	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000003264	18	13884766	18	13884767	3264	18303	rs104894662	NC_000018.10:13884766:C:A
MC2R, 1-BP INS, 1347A	MC2R		ACTH resistance	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000003263					3263	18302		
NM_000529.2(MC2R):c.319G>A (p.Asp107Asn)	MC2R	D107N	ACTH resistance	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000003262	18	13885199	18	13885200	3262	18301	rs104894661	NC_000018.10:13885199:C:T
NM_000529.2(MC2R):c.382C>T (p.Arg128Cys)	MC2R	R128C	ACTH resistance	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000003261	18	13885136	18	13885137	3261	18300	rs104894657	NC_000018.10:13885136:G:A
NM_000529.2(MC2R):c.360C>G (p.Ser120Arg)	MC2R	S120R	ACTH resistance	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000003260	18	13885158	18	13885159	3260	18299	rs104894656	NC_000018.10:13885158:G:C
NM_000529.2(MC2R):c.601C>T (p.Arg201Ter)	MC2R	R201*	ACTH resistance	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000003259	18	13884917	18	13884918	3259	18298	rs104894659	NC_000018.10:13884917:G:A
NM_000529.2(MC2R):c.221G>T (p.Ser74Ile)	MC2R	S74I	Glucocorticoid Deficiency|ACTH resistance	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003258	18	13885297	18	13885298	3258	18297	rs104894658	NC_000018.10:13885297:C:A
NM_001353215.2(DYM):c.1729-21351T>C	DYM	C542R, C541R, C596R, C597R	Smith-McCort dysplasia 1	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000003193	18	46645236	18	49118866	3193	18232	rs120074165	NC_000018.10:49118865:A:G
NM_017653.5(DYM):c.422-2A>G	DYM		Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: Sep 15, 2005)	no assertion criteria provided	VCV000003192	18	46889605	18	49363235	3192	18231	rs1568319747	NC_000018.10:49363234:T:C
NM_017653.5(DYM):c.1252-1G>A	DYM		Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000003190	18	46784864	18	49258494	3190	18229	rs1568119124	NC_000018.10:49258493:C:T
NM_017653.5(DYM):c.1405A>T (p.Asn469Tyr)	DYM	N469Y, N468Y	Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000003187	18	46783435	18	49257065	3187	18226	rs120074163	NC_000018.10:49257064:T:A
NM_017653.5(DYM):c.396T>A (p.Tyr132Ter)	DYM	Y132*, Y131*	Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000003186	18	46904962	18	49378592	3186	18225	rs120074162	NC_000018.10:49378591:A:T
NM_017653.5(DYM):c.763del (p.Thr255fs)	DYM	T255fs, R255fs, T254fs	Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000003185	18	46858234	18	49331864	3185	18224	rs1568264929	NC_000018.10:49331863:TT:T
NM_017653.5(DYM):c.48C>G (p.Tyr16Ter)	DYM	Y16*	Dyggve-Melchior-Clausen syndrome	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000003184	18	46956717	18	49430347	3184	18223	rs120074161	NC_000018.10:49430346:G:C
NM_153000.5(APCDD1):c.26T>G (p.Leu9Arg)	APCDD1	L9R		Pathogenic(Last reviewed: Oct 1, 2012)	no assertion criteria provided	VCV000003161	18	10455004	18	10455007	3161	18200	rs267606659	NC_000018.10:10455006:T:G
NM_000487.6(ARSA):c.1279C>A (p.Pro427Thr)	ARSA	P425T, P427T, P341T	Metachromatic leukodystrophy, juvenile type	Pathogenic(Last reviewed: Jun 20, 2003)	no assertion criteria provided	VCV000003094	22	51063824	22	50625396	3094	18133	rs74315485	NC_000022.11:50625395:G:T
NM_000487.6(ARSA):c.905G>T (p.Cys302Phe)	ARSA	C300F, C302F, C216F	not provided|Metachromatic leukodystrophy, late infantile	Pathogenic(Last reviewed: Jun 20, 2003)	no assertion criteria provided	VCV000003093	22	51064656	22	50626228	3093	18132	rs74315484	NC_000022.11:50626227:C:A
NM_000487.6(ARSA):c.1229C>T (p.Thr410Ile)	ARSA	T408I, T410I, T324I	Metachromatic leukodystrophy, adult type	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000003092	22	51063874	22	50625446	3092	18131	rs28940895	NC_000022.11:50625445:G:A
NM_000487.6(ARSA):c.763G>A (p.Glu255Lys)	ARSA	E253K, E255K, E169K	not provided|Metachromatic leukodystrophy|Metachromatic leukodystrophy, late infantile	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003091	22	51065110	22	50626682	3091	18130	rs74315483	NC_000022.11:50626681:C:T
NM_000487.6(ARSA):c.862A>C (p.Thr288Pro)	ARSA	T286P, T288P, T202P	Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000003090	22	51064699	22	50626271	3090	18129	rs28940894	NC_000022.11:50626270:T:G
NM_000487.6(ARSA):c.410T>C (p.Leu137Pro)	ARSA	L137P, P135L, L51P	Metachromatic leukodystrophy, adult type	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000003089	22	51065649	22	50627221	3089	18128	rs121434215	NC_000022.11:50627220:A:G
NM_000487.6(ARSA):c.1462C>T (p.Gln488Ter)	ARSA	Q486*, Q488*, Q402*	Arylsulfatase A pseudodeficiency	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000003088	22	51063641	22	50625213	3088	18127	rs74315482	NC_000022.11:50625212:G:A
NM_000487.6(ARSA):c.1198_1200TTC[1] (p.Phe401del)	ARSA	F398del, F401del	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000003086	22	51064014 - 51064016	22	50625586 - 50625588	3086	18125	rs1569077723	NC_000022.11:50625585:GAAGAAG:GAAG
NM_000487.6(ARSA):c.1150G>A (p.Glu384Lys)	ARSA	E382K, E384K, E298K	Metachromatic leukodystrophy|Arylsulfatase a pseudodeficiency, intermediate|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003084	22	51064067	22	50625639	3084	18123	rs74315479	NC_000022.11:50625638:C:T
NM_000487.6(ARSA):c.1136C>T (p.Pro379Leu)	ARSA	P377L, P379L, P293L	Arylsulfatase a pseudodeficiency, severe	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000003083	22	51064081	22	50625653	3083	18122	rs74315478	NC_000022.11:50625652:G:A
NM_000487.6(ARSA):c.1114C>T (p.Arg372Trp)	ARSA	R370W, R372W, R286W	not provided|Metachromatic leukodystrophy, severe|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000003081	22	51064103	22	50625675	3081	18120	rs74315476	NC_000022.11:50625674:G:A
NM_000487.6(ARSA):c.1010A>T (p.Asp337Val)	ARSA	D335V, D337V, D251V	Leukodystrophy|not provided|Metachromatic leukodystrophy, severe|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003080	22	51064461	22	50626033	3080	18119	rs74315475	NC_000022.11:50626032:T:A
ARSA, IVS5DS, G-T, -1, GLY325CYS	ARSA	G325C	Arylsulfatase A pseudodeficiency	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000003079					3079	18118		
NM_000487.6(ARSA):c.890C>A (p.Ser297Tyr)	ARSA	S295Y, S297Y, S211Y	Metachromatic leukodystrophy|Metachromatic leukodystrophy, severe	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000003078	22	51064671	22	50626243	3078	18117	rs74315474	NC_000022.11:50626242:G:T
NM_000487.6(ARSA):c.868C>T (p.Arg290Cys)	ARSA	R288C, R290C, R204C	Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003077	22	51064693	22	50626265	3077	18116	rs74315473	NC_000022.11:50626264:G:A
ARSA, IVS4DS, G-A, +1	ARSA		Metachromatic leukodystrophy, severe	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000003076					3076	18115		
NM_000487.6(ARSA):c.827C>T (p.Thr276Met)	ARSA	T274M, T276M, T190M	Metachromatic leukodystrophy|not provided|Metachromatic leukodystrophy, severe	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003075	22	51065046	22	50626618	3075	18114	rs74315472	NC_000022.11:50626617:G:A
NM_000487.6(ARSA):c.739G>A (p.Gly247Arg)	ARSA	G245R, G247R, G161R	not provided|Metachromatic leukodystrophy|Metachromatic leukodystrophy, severe	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003074	22	51065134	22	50626706	3074	18113	rs74315471	NC_000022.11:50626705:C:T
NM_000487.6(ARSA):c.736C>T (p.Arg246Cys)	ARSA	R244C, R246C, R160C	Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003073	22	51065137	22	50626709	3073	18112	rs74315470	NC_000022.11:50626708:G:A
NM_000487.6(ARSA):c.697C>A (p.Pro233Thr)	ARSA	P231T, P233T, P147T	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000003072	22	51065176	22	50626748	3072	18111	rs74315469	NC_000022.11:50626747:G:T
NM_000487.6(ARSA):c.641C>T (p.Ala214Val)	ARSA	A212V, A214V, A128V	Metachromatic leukodystrophy|not provided	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003070	22	51065305	22	50626877	3070	18109	rs74315467	NC_000022.11:50626876:G:A
NM_000487.6(ARSA):c.506C>G (p.Pro169Arg)	ARSA	P169R, P83R	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000003068	22	51065440	22	50627012	3068	18107	rs74315465	NC_000022.11:50627011:G:C
NM_000487.6(ARSA):c.470C>G (p.Pro157Arg)	ARSA	P157R, P71R	Arylsulfatase A pseudodeficiency	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000003067	22	51065476	22	50627048	3067	18106	rs74315464	NC_000022.11:50627047:G:C
NM_000487.6(ARSA):c.467G>A (p.Gly156Asp)	ARSA	G156D, G70D	Metachromatic leukodystrophy	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000003066	22	51065479	22	50627051	3066	18105	rs74315463	NC_000022.11:50627050:C:T
ARSA, 1-BP DEL, 297C	ARSA		Metachromatic leukodystrophy	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000003065					3065	18104		
NM_000487.6(ARSA):c.292_293delinsCT (p.Ser98Leu)	ARSA	S96L	not provided|Metachromatic leukodystrophy, severe	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000003062	22	51065766 - 51065767	22	50627338 - 50627339	3062	18101	rs199476371	NC_000022.11:50627337:GA:AG
NM_000487.6(ARSA):c.263G>A (p.Gly88Asp)	ARSA	G88D, G2D	Metachromatic leukodystrophy, severe	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000003061	22	51065796	22	50627368	3061	18100	rs74315460	NC_000022.11:50627367:C:T
NM_000487.6(ARSA):c.1210+1G>A	ARSA		not provided|Metachromatic leukodystrophy|Metachromatic leukodystrophy, juvenile type	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003058	22	51064006	22	50625578	3058	18097	rs80338820	NC_000022.11:50625577:C:T
NM_000487.6(ARSA):c.542T>G (p.Ile181Ser)	ARSA	I179S, I181S, I95S	not provided|Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|Metachromatic leukodystrophy, adult type	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003057	22	51065404	22	50626976	3057	18096	rs74315457	NC_000022.11:50626975:A:C
ARSA, 1-BP DEL, 447C	ARSA		Metachromatic leukodystrophy, late infantile	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000003056					3056	18095		
ARSA, 11-BP DEL, EX8	ARSA		Metachromatic leukodystrophy, late infantile	Pathogenic(Last reviewed: Jun 1, 1991)	no assertion criteria provided	VCV000003055					3055	18094		
NM_000487.6(ARSA):c.293C>T (p.Ser98Phe)	ARSA	S96F, S98F, S12F	not provided|Metachromatic leukodystrophy|Metachromatic leukodystrophy, late infantile	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003054	22	51065766	22	50627338	3054	18093	rs74315456	NC_000022.11:50627337::A
NM_000487.6(ARSA):c.302G>A (p.Gly101Asp)	ARSA	G99D, G101D, G15D	not provided|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003053	22	51065757	22	50627329	3053	18092	rs74315455	NC_000022.11:50627328:C:T
NM_000487.6(ARSA):c.1283C>T (p.Pro428Leu)	ARSA	P426L, P428L, P342L	not provided|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy|Arylsulfatase a, allele a	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003052	22	51063820	22	50625392	3052	18091	rs28940893	NC_000022.11:50625391:G:A
NM_000487.6(ARSA):c.465+1G>A	ARSA		not provided|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type|Metachromatic leukodystrophy	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003051	22	51065593	22	50627165	3051	18090	rs80338815	NC_000022.11:50627164:C:T
NM_000271.5(NPC1):c.3611_3614del (p.Leu1204fs)	NPC1	L1204fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000002979	18	21113459 - 21113462	18	23533495 - 23533498	2979	18018	rs786200879	NC_000018.10:23533494:GTAAGT:GT
NM_000271.5(NPC1):c.337T>C (p.Cys113Arg)	NPC1	C113R	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000002978	18	21148913	18	23568949	2978	18017	rs120074136	NC_000018.10:23568948:A:G
NM_000271.5(NPC1):c.3662del (p.Phe1221fs)	NPC1	F1221fs	Niemann-Pick disease type C1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000002977	18	21113411	18	23533447	2977	18016	rs786200878	NC_000018.10:23533446:AAAA:AAA
NM_000271.5(NPC1):c.2932C>T (p.Arg978Cys)	NPC1	R978C	not provided|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002976	18	21118615	18	23538651	2976	18015	rs28942108	NC_000018.10:23538650:G:A
NPC1, IVS16, G-A, -82	NPC1		Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000002975					2975	18014		
NM_000271.5(NPC1):c.530G>A (p.Cys177Tyr)	NPC1	C177Y	Inborn genetic diseases|Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002974	18	21141425	18	23561461	2974	18013	rs80358252	NC_000018.10:23561460:C:T
NM_000271.5(NPC1):c.3104C>T (p.Ala1035Val)	NPC1	A1035V	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002972	18	21116778	18	23536814	2972	18011	rs28942107	NC_000018.10:23536813:G:A
NM_000271.5(NPC1):c.2848G>A (p.Val950Met)	NPC1	V950M	Niemann-Pick disease type C1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002971	18	21119382	18	23539418	2971	18010	rs120074135	NC_000018.10:23539417:C:T
NM_000271.5(NPC1):c.1133T>C (p.Val378Ala)	NPC1	V378A	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000002970	18	21136400	18	23556436	2970	18009	rs120074134	NC_000018.10:23556435:A:G
NM_000271.5(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	G992R	Niemann-Pick disease type C1|not provided|Niemann-Pick disease, type C	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002969	18	21118573	18	23538609	2969	18008	rs80358254	NC_000018.10:23538608:C:G
NM_000271.5(NPC1):c.2873G>A (p.Arg958Gln)	NPC1	R958Q	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000002968	18	21119357	18	23539393	2968	18007	rs120074132	NC_000018.10:23539392:C:T
NM_000271.5(NPC1):c.3182T>C (p.Ile1061Thr)	NPC1	I1061T	Inborn genetic diseases|Niemann-Pick disease type C1|not provided|Niemann-Pick disease, type C	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002967	18	21116700	18	23536736	2967	18006	rs80358259	NC_000018.10:23536735:A:G
NM_000271.5(NPC1):c.3639G>C (p.Leu1213Phe)	NPC1	L1213F	Niemann-Pick disease, type C1, juvenile form	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000002965	18	21113434	18	23533470	2965	18004	rs120074131	NC_000018.10:23533469:C:G
NM_000271.5(NPC1):c.2665G>A (p.Val889Met)	NPC1	V889M	Niemann-Pick disease, type C1, adult form	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000002962	18	21119905	18	23539941	2962	18001	rs120074130	NC_000018.10:23539940:C:T
NM_000271.5(NPC1):c.3467A>G (p.Asn1156Ser)	NPC1	N1156S	Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002959	18	21115443	18	23535479	2959	17998	rs28942105	NC_000018.10:23535478:T:C
NM_000271.5(NPC1):c.2783A>C (p.Gln928Pro)	NPC1	Q928P	Niemann-Pick disease type C1	Pathogenic(Last reviewed: Jul 11, 1997)	no assertion criteria provided	VCV000002957	18	21119787	18	23539823	2957	17996	rs28940897	NC_000018.10:23539822:T:G
NM_173477.5(USH1G):c.394dup (p.Val132fs)	USH1G		Usher syndrome, type 1G|	Pathogenic(Last reviewed: May 19, 2016)	no assertion criteria provided	VCV000002917	17	72916536 - 72916537	17	74920441 - 74920442	2917	17956	rs587776546	NC_000017.11:74920441:CC:CCC
NM_173477.5(USH1G):c.832_851del (p.Ser278fs)	USH1G	S175fs, S278fs	Usher syndrome, type 1G|	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000002916	17	72916080 - 72916099	17	74919985 - 74920004	2916	17955	rs397515345	NC_000017.11:74919984:GAGACGCTGTCCTCGTCCGAGAG:GAG
NM_173477.5(USH1G):c.186_187del (p.Ile63fs)	USH1G	I63fs	Usher syndrome, type 1G	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000002915	17	72916744 - 72916745	17	74920649 - 74920650	2915	17954	rs730880268	NC_000017.11:74920648:TGT:T
NM_173477.5(USH1G):c.143T>C (p.Leu48Pro)	USH1G	L48P	Usher syndrome, type 1G	Pathogenic(Last reviewed: Mar 1, 2003)	no assertion criteria provided	VCV000002914	17	72919026	17	74922931	2914	17953	rs104894651	NC_000017.11:74922930:A:G
NM_207391.3(RGS9BP):c.193dup (p.Arg65fs)	RGS9BP		Bradyopsia	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000002831	19	33167360 - 33167361	19	32676454 - 32676455	2831	17870		NC_000019.10:32676454:CC:CCC
DSG4, EX5-8DEL	DSG4		Hypotrichosis 6	Pathogenic(Last reviewed: Apr 18, 2003)	no assertion criteria provided	VCV000002719					2719	17758		
NM_017671.4(FERMT1):c.862C>T (p.Arg288Ter)	FERMT1	R288*	Kindler's syndrome	Pathogenic(Last reviewed: Jan 7, 2016)	no assertion criteria provided	VCV000002718	20	6078266	20	6097619	2718	17757	rs121918294	NC_000020.11:6097618:G:A
NM_017671.4(FERMT1):c.811C>T (p.Arg271Ter)	FERMT1	R271*	Kindler's syndrome	Pathogenic(Last reviewed: Dec 30, 2017)	no assertion criteria provided	VCV000002717	20	6088217	20	6107570	2717	17756	rs121918293	NC_000020.11:6107569:G:A
NM_017671.4(FERMT1):c.464del (p.Asn155fs)	FERMT1	N155fs	Kindler's syndrome	Pathogenic(Last reviewed: Apr 15, 2003)	no assertion criteria provided	VCV000002716	20	6093192	20	6112545	2716	17755	rs1568664492	NC_000020.11:6112544:TTTTT:TTTT
NM_017671.4(FERMT1):c.1714_1715insA (p.Val572fs)	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Apr 15, 2003)	no assertion criteria provided	VCV000002715	20	6064690 - 6064691	20	6084043 - 6084044	2715	17754	rs1568654138	NC_000020.11:6084043::T
NM_017671.4(FERMT1):c.787C>T (p.Gln263Ter)	FERMT1	Q263*	not provided|Kindler's syndrome	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000002714	20	6088241	20	6107594	2714	17753	rs121918292	NC_000020.11:6107593:G:A
FERMT1, IVS3DS, T-C, +2	FERMT1		Kindler's syndrome	Pathogenic(Last reviewed: Apr 15, 2003)	no assertion criteria provided	VCV000002713					2713	17752		
APOC2, 1-BP DEL, 2943G	APOC2		APOLIPOPROTEIN C-II (NIJMEGEN)|Apolipoprotein C2 deficiency	Pathogenic(Last reviewed: Dec 5, 1988)	no assertion criteria provided	VCV000002578					2578	17617		
APOC2, 1-BP DEL	APOC2		APOLIPOPROTEIN C-II (TORONTO)|Apolipoprotein C2 deficiency	Pathogenic(Last reviewed: Oct 1, 1988)	no assertion criteria provided	VCV000002576					2576	17615		
APOC2, 1-BP INS	APOC2		APOLIPOPROTEIN C-II (ST. MICHAEL)|Apolipoprotein C2 deficiency	Pathogenic(Last reviewed: Dec 1, 1987)	no assertion criteria provided	VCV000002575					2575	17614		
NM_000346.4(SOX9):c.1103dup (p.Gln369fs)	SOX9		Camptomelic dysplasia|Campomelic dysplasia with autosomal sex reversal	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000002518	17	70120100 - 70120101	17	72123959 - 72123960	2518	17557		NC_000017.11:72123959:A:AA
NM_000346.4(SOX9):c.472G>A (p.Ala158Thr)	SOX9	A158T	Campomelic dysplasia with autosomal sex reversal	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000002517	17	70118900	17	72122759	2517	17556	rs137853130	NC_000017.11:72122758:G:A
NM_000346.4(SOX9):c.462C>G (p.Phe154Leu)	SOX9	F154L	Camptomelic dysplasia	Pathogenic(Last reviewed: Jul 27, 2001)	no assertion criteria provided	VCV000002516	17	70118890	17	72122749	2516	17555	rs137853129	NC_000017.11:72122748:C:G
SOX9, 30-BP DEL	SOX9		Camptomelic dysplasia	Pathogenic(Last reviewed: Jun 15, 2003)	no assertion criteria provided	VCV000002515					2515	17554		
NM_000346.4(SOX9):c.493C>T (p.His165Tyr)	SOX9	H165Y	Acampomelic campomelic dysplasia	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000002513	17	70118921	17	72122780	2513	17552	rs28940282	NC_000017.11:72122779:C:T
NM_000346.4(SOX9):c.517A>G (p.Lys173Glu)	SOX9	K173E	Acampomelic campomelic dysplasia	Pathogenic(Last reviewed: Aug 28, 2000)	no assertion criteria provided	VCV000002511	17	70118945	17	72122804	2511	17550	rs104894647	NC_000017.11:72122803:A:G
NM_000346.4(SOX9):c.1320C>G (p.Tyr440Ter)	SOX9	Y440*	Camptomelic dysplasia|not provided|Campomelic dysplasia with autosomal sex reversal	Pathogenic(Last reviewed: Sep 6, 2016)	criteria provided, single submitter	VCV000002510	17	70120318	17	72124177	2510	17549	rs80338688	NC_000017.11:72124176:C:G
NM_000346.4(SOX9):c.736dup (p.Gln246fs)	SOX9		Camptomelic dysplasia|Campomelic dysplasia with autosomal sex reversal	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000002509	17	70119733 - 70119734	17	72123592 - 72123593	2509	17548	rs587776541	NC_000017.11:72123592:C:CC
SOX9, 4-BP INS	SOX9		Campomelic dysplasia with autosomal sex reversal	Pathogenic(Last reviewed: Dec 8, 1994)	no assertion criteria provided	VCV000002508					2508	17547		
NM_000346.4(SOX9):c.788dup (p.Arg264fs)	SOX9		Campomelic dysplasia with autosomal sex reversal	Pathogenic(Last reviewed: Dec 8, 1994)	no assertion criteria provided	VCV000002507	17	70119780 - 70119781	17	72123639 - 72123640	2507	17546		NC_000017.11:72123639:GGGGGG:GGGGGGG
NM_000346.4(SOX9):c.583C>T (p.Gln195Ter)	SOX9	Q195*	Camptomelic dysplasia	Pathogenic(Last reviewed: Dec 8, 1994)	no assertion criteria provided	VCV000002506	17	70119011	17	72122870	2506	17545		NC_000017.11:72122869:C:T
ATCAY, IVS9, G-T, +3, SER301ARG	ATCAY		Cerebellar ataxia, Cayman type	Pathogenic(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000002491					2491	17530		
NM_000026.4(ADSL):c.674T>C (p.Met225Thr)	ADSL	M225T, M161T	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000002468	22	40755283	22	40359279	2468	17507	rs119450945	NC_000022.11:40359278:T:C
ADSL, -49T-C, PROMOTER	ADSL		Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000002467					2467	17506		
NM_000026.4(ADSL):c.298C>G (p.Pro100Ala)	ADSL	P100A, P36A	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Feb 27, 1998)	no assertion criteria provided	VCV000002463	22	40745980	22	40349976	2463	17502	rs119450942	NC_000022.11:40349975:C:G
NM_000026.4(ADSL):c.1277G>A (p.Arg426His)	ADSL	R426H, R362H	Adenylosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002462	22	40760969	22	40364965	2462	17501	rs119450941	NC_000022.11:40364964:G:A
NM_000026.4(ADSL):c.1312T>C (p.Ser438Pro)	ADSL	S438P, S374P	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Apr 1, 1992)	no assertion criteria provided	VCV000002461	22	40761004	22	40365000	2461	17500	rs119450940	NC_000022.11:40364999:T:C
BCKDHA, 1-BP DEL, 117C	BCKDHA		Maple syrup urine disease type 1A	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000002383					2383	17422		
NM_000709.4(BCKDHA):c.792C>G (p.Cys264Trp)	BCKDHA	C219W, C264W	Maple syrup urine disease type 1A	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000002382	19	41928214	19	41422309	2382	17421	rs137852876	NC_000019.10:41422308:C:G
NM_000709.4(BCKDHA):c.929C>G (p.Thr310Arg)	BCKDHA	T265R, T309R, T310R	Maple syrup urine disease type 1A|not provided	Pathogenic(Last reviewed: Aug 25, 2013)	criteria provided, single submitter	VCV000002381	19	41928609	19	41422704	2381	17420	rs137852875	NC_000019.10:41422703:C:G
NM_000709.4(BCKDHA):c.1226T>G (p.Phe409Cys)	BCKDHA	F364C, F408C, F409C	Maple syrup urine disease type 1A|MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA	Pathogenic(Last reviewed: May 22, 1998)	no assertion criteria provided	VCV000002378	19	41930401	19	41424496	2378	17417	rs137852872	NC_000019.10:41424495:T:G
NM_000709.4(BCKDHA):c.868G>A (p.Gly290Arg)	BCKDHA	G245R, G289R, G290R	Maple syrup urine disease|MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002377	19	41928548	19	41422643	2377	17416	rs137852871	NC_000019.10:41422642:G:A
ETHE1, EX4DEL	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000002323					2323	17362		
ETHE1, IVS4DS, G-T, +1	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000002322					2322	17361		
ETHE1, 11-BP DEL, NT440	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000002321					2321	17360		
ETHE1, 1-BP INS, 221A	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000002320					2320	17359		
ETHE1, 1-BP INS, 604G	ETHE1		Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000002319					2319	17358		
NM_014297.5(ETHE1):c.3G>T (p.Met1Ile)	ETHE1	M1I	Ethylmalonic encephalopathy|not provided	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000002318	19	44031327	19	43527175	2318	17357	rs119103249	NC_000019.10:43527174:C:A
NM_014297.5(ETHE1):c.487C>T (p.Arg163Trp)	ETHE1	R163W, R152W, R40W, R65W	Ethylmalonic encephalopathy	Pathogenic(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000002317	19	44015607	19	43511455	2317	17356	rs28940289	NC_000019.10:43511454:G:A
STRADA, 7-KB DEL	STRADA		Polyhydramnios, megalencephaly, and symptomatic epilepsy	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000002186					2186	17225		
NM_001127649.3(PEX26):c.230+1G>T	PEX26		Peroxisome biogenesis disorder 7A	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000002159	22	18561373	22	18078607	2159	17198	rs267608190	NC_000022.11:18078606:G:T
NM_001127649.3(PEX26):c.254dup (p.Cys86fs)	PEX26		Peroxisome biogenesis disorder 7A|Peroxisome biogenesis disorder 7B	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000002158	22	18562662 - 18562663	22	18079896 - 18079897	2158	17197	rs61752133	NC_000022.11:18079896:T:TT
NM_017929.5(PEX26):c.668_814del (p.Gly223_Pro271del)	PEX26		Peroxisome biogenesis disorder 7A	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000002155					2155	17194		
NM_001127649.3(PEX26):c.34dup (p.Leu12fs)	PEX26		Peroxisome biogenesis disorder 7A|Peroxisome biogenesis disorder 7B|not provided|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002154	22	18561170 - 18561171	22	18078404 - 18078405	2154	17193	rs61752129	NC_000022.11:18078404:CCCCCC:CCCCCCC
NM_001127649.3(PEX26):c.265G>A (p.Gly89Arg)	PEX26	G89R	Peroxisome biogenesis disorder 7A	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000002153	22	18562674	22	18079908	2153	17192	rs28940308	NC_000022.11:18079907:G:A
NM_001127649.3(PEX26):c.292C>T (p.Arg98Trp)	PEX26	R98W	not provided|Peroxisome biogenesis disorders, Zellweger syndrome spectrum|Peroxisome biogenesis disorder 7B|Peroxisome biogenesis disorder 7A|Peroxisome biogenesis disorder 7B	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002152	22	18562701	22	18079935	2152	17191	rs62641228	NC_000022.11:18079934:C:T
NM_000159.4(GCDH):c.680G>C (p.Arg227Pro)	GCDH	R227P	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002089	19	13007063	19	12896249	2089	17128	rs121434373	NC_000019.10:12896248:G:C
NM_000159.4(GCDH):c.1198G>A (p.Val400Met)	GCDH	V400M	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002088	19	13008632	19	12897818	2088	17127	rs121434372	NC_000019.10:12897817:G:A
NM_000159.4(GCDH):c.91+5G>T	GCDH		Glutaric aciduria, type 1	Pathogenic(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000002087	19	13002214	19	12891400	2087	17126		NC_000019.10:12891399:G:T
NM_000159.4(GCDH):c.1093G>A (p.Glu365Lys)	GCDH	E365K	not provided|Glutaric aciduria, type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002086	19	13008527	19	12897713	2086	17125	rs121434370	NC_000019.10:12897712:G:A
NM_000159.4(GCDH):c.1204C>T (p.Arg402Trp)	GCDH	R402W	Glutaric aciduria, type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002085	19	13008638	19	12897824	2085	17124	rs121434369	NC_000019.10:12897823:C:T
NM_000159.4(GCDH):c.883T>C (p.Tyr295His)	GCDH	Y295H	not provided|Glutaric aciduria, type 1	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, single submitter	VCV000002081	19	13007754	19	12896940	2081	17120	rs121434366	NC_000019.10:12896939:T:C
NM_199242.2(UNC13D):c.2570T>G (p.Phe857Cys)	UNC13D	F857C		Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000002003	17	73827234	17	75831153	2003	17042	rs121434354	NC_000017.11:75831152:A:C
NM_199242.2(UNC13D):c.1208T>C (p.Leu403Pro)	UNC13D	L403P		Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000002002	17	73832743	17	75836662	2002	17041	rs121434353	NC_000017.11:75836661:A:G
NM_199242.2(UNC13D):c.753+1G>T	UNC13D		not provided|	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002001	17	73836587	17	75840506	2001	17040	rs201908137	NC_000017.11:75840505:C:A
NM_199242.2(UNC13D):c.766C>T (p.Arg256Ter)	UNC13D	R256*	not provided|	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002000	17	73836398	17	75840317	2000	17039	rs121434352	NC_000017.11:75840316:G:A
NM_199242.2(UNC13D):c.1389+1G>A	UNC13D		not provided|	Pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001999	17	73832419	17	75836338	1999	17038	rs777759523	NC_000017.11:75836337:C:T
NM_199242.2(UNC13D):c.1754dup (p.His586fs)	UNC13D			Pathogenic(Last reviewed: Nov 14, 2003)	no assertion criteria provided	VCV000001998	17	73831583 - 73831584	17	75835502 - 75835503	1998	17037	rs796065026	NC_000017.11:75835502:AAA:AAAA
NM_199242.2(UNC13D):c.216del (p.Asn73fs)	UNC13D	N73fs		Pathogenic(Last reviewed: Nov 14, 2003)	no assertion criteria provided	VCV000001997	17	73839285	17	75843204	1997	17036	rs796065025	NC_000017.11:75843203:GGG:GG
NM_199242.2(UNC13D):c.1828_1839del (p.Arg610_Gln613del)	UNC13D			Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000001996	17	73831499 - 73831510	17	75835418 - 75835429	1996	17035	rs796065024	NC_000017.11:75835417:CTGCACAGCGCGCTGCAC:CTGCAC
ADA, IVS11AS, 31701T-A AND 11-BP DEL, NT31702	ADA		SCID due to ADA deficiency, delayed onset	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000001983					1983	17022		
NM_000022.4(ADA):c.1079-15T>A	ADA		SCID due to ADA deficiency, delayed onset	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000001982	20	43248503	20	44619862	1982	17021	rs387906268	NC_000020.11:44619861:A:T
NM_000022.4(ADA):c.698C>T (p.Thr233Ile)	ADA	T233I, T209I, T98I	Severe combined immunodeficiency due to ADA deficiency|Partial adenosine deaminase deficiency	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000001980	20	43251552	20	44622911	1980	17019	rs121908729	NC_000020.11:44622910:G:A
NM_000022.4(ADA):c.33+1G>C	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001976	20	43280215	20	44651574	1976	17015	rs587776534	NC_000020.11:44651573:C:G
ADA, 7-BP INS, IVS8AS	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000001975	20	43251293 - 43251296			1975	17014		
ADA, IVS2DS, G-A, +1	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: May 1, 1994)	no assertion criteria provided	VCV000001974					1974	17013		
NM_000022.4(ADA):c.976-34G>A	ADA		SCID due to ADA deficiency, delayed onset	Pathogenic(Last reviewed: Nov 1, 1993)	no assertion criteria provided	VCV000001972	20	43249076	20	44620435	1972	17011	rs1194494050	NC_000020.11:44620434:C:T
NM_000022.4(ADA):c.872C>T (p.Ser291Leu)	ADA	S291L, S267L, S156L	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001971	20	43249762	20	44621121	1971	17010	rs121908721	NC_000020.11:44621120:G:A
NM_000022.4(ADA):c.466C>T (p.Arg156Cys)	ADA	R156C	Severe combined immunodeficiency disease|Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001970	20	43254222	20	44625581	1970	17009	rs121908735	NC_000020.11:44625580:G:A
NM_000022.4(ADA):c.646G>A (p.Gly216Arg)	ADA	G216R, G81R	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001968	20	43251680	20	44623039	1968	17007	rs121908723	NC_000020.11:44623038:C:T
NM_000022.4(ADA):c.320T>C (p.Leu107Pro)	ADA	L107P, W11R	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001965	20	43255139	20	44626498	1965	17004	rs121908739	NC_000020.11:44626497:A:G
NM_000022.4(ADA):c.890C>A (p.Pro297Gln)	ADA	P297Q, P162Q, P273Q	Partial adenosine deaminase deficiency|Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Feb 1, 1989)	no assertion criteria provided	VCV000001961	20	43249744	20	44621103	1961	17000	rs121908718	NC_000020.11:44621102:G:T
ADA, 3.25-KB DEL, ALU-RELATED	ADA		Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Dec 1, 1997)	no assertion criteria provided	VCV000001960					1960	16999		
NM_000022.2(ADA):c.986C>T	ADA	A329V, A305V, A194V	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001959	20	43249032	20	44620391	1959	16998	rs121908715	NC_000020.11:44620390:G:A
NM_000022.4(ADA):c.632G>A (p.Arg211His)	ADA	R211H, R76H	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001957	20	43251694	20	44623053	1957	16996	rs121908716	NC_000020.11:44623052:C:T
NM_000022.4(ADA):c.302G>A (p.Arg101Gln)	ADA	R101Q, G5S	not provided|Severe combined immunodeficiency due to ADA deficiency	Pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000001956	20	43255157	20	44626516	1956	16995	rs121908714	NC_000020.11:44626515:C:T
NM_030957.4(ADAMTS10):c.2098G>T (p.Gly700Cys)	ADAMTS10	G700C, G187C	Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000001950	19	8654186	19	8589302	1950	16989	rs267606637	NC_000019.10:8589301:C:A
NM_030957.4(ADAMTS10):c.1553G>A (p.Gly518Asp)	ADAMTS10	G518D	Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000001949	19	8657681	19	8592797	1949	16988	rs267606636	NC_000019.10:8592796:C:T
NM_030957.4(ADAMTS10):c.952C>T (p.Gln318Ter)	ADAMTS10	Q318*	Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000001948	19	8661959	19	8597075	1948	16987	rs121434359	NC_000019.10:8597074:G:A
NM_030957.4(ADAMTS10):c.73G>A (p.Ala25Thr)	ADAMTS10	A25T	Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000001947	19	8670523	19	8605638	1947	16986	rs121434358	NC_000019.10:8605637:C:T
NM_030957.4(ADAMTS10):c.810+1G>A	ADAMTS10		Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000001946	19	8665811	19	8600927	1946	16985	rs387906266	NC_000019.10:8600926:C:T
NM_030957.4(ADAMTS10):c.1190+1G>A	ADAMTS10		Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000001945	19	8661190	19	8596306	1945	16984	rs431825170	NC_000019.10:8596305:C:T
NM_030957.4(ADAMTS10):c.709C>T (p.Arg237Ter)	ADAMTS10	R237*	Weill-Marchesani syndrome 1	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	VCV000001944	19	8665913	19	8601029	1944	16983	rs121434357	NC_000019.10:8601028:G:A
NM_000411.8(HLCS):c.647T>G (p.Leu216Arg)	HLCS	L216R, L363R	Holocarboxylase synthetase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001914	21	38309098	21	36936798	1914	16953	rs28934602	NC_000021.9:36936797:A:C
NM_000411.8(HLCS):c.655dup (p.Ile219fs)	HLCS		Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000001913	21	38309089 - 38309090	21	36936789 - 36936790	1913	16952	rs773102942	NC_000021.9:36936789:T:TT
NM_000411.8(HLCS):c.1519+5G>A	HLCS		Holocarboxylase synthetase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001912	21	38139514	21	36767213	1912	16951	rs753887925	NC_000021.9:36767212:C:T
NM_000411.8(HLCS):c.1648G>A (p.Val550Met)	HLCS	V550M, V697M	not provided|Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001911	21	38137345	21	36765044	1911	16950	rs119103231	NC_000021.9:36765043:C:T
NM_000411.8(HLCS):c.1741G>A (p.Gly581Ser)	HLCS	G581S, G728S	Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001910	21	38132082	21	36759781	1910	16949	rs119103230	NC_000021.9:36759780:C:T
NM_000411.8(HLCS):c.1522C>T (p.Arg508Trp)	HLCS	R508W, R655W	Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001909	21	38137471	21	36765170	1909	16948	rs119103229	NC_000021.9:36765169:G:A
HLCS, 1-BP DEL, 780G	HLCS		Holocarboxylase synthetase deficiency	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000001906					1906	16945		
NM_206898.1(MRAP):c.17_23del (p.Asn6fs)	MRAP	N6fs	Glucocorticoid deficiency 2	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000001843	21	33671299 - 33671305	21	32298988 - 32298994	1843	16882	rs1569025178	NC_000021.9:32298987:ACGCCTC:
NM_206898.1(MRAP):c.3G>A (p.Met1Ile)	MRAP	M1I	Glucocorticoid deficiency 2|ACTH resistance	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000001841	21	33671285	21	32298974	1841	16880	rs80358231	NC_000021.9:32298973:G:A
MRAP, IVS3, T INS, +3	MRAP		Glucocorticoid deficiency 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001840					1840	16879		
MRAP, IVS3, G DEL, +1	MRAP		Glucocorticoid deficiency 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001839					1839	16878		
NM_206898.1(MRAP):c.106+1G>A	MRAP		Glucocorticoid deficiency 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001838	21	33671389	21	32299078	1838	16877		NC_000021.9:32299077:G:A
NM_206898.1(MRAP):c.106+1G>C	MRAP		Glucocorticoid deficiency 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001837	21	33671389	21	32299078	1837	16876		NC_000021.9:32299077:G:C
NM_206898.1(MRAP):c.106+1G>T	MRAP		Glucocorticoid deficiency 2	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000001836	21	33671389	21	32299078	1836	16875		NC_000021.9:32299077:G:T
NM_000528.4(MAN2B1):c.2248C>T (p.Arg750Trp)	MAN2B1	R750W, R749W	Deficiency of alpha-mannosidase|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001687	19	12760746	19	12649932	1687	16726	rs80338680	NC_000019.10:12649931:G:A
NM_000528.4(MAN2B1):c.1915C>T (p.Gln639Ter)	MAN2B1	Q639*, Q638*	Deficiency of alpha-mannosidase	Pathogenic(Last reviewed: Oct 1, 1998)	no assertion criteria provided	VCV000001686	19	12763190	19	12652376	1686	16725	rs121434332	NC_000019.10:12652375:G:A
NM_000528.4(MAN2B1):c.2278C>T (p.Arg760Ter)	MAN2B1	R760*, R759*	Deficiency of alpha-mannosidase	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000001685	19	12760232	19	12649418	1685	16724	rs121434331	NC_000019.10:12649417:G:A
NM_144687.3(NLRP12):c.2072+2dup	NLRP12		Familial cold autoinflammatory syndrome 2|not provided	Pathogenic(Last reviewed: Feb 5, 2008)	no assertion criteria provided	VCV000001597	19	54312838 - 54312839	19	53809584 - 53809585	1597	16636	rs104895565	NC_000019.10:53809584:A:AA
NM_001127255.1(NLRP7):c.1951C>T (p.Pro651Ser)	NLRP7	P651S	Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001593	19	55449590	19	54938222	1593	16632	rs104895549	NC_000019.10:54938221:G:A
NM_001127255.1(NLRP7):c.1193T>G (p.Leu398Arg)	NLRP7	L398R	Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001592	19	55450994	19	54939626	1592	16631	rs104895548	NC_000019.10:54939625:A:C
NLRP7, 1-BP INS, 337G	NLRP7		Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001590					1590	16629		
NM_001127255.1(NLRP7):c.1294C>T (p.Arg432Ter)	NLRP7	R432*	Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001589	19	55450893	19	54939525	1589	16628	rs104895530	NC_000019.10:54939524:G:A
NM_001127255.1(NLRP7):c.352+1G>A	NLRP7		Hydatidiform mole, recurrent, 1	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000001584	19	55452298	19	54940930	1584	16623	rs104895504	NC_000019.10:54940929:C:T
nsv513790	ACOX1			Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000001504					1504	16543		
NM_004035.7(ACOX1):c.372_389del (p.Phe124_Asn129del)	ACOX1			Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001503	17	73956337 - 73956354	17	75960256 - 75960273	1503	16542	rs387906248	NC_000017.11:75960255:AAGTTCCAGGCGGGCATGAAG:AAG
NM_004035.7(ACOX1):c.442C>T (p.Arg148Ter)	ACOX1	R148*, R110*	|not provided	Pathogenic(Last reviewed: Nov 30, 2017)	criteria provided, single submitter	VCV000001502	17	73953636	17	75957555	1502	16541	rs118204093	NC_000017.11:75957554:G:A
NM_004035.7(ACOX1):c.926A>G (p.Gln309Arg)	ACOX1	Q309R, Q271R		Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001501	17	73949550	17	75953469	1501	16540	rs118204092	NC_000017.11:75953468:T:C
NM_004035.7(ACOX1):c.532G>T (p.Gly178Cys)	ACOX1	G178C, G140C		Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000001500	17	73953546	17	75957465	1500	16539	rs118204091	NC_000017.11:75957464:C:A
NM_004035.7(ACOX1):c.832A>G (p.Met278Val)	ACOX1	M278V, M240V		Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000001499	17	73949644	17	75953563	1499	16538	rs118204090	NC_000017.11:75953562:T:C
nsv513791	ACOX1			Pathogenic(Last reviewed: Aug 1, 1994)	no assertion criteria provided	VCV000001498					1498	16537		
TRIOBP, 1-BP INS, 3225C	TRIOBP		Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001497					1497	16536		
NM_001039141.3(TRIOBP):c.3202_3203del (p.Asp1069fs)	TRIOBP	D1069fs	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001496	22	38121765 - 38121766	22	37725758 - 37725759	1496	16535		NC_000022.11:37725757:CG:
NM_001039141.3(TRIOBP):c.3349C>T (p.Arg1117Ter)	TRIOBP	R1117*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001495	22	38121912	22	37725905	1495	16534	rs118204031	NC_000022.11:37725904:C:T
NM_001039141.3(TRIOBP):c.3202C>T (p.Arg1068Ter)	TRIOBP	R1068*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001494	22	38121765	22	37725758	1494	16533	rs118204030	NC_000022.11:37725757:C:T
NM_001039141.3(TRIOBP):c.2362C>T (p.Arg788Ter)	TRIOBP	R788*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001493	22	38120925	22	37724918	1493	16532	rs118204029	NC_000022.11:37724917:C:T
NM_001039141.3(TRIOBP):c.889C>T (p.Gln297Ter)	TRIOBP	Q297*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001492	22	38119452	22	37723445	1492	16531	rs118204028	NC_000022.11:37723444:C:T
NM_001039141.3(TRIOBP):c.1741C>T (p.Gln581Ter)	TRIOBP	Q581*	Deafness, autosomal recessive 28	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000001491	22	38120304	22	37724297	1491	16530	rs118204027	NC_000022.11:37724296:C:T
NM_001039141.3(TRIOBP):c.1039C>T (p.Arg347Ter)	TRIOBP	R347*	Deafness, autosomal recessive 28|not provided	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000001490	22	38119602	22	37723595	1490	16529	rs118204026	NC_000022.11:37723594:C:T
NM_212550.4(BLOC1S3):c.448del (p.Gln150fs)	BLOC1S3	Q150fs	Hermansky-Pudlak syndrome 8	Pathogenic(Last reviewed: Oct 11, 2012)	no assertion criteria provided	VCV000001489	19	45683000	19	45179742	1489	16528	rs281865116	NC_000019.10:45179741:CCC:CC
NM_153609.3(TMPRSS6):c.353C>A (p.Ala118Asp)	TMPRSS6	A118D, A109D	Microcytic anemia	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000001410	22	37494466	22	37098426	1410	16449	rs267607121	NC_000022.11:37098425:G:T
NM_153609.3(TMPRSS6):c.2055_2058dup (p.Val687fs)	TMPRSS6		Microcytic anemia	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000001409	22	37465194 - 37465195	22	37069154 - 37069155	1409	16448	rs786205060	NC_000022.11:37069154:GGGG:GGGGGGGG
NM_153609.3(TMPRSS6):c.1795C>T (p.Arg599Ter)	TMPRSS6	R599*, R590*	Microcytic anemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000001408	22	37466597	22	37070557	1408	16447	rs137853123	NC_000022.11:37070556:G:A
NM_153609.3(TMPRSS6):c.1179T>G (p.Tyr393Ter)	TMPRSS6	Y393*, Y384*	Microcytic anemia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000001407	22	37480379	22	37084339	1407	16446	rs137853122	NC_000022.11:37084338:A:C
NM_153609.3(TMPRSS6):c.1382del (p.Glu461fs)	TMPRSS6	E461fs, E452fs	Microcytic anemia	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000001406	22	37470736	22	37074696	1406	16445		NC_000022.11:37074695:T:
NM_153609.3(TMPRSS6):c.1065C>A (p.Tyr355Ter)	TMPRSS6	Y355*, Y346*	Microcytic anemia	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000001405	22	37480815	22	37084775	1405	16444	rs137853121	NC_000022.11:37084774:G:T
NM_153609.3(TMPRSS6):c.1561G>A (p.Asp521Asn)	TMPRSS6	D521N, D512N	Microcytic anemia	Pathogenic(Last reviewed: May 28, 2009)	no assertion criteria provided	VCV000001404	22	37469593	22	37073553	1404	16443	rs137853120	NC_000022.11:37073552:C:T
NM_153609.3(TMPRSS6):c.1324G>A (p.Gly442Arg)	TMPRSS6	G442R, G433R	Microcytic anemia	Pathogenic(Last reviewed: May 28, 2009)	no assertion criteria provided	VCV000001403	22	37471220	22	37075180	1403	16442	rs137853119	NC_000022.11:37075179:C:T
NM_153609.3(TMPRSS6):c.2140+1G>C	TMPRSS6		Microcytic anemia	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000001402	22	37465112	22	37069072	1402	16441	rs786205059	NC_000022.11:37069071:C:G
NM_153609.3(TMPRSS6):c.1582+1G>A	TMPRSS6		Microcytic anemia	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000001401	22	37469571	22	37073531	1401	16440	rs786205058	NC_000022.11:37073530:C:T
NM_153609.3(TMPRSS6):c.1813del (p.Ala605fs)	TMPRSS6	A605fs, A596fs	Microcytic anemia	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000001400	22	37466579	22	37070539	1400	16439	rs767094129	NC_000022.11:37070538:CCCCCCC:CCCCCC
NM_153609.3(TMPRSS6):c.1904_1905dup (p.Lys636fs)	TMPRSS6		Microcytic anemia	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000001399	22	37465347 - 37465348	22	37069307 - 37069308	1399	16438	rs869320724	NC_000022.11:37069307:GC:GCGC
NM_001165927.1(MKS1):c.1082_1084del (p.Phe361del)	MKS1	F361del, F371del, F168del	Bardet-Biedl syndrome 13	Pathogenic(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	VCV000001394	17	56285517 - 56285519	17	58208156 - 58208158	1394	16433	rs587777804	NC_000017.11:58208155:AGAAG:AG
NM_001165927.1(MKS1):c.994+1G>A	MKS1		Meckel-Gruber syndrome|Joubert syndrome|Meckel syndrome type 1|Bardet-Biedl syndrome 13|Joubert syndrome 28|Meckel syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001391	17	56288019	17	58210658	1391	16430	rs199874059	NC_000017.11:58210657:C:T
NM_001165927.1(MKS1):c.50+281_50+285dup	MKS1		Meckel syndrome type 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000001389	17	56296537 - 56296538	17	58219176 - 58219177	1389	16428	rs730880323	NC_000017.11:58219176:CCGGG:CCGGGCCGGG
CC2D1A, IVS13-16DEL	CC2D1A		Mental retardation, autosomal recessive 3	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000001354					1354	16393		
NM_001174089.2(SLC4A11):c.1147G>A (p.Glu383Lys)	SLC4A11	E399K, E383K, E426K	Corneal dystrophy, Fuchs endothelial, 4	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001323	20	3211600	20	3230954	1323	16362	rs267607065	NC_000020.11:3230953:C:T
NM_001174089.2(SLC4A11):c.49_50TC[1] (p.Pro18fs)	SLC4A11		Corneal dystrophy, Fuchs endothelial, 4	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001322	20	3218226 - 3218227	20	3237580 - 3237581	1322	16361		NC_000020.11:3237579:GAGAG:GAG
NM_001174089.2(SLC4A11):c.2213C>T (p.Thr738Met)	SLC4A11	T754M, T738M, T781M, T700M	Corneal dystrophy, Fuchs endothelial, 4	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001321	20	3209333	20	3228687	1321	16360	rs267607066	NC_000020.11:3228686:G:A
NM_001174089.2(SLC4A11):c.2078G>A (p.Gly693Glu)	SLC4A11	G709E, G693E, G736E, G655E	Corneal dystrophy, Fuchs endothelial, 4	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000001320	20	3209598	20	3228952	1320	16359	rs267607064	NC_000020.11:3228951:C:T
NM_001174089.2(SLC4A11):c.589T>C (p.Ser197Pro)	SLC4A11	S213P, S197P, S240P	Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001319	20	3214583	20	3233937	1319	16358	rs121909395	NC_000020.11:3233936:A:G
SLC4A11, 32-BP DEL, NT2423	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001318					1318	16357		
SLC4A11, 8-BP DUP, NT2233	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001317					1317	16356		
NM_001174089.2(SLC4A11):c.2518A>G (p.Met840Val)	SLC4A11	M856V, M840V, M802V, M883V	Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001315	20	3208945	20	3228299	1315	16354	rs121909396	NC_000020.11:3228298:T:C
NM_001174089.2(SLC4A11):c.1415G>A (p.Arg472Lys)	SLC4A11	R488K, R472K, R434K, R515K	Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001314	20	3211161	20	3230515	1314	16353	rs121909393	NC_000020.11:3230514:C:T
NM_001174089.2(SLC4A11):c.1330_1333delinsA (p.Tyr444_Ala445delinsThr)	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001313	20	3211243 - 3211246	20	3230597 - 3230600	1313	16352	rs869320722	NC_000020.11:3230596:CGTA:T
NM_001174089.2(SLC4A11):c.417_424GCTTCGCC[1] (p.Arg142fs)	SLC4A11		Corneal dystrophy-perceptive deafness syndrome	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000001312	20	3214820 - 3214827	20	3234174 - 3234181	1312	16351	rs869320721	NC_000020.11:3234173:GGCGAAGCGGCGAAGC:GGCGAAGC
NM_001174089.2(SLC4A11):c.2558G>A (p.Arg853His)	SLC4A11	R869H, R853H, R815H, R896H	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001311	20	3208905	20	3228259	1311	16350	rs121909392	NC_000020.11:3228258:C:T
NM_001174089.2(SLC4A11):c.2019-16_2019-6delinsGGCCGGCCGG	SLC4A11		Corneal endothelial dystrophy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001310	20	3209663 - 3209673	20	3229017 - 3229027	1310	16349	rs869320617	NC_000020.11:3229016:GCAGACGGGCA:CCGGCCGGCC
NM_001174089.2(SLC4A11):c.2557C>T (p.Arg853Cys)	SLC4A11	R869C, R853C, R815C, R896C	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001309	20	3208906	20	3228260	1309	16348	rs121909391	NC_000020.11:3228259:G:A
NM_001174089.2(SLC4A11):c.305_308del (p.Lys102fs)	SLC4A11	K102fs, K118fs, K145fs	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001308	20	3214944 - 3214947	20	3234298 - 3234301	1308	16347	rs869320720	NC_000020.11:3234297:TTCTTT:TT
NM_001174089.2(SLC4A11):c.1765C>T (p.Arg589Ter)	SLC4A11	R605*, R589*, R551*, R632*	Corneal endothelial dystrophy|not provided	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000001307	20	3210076	20	3229430	1307	16346	rs121909390	NC_000020.11:3229429:G:A
NM_001174089.2(SLC4A11):c.1343G>A (p.Gly448Asp)	SLC4A11	G464D, G448D, G410D, G491D	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001306	20	3211233	20	3230587	1306	16345	rs121909389	NC_000020.11:3230586:C:T
NM_001174089.2(SLC4A11):c.1418C>T (p.Ser473Leu)	SLC4A11	S489L, S473L, S435L, S516L	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001305	20	3210904	20	3230258	1305	16344	rs121909388	NC_000020.11:3230257:G:A
NM_001174089.2(SLC4A11):c.2216G>A (p.Arg739Gln)	SLC4A11	R755Q, R739Q, R782Q, R701Q	Corneal endothelial dystrophy	Pathogenic(Last reviewed: Mar 1, 2008)	no assertion criteria provided	VCV000001304	20	3209330	20	3228684	1304	16343	rs121909387	NC_000020.11:3228683:C:T
NM_018993.3(RIN2):c.1731del (p.Ile578fs)	RIN2	I578fs, I627fs	Macrocephaly, alopecia, cutis laxa, and scoliosis	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000001296	20	19956394	20	19975750	1296	16335	rs759390822	NC_000020.11:19975749:CCCCCCC:CCCCCC
GNASAS, 4.7-KB DEL	GNAS-AS1		Pseudohypoparathyroidism type 1B	Pathogenic(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000001212					1212	16251		
NM_001029871.4(RSPO4):c.98dup (p.Asn34fs)	RSPO4		Anonychia	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000001194	20	948762 - 948763	20	968119 - 968120	1194	16233	rs768138495	NC_000020.11:968119:CCCCCC:CCCCCCC
NM_001029871.4(RSPO4):c.218G>A (p.Cys73Tyr)	RSPO4	C73Y	Anonychia	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000001193	20	948643	20	968000	1193	16232	rs74315423	NC_000020.11:967999:C:T
NM_001029871.4(RSPO4):c.353G>A (p.Cys118Tyr)	RSPO4	C118Y	Anonychia	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001192	20	947873	20	967230	1192	16231	rs74315422	NC_000020.11:967229:C:T
NM_001029871.4(RSPO4):c.319T>C (p.Cys107Arg)	RSPO4	C107R	Anonychia	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001191	20	947907	20	967264	1191	16230	rs74315421	NC_000020.11:967263:A:G
NM_001029871.4(RSPO4):c.194A>G (p.Gln65Arg)	RSPO4	Q65R	Anonychia	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001190	20	948667	20	968024	1190	16229	rs74315420	NC_000020.11:968023:T:C
NM_176812.5(CHMP4B):c.481G>A (p.Glu161Lys)	CHMP4B	E161K		Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001086	20	32438870	20	33851064	1086	16125	rs118203966	NC_000020.11:33851063:G:A
NM_176812.5(CHMP4B):c.386A>T (p.Asp129Val)	CHMP4B	D129V		Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000001085	20	32438775	20	33850969	1085	16124	rs118203965	NC_000020.11:33850968:A:T
NM_015559.3(SETBP1):c.2608G>A (p.Gly870Ser)	SETBP1	G870S	Schinzel-Giedion syndrome|Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	VCV000001035	18	42531913	18	44951948	1035	16074	rs267607040	NC_000018.10:44951947:G:A
NM_015559.3(SETBP1):c.2609G>A (p.Gly870Asp)	SETBP1	G870D	Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000001034	18	42531914	18	44951949	1034	16073	rs267607039	NC_000018.10:44951948:G:A
NM_015559.3(SETBP1):c.2603A>C (p.Asp868Ala)	SETBP1	D868A	Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000001033	18	42531908	18	44951943	1033	16072	rs267607041	NC_000018.10:44951942:A:C
NM_015559.3(SETBP1):c.2602G>A (p.Asp868Asn)	SETBP1	D868N	Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29|Schinzel-Giedion syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000001032	18	42531907	18	44951942	1032	16071	rs267607042	NC_000018.10:44951941:G:A
CYP4F22, EX3-12DEL	CYP4F22		Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000000912					912	15951		
NM_173483.4(CYP4F22):c.728G>A (p.Arg243His)	CYP4F22	R243H	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000000911	19	15651317	19	15540506	911	15950	rs118203937	NC_000019.10:15540505:G:A
NM_173483.4(CYP4F22):c.1306C>G (p.His436Asp)	CYP4F22	H436D	Autosomal recessive congenital ichthyosis 5	Pathogenic(Last reviewed: Apr 23, 2018)	no assertion criteria provided	VCV000000910	19	15659984	19	15549173	910	15949	rs118203936	NC_000019.10:15549172:C:G
NM_173483.4(CYP4F22):c.1303C>T (p.His435Tyr)	CYP4F22	H435Y	Autosomal recessive congenital ichthyosis 5|not provided	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000000909	19	15659981	19	15549170	909	15948	rs118203935	NC_000019.10:15549169:C:T
NM_024120.5(NDUFAF5):c.477A>C (p.Leu159Phe)	NDUFAF5	L159F	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000000571	20	13775585	20	13794939	571	15610	rs267606689	NC_000020.11:13794938:A:C
NM_024120.5(NDUFAF5):c.686T>C (p.Leu229Pro)	NDUFAF5	L229P, L42P, L201P, L72P	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000000570	20	13782298	20	13801652	570	15609	rs118203929	NC_000020.11:13801651:T:C
NM_000140.4(FECH):c.315-48T>C	FECH		Protoporphyria, erythropoietic, 1|Jaundice|Erythema	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000562	18	55238820	18	57571588	562	15601	rs2272783	NC_000018.10:57571587:A:G
NM_000140.4(FECH):c.580_584del (p.Tyr194fs)	FECH	Y194fs, Y200fs	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000560	18	55233693 - 55233697	18	57566461 - 57566465	560	15599	rs786205248	NC_000018.10:57566460:CTGTACTGT:CTGT
NM_000140.4(FECH):c.194+11A>G	FECH	N69D	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000559	18	55247294	18	57580062	559	15598	rs786205247	NC_000018.10:57580061:T:C
NM_000140.4(FECH):c.1136del (p.Lys379fs)	FECH	K379fs, K385fs	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000558	18	55218548	18	57551316	558	15597	rs764466739	NC_000018.10:57551315:TT:T
NM_000140.3(FECH):c.1078_1137del	FECH	K379*, K385*	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000557	18	55218549	18	57551317	557	15596	rs879255507	NC_000018.10:57551316:T:A
NM_000140.4(FECH):c.314+6A>C	FECH		Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000556	18	55240472	18	57573240	556	15595	rs786205246	NC_000018.10:57573239:T:G
NM_000140.4(FECH):c.314+2T>G	FECH		Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000000555	18	55240476	18	57573244	555	15594	rs149067146	NC_000018.10:57573243:A:C
NM_000140.4(FECH):c.1085T>G (p.Val362Gly)	FECH	V363G, V368G, V362G	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jun 4, 1994)	no assertion criteria provided	VCV000000554	18	55218599	18	57551367	554	15593	rs118204040	NC_000018.10:57551366:A:C
NM_000140.4(FECH):c.1137+3A>G	FECH		Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jun 4, 1994)	no assertion criteria provided	VCV000000553	18	55218544	18	57551312	553	15592	rs202147607	NC_000018.10:57551311:T:C
NM_000140.4(FECH):c.1077+1G>A	FECH		Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: May 1, 1993)	no assertion criteria provided	VCV000000552	18	55221491	18	57554259	552	15591	rs786205245	NC_000018.10:57554258:C:T
NM_000140.4(FECH):c.1250T>C (p.Phe417Ser)	FECH	F417S, F423S	Protoporphyria, erythropoietic, 1	Pathogenic(Last reviewed: Jun 1, 1992)	no assertion criteria provided	VCV000000551	18	55217966	18	57550734	551	15590	rs118204039	NC_000018.10:57550733:A:G
NM_133459.4(CCBE1):c.520T>C (p.Cys174Arg)	CCBE1	C174R	Hennekam lymphangiectasia-lymphedema syndrome 1	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000000450	18	57134004	18	59466772	450	15489	rs121908254	NC_000018.10:59466771:A:G
NM_133459.4(CCBE1):c.683_684insT (p.Leu229fs)	CCBE1		Hennekam lymphangiectasia-lymphedema syndrome 1	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000000448	18	57115306 - 57115307	18	59448074 - 59448075	448	15487	rs563023244	NC_000018.10:59448074::A
NM_133459.4(CCBE1):c.979G>C (p.Gly327Arg)	CCBE1	G327R	Hennekam lymphangiectasia-lymphedema syndrome 1	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000000447	18	57105351	18	59438119	447	15486	rs121908252	NC_000018.10:59438118:C:G
NM_133459.4(CCBE1):c.305G>C (p.Cys102Ser)	CCBE1	C102S	Hennekam lymphangiectasia-lymphedema syndrome 1	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000000446	18	57136800	18	59469568	446	15485	rs121908251	NC_000018.10:59469567:C:G
NM_133459.4(CCBE1):c.223T>A (p.Cys75Ser)	CCBE1	C75S	Hennekam lymphangiectasia-lymphedema syndrome 1|not provided	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000000445	18	57147460	18	59480228	445	15484	rs121908250	NC_000018.10:59480227:A:T
NM_001042631.2(SDHAF1):c.164G>C (p.Arg55Pro)	SDHAF1	R55P	Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000430	19	36486340	19	35995438	430	15469	rs137853193	NC_000019.10:35995437:G:C
NM_001042631.2(SDHAF1):c.169G>C (p.Gly57Arg)	SDHAF1	G57R	Mitochondrial complex II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000429	19	36486345	19	35995443	429	15468	rs137853192	NC_000019.10:35995442:G:C
NM_144612.6(LOXHD1):c.2008C>T (p.Arg670Ter)	LOXHD1	R670*	not provided|Deafness, autosomal recessive 77	Pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000000395	18	44152088	18	46572125	395	15434	rs121918370	NC_000018.10:46572124:G:A
NM_000308.3(CTSA):c.831+9C>G	CTSA		Galactosialidosis, late infantile	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000000389	20	44522720	20	45894081	389	15428	rs1337995343	NC_000020.11:45894080:C:G
NM_000308.3(CTSA):c.1411A>G (p.Lys471Glu)	CTSA	K453E, K454E, K471E	Galactosialidosis, late infantile	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000000388	20	44526746	20	45898107	388	15427	rs137854549	NC_000020.11:45898106:A:G
NM_000308.3(CTSA):c.571_572del (p.Phe191fs)	CTSA	F173fs, F191fs, F174fs	Galactosialidosis, late infantile	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000000387	20	44521434 - 44521435	20	45892795 - 45892796	387	15426	rs769812697	NC_000020.11:45892794:TTTT:TT
NM_000308.3(CTSA):c.1271T>C (p.Met424Thr)	CTSA	M378T, M406T, M407T, M424T	Galactosialidosis, late infantile	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000386	20	44526408	20	45897769	386	15425	rs137854548	NC_000020.11:45897768:T:C
NM_000308.3(CTSA):c.1369G>A (p.Gly457Ser)	CTSA	G411S, G439S, G440S, G457S	Galactosialidosis, early infantile	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000385	20	44526704	20	45898065	385	15424	rs137854547	NC_000020.11:45898064:G:A
NM_001127695.1(CTSA):c.707T>C (p.Leu236Pro)	CTSA	L208P, L236P, L237P, L254P	Galactosialidosis, early infantile	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000384	20	44522641	20	45894002	384	15423	rs137854546	NC_000020.11:45894001:T:C
NM_000308.3(CTSA):c.448G>A (p.Val150Met)	CTSA	V104M, V132M, V133M, V150M	Combined deficiency of sialidase AND beta galactosidase|Galactosialidosis, early infantile	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000383	20	44521073	20	45892434	383	15422	rs137854545	NC_000020.11:45892433:G:A
NM_000308.3(CTSA):c.799T>A (p.Tyr267Asn)	CTSA	Y249N, Y267N, Y250N	Combined deficiency of sialidase AND beta galactosidase|Galactosialidosis, late infantile	Pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	VCV000000381	20	44522679	20	45894040	381	15420	rs137854544	NC_000020.11:45894039:T:A
NM_000308.3(CTSA):c.1238A>G (p.Tyr413Cys)	CTSA	Y395C, Y396C, Y413C	Combined deficiency of sialidase AND beta galactosidase	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000000380	20	44526375	20	45897736	380	15419	rs137854543	NC_000020.11:45897735:A:G
NM_000308.3(CTSA):c.323C>T (p.Ser108Leu)	CTSA	S90L, S108L	Combined deficiency of sialidase AND beta galactosidase	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000000379	20	44520629	20	45891990	379	15418	rs137854542	NC_000020.11:45891989:C:T
NM_000308.3(CTSA):c.247T>C (p.Trp83Arg)	CTSA	W65R, W83R	Combined deficiency of sialidase AND beta galactosidase	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000000378	20	44520400	20	45891761	378	15417	rs28934603	NC_000020.11:45891760:T:C
NM_000308.3(CTSA):c.200A>G (p.Gln67Arg)	CTSA	Q49R, Q67R	Combined deficiency of sialidase AND beta galactosidase	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000000377	20	44520353	20	45891714	377	15416	rs137854541	NC_000020.11:45891713:A:G
NM_000308.3(CTSA):c.746+3A>G	CTSA		Galactosialidosis, adult|Combined deficiency of sialidase AND beta galactosidase	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000000376	20	44521953	20	45893314	376	15415	rs786200859	NC_000020.11:45893313:A:G
NM_000308.3(CTSA):c.1372T>G (p.Phe458Val)	CTSA	F412V, F458V, F440V, F441V	Galactosialidosis, late infantile	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000375	20	44526707	20	45898068	375	15414	rs137854540	NC_000020.11:45898067:T:G
NM_001159773.2(CANT1):c.896C>T (p.Pro299Leu)	CANT1	P299L	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000283	17	76989942	17	78993860	283	15322	rs267606700	NC_000017.11:78993859:G:A
NM_001159773.2(CANT1):c.374G>A (p.Trp125Ter)	CANT1	W125*	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000282	17	76993331	17	78997249	282	15321	rs267606702	NC_000017.11:78997248:C:T
NM_001159773.2(CANT1):c.909_910insGCCGC (p.Gln304fs)	CANT1		Desbuquois dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000281	17	76989928 - 76989929	17	78993846 - 78993847	281	15320	rs587776510	NC_000017.11:78993846:GC:GCGGCGC
NM_001159773.2(CANT1):c.899G>A (p.Arg300His)	CANT1	R300H	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000280	17	76989939	17	78993857	280	15319	rs267606699	NC_000017.11:78993856:C:T
NM_001159773.2(CANT1):c.898C>T (p.Arg300Cys)	CANT1	R300C	Desbuquois dysplasia 1|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000000279	17	76989940	17	78993858	279	15318	rs267606701	NC_000017.11:78993857:G:A
NM_001159773.2(CANT1):c.734del (p.Pro245fs)	CANT1	P245fs	Desbuquois dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000278	17	76991201	17	78995119	278	15317	rs587776509	NC_000017.11:78995118:GGG:GG
5'UTR-exon 1 deletion (2703 bp)	CANT1		Desbuquois dysplasia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000000277			17	79009664 - 79009817	277	15316		
NM_000398.7(CYB5R3):c.719A>G (p.Asp240Gly)	CYB5R3	D240G, D273G, D217G	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000252	22	43019809	22	42623803	252	15291	rs121965018	NC_000022.11:42623802:T:C
NM_000398.7(CYB5R3):c.763_765GAG[1] (p.Glu256del)	CYB5R3	E256del, E233del, E289del	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000251	22	43015917 - 43015919	22	42619911 - 42619913	251	15290	rs121965017	NC_000022.11:42619910:CTCCTC:CTC
NM_000398.7(CYB5R3):c.875G>A (p.Gly292Asp)	CYB5R3	G292D, G325D, G269D	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000250	22	43015810	22	42619804	250	15289	rs121965016	NC_000022.11:42619803:C:T
NM_000398.7(CYB5R3):c.611G>A (p.Cys204Tyr)	CYB5R3	C204Y, C181Y, C237Y	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000249	22	43023332	22	42627326	249	15288	rs121965015	NC_000022.11:42627325:C:T
NM_000398.7(CYB5R3):c.478C>T (p.Arg160Ter)	CYB5R3	R160*, R193*, R137*	not provided|Methemoglobinemia type 2	Pathogenic(Last reviewed: May 26, 2017)	criteria provided, single submitter	VCV000000248	22	43023680	22	42627674	248	15287	rs61732609	NC_000022.11:42627673:G:A
NM_000398.7(CYB5R3):c.229C>T (p.Gln77Ter)	CYB5R3	Q77*, Q110*, Q54*	Methemoglobinemia type 2	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000000247	22	43026992	22	42630986	247	15286	rs121965014	NC_000022.11:42630985:G:A
NM_000398.7(CYB5R3):c.218T>C (p.Leu73Pro)	CYB5R3	L73P, L106P, L50P	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000246	22	43027392	22	42631386	246	15285	rs121965013	NC_000022.11:42631385:A:G
NM_000398.7(CYB5R3):c.464-2A>C	CYB5R3		Deficiency of cytochrome-b5 reductase|Methemoglobinemia type 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000000245	22	43023696	22	42627690	245	15284	rs794728013	NC_000022.11:42627689:T:G
NM_000398.7(CYB5R3):c.895_897del (p.Phe299del)	CYB5R3	F276del, F299del, F332del	Methemoglobinemia type 2	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000243	22	43015788 - 43015790	22	42619782 - 42619784	243	15282	rs121965012	NC_000022.11:42619781:GAAG:G
NM_000398.7(CYB5R3):c.817_819del (p.Met273del)	CYB5R3	M273del, M306del, M250del	Methemoglobinemia type 2	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000242	22	43015866 - 43015868	22	42619860 - 42619862	242	15281	rs794728012	NC_000022.11:42619859:CATCA:CA
NM_000398.7(CYB5R3):c.610T>C (p.Cys204Arg)	CYB5R3	C204R, C181R, C237R	Methemoglobinemia type 2	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000241	22	43023333	22	42627327	241	15280	rs121965011	NC_000022.11:42627326:A:G
NM_000398.7(CYB5R3):c.655C>T (p.Arg219Ter)	CYB5R3	R219*, R196*, R252*	Methemoglobinemia type 2	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000240	22	43019873	22	42623867	240	15279	rs121965010	NC_000022.11:42623866:G:A
NM_000398.7(CYB5R3):c.463+8G>C	CYB5R3		Methemoglobinemia type 2	Pathogenic(Last reviewed: Apr 15, 1995)	no assertion criteria provided	VCV000000239	22	43024150	22	42628144	239	15278	rs200872504	NC_000022.11:42628143:C:G
NM_000398.7(CYB5R3):c.734-1G>T	CYB5R3		Methemoglobinemia type 2	Pathogenic(Last reviewed: Aug 1, 1995)	no assertion criteria provided	VCV000000238	22	43015952	22	42619946	238	15277	rs794728011	NC_000022.11:42619945:C:A
NM_000398.7(CYB5R3):c.316G>A (p.Val106Met)	CYB5R3	V106M, V83M, V139M	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000237	22	43026905	22	42630899	237	15276	rs121965009	NC_000022.11:42630898:C:T
NM_000398.7(CYB5R3):c.446T>C (p.Leu149Pro)	CYB5R3	L149P, L126P, L182P	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000236	22	43024175	22	42628169	236	15275	rs121965008	NC_000022.11:42628168:A:G
NM_000398.7(CYB5R3):c.173G>A (p.Arg58Gln)	CYB5R3	R58Q, R35Q, R91Q	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000235	22	43027437	22	42631431	235	15274	rs121965007	NC_000022.11:42631430:C:T
NM_000398.7(CYB5R3):c.382T>C (p.Ser128Pro)	CYB5R3	S128P, S161P, S105P	Methemoglobinemia type 2	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000234	22	43024239	22	42628233	234	15273	rs121965006	NC_000022.11:42628232:A:G
NM_148923.4(CYB5A):c.130-2A>G	CYB5A		Methemoglobinemia type 4	Pathogenic(Last reviewed: Mar 20, 1986)	no assertion criteria provided	VCV000000230	18	71930714	18	74263479	230	15269	rs794728010	NC_000018.10:74263478:T:C
NM_000285.4(PEPD):c.605C>T (p.Ser202Phe)	PEPD	S202F, S138F	Prolidase deficiency	Pathogenic(Last reviewed: Apr 6, 2015)	no assertion criteria provided	VCV000000218	19	33954912	19	33464006	218	15257	rs267606943	NC_000019.10:33464005:G:A
NM_000285.4(PEPD):c.611_623dup (p.Val209_Met210insGlyProProTer)	PEPD		Prolidase deficiency	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000000217	19	33954893 - 33954894	19	33463987 - 33463988	217	15256	rs794728008	NC_000019.10:33463987:TCACGGTGGGCCT:TCACGGTGGGCCTTCACGGTGGGCCT
NM_000285.4(PEPD):c.1234G>A (p.Glu412Lys)	PEPD	E412K, E371K, E348K	Prolidase deficiency	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000000216	19	33878906	19	33388000	216	15255	rs267606944	NC_000019.10:33387999:C:T
NM_000285.4(PEPD):c.793C>T (p.Arg265Ter)	PEPD	R265*, R201*, R224*	Prolidase deficiency	Pathogenic(Last reviewed: Apr 6, 2015)	no assertion criteria provided	VCV000000215	19	33902603	19	33411697	215	15254	rs121917725	NC_000019.10:33411696:G:A
NM_000285.4(PEPD):c.1356_1358GGA[1] (p.Glu453del)	PEPD	E452del, E453del	Prolidase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000000214	19	33878371 - 33878373	19	33387465 - 33387467	214	15253	rs757386104	NC_000019.10:33387464:TCCTCCTC:TCCTC
NM_000285.4(PEPD):c.1342G>A (p.Gly448Arg)	PEPD	G448R, G384R, G407R	Prolidase deficiency	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000213	19	33878798	19	33387892	213	15252	rs121917724	NC_000019.10:33387891:C:T
NM_000285.4(PEPD):c.833G>A (p.Gly278Asp)	PEPD	G278D, G214D, G237D	Prolidase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000000212	19	33892761	19	33401855	212	15251	rs121917723	NC_000019.10:33401854:C:T
NM_000285.4(PEPD):c.551G>A (p.Arg184Gln)	PEPD	R184Q, R120Q	Prolidase deficiency	Pathogenic(Last reviewed: Nov 1, 1996)	no assertion criteria provided	VCV000000211	19	33954966	19	33464060	211	15250	rs121917722	NC_000019.10:33464059:C:T
NM_000285.3(PEPD):c.1153_1344del (p.Gly385_Gly448del)	PEPD		Prolidase deficiency	Pathogenic(Last reviewed: Apr 1, 1991)	no assertion criteria provided	VCV000000209	19	33878749 - 33879530	19	33387843 - 33388624	209	15248		
NM_000285.4(PEPD):c.826G>A (p.Asp276Asn)	PEPD	D276N, D212N, D235N	Prolidase deficiency|not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000000208	19	33892768	19	33401862	208	15247	rs121917721	NC_000019.10:33401861:C:T
NM_000071.2(CBS):c.572C>T (p.Thr191Met)	CBS	T191M, T86M	Homocystinuria, pyridoxine-nonresponsive|Classic homocystinuria|Homocystinuria|not provided	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000132	21	44485591	21	43065481	132	15171	rs121964973	NC_000021.9:43065480:G:A
NM_000071.2(CBS):c.1058C>T (p.Thr353Met)	CBS	T353M, T248M	Homocystinuria, pyridoxine-nonresponsive|Cardiovascular phenotype|Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000131	21	44480638	21	43060528	131	15170	rs121964972	NC_000021.9:43060527:G:A
NM_000071.2(CBS):c.1224-2A>C	CBS		Classic homocystinuria|Homocystinuria, pyridoxine-responsive|Homocystinuria|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000128	21	44479080	21	43058970	128	15167	rs375846341	NC_000021.9:43058969:T:G
NM_000071.2(CBS):c.1330G>A (p.Asp444Asn)	CBS	D444N, D339N	Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|not provided|Homocystinuria	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000126	21	44478972	21	43058862	126	15165	rs28934891	NC_000021.9:43058861:C:T
NM_000071.2(CBS):c.797G>A (p.Arg266Lys)	CBS	R266K, R161K	Classic homocystinuria|Homocystinuria, pyridoxine-responsive|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000125	21	44484041	21	43063931	125	15164	rs121964969	NC_000021.9:43063930:C:T
NM_000071.2(CBS):c.1150A>G (p.Lys384Glu)	CBS	K384E, K279E	Homocystinuria, pyridoxine-responsive	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000000123	21	44479409	21	43059299	123	15162	rs121964967	NC_000021.9:43059298:T:C
NM_000071.2(CBS):c.430G>A (p.Glu144Lys)	CBS	E144K, E39K	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000000122	21	44486374	21	43066264	122	15161	rs121964966	NC_000021.9:43066263:C:T
NM_000071.2(CBS):c.415G>A (p.Gly139Arg)	CBS	G139R, G34R	Homocystinuria, pyridoxine-responsive	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000000121	21	44486389	21	43066279	121	15160	rs121964965	NC_000021.9:43066278:C:T
NM_000071.3(CBS):c.833T>C (p.Ile278Thr)	CBS	I278T, I173T	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Cardiovascular phenotype|not specified|Homocystinuria|not provided	Pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000120	21	44483184	21	43063074	120	15159	rs5742905	NC_000021.9:43063073:A:G
NM_000071.2(CBS):c.341C>T (p.Ala114Val)	CBS	A114V, A9V	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000119	21	44486463	21	43066353	119	15158	rs121964964	NC_000021.9:43066352:G:A
NM_000071.3(CBS):c.919G>A (p.Gly307Ser)	CBS	G307S, G202S	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-nonresponsive|Cardiovascular phenotype|Classic homocystinuria|Homocystinuria|not provided	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000117	21	44483098	21	43062988	117	15156	rs121964962	NC_000021.9:43062987:C:T
NM_000355.4(TCN2):c.581-176A>T	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000100	22	31011112	22	30615125	100	15139	rs372866837	NC_000022.11:30615124:A:T
TCN2, 2,152-BP DEL AND 4-BP INS	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000099					99	15138		
NM_000355.4(TCN2):c.427+2T>G	TCN2		Transcobalamin II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000098	22	31009031	22	30613044	98	15137	rs606231119	NC_000022.11:30613043:T:G
NM_000355.4(TCN2):c.927_930del (p.Cys309fs)	TCN2	C282fs, C309fs	Transcobalamin II deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000096	22	31011758 - 31011761	22	30615771 - 30615774	96	15135	rs1157135425	NC_000022.11:30615770:CTGTCTG:CTG
XPNPEP3, 4-BP DEL, 931AACA	XPNPEP3		Nephronophthisis-like nephropathy 1	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000000052					52	15091		
NM_022098.4(XPNPEP3):c.1357G>T (p.Gly453Cys)	XPNPEP3	G453C	Nephronophthisis-like nephropathy 1	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000000051	22	41320486	22	40924482	51	15090	rs267607179	NC_000022.11:40924481:G:T
NM_001083961.2(WDR62):c.3839_3855del (p.Gly1280fs)	WDR62	G1275fs, G1280fs	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 9, 2010)	no assertion criteria provided	VCV000000044	19	36594568 - 36594584	19	36103666 - 36103682	44	15083	rs397704725	NC_000019.10:36103665:GGCCAAGAGCCTGCCCTG:G
NM_001083961.2(WDR62):c.1408C>T (p.Gln470Ter)	WDR62	Q470*	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 9, 2010)	no assertion criteria provided	VCV000000043	19	36574001	19	36083099	43	15082	rs267607177	NC_000019.10:36083098:C:T
NM_001083961.2(WDR62):c.671G>C (p.Trp224Ser)	WDR62	W224S	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 9, 2010)	no assertion criteria provided	VCV000000042	19	36558317	19	36067415	42	15081	rs267607176	NC_000019.10:36067414:G:C
NM_001083961.2(WDR62):c.4205_4208del (p.Val1402fs)	WDR62	V1397fs, V1402fs	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 9, 2010)	no assertion criteria provided	VCV000000040	19	36595471 - 36595474	19	36104569 - 36104572	40	15079	rs397704721	NC_000019.10:36104568:TGCC:
NM_001042472.3(ABHD12):c.1054C>T (p.Arg352Ter)	ABHD12	R352*	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000000027	20	25282958	20	25302322	27	15066	rs267606624	NC_000020.11:25302321:G:A
NM_001042472.3(ABHD12):c.846_852dup (p.His285Ter)	ABHD12		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000000026	20	25288616 - 25288617	20	25307980 - 25307981	26	15065	rs397704714	NC_000020.11:25307980:GCTCTTAGCT:GCTCTTAGCTCTTAGCT
NM_015600.4(ABHD12):c.-6898_191+7002delinsCC	ABHD12		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	Pathogenic(Last reviewed: Sep 10, 2010)	no assertion criteria provided	VCV000000025	20	25364147 - 25378237	20	25383511 - 25397601	25	15064		
NM_001042472.3(ABHD12):c.337_338delinsTTT (p.Asp113fs)	ABHD12		Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract|not provided	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000000024	20	25304045 - 25304046	20	25323409 - 25323410	24	15063	rs1555813914	NC_000020.11:25323408:TC:AAA
